PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Mattox, KL; Brundage, SI; Hirshberg, A				Mattox, KL; Brundage, SI; Hirshberg, A			Initial resuscitation	NEW HORIZONS-THE SCIENCE AND PRACTICE OF ACUTE MEDICINE			English	Article						resuscitation; shock; trauma; crystalloid; hypotension; military antishock trousers (MAST); Advanced Trauma Life Support (ATLS); acute respiratory distress syndrome (ARDS); systemic inflammatory response syndrome (SIRS); Emergency Medical Services (EMS)	UNCONTROLLED HEMORRHAGIC-SHOCK; DELAYED FLUID RESUSCITATION; HYPERTONIC SALINE; BRAIN INJURY; HEAD-INJURY; INTRACRANIAL-PRESSURE; P-SELECTIN; MODEL; SURVIVAL; VOLUME	Resuscitation refers to a series of therapeutic maneuvers intended to restore a hemorrhaging patient's cardiovascular system as well as to obtain surgical control of the source of bleeding and subsequently ensure adequate tissue perfusion postoperatively. The term "initial resuscitation" refers to interventions performed either in the field, in the ambulance en route to the hospital, or as part of the primary survey in the emergency center. Initial resuscitation of trauma patients should achieve the following objectives: a) identify potentially life-threatening injuries; b) optimize physiologic compensatory mechanisms; c) produce minimal immediate or long-term new injuries or complications; and d) assure maintenance of critical organ perfusion. The traditional approach to traumatic shock with aggressive volume replacement has remained relatively unchanged for over 40 yrs, After achieving venous access, intravenous fluids were administered to accomplish immediate restoration of intravascular volume, During the late 1980s, clinical and laboratory studies questioned the logic and clinical appropriateness of traditional resuscitative approaches to the critically injured patient. Challenging aggressive blood pressure elevation during ongoing hemorrhage has resulted in a major paradigm shift in the approach to initial resuscitation in the past decade. This article addresses current controversies of initial resuscitation including the type, volume, and timing of intravenous fluids; the role of intentional hypotensive resuscitation; organization issues within trauma systems; and the resultant critical care implications of these changing practices.	Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; Ben Taub Gen Hosp, Dept Surg, Houston, TX 77030 USA; Ben Taub Gen Hosp, Emergency Surg Serv, Houston, TX 77030 USA; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sheba Med Ctr, Dept Surg, IL-69978 Tel Aviv, Israel		Mattox, KL (corresponding author), Baylor Coll Med, Dept Surg, 1 Baylor Plaza, Houston, TX 77030 USA.						ALI J, 1995, J TRAUMA, V38, P612, DOI 10.1097/00005373-199504000-00025; ALI J, 1991, J TRAUMA, V31, P846, DOI 10.1097/00005373-199106000-00017; Anaya-Prado R, 1998, J AM COLL SURGEONS, V187, P22, DOI 10.1016/S1072-7515(98)00125-2; Anderson JT, 1997, J TRAUMA, V42, P592, DOI 10.1097/00005373-199704000-00003; BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; BICKELL WH, 1991, SURGERY, V110, P529; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BICKELL WH, 1987, ANN EMERG MED, V16, P653, DOI 10.1016/S0196-0644(87)80064-1; BISHOP MH, 1993, CRIT CARE MED, V21, P56, DOI 10.1097/00003246-199301000-00013; Bourguignon PR, 1998, ARCH SURG-CHICAGO, V133, P390, DOI 10.1001/archsurg.133.4.390; CAPONE A, 1995, RESUSCITATION, V29, P143, DOI 10.1016/0300-9572(95)00829-I; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; Carrillo P, 1998, J TRAUMA, V45, P239, DOI 10.1097/00005373-199808000-00007; CRAIG RL, 1994, AM SURGEON, V60, P59; CRAWFORD ES, 1991, J VASC SURG, V13, P348; Demetriades D, 1996, ARCH SURG-CHICAGO, V131, P133; Dries DJ, 1996, SHOCK, V6, P311, DOI 10.1097/00024382-199611000-00001; Healey MA, 1998, J TRAUMA, V45, P894, DOI 10.1097/00005373-199811000-00010; Kim SH, 1997, J TRAUMA, V42, P213, DOI 10.1097/00005373-199702000-00006; KRAUSZ MM, 1995, SHOCK, V3, P69, DOI 10.1097/00024382-199501000-00012; MATTOX KL, 1989, J TRAUMA, V29, P1104, DOI 10.1097/00005373-198908000-00007; MATTOX KL, 1986, J TRAUMA, V26, P779, DOI 10.1097/00005373-198609000-00002; OWENS TM, 1995, J TRAUMA, V39, P200, DOI 10.1097/00005373-199508000-00004; PROUGH DS, 1985, CRIT CARE MED, V13, P407, DOI 10.1097/00003246-198505000-00008; Rivera-Chavez F, 1998, J TRAUMA, V45, P440, DOI 10.1097/00005373-199809000-00003; Sakles JC, 1997, ANN EMERG MED, V29, P392, DOI 10.1016/S0196-0644(97)70352-4; Schierhout G, 1998, BMJ-BRIT MED J, V316, P961, DOI 10.1136/bmj.316.7136.961; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; Schuster D P, 1993, New Horiz, V1, P478; Sheffer N, 1997, J TRAUMA, V42, P647, DOI 10.1097/00005373-199704000-00011; SMITH JP, 1985, J TRAUMA, V25, P65, DOI 10.1097/00005373-198501000-00011; STANFORD GG, 1989, ARCH SURG-CHICAGO, V124, P733; STERN SA, 1993, ANN EMERG MED, V22, P155, DOI 10.1016/S0196-0644(05)80195-7; Taylor G, 1996, J PEDIATR SURG, V31, P65, DOI 10.1016/S0022-3468(96)90321-8; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; Waxman K, 1996, CRIT CARE MED, V24, P1724, DOI 10.1097/00003246-199610000-00021; WEINSTEIN PD, 1992, CRIT CARE CLIN, V8, P439, DOI 10.1016/S0749-0704(18)30259-8; WINN RK, 1994, AM J PHYSIOL-HEART C, V267, pH2391, DOI 10.1152/ajpheart.1994.267.6.H2391; Xu YX, 1998, J TRAUMA, V44, P335, DOI 10.1097/00005373-199802000-00018	40	4	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1063-7389			NEW HORIZ-SCI PRACT	New Horiz.-Sci. Pract. Acute Med.	SPR	1999	7	1					4	9					6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	184DH	WOS:000079594300002					2022-02-06	
J	Raisanen, J; Ghougassian, DF; Moskvitch, M; Lawrence, C				Raisanen, J; Ghougassian, DF; Moskvitch, M; Lawrence, C			Diffuse axonal injury in a rugby player	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						central nervous system; brain; diffuse axonal injury; sports; football; rugby	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN INJURY; HEAD-INJURY; ASSAULT; FALL; MILD	Sections of the cerebrum, cerebellum, and brain stem of a rugby player who died 15 hours after being tackled were stained using an immunoperoxidase technique to detect beta-amyloid protein. The sections of the pens showed axonal spheroids in the base, and those of the cerebellum showed axonal spheroids in deep white matter. The findings demonstrated axonal injury following a fall from the victim's height in a team sporting event.	New S Wales Inst Forens Med, Sydney, NSW, Australia		Raisanen, J (corresponding author), Stanford Univ, Dept Pathol, L-235,300 Pasteur Dr, Stanford, CA 94305 USA.						ADAMS JH, 1984, LANCET, V2, P1420; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; IMAJO T, 1992, AM J FOREN MED PATH, V13, P169; IMAJO T, 1987, AM J FOREN MED PATH, V8, P217, DOI 10.1097/00000433-198708030-00004; LEESTMA JE, 1988, FORENSIC NEUROPATHOL, P184; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163	16	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	1999	20	1					70	72		10.1097/00000433-199903000-00017			3	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	181QR	WOS:000079453800017	10208342				2022-02-06	
J	Walter, B; Bauer, R; Fritz, H; Jochum, T; Wunder, L; Zwiener, U				Walter, B; Bauer, R; Fritz, H; Jochum, T; Wunder, L; Zwiener, U			Evaluation of micro tip pressure tranducers for the measurement of intracerebral pressure transients induced by fluid percussion	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	IIIrd International Congress of Pathophysiology	JUN 28-JUL 03, 1998	LAHTI, FINLAND			traumatic brain injury; pressure, intracranial; fluid percussion; intracranial pressure transients; micro tip pressure transducer; piezoelectric pressure transducer	HEAD-INJURY; MECHANISMS	We describe the application of MIKRO TIP(R) miniature pressure transducers (MPT) for the in vivo measurement of intracerebral stresses induced by traumatic brain injury (TBI). In order to test the linearity of these transducers pressure pulses of different amplitudes (duration approximate to 10ms) were generated in a closed calibration chamber. A piezoelectric pressure transducer (PPT) served as the reference measure. A linear correlation was found within the pressure range between 0.57 and 5.09 bar (R-2 = 0.998). The frequency transmission characteristics of the MPTs are comparable to the PPT. In three juvenile swines (6 weeks of age) pressures within the brain tissue were induced by fluid percussion (FP) and were measured in the anterior, middle, and posterior cranial cavity as well as in the extracranial part of the medulla oblongata. The data obtained in our experiments agree with the basic biomechanics of FP known from studies in cats and rabbits. Due to their small size, MPTs can be applied in living animals. Stereotaxic positioning of these catheters at any site of the brain and spinal cord requires only minimal surgery. Therefore, MPTs are useful in evaluating animal models of brain injury and in generating input data for computational models of head injury as well as to validate the mathematical results of such models with experimental data.	Univ Jena, Inst Pathophysiol, D-07740 Jena, Germany; Univ Jena, Clin Anaesthesiol & Intens Care Med, D-07740 Jena, Germany		Walter, B (corresponding author), Univ Jena, Inst Pathophysiol, D-07740 Jena, Germany.	bwal@mti-n.uni-jena.de					BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; EDBERG S, 1963, LAB INVEST, V12, P1305; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; Turquier F, 1996, STAPP CAR C, VP-30, P283; VOSSOUGHI J, 1995, J NEUROTRAUM, V12, P755, DOI 10.1089/neu.1995.12.755; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743	14	4	4	0	1	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	FEB	1999	51	2					124	129		10.1016/S0940-2993(99)80085-2			6	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pathology; Toxicology	177NZ	WOS:000079218000003	10192580				2022-02-06	
J	Gutman, SA				Gutman, SA			Alleviating gender role strain in adult men with traumatic brain injury: An evaluation of a set of guidelines for occupational therapy	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						head injuries; personality development; role expectation	HEAD-INJURY; REHABILITATION	Objective. A set of guidelines to assist men with traumatic brain injury (TBI) to alleviate gender role strain was assessed to determine its effectiveness and acceptability to participants. Method. Four adult male participants with TBI received the intervention (the set of guidelines)for 4 months. The intervention consisted of rebuilding self-identified gendered social roles and activities. Focused interviews and participant observation were used to determine whether gender role strain changed after intervention Results. The participants reported that the intervention enabled them to (a) enhance their gender role satisfaction through newly rebuilt roles and activities, (6) attain certain long-held personal goals, (c)feel more like members of society, (d) perceive a greater congruency between their internal self-images and external postinjury roles, (e) learn more about personal skills and comfortable using help-seeking values as men, (f)feel more behaviors, (g) feel a sense of shared experience and affinity, (h)feel more understood and accepted and (i) contribute to others through community member roles. Discussion. The set of guidelines for alleviating gender role strain was effective in assisting these participants to enhance their gender role satisfaction through rebuilding desired male-gendered social roles and activities. Dating, courtship, extended family member, community member, friend, and mentor-protege roles, lost as a result of TBI, were rebuilt through gender-neutral activities that facilitated a sense of volitional control! competency and normalcy Nonetheless, the men continued to lack desired rites of passage leading from male adolescence to adulthood.	Long Isl Univ, Sch Hlth Profess, Div Occupat Therapy, Brooklyn, NY 11201 USA		Gutman, SA (corresponding author), Long Isl Univ, Sch Hlth Profess, Div Occupat Therapy, Univ Plaza, Brooklyn, NY 11201 USA.						Bogdan R., 1992, QUALITATIVE RES ED I; *BRIN INJ ASS, 1997, FACT SHEET; Ely M., 1991, DOING QUALITATIVE RE; Erikson E. H., 1963, CHILDHOOD SOC; GILES GM, 1994, AM J OCCUP THER, V48, P199, DOI 10.5014/ajot.48.3.199; Gutman SA, 1996, AM J OCCUP THER, V50, P535, DOI 10.5014/ajot.50.7.535; GUTMAN SA, 1997, OCCUPATIONAL THERAPY, V13, P25; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; JACKSON JD, 1994, AM J OCCUP THER, V48, P251, DOI 10.5014/ajot.48.3.251; Jordan J., 1991, WOMENS GROWTH CONNEC; Kaschak E., 1992, ENGENDERED LIVES NEW; Kazdin A., 1982, SINGLE CASE RES DESI; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; KWASNICA CM, 1994, ARCH PHYS MED REHAB, V75, P384, DOI 10.1016/0003-9993(94)90159-7; Levinson D. J., 1978, SEASONS MANS LIFE; MILLER L, 1993, PSYCHOTHERAPY BRAIN; Moore A D, 1994, NeuroRehabilitation, V4, P122, DOI 10.3233/NRE-1994-4208; Mosey A.C., 1996, APPL SCI INQUIRY HLT; MUNHALL PL, 1993, NURSING RES QUALITAT; *RANCH LOS AM HOSP, 1985, MEAS COGN FUNCT REH; SCHMIDT MF, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199508000-00003; SCREUBERT HJ, 1995, QUALITATIVE RES NURS; Strauss A., 1990, BASICS QUALITATIVE R; Worthington J, 1989, Rehabil Nurs, V14, P118; Yalom ID, 1970, THEORY PRACTICE GROU	25	4	4	0	8	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	1999	53	1					101	110		10.5014/ajot.53.1.101			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	158HA	WOS:000078108900016	9926226				2022-02-06	
J	Sbordone, RJ				Sbordone, RJ			Post-traumatic stress disorder: An overview and its relationship to closed head injuries	NEUROREHABILITATION			English	Article						post-traumatic stress disorder; risk factors; neuropsychological assessment; closed head injuries	NATIONAL COMORBIDITY SURVEY; MOTOR-VEHICLE ACCIDENTS; VIETNAM COMBAT VETERANS; POSTTRAUMATIC-STRESS; BRAIN INJURY; PTSD; VALIDITY; MEMORY; EVENT; RELIABILITY	While exposure to traumatic psychological and physical trauma can produce post-traumatic stress disorder (PTSD), multiple factors determine whether a person will develop PTSD following trauma exposure. Such factors include, but are not limited to, female gender, social disadvantage, childhood adversity, genetic predisposition, and substance abuse. PTSD has a high rate of comorbidity with psychiatric, substance abuse, and somatization disorders. Persons with PTSD experience profound and persistent alterations in their physiological reactivity to internal and external stimuli which prevents them from utilizing their emotions to process incoming information. These patients have chronically high levels of sympathetic nervous system activity and low levels of glucocorticoids to cope with stress and modulate their catecholamine levels. Neuropsychological assessment of patients with PTSD depends to a large degree on the sensitivity of the measures which are utilized and a pre-existing history of learning disabilities, head trauma, and/or neurological disorders. While closed head injuries (CHI) are unlikely to produce PTSD symptoms, persons with CHI are likely to develop PTSD symptoms if they are exposed to trauma prior to the onset of retrograde amnesia or after the resolution of post-traumatic amnesia. If the traumatic event occurs while the patient with CHI is amnestic or unconscious, they are unlikely to develop PTSD symptoms. The liberal criteria used to diagnose mild CHI is likely to result in patients with acute stress disorders being misdiagnosed with CHI as a result of their dissociative symptoms which reduce their awareness and encoding of the traumatic event.			Sbordone, RJ (corresponding author), 7700 Irvine Ctr Dr,Suite 750, Irvine, CA 92618 USA.						BELL JL, 1995, SOC WORK, V40, P36; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; BLANCHARD EB, 1986, BEHAV THER, V17, P592, DOI 10.1016/S0005-7894(86)80097-1; Blanchard EB, 1997, J TRAUMA STRESS, V10, P215, DOI 10.1002/jts.2490100205; BLANCHARD EB, 1994, BEHAV RES THER, V32, P283, DOI 10.1016/0005-7967(94)90123-6; BOUDEWYNS PA, 1996, PROGR BEHAV MODIFI C, V3, P165; Bray G., 1990, EMERGENCY SERVICES S; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; BREMNER JD, 1993, AM J PSYCHIAT, V150, P234; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Bromet E, 1998, AM J EPIDEMIOL, V147, P353; Bryant RA, 1997, CLIN PSYCHOL REV, V17, P757, DOI 10.1016/S0272-7358(97)00052-4; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Buckley TC, 1996, J ABNORM PSYCHOL, V105, P617, DOI 10.1037/0021-843X.105.4.617; BURGESS AW, 1974, AM J PSYCHIAT, V131, P981; DAVIDSON J, 1989, J NERV MENT DIS, V177, P336, DOI 10.1097/00005053-198906000-00003; DAVIDSON J, 1985, AM J PSYCHIAT, V142, P90; DAVIES RJ, 1991, CLIN EXP ALLERGY, V21, P1, DOI 10.1111/j.1365-2222.1991.tb01750.x; Delahanty DL, 1997, J CONSULT CLIN PSYCH, V65, P560, DOI 10.1037/0022-006X.65.4.560; Foa E.B., 1995, PDS POSTTRAUMATIC ST; Foa EB, 1997, ANNU REV PSYCHOL, V48, P449, DOI 10.1146/annurev.psych.48.1.449; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; FOX RP, 1972, COMPR PSYCHIAT, V13, P435, DOI 10.1016/0010-440X(72)90085-5; GERARD G, NEUROPSYCHOLOGY, V32, P72; GIACONIA RM, 1995, J AM ACAD CHILD PSY, V34, P1369, DOI 10.1097/00004583-199510000-00023; GOLDSMITH W, 1969, ARCH GEN PSYCHIAT, V20, P78; Grinker Roy R., 1945, MEN STRESS; GURVITS TV, 1996, ANN NY ACAD SCI, V821, P468; Hammaiberg M., 1992, PSYCHOL ASSESSMENT, V4, P67, DOI [10.1037/1040-3590.4.1.67, DOI 10.1037/1040-3590.4.1.67]; HAMNER MB, 1994, GEN HOSP PSYCHIAT, V16, P135, DOI 10.1016/0163-8343(94)90058-2; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; Hoeber P.B., 1941, TRAUMATIC NEUROSES W; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Horowitz M. J., 1976, STRESS RESPONSE SYND; KEANE TM, 1987, J CLIN PSYCHOL, V43, P32, DOI 10.1002/1097-4679(198701)43:1<32::AID-JCLP2270430106>3.0.CO;2-X; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; KLUZNICK JC, 1986, AM J PSYCHIAT, V43, P1443; KOSTEN TR, 1987, PSYCHONEUROENDOCRINO, V12, P13, DOI 10.1016/0306-4530(87)90017-5; KULKA RA, 1991, PSYCHOL ASSESSMENT, V3, P547, DOI DOI 10.1037/1040-3590.3.4.547; Malhi GS, 1998, BRIT J PSYCHIAT, V173, P537, DOI 10.1192/bjp.173.6.537a; MALLOY PF, 1983, J CONSULT CLIN PSYCH, V51, P488, DOI 10.1037/0022-006X.51.4.488; March J. S., 1993, POSTTRAUMATIC STRESS, P37; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MCCRANIE EW, 1992, J NERV MENT DIS, V180, P431, DOI 10.1097/00005053-199207000-00005; MCCULLOCH MJ, 1996, BRIT  J PSYCHIAT, V169, P571; MCFALL ME, 1990, AM J PSYCHIAT, V147, P645; MCFARLANE AC, 1989, BRIT J MED PSYCHOL, V62, P81, DOI 10.1111/j.2044-8341.1989.tb02813.x; MCFARLANE AC, 1989, BRIT J PSYCHIAT, V154, P221, DOI 10.1192/bjp.154.2.221; MCFARLANE AC, 1996, NEW YORK AC SCI SEPT; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; MILLEN FJ, 1966, IND MED SURG, V35, P929; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; ORNITZ EM, 1989, AM J PSYCHIAT, V146, P866; PITMAN RK, 1987, ARCH GEN PSYCHIAT, V44, P970; PITMAN RK, 1991, J CLIN PSYCHIAT, V52, P17; RAINEY JM, 1987, AM J PSYCHIAT, V144, P1317; RESICK PA, 1992, J CONSULT CLIN PSYCH, V60, P748, DOI 10.1037/0022-006X.60.5.748; RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984; SAPOLSKY RM, 1984, ENDOCRINOLOGY, V114, P287, DOI 10.1210/endo-114-1-287; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SCHNURR PP, 1993, AM J PSYCHIAT, V150, P479; SHALEV AY, 1992, ARCH GEN PSYCHIAT, V49, P870; Shalev AY, 1996, PSYCHOSOM MED, V58, P165, DOI 10.1097/00006842-199603000-00012; SHAPIRO F, 1989, J BEHAV THER EXP PSY, V20, P211, DOI 10.1016/0005-7916(89)90025-6; SOLOMON Z, 1992, J TRAUMA STRESS, V5, P1225; SOUTHWICK SM, 1993, ARCH GEN PSYCHIAT, V50, P266; SPARR LF, 1995, NEUROL CLIN, V13, P413, DOI 10.1016/S0733-8619(18)30054-9; Spitzer R. L., 1990, STRUCTURED CLIN INTE; STUTMAN RK, 1985, AM J PSYCHIAT, V142, P741; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; vanderKolk BA, 1997, J CLIN PSYCHIAT, V58, P16; VANDERKOLK BA, 1994, HARVARD REV PSYCHIAT, V1, P253, DOI 10.3109/10673229409017088; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; WATSON CG, 1991, J CLIN PSYCHOL, V47, P179, DOI 10.1002/1097-4679(199103)47:2<179::AID-JCLP2270470202>3.0.CO;2-P; Wolfe J, 1997, ANN NY ACAD SCI, V821, P208, DOI 10.1111/j.1749-6632.1997.tb48280.x; Wolfe J, 1991, PSYCHOL ASSESSMENT J, V3, P573, DOI DOI 10.1037/1040-3590.3.4.573; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137; YEHUDA R, 1991, BIOL PSYCHIAT, V30, P1031, DOI 10.1016/0006-3223(91)90123-4; YEHUDA R, 1995, AM J PSYCHIAT, V152, P982; YEHUDA R, 1990, BIOL ASSESSMENT TREA; ZAIDI LY, 1994, J TRAUMA STRESS, V7, P33, DOI 10.1002/jts.2490070105; 1994, DIAGNOSTIC STAT MAN	85	4	4	0	13	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		1999	13	2					69	78					10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	253HF	WOS:000083550400002					2022-02-06	
J	Velmahos, GC; Shoemaker, WC; Wo, CCJ; Demetriades, D				Velmahos, GC; Shoemaker, WC; Wo, CCJ; Demetriades, D			Physiologic monitoring of circulatory dysfunction in patients with severe head injuries	WORLD JOURNAL OF SURGERY			English	Article							CARDIAC-OUTPUT; ILLNESS; BRAIN	Secondary brain insults influence outcome significantly in patients with severe head injuries. Inadequate tissue perfusion should be identified and treated early to avoid such insults, Conventional hemodynamic monitoring (blood pressure, heart rate, urine output) is not a reliable method for evaluating circulatory function in such patients. Invasive monitoring by means of pulmonary artery catheters may offer more precise information on early circulatory abnormalities. The objective of this study was to study the hemodynamic patterns of patients with severe closed head trauma by invasive methods and to correlate the derived information with survival. Fifty-nine concecutive patients with blunt trauma, closed head injuries, and Glascow Coma Scale < 8 were studied, Pulmonary artery catheters were placed in all patients shortly after admission, and Bow and Bow-derived variables were monitored for 96 hours or patient demise. Survivors had higher cardiac index, oxygen delivery, and oxygen consumption values compared to nonsurvivors during the first 23 hours after injury, Following this period increased values were recorded in both groups. These temporal hemodynamic patterns were similar for patients with isolated head trauma and patients with other associated injuries. Thus initial hemodynamic patterns are associated with final outcome in patients with severe head injuries. Aggressive early hemodynamic monitoring may reveal subtle but significant changes. Further studies are warranted to investigate whether treatment guided by such information can improve survival.	Univ So Calif, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90033 USA; Univ So Calif, Med Ctr, Los Angeles, CA 90033 USA		Velmahos, GC (corresponding author), Univ So Calif, Dept Surg, Div Trauma & Crit Care, 1200 N State St,Room 9900, Los Angeles, CA 90033 USA.						BISHOP MH, 1993, CRIT CARE MED, V21, P56, DOI 10.1097/00003246-199301000-00013; BLAND RD, 1985, CRIT CARE MED, V13, P91, DOI 10.1097/00003246-198502000-00007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESTNUT RM, 1993, ACTA NEUROCHIR WIE S, V59, pS121; COURNAND A, 1945, J CLIN INVEST, V24, P106, DOI 10.1172/JCI101570; MARMAROU A, 1991, J NEUROSURG S, V75, pS158; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; SHOEMAKER WC, 1993, CRIT CARE MED, V21, P977, DOI 10.1097/00003246-199307000-00010; SHOEMAKER WC, 1990, ARCH SURG-CHICAGO, V125, P1332; SHOEMAKER WC, 1994, CRIT CARE MED, V22, P1907; WADE OL, 1962, CARDIAC OUTPUT REGIO, P1; WO CCJ, 1993, CRIT CARE MED, V21, P218, DOI 10.1097/00003246-199302000-00012	13	4	5	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0364-2313			WORLD J SURG	World J.Surg.	JAN	1999	23	1					54	58		10.1007/s002689900564			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	146DF	WOS:000077412200009	9841763				2022-02-06	
J	Ton-That, N				Ton-That, N			Post-traumatic stress disorder in Asian refugees	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						culture background; global prevention program; internalization; mental injury; organic brain damage; post-traumatic stress disorder; refugees		This study profiles 127 cases of Vietnamese, Cambodian, Laotian and Chinese refugee outpatients diagnosed with post-traumatic stress disorder (PTSD). Traumatic etiologies included victims of wars such as political refugees, concentration camp prisoners and victims of rape, severe personal losses (property or human lives). These traumata were experienced by our subjects during the period between the end of the Vietnam war in April 1975 and recent times, when they finally arrived in the USA. Clinical symptoms of these subjects reflected many influences of their oriental culture background and are characterized by internalization that needs to be overcome for assessment as well as for therapy. Symptomatic treatment with psychopharmacology and supportive therapy are helpful while cultural approaches have been adopted by many patients to reach the inner self pathology that could be of both mental and organic in nature. These facts need to be taken into consideration in the future description of the PTSD clinical picture. Recommendations are made for future PTSD studies in Vietnam, Cambodia and Laos, and to promote a global movement for prevention of any socio-political situation that may generate PTSD.	Univ Calif Los Angeles, NPI, Westminster, CA 92683 USA		Ton-That, N (corresponding author), Univ Calif Los Angeles, NPI, 9533 Bolsa Ave, Westminster, CA 92683 USA.						DAVIDSON J, 1995, J PRACT PSYCHIAT BEH, V1, P84; EITINGER L, 1985, INTEGRATIVE PSYCHIAT, V3, P115; FRANK MO, 1990, POSTTRAUMATIC THERAP; Frankl V. E., 1962, DOCTOR SOUL INTRO LO; Fromm E., 1967, PSYCHOANALYSIS RELIG; MORRIS P, 1992, HOSP COMMUNITY PSYCH, V43, P820; RICHARD FM, 1995, TRAUMA STORY PSYCHIA; SCOTT PO, 1994, PTSD RES Q, P5; STUART WT, 1995, PSYCHIAT ANN, V25, P46; Suzuki DT, 1960, ZEN BUDDHISM PSYCHOA; Watts A. W., 1969, PSYCHOTHERAPY E W	11	4	4	1	11	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	1323-1316			PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	DEC	1998	52			S			S377	S379		10.1111/j.1440-1819.1998.tb03274.x			3	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	167TU	WOS:000078650200065	9895199	Bronze			2022-02-06	
J	Nishigaki, R; Aramaki, T; Hirakawa, K; Asano, G				Nishigaki, R; Aramaki, T; Hirakawa, K; Asano, G			Nitric oxide production and energy state in the heart after endotoxin administration	JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION			English	Article						nitric oxide (NO); endotoxin; heart; magnetic resonance spectroscopy (MRS)	NUCLEAR MAGNETIC-RESONANCE; TRAUMATIC BRAIN INJURY; SMOOTH-MUSCLE CELLS; SYNTHASE; LOCALIZATION; INDUCTION; PROTEINS; SHOCK; RATS; PH	To evaluate nitric oxide (NO) production and the energy state of the heart after endotoxin administration, Wistar rats were injected ip with 10 mg/kg Escherichia coli lipopolysaccharide (endotoxin). Morphologic changes, plasma nitrite concentration, expression of inducible NO synthase (NOS), and cardiac energy state, as reflected by several metabolites, were observed chronologically 0 (control), 4, 6 and 8h after endotoxin administration. Electrocardiography (ECG) demonstrated arrhythmia after endotoxin administration. Biochemically, NO production increased in blood and iNOS increased in the heart. The amount of myocardial beta-ATP measured by P-31 magnetic resonance spectroscopy (P-31-MRS) increased transiently and then decreased. This transient increase might be a hyperdynamic response to endotoxin administration. At 4 and 6h after endotoxin administration, pH measured by P-31-MRS was slightly decreased, but this decline was not statistically significant. On the other hand, the amount of lactate in heart samples increased in the H-1 magnetic resonance spectra (H-1-MRS). Ultrastructurally, in cardiovascular tissue, intracytoplasmic organelles were observed to be injured in blood vessels and cardiomyocytes associated with mast cell infiltration. These results suggest significant metabolic and morphologic abnormalities in the heart after endotoxin administration.	Nippon Med Sch, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan; Nippon Med Sch, Dept Internal Med 1, Tokyo 113, Japan; Nippon Med Sch, Dept Legal Med, Tokyo 113, Japan		Nishigaki, R (corresponding author), Nippon Med Sch, Dept Pathol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.						AMEZCUA JL, 1988, BRIT J PHARMACOL, V95, P830, DOI 10.1111/j.1476-5381.1988.tb11711.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL ID, 1973, J MAGN RESON, V11, P172, DOI 10.1016/0022-2364(73)90004-8; DECKING UKM, 1995, AM J PHYSIOL-HEART C, V268, pH2460, DOI 10.1152/ajpheart.1995.268.6.H2460; EVANS T, 1993, CIRC SHOCK, V41, P77; Fishman D, 1997, CRIT CARE MED, V25, P469, DOI 10.1097/00003246-199703000-00016; Fukui Makoto, 1993, Medical Electron Microscopy, V26, P151, DOI 10.1007/BF02348041; Hirakawa K, 1994, JPN J LEGAL MED, V48, P63; Ishiwata T, 1997, JPN HEART J, V38, P445; KANNO K, 1993, HYPERTENSION, V22, P34, DOI 10.1161/01.HYP.22.1.34; KILBOURN RG, 1992, J NATL CANCER I, V84, P827, DOI 10.1093/jnci/84.11.827; Kinugawa KI, 1997, AM J PHYSIOL-HEART C, V272, pH35, DOI 10.1152/ajpheart.1997.272.1.H35; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LITT L, 1985, J CEREBR BLOOD F MET, V5, P537, DOI 10.1038/jcbfm.1985.81; LIU MS, 1992, MOL CELL BIOCHEM, V112, P135; LOESCH A, 1993, CELL TISSUE RES, V274, P539, DOI 10.1007/BF00314551; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; NIKULIN O V, 1982, Byulleten' Eksperimental'noi Biologii i Meditsiny, V94, P107; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; POLLOCK JS, 1993, AM J PHYSIOL, V265, pC1379, DOI 10.1152/ajpcell.1993.265.5.C1379; SCHULZ R, 1992, BRIT J PHARMACOL, V105, P575, DOI 10.1111/j.1476-5381.1992.tb09021.x; SCHWEIZER M, 1994, BIOCHEM BIOPH RES CO, V204, P169, DOI 10.1006/bbrc.1994.2441; SUGIMOTO T, 1977, JPN CIRC J, V41, P389, DOI 10.1253/jcj.41.389; Szabo C, 1996, P NATL ACAD SCI USA, V93, P1753, DOI 10.1073/pnas.93.5.1753; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; Wang DC, 1996, LAB INVEST, V75, P809; WINKLUND CU, 1993, BRIT J PHARMACOL, V110, P833; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P259, DOI 10.1038/sj.bjp.0700872	32	4	4	0	0	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	0047-1828			JPN CIRC J	Jpn. Circ. J.-Engl. Ed.	JUL	1998	62	7					527	531		10.1253/jcj.62.527			5	History & Philosophy Of Science; Social Sciences, Biomedical; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	History & Philosophy of Science; Biomedical Social Sciences; Cardiovascular System & Cardiology	ZX099	WOS:000074479300010	9707010	Bronze			2022-02-06	
J	Lagerkvist, B				Lagerkvist, B			Rehabilitation research under fire	SCANDINAVIAN JOURNAL OF SOCIAL MEDICINE			English	Article								Catastrophes in the health area are frequent. A template for conduct and reporting of research in disaster responses has recently been published. The WHO Rehabilitation of War Victims Project basically followed these principles in former Yugoslavia to estimate defined needs, prioritise and evaluate methods used. Around 30% of war victims reported to be wounded were found to be in need of physical rehabilitation. Priority was given to the 5% with severe disabilities caused by amputations, spinal cord injuries and traumatic brain injuries. Most of the infrastructure was destroyed and WHO supported a community based rehabilitation approach (CBR). Evaluating this type of service delivery became extremely difficult under present circumstances. Waves of refugees rolled both within the republics and over the borders demonstrating both the needs and problems listed in the template referred to. The CBR service delivery worked out satisfactorily with high patient satisfaction. Limited medical training greatly improved the situation for the personnel. Even in a disaster situation research is needed for proper decision-making and to gain experiences for future aid.	Univ Uppsala Hosp, Pediat Clin, SE-75185 Uppsala, Sweden		Lagerkvist, B (corresponding author), Univ Uppsala Hosp, Pediat Clin, SE-75185 Uppsala, Sweden.						Eldar R, 1990, Med War, V6, P105, DOI 10.1080/07488009008408914; Helander Einar, 1989, TRAINING COMMUNITY P; HENIGSBERG N, 1997, SCAND J SOC MED, V25, P200; KocijanHercigonja D, 1997, SCAND J SOC MED, V25, P14, DOI 10.1177/140349489702500104; *WAD TASK FORC QUA, 1996, PREHOSPITAL DISASTER, V11, P82	5	4	4	0	3	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0300-8037			SCAND J SOC MED	Scand. J. Soc. Med.	JUN	1998	26	2					85	86					2	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	ZV195	WOS:000074279900002	9658505				2022-02-06	
J	Legros, B; Fournier, P; Chiaroni, P; Mercier, C; Degiovanni, E; Lucas, B; de Toffol, B; Aesch, B				Legros, B; Fournier, P; Chiaroni, P; Mercier, C; Degiovanni, E; Lucas, B; de Toffol, B; Aesch, B			Emergency EEG and brain trauma	NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY			French	Article; Proceedings Paper	Consensus Conference on Emergency EEG	MAY, 1996	TOURS, FRANCE			EEG; brain trauma; emergency; cerebral death; seizures; neurological intensive care	HYPOTHERMIA; ISCHEMIA; INJURY	Emergency EEG and brain trauma. The aim of this study is to review indications for emergency EEG in case of brain trauma The authors emphasize the indication of emergency EEG for the diagnosis of either cerebral death or early post traumatic seizures, and for the monitoring of intensive neurological treatments. Emergency EEG and diagnosis of cerebral death has been reviewed in another issue of this journal Diagnosis of early post-traumatic seizures may be difficult in case of cranial trauma in either the presence or the absence of coma. Emergency EEG help guide the diagnosis of electrical signs of seizures, thus indicating that treatment with antiepileptic drugs is advisable. Severe post-traumatic coma requires barbiturate impregnation and moderate hypothermia. In this last case, emergency EEG is essential for the monitoring of pharmacological treatments The authors conclude that continuous EEG monitoring could in the future substitute for standard EEG recorded in emergency. (C) 1998 Elsevier, Paris.	CHU Tours, Serv Anesthesie Reanimat, F-37044 Tours, France; CHU Tours, Serv Explorat Fonct Neurol, F-37044 Tours, France; CHU Tours, Serv Neurotraumatol, F-37044 Tours, France		Legros, B (corresponding author), CHU Tours, Serv Anesthesie Reanimat, F-37044 Tours, France.			de Toffol, Bertrand/0000-0002-2006-631X			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Benbadis S R, 1997, J Fla Med Assoc, V84, P320; BUHRER M, 1992, ANESTHESIOLOGY, V77, P226; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; DEUTSCHMAN CS, 1985, NEUROSURGERY, V17, P510, DOI 10.1227/00006123-198509000-00021; DRUMMOND JC, 1993, ANESTHESIOLOGY, V78, P611; DURAND G, 1994, ENCY MED CHIR; GARREL S, 1979, REV EEG NEUROPHYSIOL, V9, P139, DOI 10.1016/S0370-4475(79)80068-4; GRAND W, 1974, J NEUROL NEUROSUR PS, V37, P178, DOI 10.1136/jnnp.37.2.178; ILLIEVICH UM, 1994, ANESTHESIOLOGY, V80, P177, DOI 10.1097/00000542-199401000-00025; KRIVOSICHORBER R, 1995, ANN FR ANESTH, V14, P12; KULUZ JW, 1992, STROKE, V23, P1792, DOI 10.1161/01.STR.23.12.1792; LAUXEROIS M, 1990, EPILEPSIES, V2, P5; LAZORTHES G, 1958, J NEUROSURG, V15, P162, DOI 10.3171/jns.1958.15.2.0162; LOISEAU P, 1991, NEUROCHIRURGIE, V37, P145; Loiseau P., 1984, EPILEPSIES, P167; MAJKOWSKI J, 1990, COMPREHENSIVE EPILEP, P281; MARTIN C, 1994, NEUROANESTHESIE NEUR, P175; MAUGUIERE F, 1979, REV EEG NEUROPHYSIOL, V9, P149, DOI 10.1016/S0370-4475(79)80069-6; MOYER DJ, 1992, STROKE, V23, P1812, DOI 10.1161/01.STR.23.12.1812; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; TENAILLON A, 1995, J SOC FRANCOPHONE UR	23	4	4	0	1	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS CEDEX 15	23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE	0987-7053			NEUROPHYSIOL CLIN	Neurophysiol. Clin.-Clin. Neurophysiol.	MAY	1998	28	2					111	120		10.1016/S0987-7053(98)80022-1			10	Clinical Neurology; Neurosciences; Physiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	ZN684	WOS:000073671300002	9622804				2022-02-06	
J	Hermann, DM; Mies, G; Hossmann, KA				Hermann, DM; Mies, G; Hossmann, KA			Effects of a traumatic neocortical lesion on cerebral metabolism and gene expression of rats	NEUROREPORT			English	Article						bioluminescence imaging; cerebral protein synthesis rate; cortical spreading depression; umbelliferone fluoroscopy	CORTICAL SPREADING DEPRESSION; NUCLEAR-MAGNETIC-RESONANCE; EXPERIMENTAL BRAIN INJURY; LACTATE; PROTEIN; DAMAGE; FLUID; P-31; H-1	THE effects of a traumatic neocortical lesion, induced by transcranial cold injury, on brain metabolism and gene expression were examined. The surrounding of the lesions was characterized by increased glucose and lactate levels without major disturbances of protein synthesis or energy state. A transient pH decrease by 0.4 units was noticed Ih post-injury, which shifted towards alkaline values by 3 h. The metabolic disturbances did not differ between injured animals with spontaneous spreading depressions (SD, n = 14) and those without SD (n=7). In SD animals, c-fos mRNA was strongly elevated in the injury-remote cortex, but hsp72 mRNA was not enhanced. Thus, in contrast to focal ischemia, the metabolic dysfunction around traumatic cortical lesions is not aggravated by SD. (C) 1998 Rapid Science Ltd.	Max Planck Inst Neurol Res, Dept Expt Neurol, D-50931 Cologne, Germany		Hermann, DM (corresponding author), Max Planck Inst Neurol Res, Dept Expt Neurol, Gleueler Str 50, D-50931 Cologne, Germany.		Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk M./AAT-3652-2021	Hermann, Dirk M./0000-0003-0198-3152			BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; CORBETT RJT, 1992, J NEUROCHEM, V59, P216, DOI 10.1111/j.1471-4159.1992.tb08894.x; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; HUSZ T, 1992, NEUROREPORT, V3, P51, DOI 10.1097/00001756-199201000-00013; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; KAMEZAWA T, 1994, ACTA NEUROCHIR, P499; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KOCHER M, 1990, J CEREBR BLOOD F MET, V10, P564, DOI 10.1038/jcbfm.1990.99; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MIES G, 1993, J NEUROCHEM, V60, P360, DOI 10.1111/j.1471-4159.1993.tb05860.x; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; NEUMANNHAEFELIN T, 1994, J CEREBR BLOOD F MET, V14, P206, DOI 10.1038/jcbfm.1994.27; NOWAK TS, 1990, STROKE, V21, P107; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; Siesjo BK, 1996, ADV NEUROL, V71, P209; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054	24	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	APR 20	1998	9	6					1249	1253		10.1097/00001756-199804200-00053			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZM026	WOS:000073497300056	9601703				2022-02-06	
J	Milders, M				Milders, M			Learning people's names following severe closed-head injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							ANOMIA; FACES	Although problems remembering people's names rank highly among the subjective complaints of patients with closed-head injuries, very few studies have examined their memory for people's names by objective measurements. An experiment is reported in which patients with severe closed-head injuries and normal controls learned the same set of words, either as names or as possessions, for unfamiliar faces. Name learning proved to be impaired in the patients. Patient recall of meaningless names and possessions which were described by nonwords was equally poor. The patients, but not the controls, recalled significantly fewer names than possessions if these items were described by concrete nouns. This last finding suggests that the patients' problems with learning people's names can not be fully explained by a general verbal learning impairment.	Univ Groningen, Dept Neuropsychol, NL-9713 GZ Groningen, Netherlands		Milders, M (corresponding author), Univ Groningen, Dept Neuropsychol, Hanzeplein 1, NL-9713 GZ Groningen, Netherlands.	m.v.milders@ppsw.rug.nl	Milders, Maarten/C-5560-2008				BERG IJ, 1993, THESIS U GRONINGEN; BREDART S, 1995, Q J EXP PSYCHOL-A, V48, P466, DOI 10.1080/14640749508401400; Brennen T, 1993, Memory, V1, P409, DOI 10.1080/09658219308258246; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BRUCE V, 1994, BRIT J PSYCHOL, V85, P335, DOI 10.1111/j.2044-8295.1994.tb02528.x; BRUYER R, 1992, ARCH PSYCHOL, V60, P243; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; BURTON AM, 1991, COGNITION, V39, P129, DOI 10.1016/0010-0277(91)90041-2; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; COHEN G, 1990, BRIT J PSYCHOL, V81, P287, DOI 10.1111/j.2044-8295.1990.tb02362.x; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; HITTMAIRDELAZER M, 1994, NEUROPSYCHOLOGIA, V32, P465, DOI 10.1016/0028-3932(94)90091-4; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LUCCHELLI F, 1992, CORTEX, V28, P221, DOI 10.1016/S0010-9452(13)80050-0; MCWEENY KH, 1987, BRIT J PSYCHOL, V78, P143, DOI 10.1111/j.2044-8295.1987.tb02235.x; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; STANHOPE N, 1993, BRIT J PSYCHOL, V84, P51, DOI 10.1111/j.2044-8295.1993.tb02462.x; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; van Loon-Vervoorn W.A., 1985, VOORSTELBAARHEIDSWAA; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VANZOMEREN AH, 1990, HDB CLIN NEUROLOGY, V13, P397; WILSON B, 1987, REHABILITATION MEMOR; Wilson B. A, 1984, CLIN MANAGEMENT MEMO, P89; [No title captured]; [No title captured]; [No title captured]	27	4	4	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1998	20	2					237	244		10.1076/jcen.20.2.237.1163			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	122GG	WOS:000076063100012	9777478				2022-02-06	
J	O'Dell, MW; Bell, KR; Sandel, ME				O'Dell, MW; Bell, KR; Sandel, ME			Brain injury rehabilitation. 3. Specific disorders	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							ANTERIOR COMMUNICATING ARTERY; MILD HEAD-INJURY; SUBARACHNOID HEMORRHAGE; NEUROPSYCHOLOGICAL SEQUELAE; INTRACRANIAL ANEURYSMS; COGNITIVE DEFICITS; CARDIAC-ARREST; MANAGEMENT; COMATOSE; PROGNOSIS	This self-directed learning module highlights new advances in selected topics related to brain injury rehabilitation. It is part of the chapter on brain injury rehabilitation in the Self-Directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation. This article explores medical and rehabilitation issues related to the care of persons with cerebral aneurysms and hypoxic brain injury, those with mild traumatic brain injury, and those who are minimally responsive as a result of severe brain injury. New advances covered in this section include a more formal definition of mild traumatic brain injury, principles for drug management in severe brain injury, and explanations of the impact of various medical issues in the rehabilitation of patients with a cerebral aneurysm or hypoxic brain injury. (C) 1998 by the American Academy of Physical Medicine and Rehabilitation.	Long Isl Jewish Med Ctr, New Hyde Pk, NY 11040 USA; Southside Hosp, Bay Shore, NY 11706 USA; Univ Washington, Sch Med, Seattle, WA 98195 USA; Kaiser Fdn Rehabil Ctr, Vallejo, CA 94589 USA		O'Dell, MW (corresponding author), Long Isl Jewish Med Ctr, New Hyde Pk, NY 11040 USA.			Bell, Kathleen/0000-0002-0928-2046			Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BAKER CJ, 1995, NEUROSURGERY, V37, P863, DOI 10.1227/00006123-199511000-00003; Barker FG, 1996, J NEUROSURG, V84, P405, DOI 10.3171/jns.1996.84.3.0405; BORNSTEIN RA, 1987, NEUROSURGERY, V21, P651, DOI 10.1227/00006123-198711000-00008; CARONNA J J, 1978, Stroke, V9, P517; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clinchot DM, 1997, ARCH PHYS MED REHAB, V78, P346, DOI 10.1016/S0003-9993(97)90223-9; CLINCHOT DM, 1994, ARCH PHYS MED REHAB, V75, P1342; Cohen N. J., 1984, NEUROPSYCHOLOGY MEMO, P83; Cooper PR, 1993, HEAD INJURY; DELUCA J, 1995, J CLIN EXP NEUROPSYC, V17, P100, DOI 10.1080/13803399508406586; DESANTIS A, 1989, J NEUROL NEUROSUR PS, V52, P1135, DOI 10.1136/jnnp.52.10.1135; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; EDGREN E, 1994, LANCET, V343, P1055, DOI 10.1016/S0140-6736(94)90179-1; Elovic E, 1996, NEUROREHABILITATION, V6, P57, DOI 10.3233/NRE-1996-6107; FEVE AP, 1993, MOVEMENT DISORD, V8, P321, DOI 10.1002/mds.870080311; FROHMAN S, 1990, COMA EMERGING PATIEN, P593; Giacino JT, 1996, NEUROREHABILITATION, V6, P69, DOI 10.3233/NRE-1996-6108; GIZZI M, 1995, J HEAD TRAUMA REHAB, V10, P60, DOI 10.1097/00001199-199512000-00009; Gorelick PB., 1996, ATLAS CEREBROVASCULA; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; Hopkins R O, 1995, J Int Neuropsychol Soc, V1, P501; Hopkins R O, 1995, J Int Neuropsychol Soc, V1, P454; HORN LJ, 1992, REHABILTATION POSTCO, P69; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; KAY T, 1992, REHABILITATION POST, P109; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Larsson C, 1989, BRIT J NEUROSURG, V3, P549, DOI 10.3109/02688698909002846; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; Madl C, 1996, ARCH NEUROL-CHICAGO, V53, P512, DOI 10.1001/archneur.1996.00550060054017; MAYBERG MR, 1994, CIRCULATION, V90, P2592, DOI 10.1161/01.CIR.90.5.2592; MCLELLAN DR, 1990, COMA EMERGING PATIEN, P389; MEYER FB, 1995, MAYO CLIN PROC, V70, P153, DOI 10.4065/70.2.153; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; ODell MW, 1996, NEUROREHABILITATION, V6, P45, DOI 10.3233/NRE-1996-6106; ODELL MW, 1996, MED REHABILITATION T, P103; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; RICHTER KJ, 1995, J HEAD TRAUMA REHAB, V10, P7, DOI 10.1097/00001199-199512000-00004; ROINE RO, 1993, JAMA-J AM MED ASSOC, V269, P237, DOI 10.1001/jama.269.2.237; ROUSH JS, 1990, COMA EMERGING PATIEN, P479; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; Sandel ME, 1996, NEUROREHABILITATION, V6, P9, DOI 10.3233/NRE-1996-6103; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; SORYAL I, 1992, CLIN REHABIL, V6, P103; Sosin DM, 1996, BRAIN INJURY, V10, P47; STENHOUSE LM, 1991, J NEUROL NEUROSUR PS, V54, P909, DOI 10.1136/jnnp.54.10.909; TROOST BT, 1992, NEUROLOGY, V42, P1441, DOI 10.1212/WNL.42.8.1441; WHITE BC, 1984, JAMA-J AM MED ASSOC, V251, P1586, DOI 10.1001/jama.251.12.1586; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson BA, 1996, BRAIN INJURY, V10, P863, DOI 10.1080/026990596123846; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004; Zasler ND, 1996, MED REHABILITATION T, P133	56	4	4	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1998	79	3		1			S16	S20		10.1016/S0003-9993(98)90115-0			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ZC421	WOS:000072576300004					2022-02-06	
J	Target, P; Wehman, P; Petersen, R; Gorton, S				Target, P; Wehman, P; Petersen, R; Gorton, S			Enhancing work outcome for three persons with traumatic brain injury	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						brain injury; compensatory strategies; medical rehabilitation; supported employment		A case study approach is used to illustrate how three survivors of severe traumatic brain injury were able to gain and maintain employment with the assistance of a supported employment programme. Emphasis on the different types of accommodations, including the design and implementation of compensatory strategies, is provided for each case. Finally, on overview of steps that can be taken to enhance the use of such strategies on the job is presented. (C) 1998 Chapman & Hall Ltd.	Virginia Commonwealth Univ, Rehabil Res & Training Ctr Supported Employment, Richmond, VA 23584 USA		Wehman, P (corresponding author), Virginia Commonwealth Univ, Rehabil Res & Training Ctr Supported Employment, Richmond, VA 23584 USA.						Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FRASER RT, 1995, NEUROREHABILITATION, V5, P39, DOI 10.3233/NRE-1995-5104; GOODALL P, 1991, SUPPORTED EMPLOYMENT; KREGEL J, 1994, NEUROREHABILITATION, V4, P114; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WESTBERG G, 1994, PORTL PR P, V8, P232	12	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	MAR	1998	21	1					41	50		10.1097/00004356-199803000-00004			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	ZA054	WOS:000072324000004	9924665				2022-02-06	
J	de la Pena, P; Porta-Etessam, J				de la Pena, P; Porta-Etessam, J			Post-traumatic epilepsy	REVISTA DE NEUROLOGIA			Spanish	Article; Proceedings Paper	XXXV Annual Meeting of the Liga-Espanola-Contra-la-Epilepsia	NOV 21-22, 1997	SEVILLE, SPAIN	Liga Espanola Epilepsia		post-traumatic epilepsy; aetiopathogenesis; risk factors; physio-pathology; prognosis; head injury	CLOSED-HEAD-INJURY; POSTTRAUMATIC SEIZURES; POPULATION; PREVENTION; MILD	Post-traumatic epilepsy is a well-known complication of head injury (TCE). There is extensive bibliography on the subject which contains contradictory data and unanswered questions. In this paper we review and update the literature emphasizing particular current definitions, incidence, risk factors and evaluation of prophyllactic treatment in relation to the physio-pathology. We give data of a retrospective study of the cases observed during the past 15 years in our unit, analyzing the factors which may help to predict the evolution of these crises. There is a relationship between the incidence of post-traumatic epilepsy and the severity of injury. One of the main risk factors is the presence of focal lesions, particularly haemorrhagic lesions. Prophyllactic treatment with anti-epileptic drugs is only during the first week in the group at risk of developing early crises. It has not been shown to be of use in preventing post-traumatic epilepsy. Other treatments, such as antioxidants, calcium antagonists and glutamate inhibitors are still only at an experimental stage [REV NEUROL 1998; 26: 256-61].	Hosp Univ 12 Octubre, Serv Neurol, Sect Epilepsia, E-28041 Madrid, Spain				Porta-Etessam, Jesus/AAG-6746-2019	Porta-Etessam, Jesus/0000-0002-7034-682X			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; CAVENESS WF, 1963, J NEUROSURG, V20, P570, DOI 10.3171/jns.1963.20.7.0570; CHADWICK DV, 1993, TXB EPILEPSY, P165; DALESSANDRO R, 1988, ARCH NEUROL-CHICAGO, V45, P42, DOI 10.1001/archneur.1988.00520250048019; Dalmady-Israel Christina, 1993, Brain Injury, V7, P263, DOI 10.3109/02699059309029679; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; DESANTIS A, 1988, B LEGA ITAL EPISSIA, P79; DESANTIS A, 1988, B LEGA ITAL EPISSIA, P62; Dudek FE, 1997, J CLIN NEUROPHYSIOL, V14, P90, DOI 10.1097/00004691-199703000-00002; Dugan Ellen M., 1994, Emergency Medicine Clinics of North America, V12, P1081; DUNCAN GS, 1995, CLIN EPILEPSY, P52; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x; HAUSER WA, 1990, NEW ENGL J MED, V323, P540, DOI 10.1056/NEJM199008233230809; JABBARI B, 1986, ELECTROEN CLIN NEURO, V64, P285, DOI 10.1016/0013-4694(86)90151-3; JALLON P, 1997, 4 INT MERR S DUBL; JENKINS A, 1986, LANCET, V2, P445; JENNET B, 1995, EPILEPSIA, V16, P251; JENNET B, 1995, EPILEPSY, P320; JENNETT B, 1975, EPILEPSY NONMISSILE, P35; KILPATRICK CJ, 1991, EPILEPSIA, V32, P358, DOI 10.1111/j.1528-1157.1991.tb04664.x; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; MAJKOWSKI J, 1991, COMPREHENSIVE EPILEP, P281; MAKOWSKI J, 1980, ADV EPILEPTOL, P323; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; MASDEU JC, 1995, J NEUROIMAGING, V5, pS53; PAGNI CA, 1990, ACT NEUR S, V50, P38; PERRY JK, 1979, NEUROLOGY, V29, P600; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; SCHAUMANN BA, 1994, EPILEPSIA, V35, P48, DOI 10.1111/j.1528-1157.1994.tb02911.x; SERVIT Z, 1981, EPILEPSIA, V22, P315, DOI 10.1111/j.1528-1157.1981.tb04115.x; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; TEMPKIN NR, 1991, NEUROSURG CLIN, V2, P425; TREIMAN DM, 1993, EPILEPSIA, V34, pS17, DOI 10.1111/j.1528-1157.1993.tb05919.x; Vidal JA, 1997, REV NEUROLOGIA, V25, P48; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; WILMORE LJ, 1993, NEUROL CLIN, V11, P823; YOUNG B, 1979, EPILEPSIA, V20, P671, DOI 10.1111/j.1528-1157.1979.tb04851.x	42	4	4	0	0	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	FEB	1998	26	150					256	261		10.33588/rn.26150.981066			6	Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZA399	WOS:000072359600010	9580443				2022-02-06	
J	Levander, MB; Sonesson, BG				Levander, MB; Sonesson, BG			Are there any mild interhemispheric effects after moderately severe closed head injury?	BRAIN INJURY			English	Article							INFORMATION	Interhemispheric communication of motor, sensory and language information in parallel with information processing was investigated in four male patients (age range 22-37 years) 3 and 6 months after moderately severe closed head injury. Specific task, of interhemispheric functions were given: linguistic tasks (tactile naming, writing and ideomotor praxis), motor tasks (graphaesthesia, tactile and finger localization) and sensory tasks (smell and colour vision). Information processing was evaluated by means of the Paced Auditory Serial Addition Task (PASAT). In comparison with age-matched controls (normals and paraplegics), post-injury findings indicated subtle motor, sensorimotor and language deficits in combinations suggesting mild interhemispheric disconnection. On most tasks, patients' performance improved over time along with gradual normalization of information processing. It is concluded that interhemispheric effects in the early phases after head injury may have a significant bearing on the process of recovery and functional restoration.	Karolinska Hosp, Dept Neurol, S-17176 Stockholm, Sweden; Univ Lund Hosp, Dept Rehabil, S-22185 Lund, Sweden		Levander, MB (corresponding author), Karolinska Hosp, Dept Neurol, S-17176 Stockholm, Sweden.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BOUMA A, 1990, LATERAL ASYMMETRIES, P56; Christman SD, 1995, HEMISPHERIC COMMUNIC, P231; DELOCHE G, 1993, BRAIN INJURY, V4, P363; Denenberg V. H., 1984, CEREBRAL DOMINANCE B, P114; EAMES P, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P134; GALABURDA AL, 1990, NEUROPSYCHOLOGIA, V25, P853; Gazzaniga MS, 1978, INTEGRATED MIND; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Harris U., 1995, HEMISPHERIC COMMUNIC, P1; LEVIN HS, 1993, SURG NEUROL, V40, P65, DOI 10.1016/0090-3019(93)90174-Y; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; MARZI CA, 1986, BRAIN COGNITION, V5, P163, DOI 10.1016/0278-2626(86)90053-9; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; WILSON J T L, 1990, Brain Injury, V4, P349; ZAIDEL E, 1995, HEMISPHERIC COMMUNIC, P85	16	4	4	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1998	12	2					165	173		10.1080/026990598122791			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YV073	WOS:000071786900007	9492964				2022-02-06	
J	Ohlinger, MJ; Rhoney, DH				Ohlinger, MJ; Rhoney, DH			Neuromuscular blocking agents in the neurosurgical intensive care unit	SURGICAL NEUROLOGY			English	Article						neuromuscular blocking agents; pharmacology; intensive care unit; neurosurgery	INTRACRANIAL-PRESSURE; HEAD-INJURY; SUCCINYLCHOLINE; BLOCKADE; PATIENT; HYPERKALEMIA; LAUDANOSINE; ATRACURIUM; INCREASES; DISORDERS	The long-term administration of neuromuscular blocking (NMB) agents in the ICU has increased in frequency the last several years. NMB agents in the ICU patient facilitate intubation and ventilatory support, decrease oxygen demand and consumption, facilitate bedside procedures and diagnostics, and potentially decrease intracranial pressure. However, NMB agents have extensive adverse effect profiles and require close monitoring. Two major classes of NMB agents exist: depolarizing and nondepolarizing. Depolarizing NMB agents work by mimicking the effect of acetylcholine at the nicotinic cholinergic receptor. Continuous depolarization inhibits repolarization, resulting in paralysis. Nondepolarizing NMB agents induce muscle paralysis by their competitive antagonism at the nicotinic cholinergic receptor. The neurosurgeon must be aware that NMB agents are paralytics only and should only be used in patients who are sedated and receiving adequate analgesia. Appropriate drug selection demands a thorough knowledge and understanding of each patient's neurologic, metabolic, and cardiovascular status and the hemodynamic, autonomic, pharmacokinetic, pharmacodynamic, and cost profiles of the NMB agents. (C) 1998 by Elsevier Science Inc.	St Vincent Mercy Med Ctr, Dept Pharmaceut Care, Toledo, OH 43608 USA; Detroit Receiving Hosp, Dept Pharm Serv, Detroit, MI USA		Ohlinger, MJ (corresponding author), St Vincent Mercy Med Ctr, Dept Pharmaceut Care, 2213 Cherry St, Toledo, OH 43608 USA.						AZAR I, 1984, ANESTHESIOLOGY, V61, P173, DOI 10.1097/00000542-198408000-00011; COOPERMAN LH, 1970, J AMER MED ASSOC, V213, P1867, DOI 10.1001/jama.213.11.1867; COURSIN DB, 1995, CRIT CARE CLIN, V11, P957, DOI 10.1016/S0749-0704(18)30048-4; FRANKVILLE DD, 1987, ANESTHESIOLOGY, V67, P264, DOI 10.1097/00000542-198708000-00022; GWINNUTT CL, 1990, BRIT J ANAESTH, V65, P829, DOI 10.1093/bja/65.6.829; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; KELLY JS, 1994, PHARM APPROACHH CRIT, P534; MINTON MD, 1986, ANESTHESIOLOGY, V65, P165, DOI 10.1097/00000542-198608000-00006; Prielipp R C, 1995, New Horiz, V3, P456; PRIELIPP RC, 1995, CRIT CARE CLIN, V11, P983, DOI 10.1016/S0749-0704(18)30049-6; PROUGH DS, 1994, CRIT CARE MED, V22, P1349; ROSA G, 1986, BRIT J ANAESTH, V58, P437, DOI 10.1093/bja/58.4.437; SMITH RB, 1971, CAN ANAESTH SOC J, V18, P199, DOI 10.1007/BF03025450; STEVENSON PH, 1979, ANESTHESIOLOGY, V51, P89, DOI 10.1097/00000542-197907000-00023; STONE WA, 1970, ANESTHESIOLOGY, V32, P168, DOI 10.1097/00000542-197002000-00019; WERBA A, 1991, ANAESTHESIST, V40, P328; WILSON JA, 1994, J NEUROSURG ANESTH, V6, P139; YATE PM, 1987, BRIT J ANAESTH, V59, P211, DOI 10.1093/bja/59.2.211	18	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0090-3019			SURG NEUROL	Surg. Neurol.	FEB	1998	49	2					217	221		10.1016/S0090-3019(97)00279-6			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YT642	WOS:000071627500032	9457275				2022-02-06	
J	Johannes, S; Jobges, ME; Dengler, R; Munte, TF				Johannes, S; Jobges, ME; Dengler, R; Munte, TF			Cortical auditory disorders: a case of non-verbal disturbances assessed with event-related brain potentials	BEHAVIOURAL NEUROLOGY			English	Article						audition; music; cortical auditory disorders; sound agnosia; amusia; event-related potentials; P3b	PURE WORD DEAFNESS; INTER-STIMULUS INTERVAL; LEFT-HEMISPHERE DAMAGE; CLOSED HEAD-INJURY; BILATERAL LESIONS; CEREBRAL EXCISION; EVOKED-POTENTIALS; TACTILE AGNOSIA; VISUAL AGNOSIA; ODDBALL TASK	In the auditory modality, there has been a considerable debate about some aspects of cortical disorders, especially about auditory forms of agnosia. Agnosia refers to an impaired comprehension of sensory information in the absence of deficits in primary sensory processes. In the non-verbal domain, sound agnosia and amusia have been reported but are frequently accompanied by language deficits whereas pure deficits are rare. Absolute pitch and musicians' musical abilities have been associated with left hemispheric functions. We report the case of a right handed sound engineer with the absolute pitch who developed sound agnosia and amusia in the absence of verbal deficits after a right perisylvian stroke. His disabilities were assessed,with the Seashore Test of Musical Functions, the tests of Wertheim and Botez (Wertheim and Botez, Brain 84, 1961, 19-30) and by event-related potentials (ERP) recorded in a modified 'odd-ball paradigm'. Auditory ERP revealed a dissociation between the amplitudes of the P3a and P3b subcomponents with the P3b being reduced in amplitude while the P3a was undisturbed. This is interpreted as reflecting disturbances in target detection processes as indexed by the P3b. The findings that contradict some aspects of current knowledge about left/right hemispheric specialization in musical processing are discussed and related to the literature concerning cortical auditory disorders.	Hannover Med Sch, Dept Neurol, D-30623 Hannover, Germany			johannes@vm.mhrz.mh-hannover.de	Munte, Thomas/C-2077-2014				Albert M L, 1972, Cortex, V8, P427; ALTENMULLER E, UNPUB NEUROPSYCHOLOG; AUERBACH SH, 1982, BRAIN, V105, P271, DOI 10.1093/brain/105.2.271; AUZOU P, 1995, NEUROPSYCHOLOGIA, V33, P25, DOI 10.1016/0028-3932(94)00100-4; BEHRMANN M, 1994, J EXP PSYCHOL HUMAN, V20, P1068, DOI 10.1037/0096-1523.20.5.1068; BEISTEINER R, 1994, EUR J COGN PSYCHOL, V6, P311, DOI 10.1080/09541449408520150; BERNARD P, 1889, APHASIE DIVERSES FOR; BEVER TG, 1974, SCIENCE, V185, P537, DOI 10.1126/science.185.4150.537; BRICK JF, 1985, NEUROLOGY, V35, P441, DOI 10.1212/WNL.35.3.441; Butsch Ch., 1966, SEASHORE TEST MUSIKA; CLARK VP, IN PRESS HUMAN BRAIN; CONFAVREUX C, 1992, ARCH NEUROL-CHICAGO, V49, P971, DOI 10.1001/archneur.1992.00530330095023; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; DORGEUILLE C, THESIS PARIS; Edgren J. G, 1895, DTSCH Z NERVENHEILKU, V6, P1; ENDO K, 1992, CORTEX, V28, P445, DOI 10.1016/S0010-9452(13)80154-2; Engelien A, 1995, BRAIN, V118, P1395, DOI 10.1093/brain/118.6.1395; EUSTACHE F, 1990, NEUROPSYCHOLOGIA, V28, P257, DOI 10.1016/0028-3932(90)90019-K; FITZGERALD PG, 1983, BIOL PSYCHOL, V17, P241, DOI 10.1016/0301-0511(83)90003-0; FUJII T, 1990, CORTEX, V26, P263, DOI 10.1016/S0010-9452(13)80355-3; GRAHAM FK, 1991, HDB COGNITIVE PSYCHO, P253; GRAHAM J, 1980, J NEUROL SCI, V48, P35, DOI 10.1016/0022-510X(80)90148-3; Grandori F., 1990, AUDITORY EVOKED MAGN, V6, P40; GUARD O, 1980, LYON MED, V243, P211; Hemphill RE, 1940, J NEUROL PSYCHIATRY, V3, P251, DOI 10.1136/jnnp.3.3.251; Hofman S., 1993, Journal of Communication Disorders, V26, P73, DOI 10.1016/0021-9924(93)90001-Q; HOLDSTOCK JH, NEW DEV EVENT RELATE; Huber W, 1984, Adv Neurol, V42, P291; JOHANNES S, IN PRESS MAPPING COG; JOHANNES S, IN PRESS EUR J NEURO; JONESGOTMAN M, 1988, NEUROPSYCHOLOGIA, V26, P387, DOI 10.1016/0028-3932(88)90093-0; KIMURA D, 1964, Q J EXP PSYCHOL, V16, P355, DOI 10.1080/17470216408416391; KIMURA D, 1961, CAN J PSYCHOLOGY, V15, P166, DOI 10.1037/h0083219; KLEIN R, 1956, J MENT SCI, V102, P112, DOI 10.1192/bjp.102.426.112; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Knoblauch A, 1888, DTSCH ARCH KLIN MED, V43, P331; KOHL G F, 1953, Wien Z Nervenheilkd Grenzgeb, V6, P219; KOIZUKA I, 1994, ORL J OTO-RHINO-LARY, V56, P273, DOI 10.1159/000276672; KOLB B, 1992, BRAIN COGNITION, V20, P74, DOI 10.1016/0278-2626(92)90062-Q; KURIKI S, 1989, EXP BRAIN RES, V77, P127; KUSSMAUL A, 1877, CYCLOPEDIA PRACTICE, P581; LAMBERT J, 1989, CORTEX, V25, P71, DOI 10.1016/S0010-9452(89)80007-3; Lichtheim L., 1885, BRAIN, V7, P433, DOI [DOI 10.1093/BRAIN/7.4.433, 10.1093/brain/7.4.433]; LIEGEOISCHAUVEL C, 1994, ELECTROEN CLIN NEURO, V92, P204, DOI 10.1016/0168-5597(94)90064-7; Lissauer H., 1890, ARCH PSYCHIAT NERVEN, V21, P222, DOI [DOI 10.1007/BF02226765, 10.1007/BF02226765]; MAVLOV L, 1980, CORTEX, V16, P331, DOI 10.1016/S0010-9452(80)80070-0; MCFARLAND HR, 1982, ARCH NEUROL-CHICAGO, V39, P725, DOI 10.1001/archneur.1982.00510230051016; MENDEZ MF, 1988, J NEUROL NEUROSUR PS, V51, P1, DOI 10.1136/jnnp.51.1.1; MUNTE TF, 1995, NEUROREPORT, V6, P1509; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; NIELSEN JM, 1939, B LOS ANGELES NEUROL, V4, P69; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OPPENHEIM H, 1886, ANN CHARITE KRANKENH, V13, P345; PARVING A, 1980, SCAND AUDIOL, V9, P161, DOI 10.3109/01050398009076350; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; PERETZ I, 1990, BRAIN, V113, P1185, DOI 10.1093/brain/113.4.1185; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Poeck K, 1984, Adv Neurol, V42, P71; POGGIO E, 1908, NEUROLOGISCHES ZENTR, V27, P817; POLICH J, 1990, INT J PSYCHOPHYSIOL, V10, P163, DOI 10.1016/0167-8760(90)90030-H; POLICH J, 1991, INT J PSYCHOPHYSIOL, V11, P219, DOI 10.1016/0167-8760(91)90015-P; POLICH J, 1994, INT J PSYCHOPHYSIOL, V17, P25, DOI 10.1016/0167-8760(94)90052-3; PRAAMSTRA P, 1991, BRAIN, V114, P1197, DOI 10.1093/brain/114.3.1197; REED CL, 1994, NEUROPSYCHOLOGIA, V32, P527, DOI 10.1016/0028-3932(94)90142-2; ROSATI G, 1982, J NEUROL, V227, P21, DOI 10.1007/BF00313543; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; SAMSON S, 1988, BRAIN COGNITION, V7, P348, DOI 10.1016/0278-2626(88)90008-5; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; SCHNIDER A, 1994, CORTEX, V30, P445, DOI 10.1016/S0010-9452(13)80340-1; SHIMOYAMA I, 1990, ARCH NEUROL-CHICAGO, V47, P681, DOI 10.1001/archneur.1990.00530060095025; SIDTIS JJ, COGNITIVE NEUROSCIEN, P91; SPINNLER H, 1966, CORTEX, V2, P227; SPREEN O, 1965, ARCH NEUROL-CHICAGO, V13, P84, DOI 10.1001/archneur.1965.00470010088012; TAKAHASHI N, 1992, CORTEX, V28, P295, DOI 10.1016/S0010-9452(13)80056-1; Takeda K, 1990, Rinsho Shinkeigaku, V30, P78; Talairach J., 1988, COPLANAR STEREOTAXIC; VANLANCKER D, 1987, NEUROPSYCHOLOGIA, V25, P829, DOI 10.1016/0028-3932(87)90120-5; VARGHAKHADEM F, 1994, BRAIN, V117, P683, DOI 10.1093/brain/117.4.683; VERKINDT C, 1995, EVOKED POTENTIAL, V96, P143, DOI 10.1016/0168-5597(94)00242-7; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; VIGNOLO LA, 1982, PHILOS T ROY SOC B, V298, P49, DOI 10.1098/rstb.1982.0071; WERTHEIM N, 1961, BRAIN, V84, P19, DOI 10.1093/brain/84.1.19; WOHLFART G, 1952, J NERV MENT DIS, V116, P818, DOI 10.1097/00005053-195212000-00034; WOODS DL, 1984, ELECTROEN CLIN NEURO, V57, P208, DOI 10.1016/0013-4694(84)90122-6; WORTIS SB, 1948, J NERV MENT DIS, V108, P181; YAQUB BA, 1988, BRAIN, V111, P457, DOI 10.1093/brain/111.2.457; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1990, PERCEPT PSYCHOPHYS, V47, P526, DOI 10.3758/BF03203105; ZATORRE RJ, 1989, CORTEX, V25, P567, DOI 10.1016/S0010-9452(89)80018-8; ZATORRE RJ, 1985, NEUROPSYCHOLOGIA, V23, P31, DOI 10.1016/0028-3932(85)90041-7	93	4	4	0	9	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	0953-4180			BEHAV NEUROL	Behav. Neurol.		1998	11	1					55	73		10.1155/1998/190715			19	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	118TL	WOS:000075856000006	11568403	gold, Green Submitted			2022-02-06	
J	Jokanovic, M; Moretto, A; Lotti, M				Jokanovic, M; Moretto, A; Lotti, M			Repeated low doses of O-(2-chloro-2,3,3 trifluorocyclobutyl) O-ethyl S-propyl phosphorothioate (KBR-2822) do not cause neuropathy in hens	ARCHIVES OF TOXICOLOGY			English	Article						neuropathy; promotion; organophosphate-induced delayed polyneuropathy (OPIDP); neuropathy target esterase (NTE)	ORGANOPHOSPHATE POLYNEUROPATHY; PHENYLMETHANESULFONYL FLUORIDE; TARGET ESTERASE; DELAYED NEUROTOXICITY; PROMOTION; PHOSPHATE	Certain esterase inhibitors such as O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl phosphorothioate (KBR-2822) and phenylmethanesulfonyl fluoride (PMSF) cause exacerbation (promotion) of toxic and traumatic axonopathies. Although these chemicals are capable of inhibiting neuropathy target esterase (NTE), which is the target for organophosphate induced delayed neuropathy, the target for promotion is unlikely to be NTE. Experiments were aimed to ascertain if neuropathy is caused by repeated dosing with a promoter not causing NTE inhibition and in the absence of deliberate injury to axons. Hens were treated with KBR-2822 (0.2 or 0.4 mg/kg per day) by gavage for 90 days and observed for clinical signs up to 21-23 days after treatment when histopathological examination was carried out. NTE and acetylcholinesterase (AChE) were measured at intervals and mean percentages of inhibition at steady state of inhibition/resynthesis (on day 20) were as follows: mean inhibition NTE was less than or equal to 8% in the 0.2 mg/kg group and between 15 and 18% in the 0.4 mg/kg group in brain, spinal cord and peripheral nerve; mean AChE inhibition in brain was 31 and 57% in the two experimental groups, respectively. Controls treated with paraoxon (not neuropathic or a promoter and given at 0.05 mg/kg per day by gavage) showed 45% mean AChE inhibition and no NTE inhibition. Neither clinical nor morphological signs of neuropathy were observed in any group. To ascertain whether subclinical lesions were produced by the repeated treatment with KBR-2822, hens were given KBR-2822 (0.2 mg/kg per day) for 21 days by gavage followed by PMSF (120 mg/kg s.c. 24 h after the last dose of KBR-2822). A control group of hens was treated with the neuropathic DFP (0.03 mg/kg s.c. daily for 21 days causing 40-50% NTE inhibition) followed by PMSF (120 mg/kg s.c.). After PMSF, the KBR-2822 treated hens did not develop neuropathy whereas DFP treated hens did. Lack of neuropathy after repeated treatment with KBR-2822 indicates that a continuous promoting 'pressure' on hen axons is harmless in the absence of a concurrent biochemical or neurotoxic injury.	Univ Padua, Ist Med Lavoro, I-35127 Padua, Italy		Lotti, M (corresponding author), Univ Padua, Ist Med Lavoro, Via Facciolati 71, I-35127 Padua, Italy.						DIXON WJ, 1992, BMDP STAT SOFTWARE; Dixon WJ, 1992, BMDP STAT SOFTWARE M; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; JOHNSON MK, 1990, TOXICOL APPL PHARM, V102, P385, DOI 10.1016/0041-008X(90)90036-T; JOHNSON MK, 1977, ARCH TOXICOL, V37, P113, DOI 10.1007/BF00293860; JOHNSON MK, 1993, CHEM-BIOL INTERACT, V87, P449, DOI 10.1016/0009-2797(93)90074-9; LOTTI M, 1991, TOXICOL APPL PHARM, V108, P234, DOI 10.1016/0041-008X(91)90114-T; LOTTI M, 1993, TOXICOL APPL PHARM, V122, P165, DOI 10.1006/taap.1993.1184; LOTTI M, 1980, ARCH TOXICOL, V45, P263, DOI 10.1007/BF00293807; LOTTI M, 1992, CRIT REV TOXICOL, V21, P465, DOI 10.3109/10408449209089884; MORETTO A, 1989, ARCH TOXICOL, V63, P469, DOI 10.1007/BF00316450; MORETTO A, 1992, ARCH TOXICOL, V66, P67, DOI 10.1007/BF02307272; MORETTO A, 1993, CHEM-BIOL INTERACT, V87, P457, DOI 10.1016/0009-2797(93)90075-A; MORETTO A, 1994, TOXICOL APPL PHARM, V129, P133, DOI 10.1006/taap.1994.1236; NOVOTNY E, 1974, STAIN TECHNOL, V49, P273, DOI 10.3109/10520297409116993; Osman KA, 1996, FUND APPL TOXICOL, V33, P294, DOI 10.1006/faat.1996.0167; PERAICA M, 1993, BIOCHEM PHARMACOL, V45, P131, DOI 10.1016/0006-2952(93)90385-A; POPE CN, 1990, J TOXICOL ENV HEALTH, V31, P261, DOI 10.1080/15287399009531455; RICHARDSON RJ, 1995, J TOXICOL ENV HEALTH, V44, P135, DOI 10.1080/15287399509531952	19	4	4	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0340-5761			ARCH TOXICOL	Arch. Toxicol.	JAN	1998	72	2					93	96					4	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	YN288	WOS:000071151900004	9456080				2022-02-06	
J	Labi, MLC; Brentjens, M; Shaffer, K; Weiss, C; Zielezny, MA				Labi, MLC; Brentjens, M; Shaffer, K; Weiss, C; Zielezny, MA			Functional Cognition Index (c): A new instrument to assess cognitive disability after traumatic brain injury	JOURNAL OF NEUROLOGIC REHABILITATION			English	Article						TBI; functional assessment; cognitive disability	RATING-SCALE; HEAD-INJURY; VALIDITY; RECOVERY; COMA	Although traumatic brain injury (TBI) may result in global impairments, the resulting cognitive dysfunction is the most devastating and most limiting for both the patient and the family. There presently are many cognitive assessment instruments, but few are applicable to the wide spectrum of severity found in TBI. A new assessment instrument, the Functional Cognition Index (FCI) has been developed to assess residual functional cognition after TBI. Preliminary studies indicate that the FCI has high interrater reliability and its validity is comparable to the Rancho Los Amigos Scale of Cognitive Function. Its main advantage is that it is short and easy to administer without great need for extensive training, as some instruments require. Although the FCI was designed as a clinical instrument, it has significant potential to be used in both clinical and epidemiologic research. Its brevity and simplicity make it an ideal instrument for use by family members or survey researchers either in person or by telephone. The instrument also has sufficient sensitivity to reflect changes over a wide spectrum so that it may be helpful in program evaluation, monitoring medication effect, or measuring outcomes.	SUNY Buffalo, Dept Rehabil Med, Buffalo, NY 14260 USA; SUNY Buffalo, Sch Med Biomed Sci, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; Erie Cty Med Ctr & Labs, Buffalo, NY 14215 USA				Weiss, Craig/K-8910-2018				Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRANGER CV, 1986, GUIDE USE UNIFORM DA; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall K, 1992, NEUROREHABILITATION, V2, P98, DOI DOI 10.3233/NRE-1992-2410; JENNETT B, 1975, LANCET, V1, P480; JOHNSTON MV, 1996, MED REHABILITATION T; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; TEASDALE G, 1974, LANCET, V2, P81; *US DEP HHS, 1989, DEP HLTH HUM SERV IN; Wade D, 1992, MEASUREMENT NEUROLOG	12	4	4	0	3	DEMOS PUBLICATIONS	NEW YORK	386 PARK AVE S STE 201, NEW YORK, NY 10016-8804 USA	0888-4390			J NEUROL REHABIL	J. Neurol. Rehabil.		1998	12	2					45	51					7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	123RB	WOS:000076137200001					2022-02-06	
J	Miki, T; Ikeda, Y; Utsugi, O; Ito, H				Miki, T; Ikeda, Y; Utsugi, O; Ito, H			Evaluation of traumatic subarachnoid haemorrhage on computed tomography	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						traumatic subarachnoid haemorrhage; diffuse brain injury; Glasgow Coma Scale; Glasgow Outcome Scale; neurotrauma	HEAD-INJURY; ANGIOGRAPHIC FINDINGS; BRAINSTEM LESIONS; CT; HEMORRHAGE; BLOOD; SPASM; SCAN	Traumatic subarachnoid haemorrhage (TSAH) is a computed tomography (CT) scan finding frequently found in the acute phase of brain injury. However, the clinical evaluation of TSAH is controversial. The subjects in the present series consisted of 46 patients in whom the initial CT scan within 6 h after injury revealed a high density area in the subarachnoid space. The subjects were divided into three types: type I (n = 10) had massive haemorrhage in the basal cisterns; type II (n = 9) had localized haemorrhage in the basal cisterns; and type III (n = 27) had localized haemorrhage in the cortical sulci or Sylvian fissure. The clinical and neuroradiological findings as well as the outcome of these three types of TSAH are discussed. The results of our study showed that TSAH observed at an acute stage of head trauma was associated with a great variety of intracranial pathological changes. Type I cases had either good or poor outcome, and diffuse brain injury was predominant in patients with poor outcome. The outcome was generally good in type II and III cases. (C) Harcourt Brace & Co. Ltd 1998.	Tokyo Med Coll, Dept Neurosurg, Shinjuku Ku, Tokyo 160, Japan		Miki, T (corresponding author), Tokyo Med Coll, Dept Neurosurg, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 160, Japan.						BRAAKMAN R, 1994, J NEUROSURG, V80, P797; COLUMELLA F, 1963, ACTA RADIOL DIAGN, V1, P239, DOI 10.1177/028418516300100217; COMTON JS, 1987, BRIT J NEUROSURG, V1, P435; COOPER PR, 1979, NEUROSURGERY, V4, P115, DOI 10.1227/00006123-197902000-00002; CROMPTON MR, 1971, LANCET, V1, P669; DEVILLASANTE JM, 1976, AM J ROENTGENOL, V126, P765; DOLINSKAS CA, 1978, RADIOLOGY, V126, P409, DOI 10.1148/126.2.409; ECKER AD, 1945, J NEUROSURG, V2, P479, DOI 10.3171/jns.1945.2.6.0479; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; FRENCH BN, 1977, SURG NEUROL, V7, P171; FREYTAG E, 1963, ARCH PATHOL, V75, P402; HAYASHI N, 1993, JPN J ACUTE MED, V17, P1041; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KAKARIEKA K, 1994, 1994 INT C REC ADV N, V1, P125; KASAMO S, 1983, PROGR COMPUTERIZED T, V5, P399; KINOSHITA Y, 1990, JJTOM, V38, P328; Kobayashi S, 1988, No To Shinkei, V40, P1131; KOBAYASHI S, 1982, Neurologia Medico-Chirurgica, V22, P838, DOI 10.2176/nmc.22.838; KOSTRON H, 1984, Neurological Research, V6, P29; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; OTSUKA S-I, 1988, Archiv fuer Japanische Chirurgie, V57, P84; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; TAKAGI H, 1981, SURG NEUROL, V16, P103, DOI 10.1016/0090-3019(81)90106-3; TAKIZAWA T, 1984, Neurologia Medico-Chirurgica, V24, P390, DOI 10.2176/nmc.24.390; TATSUNO Y, 1974, ARCH PATHOL, V97, P211; TSAI FY, 1980, AM J NEURORADIOL, V1, P23; TSAI FY, 1984, NEURORADIOLOGY HEAD, P99; Wilkins R H, 1975, Surg Neurol, V4, P472; WILKINS RH, 1968, J NEUROSURG, V29, P121, DOI 10.3171/jns.1968.29.2.0121; YASUKAWA K, 1988, NEUROL SOC, V16, P483; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	35	4	4	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	1998	5	1					49	57		10.1016/S0967-5868(98)90202-8			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE300	WOS:000072778500011	18644288				2022-02-06	
J	Heilbronner, RL; Karavidas, T				Heilbronner, RL; Karavidas, T			Presenting neuropsychological evidence in traumatic brain injury litigation	CLINICAL NEUROPSYCHOLOGIST			English	Article								The purpose of this paper is to educate the reader about some of the issues involved in presenting neuropsychological evidence in cases where a traumatic brain injury (TBI) is either obvious or suspected. Particular emphasis will be directed toward the admissibility of neuropsychological evidence and clarifying the roles of neuropsychologists as treaters and experts. Some strategies will also be presented to assist neuropsychologists in preparing to give opinion testimony.	Northwestern Univ, Sch Med, NeuroBehav & Rehabil Network, Chicago, IL USA; Law Off Donald J Nolan, Chicago, IL USA		Heilbronner, RL (corresponding author), 333 N Michigan Ave,Ste 1801, Chicago, IL 60601 USA.						*AM PSYCH ASS, 1992, APA ETH PRINC PSYCH; BLAU TH, 1984, PSYCHOL EXPERT WITNE; FAUST D, 1994, DEFENSE, P22; *INS DIV 40 TASK F, 1987, CLIN NEUROPSYCHOL, V1, P29; MCMAHON EA, 1981, HDB CLIN NEUROPSYCHO; RICHARDSON REL, 1992, CLIN NEUROPSYCHOLOGI, V6, P296; ROTHKE S, 1992, CLIN NEUROPSYCHOL, V6, P85; SATZ P, 1988, CLIN NEUROPSYCHOL, V2, P89; SCHWARTZ ML, 1987, CLIN NEUROPSYCHOL, V1, P51; TRANEL D, 1994, PROF PSYCHOL-RES PR, V25, P33, DOI 10.1037/0735-7028.25.1.33	10	4	4	0	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	1997	11	4					445	453		10.1080/13854049708400477			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	136GW	WOS:000076851900015					2022-02-06	
J	Leathem, JM; Body, CM				Leathem, JM; Body, CM			Neuropsychological sequelae of head injury in a New Zealand adolescent sample	BRAIN INJURY			English	Article							CHILDREN; CONCUSSION; RECOVERY	The purpose of this study was to determine the nature and extent of any difficulties experienced by students after head injury, and the degree to which these were recognized by their parents and teachers. All year 10 students at a co-educational high school in New Zealand were surveyed for information regarding incidence, aetiology and severity of head injury-related symptomatology and general everyday competency. A proportion of students reporting injury (mostly mild) and a matched control group were studied in more detail. information was obtained through a self-report questionnaire, neuropsychological measures, and teacher and parent rating forms. Apart from trials 5 and 6 of the AVLT, in which the head-injured group scored significantly lower than the control group, there were no other significant differences between the two groups on neuropsychological measures. There was a low level of agreement between students, teachers and parents with regard to behavioural and cognitive difficulties that the students were experiencing.	MID CENT HLTH, PALMERSTON NORTH, NEW ZEALAND		Leathem, JM (corresponding author), MASSEY UNIV, DEPT PSYCHOL, PSYCHOL CLIN, POB 11-222, PALMERSTON NORTH, NEW ZEALAND.						*ACC COMP CORP, 1991, ACC INJ STAT HOM INJ, V3; *ACC COMP CORP, 1992, ACC INJ STAT VEH, V4; ACHENBACH TM, 1979, J CONSULT CLIN PSYCH, V47, P223, DOI 10.1037/0022-006X.47.2.223; Bellack A.S., 1988, BEHAV ASSESSMENT PRA; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Edelbrock C., 1986, MANUAL TEACHERS REPO; Forrester G., 1991, CLIN NEUROPSYCHOL, V5, P345, DOI [10.1080/13854049108404102, DOI 10.1080/13854049108404102]; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; JOHNSON DA, 1988, J CHILD PSYCHOL PSYC, V29, P199, DOI 10.1111/j.1469-7610.1988.tb00704.x; JOHNSON DA, 1989, CHILDRENS HEAD INJUR; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lezak MD, NEUROPSYCHOLOGICAL A; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; Morse P, 1992, CLIN SYNDROMES ADULT, P85; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P96; Rey A., 1964, EXAMEN CLIN PSYCHOL; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SCHAPIRO SR, 1993, MINOR HEAD TRAUMA AS, P86; STERN B, 1985, SCAND J REHABIL MED, P27; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; Wechsler D., 1974, WECHSLER INTELLIGENC; WRIGHTSON P, 1994, SAFEPATH NORTHLAND A, V13, P3	27	4	4	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	1997	11	8					565	575		10.1080/026990597123269			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XL930	WOS:A1997XL93000002	9251865				2022-02-06	
J	Shimura, T; Mukai, T; Endo, T; Nakamura, T; Takatori, T				Shimura, T; Mukai, T; Endo, T; Nakamura, T; Takatori, T			Clinicopathological studies of craniocerebral gunshot injuries	NEUROLOGICAL SURGERY			Japanese	Article						gun shot wound; craniocerebral; CT scan; autopsy case; histopathology	WOUNDS; HEAD	Gunshot wounds are rare in Japan because of few regulatory laws against the possession of guns. Nevertheless such wounds are increasing in prevalence these days, Reports on the microscopic findings concerning these intracerebral lesions are fewer than those on the macroscopic findings in the scalp, the skull and the intracranial cavity. In this study we evaluated computed tomographical and histopathological findings in craniocerebral gunshot injures. Cases: Nine patients with gunshot wounds to the head were presented. All were male and the age ranged from 17 to 66 years. Four were suicides and four were attempted murders and the last one was of unknown etiology. Morphological examination was performed on 5 autopsy cases. The distance of the bullet from the cranial cavity was as follows: long distance, 4 cases: close contiguity, 5 cases; The calibers of the weapons were as follows: 38mm in 6 cases. 45mm in 1 case and unknown in 2 cases. Results: CT scans were examined in six cases, which revealed a missile track, hemorrhagic contusion, traumatic subarachnoid hemorrhage and marked tension pneumocephalus. In some cases, CT scan also rc revealed bony and metallic fragments, some deep within the cranial cavity. In the histopathological study, we found marked swollen brain (brain weight over 1500mg) and hemorrhagic contusion in the vicinity of the missile track and interhemispheric fissure, and widespread traumatic subarachnoid hemorrhage and intraventricular hematoma. We would like to emphasize especially the remote contusion seen in the distant part of the missile track as well as massive exsudation and hemorrhage around the nerve fiber bundles. Remote contusion was observed in the inferior sur face of the fronto-temporal lobes, and bilateral hemorrhagic contusion was seen in the vicinity of the superior longitudinal fissure on CT scans and autopsy findings. In one case. the bullet rotated within the intracranial cavity. In conclusion, nine cases of craniocerebral gunshot injuries were examined while we also reviewed the medical literature concerning the shearing injury produced by gunshot brain wounds. The head injuries were further delineated by the correlation between autopsy and computerized tomography findings.	NIPPON MED COLL, DEPT NEUROSURG, TOKYO, JAPAN; TOKYO MED COLL, DEPT LEGAL MED, TOKYO 160, JAPAN; TOKYO METROPOLITAN GOVT MED EXAMINERS OFF, TOKYO, JAPAN; UNIV TOKYO, FAC MED, DEPT LEGAL MED, TOKYO 113, JAPAN; NIPPON MED COLL, DEPT CRIT CARE MED, TOKYO, JAPAN								ADAMS JH, 1992, GREENFIELDS NEUROPAT, P143; COOPER PR, 1979, NEUROSURGERY, V4, P373, DOI 10.1227/00006123-197905000-00001; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HOPKINSON DA, 1967, BRIT J SURG, V54, P344, DOI 10.1002/bjs.1800540507; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; KIRKPATRICK JB, 1978, J NEUROSURG, V49, P185, DOI 10.3171/jns.1978.49.2.0185; Leestma JE, 1988, FORENSIC NEUROPATHOL	8	4	4	0	3	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	JUL	1997	25	7					607	612					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XN614	WOS:A1997XN61400003	9218254				2022-02-06	
J	Okuyama, S; Yamada, S; Ogawa, S; Shima, K; Kamata, K; Tomisawa, K				Okuyama, S; Yamada, S; Ogawa, S; Shima, K; Kamata, K; Tomisawa, K			Effect of VA-045, a novel apovincaminic acid derivative, on closed head injury-induced neurological dysfunction in aged rats	NEUROLOGICAL RESEARCH			English	Article						closed head injury; motor deficits; aged rats; VA-045; TRH	TRAUMATIC BRAIN INJURY; MODEL; CONCUSSION; DEFICITS	Effects of VA-045, a novel apovincaminic acid derivative, on behavioral outcome following closed head injury (CHI) were examined in aged (21-28 months) rats. CHI was induced by dropping a 400 g weight through a tube from 150 cm above a steel helmet placed on the vertex. Beam balancing latency, neurological deficits and body weight were recorded before CHI and for up to 14 days after CHI. When compared with the sham group, all measurements of parameters of behavioral outcome in the CHI group were significantly worsened after CHI. Intraperitoneal administration of VA-045 (1 and 3 mg kg(-1)) or thyrotropin-releasing hormone (TRH 10 mg kg(-1)) and vehicle was started 24 h after CHI, and continued once daily far 13 days. VA-045 but not TRH significantly overcame the CHI-induced neurological deficits, shortened the latency of beam balancing and decreased body weight loss. VA-045 may prove useful for treating aged patients with disturbances of consciousness or molar deficits after CHI.	NIHON BIORES CTR INC,GIFU,JAPAN; NATL DEF MED COLL,DEPT NEUROSURG,TOKOROZAWA,SAITAMA 359,JAPAN; HOSHI UNIV,INST MED CHEM,DEPT PHYSIOL & MORPHOL,TOKYO 142,JAPAN		Okuyama, S (corresponding author), TAISHO PHARMACEUT CO LTD,LAB 1,MED RES LABS,1-403 YOSHINO CHO,OMIYA,SAITAMA 330,JAPAN.						ARAKAWA S, 1995, LIFE SCI, V57, P1803, DOI 10.1016/0024-3205(95)02158-F; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; KAWASHIMA Y, 1993, J MED CHEM, V36, P815, DOI 10.1021/jm00059a004; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MIYATA N, 1993, LIFE SCI, V52, P181; OKUYAMA S, 1994, GEN PHARMACOL, V25, P1311; OKUYAMA S, 1993, RES COMMUN CHEM PATH, V82, P91; OKUYAMA S, 1994, LIFE SCI, V20, P1577; OKUYAMA S, 1993, LIFE SCI, V53, P273; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SUZUKI M, 1994, JPN J PHARMACOL, V64, P197; TOPP KS, 1989, GLIA, V2, P201, DOI 10.1002/glia.440020309; UCHIYAMATSUYUKI Y, 1993, JPN J PHARMACOL, V61, P288; YAMADA S, 1994, RES COMMUN MOL PATH, V86, P83; YAMADA S, 1994, JPN J PHARMACOL, V64, P198	24	4	4	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897	0161-6412			NEUROL RES	Neurol. Res.	JUN	1997	19	3					300	304		10.1080/01616412.1997.11740816			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XC468	WOS:A1997XC46800015	9192383				2022-02-06	
J	Papero, PH; Snyder, HM; Gotschall, CS; Johnson, DL; Eichelberger, MR				Papero, PH; Snyder, HM; Gotschall, CS; Johnson, DL; Eichelberger, MR			Relationship of two measures of injury severity to pediatric psychological outcome 1-3 years after acute head injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; COGNITIVE SEQUELAE; CHILDREN; SCALE; COMA; DISABILITY; COMPETENCE; SCORE; AGE	Objective: To compare the strength of relationship of the Glasgow Coma Scale (GCS) versus the ASCOT probability of survival (Ps), a multidimensional trauma severity index, with a comprehensive range of core areas of psychological functioning assumed to influence quality of life in pediatric head injury survivors. Design: Correlational relationships between the GCS versus the Ps and standardized outcome measures in six psychological domains were compared. Ordering effects of level of severity on outcome were studied through analyses of variance for the GCS versus the Ps. Setting: A pediatric level I trauma center. Patients: Eighty-six children with mild to severe traumatic brain injury retrospectively recruited from consecutive head injury admissions for a 30-month period. Measures: Wechsler Intelligence Scale for Children-Revised, Trail Making Test, Tactual Performance Test, Fuld Object Memory Evaluation, Finger Tapping, Grooved Pegboard, Beery Developmental Test of Visual-Motor Integration, Detroit Oral Directions, Woodcock-Johnson Tests of Achievement, Vineland Adaptive Behavior Scales, Achenbach Child Behavior Checklist, Harter Self-Perception Scales. Results: Significant correlations were found between each of the severity indices (GCS and Ps) and the IQ and neuropsychological variables. Both Ps and GCS were able to distinguish the severe injury group from lesser injury. Ps yielded a stronger pattern of correlations and a clearer step-wise separation of the three injury severity levels on neuropsychological variables. Only the GCS was related to adaptive behavior. Neither severity index showed strong correlational patterns with behavioral or self-perception psychological domains. Conclusions: Multidimensional trauma severity measures such as the Ps merit further study as tools for prediction of longterm neuropsychological outcome following pediatric head injury, especially in the case of children with moderate head injuries. Findings must be considered preliminary due to sample limitations but do emphasize the greater degree of independence of psychosocial, as compared to neurocognitive, outcome relative to initial injury severity.	CHILDRENS NATL MED CTR,EMERGENCY TRAUMA SERV,WASHINGTON,DC 20010; CHILDRENS NATL MED CTR,DEPT NEUROSURG,WASHINGTON,DC 20010		Papero, PH (corresponding author), CHILDRENS NATL MED CTR,DEPT PSYCHIAT & BEHAV SCI,NEUROPSYCHOL SERV,111 MICHIGAN AVE NW,WASHINGTON,DC 20010, USA.						ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; *AM ASS AUT MED, 1985, ABB INJ SCAL AIS 198; Beery K, 1989, VMI DEV TEST VISUAL; BIJUR PE, 1990, PEDIATRICS, V86, P337; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BRUCE DA, 1979, CHILD BRAIN, V5, P174; CARNEY J, 1994, PEDIATR ANN, V23, P47, DOI 10.3928/0090-4481-19940101-10; CASEY R, 1986, PEDIATRICS, V78, P497; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Ciccetti D., 1984, VINELAND ADAPTIVE BE; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; Cohen J., 2013, STAT POWER ANAL BEHA; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; EICHELBERGER MR, 1993, J TRAUMA, V34, P319, DOI 10.1097/00005373-199303000-00001; EICHELBERGER MR, 1990, EMSC ASSESSMENT BATT; EICHELBERGER MR, 1991, EMSC FOCUS TRAUMATIC; EICHELBERGER MR, 1988, J TRAUMA, V28, P1; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; EWINGCOBBS L, 1986, J HEAD TRAUMA REHAB, V1, P57; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FULD PA, 1977, 33925M STOELT; Goodglass H., 1972, ASSESSMENT APHASIA R; GOTSCHALL CS, 1995, J NEUROTRAUM, V12, P611, DOI 10.1089/neu.1995.12.611; Hammill DD, 1985, DETROIT TESTS LEARNI; HARTER S, 1984, CHILD DEV, V55, P1969, DOI 10.1111/j.1467-8624.1984.tb03895.x; HARTER S, 1988, SELFPERCEPTION PROFI; HARTER S, 1985, SELFPERCEPTION PROFI; JENNETT B, 1975, LANCET, V1, P480; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS., 1982, NEUROBEHAVIORAL CONS; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MASSAGLI TL, 1994, PEDIATR ANN, V23, P29, DOI 10.3928/0090-4481-19940101-08; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pocock, 1983, CLIN TRIALS PRACTICA; PRIGATANO GP, 1991, J CLIN EXP NEUROPSYC, V13, P437; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan RM, 1985, HALSTEADREITAN NEURO; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; SATTLER JM, 1988, ASSESSMENT CHILDRENS; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P161; TEASDALE G, 1974, LANCET, V2, P81; Tukey JW, 1977, EXPLORATORY DATA ANA, V2, P131; Wechsler D., 1974, WECHSLER INTELLIGENC; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; WOODCOCK RW, 1977, MANUAL WOODCOCKJOHNS; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48; [No title captured], DOI DOI 10.1097/00001199-198812000-00004	63	4	4	0	5	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1997	12	3					51	67		10.1097/00001199-199706000-00006			17	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XC699	WOS:A1997XC69900006					2022-02-06	
J	Mooney, G; Speed, J				Mooney, G; Speed, J			Differential diagnosis in mild brain injury: Understanding the role of non-organic conditions	NEUROREHABILITATION			English	Article						traumatic brain injury; depression; anxiety; conversion disorder; litigation	MINOR HEAD-INJURY; BASE RATES; SYMPTOMS; TRAUMA; CLASSIFICATION; CONCUSSION; SPECTRUM; DEFICITS	(O)ver one million mild traumatic brain injuries (TBI) occur annually in the United States, Most of these patients recover full function within about 3 months, but a significant minority do not. Failure to recover as expected following a diagnosed or suspected mild TBI is most commonly related to a concurrent diagnosis or alternative diagnosis or condition. Consideration during the diagnostic process must be given to alternative organic conditions (prior or unsuspected severe TBI, pain, medication side effects or dementia), pre-existing non-organic conditions (active or dormant psychiatric conditions, pre-existing personality characteristics, or social/economic factors), non-clinical conditions (compensation/litigation, malingering) or post-injury psychiatric morbidity (notably depression, anxiety, post-traumatic stress disorder, panic disorder, or conversion disorder), Scrupulous care must be given during the history, physical examination, and neuropsychologic assessment of the patient to evaluate for different or contributory diagnostic possibilities; not all patients that have symptoms following a blow to the head have traumatic brain injury as the sole etiologic agent for their symptoms. Accurate diagnosis will lead to better treatment and optimal outcomes. Future research should focus on early identification of the 'slow to recover' group to allow early and appropriate treatment. (C) 1997 Elsevier Science Ireland Ltd.			Mooney, G (corresponding author), UNIV UTAH,HLTH SCI CTR,DIV PHYS MED & REHABIL,REHABIL SERV,50 N MED DR,SALT LAKE CITY,UT 84132, USA.						BIGOS SJ, 1991, SPINE, V16, P1, DOI 10.1097/00007632-199101000-00001; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; CICERONE K, 1993, 70 ANN SESS AM C REH; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; CICERONE KD, 1994, ANN M AM C REH MED M; EAMES P, 1992, J NEUROL NEUROSUR PS, V55, P10463; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; GRIGSBY J, 1993, BRAIN INJURY, V7, P507, DOI 10.3109/02699059309008178; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V81, P403, DOI 10.2466/pms.1995.81.2.403; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; HARPER M, 1962, COMPR PSYCHIAT, V3, P129; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin H.S., 1989, MILD HEAD INJURY; MOONEY G, 1994, 4 ANN C INT ASS STUD; MOONEY G, 1994, 12 ANN SHELD BERR MD; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Sosin DM, 1996, BRAIN INJURY, V10, P47; Speed J, 1996, ARCH PHYS MED REHAB, V77, P147, DOI 10.1016/S0003-9993(96)90159-8; Taylor AE, 1996, ARCH PHYS MED REHAB, V77, P529, DOI 10.1016/S0003-9993(96)90290-7; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; ZASLER ND, 1996, J LEGAL NURSE CONSUL, V7, P2	31	4	4	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	MAY	1997	8	3					223	233		10.1016/S1053-8135(96)00225-9			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WT831	WOS:A1997WT83100008	24526050				2022-02-06	
J	Sasaoka, Y; Kanemoto, Y; Otsuka, H; Sakitani, H; Motoyama, Y				Sasaoka, Y; Kanemoto, Y; Otsuka, H; Sakitani, H; Motoyama, Y			Ruptured traumatic aneurysm of the peripheral anterior cerebral artery: Study of delayed hemorrhage after dosed head injury	NEUROLOGICAL SURGERY			Japanese	Article						traumatic aneurysm; false aneurysm; closed head injury; peripheral cerebral artery; delayed hemorrhage		We report three cases of ruptured traumatic aneurysms of the peripheral anterior cerebral artery after closed head injury. These cases were all young men with closed head injury due to traffic accidents. Consciousness level on admission was coma in all three cases. Case 1 was a 19-year-old man with interhemispheric hematoma on initial CT, then 7 days later his consciousness cleared. However, 14 days later he suddenly lapsed into a deep coma with a severe frontal hemorrhage. Case 2 was a 13-year-old boy. Plain skull films demonstrated a frontal depressed fracture, but CT scan showed no breeding. Four days later his consciousness cleared but 11 days after trauma, he lapsed into a deep coma with a frontal hemorrhage. Case 3 was a 22-year-old man. Initial CT showed a slight ventricular hemorrhage. Fourteen days later, his consciousness had almost cleared, but then he lapsed into a deep coma with a large frontal hemorrhage 11 weeks after the trauma. These patients all died within a few days after intracranial bleeding. All patients underwent cerebral angiography but none of them showed filling defect Autopsy was performed and ruptured aneurysms were found on the distal anterior cerebral artery that had no relation to the branch of bifurcation. Histological examination demonstrated a lack of elastic lamina and media in all of these three cases, so each of them was a victim of so-called false aneurysm. Twenty reported cases of ruptured traumatic aneurysms of the peripheral cerebral artery with delayed hemorrhage after closed head injury were reviewed. Factors in the traumatic aneurysm showed no relation to the duration of disturbed consciousness. Within one month, delayed hemorrhage due to ruptured traumatic aneurysm occurred. None of the delayed hemorrhages involved subarachnoid hemorrhage. Subdural hematoma was seen in the distal middle cerebral artery and frontal hemorrhage was found in the distal anterior cerebral artery. We consider that frontal hemorrhage a predictive finding for the type of delayed hemorrhage due to traumatic aneurysm in the distal anterior cerebral artery.	NARA PREFECTURAL CRIT CARE MED CTR,DEPT NEUROSURG,NARA,JAPAN; NARA PREFECTURAL GOJYO HOSP,DEPT NEUROSURG,NARA,JAPAN								ACOSTA C, 1972, J NEUROSURG, V36, P531, DOI 10.3171/jns.1972.36.5.0531; AOKI S, 1992, AM J NEURORADIOL, V13, P1115; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; Birley JL, 1928, BRAIN, V51, P184, DOI 10.1093/brain/51.2.184; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; COURSON B, 1970, NEURO-CHIR, V16, P15; COURVILLE C B, 1960, Bull Los Angel Neuro Soc, V25, P48; EICHLER A, 1969, J NEUROSURG, V31, P72, DOI 10.3171/jns.1969.31.1.0072; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; HANDA J, 1970, AMER J ROENTGENOL RA, V109, P127, DOI 10.2214/ajr.109.1.127; KOMATSU S, 1979, NEUROSURGERY, V5, P32, DOI 10.1227/00006123-197907010-00005; MENEZES AH, 1974, J NEUROSURG, V40, P544, DOI 10.3171/jns.1974.40.4.0544; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; SMITH DR, 1970, J NEUROSURG, V32, P357, DOI 10.3171/jns.1970.32.3.0357; SMITH KR, 1968, J NEUROSURG, V29, P551, DOI 10.3171/jns.1968.29.5.0551; Tsuchiya K, 1994, Radiat Med, V12, P161; UMEBAYASHI Y, 1970, Clinical Radiology, V21, P36, DOI 10.1016/S0009-9260(70)80136-2	18	4	4	0	1	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	APR	1997	25	4					337	344					8	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WX240	WOS:A1997WX24000007	9125717				2022-02-06	
J	Thomas, DF; Botterbusch, KF				Thomas, DF; Botterbusch, KF			The vocational assessment protocol for school-to-work transition programs	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						functional assessment; school-to-work transition; traumatic brain injury; vocational assessment; vocational assessment protocol	TRAUMATIC BRAIN INJURY	Objective: A total of 149 persons involved in 20 community-based vocational rehabilitation programs located throughout the United States that serve persons with traumatic brain injury (TBI) participated in a study to examine the structure and content of a vocational assessment process and functional abilities rating instruments. These are applicable for educators to use when examining work-related skills of students with TBI transitioning from school to work. Measures: Nine rating instruments that constitute the Vocational Assessment Protocol (VAP) were used, including two demographic profiles, three clinical profiles, and four vocational profiles. Data from case records and input from service providers, examinees, and significant others were used to complete the nine profiles. Results: Data collected with the VAP identified a high incidence rate of common barriers to employment. Barriers involving social and adaptive skills, physical demands, emotional behaviors, and cognitive skills mere common. Conclusions: The data presented underscore the need for educators to examine and develop work-related skills of youth in school-to-work transition.	MAYO HLTH SYST,LUTHER MIDELFORT,EAU CLAIRE,WI		Thomas, DF (corresponding author), UNIV WISCONSIN STOUT,STOUT VOCAT REHABIL INST,REHABIL RES & TRAINING CTR,214 10TH AVE,MENOMONIE,WI 54751, USA.						DEPOMPEI R, 1995, ED DIMENSIONS ACQUIR; HASAZI SB, 1987, J SPEC EDUC, V23, P243; Inge K. J., 1994, J VOCATIONAL REHABIL, V4, P272; MCPHERSON A, 1994, J VOCATIONAL REHABIL, V4, P131; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; THOMAS DF, 1996, VOCATIONAL ASSESSMEN; THOMAS DF, 1988, VOCATIONAL ADAPTIVIT; Thomas DF, 1996, J VOCATIONAL REHABIL, V7, P243; THOMAS DF, 1988, MODEL SCH WORK TRANS; THOMAS DF, 1990, AM REHABIL       SUM, P20; TYLER JS, 1991, LD FORUM TRANSLATING; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P25, DOI 10.1097/00001199-199512000-00006	14	4	4	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1997	12	2					48	66		10.1097/00001199-199704000-00006			19	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WT782	WOS:A1997WT78200007					2022-02-06	
J	Nichols, JS; Elger, C; Hemminger, L; Prall, JA; Shaver, K; Brennan, R; Whitaker, JB				Nichols, JS; Elger, C; Hemminger, L; Prall, JA; Shaver, K; Brennan, R; Whitaker, JB			Magnetic resonance imaging: Utilization in the management of central nervous system trauma	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	56th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 19-21, 1996	HOUSTON, TX	Amer Assoc Surg Trauma		MR; CT; trauma; brain; spinal cord	CLOSED-HEAD INJURY; COMPUTED-TOMOGRAPHY; ACUTE PHASE; MRI; CT; SPECT	Objective: To determine the availability, use, and perceived value of magnetic resonance imaging (MR) in the management of acute central nervous system (CNS) trauma in United States Level I(or equivalent) trauma centers (TCs), Design, Materials, and Methods: One hundred sixty-nine American College of Surgeons, state or locally designated Level I(or equivalent) TCs were identified using compiled lists and telephone contacts, Surveys about MR use in CNS trauma were mailed to each institution, Follow-up telephone calls were made to nonresponding institutions, Data were analyzed using frequency distribution, Measurements: Using returned questionnaires from trauma directors and follow-up telephone contacts, data on the physical location, technologist availability, and patient monitoring capabilities were accrued, The questionnaire addressed the perceived value and cost-effectiveness of MR for acute CNS trauma in general, distinguishing between spinal cord and traumatic brain injury, using a Likert-type rating scale, Main Results: One hundred nine (65%) of identified TCs responded by mail. Sixty (33%) required contact by telephone, One hundred fifty-two (93%) reported MR scanners ''on site.'' Five of seven TCs without on-site MR had facilities within 5 miles, No TC reported the inability to obtain MR scans, Seventy-four percent of TCs reported MR angiography capabilities, Ninety-seven percent of MR facilities were staffed 24 hours per day, 83% by on-call, out of-hospital technologists at night and on weekends, TCs reported patient monitoring capabilities including cardiac monitoring (83%) and pulse oximetry (91%), Seventy-one percent reported the ability to scan intubated patients, Forty-five percent of TCs ''rarely'' use MR, 51% report ''occasional'' use, and 4% ''frequently'' use MR for acute trauma, Ninety-four percent of trauma directors agreed or strongly agreed that MR directed management and was cost-effective for spinal cord trauma, Fifty-four percent agreed or strongly agreed that MR directed management and was cost-effective for traumatic brain injury, No correlation existed between perceptions of MR applicability in CNS trauma and the number of trauma admissions or on-site availability, Conclusions: Most trauma directors consider MR important in the acute evaluation of spinal trauma and, to a lesser extent, for traumatic brain injury, Despite these opinions, the vast majority of these centers reported only ''rare'' to ''occasional'' use of MR in the setting of acute CNS trauma, Our results show that most TCs have on-site and continuously available MR facilities capable of cardiac and pulmonary monitoring, Other factors such as the higher relative cost of MR may be responsible for the discrepancy between the perceived value and the actual utilization of MR imaging in the setting of CNS trauma.	PROVENANT ST ANTHONY HOSP CENT,TRAUMA SERV,DENVER,CO								*AM HOSP ASS, 1995, GUID HLTH CAR FIELD; DEROSIER C, 1991, J NEURORADIOLOGY, V18, P309; GENTRY LR, 1994, RADIOLOGY, V191, P1; ICHISE M, 1994, J NUCL MED, V35, P217; JOHNSON MH, 1992, RADIOL CLIN N AM, V30, P325; LEVITT MA, 1991, AM J EMERG MED, V9, P131, DOI 10.1016/0735-6757(91)90173-H; MASCALCHI M, 1993, CLIN RADIOL, V48, P100, DOI 10.1016/S0009-9260(05)81081-5; MIRVIS SE, 1989, ANN EMERG MED, V18, P1315, DOI 10.1016/S0196-0644(89)80268-9; OBEIRNE J, 1993, INJURY, V24, P149, DOI 10.1016/0020-1383(93)90278-E; *PENNS TRAUM SYST, 1994, ACCR TRAUM CTR; PEROVITCH M, 1992, PARAPLEGIA, V30, P305, DOI 10.1038/sc.1992.74; PRAYER L, 1993, ACTA RADIOL, V34, P593; QUENCER RM, 1992, NEURORADIOLOGY, V34, P85, DOI 10.1007/BF00588148; SALCMAN M, 1992, NEUROCHIRURGIE, V38, P329; SCHAEFER DM, 1992, J NEUROSURG, V76, P218, DOI 10.3171/jns.1992.76.2.0218; SETT P, 1991, PARAPLEGIA, V29, P369; Silberstein M, 1992, Australas Radiol, V36, P198, DOI 10.1111/j.1440-1673.1992.tb03151.x; SKLAR EML, 1992, RADIOL CLIN N AM, V30, P353; Takahashi M, 1993, Radiat Med, V11, P127; TEASDALE G, 1992, J NEUROTRAUM, V9, pS249; YAMASHITA Y, 1991, BRIT J RADIOL, V64, P201, DOI 10.1259/0007-1285-64-759-201; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007	22	4	4	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1997	42	3					520	523		10.1097/00005373-199703000-00021			4	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	WR152	WOS:A1997WR15200039	9095121				2022-02-06	
J	Iverson, GL; Slick, D; Seemiller, LS				Iverson, GL; Slick, D; Seemiller, LS			Screening for visual-perceptual deficits following closed head injury: A short form of the Visual Form Discrimination Test	BRAIN INJURY			English	Article								The purpose of this study was to evaluate the concurrent validity and clinical utility of a shea form of the Visual Form Discrimination Test in persons with closed head injuries (n = 62). Given the homogeneity of the items, and patients' apparent consistency in responding, we hypothesized that scores from an eight-item short form would be highly similar to the scores derived from the full version of the test (i.e. 16 items). The mean difference between the shea form and full version was less than one point, and the correlation between the two forms was 0.86. Applying a clinical decision rule resulted in a 'normal/impaired' overall correct classification rate of 98.4%. The short form shows considerable promise as a brief test of visual discrimination in persons with closed head injuries.	RIVERVIEW HOSP,VANCOUVER,BC,CANADA; UNIV VICTORIA,VICTORIA,BC,CANADA; ALLEGHENY GEN HOSP,PITTSBURGH,PA 15212; ALLEGHENY GEN HOSP,MED COLL PENN & HAHNEMANN UNIV,PITTSBURGH,PA 15212		Iverson, GL (corresponding author), UNIV BRITISH COLUMBIA,DEPT PSYCHIAT,2255 WESBROOK MALL,VANCOUVER,BC V6T 2A1,CANADA.			Iverson, Grant/0000-0001-7348-9570			Benedict R. H. B., 1992, PSYCHOL ASSESSMENT, V4, P322, DOI DOI 10.1037//1040-3590.4.3.322; Benton A., 1994, CONTRIBUTIONS NEUROP; BENTON AL, 1983, CONTRIBUTIONS NEUROP, P55; IVERSON GL, IN PRESS PSYCHOL ASS; Paolo A. M, 1993, PSYCHOL ASSESSMENT, V5, P425; Robinson L J, 1991, Arch Clin Neuropsychol, V6, P27, DOI 10.1016/0887-6177(91)90019-6; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; [No title captured]	8	4	4	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1997	11	2					125	128		10.1080/026990597123719			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WD430	WOS:A1997WD43000004	9012945				2022-02-06	
J	Cicerone, KD				Cicerone, KD			Cognitive rehabilitation: Learning from experience and planning ahead	NEUROREHABILITATION			English	Article						cognition; cognitive remediation; neuropsychological rehabilitation; rehabilitation	CLOSED HEAD-INJURY; PROGRAM; REMEDIATION; PERFORMANCE; RECOVERY	Cognitive rehabilitation has evolved to be a common clinical practice, despite questions regarding the scientific basis for its effectiveness. A selective interpretation of existing studies suggests that non-specific treatment factors play an important role in the efficacy of cognitive rehabilitation. Some future directions for the science and practice of cognitive rehabilitation are discussed. Copyright (C) 1997 Elsevier Science Ireland Ltd.			Cicerone, KD (corresponding author), JFK JOHNSON REHABIL INST,2048 OAK TREE RD,EDISON,NJ 08820, USA.						ALDERMAN N, 1995, NEUROPSYCHOL REHABIL, V5, P193, DOI 10.1080/09602019508401467; Baribeau J, 1989, J NEUROL REHABIL, V3, P71; BUTTER CM, 1992, ARCH PHYS MED REHAB, V73, P1113; CARAMAZZA A, 1993, NEUROPSYCHOL REHABIL, V3, P217, DOI 10.1080/09602019308401437; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; DEARY IJ, 1994, BIOL PSYCHOL, V38, P1, DOI 10.1016/0301-0511(94)90046-9; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GLISKY EL, 1987, NEUROPSYCHOLOGIA, V25, P893, DOI 10.1016/0028-3932(87)90094-7; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; GORDON WA, 1985, ARCH PHYS MED REHAB, V66, P353; GROSSMAN M, 1995, J NEUROL REHABIL, V9, P91; Harley J. P., 1992, NEUROREHABILITATION, V2, P62; KARNI A, 1995, NATURE, V377, P155; Klonoff PS, 1989, J HEAD TRAUMA REHAB, V4, P37; Langer KG., 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI [DOI 10.1080/09602019208401395, 10.1080/09602019208401395]; LAWSON MJ, 1989, J CLIN EXP NEUROPSYC, V11, P842, DOI 10.1080/01688638908400939; LEVIN HS, 1990, ARCH NEUROL-CHICAGO, V47, P223, DOI 10.1001/archneur.1990.00530020131027; MAYER NH, 1986, CLIN NEUROPSYCHOLOGY; McLean A Jr, 1987, Brain Inj, V1, P145, DOI 10.3109/02699058709034453; MIDLERS MV, 1995, NEUROPSYCHOL REHABIL, V3, P223; Novack TA, 1996, J HEAD TRAUMA REHAB, V11, P52, DOI 10.1097/00001199-199606000-00008; RATTOK J, 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; Rebmann MJ, 1995, REHABIL PSYCHOL, V40, P279, DOI 10.1037/0090-5550.40.4.279; ROZELLE GR, 1995, BIOFEEDBACK SELF-REG, V20, P211, DOI 10.1007/BF01474514; RUFF R M, 1990, Brain Injury, V4, P339, DOI 10.3109/02699059009026187; Ruff R. M., 1989, J HEAD TRAUMA REHAB, V4, P20, DOI [10.1097/00001199-198909000-00006, DOI 10.1097/00001199-198909000-00006]; SKARDA CA, 1987, BEHAV BRAIN SCI, V10, P161, DOI 10.1017/S0140525X00047336; SODERBACK I, 1992, ARCH PHYS MED REHAB, V73, P1140; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Squires EJ, 1996, NEUROPSYCHOL REHABIL, V6, P55, DOI 10.1080/713755494; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; YOUNGJOHN JR, 1989, REHABIL PSYCHOL, V34, P217, DOI 10.1037//0090-5550.34.3.217; [No title captured]	35	4	4	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JAN	1997	8	1					13	19		10.1016/S1053-8135(96)00204-1			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WE987	WOS:A1997WE98700003	24525940				2022-02-06	
J	Mysiw, WJ; Bogner, JA; Arnett, JA; Clinchot, DM; Corrigan, JD				Mysiw, WJ; Bogner, JA; Arnett, JA; Clinchot, DM; Corrigan, JD			The orientation group monitoring system for measuring duration of posttraumatic amnesia and assessing therapeutic interventions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						amnesia; outcome rehabilitation; traumatic brain injury	TRAUMATIC BRAIN INJURY; CLOSED HEAD-INJURY; COGNITION; MEMORY; SEVERITY; RECOVERY; SCALE	The Orientation Group Monitoring System (OGMS) is a reliable and valid instrument that prospectively monitors cognitive functions through clearing posttraumatic amnesia. This article describes how the OGMS is easily incorporated into a daily 30-minute therapeutic orientation group. Specifically, we describe the content of the seven subscales that make lip the OGMS, how responses are scored, and how weekly aggregate OGMS scores assist clinicians in both medical and programming decisions.			Mysiw, WJ (corresponding author), OHIO STATE UNIV,DEPT PHYS MED & REHABIL,DODD HALL,480 W 9TH AVE,COLUMBUS,OH 43210, USA.		Corrigan, John D./E-2921-2011; Mysiw, Walter/E-3724-2011	Clinchot, Daniel/0000-0002-2810-7227			BARNS EK, 1973, GERONTOLOGIST, V13, P513; BOCH M, 1980, REHABILITATION HEAD; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; CERNY J, 1983, REHABILITATION HEAD, P345; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; JACKSON RD, 1989, ARCH PHYS MED REHAB, V70, P33; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; JENNETT B, 1983, REHABILITATION HEAD; JENNETT HB, 1983, REHABILITATION HEAD; KAPLAN CP, 1994, ARCH PHYS MED REHAB, V75, P643, DOI 10.1016/0003-9993(94)90186-4; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; OTTO RI, 1994, APA 102 ANN CONV LOS; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Symonds CP, 1943, LANCET, V1, P7	22	4	4	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1996	11	6					1	8		10.1097/00001199-199612000-00003			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VW427	WOS:A1996VW42700002					2022-02-06	
J	Bullock, MR; Povlishock, JT				Bullock, MR; Povlishock, JT			The role of antiseizure prophylaxis following head injury	JOURNAL OF NEUROTRAUMA			English	Article							POST-TRAUMATIC SEIZURES; PROPHYLACTICALLY ADMINISTERED PHENYTOIN; SEVERE BRAIN INJURIES; POSTTRAUMATIC SEIZURES; EPILEPSY PROPHYLAXIS; PREVENTION; FAILURE; RISK		UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143; UNIV TEXAS,SCH MED,HOUSTON,TX; CORNELL UNIV,COLL MED,ITHACA,NY 14853; UNIV PITTSBURGH,COLL MED,PITTSBURGH,PA 15260; TEMPLE UNIV,SCH MED,PHILADELPHIA,PA 19122; UNIV WASHINGTON,SCH MED,SEATTLE,WA 98195; UNIV ALABAMA,BIRMINGHAM,AL; ALLEGHENY GEN HOSP,DEPT NEUROL SURG,PITTSBURGH,PA 15212		Bullock, MR (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23284, USA.						DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; MANAKA S, 1992, JPN J PSYCHIAT NEUR, V46, P311; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; PECHADRE JC, 1991, PRESSE MED, V20, P841; PENRY JK, 1979, NEUROLOGY, V29, pA600; RAPPORT RL, 1973, J NEUROSURG, V38, P159, DOI 10.3171/jns.1973.38.2.0159; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; WOHNS RNW, 1979, J NEUROSURG, V51, P507, DOI 10.3171/jns.1979.51.4.0507; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231; YOUNG B, 1979, EPILEPSIA, V20, P671, DOI 10.1111/j.1528-1157.1979.tb04851.x	14	4	4	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	1996	13	11					731	734					4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	VU812	WOS:A1996VU81200016					2022-02-06	
J	Moreci, G				Moreci, G			A model system of traumatic brain injury peer support importance, development and process	NEUROREHABILITATION			English	Article						peer support; traumatic brain injury (TBI); community program; family support; model system; rehabilitation	RELATIVES	This manuscript describes the development and implementation of a unique volunteer service intended to meet the support needs of individuals with traumatic brain injury (TBI) and their families. As a part of the Traumatic Brain Injury Model System of Care, funded by the National Institute on Disability and Rehabilitation Research (NIDRR), the TBI Peer Support Program provides a valuable service of volunteer support from admission through community integration after discharge. TBI Peer Support Volunteers give individual attention to people with TBI and families through active listening, referral to community resources, and provision of information regarding TBI. The importance of including a structured individual peer support system is supported by clinical research review and patient and family interviews. The establishment and evolution of the program are described as well as suggestions for the creation and development of new volunteer TBI Peer Support Programs.			Moreci, G (corresponding author), TRAUMAT BRAIN INJURY MODEL SYST CARE,950 S BASCOM AVE,SUITE 2011,SAN JOSE,CA 95128, USA.						Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Kbler-Ross E., 1969, DEATH DYING; LEZAK M, 1981, 4 ANN C HEAD TRAUM R; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LEZAK MD, 1980, 8 ANN M INT NEUR SOC; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Stern J M, 1988, Brain Inj, V2, P259, DOI 10.3109/02699058809150951; WITOL A, 1996, MOD SYST C WASH DC A	11	4	4	1	2	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	NOV	1996	7	3					211	218		10.1016/1053-8135(96)00194-1			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VQ826	WOS:A1996VQ82600007	24525891				2022-02-06	
J	Tsurushima, H; Meguro, K; Narushima, K; Nagotomo, Y; Suzuki, K; Nakai, K; Wada, M; Yoshii, Y; Nose, T				Tsurushima, H; Meguro, K; Narushima, K; Nagotomo, Y; Suzuki, K; Nakai, K; Wada, M; Yoshii, Y; Nose, T			FLAIR images of patients with head injuries	NEUROLOGICAL SURGERY			Japanese	Article						magnetic resonance images; fluid-attenuated inversion recovery; cerebral contusion; diffuse axonal injury; traumatic subarachnoid hemorrhage	RECOVERY PULSE SEQUENCES; SUBARACHNOID HEMORRHAGE; MR; BRAIN	FLAIR (fluid-attenuated inversion recovery) images are MR images obtained with an inversion recovery sequence, which has a long inversion time (TI) and a long echo time (TE). We examined 29 cases (49 graphics) of cerebral contusion, 11 cases (22 graphics) of diffuse axonal injury (DAI) and 11 cases (11 graphics) of traumatic subarachnoid hemorrhage (t-SAH) with FLAIR sequence consisting of a repetitive time (TR) of 6500msec, TI of 1700msec and TE of 110msec, and these graphics were compared with T2-weighted images by spin-echo sequence (TR 2500msec, TE 90 msec) and computed tomographic (CT) scans. Some lesions of DAI were demonstrated more clearly with FLAIR images than with conventional T2-weighted images. Although contusion could be detected with FLAIR images as well as with conventional T2-weighted images, lesions adjacent to cerebral sulci were better delineated with FLAIR images. Because the cerebrospinal fluid signals in cerebral sulci were low-intensity, FLAIR images were useful in detecting lesions of the cerebral cortex adjacent to cerebral sulci. Although it has been reported that detection of SAH is difficult with standard T1-and T2-weighted images, the presence of t-SAH could be confirmed with FLAIR im ages as seen in CT scans.	TSUKUBA MED CTR HOSP,DEPT NEUROSURG,TSUKUBA,IBARAKI,JAPAN; TSUKUBA MED CTR HOSP,DEPT RADIOL,TSUKUBA,IBARAKI,JAPAN; UNIV TSUKUBA,INST CLIN MED,DEPT NEUROSURG,TSUKUBA,IBARAKI 305,JAPAN								BRADLEY WG, 1985, RADIOLOGY, V156, P99, DOI 10.1148/radiology.156.1.4001427; DECOENE B, 1992, AM J NEURORADIOL, V13, P1555; GENNARELLI, 1987, HEAD INJURY, P117; HAJNAL JV, 1992, J COMPUT ASSIST TOMO, V16, P841, DOI 10.1097/00004728-199211000-00001; HAJNAL JV, 1992, J COMPUT ASSIST TOMO, V16, P506, DOI 10.1097/00004728-199207000-00002; NOGUCHI K, 1994, AM J NEURORADIOL, V15, P1940; RYBERG JN, 1994, RADIOLOGY, V193, P173; WHITE SJ, 1992, MAGNET RESON MED, V28, P153, DOI 10.1002/mrm.1910280116	8	4	4	0	1	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	OCT	1996	24	10					891	895					5	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	VT801	WOS:A1996VT80100004	8914147				2022-02-06	
J	CaradocDavies, TH				CaradocDavies, TH			Traumatic mutism in severe head injury relieved by oral diazepam	DISABILITY AND REHABILITATION			English	Article						mutism; head injury; diazepam		A 34-year-old woman with a severe closed-head injury had many impairments including apparent global aphasia. After a diazepam premedication for a motor point block she was heard to speak a few words. A trial of oral diazepam succeeded in restoring speech adequate to make her needs known, which persisted on a maintenance dose of 5 mg t.d.s. The possible diagnoses and reasons for this phenomenon are discussed. We suggest that diazepam may be useful in assessing speech in selected people with severe head injuries.			CaradocDavies, TH (corresponding author), UNIV OTAGO,DEPT MED,POB 913,DUNEDIN,NEW ZEALAND.						ATSHULER LL, 1986, AM J PSYCHIAT, V142, P1409; COLE AJ, 1988, NEUROLOGY, V38, P31, DOI 10.1212/WNL.38.1.31; JORDAN F M, 1990, Brain Injury, V4, P101, DOI 10.3109/02699059009026154; REYNOLDS JEF, 1989, MARTINDALE EXTRA PHA, P731; VONCRAMON D, 1981, NEUROPSYCHOLOGIA, V19, P801, DOI 10.1016/0028-3932(81)90092-0; WETZEL H, 1987, J NERV MENT DIS, V175, P240, DOI 10.1097/00005053-198704000-00010	6	4	4	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0963-8288			DISABIL REHABIL	Disabil. Rehabil.	SEP	1996	18	9					482	484		10.3109/09638289609165913			3	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	VG326	WOS:A1996VG32600007	8877308				2022-02-06	
J	Okuyama, S; Yamada, S; Ogawa, S; Kawashima, N; Tomisawa, K; Shima, K; Kamata, K				Okuyama, S; Yamada, S; Ogawa, S; Kawashima, N; Tomisawa, K; Shima, K; Kamata, K			Effect of VA-045 on central noradrenergic neuronal system in rats	GENERAL PHARMACOLOGY			English	Article						VA-045; closed head injury; DSP4; microdialysis; clonidine; frontal cortex; rat locus coeruleus	BRAIN	1. Administration of VA-045 [2-(nitrooxy)ethyl apovincaminate] and thyrotropin-releasing hormone (TRH) led to improvement in the closed head injury (CHI) induced neuronal dysfunction such as the loss of righting reflex and disruption of spontaneous movement in rats. 2. The improvement seen with effect of VA-045, but not TRH, was abolished in rats pretreated with N-2-chloroethyl-N-ethyl-2-bromobenzylamine (DSP4), a selective noradrenaline (NA) neurotoxin. DSP4 reduced endogenous NA levels in all central nervous system (CNS) regions analyzed. 3. The extracellular concentrations of NA in the frontal cortex (FC) and in the locus coeruleus (LC) of urethane anesthetized rats were measured using in vivo microdialysis coupled with high-performance liquid chromatography (HPLC) with electrochemical detection. VA-045 had no effect on extra-cellular concentrations of NA, in both FC and LC. Perfusion with clonidine, an alpha(2) adrenoceptor agonist, led to inhibition in NA output in both FC and LC, and VA 045 antagonized the effect of clonidine. 4. These findings indicate that the mode of action of VA-045 may be, at least in part, related to central NA neuronal systems.	NIHON BIORES CTR INC,HASHIMA,GIFU,JAPAN; NATL DEF MED COLL,TOKOROZAWA,SAITAMA 359,JAPAN; HOSHI UNIV,INST MED CHEM,DEPT PHYSIOL & MORPHOL,TOKYO 142,JAPAN		Okuyama, S (corresponding author), TAISHO PHARMACEUT CO LTD,MED RES LABS,LAB 1,1-403 YOSHINO CHO,OMIYA,SAITAMA 330,JAPAN.						ARAKAWA S, 1995, IN PRESS LIFE SCI; BOYAJIAN C, 1977, J PHARMACOL EXP THER, V241, P1079; JONSSON G, 1982, NEUROSCIENCE, V7, P2895, DOI 10.1016/0306-4522(82)90112-9; KAWASHIMA Y, 1993, J MED CHEM, V36, P815, DOI 10.1021/jm00059a004; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MIYAMOTO M, 1982, PHARMACOL BIOCHEM BE, V17, P797, DOI 10.1016/0091-3057(82)90363-X; MIYATA N, 1993, LIFE SCI, V52, P181; OKUYAMA S, 1987, N-S ARCH PHARMACOL, V335, P667, DOI 10.1007/BF00166984; OKUYAMA S, 1994, GEN PHARMACOL, V25, P1311; OKUYAMA S, 1993, RES COMMUN CHEM PATH, V82, P91; OKUYAMA S, 1994, LIFE SCI, V20, P1577; OKUYAMA S, 1993, LIFE SCI, V53, P273; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; ROSS SB, 1976, BRIT J PHARMACOL, V58, P521, DOI 10.1111/j.1476-5381.1976.tb08619.x; Suzuki Masahiko, 1994, Japanese Journal of Pharmacology, V64, p197P; SVENSSON TH, 1975, BRAIN RES, V92, P291, DOI 10.1016/0006-8993(75)90276-0; Uchiyama-Tsuyuki Yoshimi, 1993, Japanese Journal of Pharmacology, V61, p288P; YAMADA S, 1994, RES COMMUN MOL PATH, V86, P83; Yamada Shigeyuki, 1994, Japanese Journal of Pharmacology, V64, p198P	19	4	4	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0306-3623			GEN PHARMACOL	Gen. Pharmacol.	SEP	1996	27	6					1013	1017		10.1016/0306-3623(95)02136-1			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	VK175	WOS:A1996VK17500013	8909984				2022-02-06	
J	Tokuno, T; Kawakami, Y; Yamamoto, T				Tokuno, T; Kawakami, Y; Yamamoto, T			Isolated infranuclear oculomotor nerve palsy caused by traumatic midbrain hemorrhage: Case report	NEUROLOGICAL SURGERY			Japanese	Article						head injury; midbrain hemorrhage; oculomotor nerve palsy; magnetic resonance imaging	BRAIN-STEM INJURY; CT	Traumatic brain stem hemorrhage is often associated with severe head injury and has a high mortality rate. When these patients survive, the midbrain syndromes are usually complicated. The authors report an unusual case with isolated oculomotor nerve palsy caused by acute traumatic midbrain hemorrhage. A 50-year-old woman was brought to Kobe City General Hospital because she had fallen off a bicycle and hit the face severely on the ground. On admission, she was drowsy. Neurological examination revealed normal muscle tone in all extremities without motor or sensory disturbance. Deep-tendon reflexes were sym metrical and there were no Babinski signs present. The left eye lid dropped and the left pupil was 5.5 mm in diameter without responses to light. The eye ball was slightly deviated to the left side on neutral position. There were no extraocular movements except for abduction to the left side. The right pupil measured 3 mm in diameter and was reactive to light promptly. Plane skull films failed to show fractures. Computed tomography (CT) scan 30 minutes after the accident suggested the existence of a hemorrhage in the anterior tegmentum of the left midbrain. Four hours later, a midbrain hemorrhage was diagnosed by consecutive CT scans. She was alert on the next day, although the third nerve palsy remained. The left blephaloptosis disappeared gradually during the next month. At 6 months after the accident, the left pupil was still dilated and did not react to light, either directly or indirectly. Medial gaze recovered almost fully, while both upward and downward movements were still limited. The mechanism of the isolated oculomotor nerve palsy in this case was discussed with a review of the related literature.	KOBE CITY GEN HOSP,DEPT NEUROSURG,KOBE,HYOGO,JAPAN								BLAKE PY, 1995, AJNR, V16, P1655; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; KRUGER M, 1986, J TRAUMA, V26, P1151, DOI 10.1097/00005373-198612000-00021; MEYER CA, 1991, RADIOLOGY, V179, P813, DOI 10.1148/radiology.179.3.2027997; ROPPER AH, 1985, ANN NEUROL, V18, P80, DOI 10.1002/ana.410180114; TSAI FY, 1980, AM J ROENTGENOL, V134, P717, DOI 10.2214/ajr.134.4.717; ZUCCARELLO M, 1983, ACTA NEUROCHIR, V67, P103, DOI 10.1007/BF01401670	8	4	4	0	0	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	SEP	1996	24	9					849	852					4	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	VL716	WOS:A1996VL71600012	8827736				2022-02-06	
J	Fukuda, T; Mikoshiba, M; Fukushima, C; Nishi, T; Nakajima, S; Hasue, M; Ikeda, K; Sengoku, Y; Ito, H				Fukuda, T; Mikoshiba, M; Fukushima, C; Nishi, T; Nakajima, S; Hasue, M; Ikeda, K; Sengoku, Y; Ito, H			Effects of traumatic subarachnoid hemorrhage on pathological properties in diffuse brain injury: A comparison with aneurysmal subarachnoid hemorrhage	NEUROLOGICAL SURGERY			Japanese	Article						head trauma; subarachnoid hemorrhage; diffuse brain injury; vasospasm; delayed ischemic neurological deficit	CEREBRAL BLOOD-FLOW; TRANSCRANIAL DOPPLER ULTRASOUND; HEAD-INJURY; COMPUTED TOMOGRAPHY; CONTROLLED TRIAL; ARTERIAL SPASM; VASOSPASM; ISCHEMIA; NIMODIPINE	As a result of recent advances in continuous monitoring equipment, it has been reported that vasospasm (VS) and delayed ischemic neurological deficit (DIND) occur as frequently in traumatic subarachnoid hemorrhage (TSAH) as in subarachnoid hemorrhage due to ruptured intracranial aneurysm (ASAH), and these VS and DIND have been reported to affect the outcome of TSAH adversely in many cases. When we compared TSAH secondary to diffuse brain injury (DBI) with ASAH, however, these two conditions were evidently different from each other in nature. Then we compared laboratory data, clinical course, and outcomes of TSAH associated with DBI with those of ASAH, to determine whether TSAH results in poor outcomes of DBI. On CT scans, patterns of SAH distribution were different from each other, and SAH was detected in 76% of the patients with ASAH on day 4, whereas only 2.0% of the patients with TSAH had detectable SAH on day 3. The incidence rates of detectable SAH in both groups remained significantly different from each other after day 2. The cerebral blood flow (CBF) decreased to around 75% of the normal flow in the acute stage of ASAH, and it decreased further to around 65% in the subacute stage. In TSAH, in contrast, CBF varied widely among the patients. The average CBF decreased to about 70% in the acute stage, and then it increased to around the lower limit of the normal range in the subacute stage. The urinary output and serum concentration of low molecular protein compositions in TSAH were markedly different from those in ASAH. In addition, the contour of a low density area (LDA) in CT scans in the subacute-chronic stage was the same as that of the area supplied by the artery being constricted due to cerebro-vascular spasm in ASAH. In TSAH, in contrast, hardly any LDA had a form that was suggestive of this conjunction, with cerebro-vascular spasm and the incidence rate of LDAs was significantly different from that for ASAH. About 30% of the patients with ASAH had ventricular enlargement, which was diagnosed as normal pressure hydrocephalus by cisternography, in the chronic stage. Surgical shunting was effective for these patients. In TSAH, ventricular enlargement was observed in more than 50% of the patients, bur almost none of these patients underwent surgical shunting, because it resulted from cerebral atrophy. Regardless of causes of SAH, the severer SAH was, the more often patients had a poor our-come. The outcome of TSAH was, however, significantly poorer than that of ASAH. When SAH was traumatic, it disappeared by the time VS developed and, in addition, changes in CBF and the form and incidence rate of LDAs were different from those in ASAH. We concluded that, although TSAH is an adverse prognostic factor for DBI, it does nor contribute to poor outcomes of DBI by giving rise to DIND caused by VS.	TOKYO MED COLL,HACHIOJI MED CTR,DEPT NEUROSURG,TOKYO 160,JAPAN; TOKYO MED COLL,HACHIOJI MED CTR,DEPT ANESTHESIOL,TOKYO 160,JAPAN								ALLEN GS, 1983, NEW ENGL J MED, V308, P619, DOI 10.1056/NEJM198303173081103; BELLNER J, 1994, ICRAN 94 P, P119; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CHAN KH, 1992, NEUROSURGERY, V30, P697; COLUMELLA F, 1963, ACTA RADIOL DIAGN, V1, P239, DOI 10.1177/028418516300100217; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; FUKUDA T, 1993, DEVEL NEUR, V8, P71; HAHN FJY, 1976, AM J ROENTGENOL, V126, P593, DOI 10.2214/ajr.126.3.593; IKEDA K, 1994, 7TH EUROPEAN CONGRESS ON INTENSIVE CARE MEDICINE, P447; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KANNO I, 1979, J COMPUT ASSIST TOMO, V3, P71, DOI 10.1097/00004728-197902000-00012; KNUCKEY NW, 1985, J NEUROSURG, V62, P850, DOI 10.3171/jns.1985.62.6.0850; KUHL DE, 1986, AM J PHYSL IMAG, V1, P186; LILIEQUIST B, 1978, ACTA NEUROL SCAND, V67, P165; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MEYER CHA, 1982, BMJ-BRIT MED J, V285, P1149, DOI 10.1136/bmj.285.6349.1149; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; PETRUK KC, 1988, J NEUROSURG, V68, P505, DOI 10.3171/jns.1988.68.4.0505; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; WILKINS RH, 1975, HDB CLIN NEUROLOGY 1, V23, P163; YONAS H, 1989, NEUROSURGERY, V24, P368, DOI 10.1227/00006123-198903000-00010	24	4	4	0	1	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	AUG	1996	24	8					723	731					9	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	VE668	WOS:A1996VE66800006	8741407				2022-02-06	
J	Gellman, H; Keenan, MAE; Botte, MJ				Gellman, H; Keenan, MAE; Botte, MJ			Recognition and management of upper extremity pain syndromes in the patient with brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						deep venous thrombosis; heterotopic ossification; reflex sympathetic dystrophy	DEEP-VENOUS THROMBOSIS; HEAD-INJURY	Pain syndromes in the patient with traumatic brain injury (TBI) are often obscure and, therefore, frequently overlooked. spasticity, with resultant joint contracture, is one of the most common causes of pain in the patient with brain injury. Missed fractures, reflex sympathetic dystrophy (RSD), heterotopic ossification (HO), and deep venous thrombosis (DVT) are frequent causes of upper extremity pain in patients alter TBI. RSD in TBI has a 12% overall incidence and presents almost exclusively in the spastic upper extremity. Patients who developed RSD had lower Glasgow Coma Scale scores than the non-RSD patients. Patients with brain injury often display agitation, hyperalgesia, and disuse or neglect of the RSD involved extremity, In addition, these patients are often cognitively unable to vocalize complaints of pain. Undiagnosed pain syndromes such as fractures, RSD, HO, and DVT in these patients can result in a significant delay in rehabilitation and possible loss of the use of an otherwise functional upper extremity.	ALBERT EINSTEIN MED CTR, DEPT ORTHOPAED SURG, PHILADELPHIA, PA USA; UNIV CALIF SAN DIEGO, SAN DIEGO, CA 92103 USA		Gellman, H (corresponding author), UNIV ARKANSAS MED SCI HOSP, DEPT ORTHOPAED SURG, HAND & UPPER EXTREM SERV, 4301 W MARKHAM ST, LITTLE ROCK, AR 72205 USA.		Keenan, Mary Ann/ABB-1551-2020				ANDERSON JM, 1990, ARCH PHYS MED REHAB, V71, P703; Andrews L G, 1971, Paraplegia, V9, P159; BARNES R, 1953, J BONE JOINT SURG BR, V35, P172, DOI 10.1302/0301-620X.35B2.172; Bonica J. J., 1953, MANAGEMENT PAIN SPEC; BOTTE MJ, 1987, J HEAD TRAUMA REHAB, V2, P34; BRAUN RM, 1971, J BONE JOINT SURG AM, VA 53, P1307, DOI 10.2106/00004623-197153070-00006; DAVIS SW, 1977, ARCH PHYS MED REHAB, V58, P353; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DONAYRE CE, 1986, AM J SURG, V152, P179, DOI 10.1016/0002-9610(86)90238-2; EVANS JA, 1947, ANN INTERN MED, V26, P417, DOI 10.7326/0003-4819-26-3-417; Frazee J G, 1986, Emerg Med Clin North Am, V4, P859; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; GARLAND DE, 1981, CLIN ORTHOP RELAT R, V155, P162; GELLMAN H, 1992, PAIN, V51, P307, DOI 10.1016/0304-3959(92)90214-V; GELLMAN H, 1988, CLIN ORTHOP RELAT R, V233, P129; HORATTAS MC, 1988, SURGERY, V104, P561; KEENAN MAE, 1987, J HEAD TRAUMA REHAB, V2, P62; Kwan ST, 1935, ANN SURG, V101, P222, DOI 10.1097/00000658-193501000-00022; LANKFORD LL, 1982, OPERATIVE HAND SURG; MACKINNON SE, 1984, J HAND SURG-AM, V9A, P556, DOI 10.1016/S0363-5023(84)80110-0; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; MIELANTS H, 1975, ACTA ORTHOP SCAND, V46, P190, DOI 10.3109/17453677508989207; MOSKOWITZ E, 1958, JAMA-J AM MED ASSOC, V167, P836, DOI 10.1001/jama.1958.02990240036007; OHRY A, 1978, PARAPLEGIA, V16, P310, DOI 10.1038/sc.1978.60; ORCUTT SA, 1990, J HAND SURG-AM, V15A, P940, DOI 10.1016/0363-5023(90)90020-R; ROWBOTHAM GF, 1941, MED PRESS, V205, P379; Rusk H. A, 1971, REHABILITATION MED; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SHUMACKER HB, 1948, SURG GYNECOL OBSTET, V86, P76; SOBUS KML, 1993, ARCH PHYS MED REHAB, V74, P902; STONE LR, 1992, ARCH PHYS MED REHAB, V73, P486; SZABORN L, 1981, J BONE JOINT SURG BR, V63, P120; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61	36	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1996	11	4					23	30		10.1097/00001199-199608000-00005			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VA386	WOS:A1996VA38600005					2022-02-06	
J	Ruff, RM; Mueller, J; Jurica, P				Ruff, RM; Mueller, J; Jurica, P			Estimation of premorbid functioning after traumatic brain injury	NEUROREHABILITATION			English	Article						premorbid functioning; traumatic brain injury; neurological impairment; treatment planning	POLYDRUG USERS; EDUCATION	Estimation of premorbid functioning in patients with traumatic brain injury (TBI) is a difficult but necessary step both in the assessment of neurological impairment and in planning treatment. Because the estimation process is almost always retrospective, its reliability is questionable. The use of multiple sources of information improves the likelihood of an accurate estimate. The effects of TBI cross a number of domains in the victim's life. Thus, premorbid functioning must be estimated in the physical, cognitive, emotional, social, financial and vocational spheres. Knowledge of baseline or premorbid functioning levels allows the clinician to appreciate the severity of injury, provide a prognosis, and shape treatment goals that are specific to the individual. In this article, we present the key questions to be addressed, suggest sources of information to obtain the answers, describe the processes through which answers should be obtained, and outline the uses for this important information in working with victims of TBI.	UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143; UNIV CALIF BERKELEY,BERKELEY,CA 94720		Ruff, RM (corresponding author), SAN FRANCISCO NEUROPSYCHIAT ASSOCIATES,SAN FRANCISCO,CA, USA.						ALEXANDER MP, 1987, NEUROBEHAVIORAL RECO, P191; BARONA A, 1984, J CLIN PSYCHOL, V52, P855; BOND MR, 1984, CLOSED HEAD INJURY; BORNSTEIN RA, 1988, DEV NEUROPSYCHOL, V4, P17, DOI 10.1080/87565648809540386; Butcher J.N., 1989, MANUAL RESTANDARDIZE; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P267, DOI 10.1111/j.2044-8260.1989.tb01376.x; CULLUM CM, 1989, NEUROPSYCHOLOGICAL F, P269; DEROGATIS L, 1983, SYMPTON CHECK LIST 9; FAHY TJ, 1967, LANCET, V2, P475; GONEN JY, 1970, J CLIN PSYCHOL, V26, P174, DOI 10.1002/1097-4679(197004)26:2<174::AID-JCLP2270260211>3.0.CO;2-L; GRANT I, 1978, ARCH GEN PSYCHIAT, V35, P1063; GRANT I, 1976, AM J PSYCHIAT, V133, P1039; HEATON RK, 1986, NEUROPSYCHOLOGICAL A; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Maccoby E.E., 1974, PSYCHOL SEX DIFFEREN; MCFIE J, 1975, ASSESSMENT ORGANIC I; Millon T., 1994, MILLON CLIN MULTIAXI; MUELLER J, 1996, SYNAPSIS MED PROFILE; Nelson H. E, 1982, NATIONAL ADULT READI; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; ROSENTHAL M, 1990, REHABILITATION ADULT, pCH13; RUFF RM, IN PRESS BRAIN INJUR; RUTTER M, 1981, AM J PSYCHIAT, V138, P1523; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; SWEENEY JA, 1989, J CLIN PSYCHOL, V45, P346, DOI 10.1002/1097-4679(198903)45:2<346::AID-JCLP2270450227>3.0.CO;2-L; Symonds C P, 1937, Proc R Soc Med, V30, P1081; THORP TR, 1959, J CLIN PSYCHOL, V15, P286, DOI 10.1002/1097-4679(195907)15:3<286::AID-JCLP2270150315>3.0.CO;2-W; TOBIS JS, 1976, AM C REH MED ANN M S; VOLLMER DG, 1991, J NEUROSURG, V75, P537; Wechsler, 1997, WECHSLER ADULT INTEL; WILSON R S, 1979, Journal of Clinical Neuropsychology, V1, P49, DOI 10.1080/01688637908401097; YATES AJ, 1954, PSYCHOL BULL, V51, P359, DOI 10.1037/h0059891; ZARIT SH, 1978, J AM GERIATR SOC, V26, P58, DOI 10.1111/j.1532-5415.1978.tb02542.x	38	4	4	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	AUG	1996	7	1					39	53		10.1016/1053-8135(96)00174-6			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UQ717	WOS:A1996UQ71700005	24525805				2022-02-06	
J	Ludlam, WM				Ludlam, WM			Rehabilitation of traumatic brain injury with associated visual dysfunction - A case report	NEUROREHABILITATION			English	Article						traumatic brain injury; visual dysfunction; rehabilitation program	PERCEPTUAL DYSFUNCTION; HIERARCHICAL MODEL	A step-by-step case report describes the rehabilitation program for visual dysfunction of a 52-year-old woman, beginning 2 years post-trauma. Methods to ameliorate such symptoms as diplopia, ocular discomfort, dry eye, inefficient saccadic movement, spasms of accommodation, poor reading comprehension and very limited stamina for near visual tasks are presented. Specific procedures are discussed and results are described and tabulated.			Ludlam, WM (corresponding author), PACIFIC UNIV, COLL OPTOMETRY, FOREST GROVE, OR 97116 USA.						Cohen A H, 1978, J Am Optom Assoc, V49, P831; COHEN AH, 1981, J AM OPTOM ASSOC, V52, P795; Jennett B, 1981, MANAGEMENT HEAD INJU; LUDLAM W, 1992, P NAT AC PRACT 4 NAT, P50; LUDLAM W, 1970, CLIN REFRACTION, P1175; MOORE JC, 1995, CLOSED HEAD INJURY C, P48; Padula W. V., 1988, BEHAV VISION APPROAC; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; REITAN RM, 1986, TRAUMATIC BRAIN INJU, V1, P43; REITAN RM, 1986, TRAUMATIC BRAIN INJU, V2, P35; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; UMPHRED DA, 1995, DISORDERS VISION VIS, P769; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42; WARREN M, 1993, AM J OCCUP THER, V47, P55, DOI 10.5014/ajot.47.1.55	14	4	4	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JUN	1996	6	3					183	192		10.1016/1053-8135(96)00164-3			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UK480	WOS:A1996UK48000004	24525770				2022-02-06	
J	Willer, B; Moscato, BS				Willer, B; Moscato, BS			National prevalence rates of traumatic brain injury among adults: The Canadian household and institutional health and activity limitation surveys, 1986-1987	NEUROREHABILITATION			English	Article						brain injuries; prevalence; epidemiology; disability	HEAD-INJURY; EPIDEMIOLOGY; POPULATION; COMMUNITY; COUNTY	The purpose of this study was to establish national point prevalence rates for traumatic brain injury, resulting in recognizable disability among adults living in institutions or in the community. The report is based on the Canadian Health and Activity Limitation Surveys (1986-1987), conducted in households and in institutions by Statistics Canada. These surveys used multi-stage cluster design with stratification, unequal probabilities of selection and computer linkage to the 1986 census of the population (households only). A combined representative sample of 632 adults with disabilities resulting from an injury to the brain provides a total population estimate of 15 000 adults. Participation rate by potential respondents was 90% in the household survey, and 97% for the institutional survey. The overall national prevalence of traumatic brain injury is 74.3 per 100 000 (95% Ct 66.3-82.4) adults, Prevalence rates are highest in the 45-64 age range. Gender specific rates are 96.9 per 100 000 males and 52.9 per 100 000 females, with a 1.8:1 male to female ratio. The vast majority (84%) of adults with traumatic brain injury reside in household, rather than institutional settings, Prevalence rates allow estimates of the national public health burden of traumatic brain injury. Findings point to the health care burden of middle aged individuals living primarily in community settings.	SUNY BUFFALO,DEPT REHABIL MED,BUFFALO,NY 14214; ONTARIO BRAIN INJURY ASSOC,CTR RES COMMUNITY INTEGRAT,ST CATHARINES,ON,CANADA; SUNY BUFFALO,DEPT SOCIAL & PREVENT MED,BUFFALO,NY 14214		Willer, B (corresponding author), SUNY BUFFALO,DEPT PSYCHIAT,FARBER HALL 197,BUFFALO,NY 14214, USA.						ANDERSON DW, 1980, J NEUROSURG, V53, pS11; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; DOLSON D, 1987, SUURVEY METHODOLOGY, V13, P93; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; FIELD JH, 1976, EPIDEMIOLOGY HEAD IN; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; FURRIE A, 1987, NATL DATABASE DISABL; GRAHAM D, 1986, VITAL HLTH STAT 13, V95; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KELLYHAYES M, 1992, AM J PUBLIC HEALTH, V82, P841, DOI 10.2105/AJPH.82.6.841; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1980, J NEUROSURG, V53, pS35; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1991, NEUROEPIDEMIOLOGY TR, P333; Kraus JF, 1987, HEAD INJURY, V2, P1; MCDOWELL I, 1988, DISABILITY SCORE HLT; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; POPE AM, 1991, DISABILITY AM NATL A; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P119; SELECKI BR, 1981, INJURIES HEAD SPINE; *STAT CAN, 1989, DAT TYP US MAN HLTH; *STAT CAN, 1991, SPEC TOP SER HLTH AC, V4; *STAT CAN, 1990, HALS I DAT VAR DICT; *STAT CAN, 1988, DIS DAT PROGR US GUI; *STAT CAN, 1991, SPEC TOP SER HLTH AC, V6; *STAT CAN, 1989, HALS HOUS DAT VAR DI; *STAT CAN, 1988, POST CENS SURV PROGR; THEBERGE A, 1988, WEIGHTING HLTH ACTIV; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; *WHO, 1980, INT CLASS IMP DIS HA, P143	36	4	4	0	2	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JUN	1996	6	3					219	228		10.1016/1053-8135(96)00168-0			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UK480	WOS:A1996UK48000008	24525774				2022-02-06	
J	Tarvydas, VM; Shaw, L				Tarvydas, VM; Shaw, L			Interdisciplinary team member perceptions of ethical issues in traumatic brain injury rehabilitation	NEUROREHABILITATION			English	Article						traumatic brain injury; interdisciplinary; ethical perceptions; rehabilitation		Traumatic brain injury (TBI) rehabilitation is one of the most challenging and complex aspects of rehabilitation clinically, administratively, and ethically. The prevailing standard of care in this area emphasizes the importance of treatment within an interdisciplinary team model. Empirical literature related to both individual clinician and team aspects of the ethical issues involved in head injury rehabilitation has been lacking. This study utilized a survey approach to describe the perceptions of interdisciplinary team members in TBI rehabilitation at various care-levels in rehabilitation regarding ethical issues in their practice. A sample of 84 interdisciplinary team members responded to a new survey instrument, the Ethical Urgency Survey (EUS), describing the frequency of issues, their importance, and the perceived level of distress with ethical dilemmas in five domains of TBI practice: legal, rehabilitation treatment, family/social, medical treatment, and research issues. Additionally, it was found that there were significant differences between how members of different disciplinary groups viewed these ethical issues.	UNIV FLORIDA,DEPT REHABIL COUNSELING,GAINESVILLE,FL 32610		Tarvydas, VM (corresponding author), UNIV IOWA,N362 LINDQUIST CTR,IOWA CITY,IA 52240, USA.						Banja J D, 1994, Rehab Manag, V7, P61; BANJA JD, 1994, REHABIL MANAGE, V7, P65; BANJA JD, 1992, J HEAD TRAUMA REHAB, V8, P116; BANJA JD, 1994, REHABIL MANAGE, V7, P136; Beauchamp T.L., 1979, PRINCIPLES BIOMEDICA; CALLAHAN D, 1988, ARCH PHYS MED REHAB, V69, P323; Caplan A L, 1987, Hastings Cent Rep, V17, P1, DOI 10.2307/3563190; CAPLAN AL, 1988, ARCH PHYS MED REHAB, V69, P312; COLE S, 1985, SEX DISABIL, V7, P71; Cope D. N., 1989, J HEAD TRAUMA REHAB, V4, P13; DeJong G., 1989, J HEAD TRAUMA REHAB, V4, P1; GARTRELL N, 1986, AM J PSYCHIAT, V143, P1126; Gatens-Robinson E., 1992, J APPLIED REHABILITA, V23, P26; Gilligan Carol, 1982, DIFFERENT VOICE; GOTTLIEB MC, 1988, PROF PSYCHOL RES PRA, V4, P459; HAAS JF, 1988, ARCH PHYS MED REHAB, V69, P329; HAHN H, 1989, WORLD REHABILITATION, P101; JENNINGS B, 1988, ETHICAL CHALLENGES C; KITCHENER KS, 1984, COUNS PSYCHOL, V12, P43, DOI 10.1177/0011000084123005; KOSCIULEK JF, 1993, J REHABIL, V59, P40; Levenson J L, 1989, Psychiatr Med, V7, P59; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; Matson J. L., 1981, CLIN PSYCHOL REV, V1, P197; McMahon B.T., 1991, ADV BRAIN INJURY REH; MCMAHON BT, 1991, ADV BRAIN INJURY REH, P5; MULLINS LL, 1994, REHABIL PSYCHOL, V39, P161, DOI 10.1037/h0080320; *NAT HEAD INJ FDN, 1988, TRAUM HEAD INJ REV G; *NAT HEAD INJ FDN, 1989, ETH MARK PRACT HLTH; Neukrug E. S., 1992, COUNS EDUC SUPERV, V32, P130; NODDINGS N, 1984, FEMININE APPROACH ET; PURTILO RB, 1988, ARCH PHYS MED REHAB, V69, P318; REST JR, 1984, COUNS PSYCHOL, V12, P10; Romano M. D., 1989, J HEAD TRAUMA REHAB, V4, P33; TARVYDAS VM, 1991, J APPL REHABIL COUNS, V24, P11; THAW J, 1978, ADM MENT HEALTH, V5, P112, DOI 10.1007/BF00820756; THOMASMA DC, 1977, J ALLIED HLTH, V7, P15; VANHOUTEN R, 1988, J APPL BEHAV ANAL, V21, P381, DOI 10.1901/jaba.1988.21-381; WATSONARMSTRONG LA, 1993, J APPL REHABIL COUNS, V25, P36; Williams J., 1990, J HEAD TRAUMA REHAB, V5, P9, DOI [https://doi.org/10.1097/00001199-199003000-00004, DOI 10.1097/00001199-199003000-00004]; 1987, J APPL REHABIL COUNS, V18, P25; 1988, AM PSYCHOL, V43, P564	42	4	4	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	APR	1996	6	2					97	111		10.1016/1053-8135(96)00155-2			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UE910	WOS:A1996UE91000002	24525721				2022-02-06	
J	Minderhoud, JM; vanZomeren, AH; vanderNaalt, J				Minderhoud, JM; vanZomeren, AH; vanderNaalt, J			The fronto-temporal component in mild and moderately severe head injury	ACTA NEUROLOGICA BELGICA			English	Article; Proceedings Paper	Symposium on Temporal Lobe Disorders	OCT   20, 1995	ELEWIJT, BELGIUM			head injury; temporal lobe; minor head injury; neurotransmitter metabolism; treatment		The history of the identification of the so-called (fronto-)temporal lobe contusion is reviewed. Treatment of minor head injuries actually starts with the right diagnosis. Injuries of the temporal lobe, characterized by a comparatively long period of post-traumatic amnesia should be distinguished from minor head injuries (cerebral concussion). Treatment of minor head injuries should include good information and explanation of the medical aspects of minor head injuries to prevent the so called post-concussional syndrome, with long lasting sequelae. Changes of neurotransmitter metabolism in various kinds of head injuries have been known for many years. Treatment with precursors of neurotransmitters (particularly physostigmine and L-DOPA) can be useful in unconsciousness and amnestic syndromes.			Minderhoud, JM (corresponding author), UNIV GRONINGEN HOSP,DEPT NEUROL,POSTBOX 30001,9700 RB GRONINGEN,NETHERLANDS.			van der Naalt, Joukje/0000-0001-9873-2418			CATSMANBERREVOETS CE, 1986, J NEUROL NEUROSUR PS, V49, P1088, DOI 10.1136/jnnp.49.9.1088; EAMES P, 1995, BRAIN INJURY, V9, P729, DOI 10.3109/02699059509008228; GOLDBERG E, 1982, ARCH NEUROL-CHICAGO, V39, P581, DOI 10.1001/archneur.1982.00510210051012; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; Minderhoud J M, 1982, Ned Tijdschr Geneeskd, V126, P1665; MINDERHOUD JM, 1976, ACTA NEUROCHIR, V34, P23, DOI 10.1007/BF01405860; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; VANWOERKOM TCAM, 1977, LANCET, V1, P812; VECHT CJ, 1975, ARCH NEUROL-CHICAGO, V32, P792, DOI 10.1001/archneur.1975.00490540036004	10	4	4	1	2	ACTA MEDICA BELGICA	BRUSSELS	AVENUE CIRCULAIRE 138-A, B-1180 BRUSSELS, BELGIUM	0300-9106			ACTA NEUROL BELG	Acta Neurol. Belg.	MAR	1996	96	1					31	34					4	Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UF643	WOS:A1996UF64300004	8669225				2022-02-06	
J	Rosenfeld, JV; Watters, DAK; Jacob, OJ				Rosenfeld, JV; Watters, DAK; Jacob, OJ			Neurosurgery in Papua New Guinea	AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY			English	Article						developing countries; education; graduate; neurosurgery; Papua New Guinea; tropical medicine		Background: An audit of neurosurgery in Papua New Guinea (PNG) based on the experience of a visiting neurosurgeon is presented. The objectives of the study were to determine the type and frequency of neurosurgical conditions in PNG, whether major neurosurgery can be performed successfully in PNG, and to develop a strategy for the development of neurosurgical services in PNG. Methods: The audit was carried out over two periods of 2 weeks duration in 1992 and 1993 in Port Moresby and Goroka. Instrumentation and equipment were limited and no additional equipment was used. Myelography and angiography were available in Port Moresby. Result: There were 82 patients in total, 55 (67.1%) were consultations, 23 (28%) had elective surgery, four 4.8% had emergency surgery and 16 (19.5%) await surgery. Cases were subdivided into nine major groupings: neurotrauma 18 (seven severe); spine 18; congenital 13; hydrancephaly four; scalp, skull and orbit six; vascular three; peripheral nerve three; and neurology five. Seventy-two (87.8%) patients required CT/MRI which were unavailable. Four ventriculograms were performed in lieu of CT/MRI. Fifteen (18.3%) cases could not be treated in PNG. Conclusions: Neurosurgical problems in PNG can often be adequately managed with limited resources. Complex procedures were performed with gratifying results and acceptable morbidity. There is sufficient pathology in a country of four million people to justify training a small number of neurosurgeons by the end of the decade. CT scanning will be a necessary adjunct.	UNIV PAPUA NEW GUINEA,DEPT SURG,PORT MORESBY,PAPUA N GUINEA		Rosenfeld, JV (corresponding author), ROYAL MELBOURNE HOSP,DEPT NEUROSURG,PARKVILLE,VIC 3050,AUSTRALIA.		Watters, David Allan/AAI-1022-2020; Rosenfeld, Jeffrey V/B-7249-2011	Watters, David Allan/0000-0002-5742-8417; 			ADELOYE A, 1983, NEUROSURGERY, V13, P333, DOI 10.1227/00006123-198309000-00024; CLEZY JKA, 1989, PAPUA NEW GUINEA MED, V32, P287; CLEZY JKA, 1993, MED J AUSTRALIA, V159, P552, DOI 10.5694/j.1326-5377.1993.tb138012.x; DAR J, 1985, NEUROSURGERY, V16, P267, DOI 10.1227/00006123-198502000-00029; DJHNGA S, 1983, NEUROSURGERY, V13, P95, DOI 10.1227/00006123-198307000-00022; JACOB OJ, 1994, AUST NZ J SURG, V64, P856, DOI 10.1111/j.1445-2197.1994.tb04564.x; Karapurkar A P, 1983, Neurosurg Rev, V6, P85, DOI 10.1007/BF01742759; LAWS ER, 1993, NEUROSURGERY, V33, P775; LEE RG, 1983, CAN J NEUROL SCI, V10, P117, DOI 10.1017/S0317167100044760; LOEFLER IJP, 1988, CLIN TROP MED COMM D, V3, P173; LOURIE JA, 1982, PAPUA NEW GUINEA MED, V25, P214; NELSON DC, 1991, ACCIDENT ANAL PREV, V23, P109, DOI 10.1016/0001-4575(91)90042-4; PUPLAMPU B, 1983, NEUROSURGERY, V12, P241, DOI 10.1097/00006123-198302000-00022; ROSENFELD JV, 1982, PAPUA NEW GUINEA MED, V25, P189; SINHA SN, 1981, PAPUA NEW GUINEA MED, V24, P322; SMITH ED, 1994, AUST NZ J SURG, V64, P1, DOI 10.1111/j.1445-2197.1994.tb02121.x; VISVANATHAN R, 1994, AUST NZ J SURG, V64, P527, DOI 10.1111/j.1445-2197.1994.tb02278.x; Watters D A, 1991, J R Coll Surg Edinb, V36, P402; Watters D A, 1988, J R Coll Surg Edinb, V33, P35; WATTERS DAK, 1987, BRIT MED J, V295, P761, DOI 10.1136/bmj.295.6601.761; WATTERS DAK, 1991, CARE CRITICALLY ILL, P294; *WORLD BANK, 1993, 1993 WORLD BANK; WYATT G B, 1980, Papua New Guinea Medical Journal, V23, P60	23	4	4	0	0	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	0004-8682			AUST NZ J SURG	Aust. N. Z. J. Surg.	FEB	1996	66	2					78	84		10.1111/j.1445-2197.1996.tb01116.x			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UQ374	WOS:A1996UQ37400005	8602819				2022-02-06	
J	Soltesz, I				Soltesz, I			Heme oxygenase inhibitors in neurotrauma - Commentary	NEUROREPORT			English	Article											Soltesz, I (corresponding author), UNIV CALIF IRVINE,DEPT ANAT & NEUROBIOL,IRVINE,CA 92717, USA.							0	4	4	0	1	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	0959-4965			NEUROREPORT	Neuroreport	JAN 31	1996	7	2					385	386					2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC299	WOS:A1996UC29900002					2022-02-06	
J	Schmieder, K; Hardenack, M; Harders, A				Schmieder, K; Hardenack, M; Harders, A			Cerebral hemodynamics in patients with traumatic subarachnoid hemorrhage-sequential studies with TCD	ACTA NEUROLOGICA SCANDINAVICA			English	Article; Proceedings Paper	3rd International Conference on Xenon/CT CBF	JUN 25-28, 1995	COPENHAGEN, DENMARK				TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; INTRACRANIAL CIRCULATORY ARREST; BLOOD-FLOW; HEAD-INJURY; ARTERIAL SPASM; ANGIOGRAPHIC FINDINGS; BRAIN-DEATH; ACUTE PHASE; VELOCITY; NIMODIPINE				Schmieder, K (corresponding author), RUHR UNIV BOCHUM,KNAPPSCHAFTSKRANKENHAUS,DEPT NEUROSURG,W-4630 BOCHUM,GERMANY.						AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; ALLEN GS, 1983, NEW ENGL J MED, V308, P619, DOI 10.1056/NEJM198303173081103; COLD GE, 1980, ACTA ANAESTH SCAND, V24, P245, DOI 10.1111/j.1399-6576.1980.tb01544.x; COLD GE, 1986, ACTA ANAESTH SCAND, V30, P453, DOI 10.1111/j.1399-6576.1986.tb02452.x; Compton J S, 1987, Br J Neurosurg, V1, P435, DOI 10.3109/02688698708999633; DAHL A, 1992, STROKE, V23, P15, DOI 10.1161/01.STR.23.1.15; FISCHER CM, 1980, NEUROSURGERY, V6, P1; FISCHER CM, 1977, NEUROSURGERY, V1, P245; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; HAMER J, 1982, ACTA NEUROCHIR, V63, P209, DOI 10.1007/BF01728874; HARDERS A, 1986, NEUROSURGICAL APPLIC; HARDERS AG, 1989, INT J NEUROSCI, V47, P91, DOI 10.3109/00207458908987421; HASSLER W, 1988, J NEUROSURG, V68, P745; HASSLER W, 1989, J NEUROSURG, V71, P195, DOI 10.3171/jns.1989.71.2.0195; KASSEL NF, 1980, CEREBRAL ARTERIAL SP; Kodama N, 1980, CEREBRAL ARTERIAL SP; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; LJUNGGREN B, 1982, ACTA NEUROCHIR, V63, P215, DOI 10.1007/BF01728875; LJUNGGREN B, 1984, J NEUROSURG, V61, P864, DOI 10.3171/jns.1984.61.5.0864; LJUNGGREN B, 1984, SURG NEUROL, V22, P605, DOI 10.1016/0090-3019(84)90438-5; LUNDAR T, 1990, ACTA NEUROCHIR, V102, P85, DOI 10.1007/BF01405419; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; NEWELL DW, 1989, NEUROSURGERY, V24, P509, DOI 10.1227/00006123-198904000-00004; NEWELL DW, 1992, CLIN NEUROSURG, V39; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PASQUALIN A, 1984, NEUROSURGERY, V15, P855, DOI 10.1227/00006123-198412000-00015; POWERS AD, 1989, NEUROSURGERY, V24, P884, DOI 10.1227/00006123-198906000-00015; REUTERN VM, 1991, DT ARZTEBL, V88, pB2844; SAITO J, 1980, CEREBRAL ARTERIAL SP; SAUNDERS FW, 1988, SURG NEUROL, V29, P401, DOI 10.1016/0090-3019(88)90049-3; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; TEASDALE G, 1974, LANCET, V2, P81; The European Study Group on Nimodipine in Severe Head Injury, 1994, J NEUROSURG, V80, P797; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; WHITE RP, 1980, CEREBRAL ARTERIAL SP; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626; WILKINS RH, CEREBRAL ATERIAL SPA, P472	42	4	4	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.		1996	93			166			123	127		10.1111/j.1600-0404.1996.tb00573.x			5	Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UP136	WOS:A1996UP13600046	8686427				2022-02-06	
J	Keller, I; Schlenker, A; Pigache, RM				Keller, I; Schlenker, A; Pigache, RM			Selective impairment of auditory attention following closed head injuries or right cerebrovascular accidents	COGNITIVE BRAIN RESEARCH			English	Article						auditory attention; dichotic listening; closed head injury; cerebrovascular accident	VISUAL-ATTENTION; SUSTAINED ATTENTION; HUMAN-BRAIN; LOCALIZATION; RESPONSES; DEFICITS; MONKEY; CORTEX; SYSTEM; LOBE	According to clinical experience a frequent consequence of head injury is an impairment of auditory attention. We investigated the possibility that patients with either closed head injuries (CHI), or cerebrovascular accidents (CVA) of the right hemisphere, would, be impaired by comparison to healthy subjects on an objective test of auditory attention. We used an experimental paradigm that consisted of four subtests which comprised strings of auditory digits heard either diotically or dichotically, at either fast or slow presentation rates, respectively. Omission and commission errors were scored for each subtest and combined by an index of errors. The results showed that CHI patients were significantly impaired initially by the fast stimulus presentation conditions, whereas CVA patients made significantly more errors on the dichotic subtests independent of the speed of presentation. It is proposed that the observed selective attention deficits of these patients were due to differential disruptions of an interactive cortical network incorporating prefrontal, anterior cingulate, and temporoparietal structures of the right hemisphere. Statistically significant correlations between the error index scores and subjectively perceived attention deficits suggested that the auditory attention task measured clinically relevant aspects of attention.	CITY HOSP MUNCHEN BOGENHAUSEN,DEPT NEUROPSYCHOL,D-81925 MUNICH,GERMANY; UNIV KONSTANZ,DEPT PSYCHOL,D-78464 CONSTANCE,GERMANY; GUYS HOSP,DIV PHARMACOL,PSYCHOPHARMACOL RES UNIT,LONDON SE1 9RT,ENGLAND								BALEYDIER C, 1980, BRAIN, V103, P525, DOI 10.1093/brain/103.3.525; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; BROUWER WH, 1985, THESIS U GRONINGEN; BROWN RG, 1991, BRAIN, V114, P215; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Cohen RM, 1988, NEUROPSY NEUROPSY BE, V1, P3; CONKEY RC, 1938, ARCH PSYCHOL, V33, P1; CROWNE DP, 1983, PSYCHOL BULL, V93, P232, DOI 10.1037/0033-2909.93.2.232; De Renzi E., 1982, DISORDERS SPACE EXPL; GEFFEN G, 1978, J NEUROL NEUROSUR PS, V41, P354, DOI 10.1136/jnnp.41.4.354; GOLDSTEIN K, 1942, EFFECTS BRAIN DAMAGE; Gronwall D, 1974, PSYCHOL EFFECTS CONC; JANER KW, 1991, J COGNITIVE NEUROSCI, V3, P231, DOI 10.1162/jocn.1991.3.3.231; Jerison H. J., 1970, ATTENTION CONT THEOR, P127; JERISON HJ, 1964, SCIENCE, V143, P970, DOI 10.1126/science.143.3609.970; Kendall M.G., 1948, RANK CORRELATION MET; KLENSCH H, 1983, FORT NEUROL PSYCHIAT, V41, P575; LEVIN HS, 1988, SCANDINAVIAN J REH S, V17, P33; LYNCH JC, 1977, J NEUROPHYSIOL, V40, P362, DOI 10.1152/jn.1977.40.2.362; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MILLER E, 1981, BRIT J CLIN PSYCHOL, V20, P69, DOI 10.1111/j.2044-8260.1981.tb00498.x; Miller E, 1970, Cortex, V6, P121; Milner B., 1962, INTERHEMISPHERIC REL; NORMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236; OKE A, 1978, SCIENCE, V200, P1411, DOI 10.1126/science.663623; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; PAYNE RW, 1961, HDB ABNORMAL PSYCHOL; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; PIGACHE RM, 1993, SCHIZOPHR RES, V10, P39, DOI 10.1016/0920-9964(93)90075-T; PIGACHE RM, 1976, PERCEPT MOTOR SKILL, V42, P243, DOI 10.2466/pms.1976.42.1.243; PIGACHE RM, 1973, BR PSYCHOL SOC B, V20, P1973; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; ROLAND PE, 1984, TRENDS NEUROSCI, V7, P430, DOI 10.1016/S0166-2236(84)80148-4; ROLAND PE, 1982, J NEUROPHYSIOL, V48, P1059, DOI 10.1152/jn.1982.48.5.1059; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TARTAGLIONE A, 1991, BRAIN, V114, P1441, DOI 10.1093/brain/114.3.1441; TROMP E, 1991, J CLIN EXP NEUROPSYC, V13, P821, DOI 10.1080/01688639108405100; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VANZOMEREN AH, 1984, CLOSED HEAD INJURY; VANZOMEREN AH, 1987, NEUROBEHAVOIRAL RECO; WHITEHEAD R, 1991, J COGNITIVE NEUROSCI, V3, P329, DOI 10.1162/jocn.1991.3.4.329; YATES AJ, 1966, AUST J PSYCHOL, V18, P103, DOI 10.1080/00049536608255721; [No title captured]	56	4	4	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-6410			COGNITIVE BRAIN RES	Cognit. Brain Res.	DEC	1995	3	1					9	15		10.1016/0926-6410(95)00013-5			7	Computer Science, Artificial Intelligence; Neurosciences; Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Neurosciences & Neurology	TN315	WOS:A1995TN31500002	8719017				2022-02-06	
J	Cava, TJ				Cava, TJ			Botulinum toxin management of spasticity in upper motor neuron lesions	EUROPEAN JOURNAL OF NEUROLOGY			English	Article; Proceedings Paper	2nd Botulinum Toxin Symposium - Dystonia and Beyond	MAR 18-19, 1995	CANNES, FRANCE	Allergan		Botulinum toxin; spasticity; BOTOX(R); BTX		The local injection of Botulinum toxin-A (BTX) as a treatment for disabling limb spasticity in patients with upper motor neuron lesions was assessed in a pilot study with an open label protocol. Sixteen patients, over 18 years old, with dysfunctional limb spasticity associated with the diagnoses of multiple sclerosis, stroke, spinal cord injury and traumatic brain injury were treated. Limb muscles injected with BOTOX(R), under electrodiagnostic guidance, included the biceps, wrist flexors, finger flexors, hip abductors, quadriceps, gastrocnemius and triceps. Spasticity was assessed with the modified Ashworth Scale, spasm frequency score and a pain index. Three patients with diffuse spasticity demonstrated no significant effect, and were better suited for intrathecal baclofen infusion. The remaining 13 patients with specific, focal spasticity all experienced a significant reduction in modified Ashworth scale, spasm frequency and pain index scores.	TOTAL REHABIL CTR,CEDAR GROVE,NJ									0	4	4	0	0	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	1351-5101			EUR J NEUROL	Eur. J. Neurol.	NOV	1995	2			3			57	60					4	Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TU596	WOS:A1995TU59600010					2022-02-06	
J	WOODSIDE, B; ROBINSON, B; AMIR, S				WOODSIDE, B; ROBINSON, B; AMIR, S			INDUCTION OF FOS PROTEIN IN A MODEL OF CLOSED-HEAD INJURY IN RATS	BRAIN RESEARCH			English	Article						CLOSED HEAD INJURY; FOS IMMUNOHISTOCHEMISTRY; NMDA RECEPTOR; LACTATION; RAT	TRAUMATIC BRAIN INJURY; CONTROLLED CORTICAL IMPACT; C-FOS; MESSENGER-RNA; STIMULATION; ACTIVATION; NEURONS; NMDA	The induction of Fos immunoreactivity in the pyriform cortex and the hippocampal formation after closed head injury was determined and compared to that seen following cortical needle injury in pentobarbital anaesthetized male rats. Robust Fos expression was observed in the ipsilateral pyriform cortex following both types of injury but was observed in the ipsilateral dentate gyrus only following closed head injury. Pretreatment with the NMDA receptor blocker MK-801 eliminated closed head injury induced Fos expression in the pyriform cortex and attenuated that seen in the hippocampus. Similar amounts of Fos expression were observed in urethane anaesthetized lactating and nonlactating rats following closed head injury. No gross behavioural impairments as reflected in body weight gain and locomotor activity were seen in animals subjected to closed head injury. These results demonstrate that as with other forms of brain damage, closed head injury at levels that produce no overt brain lesion nor gross behavioural impairment induce Fos expression in the pyriform cortex and the dentate gyrus which is dependent on the activation of NMDA receptors. Further, this response to brain injury is not modulated by lactation.	CONCORDIA UNIV,CTR STUDIES BEHAV NEUROBIOL,DEPT PSYCHOL,MONTREAL,PQ H3G 1M8,CANADA								ABBUD R, 1992, MOL CELL NEUROSCI, V3, P244, DOI 10.1016/1044-7431(92)90044-3; ABBUD R, 1993, BRAIN RES, V604, P16, DOI 10.1016/0006-8993(93)90347-P; AMIR S, 1994, BRAIN RES, V652, P341, DOI 10.1016/0006-8993(94)90245-3; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; DRAGUNOW M, 1990, EXP NEUROL, V107, P236, DOI 10.1016/0014-4886(90)90141-E; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; GOLDMAN H, 1993, ANN EMERG MED, V22, P1035, DOI 10.1016/S0196-0644(05)82747-7; GROTA LJ, 1967, J REPROD FERTIL, V13, P83, DOI 10.1530/jrf.0.0130083; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HERRERA DG, 1989, BRAIN RES, V503, P205, DOI 10.1016/0006-8993(89)91665-X; KINOUCHI H, 1994, NEUROSCI LETT, V179, P111, DOI 10.1016/0304-3940(94)90947-4; LEE S, 1994, MOL BRAIN RES, V24, P192, DOI 10.1016/0169-328X(94)90132-5; LINCOLN DW, 1973, J ENDOCRINOL, V57, P459, DOI 10.1677/joe.0.0570459; LIU JL, 1994, P NATL ACAD SCI USA, V91, P8537, DOI 10.1073/pnas.91.18.8537; LIU SL, 1994, J NEUROTRAUM, V11, P73, DOI 10.1089/neu.1994.11.73; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; NITSCH R, 1992, P NATL ACAD SCI USA, V89, P5197, DOI 10.1073/pnas.89.11.5197; OGATA T, 1993, NEUROSCIENCE, V55, P445, DOI 10.1016/0306-4522(93)90513-F; PFAUS JG, 1993, BRAIN RES, V624, P253, DOI 10.1016/0006-8993(93)90085-2; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; SHARP FR, 1991, J NEUROSCI, V11, P2321, DOI 10.1523/jneurosci.11-08-02321.1991; SHARP JW, 1990, EXP NEUROL, V109, P323, DOI 10.1016/S0014-4886(05)80023-8; VANDRELL M, 1993, ANN NY ACAD SCI, V679, P132; WALKER CD, 1992, ENDOCRINOLOGY, V130, P115, DOI 10.1210/en.130.1.115; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X	28	4	4	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	AUG 28	1995	690	1					48	54		10.1016/0006-8993(95)00586-F			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RT437	WOS:A1995RT43700007	7496806				2022-02-06	
J	BLACK, ER; WEISS, KD; ERBAN, S; SHULKIN, D				BLACK, ER; WEISS, KD; ERBAN, S; SHULKIN, D			PHYSICIAN PARTICIPATION IN QUALITY MANAGEMENT - INNOVATIONS IN PATIENT-CARE - CHANGING CLINICAL-PRACTICE AND IMPROVING QUALITY	JOINT COMMISSION JOURNAL ON QUALITY IMPROVEMENT			English	Article								Background: In the traditional hospital organization, administrators supply the resources while physicians ermine their use. Given this dichotomy, a partnership clinicians and hospital management is essential efforts to enhance the quality of care while controlling costs. To foster this partnership, in 1986 the University of Rochester's Strong Memorial Hospital developed Innovations in Patient Care (IPC) program, which other medical centers have duplicated. Current status and logistics: Hospital operating revenues of approximately $175,000 per year are provided to both fund proposals and support core IPC staff. Clinical staff submit proposals to study innovations to promote higher quality care and/or the efficient and appropriate use of diagnostic and therapeutic services. any of the 77 projects funded to date have led to important changes in clinical practice. Case studies: One study, whose principal investigator was assistant director of emergency medicine, showed that structured, condition-specific (for example, asthma, pharyngitis, lacerations, and isolated closed-head injury) quicksheets improved documentation of clinical findings, resource use, and clinical practice. A study organized by the leadership of surgical nursing revealed that a nursing case management model led to reductions in patient length of stay and increases in nurse satisfaction. Another study, designed by a fellow in neonatalogy, developed and tested guidelines for the use of head ultrasounds in screening very-low-birthweight infants for intraventricular hemorrhage. Conclusions: IPC programs, which integrate well with initiatives in total quality management, can be effectively used to change clinical practice and improve the quality and efficiency of patient care.	UNIV MASSACHUSETTS,PROGRAM HEALTHCARE INNOVAT,WORCESTER,MA 01605; UNIV PENN,PHILADELPHIA,PA 19104		BLACK, ER (corresponding author), UNIV ROCHESTER,STRONG MEM HOSP,MED CTR,OFF CLIN PRACTICE EVALUAT,PATIENT CARE PROGRAM,ROCHESTER,NY 14642, USA.						BLOCK JA, 1987, JAMA-J AM MED ASSOC, V257, P193, DOI 10.1001/jama.257.2.193; CHESS PR, 1995, UNPUB INDICATIONS SC; FRANKLIN PD, 1990, ACAD MED, V65, P355, DOI 10.1097/00001888-199006000-00002; FRANKLINPF, 1991, IMPROVING PATIENT CA, P49; *JOINT COMM ACCR H, 1992, STRIV IMPR 6 HOSP SE, P165; KOMAROFF AL, 1991, DIAGNOSTIC STRATEGIE, P186; MAAS B, 1992, 27TH ANN AM SOC HOSP; PANZER RJ, 1991, IMPROVING PATIENT CA, P39; PANZER RJ, 1991, QUALITY LETT, V3, P69; PARRINELLO K, 1994, UNPUB EVALUATION CAS; TIETZE KJ, 1994, CRITICAL CARE, V1, pA15; WRENN K, 1993, ANN EMERG MED, V2, P805	12	4	4	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	1070-3241			JOINT COMM J QUAL IM	Jt. Comm. J. Qual. Improv.	AUG	1995	21	8					376	393		10.1016/S1070-3241(16)30167-5			18	Health Policy & Services	Social Science Citation Index (SSCI)	Health Care Sciences & Services	RR469	WOS:A1995RR46900001	7496452				2022-02-06	
J	VOSSOUGHI, J; BANDAK, FA				VOSSOUGHI, J; BANDAK, FA			MECHANICAL CHARACTERISTICS OF VASCULAR TISSUE AND THEIR ROLE IN BRAIN INJURY MODELING - A REVIEW	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, DC	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		SOFT TISSUE; MATERIAL CHARACTERIZATION; VASCULAR; STRAIN ENERGY; ARTERIES	HUMAN AORTIC TISSUE; FAILURE PROPERTIES; TENSION TESTS; SOFT-TISSUES; ARTERIES; STRAIN; BEHAVIOR; SEGMENTS; STRESS	A review of the mechanical characterization of vascular tissue is presented in the context of its relevance to the computational modeling of traumatic brain injury (TBI). Mathematical representations of experimentally observed vascular behavior are described. Several material models, for large vessels, and their applicability to blood vessels in the brain are discussed, Integration of vascular tissue behavior into an existing computational model of the brain, to account for the anisotropic effects they produce, is discussed.	GEORGE WASHINGTON UNIV,SCH ENGN & APPL SCI,WASHINGTON,DC 20052; NATL HIGHWAY TRAFF SAFETY ADM,WASHINGTON,DC		VOSSOUGHI, J (corresponding author), UNIV DIST COLUMBIA,ENGN RES CTR,WASHINGTON,DC 20008, USA.			Vossoughi, Jafar/0000-0001-6369-962X			BANDAK FA, 1995, J NEUROTRAUM, V12, P679, DOI 10.1089/neu.1995.12.679; BANDAK FA, 1994, SAE P, V279, P145; BURGEL DH, 1960, THESIS U LONDON; BURTON AC, 1954, PHYSIOL REV, V34, P619, DOI 10.1152/physrev.1954.34.4.619; BUSBY DE, 1965, CAN J PHYSIOL PHARM, V43, P185, DOI 10.1139/y65-018; CANDFIELD TR, 1987, HDB BIOENGINEERING, pCH16; CAREW TE, 1968, CIRC RES, V23, P61, DOI 10.1161/01.RES.23.1.61; CHALUPNIK JD, 1971, MATERIAL PROPERTIES; DEMIRAY H, 1988, J BIOMECH, V21, P369, DOI 10.1016/0021-9290(88)90143-1; DEMIRAY H, 1986, BIOMED TECH, V31, P46, DOI 10.1515/bmte.1986.31.3.46; Dobrin P, 1983, HDB PHYSL 1, V3.2, P65; DOBRIN PB, 1978, PHYSIOL REV, V58, P397, DOI 10.1152/physrev.1978.58.2.397; ERINGEN AC, 1967, MECHANICS CONTINUA; Fung, 1990, BIOMECHANICS MOTION; FUNG YC, 1979, AM J PHYSIOL, V237, pH620, DOI 10.1152/ajpheart.1979.237.5.H620; Green A. E., 1963, THEORETICAL ELASTICI; Greendyke R.M., 1996, JAMA-J AM MED ASSOC, V195, P119, DOI 10.1001/jama.1966.03100070071021; HAJDU MA, 1994, AM J PHYSIOL, V266, pH1027, DOI 10.1152/ajpheart.1994.266.3.H1027; HAYASHI K, 1993, J BIOMECH ENG-T ASME, V115, P481, DOI 10.1115/1.2895528; HAYASHI K, 1980, J BIOMECH, V13, P175, DOI 10.1016/0021-9290(80)90191-8; HOSEY RR, 1982, FINITE ELEMENTS BIOM; HUDETZ AG, 1979, J BIOMECH, V12, P651, DOI 10.1016/0021-9290(79)90015-0; HUMPHREY JD, 1989, BIORHEOLOGY, V26, P687; HUMPHREY JD, 1987, BIOPHYS J, V52, P563, DOI 10.1016/S0006-3495(87)83245-9; HUNG EJ, 1975, J BIOMECH, V8, P385; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; LAKIN W D, 1992, Neurological Research, V14, P219; LEE MC, 1985, ADV BIOENG, P111; LOCKSLEY HB, 1966, J NEUROSURG, V25, P219, DOI 10.3171/jns.1966.25.2.0219; McDonald D. A., 1974, BLOOD FLOW ARTERIES; MCMINN RMH, 1984, COLOR ATLAS HUMAN AN; MOHAN D, 1983, J BIOMECH, V16, P31, DOI 10.1016/0021-9290(83)90044-1; MOHAN D, 1982, J BIOMECH, V15, P887, DOI 10.1016/0021-9290(82)90055-0; MORITAKE K, 1974, Neurologia Medico-Chirurgica, V14, P47, DOI 10.2176/nmc.14pt1.SUPPLEMENT_47; MORITAKE K, 1975, ARCH JAP CHIR, V44, P108; MORITAKE K, 1975, ARCH JAP CHIR, V44, P87; NAGASAWA S, 1979, SURG NEUROL, V12, P297; PATEL DJ, 1966, CIRC RES, V19, P1011, DOI 10.1161/01.RES.19.6.1011; PATEL DJ, 1969, CIRC RES, V24, P1; PATEL DJ, 1980, HEMODYNAMICS ITS ROL; ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681, DOI 10.1139/o57-080; Roy C S, 1881, J Physiol, V3, P125; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; SHARMA MG, 1976, J BIOMECH, V9, P293, DOI 10.1016/0021-9290(76)90051-8; SHENNAN T, 1928, J PATHOL, V32, P795; STRASSMANN G, 1947, AM HEART J, V33, P508, DOI 10.1016/0002-8703(47)90098-7; TAKAMIZAWA K, 1987, J BIOMECH, V20, P7, DOI 10.1016/0021-9290(87)90262-4; TANAKA TT, 1974, J BIOMECH, V7, P357, DOI 10.1016/0021-9290(74)90031-1; VAISHNAV RN, 1984, J BIOMECH ENG-T ASME, V106, P105, DOI 10.1115/1.3138465; VAISHNAV RN, 1987, J BIOMECH, V20, P235, DOI 10.1016/0021-9290(87)90290-9; VAISHNAV RN, 1983, ESTIMATION RESIDUAL, P330; VITO RP, 1980, J BIOMECH, V13, P951, DOI 10.1016/0021-9290(80)90166-9; VOSSOUGHI J, 1994, BIOMEDICAL ENG RECEN, P200; VOSSOUGHI J, 1986, 12TH P ANN NE BIOENG, P165; VOSSOUGHI J, 1995, BIOMEDICAL ENG HDB, pCH19; VOSSOUGHI T, 1993, SUM P ASME BIOENG M, P434; WEIZSACKER HW, 1988, J BIOMECH, V21, P477, DOI 10.1016/0021-9290(88)90240-0; [No title captured]	58	4	4	0	5	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					755	763		10.1089/neu.1995.12.755			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000027	8683627				2022-02-06	
J	LUCCHI, S; GIUA, G; BETTINELLI, A; FARABOLA, M; SINA, C; MANGIAGALLI, E; RESTA, F; RIGHINI, A; LEONARDI, M				LUCCHI, S; GIUA, G; BETTINELLI, A; FARABOLA, M; SINA, C; MANGIAGALLI, E; RESTA, F; RIGHINI, A; LEONARDI, M			THE ROLE OF COMPUTERIZED-TOMOGRAPHY IN THE MANAGEMENT OF MILD HEAD-INJURY PATIENTS	RIVISTA DI NEURORADIOLOGIA			Italian	Article						CT; HEAD INJURIES; TRAUMA	TRAUMATIC INTRACRANIAL HEMATOMA; CLINICAL PREDICTORS; ADULT	We reviewed all cranial CT scans at our Neuroradiological Service requested by the Emergency Room from August 1993 to April 1994 and we noted that 41% of them dealt with patients admitted for closed head injuries. A retrospective study of 300 head injured patients who underwent CT examination on admission was performed CT scans were negative in 92% of cases. All patients with a normal neurological examination at the Emergency Room were regarded as mild head injury patients. This group comprised 79% of all the observations; intracranial lesions were disclosed by CT scans in 2% of them; whereas, in patients with neurological signs, CT scans demonstrated intracranial lesions in 17% of cases. We observed intracranial lesions more frequently in patients over 50 years, or in road accident head injury patients, or in parietal head injury patients and in patients who developed amnesia or episodes of vomiting following trauma. No relation was found between loss of consciousness and positive CT scans. On the basis of their experience and a review of the literature, we propose some guidelines for the management of mild head injury patients. All patients with a negative neurological examination should undergo 6-12 hours of clinical observation; after this period they might be simply discharged if there are no clinical changes. However, if the evaluation is threatened because the patient is intoxicated or uncooperative, then a CT scan is mandatory. Patients with a high risk disease such as coagulation defects or patients with a suspected cranial fracture should immediately undergo CT scans. If the patient's clinical status deteriorates during clinical observation, then CT scans should be performed before dismissal. We should bear in mind that a negative CT at an early stage does not completely rule out delayed complications. In conclusion the clinical observation is the mainstay in the management of mild head injuries.	OSPED MAGGIORE POLICLIN,IRCCS,SERV NEURORADIOL,MILAN,ITALY								BOZZAMARRUBINI ML, 1983, ADV NEUROTRAUMATOLOG, P33; CIUCCI G, 1993, NUOVO PRONTO SOCCORS, V1, P17; DEBENEDITTIS G, 1983, ADV NEUROTRAUMATOLOG, P315; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; LEONARDI M, 1992, 2ND REFRESHER COURSE OF THE ESNR, P7; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; SCOTTI G, 1992, 2ND REFRESHER COURSE OF THE ESNR, P39; SERVADEI F, 1988, J NEUROL NEUROSUR PS, V51, P526, DOI 10.1136/jnnp.51.4.526; SERVADEI F, 1993, SURG NEUROL, V39, P269, DOI 10.1016/0090-3019(93)90003-J; STEIN SC, 1993, NEUROSURGERY, V33, P339; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363	15	4	4	0	0	EDIZIONI CENTAURO	UDINE	VIA COSATTINI 32, 33100 UDINE, ITALY	1120-9976			RIV NEURORADIOL	Riv. Neuroradiol.	JUN	1995	8	3					415	428		10.1177/197140099500800308			14	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	RH340	WOS:A1995RH34000008					2022-02-06	
J	GROCE, R; HORVAT, M; ROSWAL, G				GROCE, R; HORVAT, M; ROSWAL, G			COINCIDENT TIMING BY NONDISABLED, MENTALLY-RETARDED, AND TRAUMATIC BRAIN-INJURED INDIVIDUALS UNDER VARYING TARGET-EXPOSURE CONDITIONS	PERCEPTUAL AND MOTOR SKILLS			English	Article							ANTICIPATION; PERFORMANCE; VELOCITY; CHILDREN	Coincident timing by 15 nondisabled individuals, 15 mentally retarded and 15 traumatically brain injured was measured under varying target-exposure conditions. Absolute constant error, constant error, and variable error were analyzed in separate repeated-measures analyses of variance for early performance (first block of practice), late performance (last block of practice), and retention (last block of retention). Subjects with mental retardation displayed the least accurate and most variable coincident-timing responses. Nondisabled subjects were most influenced by target-exposure time; subjects with traumatic brain injury were most influenced by target-viewing distance; and subjects with mental retardation were most influenced by a combination of target velocity and target-viewing distance. Subjects with mental retardation displayed a too-early response bias, while nondisabled subjects tended to have a too-late response bias. Individuals with traumatic brain injury had a variable response bias.	UNIV GEORGIA, ATHENS, GA 30602 USA; JACKSONVILLE STATE UNIV, JACKSONVILLE, AL 36265 USA		GROCE, R (corresponding author), UNIV NEW HAMPSHIRE, DEPT KINESIOL, NEW HAMPSHIRE HALL, 124 MAIN ST, DURHAM, NH 03824 USA.						BALL CT, 1992, PERCEPT MOTOR SKILL, V75, P1074, DOI 10.2466/PMS.75.8.1074-1074; BARD C, 1990, DEV EYE HAND COORDIN, P283; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; COPE DN, 1990, KRUSENS HDB PHYSICAL, P1217; GOODGOLDEDWARDS S, 1991, PHYSICAL OCCUPATIONA, V10, P49; JENNETT B, 1975, LANCET, V1, P480; KEPPEL G, 1982, DESIGN ANAL RES HDB; Luckasson R., 1992, MENTAL RETARDATION D; Magill R. A., 1993, MOTOR LEARNING CONCE; Proteau L., 1992, VISION MOTOR CONTROL, P315; SCHUTZ R, 1977, MEASUREMENT CHANGE P, P82; SCHUTZ RW, 1973, J MOTOR BEHAV, V5, P141, DOI 10.1080/00222895.1973.10734959; SHEA CH, 1981, RES Q EXERCISE SPORT, V52, P86, DOI 10.1080/02701367.1981.10609300; SUGDEN DA, 1990, PROBLEMS MOVEMENT SK, P68; TRESILIAN JR, 1993, PERCEPTION, V22, P653, DOI 10.1068/p220653; WADE MG, 1980, J MOTOR BEHAV, V12, P103; WADE MG, 1982, AM J MENT DEF, V86, P643; WRISBERG CA, 1983, AM J MENT DEF, V87, P627	18	4	4	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0031-5125	1558-688X		PERCEPT MOTOR SKILL	Percept. Mot. Skills	APR	1995	80	2					487	496		10.2466/pms.1995.80.2.487			10	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	RC315	WOS:A1995RC31500025	7675579				2022-02-06	
J	OWENS, JG; KAMERLING, SG; KEOWEN, ML				OWENS, JG; KAMERLING, SG; KEOWEN, ML			EICOSANOID CONCENTRATIONS IN DIGITAL VENOUS-BLOOD FROM HORSES WITH CHRONIC LAMINITIS	AMERICAN JOURNAL OF VETERINARY RESEARCH			English	Article							RESPIRATORY SYNCYTIAL VIRUS; FLUNIXIN MEGLUMINE; NEONATAL CALVES; PLASMA; ENDOTOXIN; PROSTAGLANDINS; INVITRO; RADIOIMMUNOASSAY; PHENYLBUTAZONE; MEDIATORS	The eicosanoids are a family of lipid-derived autocoids that are released in response to a variety of physical and hormonal stimuli. In this study, prostaglandin E(2) (PGE(2)) and leukotriene B-4 (LTB(4)) were measured in the digital veins of clinically normal horses and horses with chronic laminitis to determine whether these arachidonic acid metabolites have a role in mediating signs of hoof pain and lesions associated with chronic laminitis. Horses were evaluated at rest and after a brief exercise period, to determine whether eicosanoids are released into the circulation after mild concussion. Digital vein eicosanoid concentrations in horses with signs of hoof pain attributable to chronic laminitis were not different than those in clinically normal horses. There was no difference in resting and postexercise PGE(2) or LTB(4) concentrations. Mean digital vein PGE(2) concentration for the 2 groups was 187.18 pg/ml, whereas mean digital vein LTB(4) concentration for the 2 groups was 74.71 pg/ml. These data do not support the hypothesis that PGE(2) and LTB(4) have a role in mediating the signs of pain and pathologic features of chronic laminitis.	LOUISIANA STATE UNIV,SCH VET MED,DEPT VET PHYSIOL PHARMACOL & TOXICOL,BATON ROUGE,LA 70803								AUER DE, 1991, J VET PHARMACOL THER, V14, P61, DOI 10.1111/j.1365-2885.1991.tb00805.x; BAXTER GM, 1989, AM J VET RES, V50, P508; BAXTER GM, 1991, EQUINE VET J, V23, P48, DOI 10.1111/j.2042-3306.1991.tb02713.x; BHATTACHERJEE P, 1984, LEUKOTRIENES CHEM BI, P195; BONICA JJ, 1990, MANAGEMENT PAIN, P95; CAREY F, 1989, PROSTAG LEUKOTR ESS, V36, P57, DOI 10.1016/0952-3278(89)90163-4; COKER SJ, 1982, J PHARMACOL METHOD, V7, P207, DOI 10.1016/0160-5402(82)90037-7; DENZLINGER C, 1985, SCIENCE, V230, P330, DOI 10.1126/science.4048937; FERREIRA SH, 1978, PROSTAGLANDINS, V16, P31, DOI 10.1016/0090-6980(78)90199-5; FERREIRA SH, 1979, HDB INFLAMMATION, V1, P113; FESSLER JF, 1982, AM J VET RES, V43, P140; FRAUENFELDER HC, 1982, AM J VET RES, V43, P405; GERROS TC, 1993, AM J VET RES, V54, P2121; GERSHWIN LJ, 1992, AM J VET RES, V53, P1670; GERSHWIN LJ, 1989, AM J VET RES, V50, P1254; GOETZ TE, 1989, VET CLIN N AM-EQUINE, V5, P73, DOI 10.1016/S0749-0739(17)30605-3; Granstrom E, 1987, PROSTAGLANDINS RELAT, P5; HOOD DM, 1979, P ANNU CONV AM EQUIN, V25, P13; HOOD DM, 1993, J VET INTERN MED, V7, P228, DOI 10.1111/j.1939-1676.1993.tb01012.x; HUNT RJ, 1990, AM J VET RES, V51, P1703; HUNT RJ, 1991, COMP CONT EDUC PRACT, V13, P1003; ISONO T, 1985, BIOCHEM BIOPH RES CO, V130, P486, DOI 10.1016/0006-291X(85)90443-7; Kameya T., 1980, Japanese Journal of Veterinary Research, V28, P37; KAMEYA T, 1980, JPN J VET SCI, V42, P361; KUROSAWA M, 1990, J ASTHMA, V27, P349, DOI 10.3109/02770909009073352; LEVINE JD, 1984, SCIENCE, V225, P743, DOI 10.1126/science.6087456; MOORE JN, 1981, EQUINE VET J, V13, P95, DOI 10.1111/j.2042-3306.1981.tb04122.x; MOORE JN, 1986, AM J VET RES, V47, P110; MORRIS HG, 1981, PROSTAGLANDINS, V21, P771, DOI 10.1016/0090-6980(81)90234-3; OLSON NC, 1988, J APPL PHYSIOL, V64, P2100, DOI 10.1152/jappl.1988.64.5.2100; PRIBYTKOV YN, 1991, TERAPEVT ARKH, V63, P86; ROBERTS ED, 1980, VET PATHOL, V17, P656, DOI 10.1177/030098588001700601; SAWAZAKI Y, 1986, NIPPON IKA DAIGAKU Z, V56, P559; SEMRAD SD, 1993, AM J VET RES, V54, P1339; SEMRAD SD, 1987, EQUINE VET J, V19, P201, DOI 10.1111/j.2042-3306.1987.tb01380.x; SPROUSE RF, 1987, EQUINE VET J, V19, P25, DOI 10.1111/j.2042-3306.1987.tb02571.x; Stashak TS, 1987, ADAMS LAMENESS HORSE, P486; Steel R. G. D, 1980, PRINCIPLES PROCEDURE, P377; Steel RGD, 1980, PRINCIPLES PROCEDURE, P172; STEEL RGD, 1980, PRINCIPLES PROCEDURE, P137; STICK JA, 1982, J AM VET MED ASSOC, V180, P251; STICK JA, 1987, CURRENT THERAPY EQUI, P277; WOLFE LS, 1976, ADV PROSTAG THROMB R, V1, P345; [No title captured]	44	4	4	0	0	AMER VETERINARY MEDICAL ASSOC	SCHAUMBURG	1931 N MEACHAM RD, SCHAUMBURG, IL 60173-4360	0002-9645			AM J VET RES	Am. J. Vet. Res.	APR	1995	56	4					507	510					4	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	QQ347	WOS:A1995QQ34700020	7785831				2022-02-06	
J	WALD, SL				WALD, SL			ADVANCES IN THE EARLY MANAGEMENT OF PATIENTS WITH HEAD-INJURY	SURGICAL CLINICS OF NORTH AMERICA			English	Article							CEREBRAL BLOOD-FLOW; CONCUSSIVE BRAIN INJURY; ELEVATED INTRACRANIAL-PRESSURE; SMALL-VOLUME RESUSCITATION; INTRA-CRANICAL PRESSURE; SUPEROXIDE-DISMUTASE; FREE-RADICALS; MODERATE HYPOTHERMIA; HYPERTONIC SALINE; HEMORRHAGIC-SHOCK	Traumatic injuries to the brain result in a series of complex pathophysiologic changes. Following a discussion of some of these processes, this article reviews various standard diagnostic and therapeutic interventions. Advances in understanding the chemical and cellular mechanisms of head injury and the role of oxygen free radicals, lactate, and excitatory amino acids are reviewed with a discussion of possible new therapies.	UNIV VERMONT,COLL MED,DEPT SURG,DIV NEUROL SURG,BURLINGTON,VT 05401		WALD, SL (corresponding author), UNIV HLTH CTR,DIV NEUROL SURG,1 S PROSPECT ST,BURLINGTON,VT 05401, USA.						ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ALI J, 1989, ADV TRAUMA LIFE SUPP, P1; ANDO Y, 1989, BRAIN RES, V477, P286, DOI 10.1016/0006-8993(89)91416-9; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ARGENTINO C, 1989, STROKE, V20, P1143, DOI 10.1161/01.STR.20.9.1143; BAILEY I, 1992, Journal of Neurotrauma, V9, pS545; BOCHICCHIO M, 1990, INTENS CARE MED, V16, P444, DOI 10.1007/BF01711223; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; BROADWELL RD, 1982, SCIENCE, V217, P164, DOI 10.1126/science.7089551; BROWN MM, 1985, BRAIN, V108, P81, DOI 10.1093/brain/108.1.81; BROWN MM, 1982, BRIT MED J, V284, P1733, DOI 10.1136/bmj.284.6331.1733; BROWN MM, 1985, LANCET, V1, P604; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1989, STROKE, V20, P1545, DOI 10.1161/01.STR.20.11.1545; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; COTTRELL JE, 1977, ANESTHESIOLOGY, V47, P28, DOI 10.1097/00000542-197707000-00006; COTTRELL JE, 1981, J TRAUMA, V21, P805, DOI 10.1097/00005373-198109000-00010; Cruz J, 1988, Acta Neurochir Suppl (Wien), V42, P35; DELATORRE JC, 1983, ANN NY ACAD SCI, V411, P293; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; EGORIN MJ, 1982, CLIN PHARMACOL THER, V32, P122, DOI 10.1038/clpt.1982.135; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; ENEVOLDSEN EM, 1977, CLIN NEUROL NEUROSUR, V80, P213; FADEN AI, 1984, JAMA-J AM MED ASSOC, V252, P1452, DOI 10.1001/jama.252.11.1452; GEISLER FH, 1991, NEW ENGL J MED, V324, P1829, DOI 10.1056/NEJM199106273242601; GENNARI FJ, 1974, NEW ENGL J MED, V291, P714, DOI 10.1056/NEJM197410032911408; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GILLMAN MA, 1981, LANCET, V2, P156; GORDON E, 1971, ACTA ANAESTH SCAND, V15, P209, DOI 10.1111/j.1399-6576.1971.tb05462.x; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GREENBERG JH, 1978, CIRC RES, V43, P324, DOI 10.1161/01.RES.43.2.324; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247, DOI 10.1152/ajpheart.1989.256.4.H1247; HALL ED, 1989, CRIT CARE CLIN, V5, P793; HASSLER W, 1988, J NEUROSURG, V68, P745; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; IKEDA Y, 1990, NEUROSURGERY, V27, P1; JACOBSEN EJ, 1990, J MED CHEM, V33, P1145, DOI 10.1021/jm00166a010; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, EPILEPSY NONMISSILE; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KARACA M, 1991, EUR J CLIN PHARMACOL, V40, P113, DOI 10.1007/BF00315149; KASSELL NF, 1982, STROKE, V13, P59, DOI 10.1161/01.STR.13.1.59; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIEN ND, 1991, CIRC SHOCK, V35, P109; KREIMEIER U, 1990, J SURG RES, V49, P493, DOI 10.1016/0022-4804(90)90174-Z; LIPARTITI M, 1991, EXP NEUROL, V112, P301; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARION DW, 1993, NEUROTRAUMA, V10, pS102; MARSHALL LF, 1984, NEUROSURGERY, V14, P659, DOI 10.1227/00006123-198406000-00002; MARSHALL LF, 1975, J NEUROSURG, V43, P323, DOI 10.3171/jns.1975.43.3.0323; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MAZZONI MC, 1988, AM J PHYSIOL, V139, pH629; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MILANI D, 1991, J NEUROSCI RES, V28, P434, DOI 10.1002/jnr.490280317; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MOHANTY SK, 1991, J TRAUMA, V31, P804; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; NAKAYAMA S, 1984, CIRC SHOCK, V13, P149; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; PAPO I, 1991, STROKE, V22, P22, DOI 10.1161/01.STR.22.1.22; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; POLLAY M, 1983, J NEUROSURG, V59, P945, DOI 10.3171/jns.1983.59.6.0945; PROUGH DS, 1989, CRIT CARE CLIN, V5, P713; REIVICH M, 1965, AM J PHYSIOL, V206, P25; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1989, INTRACRANIAL PRESSUR, V7, P611; SANADA T, 1993, J NEUROTRAUM, V10, P65, DOI 10.1089/neu.1993.10.65; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; SCHETTINI A, 1982, J NEUROSURG, V56, P679, DOI 10.3171/jns.1982.56.5.0679; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SHACKFORD SR, 1988, SURGERY, V104, P553; SHACKFORD SR, 1987, PROBLEMS CRITICAL CA, V1, P576; SHENKIN HA, 1976, J NEUROSURG, V45, P432, DOI 10.3171/jns.1976.45.4.0432; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; STAHL WM, 1965, NEW ENGL J MED, V272, P381, DOI 10.1056/NEJM196502252720801; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; WALD S, 1993, J TRAUMA, V31, P1038; WALLER FT, 1983, ANN NY ACAD SCI, V411, P286, DOI 10.1111/j.1749-6632.1983.tb47310.x; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Ward JD, 1989, INTRACRANIAL PRESSUR, P630; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; WILKINSON HA, 1983, NEUROSURGERY, V12, P405, DOI 10.1227/00006123-198304000-00006	97	4	4	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0039-6109			SURG CLIN N AM	Surg. Clin.-North Am.	APR	1995	75	2					225	242		10.1016/S0039-6109(16)46585-0			18	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	QQ085	WOS:A1995QQ08500007	7899995				2022-02-06	
J	Yeates, KO; Ris, MD; Taylor, HG				Yeates, KO; Ris, MD; Taylor, HG			Hospital referral patterns in pediatric neuropsychology	CHILD NEUROPSYCHOLOGY			English	Article							CLINICAL-NEUROPSYCHOLOGY	The practice of pediatric neuropsychologists was examined by reviewing all referrals made in 1 year to neuropsychology programs located in three children's hospitals. The review identified 472 cases, 75% of whom were between the ages of 7 and 11. The sample included 86 inpatients and 386 outpatients. The most common diagnoses, accounting for 87% of the cases, were learning disability, traumatic brain injury, attention deficit-hyperactivity disorder, seizure disorder, primary psychiatric disorder, phenylketonuria, idiopathic mental retardation, brain tumor, leukemia, stroke, and encephalitis. The most common referral sources, accounting for 92% of the cases, were neurologists, pediatricians, parents, physiatrists, neurosurgeons, oncologists, specialists in metabolic disease, psychologists, rheumatologists, and psychiatrists. The distribution of diagnoses and referral sources differed significantly for inpatients and outpatients and across the three hospitals. The results may distinguish child neuropsychology from adult neuropsychology and highlight the diversity that characterizes its practitioners.	CHILDRENS HOSP,DEPT PSYCHOL,COLUMBUS,OH 43205; OHIO STATE UNIV,DEPT PEDIAT,COLUMBUS,OH 43210; UNIV CINCINNATI,DEPT PEDIAT,CINCINNATI,OH 45221; CHILDRENS HOSP,MED CTR,CINCINNATI,OH 45229; CASE WESTERN RESERVE UNIV,DEPT PEDIAT,CLEVELAND,OH 44106; RAINBOW BABIES & CHILDRENS HOSP,CLEVELAND,OH 44106				Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892			[Anonymous], 1987, CLIN NEUROPSYCHOL, V1, P29; BERNSTEIN JH, 1990, NEUROMETHODS, V17, P311; BORNSTEIN RA, 1988, CLIN NEUROPSYCHOL, V2, P25; BORNSTEIN RA, 1988, CLIN NEUROPSYCHOL, V2, P213, DOI DOI 10.1080/13854048808520103; Division 40 Executive Committee, 1989, CLIN NEUROPSYCHOL, V3, P22; FLETCHER JM, 1984, J CLIN NEUROPSYCHOL, V6, P39, DOI 10.1080/01688638408401195; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; Hammeke Thomas A, 1993, Clin Neuropsychol, V7, P197, DOI 10.1080/13854049308401522; Henry B., 1994, PSYCHOL ASSESSMENT, V6, P92, DOI [10.1037/1040-3590.6.2.92, DOI 10.1037/1040-3590.6.2.92]; HERMANN BP, 1989, CHILDHOOD EPILEPSIES; OBRZUT JE, 1986, CHILD NEUROPSYCHOLOG, V2; OBRZUT JE, 1986, CHILD NEUROPSYCHOLOG, V1; Pennington B.F., 1991, DIAGNOSING LEARNING; PUENTE AE, 1992, ARCH CLIN NEUROPSYCH, V7, P297, DOI 10.1016/0887-6177(92)90024-H; Putnam S.H., 1990, CLIN NEUROPSYCHOL, V4, P199, DOI [https://doi.org/10.1080/13854049008401906, DOI 10.1080/13854049008401906]; REYNOLDS CR, 1989, HDB CLIN CHILD NEURO; RIS MD, 1994, J CLIN EXP NEUROPSYC, V16, P21, DOI 10.1080/01688639408402615; Rourke B P, 1991, Arch Clin Neuropsychol, V6, P1, DOI 10.1016/0887-6177(91)90017-4; ROURKE BP, 1986, NEUROPSYCHOLOGICAL A; SLAY DK, 1988, PROF PSYCHOL-RES PR, V19, P323; Strang J.D., 1983, CHILD NEUROPSYCHOLOG; SWEET JJ, 1990, CLIN NEUROPSYCHOL, V4, P101, DOI DOI 10.1080/13854049008401504; Taylor H. G., 1990, HDB PSYCHOL ASSESSME, P228; TRAMONTONA MG, 1988, ASSESSMENT ISSUES CH; [No title captured]	25	4	4	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	APR	1995	1	1					56	62		10.1080/09297049508401342			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	TY623	WOS:A1995TY62300006					2022-02-06	
J	VITALE, AE; SULLIVAN, SJ; JANKOWSKI, LW				VITALE, AE; SULLIVAN, SJ; JANKOWSKI, LW			UNDERESTIMATION OF SUBJECTS MONITORED RADIAL PULSE RATES FOLLOWING TRAUMATIC BRAIN INJURY	PERCEPTUAL AND MOTOR SKILLS			English	Article								The measurement of heart rate is fundamental to the scientific programming of physical activity. In this analysis, 20 male subjects with traumatic brain injuries underestimated their heart rates as measured by the radial pulse both at rest and after brief, light exercise.	UNIV MONTREAL,ECOLE READAPTAT,INST READAPTAT MONTREAL,CTR RECH,MONTREAL,PQ H3S 2J4,CANADA; CONCORDIA UNIV,DEPT EXERCISE SCI,MONTREAL,PQ,CANADA								*AM COLL SPORTS ME, 1991, GUID EX TEST PRESCR; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; LEGER L, 1988, PHYSICIAN SPORTSMED, V16, P143, DOI 10.1080/00913847.1988.11709511; Sedlock D.A., 1983, PHYSICIAN SPORTSMED, V11, P106, DOI [10.1080/00913847.1983.11708512, DOI 10.1080/00913847.1983.11708512]; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194	5	4	4	0	0	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	FEB	1995	80	1					57	58		10.2466/pms.1995.80.1.57			2	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	QW474	WOS:A1995QW47400010	7624219				2022-02-06	
J	RIVEY, MP; ALLINGTON, DR; STONE, JD; SERFOSS, ML				RIVEY, MP; ALLINGTON, DR; STONE, JD; SERFOSS, ML			ALTERATION OF CARBAMAZEPINE PHARMACOKINETICS IN PATIENTS WITH TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							PHENYTOIN	All patients admitted to a rehabilitation unit with closed-head injury over a 3-year period were reviewed for carbamazepine use exceeding 30 days in the hospital. Nine patients met the study inclusion criteria for age and duration of carbamazepine therapy. On review of the dose : serum concentration relationship, significant changes were noted in four patients. An initial increase in the dose : serum concentration ratio during the first few months of therapy was thought to reflect the well-known auto-induction of carbamazepine metabolism. However, unexplainable decreases in the dose : serum concentration occurred in the following months, and suggested alteration of carbamazepine pharmacokinetics in patients with traumatic brain injury. The finding may be important in determining the optimal approach to therapeutic drug monitoring of carbamazepine in brain-injured patients.	COMMUNITY MED CTR,REHABIL UNIT,MISSOULA,MT 59801		RIVEY, MP (corresponding author), UNIV MONTANA,SCH PHARM,DEPT PHARM PRACTICE,MISSOULA,MT 59812, USA.						BOUCHER BA, 1987, CLIN PHARMACY, V6, P881; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CLOYD J, 1991, EPILEPSIA, V32, pS53; EDWARDS DJ, 1982, CLIN PHARMACOL THER, V31, P62, DOI 10.1038/clpt.1982.10; EVANS RW, 1985, CLIN NEUROPHARMACOL, V8, P221, DOI 10.1097/00002826-198509000-00003; KUMPS AH, 1981, THER DRUG MONIT, V3, P281; Levy R., 1992, APPL PHARMACOKINETIC, V3rd, P1; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; MCLURG D L, 1990, Pharmacotherapy, V10, P242; OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738; OTT L, 1991, NUTRITION CLIN PRACT, V6, P223; SLAUGHTER RL, 1985, DRUG INTEL CLIN PHAR, V19, P799, DOI 10.1177/106002808501901101; TOMSON T, 1989, THER DRUG MONIT, V11, P553; Wroblewski B A, 1989, Brain Inj, V3, P149, DOI 10.3109/02699058909004546; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	15	4	4	0	0	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1995	9	1					41	47		10.3109/02699059509004570			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	QB052	WOS:A1995QB05200006	7874095				2022-02-06	
J	SANDEL, ME				SANDEL, ME			OUTCOME MEASURES AND PROGNOSIS IN TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROLOGIC REHABILITATION			English	Article							SEVERE HEAD-INJURY; FOLLOW-UP; REHABILITATION; PREDICTION; STANDARDS; SCALE		HOSP UNIV PENN,SCH MED,DEPT REHABIL MED,DIV NEUROREHABIL,PHILADELPHIA,PA 19104								ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; BARLOW P, 1986, NEUROSURGERY, V19, P989, DOI 10.1227/00006123-198612000-00014; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; BROOKS DN, 1989, BRAIN INJURY, V3, P325; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Condeluci A., 1992, J HEAD TRAUMA REHAB, V7, P37; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; COPE ND, 1988, ARCH PHYS MED REHAB, V69, P483; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; EPSTEIN AM, 1990, NEW ENGL J MED, V323, P266, DOI 10.1056/NEJM199007263230410; Evans RW, 1992, J HEAD TRAUMA REHAB, V7, P24; FRYER LJ, 1987, J HEAD TRAUMA REHAB, V2, P51, DOI DOI 10.1097/00001199-198709000-00007; GLADMAN JRF, 1991, JNNP, V55, P347; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; JOHNSON EW, 1992, AM J PHYS MED REHAB, V71, P201, DOI 10.1097/00002060-199208000-00001; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; JOHNSTON MV, 1992, ARCH PHYS MED REHAB, V73, pS3; JOHNSTON MV, 1991, AM J PHYS MED REHAB, V70, pS114; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; KRIEL RL, 1988, ARCH PHYS MED REHAB, V69, P678; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RONDINELLI RD, 1991, ARCH PHYS MED REHAB, V72, P447; SANDEL ME, 1993, ARCH PHYS MED REHAB, V74, P411; Sandel ME, 1990, PHYS MED REHABIL STA, V4, P409; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; WILLIAMS JM, 1984, J NEUROSURG, V61, P581, DOI 10.3171/jns.1984.61.3.0581	48	4	4	0	2	DEMOS PUBLICATIONS	NEW YORK	386 PARK AVE S STE 201, NEW YORK, NY 10016-8804	0888-4390			J NEUROL REHABIL	J. Neurol. Rehabil.		1995	9	2					111	115					5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	TF488	WOS:A1995TF48800008					2022-02-06	
J	WHYTE, J				WHYTE, J			TOWARD RATIONAL PSYCHOPHARMACOLOGICAL TREATMENT - INTEGRATING RESEARCH AND CLINICAL-PRACTICE	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						BRAIN INJURY(IES); DRUG TREATMENT; PSYCHOPHARMACOLOGY; RESEARCH METHODS	DIFFUSE AXONAL INJURY; HEAD-INJURY	Psychopharmacological agents are in common clinical use in traumatic brain injury rehabilitation despite relatively Little formal research on their efficacy. Traditional, large, group studies of drug efficacy are exceedingly difficult and expensive to conduct in a heterogeneous population that is constantly evolving due to spontaneous recovery and nonpharmacological, treatment interventions. This article proposes methods for combining individual clinical outcome measures, standardized treatment protocols, and a clinical database to allow integration of research and clinical care. At a minimum, this approach should improve documentation of patient progress. In its most developed form, it offers the potential to demonstrate drug efficacy in specific patient subgroups.			WHYTE, J (corresponding author), TEMPLE UNIV,SCH MED,MOSS REHABIL RES INST,PHILADELPHIA,PA, USA.			Whyte, John/0000-0002-4381-1474			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BARLOW DH, 1984, SINGLE CASE EXPT DES; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; GLENN MB, 1989, AM J PHYS MED REHAB, V68, P221, DOI 10.1097/00002060-198910000-00004; GREENDYKE RM, 1986, J CLIN PSYCHIAT, V47, P423; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA; GUYATT G, 1986, NEW ENGL J MED, V314, P889, DOI 10.1056/NEJM198604033141406; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; JORDAN BD, 1988, SEMIN NEUROL, V5, P221; MENDELOW AD, 1983, BRIT J SURG, V70, P641, DOI 10.1002/bjs.1800701102; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; Ottenbacher K. J., 1986, EVALUATING CLIN CHAN; OTTENBACHER KJ, 1989, AM J PHYS MED REHAB, V68, P52, DOI 10.1097/00002060-198904000-00002; ROBBINS TW, 1986, ENERGETICS HUMAN INF; TEASDALE G, 1984, CLOSED HEAD INJURY P; WHYTE J, IN PRESS AM J PHYS M; WHYTE J, 1988, J HEAD TRAUMA REHAB, V3, P95; WHYTE J, 1989, REHABILITATION CHILD; WHYTE J, 1993, REHABILITATION MED P	22	4	4	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP	1994	9	3					91	103		10.1097/00001199-199409000-00008			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QD376	WOS:A1994QD37600008					2022-02-06	
J	BLAUTH, M; SCHMIDT, U; OTTE, D; HAAS, N				BLAUTH, M; SCHMIDT, U; OTTE, D; HAAS, N			LESIONS OF THE ODONTOID PROCESS IN SMALL CHILDREN - BIOMECHANICAL ANALYSIS, OPERATIVE AND CONSERVATIVE TREATMENT IN 2 CASES	UNFALLCHIRURG			German	Article								Odontoid ''fractures'' in children are in fact typical lesions of the cartilaginous plate (''synchondrosis'') separating the odontoid process from the body of the axis, 54 cases of which have been described in the literature so far. In our review we report about two 2-year-old children who were back-seat passengers restrained by four-point children's seat belts, in a car involved in a head-on motor vehicle accident. According to the accident research unit of our institution, trauma sustained in such circumstances is adequate for the causation of odontoid lesions in healthy children. Head-on collisions at a speed absorption of at least 40 km/h is described as a typical mechanism of such injury. Both children were immediately symptomatic, and the diagnosis was easily made from the X-rays. Neither child had neurologic deficits, which is in keeping with the literature, where neurologic injuries were found to have been reported exclusively in conjunction with head injuries. After closed reduction, conservative treatment was initiated in one child, in whom the extent of the anterior dislocation was smaller than the diameter of the odontoid shaft. In cases of major dislocation and more pronounced instability we recommend primarily open reduction and osteosynthesis with adequate implants. Our second case was treated with a halo fixator and a plaster vest for 12 weeks, but despite anatomic reduction there was no healing of the odontoid process. After temporary posterior fusion of CI/C2 we reamed the synchondrosis from an anterior approach and performed autogenous bone grafting. The posterior cerclage wire was removed after-5 months. In contrast to the literature, we do not recommend permanent posterior fusion of C1/C2, as has been described in 4 cases. We were able to examine our two little patients at a 3-year follow up. Clinical and radiologic examination demonstrated normal findings at this time with no si ns of atypical growth of the odontoid.			BLAUTH, M (corresponding author), HANNOVER MED SCH,UNFALLCHIRURG KLIN,D-30623 HANNOVER,GERMANY.			Otte, Dietmar/0000-0002-5927-4060				0	4	4	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	AUG	1994	97	8					413	418					6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	PB656	WOS:A1994PB65600006	7973741				2022-02-06	
J	BAHR, M; ESCHWEILER, GW; DICHGANS, J				BAHR, M; ESCHWEILER, GW; DICHGANS, J			NEURONAL PROTECTION IN NEUROLOGICAL DISEASE	NERVENARZT			German	Article						NEUROPROTECTION; EXCITATORY AMINO ACIDS; TRAUMA; CALCIUM-ANTAGONISTS; NEUROTROPHIC FACTORS	RETINAL GANGLION-CELLS; AMYOTROPHIC-LATERAL-SCLEROSIS; AMINO-ACID RECEPTORS; SPINAL-CORD INJURY; NMDA ANTAGONISTS; NERVOUS-SYSTEM; GROWTH-FACTOR; BRAIN INJURY; OPTIC-NERVE; ADULT-RATS	Several types of lesions of the mature central nervous system (CNS), such as craniocerebral trauma or spinal cord trauma, may initiate secondary cascades, which may cause damage to primarily uninjured neurons. The exact mechanisms which cause neuronal cell death are still unknown. It has been suggested that retrogradely transported target-derived neurotrophic factors which are neccessary for neuronal survival might be lacking after certain types of lesions. On the other hand, neurons might be damaged by calcium-overload resulting from excessive release of excitatory amino acids (EAAs) after trauma. The present review summarizes current concepts of post-traumatic neuronal cell damage with a focus on the putative neuroprotective role of calcium channel blockers and their interaction with glutamate mediated cytotoxicity, neurotrophic factors and free radicals.			BAHR, M (corresponding author), UNIV TUBINGEN,NEUROL KLIN,HOPPE SEYLER STR 3,D-72076 TUBINGEN,GERMANY.		Baehr, Mathias/K-2188-2014				AIZENMAN E, 1988, J PHYSIOL-LONDON, V396, P75, DOI 10.1113/jphysiol.1988.sp016951; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P181, DOI 10.1113/jphysiol.1989.sp017610; ALBERS GW, 1992, ARCH NEUROL-CHICAGO, V49, P418, DOI 10.1001/archneur.1992.00530280112031; APPEL SH, 1993, TRENDS NEUROSCI, V16, P3, DOI 10.1016/0166-2236(93)90039-O; BAHR M, 1989, NEUROSCI LETT, V96, P197, DOI 10.1016/0304-3940(89)90057-8; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; CARMIGNOTO G, 1989, J NEUROSCI, V9, P1263; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1992, SCIENCE, V258, P241, DOI 10.1126/science.1357748; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; CHOI DW, 1992, NEW ENGL J MED, V326, P1464; CHOUZA C, 1986, LANCET, V1, P1303; ESCHWEILER GW, 1993, J NEUROL SCI, V116, P34, DOI 10.1016/0022-510X(93)90086-E; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1984, J NEUROSURG, V60, P796, DOI 10.3171/jns.1984.60.4.0796; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; FEHLINGS MG, 1989, J NEUROSURG, V71, P403, DOI 10.3171/jns.1989.71.3.0403; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Ford R W, 1985, Cent Nerv Syst Trauma, V2, P9; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; GONCALVES T, 1991, EUR J PHARMACOL, V204, P315, DOI 10.1016/0014-2999(91)90858-N; KAKU DA, 1993, SCIENCE, V260, P1516, DOI 10.1126/science.8389056; KARSCHIN A, 1989, J PHYSIOL-LONDON, V418, P379, DOI 10.1113/jphysiol.1989.sp017847; KARSCHIN A, 1988, J NEUROSCI, V8, P2895; LIPTON SA, 1993, TRENDS NEUROSCI, V16, P527, DOI 10.1016/0166-2236(93)90198-U; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LUGNIER C, 1984, EUR J PHARMACOL, V98, P157, DOI 10.1016/0014-2999(84)90128-6; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PERRY TL, 1990, ANN NEUROL, V28, P12, DOI 10.1002/ana.410280105; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; RICH KM, 1990, SCIENCE, V248, P1419, DOI 10.1126/science.2356470; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; ROTHSTEIN JD, 1992, ANN NEUROL, V30, P235; Sapolsky R.M, 1992, STRESS AGING BRAIN M; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SIEVERS J, 1987, NEUROSCI LETT, V76, P157, DOI 10.1016/0304-3940(87)90708-7; SILIPRANDI R, 1993, INVEST OPHTH VIS SCI, V34, P3232; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; TAKAHASHI K, 1991, J PHARMACOL EXP THER, V256, P169; THANOS S, 1989, EUR J NEUROSCI, V1, P19, DOI 10.1111/j.1460-9568.1989.tb00770.x; THANOS S, 1993, J NEUROSCI, V13, P455; TURSKI L, 1991, NATURE, V349, P414, DOI 10.1038/349414a0; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; WIELOCH T, 1990, LIPID MEDIATORS ISCH, P203	50	4	4	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0028-2804			NERVENARZT	Nervenarzt	JUN	1994	65	6					355	360					6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	NU514	WOS:A1994NU51400001	8072588				2022-02-06	
J	JORDAN, FM				JORDAN, FM			WHATEVER HAPPENED AFTER THE RETURN FROM SILENCE	BRAIN INJURY			English	Article							CHILDREN	A case is presented of a child who, following unexpected rapid recovery of functional communication skills 9 months post-severe closed head injury, continued to progress in speech and language skills even 4 years post-injury. Although the child did not recover to premorbid levels of functioning, her recovery over such a protracted period proved quite remarkable. The case is considered in the light of recent findings on the recovery of linguistic skills subsequent to childhood closed head injury.									BEUEKELMAN DR, 1988, AUGMENTATIVE ALTERNA, V4, P104; Crystal D, 1976, GRAMMATICAL ANAL LAN; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; Enderby P, 1983, FRENCHAY DYSARTHRIA; Ewing-Cobbs L., 1985, SPEECH LANGUAGE EVAL, P97; Fried-Oken M., 1987, LANG SPEECH HEAR SER, V18, P206; GADDES WH, 1973, RES MONOGRAPH U VICT, V25; HAMMILL DD, 1982, TEST LANGUAGE DEV IN; Jennett B, 1981, MANAGEMENT HEAD INJU; JORDAN F M, 1990, Brain Injury, V4, P27; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN F M, 1990, Brain Injury, V4, P101, DOI 10.3109/02699059009026154; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; JORDAN FM, 1993, UNPUB J MED SPEECH L; Kaplan E, 1983, BOSTON NAMING TEST; Light J., 1988, AUGMENTATIVE ALTERNA, V4, P2, DOI DOI 10.1080/07434618812331274557; Spreen O., 1969, NEUROSENSORY CTR COM; TEASDALE G, 1974, LANCET, V2, P81; WORKINGER M S, 1992, Brain Injury, V6, P183, DOI 10.3109/02699059209029657	19	4	4	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	1994	8	3					277	283		10.3109/02699059409150979			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ND714	WOS:A1994ND71400008	8004085				2022-02-06	
J	HORVAT, JC				HORVAT, JC			SPINAL-CORD RECONSTRUCTION AND NEURAL TRANSPLANTS - NEW THERAPEUTIC VECTORS	BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE			French	Article						SPINAL CORD INJURIES; SPINAL CORD COMPRESSION; PERIPHERAL NERVES; TRANSPLANTATION; NEURONS; GENE THERAPY; SPINAL CORD; AXONS		Spontaneous recovery from severe traumatic lesions of the central nervous system (CNS) does not occur in adult mammals for two main reasons : the lost neurons are not replaced and the surviving axotomized nerve cells do not regenerate the missing part of their cut axon, thus failing to reestablish the original anatomical and functional connections. The likeliest explanation for this lack of axonal regrowth is powerful inhibitory effects from mature reactive astrocytes and oligodendrocytes. However, experimental strategies making use of transplantation techniques have proved to be rather efficient. Thus, with regard to spinal cord injury : 1) lost spinal neurons (especially motoneurons) can, to some extent, be replaced by foetal spinal neurons transplanted to the lesion site ; 2) irreversible damage to spinal projections from supraspinal neurons (mainly localized in the brain stem) can partially be compensated by grafting homologous foetal nerve cells caudally with regard to the spinal lesion site ; 3) axogenesis from transplanted nerve cells or axonal regrowth from injured host neurons can be triggered and guided towards central or peripheral targets by autologous peripheral nerve segments which bypass the lesion site. This efficient cellular therapy is on the way to be complemented by a gene therapy that will allow the introduction, into the brain and the spinal cord, either of genetically modified cells from, various origins, or of selected beneficial genes previously integrated into viral vectors.			HORVAT, JC (corresponding author), UNIV PARIS 05,NEUROBIOL LAB,FAMILY MED,URA 1448,45 RUE ST PERES,F-75270 PARIS 06,FRANCE.							0	4	4	0	1	ACADEMIE NATL DE MEDECINE	PARIS 06	16 RUE BONAPARTE, 75272 PARIS 06, FRANCE	0001-4079			B ACAD NAT MED PARIS	Bull. Acad. Natl. Med.	MAR 1	1994	178	3					455	463					9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NX432	WOS:A1994NX43200021	8076186				2022-02-06	
J	WANG, WP; QIU, MD; REN, HJ; ZHANG, XH				WANG, WP; QIU, MD; REN, HJ; ZHANG, XH			RELATIONS OF INTRACRANIAL-PRESSURE, CREATINE-KINASE AND BRAIN-STEM AUDITORY-EVOKED POTENTIAL IN PATIENTS WITH TRAUMATIC BRAIN EDEMA	CHINESE MEDICAL JOURNAL			English	Article							SEVERE HEAD-INJURY; PREDICTION	We studied the relations of intracranial pressure (ICP), creatine kinase (CK) and brainstem auditory evoked potential (BAEP) in 44 patients with traumatic brain edema who were admitted to our hospital from June 1990 to February 1991. There were 30 males and 14 females, with age range from 9 to 67 years. The results showed that the abnormal BAEP could reflect the severity of cerebral edema in acute head injury and was related to ICP and serum CK levels. When ICP greater-than-or-equal-to 30 mmHg (4kPa), the abnormality of BAEP was more obvious than that of the control group (P < 0.05); the serum CK levels were also elevated markedly. In patients with ICP over and below 4kPa, the rate of abnormal BAEP was 38.46% and 77.78% respectively (P < 0.05). The serum CK level in the normal group or in the group with moderate abnormality of BAEP was significantly different from that in the group with severe abnormality or lack of BAEP (274.8 +/- 98.24 U / L vs 705.3 +/- 364.27 U / L; P < 0.001). After treatment, the ICP returned to normal, and the BAEP normalized too, but the serum CK level decreased. The results showed that BAEP may provide some indirect evidences for the relevant biochemical and biophysical changes after the occurrence of traumatic brain edema and an important clinical index for judging the severity of the edema.	LANZHOU MED COLL,INST NEUROL,LANZHOU 730030,PEOPLES R CHINA		WANG, WP (corresponding author), LANZHOU MED COLL,SECOND AFFILIATED HOSP,DEPT NEUROSURG,LANZHOU 730030,PEOPLES R CHINA.						GEENNERG RP, 1981, J NEUROSURG, V55, P27; MILLER JD, 1987, ACTA NEUROCHIR, V85, P80, DOI 10.1007/BF01456102; NAGAO S, 1987, Surgical Neurology, V27, P81, DOI 10.1016/0090-3019(87)90113-3; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NIEDEGGEN A, 1989, ACTA NEUROCHIR, V101, P117, DOI 10.1007/BF01410525; QIU MD, 1983, NEUROL SURG, P32; RABOW L, 1989, ACTA NEUROCHIR, V100, P155, DOI 10.1007/BF01403604	7	4	9	1	1	CHINESE MEDICAL ASSOCIATION	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	MAR	1994	107	3					205	208					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NG969	WOS:A1994NG96900012	8088181				2022-02-06	
J	CORADDU, M; FLORIS, F; NURCHI, G; MELEDDU, V; LOBINA, G; MARCUCCI, M				CORADDU, M; FLORIS, F; NURCHI, G; MELEDDU, V; LOBINA, G; MARCUCCI, M			EVACUATION OF TRAUMATIC INTRACEREBRAL HEMATOMAS USING A SIMPLIFIED STEREOTAXIC PROCEDURE	ACTA NEUROCHIRURGICA			English	Article						HEAD TRAUMA; TRAUMATIC INTRACEREBRAL HEMATOMA; ANATOMICAL LOCALIZATION; SCALP MARKING	ACUTE SUBDURAL-HEMATOMA; SEVERE HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; BRAIN EDEMA; MANAGEMENT; SURGERY; SCALP; COMA	The autors present a serie of 37 traumatic intracerebral haematomas (ICH) evacuated by a simplified stereotatic surgical procedure. The mortality rate was 80% in patients with Glasgow coma scale (G.C.S.) scores of 3-5 and 25% in patients with scores of 6-7. There were no deaths in patients with G.C.S. of 8 or more. With the exception of the first group of patients, the results were better than those archieved by wide craniotomy. The importance of reduced operative trauma in patients with ICH, which often are associated with multifocal or diffuse brain injuries, are discussed.			CORADDU, M (corresponding author), OSPED BROTZU,DIV NEUROCHIRURG,VIA PERETTI,I-09100 CAGLIARI,ITALY.						ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; AUER LM, 1989, J NEUROSURG, V70, P530, DOI 10.3171/jns.1989.70.4.0530; BACKLUND EO, 1978, SURG NEUROL, V9, P99; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; COOPER PR, 1985, NEUROSURGERY, P1657; Coraddu M, 1990, J Neurosurg Sci, V34, P35; CORADDU M, 1988, RICERCA NEUROCHIRGIC, V2, P335; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; GADE GF, 1988, OPERATIVE NEUROSURGI, P19; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HIRSCHBERG H, 1981, J NEUROSURG, V20, P255; ITO U, 1988, ACTA NEUROCHIR WIEN, V79, P120; JAYAKUMAR PN, 1991, ACTA NEUROCHIR, V108, P30, DOI 10.1007/BF01407663; KANDEL EI, 1985, J NEUROSURG, V62, P206, DOI 10.3171/jns.1985.62.2.0206; KAUFMAN HH, 1980, NEUROSURGERY, V7, P446; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; McCormick W.F., 1985, NEUROSURGERY, P1544; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OVERGAARD J, 1991, J NEUROSURG, V59, P439; PATERNITI S, 1991, RIV NEUROBIOLOGIA, V37, P109; PATIL AA, 1986, ACTA NEUROCHIR, V80, P62, DOI 10.1007/BF01809559; PENNING L, 1987, J NEUROSURG, V66, P474, DOI 10.3171/jns.1987.66.3.0474; POPP AJ, 1985, NEUROSURGERY, P1536; Rivano C, 1980, J Neurosurg Sci, V24, P77; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049; Wester K, 1981, Neuroradiology, V20, P255; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830; ZIMMERMAN RA, 1978, AM J ROENTGENOL, V131, P27, DOI 10.2214/ajr.131.1.27	40	4	4	0	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1994	129	1-2					6	10		10.1007/BF01400865			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NY476	WOS:A1994NY47600002	7998498				2022-02-06	
J	GOLDMAN, H; MOREHEAD, M; MURPHY, S				GOLDMAN, H; MOREHEAD, M; MURPHY, S			AN ACTH ANALOG MINIMIZES CEREBROVASCULAR DAMAGE IN AN ANIMAL-MODEL OF MODERATE BRAIN INJURY	JOURNAL OF NEUROTRAUMA			English	Article							ACTH(4-9) ANALOG; HEAD-INJURY; BLOOD-FLOW; BARRIER; RATS; NEUROTOXICITY; ORG-2766	An ACTH(1-14)-related analog (GMM(2)) was tested for efficacy in reducing the cerebrovascular pathology that follows moderate, closed-head injury in our rat model. Posttraumatic subcutaneous administration of nanomolar amounts of GMM(2) significantly minimized both the hypoperfusion and the increased blood-brain permeability observed 2 h following a concussion. Posttraumatic administration of the peptide also reduced the elevated brain water content observed at 24 and 48 h postinjury to nonsignificant levels. These findings complement previously described observations that GMM(2) treatment prevents dangerous elevations of ICP (>25 mm Hg) at 24 to 72 h in this model of head injury. In view of the potency and low toxicity of GMM(2) these observation suggest that the peptide may have considerable clinical application in interrupting pathologic sequelae of traumatic brain injury.			GOLDMAN, H (corresponding author), WAYNE STATE UNIV, SCH MED, DEPT PHARMACOL, 540 E CANFIELD AVE, DETROIT, MI 48201 USA.				NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R24RR002022, R01RR002022] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [NIDRR G0087C2022] Funding Source: Medline		AREFYEVA IA, 1992, NEUROSCI RES COMMUN, V11, P37; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BRAUGHLER JM, 1987, J BIOL CHEM, V262, P10438; BRAUGHLER JM, 1988, J PHARMACOL EXP THER, V244, P423; DEKKER AJAM, 1987, PEPTIDES, V8, P1057, DOI 10.1016/0196-9781(87)90136-7; DEKONING P, 1987, EXP NEUROL, V97, P746, DOI 10.1016/0014-4886(87)90132-4; DEWIED D, 1990, NEUROPEPTIDES BASICS, P1; GISPEN WH, 1982, SCAND J PSYCHOL, P16; GOLDMAN H, 1981, PHARMACOL BIOCHEM BE, V14, P845, DOI 10.1016/0091-3057(81)90372-5; GOLDMAN H, 1993, ANN EMERG MED, V22, P1035, DOI 10.1016/S0196-0644(05)82747-7; GOLDMAN H, 1973, AM J PHYSIOL, V224, P122, DOI 10.1152/ajplegacy.1973.224.1.122; GOLDMAN H, 1975, PHARMACOL BIOCHEM BE, V3, P661, DOI 10.1016/0091-3057(75)90188-4; GOLDMAN H, 1982, PEPTIDES, V3, P649, DOI 10.1016/0196-9781(82)90166-8; GOLDMAN H, 1987, ADV BIOCHEM PSYCHOPH, V43, P317; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; GUARINI S, 1987, PHARMACOL RES, V19, P255, DOI 10.1016/0031-6989(87)90068-3; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MILLER TP, 1993, BIOL PSYCHIAT, V33, P307, DOI 10.1016/0006-3223(93)90303-U; OHNO K, 1979, SURG NEUROL, V12, P323; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; RAPOPORT SI, 1980, AM J PHYSIOL, V238, pR421, DOI 10.1152/ajpregu.1980.238.5.R421; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; SANDRINI M, 1988, PHARMACOL RES, V20, P739, DOI 10.1016/S0031-6989(88)80714-8; SAPIRSTEIN LA, 1958, AM J PHYSIOL, V193, P161, DOI 10.1152/ajplegacy.1958.193.1.161; STRAND FL, 1989, PROG NEUROBIOL, V33, P45, DOI 10.1016/0301-0082(89)90035-X; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; VANDERHOOP RG, 1990, NEW ENGL J MED, V322, P89, DOI 10.1056/NEJM199001113220204; VANDERNEUT R, 1988, PEPTIDES, V9, P1015, DOI 10.1016/0196-9781(88)90082-4; VERHOEF J, 1976, PHARMACOL BIOCHEM BE, V4, P583, DOI 10.1016/0091-3057(76)90201-X	30	4	4	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	WIN	1993	10	4					385	395		10.1089/neu.1993.10.385			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MQ818	WOS:A1993MQ81800003	8145262				2022-02-06	
J	MAIERHAUFF, K; GATZOUNIS, G; BORSCHEL, M				MAIERHAUFF, K; GATZOUNIS, G; BORSCHEL, M			PEDIATRIC CRANIOCEREBRAL TRAUMA - PARTICULAR FEATURES, TREATMENT AND PROGNOSIS	UNFALLCHIRURG			German	Article								The mortality rate after traumatic brain injury in children ranges between 2.5 % and 21 %. Standardized diagnostic procedures and therapeutic strategies for the management of traumatic brain damage are presented in this article. Children with traumatic cerebral lesions have a better clinical outcome than head-injured adults. Optimized medical management and intensive rehabilitation may help to reduce the frequency of mental retardation and physical disability following such injuries in children.			MAIERHAUFF, K (corresponding author), FREIEN UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,NEUROCHIRURG ABT,AUGUSTENBURGER PL 1,D-13353 BERLIN,GERMANY.			Gatzounis, Georgios/0000-0002-4022-6691				0	4	4	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	NOV	1993	96	11					604	608					5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	MK626	WOS:A1993MK62600009	8284683				2022-02-06	
J	GOODALL, P; DEDRICK, D; ZASLER, ND; KREUTZER, JS; RIDDICK, S				GOODALL, P; DEDRICK, D; ZASLER, ND; KREUTZER, JS; RIDDICK, S			SURVEY OF CASE MANAGER TRAINING NEEDS IN TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article								The results of 138 surveys assessing the training needs of case managers in the area of traumatic brain injury were analysed. Sixty-six per cent of the respondents were case managers working primarily with adults in a variety of work settings. Respondents rated working with families, vocational rehabilitation, and community re-entry as the top three areas for training. Mild traumatic brain injury, paediatric traumatic brain injury, neuropsychological assessment, and medicolegal aspects received the highest rankings by case managers with more than 8 years experience. The need for certification of case managers in specialty areas was supported by 83% of all respondents.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,SCH MED,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHYS MED & REHABIL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,REHABIL RES & TRAIN CTR SEVERE TRAUMAT BRAIN INJURY,RICHMOND,VA 23298; RIDDICK & ASSOCIATES,RICHMOND,VA								BOLING J, 1991, CASE MANAGER     MAR; BOLING J, 1992, CASE MANAGER     FEB; BOLING J, 1992, CASE MANAGER     JAN, P6; Bush G W, 1989, Brain Inj, V3, P91, DOI 10.3109/02699058909008079; DIXON TP, 1988, REHABIL COUNS BULL, V31, P325; HUMPHREYS S, 1991, CMSA PROFILES CASE R, P3; HURLEY RE, 1986, SOC SCI MED, V23, P75, DOI 10.1016/0277-9536(86)90326-6; Intagliata J, 1988, New Dir Ment Health Serv, P39; KANTER J, 1989, HOSP COMMUNITY PSYCH, V40, P361; MCCOLLOM PL, 1991, CASE MANAGEMENT GUID; ROUGHAN J, 1990, CASE MANAGER     MAY; ROUGHAN J, 1990, CASE MANAGER     APR, P40; ROUGHAN J, 1990, CASE MANAGER     JUN; VANDERSCHAAF S, 1990, J HEAD TRAUMA REHABI, V5, P40; Whitman M, 1991, Rehabil Nurs, V16, P19	15	4	4	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	SEP-OCT	1993	7	5					455	461		10.3109/02699059309029689			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	MA172	WOS:A1993MA17200009	8401487				2022-02-06	
J	PINZUR, MS				PINZUR, MS			DYNAMIC ELECTROMYOGRAPHY IN FUNCTIONAL SURGERY FOR UPPER LIMB SPASTICITY	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article								Surgery to improve upper limb function after stroke, closed head injury, or other causes of acquired spasticity is generally accomplished by a combination of muscle transfer, lengthening, and/or release. Dynamic electromyography can be used to identify voluntary muscle action, delineate the deforming motor forces when spasticity is present, and provide guidance for surgical planning to improve prehensile hand function.			PINZUR, MS (corresponding author), LOYOLA UNIV,SCH MED,DEPT ORTHOPAED SURG,2160 S 1ST AVE,MAYWOOD,IL 60153, USA.						BRAUN RM, 1970, J BONE JOINT SURG AM, VA 52, P907, DOI 10.2106/00004623-197052050-00005; CLOSE JR, 1959, J BONE JOINT SURG AM, V41, P189, DOI 10.2106/00004623-195941020-00001; INGLIS AE, 1966, J BONE JOINT SURG AM, VA 48, P847, DOI 10.2106/00004623-196648050-00002; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P607, DOI 10.1016/S0363-5023(09)90023-5; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P575, DOI 10.1016/S0363-5023(87)80211-3; KEENAN MAE, 1989, J BONE JOINT SURG AM, V71A, P120, DOI 10.2106/00004623-198971010-00018; LIGHT TL, 1985, ATLAS ORTHOTICS, P126; MITAL MA, 1979, J BONE JOINT SURG AM, V61, P515, DOI 10.2106/00004623-197961040-00005; Mooney V, 1969, Clin Orthop Relat Res, V63, P7; OSTERHOUT TM, 1987, OCCUP THER HLTH CARE, V4, P135; PINZUR MS, 1991, J HAND SURG-BRIT EUR, V16B, P133, DOI 10.1016/0266-7681(91)90161-G; PINZUR MS, 1986, J BONE JOINT SURG AM, V68A, P1249, DOI 10.2106/00004623-198668080-00016; PINZUR MS, 1985, J HAND SURG-AM, V10A, P547, DOI 10.1016/S0363-5023(85)80081-2; PINZUR MS, 1988, J HAND SURG-AM, V13A, P549, DOI 10.1016/S0363-5023(88)80093-5; PINZUR MS, 1987, ARCH PHYS MED REHAB, V68, P446; ROPER BA, 1991, J HAND SURG-BRIT EUR, V16B, P123, DOI 10.1016/0266-7681(91)90158-K	16	4	5	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	MAR	1993		288					118	122					5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	KW036	WOS:A1993KW03600014	8458123				2022-02-06	
J	TANNER, BA				TANNER, BA			COMPUTER-AIDED REPORTING OF THE RESULTS OF NEUROPSYCHOLOGICAL EVALUATIONS OF TRAUMATIC BRAIN INJURY	COMPUTERS IN HUMAN BEHAVIOR			English	Article								The TBI Report Assistant is designed to perform the types of routine tasks that computers do well, while freeing the skilled psychologist to concentrate on tasks best done by knowledgeable humans. The Assistant is intended for reporting the results of neuropsychological evaluation of traumatic brain injury patients using a standard battery. The program encourages the inclusion of additional information by writing to a disk file suitable for editing with a word processor rather than directly to the printer The resulting file contains prompts for summary and interpretive statements by the psychologist.	WAYNE STATE UNIV, DETROIT, MI 48202 USA		TANNER, BA (corresponding author), DETROIT RECEIVING HOSP & UNIV HLTH CTR, 4201 ST ANTOINE, DETROIT, MI 48201 USA.						ADAMS KM, 1984, J CLIN NEUROPSYCHOL, V6, P413, DOI 10.1080/01688638408401232; *AM PSYCH ASS, 1986, GUID COMP BAS TESTS; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; DAVIES ADM, 1968, J CLIN PSYCHOL, V24, P98; FOWLER RD, 1985, J CONSULT CLIN PSYCH, V53, P748, DOI 10.1037/0022-006X.53.6.748; HEATON R K, 1981, Journal of Clinical Neuropsychology, V3, P121, DOI 10.1080/01688638108403118; Heaton R.K., 1981, WISCONSIN CARD SORTI; Honaker L. M., 1986, Computers in Human Behaviour, V2, P77, DOI 10.1016/0747-5632(86)90024-5; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Matarazzo J. D., 1985, Computers in Human Behaviour, V1, P235, DOI 10.1016/0747-5632(85)90015-9; MATARAZZO JD, 1986, AM PSYCHOL, V41, P14, DOI 10.1037/0003-066X.41.1.14; Moreland K. L., 1985, Computers in Human Behaviour, V1, P221, DOI 10.1016/0747-5632(85)90014-7; *NAT I DIS REH RES, 1989, COMPR MOD RES REH TR; TANNER BA, 1991, MAR INT BRAIN INJ S; TANNER BA, 1991, 43RD I HOSP COMM PSY; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wiens A. N., 1988, CLIN NEUROPSYCHOL, V2, P67	20	4	4	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0747-5632	1873-7692		COMPUT HUM BEHAV	Comput. Hum. Behav.	SPR	1993	9	1					51	56		10.1016/0747-5632(93)90020-S			6	Psychology, Multidisciplinary; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	KA733	WOS:A1993KA73300004					2022-02-06	
J	CORRELL, RE; BRODGINSKI, SE; ROKOSZ, SF				CORRELL, RE; BRODGINSKI, SE; ROKOSZ, SF			WAIS PERFORMANCE DURING THE ACUTE RECOVERY STAGE FOLLOWING CLOSED-HEAD INJURY	PERCEPTUAL AND MOTOR SKILLS			English	Article							MODERATE; TRAUMA	WAIS profiles of 50 acute closed head-injured patients were examined and compared with those of 40 psychiatric inpatients. Patients with moderate and severe, but not with mild, head injury differed significantly from the control group on level of subtest performance. There was no significant interaction of group by subtest. The groups also differed significantly on a measure of between-subtest scatter. Discriminant function analysis incorporating measures of within-subtest scatter correctly classified 89% of all subjects. Within the head-injured group Similarities and Block Design scores were elevated, and the Digit Symbol score depressed. These results indicate that closed head-injured patients can be discriminated from psychiatric inpatients on the basis of WAIS performance, but that they do not necessarily show a characteristic WAIS profile. Within-subtest scatter may indicate information-processing deficits.			CORRELL, RE (corresponding author), HARTFORD HOSP,80 SEYMOUR ST,HARTFORD,CT 06115, USA.						ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BECKER B, 1975, J CLIN PSYCHOL, V31, P307, DOI 10.1002/1097-4679(197504)31:2<307::AID-JCLP2270310231>3.0.CO;2-Y; BORNSTEIN RA, 1987, CLIN NEUROPSYCHOL, V1, P185; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; FAHY TJ, 1967, LANCET, V2, P475; GOLDEN CJ, 1977, J CONSULT CLIN PSYCH, V45, P1043, DOI 10.1037/0022-006X.45.6.1043; HAGEN C, 1977, HEAD TRAUMA REHABILI; HALLENBECK CE, 1965, PSYCHOL REP, V17, P339, DOI 10.2466/pr0.1965.17.2.339; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Long C J, 1983, Psychiatr Med, V1, P35; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; Mittenberg W., 1989, PSYCHOL ASSESSMENT J, V1, P273; NICKOLS J, 1963, J CLIN PSYCHOL, V19, P420, DOI 10.1002/1097-4679(196310)19:4<420::AID-JCLP2270190413>3.0.CO;2-X; O'Shanick G J, 1986, Adv Psychosom Med, V16, P173; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; Reitan Ralph M, 1990, Clin Neuropsychol, V4, P80, DOI 10.1080/13854049008401499; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; SELZ M, 1979, J CONSULT CLIN PSYCH, V47, P258, DOI 10.1037/0022-006X.47.2.258; TEASDALE G, 1974, LANCET, V2, P81; TOOTH G, 1947, J NEUROL NEUROSUR PS, V10, P1, DOI 10.1136/jnnp.10.1.1; WATSON CG, 1965, J CONSULT PSYCHOL, V29, P596, DOI 10.1037/h0022785; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn	28	4	4	0	0	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	FEB	1993	76	1					99	109		10.2466/pms.1993.76.1.99			11	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	KP953	WOS:A1993KP95300019	8451158				2022-02-06	
J	JEANNERET, B; HOLDENER, HJ				JEANNERET, B; HOLDENER, HJ			FRACTURES OF THE SPINE AND ABDOMINAL-TRAUMA - A RETROSPECTIVE ANALYSIS OF 415 DOCUMENTED SPINAL FRACTURES	UNFALLCHIRURG			German	Article								415 spinal fractures were analysed retrospectively. A simultaneous occurrence of vertebral fracture and abdominal trauma was found in 14 patients (3.4%). The mechanism of injury was a fall from a considerable height in 9 cases, a car accident in 3 and a motorcycle accident in 2. Isolated fractures of the transverse processes and rotational injuries of the spine were found to be associated particularly frequently with an abdominal trauma (3 of 14 isolated fractures of the transverse processes = 22%, 5 of 61 rotational injuries = 8.2%), while compression injuries only showed such a simultaneous abdominal injury in 2% of the 300 fractures of this type. We never encountered the combination of distraction injury/abdominal trauma. This is probably because two-point lap-type seat belts are only rarely used in our country. In 2 patients with rotational injuries neurological deficits were observed. The abdominal injuries encountered in our patients were: massive concussion of the kidney (6 cases), rupture of the spleen (3 cases), rupture of the liver (2 cases), rupture of the mesocolon (2 cases), rupture of the caecum (1 case), rupture of a pre-existent aneurysm of the aorta (1 case), rupture of a renal artery (1 case), massive retroperitoneal haematoma (1 case). Other injuries were present in 12 of the 14 patients: 3 craniocerebral injuries, 7 fractures of the long bones, 6 injuries to the thorax and 3 to the pelvis. In conclusion, a simultaneous finding of vertebral fracture and abdominal trauma is rare in our patients. However, in the presence of isolated fractures of the transverse processes or in the presence of a rotational injury of the spine, the possibility of a simultaneous abdominal trauma must be ruled out very carefully even if the patient is not polytraumatized. A simultaneous injury also has to be ruled out if a distraction injury of the spine is the result of a car accident in combination with the use of lap-type seat belts.			JEANNERET, B (corresponding author), KANTONSSPITAL,ORTHOPAD CHIRURG KLIN,CH-9007 ST GALLEN,SWITZERLAND.							0	4	4	0	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	DEC	1992	95	12					603	607					5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	KH056	WOS:A1992KH05600002	1287843				2022-02-06	
J	LEVIN, HS				LEVIN, HS			HEAD-INJURY AND ITS REHABILITATION	CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY			English	Article							MULTIMODALITY EVOKED-POTENTIALS; TRAUMATIC BRAIN INJURY; RECOVERY	Investigation of outcome following head injury is changing from studies with a broad scope to more focussed issues concerning specific subgroups, the application of new technologies such as functional brain imaging, clinical trials of medication, and strategies of rehabilitation. This review primarily addresses outcome and intervention studies relevant to the sequelae and rehabilitation of head-injured patients.			LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,DIV NEUROSURG,D73,GALVESTON,TX 77550, USA.						ANSELL BJ, 1991, J SPEECH HEAR RES, V34, P1017, DOI 10.1044/jshr.3405.1017; CHRISTENSEN AL, 1992, ACTA NEUROL SCAND, V85, P32; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; MAYO NE, 1991, AM J PHYS MED REHAB, V70, P118, DOI 10.1097/00002060-199106000-00002; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; RICHARDS JS, 1991, ARCH PHYS MED REHAB, V72, P275; RICHARDSON JTE, 1992, NEUROLOGY, V42, P283, DOI 10.1212/WNL.42.2.283; SAZBON L, 1991, J NEUROL NEUROSUR PS, V54, P149, DOI 10.1136/jnnp.54.2.149; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; TURKSTRA LS, 1992, ARCH PHYS MED REHAB, V73, P138; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; WEHMAN PH, 1991, ARCH PHYS MED REHAB, V72, P101; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460	18	4	4	0	4	CURRENT SCIENCE LTD	LONDON	34-42 CLEVELAND STREET, LONDON, ENGLAND W1P 6LB	0951-7383			CURR OPIN NEUROL NEU		OCT	1992	5	5					673	676					4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT205	WOS:A1992JT20500014	1392140				2022-02-06	
J	STOCKHAMMER, G; REINDL, H; SALTUARI, L; SPOGLER, F; BENEDETTO, K; KADLEZ, R; FRISCHHUT, B				STOCKHAMMER, G; REINDL, H; SALTUARI, L; SPOGLER, F; BENEDETTO, K; KADLEZ, R; FRISCHHUT, B			PERIARTICULAR OSSIFICATIONS FOLLOWING BRAIN INJURY - NATURAL COURSE AND MANAGEMENT	ORTHOPADE			German	Article						PERIARTICULAR OSSIFICATION; HEAD INJURY; SURGICAL ARTHROLYSIS		Occurrence of periarticular ossification (PAO) is a serious complication in the rehabilitation of patients with neurological diseases, especially those with severe head injuries. The present concept for operative intervention in PAO postulates late surgical treatment after "maturation" of these heterotopic ossifications, because of a suspected higher rate of reoccurrence after early removal. In a retrospective analysis of nine arthrolyses in six patients with neurological diseases suffering from PAO (five patients with traumatic appallic syndrome and one patient with spontaneous subarachnoidal haemorrhage), the validity of a new concept of treatment of primary neurological diseases was investigated. Because of the well-known secondary and tertiary problems (fibrotic stiffness, osteoporosis, compression syndrome of peripheral nerves, muscle atrophy), we chose early removal of the ossifications. Our results demonstrate that the former concept of surgical intervention in "mature PAO" only can no longer be recommended as superior to early surgical treatment in neurological diseases, particularly in patients with traumatic apallic syndrome associated with PAO.			STOCKHAMMER, G (corresponding author), UNIV INNSBRUCK,NEUROL KLIN,ANICHSTR 35,A-6020 INNSBRUCK,AUSTRIA.							0	4	4	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0085-4530			ORTHOPADE	Orthopade	SEP	1992	21	5					346	352					7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	JN340	WOS:A1992JN34000010	1408129				2022-02-06	
J	HERISHANU, YO				HERISHANU, YO			ABNORMAL CANCELLATION OF THE VESTIBULOOCULAR REFLEX (VOR) AFTER MILD HEAD AND OR NECK TRAUMA	NEURO-OPHTHALMOLOGY			English	Article						VOR; FLOCCULUS; SMOOTH PURSUIT; BRAIN CONCUSSION; WHIPLASH	PURKINJE-CELL ACTIVITY; PURSUIT EYE-MOVEMENTS; PRIMATE FLOCCULUS; SUPPRESSION; CEREBELLAR; NYSTAGMUS	Dizziness and/or feeling of unsteadiness are frequent symptoms of post-concussion syndrome and may last for months or even years. Because of the ill-defined nature of these symptoms and the difficulty to localize the site of the lesion, the patient is frequently diagnosed as psychoneurotic. Since an abnormal cancellation of the vestibulo-ocular reflex (VOR) by fixation and tracking can be responsible for dizziness, we evaluated it by a simple clinical test. Patients complaining of dizziness who underwent a head and/or neck trauma were compared with healthy controls and with patients suffering from a known vestibulo-cerebellar pathology. Abnormal cancellation of VOR was found in the post-traumatic patients and in those with a vestibulo-cerebellar pathology and can explain their complaints.			HERISHANU, YO (corresponding author), BEN GURION UNIV NEGEV,SOROKA MED CTR KUPAT HOLIM,FAC HLTH SCI,DEPT NEUROL,POB 151,IL-84105 BEER SHEVA,ISRAEL.						BUTTNER U, 1984, EXP BRAIN RES, V55, P97; BUTTNER U, 1986, PROG BRAIN RES, V64, P225; DICHGANS J, 1978, ARCH PSYCHIAT NERVEN, V226, P183, DOI 10.1007/BF00341710; HALMAGYI GM, 1979, J NEUROL NEUROSUR PS, V42, P934, DOI 10.1136/jnnp.42.10.934; ITO M, 1977, J PHYSIOL-LONDON, V265, P833, DOI 10.1113/jphysiol.1977.sp011747; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; LONGRIDGE NS, 1987, ACTA OTO-LARYNGOL, V103, P273, DOI 10.3109/00016488709107794; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; ROBINSON DA, 1981, HDB PHYSL NERVOUS SY, V2, P1275; TAKEMORI S, 1974, BRAIN RES, V72, P213, DOI 10.1016/0006-8993(74)90860-9; WESTHEIMER G, 1974, EXP BRAIN RES, V21, P463; ZEE DS, 1981, J NEUROPHYSIOL, V46, P878, DOI 10.1152/jn.1981.46.4.878	12	4	4	0	7	AEOLUS PRESS	BUREN	PO BOX 740, 4116 ZJ BUREN, NETHERLANDS	0165-8107			NEURO-OPHTHALMOLOGY	Neuro-Ophthalmol.	AUG	1992	12	4					237	240		10.3109/01658109209058144			4	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	JK626	WOS:A1992JK62600007					2022-02-06	
J	LEWIS, L; ATHEY, GI; EYMAN, J; SAEKS, S				LEWIS, L; ATHEY, GI; EYMAN, J; SAEKS, S			PSYCHOLOGICAL TREATMENT OF ADULT PSYCHIATRIC-PATIENTS WITH TRAUMATIC FRONTAL-LOBE INJURY	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							BRAIN; PSYCHOTHERAPY	In the spring 1992 issue, we began a series of articles, to appear occasionally, addressing psychological management of patients with cerebral disease. The goal is to offer practical, specific advice about management, informed by psychodynamic insight if not necessarily using psychodynamic technique. In this issue, a group of psychologists report on their experience in treating traumatically brain-injured patients in a psychoanalytically oriented psychiatric hospital. The authors argue that the frontal lobe damage produced by head trauma creates a requirement for clinicians to tailor hospital, family, and individual treatment to the new cognitive and emotional states of their patients. They describe how they do this in their setting. All four authors are neuropsychologists at the Menninger Clinic. Dr. Lewis is Coordinator of Neuropsychological Services at the Menninger Clinic and a faculty member of the Karl Menninger School of Psychiatry and Mental Health Sciences. Dr. Athey's primary activity is with the Alcohol and Drug Rehabilitation Program at the C. F. Menninger Memorial Hospital. Dr. Eyman is the Paul W. Pruyser Professor at the Menninger School of Psychiatry and Mental Health Sciences. Dr. Saeks's primary activities are on the Short-Term Diagnostic and Treatment Unit and in the Professionals in Crisis Program at the C. F. Menninger Memorial Hospital.			LEWIS, L (corresponding author), MENNINGER FDN,BOX 829,TOPEKA,KS 66601, USA.						BALL JD, 1988, J MED PSYCHOTHERAPY, V1, P15; BUTLER RW, 1988, PROF PSYCHOL-RES PR, V19, P536, DOI 10.1037/0735-7028.19.5.536; COURVILLE CB, 1942, ARCH SURG-CHICAGO, V5, P19; Cummings J, 1985, CLIN NEUROPSYCHIATRY; Fuster JM., 1980, PREFRONTAL CORTEX; HART T, 1986, CLIN NEUROPSYCHOLOGY; Kaplan SP, 1991, CLIN NEUROPSYCHOL, V5, P360; Klonoff P. S., 1991, J HEAD TRAUMA REHAB, V6, P11, DOI [10.1097/00001199-199112000-00005, DOI 10.1097/00001199-199112000-00005]; LEWIS L, 1990, J NERV MENT DIS, V178, P69, DOI 10.1097/00005053-199002000-00001; LEWIS L, 1986, B MENNINGER CLIN, V50, P75; Lewis L, 1991, J HEAD TRAUMA REHAB, V6, P22; LEWIS L, 1983, J CLIN NEUROPSYCHOLO, V2, P65; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LINDGREN SO, 1966, ACTA CHIR SCAND S, V132; MCALLISTER TW, 1987, COMPR PSYCHIAT, V28, P1; MURRAY JE, 1968, NEW ENGL J MED, V278, P1383; NOVACK TA, 1984, INT J CLIN NEUROPSYC, V6, P139; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; OMMAYA AK, 1970, NEUROLOGY, V20, P388; Orsini D. L., 1988, NEUROPSYCHOLOGY CASE; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; Reitan R. M., 1986, TRAUMATIC BRAIN INJU, VI; ROSS ED, 1981, ARCH NEUROL-CHICAGO, V38, P561, DOI 10.1001/archneur.1981.00510090055006; STERN JM, 1985, ISRAEL J PSYCHIAT, V22, P83; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; TEASDALE G, 1984, CLOSED HEAD INJURY P; Wiederholt W. C., 1982, NEUROLOGY NONNEUROLO; [No title captured]; [No title captured]	31	4	4	0	0	AMER PSYCHIATRIC ASSOCIATION	WASHINGTON	1400 K ST NW, WASHINGTON, DC 20005	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	1992	4	3					323	330					8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	JG128	WOS:A1992JG12800013	1498586				2022-02-06	
J	DONDERS, J				DONDERS, J			VALIDITY OF THE KAUFMAN ASSESSMENT BATTERY FOR CHILDREN WHEN EMPLOYED WITH CHILDREN WITH TRAUMATIC BRAIN INJURY	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							CONSTRUCT-VALIDITY	The K-ABC and WISC-R were administered to 43 children with traumatic brain injury. The amount of shared variance between standard score indices of these two tests ranged from 42% to 71%, depending on which scores were considered. Correlations with degree of cerebral impairment, as measured by length of coma, were slightly higher for WISC-R IQ scores than for K-ABC global scale scores. Performance on both the K-ABC and the WISC-R was affected by the presence or absence of ocular and/or motor deficits. It is concluded that the K-ABC is not superior to the WISC-R in sensitivity to cerebral impairment and that caution is needed when one is making neuropsychological interpretations on the basis of the K-ABC.			DONDERS, J (corresponding author), MARY FREE BED HOSP,DEPT PSYCHOL,235 WEALTHY SE,GRAND RAPIDS,MI 49503, USA.						FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GOETZ ET, 1984, J SPEC EDUC, V18, P281, DOI 10.1177/002246698401800309; KAMPHAUS R, 1987, CLIN RES APPLICATION; Kaufman A. S, 1983, KAUFMAN ASSESSMENT B; MORRIS JM, 1987, DEV NEUROPSYCHOL, V3, P67, DOI 10.1080/87565648709540364; NAGLIERI JA, 1985, AM J MENT DEF, V89, P367; NAGLIERI JA, 1984, J PSYCHOEDUCATIONAL, V2, P49; OBRZUT A, 1984, PSYCHOL SCHOOLS, V21, P417, DOI 10.1002/1520-6807(198410)21:4<417::AID-PITS2310210402>3.0.CO;2-9; OBRZUT A, 1987, AM J MENT RETARD, V92, P74; Pommer L. T., 1986, J PSYCHOEDUCATIONAL, V4, P155, DOI [10.1177/073428298600400207, DOI 10.1177/073428298600400207]; Rourke B. P., 1988, CLIN NEUROPSYCHOL, V2, P293, DOI DOI 10.1080/13854048808403271; SATZ P, 1981, J CONSULT CLIN PSYCH, V49, P851, DOI 10.1037/0022-006X.49.6.851; Strang J.D., 1983, CHILD NEUROPSYCHOLOG; STROMMEN E, 1988, J SCHOOL PSYCHOL, V26, P13, DOI 10.1016/0022-4405(88)90028-3; Wechsler D., 1974, WECHSLER INTELLIGENC; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48	17	4	4	0	2	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	MAR	1992	48	2					225	230		10.1002/1097-4679(199203)48:2<225::AID-JCLP2270480213>3.0.CO;2-S			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	HN264	WOS:A1992HN26400012	1573024				2022-02-06	
J	ROESSLER, RT; SCHRINER, KF; PRICE, P				ROESSLER, RT; SCHRINER, KF; PRICE, P			EMPLOYMENT CONCERNS OF PEOPLE WITH HEAD-INJURIES	JOURNAL OF REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; AGENDA	In a 10-state study, 1052 people with head injuries completed the Employment Concerns Questionnaire. Respondents were primarily young adults (66% males) who had experienced a closed head injury. Approximately seven years postinjury, most of the participants were unemployed (70%) and reported multiple symptoms affecting their vocational and social functioning. While they considered employment services very important, respondents were not satisfied with the availability and quality of specific preparation, placement, and postemployment services. Policy and practice changes are needed to address gaps in employment services for people with head injuries.			ROESSLER, RT (corresponding author), UNIV ARKANSAS,ARKANSAS RES & TRAINING CTR VOCAT REHABIL,FAYETTEVILLE,AR 72701, USA.						BERKOWITZ ED, 1987, DISABLED POLICY AM P; BLAIR JR, 1989, J REHABIL, V55, P46; DIXON TP, 1988, REHABIL COUNS BULL, V31, P325; FAWCETT SB, 1982, MENTAL HLTH MENTAL R, V1, P1; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; FRASER RT, 1988, CONT CHALLENGES REHA, P217; HAFFEY WJ, 1989, REHABIL PSYCHOL, V34, P147, DOI 10.1037//0090-5550.34.2.147; MCMAHON B, 1988, CONT CHALLENGES REHA, P197; MCMAHON BT, 1988, REHABIL COUNS BULL, V31, P274; NOBLE JH, FINANCING SERVICES P; NOBLE JH, 1990, SUPPORTED EMPLOYMENT; ROESSLER R, 1990, EMPLOYMENT CONCERNS; SCHRINER KF, 1990, J COLL STUDENT DEV, V31, P307; SCHRINER KF, 1988, J COMMUNITY PSYCHOL, V16, P306, DOI 10.1002/1520-6629(198807)16:3<306::AID-JCOP2290160306>3.0.CO;2-5; SCHRINER KF, 1988, J COMMUNITY DEV SOC, V19, P108; SEEKINS T, 1987, AM J COMMUN PSYCHOL, V15, P305, DOI 10.1007/BF00922700; UOMOTO JM, 1989, REHABIL PSYCHOL, V34, P71, DOI 10.1037//0090-5550.34.2.71; WELUNAN P, 1988, REHABILITATION COUNS, V31, P298	18	4	4	0	0	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109	0022-4154			J REHABIL	J. Rehabil.	JAN-MAR	1992	58	1					17	22					6	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	HM474	WOS:A1992HM47400002					2022-02-06	
J	THOMAS, C; QUINIO, P; TANDE, D				THOMAS, C; QUINIO, P; TANDE, D			LUNG PASTEURELLOSIS IN A YOUNG POLYTRAUMA PATIENT	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article								A case is reported of an 18-year-old male patient who had a road traffic accident, with head and chest injuries. The patient was admitted to the surgical intensive care unit 24 h later because of an alteration of his level of consciousness. He required artificial ventilation. Five days later, he developed right-sided lower lobe pneumonia, treated with positive end-expiratory pressure. A Gram negative organism was found on bronchial brushing, but not in haemocultures. It was identified as Pasteurella multocida, sensitive to beta-lactamines, but not to amikacin. Cefotaxime, which had been started immediately after the arrival of the Gram stain result, was continued. Artificial ventilation was discontinued on day 12, and the patient left the unit on day 15. The patient was probably a P. multocida carrier, being in close contact with animals before his accident. This bacteria is often found in infected animal bite wounds. Pneumonia due to this bacteria usually occurs in immunodepressed patients, which was not the case here.			THOMAS, C (corresponding author), CTR HOSP REG & UNIV MORVAN,DEPT ANESTHESIE REANIMAT CHIRURG,F-29200 BREST,FRANCE.							0	4	4	0	0	EDITIONS SCIENTIFIQUES ELSEVIER	PARIS CEDEX 15	141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.		1992	11	1					103	104		10.1016/S0750-7658(05)80327-2			2	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	HF111	WOS:A1992HF11100017	1443800				2022-02-06	
J	GRATZ, KW; IMHOF, HG; VALAVANIS, A				GRATZ, KW; IMHOF, HG; VALAVANIS, A			TRAUMATIC CAROTID CAVERNOUS SINUS FISTULA DUE TO A GUN SHOT INJURY	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						TRAUMA; GUNSHOT WOUNDS; CAROTID CAVERNOUS SINUS FISTULA	ANEURYSM; GUNSHOT; WOUNDS; BRAIN	A case of a traumatic carotid cavernous sinus fistula is presented, the result of a bullet passing through both condylar regions of the mandible. The fistula was occluded by a detachable balloon brought in place using endovascular techniques.	UNIV HOSP ZURICH,DEPT MAXILLOFACIAL SURG,CH-8091 ZURICH,SWITZERLAND; UNIV HOSP ZURICH,DEPT NEUROSURG,CH-8091 ZURICH,SWITZERLAND; UNIV HOSP ZURICH,DEPT NEURORADIOL,CH-8091 ZURICH,SWITZERLAND								Daxecker F, 1984, Fortschr Ophthalmol, V81, P85; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; GRATZ KW, 1982, MED WOCHENSCHR, V112, P1007; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HELLNER KA, 1961, NEUROCHIRURGIA STUTT, V4, P193; JELSMA LF, 1969, MIL MED, V134, P417; KONIG A, 1985, NEUROCHIRURGIA, V28, P22; Lee S H, 1975, Surg Neurol, V4, P483; Meirowsky A., 1965, NEUROLOGICAL SURGERY, P103; PELOFSKY S, 1972, J TRAUM, V12, P1003; SALAR G, 1978, J NEUROSURG, V49, P100, DOI 10.3171/jns.1978.49.1.0100; SEDZIMIR CB, 1967, J NEUROSURG, V27, P309, DOI 10.3171/jns.1967.27.4.0309; VALAVANIS A, 1988, MICROSURGERY SKULL B, P641; ZISCH R, 1988, ULTRASCHALL MED, V9, P227, DOI 10.1055/s-2007-1011631	14	4	4	0	1	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0901-5027			INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	OCT	1991	20	5					280	282		10.1016/S0901-5027(05)80155-9			3	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	GR333	WOS:A1991GR33300009	1761879				2022-02-06	
J	DAVIS, AM; FINDLEY, TW				DAVIS, AM; FINDLEY, TW			RESEARCH IN PHYSICAL MEDICINE AND REHABILITATION .10. INFORMATION RESOURCES	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						RESEARCH; PHYSICAL MEDICINE; INFORMATION SYSTEMS; REHABILITATION		Researchers in physical medicine and rehabilitation require access to information regarding possible interventions and programs, available services and technology, research (published, unpublished and in progress), statistics on incidence, prevalence and expected recovery, and funding sources. This paper provides an overview to the most readily available sources of information, including 16 abstracts and indexes, 6 sources of review articles, 9 population statistical databases and 84 journals specifically devoted to rehabilitation. Of these journals, 29 may be accessed through Medline and 32 through other sources. An additional 58 journals indexed in Medline publish more than 16 rehabilitation articles per year. The journals within Medline that publish the most rehabilitation articles are listed by topic area: geriatric rehabilitation, cardiac rehabilitation, pediatric rehabilitation, rehabilitation research, self-help devices, sports medicine and rheumatologic rehabilitation. Specific search strategies that may be used for any computer assisted search of Medline are given to locate articles in these topic areas and also the following areas: amputee rehabilitation, spinal cord injury rehabilitation, traumatic brain injury rehabilitation, cerebral palsy rehabilitation, stroke rehabilitation, decubitus care, electrodiagnosis, rehabilitation engineering, pain rehabilitation, pulmonary rehabilitation, sexual rehabilitation and urologic rehabilitation. The user friendly Grateful Med software is introduced for simplified online Medline searching. Exercises are provided for starting a journal club with the retrieved articles.	UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT PHYS MED & REHABIL,W ORANGE,NJ		FINDLEY, TW (corresponding author), KESSLER INST REHABIL,PLEASANT VALLEY WAY,W ORANGE,NJ 07052, USA.						Bohannon R W, 1989, Am J Phys Med Rehabil, V68, P257, DOI 10.1097/00002060-198910000-00014; ENDERS A, 1990, ASSISTIVE TECHNOLOGY; FINDLEY TW, 1989, AM J PHYS MED REHAB, V68, P97, DOI 10.1097/00002060-198904000-00010; FINDLEY TW, 1989, AM J PHYS MED REHAB, V68, P26, DOI 10.1097/00002060-198902000-00008; 1990, HLTH HOTLINES    JAN; UN DISABILITY STATIS; VA REHABILITATION DA; DISABILITY STUDIES Q	8	4	4	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	1991	70	1		S			S94	S106					13	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FA452	WOS:A1991FA45200014					2022-02-06	
J	EDLUND, MJ; GOLDBERG, RJ; MORRIS, PLP				EDLUND, MJ; GOLDBERG, RJ; MORRIS, PLP			THE USE OF PHYSICAL RESTRAINT IN PATIENTS WITH CEREBRAL CONTUSION	INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE			English	Article						CEREBRAL CONTUSION; HEAD INJURY; PHYSICAL RESTRAINT; PSYCHIATRIC CO-MORBIDITY; ALCOHOL; HOSPITAL LENGTH OF STAY	PROLONGED HOSPITAL STAY	Behavioral problems resulting in the use of physical restraint is a clinical problem seen in the acute phase of recovery from cerebral contusion. However, little is known about the frequency of physical restraint, factors that might predispose to its use, the pattern of adjunctive psychotropic drugs used or the outcome for patients needing this form of management. In order to examine these issues, a retrospective study of all patients (N = 34) admitted with cerebral contusion to a neurosurgical service over a one-year period was undertaken. Physical restraint was used in twelve patients (35%) for an average length of 4.3 days. The use of physical restraint was associated with presumptive evidence of alcohol abuse or dependence but not with level of consciousness on admission. Restrained patients were frequently prescribed psychotropic drugs during hospitalization. Patients requiring physical restraint stayed in hospital nearly twice as long as those not needing restraint. Close attention to the identification and treatment of alcohol problems and their complications in this population may reduce the need for physical restraint and shorten length of hospital stay.	UNIV MARYLAND,MARYLAND PSYCHIAT RES CTR,DEPT PSYCHIAT,CATONSVILLE,MD 21228; RHODE ISL HOSP,PROVIDENCE,RI 02902								BERROL S, 1988, ARCH PHYS MED REHAB, V69, P537; CARPENTER MD, 1988, HOSP COMMUNITY PSYCH, V39, P418; EVANS LK, 1989, J AM GERIATR SOC, V37, P65, DOI 10.1111/j.1532-5415.1989.tb01571.x; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; FRENGLEY JD, 1986, J AM GERIATR SOC, V34, P565, DOI 10.1111/j.1532-5415.1986.tb05760.x; FULOP G, 1989, HOSP COMMUNITY PSYCH, V40, P80; GOLDBERG RJ, 1989, CLIN NEUROPHARMACOL, V12, P233, DOI 10.1097/00002826-198908000-00001; Katz L, 1981, Dimens Health Serv, V58, P10; MION LC, 1989, J AM GERIATR SOC, V37, P949, DOI 10.1111/j.1532-5415.1989.tb07280.x; OISHANICK GJ, 1986, ADV PSYCHOSOMATIC ME, V16, P173; ROBBINS LJ, 1987, J AM GERIATR SOC, V35, P290, DOI 10.1111/j.1532-5415.1987.tb04633.x; THOMAS RI, 1988, ARCH GEN PSYCHIAT, V45, P937	13	4	4	0	0	BAYWOOD PUBL CO INC	AMITYVILLE	26 AUSTIN AVE, AMITYVILLE, NY 11701	0091-2174			INT J PSYCHIAT MED	Int. J. Psychiatr. Med.		1991	21	2					173	182		10.2190/Q21D-EWW7-53EJ-FUC6			10	Psychiatry	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	FX740	WOS:A1991FX74000006	1894456				2022-02-06	
J	MURERIWA, J				MURERIWA, J			HEAD-INJURY AND COMPENSATION - A PRELIMINARY INVESTIGATION OF THE POSTCONCUSSIONAL SYNDROME IN HARARE	CENTRAL AFRICAN JOURNAL OF MEDICINE			English	Article								A preliminary survey was carried out on forty-two (42) neurosurgical out-patients at Harare and Parirenyatwa Central Hospitals to establish some parameters of the postconcussional syndrome in victims of head injury. Both unstructured and structured forms of interview were used to obtain spontaneous (SPO) and elicited (ELC) responses. The symptoms of headache, dizziness and anxiety were spontaneously endorsed by 28.6 pc, 21.4 pc and 16.7 pc of the patients respectively. There was a close association between headache and dizziness (x2 = 5.9; p = 01; df = 1). In the ELC condition, all the nine postconcussional symptoms were endorsed as present by 59.5 pc - 85.7 pc of the patients and the various symptoms were significantly associated with each other. Application for compansation was not found to be associated with increased symptomatology.			MURERIWA, J (corresponding author), UNIV ZIMBABWE,DEPT PSYCHOL,HARARE,ZIMBABWE.							0	4	4	0	0	CENTRAL AFRICAN J MED	HARARE	PO BOX A195 AVONDALE, HARARE, ZIMBABWE	0008-9176			CENT AFR J MED	Cent. Afr. J. Med.	DEC	1990	36	12					315	318					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB932	WOS:A1990FB93200006	2151182				2022-02-06	
J	LAPIERRE, F; MASQUELET, A; AESCH, B; ROMANA, C				LAPIERRE, F; MASQUELET, A; AESCH, B; ROMANA, C			CRANIOPLASTIES USING A FREE OSTEOPERIOSTIC FEMORAL VASCULARIZED FLAP	NEUROCHIRURGIE			French	Article						HEAD INJURY; SKULL DEFECT CRANIOPLASTY; FREE PERIOSTI FLAP	PERIOSTEAL GRAFTS; HYDROXYLAPATITE; RECONSTRUCTION; DEFECTS; BONE	The management of large defects after head injury, osteomyelitis or both is usually solved by the use of bone grafts, polymerised material or metallic prothesis. The post-operative course is often frustrating when those materials are close to the frontal sinus leading to the removal of this material. Fort these reasons, we decided to use free periostic flaps for the management of these skull defects. The flap comes from the internal part of the femur creating no other defect in the body. Three patients with post infectious and post traumatic skull defects have been operated. The post-operative course was uneventful, the cosmetic result good and the protection of the cranial content effective after three months. Of these three patients one had eleven previous attempts of repair for his defect. This method seems to be a good one for those risky cases, and somewhat better than the use of great omentum transfer sometimes associated with bone grafts.	HOP AVICENNE, SERV PR NORDIN, F-93000 BOBIGNY, FRANCE		LAPIERRE, F (corresponding author), HOP JEAN BERNARD LA MILETRIE, SERV NEUROCHIRURG, F-86021 POITIERS, FRANCE.						BARROW DL, 1984, J NEUROSURG, V60, P305, DOI 10.3171/jns.1984.60.2.0305; BENZEL EC, 1987, SURG NEUROL, V27, P223, DOI 10.1016/0090-3019(87)90033-4; FINLEY JM, 1978, PLAST RECONSTR SURG, V61, P1; GEORGE B, 1989, NEUROCHIRURGIE, V35, P145; KYOSHIMA K, 1985, J NEUROSURG, V62, P607, DOI 10.3171/jns.1985.62.4.0607; MALIS LI, 1989, NEUROSURGERY, V25, P351, DOI 10.1227/00006123-198909000-00005; MASQUELET AC, 1989, VASCULARIZED PERIOST, P259; RAWLINGS CE, 1988, J NEUROSURG, V69, P269, DOI 10.3171/jns.1988.69.2.0269; SANGER J, 1982, SURG NEUROL, V18, P267, DOI 10.1016/0090-3019(82)90342-1; TAKATO T, 1986, PLAST RECONSTR SURG, V78, P489, DOI 10.1097/00006534-198610000-00010; VANDENWILDENBERG FAJM, 1984, BRIT J PLAST SURG, V37, P226, DOI 10.1016/0007-1226(84)90014-6; YAMASHIMA T, 1988, ACTA NEUROCHIR, V90, P157, DOI 10.1007/BF01560572	12	4	4	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie		1990	36	6					366	369					4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EW682	WOS:A1990EW68200005	2084568				2022-02-06	
J	LOHMAN, T; ZIGGAS, D; PIERCE, RS				LOHMAN, T; ZIGGAS, D; PIERCE, RS			WORD FLUENCY PERFORMANCE ON COMMON CATEGORIES BY SUBJECTS WITH CLOSED HEAD-INJURIES	APHASIOLOGY			English	Article									KENT STATE UNIV,MUSIC & SPEECH SPEECH PATHOL & AUDIOL,KENT,OH 44242									0	4	4	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0268-7038			APHASIOLOGY	Aphasiology	DEC	1989	3	8					685	693		10.1080/02687038908249036			9	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	CA060	WOS:A1989CA06000001					2022-02-06	
J	DEMEDIUK, P; FADEN, AI; VINK, R; ROMHANYI, R; MCINTOSH, TK				DEMEDIUK, P; FADEN, AI; VINK, R; ROMHANYI, R; MCINTOSH, TK			EFFECTS OF TRAUMATIC BRAIN INJURY ON ARACHIDONIC-ACID METABOLISM AND BRAIN WATER-CONTENT IN THE RAT	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES			English	Article									UNIV CALIF SAN FRANCISCO, DEPT NEUROL, CTR NEURAL INJURY, SAN FRANCISCO, CA 94143 USA		DEMEDIUK, P (corresponding author), VET ADM MED CTR, NEUROL SERV 127, 4150 CLEMENT ST, SAN FRANCISCO, CA 94121 USA.						CHAN PH, 1986, HDB NEUROCHEMISTRY, V10, P153; DEMEDIUK P, 1988, PHARM APPROACHES TRE, P23; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; VINK R, 1988, J BIOL CHEM, V263, P757	5	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0077-8923			ANN NY ACAD SCI	Ann.NY Acad.Sci.	JUL 5	1989	559						431	432					2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE255	WOS:A1989DE25500036					2022-02-06	
J	UOMOTO, JM; MCLEAN, A				UOMOTO, JM; MCLEAN, A			CARE CONTINUUM IN TRAUMATIC BRAIN INJURY REHABILITATION	REHABILITATION PSYCHOLOGY			English	Article											UOMOTO, JM (corresponding author), UNIV WASHINGTON,SCH MED,DEPT REHABIL MED,RJ 30,SEATTLE,WA 98195, USA.		Uomoto, Jay/AAF-4809-2019				Burke D C, 1987, Brain Inj, V1, P189, DOI 10.3109/02699058709034457; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; HOBBS N, 1964, AM J ORTHOPSYCHIAT, V34, P1; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KORCHIN SJ, 1976, MODERN CLIN PSYCHOL; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; UOMOTO JM, IN PRESS KRUSENS HDB	8	4	5	0	2	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	SUM	1989	34	2					71	79		10.1037//0090-5550.34.2.71			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AE974	WOS:A1989AE97400003					2022-02-06	
J	VINK, R; MCINTOSH, TK; FERNYAK, SE; WEINER, MW; FADEN, AI				VINK, R; MCINTOSH, TK; FERNYAK, SE; WEINER, MW; FADEN, AI			PROTON AND PHOSPHORUS NMR-STUDIES OF TRAUMATIC BRAIN INJURY IN RATS	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES			English	Article											VINK, R (corresponding author), UNIV CALIF SAN FRANCISCO, SAN FRANCISCO VET ADM MED CTR, CTR NEURAL INJURY, MAGNET RESONANCE UNIT, SAN FRANCISCO, CA 94121 USA.		Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			HANSTOCK CC, 1986, SOC MAGN RESON MED, V5, P977; SIESJO BK, 1985, 1985 NIH CENTRAL NER, P513	2	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0077-8923			ANN NY ACAD SCI	Ann.NY Acad.Sci.	NOV 30	1987	508						497	500		10.1111/j.1749-6632.1987.tb32948.x			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	R0947	WOS:A1987R094700061					2022-02-06	
J	DRAKE, ME				DRAKE, ME			SPASMODIC TORTICOLLIS AFTER CLOSED HEAD-INJURY	JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION			English	Article									OHIO STATE UNIV HOSP,DEPT NEUROL,COLUMBUS,OH 43210									0	4	4	0	1	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086	0027-9684			J NATL MED ASSOC	J. Natl. Med. Assoc.	MAY	1987	79	5					561	562					2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	M5618	WOS:A1987M561800016	3586052				2022-02-06	
J	COPE, DN				COPE, DN			TRAUMATIC CLOSED HEAD-INJURY - STATUS OF REHABILITATION TREATMENT	SEMINARS IN NEUROLOGY			English	Article											COPE, DN (corresponding author), VET ADM MED CTR, DEPT REHABIL MED SERV, 3801 MIRANDA AVE, PALO ALTO, CA 94304 USA.						ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; ARONOW HU, 1984, 61ST AM C REH MED BO; Bach-y-Rita P., 1980, RECOVERY FUNCTION TH; BACHYRITA P, 1981, SCAND J REHABIL MED, V13, P73; Baddeley A, 1980, Int Rehabil Med, V2, P138; BENYISHAY Y, 1981, NEW YORK U MED CTR I, V62; Bond M R, 1979, Acta Neurochir Suppl (Wien), V28, P124; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CAPLAN B, 1982, ARCH PHYS MED REHAB, V63, P362; COLE JR, 1985, ARCH PHYS MED REHAB, V66, P38; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; COPE DN, NEURAL TRAUMA TREATM; Delis D C, 1983, Int Rehabil Med, V5, P132; DILLER L, 1981, J CONSULT CLIN PSYCH, V49, P822, DOI 10.1037/0022-006X.49.6.822; DONOVAN WH, 1984, CURR CONCEPTS REHABI, V1, P30; EAMES P, 1984, 7TH ANN C HEAD TRAUM; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; Finger S., 1982, BRAIN DAMAGE RECOVER; GIANUTSOS R, 1979, Journal of Clinical Neuropsychology, V1, P117, DOI 10.1080/01688637908414446; GROSWASSER Z, 1977, SCAND J REHABIL MED, V9, P147; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hiorns R W, 1979, Int Rehabil Med, V1, P173; ILLIS LS, 1983, INT REHABIL MED, V5, P132; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P87; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 1981, MANAGEMENT HEAD INJU; KEITH RA, 1984, ARCH PHYS MED REHAB, V65, P74; MALEC J, 1983, ARCH PHYS MED REHAB, V64, P436; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; RAO N, 1984, ARCH PHYS MED REHAB, V65, P780; RAPPAPORT M, 1977, ARCH PHYS MED REHAB, V58, P333; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; SIVAK M, 1984, ARCH PHYS MED REHAB, V65, P163; TANHEHCO J, 1982, ARCH PHYS MED REHAB, V63, P36; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; THOMAS GM, 1979, ARCH PHYS MED REHAB, V60, P532; TIMMING R, 1982, ARCH PHYS MED REHAB, V63, P154; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VARGHESE G, 1984, ARCH PHYS MED REHAB, V65, P654; WEINBERG J, 1979, ARCH PHYS MED REHAB, V60, P491; WEINBERG J, 1977, ARCH PHYS MED REHAB, V58, P479; 1982, SEVERE HEAD TRAUMA C; 1984, NATIONAL DIRECTORY H	45	4	4	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.		1985	5	3					212	220		10.1055/s-2008-1041518			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	APU75	WOS:A1985APU7500004					2022-02-06	
J	DEUTSCHMAN, CS; KONSTANTINIDES, FN; RAUP, S; CERRA, FB				DEUTSCHMAN, CS; KONSTANTINIDES, FN; RAUP, S; CERRA, FB			STEROIDS POTENTIATE THE METABOLIC ABNORMALITIES AND MALNUTRITION OF ISOLATED CLOSED-HEAD INJURY	SURGICAL FORUM			English	Article											DEUTSCHMAN, CS (corresponding author), UNIV MINNESOTA,DEPT SURG,MINNEAPOLIS,MN 55455, USA.		Deutschman, Clifford/AAN-2742-2021				CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; DEUTSCHMAN CS, UNPUB J NEUROSURG; MOLOFSKY WJ, 1984, NEUROSURGERY, V15, P424, DOI 10.1227/00006123-198409000-00022; PAPP RP, 1983, J NEUROSURG, V58, P906	4	4	4	0	0	AMER COLL SURGEONS	CHICAGO	54 EAST ERIE ST, CHICAGO, IL 60611	0071-8041			SURG FORUM	Surg. Forum		1985	36						46	48					3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AVR39	WOS:A1985AVR3900020					2022-02-06	
J	TINDALL, GT; BECKER, DP				TINDALL, GT; BECKER, DP			SEVERE CLOSED HEAD-INJURY	NEUROSURGERY			English	Article											TINDALL, GT (corresponding author), EMORY UNIV,SCH MED,DIV NEUROSURG,ATLANTA,GA 30322, USA.							0	4	4	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery		1979	4	3					277	278					2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GP343	WOS:A1979GP34300018	460563				2022-02-06	
J	HENRY, RC; TAYLOR, PH				HENRY, RC; TAYLOR, PH			CEREBROSPINAL-FLUID OTORRHOEA AND OTORHINORRHOEA FOLLOWING CLOSED HEAD-INJURY	JOURNAL OF LARYNGOLOGY AND OTOLOGY			English	Article									MANCHESTER VICTORIA MEM JEWISH HOSP,MANCHESTER M8 8IT,ENGLAND								ALBERTI P W, 1961, J Laryngol Otol, V75, P123, DOI 10.1017/S002221510005756X; AMES RH, 1951, AMA ARCH OTOLARYNGOL, V53, P451; BLATT I M, 1963, Laryngoscope, V73, P446; BRAWLEY BW, 1967, J NEUROSURG, V26, P57, DOI 10.3171/jns.1967.26.1part1.0057; CALCATERRA TC, 1973, ARCH OTOLARYNGOL, V97, P388; CAPAROSA RJ, 1968, ARCH OTOLARYNGOL, V87, P588; ECKER A, 1947, J NEUROSURG, V4, P177, DOI 10.3171/jns.1947.4.2.0177; FRABLE MA, 1962, ARCHIV OTOLARYNGOL, V75, P208; GROVE WE, 1947, ANN OTO RHINOL LARYN, V56, P264; HALL GM, 1967, ARCHIV OTOLARYNGOL, V86, P377; Hingorani R K, 1971, J Laryngol Otol, V85, P999, DOI 10.1017/S0022215100074399; HOUSE W F, 1964, Arch Otolaryngol, V80, P617; Kinnman J, 1966, J Laryngol Otol, V80, P66, DOI 10.1017/S0022215100064963; LEECH PJ, 1973, LANCET, V1, P1013; LILLIE HI, 1947, ARCH OTOLARYNGOL, V46, P779; MACGEE EE, 1970, J NEUROSURG, V33, P312, DOI 10.3171/jns.1970.33.3.0312; MAXWELL JH, 1953, LARYNGOSCOPE, V63, P355; MONTGOMERY WW, 1966, ARCHIV OTOLARYNGOL, V84, P538; MORLEY TP, 1957, SURG GYNECOL OBSTET, V104, P88; Perlman HB, 1939, ARCHIV OTOLARYNGOL, V29, P287; PROCTOR B, 1956, Laryngoscope, V66, P16; RAAF J, 1967, ARCH SURG-CHICAGO, V95, P648; RAMSDEN RT, 1976, J LARYNGOL OTOL, V90, P345, DOI 10.1017/S0022215100082165; SKOLNIK EM, 1959, ARCHIV OTOLARYNGOL, V70, P795; SPITZ EB, 1961, J PEDIATR-US, V59, P397, DOI 10.1016/S0022-3476(61)80295-3; TSCHIANG H H, 1973, Journal of Laryngology and Otology, V87, P475, DOI 10.1017/S002221510007715X	26	4	4	0	0	HEADLEY BROTHERS LTD	ASHFORD	INVICTA PRESS, ASHFORD, KENT, ENGLAND TN24 8HH	0022-2151			J LARYNGOL OTOL	J. Laryngol. Otol.		1978	92	9					743	756		10.1017/S0022215100086059			14	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	FN995	WOS:A1978FN99500001	701976				2022-02-06	
J	PIAZZA, G; CRISTI, G				PIAZZA, G; CRISTI, G			ROLE OF RADIOGRAPHIC SKULL EXAMINATION IN EMERGENCY EVALUATION OF INTRACRANIAL EXPANDING LESIONS FOLLOWING CLOSED HEAD-INJURIES	NEURORADIOLOGY			English	Article									OSPED MAGGIORE BOLOGNA,DEPT NEUROSURG,BOLOGNA,ITALY; OSPED MAGGIORE BOLOGNA,NEURORADIOL SERV,BOLOGNA,ITALY								COLUMELLA F, 1963, ACTA RADIOL DIAGN, V1, P239, DOI 10.1177/028418516300100217; COLUMELLA F, 1970, NEUROCHIRURGIA, V13, P232; HOUDART R, 1962, TRAUMATISMES CRANIEN; ROWBOTHAM GF, 1964, ACUTE INJURIES HEAD; RUGGIERO G, 1964, ACTA RADIOL DIAGN, V2, P487, DOI 10.1177/028418516400200604; STJOHN EG, 1956, AMER J ROENTGENOL RA, V76, P315; WERTHEIMER P, 1961, TRAUMATOLOGIE CRANIE	7	4	4	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0028-3940			NEURORADIOLOGY	Neuroradiology		1973	6	2					101	103		10.1007/BF00399816			3	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	R4817	WOS:A1973R481700008	4788977				2022-02-06	
J	ELIA, JC				ELIA, JC			POST CONCUSSION SYNDROME	INDUSTRIAL MEDICINE AND SURGERY			English	Article																	AUERBACH AH, 1960, AM J PSYCHIAT, V117, P499, DOI 10.1176/ajp.117.6.499; BLONSTEIN JL, 1969, J ROY COLLEGE GEN PR, P18; Brunner H, 1940, LARYNGOSCOPE, V50, P921; BUCY PC, J OCCUP MED, V12, P318; Cremin M D, 1969, J Laryngol Otol, V83, P845; DILLON H, 1961, J AM MED ASS, V14, P175; ECHLIN FA, 1956, AM PRACTITIONER DIGE, V7, P868; ELIA JC, 1963, JUN ANN M AM ASS STU; FISHBEIN M, 1970, MEDICAL WORLD NEWS; GAVONS, 1968, CONFIN NEUROL, V30, P77; HARRISON MS, 1956, BRAIN, V79, P474, DOI 10.1093/brain/79.3.474; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; SCHUTT CH, 1969, J AM MED ASS; TOGLIA JU, 1969, FORENSIC SCIENCES, V14, P72; TOGLIA JU, 1970, ARCH OTOLARYNG, V92; TUBBS ON, 1970, LANCET, V2, P128; WELCH LK, 1968, AEROSPACE MED, V39, P1231; YARNELL PR, 1970, LANCET, P863; 1971, JUN MED TRIB SPORTS	20	4	4	0	1							IND MED SURG			1972	41	5					23	&					0	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	N4112	WOS:A1972N411200004	4503275				2022-02-06	
J	ANDREASSEN, J; BACHNIELSEN, P; HECKSCHER, H; LINDENEG, O				ANDREASSEN, J; BACHNIELSEN, P; HECKSCHER, H; LINDENEG, O			REASSURANCE AND SHORT PERIOD OF BED REST IN THE TREATMENT OF CONCUSSION - FOLLOW-UP AND COMPARISON WITH RESULTS IN OTHER SERIES TREATED BY PROLONGED BED REST	ACTA MEDICA SCANDINAVICA			English	Article																	AKERLUND EA, 1953, ACTA CHIR SCAND    S, V174; BORCHARDT M, 1935, ARCH ORTHOP UNFALL C, V35, P227; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; DENNYBROWN D, 1945, U A M A, V127, P429; FISCHER AW, 1935, ARCH ORTHOP UNFALL C, V35, P34; FJELDBORG P, 1939, 22ND P NO SOC SURG M; Guttmann E, 1943, Br Med J, V1, P94; KNOFLACH JG, 1937, ARCH KLIN CHIR, V190, P452; KNUTZEN H, 1936, ARCH KLIN CHIR, V186, P322; MIKKELSON O, 1939, 22ND P NO SOC SURG M; MULLER R, 1956, Nord Med, V55, P686; MULLER R, 1955, Nord Med, V53, P677; OLSEN R, 1936, UGESKRIFT LAEGER, V98, P782; SILFVERSKIOLD BP, 1950, SVENSKA LAKARTIDN, V47, P1281; SIMONS DJ, 1946, PSYCHOSOM MED, V8, P227, DOI 10.1097/00006842-194607000-00001; SKINHOJ E, 1954, UGESKRIFT LAEGER, V45, P1595; SOMMER R, 1935, ARCH KLIN CHIR, V183, P115; Symonds CP, 1943, LANCET, V1, P7; WITH S, 1939, NORD MED, V3, P2057	19	4	4	0	0	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0001-6101			ACTA MED SCAND	Acta Med. Scand.		1957	158	3-4					239	248					10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WJ667	WOS:A1957WJ66700009	13469245				2022-02-06	
J	STUCKE, K; CARSTENSEN, G				STUCKE, K; CARSTENSEN, G			ABNORMAL RENAL FUNCTION AFTER BRAIN CONCUSSION	DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT			English	Article																	BUTHE KE, 1955, THESIS WURZBURG; CARSTENSEN G, 1955, Arztl Wochensch, V10, P76; DELACAMP B, 1951, LANGENBECKS ARCH KLI, V270, P392; EIERMANN H, 1949, CHIRURG, V20, P337; FIEDLER HH, 1951, ZBL NEUROCHIR, V11, P14; FUSS H, 1953, Langenbecks Arch Klin Chir Ver Dtsch Z Chir, V274, P452, DOI 10.1007/BF01403265; FUSS H, 1954, LANGENBECKS ARCH KLI, V11, P207; FUSS H, 1954, LANGENBECKS ARCH KLI, V11, P278; HEIPERTZ W, 1952, MSCHR UNFALLHK, V54, P353; HEIPERTZ W, 1951, MSCHR UNFALLHEILK, V54, P167; SCHWARZ E, 1949, ZBL NEUROCHIR, V9, P313; TONNIS W, 1951, Langenbecks Arch Klin Chir Ver Dtsch Z Chir, V270, P372, DOI 10.1007/BF01400429; TONNIS W, 1951, ZBL NEUROCHIR, V11, P146; TRENDELENBURG F, 1910, DTSCH MED WCHNSCHR, V36, P1; USBECK W, 1953, Zentralbl Chir, V78, P1361; WACHS E, 1955, Bruns Beitr Klin Chir, V191, P448; WANKE R, 1951, Langenbecks Arch Klin Chir Ver Dtsch Z Chir, V270, P384, DOI 10.1007/BF01400430; WANKE R, 1949, LANGENBECKS ARCH KLI, V261, P167; WANKE R, 1947, CHIRURG, V17, P577	19	4	4	0	0	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0012-0472			DEUT MED WOCHENSCHR	Dtsch. Med. Wochenschr.		1957	82	5					177	179		10.1055/s-0028-1114659			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WN600	WOS:A1957WN60000003	13414503				2022-02-06	
J	Baldwin, RS				Baldwin, RS			Spinal concussion - A histologic study of two cases	ARCHIVES OF NEUROLOGY AND PSYCHIATRY			English	Article									Univ Illinois, Coll Med, Div Neuropathol, Chicago, IL USA								BALLET G, 1915, REV NEUROL, V2, P768; BLAKE JB, 1918, INT CLIN, V2, P86; Claude H, 1919, LANCET, V1, P67; Cramer F, 1932, ARCH PATHOL, V13, P23; Davison C, 1933, ARCH NEURO PSYCHIATR, V30, P326, DOI 10.1001/archneurpsyc.1933.02240140090004; DONNET, 1915, REV NEUROL, V2, P987; GUILLAIN G, 1931, B ACAD MED PARIS, V105, P996; Hassin GB, 1925, ARCH NEURO PSYCHIATR, V13, P369, DOI 10.1001/archneurpsyc.1925.02200090083003; Hassin GB, 1923, ARCH NEURO PSYCHIATR, V10, P194, DOI 10.1001/archneurpsyc.1923.02190260055004; Hassin GB, 1922, ARCH NEURO PSYCHIATR, V7, P589, DOI 10.1001/archneurpsyc.1922.02190110040005; HASSIN GB, 1917, MED REC, V91, P228; Holmes G, 1915, Br Med J, V2, P769; Jakob A., 1912, HISTOL HISTOPATH ARB, V5, P182; JAKOB A, 1912, HISTOLOG HISTOPATHOL, V5, P1; Kirchgasser G., 1897, DTSCH Z NERVENH, V11, P406; KIRCHGASSER G, 1899, DTSCH Z NERVENH, V13, P422; MARIE P, 1915, REV NEUROL, V2, P777; SCHMAUS H, 1899, MUNCHEN MED WCHNSCHR, V46, P75; SCHMAUS H, 1901, VORLESUNGEN PATHOLOG, P388; SCHMAUS H, 1899, ERGEBN ALLG PATH PAT, V4, P676; SCHMAUS H, 1890, VIRCHOWS ARCH PATH A, V122, P326; SPILLER WG, 1899, AM J M SC, V118, P190; SPILLER WG, 1903, U PENNSYLVANIA M B, V15, P483; Thorburn W, 1887, BRAIN, V9, P510, DOI [10.1093/brain/9.4.510, DOI 10.1093/BRAIN/9.4.510]	24	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0096-6754			ARCH NEURO PSYCHIATR		SEP	1934	32	3					493	500		10.1001/archneurpsyc.1934.02250090028002			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	V23WI	WOS:000201612800002					2022-02-06	
J	Procter, AP				Procter, AP			Three cases of concussion aphasia treatment by general anaesthesia	LANCET			English	Article																		0	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet		1915	2						977	977					1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V9657	WOS:000188901000473					2022-02-06	
J	Schulz-Drost, S; Finkbeiner, R; Lefering, R; Grosso, M; Krinner, S; Langenbach, A				Schulz-Drost, Stefan; Finkbeiner, Rebekka; Lefering, Rolf; Grosso, Marco; Krinner, Sebastian; Langenbach, Andreas		TraumaRegister DGU	Lung Contusion in Polytrauma: An Analysis of the TraumaRegister DGU	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						chest trauma; lung contusion; pulmonary contusion; Polytrauma; TraumaRegister	PULMONARY CONTUSION; FLAIL CHEST; MANAGEMENT; INJURY; RISK; PROGNOSIS; MORTALITY; SCORE; ARDS	Background Thorax trauma frequently occurs in which injuries to the bony chest, lung contusions (LCs), and others are diagnosed. The significance of this violation is described very differently and is mostly based on monocentric data. Methods A retrospective analysis of the TraumaRegister DGU (R) (TR-DGU) dataset (Project 2014-062) was performed between 2009 and 2014 (injury severity score [ISS] >= 16, primary admission to a trauma center, no isolated traumatic brain injury). Patients with LC (Abbreviated Injury Scale [AIS] 3 + 4) were compared with the control group, and an analysis of different age groups was performed. Results A total of 49,567 patients were included, thereunder 14,521 (29.3%) without relevant thoracic trauma (TT); 95.9% blunt traumas. 18,892 patients (38.1%) had LC and 14,008 (28.3%) had severe LC with AIS 3 + 4; thereunder 72.7% males. For severe LC, the average age was the lowest (44.7 +/- 19.7 years) and ISS the highest (30.4 +/- 12.1 points). Intubation, intensive care, (multi-) organ failure, sepsis, and extrathoracic injuries were most common in severe LC. Shock, chest tubes, further thoracic injuries, and patient death occurred most frequently in TT without LC. Younger patients showed a higher incidence of LC than the older ones; however, high patient age was a highly significant risk factor for the development of complications and poor outcome. Conclusion Since LC was present in almost 40% of the severely injured and was related to higher morbidity, LC should be detected and managed at the earliest possible time. Proper follow-ups employing chest X-rays and computed tomography (CT) scans are recommended.	[Schulz-Drost, Stefan; Finkbeiner, Rebekka; Grosso, Marco; Krinner, Sebastian; Langenbach, Andreas] Univ Hosp Erlangen, Dept Trauma & Orthoped Surg, Erlangen, Germany; [Schulz-Drost, Stefan] BG Hosp Unfallkrankenhaus Berlin GmbH, Dept Trauma & Orthoped Surg, Warener Str 7, D-12683 Berlin, Germany; [Lefering, Rolf] Univ Witten Herdecke, Fac Hlth, Inst Res Operat Med, IFOM, Ostmerheimer Str 200, D-51109 Cologne, Germany		Schulz-Drost, S (corresponding author), BG Hosp Unfallkrankenhaus Berlin GmbH, Dept Trauma & Orthoped Surg, Warener Str 7, D-12683 Berlin, Germany.	stefan.schulz-drost@gmx.de		Schulz-Drost, Stefan/0000-0002-0945-8523			Alisha C, 2015, J CLIN DIAGN RES, V9, pOC17, DOI 10.7860/JCDR/2015/13285.6375; Allen GS, 1996, AM SURGEON, V62, P895; AUC TraumaRegister DGU, DTSCH GES UNF; AUC TraumaRegister DGU, JAHR; Barth, 2012, CHIRURG DUALE REIHE; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Cohn SM, 1997, J TRAUMA, V42, P973, DOI 10.1097/00005373-199705000-00033; Cohn SM, 2010, WORLD J SURG, V34, P1959, DOI 10.1007/s00268-010-0599-9; Daurat A, 2016, INJURY, V47, P147, DOI 10.1016/j.injury.2015.08.031; DEMUTH WE, 1965, AM J SURG, V109, P819, DOI 10.1016/S0002-9610(65)80061-7; El-Menyar A, 2013, EUR J TRAUMA EMERG S, V39, P397, DOI 10.1007/s00068-013-0281-7; FOWLER AW, 1957, J BONE JOINT SURG BR, V39, P487, DOI 10.1302/0301-620X.39B3.487; Gavelli G, 2002, EUR RADIOL, V12, P1273, DOI 10.1007/s00330-002-1439-6; Hanschen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131362; Hubert A, PULMONARY CONTUSIONS; Johnson SB, 2008, SEMIN THORAC CARDIOV, V20, P52, DOI 10.1053/j.semtcvs.2007.09.001; Karmy-Jones Riyad, 2004, Curr Probl Surg, V41, P211, DOI 10.1016/j.cpsurg.2003.12.003; Keel M, 2007, CURR OPIN CRIT CARE, V13, P674, DOI 10.1097/MCC.0b013e3282f1fe71; KOLLMORGEN DR, 1994, AM J SURG, V168, P659, DOI 10.1016/S0002-9610(05)80140-0; Krinner S, 2018, UNFALLCHIRURG, V121, P642, DOI 10.1007/s00113-018-0460-4; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Malczyk A., 2012, GMTTB S DEC 7; Mason Christopher, 2016, Clin Med (Lond), V16, ps66; Miller PR, 2001, J TRAUMA, V51, P223, DOI 10.1097/00005373-200108000-00003; Moloney JT, 2008, CURR OPIN ANESTHESIO, V21, P41, DOI 10.1097/ACO.0b013e3282f2aadc; Schmitt, 2014, TRAUMA BIOMECHANIK E; Schmitt S, 2018, THORAC CARDIOV SURG, V66, P670, DOI 10.1055/s-0037-1607305; Schulz-Drost S, 2016, UNFALLCHIRURG, V119, P1023, DOI 10.1007/s00113-015-0026-7; Schuster H., 1993, INTENSIVTHERAPIE BEI; Sharma Anita, 2008, J Emerg Trauma Shock, V1, P34, DOI 10.4103/0974-2700.41789; Simon B, 2012, J TRAUMA ACUTE CARE, V73, pS351, DOI 10.1097/TA.0b013e31827019fd; Trinkle J K, 1973, Ann Thorac Surg, V16, P568; Ullman EA, 2003, EMERG MED CLIN N AM, V21, P291, DOI 10.1016/S0733-8627(03)00016-6; Voggenreiter G, 1996, UNFALLCHIRURG, V99, P425; White C., 1999, CHEST RADIOLOGY COMP; Yeh DD, 2014, J SURG RES, V186, P39, DOI 10.1016/j.jss.2013.08.025; Zhang Y, 2015, AM J EMERG MED, V33, P937, DOI 10.1016/j.ajem.2015.04.005; ZIEGLER DW, 1994, J TRAUMA, V37, P975, DOI 10.1097/00005373-199412000-00018; ZUMTOBEL V, 1971, LANGENBECK ARCH CHIR, V329, P210, DOI 10.1007/BF01770474	39	3	3	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	DEC	2021	69	08					735	748		10.1055/s-0039-1700505			14	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	XM6IQ	WOS:000728928700011	31858497				2022-02-06	
J	Leddy, JJ; Master, CL; Mannix, R; Wiebe, DJ; Grady, MF; Meehan, WP; Storey, EP; Vernau, BT; Brown, NJ; Hunt, D; Mohammed, F; Mallon, A; Rownd, K; Arbogast, KB; Cunningham, A; Haider, MN; Mayer, AR; Willer, BS				Leddy, John J.; Master, Christina L.; Mannix, Rebekah; Wiebe, Douglas J.; Grady, Matthew F.; Meehan, William P.; Storey, Eileen P.; Vernau, Brian T.; Brown, Naomi J.; Hunt, Danielle; Mohammed, Fairuz; Mallon, Andrea; Rownd, Kate; Arbogast, Kristy B.; Cunningham, Adam; Haider, Mohammad N.; Mayer, Andrew R.; Willer, Barry S.			Early targeted heart rate aerobic exercise versus placebo stretching for sport-related concussion in adolescents: a randomised controlled trial	LANCET CHILD & ADOLESCENT HEALTH			English	Article							POSTCONCUSSION SYNDROME; SYMPTOMS; CHILDREN	Background Sport-related concussion is a public health problem, particularly in adolescents. Quality of life is reduced in adolescents with persistent post-concussive symptoms (symptoms >28 days). We replicated a previous randomised controlled trial to validate the safety, efficacy, and generalisability of, and objective adherence to, prescribed early targeted heart rate subsymptom threshold aerobic exercise compared with placebo-like stretching exercise for adolescent recovery from sport-related concussion and for reducing the risk of persistent post-concussive symptoms. Methods This randomised controlled trial was done at three community and hospital-affiliated sports medicine concussion centres in the USA. Male and female adolescent athletes (aged 13-18 years) presenting within 10 days of sport-related concussion were randomly assigned to individualised subsymptom threshold aerobic or stretching exercise at least 20 min daily, for up to 4 weeks after injury. Exercise adherence and intensity were measured by heart rate monitors. The primary outcome was clinical recovery (ie, return to baseline symptoms, normal exercise tolerance, and a normal physical examination) within the 4-week intervention period, and development of persistent post-concussive symptoms beyond 28 days after injury. This study is registered with ClinicalTrials.gov, NCT02959216. Findings Between Aug 1, 2018, and March 31, 2020, 118 adolescents were recruited (61 were randomly assigned to the aerobic exercise group and 57 to the stretching exercise group) and included in the intention-to-treat analysis. On survival analysis, controlling for sex, site, and mean daily exercise time, patients assigned to aerobic exercise were more likely to recover within 4 weeks after injury compared with those assigned to stretching exercise, with a 48% reduced risk of persistent post-concussive symptoms (hazard ratio for stretching vs aerobic exercise of 0.52 [95% CI 0.28-0.97], p=0.039). No adverse events were reported. Interpretation This multicentre study found that early treatment with subsymptom threshold aerobic exercise safely speeds recovery from sport-related concussion and reduces the risk for persistent post-concussive symptoms, an important result given the impact of delayed recovery on adolescent quality of life. Adherence was good and there were no adverse events from this non-pharmacological treatment. These results suggest that physicians should not only permit, but consider prescribing, early subsymptom threshold physical activity to adolescents as treatment for sport-related concussion and to reduce the risk of persistent post-concussive symptoms. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Leddy, John J.; Cunningham, Adam; Haider, Mohammad N.] SUNY Buffalo, UBMD Orthopaed & Sports Med, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Willer, Barry S.] SUNY Buffalo, Dept Psychiat, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Master, Christina L.; Grady, Matthew F.; Brown, Naomi J.; Arbogast, Kristy B.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Wiebe, Douglas J.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Master, Christina L.; Storey, Eileen P.; Mohammed, Fairuz; Rownd, Kate; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Master, Christina L.; Grady, Matthew F.; Storey, Eileen P.; Vernau, Brian T.; Brown, Naomi J.; Mallon, Andrea] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Mannix, Rebekah; Meehan, William P.] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Meehan, William P.; Hunt, Danielle] Boston Childrens Hosp, Sports Concuss Clin, Div Sports Med, Boston, MA USA; [Storey, Eileen P.] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Mind Res Network,Lovelace Biomed & Environm Res I, Albuquerque, NM 87131 USA		Leddy, JJ (corresponding author), SUNY Buffalo, UBMD Orthopaed & Sports Med, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	leddy@buffalo.edu			American Medical Society for Sports Medicine	American Medical Society for Sports Medicine.	Alderman BL, 2007, PSYCHOPHYSIOLOGY, V44, P759, DOI 10.1111/j.1469-8986.2007.00548.x; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Haider MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00395; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hermand E, 2019, INT J SPORTS MED, V40, P462, DOI 10.1055/a-0875-4033; Johnson BD, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13694; Langevin P, 2020, MED SCI SPORT EXER, V52, P2491, DOI 10.1249/MSS.0000000000002402; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy J, 2021, CLIN J SPORT MED, V31, P7, DOI 10.1097/JSM.0000000000000686; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Micay R, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000404; Rabinowitz AR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57220-1; Russell K, 2019, J NEUROSURG-PEDIATR, V23, P455, DOI 10.3171/2018.8.PEDS18356; Sallis R, 2015, PHYSICIAN SPORTSMED, V43, P22, DOI 10.1080/00913847.2015.1001938; Smith RL, 1990, HDB APPL MATH S, P437; Teel EF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00672; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	27	3	3	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2352-4642			LANCET CHILD ADOLESC	Lancet Child. Adolesc. Health	NOV	2021	5	11					792	799		10.1016/S2352-4642(21)00267-4			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	WL6EW	WOS:000710497600010	34600629				2022-02-06	
J	Mohamed, AZ; Cumming, P; Nasrallah, FA				Mohamed, Abdalla Z.; Cumming, Paul; Nasrallah, Fatima A.		Dept Def Alzheimer's Dis Neuroimag	White Matter Alterations Are Associated With Cognitive Dysfunction Decades After Moderate-to-Severe Traumatic Brain Injury and/or Posttraumatic Stress Disorder	BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING			English	Article							HIPPOCAMPAL VOLUME; AMYLOID PATHOLOGY; CONNECTIVITY; INTEGRITY; ABNORMALITIES; ATROPHY; PTSD; DISRUPTION; REDUCTION; CINGULATE	BACKGROUND: Possible white matter (WM) alterations following moderate-to-severe traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) and their relationship to clinical outcome have yet to be investigated decades after trauma. We utilized structural magnetic resonance imaging and diffusion tensor images to investigate brain volume and WM alterations in Vietnam War veterans with moderate-to-severe TBI and/or PTSD examined 5 decades after trauma. METHODS: Data from 160 veterans-history of moderate-to-severe TBI (n = 23), history of TBI+PTSD (n = 36), history of PTSD (n = 53), and control veterans (n = 48)-were obtained from the Department of Defense Alzheimer's Disease Neuroimaging Initiative database. Voxel-based morphometry and tract-based spatial statistics were used to investigate ongoing brain morphometry and WM abnormalities. The fractional anisotropy (FA) and mean diffusivity were then correlated with neuropsychological scores and amyloid deposition in the trauma groups. RESULTS: Compared with control subjects, the three trauma groups showed gray matter atrophy, lower FA, and distinctly higher diffusivity in the major WM tracts, including the corpus callosum, external and internal capsules, cingulum, and inferior and superior longitudinal fasciculi. The FA and mean diffusivity correlated with cognitive deficits in the trauma groups. Furthermore, the FA in the cingulum correlated negatively with amyloid deposition in the posterior cingulate cortex of all three trauma groups. CONCLUSIONS: Diffusion tensor imaging detected WM abnormalities that correlated with the severity of present cognitive dysfunction and the degree of cortical amyloid deposition decades after moderate-to-severe TBI and/or PTSD. These results may hint that PTSD secondary to TBI may incur late cognitive sequalae and persistence of brain microstructure alterations.	[Mohamed, Abdalla Z.; Nasrallah, Fatima A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Cumming, Paul] Queensland Univ Technol, Sch Psychol & Counselling & IHBI, Brisbane, Qld, Australia; [Mohamed, Abdalla Z.] Univ Sunshine Coast, Thompson Inst, Birtinya, Qld, Australia; [Cumming, Paul] Univ Bern, Dept Nucl Med, Inselspital, Bern, Switzerland		Nasrallah, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	f.nasrallah@uq.edu.au	Mohaned, Abdalla/AAL-8721-2020; Mohamed, Abdalla/ABG-8718-2021	Mohaned, Abdalla/0000-0003-4499-672X; 	Motor Accident Insurance Commission, The Queensland Government, Australia [2014000857]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 AG024904]; DOD-ADNI (Department of Defense)United States Department of Defense [W81XWH-12-2-0012]	This research was sponsored by Motor Accident Insurance Commission, The Queensland Government, Australia (Grant No. 2014000857 [to FAN]). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant No. U01 AG024904) and DOD-ADNI (Department of Defense award number W81XWH-12-2-0012).	Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Akiki TJ, 2018, NEUROIMAGE, V176, P489, DOI 10.1016/j.neuroimage.2018.05.005; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bisby JA, 2017, CURR OPIN BEHAV SCI, V17, P124, DOI 10.1016/j.cobeha.2017.07.012; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Caballero MAA, 2018, BRAIN, V141, P3065, DOI 10.1093/brain/awy229; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chiou KS, 2019, BRAIN INJURY, V33, P846, DOI 10.1080/02699052.2019.1606449; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Dennis EL, 2021, MOL PSYCHIATR, V26, P4315, DOI 10.1038/s41380-019-0631-x; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dretsch Michael N, 2017, Open Neuroimag J, V11, P46, DOI 10.2174/1874440001711010046; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kim TD, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9020107; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Li L, 2016, EBIOMEDICINE, V4, P176, DOI 10.1016/j.ebiom.2016.01.012; Li L, 2014, NEUROSCI BIOBEHAV R, V43, P163, DOI 10.1016/j.neubiorev.2014.04.003; Liberzon I, 2016, NEURON, V92, P14, DOI 10.1016/j.neuron.2016.09.039; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Olson EA, 2017, DEPRESS ANXIETY, V34, P437, DOI 10.1002/da.22615; Palmqvist S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01150-x; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Racine AM, 2014, NEUROIMAGE-CLIN, V4, P604, DOI 10.1016/j.nicl.2014.02.001; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Saar-Ashkenazy R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144766; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Schuff N, 2008, PSYCHIAT RES-NEUROIM, V162, P147, DOI 10.1016/j.pscychresns.2007.04.011; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Siehl S, 2018, NEUROIMAGE-CLIN, V19, P581, DOI 10.1016/j.nicl.2018.05.013; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun YW, 2015, J AFFECT DISORDERS, V188, P80, DOI 10.1016/j.jad.2015.08.021; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Van Praag DLG, 2019, J NEUROTRAUM, V36, P3220, DOI 10.1089/neu.2018.5759; van Rooij SJH, 2015, PSYCHOL MED, V45, P2737, DOI 10.1017/S0033291715000707; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Waltzman D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170564; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zass LJ, 2017, PSYCHIAT GENET, V27, P1, DOI 10.1097/YPG.0000000000000143; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	52	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2451-9022	2451-9030		BIOL PSYCHIAT-COGN N	Biol. Psychiat.-Cogn. Neurosci. Neuroimag.	NOV	2021	6	11					1100	1109		10.1016/j.bpsc.2021.04.014			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WW5JU	WOS:000717953300011	33957321				2022-02-06	
J	Sasaki, Y; Zhu, J; Shi, Y; Gu, WX; Kobe, B; Ve, T; DiAntonio, A; Milbrandt, J				Sasaki, Yo; Zhu, Jian; Shi, Yun; Gu, Weixi; Kobe, Bostjan; Ve, Thomas; DiAntonio, Aaron; Milbrandt, Jeffrey			Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection	EXPERIMENTAL NEUROLOGY			English	Article						NADase; Neuropathy; TIR; NAMPT; Wallerian degeneration; Traumatic brain injury; Vitamin; crystallography; NMR; X-ray; mass spectrometer	NAD(+) CLEAVAGE ACTIVITY; TIR DOMAINS; CELL-DEATH; DEGENERATION; RIBOSIDE; INJURY; DEFICIENCY; ACTIVATION; DELETION; GENE	SARM1 is an inducible NAD+ hydrolase that is the central executioner of pathological axon loss. Recently, we elucidated the molecular mechanism of SARM1 activation, demonstrating that SARM1 is a metabolic sensor regulated by the levels of NAD+ and its precursor, nicotinamide mononucleotide (NMN), via their competitive binding to an allosteric site within the SARM1 N-terminal ARM domain. In healthy neurons with abundant NAD+, binding of NAD+ blocks access of NMN to this allosteric site. However, with injury or disease the levels of the NAD+ biosynthetic enzyme NMNAT2 drop, increasing the NMN/ NAD+ ratio and thereby promoting NMN binding to the SARM1 allosteric site, which in turn induces a conformational change activating the SARM1 NAD+ hydrolase. Hence, NAD+ metabolites both regulate the activation of SARM1 and, in turn, are regulated by the SARM1 NAD+ hydrolase. This dual upstream and downstream role for NAD+ metabolites in SARM1 function has hindered mechanistic understanding of axoprotective mechanisms that manipulate the NAD+ metabolome. Here we reevaluate two methods that potently block axon degeneration via modulation of NAD+ related metabolites, 1) the administration of the NMN biosynthesis inhibitor FK866 in conjunction with the NAD+ precursor nicotinic acid riboside (NaR) and 2) the neuronal expression of the bacterial enzyme NMN deamidase. We find that these approaches not only lead to a decrease in the levels of the SARM1 activator NMN, but also an increase in the levels of the NAD+ precursor nicotinic acid mononucleotide (NaMN). We show that NaMN inhibits SARM1 activation, and demonstrate that this NaMN-mediated inhibition is important for the long-term axon protection induced by these treatments. Analysis of the NaMN-ARM domain co-crystal structure shows that NaMN competes with NMN for binding to the SARM1 allosteric site and promotes the open, autoinhibited configuration of SARM1 ARM domain. Together, these results demonstrate that the SARM1 allosteric pocket can bind a diverse set of metabolites including NMN, NAD+, and NaMN to monitor cellular NAD+ homeostasis and regulate SARM1 NAD+ hydrolase activity. The relative promiscuity of the allosteric site may enable the development of potent pharmacological inhibitors of SARM1 activation for the treatment of neurodegenerative disorders.	[Sasaki, Yo; Zhu, Jian; Milbrandt, Jeffrey] Washington Univ, Dept Genet, Sch Med St Louis, St Louis, MO 63110 USA; [Shi, Yun; Ve, Thomas] Griffith Univ, Inst Glyc, Southport, Qld 4222, Australia; [Gu, Weixi; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Gu, Weixi; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [DiAntonio, Aaron] Washington Univ, Dept Dev Biol, Sch Med St Louis, St Louis, MO 63110 USA; [Sasaki, Yo; Zhu, Jian; DiAntonio, Aaron; Milbrandt, Jeffrey] Needleman Ctr Neurometab & Axonal Therapeut, St Louis, MO USA		Sasaki, Y; DiAntonio, A; Milbrandt, J (corresponding author), Washington Univ, Dept Genet, Sch Med St Louis, St Louis, MO 63110 USA.	sasaki@wustl.edu			National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [1107804, 1160570, 1071659, 1196590]; Australian Research Council (ARC)Australian Research Council [FL180100109, FT200100572]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01CA219866, RO1NS087632, RF1AG013730]; Needleman Center for Neurometabolism and Axonal Therapeutics	The work was supported by the National Health and Medical Research Council (NHMRC grants 1107804 and 1160570 to B.K. and T. V., 1071659 to B.K., and 1196590 to T.V.) , Needleman Center for Neurometabolism and Axonal Therapeutics (J.M. and A.D.) , the Australian Research Council (ARC) Laureate Fellowship (FL180100109 to B.K.) , and Future Fellowship (FT200100572 to T.V.) , and National Institutes of Health grants (R01CA219866 and RO1NS087632 to A.D. and J.M. and RF1AG013730 to J.M.) . We thank Matthew Figley for sharing unpublished observations. We thank Kelli Simburger and Tim Fahrner for support with molecular cloning, Cassidy Menendez, Rachel McClarney and Mihir Vohra for animal husbandry and maintenance, Alicia Neiner for processing LC-MS-MS samples, and Tamim Mosaiab and Veronika Masic for support with NMR experiments and protein production. We thank the use of the University of Queensland Remote Operation Crystallization and X-ray (UQROCX) Facility at the Centre forMicroscopy and Microanalysis, and Australian Synchrotron MX facility. We thank members of the Kobe, Ve, DiAntonio and Milbrandt labs for helpful discussions.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Bloom AJ., 2021, NUCLEIC ACIDS RES, DOI [10.1101/2021.04.16.439886, DOI 10.1101/2021.04.16.439886]; Bosanac T, 2021, BRAIN, V144, P3226, DOI 10.1093/brain/awab184; Cetinkaya-Fisgin A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78896-w; Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164; Di Stefano M, 2017, CURR BIOL, V27, P784, DOI 10.1016/j.cub.2017.01.070; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essuman K, 2018, CURR BIOL, V28, P421, DOI 10.1016/j.cub.2017.12.024; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Figley MD, 2021, NEURON, V109, DOI 10.1016/j.neuron.2021.02.009; Figley MD, 2020, CURR OPIN NEUROBIOL, V63, P59, DOI 10.1016/j.conb.2020.02.012; Geisler S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129920; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gilley J, 2021, ELIFE, V10, DOI [10.7554/eLife.70905, 10.7554/eLife.70905.sa0, 10.7554/eLife.70905.sa1, 10.7554/eLife.70905.sa2]; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hikosaka K, 2014, J BIOL CHEM, V289, P14796, DOI 10.1074/jbc.M114.554378; Horsefield S, 2019, SCIENCE, V365, P793, DOI 10.1126/science.aax1911; Hughes RO, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108588; Jiang YF, 2020, NATURE, V588, P658, DOI 10.1038/s41586-020-2862-z; Ko KW, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201912047; Krauss R, 2020, TRENDS PHARMACOL SCI, V41, P281, DOI 10.1016/j.tips.2020.01.006; LI WH, 2021, PERMEANT FLUORESCENT, V10, DOI DOI 10.7554/ELIFE.67381; Liu HW, 2018, P NATL ACAD SCI USA, V115, P10654, DOI 10.1073/pnas.1809392115; Loreto A., 2021, BIORXIV, DOI DOI 10.1101/2020.09.18.304261; Marion CM, 2019, EXP NEUROL, V321, DOI 10.1016/j.expneurol.2019.113040; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Ozaki E, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900618; Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103; Sambeat A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12262-x; Sasaki Y, 2020, ELIFE, V9, DOI 10.7554/eLife.62027; Sasaki Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19749; Sasaki Y, 2010, J BIOL CHEM, V285, P41211, DOI 10.1074/jbc.C110.193904; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Shen C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023151118; Sporny M, 2020, ELIFE, V9, DOI 10.7554/eLife.62021; Sporny M, 2019, J MOL BIOL, V431, P3591, DOI 10.1016/j.jmb.2019.06.030; Summers DW, 2020, MOL NEUROBIOL, V57, P1146, DOI 10.1007/s12035-019-01796-2; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Turkiew E, 2017, J PERIPHER NERV SYST, V22, P162, DOI 10.1111/jns.12219; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wan L, 2019, SCIENCE, V365, P799, DOI 10.1126/science.aax1771; Wu T, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109872; Zhao ZY, 2019, ISCIENCE, V15, P452, DOI 10.1016/j.isci.2019.05.001	51	3	3	7	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2021	345								113842	10.1016/j.expneurol.2021.113842			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UM2RM	WOS:000693183500006	34403688	Green Submitted			2022-02-06	
J	Kim, JM; Kim, SC; Lee, KH; Kim, HJ; Kim, H; Lee, SW; Na, DS; Park, JS				Kim, Ji-Min; Kim, Sang-Chul; Lee, Kang-Hyun; Kim, Ho-Jung; Kim, Hoon; Lee, Seok-Woo; Na, Dae-Seok; Park, Jung-Soo			Preventive effects of seat belts on traumatic brain injury in motor vehicle collisions classified by crash severities and collision directions	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Motor vehicle collisions; Seat belts; Traumatic brain injury; Hospital mortality; Trauma severity indices	HEAD-INJURY; CARE; REDUCTION; EFFICACY; RISK	Purpose This study aimed to measure the preventive effect of seat belt on traumatic brain injury (TBI) and to compare the effect according to the crash severities and collision directions. Methods Korea In-Depth Accident Study (KIDAS) has collected vehicle and demographic data on injured occupants involved in motor vehicle collisions (MVCs) who visited three emergency medical centers for calendar years 2011-2016. Primary and secondary end points were TBI (abbreviated injury score 2+) and in-hospital mortality. Crush extent (CE) was classified into 1-2, 3-4, 5-6, and 7-9 according to the crash severity. We calculated adjusted odds ratios (ORs) of seat belts and CE for study outcomes and developed an interaction model in each collision direction using multivariate logistic regression analysis. Results Of the 2,245 occupants who were injured in MVCs, 295 (13.1%) occupants sustained TBI. In univariate analysis, old age, unbelted status, lateral collision, and higher CE were factors associated with TBI in MVCs. Occupants with belted status was less likely to have TBI and in-hospital mortality compared with those with unbelted status [AORs (95% CI) 0.48 (0.37-0.62) and 0.49 (0.30-0.81), respectively]. In interaction analysis, preventive effects of seat belts on TBI from MVCs were retained within CE 5-6 in frontal MVCs and within CE 1-2 in near side lateral MVCs, and those of seat belts on in-hospital mortality were reserved within CE 3-4 in frontal and rollover MVCs. Conclusions The preventive effects of seat belts on TBI and in-hospital mortality are preserved within a limited crash severity in each collision direction.	[Kim, Ji-Min; Kim, Sang-Chul; Kim, Hoon; Lee, Seok-Woo; Na, Dae-Seok] Chungbuk Natl Univ Hosp, Dept Emergency Med, 776,1st Sunhwan Ro, Cheongju 28646, Chungcheongbuk, South Korea; [Lee, Kang-Hyun] Yonsei Univ, Wonju Severance Christian Hosp, Dept Emergency Med, Wonju Coll Med, 20 Ilsan Ro, Wonju 26426, Gangwon Do, South Korea; [Kim, Ho-Jung] Soonchunhyang Univ, Dept Emergency Med, Sch Med, Bucheon Hosp, 170 Jomaru Ro, Bucheon 14584, Gyeonggi Do, South Korea; [Park, Jung-Soo] Chungnam Natl Univ, Dept Emergency Med, Sch Med, 266 Daehak Ro, Daejeon 35015, Chungcheongnam, South Korea		Kim, SC (corresponding author), Chungbuk Natl Univ Hosp, Dept Emergency Med, 776,1st Sunhwan Ro, Cheongju 28646, Chungcheongbuk, South Korea.	jimin.kim7@gmail.com; oarahan@gmail.com; ed119@yonsei.ac.kr; khj995375@naver.com; nichekh2000@hanmail.net; drrhec@chungbuk.ac.kr; dsna0404@gmail.com; chopin-park@hanmail.net		Kim, Sang Chul/0000-0001-9377-4993; Lee, Kang Hyun/0000-0001-9664-9186; Kim, jimin/0000-0003-2138-7120			Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Bennett MH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004609.pub3; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; D'Elia A, 2013, ACCIDENT ANAL PREV, V54, P67, DOI 10.1016/j.aap.2013.02.020; El Sayed I., 2016, NEUROSURG REV, V41, P1; Ferguson SA, 2003, J SAFETY RES, V34, P71, DOI 10.1016/S0022-4375(02)00082-8; Gabauer D J, 2006, Annu Proc Assoc Adv Automot Med, V50, P57; Griffin R, 2012, J TRAUMA ACUTE CARE, V73, P914, DOI 10.1097/TA.0b013e31825a7636; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Hendricks DL., 1981, COLLISION DEFORMATIO; Hillary FG, 2002, BRAIN INJURY, V16, P729, DOI 10.1080/02699050110119844; JONES IS, 1989, J TRAUMA, V29, P646, DOI 10.1097/00005373-198905000-00020; Kim SC, 2017, EUR J TRAUMA EMERG S, V43, P663, DOI 10.1007/s00068-016-0714-1; Kuo CY, 2015, IRAN J PUBLIC HEALTH, V44, P470; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Mallory Ann, 2010, Ann Adv Automot Med, V54, P51; McCartt Anne T, 2007, Traffic Inj Prev, V8, P162, DOI 10.1080/15389580601173875; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Ndiaye A, 2009, FORENSIC SCI INT, V184, P21, DOI 10.1016/j.forsciint.2008.11.007; Newgard CD, 2002, ACAD EMERG MED, V9, P924, DOI 10.1197/aemj.9.9.924; Pintar F A, 2000, Annu Proc Assoc Adv Automot Med, V44, P149; REDELMEIER DA, 1993, J GEN INTERN MED, V8, P199, DOI 10.1007/BF02599267; SIEGEL JH, 1993, J TRAUMA, V34, P736, DOI 10.1097/00005373-199305000-00017; Talmor D, 2006, ACCIDENT ANAL PREV, V38, P767, DOI 10.1016/j.aap.2006.01.008; Tonning J, 2001, ANN EMERG MED, V37, P728; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5; Viano DC, 2015, TRAFFIC INJ PREV, V16, P747, DOI 10.1080/15389588.2015.1013188; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5; Yoganandan Narayan, 2011, Ann Adv Automot Med, V55, P267	30	3	3	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2021	47	5			SI		1437	1449		10.1007/s00068-019-01095-4			13	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UW8UR	WOS:000700428900023	30798345				2022-02-06	
J	Zhao, W; Wu, ZY; Ji, SB				Zhao, Wei; Wu, Zheyang; Ji, Songbai			Displacement Error Propagation From Embedded Markers to Brain Strain	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						concussion; traumatic brain injury; head injury model; model validation; marker-based strain	HEAD IMPACT; INJURY; MODELS; VALIDATION; RESPONSES	Head injury model validation has evolved from against pressure to relative brain-skull displacement, and more recently, against marker-based strain. However, there are concerns on strain data quality. In this study, we parametrically investigate how displacement random errors and synchronization errors propagate into strain. Embedded markers from four representative configurations are used to form unique and nonoverlapping tetrahedrons, triangles, and linear elements. Marker displacements are then separately subjected to up to +/- 10% random displacement errors and up to +/- 2 ms synchronization errors. Based on 100 random trials in each perturbation test, we find that smaller strain errors relative to the baseline peak strains are significantly associated with larger element sizes (volume, area, or length; p < 0.05). When displacement errors are capped at the two extreme levels, the earlier "column" and "cluster" configurations provide few usable elements with relative strain error under an empirical threshold of 20%, while about 30-80% of elements in recent "repeatable" and "uniform" configurations are considered otherwise usable. Overall, denser markers are desired to provide exhaustive pairwise linear elements with a range of sizes to balance the need for larger elements to minimize strain error but smaller elements to increase the spatial resolution in strain sampling. Their signed strains also provide unique and unambiguous information on tissue tension and compression. This study may provide useful insights into the scrutinization of existing experimental data for head injury model strain validation and to inform how best to design new experiments in the future.	[Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Wu, Zheyang] Worcester Polytech Inst, Dept Math, Worcester, MA 01609 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.; Ji, SB (corresponding author), Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA.	sji@wpi.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, 10.13039/100000002]	NIH (Grant No. R01 NS092853; Funder ID: 10.13039/100000002).	Alshareef A, 2020, J NEUROTRAUM, V37, P1546, DOI 10.1089/neu.2019.6847; Alshareef A, 2020, BIOMED SIGNAL PROCES, V56, DOI 10.1016/j.bspc.2019.101691; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bryden DW, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519872213; Centers for Disease Control and Prevention (CDC), 2015, REP C TRAUM BRAIN IN; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Fahlstedt M, 2021, ANN BIOMED ENG, V49, P1097, DOI 10.1007/s10439-020-02703-w; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; GEHRE C, 2009, P 21 INT TECH C ENH, P1; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guettler A.J., 2018, THESIS VIRGINIA TECH; Hardy, 2018, SAE TECHNICAL PAPER; Hardy W., 2007, THESIS WAYNE STATE U; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Li XG, 2021, BIOMECH MODEL MECHAN, V20, P403, DOI 10.1007/s10237-020-01391-8; Madhukar A, 2019, ANN BIOMED ENG, V47, P1832, DOI 10.1007/s10439-019-02205-4; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Morfey, 2001, P 17 INT TECHN C ENH; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Newman J.A., 2000, STAPP CAR CRASH J; Petrone N, 2019, J SCI MED SPORT, V22, pS78, DOI 10.1016/j.jsams.2019.05.015; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Whyte T, 2019, J BIOMECH, V95, DOI 10.1016/j.jbiomech.2019.07.023; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang King H, 2006, Stapp Car Crash J, V50, P429; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215; Zhao W, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109732; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0; Zhou Zhou, 2019, Stapp Car Crash J, V63, P1; Zhou Zhou, 2018, Stapp Car Crash J, V62, P293	48	3	3	0	2	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	OCT 1	2021	143	10							101001	10.1115/1.4051050			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	UJ8ZD	WOS:000691566800008	33954705				2022-02-06	
J	Chen, SW; Ma, GP; Zhang, P; Kang, QL				Chen, Shanwen; Ma, Gengping; Zhang, Peng; Kang, Quanli			Isolated traumatic supraclinoid internal carotid artery dissection diagnosed by high-resolution vessel wall MRI	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Early Access						Arterial dissection; internal carotid artery; blunt trauma; high-resolution vessel wall MR imaging	BLUNT; MANAGEMENT	Background Isolated traumatic supraclinoid internal carotid artery (ICA) dissection is a rare complication of blunt craniomaxillofacial trauma, and differentiation from atherosclerosis is the key factor for confirming the diagnosis. Case description A 53-year-old man was admitted because of blunt trauma to his head and face. His primary manifestations were disability of abduction of the left eye on day 2, recurrent epistaxis and a blowing murmur in the left ear on day 4. Neurological physical examination showed bilateral normal pupil diameter, a corrected visual acuity of 0.6 in the right eye and 0.3 in the left eye, and loss of abduction of the left eye. Craniofacial computed tomography scans revealed multiple craniomaxillofacial fractures mainly including a LeFort III injury of the left maxilla, fractures of the left ramus of the mandible, fractures of the left orbital apex, fractures of the sellar turcica, etc. Brain magnetic resonance (MR) findings showed multifocal lacunar infarcts in the left hemisphere. Cerebral angiography demonstrated severe intraluminal stenosis of the left supraclinoid ICA, which was highly suspicious of arterial dissection. A high-resolution vessel wall MR imaging performed on day 7 showed proximal intramural subacute haemorrhage and two distal intimal flaps at the injured region, both of which facilitated the exclusion of atherosclerosis and thus, confirmation of isolated arterial dissection. The patient underwent treatment with endovascular stent placement and antiplatelet agents two weeks later and had no ictus of symptomatic stroke during the next half-year duration. Conclusions HR vw-MRI is able to assist in the diagnosis of isolated traumatic supraclinoid dissection complicated with underlying atherosclerosis.	[Chen, Shanwen; Ma, Gengping; Kang, Quanli] Hosp Shunyi Dist, Dept Neurosurg, 3 Guangming Nan St, Beijing 101300, Peoples R China; [Zhang, Peng] Capital Med Univ, Xuan Wu Hosp, Dept Neurosurg, Beijing, Peoples R China		Chen, SW (corresponding author), Hosp Shunyi Dist, Dept Neurosurg, 3 Guangming Nan St, Beijing 101300, Peoples R China.	csw_1981_1999@126.com					Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Chen LG, 2018, BMC MED IMAGING, V18, DOI 10.1186/s12880-018-0293-1; Coppenrath E, 2017, ROFO-FORTSCHR RONTG, V189, P624, DOI 10.1055/s-0043-104632; Gao PH, 2016, CLIN NEURORADIOL, V26, P81, DOI 10.1007/s00062-014-0337-z; Kelts G, 2017, LARYNGOSCOPE, V127, P79, DOI 10.1002/lary.26186; Malhotra A, 2018, AM J NEURORADIOL, V39, pE103, DOI 10.3174/ajnr.A5733; Nagpal P, 2018, AM J NEURORADIOL, V39, P406, DOI 10.3174/ajnr.A5412; Rutman AM, 2018, RADIOGRAPHICS, V38, P542, DOI 10.1148/rg.2018170140; Shahan CP, 2016, J TRAUMA ACUTE CARE, V80, P915, DOI 10.1097/TA.0000000000001041; Vranic JE, 2020, J NEURORADIOLOGY, V47, P210, DOI 10.1016/j.neurad.2019.01.091	10	3	3	13	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.												10.1080/02688697.2021.1919861		SEP 2021	4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UY4XQ	WOS:000701529000001	34585640				2022-02-06	
J	Dias, DO; Kalkitsas, J; Kelahmetoglu, Y; Estrada, CP; Tatarishvili, J; Holl, D; Jansson, L; Banitalebi, S; Amiry-Moghaddam, M; Ernst, A; Huttner, HB; Kokaia, Z; Lindvall, O; Brundin, L; Frisen, J; Goritz, C				Dias, David O.; Kalkitsas, Jannis; Kelahmetoglu, Yildiz; Estrada, Cynthia P.; Tatarishvili, Jemal; Holl, Daniel; Jansson, Linda; Banitalebi, Shervin; Amiry-Moghaddam, Mahmood; Ernst, Aurelie; Huttner, Hagen B.; Kokaia, Zaal; Lindvall, Olle; Brundin, Lou; Frisen, Jonas; Goritz, Christian			Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions	NATURE COMMUNICATIONS			English	Article							SPINAL-CORD-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INFLAMMATORY RESPONSE; FIBROBLASTS FORM; CELLS; BLOOD; ORIGIN; GROWTH; ADULT; MICE	Fibrotic scar tissue limits central nervous system regeneration in adult mammals. The extent of fibrotic tissue generation and distribution of stromal cells across different lesions in the brain and spinal cord has not been systematically investigated in mice and humans. Furthermore, it is unknown whether scar-forming stromal cells have the same origin throughout the central nervous system and in different types of lesions. In the current study, we compared fibrotic scarring in human pathological tissue and corresponding mouse models of penetrating and non-penetrating spinal cord injury, traumatic brain injury, ischemic stroke, multiple sclerosis and glioblastoma. We show that the extent and distribution of stromal cells are specific to the type of lesion and, in most cases, similar between mice and humans. Employing in vivo lineage tracing, we report that in all mouse models that develop fibrotic tissue, the primary source of scar-forming fibroblasts is a discrete subset of perivascular cells, termed type A pericytes. Perivascular cells with a type A pericyte marker profile also exist in the human brain and spinal cord. We uncover type A pericyte-derived fibrosis as a conserved mechanism that may be explored as a therapeutic target to improve recovery after central nervous system lesions. Fibrotic scar tissue limits central nervous system regeneration. Here, Dias et al. show that fibrotic scarring is common in mice and humans, following distinct lesions to the adult brain and spinal cord, and derives from a discrete population of GLAST-expressing perivascular cells.	[Dias, David O.; Kalkitsas, Jannis; Kelahmetoglu, Yildiz; Holl, Daniel; Ernst, Aurelie; Frisen, Jonas; Goritz, Christian] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Estrada, Cynthia P.; Brundin, Lou] Karolinska Univ Hosp, Dept Clin Neurosci, Solna, Sweden; [Tatarishvili, Jemal; Jansson, Linda; Kokaia, Zaal; Lindvall, Olle] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden; [Banitalebi, Shervin; Amiry-Moghaddam, Mahmood] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Div Anat, Oslo, Norway; [Ernst, Aurelie] German Canc Res Ctr, Grp Genome Instabil Tumors, Heidelberg, Germany; [Huttner, Hagen B.] Univ Hosp Erlangen, Dept Neurol, Erlangen, Germany; [Goritz, Christian] Karolinska Inst, Ming Wai Lau Ctr Reparat Med, Stockholm Node, Stockholm, Sweden		Goritz, C (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	christian.goeritz@ki.se		Brundin, Lou/0000-0003-4408-7817; Jansson, Linda/0000-0002-5006-5123; Oliveira Dias, David/0000-0002-2144-6621	Karolinska InstituteKarolinska Institutet	Open access funding provided by Karolinska Institute.	Al-Mayhani MTF, 2011, NEURO-ONCOLOGY, V13, P830, DOI 10.1093/neuonc/nor088; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Andsberg G, 2001, EXP NEUROL, V169, P351, DOI 10.1006/exnr.2001.7646; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Brambilla R, 2011, BRAIN, V134, P2736, DOI 10.1093/brain/awr199; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Buss A, 2007, BRAIN, V130, P940, DOI 10.1093/brain/awl374; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Davis ME, 2016, CLIN J ONCOL NURS, V20, P2, DOI 10.1188/16.CJON.S1.2-8; Dias DO, 2018, MATRIX BIOL, V68-69, P561, DOI 10.1016/j.matbio.2018.02.009; Dias DO, 2018, CELL, V173, P153, DOI 10.1016/j.cell.2018.02.004; Dorrier CE, 2021, NAT NEUROSCI, V24, P234, DOI 10.1038/s41593-020-00770-9; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Fernandez-Klett F, 2013, J CEREBR BLOOD F MET, V33, P428, DOI 10.1038/jcbfm.2012.187; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Guimaraes-Camboa N, 2017, CELL STEM CELL, V20, P345, DOI 10.1016/j.stem.2016.12.006; Guo FZ, 2012, J NEUROSCI, V32, P639, DOI 10.1523/JNEUROSCI.4073-11.2012; Hackett AR, 2018, EXP NEUROL, V308, P72, DOI 10.1016/j.expneurol.2018.07.001; Hackett AR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00199; Hartmann DA, 2021, NAT NEUROSCI, V24, P633, DOI 10.1038/s41593-020-00793-2; Hesp ZC, 2018, J NEUROSCI, V38, P1366, DOI 10.1523/JNEUROSCI.3953-16.2017; Hoddevik EH, 2017, BRAIN STRUCT FUNCT, V222, P1753, DOI 10.1007/s00429-016-1305-y; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iacobaeus E, 2017, STEM CELL TRANSL MED, V6, P1840, DOI 10.1002/sctm.17-0028; Kelly KK, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0284-5; Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Namimatsu S, 2005, J HISTOCHEM CYTOCHEM, V53, P3, DOI 10.1369/jhc.4C6466.2005; Newcomb E.W., 2009, CANCER DRUG DISCOV D, P227; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Park JS, 2016, CANCER CELL, V30, P953, DOI 10.1016/j.ccell.2016.10.018; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Perez-de Puig I, 2013, J CEREBR BLOOD F MET, V33, P1955, DOI 10.1038/jcbfm.2013.155; Riew TR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00402; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Roth M, 2020, J NEUROSCI RES, V98, P826, DOI 10.1002/jnr.24557; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Shimauchi-Ohtaki H, 2019, NEUROSCI LETT, V692, P70, DOI 10.1016/j.neulet.2018.10.057; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sundberg C, 1996, LAB INVEST, V74, P452; Valny M, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00243; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Yahn SL, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104674; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	60	3	3	7	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2041-1723		NAT COMMUN	Nat. Commun.	SEP 17	2021	12	1							5501	10.1038/s41467-021-25585-5			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR9AR	WOS:000697033200016	34535655	Green Submitted, Green Published, gold			2022-02-06	
J	Holden, SS; Grandi, FC; Aboubakr, O; Higashikubo, B; Cho, FS; Chang, AH; Forero, AO; Morningstar, AR; Mathur, V; Kuhn, LJ; Suri, P; Sankaranarayanan, S; Andrews-Zwilling, Y; Tenner, AJ; Luthi, A; Aronica, E; Corces, MR; Yednock, T; Paz, JT				Holden, Stephanie S.; Grandi, Fiorella C.; Aboubakr, Oumaima; Higashikubo, Bryan; Cho, Frances S.; Chang, Andrew H.; Forero, Alejandro Osorio; Morningstar, Allison R.; Mathur, Vidhu; Kuhn, Logan J.; Suri, Poojan; Sankaranarayanan, Sethu; Andrews-Zwilling, Yaisa; Tenner, Andrea J.; Luthi, Anita; Aronica, Eleonora; Corces, M. Ryan; Yednock, Ted; Paz, Jeanne T.			Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury	SCIENCE			English	Article							RECIPROCAL INHIBITORY CONNECTIONS; CORTICOTHALAMIC PROJECTIONS; NETWORK SYNCHRONY; MOUSE MODELS; COMPONENT; ACTIVATION; CIRCUITS; THALAMUS; ORGANIZATION; EXPRESSION	Although traumatic brain injury (TBI) acutely disrupts the cortex, most TBI-related disabilities reflect secondary injuries that accrue over time. The thalamus is a likely site of secondary damage because of its reciprocal connections with the cortex. Using a mouse model of mild TBI (mTBI), we found a chronic increase in C1q expression specifically in the corticothalamic system. Increased C1q expression colocalized with neuron loss and chronic inflammation and correlated with disruption in sleep spindles and emergence of epileptic activities. Blocking C1q counteracted these outcomes, suggesting that C1q is a disease modifier in mTBI. Single-nucleus RNA sequencing demonstrated that microglia are a source of thalamic C1q. The corticothalamic circuit could thus be a new target for treating TBI-related disabilities.	[Holden, Stephanie S.; Cho, Frances S.; Paz, Jeanne T.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94158 USA; [Holden, Stephanie S.; Grandi, Fiorella C.; Aboubakr, Oumaima; Higashikubo, Bryan; Cho, Frances S.; Chang, Andrew H.; Morningstar, Allison R.; Corces, M. Ryan; Paz, Jeanne T.] Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Holden, Stephanie S.; Grandi, Fiorella C.; Cho, Frances S.; Corces, M. Ryan; Paz, Jeanne T.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Forero, Alejandro Osorio; Luthi, Anita] Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland; [Mathur, Vidhu; Kuhn, Logan J.; Suri, Poojan; Sankaranarayanan, Sethu; Andrews-Zwilling, Yaisa; Yednock, Ted] Annexon Biosci, San Francisco, CA 94080 USA; [Tenner, Andrea J.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Aronica, Eleonora] Univ Amsterdam, Amsterdam UMC, Dept Neuropathol, NL-1105 AZ Amsterdam, Netherlands; [Aronica, Eleonora] Stichting Epilepsie Instellingen Nederland SEIN, NL-2103 SW Heemstede, Netherlands; [Paz, Jeanne T.] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA; [Paz, Jeanne T.] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94158 USA		Paz, JT (corresponding author), Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94158 USA.; Paz, JT (corresponding author), Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.; Paz, JT (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.; Paz, JT (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA.; Paz, JT (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94158 USA.	jeanne.paz@gladstone.ucsf.edu	Luthi, Anita/ABE-1411-2021	Cho, Frances/0000-0002-2576-7801; Morningstar, Allison/0000-0002-3857-0450; Grandi, Fiorella/0000-0002-1303-6710; Osorio-Forero, Alejandro/0000-0003-4341-4206; ABOUBAKR, Oumaima/0000-0002-7280-6201; Kuhn, Logan/0000-0002-1149-3213	Department of DefenseUnited States Department of Defense [EP150038]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS078118, T32-GM007449, R01AG060148]; National Science Foundation (NSF)National Science Foundation (NSF) [1608236, 1144247]; Gladstone InstitutesUniversity of California System; Michael Prize; Vilcek Prize; Kavli Institute for Fundamental Neuroscience; Achievement Rewards for College Scientists Scholarship; Ford Foundation Dissertation Fellowship; Faculty of Biology and Medicine-University of Lausanne; Weill Foundation; American Epilepsy Society Postdoctoral Research Fellowship; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31 NS111819-01A1]; UCSF Discovery Fellowship; Epilepsiefonds project [2020-02]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [310030-184759]	This study was funded mainly by Department of Defense grant EP150038 to J.T.P., who also had support from the National Institutes of Health (NIH grant R01 NS078118), the National Science Foundation (NSF grant 1608236), Gladstone Institutes, the Michael Prize, the Vilcek Prize, and the Kavli Institute for Fundamental Neuroscience. S.S.H. was supported by an Achievement Rewards for College Scientists Scholarship, a Ford Foundation Dissertation Fellowship, the NIH (grant T32-GM007449), and the Weill Foundation. B.H. was supported by an American Epilepsy Society Postdoctoral Research Fellowship. F.S.C. was supported by the National Institute of Neurological Disorders and Stroke (NINDS grant F31 NS111819-01A1), the NSF (Graduate Research Fellowship 1144247), and by a UCSF Discovery Fellowship. E.A. was supported by Epilepsiefonds project 2020-02. A.L. was supported by the Swiss National Science Foundation (grant 310030-184759). A.O.F. was supported by the Faculty of Biology and Medicine-University of Lausanne doctoral fellowship. A.J.T. was supported by the NIH (grant R01AG060148).	Alawieh A, 2021, J NEUROSCI, V41, P1830, DOI 10.1523/JNEUROSCI.1734-20.2020; Andrade P, 2017, J NEUROTRAUM, V34, P1482, DOI 10.1089/neu.2016.4675; Anton-Bolanos N, 2018, CURR OPIN NEUROBIOL, V52, P33, DOI 10.1016/j.conb.2018.04.018; Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Beenhakker MP, 2009, NEURON, V62, P612, DOI 10.1016/j.neuron.2009.05.015; Bell JE, 2008, ACTA NEUROPATHOL, V115, P497, DOI 10.1007/s00401-008-0360-8; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Benoit ME, 2013, J BIOL CHEM, V288, P654, DOI 10.1074/jbc.M112.400168; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; BioSpace, 2021, ANN ANN IN PHAS 2 3; BioSpace, ANN ANN IN PHAS 2 3, V2021; BLAKEMORE C, 1990, COLD SH Q B, V55, P491; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; Briggs F, 2008, CURR OPIN NEUROBIOL, V18, P403, DOI 10.1016/j.conb.2008.09.002; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cho FS, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P273, DOI 10.1016/B978-0-12-804066-9.00019-5; Cho K, 2019, AGING DIS, V10, P652, DOI 10.14336/AD.2019.0118; Clemente-Perez A, 2017, CELL REP, V19, P2130, DOI 10.1016/j.celrep.2017.05.044; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/nmeth.4396, 10.1038/NMETH.4396]; Corces R., 2019, ISOLATION NUCLEI FRO, DOI [10.17504/protocols.io.6t8herw, DOI 10.17504/PROTOCOLS.IO.6T8HERW]; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Ding K., 2016, EPILEPSY TRAUMATIC B; Fernandez LMJ, 2018, ELIFE, V7, DOI 10.7554/eLife.39111; Golshani P, 2001, P NATL ACAD SCI USA, V98, P4172, DOI 10.1073/pnas.061013698; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Lam YW, 2011, J NEUROSCI, V31, P6791, DOI 10.1523/JNEUROSCI.3073-10.2011; Lansita JA, 2017, INT J TOXICOL, V36, P449, DOI 10.1177/1091581817740873; LEPOW IH, 1963, J EXP MED, V117, P983, DOI 10.1084/jem.117.6.983; Li YQ, 2020, NATURE, V583, P819, DOI 10.1038/s41586-020-2504-5; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mallah K, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01179-6; Manoach DS, 2016, BIOL PSYCHIAT, V80, P599, DOI 10.1016/j.biopsych.2015.10.003; Martinez-Garcia RI, 2020, NATURE, V583, P813, DOI 10.1038/s41586-020-2512-5; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; McGonigal R, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0291-x; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Paz JT, 2015, NAT NEUROSCI, V18, P351, DOI 10.1038/nn.3950; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Pisalyaput K, 2008, J NEUROCHEM, V104, P696, DOI 10.1111/j.1471-4159.2007.05012.x; Ritter-Makinson S, 2019, CELL REP, V26, P54, DOI 10.1016/j.celrep.2018.12.018; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schartz ND, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02024-8; Schiering IAM, 2014, J NEUROPATH EXP NEUR, V73, P324, DOI 10.1097/NEN.0000000000000056; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sohal VS, 2003, J NEUROSCI, V23, P8978; Sohal VS, 2000, J NEUROSCI, V20, P1735; Sorokin JM, 2017, NEURON, V93, P194, DOI 10.1016/j.neuron.2016.11.026; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Talley EM, 1999, J NEUROSCI, V19, P1895; Thrupp N, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108189; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Vukojicic A, 2019, CELL REP, V29, P3087, DOI 10.1016/j.celrep.2019.11.013; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; Wu T, 2019, CELL REP, V28, P2111, DOI 10.1016/j.celrep.2019.07.060; Wyatt SK, 2017, EXP NEUROL, V295, P184, DOI 10.1016/j.expneurol.2017.06.009; Yilmaz M, 2021, NAT NEUROSCI, V24, P214, DOI 10.1038/s41593-020-00763-8; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Young MD, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa151; Zelek WM, 2019, MOL IMMUNOL, V114, P341, DOI 10.1016/j.molimm.2019.07.030	81	3	3	20	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1217	+		10.1126/science.abj2685			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	WOS:000695436000024	34516796	Green Accepted			2022-02-06	
J	Palmer, D; Engebretsen, L; Carrard, J; Grek, N; Konigstein, K; Maurer, DJ; Roos, T; Stollenwerk, L; Tercier, S; Weinguni, R; Soligard, T				Palmer, Debbie; Engebretsen, Lars; Carrard, Justin; Grek, Natalia; Koenigstein, Karsten; Maurer, Debbie J.; Roos, Thomas; Stollenwerk, Lauren; Tercier, Stephane; Weinguni, Raphael; Soligard, Torbjorn			Sports injuries and illnesses at the Lausanne 2020 Youth Olympic Winter Games: a prospective study of 1783 athletes from 79 countries	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							PHYSICAL-ACTIVITY; RISK-FACTORS; ICE HOCKEY; MUSCULOSKELETAL INJURY; PREVENTION PROGRAM; CONCUSSION RISK; REDUCE INJURIES; JOINT INJURY; SUMMER GAMES; HEALTH	Objective To describe the injury and illness characteristics among participating athletes during the Lausanne 2020 Youth Olympic Winter Games (YOG 2020), 9-22 January 2020. Methods The daily number of athlete injuries and illnesses were recorded (1) through the reporting of all National Olympic Committee (NOC) medical teams and (2) in the polyclinic and medical venues by the Lausanne 2020 medical staff. Results In total, 1783 athletes from 79 NOCs were observed. NOC and Lausanne 2020 medical staff reported 228 injuries and 167 illnesses, equating 11.7 injuries and 8.6 illnesses per 100 athletes over the 14-day period. Injury incidence was highest for snowboard slopestyle (39%), bobsleigh (36%), snowboard big air (29%), ski slopestyle (29%), snowboard cross (24%) and ski cross (21%), and lowest for speed skating, snowboard halfpipe and curling (2%-4%). The highest incidence of illness was recorded for curling (21%), ski mountaineering (15%), snowboard halfpipe (13%), bobsleigh (11%), cross-country skiing (10%) and figure skating (10%). Almost one-third of injuries were expected to result in time loss and 17% of illnesses. Most injuries occurred to the knee (12%) and head (11%), and 64% of illnesses affected the respiratory system. Overall, women suffered more injuries and illness than males. Conclusion Overall, injury and illness rates were similar compared with recent YOG. While the rate and characteristics of injury and illness varied between sports, consistent patterns across YOG are emerging. If addressed, changes in highlighted areas of risk could have a positive impact on the health and well-being of these young athletes.	[Palmer, Debbie] Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland; [Palmer, Debbie] Univ Edinburgh, Moray House Sch Educ & Sport, Edinburgh EH8 8AQ, Midlothian, Scotland; [Engebretsen, Lars] Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Dept Sports Med, Oslo, Norway; [Engebretsen, Lars; Tercier, Stephane; Soligard, Torbjorn] Int Olymp Comm, Med & Sci Dept, Lausanne, Switzerland; [Carrard, Justin; Koenigstein, Karsten] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland; [Grek, Natalia] GE Healthcare Moscow, Moscow, Russia; [Maurer, Debbie J.] Davos Hosp, Dept Internal Med, Davos, Switzerland; [Maurer, Debbie J.] Davos Hosp, Dept Sports Med, Davos, Switzerland; [Maurer, Debbie J.] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Roos, Thomas] Univ Lausanne, Int Acad Sport Sci & Technol, Lausanne, Switzerland; [Stollenwerk, Lauren] Univ Hosp Zurich, Med Sch, Zurich, Switzerland; [Tercier, Stephane] Lausanne Univ Hosp, Dept Women Mother Child, SportAdo Ctr, Lausanne, Switzerland; [Weinguni, Raphael] Protect & Rescue Serv, Adv Med Post Detachment, Lausanne, Switzerland; [Soligard, Torbjorn] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada		Palmer, D (corresponding author), Univ Edinburgh, Moray House Sch Educ & Sport, Edinburgh EH8 8AQ, Midlothian, Scotland.	dpalmer@ed.ac.uk		Carrard, Justin/0000-0002-2380-105X; Roos, Thomas/0000-0003-3677-3219; engebretsen, lars/0000-0003-2294-921X	IOC	The IOC funded the data collection of the study.	Bahr R, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120902908; Bakken A, 2011, BRIT J SPORT MED, V45, P1315, DOI 10.1136/bjsports-2011-090527; Barboza SD, 2019, J ATHL TRAINING, V54, P374, DOI 10.4085/1062-6050-79-18; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Carlsen KH, 2008, ALLERGY, V63, P387, DOI 10.1111/j.1398-9995.2008.01662.x; Cooper DJ, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2017-098315; Dodwell ER, 2014, AM J SPORT MED, V42, P675, DOI 10.1177/0363546513518412; Drew MK, 2017, J SCI MED SPORT, V20, P745, DOI 10.1016/j.jsams.2017.02.010; Emery CA, 2010, BRIT J SPORT MED, V44, P555, DOI 10.1136/bjsm.2010.074377; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Emery CA, 2019, INT J SPORTS PHYS TH, P14; Emery CA, 2018, CLIN J SPORT MED, V28, pE48; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Engebretsen L, 2014, BRIT J SPORT MED, V48, P1270, DOI 10.1136/bjsports-2014-093992; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Engebretsen L, 2010, BRIT J SPORT MED, V44, P772, DOI 10.1136/bjsm.2010.076992; Fernandes GS, 2018, BRIT J SPORT MED, V52, P678, DOI 10.1136/bjsports-2017-097503; Florenes TW, 2012, SCAND J MED SCI SPOR, V22, P58, DOI 10.1111/j.1600-0838.2010.01147.x; Florenes TW, 2010, BRIT J SPORT MED, V44, P803, DOI 10.1136/bjsm.2009.071159; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gleeson M, 2013, NESTLE NUTR WORKS SE, V76, P39, DOI 10.1159/000350254; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Jones CM, 2017, SPORTS MED, V47, P943, DOI 10.1007/s40279-016-0619-5; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Ljungqvist A, 2008, BRIT J SPORT MED, V42, P391; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Major DH, 2014, BRIT J SPORT MED, V48, P18, DOI 10.1136/bjsports-2013-092573; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 5 INT C CONC SPORT H; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Metz John P, 2003, Curr Sports Med Rep, V2, P84; Micheli L, 2011, BRIT J SPORT MED, V45, P931, DOI 10.1136/bjsports-2011-090237; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Mountjoy M, 2011, BRIT J SPORT MED, V45, P839, DOI 10.1136/bjsports-2011-090228; Nabhan D, 2020, BRIT J SPORT MED, V54, P997, DOI 10.1136/bjsports-2018-100015; Palmer-Green D, 2015, BRIT J SPORT MED, V49, P25, DOI 10.1136/bjsports-2014-094206; Richmond SA, 2016, CLIN J SPORT MED, V26, P291, DOI 10.1097/JSM.0000000000000261; Richmond SA, 2013, J ORTHOP SPORT PHYS, V43, P515, DOI 10.2519/jospt.2013.4796; Ruedl G, 2016, BRIT J SPORT MED, V50, P631, DOI 10.1136/bjsports-2015-095665; Ruedl G, 2012, BRIT J SPORT MED, V46, P1030, DOI 10.1136/bjsports-2012-091534; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Schwellnus MP, 2012, BRIT J SPORT MED, V46, P816, DOI 10.1136/bjsports-2012-091395; Schwellnus MP, 2008, OLYMPIC TXB MED SPOR, P344; Senorski EH, 2018, KNEE SURG SPORT TR A, V26, P1011, DOI 10.1007/s00167-017-4811-4; Soligard T, 2019, BRIT J SPORT MED, V53, P1085, DOI 10.1136/bjsports-2018-100236; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; Soligard T, 2015, BRIT J SPORT MED, V49, P441, DOI 10.1136/bjsports-2014-094538; Steenstrup SE, 2014, BRIT J SPORT MED, V48, P41, DOI 10.1136/bjsports-2013-093145; Steffen K, 2020, BRIT J SPORT MED, V54, P168, DOI 10.1136/bjsports-2019-101040; Steffen K, 2017, BRIT J SPORT MED, V51, P29, DOI 10.1136/bjsports-2016-096977; Steffen K, 2013, BRIT J SPORT MED, V47, P480, DOI 10.1136/bjsports-2012-091887; Steffen K, 2012, BRIT J SPORT MED, V46, P466, DOI 10.1136/bjsports-2012-091168; Steffen K, 2010, BRIT J SPORT MED, V44, P485, DOI 10.1136/bjsm.2010.073833; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; The Guardian, 2014, THE GUARDIAN; Toomey CM, 2017, J ORTHOP SPORT PHYS, V47, P80, DOI 10.2519/jospt.2017.7101; Torjussen J, 2006, BRIT J SPORT MED, V40, P230, DOI 10.1136/bjsm.2005.021329; Tuominen M, 2017, BRIT J SPORT MED, V51, P244, DOI 10.1136/bjsports-2016-097119; Whittaker JL, 2019, MED SCI SPORT EXER, V51, P255, DOI 10.1249/MSS.0000000000001787; Whittaker JL, 2018, BRIT J SPORT MED, V52, P934, DOI 10.1136/bjsports-2017-097576	63	3	3	10	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	2021	55	17					968	974		10.1136/bjsports-2020-103514			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UO4GS	WOS:000694654200011	33658186	Bronze, Green Submitted			2022-02-06	
J	Theilen, TM; Mueller-Eising, W; Bettink, PW; Rolle, U				Theilen, Till-Martin; Mueller-Eising, Wiebke; Bettink, Peter W.; Rolle, Udo			Video Analysis of Acute Injuries in Elite Field Hockey	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sports injury; prevention; video analysis; field hockey	SPORTS INJURIES; INCIDENT ANALYSIS; RUGBY UNION; LEAGUE NHL; HEAD; SURVEILLANCE; CONCUSSIONS; PLAYERS; FACE; MECHANISMS	Objective: With this study, we aim to determine the value of video assessment of acute injuries in field hockey. Design: Retrospective video analysis for acute injuries. Setting: Professional field hockey. Participants: Seven women and men's field hockey tournaments (World League, Champions Trophy) in 2015. Interventions: Not applicable. Outcome Measures: An injury was defined as any new musculoskeletal complaint leading to time stoppage and medical attention. The outcome measures were time at play, location on the pitch, type of injury, injured body part, and injury mechanism. Results: A total of 190 injuries occurred in 179 matches (55/73 female and 135/106 male matches). There were 0.75 injuries per match for women [confidence interval (CI, 0.31-1.13)] and 1.27 injuries per match for men (CI, 0.88-1.61). The number of injuries per 1000 player match hours was 34.20 for women (CI, 14.04-51.29) and 57.89 for men (CI, 29.78-73.12). The highest injury frequency occurred within the third quarter and within the circle. Contusion was the most common injury type (90.9% in women and 96.3% in men). The leading causes of injuries were hits by the ball or stick and collisions with another player. The head/face was the most affected body part in both sex groups (32.7% in women and 29.6% in men). Conclusions: Video analysis revealed data on injury incidence within the same range of previous reports in elite field hockey. Its advantages, such as slow motion and repetitive play of injury scenes, could contribute valuable information if incorporated into the injury recording process.	[Theilen, Till-Martin; Rolle, Udo] Univ Hosp Frankfurt, Dept Paediat Surg & Paediat Urol, Frankfurt, Germany; [Mueller-Eising, Wiebke; Bettink, Peter W.; Rolle, Udo] Federat Int Hockey FIH, Hlth & Safety Panel, Lausanne, Switzerland		Rolle, U (corresponding author), Univ Hosp Frankfurt, FIH Hlth & Safety Panel, Dept Paediat Surg & Paediat Urol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	udo.rolle@kgu.de		Rolle, Udo/0000-0002-1268-6092			Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bakken A, 2011, BRIT J SPORT MED, V45, P1315, DOI 10.1136/bjsports-2011-090527; Barboza SD, 2018, SPORTS MED, V48, P849, DOI 10.1007/s40279-017-0839-3; Bere T, 2014, SCAND J MED SCI SPOR, V24, P667, DOI 10.1111/sms.12038; Bere T, 2014, BRIT J SPORT MED, V48, P738, DOI 10.1136/bjsports-2014-093528; Bittencourt NFN, 2016, BRIT J SPORT MED, V50, P1309, DOI 10.1136/bjsports-2015-095850; Bjorneboe J, 2014, SCAND J MED SCI SPOR, V24, P189, DOI 10.1111/j.1600-0838.2012.01476.x; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Dick R, 2007, J ATHL TRAINING, V42, P211; Dvorak J, 2011, BRIT J SPORT MED, V45, P626, DOI 10.1136/bjsm.2010.079905; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Gardner EC, 2015, AM J SPORT MED, V43, P2027, DOI 10.1177/0363546515588175; Hendrickson CD, 2008, CLIN J SPORT MED, V18, P399, DOI 10.1097/JSM.0b013e318188b89d; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Kriz PK, 2015, PEDIATRICS, V136, P521, DOI 10.1542/peds.2015-0216; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P215; Mukherjee S, 2012, AM J SPORT MED, V40, P686, DOI 10.1177/0363546511426697; Randjelovic S, 2014, BRIT J SPORT MED, V48, P29, DOI 10.1136/bjsports-2012-091999; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P71; Theilen TM, 2016, BRIT J SPORT MED, V50, P657, DOI 10.1136/bjsports-2015-094847; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895	28	3	3	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2021	31	5					448	452		10.1097/JSM.0000000000000785			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3KG	WOS:000711670400023	32032161				2022-02-06	
J	Morris, NM; Mattera, J; Golden, B; Moses, S; Ingram, PB				Morris, Nicole M.; Mattera, Jessica; Golden, Brittney; Moses, Serena; Ingram, Paul B.			Evaluating the performance of the MMPI-3 over-reporting scales: sophisticated simulators and the effects of comorbid conditions	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						Minnesota Multiphasic Personality Inventory-3; PTSD; traumatic brain injury; feigning; validity scales; assessment	POSTTRAUMATIC-STRESS-DISORDER; VALIDITY; FORM	Objective We examined the utility of the Minnesota Multiphasic Personality Inventory-3 (MMPI-3) to detect feigned over-reporting using a symptom-based coaching simulation design across a control group and three diagnostic conditions: posttraumatic stress disorder (PTSD), minor traumatic brain injury (mTBI), and comorbid PTSD and mTBI. Method Participants were310 college students who wererandomly assigned to one of the four conditions. For participants in the feigning conditions, they were provided with a descriptionof their respective disorder condition throughout the duration of the session and asked to feign according to their condition while completing the MMPI-3. Results MMPI-3 over-reporting scales perform well at classifying feigning. There is low sensitivity, high specificity, and effect magnitudes are medium to large range (1.12 - 2.47). There are no differences in scales assessing over-reporting between diagnostic conditions with dissimilar symptoms. Conclusions Findings provide initial support for the use of the MMPI-3 overreporting scales for detecting feigned PTSD, mTBI, and comorbid PTSD and mTBI. Further, individuals feigning different disorders, namely PTSD, mTBI, and comorbid PTSD and mTBI, feign predominantly general psychopathological symptoms, making Fp the strongest scale in terms of detecting these feigned disorders. Future research will benefit from establishing relevant diagnostic comparison groups to contrast with this study and utilizing known-group designs withboth PVT and SVT administration.	[Morris, Nicole M.; Mattera, Jessica; Golden, Brittney; Moses, Serena; Ingram, Paul B.] Texas Tech Univ, Dept Psychol Sci, 2810 18th St, Lubbock, TX 79424 USA		Morris, NM (corresponding author), Texas Tech Univ, Dept Psychol Sci, 2810 18th St, Lubbock, TX 79424 USA.	nmlemaster1@gmail.com	; Ingram, Paul/ABB-3657-2020	Morris, Nicole/0000-0001-6565-9816; Ingram, Paul/0000-0002-5409-4896			Arbisi PA, 2011, PSYCHOL ASSESSMENT, V23, P203, DOI 10.1037/a0021339; Ben-Porath Y.S., 2020, MMPI 3 MANUAL ADM SC; Ben-Porath Y.S., 2020, MMPI 3 TECHNICAL MAN; Ben-Porath YS., 2008, MMPI 2 RF MANUAL ADM; Burchett DL, 2010, ASSESSMENT, V17, P497, DOI 10.1177/1073191110378972; Currin J.M., 2020, TRAIN EDUC PROF PSYC, DOI [10.1037/tep0000348, DOI 10.1037/TEP0000348]; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Hall JT, 2021, ASSESSMENT, DOI 10.1177/1073191121991921; Ingram PB, 2016, CLIN NEUROPSYCHOL, V30, P473, DOI 10.1080/13854046.2016.1187769; Jurick SM, 2019, ARCH CLIN NEUROPSYCH, V34, P366, DOI 10.1093/arclin/acy048; Olsen AM, 2019, J PERS ASSESS, V101, P264, DOI 10.1080/00223891.2018.1472099; Rogers R., 2018, CLIN ASSESSMENT MALI; Rogers R., 2003, COMPREHENSIVE HDB PS, V11, P109, DOI DOI 10.1002/0471264385.WEI1107; Rogers R, 2018, CLIN ASSESSMENT MALI, V3, P14; Rosnow RL, 2000, PSYCHOL SCI, V11, P446, DOI 10.1111/1467-9280.00287; Sellbom M, 2012, PSYCHIAT RES, V197, P295, DOI 10.1016/j.psychres.2011.12.043; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P757, DOI 10.1037/a0020825; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Taylor S, 2007, J ANXIETY DISORD, V21, P22, DOI 10.1016/j.janxdis.2006.03.016; Tylicki JL, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1856414; Veltri COC, 2013, ASSESSMENT, V20, P199, DOI 10.1177/1073191112464619; Whitman MR, 2021, PSYCHOL ASSESSMENT, V33, P411, DOI 10.1037/pas0000988; Wright CV, 2017, PROF PSYCHOL-RES PR, V48, P73, DOI 10.1037/pro0000086	23	3	3	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2021.1968037		AUG 2021	9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	UL8PH	WOS:000692906500001	34470583				2022-02-06	
J	Owens, TS; Calverley, TA; Stacey, BS; Iannatelli, A; Venables, L; Rose, G; Fall, L; Tsukamoto, H; Berg, RMG; Jones, GL; Marley, CJ; Bailey, DM				Owens, Thomas S.; Calverley, Thomas A.; Stacey, Benjamin S.; Iannatelli, Angelo; Venables, Lucy; Rose, George; Fall, Lewis; Tsukamoto, Hayato; Berg, Ronan M. G.; Jones, Gareth L.; Marley, Christopher J.; Bailey, Damian M.			Contact events in rugby union and the link to reduced cognition: evidence for impaired redox-regulation of cerebrovascular function	EXPERIMENTAL PHYSIOLOGY			English	Article						cerebral blood flow; cognition; contact; rugby union	METABOLIC BRAIN VULNERABILITY; OXIDATIVE-NITROSATIVE STRESS; CEREBRAL-BLOOD-FLOW; TEMPORAL WINDOW; CONCUSSION; INJURY; FOOTBALL	New Findings What is the central question of this study? How does recurrent contact incurred across a season of professional rugby union impact molecular, cerebrovascular and cognitive function? What is the main findings and its importance? A single season of professional rugby union increases systemic oxidative-nitrosative stress (OXNOS) confirmed by a free radical-mediated suppression in nitric oxide bioavailability. Forwards encountered a higher frequency of contact events compared to backs, exhibiting elevated OXNOS and lower cerebrovascular function and cognition. Collectively, these findings provide mechanistic insight into the possible cause of reduced cognition in rugby union subsequent to impairment in the redox regulation of cerebrovascular function. Contact events in rugby union remain a public health concern. We determined the molecular, cerebrovascular and cognitive consequences of contact events during a season of professional rugby. Twenty-one male players aged 25 (mean) +/- 4 (SD) years were recruited from a professional rugby team comprising forwards (n = 13) and backs (n = 8). Data were collected across the season. Pre- and post-season, venous blood was assayed for the ascorbate free radical (A(center dot-), electron paramagnetic resonance spectroscopy) and nitric oxide (NO, reductive ozone-based chemiluminescence) to quantify oxidative-nitrosative stress (OXNOS). Middle cerebral artery velocity (MCAv, Doppler ultrasound) was measured to assess cerebrovascular reactivity (CVR), and cognition was assessed using the Montreal Cognitive Assessment (MoCA). Notational analysis determined contact events over the season. Forwards incurred more collisions (Mean difference [M-D] 7.49; 95% CI, 2.58-12.40; P = 0.005), tackles (M-D 3.49; 95% CI, 0.42-6.56; P = 0.028) and jackals (M-D 2.21; 95% CI, 0.18-4.24; P = 0.034). Forwards suffered five concussions while backs suffered one concussion. An increase in systemic OXNOS, confirmed by elevated A(center dot-) (F-2,F-19 = 10.589, P = 0.004) and corresponding suppression of NO bioavailability (F-2,F-19 = 11.492, P = 0.003) was apparent in forwards and backs across the season. This was accompanied by a reduction in cerebral oxygen delivery (cDO2, F-2,F-19 = 9.440, P = 0.006) and cognition (F-2,F-19 = 4.813, P = 0.041). Forwards exhibited a greater decline in the cerebrovascular reactivity range to changes in PETCO2 (CVRCO2RANG compared to backs (M-D 1.378; 95% CI, 0.74-2.02; P < 0.001).	[Owens, Thomas S.; Calverley, Thomas A.; Stacey, Benjamin S.; Iannatelli, Angelo; Venables, Lucy; Rose, George; Jones, Gareth L.; Marley, Christopher J.; Bailey, Damian M.] Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Alfred Russel Wallace Bldg, Pontypridd CF374AT, M Glam, Wales; [Fall, Lewis] Univ South Wales, Fac Comp Engn & Sci, Pontypridd, M Glam, Wales; [Tsukamoto, Hayato] Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan; [Berg, Ronan M. G.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark		Bailey, DM (corresponding author), Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Alfred Russel Wallace Bldg, Pontypridd CF374AT, M Glam, Wales.	damian.bailey@southwales.ac.uk		Owens, Tom/0000-0003-0097-0616; Rose, George/0000-0002-9598-6372; Fall, Lewis/0000-0002-1515-0672; Venables, Lucy/0000-0001-9772-1629; Berg, Ronan/0000-0002-5757-9506; Stacey, Benjamin S/0000-0003-1005-7038	JPRWilliams Research Fellowship; Royal SocietyWolfson Research Fellowship; Royal Society International Exchanges Award [IES\R2\192137]; Japan Society for thePromotion of Science Research FellowshipMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [JSPS/OF317]	JPRWilliams Research Fellowship; Royal SocietyWolfson Research Fellowship; Royal Society International Exchanges Award, Grant/Award Number: IES\R2\192137; Japan Society for thePromotion of Science Research Fellowship, Grant/Award Number: JSPS/OF317	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bailey DM, 2019, J PHYSIOL-LONDON, V597, P611, DOI 10.1113/JP276898; Bailey DM, 2017, CIRCULATION, V135, P166, DOI 10.1161/CIRCULATIONAHA.116.024226; Bailey DM, 2013, STROKE, V44, P3235, DOI 10.1161/STROKEAHA.113.002589; Bailey DM, 2013, CHEST, V143, P444, DOI 10.1378/chest.12-0728; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bailey DM, 2011, EXP PHYSIOL, V96, P1196, DOI 10.1113/expphysiol.2011.060178; Baker J.S., 2021, DYNAMICS MODERN RUGB, P109; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58073-9; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Davis GA., 2017, BRIT J SPORT MED, P1, DOI [DOI 10.1136/BJSPORTS-2017-097506SCAT5, 10.1136/bjsports-2017-097506SCAT5]; England Rugby, 2020, ENGL PROF RUGB INJ S; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Gelman A, 2014, PERSPECT PSYCHOL SCI, V9, P641, DOI 10.1177/1745691614551642; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hendricks S, 2020, BRIT J SPORT MED, V54, P566, DOI 10.1136/bjsports-2019-101293; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kopecek M, 2017, INT J GERIATR PSYCH, V32, P868, DOI 10.1002/gps.4539; Lavi S, 2003, CIRCULATION, V107, P1901, DOI 10.1161/01.CIR.0000057973.99140.5A; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Rafferty J, 2019, BRIT J SPORT MED, V53, P969, DOI 10.1136/bjsports-2017-098417; Silvestrini M, 2006, STROKE, V37, P1010, DOI 10.1161/01.STR.0000206439.62025.97; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Wolters FJ, 2017, CIRCULATION, V136, P719, DOI 10.1161/CIRCULATIONAHA.117.027448	34	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0670	1469-445X		EXP PHYSIOL	Exp. Physiol.	SEP	2021	106	9					1971	1980		10.1113/EP089330		AUG 2021	10	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	UK2NC	WOS:000681479100001	34355451				2022-02-06	
J	Benassi, SK; Alves, JGSM; Guidoreni, CG; Massant, CG; Queiroz, CM; Garrido-Sanabria, E; Loduca, RDD; Susemihl, MA; Paiva, WS; de Andrade, AF; Teixeira, MJ; Andrade, JQ; Garzon, E; Foresti, ML; Mello, LE				Benassi, Simone Kastropil; Silva Macedo Alves, Julieta Goncalves; Guidoreni, Cristiane Gorgatti; Massant, Cristina Goncalves; Queiroz, Claudio M.; Garrido-Sanabria, Emilio; de Souza Loduca, Rafael Duarte; Susemihl, Maria Alice; Paiva, Wellingson Silva; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Andrade, Joaquina Queiroz; Garzon, Eliana; Foresti, Maira Licia; Mello, Luiz E.			Two decades of research towards a potential first anti-epileptic drug	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Status epilepticus; Seizure; Scopolamine; Biperiden; Post-traumatic epilepsy; Epileptogenesis	SYNAPTIC REORGANIZATION; DENTATE GYRUS; KAINIC ACID; SEIZURES; PILOCARPINE; ACETYLCHOLINE; MECHANISMS; BIPERIDEN	The basic mechanisms by which brain insults, such as trauma, stroke or status epilepticus produce epilepsy are not completely understood, and effective preventive measures and treatment are still not available in the clinical setting. Over the last 2 decades we have conducted several studies with animal models of epilepsy (rodents and non-human primates) and demonstrated that drugs that modify neuronal plastic processes, such as anticholinergic agents (e.g., antimuscarinic compounds), if administered soon after brain injury and over a period of 10-20 days, have the potential to modify the natural course of post-traumatic epilepsy. To that end treatment with scopolamine showed promising results as a candidate agent in both the pilocarpine and kainate models. We then showed that biperiden, yet another cholinergic antagonist acting in the muscarinic receptor, that is widely used to treat Parkinson's disease, also decreased the incidence and intensity of spontaneous epileptic seizures, delaying their appearance in the pilocarpine model of epilepsy. In other words, biperiden showed to be a potential candidate to be further investigated as an antiepileptogenic agent. Accordingly, we tested the safety of biperiden in a small group of patients (as a small phase II safety assessment) and confirmed its safety in the context of traumatic brain injury (TBI). Now, we provide information on our ongoing project to evaluate the efficacy of biperiden in preventing the development of epilepsy in patients that suffered TBI, in a double blind, randomized, placebo-controlled trial.	[Benassi, Simone Kastropil; Silva Macedo Alves, Julieta Goncalves; Guidoreni, Cristiane Gorgatti; Massant, Cristina Goncalves; Queiroz, Claudio M.; Garrido-Sanabria, Emilio; de Souza Loduca, Rafael Duarte; Susemihl, Maria Alice; Foresti, Maira Licia; Mello, Luiz E.] Univ Fed Sao Paulo, Physiol Dept, Rua Pedro Toledo 669,L3A, BR-04039032 Sao Paulo, SP, Brazil; [Paiva, Wellingson Silva; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Hosp Clin, Dept Neurol, Div Neurosurg, Sao Paulo, SP, Brazil; [Andrade, Joaquina Queiroz; Garzon, Eliana] Univ DesaoPaulo, Hosp Clin, Fac Med, Dept Neurol,Div Neurol Clin, Sao Paulo, SP, Brazil; [Foresti, Maira Licia; Mello, Luiz E.] Inst DOr Pesquisa & Ensino, Rio De Janeiro, RJ, Brazil; [Massant, Cristina Goncalves] Hosp Israelita Albert Einstein, Neurol, Sao Paulo, SP, Brazil; [Silva Macedo Alves, Julieta Goncalves] Hosp Sirio Libanes Soc Beneficente Senhoras SBSHS, Neurosurg, Sao Paulo, SP, Brazil; [Guidoreni, Cristiane Gorgatti] Fundacao Oswaldo Aranha UniFOA, Ctr Univ Volta Redonda, Volta Redonda, RJ, Brazil; [de Souza Loduca, Rafael Duarte] Hosp Mil Area Sao Paulo, Sao Paulo, SP, Brazil; [Susemihl, Maria Alice] Assoc Brasileira Epilepsia ABE, Sao Paulo, SP, Brazil; [Queiroz, Claudio M.] Univ Fed Rio Grande do Norte, Brain Inst, Natal, RN, Brazil		Mello, LE (corresponding author), Univ Fed Sao Paulo, Physiol Dept, Rua Pedro Toledo 669,L3A, BR-04039032 Sao Paulo, SP, Brazil.	luiz.emello@idor.org	Paiva, Wellingson S/G-5517-2013	Paiva, Wellingson S/0000-0002-5165-7040	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/24561-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [311619/2019-3]	Work in the laboratory is supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grant 2018/24561-5) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant 311619/2019-3).	AITKEN PG, 1985, BRAIN RES, V325, P261, DOI 10.1016/0006-8993(85)90322-1; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; ARNOLD PS, 1973, EXP NEUROL, V40, P457, DOI 10.1016/0014-4886(73)90087-3; BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Bertram E, 2007, EPILEPSIA, V48, P65, DOI 10.1111/j.1528-1167.2007.01068.x; Bittencourt S, 2017, EPILEPSY RES, V138, P88, DOI 10.1016/j.eplepsyres.2017.10.019; Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; CAIN DP, 1988, EXP NEUROL, V100, P179, DOI 10.1016/0014-4886(88)90210-5; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; DASILVA AM, 1990, ACT NEUR S, V50, P48; GODDARD GV, 1967, NATURE, V214, P1020, DOI 10.1038/2141020a0; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; JARVIK ME, 1967, PSYCHOL REP, V21, P221, DOI 10.2466/pr0.1967.21.1.221; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimura Y, 1999, BRAIN RES, V834, P6, DOI 10.1016/S0006-8993(99)01526-7; Kokaia M, 1996, NEUROSCIENCE, V70, P313, DOI 10.1016/0306-4522(95)00384-3; LEMOS T, 1995, EXP BRAIN RES, V102, P423; LERNER P F, 1960, South Med J, V53, P465; LEVEY AI, 1995, J NEUROSCI, V15, P4077; MARKOWSKA AL, 1995, J NEUROSCI, V15, P2063, DOI 10.1523/JNEUROSCI.15-03-02063.1995; McDonough JH, 2000, EPILEPSY RES, V38, P1; Mello L E, 1996, Epilepsy Res Suppl, V12, P205; Mosini AC, 2021, BRAZ J MED BIOL RES, V54, DOI [10.1590/1414-431X202010656, 10.1590/1414-431x202010656]; PRINCE DA, 1993, CURR PROB E, V8, P17; PRINCE DA, 1985, EPILEPSIA, V26, pS3, DOI 10.1111/j.1528-1157.1985.tb05721.x; ROSSNER S, 1995, BRAIN RES, V696, P165; Rouse ST, 2000, NEUROSCI LETT, V278, P61, DOI 10.1016/S0304-3940(99)00914-3; Schmidt D, 2012, EPILEPTIC DISORD, V14, P105, DOI 10.1684/epd.2012.0512; Schwartzkroin Philip A., 1993, P83; Stringer JL, 2000, EPILEPSY RES, V40, P147, DOI 10.1016/S0920-1211(00)00118-2; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; WILEY RG, 1991, BRAIN RES, V562, P149, DOI 10.1016/0006-8993(91)91199-B; World Health Organization, 2019, WHO MOD LIST ESS MED; Wuarin JP, 1996, J NEUROSCI, V16, P4438	38	3	3	5	5	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	AUG	2021	90				SI		99	109		10.1016/j.seizure.2021.02.031			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TY1GR	WOS:000683532700013	33714677				2022-02-06	
J	Komisar, V; Shishov, N; Yang, YJ; Robinovitch, SN				Komisar, Vicki; Shishov, Nataliya; Yang, Yijian; Robinovitch, Stephen N.			Effect of Holding Objects on the Occurrence of Head Impact in Falls by Older Adults: Evidence From Real-Life Falls in Long-Term Care	JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES			English	Article						Falls; Injury prevention; Long-term care; Mobility aids; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; BALANCE RECOVERY; STRENGTH; CIRCUMSTANCES; FRACTURES; RISK; HIP; DEMANDS; HEIGHT; PEOPLE	Background: Falls cause approximately 80% of traumatic brain injuries in older adults, and nearly one third of falls by residents in long-term care (LTC) result in head impact. Holding objects during falls, such as mobility aids, may affect the ability of LTC residents to avoid head impact by arresting the fall with their upper limbs. We examined the prevalence of holding objects and their effect on risk for head impact during real-life falls in older adults living in LTC. Methods: We analyzed videos of 1105 real-life falls from standing height by 425 LTC residents, using a validated questionnaire to characterize the occurrence of head impact and whether the resident held objects during descent and impact. We classified objects as either "weight-bearing" (via contact to the fixed environment, eg, chairs and walkers) or "non-weight-bearing" (eg, cups) and tested their effect on odds for head impact with generalized estimating equations. Results: Residents held objects in more than 60% of falls. The odds for head impact were reduced for falls where weight-bearing objects were held or grasped during descent (odds ratio = 0.52; 95% confidence interval = 0.39-0.70) or maintained throughout the fall (odds ratio = 0.34; 95% confidence interval = 0.23-0.49). The most commonly held objects were chairs/wheelchairs (23% of cases), tables/counters (10% of cases), and walkers/rollators (22% of cases); all reduced the odds of head impact when held during descent. Holding non-weight-bearing objects did not affect the odds of head impact (odds ratio = 1.00; 95% confidence interval = 0.64-1.55). Conclusion: Our results show that older adults in LTC use held, weight-bearing objects to reduce their risk for head impact during falls.	[Komisar, Vicki; Shishov, Nataliya; Robinovitch, Stephen N.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada; [Yang, Yijian] Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Hong Kong, Peoples R China; [Robinovitch, Stephen N.] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada		Komisar, V (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	vkomisar@sfu.ca	Yang, Yijian/G-1580-2016	Yang, Yijian/0000-0002-5831-186X; Robinovitch, Stephen/0000-0003-3881-6227; Komisar, Vicki/0000-0003-3504-1796	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [AMG-100487, TIR103945, TEI-138295]; AGE-WELL Core Research Program [AW CRP 2015-WP5.2, AW CRP 2020-04]; Michael Smith Foundation for Health Research (MSFHR) Postdoctoral Award [18481]; AGE-WELL Network of Centres of Excellence in Technology and Aging Postdoctoral Award; CIHR Community Support Travel AwardCanadian Institutes of Health Research (CIHR) [164465, 164472]; MITACS Accelerate Postdoctoral Award; Simon Fraser University Graduate Dean's Entrance Scholarship; Michael Smith Foundation for Health Research Postdoctoral Award [16556]	This work was supported by operating grants from the Canadian Institutes of Health Research (CIHR; funding reference numbers AMG-100487, TIR103945, and TEI-138295) and the AGE-WELL Core Research Program (AW CRP 2015-WP5.2 and AW CRP 2020-04). V.K. was supported by a Michael Smith Foundation for Health Research (MSFHR) Postdoctoral Award (18481), an AGE-WELL Network of Centres of Excellence in Technology and Aging Postdoctoral Award, a CIHR Community Support Travel Award (164465), and a MITACS Accelerate Postdoctoral Award; N.S. was supported by an Simon Fraser University Graduate Dean's Entrance Scholarship and a CIHR Community Support Travel Award (164472); and Y.Y. was supported by an Michael Smith Foundation for Health Research Postdoctoral Award (16556). None of the funding agencies influenced the experimental design; the collection, analysis, or interpretation of data; the writing of the manuscript; or the decision to submit the manuscript for publication.	Arnold AJ, 2017, J MOT LEARN DEV, V5, P181, DOI [10.1123/ jmld. 2016-0052, DOI 10.1123/JMLD.2016-0052]; Avlund K., 1994, Scandinavian Journal of Medicine and Science in Sports, V4, P32; Bateni H, 2004, EXP BRAIN RES, V157, P49, DOI 10.1007/s00221-003-1815-8; Bowers B, 2008, REHABIL NURS, V33, P253, DOI 10.1002/j.2048-7940.2008.tb00237.x; Carpenter MG, 2004, J NEUROPHYSIOL, V92, P3255, DOI 10.1152/jn.01139.2003; Connell BR, 1997, ARCH PHYS MED REHAB, V78, P179, DOI 10.1016/S0003-9993(97)90261-6; CUMMINGS SR, 1989, J GERONTOL, V44, pM107; CUMMINGS SR, 1994, OSTEOPOROSIS INT, V4, P67; DeGoede KM, 2002, J BIOMECH, V35, P843, DOI 10.1016/S0021-9290(02)00011-8; Feldman F, 2007, J BIOMECH, V40, P2612, DOI 10.1016/j.jbiomech.2007.01.019; FOTHERGILL DM, 1992, ERGONOMICS, V35, P203, DOI 10.1080/00140139208967807; Fraser A, 1999, RHEUMATOLOGY, V38, P521, DOI 10.1093/rheumatology/38.6.521; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Ganz DA, 2005, J AM GERIATR SOC, V53, P2190, DOI 10.1111/j.1532-5415.2005.00509.x; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gosine P, 2019, APPL ERGON, V81, DOI 10.1016/j.apergo.2019.102900; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Heller MF, 2009, GAIT POSTURE, V30, P115, DOI 10.1016/j.gaitpost.2009.02.015; Holliday P., 1990, SLIPS STUMBLES FALLS, P7, DOI [10.1520/STP15497S, DOI 10.1520/STP15497S]; Hsiao ET, 1998, J BIOMECH, V31, P1; Hughes RE, 1999, AM J SPORT MED, V27, P651, DOI 10.1177/03635465990270051801; Jutai J, 2007, ARCH PHYS MED REHAB, V88, P1268, DOI 10.1016/j.apmr.2007.06.773; Komisar V, 2018, GAIT POSTURE, V60, P209, DOI 10.1016/j.gaitpost.2017.12.009; Lattimer LJ, 2018, CLIN BIOMECH, V52, P102, DOI 10.1016/j.clinbiomech.2018.01.018; Lester P, 2008, J AM MED DIR ASSOC, V9, P684, DOI 10.1016/j.jamda.2008.06.007; Luz C, 2017, GERONTOLOGIST, V57, P211, DOI 10.1093/geront/gnv096; MAKI BE, 1991, J GERONTOL, V46, pM123, DOI 10.1093/geronj/46.4.M123; Maki BE, 1998, SAFETY SCI, V28, P189, DOI 10.1016/S0925-7535(98)80008-8; McArthur C, 2016, CAN J AGING, V35, P491, DOI 10.1017/S0714980816000556; Metter EJ, 1997, J GERONTOL A-BIOL, V52, pB267, DOI 10.1093/gerona/52A.5.B267; MURPHY J, 1982, GERONTOLOGY, V28, P265, DOI 10.1159/000212543; Myung R, 1997, ERGONOMICS, V40, P235, DOI 10.1080/001401397188323; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; Nurmi I, 2002, SCAND J PRIM HEALTH, V20, P118, DOI 10.1080/713796400; Pater ML, 2015, GAIT POSTURE, V41, P335, DOI 10.1016/j.gaitpost.2014.10.026; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Rosengren KS, 2014, ECOL PSYCHOL, V26, P167, DOI 10.1080/10407413.2014.875357; Schonnop R, 2013, CAN MED ASSOC J, V185, pE803, DOI 10.1503/cmaj.130498; Van Ooteghem K, 2013, EXP BRAIN RES, V231, P191, DOI 10.1007/s00221-013-3682-2; Vidt ME, 2012, J BIOMECH, V45, P334, DOI 10.1016/j.jbiomech.2011.10.007; Weaver TB, 2016, J AM GERIATR SOC, V64, P96, DOI 10.1111/jgs.13878; Yang YJ, 2020, J BONE MINER RES, V35, P1914, DOI 10.1002/jbmr.4048; Yang Y, 2017, J HEAD TRAUMA REHAB, V32, P168, DOI 10.1097/HTR.0000000000000257; Yang YJ, 2015, J AM MED DIR ASSOC, V16, P388, DOI 10.1016/j.jamda.2014.12.003	44	3	3	3	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5006	1758-535X		J GERONTOL A-BIOL	J. Gerontol. Ser. A-Biol. Sci. Med. Sci.	AUG	2021	76	8					1463	1470		10.1093/gerona/glaa168			8	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	UT2YY	WOS:000697988000030	32622345	Green Published			2022-02-06	
J	Weis, CN; Webb, EK; Huggins, AA; Kallenbach, M; Miskovich, TA; Fitzgerald, JM; Bennett, KP; Krukowski, JL; DeRoon-Cassini, TA; Larson, CL				Weis, C. N.; Webb, E. K.; Huggins, A. A.; Kallenbach, M.; Miskovich, T. A.; Fitzgerald, J. M.; Bennett, K. P.; Krukowski, J. L.; DeRoon-Cassini, T. A.; Larson, C. L.			Stability of hippocampal subfield volumes after trauma and relationship to development of PTSD symptoms	NEUROIMAGE			English	Article						FreeSurfer; Magnetic resonance imaging; PTSD; Hippocampal subfields; Test-retest reliability	POSTTRAUMATIC-STRESS-DISORDER; SURFACE-BASED ANALYSIS; COMPUTATIONAL ATLAS; AUTOMATED METHODS; AMYGDALA VOLUMES; SEGMENTATION; MRI; RELIABILITY; VULNERABILITY; THICKNESS	Background: The hippocampus plays a central role in post-traumatic stress disorder (PTSD) pathogenesis, and the majority of neuroimaging research on PTSD has studied the hippocampus in its entirety. Although extensive literature demonstrates changes in hippocampal volume are associated with PTSD, fewer studies have probed the relationship between symptoms and the hippocampus' functionally and structurally distinct subfields. We utilized data from a longitudinal study examining post-trauma outcomes to determine whether hippocampal subfield volumes change post-trauma and whether specific subfields are significantly associated with, or prospectively related to, PTSD symptom severity. As a secondary aim, we leveraged our unique study design sample to also investigate reliability of hippocampal subfield volumes using both cross-sectional and longitudinal pipelines available in FreeSurfer v6.0 . Methods: Two-hundred and fifteen traumatically injured individuals were recruited from an urban Emergency Department. Two-weeks post-injury, participants underwent two consecutive days of neuroimaging (time 1: T1, and time 2: T2) with magnetic resonance imaging (MRI) and completed self-report assessments. Six-months later (time 3: T3), participants underwent an additional scan and were administered a structured interview assessing PTSD symptoms. First, we calculated reliability of hippocampal measurements at T1 and T2 (automatically segmented with FreeSurfer v6.0). We then examined the prospective (T1 subfields) and cross-sectional (T3 subfields) relationship between volumes and PTSD. Finally, we tested whether change in subfield volumes between T1 and T3 explained PTSD symptom variability. Results: After controlling for sex, age, and total brain volume, none of the subfield volumes (T1) were prospectively related to T3 PTSD symptoms nor were subfield volumes (T3) associated with current PTSD symptoms (T3). Tl-T2 reliability of all hippocampal subfields ranged from good to excellent (intraclass correlation coefficient (ICC) values > 0.83), with poorer reliability in the hippocampal fissure. Conclusion: Our study was a novel examination of the prospective relationship between hippocampal subfield volumes in relation to PTSD in a large trauma-exposed urban sample. There was no significant relationship between subfield volumes and PTSD symptoms, however, we confirmed FreeSurfer v6.0 hippocampal subfield segmentation is reliable when applied to a traumatically-injured sample, using both cross-sectional and longitudinal analysis pipelines. Although hippocampal subfield volumes may be an important marker of individual variability in PTSD, findings are likely conditional on the timing of the measurements (e.g. acute or chronic post-trauma periods) and analysis strategy (e.g. cross-sectional or prospective).	[Weis, C. N.; Webb, E. K.; Huggins, A. A.; Kallenbach, M.; Miskovich, T. A.; Fitzgerald, J. M.; Bennett, K. P.; Krukowski, J. L.; DeRoon-Cassini, T. A.; Larson, C. L.] Univ Wisconsin, Psychol, Dept Psychol, 2441 E Hartford Ave, Milwaukee, WI 53211 USA		Weis, CN (corresponding author), Univ Wisconsin, Psychol, Dept Psychol, 2441 E Hartford Ave, Milwaukee, WI 53211 USA.	cnweis@uwm.edu	Weis, Carissa/AAX-3969-2021	Weis, Carissa/0000-0002-9199-8632; Webb, Elisabeth/0000-0002-4993-7836; Kallenbach, Madeline/0000-0001-6047-3545; Larson, Christine/0000-0002-1359-6080; Krukowski, Jessica/0000-0003-1921-7480; Bennett, Kenneth/0000-0002-8023-3327	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-M1H106574]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001437]	Support for the research, authorship, and/or publication of this article include the following: a NIH grant R01-M1H106574 (PI: Larson) . E.K.W is supported by the National Center for Advancing Translational Sciences, National Institutes of Health (TL1TR001437) . The content is solely the responsibility of the author (s) and does not necessarily represent the official views of the NIH.	Abdallah C.L, 2017, CHRON STRESS, V1, DOI [10.1177/2470547017744538, 2470547017744538, DOI 10.1177/2470547017744538,2470547017744538]; Ahmed-Leitao F, 2016, PSYCHIAT RES-NEUROIM, V256, P33, DOI 10.1016/j.pscychresns.2016.09.008; American Psychiatric Association, 2013, DSM, VV; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Bartsch T, 2015, NEUROSCIENCE, V309, P1, DOI 10.1016/j.neuroscience.2015.07.084; Bartsch T, 2011, P NATL ACAD SCI USA, V108, P17562, DOI 10.1073/pnas.1110266108; Besnard A, 2016, NEUROPSYCHOPHARMACOL, V41, P24, DOI 10.1038/npp.2015.167; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Brown EM, 2020, NEUROIMAGE, V210, DOI 10.1016/j.neuroimage.2020.116563; Burke SN, 2010, TRENDS NEUROSCI, V33, P153, DOI 10.1016/j.tins.2009.12.003; Carter RT, 2007, COUNS PSYCHOL, V35, P13, DOI 10.1177/0011000006292033; Chen LW, 2018, DEPRESS ANXIETY, V35, P1018, DOI 10.1002/da.22833; Coburn D, 2018, RADIOL TECHNOL, V89, P501; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Dalton MA, 2017, CURR OPIN BEHAV SCI, V17, P34, DOI 10.1016/j.cobeha.2017.06.001; Davidson R, 2019, HIPPOCAMPAL SUBFIELD, DOI [10.1101/739094, DOI 10.1101/739094]; de Flores R, 2015, HUM BRAIN MAPP, V36, P463, DOI 10.1002/hbm.22640; Dhama SK, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00091; Dill V, 2015, NEUROINFORMATICS, V13, P133, DOI 10.1007/s12021-014-9243-4; El-Falougy H, 2006, Bratisl Lek Listy, V107, P103; Iglesias JE, 2015, NEUROIMAGE, V115, P117, DOI 10.1016/j.neuroimage.2015.04.042; Fenster RJ, 2018, NAT REV NEUROSCI, V19, P535, DOI 10.1038/s41583-018-0039-7; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frohner JH, 2019, NEUROIMAGE, V195, P174, DOI 10.1016/j.neuroimage.2019.03.053; Gamer M, 2012, IRR VARIOUS COEFFICI; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gurvits TV, 2006, ARCH GEN PSYCHIAT, V63, P571, DOI 10.1001/archpsyc.63.5.571; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Haddad L, 2015, SCHIZOPHRENIA BULL, V41, P115, DOI 10.1093/schbul/sbu072; Haladaj R, 2020, SURG RADIOL ANAT, V42, P193, DOI 10.1007/s00276-019-02298-5; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hanson C.R, 2020, NEUROSCIENCE, DOI [10.1101/2020.06.12.149203, DOI 10.1101/2020.06.12.149203]; Haukvik UK, 2018, J PSYCHIATR RES, V104, P217, DOI 10.1016/j.jpsychires.2018.08.012; Hayes JP, 2017, J PSYCHIATR RES, V95, P247, DOI 10.1016/j.jpsychires.2017.09.007; HOLM S, 1979, SCAND J STAT, V6, P65; Hsu YY, 2002, J MAGN RESON IMAGING, V16, P305, DOI 10.1002/jmri.10163; Jin JJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00170; Johnson SB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3075; Joshi SA, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13357; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kim EJ, 2015, LEARN MEMORY, V22, P411, DOI 10.1101/lm.037291.114; Knierim JJ, 2015, CURR BIOL, V25, pR1116, DOI 10.1016/j.cub.2015.10.049; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kremen WS, 2012, NEUROPHARMACOLOGY, V62, P647, DOI 10.1016/j.neuropharm.2011.03.012; Lazarov A, 2017, J PSYCHIATR RES, V94, P15, DOI 10.1016/j.jpsychires.2017.06.003; Lehrner A, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23797; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Lupien SJ, 2001, BEHAV BRAIN RES, V127, P137, DOI 10.1016/S0166-4328(01)00361-8; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Malivoire BL, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1716-9; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Marizzoni M, 2015, HUM BRAIN MAPP, V36, P3516, DOI 10.1002/hbm.22859; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1602/neurorx.1.2.182; McCarthy CS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00379; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; Miller DB, 2005, AGEING RES REV, V4, P123, DOI 10.1016/j.arr.2005.03.002; Miller JK, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00100; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mulder ER, 2014, NEUROIMAGE, V92, P169, DOI 10.1016/j.neuroimage.2014.01.058; Noble KG, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00307; Ortiz JB, 2018, FRONT NEUROENDOCRIN, V49, P114, DOI 10.1016/j.yfrne.2018.02.005; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Postel C, 2019, HUM BRAIN MAPP, V40, P1244, DOI 10.1002/hbm.24443; Preston-Ferrer P, 2018, CELL TISSUE RES, V373, P605, DOI 10.1007/s00441-017-2732-7; Quattrini G, 2020, NEUROIMAGE, V218, DOI 10.1016/j.neuroimage.2020.116932; Radonjic V, 2014, VOJNOSANIT PREGL, V71, P195, DOI 10.2298/VSP130222043R; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rothbaum BO, 2014, J CLIN PSYCHIAT, V75, P1380, DOI 10.4088/JCP.13m08715; Schmidt MF, 2018, HUM BRAIN MAPP, V39, P2500, DOI 10.1002/hbm.24017; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Squire LR, 2009, NEURON, V61, P6, DOI 10.1016/j.neuron.2008.12.023; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Tatu L, 2014, FRONT NEUROL NEUROSC, V34, P18, DOI 10.1159/000356440; Tural U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197889; van Rooij SJH, 2018, BIOL PSYCHIAT, V84, P106, DOI 10.1016/j.biopsych.2017.09.005; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Whelan CD, 2016, NEUROIMAGE, V128, P125, DOI 10.1016/j.neuroimage.2015.12.039; Wisse LEM, 2016, AM J NEURORADIOL, V37, P1050, DOI 10.3174/ajnr.A4659; Witter MP, 2017, BRAIN BEHAV EVOLUT, V90, P15, DOI 10.1159/000475703; Wixted JT, 2011, TRENDS COGN SCI, V15, P210, DOI 10.1016/j.tics.2011.03.005; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; Xie H, 2018, BIOL PSYCHIAT-COGN N, V3, P968, DOI 10.1016/j.bpsc.2017.11.010; Yushkevich PA, 2015, NEUROIMAGE, V111, P526, DOI 10.1016/j.neuroimage.2015.01.004; Yushkevich PA, 2015, HUM BRAIN MAPP, V36, P258, DOI 10.1002/hbm.22627; Yushkevich PA, 2009, NEUROIMAGE, V44, P385, DOI 10.1016/j.neuroimage.2008.08.042; Zimmerman ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154530	98	3	3	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	AUG 1	2021	236								118076	10.1016/j.neuroimage.2021.118076			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	TC9KY	WOS:000668957500010	33878374	gold, Green Accepted			2022-02-06	
J	Wiegers, EJA; Lingsma, HF; Huijben, JA; Cooper, DJ; Citerio, G; Frisvold, S; Helbok, R; Maas, AIR; Menon, DK; Moore, EM; Stocchetti, N; Dippel, DW; Steyerberg, EW; van der Jagt, M				Wiegers, Eveline Janine Anna; Lingsma, Hester Floor; Huijben, Jilske Antonia; Cooper, David James; Citerio, Giuseppe; Frisvold, Shirin; Helbok, Raimund; Maas, Andrew Ian Ramsay; Menon, David Krishna; Moore, Elizabeth Madeleine; Stocchetti, Nino; Dippel, Diederik Willem; Steyerberg, Ewout Willem; van der Jagt, Mathieu		CENTER-TBI Collaboration Grp; OzENTER-TBI Collaboration Grp	Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI and OzENTER-TBI) : a prospective, multicentre, comparative effectiveness study	LANCET NEUROLOGY			English	Article							INTRACRANIAL-PRESSURE; MANAGEMENT; GUIDELINES	Background Fluid therapy-the administration of fluids to maintain adequate organ tissue perfusion and oxygenation-is essential in patients admitted to the intensive care unit (ICU) with traumatic brain injury. We aimed to quantify the variability in fluid management policies in patients with traumatic brain injury and to study the effect of this variability on patients' outcomes. Methods We did a prospective, multicentre, comparative effectiveness study of two observational cohorts: CENTER-TBI in Europe and OzENTER-TBI in Australia. Patients from 55 hospitals in 18 countries, aged 16 years or older with traumatic brain injury requiring a head CT, and admitted to the ICU were included in this analysis. We extracted data on demographics, injury, and clinical and treatment characteristics, and calculated the mean daily fluid balance (difference between fluid input and loss) and mean daily fluid input during ICU stay per patient. We analysed the association of fluid balance and input with ICU mortality and functional outcome at 6 months, measured by the Glasgow Outcome Scale Extended (GOSE). Patient-level analyses relied on adjustment for key characteristics per patient, whereas centre-level analyses used the centre as the instrumental variable. Findings 2125 patients enrolled in CENTER-TBI and OzENTER-TBI between Dec 19, 2014, and Dec 17, 2017, were eligible for inclusion in this analysis. The median age was 50 years (IQR 31 to 66) and 1566 (74%) of patients were male. The median of the mean daily fluid input ranged from 1middot48 L (IQR 1middot12 to 2middot09) to 4middot23 L (3middot78 to 4middot94) across centres. The median of the mean daily fluid balance ranged from -0middot85 L (IQR -1middot51 to -0middot49) to 1middot13 L (0middot99 to 1middot37) across centres. In patient-level analyses, a mean positive daily fluid balance was associated with higher ICU mortality (odds ratio [OR] 1middot10 [95% CI 1middot07 to 1middot12] per 0middot1 L increase) and worse functional outcome (1middot04 [1middot02 to 1middot05] per 0middot1 L increase); higher mean daily fluid input was also associated with higher ICU mortality (1middot05 [1middot03 to 1middot06] per 0middot1 L increase) and worse functional outcome (1middot04 [1middot03 to 1middot04] per 1-point decrease of the GOSE per 0middot1 L increase). Centre-level analyses showed similar associations of higher fluid balance with ICU mortality (OR 1middot17 [95% CI 1middot05 to 1middot29]) and worse functional outcome (1middot07 [1middot02 to 1middot13]), but higher fluid input was not associated with ICU mortality (OR 0middot95 [0middot90 to 1middot00]) or worse functional outcome (1middot01 [0middot98 to 1middot03]). Interpretation In critically ill patients with traumatic brain injury, there is significant variability in fluid management, with more positive fluid balances being associated with worse outcomes. These results, when added to previous evidence, suggest that aiming for neutral fluid balances, indicating a state of normovolaemia, contributes to improved outcome. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Wiegers, Eveline Janine Anna; Lingsma, Hester Floor; Huijben, Jilske Antonia; Steyerberg, Ewout Willem] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Cooper, David James] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Cooper, David James] Alfred, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Monza, MB, Italy; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Neurointens Care Unit, Monza, MB, Italy; [Frisvold, Shirin] Univ Hosp North Norway, Dept Intens Care Med, Tromso, Norway; [Frisvold, Shirin] UiT Arctic Univ Norway, Tromso, Norway; [Helbok, Raimund] Med Univ Innsbruck, Dept Neurol Neurocrit Care, Anichstr, Innsbruck, Austria; [Maas, Andrew Ian Ramsay] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew Ian Ramsay] Univ Antwerp, Edegem, Belgium; [Menon, David Krishna] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Moore, Elizabeth Madeleine] Monash Univ, Sch Publ Hlth & Prevent Med, Transfus Res Unit, Melbourne, Vic, Australia; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci Intens Care Unit, Milan, Italy; [Dippel, Diederik Willem] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Steyerberg, Ewout Willem] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [van der Jagt, Mathieu] Erasmus MC Univ Med Ctr, Dept Intens Care Adults, NL-3000 CA Rotterdam, Netherlands		van der Jagt, M (corresponding author), Erasmus MC Univ Med Ctr, Dept Intens Care Adults, NL-3000 CA Rotterdam, Netherlands.	m.vanderjagt@erasmusmc.nl	Vande Vyvere, Thijs/AAB-5180-2022; Posti, Jussi P./Y-2908-2019; Lagares, Alfonso/B-2969-2011; Volovici, Victor/AAZ-8901-2020; van der Jagt, Mathieu/G-1905-2017; Raj, Rahul/K-7693-2012; Gomez, Pedro/E-2411-2014; Ercole, Ari/B-6288-2009	Vande Vyvere, Thijs/0000-0003-4032-5443; Posti, Jussi P./0000-0002-5925-5193; Lagares, Alfonso/0000-0003-3996-0554; Volovici, Victor/0000-0002-5798-5360; Parizel, Paul M./0000-0002-0221-2854; Rossi, Sandra/0000-0002-9963-8121; van der Jagt, Mathieu/0000-0003-2566-8325; van der Naalt, Joukje/0000-0001-9873-2418; Huijben, Jilske (Antonia)/0000-0002-2892-5406; Stewart, William/0000-0003-2199-2582; Raj, Rahul/0000-0003-4243-9591; Van Essen, Thomas/0000-0003-4657-5283; Radoi, Andreea/0000-0002-0677-3544; Gomez, Pedro/0000-0002-4185-5238; Dark, Paul/0000-0003-3309-0164; Zeiler, Frederick/0000-0003-1737-0510; Ercole, Ari/0000-0001-8350-8093; Coles, Jonathan/0000-0003-4013-679X	European Commission 7th Framework program; Australian Health and Medical Research CouncilNational Health and Medical Research Council of Australia	European Commission 7th Framework program and the Australian Health and Medical Research Council.	Beaubien-Souligny W, 2020, ULTRASOUND J, V12, DOI 10.1186/s13089-020-00163-w; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Brookhart M Alan, 2007, Int J Biostat, V3, P14; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cnossen MC, 2018, CLIN EPIDEMIOL, V10, P841, DOI 10.2147/CLEP.S154500; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V305, P1846, DOI 10.1001/jama.2011.597; Li HP, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01764-7; Luo JF, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0239-8; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; MCMANUS ML, 1993, ANESTHESIOLOGY, V78, P1132, DOI 10.1097/00000542-199306000-00017; Mutoh T, 2009, STROKE, V40, P2368, DOI 10.1161/STROKEAHA.109.547463; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Oddo M, 2018, INTENS CARE MED, V44, P449, DOI 10.1007/s00134-018-5086-z; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHMOKER JD, 1992, J TRAUMA, V33, P476, DOI 10.1097/00005373-199209000-00024; SHENKIN HA, 1976, J NEUROSURG, V45, P432, DOI 10.3171/jns.1976.45.4.0432; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Van Regenmortel N, 2018, INTENS CARE MED, V44, P409, DOI 10.1007/s00134-018-5147-3; Volovici V, 2019, WORLD NEUROSURG, V125, pE515, DOI 10.1016/j.wneu.2019.01.116; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	29	3	3	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2021	20	8					627	638					12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TP6CG	WOS:000677684700016	34302787				2022-02-06	
J	Wilkerson, GB; Nabhan, DC; Crane, RT				Wilkerson, Gary B.; Nabhan, Dustin C.; Crane, Ryan T.			Upper-Extremity Perceptual-Motor Training Improves Whole-Body Reactive Agility Among Elite Athletes With History of Sport-Related Concussion	JOURNAL OF SPORT REHABILITATION			English	Article						reaction time; mild traumatic brain injury; training adaptation	INTERFERENCE; INDIVIDUALS; INTEGRATION; NETWORKS; INSIGHTS; INJURY	Context: Sport-related concussion (SRC) elevates risk for subsequent injury, which may relate to impaired perceptual-motor processes that are potentially modifiable. Objective: To assess a possible upper-extremity (UE) training effect on whole-body (WB) reactive agility performance among elite athletes with history of SRC (HxSRC) and without such history of SRC. Design: Cohort study. Setting: Residential training center. Participants: Elite athletes (12 males and 8 females), including 10 HxSRC and 10 without such history of SRC. Intervention: One-minute training sessions completed 2 to 3 times per week over a 3-week period involved verbal identification of center arrow direction for 10 incongruent and 10 congruent flanker test trials with simultaneous reaching responses to deactivate illuminated buttons. Main Outcome Measures: Pretraining and posttraining assessments of UE and WB reactive responses included flanker test conflict effect (incongruent minus congruent reaction time) and WB lateral average asymmetry derived from reaction time, speed, acceleration, and deceleration in opposite directions. Discrimination was assessed by receiver operating characteristic analysis, and training effect was assessed by repeated-measures analysis of variance. Results: Pretraining discrimination between HxSRC and without such history of SRC was greatest for conflict effect >= 80 milliseconds and WB lateral average asymmetry >= 18%. Each athlete completed 6 training sessions, which improved UE mean reaction time from 767 to 646 milliseconds (P <.001) and reduced mean conflict effect from 96 to 53 milliseconds (P =.039). A significant group x trial interaction was evident for WB lateral average asymmetry (P =.004), which was reduced from 24.3% to 12.5% among those with HxSRC. Conclusions: Suboptimal perceptual-motor performance may represent a subtle long-term effect of concussion that is modifiable through UE training, which appears to improve WB reactive capabilities.	[Wilkerson, Gary B.] Univ Tennessee, Dept Hlth & Human Performance, Chattanooga, TN 37403 USA; [Nabhan, Dustin C.] US Olympic Comm, Sports Med Div, Colorado Springs, CO USA; [Crane, Ryan T.] Emory Orthopaed, Atlanta, GA USA		Wilkerson, GB (corresponding author), Univ Tennessee, Dept Hlth & Human Performance, Chattanooga, TN 37403 USA.	Gary-Wilkerson@utc.edu					Adams RA, 2013, BRAIN STRUCT FUNCT, V218, P611, DOI 10.1007/s00429-012-0475-5; Bartolomeo P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00110; Beavan A, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02773; Borich MR, 2015, NEUROPSYCHOLOGIA, V79, P246, DOI 10.1016/j.neuropsychologia.2015.07.007; Brett BL, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01345; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Churchill NW, 2021, BRAIN IMAGING BEHAV, V15, P1508, DOI 10.1007/s11682-020-00349-9; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Engeroff T, 2019, PERCEPT MOTOR SKILL, V126, P675, DOI 10.1177/0031512519841755; Erickson KI, 2005, COGNITIVE BRAIN RES, V22, P349, DOI 10.1016/j.cogbrainres.2004.09.004; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Filley CM, 2016, J NEUROPHYSIOL, V116, P2093, DOI 10.1152/jn.00221.2016; Hadlow SM, 2018, J SCI MED SPORT, V21, P950, DOI 10.1016/j.jsams.2018.01.011; Harada GK, 2019, AM J SPORT MED, V47, P3256, DOI 10.1177/0363546519872502; Hunzinger Katherine J, 2020, J Clin Transl Res, V5, P178; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kropotov JD, 2016, FUNCTIONAL NEUROMARKERS FOR PSYCHIATRY: APPLICATIONS FOR DIAGNOSIS AND TREATMENT, P1; Leone C, 2017, NEUROSCI BIOBEHAV R, V75, P348, DOI 10.1016/j.neubiorev.2017.01.010; McGowan AL, 2019, NEUROPSYCHOLOGIA, V131, P223, DOI 10.1016/j.neuropsychologia.2019.05.026; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Mertler CA., 2016, ADV MULTIVARIATE STA, DOI [10.4324/9781315266978, DOI 10.4324/9781315266978]; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Parr T, 2017, NEUROPSYCHOLOGIA, V104, P92, DOI 10.1016/j.neuropsychologia.2017.08.003; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Scheurer SA, 2020, EXP BRAIN RES, V238, P283, DOI 10.1007/s00221-019-05713-w; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Selen LPJ, 2012, J NEUROSCI, V32, P2276, DOI 10.1523/JNEUROSCI.5273-11.2012; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Svoboda K, 2018, CURR OPIN NEUROBIOL, V49, P33, DOI 10.1016/j.conb.2017.10.023; van Andel S, 2017, HUM MOVEMENT SCI, V51, P59, DOI 10.1016/j.humov.2016.11.004; Wilkerson GB, 2020, J ATHL TRAINING, V55, P594, DOI 10.4085/1062-6050-0401.19; Wilkerson GB, 2018, MED SCI SPORT EXER, V50, P1750, DOI 10.1249/MSS.0000000000001647; Wilkerson GB, 2017, J SPORT REHABIL, V26, P26, DOI 10.1123/jsr.2015-0068; Wong AL, 2015, NEUROSCIENTIST, V21, P385, DOI 10.1177/1073858414541484; Wu T, 2013, NEUROIMAGE, V65, P466, DOI 10.1016/j.neuroimage.2012.10.004; Wylie SA, 2007, NEUROPSYCHOLOGIA, V45, P1408, DOI 10.1016/j.neuropsychologia.2006.11.003	38	3	3	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	AUG	2021	30	6					844	849		10.1123/jsr.2020-0337			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	TM8VK	WOS:000675824200002	33418536				2022-02-06	
J	Yang, WC; Cao, HL; Wang, YZ; Li, TT; Hu, HY; Wan, Q; Li, WZ				Yang, Wan-Chao; Cao, Hong-Ling; Wang, Yue-Zhen; Li, Ting-Ting; Hu, Hong-Yu; Wan, Qiang; Li, Wen-Zhi			Inhibition of nitric oxide synthase aggravates brain injury in diabetic rats with traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						apoptosis; blood-brain barrier; brain edema; diabetes mellitus; inflammation; injury; neurological function; nitric oxide synthase; traumatic brain injury	STRESS; CELLS	Studies have shown that hyperglycemia aggravates brain damage by affecting vascular endothelial function. However, the precise mechanism remains unclear. Male Sprague-Dawley rat models of diabetes were established by a high-fat diet combined with an intraperitoneal injection of streptozotocin. Rat models of traumatic brain injury were established using the fluid percussion method. Compared with traumatic brain injury rats without diabetic, diabetic rats with traumatic brain injury exhibited more severe brain injury, manifested as increased brain water content and blood-brain barrier permeability, the upregulation of heme oxygenase-1, myeloperoxidase, and Bax, the downregulation of occludin, zona-occludens 1, and Bcl-2 in the penumbra, and reduced modified neurological severity scores. The intraperitoneal injection of a nitric oxide synthase inhibitor N(5)-(1-iminoethyl)-L-ornithine (10 mg/kg) 15 minutes before brain injury aggravated the injury. These findings suggested that nitric oxide synthase plays an important role in the maintenance of cerebral microcirculation, including anti-inflammatory, anti-oxidative stress, and anti-apoptotic activities in diabetic rats with traumatic brain injury. The experimental protocols were approved by the Institutional Animal Care Committee of Harbin Medical University, China (approval No. ky2017-126) on March 6, 2017.	[Yang, Wan-Chao; Wang, Yue-Zhen; Li, Ting-Ting; Hu, Hong-Yu; Wan, Qiang; Li, Wen-Zhi] Harbin Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Harbin, Heilongjiang, Peoples R China; [Cao, Hong-Ling] Jilin Prov Tumor Hosp, Dept Anesthesiol, Changchun, Jilin, Peoples R China		Li, WZ (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Harbin, Heilongjiang, Peoples R China.	Wenzhili9@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400989]	This study was supported by the National Natural Science Foundation of China, No. 81400989 (to WCY). The funder had no roles in the study design, conduction of experiment, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-El-Hassan H, 2017, MED HYPOTHESES, V108, P69, DOI 10.1016/j.mehy.2017.08.008; Alvis-Miranda Hernando Raphael, 2014, Bull Emerg Trauma, V2, P65; Bharucha AE, 2010, CLIN PHARMACOL THER, V87, P187, DOI 10.1038/clpt.2009.221; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Brizuela M, 2017, J NEUROTRAUM, V34, P2504, DOI 10.1089/neu.2017.4977; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen LK, 2014, J BIOMED NANOTECHNOL, V10, P3219, DOI 10.1166/jbn.2014.2018; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; De Cilla S, 2017, CELL PHYSIOL BIOCHEM, V42, P1725, DOI 10.1159/000479441; Demir D, 2019, INJURY, V50, P1586, DOI 10.1016/j.injury.2019.08.036; Desposito D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09721-0; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Govindaraj J, 2015, MOL CELL BIOCHEM, V404, P143, DOI 10.1007/s11010-015-2374-6; Greco R, 2018, J NEUROSCI RES, V96, P151, DOI 10.1002/jnr.24101; Greco R, 2017, EUR J PHARMACOL, V800, P16, DOI 10.1016/j.ejphar.2017.02.008	17	3	3	3	29	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	AUG	2021	16	8					1574	1581		10.4103/1673-5374.303035			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	PU9MM	WOS:000609622400029	33433486	Green Published			2022-02-06	
J	Connolly, LJ; Rajaratnam, SMW; Murray, JM; Spitz, G; Lockley, SW; Ponsford, JL				Connolly, Laura J.; Rajaratnam, Shantha M. W.; Murray, Jade M.; Spitz, Gershon; Lockley, Steven W.; Ponsford, Jennie L.			Home-based light therapy for fatigue following acquired brain injury: a pilot randomized controlled trial	BMC NEUROLOGY			English	Article						Traumatic brain injury; Stroke; Light therapy; Fatigue; Sleepiness; Sleep disturbance	EXCESSIVE DAYTIME SLEEPINESS; INSOMNIA; QUALITY; SEVERITY; STROKE; PERFORMANCE; DISORDERS; MODAFINIL; ALERTNESS; EXPOSURE	Background and objectivesFatigue and sleep disturbance are debilitating problems following brain injury and there are no established treatments. Building on demonstrated efficacy of blue light delivered via a lightbox in reducing fatigue and daytime sleepiness after TBI, this study evaluated the efficacy of a novel in-home light intervention in alleviating fatigue, sleep disturbance, daytime sleepiness and depressive symptoms, and in improving psychomotor vigilance and participation in daily productive activity, following injuryMethodsThe impact of exposure to a dynamic light intervention (Treatment) was compared to usual lighting (Control) in a randomized within-subject, crossover trial. Outcomes were fatigue (primary outcome), daytime sleepiness, sleep disturbance, insomnia symptoms, psychomotor vigilance, mood and activity levels. Participants (N=24, MSDage=44.311.4) had mild-severe TBI or stroke3 months previously, and self-reported fatigue (Fatigue Severity Scale >= 4). Following 2-week baseline, participants completed each condition for 2 months in counter-balanced order, with 1-month follow-up. Treatment comprised daytime blue-enriched white light (CCT>5000 K) and blue-depleted light (<3000 K) 3 h prior to sleep.ResultsRandom-effects mixed-model analysis showed no significantly greater change in fatigue on the Brief Fatigue Inventory during Treatment, but a medium effect size of improvement (p=.33, d=-0.42). There were significantly greater decreases in sleep disturbance (p=.004), insomnia symptoms (p=.036), reaction time (p=.004) and improvements in productive activity (p=.005) at end of Treatment relative to Control, with large effect sizes (d>0.80). Changes in other outcomes were non-significant.Conclusions This pilot study provides preliminary support for in-home dynamic light therapy to address sleep-related symptoms in acquired brain injury.Trial registration This trial was registered with the Australian and New Zealand Clinical Trials Registry on 13 June 2017, www.anzctr.org.au, ACTRN12617000866303.	[Connolly, Laura J.; Spitz, Gershon; Ponsford, Jennie L.] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Connolly, Laura J.; Rajaratnam, Shantha M. W.; Murray, Jade M.; Spitz, Gershon; Lockley, Steven W.; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Rajaratnam, Shantha M. W.; Lockley, Steven W.] Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Rajaratnam, Shantha M. W.; Lockley, Steven W.] Brigham & Womens Hosp, Dept Neurol, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Rajaratnam, Shantha M. W.; Lockley, Steven W.] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA		Connolly, LJ (corresponding author), Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia.	laura.connolly@monash.edu	Spitz, Gershon/H-7755-2014	Spitz, Gershon/0000-0002-7810-1480; Rajaratnam, Shantha/0000-0001-7527-8558	Summer Foundation; Epworth HealthCare Seeding Research Grant; National Health and Research Council Early Career Fellowship [APP1104692]; CogSleep Centre for Research Excellence postdoctoral fellowship	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This work was supported by funding from The Summer Foundation ($5,000 award); Epworth HealthCare Seeding Research Grant ($10,000), both utilized for costs associated with installation of the study lighting; and a National Health and Research Council Early Career Fellowship [APP1104692 to GS]. Dr. Murray is supported by a CogSleep Centre for Research Excellence postdoctoral fellowship.	Anderson JL, 2009, ACTA PSYCHIAT SCAND, V120, P203, DOI 10.1111/j.1600-0447.2009.01345.x; Bajaj S., 2019, SLEEP, V42, pA378, DOI [10.1093/sleep/zsz067.120, DOI 10.1093/SLEEP/ZSZ067.120]; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cain SW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75622-4; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Chellappa SL, 2013, J SLEEP RES, V22, P573, DOI 10.1111/jsr.12050; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Cohen J, 1998, STAT POWER ANAL BEHA; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Duncan F, 2012, J PSYCHOSOM RES, V73, P18, DOI 10.1016/j.jpsychores.2012.04.001; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Gimenez MC, 2017, J SLEEP RES, V26, P236, DOI 10.1111/jsr.12470; Glickman G, 2006, BIOL PSYCHIAT, V59, P502, DOI 10.1016/j.biopsych.2005.07.006; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; International Commission on Illumination (CIE), 2018, S026E2018 CIE S026E2018 CIE; Jeste N, 2013, QUAL LIFE RES, V22, P1239, DOI 10.1007/s11136-012-0243-2; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Katzan IL, 2020, J CLIN SLEEP MED, V16, P1863, DOI 10.5664/jcsm.8700; Keis O, 2014, TRENDS NEUROSCI EDUC, V3, P86, DOI 10.1016/j.tine.2014.09.001; Killgore WDS, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104679; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Leppavuori A, 2002, CEREBROVASC DIS, V14, P90, DOI 10.1159/000064737; Liu LQ, 2005, SUPPORT CARE CANCER, V13, P1010, DOI 10.1007/s00520-005-0824-5; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Phillips AJK, 2019, P NATL ACAD SCI USA, V116, P12019, DOI 10.1073/pnas.1901824116; Pittman M, 2013, EUR RESPIR J, V42; Ponchel A, 2015, STROKE RES TREAT, V2015, DOI 10.1155/2015/347920; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Rahman SA, 2017, PHYSIOL BEHAV, V177, P221, DOI 10.1016/j.physbeh.2017.05.002; Rahman SA, 2014, SLEEP, V37, P271, DOI 10.5665/sleep.3396; Raikes AC, 2020, J HEAD TRAUMA REHAB, V35, pE405, DOI 10.1097/HTR.0000000000000579; RStudio Team, 2020, RSTUDIO INT DEV ENV; Salva MAQ, 2020, J HEAD TRAUMA REHAB, V35, pE78, DOI 10.1097/HTR.0000000000000500; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Sletten TL, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002587; Souman JL, 2018, BEHAV BRAIN RES, V337, P228, DOI 10.1016/j.bbr.2017.09.016; Srisurapanont K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246172; Terzoudi A, 2009, EUR NEUROL, V61, P16, DOI 10.1159/000165344; Videnovic A, 2017, JAMA NEUROL, V74, P411, DOI 10.1001/jamaneurol.2016.5192; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; West A, 2019, NEUROREHABILITATION, V45, P187, DOI 10.3233/NRE-192752; Yuda E, 2017, J PHYSIOL ANTHROPOL, V36, DOI 10.1186/s40101-017-0126-x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	61	3	3	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JUL 5	2021	21	1							262	10.1186/s12883-021-02292-8			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TI0JC	WOS:000672466400002	34225698	Green Published, gold			2022-02-06	
J	Guehl, NJ; Ramos-Torres, KM; Linnman, C; Moon, SH; Dhaynaut, M; Wilks, MQ; Han, PK; Ma, C; Neelamegam, R; Zhou, YP; Popko, B; Correia, JA; Reich, DS; El Fakhri, G; Herscovitch, P; Normandin, MD; Brugarolas, P				Guehl, Nicolas J.; Ramos-Torres, Karla M.; Linnman, Clas; Moon, Sung-Hyun; Dhaynaut, Maeva; Wilks, Moses Q.; Han, Paul K.; Ma, Chao; Neelamegam, Ramesh; Zhou, Yu-Peng; Popko, Brian; Correia, John A.; Reich, Daniel S.; El Fakhri, Georges; Herscovitch, Peter; Normandin, Marc D.; Brugarolas, Pedro			Evaluation of the potassium channel tracer [F-18]3F4AP in rhesus macaques	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Demyelination; PET imaging; pharmacokinetics; traumatic brain injury	MULTIPLE-SCLEROSIS; SPINAL-CORD; PET RADIOLIGAND; WHITE-MATTER; 4-AMINOPYRIDINE; BRAIN; DEMYELINATION; MRI; NOMENCLATURE; MYELINATION	Demyelination causes slowed or failed neuronal conduction and is a driver of disability in multiple sclerosis and other neurological diseases. Currently, the gold standard for imaging demyelination is MRI, but despite its high spatial resolution and sensitivity to demyelinated lesions, it remains challenging to obtain specific and quantitative measures of molecular changes involved in demyelination. To understand the contribution of demyelination in different diseases and to assess the efficacy of myelin-repair therapies, it is critical to develop new in vivo imaging tools sensitive to changes induced by demyelination. Upon demyelination, axonal K+ channels, normally located underneath the myelin sheath, become exposed and increase in expression, causing impaired conduction. Here, we investigate the properties of the K+ channel PET tracer [F-18]3F4AP in primates and its sensitivity to a focal brain injury that occurred three years prior to imaging. [F-18]3F4AP exhibited favorable properties for brain imaging including high brain penetration, high metabolic stability, high plasma availability, high reproducibility, high specificity, and fast kinetics. [F-18]3F4AP showed preferential binding in areas of low myelin content as well as in the previously injured area. Sensitivity of [F-18]3F4AP for the focal brain injury was higher than [F-18]FDG, [C-11]PiB, and [C-11]PBR28, and compared favorably to currently used MRI methods.	[Guehl, Nicolas J.; Ramos-Torres, Karla M.; Moon, Sung-Hyun; Dhaynaut, Maeva; Wilks, Moses Q.; Han, Paul K.; Ma, Chao; Neelamegam, Ramesh; Zhou, Yu-Peng; Correia, John A.; El Fakhri, Georges; Normandin, Marc D.; Brugarolas, Pedro] Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Dept Radiol, Boston, MA 02114 USA; [Guehl, Nicolas J.; Ramos-Torres, Karla M.; Moon, Sung-Hyun; Dhaynaut, Maeva; Wilks, Moses Q.; Han, Paul K.; Ma, Chao; Neelamegam, Ramesh; Zhou, Yu-Peng; Correia, John A.; El Fakhri, Georges; Normandin, Marc D.; Brugarolas, Pedro] Harvard Med Sch, Boston, MA 02115 USA; [Linnman, Clas] Spaulding Rehabil Hosp, Spaulding Neuroimag Ng Lab, Charlestown, MA USA; [Linnman, Clas] Harvard Med Sch, Charlestown, MA USA; [Popko, Brian] Northwestern Feinberg Sch Med, Dept Neurol, Chicago, IL USA; [Reich, Daniel S.] NINDS, Translat Neuroradiol Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Herscovitch, Peter] NIH, Positron Emiss Tomog Dept, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA		Brugarolas, P (corresponding author), 55 Fruit St,Bulfinch 051, Boston, MA 02114 USA.; Normandin, MD (corresponding author), 55 Fruit St,White 427, Boston, MA 02114 USA.	normandin@mgh.harvard.edu; pbrugarolas@mgh.harvard.edu	Reich, Daniel S./E-5701-2010; Normandin, Marc/C-6728-2015	Reich, Daniel S./0000-0002-2628-4334; Normandin, Marc/0000-0003-1645-523X	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB022544, T32 EB013180, R00 EB020075] Funding Source: Medline; NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10 OD018035] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS114066, R21 NS120139] Funding Source: Medline		Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armstrong CM, 2001, BIOPHYS J, V81, P895, DOI 10.1016/S0006-3495(01)75749-9; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Arroyo EJ, 2004, J COMP NEUROL, V479, P424, DOI 10.1002/cne.20321; Bagchi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087736; Bakshi R, 2008, LANCET NEUROL, V7, P615, DOI 10.1016/S1474-4422(08)70137-6; Basuli F, 2018, J LABELLED COMPD RAD, V61, P112, DOI 10.1002/jlcr.3560; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Bodini Benedetta, 2016, Brain Plast, V2, P93, DOI 10.3233/BPL-160042; Brugarolas P, 2016, CHEM COMMUN, V52, P7150, DOI 10.1039/c6cc02362b; Brugarolas P, 2018, MOL IMAGING, V17, DOI 10.1177/1536012118785471; Brugarolas P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18747-3; Brugarolas P, 2017, JOVE-J VIS EXP, DOI 10.3791/55537; Carvalho RHF, 2019, MULT SCLER RELAT DIS, V35, P108, DOI 10.1016/j.msard.2019.07.020; Collier T., 2013, SOC NUCL MED ANN MEE, V54, P1133; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; Etxeberria A, 2016, J NEUROSCI, V36, P6937, DOI 10.1523/JNEUROSCI.0908-16.2016; Fehlings MG, 1996, BRAIN RES, V736, P135, DOI 10.1016/S0006-8993(96)00667-1; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Filippi M, 2011, RADIOLOGY, V259, P659, DOI 10.1148/radiol.11101362; Fox RJ, 2011, NEUROL CLIN, V29, P357, DOI 10.1016/j.ncl.2010.12.011; Franklin RJM, 2014, GLIA, V62, P1905, DOI 10.1002/glia.22622; Fujita M, 2008, NEUROIMAGE, V40, P43, DOI 10.1016/j.neuroimage.2007.11.011; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; GROSSMAN RI, 1994, RADIOGRAPHICS, V14, P279, DOI 10.1148/radiographics.14.2.8190954; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; HAYES KC, 1993, PARAPLEGIA, V31, P216, DOI 10.1038/sc.1993.40; Heath F, 2018, DEV NEUROBIOL, V78, P136, DOI 10.1002/dneu.22552; Hilton J, 2000, NUCL MED BIOL, V27, P627, DOI 10.1016/S0969-8051(00)00125-6; Ichise M, 2002, J CEREBR BLOOD F MET, V22, P1271, DOI 10.1097/01.WCB.0000038000.34930.4E; Ihara M, 2010, ACTA NEUROPATHOL, V119, P579, DOI 10.1007/s00401-009-0635-8; Imaizumi M, 2008, NEUROIMAGE, V39, P1289, DOI 10.1016/j.neuroimage.2007.09.063; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jukkola PI, 2012, NEUROBIOL DIS, V47, P280, DOI 10.1016/j.nbd.2012.04.012; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; MIHALY A, 1985, ACTA NEUROPATHOL, V66, P145, DOI 10.1007/BF00688690; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; NOSEWORTHY JH, 1984, NEUROL CLIN, V2, P759, DOI 10.1016/S0733-8619(18)31073-9; PATY DW, 1993, CURR OPIN NEUROL NEU, V6, P202; Pike VW, 2009, TRENDS PHARMACOL SCI, V30, P431, DOI 10.1016/j.tips.2009.05.005; Quinn B, 2016, BMC MED IMAGING, V16, DOI 10.1186/s12880-016-0143-y; Rasband M, 1998, J NEUROSCI, V18, P36; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Richards M, 2012, REPRODUCTIVE DONATION: PRACTICE, POLICY AND BIOETHICS, P1; Rodriguez-Rangel S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56245-w; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Sai KKS, 2015, SCI PHARM, V83, P413, DOI 10.3797/scipharm.1505-06; SCHAFER EW, 1973, TOXICOL APPL PHARM, V26, P532, DOI 10.1016/0041-008X(73)90291-3; Seidlitz J, 2018, NEUROIMAGE, V170, P121, DOI 10.1016/j.neuroimage.2017.04.063; SHERRATT RM, 1980, NATURE, V283, P570, DOI 10.1038/283570a0; Simpson DM, 2015, J REHABIL MED, V47, P924, DOI 10.2340/16501977-2033; Sinha K, 2006, J NEUROPHYSIOL, V95, P1683, DOI 10.1152/jn.00899.2005; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Stankoff B, 2011, ANN NEUROL, V69, P673, DOI 10.1002/ana.22320; STEFOSKI D, 1987, ANN NEUROL, V21, P71, DOI 10.1002/ana.410210113; Tillema JM, 2013, THER ADV NEUROL DISO, V6, P249, DOI 10.1177/1756285613478870; TRANCHANT C, 1995, MOVEMENT DISORD, V10, P418, DOI 10.1002/mds.870100403; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; WAXMAN SG, 1989, J NEUROL SCI, V91, P1, DOI 10.1016/0022-510X(89)90072-5; Wilson AA, 2004, J LABELLED COMPD RAD, V47, P679, DOI 10.1002/jlcr.854; Wu CY, 2010, BIOORGAN MED CHEM, V18, P8592, DOI 10.1016/j.bmc.2010.10.018	65	3	3	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUL	2021	41	7					1721	1733		10.1177/0271678X20963404			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	SW0NI	WOS:000664214100019	33090071	Green Submitted, Green Published			2022-02-06	
J	Islam, MBAR; Davis, BT; Kando, MJ; Mao, QW; Procissi, D; Weiss, C; Schwulst, SJ				Islam, Mecca B. A. R.; Davis IV, Booker T.; Kando, Mary J.; Mao, Qinwen; Procissi, Daniele; Weiss, Craig; Schwulst, Steven J.			Differential neuropathology and functional outcome after equivalent traumatic brain injury in aged versus young adult mice	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Age; Neurodegeneration; Behavior; Fear; Trauma; Controlled cortical impact	OLDER-ADULTS; UNITED-STATES; SHORT-TERM; EPIDEMIOLOGY; IMPACT; MODEL	The CDC estimate that nearly 3 million Americans sustain a traumatic brain injury (TBI) each year. Even when medical comorbidities are accounted for, age is an independent risk factor for poor outcome after TBI. Nonetheless, few studies have examined the pathophysiology of age-linked biologic outcomes in TBI. We hypothesized that aged mice would demonstrate more severe neuropathology and greater functional deficits as compared to young adult mice after equivalent traumatic brain injuries. Young adult (14-week-old) and aged (80-week-old) C57BL/6 male mice underwent an open-head controlled cortical impact to induce TBI or a sham injury. At 30days post-injury groups underwent behavioral phenotyping, magnetic resonance imaging, and histologic analyses. Contrary to our hypothesis, young adult TBI mice exhibited more severe neuropathology and greater loss of white matter connectivity as compared to aged mice after TBI. These findings correlated to differential functional outcomes in anxiety response, learning, and memory between young adult and aged mice after TBI. Although the mechanisms underlying this age-effect remain unclear, attenuated signs of secondary brain injury in aged TBI mice point towards different inflammatory and repair processes between age groups. These data suggest that age may need to be an a priori consideration in future clinical trial design.	[Islam, Mecca B. A. R.; Davis IV, Booker T.; Schwulst, Steven J.] Northwestern Univ, Div Trauma & Crit Care, Dept Surg, Chicago, IL 60611 USA; [Kando, Mary J.; Weiss, Craig] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Mao, Qinwen] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Mao, Qinwen] Northwestern Univ, Feinberg Sch Med, Mesulam Ctr Cognit Neurol & Alzheimers Dis, Chicago, IL 60611 USA; [Procissi, Daniele] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Procissi, Daniele] Northwestern Univ, Feinberg Sch Med, Ctr Translat Pain Res, Chicago, IL 60611 USA		Davis, BT (corresponding author), Northwestern Univ, Div Trauma & Crit Care, Dept Surg, Chicago, IL 60611 USA.	booker.iv@northwestern.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01GM13066, 3R01 GM130662-01S1]	This work was supported by the National Institutes of Health 1R01GM13066 and 3R01 GM130662-01S1.	Agliozzo S, 2012, MED PHYS, V39, P1704, DOI 10.1118/1.3691178; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Centers for Disease Control and Prevention, 2016, RAT TBI REL DEATHS A; Corder KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200809; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Crawley J.N., 2009, METHODS BEHAV ANAL N, V2nd; Faul M, 2010, TRAUMATIC BRAIN INJU; Fraser EE, 2019, J NEUROTRAUM, V36, P2753, DOI 10.1089/neu.2019.6430; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Iboaya A, 2019, NEUROREHAB NEURAL RE, V33, P975, DOI 10.1177/1545968319883879; Johnson FK, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0092-z; Makinde HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202722; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; Mao QW, 2019, J NEUROPATH EXP NEUR, V78, P844, DOI 10.1093/jnen/nlz059; Mao QW, 2017, J NEUROPATH EXP NEUR, V76, P957, DOI 10.1093/jnen/nlx085; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Oh MM, 2003, J NEUROPHYSIOL, V90, P2171, DOI 10.1152/jn.01177.2002; Oliveira Carla Oliveira de, 2008, Rev Bras Ter Intensiva, V20, P411; Ott BR, 2010, J ALZHEIMERS DIS, V20, P647, DOI 10.3233/JAD-2010-1406; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pergola G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00162; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Popovitz J, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00006; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schwulst SJ, 2019, JOVE-J VIS EXP, DOI 10.3791/60027; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Shipton OA, 2014, P NATL ACAD SCI USA, V111, P15238, DOI 10.1073/pnas.1405648111; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Sobel R.A, 2015, GREENFIELDS NEUROPAT, Vninth; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Sun M, 2020, NEUROSCI BIOBEHAV R, V109, P114, DOI 10.1016/j.neubiorev.2019.12.027; Sun MJ, 2019, BRAIN BEHAV IMMUN, V80, P536, DOI 10.1016/j.bbi.2019.04.038; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Wang D.V., 2011, PLOS ONE, V6; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Weiss C, 2020, SHOCK, V53, P744, DOI 10.1097/SHK.0000000000001424; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0	52	3	3	2	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2021	341								113714	10.1016/j.expneurol.2021.113714			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SU9BV	WOS:000663426000004	33831399				2022-02-06	
J	Kredel, M; Reinhold, AK; Wirbelauer, J; Muellges, W; Kunze, E; Rehn, M; Wockel, A; Lassmann, M; Markus, CK; Meybohm, P; Kranke, P				Kredel, Markus; Reinhold, Ann-Kristin; Wirbelauer, Johannes; Muellges, Wolfgang; Kunze, Ekkehard; Rehn, Monika; Wockel, Achim; Lassmann, Michael; Markus, Christian K.; Meybohm, Patrick; Kranke, Peter			Pregnancy and Irreversible Loss of Brain Functions - Case Report	ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE			German	Article						pregnant women; brain death; intensive care; organ donation; parturition	UTERINE BLOOD-FLOW; SOMATIC SUPPORT; MANAGEMENT; WOMAN; RESUSCITATION; HYPERTENSION; ALBUMIN; DEATH; WOMEN; FETAL	Zusammenfassung Eine 29-jahrige Frau erlitt durch einen Verkehrsunfall ein schweres Schadel-Hirn-Trauma mit im Verlauf infauster zerebraler Prognose. Es stellte sich heraus, dass die Patientin in der 9. Woche schwanger war. Nach Diagnose eines irreversiblen Hirnfunktionsausfalls in der 10. Schwangerschaftswoche (SSW) wurde die Patientin fur insgesamt 5 Monate intensivmedizinisch weiterbehandelt bis zur assistierten vaginalen Entbindung eines gesunden Kindes auf der Intensivstation in der 31.SSW. Im Anschluss erfolgte, gema ss dem mutma ss lichen Willen der Patientin, eine Multiorganentnahme bei der Mutter. Der Artikel stellt die Details der intensivmedizinischen Therapie dar und diskutiert die notwendigen medizinischen Ma ss nahmen. Diese Ma ss nahmen dienten in erster Linie der Erhaltung der Schwangerschaft und Forderung einer gesunden Entwicklung mit dem Ziel der Entbindung des Fetus, erst in zweiter Linie der organerhaltenden Therapie mit dem Ziel der Organspende. Notwendig waren Ma ss nahmen zur Erhaltung der Vitalfunktionen, Elektrolythomoostase, Ernahrung, Behandlung von Infektionen, Vermeidung fruchtschadigender Einflusse, Substitution von Hormonen und Vitaminen und die Vorbereitung einer geplanten oder ungeplanten Entbindung. Die Aufrechterhaltung der Intensivtherapie bei einer schwangeren Patientin mit einer schweren Hirnschadigung, bei der schlie ss lich ein irreversibler Hirnfunktionsausfall diagnostiziert wird, ist eine intensivmedizinische und multidisziplinare Herausforderung. Dieser Fallbericht schildert die Intensivtherapie uber 5 Monate bis zur Entbindung und Organspende. Abstract A 29-year-old woman suffered major traumatic brain injury caused by a car accident. As diagnostic measures had revealed an early pregnancy (9th week), treatment on the intensive care unit was continued for 5 months, after unfavourable cerebral prognosis was followed by an irreversible loss of brain function in the 10th week of pregnancy. After assisted vaginal delivery of a healthy child in the 31th week of pregnancy on the critical care unit, organ procurement took place according to the presumed will of the patient. The article presents the details of the critical care therapy and discusses the supportive medical measures. Those measures served primarily to uphold the pregnancy und support the healthy development and delivery of the fetus and only in second instance the organ preservation aiming on organ donation. Necessary measures included maintenance of vital functions, hemostasis of electrolytes, nutrition, treatment of infection, prevention of adverse effects on the fetus, substitution of hormones and vitamins as well as the preparation of a planned or an unplanned delivery.	[Kredel, Markus] Univ Wurzburg, Klin & Poliklin Anasthesiol, Intensivmed & Schmerz Thrapie, Notarztin, Germany; [Reinhold, Ann-Kristin] Univ Klinikum Wurzburg, Klin & Poliklin Anasthesiol, Notfallmed & Schmerztherapie, Facharztin Anasthesiol, Notarztin, Germany; [Wirbelauer, Johannes] Univ Klinikum Wurzburg, Kinderklin & Poliklin, Wurzburg, Germany; [Muellges, Wolfgang] Univ Klinikum Wurzburg, Oberarzt Neurol Klin, Med & Fac Weiterbildung Neurol, Wurzburg, Germany; [Muellges, Wolfgang] Rhein Westfal TH Aachen, Psychiat Krankenhaus Gangelt, Wurzburg, Germany; [Kunze, Ekkehard] Univ Klinikums Wurzburg, Neurosurg Clin & Polyclin, Wurzburg, Germany; [Rehn, Monika] Univ Klinikums Wurzburg, Jugendgynakol Frauenklin & Poliklin, Youth Gynecol Cin & polyclin, Wurzburg, Germany; [Wockel, Achim] Univ Klinikum Wurzburg, Frauenklin, Wurzburg, Germany; [Lassmann, Michael] Univ Wurzburg, Klin & Poliklin Nukl Med, Wurzburg, Germany; [Markus, Christian K.] Univ Klinkums Wurzburg, Notfallmed & Schmerztherapie, Oberarzt Klin & Poliklinik Anasthesiol, Intens Med Notfallmed,Fac Anasthesiol,AQM, Wurzburg, Germany; [Meybohm, Patrick] Univ Klinikum Wurzburg, Klin & Poliklin Anasthesiol Intens Med Not, Wurzburg, Germany; [Kranke, Peter] Univ Klinikum Wurzburg, Notfallmed & Schmerztherapie, Poliklinik Anasthesiol Intensivmed, Oberarzt & Leiter klin Forsch Klin, Wurzburg, Germany		Kranke, P (corresponding author), Univ Klinikum Wurzburg, Notfallmed & Schmerztherapie, Klin & Poliklin Anasthesiol Intens Med, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany.	kranke_p@ukw.de					AKERLUND M, 1994, ANN NY ACAD SCI, V734, P47, DOI 10.1111/j.1749-6632.1994.tb21735.x; Akhyari P, 2019, J HEART LUNG TRANSPL, V38, P1121, DOI 10.1016/j.healun.2019.06.011; ANSTOTZ C, 1993, BIOETHICS, V7, P340, DOI 10.1111/j.1467-8519.1993.tb00224.x; Banhidy F, 2011, HYPERTENS RES, V34, P55, DOI 10.1038/hr.2010.172; Bates SM, 2018, BLOOD ADV, V2, P3317, DOI 10.1182/bloodadvances.2018024802; Bitzani M, 1999, INTENS CARE MED, V25, P970, DOI 10.1007/s001340050991; Brauer M., 2018, ANAESTHESIST, V68, P22; Bugge JF, 2009, ACTA ANAESTH SCAND, V53, P1239, DOI 10.1111/j.1399-6576.2009.02064.x; Burkle CM, 2015, INT J GYNECOL OBSTET, V129, P276, DOI 10.1016/j.ijgo.2014.12.011; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Dimopoulou I, 2003, CRIT CARE MED, V31, P1113, DOI 10.1097/01.CCM.0000059644.54819.67; Durbin CG, 2010, RESP CARE, V55, P1056; Embryotox-Pharmakovigilanz- und Beratungszentrum fur Embryonaltoxikologie der Charite-Universitatsmedizin Berlin, METOCLOPRAMID; Embryotox-Pharmakovigilanz- und Beratungszentrum fur Embryonaltoxikologie der Charite-Universitatsmedizin Berlin, HYDROCHLOROTHIAZID; Esmaeilzadeh M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-74; Executive Committee of the German Medical Association on the Recommendation of the Scientific Advisory Board, 2009, TRANSFUS MED HEMOTH, V36, P362; Executive Committee of the German Medical Association on the Recommendation of the Scientific Advisory Board, 2020, TRANSFUS MED HEMOTH, V43, P223; Gopcevic A, 2017, INT J OBSTET ANESTH, V32, P82, DOI 10.1016/j.ijoa.2017.06.007; GRAMM HJ, 1992, TRANSPLANTATION, V54, P851, DOI 10.1097/00007890-199211000-00016; GREISS FC, 1966, AM J OBSTET GYNECOL, V96, P41, DOI 10.1016/S0002-9378(16)34639-7; Hamaoui E, 2003, GASTROENTEROL CLIN N, V32, P59, DOI 10.1016/S0889-8553(02)00132-2; HAUKSSON A, 1988, BRIT J OBSTET GYNAEC, V95, P898, DOI 10.1111/j.1471-0528.1988.tb06577.x; Holliday S, 2017, HEART LUNG, V46, P397, DOI 10.1016/j.hrtlng.2017.05.008; Hosokawa K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1138-8; Jung J, 2019, ANN NY ACAD SCI, V1450, P69, DOI 10.1111/nyas.14112; Kiefer RT, 2003, ANAESTHESIST, V52, P1073, DOI 10.1007/s00101-003-0596-6; Kinoshita Y., 2014, ACUTE MED SURG, V2, P211; Lang C, 2002, ANAESTHESIST, V51, P409, DOI 10.1007/s00101-002-0293-x; Magee LA, 2015, NEW ENGL J MED, V372, P407, DOI 10.1056/NEJMoa1404595; McAuliffe F, 2001, BRIT J OBSTET GYNAEC, V108, P980, DOI 10.1111/j.1471-0528.2001.00225.x; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Novitzky D, 2016, CLIN TRANSPLANT, V30, P754, DOI 10.1111/ctr.12742; Pavord S, 2020, BRIT J HAEMATOL, V188, P819, DOI 10.1111/bjh.16221; Pikto-Pietkiewicz I, 2019, J CRIT CARE MED, V5, P111, DOI 10.2478/jccm-2019-0015; Powner DJ, 2003, CRIT CARE MED, V31, P1241, DOI 10.1097/01.CCM.0000059643.45027.96; Prodromakis E, 2004, ACTA OBSTET GYN SCAN, V83, P159; Reinhold AK, 2019, BMJ CASE REP, V12, DOI 10.1136/bcr-2019-231601; Reinhold AK, 2021, ANASTH INTENSIV NOTF, V56, P536, DOI 10.1055/a-1203-2826; RIGGS KW, 1990, J PHARM SCI, V79, P1056, DOI 10.1002/jps.2600791204; Robba C, 2020, CURR OPIN ANESTHESIO, V33, P146, DOI 10.1097/ACO.0000000000000826; Robinson AM, 2014, NEUROSCIENCE, V256, P53, DOI 10.1016/j.neuroscience.2013.10.012; Rodriguez A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002746; Said Abuhasna, 2013, Int J Crit Illn Inj Sci, V3, P220, DOI 10.4103/2229-5151.119205; Scholtens DM, 2019, DIABETES CARE, V42, P381, DOI 10.2337/dc18-2021; Sifakis S, 2000, ANN NY ACAD SCI, V900, P125, DOI 10.1111/j.1749-6632.2000.tb06223.x; Sim KB, 2001, J KOREAN MED SCI, V16, P669, DOI 10.3346/jkms.2001.16.5.669; Spiropoulos K, 2004, GYNECOL OBSTET INVES, V58, P22, DOI 10.1159/000077349; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Wawrzyniak J, 2015, ANAESTH INTENSIVE TH, V47, P40, DOI 10.5603/AIT.2015.0005; WILLIAMS GR, 1989, LANCET, V2, P1477	50	3	3	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0939-2661	1439-1074		ANASTH INTENSIV NOTF	Anasthesiol. Intensivmed. NotfMed. Schmerzther.	JUL	2021	56	07/08					526	535		10.1055/a-1203-3031			10	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	TN1RH	WOS:000676019500011	34298572				2022-02-06	
J	Reinhold, AK; Markus, CK; Kredel, M; Beckmann, R; Muellges, W; Rehn, M; Wockel, A; Meybohm, P; Roewer, N; Kranke, P				Reinhold, Ann-Kristinq; Markus, Christian K.; Kredel, Markus; Beckmann, Rainer; Muellges, Wolfgang; Rehn, Monika; Wockel, Achim; Meybohm, Patrick; Roewer, Norbert; Kranke, Peter			Ethical, Psychosocial and Legal Aspects of the Treatment of Pregnant Patients with Brain Death	ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE			German	Article						pregnancy; brain death; organ donation; legal care; ethics	WOMAN	Zusammenfassung Die Therapie Schwangerer mit irreversiblem Hirnfunktionsausfall ist ein Extrembeispiel nicht nur fur die Moglichkeiten moderner Intensivmedizin, sondern auch fur die daraus resultierenden ethischen, sozialen und rechtlichen Spannungsfelder, die fur Mediziner kein vertrautes Terrain sind. Im Folgenden wird der Fall einer in der 9.SSW verunfallten Patientin mit infauster Prognose bei massivem Schadel-Hirn-Trauma und anamnestischem Wunsch zur Organspende vorgestellt. Vor diesem Hintergrund werden anhand ausgewahlter Falle aus der Literatur verschiedene Aspekte beleuchtet: die Frage der Therapiezielfestlegung, insbesondere Palliation vs. Fortfuhrung; die Implikationen einer Hirntoddiagnostik; betreuungsrechtliche uberlegungen; Einbindung der Angehorigen, v.a. des Kindsvaters; Dynamiken im Behandlungsteam sowie schlie ss lich die Frage einer moglichen Organspende. Das Fallbeispiel verdeutlicht zudem, dass auch bei denkbar ungunstigen Rahmenbedingungen und dem Zusammenkommen scheinbar unvereinbarer Faktoren eine Schwangerschaft uberraschend unbeeintrachtigt ausgetragen werden kann. Die recherchierten Fakten und Erwagungen sowie die zitierte weiterfuhrende Literatur in diesem Artikel sollen einen uberblick uber potenzielle Dilemmata verschaffen und als fundierter Ausgangspunkt fur ahnlich gelagerte Falle dienen. Die Therapie Schwangerer mit irreversiblem Hirnfunktionsausfall ist ein Extrembeispiel - nicht nur fur die moderne Intensivmedizin, sondern auch fur die daraus resultierenden ethischen, sozialen und rechtlichen Spannungsfelder. Anhand einer in der 9.SSW verunfallten Patientin mit infauster Prognose und Wunsch zur Organspende werden Falle der Literatur unter verschiedenen Aspekten beleuchtet. Abstract The therapy of brain-dead pregnant women is an extreme example not only of the possibilities in current critical care, but also of resulting ethical, social and legal controversies, an area not familiar to most clinicians. Based on the case of a patient with fatal traumatic brain injury, a previously unknown early pregnancy and stated will to donate organs, we will discuss several aspects using published case reports: therapeutic goals, especially palliative care vs. continuation; implications of brain death diagnosis; considerations on legal care; involvement of relatives, especially the childs father; dynamics within the care team; and finally the issue of putative organ donation. This complex case once more depicts that even facing such highly unfavourable framework and seemingly irreconcilable factors, pregnancy can prevail. The researched facts and considerations in this article are intended to give an overview of potential dilemmas and might serve as a starting point in similar situations.	[Reinhold, Ann-Kristinq] Univ Klinikum Wurzburg, Klin & Poliklin Anasthesiol, Fac Anasthesiol, Wurzburg, Germany; [Markus, Christian K.] Univ Klinikum Wurzburg, Oberarzt Klin & Poliklin Anasthesiol, Intens Med Notfallmed, Fac Anasthesiol,AQM, Wurzburg, Germany; [Kredel, Markus] Univ Ulm, Studium Humanmed, Ulm, Germany; [Kredel, Markus] Univ Klinikum Wurzburg, Klin & Poliklin Anasthesiol Intens Med & Schmerzt, Heidelberg, Germany; [Beckmann, Rainer] Jurastudium Wurzburg, Amtsgericht Wurzburg, Wurzburg, Germany; [Beckmann, Rainer] Wurzburg & Gemunden, Richter Amtsgericht, Wurzburg, Germany; [Beckmann, Rainer] Heidelberg Univ, Med Fak Mannheim, Lehrbeauftragter Med, Heidelberg, Germany; [Muellges, Wolfgang] Univ Klinikum Wurzburg, Oberarzt Neurol Klin, Med & Facharztweiterbildung Neurol, Wurzburg, Germany; [Muellges, Wolfgang] Oberarzt & Leiter Neurolog Intens Stat Wurzburg, Wurzburg, Germany; [Wockel, Achim] Univ Klinikum Wurzburg & Koordinator, Interdisziplinare Fruherkennung Diagnost, Therapie & Nachsorge Mammakarzinoms, Wurzburg, Germany; [Meybohm, Patrick] Univ Klinikum Wurzburg, Klin & Poliklin Anasthesiol, Klin & Wissenschaftliche Schwerpunkte, Wurzburg, Germany; [Roewer, Norbert] Univ Klinikum Wurzburg, Klin & Poliklin Anasthesiol, Wurzburg, Germany; [Kranke, Peter] Univ Klinikum Wurzburg, Notfallmed & Schmerztherapie, Klin & Poliklin Anasthesiol Intens Med, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany; [Rehn, Monika] Univ Klinikum Wurzbur, Kinder & Jugendgynakol, Frauenklin & Poliklin, Geburtsmed & Pranataldiagnost, Wurzburg, Germany; [Kranke, Peter] Univ Klinikum Wurzburg, Klin Forsch, Klin & Poliklin Anasthesiol, Wurzburg, Germany		Kranke, P (corresponding author), Univ Klinikum Wurzburg, Notfallmed & Schmerztherapie, Klin & Poliklin Anasthesiol Intens Med, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany.	kranke_p@ukw.de					Akhyari P, 2019, J HEART LUNG TRANSPL, V38, P1121, DOI 10.1016/j.healun.2019.06.011; Amtsgericht Hersbruck, 1992, BETR HIRN SCHWANG FR, P1471; Amtsgericht Wrzburg, 2019, BETREUUNGSRECHTLICHE, V5, P207; [Anonymous], 2015, Obstet Gynecol, V125, P261, DOI 10.1097/01.AOG.0000459869.98866.91; [Anonymous], 1992, LEBEN LEICHE, V43, P320; ANSTOTZ C, 1993, BIOETHICS, V7, P340, DOI 10.1111/j.1467-8519.1993.tb00224.x; Bruck S, 2019, ANAESTHESIST, V68, P461, DOI 10.1007/s00101-019-0613-z; Bundesorztekammer, 2015, DTSCH ARZTEBL, V112, P1; Burkle CM, 2015, INT J GYNECOL OBSTET, V129, P276, DOI 10.1016/j.ijgo.2014.12.011; Cartolovni A, 2019, INT J GYNECOL OBSTET, V146, P149, DOI 10.1002/ijgo.12871; Chappell D, 2019, ANAESTHESIST, V68, P228, DOI 10.1007/s00101-019-0560-8; Deutsche Welle, 2019, HIRNT BRINGT KIND WE; Dyer C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7830; Ecker JL, 2014, NEW ENGL J MED, V370, P889, DOI 10.1056/NEJMp1400969; Esmaeilzadeh M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-74; FIELD DR, 1988, JAMA-J AM MED ASSOC, V260, P816, DOI 10.1001/jama.260.6.816; Hagenmair M., 1992, SCHADEN SEELE, V43, P322; Hansen, 1986, LOS ANGELES TIMES; Heywood R, 2017, MED LAW REV, V25, P628, DOI 10.1093/medlaw/fwx026; Hussein IY, 2006, BJOG-INT J OBSTET GY, V113, P120, DOI 10.1111/j.1471-0528.2005.00801.x; Kinoshita Y, 2015, ACUTE MED SURG, V2, P211, DOI 10.1002/ams2.95; Kredel M, 2021, ANASTH INTENSIV NOTF, V56, P526, DOI 10.1055/a-1203-3031; Lapin, 2017, NEW YORK POST; Nair-Collins M, 2017, J MED ETHICS, V43, P747, DOI 10.1136/medethics-2016-103867; Nowak, 2018, ETHICS BIOETHICS, V8, P167; Oberlandesgericht Frankfurt am Main, 2012, OPENJUR, P30778; Pikto-Pietkiewicz I, 2019, J CRIT CARE MED, V5, P111, DOI 10.2478/jccm-2019-0015; Reinhold AK, 2019, BMJ CASE REP, V12, DOI 10.1136/bcr-2019-231601; SpiegelOnline, WACHK PAT BRINGT KIN; Superior Court of Richmond County GA, 1987, ISSUES LAW MED, V2, P415; Verheijde JL, 2018, J RELIG HEALTH, V57, P1745, DOI 10.1007/s10943-018-0654-7	31	3	3	8	8	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0939-2661	1439-1074		ANASTH INTENSIV NOTF	Anasthesiol. Intensivmed. NotfMed. Schmerzther.	JUL	2021	56	07/08					536	543		10.1055/a-1203-2826			8	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; General & Internal Medicine	TN1RH	WOS:000676019500012	34298573				2022-02-06	
J	Tagini, S; Seyed-Allaei, S; Scarpina, F; Toraldo, A; Mauro, A; Cherubini, P; Reverberi, C				Tagini, Sofia; Seyed-Allaei, Shima; Scarpina, Federica; Toraldo, Alessio; Mauro, Alessandro; Cherubini, Paolo; Reverberi, Carlo			When Fruits Lose to Animals: Disorganized Search of Semantic Memory in Parkinson's Disease	NEUROPSYCHOLOGY			English	Article						Parkinson's disease; semantic fluency task; neuropsychological assessment; executive function; semantic category size	VERBAL FLUENCY PERFORMANCE; FRONTAL ASSESSMENT BATTERY; TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX; WORD FLUENCY; COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTIONS; COMPONENT ANALYSIS; FREE-RECALL; ALZHEIMERS	Objective: The semantic fluency task is widely used in both clinical and research settings to assess both the integrity of the semantic store and the effectiveness of the search through it. Our aim was to investigate whether nondemented Parkinson's disease (PD) patients show an impairment in the strategic exploration of the semantic store and whether the tested semantic category has an impact on multiple measures of performance. Method: We compared 74 nondemented PD patients with 254 healthy subjects in a semantic fluency test using relatively small (fruits) and large (animals) semantic categories. Number of words produced, number of explored semantic subcategories, and degree of order in the produced sequences were computed as dependent variables. Results: PD patients produced fewer words than healthy subjects did, regardless of the category. Number of subcategories was also lower in PD patients than in healthy subjects, without a significant difference between categories. Critically, PD patients' sequences were less semantically organized than were those of controls, but this effect appeared in only the smaller category (fruits), thus pointing to a lack of strategy in exploring the semantic store. Conclusions: Our results show that the semantic fluency deficit in PD patients has a strategic component, even though that may not be the only cause of the impaired performance. Furthermore, our evidence suggests that the semantic category used in the test influences performance, hence providing an explanation for the failure by previous studies, which often used large categories such as animals, to detect strategy deficits in PD.	[Tagini, Sofia; Scarpina, Federica; Mauro, Alessandro] IRCCS, Ist Auxol Italian Osped San Giuseppe, Oggebbio, Italy; [Tagini, Sofia] Univ Trento, CiMeC Ctr Mind Brain Sci, Trento, Italy; [Seyed-Allaei, Shima; Cherubini, Paolo; Reverberi, Carlo] Univ Milano Bicocca, Dept Psychol, Piazza Ateneo Nuovo 1, I-20126 Milan, Italy; [Seyed-Allaei, Shima; Toraldo, Alessio; Cherubini, Paolo; Reverberi, Carlo] NeuroMi Milan Ctr Neurosci, Milan, Italy; [Scarpina, Federica; Mauro, Alessandro] Univ Turin, Rita Levi Montalcini Dept Neurosci, Turin, Italy; [Toraldo, Alessio] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy; [Seyed-Allaei, Shima] Univ Tehran, Coll Engn, Sch Elect & Comp Engn, Cognit Syst Lab, Tehran, Iran		Reverberi, C (corresponding author), Univ Milano Bicocca, Dept Psychol, Piazza Ateneo Nuovo 1, I-20126 Milan, Italy.		Cherubini, Paolo/AAD-5038-2022; Scarpina, Federica/AAB-6335-2019	Scarpina, Federica/0000-0003-4326-1596			Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; Auriacombe S., 1993, NEUROPSYCHOLOGY, V7, P182, DOI [DOI 10.1037/0894-4105.7.2.182, 10.1037/0894-4105.7.2.182]; Azuma T, 1997, NEUROPSYCHOLOGY, V11, P488, DOI 10.1037/0894-4105.11.4.488; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Badre David, 2002, Behav Cogn Neurosci Rev, V1, P206, DOI 10.1177/1534582302001003002; BAYLES KA, 1993, J CLIN EXP NEUROPSYC, V15, P547, DOI 10.1080/01688639308402578; Beatty W W, 1989, J Geriatr Psychiatry Neurol, V2, P145, DOI 10.1177/089198878900200305; Bousfield WA, 1944, J GEN PSYCHOL, V30, P149, DOI 10.1080/00221309.1944.10544467; BROWN RG, 1988, MOVEMENT DISORD, V3, P152, DOI 10.1002/mds.870030207; CALTAGIRONE C, 1989, J NEUROL NEUROSUR PS, V52, P334, DOI 10.1136/jnnp.52.3.334; Capitani E, 1999, CORTEX, V35, P273, DOI 10.1016/S0010-9452(08)70800-1; Capitani E, 2009, NEUROPSYCHOLOGIA, V47, P423, DOI 10.1016/j.neuropsychologia.2008.09.016; Colman KSF, 2009, CORTEX, V45, P930, DOI 10.1016/j.cortex.2008.12.010; COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095; Cralidis A, 2014, BRAIN INJURY, V28, P456, DOI 10.3109/02699052.2014.896945; CUMMINGS JL, 1988, NEUROLOGY, V38, P680, DOI 10.1212/WNL.38.5.680; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Della Sala S, 1998, ARCH CLIN NEUROPSYCH, V13, P663, DOI 10.1016/S0887-6177(97)00093-0; Dieci, 2002, NUOVA RIV NEUROLOGIA, V12, P111; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dujardin K, 2015, PARKINSONISM RELAT D, V21, P1299, DOI 10.1016/j.parkreldis.2015.08.032; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fine EM, 2011, J CLIN EXP NEUROPSYC, V33, P226, DOI 10.1080/13803395.2010.507185; Flowers KA, 1995, J NEUROLINGUIST, V9, P33, DOI 10.1016/0911-6044(95)00004-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067; GRUEN AK, 1990, J COMMUN DISORD, V23, P163, DOI 10.1016/0021-9924(90)90020-Y; GRUENEWALD PJ, 1980, J EXP PSYCHOL-HUM L, V6, P225, DOI 10.1037/0278-7393.6.3.225; HANLEY JR, 1990, NEUROPSYCHOLOGIA, V28, P737, DOI 10.1016/0028-3932(90)90129-C; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Herrera E, 2012, NEUROPSYCHOLOGIA, V50, P3636, DOI 10.1016/j.neuropsychologia.2012.09.016; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Janvin C, 2003, DEMENT GERIATR COGN, V15, P126, DOI 10.1159/000068483; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Kudlicka A, 2011, MOVEMENT DISORD, V26, P2305, DOI 10.1002/mds.23868; Levy G, 2002, MOVEMENT DISORD, V17, P1221, DOI 10.1002/mds.10280; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mimura M, 2006, PARKINSONISM RELAT D, V12, P169, DOI 10.1016/j.parkreldis.2005.12.003; Monaco M, 2013, NEUROL SCI, V34, P749, DOI 10.1007/s10072-012-1130-x; Neely J., 1991, BASIC PROCESSES READ; OWEN AM, 1995, NEUROPSYCHOLOGIA, V33, P1, DOI 10.1016/0028-3932(94)00098-A; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Piatt AL, 1999, J CLIN EXP NEUROPSYC, V21, P435, DOI 10.1076/jcen.21.4.435.885; Price A, 2009, BRAIN COGNITION, V69, P252, DOI 10.1016/j.bandc.2008.07.013; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Reuerberi C, 2014, CORTEX, V54, P150, DOI 10.1016/j.cortex.2014.02.006; Reverberi C, 2006, NEUROPSYCHOLOGIA, V44, P469, DOI 10.1016/j.neuropsychologia.2005.05.011; Robbins TW, 2014, MOVEMENT DISORD, V29, P597, DOI 10.1002/mds.25853; Robinson G, 2012, BRAIN, V135, P2202, DOI 10.1093/brain/aws142; ROGERS D, 1987, BRAIN, V110, P761, DOI 10.1093/brain/110.3.761; Rosen VM, 1997, J EXP PSYCHOL GEN, V126, P211, DOI 10.1037/0096-3445.126.3.211; Sawamoto N, 2002, J NEUROSCI, V22, P5198, DOI 10.1523/JNEUROSCI.22-12-05198.2002; Schuck NW, 2015, NEURON, V86, P331, DOI 10.1016/j.neuron.2015.03.015; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TAYLOR AE, 1986, BRAIN, V109, P845, DOI 10.1093/brain/109.5.845; Thiele K, 2016, J CLIN EXP NEUROPSYC, V38, P764, DOI 10.1080/13803395.2016.1163327; Tremblay C, 2013, J NEUROL NEUROSUR PS, V84, P1265, DOI 10.1136/jnnp-2013-305021; Tremblay C, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/308501; Troster AI, 1998, NEUROPSYCHOLOGIA, V36, P295, DOI 10.1016/S0028-3932(97)00153-X; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Unsworth N, 2011, Q J EXP PSYCHOL, V64, P447, DOI 10.1080/17470218.2010.505292; Velazquez-Cardoso J, 2014, NEUROLOGIA, V29, P139, DOI 10.1016/j.nrl.2013.03.007; Vlagsma TT, 2016, J CLIN EXP NEUROPSYC, V38, P844, DOI 10.1080/13803395.2016.1167840; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; WEINGARTNER H, 1984, PSYCHIAT RES, V11, P223, DOI 10.1016/0165-1781(84)90071-4; Witt K, 2006, BRAIN RES, V1114, P173, DOI 10.1016/j.brainres.2006.07.055; WIXTED JT, 1994, PSYCHON B REV, V1, P89, DOI 10.3758/BF03200763; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496; Zaninotto AL, 2014, NEUROPSYCH DIS TREAT, V10, P1155, DOI 10.2147/NDT.S62728; Zec RF, 1999, ARCH CLIN NEUROPSYCH, V14, P255, DOI 10.1016/S0887-6177(98)00008-0; Zgaljardic Dennis J, 2003, Cogn Behav Neurol, V16, P193, DOI 10.1097/00146965-200312000-00001	74	3	3	1	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2021	35	5					529	539		10.1037/neu0000429			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	TP3HW	WOS:000677485500006	29658723				2022-02-06	
J	Tejerina, EE; Pelosi, P; Robba, C; Penuelas, O; Muriel, A; Barrios, D; Frutos-Vivar, F; Raymondos, K; Du, B; Thille, AW; Rios, F; Gonzalez, M; del-Sorbo, L; Marin, MD; Pinheiro, BV; Soares, MA; Nin, N; Maggiore, SM; Bersten, A; Amin, P; Cakar, N; Suh, GY; Abroug, F; Jibaja, M; Matamis, D; Zeggwagh, AA; Sutherasan, Y; Anzueto, A; Esteban, A				Tejerina, Eva E.; Pelosi, Paolo; Robba, Chiara; Penuelas, Oscar; Muriel, Alfonso; Barrios, Deisy; Frutos-Vivar, Fernando; Raymondos, Konstantinos; Du, Bin; Thille, Arnaud W.; Rios, Fernando; Gonzalez, Marco; del-Sorbo, Lorenzo; del Carmen Marin, Maria; Pinheiro, Bruno Valle; Soares, Marco Antonio; Nin, Nicolas; Maggiore, Salvatore M.; Bersten, Andrew; Amin, Pravin; Cakar, Nahit; Suh, Gee Young; Abroug, Fekri; Jibaja, Manuel; Matamis, Dimitros; Zeggwagh, Amine Ali; Sutherasan, Yuda; Anzueto, Antonio; Esteban, Andres		VENTILA Grp	Evolution Over Time of Ventilatory Management and Outcome of Patients With Neurologic Disease*	CRITICAL CARE MEDICINE			English	Article						mechanical ventilation; mortality; neurologic patients; prognosis factors; pulmonary complications	TRAUMATIC BRAIN-INJURY; RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; NEUROCRITICAL CARE; MECHANICAL VENTILATION; CASE-FATALITY; MORTALITY; TRENDS; POPULATION	OBJECTIVES: To describe the changes in ventilator management over time in patients with neurologic disease at ICU admission and to estimate factors associated with 28-day hospital mortality. DESIGN: Secondary analysis of three prospective, observational, multicenter studies. SETTING: Cohort studies conducted in 2004, 2010, and 2016. PATIENTS: Adult patients who received mechanical ventilation for more than 12 hours. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among the 20,929 patients enrolled, we included 4,152 (20%) mechanically ventilated patients due to different neurologic diseases. Hemorrhagic stroke and brain trauma were the most common pathologies associated with the need for mechanical ventilation. Although volume-cycled ventilation remained the preferred ventilation mode, there was a significant (p < 0.001) increment in the use of pressure support ventilation. The proportion of patients receiving a protective lung ventilation strategy was increased over time: 47% in 2004, 63% in 2010, and 65% in 2016 (p < 0.001), as well as the duration of protective ventilation strategies: 406 days per 1,000 mechanical ventilation days in 2004, 523 days per 1,000 mechanical ventilation days in 2010, and 585 days per 1,000 mechanical ventilation days in 2016 (p < 0.001). There were no differences in the length of stay in the ICU, mortality in the ICU, and mortality in hospital from 2004 to 2016. Independent risk factors for 28-day mortality were age greater than 75 years, Simplified Acute Physiology Score II greater than 50, the occurrence of organ dysfunction within first 48 hours after brain injury, and specific neurologic diseases such as hemorrhagic stroke, ischemic stroke, and brain trauma. CONCLUSIONS: More lung-protective ventilatory strategies have been implemented over years in neurologic patients with no effect on pulmonary complications or on survival. We found several prognostic factors on mortality such as advanced age, the severity of the disease, organ dysfunctions, and the etiology of neurologic disease.	[Tejerina, Eva E.; Penuelas, Oscar; Frutos-Vivar, Fernando; Esteban, Andres] Hosp Univ Getafe, Madrid, Spain; [Tejerina, Eva E.; Penuelas, Oscar; Frutos-Vivar, Fernando; Esteban, Andres] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Pelosi, Paolo; Robba, Chiara] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Pelosi, Paolo; Robba, Chiara] San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Genoa, Italy; [Muriel, Alfonso] Inst Raman Y Cajal Invest Sanitarias IRYCIS, Unidad Bioestadist, Clin Hosp Ramon Y Cajal, Madrid, Spain; [Muriel, Alfonso] Ctr Invest Red Epidemiol & Salud PObl CIBERESP, Madrid, Spain; [Barrios, Deisy] Inst Raman Y Cajal Invest Sanitarias IRYCIS, Serv Neumol, Madrid, Spain; [Raymondos, Konstantinos] Hannover Med Sch, Hannover, Germany; [Du, Bin] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Thille, Arnaud W.] Univ Hosp Poitiers, Poitiers, France; [Rios, Fernando] Hosp Nacl Alejandro Posadas, Buenos Aires, DF, Argentina; [Gonzalez, Marco] Clin Medellin, Medellin, Colombia; [Gonzalez, Marco] Univ Pontificia Bolivariana, Medellin, Colombia; [del-Sorbo, Lorenzo] Interdept Div Crit Care Med, Toronto, ON, Canada; [del Carmen Marin, Maria] Hosp Reg 1 Octubre, Inst Seguridad & Serv Sociales Trabajadores Estad, Mexico City, DF, Mexico; [Pinheiro, Bruno Valle] Univ Fed Juiz de Fora, Pulm Res Lab, Juiz De Fora, MG, Brazil; [Soares, Marco Antonio] Hosp Univ Sao Jose, Belo Horizonte, MG, Brazil; [Nin, Nicolas] Hosp Univ Montevideo, Montevideo, Uruguay; [Maggiore, Salvatore M.] Univ G dAnnunzio Chieti & Pescara, Chieti, Italy; [Bersten, Andrew] Flinders Univ S Australia, Dept Crit Care Med, Adelaide, SA, Australia; [Amin, Pravin] Bombay Hosp Inst Med Sci, Mumbai, Maharashtra, India; [Cakar, Nahit] Istanbul Fac Med, Istanbul, Turkey; [Suh, Gee Young] Samsung Med Ctr, Ctr Clin Epidemiol, Seoul, South Korea; [Abroug, Fekri] Hosp Fattouma Bourguina, Monastir, Tunisia; [Jibaja, Manuel] Hosp Especialidades Eugenio Espejo, Quito, Ecuador; [Matamis, Dimitros] Papageorgiou Hosp, Thessaloniki, Greece; [Zeggwagh, Amine Ali] Ctr Hosp Univ Ibn Sina Mohammed V Univ, Rabat, Morocco; [Sutherasan, Yuda] Mahidol Univ, Fac Med, Ramathibodi Hosp, Bangkok, Thailand; [Anzueto, Antonio] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Anzueto, Antonio] Univ Texas Hlth, San Antonio, TX USA		Tejerina, EE (corresponding author), Hosp Univ Getafe, Intens Care Unit, Carretera Toledo,Km 12-5, Getafe 28905, Spain.	evateje@gmail.com	Kirov, Mikhail/R-2320-2016; Bottiroli, Maurizio/L-4801-2019; Muriel, Alfonso/F-9948-2015	Kirov, Mikhail/0000-0002-4375-3374; Bottiroli, Maurizio/0000-0002-1579-7767; Muriel, Alfonso/0000-0002-4805-4011	Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias, Centro de Investigacion Biomedica en Red en Epidemiologia y Salud Publica, Instituto de Salud Carlos III, Madrid, Spain; Instituto Ramon y Cajal de Investigacion Sanitaria, Madrid, Spain	Supported, in part, by grant from Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias, Centro de Investigacion Biomedica en Red en Epidemiologia y Salud Publica, Instituto de Salud Carlos III, Madrid, Spain, and Instituto Ramon y Cajal de Investigacion Sanitaria, Madrid, Spain.	Asehnoune K, 2017, INTENS CARE MED, V43, P957, DOI 10.1007/s00134-017-4764-6; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Broessner G, 2007, CRIT CARE MED, V35, P2025, DOI 10.1097/01.ccm.0000281449.07719.2b; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Burns JD, 2013, NEUROCRIT CARE, V18, P305, DOI 10.1007/s12028-013-9818-1; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Cnossen MC, 2017, CRIT CARE MED, V45, P660, DOI 10.1097/CCM.0000000000002263; Damian MS, 2013, INTENS CARE MED, V39, P1405, DOI 10.1007/s00134-013-2960-6; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Elmer J, 2013, CRIT CARE MED, V41, P1992, DOI 10.1097/CCM.0b013e31828a3f4d; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Frisvold SK, 2019, INTENS CARE MED, V45, P683, DOI 10.1007/s00134-019-05556-7; Gajic O, 2005, INTENS CARE MED, V31, P922, DOI 10.1007/s00134-005-2625-1; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; Hoesch RE, 2012, CRIT CARE MED, V40, P587, DOI 10.1097/CCM.0b013e3182329617; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Knopf L, 2012, NEUROCRIT CARE, V16, P63, DOI 10.1007/s12028-011-9620-x; Kramer AH, 2014, CURR OPIN CRIT CARE, V20, P174, DOI 10.1097/MCC.0000000000000076; Kramer AH, 2013, CAN J ANESTH, V60, P966, DOI 10.1007/s12630-013-0001-0; Kramer AH, 2011, NEUROCRIT CARE, V14, P329, DOI 10.1007/s12028-011-9530-y; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Moskowitz A, 2018, RESUSCITATION, V124, P106, DOI 10.1016/j.resuscitation.2017.12.031; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Penuelas O, 2020, INTENS CARE MED, V46, P444, DOI 10.1007/s00134-019-05867-9; Redpath C, 2010, AM HEART J, V159, P577, DOI 10.1016/j.ahj.2009.12.030; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roquilly A, 2013, AM J RESP CRIT CARE, V188, P958, DOI 10.1164/rccm.201301-0116OC; Sandvei MS, 2011, NEUROLOGY, V77, P1833, DOI 10.1212/WNL.0b013e3182377de3; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sutherasan Y, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0922-9; Sutherasan Y, 2014, CRIT CARE, V18, DOI 10.1186/cc13778; Tejerina E, 2017, J CRIT CARE, V38, P341, DOI 10.1016/j.jcrc.2016.11.010; Tiruvoipati R, 2018, JAMA NEUROL, V75, P818, DOI 10.1001/jamaneurol.2018.0123; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	45	3	3	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2021	49	7					1095	1106		10.1097/CCM.0000000000004921			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SV7YW	WOS:000664035700031	33729719				2022-02-06	
J	Tata, S; Zusman, BE; Kochanek, PM; Gerzanich, V; Kwon, MS; Woo, SK; Clark, RSB; Janesko-Feldman, K; Vagni, VA; Simard, JM; Jha, RM				Tata, Swathi; Zusman, Benjamin E.; Kochanek, Patrick M.; Gerzanich, Volodymyr; Kwon, Min Seong; Woo, Seung Kyoon; Clark, Robert S. B.; Janesko-Feldman, Keri; Vagni, Vincent A.; Simard, J. Marc; Jha, Ruchira M.			Abcc8 (Sulfonylurea Receptor-1) Impact on Brain Atrophy after Traumatic Brain Injury Varies by Sex	JOURNAL OF NEUROTRAUMA			English	Article						atrophy; brain injuries; central nervous system; genotypic intracranial hemorrhage; sex; mice; traumatic	CONTROLLED CORTICAL IMPACT; GENDER ASSOCIATIONS; HEMORRHAGIC-SHOCK; DOUBLE-BLIND; FEMALE RATS; PROGESTERONE; EDEMA; GLIBENCLAMIDE; DAMAGE; MODEL	Females have been understudied in pre-clinical and clinical traumatic brain injury (TBI), despite distinct biology and worse clinical outcomes versus males. Sulfonylurea receptor 1 (SUR1) inhibition has shown promising results in predominantly male TBI. A phase II trial is ongoing. We investigated whether SUR1 inhibition effects on contusional TBI differ by sex given that this may inform clinical trial design and/or interpretation. We studied the moderating effects of sex on post-injury brain tissue loss in 142 male and female ATP-binding cassette transporter subfamily C member 8 (Abcc8) wild-type, heterozygote, and knockout mice (12-15 weeks). Monkey fibroblast-like cells and mouse brain endothelium-derived cells were used for in vitro studies. Mice were injured with controlled cortical impact and euthanized 21 days post-injury to assess contusion, brain, and hemisphere volumes (vs. genotype- and sex-matched naives). Abcc8 knockout mice had smaller contusion volumes (p = 0.012) and larger normalized contralateral (right) hemisphere volumes (nRHV; p = 0.03) after injury versus wild type. This was moderated by sex: Contusions were smaller (p = 0.020), nRHV was higher (p = 0.001), and there was less global atrophy (p = 0.003) in male, but not female, knockout versus wild-type mice after TBI. Less atrophy occurred in males for each copy of Abcc8 lost (p = 0.023-0.002, all outcomes). In vitro, sex-determining region Y (SRY) stimulated Abcc8 promoter activity and increased Abcc8 expression. Loss of Abcc8 strongly protected against post-traumatic cerebral atrophy in male, but not female, mice. This may partly be mediated by SRY on the Y-chromosome. Sex differences may have important implications for ongoing and future trials of SUR1 blockade.	[Tata, Swathi] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Zusman, Benjamin E.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.; Clark, Robert S. B.; Janesko-Feldman, Keri; Vagni, Vincent A.] Univ Pittsburgh, Dept Crit Care Med, Sch Med, Pittsburgh, PA USA; [Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.; Clark, Robert S. B.; Janesko-Feldman, Keri; Vagni, Vincent A.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Sch Med, Pittsburgh, PA USA; [Kochanek, Patrick M.; Clark, Robert S. B.] UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Gerzanich, Volodymyr; Kwon, Min Seong; Woo, Seung Kyoon; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurol, 350 West Thomas Rd, Phoenix, AZ 85013 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurobiol & Neurosurg, Phoenix, AZ 85013 USA		Jha, RM (corresponding author), Barrow Neurol Inst, Dept Neurol, 350 West Thomas Rd, Phoenix, AZ 85013 USA.; Jha, RM (corresponding author), Barrow Neurol Inst, Dept Neurosurg, 350 West Thomas Rd, Phoenix, AZ 85013 USA.; Jha, RM (corresponding author), Barrow Neurol Inst, Dept Neurobiol, 350 West Thomas Rd, Phoenix, AZ 85013 USA.	Ruchira.jha@barrowneuro.org			National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101036, 1R01NS115815-01A1, R01NS102589]; Chuck Noll Foundation; Ake Grenvik Endowment	The authors are grateful to funding from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS; K23NS101036 and 1R01NS115815-01A1 [to R.M.J.] and R01NS102589 [to J.M.S.]). Drs. Jha and Kochanek are supported by the Chuck Noll Foundation. Dr. Kochanek is also supported by the Ake Grenvik Endowment.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bohnen MS, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002087; Bramlett HM, 2009, NEUROSCI LETT, V461, P49, DOI 10.1016/j.neulet.2009.05.071; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Chen YF, 2021, J NEUROTRAUM, V38, P1809, DOI 10.1089/neu.2020.7217; Clevenger AC, 2018, J MOL NEUROSCI, V64, P410, DOI 10.1007/s12031-018-1038-x; COHEN DR, 1994, P NATL ACAD SCI USA, V91, P4372, DOI 10.1073/pnas.91.10.4372; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Eisenberg HM, 2020, J NEUROTRAUM, V37, P185, DOI 10.1089/neu.2019.6538; Free KE, 2017, EXP NEUROL, V296, P62, DOI 10.1016/j.expneurol.2017.07.004; Gerzanich V, 2019, J NEUROTRAUM, V36, P1060, DOI 10.1089/neu.2018.5986; Gerzanich V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195526; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jha RM, 2021, J NEUROTRAUM, V38, P628, DOI 10.1089/neu.2020.7421; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Khalili H, 2017, WORLD NEUROSURG, V101, P130, DOI 10.1016/j.wneu.2017.01.103; Kimberly WT, 2018, NEUROLOGY, V91, pE2163, DOI 10.1212/WNL.0000000000006618; Korley F, 2021, J NEUROTRAUM, V38, P1953, DOI 10.1089/neu.2020.7072; La Fountaine MF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00691; Ma JP, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub4; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Niu K, 2011, NEUROSCIENCE, V180, P344, DOI 10.1016/j.neuroscience.2011.01.045; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Rakholia MV, 2019, J NEUROTRAUM, V36, P1156, DOI 10.1089/neu.2018.5782; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Shansky RM, 2021, NAT NEUROSCI, V24, P457, DOI 10.1038/s41593-021-00806-8; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Sheth KN, 2014, NEUROCRIT CARE, V21, P43, DOI 10.1007/s12028-014-9970-2; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Spaite DW, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.1152; Stokum JA, 2018, GLIA, V66, P108, DOI 10.1002/glia.23231; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tucker LB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00509; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wiley CA, 2016, J NEUROTRAUM, V33, P1866, DOI 10.1089/neu.2015.4272; Woo SK, 2012, J CEREBR BLOOD F MET, V32, P525, DOI 10.1038/jcbfm.2011.159; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu JB, 2009, FASEB J, V23, P4029, DOI 10.1096/fj.09-139097; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; YING X, 1991, J COMP NEUROL, V314, P278, DOI 10.1002/cne.903140206; Zafardoost P, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.25113; Zhou XJ, 2019, MOL MED, V25, DOI 10.1186/s10020-018-0067-9; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	74	3	3	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2021	38	17					2473	2485		10.1089/neu.2021.0105		JUN 2021	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UK1GM	WOS:000666966400001	33940936				2022-02-06	
J	Feng, JG; Zhou, ZL; Feng, RH; Zeng, CH; Wei, MJ; Hong, T				Feng, Jiugeng; Zhou, Zhiliang; Feng, Ronghua; Zeng, Chunhui; Wei, Minjun; Hong, Tao			Silencing long non-coding RNA zinc finger antisense 1 restricts secondary cerebral edema and neuron injuries after traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Long non-coding RNA zinc finger antisense 1; Traumatic brain injury; Cerebral edema; Neuron injury; Apoptosis; Inflammation	PATHOPHYSIOLOGY; NEUROPROTECTION; EXPRESSION; MODEL; MICE	Objective: To investigate the interaction of long non-coding RNA zinc finger antisense 1 (lncRNA ZFAS1) in secondary cerebral edema (CE) and neuron injuries after traumatic brain injury (TBI) in a mouse model. Methods: TBI mouse models was established by free-fall strike. Adeno-associated virus-short hairpin-ZFAS1 was administrated into mice via intracerebral injection to downregulate lncRNA ZFAS1. LncRNA ZFAS1 in mouse brain was examined. Neurological severity score (NSS), cerebral water content (CWC) and lesion volume were measured. The number of TUNEL-positive cells in brain tissue was accessed. Bax and cleaved caspase-3 in brain tissues were measured by western blot analysis, and pro-inflammatory factor levels were detected. Results: LncRNA ZFAS1 expression was upregulated in mouse brain tissues 3 days after TBI modelling. After the knockdown of lncRNA ZFAS1, NSS, CWC and lesion volume were decreased, apoptotic gene levels were decreased and pro-inflammatory cytokine levels were reduced, suggesting that lncRNA ZFAS1 knockdown could alleviate TBI-induced brain injuries in mice. Conclusion: This study demonstrated that silencing lncRNA ZFAS1 inhibited TBI by quenching apoptosis, reducing inflammatory response and improving the recovery of neurological function in TBI mice. LncRNA ZFAS1 might function as a possible curative management in secondary CE and neuron injury in TBI mice.	[Feng, Jiugeng; Zeng, Chunhui; Wei, Minjun; Hong, Tao] Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Yong Wai Zheng St 17, Nanchang 330006, Jiangxi, Peoples R China; [Zhou, Zhiliang] Nanchang Univ, Med Coll, Dept Postgrad, Nanchang, Jiangxi, Peoples R China; [Feng, Ronghua] Jiangxi Univ Tradit Chinese Med, Affiliated Hosp, Dept Cardiovasc Med, Nanchang, Jiangxi, Peoples R China		Hong, T (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Yong Wai Zheng St 17, Nanchang 330006, Jiangxi, Peoples R China.	hongtao202010@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81960236]; Key R&D Project of Jiangxi Provincial Department of Science and Technology [20192BBGL70022]	This study is supported by National Natural Science Foundation of China (81960236) and Key R&D Project of Jiangxi Provincial Department of Science and Technology (20192BBGL70022) .	Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Bierbach B, 2008, STROKE, V39, P213, DOI 10.1161/STROKEAHA.107.496620; Deng RY, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000018465; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hu F, 2020, NEUROCHEM RES, V45, P2433, DOI 10.1007/s11064-020-03103-1; Huang P, 2020, MOL MED REP, V22, P2300, DOI 10.3892/mmr.2020.11340; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Ji XR, 2014, BRAIN RES, V1585, P13, DOI 10.1016/j.brainres.2014.08.026; Jiao L, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2136-6; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Li ZX, 2019, NEUROPSYCH DIS TREAT, V15, P1671, DOI 10.2147/NDT.S206624; Liu J.J., 2020, ARCH BIOCHEM BIOPHYS; Lv QL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695022; Murayi R, 2016, CHILD NERV SYST, V32, P2293, DOI 10.1007/s00381-016-3240-x; Pan CY, 2020, MOL THER-NUCL ACIDS, V21, P983, DOI 10.1016/j.omtn.2020.07.028; Riva P, 2016, CURR ALZHEIMER RES, V13, P1219, DOI 10.2174/1567205013666160622112234; Sun P, 2018, J CEREBR BLOOD F MET, V38, P1125, DOI 10.1177/0271678X18773871; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wang CH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00123; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Xiang X., 2020, J CARDIOVASC PHARM; Xu YH, 2019, MEDICINE, V98, DOI [10.1097/md.0000000000014558, 10.1097/MD.0000000000014558]; Yang S., 2020, BIOSCIENCE REP, V40; Yang YN, 2020, AGING-US, V12, P9085, DOI 10.18632/aging.103176; Ye Y, 2018, HUM CELL, V31, P14, DOI 10.1007/s13577-017-0179-5; Zhai PP, 2015, NEUROPHARMACOLOGY, V95, P1, DOI 10.1016/j.neuropharm.2015.02.026; Zhang YY, 2020, INFLAMMATION, V43, P1337, DOI 10.1007/s10753-020-01212-1; Zhao ZL, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-1049-x; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002	34	3	3	4	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 21	2021	756								135958	10.1016/j.neulet.2021.135958			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SJ6QP	WOS:000655657500007	34000346				2022-02-06	
J	Debaud, C; Tseng, HW; Chedik, M; Kulina, I; Genet, F; Ruitenberg, MJ; Levesque, JP				Debaud, Charlotte; Tseng, Hsu-Wen; Chedik, Malha; Kulina, Irina; Genet, Francois; Ruitenberg, Marc J.; Levesque, Jean-Pierre			Local and Systemic Factors Drive Ectopic Osteogenesis in Regenerating Muscles of Spinal-Cord-Injured Mice in a Lesion-Level-Dependent Manner	JOURNAL OF NEUROTRAUMA			English	Article						immune dysfunction; muscular regeneration; neurogenic heterotopic ossification; spinal cord injury; substance P; sympathetic nervous system	NEUROGENIC HETEROTOPIC OSSIFICATION; TRAUMATIC BRAIN-INJURY; SKELETAL-MUSCLE; SUBSTANCE-P; RISK-FACTORS; HEALTH; INFLAMMATION; CATECHOLAMINES; MYOKINES; MODEL	Neuroimmune dysfunction is thought to promote the development of several acute and chronic complications in spinal cord injury (SCI) patients. Putative roles for adrenal stress hormones and catecholamines are increasingly being recognized, yet how these adversely affect peripheral tissue homeostasis and repair under SCI conditions remains elusive. Here, we investigated their influence in a mouse model of SCI with acquired neurogenic heterotopic ossification. We show that spinal cord lesions differentially influence muscular regeneration in a level-dependent manner and through a complex multi-step process that creates an osteopermissive environment within the first hours of injury. This cascade of events is shown to critically involve adrenergic signals and drive the acute release of the neuropeptide, substance P. Our findings generate new insights into the kinetics and processes that govern SCI-induced deregulations in skeletal muscle homeostasis and regeneration, thereby aiding the development of sequential therapeutic strategies that can prevent or attenuate neuromusculoskeletal complications in SCI patients.	[Debaud, Charlotte; Tseng, Hsu-Wen; Kulina, Irina; Levesque, Jean-Pierre] Univ Queensland, Translat Res Inst, Mater Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia; [Debaud, Charlotte] Princess Alexandra Hosp, Orthopaed Surg Dept, Spine Div, Queensland Hlth, 199 Ipswich Rd, Woolloongabba, Qld 4102, Australia; [Debaud, Charlotte; Chedik, Malha; Genet, Francois] Univ Versailles St Quentin Yvelines, UFR Sci Sante Simone Veil, U1179, INSERM, Montigny Le Bretonneux, France; [Debaud, Charlotte; Ruitenberg, Marc J.] Univ Queensland, Fac Med, Sch Biomed Sci, St Lucia, Qld, Australia; [Genet, Francois] Hop Raymond Poincare, AP HP, CIC IT, Serv Rehabil, Garches, France		Levesque, JP (corresponding author), Univ Queensland, Translat Res Inst, Mater Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia.; Debaud, C (corresponding author), Princess Alexandra Hosp, Orthopaed Surg Dept, Spine Div, Queensland Hlth, 199 Ipswich Rd, Woolloongabba, Qld 4102, Australia.; Ruitenberg, MJ (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia Campus,Chancellors Pl, Brisbane, Qld 4072, Australia.	charlotte.debaud@hotmail.fr; m.ruitenberg@uq.edu.au; jp.levesque@mater.uq.edu.au	Levesque, Jean-Pierre/C-5426-2011	Levesque, Jean-Pierre/0000-0002-7299-6025	Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [1181053]; Mater Foundation; NHMRCNational Health and Medical Research Council of Australia [1136130]; L'Institut Servier (France)	Experiments were supported, in part, by Ideas Grant 1181053 (to J.P.L., H.W.T., and F.G.) from the Australian National Health andMedical Research Council (NHMRC) and by the Mater Foundation. All work conducted in the laboratory of M.J.R. was made possible by SpinalCure Australia. J.P.L. was supported by Research Fellowship 1136130 from the NHMRC, and C.D. by a Research Fellowship from L'Institut Servier (France).	Alexander KA, 2020, CURR OSTEOPOROS REP, V18, P666, DOI 10.1007/s11914-020-00636-w; Alexander KA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00377; Avila G, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010055; Barnes MA, 2015, CYTOKINE, V72, P210, DOI 10.1016/j.cyto.2015.01.008; Biering-Sorensen F, 2018, AUTON NEUROSCI-BASIC, V209, P4, DOI 10.1016/j.autneu.2017.02.004; Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145; Carpentier VT, 2021, EUR J PHYS REHAB MED, V57, P527, DOI 10.23736/S1973-9087.21.06589-8; Citak M, 2012, SPINE, V37, P1953, DOI 10.1097/BRS.0b013e31825ee81b; Clark JM, 2017, CURR OSTEOPOROS REP, V15, P433, DOI 10.1007/s11914-017-0400-1; Davies OG, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00194; Debaud C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182454; Foley KL, 2018, BONE, V109, P65, DOI 10.1016/j.bone.2017.12.006; Frewin D B, 1973, Paraplegia, V11, P238; Genet F, 2015, J PATHOL, V236, P229, DOI 10.1002/path.4519; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Godoy LD, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00127; Gorgey AS, 2019, EUR J APPL PHYSIOL, V119, P315, DOI 10.1007/s00421-018-4039-0; GRIMBY G, 1976, SCAND J REHABIL MED, V8, P37; HARVEY AL, 1985, J TOXICOL-TOXIN REV, V4, P41, DOI 10.3109/15569548509014413; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hepple RT, 2016, FREE RADICAL BIO MED, V98, P177, DOI 10.1016/j.freeradbiomed.2016.03.017; HERNANDEZ AM, 1978, PARAPLEGIA, V16, P272, DOI 10.1038/sc.1978.52; Huang H, 2018, J ORTHOP TRANSL, V12, P16, DOI 10.1016/j.jot.2017.10.002; Joers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104850; Juarez JK, 2018, CTS-CLIN TRANSL SCI, V11, P365, DOI 10.1111/cts.12552; Jung WC, 2017, SEMIN CELL DEV BIOL, V61, P60, DOI 10.1016/j.semcdb.2016.08.010; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim TH, 2019, FASEB J, V33, P3997, DOI 10.1096/fj.201801429RR; KOSTRZEWA RM, 1974, PHARMACOL REV, V26, P199; Krause JS, 2011, ARCH PHYS MED REHAB, V92, P1770, DOI 10.1016/j.apmr.2011.05.024; Lee JH, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00042; Leonard AV, 2014, SPINAL CORD, V52, P17, DOI 10.1038/sc.2013.136; Levi B, 2015, J TRAUMA ACUTE CARE, V79, P870, DOI 10.1097/TA.0000000000000838; Lewis KM, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/578480; Li YX, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00352; Linley JE, 2012, P NATL ACAD SCI USA, V109, pE1578, DOI 10.1073/pnas.1201544109; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Mageriu V, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/9079083; MAGGI CA, 1993, J AUTON PHARMACOL, V13, P23, DOI 10.1111/j.1474-8673.1993.tb00396.x; Meyers Carolyn, 2019, JBMR Plus, V3, pe10172, DOI 10.1002/jbm4.10172; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Oberbeck R, 2006, CURR MED CHEM, V13, P1979, DOI 10.2174/092986706777584997; Ohlmeier M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54986-2; ORZEL JA, 1985, J NUCL MED, V26, P125; Popovich P, 2009, NAT MED, V15, P736, DOI 10.1038/nm0709-736; Pruss H, 2017, NAT NEUROSCI, V20, P1549, DOI 10.1038/nn.4643; Qiao GX, 2019, CANCER IMMUNOL IMMUN, V68, P11, DOI 10.1007/s00262-018-2243-8; Qiao GX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00164; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Rossier A B, 1973, Paraplegia, V11, P38; Ryall JG, 2010, CLIN EXP PHARMACOL P, V37, P397, DOI 10.1111/j.1440-1681.2009.05312.x; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schulze J, 2014, AGING DIS, V5, P327, DOI 10.14336/AD.2014.0500327; Sezer N, 2015, WORLD J ORTHOP, V6, P24, DOI 10.5312/wjo.v6.i1.24; Shehab D, 2002, J NUCL MED, V43, P346; SHIAU SYL, 1976, J PHARMACOL EXP THER, V196, P758; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Sorkin M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14172-4; Springer J, 2003, EUR RESPIR J, V22, P596, DOI 10.1183/09031936.03.00027903; Squire L.R, 2010, ENCY NEUROSCIENCE, P679; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152; Sun X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0736-y; Talmadge RJ, 2002, J APPL PHYSIOL, V92, P147, DOI 10.1152/japplphysiol.000247.2001; TANAKA T, 1977, RADIOLOGY, V123, P217, DOI 10.1148/123.1.217; Taylor MP, 2017, EMERG MED J, V34, P157, DOI 10.1136/emermed-2016-205780; Torossian F, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96034; Tuzmen C, 2018, J ORTHOP RES, V36, P1444, DOI 10.1002/jor.23833; van Eerd JEM, 2006, J NUCL MED, V47, P528; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wang QS, 2014, J NEUROSCI, V34, P12490, DOI 10.1523/JNEUROSCI.2238-14.2014; Williams HF, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007041; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215, DOI 10.1302/0301-620X.74B2.1544955; Xia HM, 2018, NAT REV MATER, V3, P174, DOI 10.1038/s41578-018-0027-6; Youssefian T, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-46	77	3	3	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 1	2021	38	15					2162	2175		10.1089/neu.2021.0058		JUN 2021	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TV9JU	WOS:000663069800001	33913747				2022-02-06	
J	Gunal, MY; Sakul, AA; Caglayan, AB; Erten, F; Kursun, OED; Kilic, E; Sahin, K				Gunal, Mehmet Yalcin; Sakul, Ayse Arzu; Caglayan, Ahmet Burak; Erten, Fusun; Kursun, Oznur Ece Durmaz; Kilic, Ertugrul; Sahin, Kazim			Protective Effect of Lutein/Zeaxanthin Isomers in Traumatic Brain Injury in Mice	NEUROTOXICITY RESEARCH			English	Article						Lutein/zeaxanthin isomers; Traumatic brain injury; NF-kappa B; Nrf2; BDNF	NF-KAPPA-B; MACULAR DEGENERATION; OXIDATIVE STRESS; LUTEIN PROTECTS; ZEAXANTHIN; INFLAMMATION; NEUROPROTECTION; CAROTENOIDS; MELATONIN; TOXICITY	Previous studies revealed that oxidative stress and inflammation are the main contributors to secondary injury after traumatic brain injury (TBI). In an earlier study, we reported that lutein/zeaxanthin isomers (L/Zi) exert antioxidative and anti-inflammatory effects by activating the nuclear factor-kappa B (NF-kappa B) and nuclear factor-erythroid 2-related factor 2 (Nrf2) pathways. However, its precise role and underlying mechanisms were largely unknown after TBI. This study was conducted to investigate the potential mechanism of L/Zi isomers in a TBI model induced by a cold injury model in mice. To investigate the effects of L/Zi, male C57BL/6j mice-induced brain injury using the cold trauma model was allocated into two groups (n = 7): (i) TBI + vehicle group and (ii) TBI + L/Zi group (20 mg/kg BW). Brain samples were collected 24 h later for analyses. L/Zi given immediately after the injury decreased infarct volume and blood-brain barrier (BBB) permeability; L/Zi treatment also significantly reduced proinflammatory cytokines, including interleukin1 beta (IL-1 beta), interleukin 6 (IL-6), and NF-kappa B levels and increased growth-associated protein 43 (GAP-43), neural cell adhesion molecule (NCAM), brain-derived neurotrophic factor (BDNF), and Nrf2 levels compared with vehicle control. These data suggest that L/Zi improves mitochondrial function in TBI models, possibly decreasing inflammation and activating the Nrf2 pathway.	[Gunal, Mehmet Yalcin; Sakul, Ayse Arzu; Caglayan, Ahmet Burak; Kilic, Ertugrul] Istanbul Medipol Univ, Regenerat & Restorat Med Res Ctr, Istanbul, Turkey; [Gunal, Mehmet Yalcin] Alanya Alaaddin Keykubat Univ, Sch Med, Dept Physiol, Antalya, Turkey; [Sakul, Ayse Arzu] Istanbul Medipol Univ, Sch Med, Dept Pharmacol, Istanbul, Turkey; [Caglayan, Ahmet Burak; Kilic, Ertugrul] Istanbul Medipol Univ, Sch Med, Dept Physiol, Istanbul, Turkey; [Erten, Fusun] Munzur Univ, Pertek Sakine Genc Vocat Sch, Dept Vet Med, Tunceli, Turkey; [Kursun, Oznur Ece Durmaz] Firat Univ, Vocat Sch Kovancilar, Dept Pharm Serv, Elazig, Turkey; [Sahin, Kazim] Firat Univ, Fac Vet Med, Dept Anim Nutr, Elazig, Turkey		Sahin, K (corresponding author), Firat Univ, Fac Vet Med, Dept Anim Nutr, Elazig, Turkey.	yalcin.gunal@alanya.edu.tr; aasakul@medipol.edu.tr; burakcaglayan7@gmail.com; fusun_87@yahoo.com; oedkursun@firat.edu.tr; kilic44@yahoo.com; nsahinkm@yahoo.com	Sahin, Kazim/D-5625-2009; Gunal, Mehmet/AAT-2910-2020; Gunal, Mehmet Yalcin/AAT-9806-2021; Erten, Fusun/AAZ-3709-2021	Sahin, Kazim/0000-0001-9542-5244; Gunal, Mehmet/0000-0001-7702-2441; Erten, Fusun/0000-0003-1657-7253; SAKUL, AYSE ARZU/0000-0002-9354-0000; Caglayan, Berrak/0000-0002-5072-132X; Kilic, Ertugrul/0000-0001-6494-8923; DURMAZ KURSUN, Oznur Ece/0000-0002-3400-7468	OmniActive Health Technologies, NJ, USA; Turkish Academy of Sciences (TUBA)Turkish Academy of Sciences	This research was supported by OmniActive Health Technologies, NJ, USA. This work was also supported in part by the Turkish Academy of Sciences (TUBA) (KS, EK).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Barker FM, 2011, INVEST OPHTH VIS SCI, V52, P3934, DOI 10.1167/iovs.10-5898; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; BOWES MP, 1993, EXP NEUROL, V119, P215, DOI 10.1006/exnr.1993.1023; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; Cheng F, 2015, IMMUNOPHARM IMMUNOT, V37, P329, DOI 10.3109/08923973.2015.1049704; Craft N E, 2004, J Nutr Health Aging, V8, P156; de Roos B, 2015, MOL NUTR FOOD RES, V59, P1229, DOI 10.1002/mnfr.201400568; Esenwa CC, 2016, NAT REV NEUROL, V12, P594, DOI 10.1038/nrneurol.2016.125; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gao B, 2008, CEREBROVASC DIS, V26, P413, DOI 10.1159/000151683; Hammond BR, 2005, OPHTHAL PHYSL OPT, V25, P315, DOI 10.1111/j.1475-1313.2005.00271.x; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Johnson EJ, 2005, NUTR REV, V63, P9, DOI 10.1111/j.1753-4887.2005.tb00105.x; Johnson EJ, 2005, INVEST OPHTH VIS SCI, V46, P692, DOI 10.1167/iovs.02-1192; Johnson EJ, 2014, NUTR REV, V72, P605, DOI 10.1111/nure.12133; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kelestemur T, 2016, NEUROSCI LETT, V612, P92, DOI 10.1016/j.neulet.2015.11.043; Keskin I, 2017, NEURAL REGEN RES, V12, P761, DOI 10.4103/1673-5374.206646; Kilic U, 2013, NEUROSCIENCE, V237, P268, DOI 10.1016/j.neuroscience.2013.01.059; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459; Kritchevsky SB, 2000, AM J EPIDEMIOL, V152, P1065, DOI 10.1093/aje/152.11.1065; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Mohn ES, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186767; Nakajima Y, 2009, CURR EYE RES, V34, P311, DOI 10.1080/02713680902745408; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101; Ravikrishnan R, 2011, FOOD CHEM TOXICOL, V49, P2841, DOI 10.1016/j.fct.2011.08.011; Renzi LM, 2010, EXP EYE RES, V91, P896, DOI 10.1016/j.exer.2010.09.015; Renzi LM, 2010, OPHTHAL PHYSL OPT, V30, P351, DOI 10.1111/j.1475-1313.2010.00720.x; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448; Song JH, 2000, J NUTR, V130, P3028, DOI 10.1093/jn/130.12.3028; Stahl W, 2001, BIOFACTORS, V15, P95, DOI 10.1002/biof.5520150209; Sun YX, 2014, J ASIAN NAT PROD RES, V16, P1084, DOI 10.1080/10286020.2014.939584; Tan DH, 2017, MOL MED REP, V16, P4235, DOI 10.3892/mmr.2017.7040; Thurnham DI, 2013, FOOD CHEM TOXICOL, V59, P455, DOI 10.1016/j.fct.2013.06.002; Venegoni W, 2017, J ADV NURS, V73, P1331, DOI 10.1111/jan.13259; Vishwanathan R, 2013, NUTR NEUROSCI, V16, P21, DOI 10.1179/1476830512Y.0000000024; Vos Pieter E, 2011, Crit Care, V15, P183, DOI 10.1186/cc10290; Wagner AE, 2012, J CELL MOL MED, V16, P836, DOI 10.1111/j.1582-4934.2011.01367.x; Wardyn JD, 2015, BIOCHEM SOC T, V43, P621, DOI 10.1042/BST20150014; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiao Guo-min, 2005, J Zhejiang Univ Sci B, V6, P28, DOI 10.1631/jzus.2005.B0028; You WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060290; Yulug B, 2018, MINI-REV MED CHEM, V18, P1479, DOI 10.2174/1389557517666170927162537	55	3	3	2	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	OCT	2021	39	5					1543	1550		10.1007/s12640-021-00385-3		JUN 2021	8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UO7NG	WOS:000661818000001	34129176				2022-02-06	
J	Maldonado-Rodriguez, N; Crocker, CV; Taylor, E; Jones, KE; Rothlander, K; Smirl, J; Wallace, C; van Donkelaar, P				Maldonado-Rodriguez, Naomi; Crocker, Clara Val; Taylor, Edward; Jones, K. Elisabeth; Rothlander, Krystal; Smirl, Jon; Wallace, Colin; van Donkelaar, Paul		Canadian Traumatic Brain Injury Re	Characterization of Cognitive-Motor Function in Women Who Have Experienced Intimate Partner Violence-Related Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						brain injury; cognitive-motor function; intimate partner violence; strangulation	ROBOTIC ASSESSMENT; PERFORMANCE; RISK	Intimate partner violence (IPV) affects at least one in three women worldwide, and up to 92% report symptoms consistent with brain injury (BI). Although a handful of studies have examined different aspects of brain structure and function in this population, none has characterized potential deficits in cognitive-motor function. This knowledge gap was addressed in the current study by having participants who had experienced IPV complete the bimanual Object Hit & Avoid (OHA) task in a Kinesiological Instrument for Normal and Altered Reaching Movement (KINARM) End-Point Laboratory. BI load, post-traumatic stress disorder (PTSD), anxiety, depression, substance use, and history of abuse were also assessed. A stepwise multiple regression was undertaken to explore the relationship between BI load and task performance while accounting for comorbid psychopathologies. Results demonstrated that BI load accounted for a significant amount of variability in the number of targets hit and the average hand speed. PTSD, anxiety, and depression also contributed significantly to the variability in these measures as well as to the number and proportion of distractor hits, and the object processing rate. Taken together, these findings suggest that IPV-related BI, as well as comorbid PTSD, anxiety, and depression, disrupt the processing required to quickly and accurately hit targets while avoiding distractors. This pattern of results reflects the complex interaction between the physical injuries induced by the episodes of IPV and the resulting impacts that these experiences have on mental health.	[Maldonado-Rodriguez, Naomi; Crocker, Clara Val; Jones, K. Elisabeth; Rothlander, Krystal; Wallace, Colin; van Donkelaar, Paul] Univ British Columbia, Sch Hlth & Exercise Sci, 1147 Res Rd, Kelowna, BC V1V 1V7, Canada; [Taylor, Edward] Univ British Columbia, Sch Social Work, Kelowna, BC, Canada; [Smirl, Jon] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada		van Donkelaar, P (corresponding author), Univ British Columbia, Sch Hlth & Exercise Sci, 1147 Res Rd, Kelowna, BC V1V 1V7, Canada.	paul.vandonkelaar@ubc.ca		Maldonado-Rodriguez, Naomi/0000-0001-5521-0433	Canada Graduate Scholarship -Master's award; Department of Women and Gender Equality [GV18315-01]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [013902]; Canadian Foundation for InnovationCanada Foundation for Innovation;  [012153]	Dr. Maldonado-Rodriguez was supported by a Canada Graduate Scholarship -Master's award. This work was supported by grants from the Department of Women and Gender Equality (GV18315-01), Canadian Institutes of Health Research (013902), Canadian Foundation for Innovation, and an anonymous donor (012153).	Brownridge DA, 2008, J FAM VIOLENCE, V23, P353, DOI 10.1007/s10896-008-9160-0; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Cusimano Michael D, 2021, Neurotrauma Rep, V2, P136, DOI 10.1089/neur.2020.0031; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; Danielsen T., 2021, J NEUROPATH EXP NEUR; Daoud N, 2013, CAN J PUBLIC HEALTH, V104, pE278, DOI 10.17269/cjph.104.3724; Daugherty JC, 2020, J INTERPERS VIOLENCE, DOI 10.1177/0886260520959621; Daugherty JC, 2019, J FORENSIC PSYCHI PS, V30, P322, DOI 10.1080/14789949.2018.1546886; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Esopenko C, 2021, BRAIN IMAGING BEHAV, V15, P475, DOI 10.1007/s11682-020-00417-0; Galovski TE, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.569335; Haag H., 2019, TRAUMA VIOLENCE ABUS; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Leung FH, 2006, NEUROEPIDEMIOLOGY, V27, P13, DOI 10.1159/000093894; Logan LM, 2018, J HEAD TRAUMA REHAB, V33, pE61, DOI 10.1097/HTR.0000000000000349; Mang CS, 2019, J NEUROTRAUM, V36, P308, DOI 10.1089/neu.2017.5587; Mang CS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196205; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Overstreet NM, 2013, BASIC APPL SOC PSYCH, V35, P109, DOI 10.1080/01973533.2012.746599; Pedersen JS, 2013, VIOLENCE AGAINST WOM, V19, P1034, DOI 10.1177/1077801213499245; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Sergio LE, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.541630; Smirl JD, 2019, BRAIN INJURY, V33, P1529, DOI 10.1080/02699052.2019.1658129; Smith P H, 1995, Womens Health, V1, P273; Statistics Canada, 2017, FOC GEOGR SER 2016 C; Stricker NH, 2015, J TRAUMA STRESS, V28, P102, DOI 10.1002/jts.22000; Subbian V, 2016, ACAD EMERG MED, V23, P382, DOI 10.1111/acem.12906; Subbian V, 2014, IEEE ENG MED BIO, P5353, DOI 10.1109/EMBC.2014.6944835; Thompson RS, 2006, AM J PREV MED, V30, P447, DOI 10.1016/j.amepre.2006.01.016; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Vila-Rodriguez F, 2013, AM J PSYCHIAT, V170, P1413, DOI 10.1176/appi.ajp.2013.12111439; World Health Organization, 2012, UND ADR VIOL WOM; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	41	3	3	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0042		JUN 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SS2YQ	WOS:000661607600001	34036801	hybrid, Green Submitted			2022-02-06	
J	Laurent-Vannier, A; Bernard, JY; Chevignard, M				Laurent-Vannier, Anne; Bernard, Jonathan Y.; Chevignard, Mathilde			Abusive Head Trauma through Shaking: Examination of the Perpetrators According to Dating of the Traumatic Event	CHILD ABUSE REVIEW			English	Article						abusive head trauma; child abuse; child maltreatment; baby; infant; perpetrators	BABY SYNDROME GUIDELINES; ROBUST DIAGNOSIS; BRAIN-INJURY; HEALTH-CARE; CHILDREN; INFANTS; ADMISSIONS; INTERVAL; HISTORY	Effective prevention of abusive head trauma (AHT) requires the identification of potential perpetrators. Current evidence suggests that infant shaking, as a mechanism of AHT, produces immediate symptoms, allowing for the dating of the event based on clinical symptoms. Determining precisely when symptoms occurred may help law enforcement to identify the perpetrator. We retrieved written legal statements and medical records from birth to age at diagnosis of 100 infants consecutively diagnosed with AHT through shaking (2011-17), using forensic expertise files. Timing of abuse allowed for the identification of perpetrators in 91 cases. All abusive events occurred inside a home (parent's or nanny's), never outdoors or in a public place, and always in the presence of only one adult. Approximately one-third (n = 32) of the perpetrators were males (31 fathers) and two-thirds (n = 59) were females: 49 of them were the infant's nanny and ten were the infant's mother. Infants were not described as crying habitually. Better knowledge of the context of AHT events and risk situations, including recent implementation of a new or unusual modality of childcare, and being the only adult in a home with an infant, should facilitate prevention, including targeted training and avoidance of situations associated with risk. Key Practitioner Messages Abusive events occur in the presence of a single adult, within the privacy of a home. First signs of abuse most commonly occur in a recent, therefore unusual, form of childcare. With rare exceptions, the perpetrator is either the nanny or one of the parents. Identification of the perpetrator and better knowledge of the context of abuse should allow improving targeted prevention.	[Laurent-Vannier, Anne; Chevignard, Mathilde] St Maurice Hosp, Rehabil Dept Children Acquired Neurol Injury, 14 Rue Val Osne, F-94410 St Maurice, France; [Laurent-Vannier, Anne; Chevignard, Mathilde] St Maurice Hosp, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France; [Bernard, Jonathan Y.] Univ Paris, Ctr Res Epidemiol & Stat, INRA, INSERM, Paris, France; [Chevignard, Mathilde] Sorbonne Univ, Lab Imagerie Biomed, Paris, France; [Chevignard, Mathilde] Sorbonne Univ, Handicap Moteur & Cognitif & Readaptat, GRC 24, Paris, France		Laurent-Vannier, A (corresponding author), St Maurice Hosp, Rehabil Dept Children Acquired Neurol Injury, 14 Rue Val Osne, F-94410 St Maurice, France.	a.laurentvannier@gmail.com	Bernard, Jonathan Y./T-7064-2017	Bernard, Jonathan Y./0000-0002-6418-983X; CHEVIGNARD, Mathilde/0000-0002-3533-3564			Adamsbaum C, 2019, J PEDIATR-US, V209, P154, DOI 10.1016/j.jpeds.2019.02.013; Adamsbaum C, 2014, PEDIATR RADIOL, V44, P578, DOI 10.1007/s00247-014-3171-1; Adamsbaum C, 2012, PEDIATR RADIOL, V42, P1298, DOI 10.1007/s00247-012-2434-y; Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; [Anonymous], 2017, SHAK BAB SYNDR NON H; Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bechtel K, 2020, CHILD ABUSE REV, V29, P282, DOI 10.1002/car.2622; Bell E, 2011, CHILD ABUSE NEGLECT, V35, P74, DOI 10.1016/j.chiabu.2010.11.001; Biron D, 2005, CHILD ABUSE NEGLECT, V29, P1347, DOI 10.1016/j.chiabu.2005.05.003; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; Chevignard MP, 2014, PEDIATR RADIOL, V44, P548, DOI 10.1007/s00247-014-3169-8; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; De Leeuw M, 2013, AM J FOREN MED PATH, V34, P271, DOI 10.1097/PAF.0b013e3182a0a454; De Leeuw M, 2013, AM J FOREN MED PATH, V34, P130, DOI 10.1097/PAF.0b013e31828629ca; Edwards GA, 2020, CHILD ABUSE REV, V29, P253, DOI 10.1002/car.2627; Esernio-Jenssen D, 2011, PEDIATRICS, V127, P649, DOI 10.1542/peds.2010-1770; Fingarson AK, 2019, J PEDIATR-US, V212, P180, DOI 10.1016/j.jpeds.2019.05.040; Gilliland MGF, 1998, J FORENSIC SCI, V43, P723; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Keenan HT, 2010, ACAD PEDIATR, V10, P389, DOI 10.1016/j.acap.2010.08.005; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Laurent-Vannier A., 2011, Annals of Physical and Rehabilitation Medicine, V54, P533, DOI 10.1016/j.rehab.2011.10.003; Laurent-Vannier A., 2011, Annals of Physical and Rehabilitation Medicine, V54, P600, DOI 10.1016/j.rehab.2011.10.002; Laurent-Vannier A., 2011, Annals of Physical and Rehabilitation Medicine, V54, P531, DOI 10.1016/j.rehab.2011.10.004; Laurent-Vannier A, 2020, CHILD ABUSE REV, V29, P231, DOI 10.1002/car.2638; Laurent-Vannier AS, 2014, PEDIATR RADIOL, V44, P654, DOI 10.1007/s00247-014-3157-z; Nahmani S., 2018, THESIS U PARIS DIDER; Ronning MM, 2018, PEDIATR RADIOL, V48, P1915, DOI 10.1007/s00247-018-4237-2; Schnitzer PG, 2005, PEDIATRICS, V116, pE687, DOI 10.1542/peds.2005-0296; Scribano PV, 2013, CHILD ABUSE NEGLECT, V37, P771, DOI 10.1016/j.chiabu.2013.04.011; Simonnet H, 2014, CHILD ABUSE NEGLECT, V38, P1914, DOI 10.1016/j.chiabu.2014.06.002; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STARLING SP, 1995, PEDIATRICS, V95, P259; Vinchon M, 2010, CHILD NERV SYST, V26, P1195, DOI 10.1007/s00381-010-1105-2; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005; Willman KY, 1997, CHILD ABUSE NEGLECT, V21, P929, DOI 10.1016/S0145-2134(97)00054-9	38	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-9136	1099-0852		CHILD ABUSE REV	Child Abus. Rev.	JUL	2021	30	4					283	299		10.1002/car.2694		JUN 2021	17	Family Studies; Social Work	Social Science Citation Index (SSCI)	Family Studies; Social Work	UP4AY	WOS:000658474500001		hybrid			2022-02-06	
J	Zideman, DA; Singletary, EM; Borra, V; Cassan, P; Cimpoesu, CD; De Buck, E; Handley, AJ; Klaassen, B; Meyran, D; Oliver, E				Zideman, David A.; Singletary, Eunice M.; Borra, Vere; Cassan, Pascal; Cimpoesu, Carmen D.; De Buck, Emmy; Handley, Anthony J.; Klaassen, Barry; Meyran, Daniel; Oliver, Emily			First aid European Resuscitation Council Guidelines 2021	NOTFALL & RETTUNGSMEDIZIN			German	Article						Recovery position; Anaphylaxis; Heat stroke; Cervical spine motion restrictions; Dental avulsion	RANDOMIZED CONTROLLED-TRIAL; CARBOHYDRATE-ELECTROLYTE BEVERAGE; 2015 INTERNATIONAL CONSENSUS; ACUTE MYOCARDIAL-INFARCTION; COUNTER-PRESSURE MANEUVERS; AMERICAN-HEART-ASSOCIATION; TRAUMATIC DENTAL INJURIES; NORMOBARIC OXYGEN-THERAPY; FOOD-INDUCED ANAPHYLAXIS; METERED-DOSE INHALER	The European Resuscitation Council has produced these first aid guidelines, which are based on the 2020 International Consensus on Cardiopulmonary Resuscitation Science with Treatment Recommendations. The topics include the first aid management of emergency medicine and trauma. For medical emergencies the following content is covered: recovery position, optimal positioning for shock, bronchodilator administration for asthma, recognition of stroke, early aspirin for chest pain, second dose of adrenaline for anaphylaxis, management of hypoglycaemia, oral rehydration solutions for treating exertion-related dehydration, management of heat stroke by cooling, supplemental oxygen in acute stroke, and presyncope. For trauma-related emergencies the following topics are covered: control of life-threatening bleeding, management of open chest wounds, cervical spine motion restriction and stabilisation, recognition of concussion, cooling of thermal burns, dental avulsion, compression wrap for closed extremity joint injuries, straightening an angulated fracture, and eye injury from chemical exposure.	[Zideman, David A.] Thames Valley Air Ambulance, Stokenchurch, England; [Singletary, Eunice M.] Univ Virginia, Dept Emergency Med, Charlottesville, VA USA; [Borra, Vere; De Buck, Emmy] Belgian Red Cross, Ctr Evidence Based Practice, Mecheln, Belgium; [Borra, Vere; De Buck, Emmy] Cochrane First Aid, Mecheln, Belgium; [Cassan, Pascal] Int Federat Red Cross & Red Crescent, Paris, France; [Cimpoesu, Carmen D.] Univ Med & Pharm Grigore T Popa, Emergency Dept, Iasi, Romania; [Cimpoesu, Carmen D.] Univ Med & Pharm Grigore T Popa, Prehosp EMS SMURD Iasi Emergency Cty Hosp Sf Spir, Iasi, Romania; [De Buck, Emmy] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Fac Med, Lowen, Belgium; [Klaassen, Barry] Ninewells Hosp, Emergency Med, Dundee, Scotland; [Klaassen, Barry] Med Sch Dundee, Dundee, Scotland; [Klaassen, Barry; Oliver, Emily] British Red Cross, Reading, Berks, England; [Meyran, Daniel] French Red Cross, Bataillon Marins Pompiers Marseille, Marseille, France		Zideman, DA (corresponding author), Thames Valley Air Ambulance, Stokenchurch, England.	vandenesch@gmx.de					Abram S, 2010, SURG-J R COLL SURG E, V8, P218, DOI 10.1016/j.surge.2010.01.002; Adams WM, 2014, J STRENGTH COND RES, V28, P2380, DOI 10.1519/JSC.0000000000000501; Adnet F, 1999, CRIT CARE MED, V27, P745, DOI 10.1097/00003246-199904000-00028; Akkus S, 2016, AM J EMERG MED, V34, P1959, DOI 10.1016/j.ajem.2016.06.105; Ali K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059274, 10.1371/journal.pone.0068161]; Amini A, 2015, TRAUMA MON, V20, pE23862; Amirav I, 2007, J AEROSOL MED, V20, P1, DOI 10.1089/jam.2006.0561; Andersson L, 2012, DENT TRAUMATOL, V28, P88, DOI 10.1111/j.1600-9657.2012.01125.x; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P59; [Anonymous], 2017, Br J Sports Med, V51, P872, DOI 10.1136/bjsports-2017-097508CRT5; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 1988, LANCET, V2, P349; Arai YCP, 2005, ANESTH ANALG, V100, P949, DOI 10.1213/01.ANE.0000148126.53015.F9; Arai YCP, 2004, ANESTH ANALG, V99, P1638, DOI 10.1213/01.ANE.0000135637.95853.1C; Arbel J, 2011, EUROINTERVENTION, V6, P1104, DOI 10.4244/EIJV6I9A192; Asimos AW, 2014, ANN EMERG MED, V64, P509, DOI 10.1016/j.annemergmed.2014.03.024; Ayling John, 2004, Emerg Med Serv, V33, P44; Balzer JO, 2007, EUR RADIOL, V17, P693, DOI 10.1007/s00330-006-0279-1; Banerji A, 2010, ALLERGY ASTHMA PROC, V31, P308, DOI 10.2500/aap.2010.31.3375; Baradaran-Rafii A, 2017, OCUL SURF, V15, P48, DOI 10.1016/j.jtos.2016.09.002; Barbash IM, 2002, CARDIOLOGY, V98, P141, DOI 10.1159/000066324; Bartlett N, 2008, J BURN CARE RES, V29, P828, DOI 10.1097/BCR.0b013e3181855c9a; Bartoletti A, 2008, EUR HEART J, V29, P618, DOI 10.1093/eurheartj/ehm563; Beaven A, 2017, MIL MED, V182, pE1929, DOI 10.7205/MILMED-D-16-00298; Behler RH, 2009, ULTRASONIC IMAGING, V31, P159, DOI 10.1177/016173460903100302; Bendahou M, 2014, AM J EMERG MED, V32, P1005, DOI 10.1016/j.ajem.2014.05.054; Bennett MT, 2015, HEART, V101, P1591, DOI 10.1136/heartjnl-2014-306627; BENTUR L, 1992, PEDIATRICS, V89, P133; Bequette BW, 2017, WILD ENVIRON MED, V28, P84, DOI 10.1016/j.wem.2017.01.030; Berger WE, 2006, CURR MED RES OPIN, V22, P1217, DOI 10.1185/030079906X112534; Bergs J, 2010, EUR J EMERG MED, V17, P2, DOI 10.1097/MEJ.0b013e32831040ec; Beynnon BD, 2006, AM J SPORT MED, V34, P1401, DOI 10.1177/0363546506288676; Bilgic S, 2015, PAK J MED SCI, V31, P1496, DOI 10.12669/pjms.316.8210; Bleakley CM, 2012, BRIT J SPORT MED, V46, P220, DOI 10.1136/bjsports-2011-090297; Borra V, 2020, J ATHL TRAINING, V55, P789, DOI 10.4085/1062-6050-0093.20; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Boulanger H, 2014, J VASC ACCESS, V15, P102, DOI 10.5301/jva.5000176; Bouvette CM, 1996, MAYO CLIN PROC, V71, P847, DOI 10.4065/71.9.847; Boyce SH, 2005, BRIT J SPORT MED, V39, P91, DOI 10.1136/bjsm.2003.009233; Bracard S, 2016, LANCET NEUROL, V15, P1138, DOI 10.1016/S1474-4422(16)30177-6; Bray JE, 2010, STROKE, V41, P1363, DOI 10.1161/STROKEAHA.109.571836; Bray JE, 2005, CEREBROVASC DIS, V20, P28, DOI 10.1159/000086201; Bridgman SA, 2003, EMERG MED J, V20, P508, DOI 10.1136/emj.20.6.508; Brignole M, 2002, J AM COLL CARDIOL, V40, P2053, DOI 10.1016/S0735-1097(02)02683-9; Brockow K, 2015, ALLERGY, V70, P227, DOI 10.1111/all.12548; Carlson JN, 2020, CUREUS, V12, DOI 10.7759/cureus.11401; Carlson JN, 2017, EMERG MED J, V34, P100, DOI 10.1136/emermed-2015-205637; Carter R, 2006, J APPL PHYSIOL, V101, P1744, DOI 10.1152/japplphysiol.00200.2006; Carter R, 2008, CURR SPORT MED REP, V7, pS20, DOI 10.1249/JSR.0b013e31817f38ff; Chang CQ, 2010, CHINESE MED J-PEKING, V123, P3220, DOI 10.3760/cma.j.issn.0366-6999.2010.22.009; Charlton NP, 2020, PREHOSP EMERG CARE, V25, P1; Chen SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070742; Chenkin J, 2009, PREHOSP EMERG CARE, V13, P153, DOI 10.1080/10903120802706146; Chlan LL, 2005, NURS RES, V54, P391, DOI 10.1097/00006199-200511000-00005; Clarke DA, 2010, J PEDIATR-US, V156, P1019, DOI 10.1016/j.jpeds.2010.01.035; Cowley A, 2017, EUR J EMERG MED, V24, P158, DOI 10.1097/MEJ.0000000000000424; Crandall CG, 2010, ACTA PHYSIOL, V199, P407, DOI 10.1111/j.1748-1716.2010.02119.x; Croci F, 2004, EUROPACE, V6, P287, DOI 10.1016/j.eupc.2004.03.008; Cuttle L, 2008, WOUND REPAIR REGEN, V16, P626, DOI 10.1111/j.1524-475X.2008.00413.x; Davies G, 1996, INJURY, V27, P647, DOI 10.1016/S0020-1383(96)00115-5; De Brier N, 2020, DENT TRAUMATOL, V36, P453, DOI 10.1111/edt.12564; De Buck E, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013283.pub2; Djarv T, 2020, CUREUS, V12, DOI 10.7759/cureus.6862; Domergue S, 2015, J BURN CARE RES, V36, pE259, DOI 10.1097/BCR.0000000000000167; Douma MJ, 2020, RESUSCITATION, V148, P173, DOI 10.1016/j.resuscitation.2020.01.007; Dubois B, 2020, BRIT J SPORT MED, V54, P72, DOI 10.1136/bjsports-2019-101253; Dylla L, 2020, AM J EMERG MED, V38, P2324, DOI 10.1016/j.ajem.2019.11.002; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Elwood P C, 1979, J R Coll Gen Pract, V29, P413; EMBERSON J, 2014, LANCET, V384, P1929, DOI [DOI 10.1016/S0140-6736(14)60584-5, 10.1016/S0140-6736(14)60584-5]; EMERMAN CL, 1990, AM J EMERG MED, V8, P512, DOI 10.1016/0735-6757(90)90153-Q; Evans GH, 2017, J APPL PHYSIOL, V122, P945, DOI 10.1152/japplphysiol.00745.2016; Flores-Salamanca R, 2014, APPL PHYSIOL NUTR ME, V39, P1175, DOI 10.1139/apnm-2013-0576; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Freimark D, 2002, AM J CARDIOL, V89, P381, DOI 10.1016/S0002-9149(01)02256-1; Freire-Tellado M, 2017, RESUSCITATION, V115, P173, DOI 10.1016/j.resuscitation.2017.03.008; Freire-Tellado M, 2016, RESUSCITATION, V105, pE1, DOI 10.1016/j.resuscitation.2016.01.040; Frilling B, 2001, AM HEART J, V141, P200, DOI 10.1067/mhj.2001.112681; GAFFNEY FA, 1982, J TRAUMA, V22, P190, DOI 10.1097/00005373-198203000-00003; Gibson Rudy, 2016, J Spec Oper Med, V16, P21; Gibson Rudy, 2016, J Spec Oper Med, V16, P29; Glick Y, 2018, MIL MED, V183, P157, DOI 10.1093/milmed/usx169; GONZALEZALONSO J, 1992, INT J SPORTS MED, V13, P399, DOI 10.1055/s-2007-1021288; Groothuis JT, 2007, CLIN SCI, V112, P193, DOI 10.1042/CS20060241; Guo JY, 2011, CHIN J TRAUMATOL, V14, P151, DOI 10.3760/cma.j.issn.1008-1275.2011.03.005; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Harcke HT, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3447; Harris PR, 2019, J INT SOC SPORT NUTR, V16, DOI 10.1186/s12970-019-0282-y; Hasler RM, 2012, J TRAUMA ACUTE CARE, V72, P975, DOI 10.1097/TA.0b013e31823f5e8e; Hauswald M, 1998, ACAD EMERG MED, V5, P214, DOI 10.1111/j.1553-2712.1998.tb02615.x; Heldenberg Eitan, 2015, Disaster Mil Med, V1, P1, DOI 10.1186/2054-314X-1-1; Hermansen MN, 2006, CHEST, V129, P1203, DOI 10.1378/chest.129.5.1203; Hertel J, 2002, J ATHL TRAINING, V37, P364; Hettiaratchy S, 2004, BRIT MED J, V328, P1555, DOI 10.1136/bmj.328.7455.1555; How CK, 2000, AM J EMERG MED, V18, P474, DOI 10.1053/ajem.2000.7349; Iguchi Y, 2011, CEREBROVASC DIS, V31, P51, DOI 10.1159/000320854; Inoue N, 2013, ASIA PAC ALLERGY, V3, P106, DOI 10.5415/apallergy.2013.3.2.106; Ismail I., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P769; Jabot J, 2009, INTENS CARE MED, V35, P85, DOI 10.1007/s00134-008-1293-3; Jacobs Lenworth, 2014, Am J Disaster Med, V9, P67, DOI 10.5055/ajdm.2014.0143; Jarvinen KM, 2008, J ALLERGY CLIN IMMUN, V122, P133, DOI 10.1016/j.jaci.2008.04.031; James LJ, 2015, EUR J APPL PHYSIOL, V115, P2621, DOI 10.1007/s00421-015-3254-1; James LJ, 2014, AMINO ACIDS, V46, P1217, DOI 10.1007/s00726-014-1680-8; Jandera V, 2000, BURNS, V26, P265, DOI 10.1016/S0305-4179(99)00133-3; Jensen JL, 2020, PREHOSP EMERG CARE, V24, P64, DOI 10.1080/10903127.2019.1605431; Jimenez-Pavon D, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0088-5; Julliand S, 2016, ARCH DIS CHILD, V101, P521, DOI 10.1136/archdischild-2015-308857; Kalman DS, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-1; Kang SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181099; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P305, DOI 10.2106/00004623-199173020-00021; Karpel JP, 1997, CHEST, V112, P348, DOI 10.1378/chest.112.2.348; KATCHERIAN DA, 1994, ORTHOP CLIN N AM, V25, P69; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Keen DA, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0129-8; Keikhavani A, 2016, CLIN CARDIA ELECTROP, V1, P5348; Kenefick RW, 2007, SPORTS MED, V37, P378, DOI 10.2165/00007256-200737040-00027; Kheirabadi BS, 2013, J TRAUMA ACUTE CARE, V75, P150, DOI 10.1097/TA.0b013e3182988afe; Kidwell CS, 2000, STROKE, V31, P71, DOI 10.1161/01.STR.31.1.71; Kim JG, 2020, HONG KONG J EMERG ME, V27, P24, DOI 10.1177/1024907918809499; Kim KH, 2005, CIRC J, V69, P1084, DOI 10.1253/circj.69.1084; Kolb JC, 1999, AM J EMERG MED, V17, P135, DOI 10.1016/S0735-6757(99)90044-X; Kordestani SS, 2012, CLIN APPL THROMB-HEM, V18, P501, DOI 10.1177/1076029611432745; Korenblat P, 1999, ALLERGY ASTHMA PROC, V20, P383, DOI 10.2500/108854199778251834; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Krediet CTP, 2008, CLIN AUTON RES, V18, P179, DOI 10.1007/s10286-008-0481-0; Krediet CTP, 2002, CIRCULATION, V106, P1684, DOI 10.1161/01.CIR.0000030939.12646.8F; Kulnik ST, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033531; Kwan I., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.Cd002803, DOI 10.1002/14651858.CD002803]; Lam R, 2016, AUST DENT J, V61, P4, DOI 10.1111/adj.12395; Lau WY, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2018-000478; Leanderson J, 1995, ACTA ORTHOP SCAND, V66, P529, DOI 10.3109/17453679509002308; Lehmann KG, 1999, AM HEART J, V138, P1118, DOI 10.1016/S0002-8703(99)70078-5; Lemyze M, 2011, EMERG MED J, V28, P532, DOI 10.1136/emj.2010.106625; Lewis CJ, 2017, J PLAST RECONSTR AES, V70, P563, DOI 10.1016/j.bjps.2017.02.013; Liao AY, 2014, BURNS, V40, P443, DOI 10.1016/j.burns.2013.08.006; Lin CB, 2012, CIRC-CARDIOVASC QUAL, V5, P514, DOI 10.1161/CIRCOUTCOMES.112.965210; LINDE F, 1984, SCAND J REHABIL MED, V16, P177; LIPSITZ LA, 1985, Q J MED, V55, P45; Litarowsky Jean A, 2004, J Sch Nurs, V20, P279; Litman RS, 2005, ANESTHESIOLOGY, V103, P484, DOI 10.1097/00000542-200509000-00009; LITTNER MR, 1983, ANN ALLERGY, V50, P309; Lott C, 2021, NOTFALL RETTUNGSMED, V24, P447, DOI 10.1007/s10049-021-00891-z; Lyles William E 3rd, 2015, J Spec Oper Med, V15, P21; Marcano-Caldera M, 2018, DENT TRAUMATOL, V34, P164, DOI 10.1111/edt.12393; March Juan A, 2002, Prehosp Emerg Care, V6, P421, DOI 10.1080/10903120290938067; Markenson D, 2010, CIRCULATION, V122, pS934, DOI 10.1161/CIRCULATIONAHA.110.971150; Masento NA, 2014, BRIT J NUTR, V111, P1841, DOI 10.1017/S0007114513004455; Matias A, 2019, J INT SOC SPORT NUTR, V16, DOI 10.1186/s12970-019-0273-z; Mazdeh Mehrdokht, 2015, Acta Med Iran, V53, P676; McConnell MKT, 2012, J CARDIOVASC NURS, V27, pE1, DOI 10.1097/JCN.0b013e318223881b; McGrath T, 2009, WILD ENVIRON MED, V20, P166, DOI 10.1580/08-WEME-BR-220R1.1; McKenna ZJ, 2017, J STRENGTH COND RES, V31, P2965, DOI 10.1519/JSC.0000000000001871; Medoro I, 2017, PREHOSP EMERG CARE, V21, P476, DOI 10.1080/10903127.2017.1294222; Meyran D, 2020, CUREUS, V12, DOI 10.7759/cureus.11386; Mlekusch W, 2006, J ENDOVASC THER, V13, P23, DOI 10.1583/05-1679.1; Montgomery Harold R, 2019, J Spec Oper Med, V19, P27; Naimer SA, 2006, MIL MED, V171, P644, DOI 10.7205/MILMED.171.7.644; Narins CR, 2008, J INVASIVE CARDIOL, V20, P579; Navarro-Paton R, 2019, RESUSCITATION, V134, P104, DOI 10.1016/j.resuscitation.2018.10.030; Nguyen N, 2007, CATHETER CARDIO INTE, V69, P801, DOI 10.1002/ccd.21024; Nguyen NL, 2002, BURNS, V28, P173, DOI 10.1016/S0305-4179(01)00094-8; Niksefat M., 2019, Acta Medica Bulgarica, V46, P43, DOI 10.2478/amb-2019-0008; Noimark L, 2012, CLIN EXP ALLERGY, V42, P284, DOI 10.1111/j.1365-2222.2011.03912.x; O'Brien W, 2012, J CLIN NEUROSCI, V19, P241, DOI 10.1016/j.jocn.2011.06.009; O'Connor G, 2011, EUR J EMERG MED, V18, P225, DOI 10.1097/MEJ.0b013e3283440efd; O'Conor Daniel K, 2017, J Spec Oper Med, V17, P27; Oliver M, 2012, INJURY, V43, P1296, DOI 10.1016/j.injury.2012.04.021; Oren E, 2007, ANN ALLERG ASTHMA IM, V99, P429, DOI 10.1016/S1081-1206(10)60568-6; OSMOND MH, 1995, ACAD EMERG MED, V2, P651, DOI 10.1111/j.1553-2712.1995.tb03607.x; Ostenson CG, 2014, DIABETIC MED, V31, P92, DOI 10.1111/dme.12261; Osterberg KL, 2010, J APPL PHYSIOL, V108, P245, DOI 10.1152/japplphysiol.91275.2008; Ottosen CI, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0647-x; Ozer Sezin, 2012, Eur J Dent, V6, P370; Pabian PS, 2017, PHYS THER SPORT, V23, P123, DOI 10.1016/j.ptsp.2016.09.006; Padma MV, 2010, ANN INDIAN ACAD NEUR, V13, P284, DOI 10.4103/0972-2327.74203; Pargament JM, 2015, CLIN DERMATOL, V33, P234, DOI 10.1016/j.clindermatol.2014.10.015; Perez-Idarraga A, 2014, APPL PHYSIOL NUTR ME, V39, P1167, DOI 10.1139/apnm-2013-0434; Perkins GD, 2021, NOTFALL RETTUNGSMED, V24, P274, DOI 10.1007/s10049-021-00883-z; Politiek MJ, 1999, EUR RESPIR J, V13, P988, DOI 10.1034/j.1399-3003.1999.13e10.x; Quan Dan, 2004, Prehosp Disaster Med, V19, P362; Rajan V, 2009, J BURN CARE RES, V30, P729, DOI 10.1097/BCR.0b013e3181ac059b; Ritwik P, 2015, DENT TRAUMATOL, V31, P97, DOI 10.1111/edt.12148; Roffe C, 2017, JAMA-J AM MED ASSOC, V318, P1125, DOI 10.1001/jama.2017.11463; Roffe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019113; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rostykus P, 2016, PREHOSP EMERG CARE, V20, P524, DOI 10.3109/10903127.2015.1128031; RUCINSKI T J, 1991, Journal of Orthopaedic and Sports Physical Therapy, V14, P65; Rudders SA, 2010, ANN ALLERG ASTHMA IM, V105, P85, DOI 10.1016/j.anai.2010.05.004; Rudders SA, 2010, PEDIATRICS, V125, pE711, DOI 10.1542/peds.2009-2832; Saat Mohamed, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P93, DOI 10.2114/jpa.21.93; Sahni GS, 2013, ANN TROP MED PUBLIC, V6, P89, DOI 10.4103/1755-6783.115203; Sairaku A, 2011, J INTERV CARD ELECTR, V31, P157, DOI 10.1007/s10840-011-9552-6; Sako A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007271; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Savoie FA, 2015, SPORTS MED, V45, P1207, DOI 10.1007/s40279-015-0349-0; Scerbo MH, 2017, J TRAUMA ACUTE CARE, V83, P1165, DOI 10.1097/TA.0000000000001666; Schlemm E, 2017, STROKE, V48, P2184, DOI 10.1161/STROKEAHA.117.017281; Schneider AM, 2007, SPINE, V32, pE1, DOI 10.1097/01.brs.0000251019.24917.44; Schwarz T, 2009, VASA-J VASCULAR DIS, V38, P53, DOI 10.1024/0301-1526.38.1.53; Seery S, 2016, BRIT J NUTR, V116, P1013, DOI 10.1017/S0007114516002907; Seifert J, 2006, INT J SPORT NUTR EXE, V16, P420, DOI 10.1123/ijsnem.16.4.420; Serletis A, 2006, EUR HEART J, V27, P1965, DOI 10.1093/eurheartj/ehl147; Shirreffs SM, 2007, BRIT J NUTR, V98, P173, DOI 10.1017/S0007114507695543; Simonsson M, 2020, EUR HEART J, V41, P833, DOI 10.1093/eurheartj/ehz593; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singletary EM, 2020, RESUSCITATION, V156, pA240, DOI 10.1016/j.resuscitation.2020.09.016; Singletary EM, 2020, CIRCULATION, V142, pS284, DOI 10.1161/CIR.0000000000000897; Singletary EM, 2015, CIRCULATION, V132, pS574, DOI 10.1161/CIR.0000000000000269; Singletary EM, 2015, CIRCULATION, V132, pS269, DOI 10.1161/CIR.0000000000000278; Skinner AM, 2004, BURNS, V30, P82, DOI 10.1016/j.burns.2003.09.009; Sundstrom T, 2014, J NEUROTRAUM, V31, P531, DOI 10.1089/neu.2013.3094; Svatikova A, 2011, SLEEP MED, V12, P262, DOI 10.1016/j.sleep.2010.12.008; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teixeira PGR, 2018, J AM COLL SURGEONS, V226, P769, DOI 10.1016/j.jamcollsurg.2018.01.047; TENHARKEL ADJ, 1994, CLIN SCI, V87, P553, DOI 10.1042/cs0870553; Thomas DT, 2016, J ACAD NUTR DIET, V116, P501, DOI 10.1016/j.jand.2015.12.006; Tomaino M, 2014, EUROPACE, V16, P1515, DOI 10.1093/europace/euu125; Toppen W, 2020, J INTENSIVE CARE MED, V35, P1123, DOI 10.1177/0885066618820492; Trabattoni D, 2012, INT J CARDIOL, V156, P53, DOI 10.1016/j.ijcard.2010.10.030; Turkington PM, 2002, STROKE, V33, P2037, DOI 10.1161/01.STR.0000023576.94311.27; Utter AC, 2010, RES SPORTS MED, V18, P85, DOI 10.1080/15438620903321102; Valiente JS, 2009, J STRENGTH COND RES, V23, P2210, DOI 10.1519/JSC.0b013e3181bac56e; van der Woude HJ, 2004, RESP MED, V98, P816, DOI 10.1016/j.rmed.2004.03.001; van Dijk N, 2006, J AM COLL CARDIOL, V48, P1652, DOI 10.1016/j.jacc.2006.06.059; VERHEUGT FWA, 1990, AM J CARDIOL, V66, P267, DOI 10.1016/0002-9149(90)90833-M; Volterman KA, 2014, APPL PHYSIOL NUTR ME, V39, P1257, DOI 10.1139/apnm-2014-0047; Walker S B, 2001, Int J Nurs Pract, V7, P366, DOI 10.1046/j.1440-172X.2001.00291.x; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Waragai T, 2011, CATHETER CARDIO INTE, V78, P262, DOI 10.1002/ccd.23057; Weidman J, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0153-8; WEISS SJ, 1994, ANN EMERG MED, V24, P873, DOI 10.1016/S0196-0644(94)70205-5; Wieling W, 1996, J PHYSIOL-LONDON, V494, P601, DOI 10.1113/jphysiol.1996.sp021518; Wijnen AHC, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00045; Wojner-Alexandrov AW, 2005, STROKE, V36, P1512, DOI 10.1161/01.STR.0000170700.45340.39; WONG DH, 1989, CRIT CARE MED, V17, P979, DOI 10.1097/00003246-198910000-00002; Wong SH, 2000, INT J SPORT NUTR EXE, V10, P375, DOI 10.1123/ijsnem.10.4.375; Wong SHS, 2011, INT J SPORT NUTR EXE, V21, P300; Wright EH, 2019, BRIT J SURG, V106, P1472, DOI 10.1002/bjs.11263; Wu O, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-5; YAQUB BA, 1986, Q J MED, V59, P523; Yava A, 2012, EMERG MED J, V29, P544, DOI 10.1136/emj.2010.098053; Zhelev Z, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011427.pub2; Zhu ZhongSheng, 2010, Journal of Chinese Clinical Medicine, V5, P582; Zideman DA, 2015, RESUSCITATION, V95, pE225, DOI 10.1016/j.resuscitation.2015.07.047; Zideman DA, 2015, RESUSCITATION, V95, P278, DOI 10.1016/j.resuscitation.2015.07.031	247	3	3	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	JUN	2021	24	4			SI		577	602		10.1007/s10049-021-00886-w		JUN 2021	26	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SS7AF	WOS:000657231500004		Bronze			2022-02-06	
J	D'Amico, R; Salinaro, AT; Fusco, R; Cordaro, M; Impellizzeri, D; Scuto, M; Ontario, ML; Lo Dico, G; Cuzzocrea, S; Di Paola, R; Siracusa, R; Calabrese, V				D'Amico, Ramona; Trovato Salinaro, Angela; Fusco, Roberta; Cordaro, Marika; Impellizzeri, Daniela; Scuto, Maria; Ontario, Maria Laura; Lo Dico, Gianluigi; Cuzzocrea, Salvatore; Di Paola, Rosanna; Siracusa, Rosalba; Calabrese, Vittorio			Hericium erinaceus and Coriolus versicolor Modulate Molecular and Biochemical Changes after Traumatic Brain Injury	ANTIOXIDANTS			English	Article						brain trauma; neurodegeneration; neuroinflammation; oxidative stress; mushrooms	CELLULAR STRESS-RESPONSE; LIPOXIN A4 EXPRESSION; NF-KAPPA-B; ALZHEIMERS-DISEASE; INFLAMMATORY RESPONSE; REDOX MODULATION; HEAD-INJURY; ACTIVATION; PATHOLOGIES; ASSOCIATION	Traumatic brain injury (TBI) is a major health and socioeconomic problem affecting the world. This condition results from the application of external physical force to the brain which leads to transient or permanent structural and functional impairments. TBI has been shown to be a risk factor for neurodegeneration which can lead to Parkinson's disease (PD) for example. In this study, we wanted to explore the development of PD-related pathology in the context of an experimental model of TBI and the potential ability of Coriolus versicolor and Hericium erinaceus to prevent neurodegenerative processes. Traumatic brain injury was induced in mice by controlled cortical impact. Behavioral tests were performed at various times: the animals were sacrificed 30 days after the impact and the brain was processed for Western blot and immunohistochemical analyzes. After the head injury, a significant decrease in the expression of tyrosine hydroxylase and the dopamine transporter in the substantia nigra was observed, as well as significant behavioral alterations that were instead restored following daily oral treatment with Hericium erinaceus and Coriolus versicolor. Furthermore, a strong increase in neuroinflammation and oxidative stress emerged in the vehicle groups. Treatment with Hericium erinaceus and Coriolus versicolor was able to prevent both the neuroinflammatory and oxidative processes typical of PD. This study suggests that PD-related molecular events may be triggered on TBI and that nutritional fungi such as Hericium erinaceus and Coriolus versicolor may be important in redox stress response mechanisms and neuroprotection, preventing the progression of neurodegenerative diseases such as PD.	[D'Amico, Ramona; Fusco, Roberta; Impellizzeri, Daniela; Cuzzocrea, Salvatore; Di Paola, Rosanna; Siracusa, Rosalba] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, I-98166 Messina, Italy; [Trovato Salinaro, Angela; Scuto, Maria; Ontario, Maria Laura; Lo Dico, Gianluigi; Calabrese, Vittorio] Univ Catania, Dept Biomed & Biotechnol Sci, I-95125 Catania, Italy; [Cordaro, Marika] Univ Messina, Dept Biomed Dent & Morphol & Funct Imaging, Via Consolare Valeria, I-98125 Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA		Cuzzocrea, S; Di Paola, R (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, I-98166 Messina, Italy.; Cuzzocrea, S (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	rdamico@unime.it; trovato@unict.it; rfusco@unime.it; marika.cordaro@unime.it; dimpellizzeri@unime.it; mary-amir@hotmail.it; marialaura.ontario@ontariosrl.it; gigilodico@gmail.com; salvator@unime.it; dipaolar@unime.it; rsiracusa@unime.it; calabres@unict.it	Ontario, Maria Laura/AAC-7849-2022; Cordaro, Marika/K-7329-2016; Siracusa, Rosalba/AAC-3110-2022; Trovato Salinaro, Angela/AAC-1326-2022; D'Amico, Ramona/AAC-9061-2019; di paola, rosanna/U-4356-2019	Cordaro, Marika/0000-0002-3980-0043; Siracusa, Rosalba/0000-0001-7868-2505; Cuzzocrea, Salvatore/0000-0001-6131-3690; TROVATO SALINARO, Angela/0000-0003-2377-858X; Scuto, Maria/0000-0003-1019-5158; D'Amico, Ramona/0000-0003-0389-3871; di paola, rosanna/0000-0001-6725-8581	"Piano di incentivi per la Ricerca, Linea Intervento 2 PIACERI, 2020-2022", University of Catania, Italy	This study was supported by grants from "Piano di incentivi per la Ricerca, Linea Intervento 2 PIACERI, 2020-2022", University of Catania, Italy.	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bonito-Oliva A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00290; Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002; Campolo M, 2019, BRAIN BEHAV IMMUN, V76, P236, DOI 10.1016/j.bbi.2018.12.003; Campolo M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0196-1; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crupi R, 2018, MOL NEUROBIOL, V55, P8455, DOI 10.1007/s12035-018-0959-2; Delic V, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00924-7; Fang XY, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/128394; Friedman M, 2015, J AGR FOOD CHEM, V63, P7108, DOI 10.1021/acs.jafc.5b02914; Fusco R, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9090238; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gugliandolo E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00590; Hall E.E., 2014, J ALZHEIMERS DIS PAR, V4, P1, DOI [10.4172/2161-0460.1000137, DOI 10.4172/2161-0460.1000137]; Impellizzeri D, 2017, J NEUROTRAUM, V34, P2609, DOI 10.1089/neu.2016.4808; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jang HJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040859; Jullienne A, 2013, FUTUR NEUROL, V8, P677, DOI 10.2217/FNL.13.55; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lizhnyak PN, 2015, EXPERT REV PROTEOMIC, V12, P75, DOI 10.1586/14789450.2015.1000869; Monro JA, 2003, ARCH ENVIRON HEALTH, V58, P533, DOI 10.3200/AEOH.58.8.533-537; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rappold PM, 2010, NEUROTHERAPEUTICS, V7, P413, DOI 10.1016/j.nurt.2010.07.001; Saleh MH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01087; Salinaro AT, 2018, IMMUN AGEING, V15, DOI 10.1186/s12979-017-0108-1; Sawant S, 2016, CLIN ORAL INVEST, V20, P43, DOI 10.1007/s00784-015-1476-6; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shi SH, 2016, INT J BIOL MACROMOL, V86, P352, DOI 10.1016/j.ijbiomac.2016.01.058; Siracusa R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090824; Siracusa R, 2016, MOL NEUROBIOL, V53, P3783, DOI 10.1007/s12035-015-9328-6; Sun XW, 2014, INT J BIOL MACROMOL, V69, P12, DOI 10.1016/j.ijbiomac.2014.05.027; Trovato A, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0078-8; Trovato A, 2016, NEUROTOXICOLOGY, V53, P350, DOI 10.1016/j.neuro.2015.09.012; Tsai YC, 2019, J MED FOOD, V22, P469, DOI 10.1089/jmf.2018.4288; Tsai-Teng T, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0266-z; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Wang LY, 2019, MOLECULES, V24, DOI 10.3390/molecules24183317; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	48	3	3	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	JUN	2021	10	6							898	10.3390/antiox10060898			25	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	SX7RO	WOS:000665397400001	34199629	Green Published, gold			2022-02-06	
J	Dowlati, E; Mortazavi, A; Keating, G; Jha, RT; Felbaum, DR; Chang, JJ; Nair, MN; Mason, RB; Aulisi, EF; Armonda, RA; Mai, JC				Dowlati, Ehsan; Mortazavi, Armin; Keating, Gregory; Jha, Ribhu Tushar; Felbaum, Daniel R.; Chang, Jason J.; Nair, Mani N.; Mason, Robert B.; Aulisi, Edward F.; Armonda, Rocco A.; Mai, Jeffrey C.			The Retroauricular Incision as an Effective and Safe Alternative Incision for Decompressive Hemicraniectomy	OPERATIVE NEUROSURGERY			English	Article						Complications; Decompressive craniectomy; Hemicraniectomy; Incision; Retroauricular; Surgical wound	TRAUMATIC BRAIN-INJURY; TEMPORAL MUSCLE; CRANIECTOMY; COMPLICATIONS; SIZE	BACKGROUND: The reverse question mark (RQM) incision has been traditionally utilized to perform decompressive hemicraniectomies (DHC) to relieve refractory intracranial hypertension. Alternative incisions have been proposed in the literature but have not been compared directly. OBJECTIVE: To present the retroauricular (RA) incision as an alternative incision that we hypothesize will increase calvarium exposure to maximize the removal of the hemicranium and will decrease wound-related complications compared to the RQM incision. METHODS: This study is a retrospective review of all DHCs performed at our institution over a span of 34 mo, stratified based on the type of scalp incision. The surface areas of the cranial defects were calculated, normalizing to their respective skull diameters. For those patients surviving beyond 1 wk, complications were examined from both cohorts. RESULTS: A total of 63 patients in the RQM group and 43 patients in the RA group were included. The average surface area for the RA and RQM incisions was 117.0 and 107.8 cm(2) (P=.0009), respectively. The ratio of average defect size to skull size for RA incision was 0.81 compared to 0.77 for the RQM group (P=.0163). Of those who survived beyond 1 wk, the absolute risk for surgical site complications was 14.0% and 8.3% for RQM and RA group (P=.5201), respectively. CONCLUSION: The RA incision provides a safe and effective alternative incision to the traditional RQM incision used for DHC. This incision affords a potentially larger craniectomy while mitigating postoperative wound complications.	[Dowlati, Ehsan; Keating, Gregory; Felbaum, Daniel R.; Nair, Mani N.; Armonda, Rocco A.; Mai, Jeffrey C.] MedStar Georgetown Univ Hosp, Dept Neurosurg, 3800 Reservoir Rd NW,PHC7, Washington, DC 20007 USA; [Mortazavi, Armin] Georgetown Univ, Sch Med, Washington, DC USA; [Jha, Ribhu Tushar] Boston Med Ctr, Dept Neurosurg, Boston, MA USA; [Felbaum, Daniel R.; Mason, Robert B.; Aulisi, Edward F.; Armonda, Rocco A.; Mai, Jeffrey C.] MedStar Washington Hosp Ctr, Dept Neurosurg, Washington, DC USA; [Chang, Jason J.] MedStar Washington Hosp Ctr, Dept Crit Care Med, Washington, DC USA		Dowlati, E (corresponding author), MedStar Georgetown Univ Hosp, Dept Neurosurg, 3800 Reservoir Rd NW,PHC7, Washington, DC 20007 USA.	edowlati@gmail.com		Dowlati, Ehsan/0000-0001-6739-0793			Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; ANTONYSHYN O, 1988, BRIT J PLAST SURG, V41, P118, DOI 10.1016/0007-1226(88)90037-9; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; Di Rienzo Alessandro, 2016, Surg Neurol Int, V7, pS737; Grille Pedro, 2015, Rev. bras. ter. intensiva, V27, P113, DOI 10.5935/0103-507X.20150021; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Johnson RD, 2011, J CLIN NEUROSCI, V18, P1023, DOI 10.1016/j.jocn.2010.12.025; Kempe L., 1968, OPER NEUROSURGERY CR, V1, P178; Kourbeti IS, 2011, BRIT J NEUROSURG, V25, P9, DOI 10.3109/02688697.2010.500411; Kurzbuch AR, 2015, NEUROSURG REV, V38, P629, DOI 10.1007/s10143-015-0626-2; Lyon KA, 2019, OPER NEUROSURG, V17, P273, DOI 10.1093/ons/opy399; Missori P, 2013, ACTA NEUROCHIR, V155, P1335, DOI 10.1007/s00701-013-1695-z; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Roberts SAG, 2016, BRIT J NEUROSURG, V30, P529, DOI 10.1080/02688697.2016.1208807; Sedney CL, 2014, J NEUROSCI RURAL PRA, V5, P212, DOI 10.4103/0976-3147.133555; TOLHURST DE, 1991, PLAST RECONSTR SURG, V87, P603, DOI 10.1097/00006534-199104000-00001; Veldeman M, 2021, J NEUROSURG, V134, P1262, DOI 10.3171/2020.2.JNS193335; Vieira E, 2018, J NEUROSURG, V129, P1017, DOI 10.3171/2017.4.JNS152954	21	3	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	JUN	2021	20	6					549	557		10.1093/ons/opab021			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SS1WY	WOS:000661534600039	33571367				2022-02-06	
J	Du, JJ; Zayed, AA; Kigerl, KA; Zane, K; Sullivan, MB; Popovich, PG				Du, Jingjie; Zayed, Ahmed A.; Kigerl, Kristina A.; Zane, Kylie; Sullivan, Matthew B.; Popovich, Phillip G.			Spinal Cord Injury Changes the Structure and Functional Potential of Gut Bacterial and Viral Communities	MSYSTEMS			English	Article						gut dysbiosis; metagenomics; microbiome; spinal cord injury; virome	CENTRAL-NERVOUS-SYSTEM; TRYPTOPHAN-METABOLISM; ANAEROBIC-BACTERIA; PHAGE-LAMBDA; MICROBIOTA; DYSBIOSIS; VIRUSES; VIROME; BRAIN; GENOMES	Emerging data indicate that gut dysbiosis contributes to many human diseases, including several comorbidities that develop after traumatic spinal cord injury (SCI). To date, all analyses of SCI-induced gut dysbiosis have used 16S rRNA amplicon sequencing. This technique has several limitations, including being susceptible to taxonomic "blind spots," primer bias, and an inability to profile microbiota functions or identify viruses. Here, SCI-induced gut dysbiosis was assessed by applying genome-and gene-resolved metagenomic analysis of murine stool samples collected 21 days after an experimental SCI at the 4th thoracic spine (T4) or 10th tho-racic spine (T10) spinal level. These distinct injuries partially (T10) or completely (T4) abolish sympathetic tone in the gut. Among bacteria, 105 medium-to high-quality metagenome-assembled genomes (MAGs) were recovered, with most (n = 96) repre-senting new bacterial species. Read mapping revealed that after SCI, the relative abundance of beneficial commensals (Lactobacillus johnsonii and CAG-1031 spp.) decreased, while potentially pathogenic bacteria (Weissella cibaria, Lactococcus lactis_A, Bacteroides thetaiotaomicron) increased. Functionally, microbial genes encoding proteins for tryptophan, vitamin B-6, and folate biosynthesis, essential pathways for central nervous system function, were reduced after SCI. Among viruses, 1,028 mostly novel viral populations were recovered, expanding known murine gut viral species sequence space similar to 3-fold compared to that of public databases. Phages of beneficial commensal hosts (CAG-1031, Lactobacillus, and Turicibacter) decreased, while phages of pathogenic hosts (Weissella, Lactococcus, and class Clostridia) increased after SCI. Although the microbiomes and viromes were changed in all SCI mice, some of these changes varied as a function of spinal injury level, implicating loss of sympathetic tone as a mechanism underlying gut dysbiosis. IMPORTANCE To our knowledge, this is the first article to apply metagenomics to characterize changes in gut microbial population dynamics caused by a clinically relevant model of central nervous system (CNS) trauma. It also utilizes the most current approaches in genome-resolved metagenomics and viromics to maximize the biological inferences that can be made from these data. Overall, this article high-lights the importance of autonomic nervous system regulation of a distal organ (gut) and its microbiome inhabitants after traumatic spinal cord injury (SCI). By providing information on taxonomy, function, and viruses, metagenomic data may better predict how SCI-induced gut dysbiosis influences systemic and neurological outcomes after SCI.	[Du, Jingjie; Zayed, Ahmed A.; Sullivan, Matthew B.] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Kigerl, Kristina A.; Popovich, Phillip G.] Ohio State Univ, Dept Neurosci, Coll Med, Columbus, OH 43210 USA; [Kigerl, Kristina A.; Popovich, Phillip G.] Ohio State Univ, Coll Med, Belford Ctr Spinal Cord Injury, Columbus, OH 43210 USA; [Kigerl, Kristina A.; Popovich, Phillip G.] Ohio State Univ, Coll Med, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA; [Zane, Kylie] Ohio State Univ, Coll Med, Training Program, Columbus, OH 43210 USA; [Sullivan, Matthew B.] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [Sullivan, Matthew B.] Ohio State Univ, Infect Dis Inst, Columbus, OH 43210 USA; [Zayed, Ahmed A.; Kigerl, Kristina A.; Sullivan, Matthew B.; Popovich, Phillip G.] Ohio State Univ, Ctr Microbiome Sci, Columbus, OH 43210 USA		Sullivan, MB (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.; Popovich, PG (corresponding author), Ohio State Univ, Dept Neurosci, Coll Med, Columbus, OH 43210 USA.; Popovich, PG (corresponding author), Ohio State Univ, Coll Med, Belford Ctr Spinal Cord Injury, Columbus, OH 43210 USA.; Popovich, PG (corresponding author), Ohio State Univ, Coll Med, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA.; Sullivan, MB (corresponding author), Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA.; Sullivan, MB (corresponding author), Ohio State Univ, Infect Dis Inst, Columbus, OH 43210 USA.; Sullivan, MB; Popovich, PG (corresponding author), Ohio State Univ, Ctr Microbiome Sci, Columbus, OH 43210 USA.	sullivan.948@osu.edu; phillip.popovich@osumc.edu	Zayed, Ahmed/ABI-1865-2020; Popovich, Phillip/C-9187-2009	Zayed, Ahmed/0000-0003-2793-2679; Popovich, Phillip/0000-0003-1329-7395	National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R35NS111582]; Belford Center for Spinal Cord Injury; Ray W. Poppleton Research designated endowment; National Institutes of Health Medical Scientist Training ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Gordon and Betty Moore FoundationGordon and Betty Moore Foundation [3790]	This work was funded by a National Institutes of Neurological Disorders and Stroke R35 award (grant no. 1R35NS111582) to P.G.P., The Belford Center for Spinal Cord Injury (P.G.P.), The Ray W. Poppleton Research designated endowment (P.G.P.), a National Institutes of Health Medical Scientist Training Program T32 grant (K.Z.), and a Gordon and Betty Moore Foundation Investigator Award (no. 3790) to M.B.S.	Abeles SR, 2014, J MOL BIOL, V426, P3892, DOI 10.1016/j.jmb.2014.07.002; Abriouel H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01197; Aggarwala V, 2017, MOBILE DNA-UK, V8, DOI 10.1186/s13100-017-0095-y; Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003; Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1; Amgarten D, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00304; Anwar MA, 2008, APPL ENVIRON MICROB, V74, P3426, DOI 10.1128/AEM.00377-08; Anwar MA, 2010, MICROBIOL-SGM, V156, P1264, DOI 10.1099/mic.0.036616-0; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Atsumi S, 2006, P NATL ACAD SCI USA, V103, P4558, DOI 10.1073/pnas.0511117103; Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bereswill S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02436-2; Bobay LM, 2018, P NATL ACAD SCI USA, V115, P6040, DOI 10.1073/pnas.1717593115; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Brook I, 2002, CRIT CARE, V6, P205, DOI 10.1186/cc1490; Browning KN, 2014, COMPR PHYSIOL, V4, P1339, DOI 10.1002/cphy.c130055; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Cao Y, 2017, J SPINAL CORD MED, V40, P85, DOI 10.1080/10790268.2016.1244314; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Chaumeil PA, 2020, BIOINFORMATICS, V36, P1925, DOI 10.1093/bioinformatics/btz848; Chen F, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013658; Chen J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0299-7; Cho EH, 2002, J BACTERIOL, V184, P5200, DOI 10.1128/JB.184.18.5200-5203.2002; Chu C, 2019, NATURE, V574, P543, DOI 10.1038/s41586-019-1644-y; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Deng L, 2014, NATURE, V513, P242, DOI 10.1038/nature13459; Diard M, 2017, SCIENCE, V355, P1211, DOI 10.1126/science.aaf8451; Duerkop BA, 2018, NAT MICROBIOL, V3, P1023, DOI 10.1038/s41564-018-0210-y; Edwards RA, 2016, FEMS MICROBIOL REV, V40, P258, DOI 10.1093/femsre/fuv048; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Emerson JB, 2018, NAT MICROBIOL, V3, P870, DOI 10.1038/s41564-018-0190-y; Emerson JB, 2016, ENVIRON MICROBIOL, V18, P1686, DOI 10.1111/1462-2920.12817; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fann JR, 2011, ARCH PHYS MED REHAB, V92, P352, DOI 10.1016/j.apmr.2010.05.016; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feiner R, 2015, NAT REV MICROBIOL, V13, P641, DOI 10.1038/nrmicro3527; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Fogg PCM, 2011, NUCLEIC ACIDS RES, V39, P2116, DOI 10.1093/nar/gkq923; Fogg PCM, 2014, J MOL BIOL, V426, P2703, DOI 10.1016/j.jmb.2014.05.014; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Fung TC, 2019, NAT MICROBIOL, V4, P2064, DOI 10.1038/s41564-019-0540-4; FURNESS JB, 1979, NEUROSCIENCE, V4, P305, DOI 10.1016/0306-4522(79)90091-5; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Galiez C, 2017, BIOINFORMATICS, V33, P3113, DOI 10.1093/bioinformatics/btx383; Gerth ML, 2012, PROTEIN J, V31, P359, DOI 10.1007/s10930-012-9412-y; Giles LC, 2019, OPEN FORUM INFECT DI, V6; Gittrich M, 2020, ECOLOGY PHAGE RESIST, V2020, DOI [10.20944/preprints202005.0232.v1, DOI 10.20944/PREPRINTS202005.0232.V1]; Glushakova O, 2008, J AM SOC NEPHROL, V19, P1712, DOI 10.1681/ASN.2007121304; Gregory AC, 2020, CELL HOST MICROBE, V28, P724, DOI 10.1016/j.chom.2020.08.003; Gregory AC, 2019, CELL, V177, P1109, DOI 10.1016/j.cell.2019.03.040; Gregory AC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3286-x; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Gungor B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145878; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hayes CL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32366-6; Hernandez SB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002459; Hickey CA, 2015, CELL HOST MICROBE, V17, P672, DOI 10.1016/j.chom.2015.04.002; Howard-Varona C, 2020, ISME J, V14, P881, DOI 10.1038/s41396-019-0580-z; Howard-Varona C, 2017, ISME J, V11, P1511, DOI 10.1038/ismej.2017.16; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Jacobson AN, 2018, MBIO, V9, DOI 10.1128/mBio.02289-17; Jang HB, 2019, NAT BIOTECHNOL, V37, P632, DOI 10.1038/s41587-019-0100-8; Jensen MP, 2007, ARCH PHYS MED REHAB, V88, P638, DOI 10.1016/j.apmr.2007.02.002; Jing YL, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01007-y; Jing YL, 2019, J NEUROTRAUM, V36, P2646, DOI 10.1089/neu.2018.6012; Kaelberer MM, 2018, SCIENCE, V361, P1219, DOI 10.1126/science.aat5236; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang DW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0225-7; Kang WB, 2019, NEURAL REGEN RES, V14, P132, DOI 10.4103/1673-5374.243718; Kennedy DO, 2016, NUTRIENTS, V8, DOI [10.1002/HUP.2236, 10.3390/nu8020068]; Kigerl KA, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113085; Kigerl KA, 2018, NEUROTHERAPEUTICS, V15, P60, DOI 10.1007/s13311-017-0583-2; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Kim MS, 2016, ENVIRON MICROBIOL, V18, P1498, DOI 10.1111/1462-2920.13182; Kuno T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19545-1; Lagkouvardos I, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0637-2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levatte MA, 1998, NEUROSCIENCE, V82, P1253; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma Q, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02625; Ma YF, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0410-y; Mabon PJ, 1997, BRAIN RES, V753, P245, DOI 10.1016/S0006-8993(97)00010-3; Manrique P, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060141; Manrique P, 2016, P NATL ACAD SCI USA, V113, P10400, DOI 10.1073/pnas.1601060113; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Migliorini C, 2008, AUST NZ J PSYCHIAT, V42, P309, DOI 10.1080/00048670801886080; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Moreno-Gallego JL, 2019, CELL HOST MICROBE, V25, P261, DOI 10.1016/j.chom.2019.01.019; Myers SA, 2019, NEUROBIOL DIS, V124, P353, DOI 10.1016/j.nbd.2018.12.008; Nakatsu G, 2018, GASTROENTEROLOGY, V155, P529, DOI 10.1053/j.gastro.2018.04.018; Nayfach S, 2019, NATURE, V568, P505, DOI 10.1038/s41586-019-1058-x; Nguyen S, 2017, MBIO, V8, DOI 10.1128/mBio.01874-17; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; O'Connor G, 2018, J NEUROTRAUM, V35, P2159, DOI 10.1089/neu.2017.5349; Ogilvie LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00918; Oh JH, 2019, CELL HOST MICROBE, V25, P273, DOI 10.1016/j.chom.2018.11.016; Ohio Supercomputer Center, 1987, OH SUP CTR COL OH OH; Olm MR, 2017, ISME J, V11, P2864, DOI 10.1038/ismej.2017.126; Paez-Espino D, 2017, NUCLEIC ACIDS RES, V45, pD457, DOI 10.1093/nar/gkw1030; Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094; Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Pickard JM, 2017, IMMUNOL REV, V279, P70, DOI 10.1111/imr.12567; Ponziani FR, 2012, EUR REV MED PHARMACO, V16, P376; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; RADWANSKI ER, 1995, PLANT CELL, V7, P921, DOI 10.1105/tpc.7.7.921; Ren J, 2020, QUANT BIOL, V8, P64, DOI 10.1007/s40484-019-0187-4; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Reynolds E, 2006, LANCET NEUROL, V5, P949, DOI 10.1016/S1474-4422(06)70598-1; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Roux S, 2016, NATURE, V537, P689, DOI 10.1038/nature19366; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; Roux S, 2015, PEERJ, V3, DOI 10.7717/peerj.985; Rowland I, 2018, EUR J NUTR, V57, P1, DOI 10.1007/s00394-017-1445-8; Ruddick Jon P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000068; Samuels AN, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00711-18; Sanders JG, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1834-9; Sausset R, 2020, MUCOSAL IMMUNOL, V13, P205, DOI 10.1038/s41385-019-0250-5; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Schmidt EKA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226128; Sharma V, 2018, CELL REP, V24, P3087, DOI 10.1016/j.celrep.2018.08.064; Shin JC, 2012, ANN REHABIL MED-ARM, V36, P119, DOI 10.5535/arm.2012.36.1.119; Shkoporov AN, 2019, CELL HOST MICROBE, V26, P527, DOI 10.1016/j.chom.2019.09.009; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Song AAL, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0669-x; Steinegger M, 2017, NAT BIOTECHNOL, V35, P1026, DOI 10.1038/nbt.3988; Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112; Strandwitz P, 2018, BRAIN RES, V1693, P128, DOI 10.1016/j.brainres.2018.03.015; Sun S, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00815-y; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Sutton TDS, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00784; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tamames J, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03349; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Townsend GE, 2019, P NATL ACAD SCI USA, V116, P233, DOI 10.1073/pnas.1813780115; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ueland PM, 2015, ANNU REV NUTR, V35, P33, DOI 10.1146/annurev-nutr-071714-034330; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Van Belleghem JD, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010010; van de Wiele T, 2007, J APPL MICROBIOL, V102, P452, DOI 10.1111/j.1365-2672.2006.03084.x; van der Beek CM, 2018, METABOLISM, V87, P25, DOI 10.1016/j.metabol.2018.06.009; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; von Schillde MA, 2012, CELL HOST MICROBE, V11, P387, DOI 10.1016/j.chom.2012.02.006; Wang Q, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0093-6; Warwick-Dugdale J, 2019, PEERJ, V7, DOI 10.7717/peerj.6800; Warwick-Dugdale J, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1120-1; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; White AR, 2018, J NEUROTRAUM, V35, P1079, DOI 10.1089/neu.2017.5369; Williams R, 2015, ARCH PHYS MED REHAB, V96, P133, DOI 10.1016/j.apmr.2014.08.016; Winek K, 2016, STROKE, V47, P1354, DOI 10.1161/STROKEAHA.115.011800; Woodcroft BJ, 2018, NATURE, V560, P49, DOI 10.1038/s41586-018-0338-1; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Wu YW, 2016, BIOINFORMATICS, V32, P605, DOI 10.1093/bioinformatics/btv638; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhang C, 2019, AM J TRANSL RES, V11, P4817; Zhang C, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1735-9; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239; Zhao GY, 2017, P NATL ACAD SCI USA, V114, pE6166, DOI 10.1073/pnas.1706359114; Zuo T, 2019, GUT, V68, P1169, DOI 10.1136/gutjnl-2018-318131	171	3	3	5	5	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2379-5077			MSYSTEMS	mSystems	JUN	2021	6	3							e01356-20	10.1128/mSystems.01356-20			23	Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Microbiology	WK6TZ	WOS:000709859100005	33975974	Green Published, gold			2022-02-06	
J	Gaudet, CE; Konin, J; Faust, D				Gaudet, Charles E.; Konin, Jeff; Faust, David			Immediate Post-concussion and Cognitive Testing: Ceiling Effects, Reliability, and Implications for Interpretation	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						ImPACT; Test-retest reliability; Concussion; Serial assessment; Neurocognitive testing; Baseline testing; Ceiling effects	TEST-PERFORMANCE; NEUROPSYCHOLOGICAL ASSESSMENT; MANAGEMENT; IMPACT; AMERICAN; VALIDITY; ADHD	Objective: The most commonly used computerized neurocognitive test in concussion assessment and management, Immediate Post-concussion and Cognitive Testing (ImPACT), has demonstrated varying and sometimes concerning levels of test-retest reliability. This study aimed to further examine ImPACT's psychometric qualities and whether ceiling effects may suppress its reliability. Method: A total of 300 consecutively selected ImPACT score reports for students attending a secondary school between 2010 and 2015 were reviewed. Test-retest reliabilities for composite scores and subscales were computed using Pearson product moment correlations (r) and intraclass correlation coefficients. To examine the potential influence of ceiling effects, we conducted frequency analyses of scores falling at, or near, the maximum possible score. Results: A total of 92 score reports met inclusion criteria. Test-retest reliabilities ranged from 0.42 to 0.69 for composite scores and 0.19 to 0.71 for subscales. Subscales comprising the Verbal and Visual Memory composites evidenced the most prominent ceiling effects. Conclusions: Obtained test-retest reliabilities were consistent with a large segment of the literature and add to concerns about ImPACT's reliability. Furthermore, at least in a select sample, this study identified sizeable ceiling effects that likely diminish the reliability of some composite scores. To mitigate the risk of false-negative errors on post-injury testing, ImPACT users should be cognizant of such ceiling effects. Supplemental, or alternative, approaches to protect against underestimating baseline functioning also warrant consideration.	[Gaudet, Charles E.; Faust, David] Univ Rhode Isl, Dept Psychol, Kingston, RI 02881 USA; [Konin, Jeff] Florida Int Univ, Dept Athlet Training, Miami, FL 33199 USA		Gaudet, CE (corresponding author), Univ Rhode Isl, Dept Psychol, Kingston, RI 02881 USA.	charles_gaudet@brown.edu		Gaudet, Charles/0000-0003-1602-9652			Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Bilder RM, 2011, J INT NEUROPSYCH SOC, V17, P7, DOI 10.1017/S1355617710001396; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Brooks BL, 2009, CAN PSYCHOL, V50, P196, DOI 10.1037/a0016066; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Calamia M, 2013, CLIN NEUROPSYCHOL, V27, P1077, DOI 10.1080/13854046.2013.809795; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Delis D.C., 2000, CALIFORNIA VERBAL LE; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Guilmette TJ, 2020, CLIN NEUROPSYCHOL, V34, P437, DOI 10.1080/13854046.2020.1722244; Harlow, 2014, ESSENCE MULTIVARIATE; Henry LC, 2015, APPL NEUROPSYCH-CHIL, V4, P266, DOI 10.1080/21622965.2014.911094; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; LeMonda BC, 2017, DEV NEUROPSYCHOL, V42, P113, DOI 10.1080/87565641.2016.1274315; Lers R.N., 2015, WINNOWER, V2, DOI [10.15200/winn.143518.81744, 10.15200/ winn.143518.81744. e143518.81744]; Lovell M. R., 2016, IMPACT ADM INTERPRET; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Masterson CJ, 2019, J CLIN EXP NEUROPSYC, V41, P925, DOI 10.1080/13803395.2019.1641184; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch JE, 2018, INT J PSYCHOPHYSIOL, V132, P31, DOI 10.1016/j.ijpsycho.2017.09.011; Russell E. W., 2003, J CONTROVERSIAL MED, V10, P1; Russell EW, 2001, CLIN NEUROPSYCHOL, V15, P423, DOI 10.1076/clin.15.3.423.10267; Sachs BC, 2016, CLIN NEUROPSYCHOL, V30, P629, DOI 10.1080/13854046.2016.1149618; Sackett PR, 2009, PSYCHOL BULL, V135, P1, DOI 10.1037/a0013978; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd	35	3	3	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2021	36	4					561	569		10.1093/arclin/acaa074			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	XT7SO	WOS:000733782900011	32978632				2022-02-06	
J	Jin, MC; Kakusa, B; Ku, S; Vaca, SD; Xu, LDW; Nalwanga, J; Kiryabwire, J; Ssenyonjo, H; Mukasa, J; Muhumuza, M; Fuller, AT; Haglund, MM; Grant, GA				Jin, Michael C.; Kakusa, Bina; Ku, Seul; Vaca, Silvia D.; Xu, Linda W.; Nalwanga, Juliet; Kiryabwire, Joel; Ssenyonjo, Hussein; Mukasa, John; Muhumuza, Michael; Fuller, Anthony T.; Haglund, Michael M.; Grant, Gerald A.			Long-term follow-up of neurosurgical outcomes for adult patients in Uganda with traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						follow-up; LMIC; low-and middle-income countries; trauma; TBI; Uganda; traumatic brain injury	MORTALITY; IMPACT; CARE	OBJECTIVE Traumatic brain injury (TBI) is a major cause of mortality and morbidity in Uganda and other low-and middle-income countries (LMICs). Due to the difficulty of long-term in-person follow-up, there is a paucity of literature on longitudinal outcomes of TBI in LMICs. Using a scalable phone-centered survey, this study attempted to investigate factors associated with both mortality and quality of life in Ugandan patients with TBI. METHODS A prospective registry of adult patients with TBI admitted to the neurosurgical ward at Mulago National Referral Hospital was assembled. Long-term follow-up was conducted between 10.4 and 30.5 months after discharge (median 18.6 months). Statistical analyses included univariable and multivariable logistic regression and Cox proportional hazards regression to elucidate factors associated with mortality and long-term recovery. RESULTS A total of 1274 adult patients with TBI were included, of whom 302 (23.7%) died as inpatients. Patients who died as inpatients received surgery less frequently (p < 0.001), had more severe TBI at presentation (p < 0.001), were older (p < 0.001), and were more likely to be female (p < 0.0001). Patients presenting with TBI resulting from assault were at reduced risk of inpatient death compared with those presenting with TBI caused by road traffic accidents (OR 0.362, 95% CI 0.128-0.933). Inpatient mortality and postdischarge mortality prior to follow-up were 23.7% and 9%, respectively. Of those discharged, 60.8% were reached through phone interviews. Higher Glasgow Coma Scale score at discharge (continuous HR 0.71, 95% CI 0.53-0.94) was associated with improved long-term survival. Tracheostomy (HR 4.38, 95% CI 1.05-16.7) and older age (continuous HR 1.03, 95% CI 1.009-1.05) were associated with poor longterm outcomes. More than 15% of patients continued to suffer from TBI sequelae years after the initial injury, including seizures (6.1%) and depression (10.0%). Despite more than 60% of patients seeking follow-up healthcare visits, mortality was still 9% among discharged patients, suggesting a need for improved longitudinal care to monitor recovery progress. CONCLUSIONS Inpatient and postdischarge mortality remain high following admission to Uganda's main tertiary hospital with the diagnosis of TBI. Furthermore, posttraumatic sequelae, including seizures and depression, continue to burden patients years after discharge. Effective scalable solutions, including phone interviews, are needed to elucidate and address factors limiting in-hospital capacity and access to follow-up healthcare.	[Jin, Michael C.; Kakusa, Bina; Ku, Seul] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Vaca, Silvia D.; Grant, Gerald A.] Stanford Univ, Dept Neurosurg, Palo Alto, CA USA; [Xu, Linda W.] Allegheny Med Grp, Dept Neurosurg, Pittsburgh, PA USA; [Nalwanga, Juliet; Kiryabwire, Joel; Ssenyonjo, Hussein; Mukasa, John; Muhumuza, Michael] Mulago Natl Referral Hosp, Dept Neurosurg, Kampala, Uganda; [Fuller, Anthony T.; Haglund, Michael M.] Duke Univ, Dept Neurosurg, Durham, NC USA; [Fuller, Anthony T.; Haglund, Michael M.] Duke Global Neurosurg & Neurol, Durham, NC USA		Grant, GA (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	ggrant2@stanford.edu		Kakusa, Bina/0000-0003-0907-2505	Stanford Medical Scholars Fellowship Program; Stanford Society of Physician Scholars fund	We would like to acknowledge Doreen Nankunda and Evarest Ahaisibwe for their assistance in data collection. Funding for this study was provided by the Stanford Medical Scholars Fellowship Program and the Stanford Society of Physician Scholars fund.	Appenteng R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201550; Bangirana P, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1246-1; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Ding K., 2016, TRANSLATIONAL RES TR; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Fuller Anthony, 2016, eNeurologicalSci, V3, P1, DOI 10.1016/j.ensci.2015.10.003; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Haglund MM, 2019, J NEUROSURG, V131, P993, DOI 10.3171/2019.4.JNS181747; Haglund MM, 2017, NEUROSURGERY, V80, P656, DOI 10.1093/neuros/nyw159; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jayaraman S, 2011, WORLD J SURG, V35, P505, DOI 10.1007/s00268-010-0871-z; JENNETT B, 1975, LANCET, V1, P480; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mehmood Amber, 2018, BMC Res Notes, V11, P299, DOI 10.1186/s13104-018-3419-1; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Prabhakaran K, 2017, J SURG RES, V219, P66, DOI 10.1016/j.jss.2017.05.103; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; Vaca SD, 2019, J NEUROSURG-PEDIATR, V23, P125, DOI 10.3171/2018.7.PEDS17601; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Xu LDW, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18280; Xu LW, 2018, WORLD NEUROSURG, V113, pE153, DOI 10.1016/j.wneu.2018.01.204; Zia N, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000259	33	3	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2021	134	6					1929	1939		10.3171/2020.4.JNS193092			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SP1YS	WOS:000659469900003	32619973	Bronze			2022-02-06	
J	Lynch, CE; Eisenbaum, M; Algamal, M; Balbi, M; Ferguson, S; Mouzon, B; Saltiel, N; Ojo, J; Diaz-Arrastia, R; Mullan, M; Crawford, F; Bachmeier, C				Lynch, Cillian E.; Eisenbaum, Maxwell; Algamal, Moustafa; Balbi, Matilde; Ferguson, Scott; Mouzon, Benoit; Saltiel, Nicole; Ojo, Joseph; Diaz-Arrastia, Ramon; Mullan, Mike; Crawford, Fiona; Bachmeier, Corbin			Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cerebral blood flow; cerebrovascular reactivity; laser speckle contrast imaging; repetitive mild traumatic brain injury; traumatic cerebral vascular injury	CEREBRAL-BLOOD-FLOW; CAPILLARY PERICYTES; ALZHEIMERS-DISEASE; DEMENTIA; BETA; AGE; ABNORMALITIES; DYSFUNCTION; PATHOLOGY; MEMORY	Incidences of repetitive mild TBI (r-mTBI), like those sustained by contact sports athletes and military personnel, are thought to be a risk factor for development of neurodegenerative disorders. Those suffering from chronic TBI-related illness demonstrate deficits in cerebrovascular reactivity (CVR), the ability of the cerebral vasculature to respond to a vasoactive stimulus. CVR is thus an important measure of traumatic cerebral vascular injury (TCVI), and a possible in vivo endophenotype of TBI-related neuropathogenesis. We combined laser speckle imaging of CVR in response to hypercapnic challenge with neurobehavioral assessment of learning and memory, to investigate if decreased cerebrovascular responsiveness underlies impaired cognitive function in our mouse model of chronic r-mTBI. We demonstrate a profile of blunted hypercapnia-evoked CVR in the cortices of r-mTBI mice like that of human TBI, alongside sustained memory and learning impairment, without biochemical or immunohistopathological signs of cerebral vessel laminar or endothelium constituent loss. Transient decreased expression of alpha smooth muscle actin and platelet-derived growth factor receptor beta, indicative of TCVI, is obvious only at the time of the most pronounced CVR deficit. These findings implicate CVR as a valid preclinical measure of TCVI, perhaps useful for developing therapies targeting TCVI after recurrent mild head trauma.	[Lynch, Cillian E.; Eisenbaum, Maxwell; Algamal, Moustafa; Ferguson, Scott; Mouzon, Benoit; Saltiel, Nicole; Ojo, Joseph; Mullan, Mike; Crawford, Fiona; Bachmeier, Corbin] Roskamp Inst, Sarasota, FL USA; [Lynch, Cillian E.; Eisenbaum, Maxwell; Algamal, Moustafa; Ferguson, Scott; Mouzon, Benoit; Ojo, Joseph; Mullan, Mike; Crawford, Fiona; Bachmeier, Corbin] Open Univ, Dept Life Sci, Milton Keynes, Bucks, England; [Lynch, Cillian E.; Mouzon, Benoit; Ojo, Joseph; Crawford, Fiona] James A Haley Vet Adm, Tampa, FL USA; [Lynch, Cillian E.; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Balbi, Matilde] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Bachmeier, Corbin] Bay Pines VA Healthcare Syst, Bay Pines, FL USA		Lynch, CE (corresponding author), Penn Presbyterian Med Ctr, Andrew Mutch Bldg,Room 417,51 North 39th St, Philadelphia, PA 19104 USA.	cillian.lynch@pennmedicine.upenn.edu	Balbi, Matilde/ABC-2246-2021	Balbi, Matilde/0000-0003-4590-5447; Algamal, Moustafa/0000-0002-6215-0122	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG041971] Funding Source: Medline		Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; Bachmeier C, 2014, NEUROMOL MED, V16, P686, DOI 10.1007/s12017-014-8318-6; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Castejon OJ, 2011, FOLIA NEUROPATHOL, V49, P162; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Danaila L, 2013, CHIRURGIA-BUCHAREST, V108, P319; DeGracia DJ, 2007, NEUROL RES, V29, P356, DOI 10.1179/016164107X204666; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Elder GA, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134294; Gao YZ, 2013, CURR NEUROVASC RES, V10, P49, DOI 10.2174/156720213804806016; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Glodzik L, 2013, J ALZHEIMERS DIS, V35, P427, DOI 10.3233/JAD-122011; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grant RI, 2019, J CEREBR BLOOD F MET, V39, P411, DOI 10.1177/0271678X17732229; Haber M, 2018, J NEUROTRAUM, V35, P2250, DOI 10.1089/neu.2018.5684; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Harraz OF, 2018, P NATL ACAD SCI USA, V115, pE3569, DOI 10.1073/pnas.1800201115; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P1119, DOI 10.1038/jcbfm.2010.202; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hillman EMC, 2014, ANNU REV NEUROSCI, V37, P161, DOI 10.1146/annurev-neuro-071013-014111; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Castejon OJ, 2014, FOLIA NEUROPATHOL, V52, P10, DOI 10.5114/fn.2014.41740; Kenney K, 2018, ANN CLIN TRANSL NEUR, V5, P418, DOI 10.1002/acn3.541; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kilianski J, 2017, J CLIN NEUROSCI, V45, P100, DOI 10.1016/j.jocn.2017.07.021; Kisler K, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00027; Kisler K, 2017, NAT NEUROSCI, V20, P406, DOI 10.1038/nn.4489; Lee J, 2016, J CEREBR BLOOD F MET, V36, P375, DOI 10.1177/0271678X15605851; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Longden TA, 2017, NAT NEUROSCI, V20, P717, DOI 10.1038/nn.4533; Lynch CE, 2016, BRAIN INJURY, V30, P1414, DOI 10.1080/02699052.2016.1219060; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Navarro JC, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00494; Nguyen TP, 2018, J ALZHEIMERS DIS, V66, P717, DOI 10.3233/JAD-180586; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Park L, 2014, STROKE, V45, P1815, DOI 10.1161/STROKEAHA.114.005179; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Pfefferkorn T, 2001, STROKE, V32, P17, DOI 10.1161/01.STR.32.1.17; Ponto LLB, 2016, J NEUROPSYCH CLIN N, V28, P89, DOI 10.1176/appi.neuropsych.15050106; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sagare AP, 2015, NEUROSCI LETT, V607, P97, DOI 10.1016/j.neulet.2015.09.025; Saito S, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0429-5; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schwarzmaier SM, 2015, J NEUROTRAUM, V32, P731, DOI 10.1089/neu.2014.3650; Shih AY, 2012, JOVE-J VIS EXP, DOI 10.3791/3742; Shin HK, 2007, BRAIN, V130, P2310, DOI 10.1093/brain/awm156; Singhal S, 2005, J NEUROL, V252, P163, DOI 10.1007/s00415-005-0624-3; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smyth LCD, 2018, J CHEM NEUROANAT, V92, P48, DOI 10.1016/j.jchemneu.2018.06.001; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Steinman J, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116101; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Svaldi DO, 2020, BRAIN IMAGING BEHAV, V14, P164, DOI 10.1007/s11682-018-9983-0; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Tong XK, 2015, J CEREBR BLOOD F MET, V35, P512, DOI 10.1038/jcbfm.2014.226; Tong XK, 2012, J NEUROSCI, V32, P4705, DOI 10.1523/JNEUROSCI.0169-12.2012; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Uhlirova H, 2016, ELIFE, V5, DOI [10.7554/elife.14315, 10.7554/eLife.14315]; van Ierssel SH, 2015, J NEUROSCI RES, V93, P866, DOI 10.1002/jnr.23566; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Viticchi G, 2015, INT J GERIATR PSYCH, V30, P1164, DOI 10.1002/gps.4269; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Wooten DW, 2017, J NUCL MED, V58, P484, DOI 10.2967/jnumed.115.170910; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yezhuvath US, 2012, NEUROBIOL AGING, V33, P75, DOI 10.1016/j.neurobiolaging.2010.02.005; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59	103	3	3	3	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2021	41	6					1362	1378		10.1177/0271678X20954015			17	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	SF2XN	WOS:000652624200016	33050825	Green Published			2022-02-06	
J	Puffer, RC; Garcia, LMC; Himes, BT; Jung, MY; Meyer, FB; Okonkwo, DO; Parney, IF				Puffer, Ross C.; Garcia, Luz M. Cumba; Himes, Benjamin T.; Jung, Mi-Yeon; Meyer, Frederic B.; Okonkwo, David O.; Parney, Ian F.			Plasma extracellular vesicles as a source of biomarkers in traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						extracellular vesicle; biomarker; microRNA; plasma; diagnostic; traumatic brain injury	EXOSOMES; MICROVESICLES	OBJECTIVE The objective of this study was to isolate extracellular vesicles (EVs) from plasma in a cohort of patients with traumatic brain injury (TBI) and analyze their contents for novel biomarkers that could prove useful for rapid diagnosis and classification of brain injury during initial evaluation. METHODS Plasma EVs were isolated by serial ultracentrifugation from patients with TBI (n = 15) and healthy controls (n = 5). Samples were obtained from the TRACK-TBI biorepository (2010-present). Size and concentration were determined by nanoparticle tracking. Glial fibrillary acidic protein (GFAP) concentration was determined in EV protein. EV RNA was isolated and deep sequencing of short noncoding RNA was performed. RESULTS Plasma EVs are physically similar but contained approximately 10 times more GFAP in TBI patients with altered consciousness than patients and controls with normal consciousness. Eleven highly differentially expressed microRNAs (miRNAs) were identified between these groups. Genes targeted by these miRNAs are highly associated with biologically relevant cellular pathways, including organismal injury, cellular development, and organismal development. Multiple additional coding and noncoding RNA species with potential biomarker utility were identified. CONCLUSIONS Isolating plasma EVs in patients with TBI is feasible. Increased GFAP concentration-a validated plasma TBI marker-in EVs from TBI patients with altered consciousness, along with differential expression of multiple miRNAs targeting TBI-relevant pathways, suggests that EVs may be a useful source of TBI biomarkers. Additional evaluation in larger patient cohorts is indicated.	[Puffer, Ross C.; Himes, Benjamin T.; Jung, Mi-Yeon; Meyer, Frederic B.; Parney, Ian F.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA; [Garcia, Luz M. Cumba; Himes, Benjamin T.; Parney, Ian F.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Garcia, Luz M. Cumba] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA		Parney, IF (corresponding author), Layo Clin, Rochester, MN 55902 USA.	parney.ian@mayo.edu			Uihlein Scholarship from the Department of Neurological Surgery, Mayo Clinic, Rochester, MN	This study was funded in part by the Uihlein Scholarship from the Department of Neurological Surgery, Mayo Clinic, Rochester, MN.	Chang CY, 2016, ARCH TOXICOL, V90, P191, DOI 10.1007/s00204-014-1364-x; Garcia LMC, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00651; Heijnen Harry F. G., 1999, Blood, V94, P3791; Hemphill M, 2020, J NEUROTRAUM, V37, P2424, DOI 10.1089/neu.2018.6220; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Li CCY, 2013, RNA BIOL, V10, P1333, DOI 10.4161/rna.25281; Manek R, 2018, MOL NEUROBIOL, V55, P6112, DOI 10.1007/s12035-017-0821-y; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Pitt JM, 2016, J CLIN INVEST, V126, P1139, DOI 10.1172/JCI87316; Proia P, 2008, INT J MOL MED, V21, P63; Schiera G, 2007, J CELL MOL MED, V11, P1384, DOI 10.1111/j.1582-4934.2007.00100.x; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Zeng XZ, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170216	17	3	3	2	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2021	134	6					1921	1928		10.3171/2020.4.JNS20305			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SP1YS	WOS:000659469900002	32707544	Bronze			2022-02-06	
J	Skandsen, T; Stenberg, J; Follestad, T; Karaliute, M; Saksvik, SB; Einarsen, CE; Lillehaug, H; Haberg, AK; Vik, A; Olsen, A; Iverson, GL				Skandsen, Toril; Stenberg, Jonas; Follestad, Turid; Karaliute, Migle; Saksvik, Simen B.; Einarsen, Cathrine E.; Lillehaug, Hanna; Haberg, Asta K.; Vik, Anne; Olsen, Alexander; Iverson, Grant L.			Personal Factors Associated With Postconcussion Symptoms 3 Months After Mild Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Post-concussion syndrome; Rehabilitation	POST-CONCUSSION SYMPTOMS; CENTER-TASK-FORCE; REPORT SCALE ASRS; THREATENING EXPERIENCES; SEX-DIFFERENCES; RESILIENCE; PREDICTORS; VALIDATION; IMPAIRMENT; RECOVERY	Objective: To describe personal factors in patients with mild traumatic brain injury (MTBI) and 2 control groups and to explore how such factors were associated with postconcussion symptoms (PCSs). Design: Prospective cohort study. Setting: Level 1 trauma center and outpatient clinic. Participants: Participants (N=541) included patients with MTBI (n=378), trauma controls (n=82), and community controls (n=81). Main Outcome Measures: Data on preinjury health and work status, personality, resilience, attention deficit/hyperactivity, and substance use. Computed tomography (CT) findings and posttraumatic amnesia were recorded. Symptoms were assessed at 3 months with the British Columbia Postconcussion Symptom Inventory and labeled as PCS+ if >3 symptoms were reported or the total score was >13. Predictive models were fitted with penalized logistic regression using the least absolute shrinkage and selection operator (lasso) in the MTBI group, and model fit was assessed with optimism-corrected area under the curve (AUC) of the receiver operating characteristic curve. Results: There were few differences in personal factors between the MTBI group and the 2 control groups without MTBI. Rates of PCS+ were 20.8% for the MTBI group, 8.0% for trauma controls, and 1.3% for community controls. In the MTBI group, there were differences between the PCS+ and PCS-group on most personal factors and injury-related variables in univariable comparisons. In the lasso models, the optimism corrected AUC for the full model was 0.79, 0.73 for the model only including personal factors, and 0.63 for the model only including injury variables. Working less than full time before injury, having preinjury pain and poor sleep quality, and being female were among the selected predictors, but also resilience and some personality traits contributed in the model. Intracranial abnormalities on CT were also a risk factor for PCS. Conclusions: Personal factors convey important prognostic information in patients with MTBI. A vulnerable work status and preinjury health problems might indicate a need for follow-up and targeted interventions. Archives of Physical Medicine and Rehabilitation 2021;102:1102-12 Objective: To describe personal factors in patients with mild traumatic brain injury (MTBI) and 2 control groups and to explore how such factors were associated with postconcussion symptoms (PCSs). Design: Prospective cohort study. Setting: Level 1 trauma center and outpatient clinic. Participants: Participants (N=541) included patients with MTBI (n=378), trauma controls (n=82), and community controls (n=81). Main Outcome Measures: Data on preinjury health and work status, personality, resilience, attention deficit/hyperactivity, and substance use. Computed tomography (CT) findings and posttraumatic amnesia were recorded. Symptoms were assessed at 3 months with the British Columbia Postconcussion Symptom Inventory and labeled as PCS+ if >3 symptoms were reported or the total score was >13. Predictive models were fitted with penalized logistic regression using the least absolute shrinkage and selection operator (lasso) in the MTBI group, and model fit was assessed with optimism-corrected area under the curve (AUC) of the receiver operating characteristic curve. Results: There were few differences in personal factors between the MTBI group and the 2 control groups without MTBI. Rates of PCS+ were 20.8% for the MTBI group, 8.0% for trauma controls, and 1.3% for community controls. In the MTBI group, there were differences between the PCS+ and PCS- group on most personal factors and injury-related variables in univariable comparisons. In the lasso models, the optimismcorrected AUC for the full model was 0.79, 0.73 for the model only including personal factors, and 0.63 for the model only including injury	[Skandsen, Toril; Stenberg, Jonas; Einarsen, Cathrine E.; Haberg, Asta K.; Vik, Anne] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Skandsen, Toril; Saksvik, Simen B.; Einarsen, Cathrine E.; Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Stenberg, Jonas; Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Follestad, Turid] Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Trondheim, Norway; [Karaliute, Migle; Saksvik, Simen B.; Lillehaug, Hanna; Olsen, Alexander] Norwegian Univ Sci & Technol NTNU, Dept Psychol, Trondheim, Norway; [Karaliute, Migle] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurol & Clin Neurophysiol, Trondheim, Norway; [Haberg, Asta K.] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] Home Base, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA		Skandsen, T (corresponding author), NTNU Fac Med & Heath Sci, N-7491 Trondheim, Norway.	toril.skandsen@ntnu.no	Stenberg, Jonas/AAN-4552-2021	Stenberg, Jonas/0000-0002-5769-7959	Norwegian University of Science and Technology [90157700, 46060918]; Central Norway Regional Health Authority [90157700, 46060918]	Supported by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (project nos. 90157700 and 46060918) .	Able SL, 2007, PSYCHOL MED, V37, P97, DOI 10.1017/S0033291706008713; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Friborg O, 2005, INT J METH PSYCH RES, V14, P29, DOI 10.1002/mpr.15; Friborg O, 2003, INT J METH PSYCH RES, V12, P65, DOI 10.1002/mpr.143; Friborg O, 2009, J INDIVID DIF, V30, P138, DOI 10.1027/1614-0001.30.3.138; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Hanks RA, 2019, J NEUROTRAUM, V36, P554, DOI 10.1089/neu.2018.5873; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; John OP., 2008, HDB PERSONAL THEORY, P114; John OP., 1999, HDB PERSONALITY THEO, P102; Jover J, 2017, BEST PRACT RES CL RH, V31, P275, DOI 10.1016/j.berh.2017.11.004; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Loprinzi CE, 2011, CLIN BREAST CANCER, V11, P364, DOI 10.1016/j.clbc.2011.06.008; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Merz ZC, 2019, BRAIN INJURY, V33, P1003, DOI 10.1080/02699052.2019.1581949; Oldenburg C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020884; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rosmalen JGM, 2012, PSYCHOL MED, V42, P2599, DOI 10.1017/S0033291712000608; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Stubbs JL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00043; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; World Health Organization, 2001, INT CLASS FUNCT HLTH; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Yue JK, 2018, NEUROREHABILITATION, V43, P169, DOI 10.3233/NRE-172375; Yuen KM, 2016, APPL NEUROPSYCH-ADUL, V23, P322, DOI 10.1080/23279095.2015.1057638	58	3	3	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2021	102	6					1102	1112		10.1016/j.apmr.2020.10.106			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	SM2ZC	WOS:000657477200007	33127352	hybrid			2022-02-06	
J	Sprau, AC; Slavin, BR; Pierrot, RG; Weber, LE; Figueroa, JM; Jagid, JR; Thaller, SR				Sprau, Annelise C.; Slavin, Benjamin R.; Pierrot, Randall G.; Weber, Lee E.; Figueroa, Javier M.; Jagid, Jonathan R.; Thaller, Seth R.			Safe at the Plate: Acute Assessment and Management of Baseball-Related Craniofacial Injuries by On-Field Personnel	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Baseball; craniofacial Injuries; field management; trauma	TRAUMATIC BRAIN-INJURIES; CONCUSSION; SPORTS	Introduction: Long regarded as "America's Past Time", over 8.6 million children partake in organized and recreational baseball. Although improved equipment has reduced contemporary injury rates, nearly half of pediatric baseball injuries requiring hospitalization are due to craniofacial trauma. Sideline personnel at the youth levels, often without advanced medical training, frequently act as first-responders in instances of acute craniofacial injury. Methods: An IRB-approved survey was distributed nationally to target field personnel working at youth, high school, collegiate, and professional baseball levels. Survey items included: comfort in assessing subtypes of acute craniofacial trauma (loss of consciousness (LOC), skull injury, orbital injury, nasal injury, and dental injury) via Likert scale, years of medical training, presence of an emergency action plan (EAP), and access to higher level care from emergency medical services (EMS) or a nearby hospital. Results: When comparing the amateur and professional cohorts, the respondents from professional teams were significantly more confident in assessing LOC (P = 0.001), skull injury (P < 0.001), orbital injury (P < 0.001), nasal injury (P < 0.001), and dental injury (P < 0.001). The professional teams had significantly more years of first aid training (P < 0.0001) and were significantly more likely to have an EAP (P < 0.0001). Professional teams also had a significantly higher average of reported craniofacial incidents (P = 0.0279). Conclusion: The authors identified a significant disparity in comfort level between amateur and professional baseball field personnel for identifying and managing acute craniofacial trauma. Based on these findings, the authors were able to develop a rudimentary tool for on-field personnel to effectively assess and manage craniofacial injuries.	[Sprau, Annelise C.; Figueroa, Javier M.; Jagid, Jonathan R.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Slavin, Benjamin R.; Pierrot, Randall G.; Weber, Lee E.; Thaller, Seth R.] Univ Miami, Miller Sch Med, Dept Surg, Div Plast Surg, Miami, FL 33136 USA		Thaller, SR (corresponding author), Div Plast Aesthet & Reconstruct Surg, 1120 NW 14th St,4th Floor, Miami, FL 33136 USA.	sthaller@med.miami.edu		Slavin, Benjamin/0000-0002-6755-2358			Alosco ML, 2019, HAND CLINIC, V167, P337, DOI 10.1016/B978-0-12-804766-8.00018-2; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Carniol ET, 2015, OTOLARYNG HEAD NECK, V153, P957, DOI 10.1177/0194599815602668; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Cusimano MD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00492; Demianczuk ANA, 1999, J CRANIOFAC SURG, V10, P323, DOI 10.1097/00001665-199907000-00007; Dobitsch AA, 2019, SURG J-NY, V5, pE146, DOI 10.1055/s-0039-1697627; Feiss R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082665; Franklin CC, 2012, CURR OPIN PEDIATR, V24, P64, DOI 10.1097/MOP.0b013e32834ec618; FRENGUELLI A, 1991, J CRANIO MAXILL SURG, V19, P178, DOI 10.1016/S1010-5182(05)80309-9; Gao H, 2020, J CRANIOFAC SURG, V31, pE121, DOI 10.1097/SCS.0000000000006010; Gopfert A, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000346; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hwang K., 2020, J CRANIOFAC SURG, V31, pE182; Kirch DG, 2017, JAMA-J AM MED ASSOC, V317, P1947, DOI 10.1001/jama.2017.2714; MacIsaac ZM, 2013, PLAST RECONSTR SURG, V131, P1339, DOI 10.1097/PRS.0b013e31828bd191; Pentecost MJ, 2017, J AM COLL RADIOL, V14, P1034, DOI 10.1016/j.jacr.2017.04.034; Neto ICP, 2018, J CRANIOFAC SURG, V29, pE562, DOI 10.1097/SCS.0000000000004565; Ramkumar PN, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118814238; Rice SG., 2012, PEDIATRICS, V129, P856; Sabesan VJ, 2018, OPEN ACCESS J SPORTS, V9, P253, DOI 10.2147/OAJSM.S157433; Scheffler P, 2019, INT J PEDIATR OTORHI, V121, P6, DOI 10.1016/j.ijporl.2019.02.036; Vriend I, 2017, SPORTS MED, V47, P2027, DOI 10.1007/s40279-017-0718-y; Wasicek PJ, 2019, J CRANIOFAC SURG, V30, P2052, DOI 10.1097/SCS.0000000000005862; Wymann NME, 2008, J ORAL MAXIL SURG, V66, P58, DOI 10.1016/j.joms.2007.04.023	28	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1557	1561		10.1097/SCS.0000000000007221			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100104	33086303				2022-02-06	
J	Rowe, RK; Murphy, SM; Handmaker, H; Lifshitz, J				Rowe, Rachel K.; Murphy, Sean M.; Handmaker, Hirsch; Lifshitz, Jonathan			Population-Level Epidemiology of Concussion Concurrent with Domestic Violence in Arizona, USA	JOURNAL OF NEUROTRAUMA			English	Article						abusive head trauma; child abuse; concussion; domestic violence; epidemiology; interpersonal violence; intimate partner violence; traumatic brain injury	INTIMATE-PARTNER-VIOLENCE; TRAUMATIC BRAIN-INJURY; AFRICAN-AMERICAN; RISK-FACTORS; WOMEN; PREVALENCE; OUTCOMES; VICTIMS; HEALTH	Domestic violence (DV) is a chronic societal epidemic that often involves physical assault to the head, neck, and face, which increases the risk of traumatic brain injuries (TBIs) in DV victims. However, epidemiological data on the extent of TBI-DV at the population scale remain sparse. We performed a statewide, multi-institution, retrospective review of all medical records for patients diagnosed with a concussion, the most common type of TBI, at health care facilities in Arizona, USA, that were licensed by Arizona Department of Health Services (ADHS) during 2016-2018. De-identified records were extracted from discharge data reported to ADHS, which we decoded and transformed to spatiotemporal demographic data of patients who were diagnosed with concussion concurrent with DV. Among 72,307 concussion diagnoses, 940 were concurrent with DV. Sixteen patients died as a result of TBI-DV injuries, where TBI is defined as concussion. Although females were most of the TBI-DV diagnoses, median ages for males and females were 1 and 32 years, respectively, demonstrating that males were predominantly child abuse victims. Whites and Hispanics were victims most diagnosed with concussion and DV, but Native Americans and Blacks comprised a much greater proportion of diagnoses compared with the representative state demographics. Although likely underreported, approximately half of the cases were inflicted by intimate partners, which corresponded closely to marital status. Surprisingly, 61% of victims sought medical treatment for non-concussion injuries and then concussion was entered as a primary diagnosis. The demographic and health care facility disparities demand TBI/concussion screening in suspected DV patients, education and training of care providers, and potential redistribution of resources to select health care facilities.	[Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Murphy, Sean M.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Handmaker, Hirsch] Univ Arizona, Coll Med Phoenix, Dept Radiol, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Murphy, Sean M.; Handmaker, Hirsch; Lifshitz, Jonathan] CACTIS Fdn, Scottsdale, AZ USA		Lifshitz, J (corresponding author), Translat Neurotrauma Res Program, 7th Floor,BSPB Bldg,475 N 5th St, Phoenix, AZ 85004 USA.	jlifshitz@email.arizona.edu		Rowe, Rachel/0000-0002-9034-3159	Phoenix Children's Hospital Mission Support Funds - Kemper and Ethel Marley Foundation	RKR and JL were funded by Phoenix Children's Hospital Mission Support Funds. SMM, HH, and JL were funded by a grant from the Kemper and Ethel Marley Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	(2016), ARCMAP; Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Anderson TK, 2009, ACCIDENT ANAL PREV, V41, P359, DOI 10.1016/j.aap.2008.12.014; [Anonymous], INT STAT CLASS DIS R; Arciniegas, 2000, Curr Treat Options Neurol, V2, P169; Berger R.P., 2016, PEDIATRICS, P138; BERRIOS DC, 1991, WESTERN J MED, V155, P133; Boserup B, 2020, AM J EMERG MED, V38, P2753, DOI 10.1016/j.ajem.2020.04.077; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Chandan JS, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014580; Chandan JS, 2021, J INTERPERS VIOLENCE, V36, pNP12279, DOI 10.1177/0886260519888515; Chandan JS, 2020, BRIT J PSYCHIAT, V217, P562, DOI 10.1192/bjp.2019.124; Chandan JS, 2019, J DENT, V82, P98, DOI 10.1016/j.jdent.2019.01.008; Coulthard P, 2020, BRIT DENT J, V228, P923, DOI 10.1038/s41415-020-1709-1; Cromartie J., 2010, 2010 RUR URB COMM AR; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Dixon a, 2020, DOMESTIC VIOLENCE IM; Duran B, 2009, AM INDIAN ALASKA NAT, V16, P11; Eismann EA, 2020, CHILD ABUSE NEGLECT, V108, DOI 10.1016/j.chiabu.2020.104643; Ellis TW, 2019, J AGGRESS MALTREAT T, V28, P838, DOI 10.1080/10926771.2019.1595803; Finfgeld-Connett D, 2015, GLOB QUALIT NURS RES, V2, DOI 10.1177/2333393614565182; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; GIN NE, 1991, J GEN INTERN MED, V6, P317, DOI 10.1007/BF02597429; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Hart T, 2014, POLICING, V37, P305, DOI 10.1108/PIJPSM-04-2013-0039; Hung KL, 2020, BIOMED J, V43, P240, DOI 10.1016/j.bj.2020.03.008; Jordan CE, 2021, J INTERPERS VIOLENCE, V36, pNP4170, DOI 10.1177/0886260518787206; Kofman YB, 2020, PSYCHOL TRAUMA-US, V12, pS199, DOI 10.1037/tra0000866; Laskey P, 2019, AGGRESS VIOLENT BEH, V47, P1, DOI 10.1016/j.avb.2019.02.014; Lifshitz J, 2019, J AGGRESS MALTREAT T, V28, P655, DOI 10.1080/10926771.2019.1644693; Lutgendorf MA, 2019, OBSTET GYNECOL, V134, P470, DOI 10.1097/AOG.0000000000003326; Machado A, 2017, J FAM VIOLENCE, V32, P513, DOI 10.1007/s10896-016-9853-8; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matoori S, 2020, EUR RADIOL, V30, P6933, DOI 10.1007/s00330-020-07043-w; Narang SK, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0203; Oetzel J, 2004, AM INDIAN ALASKA NAT, V11, P49; Olive P, 2018, J HEALTH SERV RES PO, V23, P212, DOI 10.1177/1355819618781413; R Core Team, 2020, RSTUDIO INT DEV RSTU; R Core Team, 2017, R LANG ENV STAT COMP; St Ivany A, 2018, QUAL HEALTH RES, V28, P1708, DOI 10.1177/1049732318786705; Stockman JK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24772; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; US Census Bureau, 2019, QUICK FACTS AR; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Walker A, 2020, PSYCHOL MEN MASCULIN, V21, P213, DOI 10.1037/men0000222; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	50	3	3	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2021	38	16					2301	2310		10.1089/neu.2021.0022		MAY 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TY0QY	WOS:000651887700001	33794670				2022-02-06	
J	Meyer, JE; Jammula, V; Arnett, PA				Meyer, Jessica E.; Jammula, Varna; Arnett, Peter A.			Head Trauma in a Community-Based Sample of Victims of Intimate Partner Violence: Prevalence, Mechanisms of Injury and Symptom Presentation	JOURNAL OF INTERPERSONAL VIOLENCE			English	Article; Early Access						Domestic violence; assessment &lt; domestic violence; battered women &lt; domestic violence	BRAIN-INJURY; DOMESTIC VIOLENCE; WOMEN	Objective. The present study aimed to explore the prevalence of subconcussive head trauma, traumatic brain injury (TBI), potential hypoxic events, and hypoxic brain injury (HBI) in victims of physical intimate partner violence (IPV). The study also aimed to characterize the injury presentation and mechanisms of injury in this population. Method. A group of 47 female participants with a history of at least one relationship that included physical violence completed a structured interview assessing for subconcussive hits, TBI, and HBI. Participants ranged in age from 19 to 55, and had an average of 15.3 years of education. Forty-four participants completed the structured interview in person and three participants completed the interview over the phone. Results. The majority of participants reported sustaining at least one impact to the head and approximately half of the participants sustained at least one impact that resulted in a mild TBI. Approximately half of the participants experienced at least one incident of having difficulty breathing due to a violent act from their partner, and approximately one-third of participants reported symptoms consistent with mild HBI. The most common mechanisms of injury were being hit with a closed fist and being strangled. Conclusions. The high levels of head trauma observed in this study highlight the need for clinical and community providers to screen victims of physical IPV for head trauma. The unique characteristics of this population (female sex, high frequency of injuries, and presence of HBIs) indicate that research evaluating the cognitive effects of injuries in this population is needed.	[Meyer, Jessica E.] Summa Hlth Syst, Dept Psychiat, Akron, OH USA; [Meyer, Jessica E.; Jammula, Varna; Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Meyer, JE (corresponding author), 75 Arch St,Suite G2, Akron, OH 44309 USA.	meyer.jessie@gmail.com			American Psychological Association Science Directorate; American Psychological Association of Graduate Students	This work was supported by the American Psychological Association Science Directorate and the American Psychological Association of Graduate Students.	Black M C., 2011, NATL INTIMATE PARTNE; Breiding MJ, 2014, MMWR SURVEILL SUMM, V63, P1; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bruce A.S., 2009, NEUROPSYCHOLOGICAL A, P336; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Esopenko C, 2021, BRAIN IMAGING BEHAV, V15, P475, DOI 10.1007/s11682-020-00417-0; Gale SD, 2004, J INT NEUROPSYCH SOC, V10, P60; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Joseph B, 2015, JAMA SURG, V150, P1177, DOI 10.1001/jamasurg.2015.2386; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mcquown C, 2016, AM J EMERG MED, V34, P1281, DOI 10.1016/j.ajem.2016.04.029; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Nemeth JM, 2019, J AGGRESS MALTREAT T, V28, P744, DOI 10.1080/10926771.2019.1591562; Oram S, 2017, LANCET PSYCHIAT, V4, P159, DOI 10.1016/S2215-0366(16)30261-9; Pill N, 2017, AGGRESS VIOLENT BEH, V34, P178, DOI 10.1016/j.avb.2017.01.014; Rajaram SS, 2021, VIOLENCE AGAINST WOM, V27, P1548, DOI 10.1177/1077801220947164; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Schafer J, 1998, AM J PUBLIC HEALTH, V88, P1702, DOI 10.2105/AJPH.88.11.1702; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; Sokoloff NJ, 2005, VIOLENCE AGAINST WOM, V11, P38, DOI 10.1177/1077801204271476; Stockman JK, 2015, J WOMENS HEALTH, V24, P62, DOI 10.1089/jwh.2014.4879; Thompson RS, 2006, AM J PREV MED, V30, P447, DOI 10.1016/j.amepre.2006.01.016; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	37	3	3	1	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0886-2605	1552-6518		J INTERPERS VIOLENCE	J. Interpers. Violence											08862605211016362	10.1177/08862605211016362		MAY 2021	20	Criminology & Penology; Family Studies; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Family Studies; Psychology	SK1OC	WOS:000655989300001	33993780				2022-02-06	
J	Lourbopoulos, A; Mourouzis, I; Xinaris, C; Zerva, N; Filippakis, K; Pavlopoulos, A; Pantos, C				Lourbopoulos, Athanasios; Mourouzis, Iordanis; Xinaris, Christodoulos; Zerva, Nefeli; Filippakis, Konstantinos; Pavlopoulos, Angelos; Pantos, Constantinos			Translational Block in Stroke: A Constructive and "Out-of-the-Box" Reappraisal	FRONTIERS IN NEUROSCIENCE			English	Article						failure of translation; translational block; stroke; translational success; interdisciplinary; clinical; preclinical; experimental stroke models	ACUTE ISCHEMIC-STROKE; CEREBRAL-ARTERY OCCLUSION; PERCUTANEOUS CORONARY INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; HEART-ASSOCIATION GUIDELINES; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; ANIMAL-MODELS; MULTIPLE-SCLEROSIS; CARDIOPULMONARY-RESUSCITATION	Why can we still not translate preclinical research to clinical treatments for acute strokes? Despite > 1000 successful preclinical studies, drugs, and concepts for acute stroke, only two have reached clinical translation. This is the translational block. Yet, we continue to routinely model strokes using almost the same concepts we have used for over 30 years. Methodological improvements and criteria from the last decade have shed some light but have not solved the problem. In this conceptual analysis, we review the current status and reappraise it by thinking "out-of-the-box" and over the edges. As such, we query why other scientific fields have also faced the same translational failures, to find common denominators. In parallel, we query how migraine, multiple sclerosis, and hypothermia in hypoxic encephalopathy have achieved significant translation successes. Should we view ischemic stroke as a "chronic, relapsing, vascular" disease, then secondary prevention strategies are also a successful translation. Finally, based on the lessons learned, we propose how stroke should be modeled, and how preclinical and clinical scientists, editors, grant reviewers, and industry should reconsider their routine way of conducting research. Translational success for stroke treatments may eventually require a bold change with solutions that are outside of the box.	[Lourbopoulos, Athanasios; Mourouzis, Iordanis; Zerva, Nefeli; Filippakis, Konstantinos; Pavlopoulos, Angelos; Pantos, Constantinos] Natl & Kapodistrian Univ Athens, Med Sch, Dept Pharmacol, Athens, Greece; [Lourbopoulos, Athanasios] Schoen Klin Bad Aibling, Dept Neurointens Care Unit, Bad Aibling, Germany; [Lourbopoulos, Athanasios] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Xinaris, Christodoulos] Ctr Anna Maria Astori, IRCCS Ist Ric Farmacol Mario Negri, Bergamo, Italy; [Xinaris, Christodoulos] Univ Nicosia, Med Sch, Nicosia, Cyprus		Lourbopoulos, A (corresponding author), Natl & Kapodistrian Univ Athens, Med Sch, Dept Pharmacol, Athens, Greece.; Lourbopoulos, A (corresponding author), Schoen Klin Bad Aibling, Dept Neurointens Care Unit, Bad Aibling, Germany.; Lourbopoulos, A (corresponding author), Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany.	alourbop@gmail.com		Xinaris, Christodoulos/0000-0002-6464-9541			Ahn S, 2018, INTERN EMERG MED, V13, P413, DOI 10.1007/s11739-017-1662-4; Alteri E, 2018, NATURE, V563, P317, DOI 10.1038/d41586-018-07352-7; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Antonic A, 2018, J STROKE CEREBROVASC, V27, P2158, DOI 10.1016/j.jstrokecerebrovasdis.2018.03.015; Aziz K, 2020, CIRCULATION, V142, pS524, DOI 10.1161/CIR.0000000000000902; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Bahor Z, 2017, CLIN SCI, V131, P2525, DOI 10.1042/CS20160722; Balbi M, 2015, J CEREBR BLOOD F MET, V35, P1445, DOI 10.1038/jcbfm.2015.107; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; Baron JC, 2018, NAT REV NEUROL, V14, P325, DOI 10.1038/s41582-018-0002-2; Bath PMW, 2009, BRIT J PHARMACOL, V157, P1157, DOI 10.1111/j.1476-5381.2009.00196.x; Bayliak MM, 2021, EXP GERONTOL, V145, DOI 10.1016/j.exger.2020.111182; Berge E, 2017, LANCET NEUROL, V16, P399, DOI 10.1016/S1474-4422(17)30078-9; Beuing O, 2014, AM J NEURORADIOL, V35, P1740, DOI 10.3174/ajnr.A3973; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Bhaduri A, 2020, NATURE, V578, P142, DOI 10.1038/s41586-020-1962-0; Bindawas SM, 2017, CLIN INTERV AGING, V12, P1791, DOI 10.2147/CIA.S145402; Bjelobaba I, 2018, J NEUROSCI RES, V96, P1021, DOI 10.1002/jnr.24224; Bolker JA, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700089; Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89; Borlongan CV, 2019, STEM CELL TRANSL MED, V8, P983, DOI 10.1002/sctm.19-0076; Borlotti A, 2019, JACC-CARDIOVASC IMAG, V12, P1783, DOI 10.1016/j.jcmg.2018.10.028; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Broderick JP, 2017, STROKE, V48, P2007, DOI 10.1161/STROKEAHA.117.017866; Brubaker DK, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006286; Bryce PJ, 2016, J ALLERGY CLIN IMMUN, V138, P769, DOI 10.1016/j.jaci.2016.01.049; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cai B, 2016, ACTA NEUROCHIR SUPPL, V121, P77, DOI 10.1007/978-3-319-18497-5_13; Caleo M, 2015, NEUROSCIENCE, V311, P180, DOI 10.1016/j.neuroscience.2015.10.029; Canazza A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00019; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Carreras N, 2018, J PEDIAT-BRAZIL, V94, P251, DOI 10.1016/j.jped.2017.05.009; Casas AI, 2019, J CLIN INVEST, V129, P1772, DOI 10.1172/JCI124283; Cenko E, 2018, JAMA INTERN MED, V178, P632, DOI 10.1001/jamainternmed.2018.0514; Charles A, 2019, LANCET, V394, P1765, DOI 10.1016/S0140-6736(19)32504-8; Charles A, 2018, LANCET NEUROL, V17, P174, DOI 10.1016/S1474-4422(17)30435-0; Chiang MC, 2017, PEDIATR NEONATOL, V58, P475, DOI 10.1016/j.pedneo.2016.11.001; Ciccarelli O, 2014, LANCET NEUROL, V13, P807, DOI 10.1016/S1474-4422(14)70101-2; Clemow DB, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01132-3; COMBS DJ, 1990, METAB BRAIN DIS, V5, P169, DOI 10.1007/BF00997070; Cook DJ, 2012, NEUROTHERAPEUTICS, V9, P371, DOI 10.1007/s13311-012-0115-z; Cook DJ, 2011, EXPERT REV CARDIOVAS, V9, P433, DOI [10.1586/erc.11.34, 10.1586/ERC.11.34]; Corbett D, 2017, INT J STROKE, V12, P462, DOI 10.1177/1747493017711814; Corbett D, 2015, PROG BRAIN RES, V218, P413, DOI 10.1016/bs.pbr.2014.12.002; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Dalgaard L, 2015, J PHARMACOL TOX MET, V74, P80, DOI 10.1016/j.vascn.2014.12.005; Daria A, 2017, EMBO J, V36, P583, DOI 10.15252/embj.201694591; Darwazeh R, 2013, NEURAL REGEN RES, V8, P2677, DOI 10.3969/j.issn.1673-5374.2013.28.010; de Boer A, 2020, HUM MOL GENET, V29, P605, DOI 10.1093/hmg/ddz288; deVeber GA, 2017, PEDIATR NEUROL, V69, P58, DOI 10.1016/j.pediatrneurol.2017.01.016; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dirnagl U, 2016, STROKE, V47, P2148, DOI 10.1161/STROKEAHA.116.013244; Dirnagl U, 2014, STROKE, V45, P1510, DOI 10.1161/STROKEAHA.113.004075; Doman SE, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00304; Dong MX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158848; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Douglas-Escobar M, 2015, JAMA PEDIATR, V169, P397, DOI 10.1001/jamapediatrics.2014.3269; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Drieu A, 2020, TRANSL STROKE RES, V11, P481, DOI 10.1007/s12975-019-00733-8; du Sert NP, 2017, J CEREBR BLOOD F MET, V37, P3488, DOI 10.1177/0271678X17709185; du Sert NP, 2017, NAT METHODS, V14, P1024, DOI 10.1038/nmeth.4462; Duda GN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.aaa0599; Duong TQ, 2013, NEUROL RES, V35, P465, DOI 10.1179/1743132813Y.0000000211; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Edvinsson L, 2018, NAT REV NEUROL, V14, P338, DOI 10.1038/s41582-018-0003-1; Edvinsson L, 2017, HEADACHE, V57, P47, DOI 10.1111/head.13081; Edvinsson L, 2015, HEADACHE, V55, P1249, DOI 10.1111/head.12656; Elkind MSV, 2020, NEUROLOGY, V95, pE1091, DOI 10.1212/WNL.0000000000010038; Elkins J, 2017, LANCET NEUROL, V16, P217, DOI 10.1016/S1474-4422(16)30357-X; Elmer J, 2017, SEMIN NEUROL, V37, P19, DOI 10.1055/s-0036-1597833; Endres M, 2008, CEREBROVASC DIS, V25, P268, DOI 10.1159/000118039; Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fluri F, 2015, DRUG DES DEV THER, V9, P3445, DOI 10.2147/DDDT.S56071; Fokkema ML, 2013, J AM COLL CARDIOL, V61, P1222, DOI 10.1016/j.jacc.2013.01.007; Galea N, 2019, EUR RADIOL, V29, P2369, DOI 10.1007/s00330-018-5895-z; Ganesh A, 2016, NEUROLOGY, V86, P898, DOI 10.1212/WNL.0000000000002443; Gannon F, 2014, EMBO REP, V15, P1107, DOI 10.15252/embr.201439587; Garner JP, 2014, ILAR J, V55, P438, DOI 10.1093/ilar/ilu047; Gennaro M, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/5089321; Geocadin RG, 2006, CRIT CARE CLIN, V22, P619, DOI 10.1016/j.ccc.2006.11.008; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Giesinger RE, 2017, J PEDIATR-US, V180, P22, DOI 10.1016/j.jpeds.2016.09.009; Glatigny S, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a028977; Goadsby PJ, 2005, NAT REV DRUG DISCOV, V4, P741, DOI 10.1038/nrd1822; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Greek R, 2011, STUD HIST PHI PART C, V42, P542, DOI 10.1016/j.shpsc.2011.07.001; Grzegorski T, 2019, REV NEUROSCIENCE, V30, P511, DOI 10.1515/revneuro-2018-0074; Hair K, 2019, RES INTEGR PEER REV, V4, DOI 10.1186/s41073-019-0069-3; Hamilton SE, 2019, LAB ANIMAL, V48, P337, DOI 10.1038/s41684-019-0421-8; Hankey GJ, 2020, LANCET, V395, P843, DOI 10.1016/S0140-6736(20)30316-0; Hankey GJ, 2017, LANCET, V389, P641, DOI 10.1016/S0140-6736(16)30962-X; Hansen FB, 2017, J NEUROSCI RES, V95, P2040, DOI 10.1002/jnr.24033; Harriott AM, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1043-7; Harrison JK, 2013, CLIN INTERV AGING, V8, P201, DOI 10.2147/CIA.S32405; Hausenloy DJ, 2019, LANCET, V394, P1415, DOI 10.1016/S0140-6736(19)32039-2; Hay DL, 2018, BRIT J PHARMACOL, V175, P3, DOI 10.1111/bph.14075; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Heusch G, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0756-8; Heusch G, 2017, CIRC RES, V120, P1477, DOI 10.1161/CIRCRESAHA.117.310820; Heusch G, 2017, EUR HEART J, V38, P774, DOI 10.1093/eurheartj/ehw224; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Hill MD, 2020, LANCET, V395, P878, DOI 10.1016/S0140-6736(20)30258-0; Hochstrasser T, 2018, EXPERT REV NEUROTHER, V18, P351, DOI 10.1080/14737175.2018.1459190; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Hoffmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092990; Holman C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002331; Holzer M, 2002, NEW ENGL J MED, V346, P549; Honegger P, 2001, CURR PROTOC PHARM, V12; Hotter B, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0989-9; Howells DW, 2012, INT J STROKE, V7, P371, DOI 10.1111/j.1747-4949.2012.00805.x; Howells DW, 2010, J CEREBR BLOOD F MET, V30, P1412, DOI 10.1038/jcbfm.2010.66; Huang Wenlong, 2020, Handb Exp Pharmacol, V257, P55, DOI 10.1007/164_2019_277; Huber C, 2019, BRAIN CIRC, V5, P195, DOI 10.4103/bc.bc_25_19; Iadecolar C, 2020, J CLIN INVEST, V130, P2777, DOI 10.1172/JCI135530; Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ishii A, 2009, P NATL ACAD SCI USA, V106, P14605, DOI 10.1073/pnas.0905936106; Ito R, 2018, J CELL PHYSIOL, V233, P3723, DOI 10.1002/jcp.26045; Jackson SJ, 2017, LAB ANIM-UK, V51, P160, DOI 10.1177/0023677216653984; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Jones SP, 2015, CIRC RES, V116, P572, DOI 10.1161/CIRCRESAHA.116.305462; Kaiser EE, 2020, NEURAL REGEN RES, V15, P1377, DOI 10.4103/1673-5374.274324; Kalmbach BE, 2018, NEURON, V100, P1194, DOI 10.1016/j.neuron.2018.10.012; Katchanov J, 2003, BRAIN PATHOL, V13, P452; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; Kawamura N, 2005, EXP NEUROL, V195, P305, DOI 10.1016/j.expneurol.2005.05.005; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kimmelman J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001863; Kipp M, 2017, BRAIN PATHOL, V27, P123, DOI 10.1111/bpa.12454; Kleinbongard P, 2020, BRIT J PHARMACOL, V177, P5252, DOI 10.1111/bph.14839; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; Kringe L, 2020, J CEREBR BLOOD F MET, V40, P2152, DOI 10.1177/0271678X20931062; Kuczynski AM, 2020, CURR NEUROL NEUROSCI, V20, DOI 10.1007/s11910-020-01029-3; Kumar A, 2016, BRAIN RES BULL, V122, P35, DOI 10.1016/j.brainresbull.2016.02.016; Kvistad CE, 2012, VASC HEALTH RISK MAN, V8, P333, DOI 10.2147/VHRM.S31614; La Rosa C, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00274; Labat-gest V, 2013, JOVE-J VIS EXP, DOI 10.3791/50370; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Lapchak PA, 2013, TRANSL STROKE RES, V4, P279, DOI 10.1007/s12975-012-0209-2; Lapchak PA, 2010, TRANSL STROKE RES, V1, P96, DOI 10.1007/s12975-010-0018-4; Lassmann H, 2017, ACTA NEUROPATHOL, V133, P223, DOI 10.1007/s00401-016-1631-4; le Feber J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147231; Leenaars CHC, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1976-2; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Li M, 2019, NEW ENGL J MED, V380, P569, DOI 10.1056/NEJMra1806175; Li NL, 2011, REJUV RES, V14, P261, DOI 10.1089/rej.2010.1115; Lindsey ML, 2018, AM J PHYSIOL-HEART C, V314, pH812, DOI 10.1152/ajpheart.00335.2017; Liu Shimin, 2009, J Exp Stroke Transl Med, V2, P16; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Llovera G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9853; Lo EH, 2014, STROKE, V45, P305, DOI 10.1161/STROKEAHA.113.001269; London AJ, 2015, ELIFE, V4, DOI 10.7554/eLife.12844; Lourbopoulos A, 2008, J NEUROSCI METH, V173, P225, DOI 10.1016/j.jneumeth.2008.06.018; Lourbopoulos A, 2017, J CEREBR BLOOD F MET, V37, P2084, DOI 10.1177/0271678X16660986; Lowenstein PR, 2009, CURR GENE THER, V9, P368, DOI 10.2174/156652309789753392; Luders E, 2002, NEUROREPORT, V13, P2371, DOI 10.1097/01.wnr.0000049603.85580.da; Ludman AJ, 2011, HEART, V97, P1560, DOI 10.1136/hrt.2011.223867; Ma H, 2012, CURR MOL MED, V12, P1282, DOI 10.2174/156652412803833517; Makin TR, 2019, ELIFE, V8, DOI 10.7554/eLife.48175; Mangion K, 2019, EUR J RADIOL, V112, P121, DOI 10.1016/j.ejrad.2019.01.010; Martic-Kehl MI, 2012, EUR J NUCL MED MOL I, V39, P1492, DOI 10.1007/s00259-012-2175-z; May A, 2017, NEUROL SCI, V38, pS125, DOI 10.1007/s10072-017-2866-0; Mergenthaler P, 2012, DIS MODEL MECH, V5, P718, DOI 10.1242/dmm.010033; Mering S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00106; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mestre H, 2020, TRENDS NEUROSCI, V43, P458, DOI 10.1016/j.tins.2020.04.003; Meuth SG, 2010, BIODRUGS, V24, P317, DOI 10.2165/11537190-000000000-00000; Miller S, 2016, NEUROSCIENCE, V328, P165, DOI 10.1016/j.neuroscience.2016.04.046; Modo MM, 2018, STROKE, V49, P1099, DOI 10.1161/STROKEAHA.117.018293; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Normand R, 2018, NAT METHODS, V15, P1067, DOI 10.1038/s41592-018-0214-9; Norris D, 2018, NATURE, V557, P302, DOI 10.1038/d41586-018-05146-5; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Panchal AR, 2020, CIRCULATION, V142, pS366, DOI 10.1161/CIR.0000000000000916; Pantos C, 2004, BASIC RES CARDIOL, V99, P101, DOI 10.1007/s00395-003-0449-0; Pascual J, 2015, LANCET NEUROL, V14, P1066, DOI 10.1016/S1474-4422(15)00244-6; Patel SD, 2015, PEDIATR RES, V78, P264, DOI 10.1038/pr.2015.100; Patino CM, 2018, J BRAS PNEUMOL, V44, P183, DOI 10.1590/S1806-37562018000000164; Pedersen F, 2014, J AM COLL CARDIOL, V64, P2101, DOI 10.1016/j.jacc.2014.08.037; Popa-Wagner A, 2007, ACTA NEUROPATHOL, V113, P277, DOI 10.1007/s00401-006-0164-7; Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211; Pugsley MK, 2002, PHARMACOL THERAPEUT, V93, P51, DOI 10.1016/S0163-7258(02)00165-1; Purkayastha J, 2016, INDIAN J PEDIATR, V83, P175, DOI 10.1007/s12098-015-1829-9; Rao R, 2017, J PEDIATR-US, V183, P37, DOI 10.1016/j.jpeds.2016.11.019; Raya TE, 1997, AM J PHYSIOL-HEART C, V273, pH2652, DOI 10.1152/ajpheart.1997.273.6.H2652; Reinstadler SJ, 2019, EUR HEART J-CARD IMG, V20, P138, DOI 10.1093/ehjci/jey101; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Rink C, 2008, P NATL ACAD SCI USA, V105, P14100, DOI 10.1073/pnas.0806678105; Ritzel RM, 2018, ACTA NEUROPATHOL, V136, P89, DOI 10.1007/s00401-018-1859-2; Rolfes L, 2020, BIODRUGS, V34, P587, DOI 10.1007/s40259-020-00435-w; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rosenzweig S, 2013, STROKE, V44, P2579, DOI 10.1161/STROKEAHA.113.001796; Rossello X, 2016, CIRCULATION, V134, P574, DOI 10.1161/CIRCULATIONAHA.116.022829; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Roubille F, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0275-3; Rubio-Beltran E, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0893-8; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; Sand IK, 2015, CURR OPIN NEUROL, V28, P193, DOI 10.1097/WCO.0000000000000206; Saver JL, 2015, NEW ENGL J MED, V372, P528, DOI 10.1056/NEJMoa1408827; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Schmidt J, 2000, BRAIN, V123, P1431, DOI 10.1093/brain/123.7.1431; Schneider H, 2017, INT J STROKE, V12, P732, DOI 10.1177/1747493017694388; Schulte-Herbruggen O, 2006, NEUROIMMUNOMODULAT, V13, P13, DOI 10.1159/000092109; Schuster NM, 2017, CLIN NEUROPHARMACOL, V40, P169, DOI 10.1097/WNF.0000000000000227; Schuster NM, 2016, NAT REV NEUROL, V12, P635, DOI 10.1038/nrneurol.2016.143; Sekhon MS, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1670-9; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shah TA, 2017, PEDIATR RES, V81, P654, DOI 10.1038/pr.2016.271; Shanks Niall, 2009, Philos Ethics Humanit Med, V4, P2, DOI 10.1186/1747-5341-4-2; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Silveira RC, 2015, J PEDIAT-BRAZIL, V91, pS78, DOI 10.1016/j.jped.2015.07.004; SIMS NR, 1992, NEUROCHEM RES, V17, P923, DOI 10.1007/BF00993269; Sloth AD, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006923; Snwoldt J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00305; Sommer CJ, 2017, ACTA NEUROPATHOL, V133, P245, DOI 10.1007/s00401-017-1667-0; Sorby-Adams AJ, 2018, AM J PHYSIOL-REG I, V315, pR165, DOI 10.1152/ajpregu.00163.2017; Steffen J, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0363-y; Steimberg N, 2020, ALTEX-ALTERN ANIM EX, V37, P136, DOI 10.14573/altex.1911071; Steiner TJ, 2013, CEPHALALGIA, V33, P289, DOI 10.1177/0333102412473843; Steinman L, 2005, TRENDS IMMUNOL, V26, P565, DOI 10.1016/j.it.2005.08.014; Stone GW, 2016, J AM COLL CARDIOL, V67, P1674, DOI 10.1016/j.jacc.2016.01.069; Stortz JA, 2017, ILAR J, V58, P90, DOI 10.1093/ilar/ilx007; 't Hart BA, 2018, EXPERT OPIN DRUG DIS, V13, P387, DOI 10.1080/17460441.2018.1443075; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Thomas A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170243; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; Titus HE, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.599717; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Tsivgoulis G, 2014, STROKE, V45, P2555, DOI 10.1161/STROKEAHA.114.006579; Uchino H, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0140-9; van der Bijl P, 2020, JACC-HEART FAIL, V8, P131, DOI 10.1016/j.jchf.2019.08.014; van Kranenburg M, 2014, JACC-CARDIOVASC IMAG, V7, P930, DOI 10.1016/j.jcmg.2014.05.010; Velagaleti RS, 2008, CIRCULATION, V118, P2057, DOI 10.1161/CIRCULATIONAHA.108.784215; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Vilela P, 2017, EUR J RADIOL, V96, P162, DOI 10.1016/j.ejrad.2017.08.014; Vina J, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.13005; Vu Q, 2014, NEUROLOGY, V82, P1277, DOI 10.1212/WNL.0000000000000278; Wang Y, 2016, PROG NEUROBIOL, V141, P45, DOI [10.1016/j.pneurobio.2016.04.00, 10.1016/j.pneurobio.2016.04.005]; Watanabe H, 2007, J NEUROSCI METH, V160, P109, DOI 10.1016/j.jneumeth.2006.08.016; Wattiez AS, 2019, HANDB EXP PHARMACOL, V255, P85, DOI 10.1007/164_2018_187; Welbourn C, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0476-3; Wells AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042157; Winek K, 2016, NEUROTHERAPEUTICS, V13, P762, DOI 10.1007/s13311-016-0475-x; Wu LF, 2020, J CEREBR BLOOD F MET, V40, P461, DOI 10.1177/0271678X19894869; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Xinaris C, 2019, CURR OPIN ORGAN TRAN, V24, P555, DOI 10.1097/MOT.0000000000000680; Yamout B, 2020, MULT SCLER RELAT DIS, V37, DOI 10.1016/j.msard.2019.101459; Yao V, 2018, NAT BIOTECHNOL, V36, P1091, DOI 10.1038/nbt.4246; Yarborough M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006343; Yarborough M, 2017, NATURE, V551, P300; Yetgin T, 2015, JACC-CARDIOVASC INTE, V8, P1990, DOI 10.1016/j.jcin.2015.08.033; Yildiz EP, 2017, EXPERT REV NEUROTHER, V17, P449, DOI 10.1080/14737175.2017.1259567; Zeiss CJ, 2017, ILAR J, V58, pCP3, DOI 10.1093/ilar/ilx017	266	3	3	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 14	2021	15								652403	10.3389/fnins.2021.652403			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SJ1TE	WOS:000655310500001	34054413	gold, Green Published			2022-02-06	
J	Harley, SBR; Willis, EF; Shaikh, SN; Blackmore, DG; Sah, P; Ruitenberg, MJ; Bartlett, PF; Vukovic, J				Harley, Samuel B. R.; Willis, Emily F.; Shaikh, Samreen N.; Blackmore, Daniel G.; Sah, Pankaj; Ruitenberg, Marc J.; Bartlett, Perry F.; Vukovic, Jana			Selective Ablation of BDNF from Microglia Reveals Novel Roles in Self-Renewal and Hippocampal Neurogenesis	JOURNAL OF NEUROSCIENCE			English	Article						cognition; glia; learning and memory; neurogenesis; neuroinflammation; repopulating microglia	NEUROTROPHIC FACTOR; PROGENITOR-CELL; ADULT; RECEPTOR; NEURONS; PROLIFERATION; SYNAPSES; DIFFERENTIATION; INFLAMMATION; DOUBLECORTIN	Microglia, the resident immune cells of the CNS, have emerged as key regulators of neural precursor cell activity in the adult brain. However, the microglia-derived factors that mediate these effects remain largely unknown. In the present study, we investigated a role for microglial brain-derived neurotrophic factor (BDNF), a neurotrophic factor with well known effects on neuronal survival and plasticity. Surprisingly, we found that selective genetic ablation of BDNF from microglia increased the production of newborn neurons under both physiological and inflammatory conditions (e.g., LPS-induced infection and traumatic brain injury). Genetic ablation of BDNF from microglia otherwise also interfered with self-renewal/proliferation, reducing their overall density. In conclusion, we identify microglial BDNF as an important factor regulating microglia population dynamics and states, which in turn influences neurogenesis under both homeostatic and pathologic conditions.	[Harley, Samuel B. R.; Willis, Emily F.; Shaikh, Samreen N.; Ruitenberg, Marc J.; Vukovic, Jana] Univ Queensland, Fac Med, Sch Biomed Sci, St Lucia, Qld 4072, Australia; [Harley, Samuel B. R.; Blackmore, Daniel G.; Sah, Pankaj; Bartlett, Perry F.; Vukovic, Jana] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia		Vukovic, J (corresponding author), Univ Queensland, Fac Med, Sch Biomed Sci, St Lucia, Qld 4072, Australia.; Vukovic, J (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia.	j.vukovic@uq.edu.au		Sah, Pankaj/0000-0001-5063-1589; Willis, Emily/0000-0002-3756-5318	Sylvia and Charles Viertel Foundation; Australian Research CouncilAustralian Research Council [150101578]; National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [1124503]; Australian government Research Training ScholarshipAustralian Government; Queensland Brain Institute Student TopUp Scholarship; UQ Career Development Scholarship Extension; University of Queensland Senate Scholarship Herdsman Fellowship in Medical Science; SpinalCure Australia; Wings for Life Spinal Cord Research Foundation; NHMRCNational Health and Medical Research Council of Australia [1060538, 1163835]; Australian Government through ARC (Australian Research Council) LIEF (Linkage Infrastructure, Equipment and Facilities) [LE100100074]	J.V. holds a Senior Medical Research Fellowship from the Sylvia and Charles Viertel Foundation and was also supported by both the Australian Research Council (Discovery Early Career Research Award 150101578) and the National Health and Medical Research Council (NHMRC; Project Grant 1124503) . S.B.R.H. was supported by an Australian government Research Training Scholarship, a Queensland Brain Institute Student TopUp Scholarship, and a UQ Career Development Scholarship Extension. E.F.W. was supported by the University of Queensland Senate Scholarship Herdsman Fellowship in Medical Science and a UQ Career Development Scholarship Extension. M.J.R. was supported by SpinalCure Australia, the Wings for Life Spinal Cord Research Foundation, and the NHMRC (Grants 1060538 and 1163835) . Imaging was performed at the Advanced Microscopy Facilities of the Queensland Brain Institute, using Yokogawa and Diskovery spinning disk confocal microscopes, Imaris software, and the stereology microscope, the use of which was supported by the Australian Government through ARC (Australian Research Council) LIEF (Linkage Infrastructure, Equipment and Facilities) Grant LE100100074. Behavioral tests were performed at the Behavior and Surgical Facility of the Queensland Brain Institute. We thank Robert Sullivan for experimental assistance. We also thank the staff of The University of Queensland Biological Resources Facility for breeding and maintaining the animals in this study. In addition, we thank the National Imaging Facility at the Center for Advanced Imaging, University of Queensland for use of the facilities, and for scientific and technical assistance.	Araki T, 2021, EUR J NEUROSCI, V54, P5880, DOI 10.1111/ejn.14969; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Chaaya N, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00214; Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Diaz-Aparicio I, 2020, J NEUROSCI, V40, P1453, DOI 10.1523/JNEUROSCI.0993-19.2019; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gomes C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-16; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Groves N, 2019, DEV NEUROBIOL, V79, P868, DOI 10.1002/dneu.22729; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; Gyoneva S, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900453; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hodge RD, 2012, J NEUROSCI, V32, P6275, DOI 10.1523/JNEUROSCI.0532-12.2012; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khan N, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.137; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lehrman EK, 2018, NEURON, V100, P120, DOI 10.1016/j.neuron.2018.09.017; Lei FY, 2020, P NATL ACAD SCI USA, V117, P23336, DOI 10.1073/pnas.1922788117; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Mizoguchi Y, 2009, J IMMUNOL, V183, P7778, DOI 10.4049/jimmunol.0901326; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Murphy PG, 2000, EUR J NEUROSCI, V12, P1891, DOI 10.1046/j.1460-9568.2000.00074.x; Nakajima K, 1998, GLIA, V24, P272, DOI 10.1002/(SICI)1098-1136(199811)24:3<272::AID-GLIA2>3.0.CO;2-4; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; O'Neil SM, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0636-8; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Quesseveur G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.30; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Sato K, 2015, GLIA, V63, P1394, DOI 10.1002/glia.22858; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sierra A, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/610343; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Spencer-Segal JL, 2011, J NEUROSCI, V31, P6780, DOI 10.1523/JNEUROSCI.0910-11.2011; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Vukovic J, 2013, J NEUROSCI, V33, P6603, DOI 10.1523/JNEUROSCI.3064-12.2013; Vukovic J, 2012, J NEUROSCI, V32, P6435, DOI 10.1523/JNEUROSCI.5925-11.2012; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wallace J, 2020, ELIFE, V9, DOI 10.7554/eLife.50531; Wang L, 2015, J NEUROSCI, V35, P8384, DOI 10.1523/JNEUROSCI.4682-14.2015; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Weinhard L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03566-5; Willis EF, 2020, STAR PROTOC, V1; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Willis EF, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00197; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang JM, 2003, EXP NEUROL, V183, P469, DOI 10.1016/S0014-4886(03)00222-X; Zhang X, 2014, CELL PHYSIOL BIOCHEM, V34, P715, DOI 10.1159/000363036; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	61	3	3	4	8	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	MAY 12	2021	41	19					4172	4186		10.1523/JNEUROSCI.2539-20.2021			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SD5AB	WOS:000651383800003	33785644	Green Published, Bronze			2022-02-06	
J	Schwab, N; Ju, YJ; Hazrati, LN				Schwab, Nicole; Ju, YoungJun; Hazrati, Lili-Naz			Early onset senescence and cognitive impairment in a murine model of repeated mTBI	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Concussion; Neuroinflammation; DNA damage response; Senescence; Ageing; Neurodegeneration	TRAUMATIC BRAIN-INJURY; DNA-DAMAGE RESPONSE; ALZHEIMERS-DISEASE; MOUSE MODEL; BCL-W; POSTCONCUSSION SYNDROME; CELLULAR SENESCENCE; RECOGNITION MEMORY; INDUCED APOPTOSIS; OXIDATIVE STRESS	Mild traumatic brain injury (mTBI) results in broad neurological symptoms and an increased risk of being diagnosed with a neurodegenerative disease later in life. While the immediate oxidative stress response and post-mortem pathology of the injured brain has been well studied, it remains unclear how early pathogenic changes may drive persistent symptoms and confer susceptibility to neurodegeneration. In this study we have used a mouse model of repeated mTBI (rmTBI) to identify early gene expression changes at 24 h or 7 days post-injury (7 dpi). At 24 h post-injury, gene expression of rmTBI mice shows activation of the DNA damage response (DDR) towards double strand DNA breaks, altered calcium and cell-cell signalling, and inhibition of cell death pathways. By 7 dpi, rmTBI mice had a gene expression signature consistent with induction of cellular senescence, activation of neurodegenerative processes, and inhibition of the DDR. At both timepoints gliosis, microgliosis, and axonal damage were evident in the absence of any gross lesion, and by 7 dpi rmTBI also mice had elevated levels of IL1 beta, p21, 53BP1, DNA2, and p53, supportive of DNA damage-induced cellular senescence. These gene expression changes reflect establishment of processes usually linked to brain aging and suggests that cellular senescence occurs early and most likely prior to the accumulation of toxic proteins. These molecular changes were accompanied by spatial learning and memory deficits in the Morris water maze. To conclude, we have identified DNA damage-induced cellular senescence as a repercussion of repeated mild traumatic brain injury which correlates with cognitive impairment. Pathways involved in senescence may represent viable treatment targets of post-concussive syndrome. Senescence has been proposed to promote neurodegeneration and appears as an effective target to prevent long-term complications of mTBI, such as chronic traumatic encephalopathy and other related neurodegenerative pathologies.	[Schwab, Nicole; Hazrati, Lili-Naz] Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, Toronto, ON, Canada; [Schwab, Nicole; Ju, YoungJun; Hazrati, Lili-Naz] Hosp Sick Children, Toronto, ON, Canada		Hazrati, LN (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, Toronto, ON, Canada.	lili-naz.hazrati@sickkids.ca			Canadian Institute of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	This study was funded by the Canadian Institute of Health Research (CIHR).	Alemi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20164; Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Arun P, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00438; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Bharadwaj VN, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700668; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bonham LW, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01170; Bras J, 2015, AM J HUM GENET, V96, P474, DOI 10.1016/j.ajhg.2015.01.005; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y; Capparelli C, 2012, CELL CYCLE, V11, P3599, DOI 10.4161/cc.21884; Castranio EL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0569-2; Castranio EL, 2017, NEUROBIOL DIS, V105, P1, DOI 10.1016/j.nbd.2017.05.006; Chalertpet K, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00645; Chang XX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16390-6; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Cheng XF, 2016, AUTOPHAGY, V12, P1330, DOI 10.1080/15548627.2016.1185590; Chinta SJ, 2015, EXP GERONTOL, V68, P3, DOI 10.1016/j.exger.2014.09.018; Choi JY, 2018, BIOCHEM BIOPH RES CO, V505, P1134, DOI 10.1016/j.bbrc.2018.10.010; Choi WS, 2010, J NEUROPATH EXP NEUR, V69, P511, DOI 10.1097/NEN.0b013e3181db8100; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Collin G, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0300-z; Czarny P, 2015, MED SCI MONITOR, V21, DOI 10.12659/MSM.892317; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; Dethlefsen MM, 2018, EXP GERONTOL, V111, P141, DOI 10.1016/j.exger.2018.07.011; Dietlein F, 2014, TRENDS GENET, V30, P326, DOI 10.1016/j.tig.2014.06.003; Diniz BS, 2017, AM J GERIAT PSYCHIAT, V25, P64, DOI 10.1016/j.jagp.2016.08.018; Doran SJ, 2020, CRIT CARE MED, V48, pE418, DOI 10.1097/CCM.0000000000004273; Duval N, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00015; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Fielder E, 2017, J ALZHEIMERS DIS, V60, pS107, DOI 10.3233/JAD-161221; Fitz NF, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00394-4; Flynn KM, 2013, AM J PATHOL, V182, P1322, DOI 10.1016/j.ajpath.2013.01.003; Fumagalli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110969; Furman JL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0158-7; Gagnon KL, 2017, J TRAUMA DISSOCIATIO, V18, P635, DOI 10.1080/15299732.2016.1252001; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; GIANNINI C, 1992, J NEUROPATH EXP NEUR, V51, P514, DOI 10.1097/00005072-199209000-00006; Gibbs-Seymour I, 2015, AGING CELL, V14, P162, DOI 10.1111/acel.12258; Gillespie DA, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1030538; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Gonzalo S, 2017, AGEING RES REV, V33, P18, DOI 10.1016/j.arr.2016.06.007; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Guidotti A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00089; Guo Y, 2019, MOL NEUROBIOL, V56, P3368, DOI 10.1007/s12035-018-1312-5; Halstrom A, 2017, J CLIN NEUROSCI, V35, P104, DOI 10.1016/j.jocn.2016.09.006; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Hartman ML, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2417-0; Haure-Mirande JV, 2019, MOL PSYCHIATR, V24, P431, DOI 10.1038/s41380-018-0255-6; Haure-Mirande JV, 2017, ACTA NEUROPATHOL, V134, P769, DOI 10.1007/s00401-017-1737-3; Hauser S, 2019, MOL THER-METH CLIN D, V15, P359, DOI 10.1016/j.omtm.2019.10.011; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Herring A, 2012, J ALZHEIMERS DIS, V30, P963, DOI 10.3233/JAD-2012-112069; Hildebrand JM, 2011, IMMUNOL REV, V244, P55, DOI 10.1111/j.1600-065X.2011.01055.x; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hoa NN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124495; Hood VL, 2019, HUM MOL GENET, V28, P3188, DOI 10.1093/hmg/ddz144; Ishii K, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00229; Ismail MA, 2017, J EXP MED, V214, P699, DOI 10.1084/jem.20160534; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jhang KA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1112-x; Jung HJ, 2013, MOL NEUROBIOL, V47, P290, DOI 10.1007/s12035-012-8350-1; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Kiss T, 2020, GEROSCIENCE, V42, P429, DOI 10.1007/s11357-020-00177-1; Knock E, 2018, NEUROBIOL DIS, V110, P154, DOI 10.1016/j.nbd.2017.11.015; Kolbe K, 2016, NEUROBIOL AGING, V48, P103, DOI 10.1016/j.neurobiolaging.2016.08.016; Koo GB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03211-z; Lane-Donovan C, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa6674; Lau L, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00586-18; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Leffa DD, 2014, ACTA NEUROPSYCHIATR, V26, P161, DOI 10.1017/neu.2013.48; Lesniak A, 2017, BEHAV BRAIN RES, V326, P209, DOI 10.1016/j.bbr.2017.03.015; Lewis ND, 2014, J NEUROIMMUNOL, V277, P26, DOI 10.1016/j.jneuroim.2014.09.014; Li JB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10677-0; Lin E, 2019, DNA REPAIR, V78, P1, DOI 10.1016/j.dnarep.2019.03.013; Lin JB, 2018, EBIOMEDICINE, V32, P9, DOI 10.1016/j.ebiom.2018.05.035; Linnartz-Gerlach B, 2019, GLIA, V67, P539, DOI 10.1002/glia.23563; Liu EY, 2015, P NATL ACAD SCI USA, V112, P773, DOI 10.1073/pnas.1409563112; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Machiya J, 2007, AM J RESP CELL MOL, V36, P418, DOI 10.1165/rcmb.2006-0248OC; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Matsuzaki S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10730; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McDonnell MA, 2003, CELL DEATH DIFFER, V10, P1005, DOI 10.1038/sj.cdd.4401271; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Huynh MB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209573; Montgomery RR, 2017, CLIN EXP IMMUNOL, V187, P26, DOI 10.1111/cei.12863; Moore R, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-39; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mounce LTA, 2013, J HEAD TRAUMA REHAB, V28, P397, DOI 10.1097/HTR.0b013e318252dd75; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Munch S, 2014, MOL CELL BIOL, V34, P1733, DOI 10.1128/MCB.01345-13; Musi CA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102190; Nagarajan P, 2019, AGING CELL, V18, DOI 10.1111/acel.12992; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nistico R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00063; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Ochi Y, 2011, ONCOL REP, V26, P805, DOI 10.3892/or.2011.1329; Olah M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19737-2; Olivieri F, 2015, ONCOTARGET, V6, P35509, DOI 10.18632/oncotarget.5899; Olstad EW, 2019, CURR BIOL, V29, P229, DOI 10.1016/j.cub.2018.11.059; Opdam FJM, 2000, J CELL SCI, V113, P2725; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Ou HL, 2018, BLOOD, V131, P488, DOI 10.1182/blood-2017-07-746396; Overall R.W., 2020, RTRACK SOFTWARE PACK, DOI [10.1101/2020.02.27.967372, DOI 10.1101/2020.02.27.967372]; Pei L, 2015, CEREB CORTEX, V25, P4559, DOI 10.1093/cercor/bhv096; Pekovic V, 2011, AGING CELL, V10, P1067, DOI 10.1111/j.1474-9726.2011.00750.x; Peterson D, 2014, ALZHEIMERS DEMENT, V10, P366, DOI 10.1016/j.jalz.2013.02.010; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Rodier F, 2009, NAT CELL BIOL, V11, P1272, DOI 10.1038/ncb1009-1272a; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Rymut N, 2020, FASEB J, V34, P597, DOI 10.1096/fj.201902126R; Sandoval K, 2019, NEUROCHEM RES, V44, P2670, DOI 10.1007/s11064-019-02890-6; Savage KI, 2014, CANCER RES, V74, P2773, DOI 10.1158/0008-5472.CAN-13-2611; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Schwab N, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0822-3; Schwab N, 2019, LAB INVEST, V99, P1008, DOI 10.1038/s41374-019-0199-8; Sekiya M, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0530-9; Selvam SP, 2018, J BIOL CHEM, V293, P9784, DOI 10.1074/jbc.RA118.003506; Shang DS, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00929; Shi LG, 2020, J CEREBR BLOOD F MET, V40, pS49, DOI 10.1177/0271678X20925655; Shi WY, 2020, GENE, V738, DOI 10.1016/j.gene.2020.144485; Shichita T, 2017, NAT MED, V23, P723, DOI 10.1038/nm.4312; Sikorska K, 2020, MATERIALS, V13, DOI 10.3390/ma13143227; Simin S., 2009, NEUROBIOL AGING, V29, P452; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Siyahhan B, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1189; Song SS, 2012, CELL RES, V22, P1285, DOI 10.1038/cr.2012.107; Sousa JC, 2007, NEUROBIOL AGING, V28, P713, DOI 10.1016/j.neurobiolaging.2006.03.015; Stefanova NA, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3984906; Su WP, 2017, J BIOL CHEM, V292, P4434, DOI 10.1074/jbc.M116.774109; Sufit A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165107; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Testa G, 2016, REDOX BIOL, V10, P24, DOI 10.1016/j.redox.2016.09.001; Testa G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096795; Tiwari V, 2019, AM J HUM GENET, V105, P237, DOI 10.1016/j.ajhg.2019.06.005; Tominaga T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213673; Tong QQ, 2017, GENE, V634, P37, DOI 10.1016/j.gene.2017.08.035; Towers CG, 2020, AUTOPHAGY, V16, P1332, DOI 10.1080/15548627.2020.1741204; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Uraoka M, 2011, HYPERTENSION, V58, P254, DOI 10.1161/HYPERTENSIONAHA.111.176701; Vacher M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53604-5; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Vrtacnik P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34255-4; Wang H, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00384-6; Wang KS, 2016, J MOL NEUROSCI, V60, P436, DOI 10.1007/s12031-016-0821-9; Wang Z, 2016, MOL CELL, V63, P781, DOI 10.1016/j.molcel.2016.08.021; Wanschers BFJ, 2007, EXP CELL RES, V313, P3408, DOI 10.1016/j.yexcr.2007.05.032; Weetman J, 2013, NEUROSCI LETT, V544, P119, DOI 10.1016/j.neulet.2013.03.057; Wu P, 2013, J NEUROTRAUM, V30, P775, DOI 10.1089/neu.2012.2391; Xiong GX, 2014, J NEUROTRAUM, V31, P1396, DOI 10.1089/neu.2013.3110; Xu LZ, 2019, MOL NEUROBIOL, V56, P2838, DOI 10.1007/s12035-018-1242-2; Xu SF., 2019, PEERJ, V7; Yadav R, 2018, ADV PHARMACOL SCI, V2018, DOI 10.1155/2018/3632159; Yarza R, 2016, FRONT PHARMACOL, V6, DOI [10.3389/fphys.2015.00321, 10.3389/fphar.2015.00321]; Yau JLW, 2003, NEUROSCIENCE, V121, P307, DOI 10.1016/S0306-4522(03)00438-X; Yoo DY, 2017, MOL MED REP, V16, P3427, DOI 10.3892/mmr.2017.6946; Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yousefzadeh MJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13094; Zhang XN, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700531; Zhang XX, 2020, J PROTEOME RES, V19, P1154, DOI 10.1021/acs.jproteome.9b00667; Zhao LY, 2020, CANCER GENE THER, V27, P461, DOI 10.1038/s41417-019-0118-6; Zhao YG, 2013, AUTOPHAGY, V9, P1258, DOI 10.4161/auto.24856; Zheng W, 1999, TOXICOL APPL PHARM, V155, P24, DOI 10.1006/taap.1998.8611; Zhu L, 2019, PATHOL RES PRACT, V215, P822, DOI 10.1016/j.prp.2019.01.022; Zhu XW, 2004, J NEUROCHEM, V89, P1233, DOI 10.1111/j.1471-4159.2004.02416.x; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344; Zhubi A, 2017, INT J DEV NEUROSCI, V62, P63, DOI 10.1016/j.ijdevneu.2017.02.003	184	3	3	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	MAY 8	2021	9	1							82	10.1186/s40478-021-01190-x			27	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RZ1XL	WOS:000648391400001	33964983	Green Published, gold			2022-02-06	
J	Iverson, GL; Caccese, JB; Merz, ZC; Buttner, F; Terry, DP				Iverson, Grant L.; Caccese, Jaclyn B.; Merz, Zachary C.; Buttner, Fionn; Terry, Douglas P.			Age of First Exposure to Football Is Not Associated With Later-in-Life Cognitive or Mental Health Problems	FRONTIERS IN NEUROLOGY			English	Article						concussion; head trauma; traumatic brain injury; chronic traumatic encephalopathy; subconcussive	HIGH-SCHOOL FOOTBALL; PARTICIPATION; DEPRESSION; SYMPTOMS; VALIDITY; SPORTS; PHQ-9; RISK	Background: The purpose of this study was to determine if earlier age of first exposure to football is associated with worse brain health in middle-aged and older adult men who played high school football. Methods: Men from the United States, aged 35 and older, who reported playing high school football, completed a customized, online health survey via the Amazon Mechanical Turk (mTurk) platform. Survey items included physical, psychological, and cognitive symptoms over the past week and over the past year, sports participation history (including age of first exposure to football), medical history, and concussion history. Participants also completed the Patient Health Questionnaire-8 (PHQ-8) and the British Columbia Post-Concussion Symptom Inventory (BC-PSI). Results: There were 186 men (age M = 51.78, SD = 10.93) who participated in high school football, and 87 (46.8%) reported football participation starting before the age of 12 and 99 (53.2%) reported football participation at or after the age of 12. Those who started playing football at an earlier age reported a greater number of lifetime concussions (M = 1.95, SD = 1.79) compared to those who started playing at age 12 or later (M = 1.28, SD = 1.52; U = 3,257.5, p = 0.003). A similar proportion of men who played football before vs. after the age of 12 reported a lifetime history of being prescribed medications for depression, anxiety, chronic pain, headaches, or memory problems. When comparing men who played football before vs. after the age of 12, the groups did not differ significantly in their ratings of depression, anger, anxiety, headaches, migraines, neck or back pain, chronic pain, concentration problems, or memory problems over the past week or the past year. The two groups did not differ significantly in their ratings of current symptoms of depression (PHQ-8; U = 4,187.0, p = 0.74) or post-concussion-like symptoms (BC-PSI; U = 3,944.0, p = 0.53). Furthermore, there were no statistically significant correlations between the age of first exposure to football, as a continuous variable, and PHQ-8 or BC-PSI scores. Conclusion: This study adds to a rapidly growing body of literature suggesting that earlier age of first exposure to football is not associated with later-in-life brain health.	[Iverson, Grant L.; Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Spaulding Res Inst, Charlestown, MA 02129 USA; [Iverson, Grant L.; Terry, Douglas P.] MassGen Hosp Children, Sports Concuss Program, Boston, MA 02114 USA; [Iverson, Grant L.; Terry, Douglas P.] Home Base, Charlestown, MA 02129 USA; [Caccese, Jaclyn B.] Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Merz, Zachary C.] Univ N Carolina, UNC Mem Hosp, Dept Phys Med & Rehabil, Chapel Hill, NC 27515 USA; [Merz, Zachary C.] Moses Cone Mem Hosp, LeBauer Dept Neurol, Greensboro, NC USA; [Buttner, Fionn] Univ Coll Dublin, Sch Publ Hlth, Physiotherapy & Sports Sci, Dublin, Ireland		Iverson, GL (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Iverson, GL (corresponding author), Spaulding Rehabil Hosp, Spaulding Res Inst, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), MassGen Hosp Children, Sports Concuss Program, Boston, MA 02114 USA.; Iverson, GL (corresponding author), Home Base, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu		Caccese, Jaclyn/0000-0003-2329-3603	ImPACT Applications, Inc.; Mooney-Reed Charitable Foundation; National Rugby League; Spaulding Research Institute	GI acknowledges unrestricted philanthropic support from ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, the National Rugby League, and the Spaulding Research Institute. These organizations were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Asken BM, 2020, CLIN NEUROPSYCHOL, V34, P919, DOI 10.1080/13854046.2019.1680735; Bohr AD, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119868658; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Caccese JB, 2020, NEUROLOGY, V95, pE2935, DOI 10.1212/WNL.0000000000010672; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2020, INT J SPORTS MED, V41, P616, DOI 10.1055/a-1141-3553; Caccese JB, 2020, SPORTS MED, V50, P1377, DOI 10.1007/s40279-020-01261-4; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Deshpande SK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229978; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Difallah DE., 2015, 24 INT C WORLD WID W; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Gaulton TG, 2020, AM J EPIDEMIOL, V189, P592, DOI 10.1093/aje/kwz260; Houck ZM, 2020, CLIN NEUROPSYCHOL, V34, P561, DOI 10.1080/13854046.2019.1666923; Huang FY, 2006, J GEN INTERN MED, V21, P547, DOI 10.1111/j.1525-1497.2006.00409.x; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2021, J NEUROTRAUM, V38, P538, DOI 10.1089/neu.2020.7041; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lund E., 2018, SAGE RES METHODS CAS, DOI [10.4135/9781526437280, DOI 10.4135/9781526437280]; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mortensen K, 2018, J GEN INTERN MED, V33, P533, DOI 10.1007/s11606-017-4246-0; National Federation of State High School Associations, 2019, HIGH SCH ATHL PART S; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Taranto E, 2018, J NATL MED ASSOC, V110, P635, DOI 10.1016/j.jnma.2018.10.001; Thomas KB, 2015, J AGGRESS MALTREAT T, V24, P623, DOI 10.1080/10926771.2015.1049766; World Health Organization, 2004, ICD 10 INT STAT CLAS	38	3	3	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 5	2021	12								647314	10.3389/fneur.2021.647314			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	SE0MS	WOS:000651769900001	34025554	Green Published, gold			2022-02-06	
J	Oggioni, M; Mercurio, D; Minuta, D; Fumagalli, S; Popiolek-Barczyk, K; Sironi, M; Ciechanowska, A; Ippati, S; De Blasio, D; Perego, C; Mika, J; Garlanda, C; De Simoni, MG				Oggioni, Marco; Mercurio, Domenico; Minuta, Denise; Fumagalli, Stefano; Popiolek-Barczyk, Katarzyna; Sironi, Marina; Ciechanowska, Agata; Ippati, Stefania; De Blasio, Daiana; Perego, Carlo; Mika, Joanna; Garlanda, Cecilia; De Simoni, Maria-Grazia			Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; MANNOSE-BINDING LECTIN; CENTRAL-NERVOUS-SYSTEM; INNATE IMMUNITY; ACUTE-PHASE; DIASTOLIC DYSFUNCTION; HEART-FAILURE; CELLS; INFLAMMATION; COMPLEMENT	Long pentraxin PTX3, a pattern recognition molecule involved in innate immune responses, is upregulated by pro-inflammatory stimuli, contributors to secondary damage in traumatic brain injury (TBI). We analyzed PTX3 involvement in mice subjected to controlled cortical impact, a clinically relevant TBI mouse model. We measured PTX3 mRNA and protein in the brain and its circulating levels at different time point post-injury, and assessed behavioral deficits and brain damage progression in PTX3 KO mice. PTX3 circulating levels significantly increased 1-3 weeks after injury. In the brain, PTX3 mRNA was upregulated in different brain areas starting from 24 h and up to 5 weeks post-injury. PTX3 protein significantly increased in the brain cortex up to 3 weeks post-injury. Immunohistochemical analysis showed that, 48 h after TBI, PTX3 was localized in proximity of neutrophils, likely on neutrophils extracellular traps (NETs), while 1- and 2- weeks post-injury PTX3 co-localized with fibrin deposits. Genetic depletion of PTX3 did not affect sensorimotor deficits up to 5 weeks post-injury. At this time-point lesion volume and neuronal count, axonal damage, collagen deposition, astrogliosis, microglia activation and phagocytosis were not different in KO compared to WT mice. Members of the long pentraxin family, neuronal pentraxin 1 (nPTX1) and pentraxin 4 (PTX4) were also over-expressed in the traumatized brain, but not neuronal pentraxin 2 (nPTX2) or short pentraxins C-reactive protein (CRP) and serum amyloid P-component (SAP). The long-lasting pattern of activation of PTX3 in brain and blood supports its specific involvement in TBI. The lack of a clear-cut phenotype in PTX3 KO mice may depend on the different roles of this protein, possibly involved in inflammation early after injury and in repair processes later on, suggesting distinct functions in acute phases versus sub-acute or chronic phases. Brain long pentraxins, such as PTX4-shown here to be overexpressed in the brain after TBI-may compensate for PTX3 absence.	[Oggioni, Marco; Mercurio, Domenico; Minuta, Denise; Fumagalli, Stefano; Ippati, Stefania; De Blasio, Daiana; Perego, Carlo; De Simoni, Maria-Grazia] Ist Ric Farmacol Mario Negri IRCCS, Via Mario Negri 2, I-20156 Milan, Italy; [Sironi, Marina] Humanitas Clin & Res Ctr IRCCS, Via Manzoni 56, I-20089 Rozzano Milan, Italy; [Popiolek-Barczyk, Katarzyna; Ciechanowska, Agata; Mika, Joanna] Polish Acad Sci, Maj Inst Pharmacol, Dept Pain Pharmacol, Krakow, Poland; [Garlanda, Cecilia] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20090 Pieve Emanuele Milan, Italy; [Minuta, Denise] Osped San Raffaele, San Raffaele Telethon Inst Gene Therapy SRTiget, I-20132 Milan, Italy; [Ippati, Stefania] Hosp San Raffaele, San Raffaele Sci Inst, I-20132 Milan, Italy		De Simoni, MG (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Via Mario Negri 2, I-20156 Milan, Italy.	desimoni@marionegri.it	sironi, marina/AAB-5757-2020	sironi, marina/0000-0002-3342-1149; Ciechanowska, Agata/0000-0001-5270-2758; Mika, Joanna/0000-0003-1986-7205; Mercurio, Domenico/0000-0001-5101-7222	ERA-NET-NEURON; National Centre for Research and Development (Narodowe Centrum Badan i Rozwoju, ERA-NET NEURON), Poland [NEURON9-FP-044, 1/LEAP/15/17]; Italian Ministry of Health (Ministero della Salute), Italy; Maj Institute of Pharmacology Polish Academy of Sciences	This work was supported by ERA-NET-NEURON, JTC 2016: LEAP, NEURON9-FP-044 from the following national funding institutions: National Centre for Research and Development (Narodowe Centrum Badan i Rozwoju, ERA-NET NEURON-Cofund/1/LEAP/15/17), Poland, and the Italian Ministry of Health (Ministero della Salute), Italy. This work was also supported by statutory funds of the Maj Institute of Pharmacology Polish Academy of Sciences.	Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Baranova NS, 2014, J BIOL CHEM, V289, P30481, DOI 10.1074/jbc.M114.568154; Bonacina F, 2016, BBA-MOL BASIS DIS, V1862, P1182, DOI 10.1016/j.bbadis.2016.03.007; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Bottazzi B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02817; Bottazzi B, 2016, J HEPATOL, V64, P1416, DOI 10.1016/j.jhep.2016.02.029; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; de Oliveira THC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01461; Cappuzzello C, 2016, J INVEST DERMATOL, V136, P293, DOI 10.1038/JID.2015.346; Carrizzo A, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0144-0; Casula M, 2017, VASC PHARMACOL, V99, P1, DOI 10.1016/j.vph.2017.10.003; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Daigo K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00344; Daigo K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00378; De Blasio D, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X18758881; De Blasio D, 2017, J CEREBR BLOOD F MET, V37, P938, DOI 10.1177/0271678X16647397; de la Torre YM, 2010, J IMMUNOL, V184, P5055, DOI 10.4049/jimmunol.0901672; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Doni A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00712; Doni A, 2016, SEMIN IMMUNOL, V28, P570, DOI 10.1016/j.smim.2016.10.012; Doni A, 2015, J EXP MED, V212, P905, DOI 10.1084/jem.20141268; Farizatto KLG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42934-z; Fossati G, 2019, EMBO J, V38, DOI 10.15252/embj.201899529; Fumagalli S, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1401-z; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Gustin C, 2008, ARTERIOSCL THROM VAS, V28, P491, DOI 10.1161/ATVBAHA.107.158642; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hill AL, 2009, BRIT J ANAESTH, V103, P833, DOI 10.1093/bja/aep298; INTRONA M, 1993, BEHRING I MITT, V6, P23; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jenkins DR, 2018, J NEUROTRAUM, V35, P2259, DOI 10.1089/neu.2017.5291; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Jimenez-Alcazar M, 2017, SCIENCE, V358, P1202, DOI 10.1126/science.aam8897; Kaess BM, 2011, NAT REV CARDIOL, V8, P246, DOI 10.1038/nrcardio.2011.50; Kimball AS, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00236; Knoflach M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031474; Koga S, 2013, JACC-CARDIOVASC INTE, V6, P945, DOI 10.1016/j.jcin.2013.04.024; Kwiatkowski K, 2017, J NEUROIMMUNE PHARM, V12, P402, DOI 10.1007/s11481-017-9729-6; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Ma YJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03046; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Magrini E, 2016, TRENDS MOL MED, V22, P497, DOI 10.1016/j.molmed.2016.04.007; Mantovani A, 2012, EUR RESPIR J, V39, P795, DOI 10.1183/09031936.00198111; Matsubara J, 2011, J AM COLL CARDIOL, V57, P861, DOI 10.1016/j.jacc.2010.10.018; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Neglia L, 2020, CELL MOL IMMUNOL, V17, P218, DOI 10.1038/s41423-019-0225-1; Norata GD, 2008, ARTERIOSCL THROM VAS, V28, P925, DOI 10.1161/ATVBAHA.107.160606; Osthoff M, 2017, J NEUROTRAUM, V34, P2560, DOI 10.1089/neu.2016.4941; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Pischiutta F, 2014, NEUROPHARMACOLOGY, V79, P119, DOI 10.1016/j.neuropharm.2013.11.001; Polentarutti N, 2000, J NEUROIMMUNOL, V106, P87, DOI 10.1016/S0165-5728(00)00214-9; Porte R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00794; Rajkovic Ivana, 2019, AMRC Open Res, V1, P10, DOI 10.12688/amrcopenres.12875.1; Rajkovic I, 2018, J MOL MED, V96, P1319, DOI 10.1007/s00109-018-1698-6; Rajkovic I, 2016, J NEUROIMMUNOL, V292, P27, DOI 10.1016/j.jneuroim.2015.12.007; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; Ristagno G, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00823; Rodriguez-Grande B, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0227-y; Rodriguez-Grande B, 2014, J CEREBR BLOOD F MET, V34, P480, DOI 10.1038/jcbfm.2013.224; Ryu WS, 2012, ATHEROSCLEROSIS, V220, P581, DOI 10.1016/j.atherosclerosis.2011.11.036; Savchenko A A, 2018, Zh Nevrol Psikhiatr Im S S Korsakova, V118, P75, DOI 10.17116/jnevro201811812275; Sciacca Pietro, 2010, Front Biosci (Elite Ed), V2, P805; Shindo A, 2016, STROKE, V47, P1094, DOI 10.1161/STROKEAHA.115.012133; Soeki T, 2011, J CARDIOL, V58, P151, DOI 10.1016/j.jjcc.2011.04.005; Thatipamula S, 2015, NEUROBIOL DIS, V75, P15, DOI 10.1016/j.nbd.2014.12.016; Thatipamula S, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0133-3; Tsui CC, 1996, J NEUROSCI, V16, P2463; Ummenthum K, 2016, EUR J IMMUNOL, V46, P701, DOI 10.1002/eji.201545950; Van Pottelberge GR, 2012, EUR RESPIR J, V39, P830, DOI 10.1183/09031936.00138110; Yu JH, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/274326; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zanier Elisa R, 2015, Intensive Care Med Exp, V3, P39, DOI 10.1186/s40635-015-0039-0; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zanier ER, 2011, INTENS CARE MED, V37, P302, DOI 10.1007/s00134-010-2075-2	83	3	3	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAY 5	2021	11	1							9616	10.1038/s41598-021-89032-7			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SK8HU	WOS:000656457900013	33953334	Green Published, gold			2022-02-06	
J	Frank, R; Bari, F; Menyhart, A; Farkas, E				Frank, Rita; Bari, Ferenc; Menyhart, Akos; Farkas, Eszter			Comparative analysis of spreading depolarizations in brain slices exposed to osmotic or metabolic stress	BMC NEUROSCIENCE			English	Article						Brain slice; Cerebral ischemia; Spreading depolarization; Osmotic stress; Oxygen&#8208; glucose deprivation	ANOXIC DEPOLARIZATION; ION CONCENTRATIONS; DEPRESSION; ISCHEMIA; TISSUE; CHLORIDE; THRESHOLD; GLUTAMATE; BLOCKADE; PROTECTS	Background Recurrent spreading depolarizations (SDs) occur in stroke and traumatic brain injury and are considered as a hallmark of injury progression. The complexity of conditions associated with SD in the living brain encouraged researchers to study SD in live brain slice preparations, yet methodological differences among laboratories complicate integrative data interpretation. Here we provide a comparative evaluation of SD evolution in live brain slices, in response to selected SD triggers and in various media, under otherwise standardized experimental conditions. Methods Rat live coronal brain slices (350 mu m) were prepared (n = 51). Hypo-osmotic medium (Na+ content reduced from 130 to 60 mM, HM) or oxygen-glucose deprivation (OGD) were applied to cause osmotic or ischemic challenge. Brain slices superfused with artificial cerebrospinal fluid (aCSF) served as control. SDs were evoked in the control condition with pressure injection of KCl or electric stimulation. Local field potential (LFP) was recorded via an intracortical glass capillary electrode, or intrinsic optical signal imaging was conducted at white light illumination to characterize SDs. TTC and hematoxylin-eosin staining were used to assess tissue damage. Results Severe osmotic stress or OGD provoked a spontaneous SD. In contrast with SDs triggered in aCSF, these spontaneous depolarizations were characterized by incomplete repolarization and prolonged duration. Further, cortical SDs under HM or OGD propagated over the entire cortex and occassionally invaded the striatum, while SDs in aCSF covered a significantly smaller cortical area before coming to a halt, and never spread to the striatum. SDs in HM displayed the greatest amplitude and the most rapid propagation velocity. Finally, spontaneous SD in HM and especially under OGD was followed by tissue injury. Conclusions While the failure of Na+/K+ ATP-ase is thought to impair tissue recovery from OGD-related SD, the tissue swelling-related hyper excitability and the exhaustion of astrocyte buffering capacity are suggested to promote SD evolution under osmotic stress. In contrast with OGD, SD propagating under hypo-osmotic condition is not terminal, yet it is associated with irreversible tissue injury. Further investigation is required to understand the mechanistic similarities or differences between the evolution of SDs spontaneously occurring in HM and under OGD.	[Frank, Rita; Bari, Ferenc; Menyhart, Akos; Farkas, Eszter] Univ Szeged, Fac Med, Dept Med Phys & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary; [Frank, Rita; Bari, Ferenc; Menyhart, Akos; Farkas, Eszter] Univ Szeged, Fac Sci & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary		Menyhart, A; Farkas, E (corresponding author), Univ Szeged, Fac Med, Dept Med Phys & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary.	menyhart.akos@med.u-szeged.hu; farkas.eszter.1@med.u-szeged.hu		Menyhart, Akos/0000-0002-1355-3208; Frank, Rita/0000-0003-2342-9937; Farkas, Eszter/0000-0002-8478-9664	National Research, Development and Innovation Office of HungaryNational Research, Development & Innovation Office (NRDIO) - Hungary [K134377, K120358, PD128821]; Economic Development and Innovation Operational Programme in Hungary; European UnionEuropean Commission; European Regional Development FundEuropean Commission [GINOP-2.3.2-15-2016-00006]; EUEuropean Commission [EFOP-3.6.1-16-2016-00008]	This work was supported by grants from the National Research, Development and Innovation Office of Hungary (K134377; K120358, and PD128821); the Economic Development and Innovation Operational Programme in Hungary co-financed by the European Union and the European Regional Development Fund (No. GINOP-2.3.2-15-2016-00006), and the EU-funded Hungarian grant No. EFOP-3.6.1-16-2016-00008.	Aiba I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4050; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Anderson TR, 2002, J NEUROPHYSIOL, V88, P2713, DOI 10.1152/jn.00321.2002; Ayata C, 2000, NEUROSCIENCE, V95, P639; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; BALESTRINO M, 1986, BRAIN RES, V385, P219, DOI 10.1016/0006-8993(86)91067-X; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Brennan KC, 2018, NEURON, V97, P1004, DOI 10.1016/j.neuron.2018.01.029; Brisson CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096585; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; CHEBABO SR, 1995, BRAIN RES, V695, P203, DOI 10.1016/0006-8993(95)00778-O; CHEBABO SR, 1995, J PHYSIOL-LONDON, V487, P685, DOI 10.1113/jphysiol.1995.sp020910; CZEH G, 1993, BRAIN RES, V632, P195, DOI 10.1016/0006-8993(93)91154-K; Dietz RM, 2007, HIPPOCAMPUS, V17, P1049, DOI 10.1002/hipo.20336; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2018, NEUROPHARMACOLOGY, V134, P189, DOI 10.1016/j.neuropharm.2017.09.027; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Esmann M, 2008, BIOPHYS J, V94, P2767, DOI 10.1529/biophysj.106.101774; Goldlust EJ, 1996, STROKE, V27, P1657, DOI 10.1161/01.STR.27.9.1657; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Harriott AM, 2021, ANN NEUROL, V89, P99, DOI 10.1002/ana.25926; Harriott AM, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1001-4; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; HATFIELD RH, 1991, NEUROPATH APPL NEURO, V17, P61, DOI 10.1111/j.1365-2990.1991.tb00694.x; Hertelendy P, 2019, NEUROCHEM INT, V127, P125, DOI 10.1016/j.neuint.2018.10.010; Hertelendy P, 2017, J CEREBR BLOOD F MET, V37, P1763, DOI 10.1177/0271678X16643735; Hoffmann U, 2013, ACTA NEUROCHIR SUPPL, V115, P161, DOI 10.1007/978-3-7091-1192-5_31; Ivankovits-Kiss O, 324103 BIORXIV, DOI [10.1101/2020.10.02.324103, DOI 10.1101/2020.10.02.324103]; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Joshi I, 2001, J NEUROPHYSIOL, V85, P414, DOI 10.1152/jn.2001.85.1.414; Juzekaeva E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75975-w; Juzekaeva E, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00390; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; KOROLEVA VI, 1979, BRAIN RES, V173, P209, DOI 10.1016/0006-8993(79)90622-X; Lauderdale K, 2015, ASN NEURO, V7, DOI 10.1177/1759091415605115; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Loonen ICM, 2019, BRAIN, V142, P412, DOI 10.1093/brain/awy325; MATSUURA T, 1971, EXP BRAIN RES, V12, P238, DOI 10.1007/BF00237916; Menyhart A, 2018, NEUROBIOL DIS, V119, P41, DOI 10.1016/j.nbd.2018.07.026; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; OSEHOBO EP, 1993, EXP NEUROL, V124, P192, DOI 10.1006/exnr.1993.1189; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Reiffurth C, 2020, J CEREBR BLOOD F MET, V40, P622, DOI 10.1177/0271678X19833757; Reinhart KM, 2018, EXP NEUROL, V305, P121, DOI 10.1016/j.expneurol.2018.04.007; Richter F, 2002, NEUROSCI LETT, V334, P123, DOI 10.1016/S0304-3940(02)01120-5; Santos E, 2014, NEUROIMAGE, V99, P244, DOI 10.1016/j.neuroimage.2014.05.021; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Szabo I, 2019, BRIT J PHARMACOL, V176, P1222, DOI 10.1111/bph.14611; Tang YT, 2014, J NEUROPHYSIOL, V112, P2572, DOI 10.1152/jn.00205.2014; Tong CK, 2000, J NEUROPHYSIOL, V84, P2449, DOI 10.1152/jn.2000.84.5.2449; Toth OM, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9120460; Vinogradova LV, 2018, CEPHALALGIA, V38, P1177, DOI 10.1177/0333102417724151; White SH, 2012, J NEUROPHYSIOL, V107, P2083, DOI 10.1152/jn.00701.2011; Wu DC, 2018, CEREB CORTEX, V28, P3204, DOI 10.1093/cercor/bhx192	60	3	3	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	MAY 3	2021	22	1							33	10.1186/s12868-021-00637-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RW5JE	WOS:000646557700001	33941084	gold, Green Published, Green Accepted			2022-02-06	
J	Zhang, YL; Zhang, Y; Chopp, M; Pang, HY; Zhang, ZG; Mahmood, A; Xiong, Y				Zhang, Yanlu; Zhang, Yi; Chopp, Michael; Pang, Haiyan; Zhang, Zheng Gang; Mahmood, Asim; Xiong, Ye			MiR-17-92 Cluster-Enriched Exosomes Derived from Human Bone Marrow Mesenchymal Stromal Cells Improve Tissue and Functional Recovery in Rats after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						exosomes; functional outcome; microRNA; neuroinflammation; neuroplasticity; traumatic brain injury	CONTROLLED CORTICAL IMPACT; NEUROVASCULAR PLASTICITY; SPATIAL MEMORY; STROKE; MICRORNA; NEUROGENESIS; ROLES; NEUROINFLAMMATION; TRANSPLANTATION; PROLIFERATION	Exosomes play an important role in intercellular communication by delivering microribonucleic acids (miRNAs) to recipient cells. Previous studies have demonstrated that multi-potent mesenchymal stromal cell (MSC)-derived exosomes improve functional recovery after experimental traumatic brain injury (TBI). This study was performed to determine efficacy of miR-17-92 cluster-enriched exosomes (Exo-17-92) harvested from human bone marrow MSCs transfected with a miR-17-92 cluster plasmid in enhancing tissue and neurological recovery compared with exosomes derived from MSCs transfected with an empty plasmid vector (Exo-empty) for treatment of TBI. Adult male rats underwent a unilateral moderate cortical contusion. Animals received a single intravenous injection of miR-17-92 cluster-enriched exosomes (100 mu g/rat, approximately 3.75x10(11) particles, Exo-17-92) or control exosomes (100 mu g/rat, Exo-empty) or Vehicle (phosphate-buffered solution) one day after injury. A battery of neurological functional tests was performed weekly after TBI for five weeks. Spatial learning and memory were measured on days 31-35 after TBI using the Morris water maze test. All animals were sacrificed five weeks after injury. Their brains were processed for histopathological and immunohistochemical analyses of lesion volume, cell loss, angiogenesis, neurogenesis, and neuroinflammation. Compared with Vehicle, both Exo-17-92 and Exo-empty treatments significantly improved sensorimotor and cognitive function, reduced neuroinflammation and hippocampal neuronal cell loss, promoted angiogenesis and neurogenesis without altering the lesion volume. Moreover, Exo-17-92 treatment exhibited a significantly more robust therapeutic effect on improvement in functional recovery by reducing neuroinflammation and cell loss, enhancing angiogenesis and neurogenesis than did Exo-empty treatment. Exosomes enriched with miR-17-92 cluster have a significantly better effect on improving functional recovery after TBI compared with Exo-empty, likely by reducing neuroinflammation and enhancing endogenous angiogenesis and neurogenesis. Engineering specific miRNA in exosomes may provide a novel therapeutic strategy for management of unilateral moderate cortical contusion TBI.	[Zhang, Yanlu; Pang, Haiyan; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Zhang, Yi; Chopp, Michael; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Xiong, Y (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, E&R Bldg,Room 3096,2799 West Grand Blvd, Detroit, MI 48202 USA.	yxiong1@hfhs.org			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100710]	This work was supported by National Institute of Neurological Disorders and Stroke Grant R01NS100710 (YX). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chen YF, 2020, AGING-US, V12, P18274, DOI 10.18632/aging.103692; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao WW, 2018, EXP NEUROL, V307, P99, DOI 10.1016/j.expneurol.2018.06.001; Ge XT, 2020, MOL THER, V28, P503, DOI 10.1016/j.ymthe.2019.11.017; Ghosh S, 2020, ACS CHEM NEUROSCI, V11, P2045, DOI 10.1021/acschemneuro.0c00368; Gowen A, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00149; Harding J, 2014, J BIOL CHEM, V289, P4585, DOI 10.1074/jbc.R113.463737; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kooijmans SAA, 2012, INT J NANOMED, V7, P1525, DOI 10.2147/IJN.S29661; Lai RC, 2013, REGEN MED, V8, P197, DOI [10.2217/RME.13.4, 10.2217/rme.13.4]; Lakshmipathy U, 2008, STEM CELLS, V26, P356, DOI 10.1634/stemcells.2007-0625; Li D, 2019, NEUROCHEM RES, V44, P1903, DOI 10.1007/s11064-019-02825-1; Li L, 2020, BRAIN RES, V1747, DOI 10.1016/j.brainres.2020.147062; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mathiyalagan P, 2017, METHODS MOL BIOL, V1521, P139, DOI 10.1007/978-1-4939-6588-5_9; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Maumus M, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00997; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Moore TL, 2019, RESTOR NEUROL NEUROS, V37, P347, DOI 10.3233/RNN-190910; Pan WL, 2019, FASEB J, V33, P5257, DOI 10.1096/fj.201801019R; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rolfe A, 2015, BRAIN NEUROTRAUMA MO; Russell AE, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1684862; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sakurai F, 2011, FRONT BIOSCI-LANDMRK, V16, P2389, DOI 10.2741/3861; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Si LL, 2020, BIOCHEM BIOPH RES CO, V523, P527, DOI 10.1016/j.bbrc.2019.11.095; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Sun LQ, 2017, ONCOTARGET, V8, P59181, DOI 10.18632/oncotarget.19469; Sun MK, 2020, J NEUROTRAUM, V37, P1358, DOI 10.1089/neu.2019.6443; Sun P, 2018, J CEREBR BLOOD F MET, V38, P1125, DOI 10.1177/0271678X18773871; Sykova Eva, 2013, Laser Ther, V22, P87, DOI 10.3136/islsm.22.87; Tang X, 2020, EXP NEUROL, V332, DOI 10.1016/j.expneurol.2020.113394; Taupin P, 2006, CURR OPIN MOL THER, V8, P225; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tsai MJ, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-5; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Wen MM, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00129; Williams AM, 2020, J TRAUMA ACUTE CARE, V89, P388, DOI 10.1097/TA.0000000000002698; Williams AM, 2020, J TRAUMA ACUTE CARE, V88, P207, DOI [10.109711-A.0000000000002563, 10.1097/TA.0000000000002563]; Williams AM, 2019, J NEUROTRAUM, V36, P54, DOI 10.1089/neu.2018.5711; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xia XH, 2020, STEM CELL REV REP, DOI 10.1007/s12015-020-10050-5; Xin HQ, 2021, J CEREBR BLOOD F MET, V41, P1131, DOI 10.1177/0271678X20950489; Xin HQ, 2017, STROKE, V48, P747, DOI 10.1161/STROKEAHA.116.015204; Xin HQ, 2017, CELL TRANSPLANT, V26, P243, DOI 10.3727/096368916X693031; Xin HQ, 2013, NEUROSCI LETT, V542, P81, DOI 10.1016/j.neulet.2013.02.046; Xin HQ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00377; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yang P, 2017, J NEUROSCI RES, V95, P1574, DOI 10.1002/jnr.23991; Yang YX, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00055; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Zhang L, 2016, INT J STROKE, V11, P347, DOI 10.1177/1747493015625645; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang YL, 2020, NEUROREHAB NEURAL RE, V34, P616, DOI 10.1177/1545968320926164; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang Y, 2017, MOL NEUROBIOL, V54, P2659, DOI 10.1007/s12035-016-9851-0; Zhang Y, 2013, J NEUROSCI, V33, P6885, DOI 10.1523/JNEUROSCI.5180-12.2013; Zhang YJ, 2019, J CANCER RES CLIN, V145, P281, DOI 10.1007/s00432-019-02840-3; Zhang ZG, 2019, NAT REV NEUROL, V15, P193, DOI 10.1038/s41582-018-0126-4; Zhang ZG, 2015, TRENDS MOL MED, V21, P543, DOI 10.1016/j.molmed.2015.07.005; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2	94	3	3	2	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2021	38	11					1535	1550		10.1089/neu.2020.7575		MAY 2021	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SL0LA	WOS:000646809800001	33787364				2022-02-06	
J	Cordaro, M; Salinaro, AT; Siracusa, R; D'Amico, R; Impellizzeri, D; Scuto, M; Ontario, ML; Crea, R; Cuzzocrea, S; Di Paola, R; Fusco, R; Calabrese, V				Cordaro, Marika; Trovato Salinaro, Angela; Siracusa, Rosalba; D'Amico, Ramona; Impellizzeri, Daniela; Scuto, Maria; Ontario, Maria Laura; Crea, Roberto; Cuzzocrea, Salvatore; Di Paola, Rosanna; Fusco, Roberta; Calabrese, Vittorio			Hidrox (R) Roles in Neuroprotection: Biochemical Links between Traumatic Brain Injury and Alzheimer's Disease	ANTIOXIDANTS			English	Article						oxidative stress; inflammation; neurodegeneration	OXIDATIVE STRESS; ISCHAEMIA/REPERFUSION INJURY; INDUCED INFLAMMATION; ANTIOXIDANT ACTIVITY; PARKINSONS-DISEASE; EXPERIMENTAL-MODEL; SAFETY ASSESSMENT; UNITED-STATES; MOUSE MODEL; HEAD-INJURY	Traumatic brain injuries (TBI) are a serious public-health problem. Furthermore, subsequent TBI events can compromise TBI patients' quality of life. TBI is linked to a number of long- and short-term complications such as cerebral atrophy and risk of developing dementia and Alzheimer's Disease (AD). Following direct TBI damage, oxidative stress and the inflammatory response lead to tissue injury-associated neurodegenerative processes that are characteristic of TBI-induced secondary damage. Hidrox (R) showed positive effects in preclinical models of toxic oxidative stress and neuroinflammation; thus, the aim of this study was to evaluate the effect of Hidrox (R) administration on TBI-induced secondary injury and on the propagation of the AD-like neuropathology. Hidrox (R) treatment reduced histological damage after controlled cortical impact. Form a molecular point of view, hydroxytyrosol is able to preserve the cellular redox balance and protein homeostasis by activating the Nrf2 pathway and increasing the expression of phase II detoxifying enzymes such as HO-1, SOD, Catalase, and GSH, thus counteracting the neurodegenerative damage. Additionally, Hidrox (R) showed anti-inflammatory effects by reducing the activation of the NFkB pathway and related cytokines overexpression. From a behavioral point of view, Hidrox (R) treatment ameliorated the cognitive dysfunction and memory impairment induced by TBI. Additionally, Hidrox (R) was associated with a significant increased number of hippocampal neurons in the CA3 region, which were reduced post-TBI. In particular, Hidrox (R) decreased AD-like phenotypic markers such as beta-amyloid accumulation and APP and p-Tau overexpression. These findings indicate that Hidrox (R) could be a valuable treatment for TBI-induced secondary injury and AD-like pathological features.	[Cordaro, Marika; Calabrese, Vittorio] Univ Messina, Dept Biomed Dent & Morphol & Funct Imaging, Via Consolare Valeria, I-98125 Messina, Italy; [Trovato Salinaro, Angela; Scuto, Maria; Ontario, Maria Laura] Univ Catania, Dept Biomed & Biotechnol Sci, I-95124 Catania, Italy; [Siracusa, Rosalba; D'Amico, Ramona; Impellizzeri, Daniela; Cuzzocrea, Salvatore; Di Paola, Rosanna; Fusco, Roberta] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, I-98166 Messina, Italy; [Crea, Roberto] Oliphenol LLC, 26225 Eden Landing Rd,Unit C, Hayward, CA 94545 USA		Cuzzocrea, S; Di Paola, R (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, I-98166 Messina, Italy.	cordarom@unime.it; trovato@unict.it; mary-amir@hotmail.it; rdamico@unime.it; dimpellizzeri@unime.it; rsiracusa@unime.it; marialaura.ontario@ontariosrl.it; robertocrea48@gmail.com; salvator@unime.it; dipaolar@unime.it; rfusco@unime.it; calabres@unict.it	Calabrese, Vittorio/AAC-8157-2021; Siracusa, Rosalba/AAC-3110-2022; Trovato Salinaro, Angela/AAC-1326-2022; FUSCO, Roberta/AAC-1745-2019; Ontario, Maria Laura/AAC-7849-2022; Cordaro, Marika/K-7329-2016; D'Amico, Ramona/AAC-9061-2019	Calabrese, Vittorio/0000-0002-0478-985X; Siracusa, Rosalba/0000-0001-7868-2505; FUSCO, Roberta/0000-0003-0223-1403; Cordaro, Marika/0000-0002-3980-0043; D'Amico, Ramona/0000-0003-0389-3871; TROVATO SALINARO, Angela/0000-0003-2377-858X; Cuzzocrea, Salvatore/0000-0001-6131-3690			Abu-Elfotuh K., 2016, OF, V11, P2; Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Angeloni C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112230; Aruoma OI, 2003, MUTAT RES-REV MUTAT, V544, P203, DOI 10.1016/j.mrrev.2003.06.017; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Biswas SK, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5698931; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; Casamenti F, 2015, J ALZHEIMERS DIS, V45, P679, DOI 10.3233/JAD-142850; Casili G, 2018, J NEUROTRAUM, V35, P1437, DOI 10.1089/neu.2017.5260; Chavali VD, 2020, J MOL NEUROSCI, V70, P836, DOI 10.1007/s12031-020-01489-9; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chen YZ, 2003, J CELL BIOL, V163, P27, DOI 10.1083/jcb.200304003; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Cordaro Marika, 2021, Cell Physiol Biochem, V55, P160, DOI 10.33594/000000353; Cordaro M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100992; Cordaro M, 2017, TOXICOL APPL PHARM, V329, P231, DOI 10.1016/j.taap.2017.06.005; Cordaro M, 2016, MOL PHARMACOL, V90, P549, DOI 10.1124/mol.116.105668; Cuzzocrea S, 2007, INTENS CARE MED, V33, P880, DOI 10.1007/s00134-007-0595-1; Cuzzocrea S, 2006, J IMMUNOL, V177, P631, DOI 10.4049/jimmunol.177.1.631; D'amico R, 2019, PHYTOMEDICINE, V54, P27, DOI 10.1016/j.phymed.2018.09.191; Di Paola R, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00051; Di Paola R, 2016, PHARMACOL RES, V111, P405, DOI 10.1016/j.phrs.2016.07.010; Di Paola R, 2016, SHOCK, V46, P202, DOI 10.1097/SHK.0000000000000578; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feart C, 2010, CURR OPIN CLIN NUTR, V13, P14, DOI 10.1097/MCO.0b013e3283331fe4; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fusco R, 2020, MOLECULES, V25, DOI 10.3390/molecules25194426; Fusco R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090781; Fusco R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080693; Fusco R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124223; Fusco R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194845; Fusco Roberta, 2018, Oncotarget, V9, P31355, DOI 10.18632/oncotarget.25823; Fusco R, 2017, FASEB J, V31, P3497, DOI 10.1096/fj.201601349R; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gottlieb S, 2000, BRIT MED J, V321, P1100; Grossi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071702; Gugliandolo E, 2020, VET SCI, V7, DOI 10.3390/vetsci7040161; Gugliandolo E, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01563; Gugliandolo E, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1303-5; Gugliandolo E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00590; Gugliandolo E, 2018, PHARMACOL RES, V132, P220, DOI 10.1016/j.phrs.2017.12.022; Gugliandolo E, 2019, SHOCK, V51, P221, DOI 10.1097/SHK.0000000000001137; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Impellizzeri D, 2019, FASEB J, V33, P11364, DOI 10.1096/fj.201900538R; Jin W, 2009, J SURG RES, V157, P251, DOI 10.1016/j.jss.2008.08.003; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Ku BM, 2006, NEUROSCI LETT, V405, P168, DOI 10.1016/j.neulet.2006.06.052; Lou DD, 2018, MOL NEUROBIOL, V55, P4928, DOI 10.1007/s12035-017-0687-z; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mahmoodzadeh T., 2016, J BIOMED OPT, V1, pE5340, DOI [10.17795/jbm-5340, DOI 10.17795/JBM-5340]; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Mariotto S, 2008, PHARMACOL RES, V57, P110, DOI 10.1016/j.phrs.2007.12.005; Miraglia N, 2016, FOOD CHEM TOXICOL, V93, P89, DOI 10.1016/j.fct.2016.04.013; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mutlu O, 2015, DRUG TARGET INSIGHT, V9, P1, DOI 10.4137/DTI.S23378; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Peritore AF, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10030464; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Radhakrishnan R, 2016, LANCET PSYCHIAT, V3, P1166, DOI 10.1016/S2215-0366(16)30266-8; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Reddy PH, 2010, J ALZHEIMERS DIS, V20, pS499, DOI 10.3233/JAD-2010-100504; Robles-Almazan M, 2018, FOOD RES INT, V105, P654, DOI 10.1016/j.foodres.2017.11.053; Salim S, 2017, J PHARMACOL EXP THER, V360, P201, DOI 10.1124/jpet.116.237503; SCOVILLE WB, 1954, J NEUROSURG, V11, P64, DOI 10.3171/jns.1954.11.1.0064; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shirley R, 2014, ANTIOXIDANTS-BASEL, V3, P472, DOI 10.3390/antiox3030472; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Siracusa R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090824; Siracusa R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030834; Soldatovic-Stajic B, 2014, EUR REV MED PHARMACO, V18, P1632; Soni MG, 2006, FOOD CHEM TOXICOL, V44, P903, DOI 10.1016/j.fct.2006.01.008; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Tarozzi A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/415078; Tasset I, 2011, NUTR NEUROSCI, V14, P106, DOI 10.1179/1476830511Y.0000000005; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Travelli C, 2017, J MED CHEM, V60, P1768, DOI 10.1021/acs.jmedchem.6b01392; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vauzour D, 2008, ARCH BIOCHEM BIOPHYS, V476, P145, DOI 10.1016/j.abb.2008.03.011; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang L, 2005, ANN CLIN LAB SCI, V35, P79; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150; Zhao XR, 2015, STROKE, V46, P1923, DOI 10.1161/STROKEAHA.115.009398	91	3	3	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	MAY	2021	10	5							818	10.3390/antiox10050818			15	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	SG3LQ	WOS:000653343800001	34065584	Green Published, gold			2022-02-06	
J	Gouttebarge, V; Kerkhoffs, GMMJ				Gouttebarge, V; Kerkhoffs, G. M. M. J.			Sports career-related concussion and mental health symptoms in former elite athletes	NEUROCHIRURGIE			English	Article						Concussion; Sports; Mental disorders; Epidemiology; Athletes	CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL FOOTBALL; ICE HOCKEY; DISORDERS; PREVALENCE; RISK; DETERMINANTS; DEPRESSION; OUTCOMES; HISTORY	Background. - In elite sports, concussion is common and recurrent, especially in high-speed contact or collision sports such as american and australian football, ice hockey and rugby. Mental health symptoms (e.g., anxiety, depression, sleep disturbance) are often reported by former elite athletes, with prevalence ranging from 16% for distress to 26% for anxiety/depression. This article focuses on the potential relationship between sports career-related concussion and mental health symptoms in former elite athletes. Method. - A narrative mini-review was based on the scientific literature. Results. - Some literature based on cross-sectional data suggests that sports career-related concussion might lead in the long term to mental health symptoms in former elite athletes. Retired professional American football players reporting three or more previous concussions were found to be three times more likely to be diagnosed with depression than those with no history of concussion. Former professional athletes from football, ice hockey and rugby who reported a history of six or more concussions were approximately up to five times more likely to report mental health symptoms. Conclusions. - While longitudinal evidence about any causal relationship is lacking, the suggested relationship between sports career-related concussion and mental health symptoms in former elite athletes warrants the development of support measures for elite athletes transitioning out of sport, especially for those with a history of concussion. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Gouttebarge, V; Kerkhoffs, G. M. M. J.] Univ Amsterdam, Dept Orthopaed Surg, Amsterdam Movement Sci, Amsterdam UMC, 9 Meibergdreef, NL-1105 AZ Amsterdam, Netherlands; [Gouttebarge, V; Kerkhoffs, G. M. M. J.] Amsterdam Univ Med Ctr, Acad Ctr Evidence Based Sports Med ACES, Amsterdam, Netherlands; [Gouttebarge, V; Kerkhoffs, G. M. M. J.] Amsterdam UMC IOC Res Ctr Excellence, Amsterdam Collaborat Hlth & Safety Sports, Amsterdam, Netherlands; [Gouttebarge, V] Univ Cape Town, Div Exercise Sci & Sports Med, Cape Town, South Africa		Gouttebarge, V (corresponding author), Univ Amsterdam, Dept Orthopaed Surg, Amsterdam Movement Sci, Amsterdam UMC, 9 Meibergdreef, NL-1105 AZ Amsterdam, Netherlands.	v.gouttebarge@amsterdamumc.nl					Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; England Professional Rugby Injury Surveillance Project Steering Group, 2016, RUGB PLAYERS ENGL PR; Gouttebarge V, 2019, BRIT J SPORT MED, V53, P700, DOI 10.1136/bjsports-2019-100671; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P252, DOI 10.1080/00913847.2017.1338497; Gouttebarge V, 2017, J SPORT SCI, V35, P2148, DOI 10.1080/02640414.2016.1258485; Gouttebarge V, 2016, J SPORT MED PHYS FIT, V56, P648; Gouttebarge V, 2016, EUR J SPORT SCI, V16, P595, DOI 10.1080/17461391.2015.1086819; Gulliver A, 2015, J SCI MED SPORT, V18, P255, DOI 10.1016/j.jsams.2014.04.006; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hidehbani N, 2013, ARCH CLIN NEUROSY, V28, P118; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kilic O, 2017, EUR J SPORT SCI, V17, P1328, DOI 10.1080/17461391.2017.1381768; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Reardon CL, 2019, BRIT J SPORT MED, V53, P667, DOI 10.1136/bjsports-2019-100715; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Saw R, 2018, SPORTS HEALTH, V10, P208, DOI 10.1177/1941738117726070; Schaal K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019007; Schuring N, 2017, PHYSICIAN SPORTSMED, V45, P463, DOI 10.1080/00913847.2017.1386069; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; van Ramele S, 2017, PSYCHOL SPORT EXERC, V28, P85, DOI 10.1016/j.psychsport.2016.10.009; Walden M, 2013, SCAND J MED SCI SPOR, V23, P424, DOI 10.1111/j.1600-0838.2011.01409.x	28	3	3	6	9	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	MAY	2021	67	3					280	282		10.1016/j.neuchi.2020.01.001			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	RU4GM	WOS:000645106900012	32017942				2022-02-06	
J	Runyan, A; Lengel, D; Huh, JW; Barson, JR; Raghupathi, R				Runyan, Avery; Lengel, Dana; Huh, Jimmy W.; Barson, Jessica R.; Raghupathi, Ramesh			Intranasal Administration of Oxytocin Attenuates Social Recognition Deficits and Increases Prefrontal Cortex Inhibitory Postsynaptic Currents following Traumatic Brain Injury	ENEURO			English	Article						excitability; GABAergic neurotransmission; intranasal administration; oxytocin; pediatric TBI; social behavior	DENTATE GYRUS; VULNERABILITY; BEHAVIOR; MODEL; AGE; CHILDREN; RECEPTOR; RELEASE; NETWORK; SYSTEM	Pediatric traumatic brain injury (TBI) results in heightened risk for social deficits that can emerge during adolescence and adulthood. A moderate TBI in male and female rats on postnatal day 11 (equivalent to children below the age of 4) resulted in impairments in social novelty recognition, defined as the preference for interacting with a novel rat compared with a familiar rat, but not sociability, defined as the preference for interacting with a rat compared with an object in the three-chamber test when tested at four weeks (adolescence) and eight weeks (adulthood) postinjury. The deficits in social recognition were not accompanied by deficits in novel object recognition memory and were associated with a decrease in the frequency of spontaneous inhibitory postsynaptic currents (IPSCs) recorded from pyramidal neurons within Layer II/III of the medial prefrontal cortex (mPFC). Whereas TBI did not affect the expression of oxytocin (OXT) or the OXT receptor (OXTR) mRNAs in the hypothalamus and mPFC, respectively, intranasal administration of OXT before behavioral testing was found to reduce impairments in social novelty recognition and increase IPSC frequency in the mPFC in brain-injured animals. These results suggest that TBI-induced deficits in social behavior may be linked to increased excitability of neurons in the mPFC and suggests that the regulation of GABAergic neurotransmission in this region as a potential mechanism underlying these deficits.	[Runyan, Avery; Lengel, Dana; Barson, Jessica R.; Raghupathi, Ramesh] Drexel Univ, Coll Med, Grad Sch Biomed Sci & Profess Studies, Program Neurosci, Philadelphia, PA 19129 USA; [Barson, Jessica R.; Raghupathi, Ramesh] Drexel Univ, Dept Neurobiol & Anat, Coll Med, Philadelphia, PA 19129 USA; [Huh, Jimmy W.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA		Raghupathi, R (corresponding author), Drexel Univ, Coll Med, Grad Sch Biomed Sci & Profess Studies, Program Neurosci, Philadelphia, PA 19129 USA.; Raghupathi, R (corresponding author), Drexel Univ, Dept Neurobiol & Anat, Coll Med, Philadelphia, PA 19129 USA.	rr79@drexel.edu		Barson, Jessica/0000-0001-7227-5730	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS110898]; Commonwealth Universal Research Enhancement from the Pennsylvania Department of Health [SAP 410-007-9710, SAP 410-007-7079]	This work weas supported in part by the National Institutes of Health Grant R01 NS110898 (to J.W.H. and R.R.) and Commonwealth Universal Research Enhancement from the Pennsylvania Department of Health Grants SAP 410-007-9710 (to R.R.) and SAP 410-007-7079 (R.R.) .	ALMAZAN G, 1989, DEV BRAIN RES, V45, P69, DOI 10.1016/0165-3806(89)90008-4; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Bakos J, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/4864107; Bicks LK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01805; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Brizuela M, 2017, J NEUROTRAUM, V34, P2504, DOI 10.1089/neu.2017.4977; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carron SF, 2020, J COMP NEUROL, V528, P175, DOI 10.1002/cne.24746; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Douglas J, 2020, NEUROPSYCHOL REHABIL, V30, P1277, DOI 10.1080/09602011.2019.1574589; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Hanlon LA, 2017, EXP NEUROL, V290, P1, DOI 10.1016/j.expneurol.2016.12.010; Hanlon LA, 2019, EXP NEUROL, V316, P39, DOI 10.1016/j.expneurol.2019.04.004; Hara Y, 2017, HORM BEHAV, V96, P130, DOI 10.1016/j.yhbeh.2017.09.013; Harden SW, 2016, HIPPOCAMPUS, V26, P1124, DOI 10.1002/hipo.22595; Harony-Nicolas H, 2017, ELIFE, V6, DOI 10.7554/eLife.18904; Holley SM, 2019, FRONT SYNAPTIC NEURO, V11, DOI 10.3389/fnsyn.2019.00014; Jurek B, 2018, PHYSIOL REV, V98, P1805, DOI 10.1152/physrev.00031.2017; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, DOI 10.3791/2473; Kannan Nithya, 2014, Int J Crit Illn Inj Sci, V4, P131, DOI 10.4103/2229-5151.134152; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Ko J, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00041; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Lengel D, 2020, EXP NEUROL, V330, DOI 10.1016/j.expneurol.2020.113329; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Meidahl AC, 2018, HEADACHE, V58, P545, DOI 10.1111/head.13248; Nakajima M, 2014, CELL, V159, P295, DOI 10.1016/j.cell.2014.09.020; Parker KJ, 2017, P NATL ACAD SCI USA, V114, P8119, DOI 10.1073/pnas.1705521114; PORTERFIELD SP, 1994, ENVIRON HEALTH PERSP, V102, P125, DOI 10.2307/3431829; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Sala M, 2011, BIOL PSYCHIAT, V69, P875, DOI 10.1016/j.biopsych.2010.12.022; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Song ZM, 2018, FRONT NEUROENDOCRIN, V51, P14, DOI 10.1016/j.yfrne.2017.10.004; Swijsen Ann, 2012, BMC Res Notes, V5, P685, DOI 10.1186/1756-0500-5-685; Timaru-Kast R, 2015, J NEUROTRAUM, V32, P1777, DOI 10.1089/neu.2014.3784; Tops M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00761; Urban-Ciecko J, 2016, NAT REV NEUROSCI, V17, P401, DOI 10.1038/nrn.2016.53; Wei ZZ, 2016, CELL TRANSPLANT, V25, P797, DOI 10.3727/096368916X690403; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Witkowski ED, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00166; Wrobel LJ, 2010, NEUROSCIENCE, V165, P723, DOI 10.1016/j.neuroscience.2009.11.001; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zamani A, 2020, J NEUROTRAUM, V37, P724, DOI 10.1089/neu.2019.6895; Zhang JB, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0278-3	54	3	3	0	0	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	MAY-JUN	2021	8	3							0061-21.2021	10.1523/ENEURO.0061-21.2021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WY1UO	WOS:000719070200006	34035071	Green Published, gold			2022-02-06	
J	Unnikrishnan, G; Mao, HJ; Sajja, VSSS; van Albert, S; Sundaramurthy, A; Rubio, JE; Subramaniam, DR; Long, J; Reifman, J				Unnikrishnan, Ginu; Mao, Haojie; Sajja, Venkata Siva Sai Sujith; van Albert, Stephen; Sundaramurthy, Aravind; Rubio, Jose E.; Subramaniam, Dhananjay Radhakrishnan; Long, Joseph; Reifman, Jaques			Animal Orientation Affects Brain Biomechanical Responses to Blast-Wave Exposure	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						traumatic brain injury; Sprague-Dawley rat; shock tube; advanced blast simulator; finite element model; brain pressure; maximum principal strain	INJURY; RAT; MODEL; MECHANISMS	In this study, we investigated how animal orientation within a shock tube influences the biomechanical responses of the brain and cerebral vasculature of a rat when exposed to a blast wave. Using three-dimensional finite element (FE) models, we computed the biomechanical responses when the rat was exposed to the same blast-wave overpressure (100 kPa) in a prone (P), vertical (V), or head-only (HO) orientation. We validated our model by comparing the model-predicted and the experimentally measured brain pressures at the lateral ventricle. For all three orientations, the maximum difference between the predicted and measured pressures was 11%. Animal orientation markedly influenced the predicted peak pressure at the anterior position along the midsagittal plane of the brain (P = 187 kPa; V = 119 kPa; and HO = 142 kPa). However, the relative differences in the predicted peak pressure between the orientations decreased at the medial (21%) and posterior (7%) positions. In contrast to the pressure, the peak strain in the prone orientation relative to the other orientations at the anterior, medial, and posterior positions was 40-88% lower. Similarly, at these positions, the cerebral vasculature strain in the prone orientation was lower than the strain in the other orientations. These results show that animal orientation in a shock tube influences the biomechanical responses of the brain and the cerebral vasculature of the rat, strongly suggesting that a direct comparison of changes in brain tissue observed from animals exposed at different orientations can lead to incorrect conclusions.	[Unnikrishnan, Ginu; Mao, Haojie; Sundaramurthy, Aravind; Rubio, Jose E.; Subramaniam, Dhananjay Radhakrishnan; Reifman, Jaques] US Army, US Dept Def, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr,Med Res & Dev Comma, Ft Detrick, MD 21702 USA; [Unnikrishnan, Ginu; Mao, Haojie; Sundaramurthy, Aravind; Rubio, Jose E.; Subramaniam, Dhananjay Radhakrishnan] Henry M Jackson Fdn Adv Mil Med Inc, 6720A Rockledge Dr, Bethesda, MD 20817 USA; [Sajja, Venkata Siva Sai Sujith; van Albert, Stephen; Long, Joseph] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Div, 503 Robert Grant Dr, Silver Spring, MD 20910 USA		Reifman, J (corresponding author), US Army, US Dept Def, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr,Med Res & Dev Comma, Ft Detrick, MD 21702 USA.	gunnikrishnan@bhsai.org; haojie.mao@uwo.ca; venkatasivasaisujith.sajja.ctr@mail.mil; steve.vanalbert@gmail.com; asundaramurthy@bhsai.org; jrubio@bhsai.org; dsubramaniam@bhsai.org; joseph.b.long.civ@mail.mil; jaques.reifman.civ@mail.mil	Sajja, Sujith/I-5289-2019; Rubio, Jose E./AAS-2201-2020	Sajja, Sujith/0000-0002-1992-9501; Rubio, Jose E./0000-0002-6320-2086; Sundaramurthy, Aravind/0000-0002-0359-8680	U.S. Department of Defense (U.S. Army Military Operational Medicine Program Area Directorate (Ft. Detrick, MD))United States Department of Defense	U.S. Department of Defense (U.S. Army Military Operational Medicine Program Area Directorate (Ft. Detrick, MD)) (Funder ID: 10.13039/100000005).	Abutarboush R, 2019, J NEUROTRAUM, V36, P3138, DOI 10.1089/neu.2019.6423; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Arun P, 2020, J NEUROTRAUM, V37, P647, DOI 10.1089/neu.2019.6591; Bell ED, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039625; Bir C., 2011, MPHFM20727; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bryden DW, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519872213; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Feng K, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00179; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Haslach HW, 2017, J MECH BEHAV BIOMED, V68, P88, DOI 10.1016/j.jmbbm.2017.01.036; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hubbard WB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5175249; Kahali S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227125; Keenan MA, 2010, J NUCL MED, V51, P471, DOI 10.2967/jnumed.109.070532; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Matveeva A, 2015, 20TH INTERNATIONAL CONFERENCE ON COMPOSITE MATERIALS; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Panzer MB, 2013, COMPUT METHOD BIOMEC, V16, P612, DOI 10.1080/10255842.2011.629615; Rakesh V, 2014, J APPL PHYSIOL, V117, P1278, DOI 10.1152/japplphysiol.00614.2014; Rakesh V, 2013, J APPL PHYSIOL, V115, P1822, DOI 10.1152/japplphysiol.00589.2013; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VS, 2018, NEUROMETHODS, V139, P123, DOI 10.1007/978-1-4939-8564-7_8; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Sundaramurthy A, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039823; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Unnikrishnan G, 2019, ANN BIOMED ENG, V47, P2033, DOI 10.1007/s10439-019-02277-2	40	3	3	0	3	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	MAY 1	2021	143	5							051007	10.1115/1.4049889			12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	RM9IY	WOS:000639970700007	33493319				2022-02-06	
J	Hegdekar, N; Lipinski, MM; Sarkar, C				Hegdekar, Nivedita; Lipinski, Marta M.; Sarkar, Chinmoy			N-Acetyl-l-leucine improves functional recovery and attenuates cortical cell death and neuroinflammation after traumatic brain injury in mice	SCIENTIFIC REPORTS			English	Article							DL-LEUCINE; GENE-EXPRESSION; NADPH OXIDASE; AUTOPHAGY; NEURODEGENERATION; ACTIVATION; STRESS	Traumatic brain injury (TBI) is a major cause of mortality and long-term disability around the world. Even mild to moderate TBI can lead to lifelong neurological impairment due to acute and progressive neurodegeneration and neuroinflammation induced by the injury. Thus, the discovery of novel treatments which can be used as early therapeutic interventions following TBI is essential to restrict neuronal cell death and neuroinflammation. We demonstrate that orally administered N-acetyl-l-leucine (NALL) significantly improved motor and cognitive outcomes in the injured mice, led to the attenuation of cell death, and reduced the expression of neuroinflammatory markers after controlled cortical impact (CCI) induced experimental TBI in mice. Our data indicate that partial restoration of autophagy flux mediated by NALL may account for the positive effect of treatment in the injured mouse brain. Taken together, our study indicates that treatment with NALL would be expected to improve neurological function after injury by restricting cortical cell death and neuroinflammation. Therefore, NALL is a promising novel, neuroprotective drug candidate for the treatment of TBI.	[Hegdekar, Nivedita; Lipinski, Marta M.; Sarkar, Chinmoy] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res STAR Ctr, Dept Anesthesiol, Baltimore, MD 21201 USA; [Lipinski, Marta M.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA		Lipinski, MM; Sarkar, C (corresponding author), Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res STAR Ctr, Dept Anesthesiol, Baltimore, MD 21201 USA.; Lipinski, MM (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	mlipinski@som.umaryland.edu; csarkar@som.umaryland.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [01NS091218, R01NS091218]; IntraBio	This work was in part supported by IntraBio. The sponsor had no role in data collection, analysis or interpretation. The study was also supported by NIH funding (R01NS091218 and R01NS091218) to MML. We thank Courtney Colson and Marie Hanscom for their technical support during the experimental study.	Barrett JP, 2020, J NEUROSCI, V40, P2357, DOI 10.1523/JNEUROSCI.2516-19.2020; Baxendale S, 2019, PRACT NEUROL, V19, P476, DOI 10.1136/practneurol-2018-002113; Bremova T, 2015, NEUROLOGY, V85, P1368, DOI 10.1212/WNL.0000000000002041; Bremova-Ertl T, 2020, NEUROPEDIATRICS, V51, P450, DOI 10.1055/s-0040-1715486; Churchill GC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229585; Cortina-Borja M, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0880-9; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Ferber-Viart C, 2009, AUDIOL NEURO-OTOL, V14, P17, DOI 10.1159/000148206; Fields T., 2021, GM2 GANGLIOSIDOSES A, V22, P84; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Gunther L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120891; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kaya E, 2021, BRAIN COMMUN, V3, DOI 10.1093/braincomms/fcaa148; Kaya E, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041050; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2004, NATURE, V431, P31, DOI 10.1038/431031a; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Mansour A., 2015, PSYCHOLOGY, V06, P323, DOI [10.4236/psych.2015.64033, DOI 10.4236/PSYCH.2015.64033]; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Neuzil E., 2002, B SOC PHARM BORDEAUX, V141, P15; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Platt F, 2016, J NEUROL, V263, P1239, DOI 10.1007/s00415-016-8048-9; Priestman DA, 2008, DIABETES OBES METAB, V10, P159, DOI 10.1111/j.1463-1326.2006.00701.x; Qin LY, 2013, GLIA, V61, P855, DOI 10.1002/glia.22479; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Sarkar C, 2020, AUTOPHAGY, V16, P466, DOI 10.1080/15548627.2019.1628538; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Schniepp Roman, 2016, Cerebellum Ataxias, V3, P8, DOI 10.1186/s40673-016-0046-2; Staib-Lasarzik I, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0531-7; Strupp M, 2019, J NEUROL, V266, P525, DOI 10.1007/s00415-018-9155-6; Strupp M, 2013, J NEUROL, V260, P2556, DOI 10.1007/s00415-013-7016-x; Te Vruchte D., 2019, Effects of N-acetyl-leucine and its enantiomers in Niemann-Pick disease type C cells, DOI 10.1101/826222v1; Tighilet B, 2015, EUR J PHARMACOL, V769, P342, DOI 10.1016/j.ejphar.2015.11.041; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Vibert N, 2001, EUR J NEUROSCI, V13, P735, DOI 10.1046/j.0953-816x.2000.01447.x; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	45	3	3	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 29	2021	11	1							9249	10.1038/s41598-021-88693-8			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SK4QK	WOS:000656201900014	33927281	Green Published, gold			2022-02-06	
J	Zhu, KX; Zhu, YB; Hou, XX; Chen, W; Qu, XL; Zhang, YL; Li, ZX; Wang, CH; Chen, JG; Lv, LQ; Wang, JY; Zhang, DF; Hou, LJ				Zhu, Kaixin; Zhu, Yibai; Hou, Xiaoxiang; Chen, Wen; Qu, Xiaolin; Zhang, Yelei; Li, Zhenxing; Wang, Chunhui; Chen, Jigang; Lv, Liquan; Wang, Junyu; Zhang, Danfeng; Hou, Lijun			NETs Lead to Sympathetic Hyperactivity After Traumatic Brain Injury Through the LL37-Hippo/MST1 Pathway	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; sympathetic hyperactivity; NETs; LL37-Hippo; MST1; pathogenesis	NEUTROPHIL EXTRACELLULAR TRAPS; ATTENUATES NEURONAL LOSS; PARAVENTRICULAR NUCLEUS; MICROGLIAL ACTIVATION; MODEL; DELETION; STROKE; STORM	Background: Paroxysmal sympathetic hyperactivity (PSH) is one of the important reasons for the high mortality and morbidity of traumatic brain injury (TBI). We aim to explore the role of the neutrophil extracellular traps (NETs) in the pathogenesis of sympathetic hyperexcitability after TBI and the underlying mechanisms, providing evidence for clinical treatment. Methods: Enzyme-linked immunosorbent assay was used to assess the plasma metanephrine and normetanephrine levels which represented the variation of the sympathetic system after TBI with rat diffuse axonal injury (DAI) model. NETs in the paraventricular nucleus (PVN) and circulating blood were examined using immunofluorescence and flow cytometry. Neutrophils-microglia co-culture system was established to further explore the effect of NETs on PSH and its mechanisms. Results: After TBI, metanephrine and normetanephrine levels began to increase at 9 h and peaked at 72 h. After the injury, the level of NETs kept increasing at 24 and 72 h in the PVN. A positive correlation was found between the concentration of the PVN NETs and blood catecholamine. Flow cytometry of peripheral blood cells revealed that NETs level in the injury group was higher than that in the control group. Immunofluorescence results confirmed the presence of NETs in the PVN after TBI. The positive result of immunoprecipitation suggested a correlation effect between LL37 and P2 x 7. Peptidyl arginine deiminase-4 (PAD4) inhibitor could inhibit the expression levels of MST1, YAP, and IL-1 beta. The hippo/MST1 pathway inhibitor could inhibit the expression levels of YAP and IL-1 beta. Conclusion: NETs formation in the PVN might be associated with sympathetic hyperactivity after TBI, which might relate to the activation of microglia cells and increased secretion of IL-1 beta via the hippo/MST1 pathway.	[Zhu, Kaixin; Zhu, Yibai; Hou, Xiaoxiang; Chen, Wen; Qu, Xiaolin; Zhang, Yelei; Li, Zhenxing; Wang, Chunhui; Chen, Jigang; Lv, Liquan; Wang, Junyu; Zhang, Danfeng; Hou, Lijun] Naval Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China		Zhang, DF; Hou, LJ (corresponding author), Naval Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China.	dfzhangsmmu@163.com; lijunhoucz@126.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81671206, 81901242]	This work was supported by the National Natural Science Foundation of China (NSFC) (Grant Numbers 81671206 and 81901242).	Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Gonzalez AMB, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-752; Busnardo C, 2016, NEUROSCIENCE, V320, P149, DOI 10.1016/j.neuroscience.2016.02.003; Chen JG, 2019, EUR J NEUROSCI, V50, P1972, DOI 10.1111/ejn.14374; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Hasen M, 2019, J NEUROTRAUM, V36, P1491, DOI 10.1089/neu.2018.6073; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Koba S, 2018, J PHYSIOL-LONDON, V596, P4581, DOI 10.1113/JP276223; Lee M, 2015, BIOCHEM PHARMACOL, V94, P130, DOI [10.1016/j.bcp.2015.02.003, 10.1016/j.bcP.2015.02.003]; Li D, 2018, BRAIN RES, V1688, P15, DOI 10.1016/j.brainres.2017.10.018; Liu Q, 2014, J INTERF CYTOK RES, V34, P870, DOI 10.1089/jir.2013.0159; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Lv LQ, 2011, ARCH PHYS MED REHAB, V92, P1515, DOI 10.1016/j.apmr.2011.01.014; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Monif M, 2010, INT J BIOCHEM CELL B, V42, P1753, DOI 10.1016/j.biocel.2010.06.021; Nejad ASM, 2020, MICROB PATHOGENESIS, V147, DOI 10.1016/j.micpath.2020.104438; Neumann A, 2014, BIOCHEM J, V464, P3, DOI 10.1042/BJ20140778; Neves AF, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00473; Pandit S, 2015, J NEUROPHYSIOL, V114, P914, DOI 10.1152/jn.00080.2015; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Pietronigro EC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00211; Qi J, 2016, CARDIOVASC TOXICOL, V16, P298, DOI 10.1007/s12012-015-9338-7; Renner CIE, 2015, J CLIN MED, V4, P1815, DOI 10.3390/jcm4091815; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Silva TM, 2018, EXP PHYSIOL, V103, P884, DOI 10.1113/EP086780; Valles J, 2017, THROMB HAEMOSTASIS, V117, P1919, DOI 10.1160/TH17-02-0130; Wang PF, 2017, MOL CELL BIOCHEM, V431, P11, DOI 10.1007/s11010-017-2969-1; Wang Y, 2019, J CELL MOL MED, V23, P112, DOI 10.1111/jcmm.13890; Yan XS, 2019, GLIA, V67, P482, DOI 10.1002/glia.23557; Zhang BJ, 2013, CHINESE MED J-PEKING, V126, P2354, DOI 10.3760/cma.j.issn.0366-6999.20122483; Zhao SQ, 2016, BRAIN BEHAV IMMUN, V55, P236, DOI 10.1016/j.bbi.2015.12.016; Zhou JJ, 2019, NEUROSCI BULL, V35, P124, DOI 10.1007/s12264-018-0316-5	39	3	3	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	APR 29	2021	15								621477	10.3389/fnins.2021.621477			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SB1LT	WOS:000649764300001	33994918	gold, Green Published			2022-02-06	
J	von Streitberg, A; Jakel, S; von Bernhardi, JE; Straube, C; Buggenthin, F; Marr, C; Dimou, L				von Streitberg, Axel; Jaekel, Sarah; von Bernhardi, Jaime Eugenin; Straube, Christoph; Buggenthin, Felix; Marr, Carsten; Dimou, Leda			NG2-Glia Transiently Overcome Their Homeostatic Network and Contribute to Wound Closure After Brain Injury	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						proliferation; migration; polarization; stab wound injury; in vivo two-photon imaging	OLIGODENDROCYTE PRECURSOR CELLS; MOTOR CORTEX; AXON GROWTH; NG2 CELLS; PROGENITORS; PROLIFERATION; GENERATION; MIGRATION; RESPONSES; DEMYELINATION	In the adult brain, NG2-glia represent a cell population that responds to injury. To further investigate if, how and why NG2-glia are recruited to the injury site, we analyzed in detail the long-term reaction of NG2-glia after a lesion by time-lapse two-photon in vivo microscopy. Live imaging over several weeks of GFP-labeled NG2-glia in the stab wounded cerebral cortex revealed their fast and heterogeneous reaction, including proliferation, migration, polarization, hypertrophy, or a mixed response, while a small subset of cells remained unresponsive. At the peak of the reaction, 2-4 days after the injury, NG2-glia accumulated around and within the lesion core, overcoming the homeostatic control of their density, which normalized back to physiological conditions only 4 weeks after the insult. Genetic ablation of proliferating NG2-glia demonstrated that this accumulation contributed beneficially to wound closure. Thus, NG2-glia show a fast response to traumatic brain injury (TBI) and participate in tissue repair.	[von Streitberg, Axel; Jaekel, Sarah; von Bernhardi, Jaime Eugenin; Straube, Christoph; Dimou, Leda] Ludwig Maximilians Univ Munchen, Biomed Ctr, Physiol Genom, Munich, Germany; [von Bernhardi, Jaime Eugenin; Dimou, Leda] Ulm Univ, Dept Neurol, Mol & Translat Neurosci, Ulm, Germany; [Buggenthin, Felix; Marr, Carsten] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Jaekel, Sarah] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Stroke & Dementia Res, Munich, Germany		Dimou, L (corresponding author), Ludwig Maximilians Univ Munchen, Biomed Ctr, Physiol Genom, Munich, Germany.; Dimou, L (corresponding author), Ulm Univ, Dept Neurol, Mol & Translat Neurosci, Ulm, Germany.	leda.dimou@uni-ulm.de			Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [251293561, (CRC) 1149]; BMBF-Federal Ministry of Education and Research, Germany (ERA-NET "Network of European Funding for Neuroscience Research," NEURON)	This project was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Project-ID 251293561-Collaborative Research Center (CRC) 1149 and the BMBF-Federal Ministry of Education and Research, Germany (ERA-NET "Network of European Funding for Neuroscience Research," NEURON).	Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; Boda E, 2011, GLIA, V59, P1958, DOI 10.1002/glia.21237; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chen ZJ, 2002, J NEUROCYTOL, V31, P481, DOI 10.1023/A:1025791614468; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Clemente D, 2011, J NEUROSCI, V31, P14899, DOI 10.1523/JNEUROSCI.1158-11.2011; Cui QL, 2013, AM J PATHOL, V183, P516, DOI 10.1016/j.ajpath.2013.04.016; Di Bello IC, 1999, J NEUROCYTOL, V28, P365, DOI 10.1023/A:1007069815302; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hayakawa K, 2011, J NEUROSCI, V31, P10666, DOI 10.1523/JNEUROSCI.1944-11.2011; Hesp ZC, 2018, J NEUROSCI, V38, P1366, DOI 10.1523/JNEUROSCI.3953-16.2017; Hill RA, 2014, NAT NEUROSCI, V17, P1518, DOI 10.1038/nn.3815; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.0.CO;2-A; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Klein S, 2007, IEEE T IMAGE PROCESS, V16, P2879, DOI 10.1109/TIP.2007.909412; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Maeda Y, 2001, ANN NEUROL, V49, P776, DOI 10.1002/ana.1015; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Metz CT, 2011, MED IMAGE ANAL, V15, P238, DOI 10.1016/j.media.2010.10.003; Murphy K.P., 2012, MACHINE LEARNING PRO; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rhodes KE, 2003, NEUROSCIENCE, V120, P41, DOI 10.1016/S0306-4522(03)00285-9; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rowntree S, 1997, EUR J NEUROSCI, V9, P2432, DOI 10.1111/j.1460-9568.1997.tb01660.x; Scheibe S, 2011, J NEUROSCI METH, V200, P47, DOI 10.1016/j.jneumeth.2011.06.013; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider S, 2016, GLIA, V64, P2201, DOI 10.1002/glia.23055; Shechter R, 2013, TRENDS MOL MED, V19, P135, DOI 10.1016/j.molmed.2012.11.007; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; Simon C, 2012, GENESIS, V50, P506, DOI 10.1002/dvg.22003; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Vigano F, 2016, GLIA, V64, P287, DOI 10.1002/glia.22929; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Whelan G, 2012, EMBO J, V31, P71, DOI 10.1038/emboj.2011.381; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002	58	3	3	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.	APR 27	2021	9								662056	10.3389/fcell.2021.662056			15	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	SD1VL	WOS:000651154900001	34012966	Green Published, gold, Green Submitted			2022-02-06	
J	Clarke, GJB; Skandsen, T; Zetterberg, H; Einarsen, CE; Feyling, C; Follestad, T; Vik, A; Blennow, K; Haberg, AK				Clarke, Gerard Janez Brett; Skandsen, Toril; Zetterberg, Henrik; Einarsen, Cathrine Elisabeth; Feyling, Casper; Follestad, Turid; Vik, Anne; Blennow, Kaj; Haberg, Asta Kristine			One-Year Prospective Study of Plasma Biomarkers From CNS in Patients With Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						concussion; axonal injury; astrocytic injury; mixed-mechanism mild TBI; soft tissue injury	FIBRILLARY ACIDIC PROTEIN; INTRACRANIAL LESIONS; BLOOD BIOMARKERS; TAU-PROTEIN; CONSCIOUSNESS; MARKER; DAMAGE; FLUID	Objective: To investigate the longitudinal evolution of three blood biomarkers: neurofilament light (NFL), glial fibrillary acidic protein (GFAP) and tau, in out-patients and hospitalized patients with mild traumatic brain injury (mTBI) compared to controls, along with their associations-in patients-with clinical injury characteristics and demographic variables, and ability to discriminate patients with mTBI from controls. Methods: A longitudinal observation study including 207 patients with mTBI, 84 age and sex-matched community controls (CCs) and 52 trauma controls (TCs). Blood samples were collected at 5 timepoints: acute (<24 h), 72 h (24-72 h post-injury), 2 weeks, 3 and 12 months. Injury-related, clinical and demographic variables were obtained at inclusion and brain MRI within 72 h. Results: Plasma GFAP and tau were most elevated acutely and NFL at 2 weeks and 3 months. The group of patients with mTBI and concurrent other somatic injuries (mTBI+) had the highest elevation in all biomarkers across time points, and were more likely to be victims of traffic accidents and violence. All biomarkers were positively associated with traumatic intracranial findings on MRI obtained within 72 h. Glial fibrillary acidic protein and NFL levels were associated with Glasgow Coma Scale (GCS) score and presence of other somatic injuries. Acute GFAP concentrations showed the highest discriminability between patients and controls with an Area Under the Curve (AUC) of 0.92. Acute tau and 2-week NFL concentrations showed moderate discriminability (AUC = 0.70 and AUC = 0.75, respectively). Tau showed high discriminability between mTBI+ and TCs (AUC = 0.80). Conclusions: The association of plasma NFL with traumatic intracranial MRI findings, together with its later peak, could reflect ongoing secondary injury or repair mechanisms, allowing for a protracted diagnostic time window. Patients experiencing both mTBI and other injuries appear to be a subgroup with greater neural injury, differing from both the mTBI without other injuries and from both control groups. Acute GFAP concentrations showed the highest discriminability between patients and controls, were highly associated with intracranial traumatic injury, and showed the largest elevations compared to controls at the acute timepoint, suggesting it to be the most clinically useful plasma biomarker of primary CNS injury in mTBI.	[Clarke, Gerard Janez Brett; Haberg, Asta Kristine] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Clarke, Gerard Janez Brett; Skandsen, Toril; Einarsen, Cathrine Elisabeth; Feyling, Casper; Vik, Anne; Haberg, Asta Kristine] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Skandsen, Toril; Einarsen, Cathrine Elisabeth] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL, Queen Sq Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Follestad, Turid] Norwegian Univ Sci & Technol NTNU, Dept Publ Hlth & Nursing, Trondheim, Norway; [Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway		Haberg, AK (corresponding author), Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway.; Haberg, AK (corresponding author), Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway.	asta.haberg@ntnu.no		CLARKE, GERARD/0000-0003-0202-1318	Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); Norwegian National Advisory Unit	This study was funded by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU), and the Norwegian National Advisory Unit for functional MRI at St. Olavs Hospital appointed by the Norwegian Ministry of Health and Care Services.	Bailes JE, 2001, J ATHL TRAINING, V36, P236; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chaban V, 2020, J NEUROTRAUM, V37, P2120, DOI 10.1089/neu.2019.6963; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; Koglsberger S, 2017, MOL NEUROBIOL, V54, P7979, DOI 10.1007/s12035-016-0299-z; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Luoto TM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00652; Mahan MY, 2019, WORLD NEUROSURG, V128, pE434, DOI 10.1016/j.wneu.2019.04.170; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; McDonald SJ, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-020-00256-7; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mehta Tejas, 2020, Open Access J Neurol Neurosurg, V12, P86; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Okonkwo DO, 2020, J NEUROTRAUM, V37, P2460, DOI 10.1089/neu.2020.7140; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pattinson CL, 2019, J TRAUMA STRESS, V32, P546, DOI 10.1002/jts.22418; R Development Core Team, 2018, R LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Sechi E, 2019, J NEUROL NEUROSUR PS, V90, P488, DOI 10.1136/jnnp-2018-318004; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; TEASDALE G, 1974, LANCET, V2, P81; U.S. Food and Drug Administration, 2018, EV AUT CLASS 3 DES B, P1; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Wang HT, 2012, NEURAL REGEN RES, V7, P620, DOI 10.3969/j.issn.1673-5374.2012.08.010; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	48	3	3	5	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 21	2021	12								643743	10.3389/fneur.2021.643743			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RX1TD	WOS:000647002700001	33967940	Green Published, gold			2022-02-06	
J	Boutte, AM; Thangavelu, B; Nemes, J; LaValle, CR; Egnoto, M; Carr, W; Kamimori, GH				Boutte, Angela M.; Thangavelu, Bharani; Nemes, Jeffrey; LaValle, Christina R.; Egnoto, Mike; Carr, Walter; Kamimori, Gary H.			Neurotrauma Biomarker Levels and Adverse Symptoms Among Military and Law Enforcement Personnel Exposed to Occupational Overpressure Without Diagnosed Traumatic Brain Injury	JAMA NETWORK OPEN			English	Article								IMPORTANCE There is a scientific and operational need to define objective measures of exposure to low-level overpressure (LLOP) and concussion-like symptoms among persons with specialized occupations. OBJECTIVE To evaluate serum levels of neurotrauma biomarkers and their association with concussion-like symptoms reported by LLOP-exposed military and law enforcement personnel who are outwardly healthy and cleared to perform duties. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study, conducted from January 23, 2017, to October 21, 2019, used serum samples and survey data collected from healthy, male, active-duty military and law enforcement personnel assigned to operational training at 4 US Department of Defense and civilian law enforcement training sites. Personnel aged 18 years or older with prior LLOP exposure but no diagnosed traumatic brain injury or with acute blast exposure during sampling participated in the study. Serum samples from 30 control individuals were obtained from a commercial vendor. MAIN OUTCOMES AND MEASURES Serum levels of glial fibrillary acidic protein, ubiquitin carboxyl hydrolase (UCH)-L1, neurofilament light chain, tau, amyloid beta (A beta)-40, and A beta-42 from a random sample (30 participants) of the LLOP-exposed cohort were compared with those of 30 age-matched controls. Associations between biomarker levels and self-reported symptoms or operational demographics in the remainder of the study cohort (76 participants) were assessed using generalized linear modeling or Spearman correlations with age as a covariate. RESULTS Among the 30 randomly sampled participants (mean [SD] age, 32 [7.75] years), serum levels of UCH-L1 (mean difference, 4.92; 95% CI, 0.71-9.14), tau (mean difference, 0.16; 95% CI, -0.06 to 0.39), A beta-40 (mean difference, 138.44; 95% CI, 116.32-160.56), and A beta-42 (mean difference, 4.97; 95% CI, 4.10-5.83) were elevated compared with those in controls. Among the remaining cohort of 76 participants (mean [SD] age, 34 [7.43] years), ear ringing was reported by 44 (58%) and memory or sleep problems were reported by 24 (32%) and 20 (26%), respectively. A total of 26 participants (34%) reported prior concussion. Amyloid beta-42 levels were associated with ear ringing (F-1,F-72 = 7.40; P = .008) and memory problems (F-1,F-72 = 9.20; P = .003). CONCLUSIONS AND RELEVANCE The findings suggest that long-term LLOP exposure acquired during occupational training may be associated with serum levels of neurotrauma biomarkers. Assessment of biomarkers and concussion-like symptoms among personnel considered healthy at the time of sampling may be useful for military occupational medicine risk management.	[Boutte, Angela M.; Thangavelu, Bharani] Walter Reed Army Inst Res, Brain Trauma Neuroprotect Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20901 USA; [Nemes, Jeffrey; LaValle, Christina R.; Egnoto, Mike; Carr, Walter; Kamimori, Gary H.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA		Boutte, AM (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20901 USA.	angela.m.boutte.civ@mail.mil			Combat Casualty Care Research ProgramUnited States Department of Defense; US Army Medical Research and Materiel Command Military Operational Medicine Research ProgramU.S. Army Medical Research & Materiel Command (USAMRMC); Broad Agency Announcement Award from the Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-16-2-0001]	This work was supported by the Combat Casualty Care Research Program; the US Army Medical Research and Materiel Command Military Operational Medicine Research Program (Research Area Directorate 3); the Broad Agency Announcement Award (W81XWH-16-2-0001) from the Office of the Assistant Secretary of Defense for Health Affairs (Dr Kamimori); and an appointment to the Research Participation Program at the Walter Reed Army Institute of Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and US Army Medical Research and Development Command.	[Anonymous], 2020, NATL DEFENSE AUTHORI; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Boutte AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221036; Cabell GH., 2017, THESIS U N CAROLINA; Carr W, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00619; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cernak I, 2015, BRAIN NEUROTRAUMA MO, P631, DOI DOI 10.1201/B18126-53; Eonta SE, 2020, MIL MED, V185, pE513, DOI 10.1093/milmed/usz185; Fish L., 2018, PROTECTING WARFIGHTE; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Goos JDC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.026; Haran FJ, 2016, APPL NEUROPSYCH-ADUL, V23, P411, DOI 10.1080/23279095.2016.1166111; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; LaValle CR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00949; Lejbman N, 2016, BRAIN INJURY, V30, P1436, DOI 10.1080/02699052.2016.1219054; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; Ono K, 2018, NEUROCHEM INT, V119, P57, DOI 10.1016/j.neuint.2017.08.010; Puig KL, 2013, EXP GERONTOL, V48, P608, DOI 10.1016/j.exger.2012.07.009; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Sajja VSSS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00891; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sharp SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101176; Maciej S, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10207193; Skotak M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00797; Skotak M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00052; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Thangavelu B, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00620; Theodoroff SM, 2020, OTOLARYNG CLIN N AM, V53, P543, DOI 10.1016/j.otc.2020.03.004; Tschiffely AE, 2020, J NEUROTRAUM, V37, P1091, DOI 10.1089/neu.2019.6512; Uhlig K, 2007, AM J KIDNEY DIS, V49, P3, DOI 10.1053/j.ajkd.2006.10.012; US Food & Drug Administration, 2018, NEWS RELEASE; van Leijsen EMC, 2018, STROKE, V49, P884, DOI 10.1161/STROKEAHA.117.019810; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang ZY, 2020, J NEUROTRAUM, V37, P1221, DOI 10.1089/neu.2019.6742; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	46	3	3	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	APR 16	2021	4	4							e216445	10.1001/jamanetworkopen.2021.6445			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN9GK	WOS:000640660700002	33861330	gold, Green Published			2022-02-06	
J	Sparvero, LJ; Tian, H; Amoscato, AA; Sun, WY; Anthonymuthu, TS; Tyurina, YY; Kapralov, O; Javadov, S; He, RR; Watkins, SC; Winograd, N; Kagan, VE; Bayir, H				Sparvero, Louis J.; Tian, Hua; Amoscato, Andrew A.; Sun, Wan-Yang; Anthonymuthu, Tamil S.; Tyurina, Yulia Y.; Kapralov, Oleksandr; Javadov, Sabzali; He, Rong-Rong; Watkins, Simon C.; Winograd, Nicholas; Kagan, Valerian E.; Bayir, Hulya			Direct Mapping of Phospholipid Ferroptotic Death Signals in Cells and Tissues by Gas Cluster Ion Beam Secondary Ion Mass Spectrometry (GCIB-SIMS)	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						cell death; imaging; lipid; mass spectrometry; oxidation	CARDIOLIPINS; REVEALS	Peroxidized phosphatidylethanolamine (PEox) species have been identified by liquid chromatography mass spectrometry (LC-MS) as predictive biomarkers of ferroptosis, a new program of regulated cell death. However, the presence and subcellular distribution of PEox in specific cell types and tissues have not been directly detected by imaging protocols. By applying gas cluster ion beam secondary ion mass spectrometry (GCIB-SIMS) imaging with a 70 keV (H2O)(n)(+) (n>28 000) cluster ion beam, we were able to map PEox with 1.2 mu m spatial resolution at the single cell/subcellular level in ferroptotic H9c2 cardiomyocytes and cortical/hippocampal neurons after traumatic brain injury. Application of this protocol affords visualization of physiologically relevant levels of very low abundance (20 pmol mu mol(-1) lipid) peroxidized lipids in subcellular compartments and their accumulation in disease conditions.	[Tian, Hua; Winograd, Nicholas] Penn State Univ, Dept Chem, State Coll, PA 16802 USA; [Sparvero, Louis J.; Amoscato, Andrew A.; Anthonymuthu, Tamil S.; Tyurina, Yulia Y.; Kapralov, Oleksandr; Kagan, Valerian E.; Bayir, Hulya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Sparvero, Louis J.; Amoscato, Andrew A.; Anthonymuthu, Tamil S.; Tyurina, Yulia Y.; Kapralov, Oleksandr; Kagan, Valerian E.; Bayir, Hulya] Univ Pittsburgh, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA 15261 USA; [Sparvero, Louis J.; Anthonymuthu, Tamil S.; Kagan, Valerian E.; Bayir, Hulya] UPMC Childrens Hosp Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA; [Sparvero, Louis J.; Anthonymuthu, Tamil S.; Kagan, Valerian E.; Bayir, Hulya] UPMC Childrens Hosp Pittsburgh, Childrens Neurosci Inst, Pittsburgh, PA 15261 USA; [Watkins, Simon C.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Watkins, Simon C.] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15261 USA; [Sun, Wan-Yang] Jinan Univ, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China; [He, Rong-Rong] Jinan Univ, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China; [He, Rong-Rong] Jinan Univ, Sch Tradit Chinese Med, Guangzhou 510632, Guangdong, Peoples R China; [Javadov, Sabzali] Univ Puerto Rico, Sch Med, Dept Physiol, San Juan, PR 00936 USA		Winograd, N (corresponding author), Penn State Univ, Dept Chem, State Coll, PA 16802 USA.; Sparvero, LJ; Kagan, VE; Bayir, H (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA.; Sparvero, LJ; Kagan, VE; Bayir, H (corresponding author), Univ Pittsburgh, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA 15261 USA.; Sparvero, LJ; Kagan, VE; Bayir, H (corresponding author), UPMC Childrens Hosp Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA.; Sparvero, LJ; Kagan, VE; Bayir, H (corresponding author), UPMC Childrens Hosp Pittsburgh, Childrens Neurosci Inst, Pittsburgh, PA 15261 USA.	sparverolj@pitt.edu; nxw@psu.edu; kagan@pitt.edu; bayihx@ccm.upmc.edu		HE, Rong-Rong/0000-0001-5505-5672; Kapralov, Oleksandr/0000-0002-3006-916X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS076511, R01NS061817, U01AI156924, P01HL114453, R01CA165065, R01AI145406, U01AI156923, R01CA243142, R01GM134715, R01GM113908, R01HL151078, R01NS117000, U54GM103529-08]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81873209, 81703696]; 111 Project of Chinese MoE [B13038]	This research was funded in part by the following grants from the National Institutes of Health: R01NS076511, R01NS061817, U01AI156924, P01HL114453, R01CA165065, R01AI145406, U01AI156923, R01CA243142, R01GM134715, R01GM113908, R01HL151078, R01NS117000, U54GM103529-08; Natural Science Foundation of China (81873209, 81703696) and 111 Project of Chinese MoE (B13038).	Angerer TB, 2015, INT J MASS SPECTROM, V377, P591, DOI 10.1016/j.ijms.2014.05.015; Anthonymuthu TS, 2017, BBA-MOL BASIS DIS, V1863, P2601, DOI 10.1016/j.bbadis.2017.03.015; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; Hayakawa J, 2004, J PHARMACEUT BIOMED, V35, P583, DOI 10.1016/j.jpba.2004.02.007; Holcapek M, 2018, ANAL CHEM, V90, P4249, DOI 10.1021/acs.analchem.7b05395; Ikeda K, 2009, J CHROMATOGR B, V877, P2639, DOI 10.1016/j.jchromb.2009.03.047; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/NCHEMBIO.2238, 10.1038/nchembio.2238]; Kapralov AA, 2020, NAT CHEM BIOL, V16, P278, DOI 10.1038/s41589-019-0462-8; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kompauer M, 2017, NAT METHODS, V14, P90, DOI [10.1038/nmeth.4071, 10.1038/NMETH.4071]; Lydic TA, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0182-9; Maguire JJ, 2017, BBA-MOL CELL BIOL L, V1862, P8, DOI 10.1016/j.bbalip.2016.08.001; Nakanishi H, 2009, METHODS MOL BIOL, V579, P287, DOI 10.1007/978-1-60761-322-0_15; Newell CL, 2020, ANGEW CHEM INT EDIT, V59, P18194, DOI 10.1002/anie.202006881; Niehaus M, 2019, NAT METHODS, V16, P925, DOI 10.1038/s41592-019-0536-2; Pareek V, 2020, SCIENCE, V368, P283, DOI 10.1126/science.aaz6465; Piwowar AM, 2010, ANAL CHEM, V82, P8291, DOI 10.1021/ac101746h; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rabbani SSN, 2015, ANAL CHEM, V87, P2367, DOI 10.1021/ac504191m; Sheraz S, 2013, ANAL CHEM, V85, P5654, DOI 10.1021/ac4013732; Sheraz S, 2019, ANAL CHEM, V91, P9058, DOI 10.1021/acs.analchem.9b01390; Sparvero LJ, 2016, J NEUROCHEM, V139, P659, DOI 10.1111/jnc.13840; Stockwell BR, 2020, TRENDS CELL BIOL, V30, P478, DOI 10.1016/j.tcb.2020.02.009; Stockwell BR, 2018, FREE RADICAL BIO MED, V120, pS7, DOI 10.1016/j.freeradbiomed.2018.04.034; Sun W, 2021, NAT PROD RES, DOI 10.1080/14786419.2021.1982935; Tian H., 2019, ANGEW CHEM, V131, P3188, DOI [10.1002/ange.201814256, DOI 10.1002/ange.201814256]; Tian H, 2019, ANGEW CHEM INT EDIT, V58, P3156, DOI 10.1002/anie.201814256; Toyoda N, 2002, NUCL INSTRUM METH B, V190, P860, DOI 10.1016/S0168-583X(02)00463-9; Tyurina YY, 2015, FREE RADICAL RES, V49, P681, DOI 10.3109/10715762.2015.1005085; Tyurina YY, 2019, CHEM PHYS LIPIDS, V221, P93, DOI 10.1016/j.chemphyslip.2019.03.012; Vickerman JC, 2011, ANALYST, V136, P2199, DOI 10.1039/c1an00008j; Yoon S, 2018, NANO CONVERG, V5, DOI 10.1186/s40580-018-0157-y	32	3	3	25	43	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	MAY 17	2021	60	21					11784	11788		10.1002/anie.202102001		APR 2021	5	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	SA0KJ	WOS:000639107000001	33684237				2022-02-06	
J	Webb, AJ; Brown, CS; Naylor, RM; Rabinstein, AA; Mara, KC; Nei, AM				Webb, Andrew J.; Brown, Caitlin S.; Naylor, Ryan M.; Rabinstein, Alejandro A.; Mara, Kristin C.; Nei, Andrea M.			Thromboelastography is a Marker for Clinically Significant Progressive Hemorrhagic Injury in Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Thromboelastography; Brain hemorrhage; Traumatic brain injuries; Blood; coagulation disorders		Background Coagulopathy in traumatic brain injury (TBI) is associated with increased risk of poor outcomes, but accurate prediction of clinically significant progressive hemorrhagic injury (PHI) in patients with severe TBI remains a challenge. Thromboelastography (TEG) is a real-time test of whole blood coagulation that provides dynamic information about global hemostasis. This study aimed to identify differences in TEG values between patients with severe TBI who did or did not experience clinically significant PHI. Methods This was a single-center retrospective cohort study of adult patients with severe TBI. Patients were eligible for inclusion if initial Glasgow coma scale (GCS) was <= 8 and baseline head computed tomography (CT) imaging and TEG were available. Exclusion criteria included receipt of hemostatic agents prior to TEG. PHI was defined as bleeding expansion on CT within 24 h associated with 2-point drop in GCS, neurosurgical intervention, or mortality within 24 h. The primary endpoint was TEG value differences between patients with and without PHI. Secondary endpoints included differences in conventional coagulation tests (CCTs) between groups. Results Of the 526 patients evaluated, 141 met inclusion criteria. The most common reason for exclusion was lack of baseline TEG and receipt of reversal product prior to TEG. Sixty-four patients experienced PHI in the first 24 h after presentation. K time (2.03 min vs. 1.33 min, P = 0.035) and alpha angle (65 degrees vs. 69 degrees, P = 0.015) were found to be significantly different in patients experiencing PHI. R time (5.25 min vs. 4.71 min), maximum amplitude (61 mm vs. 63 mm), and clot lysis at 30 min after maximum clot strength (3.5% vs. 1.7%) were not significantly different between groups. Of the CCTs, only activated partial thromboplastin time (30.3 s vs. 27.6 s, P = 0.014) was found to be different in patients with PHI. Conclusions Prolonged K time and narrower alpha angle were found to be associated with developing clinically significant PHI in patients with severe TBI. Despite differences detected in alpha angle, median values in both groups were within normal reference ranges. These abnormalities may reflect pathologic hypoactivity of fibrinogen, and further study is warranted to evaluate TEG-guided cryoprecipitate administration in this patient population.	[Webb, Andrew J.] Oregon Hlth & Sci Univ, Dept Pharm, Portland, OR 97201 USA; [Brown, Caitlin S.; Nei, Andrea M.] Mayo Clin, Dept Pharm, Rochester, MN USA; [Naylor, Ryan M.] Mayo Clin, Dept Neurosurg, Rochester, MN USA; [Rabinstein, Alejandro A.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Mara, Kristin C.] Mayo Clin, Dept Biomed Stat, Rochester, MN USA		Webb, AJ (corresponding author), Oregon Hlth & Sci Univ, Dept Pharm, Portland, OR 97201 USA.	ajwebb3@gmail.com	Webb, Andrew/AAS-6521-2021	Webb, Andrew/0000-0003-3425-7181			[Anonymous], 2016, TEG 5000 PACKAGE INS; [Anonymous], 2015, TEG 5000 KAOLIN REAG; Bauer Derek, 2015, Semin Neurol, V35, pe14, DOI 10.1055/s-0035-1549095; Bolliger D, 2012, TRANSFUS MED REV, V26, P1, DOI 10.1016/j.tmrv.2011.07.005; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Cotton BA, 2011, J TRAUMA, V71, P407, DOI 10.1097/TA.0b013e31821e1bf0; Da Luz LT, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0518-9; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Folkerson LE, 2018, AM J EMERG MED, V36, P38, DOI 10.1016/j.ajem.2017.06.057; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Gratz J, 2019, ANAESTHESIA, V74, P883, DOI 10.1111/anae.14670; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Karri J, 2017, SHOCK, V48, P644, DOI 10.1097/SHK.0000000000000912; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Martin G, 2018, NEUROCRIT CARE, V28, P330, DOI 10.1007/s12028-017-0485-5; Nakae R, 2019, ACTA NEUROCHIR, V161, P1943, DOI 10.1007/s00701-019-04010-3; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Pezold M, 2012, SURGERY, V151, P48, DOI 10.1016/j.surg.2011.06.023; Picetti E., 2019, WORLD J EMERG SURG, V14, P1, DOI [10.1186/s13017-018-0220-3, DOI 10.1186/S13017-018-0220-3]; Rao A, 2017, NEUROSURGERY, V64, P182, DOI 10.1093/neuros/nyx210; Rao AJ, 2018, WORLD NEUROSURG, V112, pE216, DOI 10.1016/j.wneu.2018.01.025; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rowell SE, 2014, J TRAUMA ACUTE CARE, V77, P846, DOI 10.1097/TA.0000000000000459; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Shibahashi K, 2019, NEUROL MED-CHIR, V59, P371, DOI 10.2176/nmc.oa.2019-0062; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Sugiyama K, 2020, BLOOD TRANSFUS-ITALY, V18, P6, DOI 10.2450/2019.0198-18; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205	37	3	3	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2021	35	3					738	746		10.1007/s12028-021-01217-0		APR 2021	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XS0FS	WOS:000639627300002	33846901				2022-02-06	
J	Izzy, S; Tahir, Z; Grashow, R; Cote, DJ; Al Jarrah, A; Dhand, A; Taylor, H; Whalen, M; Nathan, DM; Miller, KK; Speizer, F; Baggish, A; Weisskopf, MG; Zafonte, R				Izzy, Saef; Tahir, Zabreen; Grashow, Rachel; Cote, David J.; Al Jarrah, Ali; Dhand, Amar; Taylor, Herman; Whalen, Michael; Nathan, David M.; Miller, Karen K.; Speizer, Frank; Baggish, Aaron; Weisskopf, Marc G.; Zafonte, Ross			Concussion and Risk of Chronic Medical and Behavioral Health Comorbidities	JOURNAL OF NEUROTRAUMA			English	Article						behavioral health; cardiovascular risk; concussion; long-term comorbidities; medical health; psychiatric disorders		While chronic neurological effects from concussion have been studied widely, little is known about possible links between concussion and long-term medical and behavioral comorbidities. We performed a retrospective cohort study of 9205 adult patients with concussion, matched to non-concussion controls from a hospital-based electronic medical registry. Patients with comorbidities before the index visit were excluded. Behavioral and medical comorbidities were defined by International Classification of Diseases, Ninth and Tenth Revision codes. Groups were followed for up to 10 years to identify comorbidity incidence after a concussion. Cox proportional hazards models were used to calculate associations between concussion and comorbidities after multi-variable adjustment. Patients with concussion were 57% male (median age: 31; interquartile range [IQR] = 23-48 years) at enrollment with a median follow-up time of 6.1 years (IQR = 4.2-9.1) and well-matched to healthy controls. Most (83%) concussions were evaluated in outpatient settings (5% inpatient). During follow-up, we found significantly higher risks of cardiovascular risks developing including hypertension (hazard ratio [HR] = 1.7, 95% confidence interval [CI]: 1.5-1.9), obesity (HR = 1.7, 95% CI: 1.3-2.0), and diabetes mellitus (HR = 1.8, 95% CI: 1.4-2.3) in the concussion group compared with controls. Similarly, psychiatric and neurological disorders such as depression (HR = 3.0, 95% CI: 2.6-3.5), psychosis (HR = 6.0, 95% CI: 4.2-8.6), stroke (HR = 2.1 95% CI: 1.5-2.9), and epilepsy (HR = 4.4, 95% CI: 3.2-5.9) were higher in the concussion group. Most comorbidities developed less than five years post-concussion. The risks for post-concussion comorbidities were also higher in patients under 40 years old compared with controls. Patients with concussion demonstrated an increased risk of development of medical and behavioral health comorbidities. Prospective studies are warranted to better describe the burden of long-term comorbidities in patients with concussion.	[Izzy, Saef; Tahir, Zabreen; Al Jarrah, Ali; Dhand, Amar] Brigham & Womens Hosp, Dept Neurol, Div Stroke Cerebrovasc & Crit Care Neurol, 75 Francis St, Boston, MA 02115 USA; [Izzy, Saef; Cote, David J.; Dhand, Amar; Nathan, David M.; Miller, Karen K.; Baggish, Aaron; Zafonte, Ross] Harvard Med Sch, Boston, MA 02115 USA; [Grashow, Rachel; Speizer, Frank; Weisskopf, Marc G.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Grashow, Rachel; Taylor, Herman; Nathan, David M.; Miller, Karen K.; Baggish, Aaron; Weisskopf, Marc G.; Zafonte, Ross] Harvard Univ, Football Players Hlth Study, Boston, MA 02115 USA; [Dhand, Amar] Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA; [Taylor, Herman] Morehouse Sch Med, Atlanta, GA 30310 USA; [Whalen, Michael] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Nathan, David M.] Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA; [Miller, Karen K.] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; [Baggish, Aaron] Massachusetts Gen Hosp, Dept Internal Med, Cardiovasc Performance Ctr, Boston, MA 02114 USA; [Zafonte, Ross] Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross] Spaulding Rehabil Hosp, Charlestown, MA USA		Zafonte, R (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp, 300 First Ave, Boston, MA 02120 USA.	RZAFONTE@mgh.harvard.edu	Cote, David James/ABG-6013-2021		Football Players Health Study at Harvard University - NFLPA	A. Baggish, H. Taylor, R. Grashow, R. Zafonte, F. Speizer, and M. Weisskopf are either partially or fully supported by the Football Players Health Study at Harvard University, which is in turn sponsored by the NFLPA. The NFLPA had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Other authors report no potential or actual conflicts of interest.	Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bisson JI, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6161; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Goldstein BA, 2019, J AM MED INFORM ASSN, V26, P1609, DOI 10.1093/jamia/ocz148; Grashow R, 2019, JAMA NEUROL, V76, P1428, DOI 10.1001/jamaneurol.2019.2664; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Institute of Medicine (US) Committee on Gulf War and Health, 2008, GULF WAR AND HLTH, V7; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; LeMier M, 2001, Inj Prev, V7, P334, DOI 10.1136/ip.7.4.334; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; Morris TP, 2019, AM J IND MED, V62, P655, DOI 10.1002/ajim.22992; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; R Core Team, 2019, R LANG ENV STAT COMP; Rao Vani, 2017, Concussion, V2, pCNC29, DOI 10.2217/cnc-2016-0018; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Stanley IH, 2017, J PSYCHIATR RES, V84, P161, DOI 10.1016/j.jpsychires.2016.10.004; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Willeumier K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.67	29	3	3	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1834	1841		10.1089/neu.2020.7484		APR 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000638033500001	33451255				2022-02-06	
J	Milling, TJ; Warach, S; Johnston, SC; Gajewski, B; Costantini, T; Price, M; Wick, J; Roward, S; Mudaranthakam, D; Dula, AN; King, B; Muddiman, A; Lip, GYH				Milling, Truman J., Jr.; Warach, Steven; Johnston, S. Claiborne; Gajewski, Byron; Costantini, Todd; Price, Michelle; Wick, Jo; Roward, Simin; Mudaranthakam, Dinesh; Dula, Adrienne N.; King, Ben; Muddiman, Alexander; Lip, Gregory Y. H.			Restart TICrH: An Adaptive Randomized Trial of Time Intervals to Restart Direct Oral Anticoagulants after Traumatic Intracranial Hemorrhage	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; clinical management of central nervous system injury; clinical trial; head trauma; traumatic brain injury		Anticoagulants prevent thrombosis and death in patients with atrial fibrillation and venous thromboembolism (VTE) but also increase bleeding risk. The benefit/risk ratio favors anticoagulation in most of these patients. However, some will have a bleeding complication, such as the common trip-and-fall brain injury in elderly patients that results in traumatic intracranial hemorrhage. Clinicians must then make the difficult decision about when to restart the anticoagulant. Restarting too early risks making the bleeding worse. Restarting too late risks thrombotic events such as ischemic stroke and VTE, the indications for anticoagulation in the first place. There are more data on restarting patients with spontaneous intracranial hemorrhage, which is very different than traumatic intracranial hemorrhage. Spontaneous intracranial hemorrhage increases the risk of rebleeding because intrinsic vascular changes are widespread and irreversible. In contrast, traumatic cases are caused by a blow to the head, usually an isolated event portending less future risk. Clinicians generally agree that anticoagulation should be restarted but disagree about when. This uncertainty leads to long restart delays causing a large, potentially preventable burden of strokes and VTE, which has been unaddressed because of the absence of high quality evidence. Restart Traumatic Intracranial Hemorrhage (the "r" distinguished intracranial from intracerebral) (TICrH) is a prospective randomized open label blinded end-point response-adaptive clinical trial that will evaluate the impact of delays to restarting direct oral anticoagulation (1, 2, or 4 weeks) on the composite of thrombotic events and bleeding in patients presenting after traumatic intracranial hemorrhage.	[Milling, Truman J., Jr.; Warach, Steven; Dula, Adrienne N.; Muddiman, Alexander] Seton Dell Med Sch, Stroke Inst, 1601 Trinity,10th Floor, Austin, TX 78712 USA; [Johnston, S. Claiborne] Dell Med Sch, Austin, TX USA; [Gajewski, Byron; Wick, Jo; Mudaranthakam, Dinesh] Univ Kansas, Med Ctr, Dept Biostat & Data Sci, Kansas City, KS 66103 USA; [Costantini, Todd] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Price, Michelle] Coalit Natl Trauma Res, San Antonio, TX USA; [Roward, Simin] Univ Texas Austin, Dept Surg, Dell Seton Med Ctr, Austin, TX 78712 USA; [King, Ben] Univ Houston, Dept Hlth Syst & Populat Hlth, Coll Med, Houston, TX USA; [Lip, Gregory Y. H.] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Inst Life Course & Med Sci, Liverpool, Merseyside, England		Milling, TJ (corresponding author), Seton Dell Med Sch, Stroke Inst, 1601 Trinity,10th Floor, Austin, TX 78712 USA.	tmilling@ascension.org			NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1 X01 HL143311-01]	Trial Design was funded under NHLBI 1 X01 HL143311-01.	Albers GW, 2017, INT J STROKE, V12, P896, DOI 10.1177/1747493017701147; Byrnes MC, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-25; Chai-Adisaksopha C, 2014, BLOOD, V124, P2450, DOI 10.1182/blood-2014-07-590323; Charidimou A, 2018, INT J STROKE, V13, P117, DOI 10.1177/1747493017741384; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Connolly SJ, 2019, NEW ENGL J MED, V380, P1326, DOI 10.1056/NEJMoa1814051; Divito A, 2019, WORLD NEUROSURG, V123, pE25, DOI 10.1016/j.wneu.2018.10.173; Flinterman LE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001155; Hagerty T, 2017, CLEV CLIN J MED, V84, P35, DOI 10.3949/ccjm.84a.16016; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Harvin J., TRAUMA SURG ACUTE CA, V1; Hawryluk GWJ, 2010, J THROMB HAEMOST, V8, P1500, DOI 10.1111/j.1538-7836.2010.03882.x; Hawryluk GWJ, 2011, WORLD NEUROSURG, V76, P299, DOI 10.1016/j.wneu.2011.03.034; Jovin TG, 2017, INT J STROKE, V12, P641, DOI 10.1177/1747493017710341; Kaatz S, 2015, J THROMB HAEMOST, V13, P2119, DOI 10.1111/jth.13140; Kahn SR, 2016, J THROMB THROMBOLYS, V41, P144, DOI 10.1007/s11239-015-1312-5; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lip GYH, 2017, THROMB HAEMOSTASIS, V117, P1230, DOI 10.1160/TH16-11-0876; Man-Son-Hing M, 1999, ARCH INTERN MED, V159, P677, DOI 10.1001/archinte.159.7.677; Milling TJ, 2016, ANN EMERG MED, V67, P96, DOI 10.1016/j.annemergmed.2015.04.036; Monette J, 1997, J AM GERIATR SOC, V45, P1060, DOI 10.1111/j.1532-5415.1997.tb05967.x; Morris TA, 2011, CRIT CARE CLIN, V27, P869, DOI 10.1016/j.ccc.2011.09.001; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nielsen PB, 2017, JAMA INTERN MED, V177, P563, DOI 10.1001/jamainternmed.2016.9369; O'Brien EC, 2014, AM HEART J, V167, P601, DOI 10.1016/j.ahj.2013.12.014; O'Neil WM, 2013, THROMB HAEMOSTASIS, V109, P497, DOI 10.1160/TH12-10-0715; Ovbiagele B, 2010, NEUROLOGY, V75, P688, DOI 10.1212/WNL.0b013e3181eee426; Park YA, 2016, HEART RHYTHM, V13, P1794, DOI 10.1016/j.hrthm.2016.05.016; Perreault S, 2020, PHARMACOTHERAPY, V40, P40, DOI 10.1002/phar.2350; Pugh D, 2011, AGE AGEING, V40, P675, DOI 10.1093/ageing/afr097; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schulman S, 2017, THROMB HAEMOSTASIS, V117, P1219, DOI 10.1160/TH16-10-0823; Sen S, 2014, AM J MED SCI, V348, P513, DOI 10.1097/MAJ.0000000000000349; Siddique MS, 2002, J NEUROSURG, V96, P86, DOI 10.3171/jns.2002.96.1.0086; Staerk L, 2018, EUR HEART J, V39, P1698, DOI 10.1093/eurheartj/ehx598; Wiegele M, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2352-6; Xu Y., 2018, PLOS ONE, V1; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109	38	3	3	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1791	1798		10.1089/neu.2020.7535		APR 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000638034900001	33470152				2022-02-06	
J	Xu, XY; Cowan, M; Beraldo, F; Schranz, A; McCunn, P; Geremia, N; Brown, Z; Patel, M; Nygard, KL; Khazaee, R; Lu, LH; Liu, XY; Strong, MJ; Dekaban, GA; Menon, R; Bartha, R; Daley, M; Mao, HJ; Prado, V; Prado, MAM; Saksida, L; Bussey, T; Brown, A				Xu, Xiaoyun; Cowan, Matthew; Beraldo, Flavio; Schranz, Amy; McCunn, Patrick; Geremia, Nicole; Brown, Zalman; Patel, Maitray; Nygard, Karen L.; Khazaee, Reza; Lu, Lihong; Liu, Xingyu; Strong, Michael J.; Dekaban, Gregory A.; Menon, Ravi; Bartha, Robert; Daley, Mark; Mao, Haojie; Prado, Vania; Prado, Marco A. M.; Saksida, Lisa; Bussey, Tim; Brown, Arthur			Repetitive mild traumatic brain injury in mice triggers a slowly developing cascade of long-term and persistent behavioral deficits and pathological changes	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Concussion; 5-Choice serial reaction time test; White matter pathology; Tauopathy; Experimental brain injury; Traumatic encephalopathy; Metabolomics; Magnetic resonance imaging		We have previously reported long-term changes in the brains of non-concussed varsity rugby players using magnetic resonance spectroscopy (MRS), diffusion tensor imaging (DTI) and functional magnetic imaging (fMRI). Others have reported cognitive deficits in contact sport athletes that have not met the diagnostic criteria for concussion. These results suggest that repetitive mild traumatic brain injuries (rmTBIs) that are not severe enough to meet the diagnostic threshold for concussion, produce long-term consequences. We sought to characterize the neuroimaging, cognitive, pathological and metabolomic changes in a mouse model of rmTBI. Using a closed-skull model of mTBI that when scaled to human leads to rotational and linear accelerations far below what has been reported for sports concussion athletes, we found that 5 daily mTBIs triggered two temporally distinct types of pathological changes. First, during the first days and weeks after injury, the rmTBI produced diffuse axonal injury, a transient inflammatory response and changes in diffusion tensor imaging (DTI) that resolved with time. Second, the rmTBI led to pathological changes that were evident months after the injury including: changes in magnetic resonance spectroscopy (MRS), altered levels of synaptic proteins, behavioural deficits in attention and spatial memory, accumulations of pathologically phosphorylated tau, altered blood metabolomic profiles and white matter ultrastructural abnormalities. These results indicate that exceedingly mild rmTBI, in mice, triggers processes with pathological consequences observable months after the initial injury.	[Xu, Xiaoyun; Cowan, Matthew; Beraldo, Flavio; Schranz, Amy; McCunn, Patrick; Geremia, Nicole; Strong, Michael J.; Menon, Ravi; Bartha, Robert; Prado, Vania; Prado, Marco A. M.; Saksida, Lisa; Bussey, Tim; Brown, Arthur] Western Univ, Schulich Sch Med & Dent, Robarts Res Inst, Translat Neurosci Grp, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Schranz, Amy; McCunn, Patrick; Menon, Ravi; Bartha, Robert] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med Biophys, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Brown, Zalman; Patel, Maitray; Daley, Mark] Univ Western Ontario, Schulich Sch Med & Dent, Dept Comp Sci, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Nygard, Karen L.; Khazaee, Reza] Univ Western Ontario, Biotron Expt Climate Change Res Ctr, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Lu, Lihong; Liu, Xingyu; Mao, Haojie] Univ Western Ontario, Schulich Sch Med & Dent, Dept Mech & Mat Engn, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Strong, Michael J.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Clin Neurol Sci, London, ON N6A 5B7, Canada; [Dekaban, Gregory A.] Western Univ, Schulich Sch Med & Dent, Robarts Res Inst, Mol Med Res Labs, London, ON, Canada; [Dekaban, Gregory A.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Microbiol & Immunol, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Menon, Ravi; Bartha, Robert] Univ Western Ontario, Robarts Res Inst, Ctr Funct & Metab Mapping, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Prado, Marco A. M.; Saksida, Lisa; Bussey, Tim] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Daley, Mark] Vector Inst Artificial Intelligence, 661 Univ Ave Suite 710, Toronto, ON, Canada; [Prado, Vania; Prado, Marco A. M.; Brown, Arthur] Univ Western Ontario, Dept Anat & Cell Biol, 1151 Richmond St North, London, ON N6A 5B7, Canada		Brown, A (corresponding author), Western Univ, Schulich Sch Med & Dent, Robarts Res Inst, Translat Neurosci Grp, 1151 Richmond St North, London, ON N6A 5B7, Canada.	abrown@robarts.ca	Bussey, Timothy J/M-2758-2016; Khazaee, Reza/AAL-5309-2021; Saksida, Lisa M/M-2753-2016; Dekaban, Gregory/L-1987-2013; Bartha, Robert/K-3611-2013; Daley, Mark/B-5679-2015	Bussey, Timothy J/0000-0001-7518-4041; Khazaee, Reza/0000-0002-9681-023X; Saksida, Lisa M/0000-0002-8416-8171; Dekaban, Gregory/0000-0002-3087-4660; Bartha, Robert/0000-0002-7118-9096; Daley, Mark/0000-0002-6939-9772	BrainsCAN at Western University through the Canada First Research Excellence Fund (CFREF); NHL PA Challenge Fund	U This research was supported in part by BrainsCAN at Western University through the Canada First Research Excellence Fund (CFREF) and by the NHL PA Challenge Fund. LMS is a CIFAR Fellow in the Brain, Mind and Consciousness program.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bartha R, 1999, NMR BIOMED, V12, P205, DOI 10.1002/(SICI)1099-1492(199906)12:4<205::AID-NBM558>3.0.CO;2-1; Bartha R, 2000, MAGNET RESON MED, V44, P185; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beraldo FH, 2019, ELIFE, V8, DOI 10.7554/eLife.49630; Beraldo FH, 2015, DIS MODEL MECH, V8, P1457, DOI 10.1242/dmm.022525; Brizuela M, 2017, J NEUROTRAUM, V34, P2504, DOI 10.1089/neu.2017.4977; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Carlen M, 2017, SCIENCE, V358, P478, DOI 10.1126/science.aan8868; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Chamard E, 2018, BRAIN INJURY, V32, P816, DOI 10.1080/02699052.2018.1463106; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Chen K, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01417; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donnelly NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111300; Dzyubenko E, 2016, J NEUROSCI METH, V273, P149, DOI 10.1016/j.jneumeth.2016.09.001; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Furcila D, 2018, J ALZHEIMERS DIS, V64, P417, DOI 10.3233/JAD-180173; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Harris RA, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0389-18.2019; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Horner AE, 2013, NAT PROTOC, V8, P1961, DOI 10.1038/nprot.2013.122; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kassem MNE, 2003, MAGNET RESON MED, V49, P918, DOI 10.1002/mrm.10443; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kazl C, 2019, SEMIN PEDIATR NEUROL, V30, P9, DOI 10.1016/j.spen.2019.03.003; Kikinis Z, 2017, BRAIN INJURY, V31, P1376, DOI 10.1080/02699052.2017.1318450; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kim H, 2016, CELL, V164, P208, DOI 10.1016/j.cell.2015.11.038; KOSIK KS, 1993, BRAIN PATHOL, V3, P39, DOI 10.1111/j.1750-3639.1993.tb00724.x; Kunker K, 2020, NEUROL SCI, V41, P1899, DOI 10.1007/s10072-020-04300-0; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Lax ID, 2015, BRAIN INJURY, V29, P1409, DOI 10.3109/02699052.2015.1043344; Li J, 2017, NEURORADIOLOGY, V59, P1203, DOI 10.1007/s00234-017-1915-y; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Liu JF, 2019, J NEUROSCI, V39, P10071, DOI 10.1523/JNEUROSCI.1005-19.2019; Liu XB, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-42; Lu LH, 2019, J NEUROTRAUM, V36, P1828, DOI 10.1089/neu.2018.5929; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manning K, 2019, INT SOC MAGN RES MED; Manning KY, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2018.101627; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Olafsdottir HF, 2018, CURR BIOL, V28, pR37, DOI 10.1016/j.cub.2017.10.073; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Pinkowski Natalie J, 2020, Neurobiol Learn Mem, V175, P107315, DOI 10.1016/j.nlm.2020.107315; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Reichard RR, 2003, J NEUROPATH EXP NEUR, V62, P237, DOI 10.1093/jnen/62.3.237; Romberg C, 2018, PSYCHOPHARMACOLOGY, V235, P3495, DOI 10.1007/s00213-018-5065-7; Romberg C, 2011, J NEUROSCI, V31, P3500, DOI 10.1523/JNEUROSCI.5242-10.2011; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Saha P, 2019, MECH AGEING DEV, V178, P72, DOI 10.1016/j.mad.2019.01.007; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Sassoe-Pognetto M, 2000, EUR J NEUROSCI, V12, P2205, DOI 10.1046/j.1460-9568.2000.00106.x; Schrantz AL, 2019, INT SOC MAGNETIC RES; Schranz AL, 2018, HUM BRAIN MAPP, V39, P1489, DOI 10.1002/hbm.23919; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Singh K, 2016, NMR BIOMED, V29, P1748, DOI 10.1002/nbm.3627; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; VANDENBOOGAART A, 1994, MAGNET RESON MED, V31, P347, DOI 10.1002/mrm.1910310402; WALAAS SI, 1988, SYNAPSE, V2, P516, DOI 10.1002/syn.890020507; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Witkowski ED, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00166; Wong D, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.4002	110	3	3	4	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	APR 6	2021	9	1							60	10.1186/s40478-021-01161-2			27	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RJ3NN	WOS:000637504800001	33823944	Green Published, gold			2022-02-06	
J	Domel, AG; Raymond, SJ; Giordano, C; Liu, YZ; Yousefsani, SA; Fanton, M; Cecchi, NJ; Vovk, O; Pirozzi, I; Kight, A; Avery, B; Boumis, A; Fetters, T; Jandu, S; Mehring, WM; Monga, S; Mouchawar, N; Rangel, I; Rice, E; Roy, P; Sami, S; Singh, H; Wu, L; Kuo, C; Zeineh, M; Grant, G; Camarillo, DB				Domel, August G.; Raymond, Samuel J.; Giordano, Chiara; Liu, Yuzhe; Yousefsani, Seyed Abdolmajid; Fanton, Michael; Cecchi, Nicholas J.; Vovk, Olga; Pirozzi, Ileana; Kight, Ali; Avery, Brett; Boumis, Athanasia; Fetters, Tyler; Jandu, Simran; Mehring, William M.; Monga, Sam; Mouchawar, Nicole; Rangel, India; Rice, Eli; Roy, Pritha; Sami, Sohrab; Singh, Heer; Wu, Lyndia; Kuo, Calvin; Zeineh, Michael; Grant, Gerald; Camarillo, David B.			A new open-access platform for measuring and sharing mTBI data	SCIENTIFIC REPORTS			English	Article								Despite numerous research efforts, the precise mechanisms of concussion have yet to be fully uncovered. Clinical studies on high-risk populations, such as contact sports athletes, have become more common and give insight on the link between impact severity and brain injury risk through the use of wearable sensors and neurological testing. However, as the number of institutions operating these studies grows, there is a growing need for a platform to share these data to facilitate our understanding of concussion mechanisms and aid in the development of suitable diagnostic tools. To that end, this paper puts forth two contributions: (1) a centralized, open-access platform for storing and sharing head impact data, in collaboration with the Federal Interagency Traumatic Brain Injury Research informatics system (FITBIR), and (2) a deep learning impact detection algorithm (MiGNet) to differentiate between true head impacts and false positives for the previously biomechanically validated instrumented mouthguard sensor (MiG2.0), all of which easily interfaces with FITBIR. We report 96% accuracy using MiGNet, based on a neural network model, improving on previous work based on Support Vector Machines achieving 91% accuracy, on an out of sample dataset of high school and collegiate football head impacts. The integrated MiG2.0 and FITBIR system serve as a collaborative research tool to be disseminated across multiple institutions towards creating a standardized dataset for furthering the knowledge of concussion biomechanics.	[Domel, August G.; Raymond, Samuel J.; Giordano, Chiara; Liu, Yuzhe; Yousefsani, Seyed Abdolmajid; Cecchi, Nicholas J.; Pirozzi, Ileana; Kight, Ali; Wu, Lyndia; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Fanton, Michael; Kuo, Calvin; Camarillo, David B.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Vovk, Olga; Fetters, Tyler] Gen Dynam Informat Technol, 3150 Fairview Pk Dr, Falls Church, VA 22042 USA; [Avery, Brett; Boumis, Athanasia; Jandu, Simran; Mehring, William M.; Rangel, India; Rice, Eli; Roy, Pritha; Sami, Sohrab; Singh, Heer] Stanford Univ, Stanford Ctr Clin Res, Stanford, CA 94305 USA; [Monga, Sam] Intel Corp, Intel Sports, Santa Clara, CA 95054 USA; [Monga, Sam] Asterix Inc, Toronto, ON M4B 1B3, Canada; [Mouchawar, Nicole; Zeineh, Michael] Stanford Univ, Dept Radiol, 300 Pasteur Dr,MC 5105, Stanford, CA USA; [Wu, Lyndia] Univ British Columbia, Dept Mech Engn, 6250 Appl Sci Lane, Vancouver, BC V6T 1Z4, Canada; [Kuo, Calvin] Univ British Columbia, Dept Biomed Engn, Lower Mall Res Stn, Vancouver, BC 2259V6T 1Z4, Canada; [Grant, Gerald] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Grant, Gerald; Camarillo, David B.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA		Raymond, SJ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	sjray@stanford.edu	Raymond, Samuel/AAV-5908-2021; Yousefsani, Seyed Abdolmajid/ABB-8788-2021; Cecchi, Nicholas J/AAC-6547-2021	Raymond, Samuel/0000-0003-2691-652X; Cecchi, Nicholas J/0000-0001-9319-4163	Stanford Athletics; Stanford Center for Clinical and Translational Research and Education; Pac-12 Conference's Student-Athlete Health and Well-Being Initiative, Taube Stanford Children's Concussion Initiative; Office of Naval Research Young Investigator ProgramOffice of Naval Research; Stanford Child Health Research Institute; National Institute of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R24NS098518]	The authors would like to thank Stanford Athletics and the football team for their support in this research. We would also like to thank the Camarillo Lab interns who helped in data collection. Research reported in this publication was supported by the Stanford Center for Clinical and Translational Research and Education, the Pac-12 Conference's Student-Athlete Health and Well-Being Initiative, Taube Stanford Children's Concussion Initiative, the Office of Naval Research Young Investigator Program, the Stanford Child Health Research Institute, and the National Institute of Neurological Disorders And Stroke of the National Institutes of Health under Award Number R24NS098518. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai S., 2018, ARXIV PREPRINT ARXIV; Bartsch A., 2014, SAE TECHNICAL PAPER; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Camarillo D, 2020, STANFORD INSTRUMENTE; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Lang L., 2016, COMMON DATA ELEMENTS; Liu Y, 2020, VALIDATION COMP INST; Mannini A, 2010, SENSORS-BASEL, V10, P1154, DOI 10.3390/s100201154; Motiwale S, 2016, 2016 3RD IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS, P204, DOI 10.1109/BHI.2016.7455870; NIH, 2020, FED INT TRAUM BRAIN; NINDS, 2020, CDE CAT COMM DAT EL; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Preece SJ, 2009, PHYSIOL MEAS, V30, pR1, DOI 10.1088/0967-3334/30/4/R01; Raymond SJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65453-8; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Sganga J, 2019, IEEE INT CONF ROBOT, P5046, DOI 10.1109/ICRA.2019.8793940; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Thompson HJ, 2015, ANNU REV NURS RES-SE, V33, P1, DOI 10.1891/0739-6686.33.1; Withnall, 2017, NFL LINEAR IMPACTOR; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wu WM, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2208; Zhang X, 2015, ADV NIPS; Zunt JR, 2018, LANCET NEUROL, V17, P1061, DOI 10.1016/S1474-4422(18)30387-9	39	3	3	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 5	2021	11	1							7501	10.1038/s41598-021-87085-2			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ7YA	WOS:000637816800026	33820939	gold, Green Published, Green Submitted			2022-02-06	
J	Alizadeh, HV; Fanton, MG; Domel, AG; Grant, G; Camarillo, DB				Alizadeh, Hossein Vahid; Fanton, Michael G.; Domel, August G.; Grant, Gerald; Camarillo, David Benjamin			A Computational Study of Liquid Shock Absorption for Prevention of Traumatic Brain Injury	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article								Mild traumatic brain injury (mTBI), more colloquially known as concussion, is common in contact sports such as American football, leading to increased scrutiny of head protective gear. Standardized laboratory impact testing, such as the yearly National Football League (NFL) helmet test, is used to rank the protective performance of football helmets, motivating new technologies to improve the safety of helmets relative to existing equipment. In this work, we hypothesized that a helmet which transmits a nearly constant minimum force will result in a reduced risk of mTBI. To evaluate the plausibility of this hypothesis, we first show that the optimal force transmitted to the head, in a reduced order model of the brain, is in fact a constant force profile. To simulate the effects of a constant force within a helmet, we conceptualize a fluid-based shock absorber system for use within a football helmet. We integrate this system within a computational helmet model and simulate its performance on the standard NFL helmet test impact conditions. The simulated helmet is compared with other helmet designs with different technologies. Computer simulations of head impacts with liquid shock absorption predict that, at the highest impact speed (9.3m/s), the average brain tissue strain is reduced by 27.6%+/- 9.3 compared to existing helmet padding when tested on the NFL helmet protocol. This simulation-based study puts forth a target benchmark for the future design of physical manifestations of this technology.	[Alizadeh, Hossein Vahid; Domel, August G.] Stanford Univ, Bioengn Dept, Stanford, CA 94305 USA; [Fanton, Michael G.; Camarillo, David Benjamin] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Grant, Gerald] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA		Alizadeh, HV (corresponding author), Stanford Univ, Bioengn Dept, Stanford, CA 94305 USA.	hva@stanford.edu; mfanton@stanford.edu; augustdomel@stanford.edu; ggrant2@stanford.edu; dcamarillo@stanford.edu	, 莺瑰之殇/ABG-2761-2020		NSF Graduate Research Fellowship ProgramNational Science Foundation (NSF); Ford Motor Company through the University Research Program (URP)	NSF Graduate Research Fellowship Program and the Ford Motor Company through the University Research Program (URP) (Funder IDs: 10.13039/100000001 and 10.13039/100002427).	Alizadeh HV, 2018, MECHATRONICS, V49, P92, DOI 10.1016/mechatronics.2017.11.005; [Anonymous], 2007, J2111 SAE; Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Archbold J., 2013, U.S. Patent, Patent No. [283,506 A1, 283506]; Balin D., 2001, APPL MECH REV, V54, pB78, DOI [10.1115/1.1399377, DOI 10.1115/1.1399377]; Ballantyne EL, 2017, SPORTS ENG, V20, P171, DOI 10.1007/s12283-017-0226-1; Begley MR, 2014, J APPL MECH-T ASME, V81, DOI 10.1115/1.4024992; Biomechanics Consulting and Research LC, 2019, BIOC MOD FOOTB HELM; Bruneau D, 2019, THESIS U WATERLOO WA; Bustamante MC, 2019, J DYNAM BEHAV MAT, V5, P117, DOI 10.1007/s40870-019-00189-9; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cecchi NJ, 2019, SPORTS ENG, V22, DOI 10.1007/s12283-019-0311-8; Cheng ZQ, 1999, SHOCK VIB, V6, P299, DOI 10.1155/1999/146458; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Colello RJ, 2018, J NEUROTRAUM, V35, P1213, DOI 10.1089/neu.2017.5446; Corrales MA, 2020, ANN BIOMED ENG, V48, P121, DOI 10.1007/s10439-019-02359-1; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Decker W, 2020, ANN BIOMED ENG, V48, P258, DOI 10.1007/s10439-019-02345-7; DeLullo A., 20066199 AIAA, DOI [10.2514/6.2006-6199, DOI 10.2514/6.2006-6199]; Dixon, 2008, SHOCK ABSORBER HDB; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Fanton M., 2018, 8 WORLD C BIOM DUBL; Fanton M, 2020, SMART MATER STRUCT, V29, DOI 10.1088/1361-665X/ab905f; Franz E, 2017, J NEUROTRAUM, V34, pA105; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Giudice JS, 2020, ANN BIOMED ENG, V48, P1524, DOI 10.1007/s10439-020-02472-6; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Greathouse B.B., 1971, U.S. Patent, Patent No. [3,600,714, 3600714]; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Habets LCGJM, 2004, AUTOMATICA, V40, P21, DOI 10.1016/j.automatica.2003.08.001; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heck JF, 2004, J ATHL TRAINING, V39, P101; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1943, LANCET, V2, P438; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Kurt M, 2017, ANN BIOMED ENG, V45, P1148, DOI 10.1007/s10439-016-1732-1; Laituri T.R., 2016, SAE TECHNICAL PAPER, DOI [10.4271/2016-22-0012, DOI 10.4271/2016-22-0012]; Laksari K, 2020, J NEUROTRAUM, V37, P982, DOI 10.1089/neu.2018.6340; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; LSTC, 2017, LS DYNA KEYWORD USER, VII; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; National Football League (NFL),, 2019, HELM LAB TEST PERF R; Newman J. A., 2002, ACCIDENTAL INJURY BI, P303; O'Brien W, 2019, J NEUROTRAUM, V36, pA101; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; Organization World Intellectual Property, 2018, WO2018148753 ORG WOR; Ouellet S, 2006, POLYM TEST, V25, P731, DOI 10.1016/j.polymertesting.2006.05.005; Ramirez BJ, 2018, MATER DESIGN, V137, P298, DOI 10.1016/j.matdes.2017.10.037; Rojanavanich V., 1988, P INT RES COUNC BIOM, P181; Rojanavanich V., P INT RES COUNC BIOM, V17, P13; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Ruchelsman J., 2009, U.S. Patent, Patent No. [12/296,843, 12296843]; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Spinelli DJ, 2018, MATER DESIGN, V154, P153, DOI 10.1016/j.matdes.2018.04.083; Sun YL, 2018, INT J IMPACT ENG, V112, P74, DOI 10.1016/j.ijimpeng.2017.10.006; Takhounts E.G., SAE TECHNICAL PAPER, DOI [10.4271/2008-22-0001, DOI 10.4271/2008-22-0001]; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Withnall, 2017, NFL LINEAR IMPACTOR	76	3	3	2	2	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	APR 1	2021	143	4							041008	10.1115/1.4049155			12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	QS7MQ	WOS:000626080400008	33210108				2022-02-06	
J	Elahi, C; Williamson, T; Spears, CA; Williams, S; Najjuma, JN; Staton, CA; Vissoci, JRN; Fuller, A; Kitya, D; Haglund, MM				Elahi, Cyrus; Williamson, Theresa; Spears, Charis A.; Williams, Sarah; Najjuma, Josephine Nambi; Staton, Catherine A.; Vissoci, Joao Ricardo Nickenig; Fuller, Anthony; Kitya, David; Haglund, Michael M.			Estimating prognosis for traumatic brain injury patients in a low-resource setting: how do providers compare to the CRASH risk calculator?	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; discrete choice experiment; neurosurgery; clinical decision support; risk calculator	PREDICTION; DECISION; IMPACT	OBJECTIVE Traumatic brain injury (TBI), a burgeoning global health concern, is one condition that could benefit from prognostic modeling. Risk stratification of TBI patients on presentation to a health facility can support the prudent use of limited resources. The CRASH (Corticosteroid Randomisation After Significant Head Injury) model is a well-established prognostic model developed to augment complex decision-making. The authors' current study objective was to better understand in-hospital decision-making for TBI patients and determine whether data from the CRASH risk calculator influenced provider assessment of prognosis. METHODS The authors performed a choice experiment using a simulated TBI case. All participant doctors received the same case, which included a patient history, vitals, and physical examination findings. Half the participants also received the CRASH risk score. Participants were asked to estimate the patient prognosis and decide the best next treatment step. The authors recruited a convenience sample of 28 doctors involved in TBI care at both a regional and a national referral hospital in Uganda. RESULTS For the simulated case, the CRASH risk scores for 14-day mortality and an unfavorable outcome at 6 months were 51.4% (95% CI 42.8%, 59.8%) and 89.8% (95% CI 86.0%, 92.6%), respectively. Overall, participants were overopti-mistic when estimating the patient prognosis. Risk estimates by doctors provided with the CRASH risk score were closer to that score than estimates made by doctors in the control group; this effect was more pronounced for inexperienced doctors. Surgery was selected as the best next step by 86% of respondents. CONCLUSIONS This study was a novel assessment of a TBI prognostic model's influence on provider estimation of risk in a low-resource setting. Exposure to CRASH risk score data reduced overoptimistic prognostication by doctors, particularly among inexperienced providers.	[Williamson, Theresa; Staton, Catherine A.; Vissoci, Joao Ricardo Nickenig; Fuller, Anthony; Haglund, Michael M.] Duke Univ, Div Global Neurosurg & Neurol, Durham, NC USA; [Elahi, Cyrus; Williams, Sarah; Staton, Catherine A.; Vissoci, Joao Ricardo Nickenig; Fuller, Anthony; Haglund, Michael M.] Duke Global Hlth Inst, Durham, NC USA; [Williamson, Theresa; Fuller, Anthony; Haglund, Michael M.] Duke Univ Hosp, Dept Neurosurg, Durham, NC USA; [Spears, Charis A.; Fuller, Anthony; Haglund, Michael M.] Duke Univ, Sch Med, Durham, NC USA; [Najjuma, Josephine Nambi; Kitya, David] Mbarara Univ Sci & Technol, Mbarara Reg Referral Hosp, Mbarara, Uganda; [Elahi, Cyrus] Paul L Foster Sch Med, El Paso, TX USA; [Staton, Catherine A.] Duke Surg, Div Emergency Med, Durham, NC USA		Haglund, MM (corresponding author), Duke Univ, Durham, NC 27708 USA.	michael.haglund@dm.duke.edu		Spears, Charis/0000-0003-2814-2767; Najjuma, Josephine/0000-0001-5894-5961; Staton, Catherine/0000-0002-6468-2894	Duke University Center for International and Global Studies Research Award; Fogarty International Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000]	Mr. Elahi acknowledges scholarship support from the Duke University Center for International and Global Studies Research Award. Dr. Staton would like to acknowledge salary support provided by the Fogarty International Center of the National Institutes of Health under Award Number K01TW010000 (PI, Staton). Dr. Haglund acknowledges salary support provided by the Duke Department of Neurosurgery and the Duke Global Health Institute.	Ashengo T, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0248-6; Capan M, 2018, AM J EMERG MED, V36, P450, DOI 10.1016/j.ajem.2017.11.018; Fuller Anthony, 2016, eNeurologicalSci, V3, P1, DOI 10.1016/j.ensci.2015.10.003; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Mundeva H, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-018-0312-3; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Phua J, 2016, INTENS CARE MED, V42, P1118, DOI 10.1007/s00134-016-4347-y; Qureshi JS, 2013, INT J SURG, V11, P265, DOI 10.1016/j.ijsu.2013.01.011; Ramesh A, 2014, CUREUS J MED SCIENCE, V5, pe179; Rocha TAH, 2020, J NEUROSURG, V132, P1961, DOI 10.3171/2019.2.JNS182098; Sacks GD, 2016, ANN SURG, V264, P889, DOI 10.1097/SLA.0000000000001750; Sayed S, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.18.00094; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; Weber S, 2011, CAN J NURS INFORM, V5, P3; Wheble JLC, 2016, J ROY ARMY MED CORPS, V162, P87, DOI 10.1136/jramc-2015-000472; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd	20	3	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2021	134	4					1285	1293		10.3171/2020.2.JNS192512			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YJ2FN	WOS:000744351600002	32244205	Bronze			2022-02-06	
J	Markou, M; Pleger, B; Grozinger, M; Pintea, B; Hamsen, U; Konen, S; Schildhauer, TA; Martinez, R; Gousias, K				Markou, Markella; Pleger, Burkhard; Groezinger, Martin; Pintea, Bogdan; Hamsen, Uwe; Koenen, Sabrina; Schildhauer, Thomas A.; Martinez, Ramon; Gousias, Konstantinos			Intake of NOAC is associated with hematoma expansion of intracerebral hematomas after traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Intracerebral hematoma; Novel oral anticoagulants; Hematoma expansion; Traumatic brain injury; Glasgow outcome scale		Purpose Novel oral anticoagulants are increasingly replacing vitamin K antagonists in the prophylaxis of thromboembolism as they are associated with lower incidence of spontaneous intracerebral hematomas and they do not require drug level monitoring. However, management dilemmas are apparent in patients on novel oral anticoagulants who have developed intracerebral hematomas after traumatic brain injury, since clinical experience with their reversal strategies is limited. Methods We retrospectively studied 90 patients with traumatic intracerebral hematomas undergoing treatment at the surgical intensive care unit of the BG University Clinic Bergmannsheil in Bochum between 2015 and 2018. We analyzed potential prognostic factors for their radiological (expansion of intracerebral hematoma) and clinical (patients' outcome) course, in particular the role of novel oral anticoagulants. Results 71.1% of patients were male; mean age was 67.3 years. Hematoma's expansion occurred in 35.9% of our patients, whereas 62.2% of our cohort showed a favorable outcome, defined as Glasgow Outcome Scale 4 and 5. Intake of novel oral anticoagulants was associated with a higher rate of hematoma's expansion compared to patients on vitamin K antagonists (p = 0.05) or to patients with normal coagulation status (p = 0.002). A younger age (p < 0.001) was identified as the sole independent prognostic factor for a more favorable outcome, after excluding our cases, who underwent a cardiopulmonary resuscitation. Conclusions Our data showed a higher rate of hematoma's expansion in patients with traumatic intracerebral hematomas on novel oral anticoagulants vs. vitamin K antagonists and recommend the consideration of prophylactic reversal of the novel oral anticoagulants at admission. Larger prospective trials are warranted to conclude whether the current specific reversal protocols are safe and effective.	[Markou, Markella] BG Hosp Duisburg, Dept Neurol & Psychotraumatol, Grossenbaumer Allee 250, D-47249 Duisburg, Germany; [Markou, Markella; Gousias, Konstantinos] Rheinische Friedrich Wilhelms Univ Bonn, Med Sch, Sigmund Freud 25, D-53127 Bonn, Germany; [Pleger, Burkhard] BG Bergmannsheil Univ Hosp Bochum, Dept Neurol, Burkle Camp Pl 1, D-44789 Bochum, Germany; [Groezinger, Martin] BG Bergmannsheil Univ Hosp Bochum, Dept Radiol, Burkle Camp Pl 1, D-44789 Bochum, Germany; [Pintea, Bogdan; Koenen, Sabrina; Martinez, Ramon; Gousias, Konstantinos] BG Bergmannsheil Univ Hosp Bochum, Dept Neurosurg & Neurotraumatol, Burkle Camp Pl 1, D-44789 Bochum, Germany; [Hamsen, Uwe; Schildhauer, Thomas A.] BG Bergmannsheil Univ Hosp Bochum, Dept Gen Surg & Trauma Surg, Burkle Camp Pl 1, D-44789 Bochum, Germany; [Gousias, Konstantinos] Univ Munster, Dept Neurosurg, St Marien Acad Hosp Lunen, Altstadtstr 23, D-44534 Lunen, Germany		Gousias, K (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Med Sch, Sigmund Freud 25, D-53127 Bonn, Germany.; Gousias, K (corresponding author), BG Bergmannsheil Univ Hosp Bochum, Dept Neurosurg & Neurotraumatol, Burkle Camp Pl 1, D-44789 Bochum, Germany.; Gousias, K (corresponding author), Univ Munster, Dept Neurosurg, St Marien Acad Hosp Lunen, Altstadtstr 23, D-44534 Lunen, Germany.	markella.markou@bg-klinikum-duisburg.de; burkhard.pleger@bergmannsheil.de; martin.groezinger@bergmannsheil.de; bogdan.pintea@bergmannsheil.de; uwe.hamsen@bergmannsheil.de; sabrina.koenen@rub.de; thomas.schildhauer@bergmannsheil.de; ramon.martinez@bergmannsheil.de; kostasgousias@yahoo.com		Schildhauer, Thomas/0000-0002-3232-9869			Abed Hany S, 2017, J Atr Fibrillation, V10, P1634, DOI 10.4022/jafib.1634; Adachi T, 2017, CEREBROVASC DIS EXTR, V7, P62, DOI 10.1159/000462985; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Coleman CI, 2017, STROKE, V48, P2142, DOI 10.1161/STROKEAHA.117.017474; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Houben R, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00100; Huisman MV, 2016, AM J EMERG MED, V34, P46, DOI 10.1016/j.ajem.2016.09.053; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Purrucker JC, 2016, JAMA NEUROL, V73, P169, DOI 10.1001/jamaneurol.2015.3682; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Singer AJ, 2017, J EMERG MED, V52, P1, DOI 10.1016/j.jemermed.2016.09.028; Tsivgoulis G, 2017, NEUROLOGY, V89, P1142, DOI 10.1212/WNL.0000000000004362; Uccella L, 2018, WORLD NEUROSURG, V110, pE339, DOI 10.1016/j.wneu.2017.10.173; von der Brelie C, 2017, ACTA NEUROCHIR, V159, P101, DOI 10.1007/s00701-016-3026-7; Wilson D, 2017, NEUROLOGY, V88, P1693, DOI 10.1212/WNL.0000000000003886; Yan KX, 2018, WORLD NEUROSURG, V110, pE671, DOI 10.1016/j.wneu.2017.11.079; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P915, DOI 10.1097/TA.0000000000001995	22	3	3	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	APR	2021	47	2			SI		565	571		10.1007/s00068-019-01228-9			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	RH0SL	WOS:000635938000032	31529164				2022-02-06	
J	Mayer, AR; Dodd, AB; Ling, JM; Stephenson, DD; Rannou-Latella, JG; Vermillion, MS; Mehos, CJ; Johnson, VE; Gigliotti, AP; Dodd, RJ; Chaudry, IH; Meier, TB; Smith, DH; Bragin, DE; Lai, C; Wagner, CL; Guedes, VA; Gill, JM; Kinsler, R				Mayer, Andrew R.; Dodd, Andrew B.; Ling, Josef M.; Stephenson, David D.; Rannou-Latella, Julie G.; Vermillion, Meghan S.; Mehos, Carissa J.; Johnson, Victoria E.; Gigliotti, Andrew P.; Dodd, Rebecca J.; Chaudry, Irshad H.; Meier, Timothy B.; Smith, Douglas H.; Bragin, Denis E.; Lai, Chen; Wagner, Chelsea L.; Guedes, Vivian A.; Gill, Jessica M.; Kinsler, Rachel			Survival Rates and Biomarkers in a Large Animal Model of Traumatic Brain Injury Combined With Two Different Levels of Blood Loss	SHOCK			English	Article						Biomarkers; hypovolemia; large animal models; mortality; shock; traumatic brain injury	DIFFUSE AXONAL INJURY; SERUM NEUROFILAMENT LIGHT; HEMORRHAGIC-SHOCK; AMYLOID-BETA; RESUSCITATION; TAU; ACCUMULATION; INFLAMMATION; ISOFLURANE; OUTCOMES	Introduction: The pathology resulting from concurrent traumatic brain injury (TBI) and hemorrhagic shock (HS; TBI+HS) are leading causes of mortality and morbidity worldwide following trauma. However, the majority of large animal models of TBI+HS have utilized focal/contusional injuries rather than incorporating the types of brain trauma (closed-head injury caused by dynamic acceleration) that typify human injury. Objective: To examine survival rates and effects on biomarkers from rotational TBI with two levels of HS. Methods: Twenty-two sexually mature Yucatan swine (30.39 +/- 2.25 kg; 11 females) therefore underwent either Sham trauma procedures (n = 6) or a dynamic acceleration TBI combined with either 55% (n = 8) or 40% (n = 8) blood loss in this serial study. Results: Survival rates were significantly higher for the TBI+40% (87.5%) relative to TBI+55% (12.5%) cohort, with the majority of TBI+55% animals expiring within 2 h post-trauma from apnea. Blood-based neural biomarkers and immunohistochemistry indicated evidence of diffuse axonal injury (increased NFL/A beta 42), blood-brain barrier breach (increased immunoglobulin G) and inflammation (increased glial fibrillary acidic protein/ionized calcium-binding adaptor molecule 1) in the injured cohorts relative to Shams. Invasive hemodynamic measurements indicated increased shock index and decreased pulse pressure in both injury cohorts, with evidence of partial recovery for invasive hemodynamic measurements in the TBI+40% cohort. Similarly, although both injury groups demonstrated ionic and blood gas abnormalities immediately postinjury, metabolic acidosis continued to increase in the TBI+55% group similar to 85 min postinjury. Somewhat surprisingly, both neural and physiological biomarkers showed significant changes within the Sham cohort across the multi-hour experimental procedure, most likely associated with prolonged anesthesia. Conclusion: Current results suggest the TBI+55% model may be more appropriate for severe trauma requiring immediate medical attention/standard fluid resuscitation protocols whereas the TBI+40% model may be useful for studies of prolonged field care.	[Mayer, Andrew R.; Dodd, Andrew B.; Ling, Josef M.; Stephenson, David D.; Rannou-Latella, Julie G.; Vermillion, Meghan S.; Gigliotti, Andrew P.; Dodd, Rebecca J.; Bragin, Denis E.] Lovelace Biomed Res Inst, Mind Res Network, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychol, Albuquerque, NM 87131 USA; [Mehos, Carissa J.] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA USA; [Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Perelman Sch Med, Penn Ctr Brain Injury & Repair, Philadelphia, PA USA; [Chaudry, Irshad H.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Bragin, Denis E.] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA; [Lai, Chen; Wagner, Chelsea L.; Guedes, Vivian A.; Gill, Jessica M.] NINR, NIH, Bethesda, MD 20892 USA; [Kinsler, Rachel] US Army Aeromed Res Lab, Enroute Care Grp, Ft Rucker, AL USA		Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domen Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org		de Alvarenga Guedes, Vivian/0000-0001-8478-2465	Departments of Defense [W81XWH-17-2-0052]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM109089]	This research was supported by a grant from the Departments of Defense (W81XWH-17-2-0052) to Andrew R. Mayer. Histological analysis was performed by the Preclinical Core Facility at the University of New Mexico Center for Brain Recovery and Repair, which is supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM109089.	Acharya NK, 2015, BRAIN RES, V1620, P29, DOI 10.1016/j.brainres.2015.04.054; American College of Surgeons Committee on Trauma, 2004, ADV TRAUM LIF SUPP P, V7; Baker Benjamin L, 2016, J Spec Oper Med, V16, P112; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BRANDFONBRENER M, 1967, CIRC RES, V21, P461, DOI 10.1161/01.RES.21.4.461; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Cairns C B, 2001, Curr Opin Crit Care, V7, P437, DOI 10.1097/00075198-200112000-00011; Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Frankel DAZ, 2007, J SURG RES, V143, P276, DOI 10.1016/j.jss.2007.01.031; Frohlich M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0340-2; Fulop A, 2013, EUR SURG RES, V50, P57, DOI 10.1159/000348808; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Gutierrez G, 2013, INTENS CARE MED, V39, P1359, DOI 10.1007/s00134-013-2937-5; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hildebrand F, 2013, SHOCK, V40, P247, DOI 10.1097/SHK.0b013e3182a3cd74; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Liu HZ, 2015, FRONT BIOSCI-LANDMRK, V20, P927, DOI 10.2741/4347; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Mayer AR, 2019, NEUROSCI BIOBEHAV R, V104, P160, DOI 10.1016/j.neubiorev.2019.06.024; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; Miller M, 2014, J TRAUMA ACUTE CARE, V76, P1409, DOI 10.1097/TA.0000000000000237; NEMOTO EM, 1978, ANESTHESIOLOGY, V49, P170, DOI 10.1097/00000542-197809000-00004; Rocha JA, 2009, CLINICS, V64, P591, DOI 10.1590/S1807-59322009000600016; SAE (Society of Automotive Engineers), 1995, J2111 SAE; Shafi S, 2016, J TRAUMA ACUTE CARE, V81, P780, DOI 10.1097/TA.0000000000001161; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; SMITH D, 1986, BRIT HEART J, V56, P531; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Stern S, 2009, SHOCK, V31, P64, DOI 10.1097/SHK.0b013e3181778dc3; Suzuki M, 2009, RESUSCITATION, V80, P109, DOI 10.1016/j.resuscitation.2008.08.013; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Wojnarowicz MW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00240; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhang B, 2013, ANESTHESIOLOGY, V119, P52, DOI 10.1097/ALN.0b013e31828ce55d; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x	55	3	3	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	APR	2021	55	4					554	562		10.1097/SHK.0000000000001653			9	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	SV3LX	WOS:000663725100016	32881755				2022-02-06	
J	Molina, B; Mastroianni, J; Suarez, E; Soni, B; Forsberg, E; Finley, K				Molina, Brandon; Mastroianni, Jessica; Suarez, Ema; Soni, Brijinder; Forsberg, Erica; Finley, Kim			Treatment with Bacterial Biologics Promotes Healthy Aging and Traumatic Brain Injury Responses in Adult Drosophila, Modeling the Gut-Brain Axis and Inflammation Responses	CELLS			English	Article						gut&#8211; brain axis; inactive bacteriologic (IAB); probiotic; neural inflammaging; traumatic brain injury (TBI); Toll-like receptor (TLR); nucleotide-binding oligomerization domain-containing protein (NOD2); nuclear factor kappa-light-chain-enhancer of activated B cells (NF-&#954; &#946; ); pathogen associated molecular pattern (PAMP); anti-microbial peptide (AMP)		Drosophila are widely used to study neural development, immunity, and inflammatory pathways and processes associated with the gut-brain axis. Here, we examine the response of adult Drosophila given an inactive bacteriologic (IAB; proprietary lysate preparation of Lactobacillus bulgaricus, ReseT(R)) and a probiotic (Lactobacillus rhamnosus, LGG). In vitro, the IAB activates a subset of conserved Toll-like receptor (TLR) and nucleotide-binding, oligomerization domain-containing protein (NOD) receptors in human cells, and oral administration slowed the age-related decline of adult Drosophila locomotor behaviors. On average, IAB-treated flies lived significantly longer (+23%) and had lower neural aggregate profiles. Different IAB dosages also improved locomotor function and longevity profiles after traumatic brain injury (TBI) exposure. Mechanistically, short-term IAB and LGG treatment altered baseline nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa beta) signaling profiles in neural and abdominal tissues. Overall, at select dosages, IAB and LGG exposure has a positive impact on Drosophila longevity, neural aging, and mild traumatic brain injury (TBI)-related responses, with IAB showing greater benefit. This includes severe TBI (sTBI) responses, where IAB treatment was protective and LGG increased acute mortality profiles. This work shows that Drosophila are an effective model for testing bacterial-based biologics, that IAB and probiotic treatments promote neuronal health and influence inflammatory pathways in neural and immune tissues. Therefore, targeted IAB treatments are a novel strategy to promote the appropriate function of the gut-brain axis.	[Molina, Brandon; Mastroianni, Jessica; Suarez, Ema; Finley, Kim] San Diego State Univ, Dept Biol, Shiley BioSci Ctr, San Diego, CA 92182 USA; [Soni, Brijinder; Forsberg, Erica] San Diego State Univ, Dept Chem & Biohemistry, San Diego, CA 92182 USA		Finley, K (corresponding author), San Diego State Univ, Dept Biol, Shiley BioSci Ctr, San Diego, CA 92182 USA.	bmolina@sdsu.edu; jmfmastroianni@yahoo.com; elsuarez@sdsu.edu; brijssoni@gmail.com; eforsberg@sdsu.edu; kfinley@sdsu.edu			BioCreations, Inc. Rochester, MN, USA	Study funding was provided by BioCreations, Inc. Rochester, MN 55901, USA.	Amirani E, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2020.102361; Arora S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01574; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Breit S, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00044; Brenner LA, 2017, BRAIN BEHAV IMMUN, V65, P57, DOI 10.1016/j.bbi.2017.06.003; Caputi V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061689; Chen K, 2019, CELL HOST MICROBE, V25, P537, DOI 10.1016/j.chom.2019.02.003; Chen YY, 2019, TOXINS, V11, DOI 10.3390/toxins11010017; Deleemans JM, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6473-8; Dus M, 2015, NEURON, V87, P139, DOI 10.1016/j.neuron.2015.05.032; Elder GA, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134294; Farzi A, 2018, NEUROTHERAPEUTICS, V15, P5, DOI 10.1007/s13311-017-0600-5; Flores L, 2004, METABOLISM, V53, P1118, DOI 10.1016/j.metabol.2004.04.005; Foley NM, 2015, MILITARY MED RES, V2, pCP10, DOI 10.1186/s40779-014-0029-7; Goldberg J, 2018, AGING CELL, V17, DOI 10.1111/acel.12715; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Hollander D, 2003, J Physiol Pharmacol, V54 Suppl 4, P183; Hug H, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020203; Iatsenko I, 2018, IMMUNITY, V49, P929, DOI 10.1016/j.immuni.2018.09.017; Kasozi KI, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4297-x; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kayisoglu O, 2021, GUT, V70, P687, DOI 10.1136/gutjnl-2019-319919; Kepchia D, 2021, AGING-US, V13, P3269, DOI 10.18632/aging.202631; Kowalski K, 2019, J NEUROGASTROENTEROL, V25, P48, DOI 10.5056/jnm18087; Krishna G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020588; Lai CH, 2016, INT J MED SCI, V13, P277, DOI 10.7150/ijms.14769; Liu G, 2021, J APPL MICROBIOL, DOI 10.1111/jam.14773; Lu YZ, 2020, DEV COMP IMMUNOL, V102, DOI 10.1016/j.dci.2019.103468; Ma S, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8071027; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; McKernan DP, 2011, ALIMENT PHARM THER, V33, P1045, DOI 10.1111/j.1365-2036.2011.04624.x; McVey Neufeld Karen-Anne, 2020, Neuronal Signal, V4, pNS20200007, DOI 10.1042/NS20200007; Neufeld KAM, 2019, NUTR NEUROSCI, V22, P425, DOI [10.1080/1028415X.2017.1397875, 10.1080/1028415x.2017.1397875]; Ratliff EP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164239; Ratliff EP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132768; Rianda D, 2019, BENEF MICROBES, V10, P873, DOI 10.3920/BM2019.0068; Rice MW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00875; Schubert D, 2018, TRENDS PHARMACOL SCI, V39, P1004, DOI 10.1016/j.tips.2018.09.008; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Simonsen A, 2007, AUTOPHAGY, V3, P499, DOI 10.4161/auto.4604; Simonsen A, 2007, GENETICS, V176, P1283, DOI 10.1534/genetics.106.065011; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; Westfall S, 2019, PROG MOL BIOL TRANSL, V168, P147, DOI 10.1016/bs.pmbts.2019.06.013; Westfall S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214985; Westfall S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25382-z; Westfall S, 2018, ARTIF CELL NANOMED B, V46, P441, DOI 10.1080/21691401.2018.1458731; Zhang S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041140	55	3	3	5	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	APR	2021	10	4							900	10.3390/cells10040900			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	RR1NB	WOS:000642872400001	33919883	gold, Green Published			2022-02-06	
J	Wang, WY; Xie, L; Zou, XS; Li, N; Yang, YG; Wu, ZJ; Tian, XY; Zhao, GY; Chen, MH				Wang, Wen-yan; Xie, Lu; Zou, Xin-sen; Li, Nuo; Yang, Ye-gui; Wu, Zhi-jiang; Tian, Xin-yue; Zhao, Gao-yang; Chen, Meng-hua			Inhibition of extracellular signal-regulated kinase/calpain-2 pathway reduces neuroinflammation and necroptosis after cerebral ischemia-reperfusion injury in a rat model of cardiac arrest	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Cardiopulmonary resuscitation; Fluorescent multiplex immunohistochemistry; MDL28170; MLKL; PD98059	TRAUMATIC BRAIN-INJURY; ERK ACTIVATION; NEURONAL DEATH; RIP KINASES; M-CALPAIN; INFLAMMATION; PROTECTION; MICROGLIA; NECROSTATIN-1; EXPRESSION	Background: Cerebral ischemia-reperfusion injury (CIRI) is the leading cause of poor neurological prognosis after cardiopulmonary resuscitation (CPR). We previously reported that the extracellular signal-regulated kinase (ERK) activation mediates CIRI. Here, we explored the potential ERK/calpain-2 pathway role in CIRI using a rat model of cardiac arrest (CA). Methods: Adult male Sprague-Dawley rats suffered from CA/CPR-induced CIRI, received saline, DMSO, PD98059 (ERK1/2 inhibitor, 0.3 mg/kg), or MDL28170 (calpain inhibitor, 3.0 mg/kg) after spontaneous circulation recovery. The survival rate and the neurological deficit score (NDS) were utilized to assess the brain function. Hematoxylin stain, Nissl staining, and transmission electron microscopy were used to evaluate the neuron injury. The expression levels of p-ERK, ERK, calpain-2, neuroinflammation-related markers (GFAP, Iba1, IL-1 beta, TNF-alpha), and necroptosis proteins (TNFR1, RIPK1, RIPK3, p-MLKL, and MLKL) in the brain tissues were determined by western blotting and immunohistochemistry. Fluorescent multiplex immunohistochemistry was used to analyze the p-ERK, calpain-2, and RIPK3 co-expression in neurons, and RIPK3 expression levels in microglia or astrocytes. Results: At 24 h after CA/CPR, the rats in the saline-treated and DMSO groups presented with injury tissue morphology, low NDS, ERK/calpain-2 pathway activation, and inflammatory cytokine and necroptosis protein over-expression in the brain tissue. After PD98059 and MDL28170 treatment, the brain function was improved, while inflammatory response and necroptosis were suppressed by ERK/calpain-2 pathway inhibition. Conclusion: Inflammation activation and necroptosis involved in CA/CPR-induced CIRI were regulated by the ERK/calpain-2 signaling pathway. Inhibition of that pathway can reduce neuroinflammation and necroptosis after CIRI in the CA model rats.	[Wang, Wen-yan; Zou, Xin-sen; Yang, Ye-gui; Wu, Zhi-jiang; Tian, Xin-yue; Zhao, Gao-yang; Chen, Meng-hua] Guangxi Med Univ, Intens Care Unit, Affiliated Hosp 2, 166 Daxuedong Rd, Nanning 530000, Guangxi, Peoples R China; [Xie, Lu; Li, Nuo] Guangxi Med Univ, Dept Physiol, Nanning 530000, Guangxi, Peoples R China		Chen, MH (corresponding author), Guangxi Med Univ, Intens Care Unit, Affiliated Hosp 2, 166 Daxuedong Rd, Nanning 530007, Peoples R China.	cmhnn@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81660312, 81860333]; Scientific Research Fund Project of Guangxi Zhuang Autonomous region Health Commission [20191933]	This research was supported by the National Natural Science Foundation of China [grant numbers: 81660312, 81860333] and the Scientific Research Fund Project of Guangxi Zhuang Autonomous region Health Commission [grant number: 20191933].	Bao ZY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00222; Bollino D, 2015, J NEUROCHEM, V133, P174, DOI 10.1111/jnc.13029; Buchwalow I, 2018, ACTA HISTOCHEM, V120, P405, DOI 10.1016/j.acthis.2018.05.002; Chen MH, 2007, RESUSCITATION, V74, P546, DOI 10.1016/j.resuscitation.2007.01.039; Chen MH, 2007, AM J EMERG MED, V25, P623, DOI 10.1016/j.ajem.2006.11.033; Cheng SY, 2018, NEURAL REGEN RES, V13, P556, DOI 10.4103/1673-5374.228762; Choi J, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012809; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; Deng XX, 2019, AGING DIS, V10, P807, DOI 10.14336/AD.2018.0728; Dhuriya YK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1235-0; Fominaya A, 2016, METHODS MOL BIOL, V1429, P35, DOI 10.1007/978-1-4939-3622-9_4; Geocadin RG, 2019, CIRCULATION, V140, pE517, DOI 10.1161/CIR.0000000000000702; Giacobbo BL, 2019, MOL NEUROBIOL, V56, P3295, DOI 10.1007/s12035-018-1283-6; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hong JM, 2016, TOXICOL APPL PHARM, V308, P1, DOI 10.1016/j.taap.2016.08.010; Hu JN, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1210-4; Jia XF, 2008, RESUSCITATION, V76, P431, DOI 10.1016/j.resuscitation.2007.08.014; Kawamura M, 2005, BRAIN RES, V1037, P59, DOI 10.1016/j.brainres.2004.12.050; Keshk WA, 2020, ARCH BIOCHEM BIOPHYS, V680, DOI 10.1016/j.abb.2019.108227; Lam PM, 2017, NEUROBIOL DIS, V102, P1, DOI 10.1016/j.nbd.2017.02.003; Li M, 2020, ACTA PHARMACOL SIN, V41, P1025, DOI 10.1038/s41401-020-0386-6; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Liu CY, 2020, NEUROCHEM INT, V135, DOI 10.1016/j.neuint.2020.104690; Liu S, 2018, INFLAMMATION, V41, P2003, DOI 10.1007/s10753-018-0843-2; Long XB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01761-0; Moghadam BF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229769; Mohamed RA, 2016, NEUROSCIENCE, V314, P145, DOI 10.1016/j.neuroscience.2015.11.059; Mohamed SK, 2019, LIFE SCI, V227, P137, DOI 10.1016/j.lfs.2019.04.035; Moriwaki K, 2016, CELL MOL LIFE SCI, V73, P2325, DOI 10.1007/s00018-016-2203-4; Nasseri B, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106546; Newton K, 2015, TRENDS CELL BIOL, V25, P347, DOI 10.1016/j.tcb.2015.01.001; Thi PAN, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3723762; Pignataro G, 2011, CURR OPIN PHARMACOL, V11, P378, DOI 10.1016/j.coph.2011.05.003; Qin SN, 2019, DRUG DES DEV THER, V13, P2759, DOI 10.2147/DDDT.S215358; Qiu LL, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1695-x; Shi KB, 2019, LANCET NEUROL, V18, P1058, DOI 10.1016/S1474-4422(19)30078-X; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sun J, 2017, INT J MOL MED, V39, P1338, DOI 10.3892/ijmm.2017.2962; Tao XG, 2017, CHINESE MED J-PEKING, V130, P187, DOI 10.4103/0366-6999.198001; Tarantino G, 2013, ANN MED, V45, P348, DOI 10.3109/07853890.2013.770333; Teng X, 2018, NEUROCHEM RES, V43, P1200, DOI 10.1007/s11064-018-2537-4; Wang H, 2001, BIOCHEM BIOPH RES CO, V286, P869, DOI 10.1006/bbrc.2001.5482; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Wang YB, 2018, EXPERT OPIN THER TAR, V22, P19, DOI 10.1080/14728222.2018.1409723; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Yagami T, 2019, MOL NEUROBIOL, V56, P3090, DOI 10.1007/s12035-018-1277-4; Zadran S, 2013, NEUROMOL MED, V15, P74, DOI 10.1007/s12017-012-8196-8; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0; Zhang M, 2013, NEUROTOX RES, V24, P64, DOI 10.1007/s12640-012-9361-4; Zheng JH, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116618; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zou XS, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107032	56	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	APR	2021	93								107377	10.1016/j.intimp.2021.107377			11	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	QX3OZ	WOS:000629257000001	33517223				2022-02-06	
J	Wattiez, AS; Castonguay, WC; Gaul, OJ; Waite, JS; Schmidt, CM; Reis, AS; Rea, BJ; Sowers, LP; Cintron-Perez, CJ; Vazquez-Rosa, E; Pieper, AA; Russo, AF				Wattiez, Anne-Sophie; Castonguay, William C.; Gaul, Olivia J.; Waite, Jayme S.; Schmidt, Chantel M.; Reis, Alyssa S.; Rea, Brandon J.; Sowers, Levi P.; Cintron-Perez, Coral J.; Vazquez-Rosa, Edwin; Pieper, Andrew A.; Russo, Andrew F.			Different forms of traumatic brain injuries cause different tactile hypersensitivity profiles	PAIN			English	Article						Traumatic brain injury; Tactile allodynia; Posttraumatic headache; Persistent sensitization	CLOSED-HEAD INJURY; CGRP; MODEL; PAIN; CONCUSSION; MIGRAINE; IMPACT; MICE; PATHOPHYSIOLOGY; CONSEQUENCES	Chronic complications of traumatic brain injury represent one of the greatest financial burdens and sources of suffering in the society today. A substantial number of these patients suffer from posttraumatic headache (PTH), which is typically associated with tactile allodynia. Unfortunately, this phenomenon has been understudied, in large part because of the lack of well-characterized laboratory animal models. We have addressed this gap in the field by characterizing the tactile sensory profile of 2 nonpenetrating models of PTH. We show that multimodal traumatic brain injury, administered by a jet-flow overpressure chamber that delivers a severe compressive impulse accompanied by a variable shock front and acceleration-deceleration insult, produces long-term tactile hypersensitivity and widespread sensitization. These are phenotypes reminiscent of PTH in patients, in both cephalic and extracephalic regions. By contrast, closed head injury induces only transient cephalic tactile hypersensitivity, with no extracephalic consequences. Both models show a more severe phenotype with repetitive daily injury for 3 days, compared with either 1 or 3 successive injuries in a single day, providing new insight into patterns of injury that may place patients at a greater risk of developing PTH. After recovery from transient cephalic tactile hypersensitivity, mice subjected to closed head injury demonstrate persistent hypersensitivity to established migraine triggers, including calcitonin gene-related peptide and sodium nitroprusside, a nitric oxide donor. Our results offer the field new tools for studying PTH and preclinical support for a pathophysiologic role of calcitonin gene-related peptide in this condition.	[Wattiez, Anne-Sophie; Castonguay, William C.; Gaul, Olivia J.; Waite, Jayme S.; Schmidt, Chantel M.; Reis, Alyssa S.; Rea, Brandon J.; Russo, Andrew F.] Univ Iowa, Dept Mol Physiol & Biophys, 51 Newton Rd, Iowa City, IA 52242 USA; [Wattiez, Anne-Sophie; Castonguay, William C.; Rea, Brandon J.; Sowers, Levi P.; Russo, Andrew F.] Vet Adm Hlth Ctr, Ctr Prevent & Treatment Visual Loss, Iowa City, IA USA; [Cintron-Perez, Coral J.; Vazquez-Rosa, Edwin; Pieper, Andrew A.] Univ Hosp Cleveland Med Ctr, Harrington Discovery Inst, Cleveland, OH USA; [Cintron-Perez, Coral J.; Vazquez-Rosa, Edwin; Pieper, Andrew A.] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Cintron-Perez, Coral J.; Vazquez-Rosa, Edwin; Pieper, Andrew A.] Louis Stokes Cleveland VA Med Ctr, GRECC, Geriatr Psychiat, Cleveland, OH USA; [Cintron-Perez, Coral J.; Vazquez-Rosa, Edwin; Pieper, Andrew A.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH USA; [Pieper, Andrew A.] Cornell Univ, Weill Cornell Autism Res Program, Weill Cornell Med, New York, NY 10021 USA; [Pieper, Andrew A.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Russo, Andrew F.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA		Wattiez, AS (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, 51 Newton Rd, Iowa City, IA 52242 USA.	anne-sophie-wattiez@uiowa.edu		Russo, Andrew/0000-0002-8156-5649	Department of DefenseUnited States Department of Defense [W81XWH-16-1-0211, W81XWH-16-1-0071]; Department of Veterans Affairs Merit awardUS Department of Veterans Affairs [1I0RX002101]; Department of Veterans Affairs Career Development AwardUS Department of Veterans Affairs [IK2 RX002010 012020]; Center for the Prevention and Treatment of Visual Loss from the Department of Veterans Affairs Rehabilitation RD Services [C9251-C]; International Headache Academy research award from the American Headache Society; Brockman Foundation; S. Livingston Samuel Mather Trust; G.R. Lincoln Family Foundation; Louis Stokes VA Medical Center; Elizabeth Ring Mather and William Gwinn Mather Fund	The authors thank Dan Levy and Dara Bree for teaching A.-S. Wattiez and L.P. Sowers the closed head impact model. This work was supported by the Department of Defense grants W81XWH-16-1-0211 and W81XWH-16-1-0071 (A.F.R. and A.A.P), Department of Veterans Affairs Merit award 1I0RX002101 (A.F.R. and A.A.P.), and Department of Veterans Affairs Career Development Award IK2 RX002010 012020 (L.P.S and A.F.R). This work was also funded by a Pilot project awarded under the Center for the Prevention and Treatment of Visual Loss (award C9251-C) from the Department of Veterans Affairs Rehabilitation R&D Services (A.-S.W.). A.-S. Wattiez was also supported for this work by the International Headache Academy research award from the American Headache Society. A.A. Pieper was supported for this work by the Brockman Foundation, Elizabeth Ring Mather and William Gwinn Mather Fund, S. Livingston Samuel Mather Trust, G.R. Lincoln Family Foundation, and the Louis Stokes VA Medical Center resources and facilities. The contents do not represent the views of VA or the United States Government. A.-S. Wattiez, A.A. Pieper, and A.F. Russo contributed equally to this manuscript.	Amyot F, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102086; Anttila Verneri, 2018, Handb Clin Neurol, V148, P493, DOI 10.1016/B978-0-444-64076-5.00031-4; Asghar MS, 2011, ANN NEUROL, V69, P635, DOI 10.1002/ana.22292; Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Benromano T, 2015, EUR J PAIN, V19, P621, DOI 10.1002/ejp.583; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bolton-Hall AN, 2019, J NEUROTRAUM, V36, P1203, DOI 10.1089/neu.2018.6096; Brasure M, 2012, MULTIDISCIPLINARY PO; Bree D, 2020, CEPHALALGIA, V40, P748, DOI 10.1177/0333102420907597; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Burgos-Vega CC, 2019, CEPHALALGIA, V39, P123, DOI 10.1177/0333102418779557; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Diel RJ, 2021, BRIT J OPHTHALMOL, V105, P751, DOI 10.1136/bjophthalmol-2020-316417; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gregers MCT, 2020, NEUROCRIT CARE, V33, P273, DOI 10.1007/s12028-020-00975-7; Guo S, 2016, PAIN, V157, P2773, DOI 10.1097/j.pain.0000000000000702; Guo S, 2013, CEPHALALGIA, V33, P301, DOI 10.1177/0333102412475239; Hansen JM, 2010, CEPHALALGIA, V30, P1179, DOI 10.1177/0333102410368444; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P4159, DOI 10.1167/iovs.19-27565; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Kim Susan, 2017, Concussion, V2, pCNC48, DOI 10.2217/cnc-2017-0013; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Leung A, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01133-2; Levy D, 2020, CEPHALALGIA, V40, P675, DOI 10.1177/0333102419896368; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Mason BN, 2017, J NEUROSCI, V37, P204, DOI 10.1523/JNEUROSCI.2967-16.2016; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Moye LS, 2019, CEPHALALGIA, V39, P77, DOI 10.1177/0333102418777507; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Navratilova E, 2019, CEPHALALGIA, V39, P1762, DOI 10.1177/0333102419877662; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Pradhan AA, 2014, PAIN, V155, P269, DOI 10.1016/j.pain.2013.10.004; Prevention CfDCa, 2015, C TRAUM BRAIN INJ US; Rea BJ, 2018, PAIN, V159, P2306, DOI 10.1097/j.pain.0000000000001337; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Russo Andrew F, 2009, Mol Cell Pharmacol, V1, P264; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Studlack PE, 2018, BRAIN INJURY, V32, P1866, DOI 10.1080/02699052.2018.1536282; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Uddin Olivia, 1800, Neurobiol Pain, V6, P100030, DOI 10.1016/j.ynpai.2019.100030; Vazquez-Rosa E, 2019, ACS CHEM NEUROSCI, V10, P1595, DOI 10.1021/acschemneuro.8b00543; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wattiez AS, 2020, EXPERT OPIN THER TAR, V24, P91, DOI 10.1080/14728222.2020.1724285; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030	71	3	3	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	APR	2021	162	4					1163	1175		10.1097/j.pain.0000000000002103			13	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	SL0VA	WOS:000656633100018	33027220				2022-02-06	
J	Wettervik, TS; Lenell, S; Enblad, P; Lewen, A				Wettervik, Teodor Svedung; Lenell, Samuel; Enblad, Per; Lewen, Anders			Decompressive Craniectomy in Traumatic Brain Injury-Craniectomy-Related and Cranioplasty-Related Complications in a Single Center	WORLD NEUROSURGERY			English	Article						Cranioplasty; Decompressive craniectomy; Postoperative complications; Posttraumatic hydrocephalus; Subdural hygroma; Traumatic brain injury		OBJECTIVE: Decompressive craniectomy (DC) relieves intracranial hypertension after severe traumatic brain injury (TBI), but it has been associated with poor clinical outcome in 2 recent randomized controlled trials. In this study, we investigated the incidence and explanatory variables for DC-related and cranioplasty (CP)-related complications after TBI. METHODS: In this retrospective study, we identified 61 patients with TBI who were treated with DC in the neurointensive care unit, Uppsala University Hospital, Sweden, between 2008 and 2018. Demography, admission status, radiology, and clinical outcome were analyzed. RESULTS: Eleven patients (18%) were reoperated because of postoperative hemorrhage after DC. Six (10%) developed postoperative infection during neurointensive care. Twenty-eight (46%) developed subdural hygromas and 10 (16%) received a permanent cerebrospinal fluid shunt. Sixteen patients (26%) died before CP. Median time to CP was 7 months (range, 2-19 months) and 32 (71%) were operated on with autologous bone and 13 (29%) with synthetic material primarily. In 9 patients with autologous bone (29%), the CP had to be replaced because of bone resorption/infection, whereas this did not occur after synthetic material (P = 0.04). However, all 4 postoperative hemorrhages after CP occurred when synthetic material was used (P = 0.005). CONCLUSIONS: DC and CP surgery have a high risk for complications, leading to additional neurosurgery in about one third of cases. Synthetic CP materials may decrease the risk of reoperation, but special care with hemostasis is required because of increased risk of postoperative hemorrhage. Future trials need to address these topics to further improve the outcome for these patients.	[Wettervik, Teodor Svedung; Lenell, Samuel; Enblad, Per; Lewen, Anders] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se		enblad, per/0000-0003-4364-1919; Lenell, Samuel/0000-0001-8914-5086			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Bobinski L, 2013, CLIN NEUROL NEUROSUR, V115, P1788, DOI 10.1016/j.clineuro.2013.04.013; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Csokay A, 2001, ACTA NEUROCHIR, V143, P173, DOI 10.1007/s007010170125; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Goedemans T, 2020, J NEUROL, V267, P1312, DOI 10.1007/s00415-020-09695-6; Guyot LL, 2000, NEUROL RES, V22, P25; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Huang YH, 2013, J NEUROTRAUM, V30, P96, DOI 10.1089/neu.2012.2563; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kowalsky RJ, 2018, J PHYS ACT HEALTH, V15, P788, DOI [10.1123/jpah.2017-0639, 10.3171/2017.7.JNS17555]; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Kurzbuch AR, 2015, NEUROSURG REV, V38, P629, DOI 10.1007/s10143-015-0626-2; Lalou AD, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00184-6; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Li XG, 2013, J CLIN NEUROSCI, V20, P509, DOI 10.1016/j.jocn.2012.04.019; Lindner D, 2017, J NEUROSURG, V126, P175, DOI 10.3171/2015.10.JNS151245; Lubillo ST, 2018, J NEUROSURG, V128, P1538, DOI 10.3171/2017.1.JNS161840; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Malcolm JG, 2018, WORLD NEUROSURG, V116, P60, DOI 10.1016/j.wneu.2018.05.009; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mathieu F, 2020, J NEUROTRAUM, V37, P2069, DOI 10.1089/neu.2019.6911; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Salunke P, 2015, J NEUROSURG, V122, P602, DOI 10.3171/2014.10.JNS14780; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Toma AK, 2011, NEUROSURGERY, V68, P939, DOI 10.1227/NEU.0b013e318208f5e0; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Wang KW, 2005, SURG NEUROL, V64, P61, DOI 10.1016/j.surneu.2004.10.009; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	56	3	3	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2021	148						E508	E517		10.1016/j.wneu.2021.01.013			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RA9IO	WOS:000631732900058	33444838	hybrid, Green Published			2022-02-06	
J	Wilkerson, GB; Acocello, SN; Davis, MB; Ramos, JM; Rucker, AJ; Hogg, JA				Wilkerson, Gary B.; Acocello, Shellie N.; Davis, Meredith B.; Ramos, Justin M.; Rucker, Abigail J.; Hogg, Jennifer A.			Wellness Survey Responses and Smartphone App Response Efficiency: Associations With Remote History of Sport-Related Concussion	PERCEPTUAL AND MOTOR SKILLS			English	Article						post-concussion syndrome; injury risk screening; biopsychosocial model; flanker test; cognitive function; mild traumatic brain injury	PERFORMANCE; EXERCISE	Recent research findings have strongly suggested that sport-related concussion (SRC) increases risk for subsequent injury of any type, as well as a potential for long-term adverse effects on neurological and psychological well-being. The primary purpose of this study was to explore the reliability and discriminatory power of clinical testing procedures for detecting persisting effects of SRC. We used a cross-sectional study design to assess both self-reported symptoms commonly associated with post-concussion syndrome, and the effects of mental or physical activity on metrics derived from a smartphone app designed to test perceptual-motor responses. Among 30 physically active college students, 15 participants reported a SRC occurrence prior to testing (M time-since-injury = 4.0 years, SD = 3.1, range = 5 months to 11 years). We found good test-retest reliability for key metrics derived from the smartphone app (ICC >= .70); and the internal consistency for the Overall Wellness Index (OWI) for 10 categories of 82 post-concussion symptoms was ideal (Cronbach's alpha >= .80). Moderate intensity treadmill running demonstrated the strongest differential effect on perceptual-motor responses between participants with a history of SRC (HxSRC) and those with no such history (No SRC), which was best represented by the speed-accuracy trade-off quantified by the inverse efficiency index (IEI: group X trial interaction p = .055). Self-reported OWI symptoms >= 4 and post-physical activity IEI >= 568 ms provided the strongest discrimination between HxSRC and NoSRC participants (>= 1 versus 0: OR = 9.75). Our findings suggest that persisting effects from a remote SRC occurrence can be detected by easily administered screening procedures that have the potential to identify individual athletes who might derive benefit from interventions to restore their optimal function and well-being.	[Wilkerson, Gary B.; Acocello, Shellie N.; Davis, Meredith B.; Ramos, Justin M.; Rucker, Abigail J.; Hogg, Jennifer A.] Univ Tennessee, Grad Athlet Training Program, 615 McCallie Ave,6606, Chattanooga, TN 37403 USA		Wilkerson, GB (corresponding author), Univ Tennessee, Grad Athlet Training Program, 615 McCallie Ave,6606, Chattanooga, TN 37403 USA.	Gary-Vlkerson@utc.edu		Wilkerson, Gary/0000-0001-8433-7329	University of Tennessee at Chattanooga (Scholarship, Engagement, the Arts, Research, Creativity, and Humanities [SEARCH] Award)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the University of Tennessee at Chattanooga (Scholarship, Engagement, the Arts, Research, Creativity, and Humanities [SEARCH] Award).	Adler CM, 2018, CLIN J SPORT MED, V28, P100, DOI 10.1097/JSM.0000000000000391; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Brett BL, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01345; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; Conder R, 2015, BRAIN INJURY, V29, P249, DOI 10.3109/02699052.2014.965209; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ellemberg D., 2020, TRANSLATIONAL J AM C, V5, P1, DOI DOI 10.1249/TJX.0000000000000130; Filbay S, 2019, SPORTS MED, V49, P1723, DOI 10.1007/s40279-019-01163-0; Filley CM, 2016, J NEUROPHYSIOL, V116, P2093, DOI 10.1152/jn.00221.2016; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Frank BS, 2019, J SCI MED SPORT, V22, P35, DOI 10.1016/j.jsams.2018.05.017; Fueger C, 2018, J CLIN EXP NEUROPSYC, V40, P1074, DOI 10.1080/13803395.2018.1458823; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Ishii A, 2014, REV NEUROSCIENCE, V25, P469, DOI 10.1515/revneuro-2014-0028; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lamb KL, 1999, BRIT J SPORT MED, V33, P336, DOI 10.1136/bjsm.33.5.336; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; McGowan AL, 2019, NEUROPSYCHOLOGIA, V131, P223, DOI 10.1016/j.neuropsychologia.2019.05.026; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Olson RL, 2018, INT J PSYCHOPHYSIOL, V132, P145, DOI 10.1016/j.ijpsycho.2018.01.006; Parks AC, 2015, INT J PSYCHOPHYSIOL, V98, P426, DOI 10.1016/j.ijpsycho.2015.08.006; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Rach S, 2011, PSYCHOL RES-PSYCH FO, V75, P77, DOI 10.1007/s00426-010-0289-0; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rozand V, 2014, MED SCI SPORT EXER, V46, P1981, DOI 10.1249/MSS.0000000000000327; Serpell BG, 2020, MED SCI SPORT EXER, V52, P2365, DOI 10.1249/MSS.0000000000002397; Taghdiri F, 2018, J NEUROTRAUM, V35, P719, DOI 10.1089/neu.2017.5274; Tanaka M, 2014, BRAIN RES, V1561, P60, DOI 10.1016/j.brainres.2014.03.009; Thomas JR, 1999, RES Q EXERCISE SPORT, V70, P11, DOI 10.1080/02701367.1999.10607726; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Trinh LN, 2020, AM J SPORT MED, V48, P1516, DOI 10.1177/0363546519882626; Verschueren J., 2020, MED SCI SPORT EXER, V50, P767, DOI [10.1007/s40279-019-01235-1, DOI 10.1007/S40279-019-01235-1]; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339	45	3	3	2	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0031-5125	1558-688X		PERCEPT MOTOR SKILL	Percept. Mot. Skills	APR	2021	128	2					714	730		10.1177/0031512520983680			17	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	QI7QC	WOS:000619177100007	33357092				2022-02-06	
J	Wilson, JC; Levek, C; Daoud, AK; Brewer, M; Brooks, K; Sochanska, A; Randall, M; Provance, AJ				Wilson, Julie C.; Levek, Claire; Daoud, Ariel K.; Brewer, Matthew; Brooks, Katelyn; Sochanska, Ada; Randall, Melissa; Provance, Aaron J.			Web-Based Exercise Program Increases Cervical Strength in Adolescent Athletes	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						neck strengthening; injury prevention; pediatric; concussion	MUSCLE STRENGTH; NECK STRENGTH; HEAD; CONCUSSION; BIOMECHANICS; ADAPTATIONS	Wilson, JC, Levek, C, Daoud, AK, Brewer, M, Brooks, K, Sochanska, A, Randall, M, and Provance, AJ. Web-based exercise program increases cervical strength in adolescent athletes. J Strength Cond Res 35(4): 1149-1155, 2021-This cohort study aimed to evaluate the efficacy of a web-based 6-week cervical strengthening program on cervical strength in adolescent athletes. It was hypothesized that subjects completing the program would demonstrate significant increase in cervical muscle strength compared with baseline strength. Eighty-three high school soccer athlete subjects were recruited from 2 local nationally competitive soccer clubs. Teams were assigned to either control or intervention groups to minimize information crossover. Fifty subjects were recruited to the intervention group (29 male, 21 female; average age 15.1 years). Thirty-three subjects were recruited to the control group (21 male, 12 female; average age 15.1 years). Intervention group subjects completed a web-based progressive cervical strengthening program over 6 weeks. Cervical strength in flexion, extension, right and left lateral flexion (LLF) was measured in Newton (N) of force at 3 time points during the competitive season for both control and intervention groups. Intervention group subjects significantly increased cervical strength [mean difference (95% confidence interval)] in LLF [24.1 (15.9-32.4)], extension [27.9 (18.4-37.5)], right lateral flexion [18.8 (11.6-26.1)], and flexion [mean ratio: 1.2 (1.1-1.2)] at follow-up testing; whereas control subjects did not see significant changes in strength. A web-based progressive cervical strengthening program improves cervical muscular strength in a population of adolescent athletes over a period of 6 weeks. Such a program could be used by researchers in future studies evaluating the influence on concussion risk and by practitioners as a means of reducing sport-related head and neck injuries.	[Wilson, Julie C.; Daoud, Ariel K.; Brewer, Matthew; Brooks, Katelyn; Sochanska, Ada; Randall, Melissa; Provance, Aaron J.] Childrens Hosp Colorado, Orthoped Inst, Aurora, CO 80045 USA; [Wilson, Julie C.; Provance, Aaron J.] Univ Colorado, Dept Orthoped, Anschutz Med Campus, Aurora, CO 80045 USA; [Levek, Claire] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO USA		Wilson, JC (corresponding author), Childrens Hosp Colorado, Orthoped Inst, Aurora, CO 80045 USA.; Wilson, JC (corresponding author), Univ Colorado, Dept Orthoped, Anschutz Med Campus, Aurora, CO 80045 USA.	Julie.Wilson@childrenscolorado.org			AMSSM Young Investigator Grant; NIH/NCATS Colorado CTSIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000154]	The authors acknowledge Gregg Brueck ATC, David Walden ATC, and Megan Penick ATC for assistance with subject recruitment and testing, as well as R. Dawn Comstock, PhD, and Nathan Estrada, DPT for input regarding study design and exercise regimen. The authors also thank the athletes from Real Colorado and Colorado Rush soccer clubs for their participation in the study. The principal investigator received funding from the AMSSM Young Investigator Grant for this study. Study used a REDCap database, which is supported by NIH/NCATS Colorado CTSI Grant Number UL1 TR000154. Contents are the authors' sole responsibility and do not necessarily represent official NIH views.	Barrett MD, 2015, OPEN ACCESS J SPORTS, V6, P137, DOI 10.2147/OAJSM.S74622; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Conley MS, 1997, EUR J APPL PHYSIOL, V75, P443, DOI 10.1007/s004210050186; Cross KM, 2003, CLIN SPORT MED, V22, P639, DOI 10.1016/S0278-5919(02)00099-6; Denny-Brown D, 1940, J PHYSIOL-LONDON, V99, P153, DOI 10.1113/jphysiol.1940.sp003887; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; KRAEMER WJ, 1988, SPORTS MED, V6, P246, DOI 10.2165/00007256-198806040-00006; LaBerge RC, 2009, PEDIATR PULM, V44, P64, DOI 10.1002/ppul.20944; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Mansell J, 2005, J ATHL TRAINING, V40, P310; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; MORITANI T, 1993, J BIOMECH, V26, P95, DOI 10.1016/0021-9290(93)90082-P; POLLOCK ML, 1993, ARCH PHYS MED REHAB, V74, P1080, DOI 10.1016/0003-9993(93)90065-I; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z	20	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	APR	2021	35	4					1149	1155		10.1519/JSC.0000000000002907			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	SL0UP	WOS:000656632000039	30335712				2022-02-06	
J	Zimmerman, KA; Kim, J; Karton, C; Lochhead, L; Sharp, DJ; Hoshizaki, T; Ghajari, M				Zimmerman, K. A.; Kim, J.; Karton, C.; Lochhead, L.; Sharp, D. J.; Hoshizaki, T.; Ghajari, M.			Player position in American football influences the magnitude of mechanical strains produced in the location of chronic traumatic encephalopathy pathology: A computational modelling study	JOURNAL OF BIOMECHANICS			English	Article						Brain injuries; Traumatic; Brain concussion; Neuroanatomy; Tauopathies; Biomechanics	BRAIN-INJURY; CONCUSSION; SYSTEM; TAUOPATHY; DURATION; IMPACTS; CORTEX	American football players are frequently exposed to head impacts, which can cause concussions and may lead to neurodegenerative diseases such as chronic traumatic encephalopathy (CTE). Player position appears to influence the risk of concussion but there is limited work on its effect on the risk of CTE. Computational modelling has shown that large brain deformations during head impacts co-localise with CTE pathology in sulci. Here we test whether player position has an effect on brain deformation within the sulci, a possible biomechanical trigger for CTE. We physically reconstructed 148 head impact events from video footage of American Football games. Players were separated into 3 different position profiles based on the magnitude and frequency of impacts. A detailed finite element model of TBI was then used to predict Green-Lagrange strain and strain rate across the brain and in sulci. Using a one-way ANOVA, we found that in positions where players were exposed to large magnitude and low frequency impacts (e.g. defensive back and wide receiver), strain and strain rate across the brain and in sulci were highest. We also found that rotational head motion is a key determinant in producing large strains and strain rates in the sulci. Our results suggest that player position has a significant effect on impact kinematics, influencing the magnitude of deformations within sulci, which spatially corresponds to where CTE pathology is observed. This work can inform future studies investigating different player-position risks for concussion and CTE and guide design of prevention systems. (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).	[Zimmerman, K. A.; Kim, J.; Karton, C.; Lochhead, L.] Imperial Coll London, Hammersmith Hosp, Dept Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London, England; [Zimmerman, K. A.; Ghajari, M.] Imperial Coll, Dyson Sch Design Engn, HEAD Lab, London, England; [Karton, C.; Hoshizaki, T.] Univ Ottawa, Neurotrauma Impact Sci Lab, Ottawa, ON, Canada; [Sharp, D. J.] UK Dementia Res Inst, Care Res & Technol Ctr, London, England		Zimmerman, KA (corresponding author), Hammersmith Hosp, C3NL, Level 3,Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England.	kaz11@imperial.ac.uk	Zimmerman, Karl/AAL-4988-2020	Zimmerman, Karl/0000-0003-1239-3414; Ghajari, Mazdak/0000-0001-5678-5124; Lochhead, Liam/0000-0001-8368-5292	National Football League Players Association; Wellcome TrustWellcome TrustEuropean Commission [212430/Z/18/Z]; ERA-NET NEURON; Imperial College NIHR Biomedical Research Centre, UK Dementia Research Institute; Care Research AMP; Technology Centre, UK Dementia Research Institute; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	The authors would like to thank the study participants, advisors, and staff of the Football Players Health Study. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Medical School, Harvard University or its affiliated academic health care centers, or the National Football League Players Association. The Football Players Health Study is funded by a grant from the National Football League Players Association. The Football Players Health study approved this manuscript for publication but was not involved in the design, analysis or interpretation of this study. MG would like to acknowledge the support from Wellcome Trust (212430/Z/18/Z) . KAZ would like to acknowledge support from ERA-NET NEURON. DJS would like to acknowledge support from the Imperial College NIHR Biomedical Research Centre and Care Research & Technology Centre, UK Dementia Research Institute.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Chen WS, 2020, SPORT BIOMECH, DOI 10.1080/14763141.2020.1754450; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; de Grau S, 2020, SPORTS ENG, V23, DOI 10.1007/s12283-020-00325-y; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dick R, 2007, J ATHL TRAINING, V42, P221; Donat CK, 2021, BRAIN, V144, P70, DOI 10.1093/brain/awaa336; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Funk JR, 2020, ANN BIOMED ENG, V48, P2652, DOI 10.1007/s10439-020-02632-8; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gennarelli T.A., 1987, SAE TECHNICAL PAPER, P6; Gennarelli T.A., 1972, SAE TECHNICAL PAPER; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Holbourn AHS, 1943, LANCET, V2, P438; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Horstemeyer MF, 2019, ANN BIOMED ENG, V47, P1873, DOI 10.1007/s10439-019-02294-1; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Karton C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54874-9; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Post A, 2020, COMPUT METHOD BIOMEC, V23, P690, DOI 10.1080/10255842.2020.1758680; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Rousseau Philippe, 2010, Stapp Car Crash J, V54, P37; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shreiber D.I., 1997, STAPP CAR CRASH J, V41, P277; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; YOGANANDAN N, 1989, Journal of Biomechanical Engineering, V111, P250; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	54	3	3	4	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAR 30	2021	118								110256	10.1016/j.jbiomech.2021.110256			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	RC8JL	WOS:000633040100007	33545573	hybrid			2022-02-06	
J	Kaukas, L; Holmes, JL; Rahimi, F; Collins-Praino, L; Corrigan, F				Kaukas, Lola; Holmes, Joshua L.; Rahimi, Freshta; Collins-Praino, Lyndsey; Corrigan, Frances			Injury during adolescence leads to sex-specific executive function deficits in adulthood in a pre-clinical model of mild traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Prefrontal cortex; Nucleus accumbens; Concussion; Dopamine; netrin-1	REACTION-TIME-TASK; CATECHOL-O-METHYLTRANSFERASE; MEDIAL PREFRONTAL CORTEX; DOPAMINE TRANSPORTER; GENDER-DIFFERENCES; WORKING-MEMORY; AXON GUIDANCE; CONCUSSION; IMPULSIVITY; NETRIN-1	Adolescents are more likely than adults to develop chronic symptoms, such as impulsivity and difficulty concentrating, following a mild traumatic brain injury (mTBI) which may relate to disruption of pre-frontal cortex (PFC development). During adolescence the PFC is undergoing extensive remodelling, driving maturation of executive functions incorporating attention, motivation and impulse control. In part maturation of the PFC is driven by outgrowth of dopaminergic neurons to the PFC under the guidance of specific axonal targeting cues, including netrin-1. How a mTBI in adolescence may alter the expression of these axonal targeting cues, and the influence on PFC development is not yet known. As such the effects of mTBI in mid-adolescence on executive functioning in adulthood (12 weeks) were examined via the 5-choice serial reaction task in both male and female Sprague Dawley rats. Animals at p35 (n = 12-16 per group) were injured via weight drop (100 g from 0.75 m) and injury confirmed by a significant increase in righting reflex. Interestingly, while a mid-adolescence mTBI in females led to significantly higher omissions and decreased accuracy when task difficulty was high (stimulus duration 1 s), males had significantly increased premature response rate when the intertrial interval was varied. Examination of levels of TH, as a reflection of dopaminergic innervation, found no difference in either gender post-TBI in the PFC, but a significant increase in the limbic system (nucleus accumbens) in males, but not fe males, chronically post-TBI, suggesting an imbalance between the regions. The increase in TH was accompanied by a chronic reduction in netrin-1 within the nucleus accumbens in males only. Taken together, these results indicate that mTBI in adolescence leads to sex specific effects in different domains of PFC function in adulthood, which may relate to subtle alterations in the developmental trajectory of the mesocortical limbic pathway in males only.	[Kaukas, Lola; Holmes, Joshua L.; Rahimi, Freshta; Collins-Praino, Lyndsey; Corrigan, Frances] Univ Adelaide, Adelaide Med Sch, North Terrace, Adelaide, SA 5005, Australia		Corrigan, F (corresponding author), Univ Adelaide, Adelaide Med Sch, North Terrace, Adelaide, SA 5005, Australia.	frances.corrigan@adelaide.edu.au		Corrigan, Frances/0000-0001-6150-8893			Alcock Bradey, 2018, Addict Behav Rep, V7, P58, DOI 10.1016/j.abrep.2018.02.001; Andersen SL, 1997, NEUROREPORT, V8, P1495, DOI 10.1097/00001756-199704140-00034; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Andrzejewski ME, 2011, BEHAV NEUROSCI, V125, P93, DOI 10.1037/a0022038; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; Arulsamy A, 2018, BEHAV BRAIN RES, V348, P127, DOI 10.1016/j.bbr.2018.04.009; Baarendse PJJ, 2012, PSYCHOPHARMACOLOGY, V219, P313, DOI 10.1007/s00213-011-2576-x; Bell MR, 2018, ENDOCRINOLOGY, V159, P2596, DOI 10.1210/en.2018-00220; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Blum Kenneth, 2008, Neuropsychiatr Dis Treat, V4, P893; Broos N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036781; Broshek DK, 2005, CLIN SPORT MED, V24, P663, DOI 10.1016/j.csm.2005.04.005; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen YH, 2017, NEUROSCIENCE, V348, P180, DOI 10.1016/j.neuroscience.2017.02.001; Chen YH, 2015, CELL TRANSPLANT, V24, P2113, DOI 10.3727/096368914X683584; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; COHEN JD, 1993, SCHIZOPHRENIA BULL, V19, P85, DOI 10.1093/schbul/19.1.85; COTZIAS GC, 1969, J AMER MED ASSOC, V210, P1255, DOI 10.1001/jama.210.7.1255; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; DeYoung C. G., 2011, HDB SELF REGULATION, P485; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Espinoza TR, 2011, J HEAD TRAUMA REHAB, V26, P497, DOI 10.1097/HTR.0b013e31823088fa; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fallon SJ, 2016, CORTEX, V82, P24, DOI 10.1016/j.cortex.2016.05.005; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Gulley JM, 2003, EUR J PHARMACOL, V479, P139, DOI 10.1016/j.ejphar.2003.08.064; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hoops D, 2017, TRENDS NEUROSCI, V40, P709, DOI 10.1016/j.tins.2017.09.004; Huang EYK, 2014, BEHAV BRAIN RES, V267, P156, DOI 10.1016/j.bbr.2014.03.033; Killeen MT, 2009, CELL ADHES MIGR, V3, P268, DOI 10.4161/cam.3.3.8398; Kim JH, 2013, PSYCHOPHARMACOLOGY, V230, P607, DOI 10.1007/s00213-013-3187-5; Kollins SH, 2007, BIOL PSYCHIAT, V62, P951, DOI 10.1016/j.biopsych.2007.08.009; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Koss WA, 2011, DEV PSYCHOBIOL, V53, P724, DOI 10.1002/dev.20543; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Lewis EM, 2002, DRUG CHEM TOXICOL, V25, P437, DOI 10.1081/DCT-120014794; Liu Y, 2019, MOL MED REP, V20, P495, DOI 10.3892/mmr.2019.10299; Loos M, 2010, BEHAV BRAIN RES, V214, P216, DOI 10.1016/j.bbr.2010.05.027; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Luchicchi A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00070; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Manitt C, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.105; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Muramatsu R, 2010, BRAIN, V133, P60, DOI 10.1093/brain/awp266; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Navarra R, 2008, PROG NEURO-PSYCHOPH, V32, P34, DOI 10.1016/j.pnpbp.2007.06.017; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Ouanes S, 2017, NEUROBIOL AGING, V51, P1, DOI 10.1016/j.neurobiolaging.2016.11.014; Paine TA, 2011, NEUROPSYCHOPHARMACOL, V36, P1703, DOI 10.1038/npp.2011.51; Pattij T, 2007, PSYCHOPHARMACOLOGY, V191, P587, DOI 10.1007/s00213-006-0533-x; Picard M, 2009, CELL SIGNAL, V21, P1961, DOI 10.1016/j.cellsig.2009.09.004; Pokinko M, 2017, NEUROSCIENCE, V346, P182, DOI 10.1016/j.neuroscience.2017.01.009; Ranganathan P, 2016, BRAIN INJURY, V30, P452, DOI 10.3109/02699052.2016.1144081; Raznahan A, 2014, P NATL ACAD SCI USA, V111, P1592, DOI 10.1073/pnas.1316911111; Reichelt AC, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00189; Reynolds LM, 2018, BIOL PSYCHIAT, V83, P181, DOI 10.1016/j.biopsych.2017.06.009; Reynolds LM, 2016, BEHAV BRAIN RES, V298, P27, DOI 10.1016/j.bbr.2015.05.020; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Rochat L, 2013, J INT NEUROPSYCH SOC, V19, P890, DOI 10.1017/S1355617713000672; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seamans JK, 1998, J NEUROSCI, V18, P1613; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Swanson JM, 2009, J CHILD PSYCHOL PSYC, V50, P180, DOI 10.1111/j.1469-7610.2008.02062.x; Tanveer S, 2017, PEDIATR NEUROL, V70, P44, DOI 10.1016/j.pediatrneurol.2017.02.001; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Tsuchiya A, 2007, BRAIN RES, V1159, P1, DOI 10.1016/j.brainres.2006.12.096; van Gaalen MM, 2006, PSYCHOPHARMACOLOGY, V187, P73, DOI 10.1007/s00213-006-0396-1; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Vosberg DE, 2020, MOL PSYCHIATR, V25, P297, DOI 10.1038/s41380-019-0561-7; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Willing J, 2015, NEUROSCIENCE, V301, P268, DOI 10.1016/j.neuroscience.2015.05.073; Willing J, 2017, DEV PSYCHOBIOL, V59, P583, DOI 10.1002/dev.21525; Wingrove J, 1997, PERS INDIV DIFFER, V22, P333, DOI 10.1016/S0191-8869(96)00222-X; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005; Zahrt J, 1997, J NEUROSCI, V17, P8528; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	100	3	3	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 26	2021	402								113067	10.1016/j.bbr.2020.113067			14	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	TI1GC	WOS:000672529300020	33333110				2022-02-06	
J	Persad, A; Pham, N; Moien-Afshari, F; Gormley, W; Yan, SD; Mannix, R; Taghibiglou, C				Persad, Amit; Pham, Nam; Moien-Afshari, Farzad; Gormley, William; Yan, Sandra; Mannix, Rebekah; Taghibiglou, Changiz			Plasma PrPC and ADAM-10 as novel biomarkers for traumatic brain injury and concussion: a pilot study	BRAIN INJURY			English	Article						ADAM-10; cellular prion protein; concussion; biomarker; traumatic brain injury		Background Cellular prion protein (PrPC) is a lipid raft protein abundant within CNS. It is regulated by a disintegrin and metalloproteinase domain containing protein 10 (ADAM10). PrPC has previously been implicated as a biomarker for TBI. ADAM10 has not been investigated as a TBI biomarker. Objective We evaluated PrPC and ADAM10 as candidate biomarkers for TBI. Methods We performed ELISA for ADAM10 and PrPC on plasma samples of patients with TBI admitted to Brigham and Women's Hospital. Plasma samples from 20 patients admitted for isolated TBI were acquired from a biobank with clinical information. Control plasma (37 samples) was acquired from a commercial source. GraphPad was used to conduct statistical analysis. Results 37 controls and 20 TBI samples were collected. Of the patients with TBI, eight were mild, three were moderate, and nine were severe. Both PrPC and ADAM10 were elevated in patients with TBI compared with control (p < .001). ADAM10 exhibited greater expression in patients with worse clinical grade. There was no significant association of either PrPC or ADAM10 with time after injury. Conclusions Our results indicate that PrPC and ADAM10 appear to be useful potential tools for screening of TBI. ADAM10 is closely associated with clinical grade.	[Persad, Amit] Univ Saskatchewan, Div Neurosurg, Saskatoon, SK, Canada; [Pham, Nam] Univ Saskatchewan, Dept Pharmacol, Saskatoon, SK, Canada; [Moien-Afshari, Farzad] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC, Canada; [Gormley, William] Harvard Med Sch, Brigham & Womens Hosp, Neurosurg Crit Care, Dept Neurosurg, Boston, MA 02115 USA; [Yan, Sandra] Brown Univ, Brown Med Sch, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02912 USA; [Mannix, Rebekah] Harvard Med Sch, Boston Childrens Hosp, Brain Injury Ctr, Div Emergency Med, Boston, MA 02115 USA; [Taghibiglou, Changiz] Univ Saskatchewan, Dept Anat Physiol, Pharmacol, Saskatoon, SK, Canada		Taghibiglou, C (corresponding author), Univ Saskatchewan, Dept Anat Physiol, Pharmacol, Saskatoon, SK, Canada.	changiz.taghibiglou@usask.ca			Defence Research and Development Canada (DRDC) [W7702145664]; College of Medicine COMRAD funding	This research was partly supported by the Defence Research and Development Canada (DRDC), Research Contract #W7702145664 (Suffield Research Center, Ralston, Alberta, Canada), as well as the College of Medicine COMRAD funding for providing the fund for mTBI research in CT's laboratory.	Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Anderson TN, 2020, J TRAUMA ACUTE CARE, V89, P80, DOI 10.1097/TA.0000000000002706; Arciniegas DB, 2005, NEUROPSYCH DIS TREAT, V1; Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Byrnes KR, 2013, FRONT NEUROENERGETIC, V5; Costello DM, 2018, J CLIN NEUROSCI, V56, P1, DOI 10.1016/j.jocn.2018.07.002; Del Turco D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084962; Faul M, 2010, TRAUMATIC BRAIN INJU; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gayen M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072312; Hajiaghamemar M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051786; Heisler FF, 2018, NEURON, V99, P1155, DOI 10.1016/j.neuron.2018.08.010; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kural A, 2020, ULUS TRAVMA ACIL CER, V26, P1, DOI 10.5505/tjtes.2018.46923; Linsenmeier L, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0248-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mitsios N, 2007, J NEUROSCI RES, V85, P602, DOI 10.1002/jnr.21142; Pham N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117286; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Parizek P, 2001, J BIOL CHEM, V276, P44627, DOI 10.1074/jbc.M107458200; Perez-Barcena J, 2021, J NEUROSURG, V134, P1644, DOI 10.3171/2020.2.JNS193079; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Pham N, 2015, J NEUROTRAUM, V32, P58, DOI 10.1089/neu.2014.3471; Phillips LL, 2014, NEURAL REGEN RES, V9, P362, DOI 10.4103/1673-5374.128237; Pitkanen A, 2021, EPILEPSY BEHAV, V121, DOI 10.1016/j.yebeh.2020.107080; Prado MAM, 2004, J NEUROCHEM, V88, P769, DOI 10.1046/j.1471-4159.2003.02199.x; Ritchie EV, 2018, BRAIN INJURY, V32, P523, DOI 10.1080/02699052.2018.1429662; Robinson Bobby Darnell, 2020, Proc (Bayl Univ Med Cent), V33, P199, DOI 10.1080/08998280.2020.1727706; Rubenstein R, 2018, BEHAV BRAIN RES, V340, P29, DOI 10.1016/j.bbr.2016.04.041; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; Slavoaca D, 2020, NEUROL SCI, V41, P2033, DOI 10.1007/s10072-019-04238-y; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Sweeney MD, 2020, ALZHEIMERS DEMENT, V16, P821, DOI 10.1002/alz.12061; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Toman E, 2016, J ROY ARMY MED CORPS, V162, P103, DOI 10.1136/jramc-2015-000517; WALZ R, 1999, EPILEPSIA, V40; Wang Kevin K W, 2012, Front Neurol, V3, P147, DOI 10.3389/fneur.2012.00147; Wang PC, 2020, INT J MED SCI, V17, P437, DOI 10.7150/ijms.39667; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Wetzel S, 2017, BBA-MOL CELL RES, V1864, P2071, DOI 10.1016/j.bbamcr.2017.06.005; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	49	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 12	2021	35	6					734	741		10.1080/02699052.2021.1900602		MAR 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SB4DP	WOS:000632282000001	33760683				2022-02-06	
J	Homayounpour, M; Gomez, NG; Vasavada, AN; Merryweather, AS				Homayounpour, Mohammad; Gomez, Nicholas G.; Vasavada, Anita N.; Merryweather, Andrew S.			Cervical Muscle Activation Due to an Applied Force in Response to Different Types of Acoustic Warnings	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Whiplash; Neck muscle; Directional acoustic warning; mTBI; Muscle-activation; Startle	STARTLE RESPONSE; PRE-ACTIVATION; REACTION-TIME; NECK MUSCLES; WHIPLASH; HEAD; SINGLE; STABILITY; BIOMECHANICS; CONCUSSION	Mild traumatic brain injury (mTBI) and whiplash-associated disorder are the most common head and neck injuries and result from a sudden head or body acceleration. The head and neck injury potential is correlated with the awareness, level of muscle activation, and posture changes at the time of the perturbation. Environmental acoustic stimuli or a warning system can influence muscle activation and posture during a head perturbation. In this study, different acoustic stimuli, including Non-Directional, Directional, and Startle, were provided 1000 ms before a head impact, and the amplitude and timing of cervical muscle electromyographic (EMG) data were characterized based on the type of warning. The startle warning resulted in 49% faster and 80% greater EMG amplitude compared to the Directional and Non-Directional warnings after warning and before the impact. The post-impact peak EMG amplitudes in Unwarned trials were lower by 18 and 21% in the retraction and rebound muscle groups, respectively, compared to any of the warned conditions. When there was no warning before the impact, the retraction and rebound muscle groups also reached their maximum activation 38 and 54 ms sooner, respectively, compared to the warned trials. Based on these results, the intensity and complexity of information that a warning sound carries change the muscle response before and after a head impact and has implications for injury potential.	[Homayounpour, Mohammad; Gomez, Nicholas G.; Merryweather, Andrew S.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA; [Vasavada, Anita N.] Washington State Univ, Gene & Linda Voiland Sch Chem & Bioengn, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Washington Ctr Muscle Biol, Pullman, WA 99164 USA		Merryweather, AS (corresponding author), Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA.	a.merryweather@utah.edu		Gomez, Nicholas/0000-0002-7206-7752; Merryweather, Andrew/0000-0002-9048-9473	National Science FoundationNational Science Foundation (NSF) [1622741]; National Institute of Occupational Safety and Health (NIOSH Education and Research Center Training Grant)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [5T42OH008414-14]	This research was funded in part by grants from the National Science Foundation (Grant No. #1622741) and the National Institute of Occupational Safety and Health (NIOSH Education and Research Center Training Grant 5T42OH008414-14). The writers also acknowledge Karina Velarde for help in data collection and Jonathan Mortensen to help in the study design.	Alsalaheen B, 2018, J ELECTROMYOGR KINES, V39, P70, DOI 10.1016/j.jelekin.2018.01.011; Avela J, 1998, EUR J APPL PHYSIOL O, V78, P403, DOI 10.1007/s004210050438; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bella F, 2017, TRANSPORT RES F-TRAF, V51, P88, DOI 10.1016/j.trf.2017.09.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blouin JS, 2007, J APPL PHYSIOL, V102, P1574, DOI 10.1152/japplphysiol.00703.2006; Blouin JS, 2006, SPINE, V31, P146, DOI 10.1097/01.brs.0000195157.75056.df; Blouin JS, 2003, EXP BRAIN RES, V150, P458, DOI 10.1007/s00221-003-1466-9; BLUMENTHAL TD, 1986, PSYCHOPHYSIOLOGY, V23, P635, DOI 10.1111/j.1469-8986.1986.tb00682.x; Boisgontier MP, 2016, NEUROSCI BIOBEHAV R, V68, P1004, DOI 10.1016/j.neubiorev.2016.05.034; Carlsen AN, 2003, EXP BRAIN RES, V152, P510, DOI 10.1007/s00221-003-1575-5; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; EVANS RW, 1992, NEUROL CLIN, V10, P975, DOI 10.1016/S0733-8619(18)30191-9; Fanta O, 2013, NEUROENDOCRINOL LETT, V34, P708; Fanton M, 2019, IEEE T BIO-MED ENG, V66, P988, DOI 10.1109/TBME.2018.2866147; FELLOWS SJ, 1989, EXP BRAIN RES, V77, P135; Ramirez-Moreno DF, 2012, BIOL CYBERN, V106, P169, DOI 10.1007/s00422-012-0485-7; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Freund BJ, 2002, CLIN J PAIN, V18, pS163, DOI 10.1097/00002508-200211001-00008; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; He J, 1998, IEEE Trans Rehabil Eng, V6, P182, DOI 10.1109/86.681184; Hunter KD, 1997, J APPL PHYSIOL, V82, P278, DOI 10.1152/jappl.1997.82.1.278; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kofler M, 2001, BRAIN RES, V921, P206, DOI 10.1016/S0006-8993(01)03120-1; Kuo C, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0086; Kuo C, 2018, J BIOMECH, V76, P220, DOI 10.1016/j.jbiomech.2018.05.024; Kuramochi R, 2004, NEUROSCI LETT, V366, P206, DOI 10.1016/j.neulet.2004.05.040; Le Flao E, 2018, SPORTS MED, V48, P2641, DOI 10.1007/s40279-018-0984-3; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Lovering RM, 2005, J BIOMECH, V38, P1501, DOI 10.1016/j.jbiomech.2004.07.008; Luttmer NG, 2020, IEEE INT CONF ROBOT, P9135, DOI 10.1109/ICRA40945.2020.9196600; Magnusson ML, 1999, EUR SPINE J, V8, P118, DOI 10.1007/s005860050140; Mang DWH, 2015, SPINE J, V15, P153, DOI 10.1016/j.spinee.2014.08.002; Mang DWH, 2012, J APPL PHYSIOL, V113, P532, DOI 10.1152/japplphysiol.00100.2012; MCCULLY K, 1985, J APPL PHYSIOL, V61, P1986; Bernety HM, 2020, AIP ADV, V10, DOI 10.1063/1.5138650; Mortensen JD, 2020, J BIOMECH, V100, DOI 10.1016/j.jbiomech.2019.109411; Muhlbeier A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209753; Olive O, 2019, CHIN J TRAUMATOL, V22, P80, DOI 10.1016/j.cjtee.2018.10.006; Reynier KA, 2020, ANN BIOMED ENG, V48, P2751, DOI 10.1007/s10439-020-02609-7; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Siegmund GP, 2003, J BIOMECH, V36, P473, DOI 10.1016/S0021-9290(02)00458-X; Siegmund GP, 2003, SPINE, V28, P671, DOI 10.1097/00007632-200304010-00010; Siegmund GP, 2001, J PHYSIOL-LONDON, V535, P289, DOI 10.1111/j.1469-7793.2001.00289.x; Siegmund GP, 2007, J BIOMECH ENG-T ASME, V129, P66, DOI 10.1115/1.2401185; Siegmund GP, 2009, TRAFFIC INJ PREV, V10, P101, DOI 10.1080/15389580802593269; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; VALLSSOLE J, 1995, NEUROSCI LETT, V195, P97, DOI 10.1016/0304-3940(94)11790-P; Yadla S, 2008, CURR REV MUSCULOSKE, V1, P65, DOI 10.1007/s12178-007-9008-x; Zhang YT, 2015, DISCRETE DYN NAT SOC, V2015, DOI 10.1155/2015/980281	52	3	3	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2021	49	9					2260	2272		10.1007/s10439-021-02757-4		MAR 2021	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	US9LA	WOS:000632808700001	33768412	Green Published, hybrid			2022-02-06	
J	Ren, DB; Zheng, P; Zou, SF; Gong, YQ; Wang, Y; Duan, J; Deng, J; Chen, HM; Feng, JG; Zhong, CL; Chen, W				Ren, Dabin; Zheng, Ping; Zou, Shufeng; Gong, Yuqin; Wang, Yang; Duan, Jian; Deng, Jun; Chen, Haiming; Feng, Jiugeng; Zhong, Chunlong; Chen, Wei			GJA1-20K Enhances Mitochondria Transfer from Astrocytes to Neurons via Cx43-TnTs After Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article; Early Access						Traumatic brain injury; Astrocyte; Mitochondria transfer; GJA1-20K; Cx43		Astrocytes are crucial in neural protection after traumatic brain injury (TBI), a global health problem causing severe brain tissue damage. Astrocytic connexin 43 (Cx43), encoded by GJA1 gene, has been demonstrated to facilitate the protection of astrocytes to neural damage with unclear mechanisms. This study aims to explore the role of GJA1-20K/Cx43 axis in the astrocyte-neuron interaction after TBI and the underlying mechanisms. Primarily cultured cortical neurons isolated from embryonic C57BL/6 mice were treated by compressed nitrogen-oxygen mixed gas to simulate TBI-like damage in vitro. The transwell astrocyte-neuron co-culture system were constructed to recapitulate the interaction between the two cell types. Quantitative PCR was applied to analyze mRNA level of target genes. Western blot and immunofluorescence were conducted to detect target proteins expression. GJA1-20K overexpression significantly down-regulated the expression of phosphorylated Cx43 (p-Cx43) without affecting the total Cx43 protein level. Besides, GJA1-20K overexpression obviously enhanced the dendrite length, as well as the expression levels of function and synthesis-related factors of mitochondria in damaged neurons. GJA1-20K up-regulated functional Cx43 expression in astrocytes, which promoted mitochondria transmission from astrocytes to neurons which might be responsible to the protection of astrocyte to neurons after TBI-like damage in vitro.	[Ren, Dabin; Zheng, Ping; Chen, Wei] Shanghai Univ Med & Hlth Sci, Peoples Hosp Shanghai Pudong New Area, Dept Neurosurg, Shanghai 201299, Peoples R China; [Zou, Shufeng; Wang, Yang; Duan, Jian; Feng, Jiugeng] Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Nanchang 330008, Jiangxi, Peoples R China; [Gong, Yuqin] Nanchang Univ, Affiliated Hosp 2, Dept Operat Room, Nanchang NANCHANG UN, Jiangxi, Peoples R China; [Deng, Jun; Chen, Haiming] Nanchang Univ, Affiliated Hosp 1, Trauma Ctr, Dept Emergency, Nanchang 330008, Jiangxi, Peoples R China; [Zhong, Chunlong; Chen, Wei] Tongji Univ, Shanghai East Hosp, Dept Neurosurg, Shanghai 201200, Peoples R China		Chen, W (corresponding author), Shanghai Univ Med & Hlth Sci, Peoples Hosp Shanghai Pudong New Area, Dept Neurosurg, Shanghai 201299, Peoples R China.; Feng, JG (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Nanchang 330008, Jiangxi, Peoples R China.; Zhong, CL; Chen, W (corresponding author), Tongji Univ, Shanghai East Hosp, Dept Neurosurg, Shanghai 201200, Peoples R China.	fengjg1979@sina.com; drchunlongzhong@126.com; weichen445@163.com		Zhong, Chunlong/0000-0002-0605-7273; Chen, Wei/0000-0001-7438-3241	Shanghai Natural Science FoundationNatural Science Foundation of Shanghai [19ZR1447400]; Key Project of Jiangxi Science and Technology Department [20192BBGL70022]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81960236]; Key scientific research projects of Jiangxi Provincial Department of Education [GJJ190022]; Scientific research plan of Jiangxi health and Family Planning Commission [20203139]; Younth Key Project of Jiangxi Natural Science Foundation [20202ACBL216005]	The study was supported by Shanghai Natural Science Foundation (19ZR1447400); Key Project of Jiangxi Science and Technology Department (20192BBGL70022); National Natural Science Foundation of China (81960236); Key scientific research projects of Jiangxi Provincial Department of Education (GJJ190022); Scientific research plan of Jiangxi health and Family Planning Commission (20203139); and Younth Key Project of Jiangxi Natural Science Foundation (20202ACBL216005).	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Basheer WA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121900; Basheer WA, 2017, CIRC RES, V121, P1069, DOI 10.1161/CIRCRESAHA.117.311955; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; Bose A, 2018, MOL NEUROBIOL, V55, P6558, DOI 10.1007/s12035-017-0861-3; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Chen W, 2018, J NEUROPHYSIOL, V119, P305, DOI 10.1152/jn.00654.2017; Chen W, 2017, RESTOR NEUROL NEUROS, V35, P217, DOI 10.3233/RNN-160705; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Cotrina ML, 2009, PURINERG SIGNAL, V5, P223, DOI 10.1007/s11302-009-9138-2; Danesh-Meyer HV, 2008, J CLIN NEUROSCI, V15, P1253, DOI 10.1016/j.jocn.2008.08.002; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Falchi AM, 2013, HISTOCHEM CELL BIOL, V139, P221, DOI 10.1007/s00418-012-1045-x; Fu Y, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00905; Greer K, 2017, BRAIN RES BULL, V134, P38, DOI 10.1016/j.brainresbull.2017.06.016; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hoang QV, 2010, MOL VIS, V16, P1343; Honsa P, 2014, GLIA, V62, P2004, DOI 10.1002/glia.22721; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Kim SN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07658-y; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nienaber M, 2011, JOVE-J VIS EXP, DOI 10.3791/2723; Pecoraro M, 2018, TOXICOL IN VITRO, V47, P120, DOI 10.1016/j.tiv.2017.11.004; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Sinclair KA, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0354-8; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Voloboueva LA, 2007, J NEUROCHEM, V102, P1383, DOI 10.1111/j.1471-4159.2007.04634.x	32	3	3	2	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.												10.1007/s10571-021-01070-x		MAR 2021	9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	QX7GK	WOS:000629512700001	33728536				2022-02-06	
J	Yao, MY; Liu, T; Zhang, L; Wang, MJ; Yang, Y; Gao, J				Yao, Min-Yi; Liu, Tao; Zhang, Liang; Wang, Ming-Jian; Yang, Yong; Gao, Jing			Role of ferroptosis in neurological diseases	NEUROSCIENCE LETTERS			English	Article						Neurological diseases; Ferroptosis; Iron; Lipid peroxide; Polyunsaturated fatty acids; Nervous system		Ferroptosis is a newly identified form of nonapoptotic regulated cell death (RCD) characterized by irondependent accumulation of lipid peroxides which leads to oxidative stress and cell death. Recent studies have indicated that ferroptosis plays an essential role in the pathology of neurological diseases, such as intracerebral hemorrhage, ischemic stroke, epilepsy, neurodegenerative diseases, traumatic brain injury and brain cancer. This review focuses on the latest researches on the relationship of ferroptosis with nervous system diseases, highlighting the ferroptosis-based mechanisms, and elaborating the new perspective therapeutic targets of neurological disorders.	[Yao, Min-Yi; Liu, Tao; Zhang, Liang; Wang, Ming-Jian; Yang, Yong; Gao, Jing] Qingdao Univ, Affiliated Hosp, Dept Neurol, Qingdao 266000, Peoples R China		Yang, Y; Gao, J (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Neurol, Qingdao 266000, Peoples R China.	yangyongdoc@126.com; jinggao79@163.com		Liu, Tao/0000-0003-2116-6563	post-doctoral fundation of Qingdao University, China [RZ1900011598]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81901323]	This paper was supported by grants from post-doctoral fundation of Qingdao University, China (to J.G., No: RZ1900011598) and the National Natural Science Foundation of China (to Y.Y. No: 81901323)	Abbott RD, 2003, J NEUROL, V250, P30, DOI 10.1007/s00415-003-1306-7; Abdelfattah MS, 2020, NEUROTOX RES, V37, P77, DOI 10.1007/s12640-019-00086-y; Acosta-Cabronero J, 2018, RADIOLOGY, V289, P195, DOI 10.1148/radiol.2018180112; Alim I, 2019, CELL, V177, P1262, DOI 10.1016/j.cell.2019.03.032; An SJ, 2017, J STROKE, V19, P3, DOI 10.5853/jos.2016.00864; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Angelova P., 2020, CELL DEATH DIFFER; [Anonymous], 2020, CANCER DISCOV, V10, P485, DOI 10.1158/2159-8290.CD-RW2020-023; Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Borjesson SI, 2011, J GEN PHYSIOL, V137, P563, DOI 10.1085/jgp.201110599; Brault S, 2004, FREE RADICAL BIO MED, V37, P358, DOI 10.1016/j.freeradbiomed.2004.05.007; Burbulla LF, 2017, SCIENCE, V357, P1255, DOI 10.1126/science.aam9080; Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1; Cenini G, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2105607; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI 10.1002/acn3.54; Chen B, 2019, BRAIN RES BULL, V153, P122, DOI 10.1016/j.brainresbull.2019.08.013; Chen D, 2017, ONCOGENE, V36, P5593, DOI 10.1038/onc.2017.146; Chen DS, 2017, ONCOTARGET, V8, P51164, DOI 10.18632/oncotarget.17737; Chen JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077023; Chen LJ, 2015, J BIOL CHEM, V290, P28097, DOI 10.1074/jbc.M115.680090; Chen YB, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1413-7; Chin JH, 2014, NEUROLOGY, V83, P349, DOI 10.1212/WNL.0000000000000610; Cong L, 2019, EUR J MED CHEM, V166, P11, DOI 10.1016/j.ejmech.2019.01.039; Crichton R., 2001, INORGANIC BIOCH IRON; Cunnane SC, 2009, PROG LIPID RES, V48, P239, DOI 10.1016/j.plipres.2009.04.001; Davis RE, 2012, J PHARMACOL EXP THER, V342, P598, DOI 10.1124/jpet.112.192104; Dixon SJ, 2019, ANNU REV CANC BIOL, V3, P35, DOI 10.1146/annurev-cancerbio-030518-055844; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Do Van B, 2016, NEUROBIOL DIS, V94, P169, DOI 10.1016/j.nbd.2016.05.011; Fanzani A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081718; Feng H, 2020, CELL REP, V30, P3411, DOI 10.1016/j.celrep.2020.02.049; Fricker M, 2018, PHYSIOL REV, V98, P813, DOI 10.1152/physrev.00011.2017; Gao J, 2014, EPILEPSY RES, V108, P162, DOI 10.1016/j.eplepsyres.2013.11.016; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; Gao XC, 2020, ANTI-CANCER DRUG, V31, P27, DOI 10.1097/CAD.0000000000000825; Geng N, 2018, EUR REV MED PHARMACO, V22, P3826, DOI 10.26355/eurrev_201806_15267; Goldstein L, 2003, J NEUROSCI RES, V73, P113, DOI 10.1002/jnr.10633; Grolez G, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0331-3; Gu YX, 2009, STROKE, V40, P2241, DOI 10.1161/STROKEAHA.108.539536; Guan XY, 2019, LIFE SCI, V235, DOI 10.1016/j.lfs.2019.116795; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021; Hassannia B, 2018, J CLIN INVEST, V128, P3341, DOI 10.1172/JCI99032; Hinman A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201369; Hou W, 2016, AUTOPHAGY, V12, P1425, DOI 10.1080/15548627.2016.1187366; Inder T, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000020088.11295.13; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Kabiraj P, 2015, PROTEIN J, V34, P349, DOI 10.1007/s10930-015-9629-7; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/NCHEMBIO.2238, 10.1038/nchembio.2238]; Kahn-Kirby AH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214250; Kang R, 2017, CURR PATHOBIOL REP, V5, P153, DOI 10.1007/s40139-017-0139-5; Karatas H, 2018, BRAIN RES, V1678, P123, DOI 10.1016/j.brainres.2017.10.024; Karuppagounder SS, 2018, ANN NEUROL, V84, P854, DOI 10.1002/ana.25356; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kumar P, 2010, BEHAV PHARMACOL, V21, P217, DOI 10.1097/FBP.0b013e32833a5bf4; Lachaier E, 2014, ANTICANCER RES, V34, P6417; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lee YS, 2018, MOL CANCER RES, V16, P1073, DOI 10.1158/1541-7786.MCR-18-0055; Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2298-2; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li Q, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00638; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Liu RZ, 2019, ACTA BIOCH BIOPH SIN, V51, P1134, DOI 10.1093/abbs/gmz104; Louandre C, 2013, INT J CANCER, V133, P1732, DOI 10.1002/ijc.28159; Lozoff B, 1996, J PEDIATR-US, V129, P382, DOI 10.1016/S0022-3476(96)70070-7; Lunov O, 2010, BIOMATERIALS, V31, P9015, DOI 10.1016/j.biomaterials.2010.08.003; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Manz DH, 2016, ANN NY ACAD SCI, V1368, P149, DOI 10.1111/nyas.13008; Martin-Bastida A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01402-2; Martinez AM, 2019, FEBS OPEN BIO, V9, P582, DOI 10.1002/2211-5463.12577; Matak P, 2016, P NATL ACAD SCI USA, V113, P3428, DOI 10.1073/pnas.1519473113; Moller HE, 2019, TRENDS NEUROSCI, V42, P384, DOI 10.1016/j.tins.2019.03.009; Moreau C, 2018, ANTIOXID REDOX SIGN, V29, P742, DOI 10.1089/ars.2017.7493; Morris G, 2018, BEHAV BRAIN RES, V341, P154, DOI 10.1016/j.bbr.2017.12.036; Moruno Felix, 2012, Cells, V1, P372, DOI 10.3390/cells1030372; Naghavi M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l94; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Nobuta H, 2019, CELL STEM CELL, V25, P531, DOI 10.1016/j.stem.2019.09.003; Okauchi M, 2009, STROKE, V40, P1858, DOI 10.1161/STROKEAHA.108.535765; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Raven EP, 2013, J ALZHEIMERS DIS, V37, P127, DOI 10.3233/JAD-130209; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; Rowley S, 2013, FREE RADICAL BIO MED, V62, P121, DOI 10.1016/j.freeradbiomed.2013.02.002; Sehm T, 2016, ONCOTARGET, V7, P74630, DOI 10.18632/oncotarget.11858; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shen ZY, 2018, ACS NANO, V12, P11355, DOI 10.1021/acsnano.8b06201; Shimada K, 2016, CELL CHEM BIOL, V23, P225, DOI 10.1016/j.chembiol.2015.11.016; Siegert E, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-016-0312-5; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Song S, 2008, ACTA NEUROCHIR SUPPL, V105, P13; Staley K, 2015, NAT NEUROSCI, V18, P367, DOI 10.1038/nn.3947; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; The Stroke Association, 2017, STAT NAT STROK STAT; Tuo QZ, 2017, MOL PSYCHIATR, V22, P1520, DOI 10.1038/mp.2017.171; Uauy R, 2000, P NUTR SOC, V59, P3, DOI 10.1017/S0029665100000021; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; van Bergen JMG, 2016, AM J NEURORADIOL, V37, P789, DOI 10.3174/ajnr.A4617; Wainwright PE, 2002, P NUTR SOC, V61, P61, DOI 10.1079/PNS2001130; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang ZQ, 2018, CANCER LETT, V428, P21, DOI 10.1016/j.canlet.2018.04.021; Ward R, 2014, LANCET NEUROL, V13, P1045, DOI 10.1016/S1474-4422(14)70117-6; Weiser MJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020099; Xiao M, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5819514; Xiao X, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0501-0; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Ye Q, 2020, EPILEPSY BEHAV, V103, DOI 10.1016/j.yebeh.2019.106670; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P1338, DOI 10.1016/j.bbrc.2016.08.124; Zhang P, 2020, FREE RADICAL BIO MED, V152, P227, DOI 10.1016/j.freeradbiomed.2020.03.015; Zhang Y, 2019, CELL CHEM BIOL, V26, P623, DOI 10.1016/j.chembiol.2019.01.008; Zhang YH, 2018, REDOX BIOL, V14, P535, DOI 10.1016/j.redox.2017.11.001; Zhang ZW, 2018, BRAIN RES, V1701, P112, DOI 10.1016/j.brainres.2018.09.012; Zhao HY, 2017, PATHOL RES PRACT, V213, P626, DOI 10.1016/j.prp.2017.04.025; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170; Zilka O, 2017, ACS CENTRAL SCI, V3, P232, DOI 10.1021/acscentsci.7b00028; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609; Zou X, 2017, BRAIN RES, V1658, P25, DOI 10.1016/j.brainres.2017.01.001; Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9	124	3	3	7	18	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 16	2021	747								135614	10.1016/j.neulet.2020.135614			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RF8RN	WOS:000635105800019	33485988				2022-02-06	
J	Kumar, RG; Ornstein, KA; Corrigan, JD; Adams, RS; Dams-O'Connor, K				Kumar, Raj G.; Ornstein, Katherine A.; Corrigan, John D.; Adams, Rachel Sayko; Dams-O'Connor, Kristen			Association between Lifetime History of Traumatic Brain Injury, Prescription Opioid Use, and Persistent Pain: A Nationally Representative Study	JOURNAL OF NEUROTRAUMA			English	Article						pain; prescription opioid use; traumatic brain injury		Pain is common among adults with traumatic brain injury (TBI), yet little data exist regarding prevalence of opioid use in this population. The objective of this retrospective cohort study was to evaluate the association between lifetime TBI exposure, opioid use, and pain in a nationally representative sample of 1022 adults aged 50+ who participated in the Health and Retirement Study (HRS). Our primary exposure was lifetime TBI history measured via the Ohio State University TBI Identification Method. We evaluated three alternate TBI exposures (years since most recent TBI, age at first TBI, and number of lifetime TBIs) in sensitivity analyses. We evaluated two outcomes: recent opioid medication use, and moderate-to-severe pain measured over two HRS waves. We classified three pain groups (persistent, intermittent, and no pain). Prevalences of opioid use among individuals with and without TBI were 19.7% and 13.6%, respectively. After adjustment for age, sex, and race, individuals with TBI had a 52% increased risk for opioid use compared with individuals without TBI (relative risk = 1.52, 95% confidence interval: 1.11, 2.04). Individuals with recent TBI (1-10 years ago), first TBI after age 40+, and 2+ lifetime TBIs had greatest risk for opioid use. Compared with individuals without TBI, individuals with TBI had 4.9-times increased odds for persistent versus no pain, and 1.9-times increased odds of intermittent versus no pain. Persistent pain among adults with lifetime TBI is elevated compared with the general population, which may contribute to increased opioid use among persons with TBI, particularly those with recent injuries or multiple lifetime TBIs.	[Kumar, Raj G.; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Ornstein, Katherine A.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Med, New York, NY 10029 USA; [Ornstein, Katherine A.] Icahn Sch Med Mt Sinai, Dept Med, Div Gen Internal Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Adams, Rachel Sayko] Brandeis Univ, Heller Sch, Inst Behav Hlth, Waltham, MA 02254 USA; [Adams, Rachel Sayko] Vet Hlth Adm, Rocky Mt Mental Illness Res Educ & Clin Ctr, Aurora, CO USA		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, Dept Rehabil & Human Performance, One Gustave L Levy Pl,Box 1163, New York, NY 10029 USA.	kristen.dams-o'connor@mountsinai.org			National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0001-01-00, 90DPGE0007, 90DP0038, 90DPTB0009]	Dr. Adams and Dr. Corrigan's effort was supported in part by a grant from the National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR) to Ohio State University (Dr. Corrigan: Grant Number 90DPTB0001-01-00, Dr. Corrigan and Dr. Adams: Grant Number 90DPGE0007). Dr. Dams-O'Connor and Dr. Kumar's effort were supported in part by a grant fromNIDLRR to the Icahn School of Medicine at Mount Sinai (90DP0038 and 90DPTB0009). The contents of this publication do not necessarily represent the policy of NIDILRR, the Administration on Community Living, nor the U.S. Department of Health and Human Services, and endorsement by the federal government should not be assumed.	Adams RS, 2020, J HEAD TRAUMA REHAB, V35, P27, DOI 10.1097/HTR.0000000000000508; Adams RS, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6451; Adams RS, 2019, J HEAD TRAUMA REHAB, V34, P167, DOI 10.1097/HTR.0000000000000481; Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barth, 2009, MANAGEMENT CONCUSSIO; Beaulieu-Bonneau S, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000341; Bogner JA., 2018, OHIO STATE U TRAUMAT; Bonci A, 2003, TRENDS PHARMACOL SCI, V24, P172, DOI 10.1016/S0165-6147(03)00068-3; Byers AL, 2020, BRAIN INJURY, V34, P328, DOI 10.1080/02699052.2019.1701708; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P45; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2019, ADDICT BEHAV, V90, P143, DOI 10.1016/j.addbeh.2018.10.030; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Dunn LK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225787; Gardner RC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002246; Hammond F., 2020, J NEUROTRAUM, V37; Han B, 2018, J CLIN PSYCHIAT, V79, P4, DOI 10.4088/JCP.17m11973; Han B, 2017, ANN INTERN MED, V167, P293, DOI 10.7326/M17-0865; Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Heeringa SG, 1995, TECHNICAL DESCRIPTIO; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Inc S.I., 2013, SAS 9 4 COMP SOFTW; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Kornblith ES, 2020, J HEAD TRAUMA REHAB, V35, pE320, DOI 10.1097/HTR.0000000000000552; Kumar RG, 2020, INT J GERIATR PSYCH, V35, P553, DOI 10.1002/gps.5271; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Academies of Sciences., FRAM OP PRESCR GUID; Peltz CB, 2020, NEUROLOGY, V95, pE1126, DOI 10.1212/WNL.0000000000010087; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Rosenberg JM, 2018, PAIN MED, V19, P928, DOI 10.1093/pm/pnx203; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Sell LA, 1999, EUR J NEUROSCI, V11, P1042, DOI 10.1046/j.1460-9568.1999.00522.x; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Weiss RD, 2014, J SUBST ABUSE TREAT, V47, P140, DOI 10.1016/j.jsat.2014.03.004; Whitlock EL, 2017, JAMA INTERN MED, V177, P1146, DOI 10.1001/jamainternmed.2017.1622; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	45	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2021	38	16					2284	2290		10.1089/neu.2020.7496		MAR 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TY0QY	WOS:000628980400001	33567980				2022-02-06	
J	Kamins, J; Richards, R; Barney, BJ; Locandro, C; Pacchia, CF; Charles, AC; Cook, LJ; Gioia, G; Giza, CC; Blume, HK				Kamins, Joshua; Richards, Rachel; Barney, Bradley J.; Locandro, Christopher; Pacchia, Christina F.; Charles, Andrew C.; Cook, Lawrence J.; Gioia, Gerard; Giza, Christopher C.; Blume, Heidi K.			Evaluation of Posttraumatic Headache Phenotype and Recovery Time After Youth Concussion	JAMA NETWORK OPEN			English	Article							TRAUMATIC BRAIN-INJURY; CHILDREN; INSTITUTE; MIGRAINE	IMPORTANCE The Four Corners Youth Consortium was created to fill the gap in our understanding of youth concussion. This study is the first analysis of posttraumatic headache (PTH) phenotype and prognosis in this cohort of concussed youth. OBJECTIVE To describe the characteristics of youth with PTH and determine whether the PTH phenotype is associated with outcome. DESIGN, SETTING, AND PARTICIPANTS This cohort study examined outcomes from patients in a multi-institutional registry of traumatic brain injury (TBI) clinics from December 2017 to June 2019. Inclusion criteria included being between ages 5 and 18 years at enrollment and presentation within 8 weeks of a mild TBI. Data were analyzed between February 2019 and January 2021. EXPOSURE Mild TBI with standard care. MAIN OUTCOMES AND MEASURES Time to recovery and headache 3 months after injury; measurement device is the Postconcussion Symptom Inventory (PCSI). PTH with migraine phenotype was defined as moderate-severe headache that is new or significantly worse compared with baseline and associated with nausea and/or photophobia and phonophobia. \ RESULTS A total of 612 patients with 625 concussions were enrolled, of whom 387 patients with 395 concussions consented to participate in this study. One hundred nine concussions were excluded (concussions, rather than patients, were the unit of analysis), leaving 281 participants with 286 concussions (168 [58.7%] girls; 195 [75.6%] White; 238 [83.2%] aged 13-18 years). At the initial visit, 133 concussions (46.5%) were from patients experiencing PTH with a migraine phenotype, 57 (20%) were from patients experiencing PTH with a nonmigraine phenotype, and 96 (34%) were from patients with no PTH. Patients with any PTH after concussion were more likely to have prolonged recovery than those without PTH (median [interquartile range], 89 [48-165] days vs 44 [26-96] days; log-rank P <.001). Patients with PTH and a migraine phenotype took significantly longer to recover than those with nonmigraine phenotype (median [interquartile range], 95 [54-195] days vs 70 [46-119] days; log-rank P =.01). Within each phenotype, there was no significant difference between sexes in recovery or PTH at 3 months. CONCLUSIONS AND RELEVANCE PTH with a migraine phenotype is associated with persistent symptoms following concussion compared with nonmigraine PTH or no PTH. Given that female sex is associated with higher rates of migraine and migraine PTH, our findingmay be one explanation for findings in prior studies that girls are at higher risk for persistent postconcussion symptoms than boys.	[Kamins, Joshua; Charles, Andrew C.] Univ Calif Los Angeles, Dept Neurol, Goldberg Migraine Program, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Kamins, Joshua; Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA 90024 USA; [Richards, Rachel; Barney, Bradley J.; Locandro, Christopher; Pacchia, Christina F.; Cook, Lawrence J.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Gioia, Gerard] Childrens Natl Hosp, Div Pediat Neuropsychol, SCORE Program, Rockville, MD USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat, Div Pediat Neurol, UCLA Mattel Childrens Hosp, Los Angeles, CA 90024 USA; [Blume, Heidi K.] Univ Washington, Seattle Childrens Hosp, Div Pediat Neurol, Seattle, WA 98195 USA		Kamins, J (corresponding author), Univ Calif Los Angeles, 300 Med Plaza Driveway,Ste B200, Los Angeles, CA 90095 USA.	jkamins@mednet.ucla.edu			Children's National Hospital, University of Washington/Seattle Children's Hospital; UCLA Steve Tisch BrainSPORT program	The 4CYC clinical registry, maintained at the University of Utah, was grant funded through the Children's National Hospital, University of Washington/Seattle Children's Hospital, and the UCLA Steve Tisch BrainSPORT program.	Barlow KM, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-2812; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Choe MC, 2020, PEDIATR NEUROL, V107, P84, DOI 10.1016/j.pediatrneurol.2020.01.008; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ervin AM, 2016, NEW ENGL J MED, V375, P2315, DOI 10.1056/NEJMp1608766; Gelfand Amy A, 2018, Continuum (Minneap Minn), V24, P1108, DOI 10.1212/CON.0000000000000638; Gioia GA., 2019, POSTCONCUSSION SYMPT; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2018, HEADACHE, V58, P811, DOI 10.1111/head.13312; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Locher C, 2020, JAMA PEDIATR, V174, P341, DOI 10.1001/jamapediatrics.2019.5856; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Oskoui M, 2019, NEUROLOGY, V93, P487, DOI 10.1212/WNL.0000000000008095; Oskoui M, 2019, NEUROLOGY, V93, P500, DOI 10.1212/WNL.0000000000008105; Pearson R, 2019, J CHILD NEUROL, V34, P739, DOI 10.1177/0883073819856837; Powers SW, 2017, NEW ENGL J MED, V376, P115, DOI 10.1056/NEJMoa1610384; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Rosenbaum PE, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21463; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	26	3	3	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	MAR 8	2021	4	3							e211312	10.1001/jamanetworkopen.2021.1312			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3TG	WOS:000627897000006	33683335	Green Published, gold			2022-02-06	
J	Rakib, F; Al-Saad, K; Ahmed, T; Ullah, E; Barreto, GE; Ashraf, GM; Ali, MHM				Rakib, Fazle; Al-Saad, Khalid; Ahmed, Tariq; Ullah, Ehsan; Barreto, George E.; Ashraf, Ghulam Md; Ali, Mohamed H. M.			Biomolecular alterations in acute traumatic brain injury (TBI) using Fourier transform infrared (FTIR) imaging spectroscopy	SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY			English	Article						Infrared imaging; Acute brain, injury; Biochemical mapping; Hippocampus; Corpus callosum; Thalamus; FTIR; Traumatic brain injury	STRONGLY INTERACTS; IR SPECTROSCOPY; MODEL MEMBRANES; PROTEINS; LIPIDS; LIVER; PHASE; AXONS; DPPC	Acute injury is one of the substantial stage post-traumatic brain injury (TBI) occurring at the moment of impact. Decreased metabolism, unregulated cerebral blood flow and direct tissue damage are triggered by acute injury. Understating the biochemical alterations associated with acute TBI is critical for brain plasticity and recovery. The objective of this study was to investigate the biochemical and molecular changes in hippocampus, corpus callosum and thalamus brain regions post-acute TBI in rats. Fourier Transform Infrared (FTIR) imaging spectroscopy were used to collect chemical images from control and 3 hrs post-TBI (Marmarou model was used for the TBI induction) rat brains and adjacent sections were treated by hematoxylin and eosin (H&E) staining to correlate with the disruption in tissue morphology and injured brain biochemistry. Our results revealed that the total lipid and total protein content decreased significantly in the hippocampus, corpus callosum and thalamus after brain injury. Reduction in lipid acyl chains (-CH2) associated with an increase in methyl (-CH3) and unsaturated lipids olefin = CH concentrations is observed. Furthermore, there is a decrease in the lipid order (disorder), which leads to an increase in acyl chain fluidity in injured rats. The results suggest acute TBI damages brain tissues mechanically rather than chemical alterations. This will help in assessing successful therapeutic strategy in order to mitigate tissue damage in acute TBI period. (C) 2020 The Authors. Published by Elsevier B.V.	[Rakib, Fazle; Al-Saad, Khalid] Qatar Univ, Dept Chem & Earth Sci, Doha, Qatar; [Ahmed, Tariq; Ali, Mohamed H. M.] Hamad Bin Khalifa Univ, Qatar Biomed Res Inst, Doha, Qatar; [Ullah, Ehsan] Hamad Bin Khalifa Univ, Qatar Comp Res Inst, Doha, Qatar; [Barreto, George E.] Univ Limerick, Dept Biol Sci, Limerick, Ireland; [Barreto, George E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Ashraf, Ghulam Md] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia		Ali, MHM (corresponding author), Hamad Bin Khalifa Univ, Qatar Biomed Res Inst, Doha, Qatar.; Ashraf, GM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.	gashraf@kau.edu.sa; mohamali@hbku.edu.qa	Ashraf, Ghulam Md/H-9485-2012	Ashraf, Ghulam Md/0000-0002-9820-2078	NPRP Award from Qatar National Research Fund (Qatar Foundation) [7-1648-3-420-4]	This study was made possible by a NPRP Award [7-1648-3-420-4] from the Qatar National Research Fund (a member of The Qatar Foundation). The statements made herein are solely the responsibility of the authors.	Ahmed SSSJ, 2010, VIB SPECTROSC, V53, P181, DOI 10.1016/j.vibspec.2010.01.019; Ali M.H.M., INVESTIGATION E FF E, V2, P1; Ali MH, 2018, J MOL STRUCT, V1163, P472, DOI 10.1016/j.molstruc.2018.03.044; Ali MHM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46056-4; Ali MHM, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8122436; Ali MHM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00647; [Anonymous], 2018, OBESITY FACTS, V11, P1, DOI 10.1159/000489691; Arciniegas D.B., 2011, DIALOGUES CLIN NEURO; Balbekova A, 2017, ANAL METHODS-UK, V9, P5464, DOI 10.1039/c7ay01369h; Baloglu FK, 2015, ANALYST, V140, P2205, DOI [10.1039/c4an02008a, 10.1039/C4AN02008A]; Barr W.B., 2014, HDB NEUROPSYCHOLOGY, DOI [10.1007/978-1-4939-0784-7_18, DOI 10.1007/978-1-4939-0784-7_18]; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bozkurt O, 2010, ANALYST, V135, P3110, DOI 10.1039/c0an00542h; Caine S, 2016, NEUROBIOL DIS, V91, P132, DOI 10.1016/j.nbd.2016.03.006; Caine S, 2012, NEUROIMAGE, V59, P3624, DOI 10.1016/j.neuroimage.2011.11.033; Cakmak G, 2006, AQUAT TOXICOL, V77, P53, DOI 10.1016/j.aquatox.2005.10.015; Cakmak G, 2012, ARCH BIOCHEM BIOPHYS, V520, P67, DOI 10.1016/j.abb.2012.02.012; Ergun S, 2014, BBA-BIOMEMBRANES, V1838, P2798, DOI 10.1016/j.bbamem.2014.07.025; Gasper R, 2009, BBA-BIOMEMBRANES, V1788, P1263, DOI 10.1016/j.bbamem.2009.02.016; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hackett MJ, 2015, ACS CHEM NEUROSCI, V6, P761, DOI 10.1021/acschemneuro.5b00037; Hackett MJ, 2015, ACS CHEM NEUROSCI, V6, P226, DOI 10.1021/cn500157j; Haris PI, 1999, J MOL CATAL B-ENZYM, V7, P207, DOI 10.1016/S1381-1177(99)00030-2; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Hovda D.A., 2014, CONCUSSIONS ATHLETIC, DOI [10.1007/978-1-4939-0295-8, DOI 10.1007/978-1-4939-0295-8]; ISHIDA KP, 1993, APPL SPECTROSC, V47, P584, DOI 10.1366/0003702934067306; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kneipp J, 2000, BBA-MOL BASIS DIS, V1501, P189, DOI 10.1016/S0925-4439(00)00021-1; Korkmaz F, 2005, ARCH BIOCHEM BIOPHYS, V440, P141, DOI 10.1016/j.abb.2005.06.013; Lin AL, 2017, J INTENSIVE CARE MED, V32, P99, DOI 10.1177/0885066615619582; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Miller LM, 2013, BBA-BIOMEMBRANES, V1828, P2339, DOI 10.1016/j.bbamem.2013.01.014; O'Keefe J., 2006, HIPPOCAMPUS BOOK, DOI [10.1093/acprof:oso/9780195100273.001.0001, DOI 10.1093/ACPROF:OSO/9780195100273.001.0001]; Ozek NS, 2010, ANALYST, V135, P3094, DOI 10.1039/c0an00543f; Petibois C, 2010, TRENDS BIOTECHNOL, V28, P495, DOI 10.1016/j.tibtech.2010.07.003; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Severcan F, 2005, ANAL BIOCHEM, V339, P36, DOI 10.1016/j.ab.2005.01.011; Severcan F, 2005, BBA-BIOMEMBRANES, V1668, P215, DOI 10.1016/j.bbamem.2004.12.009; Severcan F, 2003, BIOPOLYMERS, V69, P440, DOI 10.1002/bip.10392; Severcan F, 1997, BIOSCIENCE REP, V17, P231, DOI 10.1023/A:1027341731230; Sevinc A, 2015, BIOMED SPECTROSC IMA, V4, P341, DOI 10.3233/BSI-150123; Shinitzky M, 1979, Int Rev Cytol, V60, P121, DOI 10.1016/S0074-7696(08)61261-9; Sierra H, 2015, J INVEST DERMATOL, V135, P612, DOI 10.1038/jid.2014.371; Smith AW, 2012, BBA-BIOMEMBRANES, V1818, P172, DOI 10.1016/j.bbamem.2011.06.015; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; Summers KL, 2017, BIOCHEMISTRY-US, V56, P4107, DOI 10.1021/acs.biochem.7b00262; Surowka AD, 2017, ANALYST, V142, P156, DOI 10.1039/c6an01797e; Szalontai B, 2000, BBA-BIOMEMBRANES, V1509, P409, DOI 10.1016/S0005-2736(00)00323-0; TAKAHASHI H, 1991, ALCOHOL CLIN EXP RES, V15, P219, DOI 10.1111/j.1530-0277.1991.tb01859.x; Tidy RJ, 2017, VIB SPECTROSC, V91, P68, DOI 10.1016/j.vibspec.2016.09.016; Toyran N, 2004, EUR BIOPHYS J BIOPHY, V33, P549, DOI 10.1007/s00249-004-0396-1; Turker S, 2011, J PHARMACEUT BIOMED, V54, P379, DOI 10.1016/j.jpba.2010.09.002; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wartenberg K.E., 2013, STROKE BOOK, DOI [10.1017/CBO9781139344296.014, DOI 10.1017/CBO9781139344296.014]; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yonar D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19303-3; Zhang J, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170720; Zhang J, 2015, J FORENSIC SCI, V60, P1488, DOI 10.1111/1556-4029.12871; Zhang J, 2015, J FORENSIC SCI, V60, P759, DOI 10.1111/1556-4029.12743; Zitnay GA, 2005, ACT NEUR S, V93, P131	63	3	3	4	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1386-1425	1873-3557		SPECTROCHIM ACTA A	Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.	MAR 5	2021	248								119189	10.1016/j.saa.2020.119189			9	Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Spectroscopy	PS8KF	WOS:000608172100008	33277210	hybrid, Green Published			2022-02-06	
J	Yeomans, C; Kenny, IC; Cahalan, R; Warrington, GD; Harrison, AJ; Purtill, H; Lyons, M; Campbell, MJ; Glynn, LG; Comyns, TM				Yeomans, Caithriona; Kenny, Ian C.; Cahalan, Roisin; Warrington, Giles D.; Harrison, Andrew J.; Purtill, Helen; Lyons, Mark; Campbell, Mark J.; Glynn, Liam G.; Comyns, Thomas M.			Injury Trends in Irish Amateur Rugby: An Epidemiological Comparison of Men and Women	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						Rugby union; injury risk; epidemiology; injury surveillance; injury prevention		Background: Rugby union is a physically demanding sport that carries an inherent risk of injury. Despite being a popular and widely played team sport, little is known about injuries occurring across the male and female amateur game. Purpose: To establish and compare injury incidence, nature, and severity in male and female Irish amateur rugby union. Study Design: Prospective cohort study. Methods: Data were collected prospectively from 25 male teams (959 players) and 8 female teams (234 players) over 2 full seasons. Both time-loss (24-hour time-loss injury definition) and non-time-loss match injury reports were collected, alongside match exposure data. Results: Time-loss match injury incidence rates were 49.1/1000 and 35.6/1000 player-hours for male and female players, respectively. Concussion and ankle ligament sprains were the most common diagnoses for male (5.6/1000 and 4.4/1000 player-hours, respectively) and female players (5.5/1000 and 3.9/1000 player-hours, respectively). Anterior cruciate ligament injuries presented the highest injury burden for male and female players with 200.3 and 307.2 days of absence per 1000 player-hours, respectively. In female players, 83% of noncontact injuries occurred in the fourth quarter of match play. Conclusion: While female players had a lower overall injury incidence rate compared with male players, concussion and ankle ligament injuries were the most common injuries in both cohorts. In female players, a high rate of noncontact injuries in the second half points to the need for strength and conditioning training programs to reduce fatigue-related injuries.	[Yeomans, Caithriona] Univ Limerick, Dept Phys Educ & Sport Sci, Limerick V94 YDE9, Ireland; [Yeomans, Caithriona; Kenny, Ian C.; Cahalan, Roisin; Warrington, Giles D.; Harrison, Andrew J.; Purtill, Helen; Glynn, Liam G.; Comyns, Thomas M.] Univ Limerick, Hlth Res Inst, Limerick, Ireland; [Cahalan, Roisin] Univ Limerick, Sch Allied Hlth, Limerick, Ireland; [Purtill, Helen] Univ Limerick, Dept Math & Stat, Limerick, Ireland; [Campbell, Mark J.] Univ Limerick, Irish Software Res Ctr, Lero, Limerick, Ireland; [Glynn, Liam G.] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland		Yeomans, C (corresponding author), Univ Limerick, Dept Phys Educ & Sport Sci, Limerick V94 YDE9, Ireland.	caithriona.yeomans@ul.ie	Campbell, Mark/C-5116-2012	Campbell, Mark/0000-0001-9607-7675	Irish Rugby Football Union (IRFU)	The Irish Rugby Injury Surveillance (IRIS) project is funded and supported by the Irish Rugby Football Union (IRFU).	Bahr R, 2018, BRIT J SPORT MED, V52, P1018, DOI 10.1136/bjsports-2017-098160; Beynnon BD, 2014, AM J SPORT MED, V42, P1806, DOI 10.1177/0363546514540862; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Brown JC, 2019, J SCI MED SPORT, V22, P1314, DOI 10.1016/j.jsams.2019.08.006; Burger N, 2017, AM J SPORT MED, V45, P278, DOI 10.1177/0363546516677548; Carling C, 2016, BRIT J SPORT MED, V50, P764, DOI 10.1136/bjsports-2015-095501; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Dompier TP, 2007, J ATHL TRAINING, V42, P395; Fitzpatrick AC, 2018, J SCI MED SPORT, V21, P160, DOI 10.1016/j.jsams.2017.08.012; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Fuller CW, 2009, SAMJ S AFR MED J, V99, P232; Gabbett TJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163161; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gabbett TJ, 2012, J SCI MED SPORT, V15, P496, DOI 10.1016/j.jsams.2012.03.017; Hulin BT, 2016, BRIT J SPORT MED, V50, P231, DOI 10.1136/bjsports-2015-094817; King D, 2019, SPORTS MED, V49, P1559, DOI 10.1007/s40279-019-01151-4; Kobusingye, 2001, INJURY SURVEILLANCE; McCall A, 2015, BRIT J SPORT MED, V49, P583, DOI 10.1136/bjsports-2014-094104; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; RFU CRISP, 2018, RFU COMM RUGB INJ SU; Roberts SP, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114562781; Salgado E, 2015, KNEE, V22, P243, DOI 10.1016/j.knee.2014.10.002; Sekulic D, 2013, J STRENGTH COND RES, V27, P802, DOI 10.1519/JSC.0b013e31825c2cb0; Tierney GJ, 2018, J SCI MED SPORT, V21, P1210, DOI 10.1016/j.jsams.2018.05.010; Tierney GJ, 2018, J BIOMECH, V72, P29, DOI 10.1016/j.jbiomech.2018.02.023; Viviers PL, 2018, SPORTS HEALTH, V10, P223, DOI 10.1177/1941738118757178; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; Windt J, 2017, BRIT J SPORT MED, V51, P645, DOI 10.1136/bjsports-2016-095973; World Rugby, 2019, RUGB WORLD CUP; World Rugby, 2018, WORLD RUGB YEAR REV; Yeomans C, 2019, PHYS THER SPORT, V35, P79, DOI 10.1016/j.ptsp.2018.11.007; Yeomans C, 2018, SPORTS MED, V48, P837, DOI 10.1007/s40279-017-0838-4	33	3	3	8	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	NOV	2021	13	6					540	547	1941738121997145	10.1177/1941738121997145		MAR 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WP1FK	WOS:000625512300001	33655802	Green Published, Green Submitted, hybrid			2022-02-06	
J	Cheng, CY; Pan, HY; Li, CJ; Chen, YC; Chen, CC; Huang, YS; Cheng, FJ				Cheng, Chi-Yung; Pan, Hsiu-Yung; Li, Chao-Jui; Chen, Yi-Chuan; Chen, Chien-Chih; Huang, Yi-Syun; Cheng, Fu-Jen			Physicians' Risk Tolerance and Head Computed Tomography Use for Pediatric Patients With Minor Head Injury	PEDIATRIC EMERGENCY CARE			English	Article						computed tomography; risk tolerance; traumatic brain injury	NEW-ORLEANS CRITERIA; TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT; UNITED-STATES; INTRACRANIAL INJURY; CT; RULE; CHILDREN; ASSOCIATION; MALPRACTICE	Objectives Traumatic brain injury is the leading cause of death and disability in children worldwide. The objective of this study was to determine the association between physician risk tolerance and head computed tomography (CT) use in patients with minor head injury (MHI) in the emergency department (ED). Methods We retrospectively analyzed pediatric patients (<17 years old) with MHI in the ED and then administered 2 questionnaires (a risk-taking subscale [RTS] of the Jackson Personality Inventory and a malpractice fear scale [MFS]) to attending physicians who had evaluated these patients and made decisions regarding head CT use. The primary outcome was head CT use during ED evaluation; the secondary outcome was ED length of stay and final diagnosis of intracranial injury (ICI). Results Of 523 patients with MHI, 233 (44.6%) underwent brain CT, and 16 (3.1%) received a final diagnosis of ICI. Among the 16 emergency physicians (EPs), the median scores of the MFS and RTS were 22 (interquartile range, 17-26) and 23 (interquartile range, 19-25), respectively. Emergency physicians who were most risk averse tended to order more head CT scans compared with the more risk-tolerant EPs (56.96% vs 37.37%; odds ratio, 8.463; confidence interval, 2.783-25.736). The ED length of stay (P = 0.442 and P = 0.889) and final diagnosis (P = 0.155 and P = 0.835) of ICI were not significantly associated with the RTS and MFS scores. Conclusions Individual EP risk tolerance, as measured by RTS, was predictive of CT use in pediatric patients with MHI.	[Cheng, Chi-Yung; Pan, Hsiu-Yung; Li, Chao-Jui; Chen, Chien-Chih; Huang, Yi-Syun; Cheng, Fu-Jen] Chang Gung Univ, Coll Med, Dept Emergency Med, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Chen, Yi-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Chiayi, Taiwan; [Chen, Yi-Chuan] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan		Cheng, FJ (corresponding author), Chang Gung Mem Hosp Kaohsiung, Dept Emergency Med, 123 Ta Pei Rd, Kaohsiung 833, Taiwan.	qzsecawsxd@cgmh.org.tw; gettingfat720@gmail.com; chaojui@cgmh.org.tw; giomacky@gmail.com; pancreas133@cgmh.org.tw; neuhaus@cgmh.org.tw; a0953283092@yahoo.com.tw					Ahsan SF, 2013, LARYNGOSCOPE, V123, P2250, DOI 10.1002/lary.23798; Andruchow JE, 2012, ANN EMERG MED, V60, pS4, DOI 10.1016/j.annemergmed.2012.06.037; [Anonymous], 2007, NEUR DIS PUBL HLTH C; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Cheng FJ, 2014, AM J EMERG MED, V32, P1284, DOI 10.1016/j.ajem.2014.07.022; Colang John E, 2007, Radiol Technol, V79, P17; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; Derrick BJ, 2011, ANN EMERG MED, V58, pS248, DOI 10.1016/j.annemergmed.2011.06.240; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HOLTGRAVE DR, 1991, MED DECIS MAKING, V11, P125, DOI 10.1177/0272989X9101100210; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; Huang YS, 2016, J EMERG MED, V51, P564, DOI 10.1016/j.jemermed.2016.06.012; Kanzaria HK, 2014, AM J EMERG MED, V32, P1253, DOI 10.1016/j.ajem.2014.07.038; Katz DA, 2005, ANN EMERG MED, V46, P525, DOI 10.1016/j.annemergmed.2005.04.016; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Mata-Mbemba D, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1781-9; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; National Center for Health Statistics Centers for Disease Control and Prevention, 2002, EM DEP FIL NAT HOSP; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Panella Massimiliano, 2015, Ig Sanita Pubbl, V71, P335; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; PEARSON SD, 1995, J GEN INTERN MED, V10, P557, DOI 10.1007/BF02640365; Pines JM, 2010, AM J EMERG MED, V28, P771, DOI 10.1016/j.ajem.2009.03.019; Pines JM, 2009, AM J EMERG MED, V27, P552, DOI 10.1016/j.ajem.2008.04.031; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; Schachar JL, 2011, PEDIATR RADIOL, V41, P971, DOI 10.1007/s00247-011-2032-4; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Wang X, 2013, RADIOLOGY, V266, P783, DOI 10.1148/radiol.12120732; Wong AC, 2011, PEDIATR EMERG CARE, V27, P182, DOI 10.1097/PEC.0b013e31820d64f7	44	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2021	37	3					E129	E135		10.1097/PEC.0000000000001540			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	SK9FG	WOS:000656523900008	29847541	Green Published			2022-02-06	
J	Galovski, TE; Smith, BN; Micol, RL; Resick, PA				Galovski, Tara E.; Smith, Brian N.; Micol, Rachel L.; Resick, Patricia A.			Interpersonal Violence and Head Injury: The Effects on Treatment for PTSD	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article						PTSD; cognitive processing therapy; TBI	TRAUMATIC BRAIN-INJURY; INTIMATE PARTNER-VIOLENCE; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; VICTIMS	Objective: This study sought to understand the extent and influence of head injuries (HIs) on recovery from posttraumatic stress disorder (PTSD) in a sample of treatment-seeking survivors of interpersonal violence, including intimate partner violence (IPV). Method: Three randomized controlled clinical trials (RCTs) investigating the efficacy of cognitive processing therapy were combined to form a repository resulting in 306 participants (92% women) diagnosed with PTSD. Participants were an average age of 36.83 years old (SD = 12.15), and 56% were White and 40% were Black. RCTs were conducted at the same location, with the same procedures and overlapping staff. PTSD was diagnosed via the Clinician-Administered PTSD Scale, depression was measured by the Beck Depression Inventory-II, and trauma history and injuries were assessed via the clinician-administered Trauma Interview. Results: Most of the sample (74.9%) reported HI during at least 1 interpersonal assault. Higher rates of HI were reported in those who endorsed IPV (84.5%; p = .001). To assess the influence of HI on outcomes, the sample was grouped into 3 conditions: HI (at least 1 significant head injury during trauma), NHI (denied head injuries, but reported serious nonhead injuries), and NI (denied any injury). All injury groups improved on PTSD and depressive symptoms with no moderation of group. Conclusion: Most individuals exposed to violence experienced at least 1 head injury, with higher rates in those assaulted by an intimate partner. The experience of HI did not negatively impact recovery from PTSD, including with participants histories of multiple head injuries.	[Galovski, Tara E.; Smith, Brian N.; Micol, Rachel L.] VA Boston Healthcare Syst, Natl Ctr PTSD, Womens Hlth Sci Div, Boston, MA USA; [Galovski, Tara E.; Smith, Brian N.] Boston Univ, Dept Psychiat, Sch Med, 150 South Huntington Ave 116B-3, Boston, MA 02130 USA; [Resick, Patricia A.] Duke Univ, Med Ctr, Durham, NC 27706 USA		Galovski, TE (corresponding author), Boston Univ, Dept Psychiat, Sch Med, 150 South Huntington Ave 116B-3, Boston, MA 02130 USA.	tara.galovski@va.gov		Galovski, Tara/0000-0002-4987-1291; Resick, Patricia/0000-0002-2203-2404	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [2-RO1-MH51509, 1R34-MH-074937]; National Center for Complementary and Integrative Health [1R21AT004079]	This work was supported by two separate grants from the National Institute of Mental Health. Grant 2-RO1-MH51509 was awarded to Patricia A. Resick and Grant 1R34-MH-074937 was awarded to Tara E. Galovski. This work was also supported by a third Grant (1R21AT004079) from the National Center for Complementary and Integrative Health awarded to Tara E. Galovski.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryant RA, 2011, DEPRESS ANXIETY, V28, P99, DOI 10.1002/da.20786; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Galovski T.E., 2020, FLEXIBLE APPL COGNIT; Galovski TE, 2016, J CONSULT CLIN PSYCH, V84, P167, DOI 10.1037/ccp0000059; Galovski TE, 2012, J CONSULT CLIN PSYCH, V80, P968, DOI 10.1037/a0030600; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MuthUn B., 1998, MPLUS VERSION 8 0; Resick P. A., 1993, COGNITIVE PROCESSING, V4; Resick PA, 2008, J CONSULT CLIN PSYCH, V76, P243, DOI 10.1037/0022-006X.76.2.243; Rothbaum BO, 2019, J ANXIETY DISORD, V68, DOI 10.1016/j.janxdis.2019.102156; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith S.G., 2017, NATL INTIMATE PARTNE; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thoennes, 2000, EXTENT NATURE CONSEQ; Truman JL, 2020, CRIMINAL VICTIMIZATI; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	38	3	3	2	4	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma	MAR	2021	13	3					376	384		10.1037/tra0000976			9	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	QT0HX	WOS:000626275000014	33271049	Bronze			2022-02-06	
J	Garland, P; Morton, M; Zolnourian, A; Durnford, A; Gaastra, B; Toombs, J; Heslegrave, AJ; More, J; Zetterberg, H; Bulters, DO; Galea, I				Garland, Patrick; Morton, Matt; Zolnourian, Ardalan; Durnford, Andrew; Gaastra, Ben; Toombs, Jamie; Heslegrave, Amanda J.; More, John; Zetterberg, Henrik; Bulters, Diederik O.; Galea, Ian			Neurofilament light predicts neurological outcome after subarachnoid haemorrhage	BRAIN			English	Article						neurofilament light; subarachnoid haemorrhage; haemoglobin; haptoglobin; glymphatic system	CEREBROSPINAL-FLUID; BLOOD; CSF; DAMAGE	To improve outcome prediction following subarachnoid haemorrhage (SAH), we sought a biomarker integrating early brain injury and multiple secondary pathological processes in a prospective study of 42 non-traumatic SAH patients and 19 control individuals. Neurofilament light (NF-L) was elevated in CSF and serum following SAH. CSF and serum NF-L on Days 1-3 post-SAH strongly predicted modified Rankin score at 6 months, independent of World Federation of Neurosurgical Societies (WFNS) score. NF-L from Day 4 onwards also had a profound impact on outcome. To link NF-L to a SAH-specific pathological process, we investigated NF-L's relationship with extracellular haemoglobin. Most CSF haemoglobin was not complexed with haptoglobin, yet was able to be bound by exogenous haptoglobin i.e. haemoglobin was scavengeable. CSF scavengeable haemoglobin was strongly predictive of subsequent CSF NF-L. Next, we investigated NF-L efflux from the brain after SAH. Serum and CSF NF-L correlated positively. The serum/CSF NF-L ratio was lower in SAH versus control subjects, in keeping with glymphatic efflux dysfunction after SAH. CSF/serum albumin ratio was increased following SAH versus controls. The serum/CSF NF-L ratio correlated negatively with the CSF/serum albumin ratio, indicating that transfer of the two proteins across the blood-brain interface is dissociated. In summary, NF-L is a strong predictive marker for SAH clinical outcome, adding value to the WFNS score, and is a promising surrogate end point in clinical trials.	[Garland, Patrick; Morton, Matt; Galea, Ian] Univ Southampton, Clin & Expt Sci, Clin Neurosci, Fac Med, Southampton, Hants, England; [Zolnourian, Ardalan; Durnford, Andrew; Gaastra, Ben; Bulters, Diederik O.; Galea, Ian] Univ Hosp Southampton NHS Fdn Trust, Wessex Neurol Ctr, Southampton, Hants, England; [Toombs, Jamie; Heslegrave, Amanda J.; Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Toombs, Jamie; Heslegrave, Amanda J.; Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [More, John] Bio Prod Lab Ltd, R&D, Elstree, Herts, England; [Zetterberg, Henrik] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden		Galea, I (corresponding author), Fac Zvers Southampton, Clin & Expt Sci, Clin Neurosci, Southampton, Hants, England.	I.Galea@soton.ac.uk	Galea, Ian/B-7997-2011	Galea, Ian/0000-0002-1268-5102; Zetterberg, Henrik/0000-0003-3930-4354; Toombs, Jamie/0000-0002-0062-0264; Bulters, Diederik/0000-0001-9884-9050	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC); Bio Products Laboratory Limited; Smile for Wessex; Royal College of Surgeons of Edinburgh; University of Southampton; European Research CouncilEuropean Research Council (ERC)European Commission [681712]; Swedish State Support for Clinical Research [ALFGBG-720931]; Alzheimer Drug Discovery Foundation (ADDF), USA [201809-2016862]; UK Dementia Research Institute at UCL; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2018-02532]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-1003] Funding Source: UKRI	This work was funded by the Medical Research Council, Engineering and Physical Sciences Research Council, Bio Products Laboratory Limited, Smile for Wessex, Royal College of Surgeons of Edinburgh, and the University of Southampton. H.Z. is a Wallenberg Scholar supported by grants from the Swedish Research Council (#2018-02532), the European Research Council (#681712), Swedish State Support for Clinical Research (#ALFGBG-720931), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809-2016862), and the UK Dementia Research Institute at UCL.	Bulters D, 2018, NAT REV NEUROL, V14, P416, DOI 10.1038/s41582-018-0020-0; DOCZI T, 1985, ACTA NEUROCHIR, V77, P110, DOI 10.1007/BF01476215; Durnford A, 1800, Acta Neurochir Suppl, V120, P51, DOI 10.1007/978-3-319-04981-6_9; Faivre B, 1998, ARTIF CELL BLOOD SUB, V26, P17, DOI 10.3109/10731199809118943; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Galea J, 2012, J NEUROCHEM, V121, P785, DOI 10.1111/j.1471-4159.2012.07716.x; Galea JP, 2017, STROKE, V48, P2958, DOI 10.1161/STROKEAHA.117.017777; Garland P, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcz053; Halawa I, 2018, ACTA NEUROL SCAND, V137, P199, DOI 10.1111/ane.12873; Hviid CVB, 2020, TRANSL STROKE RES, V11, P671, DOI 10.1007/s12975-019-00761-4; Jaja BNR, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5745; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; Kern S, 2019, JAMA NEUROL, V76, P187, DOI 10.1001/jamaneurol.2018.3459; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Nylen K, 2006, NEUROSCI LETT, V404, P132, DOI 10.1016/j.neulet.2006.05.029; Petzold A, 2006, J NEUROL NEUROSUR PS, V77, P753, DOI 10.1136/jnnp.2005.085175; Petzold A, 2005, J NEUROTRAUM, V22, P407, DOI 10.1089/neu.2005.22.407; Pu TL, 2019, EXP NEUROBIOL, V28, P104, DOI 10.5607/en.2019.28.1.104; Quinn TJ, 2009, STROKE, V40, P3393, DOI [10.1161/STROKEAHA.108.522516, 10.1161/STROKEAHA.109.557256]; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Scholler K, 2007, BRAIN RES, V1142, P237, DOI 10.1016/j.brainres.2007.01.034; Simren J, 2020, CURR OPIN NEUROBIOL, V61, P29, DOI 10.1016/j.conb.2019.11.019; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Thompson EJ, 2005, PROTEINS CEREBROSPIN, P43; TIBBLING G, 1977, SCAND J CLIN LAB INV, V37, P385, DOI 10.3109/00365517709091496; Verheggen ICM, 2018, NEUROSCI BIOBEHAV R, V90, P26, DOI 10.1016/j.neubiorev.2018.03.028; WEISNER B, 1978, J NEUROL SCI, V37, P205, DOI 10.1016/0022-510X(78)90204-6; Zanier ER, 2011, J NEUROL NEUROSUR PS, V82, P157, DOI 10.1136/jnnp.2009.177667	30	3	3	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAR	2021	144		3				761	768		10.1093/brain/awaa451			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SA6YS	WOS:000649448200020	33517369	Green Published, hybrid, Green Accepted			2022-02-06	
J	Huber, CM; Patton, DA; McDonald, CC; Jain, D; Simms, K; Lallo, VA; Margulies, SS; Master, CL; Arbogast, KB				Huber, Colin M.; Patton, Declan A.; McDonald, Catherine C.; Jain, Divya; Simms, Katherine; Lallo, Valerie A.; Margulies, Susan S.; Master, Christina L.; Arbogast, Kristy B.			Sport- and Gender-Based Differences in Head Impact Exposure and Mechanism in High School Sports	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						head injuries; concussion; pediatric sports medicine; injury prevention; football (soccer); basketball; lacrosse		Background: Repeated head impacts sustained by athletes have been linked to short-term neurophysiologic deficits; thus, there is growing concern about the number of head impacts sustained in sports. Accurate head impact exposure data obtained via head impact sensors may help identify appropriate strategies across sports and between genders to mitigate repetitive head impacts. Purpose: To quantify sport- and gender-based differences in head impact rate and mechanism for adolescents. Study Design: Cohort study; Level of evidence, 2. Methods: High school female and male varsity soccer, basketball, lacrosse, and field hockey (female only) teams were instrumented with headband-mounted impact sensors during games over 2 seasons of soccer and 1 season of basketball, lacrosse, and field hockey. Video review was used to remove false-positive sensor-recorded events, and the head impact rate per athlete-exposure (AE) was calculated. Impact mechanism was categorized as equipment to head, fall, player to head, or head to ball (soccer only). Results: Male players had significantly higher head impact rates as compared with female players in soccer (3.08 vs 1.41 impacts/AE; rate ratio, 2.2 [95% CI, 1.8-2.6]), basketball (0.90 vs 0.25; 3.6 [2.6-4.6]), and lacrosse (0.83 vs 0.06; 12.9 [10.1-15.8]). Impact mechanism distributions were similar within sports between boys and girls. In soccer, head to ball represented 78% of impacts, whereas at least 88% in basketball were player-to-player contact. Conclusion: Across sports for boys and girls, soccer had the highest impact rate. Male high school soccer, basketball, and lacrosse teams had significantly higher head impact rates than did female teams of the same sport. For girls, basketball had a higher head impact rate than did lacrosse and field hockey, and for boys, basketball had a similar impact rate to lacrosse, a collision sport. Sport differences in the distribution of impact mechanisms create sport-specific targets for reducing head impact exposure.	[Huber, Colin M.; Jain, Divya; Simms, Katherine] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Huber, Colin M.; Patton, Declan A.; McDonald, Catherine C.; Jain, Divya; Simms, Katherine; Lallo, Valerie A.; Margulies, Susan S.; Master, Christina L.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19146 USA; [McDonald, Catherine C.; Jain, Divya] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [McDonald, Catherine C.; Master, Christina L.; Arbogast, Kristy B.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lallo, Valerie A.] Widener Univ, Biomed Engn Dept, Chester, PA 19013 USA; [Margulies, Susan S.] Georgia Inst Technol, Walter H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Margulies, Susan S.] Emory Univ, Atlanta, GA 30322 USA		Arbogast, KB (corresponding author), Childrens Hosp Philadelphia, 2716 South St, Philadelphia, PA 19146 USA.	ARBOGAST@chop.edu		HUBER, COLIN/0000-0002-0045-5940; Jain, Divya/0000-0002-2255-8764; McDonald, Catherine/0000-0003-3856-8542	Shipley School administration and athletic department	The authors thank members of the research team for their contributions to data collection: Ronni Kessler, Fairuz Mohammed, Shelly Sharma, Ari Fish, and Julia Vanni. In addition, the authors thank the students and parents from the Shipley School for their participation. The authors appreciate the support from the Shipley School administration and athletic department: Steve Piltch, Michael Turner, Mark Duncan, Katelyn Taylor, Dakota Carroll, Kimberly Shaud, and Kayleigh Jenkins.	Acabchuk Rebecca L, 2017, Concussion, V2, pCNC39, DOI 10.2217/cnc-2017-0005; Alosco ML, 2019, SEMIN PEDIATR NEUROL, V30, P107, DOI 10.1016/j.spen.2019.03.016; Bowman TG, 2020, ANN BIOMED ENG, V48, P1491, DOI 10.1007/s10439-020-02467-3; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Caswell SV, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119835587; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Chandran Avinash, 2017, Inj Epidemiol, V4, P28, DOI 10.1186/s40621-017-0127-6; Clair R, 2020, APPL NEUROPSYCH-CHIL, V9, P206, DOI 10.1080/21622965.2018.1556102; Clark JM, 2016, AM J SPORT MED, V44, P1047, DOI 10.1177/0363546515623272; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2015, J APPL BIOMECH, V31, P122, DOI [10.1123/jab.2014-0102, 10.1123/JAB.2014-0102]; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Le RK, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118807678; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Miller LE, 2020, RES SPORTS MED, V28, P55, DOI 10.1080/15438627.2019.1590833; Miyashita T, 2016, ATHLETIC TRAINING SP, V8, P202, DOI DOI 10.3928/19425864-20160503-01; Neidecker JM, 2017, J AM OSTEOPATH ASSOC, V117, P635, DOI 10.7556/jaoa.2017.120; Nevins D., 2019, ATHLETIC TRAINING SP, V11, P174, DOI [10.3928/19425864-20180802-02, DOI 10.3928/19425864-20180802-02]; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; O'Day KM, 2017, CLIN BIOMECH, V43, P23, DOI 10.1016/j.clinbiomech.2017.01.013; Oeur RA, 2016, 34 INT C BIOM SPORTS; Patton DA, 2020, AM J SPORT MED, V48, P1246, DOI 10.1177/0363546520906406; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sandmo SB, 2020, SCAND J MED SCI SPOR, V30, P193, DOI 10.1111/sms.13562; Saunders TD, 2020, CLIN BIOMECH, V74, P14, DOI 10.1016/j.clinbiomech.2020.02.003; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; The Outdoor Foundation , 2019, OUTD PART REP; Triax Technologies, 2014, LAB VAL SIM G HEAD I; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; US Youth Soccer, 2016, US YOUTH SOCC POL PL; Vollavanh LR, 2018, J APPL BIOMECH, V34, P396, DOI 10.1123/jab.2017-0231; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	54	3	3	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR	2021	9	3							2325967120984423	10.1177/2325967120984423			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	QS9CQ	WOS:000626190500001	33738313	Green Published, gold			2022-02-06	
J	Kerr, ZY; Nedimyer, AK; Kay, MC; Chandran, A; Gildner, P; Byrd, KH; Haarbauer-Krupa, JK; Register-Mihalik, JK				Kerr, Zachary Y.; Nedimyer, Aliza K.; Kay, Melissa C.; Chandran, Avinash; Gildner, Paula; Byrd, K. Hunter; Haarbauer-Krupa, Juliet K.; Register-Mihalik, Johna K.			Factors associated with concussion-symptom knowledge and attitudes toward concussion care seeking in a national survey of parents of middle-school children in the US	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Pediatrics; Traumatic brain injury; Youth	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; YOUTH; EPIDEMIOLOGY; EDUCATION; BARRIERS; BEHAVIOR; TRENDS	Background: Developing appropriate concussion prevention and management paradigms in middle school (MS) settings requires understanding parents' general levels of concussion-related knowledge and attitudes. This study examined factors associated with concussion-symptom knowledge and care-seeking attitudes among parents of MS children (aged 10-15 years). Methods: A panel of 1224 randomly selected U.S. residents, aged >= 18 years and identifying as parents of MS children, completed an online questionnaire capturing parental and child characteristics. The parents' concussion-symptom knowledge was measured using 25 questions, with possible answers being "yes", "maybe", and "no". Correct answers earned 2 points, "maybe" answers earned 1 point, and incorrect answers earned 0 point (range: 0-50; higher scores = better knowledge). Concussion care-seeking attitudes were also collected using five 7-point scale items (range: 5-35; higher scores = more positive attitudes). Multivariable ordinal logistic regression models identified predictors of higher scores. Models met proportional odds assumptions. Adjusted odds ratios (aORs) with 95% confidence intervals (95%CIs) (excluding 1.00) were deemed statistically significant. Results: Median scores were 39 (interquartile range: 32-44) for symptom knowledge and 32 (interquartile range: 28-35) for care-seeking attitude. In multivariable models, odds of better symptom knowledge were higher in women vs. men (aOR = 2.28; 95%CI: 1.71-3.05), white/non-Hispanics vs. other racial or ethnic groups (aOR = 1.88; 95%CI: 1.42-2.49), higher parental age (10-year-increase aOR = 1.47; 95%CI: 1.26-1.71), and greater competitiveness (10%-scale-increase aOR = 1.24; 95%CI: 1.13-1.36). Odds of more positive care-seeking attitudes were higher in white/non-Hispanics vs. other racial or ethnic groups (aOR = 1.45; 95%CI: 1.06-1.99) and in older parental age (10-year-increase aOR = 1.24; 95%CI: 1.05-1.47). Conclusion: Characteristics of middle school children's parents (e.g., sex, race or ethnicity, age) are associated with their concussion-symptom knowledge and care-seeking attitudes. Parents' variations in concussion knowledge and attitudes warrant tailored concussion education and prevention.	[Kerr, Zachary Y.; Nedimyer, Aliza K.; Register-Mihalik, Johna K.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Nedimyer, Aliza K.; Register-Mihalik, Johna K.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Gildner, Paula; Byrd, K. Hunter; Register-Mihalik, Johna K.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27510 USA; [Nedimyer, Aliza K.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC 27599 USA; [Kay, Melissa C.] Univ Southern Mississippi, Sch Hlth Profess, Hattiesburg, MS 39406 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN 46202 USA; [Haarbauer-Krupa, Juliet K.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA		Kerr, ZY (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA.; Kerr, ZY (corresponding author), Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27599 USA.; Kerr, ZY (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27510 USA.	zkerr@email.unc.edu			Division of Unintentional Injury, Centers for Disease Control and Prevention [5U01CE002885-02]; Injury Control Research Center award from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention [R49/CE002479]	The authors thank the research participants for their participating in the study. Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This work was funded by a grant from the Division of Unintentional Injury, Centers for Disease Control and Prevention (5U01CE002885-02). The University of North Carolina Injury Prevention Research Center is also partly supported by an Injury Control Research Center award (R49/CE002479) from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention. There are no other financial relationships relevant to the development of this article.	Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Bacon CEW, 2017, J INTERPROF CARE, V31, P725, DOI 10.1080/13561820.2017.1345873; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Diaz Anne L, 2013, NASN Sch Nurse, V28, P110; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Feiss RS, 2020, J CONCUSSION, DOI [10.1177/2059700219900053, DOI 10.1177/2059700219900053]; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Kay MC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117742370; Kerr Zachary Y, 2020, J Sport Health Sci, DOI 10.1016/j.jshs.2020.04.008; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2019, AM J SPORT MED, V47, P933, DOI 10.1177/0363546518825361; Kerr Zachary Y, 2018, Inj Epidemiol, V5, P28, DOI 10.1186/s40621-018-0158-7; Kerr ZY, 2018, MED SCI SPORT EXER, V50, P284, DOI 10.1249/MSS.0000000000001422; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115603979; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kim S, 2018, J AMATEUR SPORT, V4, P82, DOI DOI 10.17161/jas.v4i1.6664; Knight CJ, 2016, SPORT EXERC PERFORM, V5, P161, DOI 10.1037/spy0000053; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kroshus E, 2019, HEALTH PROMOT PRACT, V20, P372, DOI 10.1177/1524839918790231; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; LOHR KN, 1986, MED CARE, V24, pUS1; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mazerolle SM, 2015, J ATHL TRAINING, V50, P1059, DOI 10.4085/1062-6050-50.10.01; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; OVERPECK MD, 1995, AM J PUBLIC HEALTH, V85, P402, DOI 10.2105/AJPH.85.3.402; Patel AV, 2007, J ATHL TRAINING, V42, P66; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rieger B, 2018, CUREUS, V10, DOI 10.7759/cureus.2268; Sanchez-Miguel PA, 2013, J HUM KINET, V36, P169, DOI 10.2478/hukin-2013-0017; SMITHER RD, 1992, EDUC PSYCHOL MEAS, V52, P407, DOI 10.1177/0013164492052002016; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Wahlin T, 2012, AUST NZ J PSYCHIAT, V46, P553, DOI 10.1177/0004867412441929; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056	53	3	3	0	0	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	MAR	2021	10	2					113	121		10.1016/j.jshs.2020.09.001			9	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	QY5AT	WOS:000630052900002	32919064	Green Published, gold			2022-02-06	
J	Lowry, R; Haarbauer-Krupa, J; Breiding, MJ; Simon, TR				Lowry, Richard; Haarbauer-Krupa, Juliet; Breiding, Matthew J.; Simon, Thomas R.			Sports- and Physical Activity-Related Concussion and Risk for Youth Violence	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article								Introduction: Sports and physical activities are an important cause of traumatic brain injury among adolescents. Childhood traumatic brain injury has been associated with cognitive impairment, emotional problems, and impaired behavior control, and these neuropsychological changes may place these youth at increased risk for engagement in violence-related behaviors. Methods: Data from the 2017 National Youth Risk Behavior Survey (N=14,765), a nationally representative survey of U.S. high school students, were analyzed in 2019 to examine the associations between sports- and physical activity-related concussion and violence-related behaviors occurring in the community and at school. Multivariable logistic regression models were used to calculate sex-stratified, adjusted (for race/ethnicity, grade, athlete status, impaired cognitive functioning, feeling sad/hopeless, and current substance use) prevalence ratios. Prevalence ratios were considered statistically significant if p<0.05. Results: Male students (17.1%) were more likely than female students (13.0%) to experience a sports- and physical activity-related concussion during the 12 months preceding the survey. Compared with students who did not have a concussion, those who experienced >= 1 sports- and physical activity-related concussion were more likely to be in a physical fight (male students, adjusted prevalence ratio=1.45; female students, adjusted prevalence ratio=1.55), carry a weapon (male students, adjusted prevalence ratio=1.24; female students, adjusted prevalence ratio=1.79), and fight at school (male students, adjusted prevalence ratio=1.40; female students, adjusted prevalence ratio=1.77). In addition, male students were more likely to carry a gun (adjusted prevalence ratio=1.62) and carry a weapon at school (adjusted prevalence ratio=1.73). Conclusions: Although the direction of these associations is unknown, return-to-school programs may benefit from inclusion of assessment and counseling around issues of psychological and social functioning, conflict resolution, and coordination with violence prevention programs. (C) 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.	[Lowry, Richard] Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA; [Haarbauer-Krupa, Juliet; Breiding, Matthew J.] Ctr Dis Control & Prevent, Traumat Brain Injury Team, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30329 USA; [Simon, Thomas R.] Ctr Dis Control & Prevent, Div Violence Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30329 USA		Lowry, R (corresponding author), Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, 1600 Clifton Rd,Northeast Mail Stop US8-6, Atlanta, GA 30329 USA.	rlowry@cdc.gov					Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Beaulieu-Bonneau S, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000341; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Brener ND, 2013, MMWR RECOMM REP, V62, P1; Centers for Disease Control and Prevention, 2018, C MAN TRAUM BRAIN IN; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Donnelly Peter., 2007, HARNESSING POWER SPO, P7; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Flannery KB, 2014, SCHOOL PSYCHOL QUART, V29, P111, DOI 10.1037/spq0000039; Gage NA, 2018, J SPEC EDUC, V52, P142, DOI 10.1177/0022466918767847; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hahn R, 2007, AM J PREV MED, V33, pS114, DOI 10.1016/j.amepre.2007.04.012; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Hall J.E., 2016, COMPREHENSIVE TECHNI; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Ilie G, 2017, INJURY, V48, P285, DOI 10.1016/j.injury.2016.09.030; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jackson TL, 2017, J EPIDEMIOL COMMUN H, V71, P800, DOI 10.1136/jech-2016-208582; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Kriz PK, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117737307; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; Moeijes J, 2019, EUR J SPORT SCI, V19, P365, DOI 10.1080/17461391.2018.1510988; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; National Center for Education Statistics, FAST FACTS ENR TREND; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pate RR, 2000, ARCH PEDIAT ADOL MED, V154, P904, DOI 10.1001/archpedi.154.9.904; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Silberg T, 2015, BRAIN INJURY, V29, P481, DOI 10.3109/02699052.2014.984758; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85	49	3	3	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	MAR	2021	60	3					352	359		10.1016/j.amepre.2020.10.018			8	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	QK2XP	WOS:000620245800012	33422395				2022-02-06	
J	Magnusdottir, BB; Haraldsson, HM; Sigurdsson, E				Magnusdottir, B. B.; Haraldsson, H. M.; Sigurdsson, E.			Trail Making Test, Stroop, and Verbal Fluency: Regression-Based Norms for the Icelandic Population	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Executive functions; Fluency (verbal/nonverbal); Norms/normative studies	TRAUMATIC BRAIN-INJURY; COLOR-WORD TEST; NORMATIVE DATA; NEUROPSYCHOLOGICAL TESTS; CATEGORY FLUENCY; IQ GAINS; AGE; EDUCATION; SCHIZOPHRENIA; INTERFERENCE	Objective: The aim of this study was to construct regression-based norms for 3 executive-function tests: the Trail Making Test, Stroop, and Verbal Fluency. Method: A sample of 1,034 healthy Icelandic adults (18-64 years) was used to calculate predicted scores for test measures from all 3 tests, controlled for the effects of age, gender, and education, as well as the interaction between these variables. Results: The 3 demographic variables showed significant effects on most test measures and were included in the final equation for estimating predicted scores. An older age and less education predicted worse cognitive performances in most cases, and women tended to outperform men. Conclusion: These results highlight the importance of adjusting for age, gender, and educational level when constructing normative data. Controlling for age alone may be insufficient or misleading in clinical-practice settings. A simple, user-friendly program for predicting executive-function test scores is provided.	[Magnusdottir, B. B.; Haraldsson, H. M.; Sigurdsson, E.] Landspitali Univ Hosp, Dept Psychiat, IS-101 Reykjavik, Iceland; [Magnusdottir, B. B.] Reykjavik Univ, Dept Psychol, Menntavegur 1, IS-101 Reykjavik, Iceland; [Haraldsson, H. M.; Sigurdsson, E.] Univ Iceland, Sch Hlth Sci, IS-101 Reykjavik, Iceland		Magnusdottir, BB (corresponding author), Reykjavik Univ, Dept Psychol, Menntavegur 1, IS-101 Reykjavik, Iceland.	brynjabm@ru.is	Magnusdottir, Brynja/AAH-3482-2019	Magnusdottir, Brynja/0000-0002-6131-7269	European Union Seventh Framework ProgramEuropean Commission [HEALTH-F2-2009-223423]; Landspitali Innovation Grant, Reykjavik, Iceland	This work was supported by the European Union Seventh Framework Program (HEALTH-F2-2009-223423) and the Landspitali Innovation Grant, Reykjavik, Iceland (2014).	Agranovich AV, 2007, ARCH CLIN NEUROPSYCH, V22, P273, DOI 10.1016/j.acn.2007.01.003; Amodio P, 2002, AGING CLIN EXP RES, V14, P117, DOI 10.1007/BF03324425; ANGOFF WH, 1987, APPL PSYCH MEAS, V11, P33, DOI 10.1177/014662168701100102; Anstey K, 2000, GERONTOLOGY, V46, P163, DOI 10.1159/000022153; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Benton Hamsher K., 1994, MULTILINGUAL APHASIA, V3rd; Bokat CE, 2003, SCHIZOPHR RES, V64, P73, DOI 10.1016/S0920-9964(02)00282-7; BOLLA KI, 1990, J CLIN PSYCHOL, V46, P623, DOI 10.1002/1097-4679(199009)46:5<623::AID-JCLP2270460513>3.0.CO;2-C; Bondi MW, 2002, NEUROPSYCHOLOGY, V16, P335, DOI 10.1037//0894-4105.16.3.335; Brickman AM, 2005, ARCH CLIN NEUROPSYCH, V20, P561, DOI 10.1016/j.acn.2004.12.006; Brugnolo A, 2016, NEUROL SCI, V37, P365, DOI 10.1007/s10072-015-2428-2; Cavaco S, 2013, ARCH CLIN NEUROPSYCH, V28, P189, DOI 10.1093/arclin/acs115; Chan E, 2015, J INT NEUROPSYCH SOC, V21, P169, DOI 10.1017/S135561771500003X; Christidi F, 2015, AGING NEUROPSYCHOL C, V22, P667, DOI 10.1080/13825585.2015.1027650; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Ewers M, 2012, NEUROBIOL AGING, V33, P1203, DOI 10.1016/j.neurobiolaging.2010.10.019; Fastenau PS, 1998, J CLIN EXP NEUROPSYC, V20, P906, DOI 10.1076/jcen.20.6.906.1104; Feigenbaum JD, 1996, NEUROPSYCHOLOGIA, V34, P163, DOI 10.1016/0028-3932(95)00107-7; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Golden CJ, 1978, STROOP COLOR WORD TE; Hair JF., 2014, MULTIVARIATE DATA AN, V7; Hameleers PAHM, 2000, HUM PSYCHOPHARM CLIN, V15, P573, DOI 10.1002/hup.218; Hankee LD, 2016, EXP AGING RES, V42, P315, DOI 10.1080/0361073X.2016.1191838; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Heled E, 2012, J CLIN EXP NEUROPSYC, V34, P151, DOI 10.1080/13803395.2011.625351; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Hester RL, 2005, CLIN NEUROPSYCHOL, V19, P45, DOI 10.1080/13854040490524137; Ivnik RJ, 1996, CLIN NEUROPSYCHOL, V10, P262, DOI 10.1080/13854049608406689; Kempler D, 1998, J INT NEUROPSYCH SOC, V4, P531, DOI 10.1017/S1355617798466013; Knight RG, 2006, BRIT J CLIN PSYCHOL, V45, P393, DOI 10.1348/014466505X68032; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014; Kourtidou P, 2015, ARCH NEUROSCI, V2, DOI 10.5812/archneurosci.21087; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Mathuranath PS, 2003, J CLIN EXP NEUROPSYC, V25, P1057, DOI 10.1076/jcen.25.8.1057.16736; Ouvrard C, 2019, EUR J NEUROL, V26, P786, DOI 10.1111/ene.13890; Parkin AJ, 1999, NEUROPSYCHOLOGY, V13, P539, DOI 10.1037/0894-4105.13.4.539; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Pietschnig J, 2015, PERSPECT PSYCHOL SCI, V10, P282, DOI 10.1177/1745691615577701; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Ratcliff G, 1998, BRAIN LANG, V61, P115, DOI 10.1006/brln.1997.1858; Reitan R, 1985, HALSTEAD REITAN NEUR; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rivera D, 2015, NEUROREHABILITATION, V37, P591, DOI 10.3233/NRE-151281; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Siciliano M, 2019, NEUROL SCI, V40, P469, DOI 10.1007/s10072-018-3673-y; Statistics Iceland, 2019, ED ATTAINMENT POPULA; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P329, DOI 10.1080/13854040590945210; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tabachnick B.G., 2001, USING MULTIVARIATE S, V5; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tucha O, 1999, J CLIN EXP NEUROPSYC, V21, P229, DOI 10.1076/jcen.21.2.229.928; UNESCO, 2006, INT STANDARD CLASSIF; Van Boxtel A, 2001, PSYCHOPHYSIOLOGY, V38, P22, DOI 10.1017/S004857720199016X; Van Breukelen GJP, 2005, PSYCHOL ASSESSMENT, V17, P336, DOI 10.1037/1040-3590.17.3.336; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; Van der Elst W, 2011, ASSESSMENT, V18, P517, DOI 10.1177/1073191110370116; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Westerhausen R, 2011, SCHIZOPHR RES, V133, P172, DOI 10.1016/j.schres.2011.08.025; ZACHARY RA, 1985, J CLIN PSYCHOL, V41, P86, DOI 10.1002/1097-4679(198501)41:1<86::AID-JCLP2270410115>3.0.CO;2-W; Zhao QH, 2013, NEUROSCI BULL, V29, P75, DOI 10.1007/s12264-013-1301-7; Zimmermann N, 2017, TRENDS PSYCHIATR PSY, V39, P188, DOI 10.1590/2237-6089-2016-0082	74	3	3	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2021	36	2					253	266		10.1093/arclin/acz049			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	SA6US	WOS:000649437600009	31732743				2022-02-06	
J	Mukherjee, S; Sivakumar, G; Goodden, JR; Tyagi, AK; Chumas, PD				Mukherjee, Soumya; Sivakumar, Gnanamurthy; Goodden, John R.; Tyagi, Atul K.; Chumas, Paul D.			Prognostic value of leukocytosis in pediatric traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatric; traumatic brain injury; leukocytosis; computed tomography; prognosis; trauma		OBJECTIVE The purpose of this study was to assess leukocytosis and its prognostic value in pediatric isolated traumatic brain injury (TBI). METHODS Two hundred one children with isolated TBI admitted to the authors' institution between June 2006 and June 2018 were prospectively followed and their data retrospectively analyzed. Initial blood leukocyte count (i.e., white cell count [WCC]), Glasgow Coma Scale (GCS) score, CT scans, duration of hospital stay, and Pediatric Cerebral Performance Category Scale (PCPCS) scores were analyzed. RESULTS The mean age was 4.2 years (range 0.2-16 years). Seventy-four, 70, and 57 patients had severe (GCS score 3-8), moderate (GCS score 9-13), and mild (GCS score 14-15) TBI, respectively, with associated WCC of 20, 15.9, and 10.7 x 10(9)/L and neutrophil counts of 15.6, 11.3, and 6.1 x 10(9)/L, respectively (p < 0.01). Higher WCC and neutrophil counts were demonstrated in patients with increased intracranial mass effect on CT, longer hospital stay, and worse 6-month PCPCS score (p < 0.05). Multivariate regression revealed a cutoff leukocyte count of 16.1 x 10(9)/L, neutrophil count of 11.9 x 10(9)/L, and neutrophil-to-lymphocyte ratio (NLR) of 5.2, above which length of hospital stay and PCPCS scores were less favorable. Furthermore, NLR was the second most important independent risk factor for a poor outcome (after GCS score). The IMPACT (International Mission for Prognosis and Analysis of Clinical Trials in TBI) adult TBI prediction model applied to this pediatric cohort demonstrated increased accuracy when WCC was incorporated as a risk factor. CONCLUSIONS In the largest and first prospective study of isolated pediatric head injury to date, the authors have demonstrated that WCC > 16.1 x 10(9)/L, neutrophil count > 11.9 x 10(9)/L and NLR > 5.2 each have predictive value for lengthy hospital stay and poor PCPCS scores, and NLR is an independent risk factor for poor outcome. Incorporating the initial leukocyte count into TBI prediction models may improve prognostication.	[Mukherjee, Soumya; Sivakumar, Gnanamurthy; Goodden, John R.; Tyagi, Atul K.; Chumas, Paul D.] Leeds Gen Infirm, Dept Paediat Neurosurg, Leeds, W Yorkshire, England		Mukherjee, S (corresponding author), Leeds Gen Infirm, Leeds, W Yorkshire, England.	soumya.mukherjee@nhs.net					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS49; Agrawal Deepak, 2016, Asian J Neurosurg, V11, P109, DOI 10.4103/1793-5482.145066; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Chowdhary M, 2018, J NEURO-ONCOL, V139, P689, DOI 10.1007/s11060-018-2914-5; Ciurea A V, 2011, J Med Life, V4, P234; Corser-Jensen CE, 2014, EXP NEUROL, V256, P7, DOI 10.1016/j.expneurol.2014.03.008; Czigner A, 2007, ACTA NEUROCHIR, V149, P281, DOI 10.1007/s00701-006-1095-8; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Everitt Brian, 2010, CAMBRIDGE DICT STAT, P409; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Gibson PH, 2007, AM HEART J, V154, P995, DOI 10.1016/j.ahj.2007.06.043; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Ishizuka M, 2012, INT SURG, V97, P299, DOI 10.9738/CC161.1; Junger WG, 2013, SHOCK, V40, P366, DOI 10.1097/SHK.0000000000000038; Kan CH, 2009, MALAYS J MED SCI, V16, P25; KESKIL S, 1994, ACTA NEUROCHIR, V131, P211, DOI 10.1007/BF01808615; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee J, 2014, J TRAUMA ACUTE CARE, V77, P709, DOI 10.1097/TA.0000000000000445; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McGirt MJ, 2003, J NEUROSURG, V98, P1222, DOI 10.3171/jns.2003.98.6.1222; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Paul AR, 2014, TRANSL PEDIATR, V3, P195, DOI 10.3978/j.issn.2224-4336.2014.06.01; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Rovlias A, 2001, SURG NEUROL, V55, P190, DOI 10.1016/S0090-3019(01)00414-1; Shah AK, 2001, EPILEPSIA, V42, P1472, DOI 10.1046/j.1528-1157.2001.11901.x; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Subramanian A, 2012, BRAIN INJURYPATHOGEN; Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.x; Van Assche E, 2006, EUR J ANAESTH, V23, P92; Wilson JRF, 2018, ACTA NEUROCHIR, V160, P793, DOI 10.1007/s00701-017-3388-5	41	3	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2021	27	3					335	345		10.3171/2020.7.PEDS19627			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	RJ0IP	WOS:000637287300011	33361484				2022-02-06	
J	Neylan, TC; Kessler, RC; Ressler, KJ; Clifford, G; Beaudoin, FL; An, XM; Stevens, JS; Zeng, DL; Linnstaedt, SD; Germine, LT; Sheikh, S; Storrow, AB; Punches, BE; Mohiuddin, K; Gentile, NT; McGrath, ME; van Rooij, SJH; Haran, JP; Peak, DA; Domeier, RM; Pearson, C; Sanchez, LD; Rathlev, NK; Peacock, WF; Bruce, SE; Joormann, J; Barch, DM; Pizzagalli, DA; Sheridan, JF; Harte, SE; Elliott, JM; Hwang, I; Petukhova, MV; Sampson, NA; Koenen, KC; McLean, SA				Neylan, Thomas C.; Kessler, Ronald C.; Ressler, Kerry J.; Clifford, Gari; Beaudoin, Francesca L.; An, Xinming; Stevens, Jennifer S.; Zeng, Donglin; Linnstaedt, Sarah D.; Germine, Laura T.; Sheikh, Sophia; Storrow, Alan B.; Punches, Brittany E.; Mohiuddin, Kamran; Gentile, Nina T.; McGrath, Meghan E.; van Rooij, Sanne J. H.; Haran, John P.; Peak, David A.; Domeier, Robert M.; Pearson, Claire; Sanchez, Leon D.; Rathlev, Niels K.; Peacock, William F.; Bruce, Steven E.; Joormann, Jutta; Barch, Deanna M.; Pizzagalli, Diego A.; Sheridan, John F.; Harte, Steven E.; Elliott, James M.; Hwang, Irving; Petukhova, Maria, V; Sampson, Nancy A.; Koenen, Karestan C.; McLean, Samuel A.			Prior sleep problems and adverse post-traumatic neuropsychiatric sequelae of motor vehicle collision in the AURORA study	SLEEP			English	Article						insomnia; major depressive episode; motor vehicle collision; nightmares; post-traumatic stress disorder; prospective design; sleep stress reactivity	STRESS-DISORDER; PSYCHIATRIC-DISORDERS; CONCUSSION SYMPTOMS; PTSD SYMPTOMS; HEAD-INJURY; INSOMNIA; DISTURBANCE; PREDICTORS; PAIN; PREVALENCE	Study objectives: Many patients in Emergency Departments (EDs) after motor vehicle collisions (MVCs) develop post-traumatic stress disorder (PTSD) or major depressive episode (MDE). This report from the AURORA study focuses on associations of pre-MVC sleep problems with these outcomes 8 weeks after MVC mediated through peritraumatic distress and dissociation and 2-week outcomes. Methods: A total of 666 AURORA patients completed self-report assessments in the ED and at 2 and 8 weeks after MVC. Peritraumatic distress, peritraumatic dissociation, and pre-MVC sleep characteristics (insomnia, nightmares, daytime sleepiness, and sleep duration in the 30 days before the MVC, trait sleep stress reactivity) were assessed retrospectively in the ED. The survey assessed acute stress disorder (ASD) and MDE at 2 weeks and at 8 weeks assessed PTSD and MDE (past 30 days). Control variables included demographics, MVC characteristics, and retrospective reports about PTSD and MDE in the 30 days before the MVC. Results: Prevalence estimates were 41.0% for 2-week ASD, 42.0% for 8-week PTSD, 30.5% for 2-week MDE, and 27.2% for 8-week MDE. Pre-MVC nightmares and sleep stress reactivity predicted 8-week PTSD (mediated through 2-week ASD) and MDE (mediated through the transition between 2-week and 8-week MDE). Pre-MVC insomnia predicted 8-week PTSD (mediated through 2-week ASD). Estimates of population attributable risk suggest that blocking effects of sleep disturbance might reduce prevalence of 8-week PTSD and MDE by as much as one-third. Conclusions: Targeting disturbed sleep in the immediate aftermath of MVC might be one effective way of reducing MVC-related PTSD and MDE.	[Neylan, Thomas C.] San Francisco VA Healthcare Syst, San Francisco, CA USA; [Neylan, Thomas C.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Neylan, Thomas C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Kessler, Ronald C.; Hwang, Irving; Petukhova, Maria, V; Sampson, Nancy A.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Ressler, Kerry J.; Germine, Laura T.; Pizzagalli, Diego A.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Ressler, Kerry J.] McLean Hosp, Div Depress & Anxiety Disorders, 115 Mill St, Belmont, MA 02178 USA; [Clifford, Gari] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA USA; [Clifford, Gari] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Beaudoin, Francesca L.] Brown Univ, Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Beaudoin, Francesca L.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Beaudoin, Francesca L.] Rhode Isl Hosp, Dept Emergency Med, Providence, RI USA; [Beaudoin, Francesca L.] Miriam Hosp, Dept Emergency Med, Providence, RI 02906 USA; [An, Xinming; Linnstaedt, Sarah D.; McLean, Samuel A.] Univ N Carolina, Inst Trauma Recovery, Dept Anesthesiol, Chapel Hill, NC 27515 USA; [Stevens, Jennifer S.; van Rooij, Sanne J. H.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Zeng, Donglin] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27515 USA; [Germine, Laura T.] McLean Hosp, Inst Technol Psychiat, 115 Mill St, Belmont, MA 02178 USA; [Germine, Laura T.] Many Brains Project, Acton, MA USA; [Sheikh, Sophia] Univ Florida, Coll Med Jacksonville, Dept Emergency Med, Jacksonville, FL USA; [Storrow, Alan B.] Vanderbilt Univ, Med Ctr, Dept Emergency Med, Nashville, TN USA; [Punches, Brittany E.] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA; [Punches, Brittany E.] Univ Cincinnati, Dept Emergency Med, Coll Nursing, Cincinnati, OH USA; [Mohiuddin, Kamran] Einstein Med Ctr, Dept Internal Med, Philadelphia, PA USA; [Mohiuddin, Kamran] Einstein Med Ctr, Dept Emergency Med, Philadelphia, PA USA; [Gentile, Nina T.] Temple Univ, Dept Emergency Med, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [McGrath, Meghan E.] Boston Med Ctr, Dept Emergency Med, Boston, MA USA; [Haran, John P.] Univ Massachusetts, Sch Med, Dept Emergency Med, Worcester, MA USA; [Peak, David A.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Domeier, Robert M.] St Joseph Mercy Hosp, Dept Emergency Med, Ann Arbor, MI 48104 USA; [Pearson, Claire] Wayne State Univ, Dept Emergency Med, Ascens St John Hosp, Detroit, MI USA; [Sanchez, Leon D.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Sanchez, Leon D.] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Rathlev, Niels K.] Univ Massachusetts, Dept Emergency Med, Med Sch Baystate, Springfield, MA USA; [Peacock, William F.] Baylor Coll Med, Henry JN Taub Dept Emergency Med, Houston, TX 77030 USA; [Bruce, Steven E.] Univ Missouri, Dept Psychol Sci, St Louis, MO 63121 USA; [Joormann, Jutta] Yale Univ, Dept Psychol, New Haven, CT USA; [Barch, Deanna M.] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO 63110 USA; [Barch, Deanna M.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Barch, Deanna M.] Washington Univ, Radiol, St Louis, MO 63110 USA; [Sheridan, John F.] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA; [Sheridan, John F.] Ohio State Univ, Coll Dent, Div Biosci, Columbus, OH 43210 USA; [Sheridan, John F.] Ohio State Univ, Inst Behav Med Res, Wexner Med Ctr, Columbus, OH 43210 USA; [Harte, Steven E.] Univ Michigan, Sch Med, Dept Anesthesiol, Chron Pain & Fatigue Res Ctr, Ann Arbor, MI USA; [Elliott, James M.] Univ Sydney, Northern Clin Sch, Kolling Inst Med Res, St Leonards, NSW, Australia; [Elliott, James M.] Univ Sydney, Fac Med & Hlth, Camperdown, NSW, Australia; [Elliott, James M.] Northwestern Univ, Feinberg Sch Med, Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Koenen, Karestan C.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [McLean, Samuel A.] Univ N Carolina, Dept Emergency Med, Chapel Hill, NC 27515 USA		Kessler, RC (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	kessler@hcp.med.harvard.edu	Stevens, Jennifer/T-4290-2018; Sanchez, Leon/R-7681-2019	Stevens, Jennifer/0000-0003-4674-0314; Sanchez, Leon/0000-0002-8807-0913; Clifford, Gari/0000-0002-5709-201X; Sheikh, Sophia/0000-0003-1939-3126; Punches, Brittany/0000-0002-7546-1966; Germine, Laura/0000-0001-8690-8412	NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH110925]; US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); One Mind Foundation; Mayday Fund	AURORA is supported by NIMH U01MH110925, the US Army Medical Research and Material Command, The One Mind Foundation, and The Mayday Fund. Verily Life Sciences and Mindstrong Health provide some of the hardware and software used to perform study assessments.	Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Benjet C, 2016, PSYCHOL MED, V46, P327, DOI 10.1017/S0033291715001981; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bonnet MH, 2003, SLEEP, V26, P1029, DOI 10.1093/sleep/26.8.1029; Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Bryant RA, 2010, SLEEP, V33, P69, DOI 10.1093/sleep/33.1.69; Buysse DJ, 2008, SLEEP, V31, P1673, DOI 10.1093/sleep/31.12.1673; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chang PP, 1997, AM J EPIDEMIOL, V146, P105; Dalenberg, 2010, SEVERITY DISSOCIATIV; Dean KR, 2020, MOL PSYCHIATR, V25, P3337, DOI 10.1038/s41380-019-0496-z; Drake C, 2004, SLEEP, V27, P285, DOI 10.1093/sleep/27.2.285; Drake CL, 2008, SLEEP MED, V9, P297, DOI 10.1016/j.sleep.2007.04.012; EATON WW, 1995, AM J PSYCHIAT, V152, P967; Eidelman P, 2016, BEHAV THER, V47, P102, DOI 10.1016/j.beth.2015.10.002; Fang H, 2019, J CELL MOL MED, V23, P2324, DOI 10.1111/jcmm.14170; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Feinberg RK, 2017, PAIN, V158, P682, DOI 10.1097/j.pain.0000000000000818; Foley DJ, 1999, SLEEP, V22, pS373; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Franzen Peter L, 2008, Dialogues Clin Neurosci, V10, P473; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Goldstein AN, 2014, ANNU REV CLIN PSYCHO, V10, P679, DOI 10.1146/annurev-clinpsy-032813-153716; Hanish AE, 2017, NURS RES, V66, P246, DOI 10.1097/NNR.0000000000000217; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; HOHAGEN F, 1993, EUR ARCH PSY CLIN N, V242, P329, DOI 10.1007/BF02190245; Jarrin DC, 2016, J CLIN SLEEP MED, V12, P1373, DOI 10.5664/jcsm.6192; Joormann J., 2020, PSYCHOL MED, P1, DOI [10.1017/S0033291720003773, DOI 10.1017/S0033291720003773]; Kalmbach DA, 2018, NAT SCI SLEEP, V10, P193, DOI 10.2147/NSS.S138823; Kalmbach DA, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12710; Kalmbach DA, 2016, SLEEP MED, V21, P63, DOI 10.1016/j.sleep.2016.02.005; Kenardy J, 2018, J AFFECT DISORDERS, V236, P172, DOI 10.1016/j.jad.2018.04.090; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kessler RC, IN PRESS; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koren D, 2002, AM J PSYCHIAT, V159, P855, DOI 10.1176/appi.ajp.159.5.855; KUPFER DJ, 1972, LANCET, V2, P684; Levine Beverly, 1800, Prev Chronic Dis, V4, pA14; Li LQ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1075-3; Linnstaedt SD, 2020, PAIN, V161, P47, DOI 10.1097/j.pain.0000000000001709; Linnstaedt SD, 2018, J NEUROSCI, V38, P8407, DOI 10.1523/JNEUROSCI.3458-17.2018; Loftis KL, 2018, TRAFFIC INJ PREV, V19, pS109, DOI 10.1080/15389588.2018.1512747; Lowe SR, 2021, PSYCHOL MED, V51, P1129, DOI 10.1017/S0033291719004008; McLean SA, 2020, MOL PSYCHIATR, V25, P283, DOI 10.1038/s41380-019-0581-3; McLean SA, 2014, PAIN, V155, P309, DOI 10.1016/j.pain.2013.10.016; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P1659; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Nielsen T, 2007, SLEEP MED REV, V11, P295, DOI 10.1016/j.smrv.2007.03.004; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Patient-Reported Outcomes Measurement Information System (PROMIS) Health Organization and PROMIS Cooperative Group, 2015, PROMIS DEPRESSION SC; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Robbins J.M., 1991, CURRENT CONCEPTS SOM, P21; ROSS RJ, 1989, AM J PSYCHIAT, V146, P697; SAS Institute Inc, 2014, SAS VERS 9 4; Schultebraucks K, 2020, NAT MED, V26, P1084, DOI 10.1038/s41591-020-0951-z; Smith B, 2007, COUNS PSYCHOL Q, V20, P149, DOI 10.1080/09515070701403679; Spoormaker VI, 2010, J PSYCHIATR RES, V44, P1121, DOI 10.1016/j.jpsychires.2010.04.017; Stein DJ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0957-8; Sun R, 2018, NTR; Utzon-Frank N, 2014, SCAND J WORK ENV HEA, V40, P215, DOI 10.5271/sjweh.3420; van Liempt S, 2013, DEPRESS ANXIETY, V30, P469, DOI 10.1002/da.22054; Wolfe F, 2003, J RHEUMATOL, V30, P369; Zuromski KL, 2019, DEPRESS ANXIETY, V36, P790, DOI 10.1002/da.22942	76	3	3	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	MAR	2021	44	3							zsaa200	10.1093/sleep/zsaa200			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SA5YT	WOS:000649380100017	32975289	Green Published			2022-02-06	
J	Niziolek, GM; Hoehn, RS; Seitz, AP; Jernigan, PL; Makley, AT; Gulbins, E; Edwards, MJ; Goodman, MD				Niziolek, Grace M.; Hoehn, Richard S.; Seitz, Aaron P.; Jernigan, Peter L.; Makley, Amy T.; Gulbins, Erich; Edwards, Michael J.; Goodman, Michael D.			The Role of Acid Sphingomyelinase Inhibition in Repetitive Mild Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Chronic traumatic encephalopathy; Repeated mild traumatic brain injury; Acid sphingomyelinase; Neurogenesis	ANXIETY-LIKE BEHAVIOR; HEAD-INJURY; HIPPOCAMPAL NEUROGENESIS; NEUROBEHAVIORAL CHANGES; AXONAL INJURY; MURINE MODEL; ANIMAL-MODEL; MOUSE MODEL; ENCEPHALOPATHY; CERAMIDE	Background: Chronic traumatic encephalopathy is a consequence of repetitive mild traumatic brain injury (rmTBI). These injuries can result in psychiatric disorders that are treated with amitriptyline. Amitriptyline improves neuronal regeneration in major depression via inhibition of acid sphingomyelinase. We hypothesized that acid sphingomyelinase inhibition would preserve neuronal regeneration and decrease depressive symptoms following rmTBI in a murine model. Methods: A murine model of rmTBI was established using a weight-drop method. Mice were subjected to mTBI every other day for 7 d. Mice received amitriptyline injection 2 h prior to each mTBI. After the final mTBI, mice underwent behavioral studies or biochemical analysis. Hippocampi were analyzed for markers of neurogenesis and phosphorylated tau aggregation. Results: Mice that underwent rmTBI showed increased hippocampal phosphorylated tau aggregation 1 mo following rmTBI as well as decreased neuronal regeneration by bromodeoxyuridine uptake and doublecortin immunohistochemistry. Mice with either genetic deficiency or pharmacologic inhibition of acid sphingomyelinase demonstrated improved neuronal regeneration and decreased phosphorylated tau aggregation compared to untreated rmTBI mice. Behavioral testing showed rmTBI mice spent significantly more time in the dark and waiting to initiate feeding compared to sham mice. These behaviors were partially prevented by the inhibition of acid sphingomyelinase. Conclusions: We established a murine model of rmTBI that leads to tauopathy, depression, and impaired hippocampal neurogenesis. Inhibition of acid sphingomyelinase prevented the harmful neurologic and behavioral effects of rmTBI. These findings highlight an important opportunity to improve recovery or prevent neuropsychiatric decline in patients at risk for chronic traumatic encephalopathy. (C) 2020 Elsevier Inc. All rights reserved.	[Niziolek, Grace M.; Hoehn, Richard S.; Seitz, Aaron P.; Jernigan, Peter L.; Makley, Amy T.; Gulbins, Erich; Edwards, Michael J.; Goodman, Michael D.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany		Goodman, MD (corresponding author), Univ Cincinnati, Dept Surg, Sect Gen Surg, Cincinnati, OH 45221 USA.	goodmamd@ucmail.uc.edu			University of Duisburg-Essen Department of Molecular Biology, DFGGerman Research Foundation (DFG) [GU 335/30-1]	This work was supported in part by the University of Duisburg-Essen Department of Molecular Biology, DFG grant GU 335/30-1.	Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; [Anonymous], Amitriptyline hydrochloride FDA insert, reference ID: 3540124; Becker Katrin Anne, 2017, Neurosignals, V25, P88, DOI 10.1159/000484621; BODNOFF SR, 1988, PSYCHOPHARMACOLOGY, V95, P298; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Briggs DI, 2016, AM J PATHOL, V186, P2869, DOI 10.1016/j.ajpath.2016.07.013; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; CRAWLEY J, 1980, PHARMACOL BIOCHEM BE, V13, P167, DOI 10.1016/0091-3057(80)90067-2; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Cutler RG, 2002, ANN NEUROL, V52, P448, DOI 10.1002/ana.10312; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Furukawa TA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010919; Geekiyanage H, 2013, NEUROBIOL AGING, V34, P2037, DOI 10.1016/j.neurobiolaging.2013.02.001; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gulbins A, 2016, CELL PHYSIOL BIOCHEM, V39, P790, DOI 10.1159/000447789; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Gulbins E, 2003, PHARMACOL RES, V47, P393, DOI 10.1016/S1043-6618(03)00052-5; Gulbins E, 2013, NAT MED, V19, P934, DOI 10.1038/nm.3214; Hoehn RS, 2017, ANN SURG, V265, P218, DOI 10.1097/SLA.0000000000001648; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Jernigan Peter L, 2015, Neurosignals, V23, P49, DOI 10.1159/000442603; Kornhuber J, 2008, J MED CHEM, V51, P219, DOI 10.1021/jm070524a; Kubota M, 1996, NEUROL RES, V18, P337; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kulesskaya N, 2014, PHYSIOL BEHAV, V133, P30, DOI 10.1016/j.physbeh.2014.05.006; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; McCrory P, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.006338; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Niziolek GM, 2020, J NEUROTRAUM, V37, P1902, DOI 10.1089/neu.2019.6436; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Peng HM, 2015, J MOL MED, V93, P675, DOI 10.1007/s00109-014-1246-y; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Rotolo J, 2012, J CLIN INVEST, V122, P1786, DOI 10.1172/JCI59920; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	51	3	3	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2021	259						296	304		10.1016/j.jss.2020.09.034			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	QK3GA	WOS:000620267800037	33131764				2022-02-06	
J	Ojo, J; Eisenbaum, M; Shackleton, B; Lynch, C; Joshi, U; Saltiel, N; Pearson, A; Ringland, C; Paris, D; Mouzon, B; Mullan, M; Crawford, F; Bachmeier, C				Ojo, Joseph; Eisenbaum, Max; Shackleton, Ben; Lynch, Cillian; Joshi, Utsav; Saltiel, Nicole; Pearson, Andrew; Ringland, Charis; Paris, Daniel; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona; Bachmeier, Corbin			Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma	NEUROBIOLOGY OF DISEASE			English	Article						Mural cells; Tau; Peri cytes; Smooth muscle cells; Traumatic brain injury; Alzheimer's disease; Caveolin-1		A pathological characteristic of repetitive traumatic brain injury (TBI) is the deposition of hyperphosphorylated and aggregated tau species in the brain and increased levels of extracellular monomeric tau are believed to play a role in the pathogenesis of neurodegenerative tauopathies. The pathways by which extracellular tau is eliminated from the brain, however, remains elusive. The purpose of this study was to examine tau uptake by cerebrovascular cells and the effect of TBI on these processes. We found monomeric tau interacts with brain vascular mural cells (pericytes and smooth muscle cells) to a greater extent than other cerebrovascular cells, indicating mural cells may contribute to the elimination of extracellular tau, as previously described for other solutes such as beta-amyloid. Consistent with other neurodegenerative disorders, we observed a progressive decline in cerebrovascular mural cell markers up to 12 months post-injury in a mouse model of repetitive mild TBI (r-mTBI) and human TBI brain specimens, when compared to control. These changes appear to reflect mural cell degeneration and not cellular loss as no difference in the mural cell population was observed between r-mTBI and r-sham animals as determined through flow cytometry. Moreover, freshly isolated r-mTBI cerebrovessels showed reduced tau uptake at 6 and 12 months post-injury compared to r-sham animals, which may be the result of diminished cerebrovascular endocytosis, as caveolin-1 levels were significantly decreased in mouse r-mTBI and human TBI cerebrovessels compared to their respective controls. Further emphasizing the interaction between mural cells and tau, similar reductions in mural cell markers, tau uptake, and caveolin-1 were observed in cerebrovessels from transgenic mural cell-depleted animals. In conclusion, our studies indicate repeated injuries to the brain causes chronic mural cell degeneration, reducing the caveolar-mediated uptake of tau by these cells. Alterations in tau uptake by vascular mural cells may contribute to tau deposition in the brain following head trauma and could represent a novel therapeutic target for TBI or other neurodegenerative disorders.	[Ojo, Joseph; Eisenbaum, Max; Shackleton, Ben; Lynch, Cillian; Joshi, Utsav; Saltiel, Nicole; Pearson, Andrew; Ringland, Charis; Paris, Daniel; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona; Bachmeier, Corbin] Roskamp Inst, Sarasota, FL USA; [Ojo, Joseph; Eisenbaum, Max; Shackleton, Ben; Lynch, Cillian; Joshi, Utsav; Pearson, Andrew; Ringland, Charis; Paris, Daniel; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona; Bachmeier, Corbin] Open Univ, Milton Keynes, Bucks, England; [Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Bachmeier, Corbin] Bay Pines VA Healthcare Syst, Bay Pines, FL USA		Bachmeier, C (corresponding author), 2040 Whitfield Ave, Sarasota, FL 34243 USA.	cbachmeier@roskampinstitute.org			Department of DefenseUnited States Department of Defense [W81XWH-16-1-0724-PRARP-CSRA]; Department of Veterans Affairs (VA) Biomedical Laboratory Research and Development ProgramUS Department of Veterans Affairs [I01BX003709]	This work was supported by the Department of Defense under award number W81XWH-16-1-0724-PRARP-CSRA. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. This work was also supported by Merit Review award number I01BX003709 from the Department of Veterans Affairs (VA) Biomedical Laboratory Research and Development Program. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. Dr. Bachmeier is a Research Scientist at the Bay Pines VA Healthcare System, Bay Pines, FL. Dr. Crawford is a Research Career Scientist at the James A. Haley Veterans Hospital, Tampa, FL. Finally, we would like to thank the Roskamp Institute for their generosity in helping to make this work possible.	Ahmed S, 2018, VESSEL PLUS, P2, DOI DOI 10.20517/2574-1209.2018.51; Alarcon-Martinez L, 2018, ELIFE, V7, DOI 10.7554/eLife.34861; Alcendor DJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051490; Aldea R, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00001; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bachmeier C, 2014, NEUROMOL MED, V16, P686, DOI 10.1007/s12017-014-8318-6; Bachmeier C, 2013, NEURODEGENER DIS, V11, P13, DOI 10.1159/000337231; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Bonds JA, 2019, J NEUROSCI, V39, P8576, DOI 10.1523/JNEUROSCI.0730-19.2019; Bourassa P, 2020, NEUROPATH APPL NEURO, V46, P458, DOI 10.1111/nan.12599; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Crouch EE, 2018, NAT PROTOC, V13, P738, DOI 10.1038/nprot.2017.158; Dalkara T, 2011, ACTA NEUROPATHOL, V122, P1, DOI 10.1007/s00401-011-0847-6; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dore-Duffy P, 2011, NEUROL RES, V33, P176, DOI 10.1179/016164111X12881719352372; ElAli A, 2014, INT J MOL SCI, V15, P6453, DOI 10.3390/ijms15046453; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Head BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015697; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hill J, 2014, J NEUROIMMUNE PHARM, V9, P591, DOI 10.1007/s11481-014-9557-x; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Karch CM, 2012, J BIOL CHEM, V287, P42751, DOI 10.1074/jbc.M112.380642; Kellerhals S., 2013, FASEB J, V27, P693; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kirabali T, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0846-8; Kolinko Y, 2018, J CHEM NEUROANAT, V91, P35, DOI 10.1016/j.jchemneu.2018.04.003; Le Meghan N, 2012, Am J Neurodegener Dis, V1, P316; Lynch CE, 2021, J CEREBR BLOOD F MET, V41, P1362, DOI 10.1177/0271678X20954015; Lynch CE, 2016, BRAIN INJURY, V30, P1414, DOI 10.1080/02699052.2016.1219060; Ma QY, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0286-0; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Majerova P, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0161-z; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medina M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00113; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; Montagne A, 2018, NAT MED, V24, P326, DOI 10.1038/nm.4482; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sundberg C, 2009, AM J PATHOL, V175, P171, DOI 10.2353/ajpath.2009.080769; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Wildsmith KR, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt187; Winkler EA, 2014, BRAIN PATHOL, V24, P371, DOI 10.1111/bpa.12152; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216	68	3	3	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	MAR	2021	150								105237	10.1016/j.nbd.2020.105237			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QI3LN	WOS:000618880500005	33383188	gold, Green Accepted			2022-02-06	
J	Popovich, M; Almeida, A; Freeman, J; Eckner, JT; Alsalaheen, B; Lorincz, M; Sas, A				Popovich, Michael; Almeida, Andrea; Freeman, Jeremiah; Eckner, James T.; Alsalaheen, Bara; Lorincz, Matthew; Sas, Andrew			Use of Supervised Exercise During Recovery Following Sports-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sport-related concussion; exercise; concussion recovery	SYMPTOMS; CHILDREN; RETURN	Objective: To assess the safety of supervised exercise (SE) in acute sport-related concussion (SRC) and its influence on recovery. Design: Retrospective cohort study. Setting: University SRC clinic at a tertiary care center. Patients: One hundred ninety-four consecutive new patient charts were reviewed. Patients were included if they were seen within 30 days of sustaining a SRC, and their medical records included all required data elements. One hundred twenty-six patients were included in the analysis. Interventions: Symptomatic patients who initiated SE within 16 days of SRC (n = 24) were compared with those who did not undergo SE or initiated SE after postinjury day 16 (n = 84). Age, sex, history of previous concussions, injury severity, relevant comorbidities, and other treatments received were included in the analysis. Main Outcome Measures: The association between early SE and clearance for return to sport was determined using a hazard ratio (HR). The number of days from SRC until clearance for return to sport and the number of days symptomatic from concussion were also compared between early SE and nonearly SE cohorts. Results: No serious adverse events occurred in the early SE group. Early SE was associated with earlier return to sport (HR = 2.35, P = 0.030). The early SE group had fewer days from SRC until clearance for return to sport (mean 26.5 +/- 11.2 days vs 35.1 +/- 26.5 days, P = 0.020). There was a trend toward fewer symptomatic days in the early SE group (P = 0.054). Conclusion: Early SE performed in the symptomatic stage of SRC was safe and associated with earlier return to sport.	[Popovich, Michael; Almeida, Andrea; Alsalaheen, Bara; Lorincz, Matthew; Sas, Andrew] Univ Michigan, Dept Neurol, 4000 Ave Marie Dr,Lobby A,Suite 1000, Ann Arbor, MI 48105 USA; [Freeman, Jeremiah] Univ Michigan, Sports Med & Phys Therapy, Ann Arbor, MI 48105 USA; [Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48105 USA		Sas, A (corresponding author), Univ Michigan, Dept Neurol, 4000 Ave Marie Dr,Lobby A,Suite 1000, Ann Arbor, MI 48105 USA.	asas@med.umich.edu	Lorincz, Matthew Thomas/P-7785-2019				Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jayakody K, 2014, BRIT J SPORT MED, V48, P187, DOI 10.1136/bjsports-2012-091287; Kelly JP, 1997, NEUROLOGY, V48, P581; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x	26	3	3	31	32	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2021	31	2					127	132		10.1097/JSM.0000000000000721			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	SL0TF	WOS:000656628200010	30768444				2022-02-06	
J	Van Deventer, KA; Seehusen, CN; Walker, GA; Wilson, JC; Howell, DR				Van Deventer, Katie A.; Seehusen, Corrine N.; Walker, Gregory A.; Wilson, Julie C.; Howell, David R.			The diagnostic and prognostic utility of the dual-task tandem gait test for pediatric concussion	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Adolescent; Balance; Mild traumatic brain injury; Postural stability; Prognosis	POSTURAL CONTROL DEFICITS; ERROR SCORING SYSTEM; BALANCE; SPORT; PERFORMANCE; CONSENSUS; SYMPTOMS; CHILDREN	Background: The tandem gait test has gained interest recently for assessment of concussion recovery. The purpose of our study was to determine the prognostic and diagnostic use of the single- and dual-task tandem gait test, alongside other clinical measures, within 10 days of pediatric concussion. Methods: We assessed 126 patients post-concussion (mean +/- SD = 6.3 +/- 2.3 days post-injury) at a pediatric sports medicine clinic and compared them to 58 healthy controls (age = 15.6 +/- 1.3 years; 43% female). We also compared the 31 patients with concussion who developed persistent post-concussion symptoms (PPCS) (age = 14.9 +/- 2.0 years; 52% female) to the 81 patients with concussion who did not develop PPCS following the initial assessment (age = 14.1 +/- 3.0 years; 59% female). All subjects completed a test battery, and concussion patients were monitored until they experienced concussion-symptom resolution. The test battery included tandem gait (single-task, dual-task (performing tandem gait while concurrently completing a cognitive test) conditions), modified Balance Error Scoring System (mBESS), and concussion symptom assessment (Health and Behavior Inventory). We defined PPCS as symptom resolution time > 28 days post-concussion for the concussion group. Measurement outcomes included tandem gait time (single- and dual-task), dual-task cognitive accuracy, mBESS errors (single/double/tandem stances), and symptom severity. Results: The concussion group completed the single-task (mean difference = 9.1 s, 95% confidential interval (CI): 6.1-12.1) and dual-task (mean difference = 12.7 s, 95%CI: 8.7-16.8) tandem gait test more slowly than the control group. Compared to those who recovered within 28 days of concussion, the PPCS group had slower dual-task tandem gait test times (mean difference = 7.9 s, 95%CI: 2.0-13.9), made more tandem-stance mBESS errors (mean difference = 1.3 errors, 95%CI: 0.2-2.3), and reported more severe symptoms (mean difference = 26.6 Health and Behavior Inventory rating, 95%CI: 21.1-32.6). Conclusion: Worse dual-task tandem gait test time and mBESS tandem stance performance predicted PPCS in pediatric patients evaluated within 10 days of concussion. Tandem gait assessments may provide valuable information augmenting common clinical practices for concussion management.	[Van Deventer, Katie A.] Univ Colorado, Sch Med, Aurora, CO 80045 USA; [Seehusen, Corrine N.; Walker, Gregory A.; Wilson, Julie C.; Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Walker, Gregory A.; Wilson, Julie C.; Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA; [Wilson, Julie C.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA.	David.Howell@CUAnschutz.edu			Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03HD094560, R01NS100952, R43NS108823]; MINDSOURCE Brain Injury Network	DRH has received research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560), the National Institute of Neurological Disorders and Stroke (R01NS100952, R03HD094560, and R43NS108823), and MINDSOURCE Brain Injury Network. The remaining authors have no disclosures.	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Corwin DJ, 2020, MED SCI SPORT EXER, V52, P542, DOI 10.1249/MSS.0000000000002163; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Howell DR, 2019, J ATHL TRAINING, V54, P1254, DOI 10.4085/1062-6050-525-18; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2018, GAIT POSTURE, V62, P291, DOI 10.1016/j.gaitpost.2018.03.038; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Lynall RC, 2019, J SCI MED SPORT, V22, P503, DOI 10.1016/j.jsams.2018.10.012; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Solomito MJ, 2018, GAIT POSTURE, V64, P260, DOI 10.1016/j.gaitpost.2018.06.165; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Wood TA, 2019, AM J PHYS MED REHAB, V98, P566, DOI 10.1097/PHM.0000000000001152; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	36	3	3	0	0	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	MAR	2021	10	2					131	137		10.1016/j.jshs.2020.08.005			7	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	QY5AT	WOS:000630052900004	32795624	gold, Green Published			2022-02-06	
J	Yang, L; Afroz, S; Valsamis, HA; Michelson, HB; Goodman, JH; Ling, DSF				Yang, Lie; Afroz, Sonia; Valsamis, Helen A.; Michelson, Hillary B.; Goodman, Jeffrey H.; Ling, Douglas S. F.			Early intervention with levetiracetam prevents the development of cortical hyperexcitability and spontaneous epileptiform activity in two models of neurotrauma in rats	EXPERIMENTAL NEUROLOGY			English	Article						Levetiracetam; Traumatic brain injury; Posttraumatic epilepsy; Anti-epileptiform; Controlled cortical impact; Early intervention	TRAUMATIC BRAIN-INJURY; SYNAPTIC VESICLE PROTEIN; POSTTRAUMATIC SEIZURES; HEAD-INJURY; UCB L059; EPILEPSY; INHIBITION; IMPACT; PHENYTOIN; NEURONS	This study examined the antiepileptogenic potential of the antiseizure drug (ASD) levetiracetam (LEV) using the in vitro traumatized-slice and in vivo controlled cortical impact (CCI) models of traumatic brain injury (TBI) in rats when administered early after the injury. For the in vitro model, acute coronal slices (400-450 mu m) of rat neocortex (P21-32) were injured via a surgical cut that separated the superficial layers from the deeper regions. Persistent stimulus-evoked epileptiform activity developed within 1-2 h after trauma. In randomly selected slices, LEV (500 mu M) was bath-applied for 1 h starting immediately or delayed by 30-80 min after injury. Treated and untreated slices were examined for epileptiform activity via intracellular and extracellular recordings. For the in vivo model, rats (P24-32) were subjected to a non-penetrating, focal, CCI injury targeting the neocortex (5.0 mm diameter; 2.0 mm depth). Immediately after injury, rats were given either a single dose of LEV (60-150 mg/kg, i.p.) or the saline vehicle. At 2-3 weeks after the injury, ex vivo cortical slices were examined for epileptiform activity. The results from the traumatized-slice experiments showed that in vitro treatment with LEV within 60 min of injury significantly reduced (> 50%) the proportion of slices that exhibited stimulus-evoked epileptiform activity. LEV treatment also increased the stimulus intensity required to trigger epileptiform bursts in injured slices by 2-4 fold. Consistent with these findings, LEV treatment of CCI-injured rats (n = 15) significantly reduced the proportion of animals that exhibited spontaneous and stimulus-evoked epileptiform bursts in ex vivo cortical slices compared to saline-treated controls (n = 15 rats), and also significantly increased the stimulus intensity required to evoke epileptiform bursts. These results suggest that early administration of LEV has the potential to prevent or reduce posttraumatic epileptogenesis and that there may be a narrow therapeutic window for successful prophylactic intervention.	[Yang, Lie; Afroz, Sonia; Valsamis, Helen A.; Michelson, Hillary B.; Goodman, Jeffrey H.; Ling, Douglas S. F.] SUNY Downstate Hlth Sci Univ, Dept Physiol & Pharmacol, 450 Clarkson Ave,Box 29, Brooklyn, NY 11203 USA; [Valsamis, Helen A.; Goodman, Jeffrey H.] SUNY Downstate Hlth Sci Univ, Dept Neurol, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Afroz, Sonia; Ling, Douglas S. F.] SUNY Downstate Hlth Sci Univ, Program Neural & Behav Sci, 450 Clarkson Ave, Brooklyn, NY 11203 USA; [Yang, Lie; Afroz, Sonia; Valsamis, Helen A.; Michelson, Hillary B.; Goodman, Jeffrey H.; Ling, Douglas S. F.] SUNY Downstate Hlth Sci Univ, Robert F Furchgott Ctr Behav & Neural Sci, 450 Clarkson Ave,Box 29, Brooklyn, NY 11203 USA; [Goodman, Jeffrey H.] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA; [Valsamis, Helen A.] Kings Cty Hosp Ctr, Neurol Serv, Brooklyn, NY 11203 USA		Ling, DSF (corresponding author), SUNY Downstate Hlth Sci Univ, Dept Physiol & Pharmacol, 450 Clarkson Ave,Box 29, Brooklyn, NY 11203 USA.	helen.valsamis@nychhc.org; hillary.michelson@downstate.edu; jeffrey.goodman@downstate.edu; douglas.ling@downstate.edu			Defense Advanced Research Projects Agency (DARPA) through the U.S. Air Force Office of Scientific Research [FA9550-06-1-0546]; Dean's Research Investment Initiative of SUNY Downstate	This work was supported by grant FA9550-06-1-0546 from the Defense Advanced Research Projects Agency (DARPA) through the U.S. Air Force Office of Scientific Research (to D.S.F.L.), and by funds from the Dean's Research Investment Initiative of SUNY Downstate (to D.S.F.L. and H.B.M.). The views, opinions, or findings contained in this paper are those of the authors and should not be construed as an official position, policy, or decision of the U.S. Department of Defense, Department of the Air Force, or DARPA, unless so designated by other documentation.	Abou-Khalil Bassel, 2008, Neuropsychiatr Dis Treat, V4, P507; Acharya MM, 2008, PROG NEUROBIOL, V84, P363, DOI 10.1016/j.pneurobio.2007.10.010; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; AYALA GF, 1973, BRAIN RES, V52, P1, DOI 10.1016/0006-8993(73)90647-1; Bakr A, 2018, BRIT J NEUROSURG, V32, P237, DOI 10.1080/02688697.2018.1464118; BARKAI E, 1995, J NEUROPHYSIOL, V73, P1462, DOI 10.1152/jn.1995.73.4.1462; Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; Brandt C, 2007, NEUROPHARMACOLOGY, V53, P207, DOI 10.1016/j.neuropharm.2007.05.001; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carunchio I, 2007, EPILEPSIA, V48, P654, DOI 10.1111/j.1528-1167.2006.00973.x; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Coppola G, 2010, SEIZURE-EUR J EPILEP, V19, P296, DOI 10.1016/j.seizure.2010.03.004; Cramer JA, 2003, EPILEPSY BEHAV, V4, P124, DOI 10.1016/S1525-5050(03)00005-2; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Dinner Dudley S., 1993, P654; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doheny HC, 1999, EPILEPSY RES, V34, P161, DOI 10.1016/S0920-1211(98)00104-1; Dooley M, 2000, DRUGS, V60, P871, DOI 10.2165/00003495-200060040-00004; Dugue R, 2018, BRAIN RES BULL, V142, P368, DOI 10.1016/j.brainresbull.2018.08.016; Gabriel WM, 2014, ANN PHARMACOTHER, V48, P1440, DOI 10.1177/1060028014549013; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gorji A, 2002, EPILEPSIA, V43, P1480, DOI 10.1046/j.1528-1157.2002.23702.x; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Ishimaru Y, 2010, BRAIN RES, V1309, P104, DOI 10.1016/j.brainres.2009.10.056; Ji-qun C, 2005, EPILEPSIA, V46, P1362, DOI 10.1111/j.1528-1167.2005.29604.x; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kaminski RM, 2009, EPILEPSIA, V50, P1729, DOI 10.1111/j.1528-1167.2009.02089.x; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kirmani BF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00170; Klein P, 2020, EPILEPSIA, V61, P359, DOI 10.1111/epi.16450; Klein P, 2012, ARCH NEUROL-CHICAGO, V69, P1290, DOI 10.1001/archneurol.2012.445; Klitgaard H, 2003, EPILEPTIC DISORD, V5, pS9; Kollevold T, 1976, J Oslo City Hosp, V26, P99; Ling DSF, 1995, J NEUROPHYSIOL, V74, P2329, DOI 10.1152/jn.1995.74.6.2329; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Lowenstein D H, 1996, Epilepsy Res Suppl, V11, P45; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Margineanu DG, 2000, PHARMACOL RES, V42, P281; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; Matagne A, 2008, BRIT J PHARMACOL, V154, P1662, DOI 10.1038/bjp.2008.198; Matagne A, 2009, EUR J PHARMACOL, V614, P30, DOI 10.1016/j.ejphar.2009.04.024; MATSUMOTO H, 1964, EXP NEUROL, V9, P286, DOI 10.1016/0014-4886(64)90025-1; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; Palma E, 2007, EPILEPSIA, V48, P1842, DOI 10.1111/j.1528-1167.2007.01131.x; PETERS A, 1985, J COMP NEUROL, V234, P242, DOI 10.1002/cne.902340209; Pisani A, 2004, EPILEPSIA, V45, P719, DOI 10.1111/j.0013-9580.2004.02204.x; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; Poulain P, 2002, NEUROPHARMACOLOGY, V42, P346, DOI 10.1016/S0028-3908(01)00185-X; PRINCE DA, 1984, ANN NEUROL, V16, pS59, DOI 10.1002/ana.410160710; PRINCE DA, 1968, EXP NEUROL, V21, P467, DOI 10.1016/0014-4886(68)90066-6; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Saletti PG, 2019, NEUROBIOL DIS, V123, P86, DOI 10.1016/j.nbd.2018.06.017; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; SOLTESZ I, 1995, J NEUROPHYSIOL, V73, P1763, DOI 10.1152/jn.1995.73.5.1763; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Stefan H, 2007, PHARMACOL THERAPEUT, V113, P165, DOI 10.1016/j.pharmthera.2006.07.005; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; UCB Inc, 2017, KEPPR LEV PACK INS; Ueda Y, 2009, BRAIN RES, V1266, P1, DOI 10.1016/j.brainres.2009.02.040; VANBREDERODE JFM, 1995, J NEUROPHYSIOL, V74, P1149, DOI 10.1152/jn.1995.74.3.1149; Vinogradova LV, 2008, EPILEPSIA, V49, P1160, DOI 10.1111/j.1528-1167.2008.01594.x; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; Wilson CD, 2018, WORLD NEUROSURG, V110, pE901, DOI 10.1016/j.wneu.2017.11.116; Yang L, 1997, J NEUROPHYSIOL, V78, P2804, DOI 10.1152/jn.1997.78.5.2804; Yang L, 1998, NEUROSCI LETT, V257, P33, DOI 10.1016/S0304-3940(98)00798-8; Yang L, 2000, EPILEPSIA, V41, P1507; Yang L, 2007, J NEUROPHYSIOL, V97, P178, DOI 10.1152/jn.01374.2005; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zangbar B, 2016, WORLD J SURG, V40, P2667, DOI 10.1007/s00268-016-3606-y	86	3	3	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2021	337								113571	10.1016/j.expneurol.2020.113571			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QD1UA	WOS:000615311200009	33340499	Bronze			2022-02-06	
J	Zhang, R; Liu, C; Li, Y; Chen, L; Xiang, JF				Zhang, Rui; Liu, Cui; Li, Yang; Chen, Liang; Xiang, Jianfeng			Tenacissoside H promotes neurological recovery of cerebral ischaemia/reperfusion injury in mice by modulating inflammation and oxidative stress via TrkB pathway	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						inflammatory response; ischaemia; reperfusion injury; tenacissoside H; TrkB	TRAUMATIC BRAIN-INJURY; KAPPA-B PATHWAY; M2 MICROGLIA; REPERFUSION INJURY; SIGNALING PATHWAY; ISCHEMIC-STROKE; UP-REGULATION; PPAR-GAMMA; ACTIVATION; NEUROINFLAMMATION	Cerebral ischaemia/reperfusion (I/R)-induced acute brain injury remains a troublesome condition in clinical practice. The present study aimed to investigate the protective effect of tenacissoside H (TH) on I/R-induced cerebral injury in mice. Here, a mouse model of middle cerebral artery occlusion (MCAO) was established by an improved Longa-Zea method. TH was given by intraperitoneal injection once a day within 1 week before establishing the mouse MCAO model. The neurological functions of mice were evaluated and the apoptosis of neurons was also detected by the TUNEL method and Nissl's staining. ELISA and western blot were used to detect the expression of inflammatory factors, oxidation factors and proteins in the cerebral ischaemic cortex. The results revealed that TH dose-dependently reduced neurological impairment, neuron apoptosis and brain oedema induced by MCAO. Furthermore, TH attenuated the expression of pro-inflammatory cytokines (including interleukin (IL)-1 beta, IL-6 and tumour necrosis factor (TNF)-alpha), iNOS and nuclear factor (NF)-kappa B while increased production of anti-inflammatory cytokines (IL-4, IL-10 and BDNF) and proteins of tropomyosin-related kinase receptor B (TrkB) and PPAR gamma. Nevertheless, after the addition of TrkB inhibitor, the effects of TH above were mostly restrained. In conclusion, TH can protect mice against I/R-induced neurological impairments via modulating inflammation and oxidative stress through TrkB signalling.	[Zhang, Rui; Li, Yang] Qingdao Univ, Affiliated Hosp, Dept NICU, Qingdao, Peoples R China; [Liu, Cui] Qingdao Univ, Affiliated Hosp, Dept Cardiovasc Surg, Qingdao, Peoples R China; [Chen, Liang; Xiang, Jianfeng] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Intervent Dept, Shanghai Fengxian Dist Cent Hosp, South Campus, Shanghai, Peoples R China		Chen, L; Xiang, JF (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Shanghai Fengxian Dist Cent Hosp, South Campus,6600 Nan Feng Rd, Shanghai 201400, Peoples R China.	lmvuic2y@163.com; jianfeng9599@sina.com			Postdoctoral Fund Project of Qingdao; Youth Fund Project of the Affiliated Hospital of Qingdao University	the Postdoctoral Fund Project of Qingdao; the Youth Fund Project of the Affiliated Hospital of Qingdao University	Bustamante A, 2016, NEUROTHERAPEUTICS, V13, P671, DOI 10.1007/s13311-016-0470-2; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Dale EA, 2017, EXP NEUROL, V287, P130, DOI 10.1016/j.expneurol.2016.05.012; Fan Y, 2018, BRAIN RES, V1679, P125, DOI 10.1016/j.brainres.2017.11.027; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Granatiero V, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900563; He XX, 2017, RES VET SCI, V112, P7, DOI 10.1016/j.rvsc.2016.12.011; Jia YS, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/464937; Juan-Juan LI., 2018, FISH SHELLFISH IMMUN, V83, P205; Kim JY, 2016, EXP NEUROBIOL, V25, P241, DOI 10.5607/en.2016.25.5.241; Koumtebaye E, 2012, CHIN J NAT MEDICINES, V10, P339, DOI 10.1016/S1875-5364(12)60068-5; Lapi D, 2015, J VASC RES, V52, P22, DOI 10.1159/000381096; Liu H, 2018, BIOCHEM CELL BIOL, V96, P672, DOI 10.1139/bcb-2017-0209; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Liu XM, 2017, LIFE SCI, V191, P132, DOI 10.1016/j.lfs.2017.10.035; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; Luo J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020455; Miao HS, 2018, J NEUROPHYSIOL, V120, P1307, DOI 10.1152/jn.00234.2018; Minutoli L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2183026; Mizuma A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00467; Nieswandt B, 2011, J PHYSIOL-LONDON, V589, P4115, DOI 10.1113/jphysiol.2011.212886; Patel Anita R, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P73; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Qi GY, 2017, FOOD FUNCT, V8, P4421, DOI 10.1039/c7fo00991g; Ruan LH, 2015, BRAIN RES, V1623, P166, DOI 10.1016/j.brainres.2015.02.042; Simmons LJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0703-7; Sun H, 2013, NEUROCHEM INT, V63, P405, DOI 10.1016/j.neuint.2013.07.010; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Surinkaew P, 2018, METAB BRAIN DIS, V33, P1019, DOI 10.1007/s11011-018-0232-4; Tobon-Velasco JC, 2014, CNS NEUROL DISORD-DR, V13, P1615, DOI 10.2174/1871527313666140806144831; Venkat P, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005819; Wen L, 2018, J NEUROTRAUM, V35, P2330, DOI 10.1089/neu.2017.5540; Wu CY, 2017, CURR MED CHEM, V24, P718, DOI 10.2174/0929867324666161118142045; Wu GY, 2018, NEUROBIOL DIS, V110, P59, DOI 10.1016/j.nbd.2017.11.009; Wu MY, 2018, CELL PHYSIOL BIOCHEM, V46, P1650, DOI 10.1159/000489241; Xiao H, 2017, J NEUROCHEM, V142, P194, DOI 10.1111/jnc.14051; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xu HB, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1117-5; Yang J, 2018, NEUROCHEM RES, V43, P702, DOI 10.1007/s11064-018-2472-4; Yao RQ, 2012, NEUROCHEM RES, V37, P2777, DOI 10.1007/s11064-012-0871-5; Ye BG, 2014, PLANTA MED, V80, P29, DOI 10.1055/s-0033-1360128; Yin CX, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01211; Yu XH, 2018, BRAIN RES, V1680, P127, DOI 10.1016/j.brainres.2017.12.019; Yuan JC, 2017, ONCOTARGET, V8, P19855, DOI 10.18632/oncotarget.15774; Zhang R, 2021, CLIN EXP PHARMACOL P, V00, P1; Zhao H, 2018, MOL NEUROBIOL, V55, P4311, DOI 10.1007/s12035-017-0552-0; Zhao SC, 2017, ACTA PHARMACOL SIN, V38, P445, DOI 10.1038/aps.2016.162; Zhu RJ, 2014, MOLECULES, V19, P13965, DOI 10.3390/molecules190913965; Zhu T, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/4927430	51	3	3	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1870	1440-1681		CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	MAY	2021	48	5					757	769		10.1111/1440-1681.13398		MAR 2021	13	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Physiology	RG8HU	WOS:000623656900001	32799328				2022-02-06	
J	Zheng, YT; Wu, G; Chen, LM; Zhang, Y; Luo, YW; Zheng, Y; Hu, FJ; Forouzanfar, T; Lin, HY; Liu, B				Zheng, Yantao; Wu, Gang; Chen, Limei; Zhang, Ying; Luo, Yuwei; Zheng, Yong; Hu, Fengjun; Forouzanfar, Tymor; Lin, Haiyan; Liu, Bin			Neuro-regenerative imidazole-functionalized GelMA hydrogel loaded with hAMSC and SDF-1 alpha promote stem cell differentiation and repair focal brain injury	BIOACTIVE MATERIALS			English	Article						Injectable hydrogel; Imidazole; Stromal-cell derived factor-1 (SDF-1 alpha); Human amniotic mesenchymal stromal cells (hAMSCs); Brain injury	NANOPARTICLES; ELASTICITY; LIGHT; SKIN	Brain tissues that are severely damaged by traumatic brain injury (TBI) is hardly regenerated, which leads to a cavity or a repair with glial scarring. Stem-cell therapy is one viable option to treat TBI-caused brain tissue damage, whose use is, whereas, limited by the low survival rate and differentiation efficiency of stem cells. To approach this problem, we developed an injectable hydrogel using imidazole groups-modified gelatin methacrylate (GelMA-imid). In addition, polydopamine (PDA) nanoparticles were used as carrier for stromal-cell derived factor-1 (SDF-1 alpha). GelMA-imid hydrogel loaded with PDA@SDF-1 alpha nanoparticles and human amniotic mesenchymal stromal cells (hAMSCs) were injected into the damaged area in an in-vivo cryogenic injury model in rats. The hydrogel had low module and its average pore size was 204.61 +/- 41.41 nm, which were suitable for the migration, proliferation and differentiation of stem cells. In-vitro cell scratch and differentiation assays showed that the imidazole groups and SDF-1 alpha could promote the migration of hAMSCs to injury site and their differentiation into nerve cells. The highest amount of nissl body was detected in the group of GelMA-imid/SDF1 alpha/hAMSCs hydrogel in the in-vivo model. Additionally, histological analysis showed that GelMA-imid/SDF-1 alpha/ hAMSCs hydrogel could facilitate the regeneration of regenerate endogenous nerve cells. In summary, the GelMA-imid/SDF-1 alpha/hAMSCs hydrogel promoted homing and differentiation of hAMSCs into nerve cells, and showed great application potential for the physiological recovery of TBI.	[Zheng, Yantao; Liu, Bin] Southern Med Univ, Zhujiang Hosp, Emergency Dept, Guangzhou, Peoples R China; [Wu, Gang] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Implantol & Prosthet Dent, Amsterdam, Netherlands; [Wu, Gang] Vrije Univ Amsterdam VU, Amsterdam, Netherlands; [Chen, Limei; Zhang, Ying; Liu, Bin] Jinan Univ, Guangzhou Red Cross Hosp, Med Coll, Dept Emergency, Guangzhou 510220, Peoples R China; [Luo, Yuwei] Southern Med Univ, Rheumatol Dept, Affiliated Hosp 3, Guangzhou, Peoples R China; [Zheng, Yong] Qingyuan Peoples Hosp, Emergency Med Dept, Qingxin Sect, Qingyuan, Peoples R China; [Hu, Fengjun] Zhejiang Shuren Univ, Inst Informat Technol, Hangzhou, Peoples R China; [Forouzanfar, Tymor] Vrije Univ Amsterdam, Amsterdam UMC, Dept Oral & Maxillofacial Surg Pathol, Amsterdam Movement Sci, de Boelelaan 1117, Amsterdam, Netherlands; [Forouzanfar, Tymor] Vrije Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Amsterdam Movement Sci, de Boelelaan 1117, Amsterdam, Netherlands; [Lin, Haiyan] Hangzhou Med Coll, Savaid Stomatol Sch, Hangzhou, Peoples R China		Liu, B (corresponding author), Southern Med Univ, Zhujiang Hosp, Emergency Dept, Guangzhou, Peoples R China.; Lin, HY (corresponding author), Hangzhou Med Coll, Savaid Stomatol Sch, Hangzhou, Peoples R China.	lhaiyanlily@163.com; nysylb@163.com			Science and Technology Project of Guangdong Province [2015A020212021]; Medical Health Science and Technology Project of Zhejiang Provincial Health Commission [2020KY625]; Zhejiang Provincial Department of Education [Y201636248]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LQY17H140023]; Science Technology Department of Zhejiang Province [2017C33168]; Zhejiang Provincial Basic Public Welfare Research Project [GJ19H140001]; China's National Key RD Programs [2018YFB0407204]	This work was financially supported by the Science and Technology Project of Guangdong Province (No. 2015A020212021), Medical Health Science and Technology Project of Zhejiang Provincial Health Commission (No. 2020KY625), Zhejiang Provincial Department of Education (No. Y201636248), Natural Science Foundation of Zhejiang Province (No. LQY17H140023) Science Technology Department of Zhejiang Province (No. 2017C33168), Zhejiang Provincial Basic Public Welfare Research Project (No. GJ19H140001) and China's National Key R&D Programs (No. 2018YFB0407204).	Ayanlaja AA, 2018, SEMIN CANCER BIOL, V53, P212, DOI 10.1016/j.semcancer.2018.07.005; Chen CM, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201806899; Cui LL, 2013, RESTOR NEUROL NEUROS, V31, P239, DOI 10.3233/RNN-120271; Dai Q, 2019, THERANOSTICS, V9, P3170, DOI 10.7150/thno.31847; Dong YX, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201606619; Eke G, 2017, BIOMATERIALS, V129, P188, DOI 10.1016/j.biomaterials.2017.03.021; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fiorini F, 2016, SMALL, V12, P4881, DOI 10.1002/smll.201601017; Fujita K, 2011, PLACENTA, V32, P737, DOI 10.1016/j.placenta.2011.07.001; Ghuman H, 2018, ACTA BIOMATER, V80, P66, DOI 10.1016/j.actbio.2018.09.020; Giampa C, 2019, J CELL MOL MED, V23, P1581, DOI 10.1111/jcmm.14113; He XT, 2019, ACTA BIOMATER, V88, P162, DOI 10.1016/j.actbio.2019.02.004; Hu DH, 2016, NANOSCALE, V8, P17150, DOI 10.1039/c6nr05502h; Jahan-Abad AJ, 2018, MOL NEUROBIOL, V55, P9122, DOI 10.1007/s12035-018-1050-8; Jian WH, 2018, BIOMATERIALS, V174, P17, DOI 10.1016/j.biomaterials.2018.05.009; Kuan CY, 2019, J MATER CHEM B, V7, P4499, DOI 10.1039/c9tb00816k; Hong LTA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00583-8; Liu BC, 2018, BIOMATERIALS, V171, P83, DOI 10.1016/j.biomaterials.2018.04.023; Modo M, 2019, BRAIN RES BULL, V150, P136, DOI 10.1016/j.brainresbull.2019.05.013; Monteiro N, 2018, DENT MATER, V34, P389, DOI 10.1016/j.dental.2017.11.020; Negah SS, 2019, ACTA BIOMATER, V92, P132, DOI 10.1016/j.actbio.2019.05.010; Ning NY, 2019, CHEM ENG J, V373, P318, DOI 10.1016/j.cej.2019.04.215; Noshadi I, 2017, BIOMATER SCI-UK, V5, P2093, DOI 10.1039/c7bm00110j; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Pradhan K, 2019, ACS CHEM NEUROSCI, V10, P1535, DOI 10.1021/acschemneuro.8b00514; Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005; Rowland MJ, 2018, BIOMATERIALS, V179, P199, DOI 10.1016/j.biomaterials.2018.05.054; Van Herck N, 2020, ANGEW CHEM INT EDIT, V59, P3609, DOI 10.1002/anie.201912902; Wang L, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.201904156; Xu Q, 2018, ACTA BIOMATER, V75, P63, DOI 10.1016/j.actbio.2018.05.039; Yao MH, 2019, BIOMATER SCI-UK, V7, P4088, DOI 10.1039/c9bm00749k; Yu YL, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201904402; Yue K, 2015, BIOMATERIALS, V73, P254, DOI 10.1016/j.biomaterials.2015.08.045; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g; Zhong QX, 2018, STEM CELL TRANSL MED, V7, P709, DOI 10.1002/sctm.17-0246; Zhou FF, 2018, APPL MATER TODAY, V13, P32, DOI 10.1016/j.apmt.2018.08.005; Zhou HL, 2016, NEUROCHEM RES, V41, P2708, DOI 10.1007/s11064-016-1987-9; Zhu Q, 2019, INT J PHARMACEUT, V566, P342, DOI 10.1016/j.ijpharm.2019.05.076	38	3	3	26	92	KEAI PUBLISHING LTD	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717, PEOPLES R CHINA		2452-199X		BIOACT MATER	Bioact. Mater.	MAR	2021	6	3					627	637		10.1016/j.bioactmat.2020.08.026			11	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	PR1EC	WOS:000606983400005	33005827	gold, Green Published			2022-02-06	
J	Zhuang, YY; Yang, QB; Han, TH; O'Malley, R; Kumar, A; Gerald, RE; Huang, J				Zhuang, Yiyang; Yang, Qingbo; Han, Taihao; O'Malley, Ryan; Kumar, Aditya; Gerald, Rex E., II; Huang, Jie			Fiber optic sensor embedded smart helmet for real-time impact sensing and analysis through machine learning	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Mild traumatic brain injury; Fiber-optic sensor; Fiber Bragg grating; Machine learning; Concussive events; Blunt-force impact-induced brain injury	TRAUMATIC BRAIN-INJURY; COMPRESSIVE STRENGTH; CONCRETE; STRAIN	Background: Mild traumatic brain injury (mTBI) strongly associates with chronic neurodegenerative impairments such as post-traumatic stress disorder (PTSD) and mild cognitive impairment. Early detection of concussive events would significantly enhance the understanding of head injuries and provide better guidance for urgent diagnoses and the best clinical practices for achieving full recovery. New method: A smart helmet was developed with a single embedded fiber Bragg grating (FBG) sensor for realtime sensing of blunt-force impact events to helmets. The transient signals provide both magnitude and directional information about the impact event, and the data can be used for training machine learning (ML) models. Results: The FBG-embedded smart helmet prototype successfully achieved real-time sensing of concussive events. Transient data "fingerprints" consisting of both magnitude and direction of impact, were found to correlate with types of blunt-force impactors. Trained ML models were able to accurately predict (R-2 similar to 0.90) the magnitudes and directions of blunt-force impact events from data not used for model training. Comparison with existing methods: The combination of the smart helmet data with analyses using ML models provides accurate predictions of the types of impactors that caused the events, as well as the magnitudes and the directions of the impact forces, which are unavailable using existing devices. Conclusion: This work resulted in an ML-assisted, FBG-embedded smart helmet for real-time identification of concussive events using a highly accurate multi-metric strategy. The use of ML-FBG smart helmet systems can serve as an early-stage intervention strategy during and immediately following a concussive event.	[Zhuang, Yiyang; Yang, Qingbo; O'Malley, Ryan; Gerald, Rex E., II; Huang, Jie] Missouri Univ Sci & Technol, Dept Elect & Comp Engn, Rolla, MO 65409 USA; [Han, Taihao; Kumar, Aditya] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO 65409 USA		Gerald, RE; Huang, J (corresponding author), Missouri Univ Sci & Technol, Dept Elect & Comp Engn, Rolla, MO 65409 USA.	geraldr@mst.edu; jieh@mst.edu			Leonard Wood Institute; United States Army Research Laboratory [W911NF-07-2-0062]	This project was supported by the Leonard Wood Institute through a Cooperative Agreement with the United States Army Research Laboratory (W911NF-07-2-0062). The authors express their gratitude for the Acute Effects of Neurotrauma Consortium in assisting and coordinating the conduct of the project at Fort Leonard Wood.	BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Cheriyan AM, 2009, IEEE INT CON MULTI, P1704, DOI 10.1109/ICME.2009.5202849; Chou JS, 2014, CONSTR BUILD MATER, V73, P771, DOI 10.1016/j.conbuildmat.2014.09.054; Chou JS, 2011, J COMPUT CIVIL ENG, V25, P242, DOI 10.1061/(ASCE)CP.1943-5487.0000088; Cook R, 2019, J MATER CIVIL ENG, V31, DOI 10.1061/(ASCE)MT.1943-5533.0002902; Dinovitzer HA, 2019, IEEE SENS J, V19, P5670, DOI 10.1109/JSEN.2019.2907867; Faul M, 2010, TRAUMATIC BRAIN INJU; Grattan KTV, 2000, SENSOR ACTUAT A-PHYS, V82, P40, DOI 10.1016/S0924-4247(99)00368-4; Guan BO, 2000, IEEE PHOTONIC TECH L, V12, P675, DOI 10.1109/68.849081; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Han TH, 2020, CONSTR BUILD MATER, V244, DOI 10.1016/j.conbuildmat.2020.118271; Han TH, 2020, ACTA BIOMATER, V107, P286, DOI 10.1016/j.actbio.2020.02.037; Ho YT, 2006, MEAS SCI TECHNOL, V17, P1733, DOI 10.1088/0957-0233/17/7/011; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jarajreh MA, 2015, IEEE PHOTONIC TECH L, V27, P387, DOI 10.1109/LPT.2014.2375960; Karanov B, 2018, J LIGHTWAVE TECHNOL, V36, P4843, DOI 10.1109/JLT.2018.2865109; Lee B, 2003, OPT FIBER TECHNOL, V9, P57, DOI 10.1016/S1068-5200(02)00527-8; Makarychev A., 2016, 2016 IEEE 26 INT WOR, P1, DOI DOI 10.1109/MLSP.2016.7738863; Mazid AM, 2008, 2008 10TH INTERNATIONAL CONFERENCE ON CONTROL AUTOMATION ROBOTICS & VISION: ICARV 2008, VOLS 1-4, P1830, DOI 10.1109/ICARCV.2008.4795806; Muller MS, 2009, J LIGHTWAVE TECHNOL, V27, P5223, DOI 10.1109/JLT.2009.2028244; Rao YJ, 2006, OPT FIBER TECHNOL, V12, P227, DOI 10.1016/j.yofte.2006.03.004; Tejedor J, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7080841; von Rosenberg W, 2016, IEEE J TRANSL ENG HE, V4, DOI 10.1109/JTEHM.2016.2609927; Wang Dandan, 2015, 2015 EUR C OPT COMM, P1; Young BA, 2019, CEMENT CONCRETE RES, V115, P379, DOI 10.1016/j.cemconres.2018.09.006	26	3	3	4	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAR 1	2021	351								109073	10.1016/j.jneumeth.2021.109073			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	RC0HR	WOS:000632485600002	33440230	hybrid			2022-02-06	
J	O'Brien, WT; Symons, GF; Bain, J; Major, BP; Costello, DM; Sun, MJ; Kimpton, JS; Chen, ZB; Brady, RD; Mychasiuk, R; O'Brien, TJ; Monif, M; Shultz, SR; McDonald, SJ				O'Brien, William T.; Symons, Georgia F.; Bain, Jesse; Major, Brendan P.; Costello, Daniel M.; Sun, Mujun; Kimpton, Joshua S.; Chen, Zhibin; Brady, Rhys D.; Mychasiuk, Richelle; O'Brien, Terence J.; Monif, Mastura; Shultz, Sandy R.; McDonald, Stuart J.			Elevated Serum Interleukin-1 beta Levels in Male, but not Female, Collision Sport Athletes with a Concussion History	JOURNAL OF NEUROTRAUMA			English	Article						cytokine; IL-1&#946; IL-18; inflammasome; mild traumatic brain injury; neuroinflammation		It is increasingly reported that a history of concussion may be associated with chronic deleterious consequences. While the pathophysiology that contributes to these consequences is not well understood, neuroinflammation is postulated to be critical. Activation of multi-protein complexes termed inflammasomes, a key component of this inflammatory response, has been reported in more severe TBIs; however, it has not been investigated in milder TBIs, such as concussion. This study investigated serum levels of interleukin (IL)-1 beta and IL-18 (key proteins activated downstream of these inflammasomes) at acute, sub-acute, and chronic time-points post-concussion. We recruited 105 Australian footballers (65 male, 40 female) during the pre-season, then prospectively followed these players for the occurrence of concussion during the season. At baseline, 58 footballers reported a previous concussion history, and 47 reported no previous concussion history. Additionally, 25 players sustained a mid-season concussion and were sampled at 2, 6, and 13 days post-concussion. Serum levels of IL-1 beta and IL-18 were quantified using highly sensitive Simoa HD-X Analyzer assays. At baseline, IL-1 beta levels were higher in male, but not female, footballers with a previous concussion history compared with footballers with no concussion history. There was also a positive correlation between years of collision sport participation and IL-18 levels in males. No evidence was found in males or females to indicate that IL-1 beta or IL-18 levels differed at 2, 6, or 13 days post-concussion. These findings provide novel insights into potential sex-specific physiological consequences of concussion, and suggest that neuroinflammation may be persistent chronically following concussion in male athletes.	[O'Brien, William T.; Symons, Georgia F.; Bain, Jesse; Major, Brendan P.; Sun, Mujun; Chen, Zhibin; Brady, Rhys D.; Mychasiuk, Richelle; O'Brien, Terence J.; Monif, Mastura; Shultz, Sandy R.; McDonald, Stuart J.] Monash Univ, Dept Neurosci, 99 Commercial Rd, Melbourne, Vic 3004, Australia; [Chen, Zhibin] Monash Univ, Dept Clin Epidemiol, Melbourne, Vic, Australia; [Costello, Daniel M.; Kimpton, Joshua S.; Brady, Rhys D.; Shultz, Sandy R.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Monif, Mastura] Univ Melbourne, Dept Physiol, Parkville, Vic, Australia; [O'Brien, Terence J.; Monif, Mastura] Melbourne Hlth, Dept Neurol, Melbourne, Vic, Australia; [O'Brien, Terence J.; Monif, Mastura] Alfred Hlth, Dept Neurol, Melbourne, Vic, Australia; [McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia		McDonald, SJ (corresponding author), Monash Univ, Dept Neurosci, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	stuart.mcdonald@monash.edu	O'Brien, Terence/L-8102-2013; Monif, Mastura/L-4124-2019; O'Brien, Terence/AAU-5525-2021; Chen, Zhibin/T-1567-2017	O'Brien, Terence/0000-0002-7198-8621; Chen, Zhibin/0000-0002-1888-6917; Sun, Mujun/0000-0002-9923-9913; Monif, Mastura/0000-0001-6404-9768; McDonald, Stuart/0000-0001-5190-3179	Monash UniversityMonash University; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This study acknowledges research funding and support from Monash University and grants and fellowships awarded to S.R.S., T.O.B., and R.M. by the Australian National Health and Medical Research Council.	Brites D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00476; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Ciaramella A, 2014, NEUROIMMUNOMODULAT, V21, P8, DOI 10.1159/000354764; Costello DM, 2018, J CLIN NEUROSCI, V56, P88, DOI 10.1016/j.jocn.2018.07.003; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Cowie AM, 2019, PAIN, V160, P1794, DOI 10.1097/j.pain.0000000000001555; Di Battista AP, 2020, BMC IMMUNOL, V21, DOI 10.1186/s12865-020-0339-3; Di Battista AP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1402-y; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164912; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Eyolfson E, 2020, J NEUROTRAUM, V37, P2718, DOI 10.1089/neu.2020.7195; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Gunther S, 2017, IMMUNITY, V47, P510, DOI 10.1016/j.immuni.2017.08.004; Hosohara K, 2002, CLIN DIAGN LAB IMMUN, V9, P777, DOI 10.1128/CDLI.9.4.777-783.2002; Kerr N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210128; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Major BP, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.549624; McGroarty NK, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120932306; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Parkin GM, 2019, J NEUROTRAUM, V36, P1768, DOI 10.1089/neu.2018.6042; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Sun YX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01120; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Symons GF, 2020, J NEUROTRAUM, V37, P792, DOI 10.1089/neu.2019.6884; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Wu LM, 2019, J CEREBR BLOOD F MET, V39, P2196, DOI 10.1177/0271678X18786633; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	42	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2021	38	10					1350	1357		10.1089/neu.2020.7479		FEB 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RZ6DB	WOS:000623955500001	33308001				2022-02-06	
J	Redmon, SN; Yarishkin, O; Lakk, M; Jo, A; Mustafic, E; Tvrdik, P; Krizaj, D				Redmon, Sarah N.; Yarishkin, Oleg; Lakk, Monika; Jo, Andrew; Mustafic, Edin; Tvrdik, Petr; Krizaj, David			TRPV4 channels mediate the mechanoresponse in retinal microglia	GLIA			English	Article						edema; microglia; osmotransduction; retina; TRPV4; volume regulation		The physiological and neurological correlates of plummeting brain osmolality during edema, traumatic CNS injury, and severe ischemia are compounded by neuroinflammation. Using multiple approaches, we investigated how retinal microglia respond to challenges mediated by increases in strain, osmotic gradients, and agonists of the stretch-activated cation channel TRPV4. Dissociated and intact microglia were TRPV4-immunoreactive and responded to the selective agonist GSK1016790A and substrate stretch with altered motility and elevations in intracellular calcium ([Ca2+](i)). Agonist- and hypotonicity-induced swelling was associated with a nonselective outwardly rectifying cation current, increased [Ca2+](i), and retraction of higher-order processes. The antagonist HC067047 reduced the extent of hypotonicity-induced microglial swelling and inhibited the suppressive effects of GSK1016790A and hypotonicity on microglial branching. Microglial TRPV4 signaling required intermediary activation of phospholipase A2 (PLA2), cytochrome P450, and epoxyeicosatrienoic acid production (EETs). The expression pattern of vanilloid thermoTrp genes in retinal microglia was markedly different from retinal neurons, astrocytes, and cortical microglia. These results suggest that TRPV4 represents a primary retinal microglial sensor of osmochallenges under physiological and pathological conditions. Its activation, associated with PLA2, modulates calcium signaling and cell architecture. TRPV4 inhibition might be a useful strategy to suppress microglial overactivation in the swollen and edematous CNS.	[Redmon, Sarah N.; Yarishkin, Oleg; Lakk, Monika; Jo, Andrew; Mustafic, Edin; Krizaj, David] Moran Eye Inst, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; [Tvrdik, Petr] Univ Virginia, Sch Med, Dept Neurol Surg, Charlottesville, VA 22908 USA; [Krizaj, David] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT USA; [Krizaj, David] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Krizaj, David] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA		Krizaj, D (corresponding author), 65 N Mario Capecchi Dr,Bldg 523,Room 54140 JMEC, Salt Lake City, UT 84132 USA.	david.krizaj@hsc.utah.edu		Krizaj, David/0000-0003-4468-3029	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EY022076, R01EY027920, P30EY014800]; Willard L. Eccles Charitable Foundation; Glaucoma Research Foundation; ALSAM-Skaggs Foundation; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); University of Utah Neuroscience Initiative	Supported by the National Institutes of Health (R01EY022076, R01EY027920; P30EY014800), Willard L. Eccles Charitable Foundation, Glaucoma Research Foundation, ALSAM-Skaggs Foundation, University of Utah Neuroscience Initiative, and unrestricted support from Research to Prevent Blindness to the Moran Eye Institute at the University of Utah. We thank Dr Wolfgang Liedtke for TRPV4<SUP>-/-</SUP> mice, Dr Naveen Nagarajan for CX3CR1<SUP>eGFP</SUP> mice, and Dr Honghzhen Hu for TRPV4<SUP>eGFP</SUP> mice.	Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Arcuri C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00191; Balak N, 2009, J KOREAN NEUROSURG S, V45, P151, DOI 10.3340/jkns.2009.45.3.151; Balakrishna S, 2014, AM J PHYSIOL-LUNG C, V307, pL158, DOI 10.1152/ajplung.00065.2014; Baron R, 2014, AGING CELL, V13, P584, DOI 10.1111/acel.12210; Basavappa S, 1998, J NEUROPHYSIOL, V79, P1441, DOI 10.1152/jn.1998.79.3.1441; Becker D, 2005, J CELL SCI, V118, P2435, DOI 10.1242/jcs.02372; Bennett FC, 2018, NEURON, V98, P1170, DOI 10.1016/j.neuron.2018.05.014; Bernier LP, 2019, CELL REP, V27, P2895, DOI 10.1016/j.celrep.2019.05.010; Birnie M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-303; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Boucsein C, 2000, EUR J NEUROSCI, V12, P2049, DOI 10.1046/j.1460-9568.2000.00100.x; Bourinet E, 2014, PHYSIOL REV, V94, P81, DOI 10.1152/physrev.00023.2013; Brawek B, 2017, CELL CALCIUM, V64, P109, DOI 10.1016/j.ceca.2017.02.011; Bringmann A, 2004, OPHTHALMIC RES, V36, P241, DOI 10.1159/000081203; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Carbonell WS, 2005, J NEUROSCI, V25, P7040, DOI 10.1523/JNEUROSCI.5171-04.2005; CHAN PH, 1983, ANN NEUROL, V13, P625, DOI 10.1002/ana.410130608; CHIAVAROLI C, 1994, J BIOL CHEM, V269, P25570; Chmelova M, 2019, EUR J NEUROSCI, V50, P1685, DOI 10.1111/ejn.14338; Choi, 2017, ENCY SIGNALING MOL; Chuang DY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0419-0; Cianciulli A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010137; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Daruich A, 2018, PROG RETIN EYE RES, V63, P20, DOI 10.1016/j.preteyeres.2017.10.006; De Biase LM, 2017, NEURON, V95, P341, DOI 10.1016/j.neuron.2017.06.020; Diaz-Otero JM, 2018, AM J PHYSIOL-HEART C, V315, pH1304, DOI 10.1152/ajpheart.00207.2018; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; Farber K, 2006, GLIA, V54, P656, DOI 10.1002/glia.20412; Fernandez-Fernandez JM, 2008, PFLUG ARCH EUR J PHY, V457, P149, DOI 10.1007/s00424-008-0516-3; Fontainhas AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015973; Gankam-Kengne F, 2010, J AM SOC NEPHROL, V21, P2099, DOI 10.1681/ASN.2010050467; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Gee JM, 2014, NEURON, V83, P1058, DOI 10.1016/j.neuron.2014.07.024; Giuliani C, 2014, J CLIN MED, V3, P1163, DOI 10.3390/jcm3041163; Gong Y, 2004, STROKE, V35, P2571, DOI 10.1161/01.STR.0000145485.67827.d0; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Gu QH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00065; Hermoso M, 2004, J BIOL CHEM, V279, P17681, DOI 10.1074/jbc.M304506200; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hoeijmakers L, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00398; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hollborn M, 2008, INVEST OPHTH VIS SCI, V49, P1262, DOI 10.1167/iovs.07-0879; Hoshi Y, 2018, J NEUROSCI, V38, P5700, DOI 10.1523/JNEUROSCI.2888-17.2018; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Izquierdo P, 2019, TRENDS NEUROSCI, V42, P278, DOI 10.1016/j.tins.2018.12.007; Jiang WL, 2009, J NEUROCHEM, V109, P485, DOI 10.1111/j.1471-4159.2009.05981.x; Jo AO, 2016, P NATL ACAD SCI USA, V113, P3885, DOI 10.1073/pnas.1515895113; Jo AO, 2015, J NEUROSCI, V35, P13525, DOI 10.1523/JNEUROSCI.1987-15.2015; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Kloss CUA, 1997, J NEUROSCI RES, V49, P248; Kongsui R, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0182-7; Konno M, 2012, GLIA, V60, P761, DOI 10.1002/glia.22306; Krizaj D, 1996, J PHYSIOL-LONDON, V492, P887, DOI 10.1113/jphysiol.1996.sp021354; Krizaj D, 1998, NEURON, V21, P249, DOI 10.1016/S0896-6273(00)80531-0; Krizaj D., 2020, MECH INDUCED CYTOSKE, DOI [10.1101/2020.08.11.247171, DOI 10.1101/2020.08.11.247171]; Krizaj D, 2014, CURR EYE RES, V39, P105, DOI 10.3109/02713683.2013.836541; Lakk, 2021, GLIA, P1; Lakk M, 2018, NEURAL REGEN RES, V13, P207, DOI 10.4103/1673-5374.226383; Lakk M, 2017, GLIA, V65, P2038, DOI 10.1002/glia.23213; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; Langfelder A, 2015, CELL CALCIUM, V57, P247, DOI 10.1016/j.ceca.2015.01.004; Lee HP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08465-x; Lee JE, 2008, INVEST OPHTH VIS SCI, V49, P4169, DOI 10.1167/iovs.08-2076; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155006; Liotta EM, 2018, CRIT CARE MED, V46, P280, DOI 10.1097/CCM.0000000000002831; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Luo JL, 2018, J ALLERGY CLIN IMMUN, V141, P608, DOI 10.1016/j.jaci.2017.05.051; Madry C, 2018, NEURON, V97, P299, DOI 10.1016/j.neuron.2017.12.002; Marker Daniel F, 2010, J Vis Exp, DOI 10.3791/2059; Matsumoto H, 2018, J NEUROSCI, V38, P8745, DOI 10.1523/JNEUROSCI.0897-18.2018; Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e; Mola MG, 2016, GLIA, V64, P139, DOI 10.1002/glia.22921; Molnar T, 2016, J NEUROSCI, V36, P3184, DOI 10.1523/JNEUROSCI.4069-15.2016; Molnar T, 2012, J PHYSIOL-LONDON, V590, P3465, DOI 10.1113/jphysiol.2012.234641; Mongin AA, 2016, PFLUG ARCH EUR J PHY, V468, P421, DOI 10.1007/s00424-015-1765-6; Morihata H, 2000, NEUROSCI RES, V38, P265, DOI 10.1016/S0168-0102(00)00170-X; Murphy TR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00275; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; O'Koren EG, 2019, IMMUNITY, V50, P723, DOI 10.1016/j.immuni.2019.02.007; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Otani T, 2010, RETINA-J RET VIT DIS, V30, P774, DOI 10.1097/IAE.0b013e3181c2e0d6; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Phuong TTT, 2017, J PHYSIOL-LONDON, V595, P6869, DOI 10.1113/JP275052; Pivonkova H, 2018, NEUROSCIENCE, V394, P127, DOI 10.1016/j.neuroscience.2018.10.028; Pozner A, 2015, FRONT MOL NEUROSCI, V8, DOI [10.3389/fnmo1.2015.00012, 10.3389/fnmol.2015.00012]; Re DB, 2006, NAT NEUROSCI, V9, P859; Renneboog B., 2006, AM J MED, V119, p71.E1, DOI 10.1016/j.amjmed.2005.09.026; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Ryskamp DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30583; Ryskamp DA, 2014, J NEUROSCI, V34, P15689, DOI 10.1523/JNEUROSCI.2540-14.2014; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Scheraga RG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00503; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlichter LC, 2011, CHANNELS, V5, P128, DOI 10.4161/chan.5.2.14310; Schneidereit D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164509; Shibasaki K, 2020, LAB INVEST, V100, P218, DOI 10.1038/s41374-019-0362-2; Shuttleworth TJ, 2009, CELL CALCIUM, V45, P602, DOI 10.1016/j.ceca.2009.02.001; Silvin A, 2018, GLIA, V66, P2045, DOI 10.1002/glia.23458; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Srinivasan R, 2015, NAT NEUROSCI, V18, P708, DOI 10.1038/nn.4001; Starkey J, 2017, RADIOGRAPHICS, V37, P562, DOI 10.1148/rg.2017160085; STAUB F, 1994, ACTA NEUROCHIR, P20; Stokum JA, 2018, GLIA, V66, P108, DOI 10.1002/glia.23231; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Sun JK, 2015, DIABETES, V64, P2560, DOI 10.2337/db14-0782; Szikra T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006723; Tanaka M, 2018, BIOCHEM BIOPH RES CO, V496, P582, DOI 10.1016/j.bbrc.2018.01.094; Tang XN, 2011, ANN NEUROL, V70, P606, DOI 10.1002/ana.22476; Taylor L, 2017, EXP EYE RES, V154, P10, DOI 10.1016/j.exer.2016.11.002; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; Toft-Bertelsen TL, 2019, J BIOL CHEM, V294, P18421, DOI 10.1074/jbc.RA119.011187; Toft-Bertelsen TL, 2017, J PHYSIOL-LONDON, V595, P3287, DOI 10.1113/JP274135; Tvrdik P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112366; Umpierre AD, 2020, ELIFE, V9, DOI 10.7554/eLife.56502; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang X, 2016, J NEUROSCI, V36, P2827, DOI 10.1523/JNEUROSCI.3575-15.2016; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; White JPM, 2016, PHYSIOL REV, V96, P911, DOI 10.1152/physrev.00016.2015; Wittbrodt MT, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13805; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Wurm A, 2011, PROG RETIN EYE RES, V30, P324, DOI 10.1016/j.preteyeres.2011.06.001; Xiao DS, 2017, ELIFE, V6, DOI 10.7554/eLife.19976; Yarishkin O, 2021, J PHYSIOL-LONDON, V599, P571, DOI 10.1113/JP281011; Yarishkin O, 2018, ADV EXP MED BIOL, V1074, P553, DOI 10.1007/978-3-319-75402-4_67; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yu C, 2020, TRENDS NEUROSCI, V43, P433, DOI 10.1016/j.tins.2020.03.012; Zemtsova I, 2011, HEPATOLOGY, V54, P204, DOI 10.1002/hep.24326; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhao SQ, 2018, CHIN J NAT MEDICINES, V16, P105, DOI 10.1016/S1875-5364(18)30036-0; Zierler S, 2008, CELL PHYSIOL BIOCHEM, V21, P55, DOI 10.1159/000113747	141	3	3	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JUN	2021	69	6					1563	1582		10.1002/glia.23979		FEB 2021	20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RK4VJ	WOS:000620977400001	33624376				2022-02-06	
J	Hajipour, S; Sarkaki, A; Dianat, M; Rashno, M; Khorsandi, LS; Farbood, Y				Hajipour, Somayeh; Sarkaki, Alireza; Dianat, Mahin; Rashno, Mohammad; Khorsandi, Laaya Sadat; Farbood, Yaghoob			The effects of thymoquinone on memory impairment and inflammation in rats with hepatic encephalopathy induced by thioacetamide	METABOLIC BRAIN DISEASE			English	Article						Hepatic encephalopathy; Thymoquinone; Extracellular single unite; Cognition; Inflammatory markers	ACUTE LIVER-FAILURE; ACUTE AMMONIA INTOXICATION; TRAUMATIC BRAIN-INJURY; NIGELLA-SATIVA; OXIDATIVE STRESS; CEREBRAL HYPOPERFUSION; INTRACRANIAL-PRESSURE; COGNITIVE IMPAIRMENT; NEUROLOGIC OUTCOMES; TNF-ALPHA	Hepatic encephalopathy (HE) is a prevalent complication of the central nervous system (CNS) that is caused by acute or chronic liver failure. This study was designed to evaluate the effects of thymoquinone (TQ) on thioacetamide (TAA)-induced HE in rats, and determine the consequential behavioral, biochemical, and histological changes. HE was induced in male Wistar rats by intraperitoneal (i.p.) injection of 200 mg/kg TAA once every 48 h for 14 consecutive days. Control groups received the normal saline containing 5% DMSO. Thymoquinone (5, 10, and 20 mg/kg) was administered for ten consecutive days intraperitoneally (i.p.) after HE induction and it was continued until the end of the tests. Then, the passive avoidance memory, extracellular single unit, BBB permeability, and brain water content were evaluated. Moreover, hippocampal tissues were used for evaluation of oxidative stress index, inflammatory biomarkers, and histological parameters following HE. As result of the treatment, TQ improved passive avoidance memory, increased the average number of simultaneous firing of spikes/bins, improved the integrity of BBB, and decreased brain water content in the animal model of HE. Furthermore, the results indicated that treatment with TQ decreased the levels of inflammatory cytokines (TNF-alpha and IL-1 beta) but increased the levels of glutathione (GSH) and anti-inflammatory cytokine (IL-10) of the surviving cells in the hippocampal tissues. This study demonstrates that TQ may have beneficial therapeutic effects on cognitive, oxidative stress, neuroinflammatory, and histological complications of HE in rat.	[Hajipour, Somayeh; Sarkaki, Alireza; Dianat, Mahin; Farbood, Yaghoob] Ahvaz Jundishapur Univ Med Sci, Med Basic Sci Res Inst, Persian Gulf Physiol Res Ctr, Ahvaz, Iran; [Sarkaki, Alireza; Dianat, Mahin; Farbood, Yaghoob] Ahvaz Jundishapur Univ Med Sci, Fac Med, Dept Physiol, Ahvaz, Iran; [Sarkaki, Alireza] Ahvaz Jundishapur Univ Med Sci, Med Plant Res Ctr, Ahvaz, Iran; [Rashno, Mohammad] Ahvaz Jundishapur Univ Med Sci, Med Basic Sci Res Inst, Cellular & Mol Res Ctr, Dept Immunol,Fac Med, Ahvaz, Iran; [Khorsandi, Laaya Sadat] Ahvaz Jundishapur Univ Med Sci, Cellular & Mol Res Ctr, Dept Anat Sci, Ahvaz, Iran		Farbood, Y (corresponding author), Ahvaz Jundishapur Univ Med Sci, Med Basic Sci Res Inst, Persian Gulf Physiol Res Ctr, Ahvaz, Iran.; Farbood, Y (corresponding author), Ahvaz Jundishapur Univ Med Sci, Fac Med, Dept Physiol, Ahvaz, Iran.	farbood_y@yahoo.com					Abulfadl YS, 2018, NEUROL RES, V40, P324, DOI 10.1080/01616412.2018.1441776; Ahmad Aftab, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P337, DOI 10.1016/S2221-1691(13)60075-1; Al-Majed AA, 2006, EUR J PHARMACOL, V543, P40, DOI 10.1016/j.ejphar.2006.05.046; Algandaby MM, 2018, SAUDI J BIOL SCI, V25, P747, DOI 10.1016/j.sjbs.2016.10.007; Alhebshi AH, 2013, BIOCHEM BIOPH RES CO, V433, P362, DOI 10.1016/j.bbrc.2012.11.139; Bai T, 2014, INT IMMUNOPHARMACOL, V19, P351, DOI 10.1016/j.intimp.2014.02.006; Bakiri Y, 2008, GLIA, V56, P233, DOI 10.1002/glia.20608; Bargi R, 2017, CYTOKINE, V96, P173, DOI 10.1016/j.cyto.2017.04.015; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BEUTLER E, 1963, EXPERIENTIA, V19, P96, DOI 10.1007/bf02148042; Beyazcicek E, 2016, NEUROSCIENCES, V21, P131, DOI 10.17712/nsj.2016.2.20150781; Bin Sayeed MS, 2013, J ETHNOPHARMACOL, V148, P780, DOI 10.1016/j.jep.2013.05.004; BRATLID D, 1971, SCAND J CLIN LAB INV, V28, P41, DOI 10.3109/00365517109090661; Butterworth RF, 2011, HEPATOLOGY, V53, P1372, DOI 10.1002/hep.24228; Cauli O, 2008, AM J PHYSIOL-GASTR L, V295, pG503, DOI 10.1152/ajpgi.00076.2008; Cauli O, 2011, GASTROENTEROLOGY, V140, P638, DOI 10.1053/j.gastro.2010.10.043; Chehl N, 2009, HPB, V11, P373, DOI 10.1111/j.1477-2574.2009.00059.x; Chen JR, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-15; Chen YC, 2012, NEUROCHEM INT, V60, P751, DOI 10.1016/j.neuint.2012.03.021; Coltart I, 2013, ARCH BIOCHEM BIOPHYS, V536, P189, DOI 10.1016/j.abb.2013.03.016; de Miranda AS, 2017, MOL NEUROBIOL, V54, P7063, DOI 10.1007/s12035-016-0226-3; Dhanda S, 2018, MOL NEUROBIOL, V55, P3642, DOI 10.1007/s12035-017-0521-7; Durand F, 2016, MANAGEMENT ACUTE ON, P141; Ebrahimi SS, 2017, TOXICOL LETT, V276, P108, DOI 10.1016/j.toxlet.2017.05.018; El Khiat A, 2019, BEHAV BRAIN RES, V367, P201, DOI 10.1016/j.bbr.2019.03.046; El-Marasy S. A., 2012, Bulletin of the Faculty of Pharmacy, Cairo University, V50, P81, DOI 10.1016/j.bfopcu.2012.05.001; Fanoudi S, 2019, METAB BRAIN DIS, V34, P1001, DOI 10.1007/s11011-019-00394-4; Felipo V., 2015, NEUROIMMUNOL NEUROIN, V2, P138, DOI [DOI 10.4103/2347-8659.160845, 10.4103/2347-8659.160845]; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Gow AG, 2017, VET CLIN N AM-SMALL, V47, P585, DOI 10.1016/j.cvsm.2016.11.008; Haghparast A, 2010, J PAIN, V11, P32, DOI 10.1016/j.jpain.2009.05.005; Hermenegildo C, 2000, HEPATOLOGY, V31, P709, DOI 10.1002/hep.510310322; Hernandez-Rabaza V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0549-z; Hernandez-Rabaza V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0505-y; Hossen MJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42995; Khaksari M, 2013, IRAN J BASIC MED SCI, V16, P858; Kosenko E, 2003, BRAIN RES, V981, P193, DOI 10.1016/S0006-8993(03)03035-X; Lashgari R, 2006, BEHAV BRAIN RES, V171, P324, DOI 10.1016/j.bbr.2006.04.013; Lu L, 2020, J ETHNOPHARMACOL, V249, DOI 10.1016/j.jep.2019.112301; Malaguarnera M, 1996, PANMINERVA MED, V38, P84; Mohammadian F, 2019, BRAIN RES BULL, V149, P96, DOI 10.1016/j.brainresbull.2019.04.015; Monfort P, 2007, EUR J NEUROSCI, V25, P2103, DOI 10.1111/j.1460-9568.2007.05444.x; Mustafa HN, 2013, TISSUE CELL, V45, P350, DOI 10.1016/j.tice.2013.06.001; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Obara-Michlewska M, 2013, METAB BRAIN DIS, V28, P161, DOI 10.1007/s11011-012-9353-3; Oja SS, 2017, NEUROCHEM RES, V42, P713, DOI 10.1007/s11064-016-2014-x; Ott P, 2005, NEUROCHEM INT, V47, P13, DOI 10.1016/j.neuint.2005.04.002; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Radad K, 2014, EXP TOXICOL PATHOL, V66, P13, DOI 10.1016/j.etp.2013.07.002; Rahmani Arshad Husain, 2019, Open Access Maced J Med Sci, V7, P311, DOI 10.3889/oamjms.2019.050; Randolph C, 2009, LIVER INT, V29, P629, DOI 10.1111/j.1478-3231.2009.02009.x; Said AM, 2019, AUSTR J BASIC APPL S, V13, P1, DOI [DOI 10.22587/AJBAS.2019.13.4.1, 10.22587/ ajbas.2019.13.4.1]; Salahshoor Mohammad Reza, 2018, Adv Biomed Res, V7, P18, DOI 10.4103/abr.abr_69_17; Sawara K, 2009, NEUROCHEM INT, V55, P119, DOI 10.1016/j.neuint.2009.01.023; SAWASAKI Y, 1976, J NEUROCHEM, V27, P577, DOI 10.1111/j.1471-4159.1976.tb12285.x; Saxena N, 2002, LIVER, V22, P190, DOI 10.1034/j.1600-0676.2002.01431.x; Schauwecker PE, 2010, EXP NEUROL, V224, P207, DOI 10.1016/j.expneurol.2010.03.013; Sedaghat R, 2014, IRAN J PHARM RES, V13, P227; Seyan AS, 2010, WORLD J GASTROENTERO, V16, P3347, DOI 10.3748/wjg.v16.i27.3347; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shawcross DL, 2004, J HEPATOL, V40, P247, DOI 10.1016/j.jhep.2003.10.016; Shooshtari MK, 2020, METAB BRAIN DIS, V35, P401, DOI 10.1007/s11011-019-00527-9; Tabeshpour J, 2020, NEUROCHEM RES, V45, P254, DOI 10.1007/s11064-019-02908-z; Tahamtan M, 2017, METAB BRAIN DIS, V32, P881, DOI 10.1007/s11011-017-9966-7; Tavakkoli A, 2017, J PHARMACOPUNCT, V20, P179, DOI 10.3831/KPI.2017.20.021; Umar S, 2015, TOXICOL APPL PHARM, V287, P299, DOI 10.1016/j.taap.2015.06.017; Umar S, 2012, CHEM-BIOL INTERACT, V197, P40, DOI 10.1016/j.cbi.2012.03.003; Vickers NJ, 2017, CURR BIOL, V27, pR713, DOI 10.1016/j.cub.2017.05.064; Wang F, 2019, EXP THER MED, V18, P1985, DOI 10.3892/etm.2019.7779; Wang LQ, 2011, ASIAN BIOMED, V5, P205, DOI 10.5372/1905-7415.0502.026; Wijdicks EFM, 2016, NEW ENGL J MED, V375, P1660, DOI 10.1056/NEJMra1600561	72	3	3	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	JUN	2021	36	5					991	1002		10.1007/s11011-021-00688-6		FEB 2021	12	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	SA1GV	WOS:000621007900002	33620578				2022-02-06	
J	Waltzman, D; Sarmiento, K; Devine, O; Zhang, XJ; DePadilla, L; Kresnow, MJ; Borradaile, K; Hurwitz, A; Jones, D; Goyal, R; Breiding, MJ				Waltzman, Dana; Sarmiento, Kelly; Devine, Owen; Zhang, Xinjian; DePadilla, Lara; Kresnow, Marcie-jo; Borradaile, Kelley; Hurwitz, Andrew; Jones, David; Goyal, Ravi; Breiding, Matthew J.			Head Impact Exposures Among Youth Tackle and Flag American Football Athletes	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						head impact; flag; tackle; football; concussion		Background: Promoted as a safer alternative to tackle football, there has been an increase in flag football participation in recent years. However, examinations of head impact exposure in flag football as compared with tackle football are currently limited. Hypothesis: Tackle football athletes will have a greater number and magnitude of head impacts compared with flag football athletes. Study Design: Cohort study. Methods: Using mouthguard sensors, this observational, prospective cohort study captured data on the number and magnitude of head impacts among 524 male tackle and flag football athletes (6-14 years old) over the course of a single football season. Estimates of interest based on regression models used Bayesian methods to estimate differences between tackle and flag athletes. Results: There were 186,239 head impacts recorded during the study. Tackle football athletes were 14.67 (95% CI 9.75-21.95) times more likely to sustain a head impact during an athletic exposure (game or practice) compared with flag football athletes. Magnitude of impact for the 50th and 95th percentile was 18.15g (17.95-18.34) and 52.55g (51.06-54.09) for a tackle football athlete and 16.84g (15.57-18.21) and 33.51g (28.23-39.08) for a flag football athlete, respectively. A tackle football athlete sustained 23.00 (13.59-39.55) times more high-magnitude impacts (>= 40g) per athletic exposure compared with a flag football athlete. Conclusion: This study demonstrates that youth athletes who play tackle football are more likely to experience a greater number of head impacts and are at a markedly increased risk for high-magnitude impacts compared with flag football athletes.	[Waltzman, Dana; Sarmiento, Kelly; Zhang, Xinjian; Kresnow, Marcie-jo; Breiding, Matthew J.] Ctr Dis Control & Prevent CDC, Natl Ctr Injury Prevent & Control NCIPC, Div Injury Prevent, Atlanta, GA USA; [Devine, Owen] Premier Fed Inc, Atlanta, GA USA; [DePadilla, Lara] Ctr Dis Control & Prevent CDC, Natl Ctr Injury Prevent & Control NCIPC, Div Overdose Prevent, Atlanta, GA USA; [Borradaile, Kelley; Hurwitz, Andrew; Jones, David; Goyal, Ravi] Mathematica, Princeton, NJ USA		Waltzman, D (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Highway NE, Atlanta, GA 30341 USA.	dwaltzman@cdc.gov			Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [2016-N-17798]	This study was funded by the Centers for Disease Control and Prevention (CDC), contract solicitation BAA#2016-N-17798. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the CDC.	Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Caswell SV, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119835587; Chrisman SPD, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2402; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Haensly J., 2016, ATHLETE INTELLIGENCE; Higgins M, 2007, J ATHL TRAINING, V42, P5; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kercher K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237800; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Kroshus E, 2019, INJURY PREV, V25, P278, DOI 10.1136/injuryprev-2017-042677; Kuriyama Andrew M, 2017, Hawaii J Med Public Health, V76, P77; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Lynall RC, 2019, J NEUROTRAUM, V36, P1752, DOI 10.1089/neu.2018.6236; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2020, ANN BIOMED ENG, V48, P104, DOI 10.1007/s10439-019-02343-9; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; National Federation of State High School Associations, 2018, HIGH SCH ATHLETICS P, DOI 1020205/2017-18_hs_participation_survey.pdf; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Peterson AR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116686784; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; The Aspen Play IP, 2018, STATE PLAY 2018 TREN; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Waltzman D, 2019, J SAFETY RES, V68, P157, DOI 10.1016/j.jsr.2018.11.005; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	54	3	3	2	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	SEP	2021	13	5					454	462	1941738121992324	10.1177/1941738121992324		FEB 2021	9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UI2DO	WOS:000621151800001	33618557	Green Published, hybrid			2022-02-06	
J	Nolan, AL; Petersen, C; Iacono, D; Mac Donald, CL; Mukherjee, P; van der Kouwe, A; Jain, S; Stevens, A; Diamond, BR; Wang, RP; Markowitz, AJ; Fischl, B; Perl, DP; Manley, GT; Keene, CD; Diaz-Arrastia, R; Edlow, BL				Nolan, Amber L.; Petersen, Cathrine; Iacono, Diego; Mac Donald, Christine L.; Mukherjee, Pratik; van der Kouwe, Andre; Jain, Sonia; Stevens, Allison; Diamond, Bram R.; Wang, Ruopeng; Markowitz, Amy J.; Fischl, Bruce; Perl, Daniel P.; Manley, Geoffrey T.; Keene, C. Dirk; Diaz-Arrastia, Ramon; Edlow, Brian L.		TRACK-TBI Investigators	Tractography-Pathology Correlations in Traumatic Brain Injury: A TRACK-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						contusion; MRI; neuropathology; tractography; traumatic axonal injury; traumatic brain injury		Diffusion tractography magnetic resonance imaging (MRI) can infer changes in network connectivity in patients with traumatic brain injury (TBI), but the pathological substrates of disconnected tracts have not been well defined because of a lack of high-resolution imaging with histopathological validation. We developed an ex vivo MRI protocol to analyze tract terminations at 750-mu m isotropic resolution, followed by histopathological evaluation of white matter pathology, and applied these methods to a 60-year-old man who died 26 days after TBI. Analysis of 74 cerebral hemispheric white matter regions revealed a heterogeneous distribution of tract disruptions. Associated histopathology identified variable white matter injury with patchy deposition of amyloid precursor protein (APP), loss of neurofilament-positive axonal processes, myelin dissolution, astrogliosis, microgliosis, and perivascular hemosiderin-laden macrophages. Multiple linear regression revealed that tract disruption strongly correlated with the density of APP-positive axonal swellings and neurofilament loss. Ex vivo diffusion MRI can detect tract disruptions in the human brain that reflect axonal injury.	[Nolan, Amber L.; Keene, C. Dirk] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA; [Nolan, Amber L.; Mac Donald, Christine L.; Keene, C. Dirk] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Nolan, Amber L.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Petersen, Cathrine] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Iacono, Diego; Perl, Daniel P.] Uniformed Serv Univ USU, Dept Pathol, Bethesda, MD USA; [Iacono, Diego] Uniformed Serv Univ USU, Dept Neurol, Edward Hebert Sch Med, Bethesda, MD USA; [Iacono, Diego; Perl, Daniel P.] Uniformed Serv Univ USU, DoD USU Brain Tissue Repository BTR & Neuropathol, Bethesda, MD USA; [Iacono, Diego] Henry M Jackson Fdn Adv Mil Med HJF, Bethesda, MD USA; [Iacono, Diego] NINDS, Complex Neurodegenerat Disorders, Motor Neuron Disorders Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [van der Kouwe, Andre; Stevens, Allison; Diamond, Bram R.; Wang, Ruopeng; Fischl, Bruce; Edlow, Brian L.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA; [Diamond, Bram R.; Edlow, Brian L.] Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA; [Diamond, Bram R.; Edlow, Brian L.] Harvard Med Sch, Boston, MA 02115 USA; [Jain, Sonia] Univ Calif San Diego, Biostat Res Ctr, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, San Diego, CA 92103 USA; [Markowitz, Amy J.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Fischl, Bruce] MIT, Div Hlth Sci & Technol, Comp Sci & Artificial Intelligence Lab CSAIL, Cambridge, MA 02139 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA		Nolan, AL (corresponding author), Harborview Med Ctr Neuropathol, Box 359791,325 Ninth Ave, Seattle, WA 98104 USA.	nolanam@uw.edu		Hemphill, Claude/0000-0003-4019-7525	NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090, K08NS114170, R21NS109627, RF1NS115268, K23NS094538, R01NS0525851, R21NS072652, R01NS070963, R01NS083534, U01NS086625, U24NS10059103, R01NS105820]; NIH Director's Office [DP2HD101400]; NIH National Institute for Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896, 1R01EB023281, R01EB006758, R21EB018907, R01EB019956]; NIH National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R56AG064027, R01AG064027, R01AG008122, R01AG016495]; NIH National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R21DK108277]; United States Department of DefenseUnited States Department of Defense [W81XWH-14-2-0176, W81XWH-18-2-0042, W81XWH-15-9-0001]; James S. McDonnell Foundation; Abbott Point of Care Inc [A133407]; National Football League Scientific Advisory Board [131769A]; Tiny Blue Dot Foundation; Nancy and Buster Alvord endowment; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10RR023401, S10RR019307, S10RR023043]; BRAIN Initiative Cell Census Network [U01MH117023]; NIH Blueprint for Neuroscience ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5U01-MH093765]; One Mind	The study was funded by the NIH National Institute of Neurological Disorders and Stroke (U01NS086090, K08NS114170, R21NS109627, RF1NS115268, K23NS094538, R01NS0525851, R21NS072652, R01NS070963, R01NS083534, U01NS086625, U24NS10059103, and R01NS105820), NIH Director's Office (DP2HD101400), NIH National Institute for Biomedical Imaging and Bioengineering (P41EB015896, 1R01EB023281, R01EB006758, R21EB018907, and R01EB019956), NIH National Institute on Aging (R56AG064027, R01AG064027, R01AG008122, and R01AG016495), NIH National Institute of Diabetes and Digestive and Kidney Diseases (R21DK108277), the United States Department of Defense (W81XWH-14-2-0176, W81XWH-18-2-0042, and W81XWH-15-9-0001), the James S. McDonnell Foundation, Abbott Point of Care Inc (A133407; G.T.M.), the National Football League Scientific Advisory Board (131769A), the Tiny Blue Dot Foundation, and the Nancy and Buster Alvord endowment (C.D.K.). This research also utilized resources provided by NIH shared instrumentation grants S10RR023401, S10RR019307, and S10RR023043. Additional support was provided by the BRAIN Initiative Cell Census Network (U01MH117023) and the NIH Blueprint for Neuroscience Research (5U01-MH093765), part of the multi-institutional Human Connectome Project, and One Mind.	Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; BOYKO OB, 1994, ARCH PATHOL LAB MED, V118, P219; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Dale Jeffrey M, 2012, J Amino Acids, V2012, P382107, DOI 10.1155/2012/382107; Dawe RJ, 2016, NEUROBIOL AGING, V45, P169, DOI 10.1016/j.neurobiolaging.2016.05.023; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Edlow BL, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0254-8; Edlow BL, 2018, J NEUROTRAUM, V35, P1604, DOI 10.1089/neu.2017.5457; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fox MD, 2018, NEW ENGL J MED, V379, P2237, DOI 10.1056/NEJMra1706158; Gangolli M, 2017, NEUROIMAGE, V153, P152, DOI 10.1016/j.neuroimage.2017.03.059; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jbabdi S, 2011, BRAIN CONNECT, V1, P169, DOI 10.1089/brain.2011.0033; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Mcnab JA, 2008, MAGN RESON MED, V60, P405, DOI 10.1002/mrm.21668; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; McNab JA, 2013, NEUROIMAGE, V69, P87, DOI 10.1016/j.neuroimage.2012.11.065; Mcnab JA, 2009, NEUROIMAGE, V46, P775, DOI 10.1016/j.neuroimage.2009.01.008; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Snider SB, 2019, NEUROLOGY, V93, pE1281, DOI 10.1212/WNL.0000000000008163; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Weber MT, 2019, BRAIN PATHOL, V29, P437, DOI 10.1111/bpa.12677; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	48	3	3	4	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1620	1631		10.1089/neu.2020.7373		FEB 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000623079800001	33412995	Green Submitted			2022-02-06	
J	Zusman, BE; Kochanek, PM; Bell, MJ; Adelson, PD; Wisniewski, SR; Au, AK; Clark, RSB; Bayir, H; Janesko-Feldman, K; Jha, RM				Zusman, Benjamin E.; Kochanek, Patrick M.; Bell, Michael J.; Adelson, P. David; Wisniewski, Stephen R.; Au, Alicia K.; Clark, Robert S. B.; Bayir, Hulya; Janesko-Feldman, Keri; Jha, Ruchira M.			Cerebrospinal Fluid Sulfonylurea Receptor-1 Is Associated with Intracranial Pressure and Outcome after Pediatric TBI: An Exploratory Analysis of the Cool Kids Trial	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; cerebrospinal fluid; pediatrics; traumatic brain injury		Sulfonylurea receptor-1 (SUR1) is recognized increasingly as a key contributor to cerebral edema, hemorrhage progression, and possibly neuronal death in multiple forms of acute brain injury. SUR1 inhibition may be protective and is actively undergoing evaluation in Phase-2/3 trials of traumatic brain injury (TBI) and stroke. In adult TBI, SUR1 expression is associated with intracranial hypertension and contusion expansion; its role in pediatric TBI remains unexplored. We tested 61 cerebrospinal fluid (CSF) samples from 16 pediatric patients with severe TBI enrolled in the multicenter Phase-3 randomized controlled "Cool Kids" trial and seven non-brain injured pediatric controls for SUR1 expression by enzyme-linked immunosorbent assay. Linear mixed models evaluated associations between mean SUR1 and intracranial pressure (ICP) over the first seven days and pediatric Glasgow Outcome Scale-Extended (GOS-E Peds) over the initial year after injury. SUR1 was undetectable in control CSF and increased versus control in nine of 16 patients with TBI. Mean SUR1 was not associated with age, sex, or therapeutic hypothermia. Each 1-point increase in initial Glasgow Coma Score was associated with a 1.68 ng/mL decrease in CSF SUR1. The CSF SUR1 was associated with increased ICP over seven days (b = 0.73, p = 0.004) and worse (higher) GOS-E Peds score (b = 0.24, p = 0.004). In this exploratory pediatric study, CSF SUR1 was undetectable in controls and variably elevated in severe TBI. Mean CSF SUR1 concentration was associated with ICP and outcome. These findings are distinct from our previous report in adults with severe TBI, where SUR1 was detected universally. SUR1 may be a viable therapeutic target in a subset of pediatric TBI, and further study is warranted.	[Zusman, Benjamin E.; Jha, Ruchira M.] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA; [Zusman, Benjamin E.; Kochanek, Patrick M.; Jha, Ruchira M.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.; Au, Alicia K.; Clark, Robert S. B.; Bayir, Hulya; Janesko-Feldman, Keri; Jha, Ruchira M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Zusman, Benjamin E.; Jha, Ruchira M.] Univ Pittsburgh, Inst Clin Res Educ, Pittsburgh, PA USA; [Kochanek, Patrick M.] UPMC, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Kochanek, Patrick M.; Clark, Robert S. B.; Bayir, Hulya; Janesko-Feldman, Keri; Jha, Ruchira M.] John G Rangos Res Ctr, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bell, Michael J.] Childrens Natl Hlth Syst, Washington, DC USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Wisniewski, Stephen R.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA		Jha, RM (corresponding author), Univ Pittsburgh, 3550 Terrace St,Scaife Hall, Pittsburgh, PA 15261 USA.	Ruchira.Jha@Barrowneuro.org			NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101036, K23 NS104133]; Chuck Noll Foundation; University of PittsburghUniversity of Pittsburgh	We would like to thank the NIH NINDS (K23NS101036, to R.M.J.; K23 NS104133, to A.K.A.), the Chuck Noll Foundation (R.M.J. and P.M.K) and the University of Pittsburgh Deans Faculty Advancement Award (to R.M.J.) for generous support.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Au A.K., 2021, PEDIATR CRIT CARE ME; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Cunningham RM, 2018, NEW ENGL J MED, V379, P2468, DOI 10.1056/NEJMsr1804754; Eisenberg HM, 2020, J NEUROTRAUM, V37, P185, DOI 10.1089/neu.2019.6538; Ferguson NM, 2017, CRIT CARE MED, V45, P1398, DOI 10.1097/CCM.0000000000002378; Gerzanich V, 2019, J NEUROTRAUM, V36, P1060, DOI 10.1089/neu.2018.5986; Jha RM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020409; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Jha RM, 2019, J NEUROTRAUM, V36, P1804, DOI 10.1089/neu.2018.6124; Jha RM, 2018, CRIT CARE MED, V46, P1792, DOI 10.1097/CCM.0000000000003361; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Khalili H, 2017, WORLD NEUROSURG, V101, P130, DOI 10.1016/j.wneu.2017.01.103; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Nakayama S, 2018, NEUROCRIT CARE, V29, P119, DOI 10.1007/s12028-017-0479-3; Olsen M, 2019, EUR J PAEDIATR NEURO, V23, P500, DOI 10.1016/j.ejpn.2019.01.009; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	24	3	3	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1615	1619		10.1089/neu.2020.7501		FEB 2021	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000620267000001	33430695				2022-02-06	
J	Duckworth, H; Sharp, DJ; Ghajari, M				Duckworth, Harry; Sharp, David J.; Ghajari, Mazdak			Smoothed particle hydrodynamic modelling of the cerebrospinal fluid for brain biomechanics: Accuracy and stability	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article						brain biomechanics; cerebrospinal fluid; finite element modelling; smoothed particle hydrodynamics		The Cerebrospinal Fluid (CSF) can undergo shear deformations under head motions. Finite Element (FE) models, which are commonly used to simulate biomechanics of the brain, including traumatic brain injury, employ solid elements to represent the CSF. However, the limited number of elements paired with shear deformations in CSF can decrease the accuracy of their predictions. Large deformation problems can be accurately modelled using the mesh-free Smoothed Particle Hydrodynamics (SPH) method, but there is limited previous work on using this method for modelling the CSF. Here we explored the stability and accuracy of key modelling parameters of an SPH model of the CSF when predicting relative brain/skull displacements in a simulation of an in vivo mild head impact in human. The Moving Least Squares (MLS) SPH formulation and Ogden rubber material model were found to be the most accurate and stable. The strain and strain rate in the brain differed across the SPH and FE models of CSF. The FE mesh anchored the gyri, preventing them from experiencing the level of strains seen in the in vivo brain experiments and predicted by the SPH model. Additionally, SPH showed higher levels of strains in the sulci compared to the FE model. However, tensile instability was found to be a key challenge of the SPH method, which needs to be addressed in future. Our study provides a detailed investigation of the use of SPH and shows its potential for improving the accuracy of computational models of brain biomechanics.	[Duckworth, Harry; Ghajari, Mazdak] Imperial Coll London, Dyson Sch Design Engn, London SW7 1A, England; [Duckworth, Harry; Sharp, David J.] Imperial Coll London, Computat Cognit & Clin Neuroimaging Lab, London, England; [Sharp, David J.] Dementia Res Inst, Care Res & Technol Ctr, London, England		Duckworth, H (corresponding author), Imperial Coll London, Dyson Sch Design Engn, London SW7 1A, England.	h.duckworth17@imperial.ac.uk		Ghajari, Mazdak/0000-0001-5678-5124; Duckworth, Harry/0000-0002-0367-0486	Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N509486/1]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	Engineering and Physical Sciences Research Council, Grant/Award Number: EP/N509486/1	[Anonymous], 2018, MATLAB STAT TOOLB RE; Atsumi N, 2018, ANN BIOMED ENG, V46, P736, DOI 10.1007/s10439-018-1988-8; Benson, 1977, HEAD IMPACT RESPONSE; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chen JK, 1999, COMPUT MECH, V23, P279, DOI 10.1007/s004660050409; Cui ZY, 2017, COMPUT METHOD BIOMEC, V20, P530, DOI 10.1080/10255842.2016.1255942; De Vuyst T, 2005, INT J IMPACT ENG, V31, P1054, DOI 10.1016/j.ijimpeng.2004.04.017; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Dyka CT, 1997, INT J NUMER METH ENG, V40, P2325, DOI 10.1002/(SICI)1097-0207(19970715)40:13<2325::AID-NME161>3.0.CO;2-8; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Fernandez-Mendez S, 2005, COMPUT STRUCT, V83, P1448, DOI 10.1016/j.compstruc.2004.10.019; Gehre C., 2009, ENHANCED SAFETY VEHI; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Hallquist JO., 1998, LS DYNA THEORETICAL; Hermange C., 2019, J COMPUTATIONAL PHYS, V1; Hu DA, 2011, COMPUT MAT CON, V584, P1; ISO, 1999, 9790 ISOTR; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Klug C., 2013, IRCOBI C GOTH, P483; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; Lui, 2003, SMOOTHED PARTICLE HY; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mill F., 2015, P 4 INT C PRACT BAS; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Monaghan JJ, 2000, J COMPUT PHYS, V159, P290, DOI 10.1006/jcph.2000.6439; Ostoja-Starzewski, 2017, INT J NUMER METHODS, V33, P1; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; R Core Team, 2019, R LANG ENV STAT COMP; Randles PW, 2000, INT J NUMER METH ENG, V48, P1445, DOI 10.1002/1097-0207(20000810)48:10<1445::AID-NME831>3.3.CO;2-0; Saboori, 2017, CEREBRAL BLOOD VESSE; SHATSKY SA, 1974, J NEUROSURG, V41, P523, DOI 10.3171/jns.1974.41.5.0523; SWEGLE JW, 1995, J COMPUT PHYS, V116, P123, DOI 10.1006/jcph.1995.1010; Tableau, 2019, TABL V2019 2 0; Takhounts EG, 2008, STAPP CAR C, V52, P1; Toma M, 2018, BRAIN INJURY, V32, P1576, DOI 10.1080/02699052.2018.1502470; Tse KM., 2015, AM J ENG TECHNOLOGY, V1, P28; Vander JS., 2011, 8 EUR LS DYNA US C; Verbeken E., 2012, J BIOMECH, V45, pS585; Wang, 2014, INTERACTION METHODS; Wang F, 2018, BIOMECH MODEL MECHAN, V17, P1165, DOI 10.1007/s10237-018-1021-z; Wittek A., 2003, P COMP MECH C, P331, DOI [10.1299/jsmecmd.2003.16.331, DOI 10.1299/JSMECMD.2003.16.331]; Wood G A, 1982, Exerc Sport Sci Rev, V10, P308; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yoganandan Narayan, 2009, V2, P281, DOI 10.1007/978-1-4020-8716-5_13; Yreux E., 2018, 15 INT LS DYNA US C, P1; Zhang ZC, 2011, ENG STRUCT, V33, P255, DOI 10.1016/j.engstruct.2010.10.020; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z	52	3	3	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	APR	2021	37	4							e3440	10.1002/cnm.3440		FEB 2021	17	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematical & Computational Biology; Mathematics	RO2TM	WOS:000616367800001	33480161	hybrid, Green Published			2022-02-06	
J	Chen, BY; Shin, S				Chen, Boyuan; Shin, Sohee			Bibliometric Analysis on Research Trend of Accidental Falls in Older Adults by Using Citespace-Focused on Web of Science Core Collection (2010-2020)	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						older adults; accidental falls; research hotspot; CiteSpace; knowledge domain visualization	ASIAN WORKING GROUP; RISK-FACTORS; UNITED-STATES; VITAMIN-D; SARCOPENIA; MORTALITY; EXERCISE; PEOPLE; CONSENSUS; WOMEN	The present study aimed to identify the trends in research on accidental falls in older adults over the last decade. The MeSH (Medical Subject Headings) and entry terms were applied in the Web of Science Core Collection. Relevant studies in English within articles or reviews on falls in older adults were included from 2010 to 2020. Moreover, CiteSpace 5.6.R5 (64-bit) was adopted for analysis with scientific measurements and visualization. Cooper Cyrus, Stephen R Lord, Minoru Yamada, Catherine Sherrington, and others have critically impacted the study of falls in older adults. Osteoporosis, dementia, sarcopenia, hypertension, osteosarcopenia, traumatic brain injury, frailty, depression, and fear of falling would be significantly correlated with falls in older adults. Multiple types of exercise can provide effective improvements in executive cognitive performance, gait performance, quality of life, and can also lower the rates of falls and fall-related fractures. Fall detection, hospitalization, classification, symptom, gender, and cost are the current research focus and development direction in research on falls in older adults. The prevention of falls in older adults is one of the most important public health issues in today's aging society. Although lots of effects and research advancements had been taken, fall prevention still is uncharted territory for too many older adults. Service improvements can exploit the mentioned findings to formulate policies, and design and implement exercise programs for fall prevention.	[Chen, Boyuan] Zhengzhou Univ, Sch Phys Educ Main Campus, Zhengzhou 450001, Peoples R China; [Chen, Boyuan; Shin, Sohee] Univ Ulsan, Sch Sport & Exercise Sci, 93 Daehak Ro, Ulsan 44610, South Korea		Shin, S (corresponding author), Univ Ulsan, Sch Sport & Exercise Sci, 93 Daehak Ro, Ulsan 44610, South Korea.	cby@haust.edu.cn; soheeshin@ulsan.ac.kr		Boyuan, Chen/0000-0002-1314-7744	University of Ulsan	This work was supported by the 2020 Research Fund of University of Ulsan.	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Avanecean Donna, 2017, JBI Database System Rev Implement Rep, V15, P3006, DOI 10.11124/JBISRIR-2016-003331; Ayalon L, 2016, INT PSYCHOGERIATR, V28, P741, DOI 10.1017/S1041610215001969; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Berkova M., 2018, VNITR LEK, V64, P1076, DOI DOI 10.36290/VNL.2018.154; Bischoff-Ferrari HA, 2015, OSTEOPOROSIS INT, V26, P2793, DOI 10.1007/s00198-015-3194-y; Boelens C, 2013, TECHNOL HEALTH CARE, V21, P521, DOI 10.3233/THC-130748; Bolland MJ, 2018, LANCET DIABETES ENDO, V6, P847, DOI [10.1016/S2213-8587(18)30265-1, 10.1016/s2213-8587(18)30265-1]; Bosscher R J, 2005, Tijdschr Gerontol Geriatr, V36, P5; Brown CVR, 2013, AM SURGEON, V79, P465; Cawthon PM, 2017, J GERONTOL A-BIOL, V72, P1383, DOI 10.1093/gerona/glw327; Chen LK, 2020, J AM MED DIR ASSOC, V21, P300, DOI 10.1016/j.jamda.2019.12.012; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chen Y., 2015, STUDIES SCI SCI, V33, P242, DOI [10.16192/j.cnki.1003-2053.2015.02.009, DOI 10.16192/J.CNKI.1003-2053.2015.02.009]; Cheng PX, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010603; Clemson L, 2008, J AGING HEALTH, V20, P954, DOI 10.1177/0898264308324672; Clemson L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4547; Codes I.-C, SARCOPENIA; Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, DOI 10.1093/ageing/afz046; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Da Silva RB, 2010, J ORTHOP SPORT PHYS, V40, P582, DOI 10.2519/jospt.2010.3239; Daly RM, 2019, BRAZ J PHYS THER, V23, P170, DOI 10.1016/j.bjpt.2018.11.011; Delbaere K, 2010, AGE AGEING, V39, P210, DOI 10.1093/ageing/afp225; Dennison EM, 2017, NAT REV RHEUMATOL, V13, P340, DOI 10.1038/nrrheum.2017.60; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; Gale CR, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0806-3; Gale CR, 2016, AGE AGEING, V45, P789, DOI 10.1093/ageing/afw129; Gallagher JC, 2016, NAT REV ENDOCRINOL, V12, P680, DOI 10.1038/nrendo.2016.123; Hagiya H, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033462; Hartholt KA, 2019, JAMA-J AM MED ASSOC, V321, P2131, DOI 10.1001/jama.2019.4185; Hartholt KA, 2018, JAMA-J AM MED ASSOC, V319, P1380, DOI 10.1001/jama.2018.1444; Holroyd Christopher R, 1800, Menopause Int, V17, P102, DOI 10.1258/mi.2011.011025; Hou JH., 2013, MODERN INFORM, V33, P99; Iaboni A, 2013, AM J GERIAT PSYCHIAT, V21, P484, DOI 10.1016/j.jagp.2013.01.008; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jang H, 2016, DISABIL REHABIL, V38, P724, DOI 10.3109/09638288.2015.1061606; Jimenez-Garcia JD, 2019, J AGING PHYS ACTIV, V27, P325, DOI 10.1123/japa.2018-0190; Kayama H, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3108; Kiadaliri AA, 2019, INJURY PREV, V25, P129, DOI 10.1136/injuryprev-2017-042425; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kojima G, 2015, J AM MED DIR ASSOC, V16, P1027, DOI 10.1016/j.jamda.2015.06.018; Kulik C, 2011, SPECIAL SUPPLEMENT A; Kumar A, 2016, AGE AGEING, V45, P345, DOI 10.1093/ageing/afw036; Kyrdalen IL, 2019, PHYSIOTHER RES INT, V24, DOI 10.1002/pri.1743; Lee DCA, 2015, HEALTH EXPECT, V18, P1593, DOI 10.1111/hex.12149; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Lord SR, 2018, HAND CLINIC, V159, P157, DOI 10.1016/B978-0-444-63916-5.00010-0; Lord SR, 2018, AGE AGEING, V47, P492, DOI 10.1093/ageing/afy059; Malasinghe LP, 2019, J AMB INTEL HUM COMP, V10, P57, DOI 10.1007/s12652-017-0598-x; Miller PD, 2016, EXPERT OPIN PHARMACO, V17, P473, DOI 10.1517/14656566.2016.1124856; Mirelman A, 2016, LANCET, V388, P1170, DOI 10.1016/S0140-6736(16)31325-3; Montero-Odasso M, 2019, J AM GERIATR SOC, V67, P1182, DOI 10.1111/jgs.15774; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; Ng CACM, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2019-000663; Padron-Monedero A, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0670-6; Paintin J, 2018, BRIT J HOSP MED, V79, P253, DOI 10.12968/hmed.2018.79.5.253; Peek K, 2020, DEMENTIA-LONDON, V19, P1621, DOI 10.1177/1471301218803201; Peel NM, 2011, CAN J AGING, V30, P7, DOI 10.1017/S071498081000070X; Qato DM, 2016, JAMA INTERN MED, V176, P473, DOI 10.1001/jamainternmed.2015.8581; Qi BT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155411; Rizzoli R, 2014, MATURITAS, V79, P122, DOI 10.1016/j.maturitas.2014.07.005; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Schaap LA, 2018, J GERONTOL A-BIOL, V73, P1199, DOI 10.1093/gerona/glx245; Sherrington C, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012424.pub2; Shier V., 2016, INJ EPIDEMIOL, V3, P16, DOI [10.1186/s40621-016-0081-8, DOI 10.1186/S40621-016-0081-8]; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stevens JA, 2012, AM J PREV MED, V43, P59, DOI 10.1016/j.amepre.2012.03.008; Thomas S, 2010, AGE AGEING, V39, P681, DOI 10.1093/ageing/afq102; Tom SE, 2013, J AM GERIATR SOC, V61, P327, DOI 10.1111/jgs.12146; Toots A, 2019, J AM MED DIR ASSOC, V20, P835, DOI 10.1016/j.jamda.2018.10.009; Gia TN, 2018, MICROPROCESS MICROSY, V56, P34, DOI 10.1016/j.micpro.2017.10.014; Uusi-Rasi K, 2015, JAMA INTERN MED, V175, P703, DOI 10.1001/jamainternmed.2015.0225; VanItallie TB, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.007; Viswanathan Anand, 2012, Handb Clin Neurol, V103, P623, DOI 10.1016/B978-0-444-51892-7.00045-0; Wales K, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-34; World Health Organization, WHO GLOB REP FALLP; Xu T, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8030418; Yamada Minoru, 2014, Nihon Rinsho, V72, P1821; Yamada M, 2011, TELEMED E-HEALTH, V17, P768, DOI 10.1089/tmj.2011.0054; Zhou X, 2018, J REHABIL MED, V50, P577, DOI 10.2340/16501977-2334	81	3	3	23	43	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB	2021	18	4							1663	10.3390/ijerph18041663			17	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	QP1XL	WOS:000623630300001	33572483	gold, Green Published			2022-02-06	
J	Costanza, A; Radomska, M; Zenga, F; Amerio, A; Aguglia, A; Serafini, G; Amore, M; Berardelli, I; Ojio, Y; Nguyen, KD				Costanza, Alessandra; Radomska, Michalina; Zenga, Francesco; Amerio, Andrea; Aguglia, Andrea; Serafini, Gianluca; Amore, Mario; Berardelli, Isabella; Ojio, Yasutaka; Nguyen, Khoa D.			Severe Suicidality in Athletes with Chronic Traumatic Encephalopathy: A Case Series and Overview on Putative Ethiopathogenetic Mechanisms	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						chronic traumatic encephalopathy; contact sports; neuropsychiatric symptoms; suicide; suicidal ideation; suicide attempt; suicidal behaviour		Chronic traumatic encephalopathy (CTE) results from repetitive brain injuries and is a common neurotraumatic sequela in contact sports. CTE is often accompanied by neuropsychiatric symptoms, which could escalate to suicidal ideation (SI) and suicidal behaviour (SB). Nevertheless, fairly limited emphasis about the association between suicidality and CTE exists in medical literature. Here, we report two cases of retired professional athletes in high contact sports (boxing and ice hockey) who have developed similar clinical trajectories characterized by progressive neuropsychiatric symptoms compatible with a CTE diagnosis and subsequent SB in its severe forms (medical serious suicide attempt (SA) and completed suicide). In addition to the description of outlining clinical, neuropsychological, neuroimaging, and differential diagnosis elements related to these cases, we also hypothesized some mechanisms that might augment the suicide risk in CTE. They include those related to neurobiological (neuroanatomic/neuroinflammatory) dysfunctions as well as those pertaining to psychiatry and psychosocial maladaptation to neurotraumas and retirement from professional competitive activity. Findings described here can provide clinical pictures to improve the identification of patients with CTE and also potential mechanistic insights to refine the knowledge of eventual severe SB development, which might enable its earlier prevention.	[Costanza, Alessandra] Univ Geneva UNIGE, Fac Med, Dept Psychiat, CH-1211 Geneva, Switzerland; [Costanza, Alessandra] ASO Santi Antonio & Biagio & Cesare Arrigo Hosp, Dept Psychiat, I-15121 Alessandria, Italy; [Radomska, Michalina] Univ Geneva UNIGE, Fac Psychol, CH-1206 Geneva, Switzerland; [Zenga, Francesco] City Hlth & Sci Hosp, Dept Neurosurg, I-10126 Turin, Italy; [Amerio, Andrea; Aguglia, Andrea; Serafini, Gianluca; Amore, Mario] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Sect Psychiat, I-16132 Genoa, Italy; [Amerio, Andrea; Aguglia, Andrea; Serafini, Gianluca; Amore, Mario] IRCCS Osped Policlin San Martino, I-16132 Genoa, Italy; [Amerio, Andrea] Tufts Univ, Dept Psychiat, Boston, MA 02111 USA; [Berardelli, Isabella] Sapienza Univ Rome, Dept Neurosci Mental Hlth & Sensory Organs, Suicide Prevent Ctr, St Andrea Hosp, I-00189 Rome, Italy; [Ojio, Yasutaka] Natl Inst Mental Hlth, Natl Ctr Neurol & Psychiat, Dept Community Mental Hlth & Law, Tokyo 1878553, Japan; [Nguyen, Khoa D.] Stanford Univ, Dept Microbiol & Immunol, Palo Alto, CA 94304 USA; [Nguyen, Khoa D.] Tranquis Therapeut, Palo Alto, CA 94304 USA; [Nguyen, Khoa D.] Hong Kong Univ Sci & Technol, Hong Kong, Peoples R China		Costanza, A (corresponding author), Univ Geneva UNIGE, Fac Med, Dept Psychiat, CH-1211 Geneva, Switzerland.; Costanza, A (corresponding author), ASO Santi Antonio & Biagio & Cesare Arrigo Hosp, Dept Psychiat, I-15121 Alessandria, Italy.	alessandra.costanza@unige.ch; michalina.radomska@outlook.com; zengafra@hotmail.com; andrea.amerio@unige.it; andrea.aguglia@unige.it; gianluca.serafini@unige.it; mario.amore@unige.it; isabella.beradelli@uniroma1.it; ojiotokio@gmail.com; khoa.d.nguyen@gmail.com	Serafini, Gianluca/K-6603-2016; Berardelli, Isabella/A-5617-2019	Serafini, Gianluca/0000-0002-6631-856X; Costanza, Alessandra/0000-0001-6387-6462; Aguglia, Andrea/0000-0002-2003-2101; Amerio, Andrea/0000-0002-3439-340X; Zenga, Francesco/0000-0001-5440-3276			ABRAMSON LY, 1989, PSYCHOL REV, V96, P358, DOI 10.1037/0033-295X.96.2.358; Amerio A, 2020, PEDIATR PULM, V55, P2204, DOI 10.1002/ppul.24928; Amerio A, 2019, INDIAN J PSYCHOL MED, V41, P133, DOI 10.4103/IJPSYM.IJPSYM_367_18; Angelino AF, 2001, SUPPORT CARE CANCER, V9, P344, DOI 10.1007/s005200000195; Baertschi M, 2019, INT J METH PSYCH RES, V28, DOI 10.1002/mpr.1755; Baertschi M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040636; Baertschi M, 2017, J AFFECT DISORDERS, V210, P323, DOI 10.1016/j.jad.2016.12.049; BECK AT, 1975, JAMA-J AM MED ASSOC, V234, P1146, DOI 10.1001/jama.234.11.1146; Belson Ken, 2017, NEW YORK TIMES; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Berardelli I, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55050200; Blennow K., 2005, LAKARTIDINGEN, V102, P2472; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brown Russell, 1986, COLLECTED POEMS AI P; Butterworth P, 2006, AUST NZ J PSYCHIAT, V40, P648, DOI 10.1080/j.1440-1614.2006.01864.x; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; Chytas Vasileios, 2019, Rev Med Suisse, V15, P1282; Clarke DM, 2002, AUST NZ J PSYCHIAT, V36, P733, DOI 10.1046/j.1440-1614.2002.01086.x; Costanza A, 2015, Rev Med Suisse, V11, P402; Costanza A, 2012, Rev Med Suisse, V8, P1770; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Costanza A., 2011, INT J CLIN REV, V27, P69, DOI [10.5275/ijcr.2011.12.01, DOI 10.5275/IJCR.2011.12.01]; Costanza A., 2020, ACTA BIOMEDICA; Costanza A, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56120725; Costanza A, 2020, JMIR RES PROTOC, V9, DOI 10.2196/24882; Costanza A, 2020, PSYCHOL RES BEHAV MA, V13, P855, DOI 10.2147/PRBM.S279829; Costanza A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.558974; Costanza A, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56060295; Costanza A, 2020, CNS NEUROL DISORD-DR, V19, P257, DOI 10.2174/1871527319666200611130804; Costanza A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00327; Costanza Alessandra, 2020, Acta Biomed, V91, P128, DOI 10.23750/abm.v91i3-S.9417; Costanza A, 2021, INT J MENT HEALTH AD, V19, P1729, DOI 10.1007/s11469-020-00259-3; Costanza A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072232; Costanza A, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55080465; Costanza Alessandra, 2018, Rev Med Suisse, V14, P335; Costanza A, 2014, INT J LEGAL MED, V128, P73, DOI 10.1007/s00414-013-0835-6; Costanza A, 2012, J ALZHEIMERS DIS, V32, P643, DOI 10.3233/JAD-2012-120835; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; DALY PJ, 1990, SPORTS MED, V10, P122, DOI 10.2165/00007256-199010020-00005; de Figueiredo JM, 2013, EUR J PSYCHIAT, V27, P61, DOI 10.4321/S0213-61632013000100008; de Neris Melanie, 2020, Rev Med Suisse, V16, P314; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Elfil M, 2020, J NEUROL, V267, P966, DOI 10.1007/s00415-019-09632-2; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Fang CK, 2014, SUPPORT CARE CANCER, V22, P3165, DOI 10.1007/s00520-014-2290-4; Fava GA, 2007, PSYCHOSOMATICS, V48, P103, DOI 10.1176/appi.psy.48.2.103; FRANK JD, 1974, AM J PSYCHIAT, V131, P271, DOI 10.1176/ajp.131.3.271; Frankl V., 1959, MANS SEARCH MEANING; Fremont R, 2020, AM J ALZHEIMERS DIS, V35, DOI 10.1177/1533317520925982; Gagner C, 2021, J NEUROTRAUM, V38, P102, DOI 10.1089/neu.2019.6936; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2020, ARCH CLIN NEUROPSYCH, V35, P332, DOI 10.1093/arclin/acz023; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jacobsen JC, 2006, INDIAN J PALLIAT CAR, V12, P8, DOI 10.4103/0973-1075.25913; Jacobsen Juliet C, 2007, Prim Care Companion J Clin Psychiatry, V9, P139; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Kempuraj D, 2021, NEUROTOX RES, V39, P359, DOI 10.1007/s12640-020-00288-9; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Kissane DW, 2001, J PALLIAT CARE, V17, P12, DOI 10.1177/082585970101700103; Lai AX, 2018, AM J GERIAT PSYCHIAT, V26, P1191, DOI 10.1016/j.jagp.2018.08.012; Levi-Belz Y, 2016, CRISIS, V37, P299, DOI 10.1027/0227-5910/a000386; Lim LJH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020254; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Liu ST, 2020, PSYCHO-ONCOLOGY, V29, P1321, DOI 10.1002/pon.5439; Mangelli L, 2005, J CLIN PSYCHIAT, V66, P391, DOI 10.4088/JCP.v66n0317; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mariani M, 2020, SEMIN NEUROL, V40, P370, DOI 10.1055/s-0040-1713624; Martela F, 2016, J POSIT PSYCHOL, V11, P531, DOI 10.1080/17439760.2015.1137623; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2002, J SCI MED SPORT, V5, P169, DOI 10.1016/S1440-2440(02)80002-0; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Mina VAL, 2015, J AFFECT DISORDERS, V172, P219, DOI 10.1016/j.jad.2014.09.057; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Nanni MG, 2018, PSYCHO-ONCOLOGY, V27, P2616, DOI 10.1002/pon.4824; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; O'Donovan A, 2013, DEPRESS ANXIETY, V30, P307, DOI 10.1002/da.22087; Ojio Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155533; Ostertag L, 2019, SWISS MED WKLY, V149, DOI 10.4414/smw.2019.20016; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Restifo K, 2009, J NERV MENT DIS, V197, P147, DOI 10.1097/NMD.0b013e318199f452; ROBERTS GW, 1988, LANCET, V2, P1456; Russell ER, 2020, J NEUROL NEUROSUR PS, V91, P1256, DOI 10.1136/jnnp-2020-323315; SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2; Serafini G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072393; Serafini G, 2016, CURR ALZHEIMER RES, V13, P1083, DOI 10.2174/1567205013666160720112608; Serafini G, 2013, EUR NEUROPSYCHOPHARM, V23, P1672, DOI 10.1016/j.euroneuro.2013.06.002; SERCL M, 1962, Rozhl Chir, V41, P597; Sorokina E G, 2020, Zh Nevrol Psikhiatr Im S S Korsakova, V120, P72, DOI 10.17116/jnevro202012004172; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tang PL, 2015, PSYCHOSOMATICS, V56, P634, DOI 10.1016/j.psym.2015.06.005; Tecuta L, 2015, PSYCHOL MED, V45, P673, DOI 10.1017/S0033291714001597; Turecki G, 2012, TRENDS NEUROSCI, V35, P14, DOI 10.1016/j.tins.2011.11.008; Unterharnscheidt F, 1995, Rev Neurol, V23, P1027; van Heeringen K, 2014, LANCET PSYCHIAT, V1, P63, DOI 10.1016/S2215-0366(14)70220-2; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Vehling S, 2017, CANCER-AM CANCER SOC, V123, P3394, DOI 10.1002/cncr.30749; Werinberg RA, 2008, NEUROL CLIN, V26, P243, DOI 10.1016/j.ncl.2007.12.002; Williams JBW, 2008, BRIT J PSYCHIAT, V192, P52, DOI 10.1192/bjp.bp.106.032532; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280; Wu YX, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.01030; Xu K, 2019, J NERV MENT DIS, V207, P326, DOI 10.1097/NMD.0000000000000974; Zucca M, 2019, AM J ALZHEIMERS DIS, V34, P265, DOI 10.1177/1533317518817609	122	3	3	3	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB	2021	18	3							876	10.3390/ijerph18030876			15	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	QD1DU	WOS:000615269000001	33498520	Green Published, gold			2022-02-06	
J	Dulf, D; Coman, MA; Tadevosyan, A; Chikhladze, N; Cebanu, S; Peek-Asa, C				Dulf, Diana; Coman, Madalina-Adina; Tadevosyan, Artashes; Chikhladze, Nino; Cebanu, Serghei; Peek-Asa, Corinne			A 3-Country Assessment of Traumatic Brain Injury Practices and Capacity	WORLD NEUROSURGERY			English	Article						Acute care; Low- and middle-income countries; Pre-hospital care; Rehabilitation services; Traumatic brain injury		BACKGROUND: The World Health Organization predicts a striking rise in the burden of traumatic brain injury (TBI) burden in the next decades. A disproportionately large increase is predicted in low- and middle-income countries, which have brain injury rates 3 times higher than high-income countries. The aim of this study was to identify current TBI practices and treatment capacity in 3 low- and middle-income countries: Republic of Armenia, Georgia, and Republic of Moldova. METHODS: After a national inventory of hospitals treating TBI, a situational analysis was conducted in the highest volume adult and pediatric hospital in each country. The situational analysis included key informant interviews with content analysis and a quantitative checklist of treatment resources. RESULTS: All 3 countries follow international, national, and hospital protocols for TBI treatment, and the in-hospital management of patients with TBI is similar to international standards in all 3 countries. Although health care specialists were well trained, however, lack of proper equipment, a scant number of hospitals outside the capital region, lack of specialized personnel in regional areas, and lack of rehabilitation services were mentioned as difficulties in interviews from all 3 countries. CONCLUSIONS: Particular gaps were found in pre-hospital and rehabilitative care, as well as national leadership and data collection. Surveillance and standardized data collection are important measures to fill treatment gaps and reduce the burden of TBI.	[Dulf, Diana; Coman, Madalina-Adina] Babes Bolyai Univ, Coll Polit Adm & Commun Sci, Dept Publ Hlth, Cluj Napoca, Romania; [Tadevosyan, Artashes] Yerevan State Med Univ, Dept Publ Hlth & Healthcare Org, Yerevan, Armenia; [Chikhladze, Nino] Tbilisi State Univ, Fac Med, Dept Publ Hlth, Tbilisi, Georgia; [Cebanu, Serghei] Nicolae Testemitanu State Univ Med & Pharm, Dept Hyg, Kishinev, Moldova; [Peek-Asa, Corinne] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA USA		Coman, MA (corresponding author), Babes Bolyai Univ, Coll Polit Adm & Commun Sci, Dept Publ Hlth, Cluj Napoca, Romania.	madalina.coman@publichealth.ro	Cebanu, Serghei/AAD-2079-2022; Coman, Madalina/AAS-9973-2021	Cebanu, Serghei/0000-0002-2493-4882; Chikhladze, Nino/0000-0002-5772-1699; Tadevosyan, Artashes/0000-0001-7737-2978	NIH-Fogarty International Trauma Training Program "iCREATE: Increasing Capacity for Research in Eastern Europe" at the University of Iowa; NIH-Fogarty International Trauma Training Program "INITIatE: International Collaboration to Increase Traumatic Brain Injury in Europe" at the University of Iowa; Babes-Bolyai University (National Institutes of Health, Fogarty International Center) [2D43TW007261, 5R21NS098850]	This publication was funded by the NIH-Fogarty International Trauma Training Program "iCREATE: Increasing Capacity for Research in Eastern Europe" and "INITIatE: International Collaboration to Increase Traumatic Brain Injury in Europe", both at the University of Iowa and Babes-Bolyai University (National Institutes of Health, Fogarty International Center 2D43TW007261 and 5R21NS098850). The authors gratefully acknowledge all members of the iCREATE and INITIatE grants for their work on the project overall and for the contributions of project documentation used in this paper.	Agrawal A, 2014, ROM NEUROSURG, V21, P307; Al-Thani Hassan, 2017, Air Med J, V36, P188, DOI 10.1016/j.amj.2017.03.003; American Trauma Society, TRAUM CTR LEV EXPL; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Balabanova D, 2012, HEALTH SERV RES, V47, P840, DOI 10.1111/j.1475-6773.2011.01323.x; Barkley AS, 2021, J NEUROSURG, V134, P244, DOI 10.3171/2019.10.JNS192118; Centers for Disease Control and Prevention, 2008, EPIDEMIOLOGY REHABIL, P15; Cociu Svetlana, 2020, Int J Adv Res (Indore), V8, P1245, DOI 10.21474/ijar01/11039; de Andrade Fabiola, 2018, J Eur CME, V7, P1506202, DOI 10.1080/21614083.2018.1506202; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; EENA, WHATS 112 ALL; Jena R, 2017, ROM NEUROSURG, V31, P339; Lavado RF, 2018, EXPANSION BENEFITS P, P1; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Pal Ranabir, 2016, Int J Crit Illn Inj Sci, V6, P127; Patel A, 2016, PLOS ONE, V11; Rechel B, 2014, OBSERVATORY STUDIES, V35; Reilly PL, 2019, J CLIN NEUROSCI, V61, P201, DOI 10.1016/j.jocn.2018.10.030; Richardson E, 2017, HEALT SYST TRANSIT, V19, P1; Richardson Erica, 2013, Health Syst Transit, V15, P1; Richardson E, 2012, HEALTH POLICY PLANN, V27, P204, DOI 10.1093/heapol/czr024; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rukhadze T, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-8; Sasser S, 2005, 7 TRANSPORTATION COM, P39; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Tonoyan T, 2004, HLTH CARE SYSTEM ARM; Tonoyan T, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-32; Turcanu G, 2012, HEALT SYST TRANSIT, V14, P1; Wooldridge G, 2020, CHILD NERV SYST, V36, P2647, DOI 10.1007/s00381-020-04603-9; World Health Organisation, 2006, NEUR DIS PUBL HLTH C, P1	33	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2021	146						E517	E526		10.1016/j.wneu.2020.10.115			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QJ6NI	WOS:000619804900084	33127569				2022-02-06	
J	Fakhry, SM; Morse, JL; Garland, JM; Wilson, NY; Shen, Y; Wyse, RJ; Watts, DD				Fakhry, Samir M.; Morse, Jennifer L.; Garland, Jeneva M.; Wilson, Nina Y.; Shen, Yan; Wyse, Ransom J.; Watts, Dorraine D.			Antiplatelet and anticoagulant agents have minimal impact on traumatic brain injury incidence, surgery, and mortality in geriatric ground level falls: A multi-institutional analysis of 33,710 patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	79th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery	SEP 08-18, 2020	ELECTR NETWORK	Amer Assoc Surg Trauma		Traumatic brain injury; anticoagulant; antiplatelet; ground level fall; geriatric		BACKGROUND Falls are the leading cause of traumatic brain injury (TBI) and TBI-related deaths for older persons (age, >= 65 years). Antiplatelet and/or anticoagulant therapy (antithrombotics [ATs]) is generally felt to increase this risk, but the literature is inconsistent. The purpose of this study was to determine the impact of AT use on the rate, severity, and outcomes of TBI in older patients following ground level falls. METHODS Ground level fall patients from 90 hospitals' trauma registries were selected. Patients were excluded if younger than 65 years or had an Abbreviated Injury Scale score of >2 in a region other than head. Electronic medical record data for preinjury AT therapy were obtained. Patients were grouped by regimen for no AT, single, or multiple agents. Groups were compared on rates of diagnosed TBI, TBI surgery, and mortality. RESULTS There were 33,710 patients (35% male; mean age, 80.5 years; mean Glasgow Coma Scale, 14.6), with 47.6% on single or combination AT therapy. The proportion of patients with TBI diagnoses did not differ between those on no AT (21.25%) versus AT (21.61%; p = 0.418). Apixaban (15.7%; p < 0.001) and rivaroxaban (13.19%; p = 0.011) were associated with lower rates of TBI, and acetylsalicylic acid-clopidogrel was associated with a higher TBI rate (24.34%; p = 0.002) versus no AT. acetylsalicylic acid-clopidogrel was associated with a higher cranial surgery rate (2.9%; p = 0.006) versus no AT (1.96%), but surgery rates were similar for all other regimens. No regimen was associated with higher mortality. CONCLUSION In this large multicenter study, the intake of ATs in older patients with ground level falls was associated with inconsistent effects on risk of TBI and no significant increases in mortality, indicating that AT use may have negligible impact on patient clinical management. A large, confirmatory, prospective study is needed because the commonly held belief that ATs uniformly increase the risk of traumatic intracranial bleeding and mortality is not supported.	[Fakhry, Samir M.; Morse, Jennifer L.; Garland, Jeneva M.; Wilson, Nina Y.; Shen, Yan; Wyse, Ransom J.; Watts, Dorraine D.] Ctr Trauma & Acute Care Surg Res, Clin Operat Grp, HCA Healthcare, 2515 Pk Plaza,Bldg 2-3W, Nashville, TN 37203 USA		Fakhry, SM (corresponding author), Ctr Trauma & Acute Care Surg Res, Clin Operat Grp, HCA Healthcare, 2515 Pk Plaza,Bldg 2-3W, Nashville, TN 37203 USA.	samir.fakhry@hcahealthcare.com		Shen, Yan/0000-0002-1372-5874; Garland, Jeneva/0000-0003-4920-3020	HCA Healthcare; HCA Healthcare affiliated entity	The authors declare no conflicts of interest. All coauthors have seen and agree with the contents of the article, and there is no financial interest to report. This research was supported (in whole or in part) by HCA Healthcare and/or an HCA Healthcare affiliated entity. The views expressed in this publication represent those of the author(s) and do not necessarily represent the official views of HCA Healthcare or any of its affiliated entities.	Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Barletta JF, 2017, EUR J TRAUMA EMERG S, V43, P445, DOI 10.1007/s00068-017-0772-z; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Borne RT, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0671-6; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Centers for Disease Control and Prevention, PERC US AD 55 OV CHR; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Feinberg M, 2015, SEMIN NEUROL, V35, P50, DOI 10.1055/s-0035-1544244; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; Forslund T, 2016, EUR J CLIN PHARMACOL, V72, P329, DOI 10.1007/s00228-015-1983-z; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Galliazzo S, 2019, THROMB RES, V174, P113, DOI 10.1016/j.thromres.2018.12.015; IQVIA, 2019, MED US SPEND USA REV; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Llompart-Pou JA, 2019, MED INTENSIVA, V43, P44, DOI 10.1016/j.medin.2018.02.009; McHorney CA, 2016, CLIN THER, V37, P2477, DOI 10.1016/j.clinthera.2016.09.014; Minhas H, 2018, BRIT J HAEMATOL, V183, P119, DOI 10.1111/bjh.15509; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Perreault S, 2020, PHARMACOTHERAPY, V40, P40, DOI 10.1002/phar.2350; Stein DM, 2018, J TRAUMA ACUTE CARE, V85, P788, DOI 10.1097/TA.0000000000001910; Suehiro E, 2019, WORLD NEUROSURG, V127, pE1221, DOI 10.1016/j.wneu.2019.04.108; The American Association for the Surgery of Trauma, 2019, TRAUM FACTS TRAUM BR; Toorop MMA, 2020, RES PRACT THROMB HAE, V4, P586, DOI 10.1002/rth2.12316; Wiegele M, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2352-6; Williams CD, 2015, AM J PREV MED, V48, P501, DOI 10.1016/j.amepre.2014.11.005; World Health Organization World Health Organization. Ageing and Life course Unit, 2008, WHO GLOB REP FALLP	28	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2021	90	2					215	223		10.1097/TA.0000000000002985			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	QH5QD	WOS:000618329200007	33060534				2022-02-06	
J	Fuller, LH; Donahue, SW				Fuller, Luca H.; Donahue, Seth W.			Material properties of bighorn sheep (Ovis canadensis) horncore bone with implications for energy absorption during impacts	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Cortical bone; Horncore bone; Energy absorption; Impact; Structure-function relationships	MECHANICAL-PROPERTIES; CORTICAL BONE; MICRODAMAGE ACCUMULATION; CEMENT LINE; POROSITY; CONCUSSION; BIOMECHANICS; ADAPTATION; MORPHOLOGY; PHYSIOLOGY	Bighorn sheep rams participate in high impact head-butting without overt signs of brain injury, thus providing a naturally occurring animal model for studying brain injury mitigation. Previously published finite element modeling showed that both the horn and bone materials play important roles in reducing brain cavity accelerations during ramming. However, in that study the elastic modulus of bone was assumed to be similar to that of human bone since the modulus of ram bone was unknown. Therefore, the goal of this study was to quantify the mechanical properties, mineral content, porosity, and microstructural organization of horncore cortical bone from juvenile and adult rams. Mineral content and elastic modulus increased with horn size, and porosity decreased. However, modulus of toughness did not change with horn size. This latter finding raises the possibility that the horncore cortical bone has not adapted exceptional toughness despite an extreme loading environment and may function primarily as an interface material between the horn and the porous bone within the horncore. Thus, geometric properties of the horn and horncore, including the porous bone architecture, may be more important for energy absorption during ramming than the horncore cortical bone. Results from this study can be used to improve accuracy of finite element models of bighorn sheep ramming to investigate these possibilities moving forward.	[Fuller, Luca H.; Donahue, Seth W.] Univ Massachusetts, Dept Biomed Engn, Amherst, MA 01003 USA		Fuller, LH (corresponding author), Univ Massachusetts, Dept Biomed Engn, Life Sci Labs, 240 Thatcher Way, Amherst, MA 01003 USA.	lhfuller@umass.edu		Fuller, Luca/0000-0002-1749-6861	State of Colorado Department of Natural Resources	The authors thank the State of Colorado Department of Natural Resources for providing the Scientific collection license to obtain the bighorn sheep skulls used in this study. The authors would also like to acknowledge and thank Steve Johnson at Colorado State University and Greg Lucarelli at the University of Massachusetts for their assistance in preparing mechanical test samples and histology slides, respectively.	BARBOS MP, 1983, ACTA ANAT, V115, P178; Barrera JW, 2016, J ANAT, V229, P568, DOI 10.1111/joa.12500; Beresheim AC, 2018, ANAT REC, V301, P1788, DOI 10.1002/ar.23933; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Buechner H. K., 1960, Wildlife Monographs.; Burr D.B., 2001, BONE MECH HDB; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; BURR DB, 1988, J BIOMECH, V21, P939, DOI 10.1016/0021-9290(88)90132-7; BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0; Currey JD, 2019, BONE, V128, DOI 10.1016/j.bone.2019.115038; Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6; CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1; CURREY JD, 1975, J BONE JOINT SURG BR, V57, P810; CURREY JD, 1979, J BIOMECH, V12, P313, DOI 10.1016/0021-9290(79)90073-3; CURREY JD, 1987, J BIOMECH, V20, P1035, DOI 10.1016/0021-9290(87)90021-2; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Doherty AH, 2015, PHYSIOLOGY, V30, P17, DOI 10.1152/physiol.00022.2014; Donahue Seth W., 2006, Critical Reviews in Biomedical Engineering, V34, P215; Donahue SW, 2018, J MUSCULOSKEL NEURON, V18, P284; Drake A, 2016, ACTA BIOMATER, V44, P41, DOI 10.1016/j.actbio.2016.08.019; Farah G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191526; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Frank JD, 2002, BONE, V30, P201, DOI 10.1016/S8756-3282(01)00623-8; GEIST V, 1966, J WILDLIFE MANAGE, V30, P634, DOI 10.2307/3798763; GOH JCH, 1989, ACTA ORTHOP SCAND, V60, P465, DOI 10.3109/17453678909149321; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Han SH, 2009, J FORENSIC SCI, V54, P519, DOI 10.1111/j.1556-4029.2009.01003.x; Hansen U, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838032; Harvey KB, 2004, J BIOMECH, V37, P1513, DOI 10.1016/j.jbiomech.2004.01.010; Havill LM, 2004, CALCIFIED TISSUE INT, V74, P95, DOI 10.1007/s00223-003-9038-3; Huang W, 2017, ACTA BIOMATER, V64, P1, DOI 10.1016/j.actbio.2017.09.043; Johnson KL, 2017, ACTA BIOMATER, V48, P300, DOI 10.1016/j.actbio.2016.10.033; Krausman P. R., 2003, WILD MAMMALS N AM BI, P1095; Landete-Castillejos T, 2012, BONE, V50, P245, DOI 10.1016/j.bone.2011.10.026; Lee TC, 2002, J ANAT, V201, P437, DOI 10.1046/j.1469-7580.2002.00123.x; Lei J., 2020, J BIOMECH ENG, V142, P1, DOI [10.1115/1.4016690, DOI 10.1115/1.4016690]; Liu YZ, 2017, INT J IMPACT ENG, V108, P263, DOI 10.1016/j.ijimpeng.2017.05.016; MARTIN B, 1992, J ORTHOP RES, V10, P818, DOI 10.1002/jor.1100100611; Martin RB, 2007, BONE, V40, P1574, DOI 10.1016/j.bone.2007.02.023; Martin R.B., 2001, BONE MECH HDB; Martin RB, 2002, BONE, V30, P8, DOI 10.1016/S8756-3282(01)00620-2; MASON MW, 1995, BONE, V17, P229, DOI 10.1016/8756-3282(95)00213-W; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; MCELHANEY JH, 1966, J APPL PHYSIOL, V21, P1231, DOI 10.1152/jappl.1966.21.4.1231; McGee-Lawrence ME, 2009, J BIOMECH, V42, P1378, DOI 10.1016/j.jbiomech.2008.11.039; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mohsin S, 2006, J ANAT, V208, P81, DOI 10.1111/j.1469-7580.2006.00509.x; Mori R, 2005, J VET MED SCI, V67, P1223, DOI 10.1292/jvms.67.1223; Osborne DL, 2005, J HISTOTECHNOL, V28, P73; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; SCHAFFLER MB, 1988, J BIOMECH, V21, P13, DOI 10.1016/0021-9290(88)90186-8; SCHAFFLER MB, 1987, ANAT REC, V217, P223, DOI 10.1002/ar.1092170302; SEDLIN ED, 1965, ACTA ORTHOP SCAND, VS, P5; Seek T.W., 2018, EXPLORATION UNIQUE P; Seref-Ferlengez Z, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.11; Skedros JG, 2004, J MORPHOL, V259, P281, DOI 10.1002/jmor.10167; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Tombolato L, 2010, ACTA BIOMATER, V6, P319, DOI 10.1016/j.actbio.2009.06.033; Trim MW, 2011, ACTA BIOMATER, V7, P1228, DOI 10.1016/j.actbio.2010.11.024; Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8; Vashishth D, 2003, J BIOMECH, V36, P121, DOI 10.1016/S0021-9290(02)00319-6; Wojda SJ, 2013, ANAT REC, V296, P1148, DOI 10.1002/ar.22720; Yeni YN, 1997, BONE, V21, P453, DOI 10.1016/S8756-3282(97)00173-7	66	3	3	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	FEB	2021	114								104224	10.1016/j.jmbbm.2020.104224			9	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	PS8OJ	WOS:000608182900003	33296863				2022-02-06	
J	Gunning, AC; Maier, RV; de Rooij, D; Leenen, LPH; Hietbrink, F				Gunning, Amy C.; Maier, Ronald V.; de Rooij, Doret; Leenen, Luke P. H.; Hietbrink, Falco			Venous thromboembolism (VTE) prophylaxis in severely injured patients: an international comparative assessment	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Venous thromboembolism prophylaxis; Severely injured patients; International comparative assessment; Bleeding complications; Thromboembolic events		Purpose Venous thromboembolisms (VTE) are a major concern after acute survival from trauma. Variations in treatment protocols for trauma patients exist worldwide. This study analyzes the differences in the number of VTE events and the associated complications of thromboprophylaxis between two level I trauma populations utilizing varying treatment protocols. Methods International multicenter trauma registry-based study was performed at the University Medical Center Utrecht (UMCU) in The Netherlands (early commencement chemical prophylaxis), and Harborview Medical Center (HMC) in the United States (restrictive early chemical prophylaxis). All severely injured patients (ISS >= 16), aged >= 18 years, and admitted in 2013 were included. Primary outcomes were VTE [deep venous thrombosis (DVT) (no screening), pulmonary embolism (PE)], and hemorrhagic complications. Results In UMCU, 279 patients were included and in HMC, 974 patients. Overall, 75% of the admitted trauma patients in UMCU and 81% in HMC (p < 0.001) received thromboprophylaxis, of which 100% in and 75% at, respectively, UMCU and HMC consisted of chemical prophylaxis. From these patients, 72% at UMCU and 47% at HMC (p < 0.001) were treated within 48 h after arrival. At UMCU, 4 patients (1.4%) (PE = 3, DVT = 1) and HMC 37 patients (3.8%) (PE = 22, DVT = 16; p = 0.06) developed a VTE. At UMCU, a greater percent of patients with VTE had traumatic brain injuries (TBI). Most VTE occurred despite adequate prophylaxis being given (75% UMCU and 81% HMC). Hemorrhagic complications occurred in, respectively, 4 (1.4%) and 10 (1%) patients in UMCU and HMC (p = 0.570). After adjustment for age, ISS, HLOS, and injury type, no significant difference was demonstrated in UMCU compared to HMC for the development of VTE, OR 2.397, p = 0.102 and hemorrhagic complications, OR 0. 586, p = 0.383. Conclusions A more early commencement protocol resulted in almost twice as much chemical prophylaxis being started within the first 48 h in comparison with a more delayed initiation of treatment. Interestingly, most episodes of VTE developed while receiving recommended prophylaxis. Early chemical thromboprophylaxis did not significantly increase the bleeding complications and it appears to be safe to start early.	[Gunning, Amy C.; de Rooij, Doret; Leenen, Luke P. H.; Hietbrink, Falco] Univ Med Ctr Utrecht, Dept Trauma Surg, Suite G04-228,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; [Maier, Ronald V.] Harborview Med Ctr, Dept Trauma Surg, Seattle, WA USA		Gunning, AC (corresponding author), Univ Med Ctr Utrecht, Dept Trauma Surg, Suite G04-228,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	a.c.gunning@umcutrecht.nl			Nederlandse Organisatie voor Wetenschappelijk OnderzoekNetherlands Organization for Scientific Research (NWO)European Commission [017.009.112] Funding Source: Medline		Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; American College of Surgeons Committee on Trauma, 2006, RESOURCES OPTIMAL CA; [Anonymous], 2015, TROMBOSEPROFYLAXE BI; Barrera LM, 2013, COCHRANE DATABASE SY, V28; Bendinelli C, 2008, CURR OPIN CRIT CARE, V14, P673, DOI 10.1097/MCC.0b013e3283196538; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; Brakenridge SC, 2013, J TRAUMA ACUTE CARE, V74, P1231, DOI 10.1097/TA.0b013e31828cc9a0; Cohn SM, 1999, VASCULAR SURG, V33, P219, DOI 10.1177/153857449903300219; Cuschieri J, 2013, GUIDELINES PREVENTIO; Datta Indraneel, 2010, J Trauma Manag Outcomes, V4, P1, DOI 10.1186/1752-2897-4-1; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Haentjens P, 1996, INJURY, V27, P385, DOI 10.1016/0020-1383(96)00042-3; Hamada SR, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0315-0; Imberti D, 2005, PATHOPHYSIOL HAEMO T, V34, P249, DOI 10.1159/000093103; Joseph B, 2015, AM J SURG, V209, P194, DOI 10.1016/j.amjsurg.2014.03.007; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Latronico N, 2008, MINERVA ANESTESIOL, V74, P543; Margolick J, 2018, CAN J NEUROL SCI, V45, P432, DOI 10.1017/cjn.2017.275; Meissner MH, 2003, J TRAUMA, V54, P224, DOI 10.1097/01.TA.0000046253.33495.70; Minami Christina A, 2015, Adv Surg, V49, P185, DOI 10.1016/j.yasu.2015.03.002; Moore L, 2014, J TRAUMA ACUTE CARE, V77, P322, DOI 10.1097/TA.0000000000000366; Moser, 1988, J INTENSIVE CARE MED, V3, P87, DOI DOI 10.1177/088506668800300205; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; OMALLEY KF, 1990, J TRAUMA, V30, P748, DOI 10.1097/00005373-199006000-00018; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Raskob GE, 2003, CHEST, V124, p379S, DOI 10.1378/chest.124.6_suppl.379S; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Schaible EV, 2013, CURR OPIN ANESTHESIO, V26, P529, DOI 10.1097/01.aco.0000432519.16586.6b; SEVITT S, 1961, BRIT J SURG, V48, P475, DOI 10.1002/bjs.18004821103; van Hensbroek P Boele, 2007, Ned Tijdschr Geneeskd, V151, P234; Velmahos GC, 2000, J TRAUMA, V49, P132, DOI 10.1097/00005373-200007000-00020; Velmahos GC, 2009, ARCH SURG-CHICAGO, V144, P928, DOI 10.1001/archsurg.2009.97; World Health Organization, 2014, INJURIES	40	3	3	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2021	47	1			SI		137	143		10.1007/s00068-019-01208-z			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	QA9JI	WOS:000613758600018	31471670	Green Published, hybrid			2022-02-06	
J	Huber, CM; Patton, DA; Wofford, KL; Margulies, SS; Cullen, DK; Arbogast, KB				Huber, Colin M.; Patton, Declan A.; Wofford, Kathryn L.; Margulies, Susan S.; Cullen, D. Kacy; Arbogast, Kristy B.			Laboratory Assessment of a Headband-Mounted Sensor for Measurement of Head Impact Rotational Kinematics	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							TRAUMATIC BRAIN-INJURY; FOOTBALL	Head impact sensors measure head kinematics in sports, and sensor accuracy is crucial for investigating the potential link between repetitive head loading and clinical outcomes. Many validation studies mount sensors to human head surrogates and compare kinematic measures during loading from a linear impactor. These studies are often unable to distinguish intrinsic instrumentation limitations from variability caused by sensor coupling. The aim of the current study was to evaluate intrinsic sensor error in angular velocity in the absence of coupling error for a common head impact sensor. Two Triax SIM-G sensors were rigidly attached to a preclinical rotational injury device and subjected to rotational events to assess sensor reproducibility and accuracy. Peak angular velocities between the SIM-G sensors paired for each test were correlated (R-2 > 0.99, y=1.00x, p<0.001). SIM-G peak angular velocity correlated with the reference (R-2 = 0.96, y=0.82x, p<0.001); however, SIM-G underestimated the magnitude by 15.0% +/- 1.7% (p<0.001). SIM-G angular velocity rise time (5% to 100% of peak) correlated with the reference (R-2 = 0.97, y=1.06x, p<0.001) but exhibited a slower fall time (100% to 5% of peak) by 9.0 +/- 3.7ms (p<0.001). Assessing sensor performance when rigidly coupled is a crucial first step to interpret on-field SIM-G rotational kinematic data. Further testing in increasing biofidelic conditions is needed to fully characterize error from other sources, such as coupling.	[Huber, Colin M.] Univ Penn, Dept Bioengn, 2716 South St, Philadelphia, PA 19146 USA; [Huber, Colin M.; Patton, Declan A.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent CIRP, 2716 South St, Philadelphia, PA 19146 USA; [Wofford, Kathryn L.] Univ Penn, Dept Neurosurg, 3320 Smith Walk,105 Hayden Hall, Philadelphia, PA 19104 USA; [Margulies, Susan S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, UA Whitaker Bldg,313 Ferst Dr,Suite 2116, Atlanta, GA 30332 USA; [Margulies, Susan S.] Emory Univ, UA Whitaker Bldg,313 Ferst Dr,Suite 2116, Atlanta, GA 30332 USA; [Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Ctr Brain Injury & Repair, 3320 Smith Walk,105E Hayden Hall, Philadelphia, PA 19104 USA; [Cullen, D. Kacy] Univ Penn, Dept Bioengn, 3320 Smith Walk,105E Hayden Hall, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.] Univ Penn, Dept Pediat, 2716 South St, Philadelphia, PA 19146 USA		Huber, CM (corresponding author), Univ Penn, Dept Bioengn, 2716 South St, Philadelphia, PA 19146 USA.; Huber, CM (corresponding author), Childrens Hosp Philadelphia, Ctr Injury Res & Prevent CIRP, 2716 South St, Philadelphia, PA 19146 USA.	chuber3@seas.upenn.edu; pattonda@email.chop.edu; kwofford@pennmedicine.upenn.edu; susan.margulies@gatech.edu; dkacy@pennmedicine.upenn.edu; arbogast@email.chop.edu		HUBER, COLIN/0000-0002-0045-5940	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097549]; Pennsylvania Department of Health (CURE Grant)	National Institute of Neurological Disorders and Stroke (No. R01NS097549; Funder ID: 10.13039/100000065).; Pennsylvania Department of Health (CURE Grant; Funder ID: 10.13039/100004897).	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Bussone WR, 2017, SAE INT J TRANSP SAF, V5, P194, DOI 10.4271/2017-01-1465; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Harriss A, 2019, MUSCULOSKEL SCI PRAC, V40, P53, DOI 10.1016/j.msksp.2019.01.009; Karton C., 2016, 34 INT C BIOM SPORT, P3; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Miller LE, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039165; Nevins D, 2018, P I MECH ENG P-J SPO, V232, P242, DOI 10.1177/1754337117739458; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Oeur RA., 2016, 34 INT C BIOMECHANIC, P4; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sandmo SB, 2019, AM J SPORT MED, V47, P974, DOI 10.1177/0363546519826953; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Steenstrup SE, 2018, BRIT J SPORT MED, V52, P709, DOI 10.1136/bjsports-2017-098050; Tiernan Stephen, 2018, [The Asian Journal of Kinesiology, 아시아 운동학 학술지], V20, P70, DOI 10.15758/ajk.2018.20.4.70; Triax Technologies, 2014, LAB VAL SIM G HEAD I; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7	30	3	3	0	1	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	FEB 1	2021	143	2							024502	10.1115/1.4048574			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	PM2JB	WOS:000603631300016	32975553				2022-02-06	
J	Mesbah, S; Ball, T; Angeli, C; Rejc, E; Dietz, N; Ugiliweneza, B; Harkema, S; Boakye, M				Mesbah, Samineh; Ball, Tyler; Angeli, Claudia; Rejc, Enrico; Dietz, Nicholas; Ugiliweneza, Beatrice; Harkema, Susan; Boakye, Maxwell			Predictors of volitional motor recovery with epidural stimulation in individuals with chronic spinal cord injury	BRAIN			English	Article						spinal cord injury; magnetic resonance imaging; spinal cord epidural stimulation; neuromodulation	CENTRAL PATTERN GENERATOR; ELECTRICAL-STIMULATION; POSTERIOR STRUCTURES; LUMBAR CORD; NEUROMODULATION; LOCOMOTION; PARALYSIS; MOVEMENTS; PATHWAYS; HUMANS	Spinal cord epidural stimulation (scES) has enabled volitional lower extremity movements in individuals with chronic and clinically motor complete spinal cord injury and no clinically detectable brain influence. The aim of this study was to understand whether the individuals' neuroanatomical characteristics or positioning of the scES electrode were important factors influencing the extent of initial recovery of lower limb voluntary movements in those with clinically motor complete paralysis. We hypothesized that there would be significant correlations between the number of joints moved during attempts with scES prior to any training interventions and the amount of cervical cord atrophy above the injury, length of post-traumatic myelomalacia and the amount of volume coverage of lumbosacral enlargement by the stimulation electrode array. The clinical and imaging records of 20 individuals with chronic and clinically motor complete spinal cord injury who underwent scES implantation were reviewed and analysed using MRI and X-ray integration, image segmentation and spinal cord volumetric reconstruction techniques. All individuals that participated in the scES study (n=20) achieved, to some extent, lower extremity voluntary movements post scES implant and prior to any locomotor, voluntary movement or cardiovascular training. The correlation results showed that neither the cross-section area of spinal cord at C3 (n=19, r=0.33, P=0.16) nor the length of severe myelomalacia (n=18, r = -0.02, P=0.93) correlated significantly with volitional lower limb movement ability. However, there was a significant, moderate correlation (n=20, r=0.59, P=0.006) between the estimated percentage of the lumbosacral enlargement coverage by the paddle electrode as well as the position of the paddle relative to the maximal lumbosacral enlargement and the conus tip (n=20, r=0.50, P=0.026) with the number of joints moved volitionally. These results suggest that greater coverage of the lumbosacral enlargement by scES may improve motor recovery prior to any training, possibly because of direct modulatory effects on the spinal networks that control lower extremity movements indicating the significant role of motor control at the level of the spinal cord.	[Mesbah, Samineh; Angeli, Claudia; Rejc, Enrico; Ugiliweneza, Beatrice; Harkema, Susan; Boakye, Maxwell] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Ball, Tyler; Rejc, Enrico; Dietz, Nicholas; Ugiliweneza, Beatrice; Harkema, Susan; Boakye, Maxwell] Univ Louisville, Dept Neurosurg, Louisville, KY 40292 USA; [Angeli, Claudia] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA; [Angeli, Claudia; Harkema, Susan] Univ Louisville Hlth, Frazier Rehab Inst, Louisville, KY USA		Boakye, M (corresponding author), Univ Louisville, Sch Med, Kentucky Spinal Cord Res Ctr, 220 Abraham Flexner Way, Louisville, KY 40292 USA.	max.boakye@louisville.edu		Angeli, Claudia/0000-0003-4127-7121	Christopher and Dana Reeve Foundation [ES-BI-2017]; Craig Neilsen Foundation [ES2-CHN-2013]; Leona M. & Harry B. Helmsley Charitable Trust [2016PG-MED001]; UofL Health - University of Louisville Hospital; Commonwealth of Kentucky Challenge for Excellence Trust Fund; Medtronic Plc.Medtronic; Ole A., Mabel Wise and Wilma Wise Nelson Endowed Research Chair; Owsley Brown Frazier Chair in Neurological Rehabilitation	This work was funded by Christopher and Dana Reeve Foundation (ES-BI-2017), Craig Neilsen Foundation (ES2-CHN-2013), Leona M. & Harry B. Helmsley Charitable Trust (2016PG-MED001), UofL Health -University of Louisville Hospital, Commonwealth of Kentucky Challenge for Excellence Trust Fund and Medtronic Plc. M.B. is supported by the 'Ole A., Mabel Wise and Wilma Wise Nelson Endowed Research Chair'. S.H. is supported by the 'Owsley Brown Frazier Chair in Neurological Rehabilitation'.	Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Angeli CA, 2018, NEW ENGL J MED, V379, P1244, DOI 10.1056/NEJMoa1803588; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Armour BS, 2016, AM J PUBLIC HEALTH, V106, P1855, DOI 10.2105/AJPH.2016.303270; Aslan SC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00565; Bui TV, 2015, J NEUROPHYSIOL, V113, P2824, DOI 10.1152/jn.00866.2014; Bussel B, 1996, PARAPLEGIA, V34, P91, DOI 10.1038/sc.1996.15; Cadotte DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045560; Calvert JS, 2019, NEUROMODULATION, V22, P244, DOI 10.1111/ner.12938; Capogrosso M, 2013, J NEUROSCI, V33, P19326, DOI 10.1523/JNEUROSCI.1688-13.2013; Chang Y, 2010, J NEUROTRAUM, V27, P2033, DOI 10.1089/neu.2009.1265; Cheran S, 2011, J NEUROTRAUM, V28, P1881, DOI 10.1089/neu.2010.1741; Darrow D, 2019, J NEUROTRAUM, V36, P2325, DOI 10.1089/neu.2018.6006; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Ellingson BM, 2008, AM J NEURORADIOL, V29, P1976, DOI 10.3174/ajnr.A1272; Formento E, 2018, NAT NEUROSCI, V21, P1728, DOI 10.1038/s41593-018-0262-6; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Gerasimenko Y, 2008, EXP NEUROL, V209, P417, DOI 10.1016/j.expneurol.2007.07.015; Gill ML, 2018, NAT MED, V24, P1677, DOI 10.1038/s41591-018-0175-7; Grabher P, 2015, ANN NEUROL, V78, P751, DOI 10.1002/ana.24508; Grahn PJ, 2017, MAYO CLIN PROC, V92, P544, DOI 10.1016/j.mayocp.2017.02.014; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Harkema SJ, 2018, JAMA NEUROL, V75, P1569, DOI 10.1001/jamaneurol.2018.2617; Harkema SJ, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00083; Herrity AN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26602-2; Hinkle DE., 2003, APPL STAT BEHAV SCI, V5th; ILLIS LS, 1995, PARAPLEGIA, V33, P239, DOI 10.1038/sc.1995.54; James ND, 2018, LANCET NEUROL, V17, P905, DOI 10.1016/S1474-4422(18)30287-4; JANKOWSKA E, 1973, BRAIN RES, V53, P227, DOI 10.1016/0006-8993(73)90786-5; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kornelsen J, 2007, SPINAL CORD, V45, P485, DOI 10.1038/sj.sc.3102019; McKay WB, 2004, NEUROREHAB NEURAL RE, V18, P144, DOI 10.1177/0888439004267674; Minassian K, 2007, HUM MOVEMENT SCI, V26, P275, DOI 10.1016/j.humov.2007.01.005; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Minassian K, 2013, BIOMED ENG-BIOMED TE, V58, DOI 10.1515/bmt-2013-4013; Murg M, 2000, SPINAL CORD, V38, P394, DOI 10.1038/sj.sc.3101038; Ranganathan Priya, 2017, Perspect Clin Res, V8, P187, DOI 10.4103/picr.PICR_123_17; Rattay F, 2000, SPINAL CORD, V38, P473, DOI 10.1038/sj.sc.3101039; Rejc E, 2019, PHYS MED REH CLIN N, V30, P337, DOI 10.1016/j.pmr.2018.12.009; Rejc E, 2017, J NEUROTRAUM, V34, P1787, DOI 10.1089/neu.2016.4516; Rejc E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133998; Rutman AM, 2018, CURR PROBL DIAGN RAD, V47, P257, DOI 10.1067/j.cpradiol.2017.07.005; Seif M, 2018, NEUROIMAGE-CLIN, V20, P556, DOI 10.1016/j.nicl.2018.08.026; SHERWOOD AM, 1992, J NEUROL SCI, V110, P90, DOI 10.1016/0022-510X(92)90014-C; Squair JW, 2016, J REHABIL MED, V48, P589, DOI 10.2340/16501977-2101; Stroman PW, 2004, SPINAL CORD, V42, P59, DOI 10.1038/sj.sc.3101559; Taccola G, 2018, PROG NEUROBIOL, V160, P64, DOI 10.1016/j.pneurobio.2017.10.004; Tanniou J, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0122-6; Voronin LL, 2004, J PHYSIOL-LONDON, V557, P3, DOI 10.1113/jphysiol.2003.058966; Wagner FB, 2018, NATURE, V563, P65, DOI 10.1038/s41586-018-0649-2; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784; WERNIG A, 1995, EUR J NEUROSCI, V7, P823, DOI 10.1111/j.1460-9568.1995.tb00686.x; West CR, 2018, JAMA NEUROL, V75, P630, DOI 10.1001/jamaneurol.2017.5055	54	3	3	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	FEB	2021	144		2				420	433		10.1093/brain/awaa423			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SA6YB	WOS:000649446500021	33367527	Bronze			2022-02-06	
J	Saber, M; Rice, AD; Christie, I; Roberts, RG; Knox, KS; Nakaji, P; Rowe, RK; Wang, T; Lifshitz, J				Saber, Maha; Rice, Amanda D.; Christie, Immaculate; Roberts, Rebecca G.; Knox, Kenneth S.; Nakaji, Peter; Rowe, Rachel K.; Wang, Ting; Lifshitz, Jonathan			Remote Ischemic Conditioning Reduced Acute Lung Injury After Traumatic Brain Injury in the Mouse	SHOCK			English	Article						Acute lung injury; diffuse brain injury; irisin; mice; myokine; remote ischemic preconditioning; sphingosine-1-phosphate	INFLAMMATORY RESPONSE; ACTIVATION; EXPRESSION; EXERCISE; CONTRIBUTES; MECHANISMS; PROTECTS; IRISIN; HEALTH; MODEL	Traumatic brain injury (TBI) can induce acute lung injury (ALI). The exact pathomechanism of TBI-induced ALI is poorly understood, limiting treatment options. Remote ischemic conditioning (RIC) can mitigate detrimental outcomes following transplants, cardiac arrests, and neurological injuries. In this study, we hypothesized that RIC would reduce TBI-induced ALI by regulating the sphingosine-1-phosphate (S1P)-dependent pathway, a central regulator of endothelial barrier integrity, lymphocyte, and myokine trafficking. Male mice were subjected to either diffuse TBI by midline fluid percussion or control sham injury and randomly assigned among four groups: sham, TBI, sham RIC, or TBI RIC; RIC was performed 1 h prior to TBI. Mice were euthanized at 1-h postinjury or 7 days post-injury (DPI) and lung tissue, bronchoalveolar lavage (BAL) fluid, and blood were collected. Lung tissue was analyzed for histopathology, irisin myokine levels, and S1P receptor levels. BAL fluid and blood were analyzed for cellularity and myokine/S1P levels, respectively. One-hour postinjury, TBI damaged lung alveoli and increased neutrophil infiltration; RIC preserved alveoli. BAL from TBI mice had more neutrophils and higher neutrophil/monocyte ratios compared with sham, where TBI RIC mice showed no injury-induced change. Further, S1P receptor 3 and irisin-associated protein levels were significantly increased in the lungs of TBI mice compared with sham, which was prevented by RIC. However, there was no RIC-associated change in plasma irisin or S1P. At 7 DPI, ALI in TBI mice was largely resolved, with evidence for residual lung pathology. Thus, RIC may be a viable intervention for TBI-induced ALI to preserve lung function and facilitate clinical management.	[Saber, Maha; Christie, Immaculate; Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Saber, Maha; Christie, Immaculate; Rowe, Rachel K.; Lifshitz, Jonathan] Barrow Neurol Inst Phoenix Childrens Hosp, Phoenix, AZ USA; [Rice, Amanda D.; Roberts, Rebecca G.; Knox, Kenneth S.; Wang, Ting] Univ Arizona, Internal Med, Coll Med Phoenix, Phoenix, AZ USA; [Nakaji, Peter] Univ Arizona, Neurosurg, Coll Med Phoenix, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix VA Hlth Care Syst, Phoenix, AZ USA		Lifshitz, J (corresponding author), Univ Arizona, Barrow Neurol Inst, Phoenix Childrens Hosp, Coll Med Phoenix, 425 N 5th St, Phoenix, AZ 85004 USA.	jlifshitz@email.arizona.edu		Saber, Maha/0000-0001-6120-3993; Christie, Immaculate/0000-0001-9282-9198; Rowe, Rachel/0000-0002-9034-3159	Phoenix Children's Hospital Mission Support, Department of Medicine; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01HL134610];  [NIH-T32-AG044402]	This research was funded, in part, by Phoenix Children's Hospital Mission Support, Department of Medicine, NIH-T32-AG044402, and NIH P01HL134610.	Alm AS, 2010, RESP PHYSIOL NEUROBI, V171, P157, DOI 10.1016/j.resp.2010.02.009; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Bromage DI, 2017, CARDIOVASC RES, V113, P288, DOI 10.1093/cvr/cvw219; Candilio L, 2011, J CARDIOVASC PHARM T, V16, P304, DOI 10.1177/1074248411411711; Centers for Disease Control and Prevention (CDC), 2010, TRAUMATIC BRAIN INJU; Chen K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao6298; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cremers NAJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020438; Cuzzocrea S, 2018, J NEUROTRAUM, V35, P1452, DOI 10.1089/neu.2017.5391; Eisner MD, 1999, CRIT CARE MED, V27, P2825, DOI 10.1097/00003246-199912000-00037; Gaire BP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1323-1; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Heinen A, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1480-0; Heusch G, 2015, J AM COLL CARDIOL, V65, P177, DOI 10.1016/j.jacc.2014.10.031; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P698, DOI 10.1097/TA.0000000000000584; Kerr N, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113080; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kim YH, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-16; Korta P, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55080485; Leung CH, 2015, ANN SURG, V261, P1215, DOI 10.1097/SLA.0000000000000877; Li DJ, 2017, METABOLISM, V68, P31, DOI 10.1016/j.metabol.2016.12.003; Li XY, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109363; Lin E, 2014, J HEART LUNG TRANSPL, V33, P1139, DOI 10.1016/j.healun.2014.04.022; Lin HJ, 2017, CELL PHYSIOL BIOCHEM, V44, P1726, DOI 10.1159/000485778; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Nicolls MR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010259; Nikkola E, 2015, STROKE, V46, P2445, DOI 10.1161/STROKEAHA.115.009618; Nikodemova M, 2011, NEUROSCIENCE, V190, P67, DOI 10.1016/j.neuroscience.2011.06.006; Otaka N, 2018, CIRC RES, V123, P1326, DOI 10.1161/CIRCRESAHA.118.313777; Rahar B, 2018, J PHYSIOL SCI, V68, P137, DOI 10.1007/s12576-016-0518-4; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Saber M, 2020, EUR J NEUROSCI, V52, P2791, DOI 10.1111/ejn.14611; Sammani S, 2011, AM J RESP CELL MOL, V45, P1022, DOI 10.1165/rcmb.2010-0267OC; Sandweiss AJ, 2017, J TRAUMA ACUTE CARE, V83, P1074, DOI 10.1097/TA.0000000000001626; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Sun XG, 2012, AM J RESP CELL MOL, V47, P628, DOI 10.1165/rcmb.2012-0048OC; Suryadevara V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010114; Tu TQ, 2020, STEM CELLS DEV, V29, P533, DOI 10.1089/scd.2019.0232; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Villapol S, 2016, NEURAL REGEN RES, V11, P226, DOI 10.4103/1673-5374.177720; Wang LC, 2014, CRIT CARE MED, V42, pE189, DOI 10.1097/CCM.0000000000000097; Wang T, 2017, AM J PHYSIOL-LUNG C, V312, pL452, DOI 10.1152/ajplung.00231.2016; Ye YQ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8072156; Zhou XF, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2286	51	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	FEB	2021	55	2					256	267		10.1097/SHK.0000000000001618			12	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	SV3ND	WOS:000663728300014	32769821	Bronze			2022-02-06	
J	Shriki, J; Galvagno, SM				Shriki, Jesse; Galvagno, Samuel M., Jr.			Sedation for Rapid Sequence Induction and Intubation of Neurologically Injured Patients	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Rapid sequence intubation; Anesthesia; Sedation; Neurologic disease	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; ENDOTRACHEAL INTUBATION; INTRAVENOUS LIDOCAINE; TRACHEAL INTUBATION; CEREBRAL-ISCHEMIA; UNITED-STATES; ETOMIDATE; PROPOFOL; HYPOTENSION		[Shriki, Jesse] Univ Maryland, Surg Crit Care, R Adams Cowley Shock Trauma Ctr, Program Trauma,Sch Med, 22 South Greene St, Baltimore, MD 21201 USA; [Galvagno, Samuel M., Jr.] Univ Maryland, Multi Trauma Crit Care Unit, R Adams Cowley Shock Trauma Ctr, Program Trauma,Sch Med, Baltimore, MD USA		Shriki, J (corresponding author), Univ Maryland, Surg Crit Care, R Adams Cowley Shock Trauma Ctr, Program Trauma,Sch Med, 22 South Greene St, Baltimore, MD 21201 USA.	Jesse.Shriki@umm.edu					Alday NJ, 2014, J CRIT CARE, V29, P517, DOI 10.1016/j.jcrc.2014.02.002; Archambault P, 2012, CAN J EMERG MED, V14, P270, DOI 10.2310/8000.2012.120453; Asserhoj LL, 2016, BRIT J ANAESTH, V116, P77, DOI 10.1093/bja/aev360; Bernard Stephen A, 2006, Emerg Med Australas, V18, P221, DOI 10.1111/j.1742-6723.2006.00850.x; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Davis D P, 2001, Prehosp Emerg Care, V5, P163, DOI 10.1080/10903120190940065; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Denninghoff KR, 2008, WEST J EMERG MED, V9, P184; Dietrich SK, 2018, AM SURGEON, V84, P1504; DONEGAN MF, 1980, ANESTHESIOLOGY, V52, P516, DOI 10.1097/00000542-198006000-00014; DRUMMOND JC, 1995, NEUROSURGERY, V37, P742, DOI 10.1227/00006123-199510000-00019; Eames WO, 1996, ANESTHESIOLOGY, V84, P1307, DOI 10.1097/00000542-199606000-00005; Filanovsky Y, 2010, CAN J EMERG MED, V12, P154; Groth CM, 2018, J CRIT CARE, V45, P65, DOI 10.1016/j.jcrc.2018.01.017; Guihard B, 2019, JAMA-J AM MED ASSOC, V322, P2303, DOI 10.1001/jama.2019.18254; Hinkewich C, 2014, CAN J ANESTH, V61, P650, DOI 10.1007/s12630-014-0161-6; Hoffman WE, 1997, NEUROL RES, V19, P41; HOLDCROFT A, 1976, BRIT J ANAESTH, V48, P199, DOI 10.1093/bja/48.3.199; Ishimaru T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53360-6; Johnson KB, 2003, ANESTHESIOLOGY, V99, P409, DOI 10.1097/00000542-200308000-00023; Jung JY, 2015, KOREAN J ANESTHESIOL, V68, P213, DOI 10.4097/kjae.2015.68.3.213; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Khan FA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004087.pub2; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Lin CC, 2012, AM J EMERG MED, V30, P1782, DOI 10.1016/j.ajem.2012.02.013; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Martyn JAJ, 2006, ANESTHESIOLOGY, V104, P158, DOI 10.1097/00000542-200601000-00022; Michetti CP, 2012, J TRAUMA ACUTE CARE, V72, P924, DOI 10.1097/TA.0b013e3182479884; Mort TC, 2004, J CLIN ANESTH, V16, P508, DOI 10.1016/j.jclinane.2004.01.007; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Osler T, 2016, INJURY, V47, P1879, DOI 10.1016/j.injury.2016.04.016; Patanwala AE, 2016, PHARMACOTHERAPY, V36, P57, DOI 10.1002/phar.1683; Picetti E, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0270-1; PINAUD M, 1990, ANESTHESIOLOGY, V73, P404, DOI 10.1097/00000542-199009000-00007; Poste Jennifer C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.04.006; PRIOR JGL, 1983, INTENS CARE MED, V9, P313, DOI 10.1007/BF01692549; Qi DY, 2013, MINERVA ANESTESIOL, V79, P1423; Ravussin P, 1988, Anaesthesia, V43 Suppl, P37, DOI 10.1111/j.1365-2044.1988.tb09066.x; Robinson N, 2001, EMERG MED J, V18, P453, DOI 10.1136/emj.18.6.453; Schifilliti D, 2010, CNS DRUGS, V24, P893, DOI 10.2165/11584760-000000000-00000; Shafer SL, 2004, ANESTHESIOLOGY, V101, P567, DOI 10.1097/00000542-200409000-00002; Sikorski RA, 2014, CURR ANESTHESIOL REP, V4, P225, DOI DOI 10.1007/s40140-014-0066-5; Smischney NJ, 2012, J TRAUMA ACUTE CARE, V73, P94, DOI 10.1097/TA.0b013e318250cdb8; Smischney NJ, 2019, J TRAUMA ACUTE CARE, V87, P883, DOI 10.1097/TA.0000000000002448; Spaite DW, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.1152; Steiner LA, 2003, ANESTH ANALG, V97, P572, DOI 10.1213/01.ANE.0000070234.17226.B0; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Taha SK, 2010, ANAESTHESIA, V65, P358, DOI 10.1111/j.1365-2044.2010.06243.x; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Vaillancourt C, 2007, ANN EMERG MED, V49, P86, DOI 10.1016/j.annemergmed.2006.09.002; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Weingart S, 2007, ANN EMERG MED, V50, P353, DOI 10.1016/j.annemergmed.2007.02.032; Xu RY, 2018, BMJ OPEN, V8; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y; Zeiler FA, 2014, NEUROCRIT CARE, V20, P502, DOI 10.1007/s12028-013-9939-6	66	3	3	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	FEB	2021	39	1					203	216		10.1016/j.emc.2020.09.012			14	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	OY8ZS	WOS:000594529600014	33218658				2022-02-06	
J	Soto, JM; Feng, DX; Sun, HY; Zhang, YL; Lyon, KA; Liang, BQ; Reed, LK; Huang, JH				Soto, Jose M.; Feng, Dongxia; Sun, Huaiyu; Zhang, Yilu; Lyon, Kristopher A.; Liang, Buqing; Reed, Laura K.; Huang, Jason H.			Novel Decompressive Hemicraniectomy Technique for Traumatic Brain Injury: Technical Note	WORLD NEUROSURGERY			English	Article						Decompression; Hemicraniectomy; TBI; Technical note; Traumatic brain injury		BACKGROUND: Traumatic brain injury (TBI) is a significant cause of morbidity and mortality across all age groups. Decompressive hemicraniectomy is the treatment for TBI-related refractory intracranial hypertension. The traditional technique for this procedure can result in wound complications due to injury of the scalp flap's vascular supply, namely the superficial temporal and postauricular arteries. METHODS: In this technical note we describe our experience using a novel technique that preserves both vascular territories by placing the inferior aspect of the incision posterior to the ear as opposed to anterior to it. This modification has the potential to reduce wound healing complications, especially in those at higher risk, while also reducing operative time by avoiding temporalis muscle incision and closure during procedure. RESULTS: After performing hospital chart review, a total of 7 patients were found who underwent this hemicraniectomy technique for severe TBI. Of these, 5 patients had this performed on the left side, and 2 patients had this performed on the right side. Six of the patients had an accompanying subdural hematoma, whereas 1 patient had no intracranial hemorrhage present. CONCLUSIONS: In each case, both the superficial temporal and postauricular arteries were preserved, and rapid healing of the scalp flap occurred. In addition to providing a large bone window to allow the brain to swell, this technique has the potential to reduce complications of wound healing by preserving the vascular supply of the scalp flap and reduce operative times by minimizing temporalis muscle dissection.	[Soto, Jose M.; Feng, Dongxia; Zhang, Yilu; Lyon, Kristopher A.; Liang, Buqing; Reed, Laura K.; Huang, Jason H.] Baylor Scott & White Med Ctr, Dept Neurosurg, Temple, TX 76508 USA; [Soto, Jose M.; Feng, Dongxia; Zhang, Yilu; Lyon, Kristopher A.; Liang, Buqing; Reed, Laura K.; Huang, Jason H.] Texas A&M Univ, Dept Surg, Coll Med, Temple, TX 76508 USA; [Sun, Huaiyu] Tiemei Gen Hosp, Dept Neurosurg, Tieling City, Liaoning, Peoples R China		Huang, JH (corresponding author), Baylor Scott & White Med Ctr, Dept Neurosurg, Temple, TX 76508 USA.; Huang, JH (corresponding author), Texas A&M Univ, Dept Surg, Coll Med, Temple, TX 76508 USA.	Jason.Huang@BSWHealth.org		Reed, Laura/0000-0002-7226-2179; Huang, Jason/0000-0002-4426-0168			Balan C, 2009, ROM NEUROSURG, V16, P20; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2015, REPORT C TRAUMATIC B; Di Rienzo Alessandro, 2016, Surg Neurol Int, V7, pS737; GUDEMAN SK, 1982, CLIN NEUR, V29, P326; Holland M, 2004, OPER TECH NEUROSURG, V7, P10, DOI DOI 10.1053/J.OTNS.2004.04.006; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Lyon KA, 2019, OPER NEUROSURG, V17, P273, DOI 10.1093/ons/opy399; Marion DW, 2006, NEUROSURGERY, V58, P655; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Veldeman M, 2021, J NEUROSURG, V134, P1262, DOI 10.3171/2020.2.JNS193335; Yang Ho Seung, 2016, Korean J Neurotrauma, V12, P72, DOI 10.13004/kjnt.2016.12.2.72	14	3	3	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2021	146						15	19		10.1016/j.wneu.2020.10.054			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QJ6NI	WOS:000619804900154	33075571				2022-02-06	
J	Tucker, R; Falvey, EC; Fuller, GW; Hislop, MD; Patricios, J; Raftery, M				Tucker, R.; Falvey, E. C.; Fuller, Gordon W.; Hislop, M. D.; Patricios, J.; Raftery, M.			Sport Concussion Assessment Tool: baseline and clinical reference limits for concussion diagnosis and management in elite Rugby Union	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Concussion; SCAT; Rugby Union; Neurological screening; Concussion management; Injury	MEDICINE POSITION STATEMENT; NORMATIVE REFERENCE VALUES; HIGH-SCHOOL; PERFORMANCE; EDITION; SOCIETY; SEX	Objectives: Rugby Union has adapted the Sports Concussion Assessment Tool (SCAT) into an abridged off field concussion screen and the complete SCAT is used during diagnostic screens performed after head impact events. No firm guidelines exist as to what should be considered "abnormal" and warrant further evaluation. This study evaluates SCAT performances in 13,479 baseline SCAT assessments, and proposes clear reference limits for each sub-component of the SCAT5. Baseline reference limits are proposed to guide management of baseline testing by identifying abnormal sub-tests, enhancing the clinical validity of baseline screens, while clinical reference limits are identified to support concussion diagnosis when no baseline is available. Design: Cross sectional census sample. Methods: 13,479 baseline SCATs from 7565 elite male rugby players were evaluated. Baseline reference limits were identified for each sub-test as the sub-test result achieved by approximately 5% of the population, while clinical references limits corresponded to the sub-test score achieved by as close as possible to 50% of the cohort. Results: Players reported symptoms 35% (95% CI 1.29-1.42) more frequently during SCAT5 than SCAT3 baseline assessments (mean 1.4 +/- 2.7 vs 1.0 +/- 2.4). Ceiling effects were identified for many cognitive sub tests within the SCAT. Baseline and Clinical reference limits corresponding to the worst performing 5th percentile and 50th percentile were described. Conclusions: Targeted baseline re-testing should be repeated when abnormal sub-tests are identified according to proposed baseline reference limits, while a more conservative clinical reference limit supports concussion diagnosis during screens in diagnostic settings. (C) 2020 Published by Elsevier Ltd on behalf of Sports Medicine Australia.	[Tucker, R.] Univ Cape Town, Sch Management Studies, Rondebosch, South Africa; [Tucker, R.; Falvey, E. C.; Hislop, M. D.; Raftery, M.] World Rugby, Dublin, Ireland; [Falvey, E. C.] Univ Coll Cork, Dept Med, Cork, Ireland; [Fuller, Gordon W.] Univ Sheffield, Ctr Urgent & Emergency Care Res, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Patricios, J.] Univ Witwatersrand, Fac Hlth Sci, Wits Inst Sport & Hlth, Johannesburg, South Africa		Tucker, R (corresponding author), Univ Cape Town, Sch Management Studies, Rondebosch, South Africa.; Tucker, R (corresponding author), World Rugby, Dublin, Ireland.	ross.tucker@mweb.co.za; eanna.falvey@worldrugby.org; g.fuller@sheffield.ac.uk; mike.hislop@worldrugby.org; jpat@mweb.co.za; martin.raftery@worldrugby.org	Hislop, Michael David/I-2339-2019	Fuller, Gordon Ward/0000-0001-8532-3500; Falvey, Eanna/0000-0003-3961-1805	World Rugby	There was no specific funding for the research study, though the research was supported by World Rugby, which employs some of the author group, as described in Competing Interests	[Anonymous], 2019, ARCH CLIN NEUROPSYCH, V32, P963; Attenborough AS, 2014, SPORTS MED, V44, P1545, DOI 10.1007/s40279-014-0218-2; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; CSx, CONC MAN APP APPL AN; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hopkins W, 2010, SPORTSCIENCE, V14, P48; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Norheim N, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000412; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Smith RG, 2018, TRENDS ISS CRIME CRI, P1; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Walton SR, 2018, MED SCI SPORT EXER, V50, P1377, DOI 10.1249/MSS.0000000000001592; World Rugby, HIA PROT DET DESCR; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	22	3	3	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	FEB	2021	24	2					122	128		10.1016/j.jsams.2020.07.006			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PT1CK	WOS:000608357100004	32888810	Green Accepted			2022-02-06	
J	Wang, JL; Jin, GL; Yuan, ZG				Wang, Jian-Li; Jin, Guo-Liang; Yuan, Zi-Gang			Artificial neural network predicts hemorrhagic contusions following decompressive craniotomy in traumatic brain injury	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain Injuries; traumatic; Subarachnoid hemorrhage; traumatic; Decompressive craniectomy	PERFUSION-PRESSURE; MORTALITY; CRANIECTOMY; VALIDATION; PROGNOSIS; MODELS; SCORE	BACKGROUND: This study aimed to explore relevant factors of hemorrhagic contusions following decompressive craniotomy (DC) in traumatic brain injury (TBI) and create an artificial neural network (ANN) prediction model of the risk factors of hemorrhagic contusions. METHODS: This study analyzed 425 patients with TBI who underwent DC in the Neurosurgery Department of Shaoxing People's Hospital between 2009 and 2014. Patients were divided into two groups according to the first postoperative CT scans: hemorrhage group and non-hemorrhage group. Gender, age, preoperative situations (Initial Rotterdam CT Score, GCS Score, pupillary response, laboratory data and preoperative hematoma), the time gap between trauma and DC, postoperative CT scans, and Glasgow Outcome Scale (GOS) scores were recorded. ANN was used to predict hematoma. Correlation analysis was used to state the relationship between increased hemorrhage volumes and GOS scores. RESULTS: The ANN prediction model was established. This model included 11 parameters: initial Rotterdam CT score, GCS score, C-reactive protein, age, the time gap between trauma and DC, pupillary response, platelet count, bone-flap size, glucose level, hernia magnitude and preoperative hematoma volume. The overall predictive accuracy of the model was 73.0%. CONCLUSIONS: Initial Rotterdam CT scores and GCS scores may predict the risk of expansion contusions following DC. The ANN prediction model has a high accuracy to forecast hemorrhage.	[Wang, Jian-Li; Jin, Guo-Liang; Yuan, Zi-Gang] Zhejiang Univ, Shaoxing Peoples Hosp, Dept Neurosurg, Shaoxing Hosp, 568 Zhongxing North Rd, Shaoxing 312000, Peoples R China		Yuan, ZG (corresponding author), Zhejiang Univ, Shaoxing Peoples Hosp, Dept Neurosurg, Shaoxing Hosp, 568 Zhongxing North Rd, Shaoxing 312000, Peoples R China.	zigangyuanton@163.com			public applied research technology projects of Science and Technology bureau of Shaoxing [2012B70075]	This study was funded by the public applied research technology projects of Science and Technology bureau of Shaoxing (2012B70075).	Adams H, 2016, NEUROSURG CLIN N AM, V27, P519, DOI 10.1016/j.nec.2016.05.007; Agatonovic-Kustrin S, 2000, J PHARMACEUT BIOMED, V22, P717, DOI 10.1016/S0731-7085(99)00272-1; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Honeybul S, 2011, J TRAUMA, V71, P128, DOI 10.1097/TA.0b013e3182117b6c; Honeybul S, 2010, ACTA NEUROCHIR, V152, P959, DOI 10.1007/s00701-010-0626-5; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Iorio-Morin C, 2016, CLIN NEUROL NEUROSUR, V142, P48, DOI 10.1016/j.clineuro.2016.01.021; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Prisco L, 2012, J NEUROSURG SCI, V56, P131; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Savegnago RP, 2011, POULTRY SCI, V90, P705, DOI 10.3382/ps.2010-00723; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Wan XY, 2016, WORLD NEUROSURG, V89, P147, DOI 10.1016/j.wneu.2016.01.084; Xie Q, 2017, WORLD NEUROSURG, V100, P118, DOI 10.1016/j.wneu.2016.12.097; Zhang ZY, 2007, PHYTOCHEM ANALYSIS, V18, P109, DOI 10.1002/pca.957	22	3	3	1	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	FEB	2021	65	1					69	74		10.23736/S0390-5616.17.04123-6			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RR4VW	WOS:000643098800010	28884559				2022-02-06	
J	Zhang, Q; Xiong, Y; Li, B; Deng, GY; Fu, WW; Cao, BC; Zong, SH; Zeng, GF				Zhang, Qiong; Xiong, Yin; Li, Bo; Deng, Gui-Ying; Fu, Wen-Wen; Cao, Bai-Chuan; Zong, Shao-Hui; Zeng, Gao-Feng			Total flavonoids of hawthorn leaves promote motor function recovery via inhibition of apoptosis after spinal cord injury	NEURAL REGENERATION RESEARCH			English	Article						apoptosis; Bax protein; Bcl-2 protein; cleaved caspase-3; inflammation; motor function recovery; neuroprotection; Nissl bodies; spinal cord injury; total flavonoids of hawthorn leaves	TRAUMATIC BRAIN-INJURY; NEURONAL APOPTOSIS; RATS; INFLAMMATION; PATHWAY; TRANSPLANTATION; EXPRESSION; DANSHEN; STRESS	Flavonoids have been reported to have therapeutic potential for spinal cord injury. Hawthorn leaves have abundant content and species of total flavonoids, and studies of the effects of the total flavonoids of hawthorn leaves on spinal cord injury have not been published in or outside China. Therefore, Sprague-Dawley rats were used to establish a spinal cord injury model by Allen's method. Rats were intraperitoneally injected with 0.2 mL of different concentrations of total flavonoids of hawthorn leaves (5, 10, and 20 mg/kg) after spinal cord injury. Injections were administered once every 6 hours, three times a day, for 14 days. After treatment with various concentrations of total flavonoids of hawthorn leaves, the Basso, Beattie, and Bresnahan scores and histological staining indicated decreases in the lesion cavity and number of apoptotic cells of the injured spinal cord tissue; the morphological arrangement of the myelin sheath and nerve cells tended to be regular; and the Nissl bodies in neurons increased. The Basso, Beattie, and Bresnahan scores of treated spinal cord injury rats were increased. Western blot assays showed that the expression levels of pro-apoptotic Bax and cleaved caspase-3 were decreased, but the expression level of the anti-apoptotic Bcl-2 protein was increased. The improvement of the above physiological indicators showed a dose-dependent relationship with the concentration of total flavonoids of hawthorn leaves. The above findings confirm that total flavonoids of hawthorn leaves can reduce apoptosis and exert neuroprotective effects to promote the recovery of the motor function of rats with spinal cord injury.	[Zhang, Qiong; Xiong, Yin; Li, Bo; Fu, Wen-Wen; Zeng, Gao-Feng] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Cao, Bai-Chuan; Zong, Shao-Hui] Guangxi Med Univ, Dept Spine Osteopath Surg, Affiliated Hosp 1, Nanning, Guangxi Zhuang, Peoples R China; [Deng, Gui-Ying; Zong, Shao-Hui] Guangxi Med Univ, Res Ctr Regenerat Med, Guangxi Key Lab Regenerat Med, Nanning, Guangxi Zhuang, Peoples R China		Zeng, GF (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi Zhuang, Peoples R China.; Zong, SH (corresponding author), Guangxi Med Univ, Dept Spine Osteopath Surg, Affiliated Hosp 1, Nanning, Guangxi Zhuang, Peoples R China.; Zong, SH (corresponding author), Guangxi Med Univ, Res Ctr Regenerat Med, Guangxi Key Lab Regenerat Med, Nanning, Guangxi Zhuang, Peoples R China.	379244544@qq.com; 1685858372@qq.com		Reis, AlessanRSS/0000-0001-8486-7469	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81860391]; Natural Science Foundation of Guangxi Zhuang Autonomous Region of China [2018GXNSFAA281144]; Key Research and Development Project of Guangxi Zhuang Autonomous Region of China [guikeAB18221021]	The study was supported by the National Natural Science Foundation of China, No. 81860391 (to GFZ); the Natural Science Foundation of Guangxi Zhuang Autonomous Region of China, No. 2018GXNSFAA281144 (to GFZ); the Key Research and Development Project of Guangxi Zhuang Autonomous Region of China, No. guikeAB18221021 (to SHZ). The funding sources had no role in study conception and design, data analysis or interpretation, paper writing or deciding to submit this paper for publication.	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Al-Qathama A, 2017, ONCOTARGET, V8, P95999, DOI 10.18632/oncotarget.21625; Alirezalu A, 2018, INT J FOOD PROP, V21, P452, DOI 10.1080/10942912.2018.1446146; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Cao F, 2020, Zhonghua Zhong Liu Za Zhi, V42, P99, DOI 10.3760/cma.j.issn.0253-3766.2020.02.003; Chen XG, 2018, CHILD NERV SYST, V34, P1479, DOI 10.1007/s00381-018-3792-z; Ding LZ, 2020, EUR REV MED PHARMACO, V24, P11, DOI 10.26355/eurrev_202001_19890; Dong PZ, 2017, J ETHNOPHARMACOL, V198, P479, DOI 10.1016/j.jep.2017.01.040; He ZL, 2017, J CELL MOL MED, V21, P3010, DOI 10.1111/jcmm.13212; Hollinshead WH, 2010, J COMP NEUROL, V62, P155; Huang JH, 2017, J NEUROTRAUM, V34, P3388, DOI 10.1089/neu.2017.5063; Jalan D, 2017, J NEUROSURG-SPINE, V26, P62, DOI 10.3171/2016.6.SPINE16343; Jian YP, 2020, EUR REV MED PHARMACO, V24, P1420, DOI 10.26355/eurrev_202002_20199; Kurkin VA, 2019, PHARM CHEM J+, V52, P850, DOI 10.1007/s11094-019-1913-y; Kwon YH, 2015, MOL CELLS, V38, P630, DOI 10.14348/molcells.2015.0030; Li G, 2017, MOL NEUROBIOL, V54, P7471, DOI 10.1007/s12035-016-0252-1; Liu ZY, 2019, NEUROLOGY, V93, pE841, DOI 10.1212/WNL.0000000000007998; Ma LY, 2010, PHYTOMEDICINE, V17, P640, DOI 10.1016/j.phymed.2009.12.010; Maggio DM, 2012, J NEUROTRAUM, V29, P2244, DOI 10.1089/neu.2012.2371; O'Connor G, 2018, J NEUROTRAUM, V35, P2159, DOI 10.1089/neu.2017.5349; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Oliveri RS, 2014, NEUROBIOL DIS, V62, P338, DOI 10.1016/j.nbd.2013.10.014; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Or CHR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051773; Orr MB, 2018, NEUROTHERAPEUTICS, V15, P541, DOI 10.1007/s13311-018-0631-6; Park KW, 2014, EXP NEUROL, V261, P65, DOI 10.1016/j.expneurol.2014.06.013; Penkowa M, 2006, J NEUROSCI RES, V84, P1452, DOI 10.1002/jnr.21043; Piltti KM, 2017, STEM CELL REP, V8, P1534, DOI 10.1016/j.stemcr.2017.04.009; Rahman MA, 2012, MOL CELL BIOCHEM, V369, P95, DOI 10.1007/s11010-012-1372-1; Sun F, 2020, EUR REV MED PHARMACO, V24, P491, DOI 10.26355/eurrev_202001_20022; Takenaga M, 2006, J CONTROL RELEASE, V110, P283, DOI 10.1016/j.jconrel.2005.10.022; Tsai CY, 2020, ARCH PHYS MED REHAB, V101, P607, DOI 10.1016/j.apmr.2019.11.010; Wan G, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20193315; Wang DJ, 2018, CHIN J INTEGR MED, V24, P265, DOI 10.1007/s11655-016-2450-0; Wang JY, 2018, CELL PHYSIOL BIOCHEM, V49, P595, DOI 10.1159/000492996; Wei ZC, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8142562; Wen L, 2017, MOLECULES, V22, DOI 10.3390/molecules22050767; Wilkins N, 2020, J NEUROTRAUM, V37, P889, DOI 10.1089/neu.2019.6731; Wu P, 2018, J TOXICOL ENV HEAL A, V81, P1108, DOI [10.1080/15287394.2018.1503073, 10.1080/15287394.2018.1504385]; Yu Xin, 2020, Zhongguo Gu Shang, V33, P140, DOI 10.12200/j.issn.1003-0034.2020.02.010; Yu YG, 2019, J SPINAL CORD MED, V42, P355, DOI 10.1080/10790268.2018.1468583; Zhang HY, 2013, CNS NEUROSCI THER, V19, P20, DOI 10.1111/cns.12013; Zhang LX, 2019, J PHARMACEUT BIOMED, V172, P103, DOI 10.1016/j.jpba.2019.04.024; Zhang P, 2017, REV NEUROSCIENCE, V28, P87, DOI 10.1515/revneuro-2016-0053; Zhang Q, 2019, PHYTOMEDICINE, V62, DOI 10.1016/j.phymed.2019.152966; Zhang Q, 2018, NEURAL REGEN RES, V13, P2200, DOI 10.4103/1673-5374.241472; Zhao H, 2016, MOL NEUROBIOL, V53, P187, DOI 10.1007/s12035-014-9000-6; Zhou ZP, 2017, ONCOTARGET, V8, P52078, DOI 10.18632/oncotarget.19107; Zhu Y, 2018, PHYTOMEDICINE, V40, P20, DOI 10.1016/j.phymed.2017.12.037	51	3	3	6	29	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	FEB	2021	16	2					350	356	PMID 32859797	10.4103/1673-5374.286975			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	NU5DI	WOS:000573661500032	32859797	gold, Green Published			2022-02-06	
J	Gage, MC; Thippeswamy, T				Gage, Meghan C.; Thippeswamy, Thimmasettappa			Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases	CNS DRUGS			English	Article							NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; D-ASPARTATE RECEPTOR; FYN TYROSINE KINASE; CHRONIC MYELOGENOUS LEUKEMIA; PERIPHERAL VASCULAR-TONE; OXIDATIVE STRESS; S-NITROSYLATION; DOUBLE-BLIND; MOUSE MODEL	Plain Language Summary Nerve cell death, oxidative stress, and inflammation of the brain are the most common pathological processes of many neurological diseases. These processes are mediated through changes in glial cells, the supporting cells in the brain, via several molecular pathways. Some of these pathways are potential drug targets for the mitigation of brain pathology. In this review, we focus on pathways involving Src family kinases, inducible nitric oxide synthase and nicotinamide adenine dinucleotide phosphate oxidase, and their inhibitors, which are promising agents for modifying neurological diseases. Neurological diseases share common neuroinflammatory and oxidative stress pathways. Both phenotypic and molecular changes in microglia, astrocytes, and neurons contribute to the progression of disease and present potential targets for disease modification. Src family kinases (SFKs) are present in both neurons and glial cells and are upregulated following neurological insults in both human and animal models. In neurons, SFKs interact with post-synaptic protein domains to mediate hyperexcitability and neurotoxicity. SFKs are upstream of signaling cascades that lead to the modulation of neurotransmitter receptors and the transcription of pro-inflammatory cytokines as well as producers of free radicals through the activation of glia. Inducible nitric oxide synthase (iNOS/NOS-II) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2), the major mediators of reactive nitrogen/oxygen species (RNS/ROS) production in the brain, are also upregulated along with the pro-inflammatory cytokines following neurological insult and contribute to disease progression. Persistent neuronal hyperexcitability, RNS/ROS, and cytokines can exacerbate neurodegeneration, a common pathognomonic feature of the most prevalent neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy. Using a wide variety of preclinical disease models, inhibitors of the SFK-iNOS-NOX2 signaling axis have been tested to cure or modify disease progression. In this review, we discuss the SFK-iNOS-NOX2 signaling pathway and their inhibitors as potential CNS targets for major neurological diseases.	[Gage, Meghan C.; Thippeswamy, Thimmasettappa] Iowa State Univ, Ames, IA 50011 USA		Thippeswamy, T (corresponding author), Iowa State Univ, Ames, IA 50011 USA.	tswamy@iastate.edu		Thippeswamy, Thimmasettappa/0000-0002-9326-1896	National Institute of Health, NINDS/CounterACT program [NS099007, NS110648, NS112779]	Support to TT is from the National Institute of Health, NINDS/CounterACT program (NS099007, NS110648, and NS112779).	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ahluwalia MS, 2010, CANCER LETT, V298, P139, DOI 10.1016/j.canlet.2010.08.014; Ahn Jee-Yin, 2014, Exp Neurobiol, V23, P200, DOI 10.5607/en.2014.23.3.200; Almad A, 2018, NAT REV NEUROL, V14, P351, DOI 10.1038/s41582-018-0010-2; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Ansari MA, 2011, FREE RADICAL BIO MED, V51, P171, DOI 10.1016/j.freeradbiomed.2011.03.025; Aoyama K, 2013, INT J MOL SCI, V14, P21021, DOI 10.3390/ijms141021021; Araujo J, 2010, CANCER TREAT REV, V36, P492, DOI 10.1016/j.ctrv.2010.02.015; Arias-Salvatierra D, 2011, CELL SIGNAL, V23, P425, DOI 10.1016/j.cellsig.2010.10.017; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Augsburger F, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101272; Azad GK, 2014, MOL BIOL REP, V41, P2717, DOI 10.1007/s11033-014-3181-y; Bachiller S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00488; Ballarin B, 2018, ACTA PHARMACOL SIN, V39, P661, DOI 10.1038/aps.2018.5; Barua Anupama, 2010, BMC Physiology, V10, P15, DOI 10.1186/1472-6793-10-15; Barua S, 2019, IBRO REP, V7, P59, DOI 10.1016/j.ibror.2019.07.1721; Baselga J, 2010, CLIN CANCER RES, V16, P4876, DOI 10.1158/1078-0432.CCR-10-0748; Beamer E, 2012, EUR J NEUROSCI, V36, P3194, DOI 10.1111/j.1460-9568.2012.08234.x; Beest V., 2006, HEART, V91, P250, DOI [10.1093/eurheartj, DOI 10.1093/eurheartj]; Belarbi K, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0225-5; Beukelman C.J., 2002, ANN GASTROENTEROL, V15, P320; Block ML, 2014, NAT CHEM BIOL, V10, P988, DOI 10.1038/nchembio.1691; Boehm SL, 2004, J PHARMACOL EXP THER, V309, P1154, DOI 10.1124/jpet.103.064444; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Boje KMK, 2004, FRONT BIOSCI-LANDMRK, V9, P763, DOI 10.2741/1268; Branca C, 2017, HUM MOL GENET, V26, P4823, DOI 10.1093/hmg/ddx361; Breen ME, 2014, ANGEW CHEM INT EDIT, V53, P7010, DOI 10.1002/anie.201311096; Bretscher LE, 2003, J BIOL CHEM, V278, P46789, DOI 10.1074/jbc.M306787200; Brindicci C, 2009, CHEST, V135, P353, DOI 10.1378/chest.08-0964; Broom L, 2011, FREE RADICAL BIO MED, V50, P633, DOI 10.1016/j.freeradbiomed.2010.12.026; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cain DP, 1995, EPILEPSY RES, V22, P107, DOI 10.1016/0920-1211(95)00029-1; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Chamoun K, 2020, HEMATOL TRANSF CELL, V42, P80, DOI 10.1016/j.htct.2019.01.003; Chen YT, 2015, J CEREBR BLOOD F MET, V35, P739, DOI 10.1038/jcbfm.2015.16; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Chong YP, 2006, J BIOL CHEM, V281, P32988, DOI 10.1074/jbc.M602951200; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Corbett John A., 1996, Methods (Orlando), V10, P21, DOI 10.1006/meth.1996.0074; Cortes JE, 2020, LEUKEMIA, V34, P2064, DOI 10.1038/s41375-020-0805-1; Cosgrave AS, 2008, NEUROBIOL DIS, V30, P281, DOI 10.1016/j.nbd.2008.02.005; COTGREAVE IA, 1989, BIOCHEM PHARMACOL, V38, P649, DOI 10.1016/0006-2952(89)90211-6; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Dagdeviren M., 2017, NITRIC OXIDE SYNTHAS, DOI [10.5772/67267, DOI 10.5772/67267]; Dalekos G, 2019, J HEPATOL, V70, pE1, DOI 10.1016/S0618-8278(19)30002-7; David B, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43024; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; Degan D, 2018, CURR PHARM DESIGN, V24, P1485, DOI 10.2174/1381612824666180327170632; DePaula-Silva AB, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1545-x; Dhawan G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-117; Diebold BA, 2015, ANTIOXID REDOX SIGN, V23, P375, DOI 10.1089/ars.2014.5862; Dover AR, 2006, CLIN SCI, V111, P275, DOI 10.1042/CS20060104; Drechsel DA, 2008, FREE RADICAL BIO MED, V44, P1873, DOI 10.1016/j.freeradbiomed.2008.02.008; DuPont JJ, 2014, AM J PHYSIOL-RENAL, V306, pF1499, DOI 10.1152/ajprenal.00058.2014; Macias-Perez ME, 2013, BIOSCIENCE REP, V33, P605, DOI 10.1042/BSR20130029; Ehlers MR, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/6817349; Engelhardt, 2010, CLIN EXP NEUROIMMUNO, V1, P79, DOI [10.1111/j.1759-1961.2010.009.x, DOI 10.1111/J.1759-1961.2010.009.X]; Eyo UB, 2019, PROG NEUROBIOL, V179, DOI 10.1016/j.pneurobio.2019.04.003; Fan Y, 2017, MOL CELLS, V40, P163, DOI 10.14348/molcells.2017.0011; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Ferguson JW, 2006, GUT, V55, P542, DOI 10.1136/gut.2005.076562; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Fuentes E, 2018, TRENDS CARDIOVAS MED, V28, P429, DOI 10.1016/j.tcm.2018.03.001; Fujisaka Y, 2013, INVEST NEW DRUG, V31, P108, DOI 10.1007/s10637-012-9809-7; Gage M, 2020, ANN NY ACAD SCI, V1479, P44, DOI 10.1111/nyas.14315; Galanis E, 2019, CANCER-AM CANCER SOC, V125, P3790, DOI 10.1002/cncr.32340; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Ghafourifar P, 1997, FEBS LETT, V418, P291, DOI 10.1016/S0014-5793(97)01397-5; Ghosh A, 2016, J NEUROIMMUNE PHARM, V11, P259, DOI 10.1007/s11481-016-9650-4; Ghosh A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-241; Gilhus NE, 2019, NAT REV NEUROL, V15, P429, DOI 10.1038/s41582-019-0227-8; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Guzman-Martinez L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01008; Hansel TT, 2003, FASEB J, V17, P1298, DOI 10.1096/fj.02-0633fje; Hatano E, 2001, GASTROENTEROLOGY, V120, P1251, DOI 10.1053/gast.2001.23239; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Hou FF, 1998, J AM SOC NEPHROL, V9, P277; Hsieh HL, 2010, NEUROTOX RES, V17, P344, DOI 10.1007/s12640-009-9111-4; Huang WY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1186-5; Huang XJ, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.1928.1928; Huerta PT, 1996, NEUROREPORT, V7, P1685, DOI 10.1097/00001756-199607080-00032; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jakel S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00024; Janakiram NB, 2012, FUTURE MED CHEM, V4, P2193, DOI [10.4155/FMC.12.168, 10.4155/fmc.12.168]; Jarvinen K, 2008, CLIN EXP RHEUMATOL, V26, P275; Jin DZ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0096-17.2017; Jin H, 2014, BBA-MOL BASIS DIS, V1842, P1282, DOI 10.1016/j.bbadis.2013.09.007; Johnson WM, 2012, NUTRIENTS, V4, P1399, DOI 10.3390/nu4101399; Jurd R, 2010, MOL CELL NEUROSCI, V44, P129, DOI 10.1016/j.mcn.2010.03.002; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kantarjian H, 2003, CANCER, V98, P1430, DOI 10.1002/cncr.11665; Kaspar JW, 2011, FASEB J, V25, P1076, DOI 10.1096/fj.10-171553; Kast RE, 2010, TRANSL ONCOL, V3, P13, DOI 10.1593/tlo.09280; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Kim JY, 2017, EXP NEUROBIOL, V26, P195, DOI 10.5607/en.2017.26.4.195; Knott AB, 2009, ANTIOXID REDOX SIGN, V11, P541, DOI [10.1089/ars.2008.2234, 10.1089/ARS.2008.2234]; Knox R, 2015, DEV NEUROSCI-BASEL, V37, P311, DOI 10.1159/000369995; Kojima N, 1998, LEARN MEMORY, V5, P429; Kopincova J, 2012, PHARMACOL REP, V64, P511, DOI 10.1016/S1734-1140(12)70846-0; Kwak YD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-49; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Langley M, 2017, ANTIOXID REDOX SIGN, V27, P1048, DOI 10.1089/ars.2016.6905; Lassman AB, 2015, NEURO-ONCOLOGY, V17, P992, DOI 10.1093/neuonc/nov011; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lee SH, 2012, GLIA, V60, P1366, DOI 10.1002/glia.22355; Lenz KM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00698; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Li ZH, 2013, ACTA PHARM SIN B, V3, P205, DOI 10.1016/j.apsb.2013.06.003; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lieu C, 2010, CLIN COLORECTAL CANC, V9, P89, DOI 10.3816/CCC.2010.n.012; Lind M, 2017, BIOMED PHARMACOTHER, V93, P370, DOI 10.1016/j.biopha.2017.06.036; Lindauer M, 2014, RECENT RESULTS CANC, V201, P27, DOI 10.1007/978-3-642-54490-3_2; Liu CY, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00193; Liu DZ, 2017, NEURAL REGEN RES, V12, P910, DOI 10.4103/1673-5374.208569; Liu DZ, 2016, ACTA NEUROCHIR SUPPL, V121, P185, DOI 10.1007/978-3-319-18497-5_33; Liu TM, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101238; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lu X, 2015, BMB REP, V48, P97, DOI 10.5483/BMBRep.2015.48.2.067; Lu YF, 1999, EUR J NEUROSCI, V11, P75, DOI 10.1046/j.1460-9568.1999.00407.x; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Maiuolo J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092693; Marin M, 2017, J AGR FOOD CHEM, V65, P4083, DOI 10.1021/acs.jafc.7b00872; Matrone C, 2004, J NEUROCHEM, V90, P368, DOI 10.1111/j.1471-4159.2004.02483.x; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McLarnon James G, 2012, Am J Neurodegener Dis, V1, P199; McWalter GK, 2004, J NUTR, V134, p3499S, DOI 10.1093/jn/134.12.3499S; Mendes NF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00382; Minami SS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.014; Mittapalli RK, 2016, MOL CANCER THER, V15, P819, DOI 10.1158/1535-7163.MCT-15-0093; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; Moussa RC, 2001, MOL BRAIN RES, V95, P36, DOI 10.1016/S0169-328X(01)00231-5; Mukherjee P, 2014, CHEM SOC REV, V43, P6814, DOI 10.1039/c3cs60467e; Murillo D, 2011, NITRIC OXIDE-BIOL CH, V25, P70, DOI 10.1016/j.niox.2011.01.003; Nakamura T, 2013, NEURON, V78, P596, DOI 10.1016/j.neuron.2013.05.005; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nogawa S, 1998, P NATL ACAD SCI USA, V95, P10966, DOI 10.1073/pnas.95.18.10966; Nygaard HB, 2018, BIOL PSYCHIAT, V83, P369, DOI 10.1016/j.biopsych.2017.06.004; Nygaard HB, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0119-0; Nygaard HB, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt238; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Olgen S, 2008, ARCH PHARM, V341, P113, DOI 10.1002/ardp.200700141; Olsen ML, 2015, J NEUROSCI, V35, P13827, DOI 10.1523/JNEUROSCI.2603-15.2015; Panday A, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.89; Panicker N, 2015, J NEUROSCI, V35, P10058, DOI 10.1523/JNEUROSCI.0302-15.2015; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Perez-Asenio FJ, 2005, NEUROBIOL DIS, V18, P375, DOI 10.1016/j.nbd.2004.10.018; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Peters EA, 2001, FREE RADICAL BIO MED, V31, P1442, DOI 10.1016/S0891-5849(01)00725-0; PETERSON DA, 1992, BIOCHEM BIOPH RES CO, V187, P797, DOI 10.1016/0006-291X(92)91266-S; Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628; Prado Carla M, 2011, ISRN Allergy, V2011, P832560, DOI 10.5402/2011/832560; Prebil Mateja, 2011, Archives of Physiology and Biochemistry, V117, P64, DOI 10.3109/13813455.2010.539616; Purcell AL, 2003, TRENDS NEUROSCI, V26, P625, DOI 10.1016/j.tins.2003.09.005; Putra M, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.592374; Putra M, 2020, ANN NY ACAD SCI, V1479, P75, DOI 10.1111/nyas.14314; Putra M, 2020, NEUROBIOL DIS, V133, DOI 10.1016/j.nbd.2019.03.031; Puttachary S, 2016, NEUROBIOL DIS, V93, P184, DOI 10.1016/j.nbd.2016.05.013; Qu J, 2012, PRION, V6, P364, DOI 10.4161/pri.21250; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rehni AK, 2009, NITRIC OXIDE-BIOL CH, V21, P120, DOI 10.1016/j.niox.2009.06.001; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sanz-Blasco S, 2018, MOL NEUROBIOL, V55, P5125, DOI 10.1007/s12035-017-0748-3; Schiff D, 2015, NEURO-ONCOLOGY, V17, P910, DOI 10.1093/neuonc/nov086; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shah NP, 2015, AM J HEMATOL, V90, P1060, DOI 10.1002/ajh.24174; Sharma B, 2013, PHARMACOL BIOCHEM BE, V103, P821, DOI 10.1016/j.pbb.2012.11.011; Sharma S, 2019, J NEUROSCI RES, V97, P1363, DOI 10.1002/jnr.24205; Sharma S, 2018, NEUROBIOL DIS, V110, P102, DOI 10.1016/j.nbd.2017.11.008; Shekh-Ahmad T, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101278; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shim HJ, 2017, ONCOL LETT, V13, P1463, DOI 10.3892/ol.2017.5564; Sierra A, 2019, TRENDS NEUROSCI, V42, P778, DOI 10.1016/j.tins.2019.09.004; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Skaper SD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00072; Socodato R, 2015, GLIA, V63, P497, DOI 10.1002/glia.22767; Sonar SA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00710; Srinivasan M, 2015, EXPERT OPIN THER TAR, V19, P471, DOI 10.1517/14728222.2014.989834; Staunton CA, 2018, EXP PHYSIOL, V103, P535, DOI 10.1113/EP086764; Stefanska J, 2012, EXP LUNG RES, V38, P90, DOI 10.3109/01902148.2011.649823; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Stover JF, 2014, J NEUROTRAUM, V31, P1599, DOI 10.1089/neu.2014.3344; Suh YH, 2018, MOL CELL NEUROSCI, V91, P10, DOI 10.1016/j.mcn.2018.03.014; Szepesi Z, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00323; Talukder MAH, 2010, AM J PHYSIOL-HEART C, V299, pH437, DOI 10.1152/ajpheart.00384.2010; Tang Y, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00542; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Tannich F, 2020, INFLAMMOPHARMACOLOGY, V28, P487, DOI 10.1007/s10787-019-00655-9; Tegtmeier F, 2020, TRIALS, V21, DOI 10.1186/s13063-019-3965-4; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Thippeswamy T, 2006, HISTOL HISTOPATHOL, V21, P445, DOI 10.14670/HH-21.445; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Trepanier CH, 2012, FEBS J, V279, P12, DOI 10.1111/j.1742-4658.2011.08391.x; Tse K, 2019, J NEUROSCI RES, V97, P1378, DOI 10.1002/jnr.24441; Tyryshkin A, 2014, CANCER RES, V74, P1996, DOI 10.1158/0008-5472.CAN-13-1256; van Dyck CH, 2019, JAMA NEUROL, V76, P1219, DOI 10.1001/jamaneurol.2019.2050; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Vitecek J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/318087; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; Walker G, 1997, J BIOL CHEM, V272, P16679, DOI 10.1074/jbc.272.26.16679; Waller CF, 2010, RECENT RESULTS CANC, V184, P3, DOI 10.1007/978-3-642-01222-8_1; Wang JYJ, 2014, MOL CELL BIOL, V34, P1188, DOI 10.1128/MCB.01454-13; Wang Q, 2008, PHYTOMEDICINE, V15, P496, DOI 10.1016/j.phymed.2007.09.019; Xian M, 2002, BIOORGAN MED CHEM, V10, P3049, DOI 10.1016/S0968-0896(02)00155-4; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; Yang HY, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00045; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zenaro E, 2017, NEUROBIOL DIS, V107, P41, DOI 10.1016/j.nbd.2016.07.007; ZHANG L, 2016, OXID MED CELL LONGEV, V2016, DOI DOI 10.1155/2016/5026984; Zhou T, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00077; Zhu YQ, 2005, J AM CHEM SOC, V127, P858, DOI 10.1021/ja0445645; Zitka O, 2012, ONCOL LETT, V4, P1247, DOI 10.3892/ol.2012.931	232	3	3	0	7	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1172-7047	1179-1934		CNS DRUGS	CNS Drugs	JAN	2021	35	1					1	20		10.1007/s40263-020-00787-5		JAN 2021	20	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	QF3BO	WOS:000613053600002	33515429	Green Accepted			2022-02-06	
J	Yu, YF; Hou, K; Ji, T; Wang, XS; Liu, YN; Zheng, YY; Xu, JY; Hou, Y; Chi, GF				Yu, Yifei; Hou, Kun; Ji, Tong; Wang, Xishu; Liu, Yining; Zheng, Yangyang; Xu, Jinying; Hou, Yi; Chi, Guangfan			The role of exosomal microRNAs in central nervous system diseases	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Exosome; MicroRNA; Central nervous system; Intercellular communication; Biomarker		MicroRNAs (miRNA), endogenous non-coding RNAs approximately 22 nucleotides long, regulate gene expression by mediating translational inhibition or mRNA degradation. Exosomes are a tool for intercellular transmission of information in which miRNA exchange plays an important role. Under pathophysiological conditions in the central nervous system (CNS), cellular transmission of exosomal miRNAs can regulate signaling pathways. Exosomal miRNAs are involved in the occurrence and development of diverse CNS diseases, such as traumatic brain injury, spinal cord injury, stroke, neurodegenerative diseases, epilepsy, and glioma. The use of exosomes as transport vehicles for certain miRNAs provides a novel therapeutic strategy for CNS diseases. Furthermore, the exosomes in body fluids change with the occurrence of diseases, indicating that subtle changes in physiological and pathological processes in vivo could be recognized by analyzing exosomes. Exosomal analysis is expected to act as a novel tool for diagnosis and prediction of neurological diseases. In this review, we present the current understanding of the implications of miRNAs in CNS diseases and summarize the role and mechanism of action of exosomal miRNA in nervous system disease models.	[Yu, Yifei; Ji, Tong; Zheng, Yangyang; Xu, Jinying; Chi, Guangfan] Jilin Univ, Coll Basic Med Sci, Key Lab Pathobiol, Minist Educ, Changchun 130000, Peoples R China; [Hou, Kun] First Hosp Jilin Univ, Dept Neurosurg, Changchun 130000, Peoples R China; [Wang, Xishu; Liu, Yining] Jilin Univ, Clin Med Coll, Changchun 130000, Peoples R China; [Hou, Yi] Jilin Univ, Dept Regenerat Med, Sch Pharmaceut Sci, Changchun 130000, Peoples R China		Chi, GF (corresponding author), Jilin Univ, Coll Basic Med Sci, Key Lab Pathobiol, Minist Educ, Changchun 130000, Peoples R China.; Hou, Y (corresponding author), Jilin Univ, Dept Regenerat Med, Sch Pharmaceut Sci, Changchun 130000, Peoples R China.	houyi@jlu.edu.cn; guangfan130@jlu.edu.cn		Hou, Kun/0000-0001-7112-7883	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571199, 81870974]	This work was supported by the National Natural Science Foundation of China (Grant number 81571199, Grant number 81870974).	Alenquer M, 2015, VIRUSES-BASEL, V7, P5066, DOI 10.3390/v7092862; Anel A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020154; Batool A, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01404; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1038/nrdp.2017.71, 10.1056/NEJMc1710379]; Cai Q, 2018, B CANCER, V105, P643, DOI 10.1016/j.bulcan.2018.05.003; Chen F, 2015, TRANSL STROKE RES, V6, P478, DOI 10.1007/s12975-015-0429-3; Chen JJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7027380; Cheng Q, 2018, J AM CHEM SOC, V140, P16413, DOI 10.1021/jacs.8b10047; Ding SQ, 2019, EXP BIOL MED, V244, P1149, DOI 10.1177/1535370219872759; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Figueroa J, 2017, CANCER RES, V77, P5808, DOI 10.1158/0008-5472.CAN-16-2524; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Friedli L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5811; Gross C, 2016, CELL REP, V17, P37, DOI 10.1016/j.celrep.2016.08.074; Guo XF, 2019, INT J CANCER, V144, P3111, DOI 10.1002/ijc.32052; Guo XF, 2018, ONCOGENE, V37, P4239, DOI 10.1038/s41388-018-0261-9; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; He CJ, 2018, THERANOSTICS, V8, P237, DOI 10.7150/thno.21945; Hombach S., 2016, ADV EXP MED BIOL, DOI 10.1007/978-3-319-42059-2_1; Hou K, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1725-8; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Hu XY, 2016, CIRC RES, V118, P970, DOI 10.1161/CIRCRESAHA.115.307516; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Ji WC, 2019, BIOCHIMIE, V167, P171, DOI 10.1016/j.biochi.2019.10.002; Jiang, 2012, J NEUROTRAUM, DOI DOI 10.1089/NEU.2011.2134; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Katsuno M, 2018, NAGOYA J MED SCI, V80, P289, DOI 10.18999/nagjms.80.3.289; Koh SH, 2017, TRANSL STROKE RES, V8, P3, DOI 10.1007/s12975-016-0460-z; Kojima R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03733-8; Kong FL, 2018, ARTIF CELL NANOMED B, V46, P200, DOI 10.1080/21691401.2017.1304408; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Li CG, 2020, ARCH PHYSIOL BIOCHEM, V126, P369, DOI 10.1080/13813455.2019.1691601; Li D, 2019, NEUROCHEM RES, V44, P1903, DOI 10.1007/s11064-019-02825-1; Li D, 2019, MED SCI MONITOR, V25, P1871, DOI 10.12659/MSM.915727; Li D, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00845; Li DB, 2017, CURR NEUROVASC RES, V14, P330, DOI 10.2174/1567202614666171005153434; Li Q, 2016, FEBS J, V283, P1720, DOI 10.1111/febs.13697; Li Q, 2015, INT J CLIN EXP PATHO, V8, P12234; Li SP, 2018, ACTA PHARMACOL SIN, V39, P542, DOI 10.1038/aps.2017.178; Lipeng, 2019, INT J MOL SCI, DOI [10.3390/ijms21010120, DOI 10.3390/IJMS21010120]; Liu CG, 2014, MOL MED REP, V10, P2395, DOI 10.3892/mmr.2014.2484; Liu W, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1726-7; Long XB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01761-0; Lu TX, 2018, J ALLERGY CLIN IMMUN, V141, P1202, DOI 10.1016/j.jaci.2017.08.034; Lu XC, 2015, CELL PHYSIOL BIOCHEM, V35, P246, DOI 10.1159/000369692; Lukiw WJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145078; Luo XM, 2019, J MOL NEUROSCI, V69, P516, DOI 10.1007/s12031-019-01341-9; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mak MKY, 2019, INT REV NEUROBIOL, V147, P1, DOI 10.1016/bs.irn.2019.06.001; Matej R, 2019, CLIN BIOCHEM, V73, P26, DOI 10.1016/j.clinbiochem.2019.08.005; Milane L, 2015, J CONTROL RELEASE, V219, P278, DOI 10.1016/j.jconrel.2015.06.029; Mingming J., 2018, CELL PHYSIOL BIOCHEM, DOI DOI 10.1159/000490078; Monfared H, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00782; Moshe SL, 2015, LANCET, V385, P884, DOI 10.1016/S0140-6736(14)60456-6; Niu M, 2016, NEUROSCIENCE, V325, P39, DOI 10.1016/j.neuroscience.2016.03.042; Oskarsson B, 2018, MAYO CLIN PROC, V93, P1617, DOI 10.1016/j.mayocp.2018.04.007; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Pinto S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00273; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Qing LM, 2018, NEUROREHAB NEURAL RE, V32, P765, DOI 10.1177/1545968318798955; Ridolfi B, 2017, CURR GENE THER, V17, P327, DOI 10.2174/1566523218666180119120726; Sandrow-Feinberg HR, 2015, BRAIN RES, V1619, P12, DOI 10.1016/j.brainres.2015.03.052; Saraiva C, 2016, J CONTROL RELEASE, V235, P291, DOI 10.1016/j.jconrel.2016.06.005; Shakespear N, 2020, NEUROCHEM RES, V45, P1020, DOI 10.1007/s11064-020-02977-5; Shen HT, 2018, J MOL NEUROSCI, V64, P421, DOI 10.1007/s12031-018-1041-2; Shi R, 2015, ONCOTARGET, V6, P26971, DOI 10.18632/oncotarget.4699; Sim SE, 2014, MOL CELLS, V37, P511, DOI 10.14348/molcells.2014.0132; Smith SD, 2011, RADIOL CLIN N AM, V49, P27, DOI 10.1016/j.rcl.2010.07.011; Song YY, 2019, THERANOSTICS, V9, P2910, DOI 10.7150/thno.30879; Tabibkhooei A, 2020, CLIN NEUROL NEUROSUR, V190, DOI 10.1016/j.clineuro.2019.105652; Tan L, 2015, MOL NEUROBIOL, V51, P1249, DOI 10.1007/s12035-014-8803-9; Theis V, 2018, CURR PROTEIN PEPT SC, V19, P589, DOI 10.2174/1389203719666180104113937; Thijs RD, 2019, LANCET, V393, P689, DOI 10.1016/S0140-6736(18)32596-0; Tiwari D, 2018, DEV DYNAM, V247, P94, DOI 10.1002/dvdy.24582; Tomasetti M, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.153; Urbanelli Lorena, 2015, Recent Pat CNS Drug Discov, V10, P10; Vieira MS, 2018, BIOTECHNOL ADV, V36, P1946, DOI 10.1016/j.biotechadv.2018.08.002; Vilaca-Faria H, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020118; Vishnoi A, 2017, METHODS MOL BIOL, V1509, P1, DOI 10.1007/978-1-4939-6524-3_1; Wang L, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00053; Wang W, 2018, CEREBROVASC DIS, V45, P204, DOI 10.1159/000488365; Wang ZF, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1181-4; Wei H, 2018, NEUROSCIENCE, V379, P167, DOI 10.1016/j.neuroscience.2018.03.016; Wu PP, 2018, CYTOTHERAPY, V20, P291, DOI 10.1016/j.jcyt.2017.11.002; Wu XB, 2017, MOL NEUROBIOL, V54, P6885, DOI 10.1007/s12035-016-0187-6; Xin HQ, 2017, STROKE, V48, P747, DOI 10.1161/STROKEAHA.116.015204; Xin HQ, 2017, CELL TRANSPLANT, V26, P243, DOI 10.3727/096368916X693031; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xu HY, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1446-z; Xu Q, 2018, INTRACTABLE RARE DIS, V7, P13, DOI 10.5582/irdr.2017.01091; Yan SF, 2017, ONCOTARGET, V8, P4136, DOI 10.18632/oncotarget.13744; Yang DB, 2020, THERANOSTICS, V10, P3684, DOI 10.7150/thno.41580; Yang JL, 2017, MOL THER-NUCL ACIDS, V7, P278, DOI 10.1016/j.omtn.2017.04.010; Yang TT, 2018, BIOMED ENVIRON SCI, V31, P87, DOI 10.3967/bes2018.011; Yang YX, 2019, NEUROCHEM RES, V44, P811, DOI 10.1007/s11064-018-02714-z; Yang YJ, 2018, J MOL NEUROSCI, V65, P74, DOI 10.1007/s12031-018-1071-9; Yao YF, 2018, EUR REV MED PHARMACO, V22, P5278, DOI 10.26355/eurrev_201808_15727; Yelick J, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113414; Yin JX, 2019, EBIOMEDICINE, V42, P238, DOI 10.1016/j.ebiom.2019.03.016; Yin ZY, 2020, BRAIN BEHAV IMMUN, V83, P270, DOI 10.1016/j.bbi.2019.11.004; Yu L, 2019, AGING-US, V11, P5300, DOI 10.18632/aging.102092; Yu T, 2019, BRAZ J MED BIOL RES, V52, DOI [10.1590/1414-431X20198735, 10.1590/1414-431x20198735]; YU X, 2016, INT J MOL SCI, DOI DOI 10.3390/ijms17101770; Yue X, 2019, MOL THER, V27, P1939, DOI 10.1016/j.ymthe.2019.07.011; Zhan Q, 2020, THERANOSTICS, V10, P7889, DOI 10.7150/thno.45028; Zhang XF, 2015, J INEQUAL APPL, DOI 10.1186/1029-242X-2015-1; Zhou JX, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1196-z	109	3	3	5	12	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	MAY	2021	476	5					2111	2124		10.1007/s11010-021-04053-0		JAN 2021	14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	RP7CA	WOS:000613986100001	33528706				2022-02-06	
J	Li, C; Kuss, M; Kong, YF; Nie, FJ; Liu, XY; Liu, B; Dunaevsky, A; Fayad, P; Duan, B; Li, XW				Li, Cui; Kuss, Mitchell; Kong, Yunfan; Nie, Fujiao; Liu, Xiaoyan; Liu, Bo; Dunaevsky, Anna; Fayad, Pierre; Duan, Bin; Li, Xiaowei			3D Printed Hydrogels with Aligned Microchannels to Guide Neural Stem Cell Migration	ACS BIOMATERIALS SCIENCE & ENGINEERING			English	Article						digital light processing; aligned microchannel; growth factor gradient; brain injury		Following traumatic or ischemic brain injury, rapid cell death and extracellular matrix degradation lead to the formation of a cavity at the brain lesion site, which is responsible for prolonged neurological deficits and permanent disability. Transplantation of neural stem/progenitor cells (NSCs) represents a promising strategy for reconstructing the lesion cavity and promoting tissue regeneration. In particular, the promotion of neuronal migration, organization, and integration of transplanted NSCs is critical to the success of stem cell-based therapy. This is particularly important for the cerebral cortex, the most common area involved in brain injuries, because the highly organized structure of the cerebral cortex is essential to its function. Biomaterials-based strategies show some promise for conditioning the lesion site microenvironment to support transplanted stem cells, but the progress in demonstrating organized cell engraftment and integration into the brain is very limited. An effective approach to sufficiently address these challenges has not yet been developed. Here, we have implemented a digital light-processing-based 3D printer and printed hydrogel scaffolds with a designed shape, uniaxially aligned microchannels, and tunable mechanical properties. We demonstrated the capacity to achieve high shape precision to the lesion site with brain tissue-matching mechanical properties. We also established spatial control of bioactive molecule distribution within 3D printed hydrogel scaffolds. These printed hydrogel scaffolds have shown high neuro-compatibility with aligned neuronal outgrowth along with the microchannels. This study will provide a biomaterial-based approach that can serve as a protective and guidance vehicle for transplanted NSC organization and integration for brain tissue regeneration after injuries.	[Li, Cui] Xuzhou Med Univ, Dept Physiol, Xuzhou 221004, Jiangsu, Peoples R China; [Li, Cui; Nie, Fujiao; Liu, Xiaoyan; Dunaevsky, Anna; Fayad, Pierre; Li, Xiaowei] Univ Nebraska Med Ctr, Dept Neurol Sci, Omaha, NE 68198 USA; [Kuss, Mitchell; Kong, Yunfan; Liu, Bo; Duan, Bin] Univ Nebraska Med Ctr, Dept Internal Med, Div Cardiol, Mary & Dick Holland Regenerat Med Program, Omaha, NE 68198 USA		Li, XW (corresponding author), Univ Nebraska Med Ctr, Dept Neurol Sci, Omaha, NE 68198 USA.; Duan, B (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Cardiol, Mary & Dick Holland Regenerat Med Program, Omaha, NE 68198 USA.	bin.duan@unmc.edu; xiaowei.li@unmc.edu		Liu, Bo/0000-0003-2455-2021; Li, Xiaowei/0000-0003-0714-1140	University of Nebraska Medical Center; American Heart Association Career Development AwardAmerican Heart Association [18CDA34110314]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AR073225]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1U54GM115458]; UNMC Center for Heart and Vascular Research	This work was partially supported by funds from University of Nebraska Medical Center, American Heart Association Career Development Award (18CDA34110314 to X.-W.L.), and National Institutes of Health (R01 AR073225 to B. D.). We also acknowledge support by a grant from the National Institute of General Medical Sciences, 1U54GM115458, and the UNMC Center for Heart and Vascular Research.	Bertassoni LE, 2014, LAB CHIP, V14, P2202, DOI 10.1039/c4lc00030g; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Chen XL, 2016, ACTA PHARM SIN B, V6, P522, DOI 10.1016/j.apsb.2016.06.013; Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003; Cheng X, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00590; De France KJ, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700927; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duan B, 2013, J BIOMED MATER RES A, V101, P1255, DOI 10.1002/jbm.a.34420; Erning K, 2020, CURR OPIN BIOMED ENG, V14, P9, DOI 10.1016/j.cobme.2020.04.002; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fan CJ, 2017, TISSUE ENG PART B-RE, V23, P451, DOI [10.1089/ten.TEB.2016.0465, 10.1089/ten.teb.2016.0465]; Fernandes R, 2003, LANGMUIR, V19, P4058, DOI 10.1021/la027052h; Filippou V, 2018, MED PHYS, V45, pE740, DOI 10.1002/mp.13058; Fluri F, 2015, DRUG DES DEV THER, V9, P3445, DOI 10.2147/DDDT.S56071; Grigoryan B, 2019, SCIENCE, V364, P458, DOI 10.1126/science.aav9750; Heintz KA, 2016, ADV HEALTHC MATER, V5, P2153, DOI 10.1002/adhm.201600351; Holodinsky JK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0646-5; Hsieh FY, 2015, BIOMATERIALS, V71, P48, DOI 10.1016/j.biomaterials.2015.08.028; Huang LJ, 2014, INT J MED SCI, V11, P344, DOI 10.7150/ijms.8140; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Koffler J, 2019, NAT MED, V25, P263, DOI 10.1038/s41591-018-0296-z; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Kuss M, 2018, ACTA BIOMATER, V71, P486, DOI 10.1016/j.actbio.2018.03.021; Lam J, 2015, ADV HEALTHC MATER, V4, P534, DOI 10.1002/adhm.201400410; Lam J, 2014, ADV FUNCT MATER, V24, P7053, DOI 10.1002/adfm.201401483; Lee A, 2019, SCIENCE, V365, P482, DOI 10.1126/science.aav9051; Lee J, 2018, TISSUE ENG REGEN MED, V15, P403, DOI 10.1007/s13770-018-0130-1; Lee JB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14480-0; Li X., 2011, U.S. Patent, Patent No. [13/ 598 343, 13598343]; Li X., 2012, THESIS CLEMSON U ANN, P262; Li XR, 2016, SMALL, V12, P5009, DOI 10.1002/smll.201601285; Li XR, 2015, ADV HEALTHC MATER, V4, P1869, DOI 10.1002/adhm.201500271; Li XW, 2020, BIOMATERIALS, V245, DOI 10.1016/j.biomaterials.2020.119978; Li XW, 2014, STEM CELL TRANSL MED, V3, P662, DOI 10.5966/sctm.2013-0015; Li XW, 2012, MED HYPOTHESES, V79, P274, DOI 10.1016/j.mehy.2012.05.010; Li XW, 2012, ACTA BIOMATER, V8, P2087, DOI 10.1016/j.actbio.2012.02.008; Ma XY, 2016, P NATL ACAD SCI USA, V113, P2206, DOI 10.1073/pnas.1524510113; McCrary MR, 2020, ADV HEALTHC MATER, V9, DOI 10.1002/adhm.201900285; Moretti A, 2015, PHARMACOL THERAPEUT, V146, P23, DOI 10.1016/j.pharmthera.2014.09.003; Moshayedi P, 2016, BIOMATERIALS, V105, P145, DOI 10.1016/j.biomaterials.2016.07.028; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Nih LR, 2018, NAT MATER, V17, P642, DOI 10.1038/s41563-018-0083-8; Obermeyer JM, 2019, TISSUE ENG PT A, V25, P1175, DOI [10.1089/ten.tea.2018.0215, 10.1089/ten.TEA.2018.0215]; Payne SL, 2019, BIOMATERIALS, V192, P309, DOI 10.1016/j.biomaterials.2018.11.020; Ravina K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123782; Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2; Sarig-Nadir O, 2009, BIOPHYS J, V96, P4743, DOI 10.1016/j.bpj.2009.03.019; Schackel T, 2019, TISSUE ENG PT A, V25, P522, DOI [10.1089/ten.tea.2018.0082, 10.1089/ten.TEA.2018.0082]; Shin J, 2017, BIOMACROMOLECULES, V18, P3060, DOI 10.1021/acs.biomac.7b00568; Sinden JD, 2017, STEM CELLS DEV, V26, P933, DOI 10.1089/scd.2017.0009; Somaa FA, 2017, CELL REP, V20, P1964, DOI 10.1016/j.celrep.2017.07.069; Song KH, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201801331; Steinberg GK, 2019, J NEUROSURG, V131, P1462, DOI 10.3171/2018.5.JNS173147; Steinberg GK, 2016, STROKE, V47, P1817, DOI 10.1161/STROKEAHA.116.012995; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Tan KM, 2008, J MOL BIOL, V381, P1213, DOI 10.1016/j.jmb.2008.06.045; Vaysse L, 2015, BIOMATERIALS, V58, P46, DOI 10.1016/j.biomaterials.2015.04.019; Wang Y, 2017, ACS BIOMATER SCI ENG, V3, P826, DOI 10.1021/acsbiomaterials.7b00101; Wei L, 2017, PROG NEUROBIOL, V157, P49, DOI 10.1016/j.pneurobio.2017.03.003; Weickenmeier J, 2018, J MECH BEHAV BIOMED, V77, P702, DOI 10.1016/j.jmbbm.2017.08.029; Wong AP, 2008, BIOMATERIALS, V29, P1853, DOI 10.1016/j.biomaterials.2007.12.044; Wu SH, 2017, J MATER CHEM B, V5, P3870, DOI [10.1039/C7TB00721C, 10.1039/c7tb00721c]; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang JM, 2020, INT J BIOPRINTING, V6, P12, DOI 10.18063/ijb.v6i1.242; Zhang WH, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/ab906e; Zhang YS, 2016, BIOMATERIALS, V110, P45, DOI 10.1016/j.biomaterials.2016.09.003	67	3	3	8	31	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2373-9878			ACS BIOMATER SCI ENG	ACS Biomater. Sci. Eng.	FEB	2021	7	2					690	700		10.1021/acsbiomaterials.0c01619		JAN 2021	11	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	QI0HD	WOS:000618655200029	33507749				2022-02-06	
J	Wojciechowski, S; Virenque, A; Vihma, M; Galbardi, B; Rooney, EJ; Keuters, MH; Antila, S; Koistinaho, J; Noe, FM				Wojciechowski, Sara; Virenque, Anais; Vihma, Maria; Galbardi, Barbara; Rooney, Erin Jane; Keuters, Meike Hedwig; Antila, Salli; Koistinaho, Jari; Noe, Francesco M.			Developmental Dysfunction of the Central Nervous System Lymphatics Modulates the Adaptive Neuro-Immune Response in the Perilesional Cortex in a Mouse Model of Traumatic Brain Injury	FRONTIERS IN IMMUNOLOGY			English	Article						controlled cortical impact (CCI); meningeal lymphatic vessels; CD8+T lymphocytes; resident memory T cells; Chronic Traumatic Brain injury	CD8(+) T-CELLS	Rationale The recently discovered meningeal lymphatic vessels (mLVs) have been proposed to be the missing link between the immune and the central nervous system. The role of mLVs in modulating the neuro-immune response following a traumatic brain injury (TBI), however, has not been analyzed. Parenchymal T lymphocyte infiltration has been previously reported as part of secondary events after TBI, suggestive of an adaptive neuro-immune response. The phenotype of these cells has remained mostly uncharacterized. In this study, we identified subpopulations of T cells infiltrating the perilesional areas 30 days post-injury (an early-chronic time point). Furthermore, we analyzed how the lack of mLVs affects the magnitude and the type of T cell response in the brain after TBI. Methods TBI was induced in K14-VEGFR3-Ig transgenic (TG) mice or in their littermate controls (WT; wild type), applying a controlled cortical impact (CCI). One month after TBI, T cells were isolated from cortical areas ipsilateral or contralateral to the trauma and from the spleen, then characterized by flow cytometry. Lesion size in each animal was evaluated by MRI. Results In both WT and TG-CCI mice, we found a prominent T cell infiltration in the brain confined to the perilesional cortex and hippocampus. The majority of infiltrating T cells were cytotoxic CD8+ expressing a CD44(hi)CD69+ phenotype, suggesting that these are effector resident memory T cells. K14-VEGFR3-Ig mice showed a significant reduction of infiltrating CD4+ T lymphocytes, suggesting that mLVs could be involved in establishing a proper neuro-immune response. Extension of the lesion (measured as lesion volume from MRI) did not differ between the genotypes. Finally, TBI did not relate to alterations in peripheral circulating T cells, as assessed one month after injury. Conclusions Our results are consistent with the hypothesis that mLVs are involved in the neuro-immune response after TBI. We also defined the resident memory CD8+ T cells as one of the main population activated within the brain after a traumatic injury.	[Wojciechowski, Sara; Keuters, Meike Hedwig; Koistinaho, Jari] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Virenque, Anais; Vihma, Maria; Rooney, Erin Jane; Keuters, Meike Hedwig; Koistinaho, Jari; Noe, Francesco M.] Univ Helsinki, Helsinki Inst Life Sci HiLIFE, Neurosci Ctr, Helsinki, Finland; [Galbardi, Barbara] IRCCS Osped San Raffaele, Dept Med Oncol, Breast Canc Unit, Milan, Italy; [Antila, Salli] Univ Helsinki, Fac Med, Wihuri Res Inst, Helsinki, Finland; [Antila, Salli] Univ Helsinki, Fac Med, Translat Canc Med Program, Helsinki, Finland		Noe, FM (corresponding author), Univ Helsinki, Helsinki Inst Life Sci HiLIFE, Neurosci Ctr, Helsinki, Finland.	francesco.noe@helsinki.fi	Keuters, Meike/AAQ-2165-2021	Keuters, Meike Hedwig/0000-0003-4216-1024; Koistinaho, Jari/0000-0001-6559-1153; Rooney, Erin Jane/0000-0002-5953-8783; Noe', Francesco Mattia/0000-0002-0019-1615; Virenque, Anais/0000-0003-1417-0361	Academy of Finland (Academy of Finland) [309479/2017-FN]; Jane and Aatos Erkko Foundation; Finnish Brain Foundation Terva Program; European Research Council (ERC) under the European UnionEuropean Research Council (ERC) [743155]	lThis study has been supported by the Academy of Finland (Academy of Finland research Fellowship #309479/2017-FN), by the Jane and Aatos Erkko Foundation (SA and JK), by the Finnish Brain Foundation Terva Program (SA), and by European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement #743155 (SA).	Alitalo AK, 2013, CANCER RES, V73, P4212, DOI 10.1158/0008-5472.CAN-12-4539; Antila S, 2017, J EXP MED, V214, P3645, DOI 10.1084/jem.20170391; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Bai RJ, 2017, NEUROCHEM RES, V42, P2892, DOI 10.1007/s11064-017-2310-0; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beura LK, 2014, CELL, V157, P1488, DOI 10.1016/j.cell.2014.05.026; Bolte AC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18113-4; Braun M, 2017, J IMMUNOL, V198, P3615, DOI 10.4049/jimmunol.1601948; BUDD RC, 1987, J IMMUNOL, V138, P3120; Card CM, 2014, J CLIN INVEST, V124, P943, DOI 10.1172/JCI73316; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Clement T, 2020, GLIA, V68, P528, DOI 10.1002/glia.23736; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; CSERR HF, 1992, BRAIN PATHOL, V2, P269, DOI 10.1111/j.1750-3639.1992.tb00703.x; Czigner A, 2007, ACTA NEUROCHIR, V149, P281, DOI 10.1007/s00701-006-1095-8; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; de Vos AF, 2002, J IMMUNOL, V169, P5415, DOI 10.4049/jimmunol.169.10.5415; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dhungana H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-102; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Fankhauser M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4712; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Fernandez-Klett F, 2014, BRAIN PATHOL, V24, P404, DOI 10.1111/bpa.12162; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gasper DJ, 2014, CRIT REV IMMUNOL, V34, P121, DOI 10.1615/CritRevImmunol.2014010373; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Guedel AE., 1927, CURRENT RES ANESTHES, V6, P157, DOI [10.1213/00000539-192708000-00001, DOI 10.1213/00000539-192708000-00001]; Hale AC, 2019, J NERV MENT DIS, V207, P38, DOI 10.1097/NMD.0000000000000915; Harling-Berg CJ, 1999, J NEUROIMMUNOL, V101, P111, DOI 10.1016/S0165-5728(99)00130-7; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hutchinson E, 2005, ILAR J, V46, P148, DOI 10.1093/ilar.46.2.148; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Loo CP, 2017, CELL REP, V20, P3176, DOI 10.1016/j.celrep.2017.09.006; Louveau A, 2018, NAT NEUROSCI, V21, P1380, DOI 10.1038/s41593-018-0227-9; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lund AW, 2016, J CLIN INVEST, V126, P3389, DOI 10.1172/JCI79434; Maegele M, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2047981614555142; Maisel K, 2021, MUCOSAL IMMUNOL, V14, P144, DOI 10.1038/s41385-020-0308-4; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; McIntosh TK, 1996, LAB INVEST, V74, P315; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Mendiburu F.D., 2019, AGRICOLAE STAT PROCE; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Revelle W.\, 2018, PSYCH PROCEDURES PSY; Ripley B.D, 2002, MODERN APPL STAT S, DOI DOI 10.1007/978-0-387-21706-2; Roederer M, 2002, CURR PROTOC CYTOM, DOI [DOI 10.1002/0471142956.CY0114S22, 10.1002/0471142956.cy0114s22]; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Schumann J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132479; Schwartz M, 2014, NEUROSCIENTIST, V20, P343, DOI 10.1177/1073858413516799; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Steinbach K, 2016, J EXP MED, V213, P1571, DOI 10.1084/jem.20151916; Thomas DL, 2008, CANCER IMMUNOL IMMUN, V57, P1323, DOI 10.1007/s00262-008-0467-8; Thomas SN, 2012, J IMMUNOL, V189, P2181, DOI 10.4049/jimmunol.1103545; Topham DJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00515; Tsunoda Ikuo, 2017, Clin Exp Neuroimmunol, V8, P177, DOI 10.1111/cen3.12405; Urra X, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00278; Vokali E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14127-9; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Wojciechowski S., 2020, 86584646 BIORXIV, DOI [10.1101/821645, DOI 10.1101/821645]; Yasmin A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00863; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	76	3	3	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	JAN 27	2021	11								559810	10.3389/fimmu.2020.559810			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QE9OY	WOS:000616534100001	33584640	gold, Green Published			2022-02-06	
J	Zhou, YR; Fan, RH; Botchway, BOA; Zhang, Y; Liu, XH				Zhou, Yiru; Fan, Ruihua; Botchway, Benson O. A.; Zhang, Yong; Liu, Xuehong			Infliximab Can Improve Traumatic Brain Injury by Suppressing the Tumor Necrosis Factor Alpha Pathway	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Infliximab; Tumor necrotizing factor alpha (TNF-alpha); Inflammation		Traumatic brain injury (TBI) has both high morbidity and mortality rates and can negatively influence physical and mental health, while also causing extreme burden to both individual and society. Hitherto, there is no effective treatment for TBI because of the complexity of the brain anatomy and physiology. Currently, management strategies mainly focus on controlling inflammation after TBI. Tumor necrotizing factor alpha (TNF-alpha) plays a crucial role in neuroinflammation post-TBI. TNF-alpha acts as the initiator of downstream inflammatory signaling pathways, and its activation can trigger a series of inflammatory reactions. Infliximab is a monoclonal anti-TNF-alpha antibody that reduces inflammation. Herein, we review the latest findings pertaining to the role of TNF-alpha and infliximab in TBI. We seek to present a comprehensive clinical application prospect of infliximab in TBI and, thus, discuss potential strategies of infliximab in treating TBI.	[Zhou, Yiru; Zhang, Yong; Liu, Xuehong] Med Coll, Dept Histol & Embryol, Shaoxing City, Peoples R China; [Fan, Ruihua] Shaoxing Univ, Sch Life Sci, Shaoxing City, Peoples R China; [Botchway, Benson O. A.] Zhejiang Univ, Inst Neurosci, Sch Med, Hangzhou, Peoples R China		Liu, XH (corresponding author), Med Coll, Dept Histol & Embryol, Shaoxing City, Peoples R China.	liuxueh6588@126.com	Botchway, Benson/ABD-3436-2021	Botchway, Benson/0000-0001-9732-7904; Liu, Xuehong/0000-0003-4325-6762	Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY19H170001]	This work was supported by the Natural Science Foundation of Zhejiang Province (Grant No. LY19H170001).	Abdelrahman AM, 2018, BIOMED PHARMACOTHER, V105, P182, DOI 10.1016/j.biopha.2018.05.118; Akdogan RA, 2014, FOLIA HISTOCHEM CYTO, V52, P36, DOI 10.5603/FHC.2014.0004; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; da Silva DAA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194430; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Arango-Davila CA, 2015, INT J NEUROSCI, V125, P936, DOI 10.3109/00207454.2014.980906; Bao ZY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00222; Barrett JP, 2020, J NEUROSCI, V40, P2357, DOI 10.1523/JNEUROSCI.2516-19.2020; Benhamou Y, 2015, VASC PHARMACOL, V71, P93, DOI 10.1016/j.vph.2015.03.014; Bhatnagar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013262; Burgler C, 2019, J DERMATOL, V46, P808, DOI 10.1111/1346-8138.14981; Cagliani J, 2019, J TRAUMA ACUTE CARE, V86, P881, DOI 10.1097/TA.0000000000002214; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Chen AQ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1716-9; Chen LX, 2018, NEURAL REGEN RES, V13, P1782, DOI 10.4103/1673-5374.238619; Chen YH, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00202; Cusimano MD, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.7.FOCUS20520; Dadsetan S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0710-8; Dai HP, 2005, CHEST, V127, P251, DOI 10.1378/chest.127.1.251; Danzer SC, 2019, EPILEPSY CURR, V19, P261, DOI 10.1177/1535759719854758; de Carvalho JF, 2018, ADV RHEUMATOL, V58, DOI 10.1186/s42358-018-0016-x; Deora A, 2017, MABS-AUSTIN, V9, P680, DOI 10.1080/19420862.2017.1304869; Eastman CL, 2020, NEUROPHARMACOLOGY, V172, DOI 10.1016/j.neuropharm.2019.107907; Ebert EC, 2009, AM J PHYSIOL-GASTR L, V296, pG612, DOI 10.1152/ajpgi.90576.2008; Eriksen N, 2019, NEUROCRIT CARE, V30, P557, DOI 10.1007/s12028-019-00692-w; Ferrari G, 2013, INVEST OPHTH VIS SCI, V54, P1680, DOI 10.1167/iovs.12-10782; Furtak A, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.558897; Gan DQ, 2020, ZEBRAFISH, V17, P73, DOI 10.1089/zeb.2019.1793; Guven C, 2010, J CLIN NEUROSCI, V17, P1563, DOI 10.1016/j.jocn.2010.04.027; Haarbauer-Krupa J, 2019, J SAFETY RES, V70, P127, DOI 10.1016/j.jsr.2019.06.003; Habib R, 2019, ECOTOX ENVIRON SAFE, V182, DOI 10.1016/j.ecoenv.2019.109398; Heuvel FO, 2019, BRAIN BEHAV IMMUN, V81, P228, DOI 10.1016/j.bbi.2019.06.019; Heydari F, 2020, ADV J EMERG MED, V4, DOI 10.22114/ajem.v0i0.170; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hoshiyama T, 2018, MOD RHEUMATOL, V28, P506, DOI 10.1080/14397595.2017.1354796; Hostenbach S, 2016, PROG NEUROBIOL, V144, P88, DOI 10.1016/j.pneurobio.2016.04.009; Hussain Tarique, 2016, Oxid Med Cell Longev, V2016, P7432797; Kanayama K, 2011, DIGEST DIS SCI, V56, P3525, DOI 10.1007/s10620-011-1780-1; Kim TH, 2020, CLIN DRUG INVEST, V40, P541, DOI 10.1007/s40261-020-00907-5; Kincheski GC, 2017, BRAIN BEHAV IMMUN, V64, P140, DOI 10.1016/j.bbi.2017.04.007; Koizumi K, 2018, PEDIATR INT, V60, P796, DOI 10.1111/ped.13555; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kurt A, 2015, ARCH BRONCONEUMOL, V51, P551, DOI 10.1016/j.arbres.2015.03.018; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Launey Y, 2020, JAMA NEUROL, V77, P339, DOI 10.1001/jamaneurol.2019.3854; Lichtenstein L, 2015, J CROHNS COLITIS, V9, P806, DOI 10.1093/ecco-jcc/jjv096; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Likhitpanichkul M, 2016, J BIOMECH, V49, P1214, DOI 10.1016/j.jbiomech.2016.02.029; Liu F, 2016, ONCOTARGETS THER, V9, P5999, DOI 10.2147/OTT.S109342; Lossi L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123999; Lugering A, 2001, GASTROENTEROLOGY, V121, P1145, DOI 10.1053/gast.2001.28702; Lv Y, 2020, BIOCHEM BIOPH RES CO, V521, P933, DOI 10.1016/j.bbrc.2019.11.003; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Mei WQ, 2015, WORLD J GASTROENTERO, V21, P6044, DOI 10.3748/wjg.v21.i19.6044; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Mitoma H, 2018, CYTOKINE, V101, P56, DOI 10.1016/j.cyto.2016.08.014; Natarajan K, 2018, FOOD CHEM TOXICOL, V118, P766, DOI 10.1016/j.fct.2018.06.040; Neri M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113544; Okada S, 2018, NEUROSCI RES, V126, P39, DOI 10.1016/j.neures.2017.10.004; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Pergel A, 2019, HUM EXP TOXICOL, V38, P1275, DOI 10.1177/0960327119867758; Popa-Wagner A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/963520; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; Rosenberg JJ, 2001, J APPL PHYSIOL, V91, P2213, DOI 10.1152/jappl.2001.91.5.2213; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Ruud TE, 2013, SURG INFECT, V14, P30, DOI 10.1089/sur.2011.093; Sahin TD, 2020, LIFE SCI, V250, DOI 10.1016/j.lfs.2020.117545; Santo AIE, 2015, BIOCHEM BIOPH RES CO, V464, P1145, DOI 10.1016/j.bbrc.2015.07.094; Shin HS, 2011, INFLAMMATION, V34, P440, DOI 10.1007/s10753-010-9251-y; Sigfridsson E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30675-4; Stevens RD, 2019, NEUROCRIT CARE, V30, P569, DOI 10.1007/s12028-019-00705-8; Takeshita M, 2015, CYTOKINE, V75, P222, DOI 10.1016/j.cyto.2015.04.011; Tarasov VV, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01612; Tasdemir C, 2012, RENAL FAILURE, V34, P1144, DOI 10.3109/0886022X.2012.717490; Tayman C, 2016, J INVEST SURG, V29, P209, DOI 10.3109/08941939.2015.1127449; Tuleta I, 2014, ATHEROSCLEROSIS, V236, P400, DOI 10.1016/j.atherosclerosis.2014.08.021; Ungar B, 2016, CLIN GASTROENTEROL H, V14, P550, DOI 10.1016/j.cgh.2015.10.025; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Virdis A, 2015, EUR HEART J, V36, P784, DOI 10.1093/eurheartj/ehu072; Wei LJ, 2020, BRAIN RES, V1726, DOI 10.1016/j.brainres.2019.146423; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Wojtal KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043361; Xiang JY, 2019, NEUROSCIENCE, V419, P121, DOI 10.1016/j.neuroscience.2019.09.001; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yucel AF, 2015, INT J CLIN EXP MED, V8, P21287; Zeni P, 2007, AM J PHYSIOL-CELL PH, V293, pC855, DOI 10.1152/ajpcell.00470.2006; Zhang H, 2018, INT J OCCUP MED ENV, V31, P503, DOI 10.13075/ijomeh.1896.01037; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhou T, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00077; Zhuang XJ, 2020, INFLAMM BOWEL DIS, V26, P1636, DOI 10.1093/ibd/izaa253	92	3	3	2	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2021	58	6					2803	2811		10.1007/s12035-021-02293-1		JAN 2021	9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SD7AR	WOS:000611927600001	33501626				2022-02-06	
J	Liu, C; Dai, SK; Shi, RX; He, XC; Wang, YY; He, BD; Sun, XW; Du, HZ; Liu, CM; Teng, ZQ				Liu, Cong; Dai, Shang-Kun; Shi, Ruo-Xi; He, Xuan-Cheng; Wang, Ying-Ying; He, Bao-Dong; Sun, Xiao-Wen; Du, Hong-Zhen; Liu, Chang-Mei; Teng, Zhao-Qian			Transcriptional profiling of microglia in the injured brain reveals distinct molecular features underlying neurodegeneration	GLIA			English	Article						microglial; neurodegeneration; sex differences; transcriptome; traumatic brain injury		Neurotrauma has been recognized as a risk factor for neurodegenerative diseases, and sex difference of the incidence and outcome of neurodegenerative diseases has long been recognized. Past studies suggest that microglia could play a versatile role in both health and disease. So far, the microglial mechanisms underlying neurodegeneration and potentially lead to sex-specific therapies are still very open. Here we applied whole transcriptome analysis of microglia acutely isolated at different timepoints after a cortical stab wound injury to gain insight into genes that might be dysregulated and transcriptionally different between males and females after cortical injury. We found that microglia displayed distinct temporal and sexual molecular signatures of transcriptome after cortical injury. Hypotheses and gene candidates that we presented in the present study could be worthy to be examined to explore the roles of microglia in neurotrauma and in sex-biased neurodegenerative diseases.	[Liu, Cong; Dai, Shang-Kun; Shi, Ruo-Xi; He, Xuan-Cheng; Wang, Ying-Ying; He, Bao-Dong; Sun, Xiao-Wen; Du, Hong-Zhen; Liu, Chang-Mei; Teng, Zhao-Qian] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Liu, Cong; Dai, Shang-Kun; Shi, Ruo-Xi; Wang, Ying-Ying; He, Bao-Dong; Sun, Xiao-Wen; Liu, Chang-Mei; Teng, Zhao-Qian] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China; [He, Xuan-Cheng; Du, Hong-Zhen; Liu, Chang-Mei; Teng, Zhao-Qian] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China		Liu, CM; Teng, ZQ (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.	liuchm@ioz.ac.cn; tengzq@ioz.ac.cn	Teng, Zhao-Qian/J-6260-2015	Teng, Zhao-Qian/0000-0002-7232-3381	National Key Research and Development Program of China Project [2018YFA0108001]	National Key Research and Development Program of China Project, Grant/Award Number: 2018YFA0108001	Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Chang HR, 2019, ARTERIOSCL THROM VAS, V39, P1967, DOI 10.1161/ATVBAHA.119.312389; Chen S, 2018, J BIOL RHYTHM, V33, P99, DOI 10.1177/0748730417745178; Cheng Y, 2018, NAT NEUROSCI, V21, P1689, DOI 10.1038/s41593-018-0261-7; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Daley D, 2017, NAT MED, V23, P556, DOI 10.1038/nm.4314; Dean JM, 2010, BRAIN BEHAV IMMUN, V24, P776, DOI 10.1016/j.bbi.2009.10.018; Fu SL, 2018, NUCLEIC ACIDS RES, V46, P11184, DOI 10.1093/nar/gky753; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Guneykaya D, 2018, CELL REP, V24, P2773, DOI 10.1016/j.celrep.2018.08.001; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hickman SE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02780; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Huang S, 2018, THERANOSTICS, V8, P2549, DOI 10.7150/thno.22523; Hytonen MK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006037; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kodama L, 2019, TRENDS MOL MED, V25, P741, DOI 10.1016/j.molmed.2019.05.001; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Labonte B, 2017, NAT MED, V23, P1102, DOI 10.1038/nm.4386; Le WD, 2001, J NEUROSCI, V21, P8447, DOI 10.1523/JNEUROSCI.21-21-08447.2001; Li MD, 2015, GLIA, V63, P754, DOI 10.1002/glia.22782; Littman D.R., 2013, MGI J; Liu C, 2021, GLIA, V69, P1292, DOI 10.1002/glia.23966; Liu C, 2019, STEM CELL RES, V39, DOI 10.1016/j.scr.2019.101501; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Maguire G, 2018, NEURAL REGEN RES, V13, P1185, DOI 10.4103/1673-5374.235026; Marcocci ME, 2020, TRENDS MICROBIOL, V28, P808, DOI 10.1016/j.tim.2020.03.003; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mattei D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21217944; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Moore SM, 2015, MOL IMMUNOL, V67, P265, DOI 10.1016/j.molimm.2015.06.001; Nakazato R, 2014, NEUROCHEM INT, V74, P24, DOI 10.1016/j.neuint.2014.04.010; Noristani HN, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00090; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Plaisier SB, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq636; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Saez PJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/216402; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Song SS, 2018, GLIA, V66, P2279, DOI 10.1002/glia.23456; Song WM, 2018, NAT IMMUNOL, V19, P1048, DOI 10.1038/s41590-018-0212-1; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Taguchi S, 2019, IBRO REP, V7, P82, DOI 10.1016/j.ibror.2019.10.002; Tamashiro TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3814; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Villa A, 2019, FRONT NEUROENDOCRIN, V52, P156, DOI 10.1016/j.yfrne.2018.11.003; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wust RCI, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202003031; Ximerakis M, 2019, NAT NEUROSCI, V22, P1696, DOI 10.1038/s41593-019-0491-3; Yan PZ, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107870; Yang QJ, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00791; Zhang Y, 2017, EXP CELL RES, V359, P449, DOI 10.1016/j.yexcr.2017.08.028; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhong YH, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00261	68	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	MAY	2021	69	5					1292	1306		10.1002/glia.23966		JAN 2021	15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QS0ND	WOS:000611232000001	33492723				2022-02-06	
J	Fontana, J; Cranmer, GA; Ash, E; Mazer, JP; Denham, BE				Fontana, Joseph; Cranmer, Gregory A.; Ash, Erin; Mazer, Joseph P.; Denham, Bryan E.			Parent-Child Communication regarding Sport-Related Concussion: An Application of the Theory of Planned Behavior	HEALTH COMMUNICATION			English	Article; Early Access								Extant research has discussed the importance of social climates surrounding sport-related concussion (SRC) reporting, especially the need to address parents/guardians' role in concussion management. This study explores parents/guardians' intentions toward SRC-related conversations with their children and their seeking of conversational resources via the Theory of Planned Behavior (TPB). Data collected from 292 parents/guardians of 1(st)-12(th) graders who play contact sports are examined via a structural equation model. The results indicate that parents/guardians' intention toward communicating with their child about SRC reporting was determined by their attitudes and subjective norms but that perceived behavioral control was not a significant predictor of intention. Furthermore, parents/guardians' intention toward having these conversations was predictive of whether they sought information to aid these conversations. This study answers calls to address parents/guardians' involvement in SRC management and provides preliminary information for persuading parents/guardians to have conversations with their children about SRC reporting.	[Fontana, Joseph; Cranmer, Gregory A.; Ash, Erin; Mazer, Joseph P.; Denham, Bryan E.] Clemson Univ, Dept Commun, Clemson, SC 29634 USA		Fontana, J (corresponding author), Clemson Univ, Dept Commun, Clemson, SC 29634 USA.	Jlfonta@g.clemson.edu					Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; Ajzen I., 2006, CONSTRUCTING A TPB Q; Andrews KR, 2010, J HEALTH COMMUN, V15, P95, DOI 10.1080/10810730903460567; Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Boneau RD, 2020, COMMUN SPORT, V8, P26, DOI 10.1177/2167479518816104; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Cranmer GA, 2018, WESTERN J COMM, V82, P631, DOI 10.1080/10570314.2018.1441431; Cranmer GA, 2018, INT J SPORT COMMUN, V11, P241, DOI 10.1123/ijsc.2017-0120; DeVellis RF., 2012, SCALE DEV THEORY APP, V34; Eccles J., 1991, J APPL SPORT PSYCHOL, V3, P7, DOI [10.1080/10413209108406432, DOI 10.1080/10413209108406432]; FISHER TD, 1986, ADOLESCENCE, V21, P517; Flores G, 2005, PEDIATRICS, V115, pE183, DOI 10.1542/peds.2004-1474; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Hair JF., 2014, MULTIVARIATE DATA AN, V7; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hausenblas HA, 1997, J SPORT EXERCISE PSY, V19, P36, DOI 10.1123/jsep.19.1.36; Huansuriya T, 2014, J HEALTH COMMUN, V19, P244, DOI 10.1080/10810730.2013.811326; Hutchinson MK, 2007, J NURS SCHOLARSHIP, V39, P141; Hutchinson MK, 2003, J ADOLESCENT HEALTH, V33, P98, DOI 10.1016/S1054-139X(03)00183-6; Hyman M., 2009, UNTIL IT HURTS AM OB; Hyman M., 2012, MOST EXPENSIVE GAME; Kline R.B., 2011, SAGE HDB INNOVATION; Kroshus E, 2019, J HEALTH COMMUN, V24, P770, DOI 10.1080/10810730.2019.1668512; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; LaBelle S, 2018, SUBST USE MISUSE, V53, P1108, DOI 10.1080/10826084.2017.1399421; Levine TR, 2005, COMMUN RES REP, V22, P335, DOI 10.1080/00036810500317730; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maria DS, 2015, PERSPECT SEX REPRO H, V47, P37, DOI 10.1363/47e2415; McCrea HJ, 2013, SPORTS HEALTH, V5, P160, DOI 10.1177/1941738112462203; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McDermott MS, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0324-z; McGlynn J, 2020, J SPORT SOC ISSUES, V44, P261, DOI 10.1177/0193723520903226; Montano DE, 2008, HLTH BEHAV HLTH ED T; Murphy AM, 2017, SPORT EXERC PERFORM, V6, P230, DOI 10.1037/spy0000102; Muth Christopher C, 2018, JAMA, V319, P840, DOI 10.1001/jama.2018.0436; Newton JD, 2014, J SCI MED SPORT, V17, P469, DOI 10.1016/j.jsams.2013.10.240; Otten R, 2007, PSYCHOL ADDICT BEHAV, V21, P1, DOI 10.1037/0893-164X.21.1.1; Patterson, 1996, COMMUNICATION RES RE, V13, P68, DOI [10.1080/08824099609362072, DOI 10.1080/08824099609362072]; Peer E, 2017, J EXP SOC PSYCHOL, V70, P153, DOI 10.1016/j.jesp.2017.01.006; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Riesch SK, 2006, J SPEC PEDIATR NURS, V11, P41, DOI 10.1111/j.1744-6155.2006.00042.x; Rigby J, 2013, J ATHL TRAINING, V48, P636, DOI 10.4085/1062-6050-48.3.10; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Sarmiento Kelly, 2019, J Concussion, V3, DOI 10.1177/2059700219861863; Shakib S, 2013, INT REV SOCIOL SPORT, V48, P295, DOI 10.1177/1012690212439172; Sniehotta FF, 2014, HEALTH PSYCHOL REV, V8, P1, DOI 10.1080/17437199.2013.869710; Starcher SC, 2015, COMMUN Q, V63, P204, DOI 10.1080/01463373.2015.1012221; Steiger J. H., 1980, M PSYCH SOC IOW CIT; Villarruel AM, 2008, AIDS EDUC PREV, V20, P371, DOI 10.1521/aeap.2008.20.5.371	64	3	3	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1041-0236	1532-7027		HEALTH COMMUN	Health Commun.												10.1080/10410236.2021.1876326		JAN 2021	12	Communication; Health Policy & Services	Social Science Citation Index (SSCI)	Communication; Health Care Sciences & Services	PX8HB	WOS:000611593300001	33487037				2022-02-06	
J	Zhao, CC; Deng, YF; He, Y; Huang, XJ; Wang, CF; Li, WP				Zhao, Chengcheng; Deng, Yuefei; He, Yi; Huang, Xianjian; Wang, Chuanfang; Li, Weiping			Decreased Level of Exosomal miR-5121 Released from Microglia Suppresses Neurite Outgrowth and Synapse Recovery of Neurons Following Traumatic Brain Injury	NEUROTHERAPEUTICS			English	Article						Exosomes; microRNA; microglia; neuron; traumatic brain injury		Activated microglia can suppress neurite outgrowth and synapse recovery in the acute stage following traumatic brain injury (TBI). However, the underlying mechanism has not been clearly elucidated. Exosomes derived from microglia have been reported to play a critical role in microglia-neuron interaction in healthy and pathological brains. Here, we aimed to investigate the role of microglia-derived exosomes in regulating neurite outgrowth and synapse recovery following TBI. In our study, exosomes derived from microglia were co-cultured with stretch-injured neurons in vitro and intravenously injected into mice that underwent fluid percussion injury (FPI) by tail vein injection in vivo. The results showed that microglia-derived exosomes could be absorbed by neurons in vitro and in vivo. Moreover, exosomes derived from stretch-injured microglia decreased the protein levels of GAP43, PSD-95, GluR1, and Synaptophysin and dendritic complexity in stretch-injured neurons in vitro, and reduced GAP43+ NEUN cell percentage and apical dendritic spine density in the pericontusion region in vivo. Motor coordination was also impaired in mice treated with stretch-injured microglia-derived exosomes after FPI. A microRNA microarray showed that the level of miR-5121 was decreased most greatly in exosomes derived from stretch-injured microglia. Overexpression of miR-5121 in stretch-injured microglia-derived exosomes partly reversed the suppression of neurite outgrowth and synapse recovery of neurons both in vitro and in vivo. Moreover, motor coordination in miR-5121 overexpressed exosomes treated mice was significantly improved after FPI. Following mechanistic study demonstrated that miR-5121 might promote neurite outgrowth and synapse recovery by directly targeting RGMa. In conclusion, our finding revealed a novel exosome-mediated mechanism of microglia-neuron interaction that suppressed neurite outgrowth and synapse recovery of neurons following TBI.	[Zhao, Chengcheng; He, Yi; Huang, Xianjian; Li, Weiping] Shenzhen Univ, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Dept Neurosurg, 3002 Sungang Rd, Shenzhen, Guangdong, Peoples R China; [Zhao, Chengcheng] Shenzhen Univ, Hlth Sci Ctr, Sch Biomed Engn, Guangdong Key Lab Biomed Measurements & Ultrasoun, Shenzhen, Guangdong, Peoples R China; [Deng, Yuefei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Wang, Chuanfang] Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, 250 Changgang East Rd, Guangzhou, Guangdong, Peoples R China; [Wang, Chuanfang] Guangzhou Med Univ, Affiliated Hosp 2, Neurosurg Dis Res Ctr, 250 Changgang East Rd, Guangzhou, Guangdong, Peoples R China		Li, WP (corresponding author), Shenzhen Univ, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Dept Neurosurg, 3002 Sungang Rd, Shenzhen, Guangdong, Peoples R China.; Wang, CF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, 250 Changgang East Rd, Guangzhou, Guangdong, Peoples R China.; Wang, CF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Neurosurg Dis Res Ctr, 250 Changgang East Rd, Guangzhou, Guangdong, Peoples R China.	cfwang2007@126.com; wpli@szu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772685]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2018A030310042]; Guangdong Basic and Applied Basic Research Foundation [2019A1515011241]	This research was supported by grants from the National Natural Science Foundation of China (81772685), the Natural Science Foundation of Guangdong Province (2018A030310042), and the Guangdong Basic and Applied Basic Research Foundation (2019A1515011241).	Arnoux I, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/689404; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Chai RC, 2013, GLIA, V61, P1748, DOI 10.1002/glia.22555; Conrad S, 2007, J BIOL CHEM, V282, P16423, DOI 10.1074/jbc.M610901200; De Vries M, 2008, J NEUROCHEM, V106, P1483, DOI 10.1111/j.1471-4159.2008.05485.x; Deleo AM, 2018, J NEUROIMMUNE PHARM, V13, P292, DOI 10.1007/s11481-017-9768-z; Deng B, 2018, MOL NEUROBIOL, V55, P652, DOI 10.1007/s12035-016-0301-9; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Foerster, 2013, JOVE-J VIS EXP, V80; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Ge XT, 2020, MOL THER, V28, P503, DOI 10.1016/j.ymthe.2019.11.017; Greening DW, 2015, METHODS MOL BIOL, V1295, P179, DOI 10.1007/978-1-4939-2550-6_15; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hu YB, 2019, AGING CELL, V18, DOI 10.1111/acel.13001; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jia G, 2018, BIOMATERIALS, V178, P302, DOI 10.1016/j.biomaterials.2018.06.029; Jiang F, 2012, NEUROCHEM RES, V37, P1906, DOI 10.1007/s11064-012-0809-y; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jin D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9074; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kincheski GC, 2017, BRAIN BEHAV IMMUN, V64, P140, DOI 10.1016/j.bbi.2017.04.007; Kokotos AC, 2019, J NEUROCHEM, V151, P28, DOI 10.1111/jnc.14797; Koritzinsky EH, 2017, J CELL PHYSIOL, V232, P1587, DOI 10.1002/jcp.25387; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kyoto A, 2007, BRAIN RES, V1186, P74, DOI 10.1016/j.brainres.2007.10.038; Leduc-Pessah H, 2017, J NEUROSCI, V37, P10154, DOI 10.1523/JNEUROSCI.0852-17.2017; Lemaire Q, 2019, J NANOBIOTECHNOL, V17, DOI 10.1186/s12951-019-0551-6; Li M, 2018, BRAIN RES BULL, V142, P54, DOI 10.1016/j.brainresbull.2018.06.010; Lin L, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0877-7; Liu J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00177; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Mothe AJ, 2020, NEUROBIOL DIS, V143, DOI 10.1016/j.nbd.2020.104995; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Popescu C, 2015, J Med Life, V8, P272; Raffo-Romero A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124124; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Schwab JM, 2005, EUR J NEUROSCI, V21, P1569, DOI 10.1111/j.1460-9568.2005.03962.x; Song YY, 2019, THERANOSTICS, V9, P2910, DOI 10.7150/thno.30879; Starkey ML, 2012, EUR J NEUROSCI, V36, P3665, DOI 10.1111/ejn.12017; Stokowska A, 2017, BRAIN, V140, P353, DOI 10.1093/brain/aww314; Takenouchi T, 2015, IMMUNOL LETT, V167, P116, DOI 10.1016/j.imlet.2015.08.002; Tao T, 2013, SYNAPSE, V67, P189, DOI 10.1002/syn.21629; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian T, 2018, BIOMATERIALS, V150, P137, DOI 10.1016/j.biomaterials.2017.10.012; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tsitsopoulos PP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00599; Turola E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00149; Wang CF, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6460; Webster SJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt182; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Xavier AL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0593; Xia Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1404-9; Yin ZY, 2020, BRAIN BEHAV IMMUN, V83, P270, DOI 10.1016/j.bbi.2019.11.004; Yue N, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0865-y; Zhao CC, 2017, J NEUROTRAUM, V34, P1636, DOI 10.1089/neu.2016.4759	66	3	3	2	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	APR	2021	18	2					1273	1294		10.1007/s13311-020-00999-z		JAN 2021	22	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	UO4GO	WOS:000609350100003	33475953	Bronze			2022-02-06	
J	DeGraba, TJ; Williams, K; Koffman, R; Bell, JL; Pettit, W; Kelly, JP; Dittmer, TA; Nussbaum, G; Grammer, G; Bleiberg, J; French, LM; Pickett, TC				DeGraba, Thomas J.; Williams, Kathy; Koffman, Robert; Bell, Jennifer L.; Pettit, Wendy; Kelly, James P.; Dittmer, Travis A.; Nussbaum, George; Grammer, Geoffrey; Bleiberg, Joseph; French, Louis M.; Pickett, Treven C.			Efficacy of an Interdisciplinary Intensive Outpatient Program in Treating Combat-Related Traumatic Brain Injury and Psychological Health Conditions	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; psychological health; post-traumatic stress disorder; integrative medicine; military health; intensive outpatient program; interdisciplinary care; creative arts therapies	POSTTRAUMATIC-STRESS-DISORDER; NEUROBEHAVIORAL SYMPTOM INVENTORY; MILITARY SERVICE MEMBERS; CLINICALLY IMPORTANT DIFFERENCE; GENERALIZED ANXIETY DISORDER; VETERANS; IRAQ; TBI; POSTCONCUSSION; POLYTRAUMA	Background: Since 2000, over 413,000 US service members (SM) experienced at least one traumatic brain injury (TBI), and 40% of those with in-theater TBIs later screened positive for comorbid psychological health (PH) conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. Many SMs with these persistent symptoms fail to achieve a recovery that results in a desirable quality of life or return to full duty. Limited information exists though to guide treatment for SMs with a history of mild TBI (mTBI) and comorbid PH conditions. This report presents the methods and outcomes of an interdisciplinary intensive outpatient program (IOP) in the treatment of SMs with combat-related mTBI and PH comorbidities. The IOP combines conventional rehabilitation therapies and integrative medicine techniques with the goal of reducing morbidity in multiple neurological and behavioral health domains and enhancing military readiness. Methods: SMs (n = 1,456) with residual symptoms from mTBI and comorbid PH conditions were treated in a 4-week IOP at the National Intrepid Center of Excellence (NICoE) at Walter Reed National Military Medical Center (WRNMMC). The IOP uses an interdisciplinary, holistic, and patient-centric rehabilitative care model. Interdisciplinary teams provide a diagnostic workup of neurological, psychiatric, and existential injuries, and from these assessments, individualized care plans are developed. Treatment response was assessed using the Neurobehavioral Symptom Inventory (NSI), PTSD Checklist-Military Version (PCL-M), Satisfaction With Life Scale (SWLS), Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), Epworth Sleepiness Scale (ESS), and Headache Impact Test-6 (HIT-6) and administered at admission, discharge, and at 1, 3, and 6 months post-discharge. Findings: Following treatment in the IOP, the symptomatic patients had statistically significant and clinically meaningful improvements across all outcome measures. The largest effect size was seen with GAD-7 (r = 0.59), followed by PHQ-8 (r = 0.56), NSI (r = 0.55), PCL-M (r = 0.52), ESS (r = 0.50), SWLS (r = 0.49), and HIT-6 (r = 0.42). In cross-sectional follow ups, the significant improvements were sustained at 1, 3, and 6 months post-discharge. Interpretation: This report demonstrates that an interdisciplinary IOP achieves significant and sustainable symptom recovery in SMs with combat-related mTBI and comorbid PH conditions and supports the further study of this model of care in complex medical conditions.	[DeGraba, Thomas J.; Koffman, Robert; Pettit, Wendy; Kelly, James P.; Nussbaum, George; Grammer, Geoffrey; Bleiberg, Joseph; French, Louis M.; Pickett, Treven C.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20814 USA; [DeGraba, Thomas J.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Williams, Kathy] Credence Management Solut, Vienna, VA USA; [Bell, Jennifer L.] Def Hlth Agcy, Psychol Hlth Ctr Excellence, J9, Mclean, VA USA; [Kelly, James P.] Univ Colorado, Dept Neurol, Sch Med, Marcus Inst Brain Hlth, Aurora, CO USA; [Dittmer, Travis A.] Booz Allen Hamilton, Mclean, VA USA		DeGraba, TJ (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20814 USA.; DeGraba, TJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA.	thomas.j.degraba.civ@mail.mil	Dittmer, Travis/X-8517-2018	Dittmer, Travis/0000-0003-1865-9228; french, louis/0000-0002-9451-0604	National Intrepid Center of Excellence, Walter Reed National Military Medical Center, Bethesda, MD, USA	This work was supported by the National Intrepid Center of Excellence, Walter Reed National Military Medical Center, Bethesda, MD, USA.	Belanger HG, 2016, CLIN NEUROPSYCHOL, V30, P1063, DOI 10.1080/13854046.2016.1193632; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brickell TA, 2014, MIL MED, V179, P839, DOI 10.7205/MILMED-D-14-00016; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Castien RF, 2012, CEPHALALGIA, V32, P710, DOI 10.1177/0333102412449933; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Defense and Veterans Brain Injury Center (DVBIC), 2019, DOD WORLDW NUMB TBI; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E., 2008, J POSIT PSYCHOL, V3, P137, DOI [10.1080/17439760701756946, DOI 10.1080/17439760701756946]; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; Duchnick JJ, 2015, PSYCHOL SERV, V12, P313, DOI 10.1037/ser0000034; Goetter EM, 2015, J TRAUMA STRESS, V28, P401, DOI 10.1002/jts.22038; Harvey MM, 2019, COGN BEHAV PRACT, V26, P323; Hernandez A, 2019, HEALTH AFFAIR, V38, P1393, DOI 10.1377/hlthaff.2019.00280; Institute of Medicine (IOM), 2014, TREATM POSTTR STRESS; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaimal G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021448; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Mac Donald CL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6676; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Pastorek NJ, 2019, J HEAD TRAUMA REHAB, V34, P150, DOI 10.1097/HTR.0000000000000480; Patel S, 2018, AM J RESP CRIT CARE, V197, P961, DOI 10.1164/rccm.201704-0672LE; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Rosenthal R., 1994, HDB RES SYNTHESIS, P231, DOI DOI 10.7758/9781610441377.20; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tanev KS, 2019, J NEUROPSYCH CLIN N, V31, P337, DOI 10.1176/appi.neuropsych.18090208; Tang YY, 2009, P NATL ACAD SCI USA, V106, P8865, DOI 10.1073/pnas.0904031106; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Toussaint A, 2020, J AFFECT DISORDERS, V265, P395, DOI 10.1016/j.jad.2020.01.032; U.S. Department of Veteran Affairs NCfP, 2020, PTSD CHECKL DSM 5 PC; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Walker MS, 2017, INT J QUAL STUD HEAL, V12, DOI 10.1080/17482631.2016.1267317; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Weathers F.W., 1993, 9 ANN C ISTSS	50	3	3	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 18	2021	11								580182	10.3389/fneur.2020.580182			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	QA3JM	WOS:000613343600001	33536993	gold, Green Published			2022-02-06	
J	Torres-Espin, A; Chou, A; Huie, JR; Kyritsis, N; Upadhyayula, PS; Ferguson, AR				Torres-Espin, Abel; Chou, Austin; Huie, J. Russell; Kyritsis, Nikos; Upadhyayula, Pavan S.; Ferguson, Adam R.			Reproducible analysis of disease space via principal components using the novel R package syndRomics	ELIFE			English	Article							TRAUMATIC BRAIN-INJURY; MISSING DATA; BOOTSTRAP; NUMBER; COEFFICIENTS; NEUROTRAUMA; IMPROVEMENT; PLASTICITY; STABILITY; POINTS	Biomedical data are usually analyzed at the univariate level, focused on a single primary outcome measure to provide insight into systems biology, complex disease states, and precision medicine opportunities. More broadly, these complex biological and disease states can be detected as common factors emerging from the relationships among measured variables using multivariate approaches. 'Syndromics' refers to an analytical framework for measuring disease states using principal component analysis and related multivariate statistics as primary tools for extracting underlying disease patterns. A key part of the syndromic workflow is the interpretation, the visualization, and the study of robustness of the main components that characterize the disease space. We present a new software package, syndRomics, an open-source R package with utility for component visualization, interpretation, and stability for syndromic analysis. We document the implementation of syndRomics and illustrate the use of the package in case studies of neurological trauma data.	[Torres-Espin, Abel; Chou, Austin; Huie, J. Russell; Kyritsis, Nikos; Ferguson, Adam R.] Univ Calif San Francisco UCSF, Brain & Spinal Injury Ctr BASIC, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Torres-Espin, Abel; Chou, Austin; Huie, J. Russell; Kyritsis, Nikos; Ferguson, Adam R.] Univ Calif San Francisco UCSF, Dept Neurol Surg, San Francisco, CA 94143 USA; [Torres-Espin, Abel; Chou, Austin; Huie, J. Russell; Kyritsis, Nikos; Ferguson, Adam R.] Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA 94110 USA; [Upadhyayula, Pavan S.] Univ Calif San Diego UCSD, Sch Med, San Diego, CA USA; [Ferguson, Adam R.] San Francisco VA Hlth Care Syst, San Francisco, CA 94121 USA		Ferguson, AR (corresponding author), Univ Calif San Francisco UCSF, Brain & Spinal Injury Ctr BASIC, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Ferguson, AR (corresponding author), Univ Calif San Francisco UCSF, Dept Neurol Surg, San Francisco, CA 94143 USA.; Ferguson, AR (corresponding author), Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA 94110 USA.; Ferguson, AR (corresponding author), San Francisco VA Hlth Care Syst, San Francisco, CA 94121 USA.	adam.ferguson@ucsf.edu	Kyritsis, Nikos/AAD-5187-2021	Kyritsis, Nikos/0000-0001-7801-5796; Torres Espin, Abel/0000-0002-9787-8738	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS106899, NS088475, I01RX02245, I01RX002787]; Department of Veterans AffairsUS Department of Veterans Affairs; Craig H. Neilsen Foundation; Wings for Life Special Project; Wings for Life Individual Grant	National Institutes of Health NS106899 Adam R Ferguson; National Institutes of Health NS088475 Adam R Ferguson; Department of Veterans Affairs I01RX02245 Adam R Ferguson; Department of Veterans Affairs I01RX002787 Adam R Ferguson; Craig H. Neilsen Foundation Special Project Adam R Ferguson; Wings for Life Special Project Adam R Ferguson; Wings for Life Individual Grant Abel Torres-Espin; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Altman N, 2018, NAT METHODS, V15, P399, DOI 10.1038/s41592-018-0019-x; Babamoradi H, 2013, CHEMOMETR INTELL LAB, V120, P97, DOI 10.1016/j.chemolab.2012.10.007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Burt C, 1948, B J PSYCHOL-STAT SEC, V1, P178, DOI 10.1111/j.2044-8317.1948.tb00236.x; Buuren, 2018, FLEXIBLE IMPUTATION; Callahan A, 2017, EXP NEUROL, V295, P135, DOI 10.1016/j.expneurol.2017.05.012; Campitelli E, 2020, ggnewscale: multiple fill and colour scales in 'ggplot2' Version: 0.4.5; Canty A, 2019, BOOT BOOTSTRAP R S P; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CATTELL RB, 1960, BRIT J STATIST PSYCH, V13, P33, DOI 10.1111/j.2044-8317.1960.tb00037.x; CATTELL RB, 1969, EDUC PSYCHOL MEAS, V29, P781, DOI 10.1177/001316446902900405; Chan W, 1999, PSYCHOL METHODS, V4, P378, DOI 10.1037/1082-989X.4.4.378; Davison A. C., 1997, BOOTSTRAP METHODS TH, DOI [10.1017/CBO9780511802843, DOI 10.1017/CBO9780511802843]; Dray S, 2015, PLANT ECOL, V216, P657, DOI 10.1007/s11258-014-0406-z; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Everitt B, 2011, USE R, P1, DOI 10.1007/978-1-4419-9650-3; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Ferguson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059712; Ferguson AR, 2011, TRANSL STROKE RES, V2, P438, DOI 10.1007/s12975-011-0121-1; Ferguson AR, 2018, OPEN DATA COMMON SPI, DOI [10.7295/W9T72FMZ, DOI 10.7295/W9T72FMZ]; Fouad K, 2020, J NEUROTRAUM, V37, P831, DOI 10.1089/neu.2019.6674; GLORFELD LW, 1995, EDUC PSYCHOL MEAS, V55, P377, DOI 10.1177/0013164495055003002; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; GUADAGNOLI E, 1991, MULTIVAR BEHAV RES, V26, P323, DOI 10.1207/s15327906mbr2602_7; Guttman L., 1954, PSYCHOMETRIKA, V19, P149, DOI [DOI 10.1007/BF02289162, 10.1007/BF02289162]; Haefeli J, 2017, AM J NEURORADIOL, V38, P648, DOI 10.3174/ajnr.A5021; Haefeli J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42474; Hollestein LM, 2017, BRIT J DERMATOL, V177, P1463, DOI 10.1111/bjd.16010; Hong SJ, 2006, BRIT J MATH STAT PSY, V59, P35, DOI 10.1348/000711005X66770; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Huie JR, 2018, CURR OPIN NEUROL, V31, P702, DOI 10.1097/WCO.0000000000000614; JACKSON JE, 1973, TECHNOMETRICS, V15, P601, DOI 10.2307/1266866; Jamshidian M, 2014, J STAT SOFTW, V56, P1; Jamshidian M, 2010, PSYCHOMETRIKA, V75, P649, DOI 10.1007/s11336-010-9175-3; Jiang H, 2000, C APPL STAT AGR, DOI [10.4148/2475-7772.1247, DOI 10.4148/2475-7772.1247]; Johnson SR, 1973, METROECONOMICA, V25, P306, DOI 10.1111/j.1467-999X.1973.tb00218.x; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kaushal Sandeep, 2014, Int J Appl Basic Med Res, V4, pS6; Konishi T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S18-S7; Krzywinski M, 2014, NAT METHODS, V11, P355, DOI 10.1038/nmeth.2900; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Nguyen LH, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006907; Landgrebe J, 2002, GENOME BIOL, V3; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lever J, 2017, NAT METHODS, V14, P641, DOI 10.1038/nmeth.4346; Linting M., 2007, THESIS; Linting M, 2007, PSYCHOL METHODS, V12, P336, DOI 10.1037/1082-989X.12.3.336; Linting M, 2007, PSYCHOL METHODS, V12, P359, DOI 10.1037/1082-989X.12.3.359; Linting M, 2011, PSYCHOMETRIKA, V76, P440, DOI 10.1007/s11336-011-9216-6; Lorenzo-Seva U., 2006, METHODOLOGY-EUR, V2, P57, DOI [10.1027/1614-2241.2.2.57, 10.1027/1614-1881.2.2.57, DOI 10.1027/1614-2241.2.2.57, 10.1027/1614-2241. 2.2.57.]; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; Muller H, 2018, DPLYR GRAMMAR DATA M; Nielson JL, 2021, J NEUROTRAUM, V38, P2530, DOI 10.1089/neu.2019.6702; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Nielson JL, 2015, BRAIN RES, V1619, P124, DOI 10.1016/j.brainres.2014.10.048; Nielson JL, 2014, J NEUROTRAUM, V31, P1789, DOI 10.1089/neu.2014.3399; Panaretos D, 2017, FACTOR ANAL TOOL PAT; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; R Development Core Team, 2012, R LANG ENV STAT COMP; Revelle W., 2018, PSYCH PROCEDURES PER; Rosenzweig ES, 2019, NAT NEUROSCI, V22, P1269, DOI 10.1038/s41593-019-0424-1; Rosenzweig ES, 2018, NAT MED, V24, P484, DOI 10.1038/nm.4502; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Team RS, 2018, RSTUDIO INT DEV R; Timmerman ME, 2007, BRIT J MATH STAT PSY, V60, P295, DOI 10.1348/000711006X109636; Tucker L.R., 1951, METHOD SYNTHESIS FAC; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Ginkel JR, 2014, J CLASSIF, V31, P242, DOI 10.1007/s00357-014-9154-y; Vitale R, 2017, J CHEMOMETR, V31, DOI 10.1002/cem.2937; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI [10.1007/978-3-319-24277-4, DOI 10.1007/978-3-319-24277-4]; Wilkinson L., 2005, GRAMMAR GRAPHICS; Yue JK, 2017, NEUROGENETICS, V18, P29, DOI 10.1007/s10048-016-0500-6; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zabala A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148087; Zhang ZH, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.07.12; Zientek LR, 2007, BEHAV RES METHODS, V39, P318, DOI 10.3758/BF03193163; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	84	3	3	0	3	eLIFE SCIENCES PUBL LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	JAN 14	2021	10								e61812	10.7554/eLife.61812			33	Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Life Sciences & Biomedicine - Other Topics	QH2KY	WOS:000618107400001	33443012	Green Published, Green Submitted, gold			2022-02-06	
J	Froese, L; Dian, J; Gomez, A; Zeiler, FA				Froese, L.; Dian, J.; Gomez, A.; Zeiler, F. A.			Sedation and cerebrovascular reactivity in traumatic brain injury: another potential avenue for personalized approaches in neurocritical care?	ACTA NEUROCHIRURGICA			English	Article						Cerebrovascular reactivity; Depth of sedation; Optimal sedation; TBI	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; LOWER LIMIT; AUTOREGULATION; THRESHOLDS; VALIDATION; MANAGEMENT; INDEXES	Background Impaired cerebrovascular reactivity appears to be linked to worse global outcome in adult traumatic brain injury (TBI). Literature suggests that current treatments administered in TBI care, in the intensive care unit (ICU), fail to greatly impact recorded cerebrovascular reactivity measures. In particular, the impact of sedation on cerebrovascular reactivity in traumatic brain injury (TBI) remains unclear in vivo. The goal of this study was to preliminarily assess the relationship between objectively measured depth of sedation and cerebrovascular reactivity in TBI. Methods Within, we describe a case series of 5 adult TBI patients with TBI, during which objective high-frequency physiology for sedation depth, using bispectral index (BIS), and both intracranial pressure (ICP) and arterial blood pressure (ABP) were recorded. Pressure reactivity index (PRx) and RAP (a metric of cerebral compensatory reserve) were derived. Relationships between cerebrovascular reactivity and compensatory reserve monitoring with BIS metrics were explored using descriptive plots. Results A total of 5 cases in our prospectively maintained database with high-frequency physiology for ICP, ABP, and BIS. Through error bar plotting, it can be seen that each patient displays a parabolic relationship between BIS and PRx. This suggests a potential "optimal" depth of sedation where cerebrovascular reactivity is the most intact. Conclusions This small series highlights the potential impact of depth of sedation on cerebrovascular reactivity in TBI. It suggests that there may be an individual optimal depth of sedation, so as to optimize cerebrovascular reactivity. Further study of objective depth of sedation and its impact on cerebrovascular physiology in TBI is required.	[Froese, L.; Zeiler, F. A.] Univ Manitoba, Biomed Engn, Fac Engn, Winnipeg, MB, Canada; [Dian, J.; Gomez, A.; Zeiler, F. A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Gomez, A.; Zeiler, F. A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, F. A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Zeiler, F. A.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England		Zeiler, FA (corresponding author), Univ Manitoba, Biomed Engn, Fac Engn, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.	log.froese@gmail.com; jdian@manitoba-physicians.ca; gomeza35@myumanitoba.ca; Frederick.Zeiler@umanitoba.ca		Zeiler, Frederick/0000-0003-1737-0510	University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; University of Manitoba; University of Manitoba-Department of Surgery GFT Research Grant; University of Manitoba Office of Research Services (ORS)-University Research Grant Program (URGP)	This study was directly supported by the University of Manitoba VPRI Research Investment Fund (RIF), the University of Manitoba Rudy Falk Clinician-Scientist Professorship, the University of Manitoba, the University of Manitoba-Department of Surgery GFT Research Grant, and the University of Manitoba Office of Research Services (ORS)-University Research Grant Program (URGP).	Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Aries MJH, 2016, CRIT CARE MED, V44, pE996, DOI 10.1097/CCM.0000000000001816; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bennis FC, 2020, NEUROCRIT CARE, V33, P542, DOI 10.1007/s12028-020-00930-6; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Klein SP, 2021, J NEUROTRAUM, V38, P506, DOI 10.1089/neu.2020.7160; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165; Zeiler FA, 2019, J NEUROSURG ANESTHES; Zeiler FA, 2020, J NEUROTRAUMA; Zeiler FA, 2019, ACTA NEUROCHIRURGICA; Zeiler FA, 2020, J NEUROTRAUM, V37, P1233, DOI 10.1089/neu.2019.6808; Zeiler FA, 2018, J NEUROTRAUM, V35, P2812, DOI 10.1089/neu.2017.5604; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	21	3	3	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2021	163	5					1383	1389		10.1007/s00701-020-04662-6		JAN 2021	7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RO5GJ	WOS:000605557000012	33404872				2022-02-06	
J	To, XV; Nasrallah, FA				Xuan Vinh To; Nasrallah, Fatima A.			A roadmap of brain recovery in a mouse model of concussion: insights from neuroimaging	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article							NEURITE ORIENTATION DISPERSION; RESTING-STATE-FMRI; HEAD IMPACT MODEL; DIFFUSION-TENSOR; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; REGIONAL HOMOGENEITY; INJURY; NETWORK; MRI	Concussion or mild traumatic brain injury is the most common form of traumatic brain injury with potentially long-term consequences. Current objective diagnosis and treatment options are limited to clinical assessment, cognitive rest, and symptom management, which raises the real danger of concussed patients being released back into activities where subsequent and cumulative injuries may cause disproportionate damages. This study conducted a cross-sectional multi-modal examination investigation of the temporal changes in behavioural and brain changes in a mouse model of concussion using magnetic resonance imaging. Sham and concussed mice were assessed at day 2, day 7, and day 14 post-sham or injury procedures following a single concussion event for motor deficits, psychological symptoms with open field assessment, T2-weighted structural imaging, diffusion tensor imaging (DTI), neurite orientation density dispersion imaging (NODDI), stimulus-evoked and resting-state functional magnetic resonance imaging (fMRI). Overall, a mismatch in the temporal onsets and durations of the behavioural symptoms and structural/functional changes in the brain was seen. Deficits in behaviour persisted until day 7 post-concussion but recovered at day 14 post-concussion. DTI and NODDI changes were most extensive at day 7 and persisted in some regions at day 14 post-concussion. A persistent increase in connectivity was seen at day 2 and day 14 on rsfMRI. Stimulus-invoked fMRI detected increased cortical activation at day 7 and 14 post-concussion. Our results demonstrate the capabilities of advanced MRI in detecting the effects of a single concussive impact in the brain, and highlight a mismatch in the onset and temporal evolution of behaviour, structure, and function after a concussion. These results have significant translational impact in developing methods for the detection of human concussion and the time course of brain recovery.	[Xuan Vinh To; Nasrallah, Fatima A.] Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia		Nasrallah, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia.	f.nasrallah@uq.edu.au	; Nasrallah, Fatima/N-3398-2016	To, Xuan Vinh/0000-0002-6527-7356; Nasrallah, Fatima/0000-0002-7385-9559	Motor Accident Insurance Commission (MAIC), The Queensland Government, Australia [2014000857]; University of QueenslandUniversity of Queensland [CRM 200221-005374]; Queensland NMR Network; National Imaging Facility (a National Collaborative Research Infrastructure Strategy capability)	This research was supported by Motor Accident Insurance Commission (MAIC), The Queensland Government, Australia (Grant Number: 2014000857) and The University of Queensland (Promoting Women's fellowship: CRM 200221-005374). We acknowledge the support from the Queensland NMR Network and the National Imaging Facility (a National Collaborative Research Infrastructure Strategy capability) for the operation of 9.4T MRI and utilisation of image processing computational resources at the Centre for Advanced Imaging, the University of Queensland.	Akiki TJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0840-4; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Anderson M, 2012, IEEE T SIGNAL PROCES, V60, P1672, DOI 10.1109/TSP.2011.2181836; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Ashburner J., 2003, HUMAN BRAIN FUNCTION; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Badea A, 2018, NEUROIMAGE-CLIN, V18, P60, DOI 10.1016/j.nicl.2018.01.007; Bajic D, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00685; Bashir A, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113116; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Braeckman K, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101669; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Bubb Emma J, 2017, Brain Neurosci Adv, V1, DOI 10.1177/2398212817723443; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Castellani RJ, 2019, J ALZHEIMERS DIS, V67, P447, DOI 10.3233/JAD-180721; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Churchill NW, 2019, HUM BRAIN MAPP, V40, P1908, DOI 10.1002/hbm.24500; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Dickie DA, 2015, MAGN RESON IMAGING, V33, P1299, DOI 10.1016/j.mri.2015.07.014; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Dohmatob E, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00064; Du YH, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00267; Du YH, 2016, HUM BRAIN MAPP, V37, P1005, DOI 10.1002/hbm.23086; Du YH, 2013, NEUROIMAGE, V69, P157, DOI 10.1016/j.neuroimage.2012.11.008; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gazdzinski LM, 2020, J NEUROTRAUM, V37, P1818, DOI 10.1089/neu.2020.6992; Golub Y, 2009, BEHAV BRAIN RES, V205, P544, DOI 10.1016/j.bbr.2009.08.019; Gopinath K, 2015, BRAIN CONNECT, V5, P267, DOI 10.1089/brain.2014.0323; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Gozzi A, 2016, NEUROIMAGE, V127, P496, DOI 10.1016/j.neuroimage.2015.12.017; Grandjean J, 2017, J NEUROSCI, V37, P8092, DOI 10.1523/JNEUROSCI.0438-17.2017; GRI L, 2017, NEUROIMAGE, V154, P188, DOI DOI 10.1016/J.NEUROIMAGE.2016.12.036; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Hehar H, 2016, NEUROSCIENCE, V332, P61, DOI 10.1016/j.neuroscience.2016.06.039; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hong X, 2015, MAGN RESON IMAGING, V33, P1098, DOI 10.1016/j.mri.2015.06.010; Hoogenboom WS, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519858627; Hoogenboom WS, 2019, PHARMACOL THERAPEUT, V198, P109, DOI 10.1016/j.pharmthera.2019.02.016; Hsu LM, 2016, P NATL ACAD SCI USA, V113, pE4541, DOI 10.1073/pnas.1601485113; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Jankowski MM, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00045; Jelescu IO, 2017, FRONT PHYS-LAUSANNE, V5, DOI 10.3389/fphy.2017.00061; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kantarci K, 2017, NEUROBIOL AGING, V56, P172, DOI 10.1016/j.neurobiolaging.2017.04.024; Kaushal M, 2019, HUM BRAIN MAPP, V40, P1211, DOI 10.1002/hbm.24440; Kikinis Z, 2017, BRAIN INJURY, V31, P1376, DOI 10.1080/02699052.2017.1318450; Laney J, 2015, J NEUROSCI METH, V247, P32, DOI 10.1016/j.jneumeth.2015.03.019; Lee JH, 2008, NEUROIMAGE, V40, P86, DOI 10.1016/j.neuroimage.2007.11.019; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Li L, 2017, J NEUROTRAUM, V34, P182, DOI 10.1089/neu.2015.4315; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCuddy WT, 2018, NEUROIMAGE-CLIN, V19, P434, DOI 10.1016/j.nicl.2018.05.011; Meier TB, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6471; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Michael J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00887; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nasrallah FA, 2014, NEUROIMAGE, V86, P417, DOI 10.1016/j.neuroimage.2013.10.025; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; O'Mara SM, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00052; Peters SK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00104; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Qiu LR, 2013, NEUROIMAGE, V83, P593, DOI 10.1016/j.neuroimage.2013.06.074; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Risling M, 2019, J INTERN MED, V285, P594, DOI 10.1111/joim.12909; Rodriguez-Grande B, 2018, GLIA, V66, P1663, DOI 10.1002/glia.23336; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Ross DE, 2020, BRAIN INJURY, V34, P11, DOI 10.1080/02699052.2019.1669074; Ross DE, 2018, BRAIN INJURY, V32, P1437, DOI 10.1080/02699052.2018.1489980; Ross DE, 2013, PSYCHOL INJ LAW, V6, P75, DOI 10.1007/s12207-012-9140-9; Salberg S, 2017, NEUROSCIENCE, V365, P146, DOI 10.1016/j.neuroscience.2017.09.053; Sauerbeck AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25737-6; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scholz J, 2015, NEUROIMAGE, V109, P190, DOI 10.1016/j.neuroimage.2015.01.027; Schwarz AJ, 2013, BRAIN CONNECT, V3, P503, DOI 10.1089/brain.2013.0168; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Sherman M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0641-4; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Tariq M, 2016, NEUROIMAGE, V133, P207, DOI 10.1016/j.neuroimage.2016.01.046; To XV, 2021, J NEUROTRAUM, V38, P967, DOI 10.1089/neu.2019.6944; Tu TW, 2017, J NEUROTRAUM, V34, P248, DOI 10.1089/neu.2015.4355; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Verley DR, 2018, J NEUROTRAUM, V35, P2448, DOI 10.1089/neu.2017.5536; Wang N, 2019, J MAGN RESON IMAGING, V50, P1852, DOI 10.1002/jmri.26758; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wortman RC, 2018, ANN CLIN TRANSL NEUR, V5, P1588, DOI 10.1002/acn3.667; Wu YC, 2018, J NEUROTRAUM, V35, P2377, DOI 10.1089/neu.2017.5566; Yi SY, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00081; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zerbi V, 2015, NEUROIMAGE, V123, P11, DOI 10.1016/j.neuroimage.2015.07.090; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2	125	3	3	2	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	JAN 6	2021	9	1							2	10.1186/s40478-020-01098-y			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PV7KN	WOS:000610162800001	33407949	Green Published, gold			2022-02-06	
J	Estraneo, A; Masotta, O; Bartolo, M; Pistoia, F; Perin, C; Marino, S; Lucca, L; Pingue, V; Casanova, E; Romoli, A; Gentile, S; Formisano, R; Salvi, GP; Scarponi, F; De Tanti, A; Bongioanni, P; Rossato, E; Santangelo, A; Diana, AR; Gambarin, M; Intiso, D; Antenucci, R; Premoselli, S; Bertoni, M; De Bellis, F				Estraneo, A.; Masotta, O.; Bartolo, M.; Pistoia, F.; Perin, C.; Marino, S.; Lucca, L.; Pingue, V; Casanova, E.; Romoli, A.; Gentile, S.; Formisano, R.; Salvi, G. P.; Scarponi, F.; De Tanti, A.; Bongioanni, P.; Rossato, E.; Santangelo, A.; Diana, A. R.; Gambarin, M.; Intiso, D.; Antenucci, R.; Premoselli, S.; Bertoni, M.; De Bellis, F.			Multi-center study on overall clinical complexity of patients with prolonged disorders of consciousness of different etiologies	BRAIN INJURY			English	Article						Disorders of consciousness; medical complications; clinical complexity; neurorehabilitation; outcome		Aim: to assess overall clinical complexity of patients with acquired disorders of consciousness (DoC) in vegetative state/unresponsive wakefulness syndrome (VS/UWS) vs. minimally conscious state- MCS) and in different etiologies.. Design: Multi-center cross-sectional observational study. Setting: 23 intensive neurorehabilitation units. Subjects: 264 patients with DoC in the post-acute phase: VS/UWS = 141, and MCS = 123 due to vascular (n = 125), traumatic (n = 83) or anoxic (n = 56) brain injury. Main Measures: Coma Recovery Scale-Revised, and Disability Rating Scale (DRS); presence of medical devices (e.g., for eating or breathing); occurrence and severity of medical complications. Results: patients in DoC, and particularly those in VS/UWS, showed severe overall clinical complexity. Anoxic patients had higher overall clinical complexity, lower level of responsiveness/consciousness, higher functional disability, and higher needs of medical devices. Vascular patients had worse premorbid clinical comorbidities. The two etiologies showed a comparable rate of MC, higher than that observed in traumatic etiology. Conclusion: overall clinical complexity is significantly higher in VS/UWS than in MCS, and in non-traumatic vs. traumatic etiology. These findings could explain the worse clinical evolution reported in anoxic and vascular etiologies and in VS/UWS patients and contribute to plan patient-tailored care and rehabilitation programmes.	[Estraneo, A.; Romoli, A.] IRCCS Fdn Don Carlo Gnocchi, Dept Acquired Brain Injury, Florence, Italy; [Estraneo, A.] Santa Maria Pieta Gen Hosp, Neurol Unit, Nola, Italy; [Masotta, O.] SB SpA Lab DoC Study, Lab DoC Study, Ist Clin Sci Maugeri IRCCS, Telese Terme, Italy; [Bartolo, M.] HABILITA Zingonia Ciserano, Neurorehabil Unit, Bergamo, Italy; [Pistoia, F.] Univ Aquila, Neurol Inst, Dept Biotechnol & Appl Clin Sci, Laquila, Italy; [Perin, C.] Ist Clin Zucchi, Unita Neuroriabilitaz Cognit, Carate Brianza, Italy; [Marino, S.] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Lucca, L.] Ist S Anna, Unita Riabilitaz Gravi Cerebroles, Crotone, Italy; [Pingue, V] SB SpA, Unita Med Riabilitat Neuromotoria, Ist Clin Sci Maugeri IRCCS, Pavia, Italy; [Casanova, E.] IRCCS Osped Maggiore, Casa Risvegli Luca Nigris, Bologna, Italy; [Gentile, S.] FT Camplani Clin Ancelle Carita, Dip Riabilitaz, Cremona, Italy; [Formisano, R.] Fdn Santa Lucia, Unita Postcoma & Ric Traslaz, IRCCS, Rome, Italy; [Salvi, G. P.] Ist Clin Quarenghi, UF Riabilitaz Neuromotoria, S Pellegrino Terme, Italy; [Scarponi, F.] Osped San Giovanni Battista, Dip Neurol UGCA, Foligno, Italy; [De Tanti, A.] S Stefano Riabilitaz, Ctr Cardinal Ferrari, Fontanellato Di Parma, Italy; [Bongioanni, P.] Azienda Osped Univ Pisana, Integrated Care Dept Med Specialties, Severe Acquired Brain Injuries Dept Sect, Pisa, Italy; [Rossato, E.] Osped Sacro Cuore Don Calabria, Ctr Med Sonno, Verona, Italy; [Santangelo, A.] Giuseppe Giglio Fdn, Rehabil Dept, Unit Severe Acquired Brain Injuries, Cefalu, Italy; [Diana, A. R.] Azienda Osped Brotzu, Dip Neurosci & Riabilitaz, Cagliari, Italy; [Gambarin, M.] Osped Riabilitat Marzana, Unita Med Fis & Riabilitaz, Verona, Italy; [Intiso, D.] IRCCS Casa Sollievo Sofferenza, Unita Med Fis & Neuroriabilitaz, San Giovanni Rotondo, Italy; [Antenucci, R.] Osped Castel San Giovanni, Unita Med Riabilitat Intens, San Giovanni Rotondo, Italy; [Premoselli, S.] Presidio Osped Vimercate, Struttura Riabilitaz Neuromotoria, Monza, Italy; [Bertoni, M.] Azienda Socio Sanitaria Terr Sette Laghi, Presidio Riabilitaz Neuromotoria, Cuasso Al Monte, Italy; [De Bellis, F.] Fdn Don Carlo Gnocchi, Dept Acquired Brain Injury, St Angelo Dei Lombardi, Italy		Estraneo, A (corresponding author), IRCCS Fdn Don Carlo Gnocchi, Florence, Italy.	aestraneo@gmail.com	Lucca, Lucia Francesca/AAB-8558-2022; Antenucci, Roberto/AAA-8195-2020; Marino, Silvia/T-5118-2019; Intiso, Domenico/H-2414-2016; pingue, valeria/AAC-1833-2020; Casanova, Emanuela/AAD-3643-2022; estraneo, anna/K-5409-2016	Antenucci, Roberto/0000-0002-7205-8995; Marino, Silvia/0000-0002-1088-6808; Intiso, Domenico/0000-0002-6564-5956; pingue, valeria/0000-0001-9376-4699; Casanova, Emanuela/0000-0002-5727-3769; estraneo, anna/0000-0001-6646-5626; LUCCA, LUCIA FRANCESCA/0000-0002-7602-2711			Anthonissen J, 2020, ARCH ORTHOP TRAUM SU, V140, P1029, DOI 10.1007/s00402-019-03326-0; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Avesani R, 2018, FUNCT NEUROL, V33, P97; Bargellesi S, 2018, CLIN REHABIL, V32, P255, DOI 10.1177/0269215517723161; Eifert B, 2013, ARCH PHYS MED REHAB, V94, P1924, DOI 10.1016/j.apmr.2013.03.030; Estraneo, 2018, COMA DISORDERS CONSC, P17; Estraneo A, 2019, BRAIN INJURY, V33, P1633, DOI 10.1080/02699052.2019.1658220; Estraneo A, 2015, EUR J PHYS REHAB MED, V51, P627; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A., BRAIN INJURY; Estraneo A, 2018, ARCH PHYS MED REHAB, V99, P2523, DOI 10.1016/j.apmr.2018.04.024; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Fins JJ, 2013, ARCH PHYS MED REHAB, V94, P1934, DOI 10.1016/j.apmr.2012.12.028; Formisano R, 2005, ACT NEUR S, V93, P201; Formisano R, 1998, EUR J NEUROL, V5, P151, DOI 10.1046/j.1468-1331.1998.520151.x; Formisano R, 2019, BRAIN INJURY, V33, P974, DOI 10.1080/02699052.2019.1622785; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Formisano R, 2011, FUNCT NEUROL, V26, P15; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Intiso D, 2017, EUR J PHYS REHAB MED, V53, P268, DOI 10.23736/S1973-9087.16.04288-X; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Martens G, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120162; Moretta P, 2017, BRAIN INJURY, V31, P1088, DOI 10.1080/02699052.2017.1290278; Moretta P, 2014, CLIN REHABIL, V28, P717, DOI 10.1177/0269215514521826; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Pascarella A, 2016, J NEUROL, V263, P2048, DOI 10.1007/s00415-016-8232-y; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Portaccio E, 2018, BRAIN INJURY, V32, P730, DOI 10.1080/02699052.2018.1440420; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Sattin D, 2014, EUR J PHYS REHAB MED, V50, P309; Scarponi F, 2019, EUR J PHYS REHAB MED, V55, P191, DOI 10.23736/S1973-9087.18.05342-X; Schonle P W, 1995, Rehabilitation (Stuttg), V34, P69; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; World Health Organization, 2007, INT CLASS FUNCT DIS; Zasler ND, 2019, BRAIN INJURY, V33, P1684, DOI 10.1080/02699052.2019.1656821	47	3	3	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 5	2021	35	1					1	7		10.1080/02699052.2020.1861652			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QU1AU	WOS:000627016800001	33331792				2022-02-06	
J	Bernick, C; Hansen, T; Ng, W; Williams, V; Goodman, M; Nalepa, B; Shan, GG; Seifert, T				Bernick, Charles; Hansen, Tucker; Ng, Winnie; Williams, Vernon; Goodman, Margaret; Nalepa, Bryce; Shan, Guogen; Seifert, Tad			Concussion occurrence and recognition in professional boxing and MMA matches: toward a concussion protocol in combat sports	PHYSICIAN AND SPORTSMEDICINE			English	Article						Concussion; traumatic brain injury; video analysis		Objectives: Determine, through video reviews, how often concussions occur in combat sport matches, what influence they have on the outcome, and how well non-physician personnel can be trained to recognize concussions. Methods: This is a retrospective video analysis by an 8-person panel of 60 professional fights (30 boxing and 30 mixed martial arts). Through video review, physician and non-physician personnel recorded details about each probable concussion and determined if and when they would have stopped the fight compared to the official stoppage time. Results: A concussion was recorded in 47/60 fights. The mean number of concussions per minute of fight time was 0.061 (0.047 for boxers and 0.085 for MMA). When stratifying by outcome of the bout, the mean number of concussions per minute for the winner was 0.010 compared to the loser at 0.111 concussions per minute. The fighter that sustained the first concussion ultimately lost 98% of the time. The physician and non-physician raters had high agreement regarding the number of concussions that occurred to each fighter per match. The physician raters judged that 24 of the 60 fights (11 boxing [37%]; 13 MMA [43%]) should have been stopped sooner than what occurred. Conclusion: Recognizing that the concussions often occur in combat sport matches, that the losing fighter almost always is concussed first and tends to sustain more concussions during the fight, along with the demonstration that non-physician personnel can be taught to recognize concussion, may guide policy changes that improve brain health in combat sports.	[Bernick, Charles; Ng, Winnie; Goodman, Margaret] Cleveland Clin, Neurol Inst, Las Vegas, NV 89106 USA; [Bernick, Charles] Univ Washington, Dept Neurol, Seattle, DC USA; [Hansen, Tucker] Yale Univ, New Haven, CT USA; [Williams, Vernon] Cedars Sinai Kerlan Jobe Inst, Ctr Sports Neurol, Los Angeles, CA USA; [Nalepa, Bryce] Banner Hlth, Concuss & Sports Med Ctr, Phoenix, AZ USA; [Shan, Guogen] UNLV, Sch Publ Hlth, Las Vegas, NV USA; [Seifert, Tad] Norton Healthcare, Dept Neurol, Louisville, KY USA		Bernick, C (corresponding author), Cleveland Clin, Neurol Inst, Las Vegas, NV 89106 USA.	bernick@uw.edu		, Tucker/0000-0002-3948-073X; Shan, Guogen/0000-0001-8690-6599			Balmer N.J., 2007, J SPORT BEHAV, V30, P130; Bernick C, 2018, J NEUROTRAUM, V35, P2351, DOI 10.1089/neu.2017.5553; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bruce JM, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-097091; Concussion policies by league, 2012, USA TODAY; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0093-0; Kelly M, 2009, CLIN SPORT MED, V28, P515, DOI 10.1016/j.csm.2009.07.003; Major League Baseball MLB, UNION ADOPT UNIVERSA; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Miarka B, 2017, HUM MOVEMENT SCI, V55, P73, DOI 10.1016/j.humov.2017.07.009; Miele VJ, 2007, NEUROSURGERY, V60, P307, DOI 10.1227/01.NEU.0000249247.48299.5B; Monseau AJ, 2021, PHYSICIAN SPORTSMED, V49, P51, DOI 10.1080/00913847.2020.1763145; National Basketball Association, CONCUSSION POLICY SU; Nevill AM, 2002, PSYCHOL SPORT EXERC, V3, P261, DOI 10.1016/S1469-0292(01)00033-4; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; Park Alice, 2016, Time, V187, P12; Purcell L, 2011, PEDIATRICS, V128, P617, DOI 10.1542/peds.2011-1165; SAMMONS JT, 1989, JAMA-J AM MED ASSOC, V261, P1484; Seifert T, 2015, PHYSICIAN SPORTSMED, V43, P395, DOI 10.1080/00913847.2015.1081551; Sethi N K, 2016, SA J. Sports Med., V28, P87, DOI 10.17159/2078-516x/2016/v28i3a1735; Shan GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097386; Souchon N, 2013, J APPL SPORT PSYCHOL, V25, P223, DOI 10.1080/10413200.2012.713440; Stephen SJ, 2020, J HEAD TRAUMA REHAB, V35, pE280, DOI 10.1097/HTR.0000000000000540; Stiller JW, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00069; Thomas RE, 2018, PHYSICIAN SPORTSMED, V46, P155, DOI 10.1080/00913847.2018.1430451; Zazryn TR, 2008, NEUROL CLIN, V26, P257, DOI 10.1016/j.ncl.2007.11.004	29	3	3	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	OCT 2	2021	49	4					469	475		10.1080/00913847.2020.1856631		JAN 2021	7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	WN3QO	WOS:000604008500001	33251911				2022-02-06	
J	Alfrey, EJ; Tracy, M; Alfrey, JR; Carroll, M; Aranda-Wikman, ED; Arora, T; Maa, J; Minnis, J				Alfrey, Edward J.; Tracy, Michelle; Alfrey, Justin R.; Carroll, Meaghan; Aranda-Wikman, Erik D.; Arora, Tarun; Maa, John; Minnis, James			Helmet Usage Reduces Serious Head Injury Without Decreasing Concussion After Bicycle Riders Crash	JOURNAL OF SURGICAL RESEARCH			English	Article						Bicycle crash victims; Helmet usage; Concussion	TRAUMATIC BRAIN-INJURY; LEGISLATION; CHILDREN	Background: The importance of bicycle helmets in reducing injuries is unclear. Our center receives a disproportionate number of bicycle crash victims. We sought to evaluate the types of injuries observed and the role of helmets in reducing head injuries. Materials and methods: We evaluated demographic data and compared injuries between bicycle riders that crashed with and without helmets over a 9-year period. Categorical variables were compared using linear regression methods and nominal variables using ANOVA. Differences were considered significant for P <= 0.05. Results: There were 906 patients evaluated, 701 with helmets (77%) and 205 (23%) without helmets. The mean Injury Severity Score was 9.3 +/- 6.4. The most common injuries were concussion (n = 385), rib fractures (n = 154), clavicle fractures (n = 139), facial fractures (n = 102), and cervical spine fractures (n = 89). There was no significant difference in the number of patients with a concussion in riders with or without helmets, [299/701, 42.6% versus 86/205, 42.0%, respectively, (P = NS)]. In helmet versus no helmet riders, there were significantly fewer patients with facial fractures, [67/701, 9.5%, versus 35/205, 17.0%, respectively, (P = 0.003)], skull fractures [8/701, 1.1% versus 9/205, 4.4%, respectively, (P = 0.003)], and serious head injuries [6/701, 0.85% versus 8/205, 3.9%, respectively, (P = 0.002)]. Conclusions: Helmeted patients involved in bicycle crashes are less likely to sustain a serious head injury, a skull fracture, or facial fractures compared to riders without helmets. The most common injury in patients with a bicycle crash is a concussion. Helmets did not prevent concussion after bicycle rider's crash in our patient population. (C)2020 Elsevier Inc. All rights reserved.	[Alfrey, Edward J.] Stanford Univ, Surg, Stanford, CA 94305 USA; [Alfrey, Edward J.; Maa, John; Minnis, James] Marin Hlth Med Ctr, Dept Surg, Greenbrae, CA USA; [Alfrey, Edward J.; Tracy, Michelle; Carroll, Meaghan; Aranda-Wikman, Erik D.] Marin Hlth Med Ctr, Trauma Serv, Greenbrae, CA USA; [Alfrey, Justin R.] 528 Hosp Ctr, Ft Bliss, TX USA; [Arora, Tarun] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA		Alfrey, EJ (corresponding author), Greenbrae, Dept Surg, Trauma Serv, 250 Bon Air Rd,L105, Greenbrae, CA 94904 USA.	ealfrey@primamedgroup.com					[Anonymous], 2019, DAT TRAUM QUAL PROGR; ASHBAUGH SJ, 1995, CLIN PEDIATR, V34, P256, DOI 10.1177/000992289503400505; Axelsson A, 2019, TRAFFIC INJ PREV, V20, pS21, DOI 10.1080/15389588.2019.1694666; Benjamin T, 2019, JAMA OTOLARYNGOL, V145, P140, DOI 10.1001/jamaoto.2018.3351; Bergenstal John, 2012, W V Med J, V108, P78; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Williams C, 2018, J SURG RES, V222, P231, DOI 10.1016/j.jss.2017.11.006; Zibung E, 2015, EUR J TRAUMA EMERG S, V41, P517, DOI 10.1007/s00068-014-0471-y; Zibung E, 2016, INJURY, V47, P1078, DOI 10.1016/j.injury.2015.11.015	12	3	3	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2021	257						593	596		10.1016/j.jss.2020.08.009			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PF4GI	WOS:000599014700005	32932191				2022-02-06	
J	Awan, N; DiSanto, D; Juengst, SB; Kumar, RG; Bertisch, H; Niemeier, J; Fann, JR; Kesinger, MR; Sperry, J; Wagner, AK				Awan, Nabil; DiSanto, Dominic; Juengst, Shannon B.; Kumar, Raj G.; Bertisch, Hilary; Niemeier, Janet; Fann, Jesse R.; Kesinger, Matthew R.; Sperry, Jason; Wagner, Amy K.			Evaluating the Cross-Sectional and Longitudinal Relationships Predicting Suicidal Ideation Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; employment; substance misuse; suicide; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; WORKING-AGE INDIVIDUALS; MAJOR DEPRESSION; SUBSTANCE-ABUSE; PARTICIPATION ASSESSMENT; NATIONAL INSTITUTE; DEIDENTIFIED DATA; MOOD DISORDERS; RISK BEHAVIOR; 1ST YEAR	Objective: Characterize relationships among substance misuse, depression, employment, and suicidal ideation (SI) following moderate to severe traumatic brain injury (TBI). Design: Prospective cohort study. Setting: Inpatient rehabilitation centers with telephone follow-up; level I/II trauma centers in the United States. Participants: Individuals with moderate to severe TBI with data in both the National Trauma Data Bank and the Traumatic Brain Injury Model Systems National Database, aged 18 to 59 years, with SI data at year 1 or year 2 postinjury (N = 1377). Main Outcome Measure: Primary outcome of SI, with secondary employment, substance misuse, and depression outcomes at years 1 and 2 postinjury. Results: Cross-lagged structural equation modeling analysis showed that year 1 unemployment and substance misuse were associated with a higher prevalence of year 1 depression. Depression was associated with concurrent SI at years 1 and 2. Older adults and women had a greater likelihood of year 1 depression. More severe overall injury (injury severity score) was associated with a greater likelihood of year 1 SI, and year 1 SI was associated with a greater likelihood of year 2 SI. Conclusions: Substance misuse, unemployment, depression, and greater extracranial injury burden independently contributed to year 1 SI; in turn, year 1 SI and year 2 depression contributed to year 2 SI. Older age and female sex were associated with year 1 depression. Understanding and mitigating these risk factors are crucial for effectively managing post-TBI SI to prevent postinjury suicide.	[Awan, Nabil; DiSanto, Dominic; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA; [Awan, Nabil] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Sperry, Jason] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Kesinger, Matthew R.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Awan, Nabil] Univ Dhaka, Inst Stat Res & Training, Dhaka, Bangladesh; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, Dallas, TX 75390 USA; [Kumar, Raj G.] Icahn Sch Med Mt Sinai, Brain Injury Res Ctr, Dept Rehabil Med, New York, NY 10029 USA; [Bertisch, Hilary] NYU Rusk Rehabil, Dept Psychol, Brooklyn, NY USA; [Niemeier, Janet] UAB Spain Rehabil Ctr, Dept Phys Med & Rehabil, Birmingham, AL USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA.	naa86@pitt.edu; jdd65@pitt.edu; shannon.juengst@utsouthwestern.edu; raj.kumar@mountsinai.org; Hilary.Bertisch@nyulangone.or; jniemeier@uabmc.edu; fann@uw.edu; matthewryankesinger@gmail.com; sperryjl@upmc.edu; wagnerak@upmc.edu		DiSanto, Dominic/0000-0002-8815-2169	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [TL1 TR0001858, R21 HD 089075-01]; NIH NIH Center for Large Data Research and Data Sharing in Rehabilitation [P2C HD065702]; NIDILRRUnited States Department of Health & Human Services [90DP0031, 90DP0041, 90DPTB0013-01-00, 90DP0044-01, 90DPTB0011-01-00, 90DP0037, 90AR5025]; VA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions [W91YTZ-13-C0015]; Defense and Veterans Brain Injury Center, U.S. Department of Veterans Affairs Health Services Research and Development COINUS Department of Veterans Affairs [1 I50 HX001233-01]	Work for this manuscript was supported by the National Institutes of Health TL1 TR0001858, R21 HD 089075-01, and NIH P2C HD065702 NIH Center for Large Data Research and Data Sharing in Rehabilitation. The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) supported the collection of original data for this manuscript.; The contents of this manuscript were developed under NIDILRR Grants 90DP0031, 90DP0041, 90DPTB0013-01-00, 90DP0044-01, 90DPTB0011-01-00, 90DP0037, and with postdoctoral fellow support by NIDILRR Grant 90AR5025. Additional support was received from VA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions grant number W91YTZ-13-C0015, and from the Defense and Veterans Brain Injury Center, U.S. Department of Veterans Affairs Health Services Research and Development COIN grant number 1 I50 HX001233-01.	Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Auerbach RP, 2017, J ABNORM CHILD PSYCH, V45, P91, DOI 10.1007/s10802-016-0146-8; Awan N, 2020, ARCH PHYS MED REHAB, V101, P797, DOI 10.1016/j.apmr.2019.10.189; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beaulieu-Bonneau S, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000341; Bogner J, 2013, J HEAD TRAUMA REHAB, V28, P337, DOI 10.1097/HTR.0b013e31829af969; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Breslau N, 2012, HEADACHE, V52, P723, DOI 10.1111/j.1526-4610.2012.02117.x; Bryant RA, 2016, J CLIN PSYCHIAT, V77, pE648, DOI 10.4088/JCP.14m09661; Bryson CN, 2017, DEATH STUD, V41, P399, DOI 10.1080/07481187.2017.1320340; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Desseilles M, 2013, J HEAD TRAUMA REHAB, V28, P149, DOI 10.1097/HTR.0b013e3182527138; DiSanto D, 2019, ARCH PHYS MED REHAB, V100, P412, DOI 10.1016/j.apmr.2018.06.022; Dreer LE, 2018, CURR OPIN PSYCHOL, V22, P73, DOI 10.1016/j.copsyc.2017.08.030; Enders C. K., 2010, APPL MISSING DATA AN; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fishbain D A, 1999, Semin Clin Neuropsychiatry, V4, P221; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Flisher AJ, 2000, J AM ACAD CHILD PSY, V39, P881, DOI 10.1097/00004583-200007000-00017; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gertler P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009871.pub2; Groswasser Z, 2009, POLYTRAUMA ASS TRAUM, DOI [10.3109/02699059009026161, DOI 10.3109/02699059009026161]; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hoyle R.H., 2014, HDB STRUCTURAL EQUAT; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ilgen MA, 2010, ARCH GEN PSYCHIAT, V67, P1152, DOI 10.1001/archgenpsychiatry.2010.129; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Juengst SB, 2019, BRAIN INJURY, V33, P567, DOI 10.1080/02699052.2019.1584333; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Karpur A, 2013, GUIDE TRAUMATIC BRAI; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Kesinger MR, 2017, AM J PHYS MED REHAB, V96, P17, DOI 10.1097/PHM.0000000000000513; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kumar RG, 2018, AM J PHYS MED REHAB, V97, P236, DOI 10.1097/PHM.0000000000000838; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Lee S, 2019, J NEUROSURG, V131, P1931, DOI 10.3171/2018.8.JNS18676; Liu RT, 2017, NEUROSCI BIOBEHAV R, V83, P440, DOI 10.1016/j.neubiorev.2017.09.019; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; March J, 2014, J TRAUMA ACUTE CARE, V76, P180, DOI 10.1097/TA.0b013e3182a900bc; McCullumsmith CB, 2015, ARCH PHYS MED REHAB, V96, P799, DOI 10.1016/j.apmr.2014.12.017; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; Merchant WR, 2013, WORK, V45, P407, DOI 10.3233/WOR-131633; Nowrangi MA, 2014, PSYCHOSOMATICS, V55, P430, DOI 10.1016/j.psym.2013.11.006; O'Neil ME, 2013, TABLE A 1 CLASSIFICA; Pagulayan KF, 2016, J NEUROTRAUM, V33, P1390, DOI 10.1089/neu.2015.4071; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; ParkLee E., 2016, KEY SUBSTANCE USE ME; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Pickett W, 2002, ARCH PEDIAT ADOL MED, V156, P786, DOI 10.1001/archpedi.156.8.786; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; R Core Team, 2019, R LANG ENV STAT COMP; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Ryb GE, 2006, J TRAUMA, V61, P799, DOI 10.1097/01.ta.0000196763.14289.4e; Salter KL, 2016, J HEAD TRAUMA REHAB, V31, pE21, DOI 10.1097/HTR.0000000000000193; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Svingos AM, 2019, J CLIN EXP NEUROPSYC, V41, P775, DOI 10.1080/13803395.2019.1620695; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Turner C, 2004, ACCIDENT ANAL PREV, V36, P93, DOI 10.1016/S0001-4575(02)00131-8; U.S. Department of Health and Human Services U.S. Department of Agriculture, 2015, 2015 2020 DIET GUID; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Yen S, 2009, ACTA PSYCHIAT SCAND, V120, P222, DOI 10.1111/j.1600-0447.2009.01366.x	94	3	3	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2021	36	1			SI		E18	E29		10.1097/HTR.0000000000000588			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZE	WOS:000604011300003	32769828				2022-02-06	
J	Chen, T; Yang, LK; Zhu, J; Hang, CH; Wang, YH				Chen, Tao; Yang, Li-Kun; Zhu, Jie; Hang, Chun-Hua; Wang, Yu-Hai			The AMPAR Antagonist Perampanel Regulates Neuronal Necroptosis via Akt/GSK3 beta Signaling After Acute Traumatic Injury in Cortical Neurons	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Traumatic brain injury; AMPAR; perampanel; necroptosis; AKT; lactate dehydrogenase	BRAIN-INJURY; RECEPTOR ANTAGONIST; DOWN-REGULATION; AKT; PHOSPHORYLATION; APOPTOSIS; SURVIVAL; GLIOMA	Background: Perampanel is a highly selective and non-competitive alpha-amino-3-hydroxy-5 -methyl-4-isoxazole propionate (AMPA) receptor (AMPAR) antagonist, which has been licensed as an orally administered antiepileptic drug in more than 55 countries. Recently, perampanel was found to exert neuroprotective effects in hemorrhagic and ischemic stroke models. Objective: In this study, the protective effect of perampanel was investigated. Methods: The protective effect of perampanel was investigated in an in vitro Traumatic Neuronal Injury (TNI) model in primary cultured cortical neurons. Results: We found that perampanel significantly preserved morphological changes, attenuated lactate dehydrogenase (LDH) release and inhibited caspase-3 activation after TNI. The TNI-induced necroptosis, as evidenced by flow cytometry, was markedly reduced by perampanel treatment. The results of western blot showed that perampanel decreased the expression and phosphorylation of the necroptotic factors, receptor protein interacting kinase 1 (RIPK1) and RIPK3. In addition, treatment with perampanel increased the phosphorylation of Akt and GSK3 beta in a time-dependent manner up to 24 h after TNI. Treatment with the Akt inhibitor LY294002 partially reversed the protective effects of perampanel. Conclusion: Our present data suggest that necroptosis plays a key role in the pathogenesis of neuronal death after TNI, and that perampanel might have therapeutic potential for patients with Traumatic Brain Injury (TBI).	[Chen, Tao; Yang, Li-Kun; Zhu, Jie; Wang, Yu-Hai] Anhui Med Univ, Med Sch, Hosp PLA 904, Dept Neurosurg, Wuxi 214044, Jiangsu, Peoples R China; [Chen, Tao; Hang, Chun-Hua] Nanjing Univ, Med Sch, Affiliated Hosp, Nanjing Drum Tower Hosp,Dept Neurosurg, Nanjing 210000, Jiangsu, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Med Sch, Affiliated Hosp, Nanjing Drum Tower Hosp,Dept Neurosurg, Nanjing 210000, Jiangsu, Peoples R China.; Wang, YH (corresponding author), Anhui Med Univ, Sch Med, Hosp PLA 101, Dept Neurosurg, Wuxi 214044, Jiangsu, Peoples R China.	hangch_neuro@126.com; prof_wyh101@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701932, 81871598, 81771291, 82072168]; Clinical Medical Science and Technology Development Foundation of Jiangsu University [JLY20180028]; Major Scientific Research Project of Wuxi Health Commission [Z202001]; Wuxi Translational Medicine Research Foundation Key Project [2019-ZZ001]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2019M651803]	This work was supported by the National Natural Science Foundation of China (No. 81701932, No. 81871598, No. 81771291 and No. 82072168), Clinical Medical Science and Technology Development Foundation of Jiangsu University (No. JLY20180028), the Major Scientific Research Project of Wuxi Health Commission (No. Z202001) Wuxi Translational Medicine Research Foundation Key Project (No. 2019-ZZ001) and China Postdoctoral Science Foundation funded project (No. 2019M651803).	Ceolin L, 2012, NEUROCHEM INT, V61, P517, DOI 10.1016/j.neuint.2012.02.035; Chautard E, 2014, J NEURO-ONCOL, V117, P205, DOI 10.1007/s11060-014-1382-9; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Covington SM, 2017, J INVEST SURG, V30, P47, DOI 10.1080/08941939.2016.1206999; Dohare P, 2016, J NEUROSCI, V36, P3363, DOI 10.1523/JNEUROSCI.4329-15.2016; Fayaz SM, 2014, CNS NEUROL DISORD-DR, V13, P42, DOI 10.2174/18715273113126660189; Hambardzumyan D, 2008, STEM CELL REV, V4, P203, DOI 10.1007/s12015-008-9021-5; Hanada T, 2011, EPILEPSIA, V52, P1331, DOI 10.1111/j.1528-1167.2011.03109.x; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Leonoudakis D, 2008, J NEUROSCI, V28, P2119, DOI 10.1523/JNEUROSCI.5159-07.2008; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Lv JM, 2016, CELL MOL NEUROBIOL, V36, P745, DOI 10.1007/s10571-015-0257-8; Nakajima M, 2018, NEUROSCIENCE, V386, P256, DOI 10.1016/j.neuroscience.2018.06.043; Niu HX, 2018, CELL MOL NEUROBIOL, V38, P459, DOI 10.1007/s10571-017-0489-x; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Patsalos PN, 2015, EPILEPSIA, V56, P12, DOI 10.1111/epi.12865; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Schulze-Bonhage A, 2015, PATIENT PREFER ADHER, V9, P1143, DOI 10.2147/PPA.S63951; Tsai JJ, 2018, ACTA NEUROL SCAND, V137, P378, DOI 10.1111/ane.12879; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wegner KW, 2017, TRENDS PHARMACOL SCI, V38, P202, DOI 10.1016/j.tips.2016.12.005; Wetzel MD, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-018-1753-7; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao SF, 2014, NEUROL RES, V36, P483, DOI 10.1179/1743132814Y.0000000353	31	3	3	2	8	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2021	20	3					266	272		10.2174/1871527319666201001110937			7	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	UY4CL	WOS:000701473600006	33001018				2022-02-06	
J	Ciechanowska, A; Ciapala, K; Pawlik, K; Oggioni, M; Mercurio, D; De Simoni, MG; Mika, J				Ciechanowska, Agata; Ciapala, Katarzyna; Pawlik, Katarzyna; Oggioni, Marco; Mercurio, Domenico; De Simoni, Maria-Grazia; Mika, Joanna			Initiators of Classical and Lectin Complement Pathways Are Differently Engaged after Traumatic Brain Injury-Time-Dependent Changes in the Cortex, Striatum, Thalamus and Hippocampus in a Mouse Model	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						complement component 1q (C1q); complement component 1s (C1s); complement component 1r (C1r); collectin 11; ficolin A; ficolin B; mannose binding lectin A (MBL-A); mannose binding lectin C (MBL-C); cortex; striatum; thalamus; hippocampus	MANNOSE-BINDING-LECTIN; FIBRILLARY ACIDIC PROTEIN; COMPONENT C1Q; MICROGLIAL ACTIVATION; DENDRITIC CELLS; IMPACT; NEURONS; RNA; NEUROINFLAMMATION; IDENTIFICATION	The complement system is involved in promoting secondary injury after traumatic brain injury (TBI), but the roles of the classical and lectin pathways leading to complement activation need to be clarified. To this end, we aimed to determine the ability of the brain to activate the synthesis of classical and lectin pathway initiators in response to TBI and to examine their expression in primary microglial cell cultures. We have modeled TBI in mice by controlled cortical impact (CCI), a clinically relevant experimental model. Using Real-time quantitative polymerase chain reaction (RT-qPCR) we analyzed the expression of initiators of classical the complement component 1q, 1r and 1s (C1q, C1r, and C1s) and lectin (mannose binding lectin A, mannose binding lectin C, collectin 11, ficolin A, and ficolin B) complement pathways and other cellular markers in four brain areas (cortex, striatum, thalamus and hippocampus) of mice exposed to CCI from 24 h and up to 5 weeks. In all murine ipsilateral brain structures assessed, we detected long-lasting, time- and area-dependent significant increases in the mRNA levels of all classical (C1q, C1s, C1r) and some lectin (collectin 11, ficolin A, ficolin B) initiator molecules after TBI. In parallel, we observed significantly enhanced expression of cellular markers for neutrophils (Cd177), T cells (Cd8), astrocytes (glial fibrillary acidic protein-GFAP), microglia/macrophages (allograft inflammatory factor 1-IBA-1), and microglia (transmembrane protein 119-TMEM119); moreover, we detected astrocytes (GFAP) and microglia/macrophages (IBA-1) protein level strong upregulation in all analyzed brain areas. Further, the results obtained in primary microglial cell cultures suggested that these cells may be largely responsible for the biosynthesis of classical pathway initiators. However, microglia are unlikely to be responsible for the production of the lectin pathway initiators. Immunofluorescence analysis confirmed that at the site of brain injury, the C1q is localized in microglia/macrophages and neurons but not in astroglial cells. In sum, the brain strongly reacts to TBI by activating the local synthesis of classical and lectin complement pathway activators. Thus, the brain responds to TBI with a strong, widespread and persistent upregulation of complement components, the targeting of which may provide protection in TBI.	[Ciechanowska, Agata; Ciapala, Katarzyna; Pawlik, Katarzyna; Mika, Joanna] Polish Acad Sci, Maj Inst Pharmacol, Dept Pain Pharmacol, PL-31343 Krakow, Poland; [Oggioni, Marco; Mercurio, Domenico; De Simoni, Maria-Grazia] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, I-20156 Milan, Italy		Mika, J (corresponding author), Polish Acad Sci, Maj Inst Pharmacol, Dept Pain Pharmacol, PL-31343 Krakow, Poland.	ciechan@if-pan.krakow.pl; kat.ciapala@gmail.com; pawlik@if-pan.krakow.pl; marco.oggioni@marionegri.it; domenico.mercurio@marionegri.it; mariagrazia.desimoni@marionegri.it; joamika@if-pan.krakow.pl		Pawlik, Katarzyna/0000-0002-8091-4974; Ciechanowska, Agata/0000-0001-5270-2758; Ciapala, Katarzyna/0000-0001-6147-1576; Mika, Joanna/0000-0003-1986-7205; Mercurio, Domenico/0000-0001-5101-7222	ERA-NET-NEURON, JTC 2016: LEAP from National Centre for Research and Development (Narodowe Centrum Badan i Rozwoju), Poland [NEURON9-FP044, ERA-NET NEURON-Cofund/1/LEAP/15/17]; ERA-NET-NEURON, JTC 2016: LEAP from Italian Ministry of Health (Ministero della Salute), Italy [NEURON9-FP044]; Maj Institute of Pharmacology Polish Academy of Sciences	This work was supported by ERA-NET-NEURON, JTC 2016: LEAP, NEURON9-FP044 from the following national funding institutions: National Centre for Research and Development (Narodowe Centrum Badan i Rozwoju, ERA-NET NEURON-Cofund/1/LEAP/15/17), Poland and the Italian Ministry of Health (Ministero della Salute), Italy. This work was also supported by statutory funds of the Maj Institute of Pharmacology Polish Academy of Sciences. Maj Institute of Pharmacology Polish Academy of Sciences supported the open access publication.	Albert-Weissenberger C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00269; Aleem M, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113290; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Benoit ME, 2013, J BIOL CHEM, V288, P654, DOI 10.1074/jbc.M112.400168; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Boone DR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214741; Bossi F, 2014, P NATL ACAD SCI USA, V111, P4209, DOI 10.1073/pnas.1311968111; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Ciechanowska A, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2020.151911; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; De Blasio D, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X18758881; De Blasio D, 2017, J CEREBR BLOOD F MET, V37, P938, DOI 10.1177/0271678X16647397; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Depboylu C, 2005, NEUROBIOL DIS, V20, P12, DOI 10.1016/j.nbd.2005.01.030; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Dyhrfort P, 2019, J NEUROTRAUM, V36, P2872, DOI 10.1089/neu.2018.6320; Endo Y, 2004, GENOMICS, V84, P737, DOI 10.1016/j.ygeno.2004.07.006; Farber K, 2009, J NEUROSCI RES, V87, P644, DOI 10.1002/jnr.21875; Farrar CA, 2016, J CLIN INVEST, V126, P1911, DOI 10.1172/JCI83000; Feng XD, 2002, J IMMUNOL, V168, P2441, DOI 10.4049/jimmunol.168.5.2441; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Fonseca MI, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0814-9; Fonseca MI, 2004, NEUROBIOL DIS, V15, P40, DOI 10.1016/j.nbd.2003.09.004; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Hellewell SC, 2016, METHODS MOL BIOL, V1462, P253, DOI 10.1007/978-1-4939-3816-2_15; Herndon JM, 2017, PRIMER CEREBROVASCUL, P51, DOI 10.1016/B978-0-12-803058-5.00009-6; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hunold K, 2012, IMMUNOBIOLOGY, V217, P982, DOI 10.1016/j.imbio.2012.01.013; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Katayama M, 2019, INT IMMUNOL, V31, P23, DOI 10.1093/intimm/dxy056; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kwiatkowski K, 2017, J NEUROIMMUNE PHARM, V12, P402, DOI 10.1007/s11481-017-9729-6; Kwon S, 2007, J BIOCHEM MOL BIOL, V40, P532; Lafrenaye AD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70266-w; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Lively S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00215; Llull L, 2017, MOL NEUROBIOL, V54, P6572, DOI 10.1007/s12035-016-0180-0; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Lu JH, 2007, IMMUNOBIOLOGY, V212, P245, DOI 10.1016/j.imbio.2006.11.008; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Lynch NJ, 2004, MOL IMMUNOL, V40, P709, DOI 10.1016/j.molimm.2003.08.009; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Mao HJ, 2018, J BIOMECH, V77, P228, DOI 10.1016/j.jbiomech.2018.07.004; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Mercurio D, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01041-1; Mohamed AZ, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102136; Morgan TE, 2000, NEUROSCIENCE, V101, P313, DOI 10.1016/S0306-4522(00)00387-0; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Mracsko E, 2014, J NEUROSCI, V34, P16784, DOI 10.1523/JNEUROSCI.1867-14.2014; Mulder SD, 2014, GLIA, V62, P493, DOI 10.1002/glia.22619; Munivenkatappa A, 2016, J NEUROSCI RURAL PRA, V7, pS76, DOI 10.4103/0976-3147.196468; Navratil JS, 2001, J IMMUNOL, V166, P3231, DOI 10.4049/jimmunol.166.5.3231; Neglia L, 2020, J CEREBR BLOOD F MET, V40, P1608, DOI 10.1177/0271678X19874509; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Peterson SL, 2015, J NEUROSCI, V35, P4332, DOI 10.1523/JNEUROSCI.4473-12.2015; Piotrowska A, 2016, NEUROPHARMACOLOGY, V108, P207, DOI 10.1016/j.neuropharm.2016.04.024; Pisalyaput K, 2008, J NEUROCHEM, V104, P696, DOI 10.1111/j.1471-4159.2007.05012.x; Pischiutta F, 2014, NEUROPHARMACOLOGY, V79, P119, DOI 10.1016/j.neuropharm.2013.11.001; Pliyev BK, 2012, APOPTOSIS, V17, P1050, DOI 10.1007/s10495-012-0738-x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Riedl MA, 2017, LANCET, V390, P1595, DOI 10.1016/S0140-6736(17)31963-3; Rojewska E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00494; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; Schafer MKH, 2000, J IMMUNOL, V164, P5446, DOI 10.4049/jimmunol.164.10.5446; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shaw M, 2008, ACT NEUR S, V102, P33, DOI 10.1007/978-3-211-85578-2_7; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Ten VS, 2005, STROKE, V36, P2244, DOI 10.1161/01.STR.0000182237.20807.d0; Thielens NM, 2017, MOL IMMUNOL, V89, P73, DOI 10.1016/j.molimm.2017.05.025; van den Berg RH, 1998, J IMMUNOL, V161, P6924; van Wageningen TA, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0850-z; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Vegh Z, 2006, MOL IMMUNOL, V43, P1402, DOI 10.1016/j.molimm.2005.07.030; Wagner S, 2003, J IMMUNOL, V170, P1462, DOI 10.4049/jimmunol.170.3.1462; West EE, 2020, IMMUNOL REV, V295, P68, DOI 10.1111/imr.12852; West EE, 2018, ANNU REV IMMUNOL, V36, P309, DOI 10.1146/annurev-immunol-042617-053245; Wohlgehagen E., 2015, MOD RES INFLAMM, V4, P9, DOI DOI 10.4236/MRI.2015.42002; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yin J, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/5150678; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang XY, 2014, ARTERIOSCL THROM VAS, V34, P587, DOI 10.1161/ATVBAHA.113.302868; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	109	3	3	5	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JAN	2021	22	1							45	10.3390/ijms22010045			29	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	PP9OS	WOS:000606183500001	33375205	gold, Green Published			2022-02-06	
J	Dunn, J; Martin, RA; Hackney, JJ; Nunnerley, JL; Snell, D; Bourke, JA; Hall, A; Derrett, S				Dunn, Jennifer; Martin, Rachelle A.; Hackney, Jonathan J.; Nunnerley, Joanne L.; Snell, Deborah; Bourke, John A.; Hall, Andrew; Derrett, Sarah			Early vocational rehabilitation for people with spinal cord injury: a research protocol using realist synthesis and interviews to understand how and why it works	BMJ OPEN			English	Article						neurological injury; rehabilitation medicine; statistics &amp; research methods	TRAUMATIC BRAIN-INJURY; RETURN; REINTEGRATION; EMPLOYMENT	Introduction Return to work after spinal cord injury (SCI) is linked to well-being and better physical and mental health outcomes. In New Zealand, work rates after SCI are lower than the general population. Vocational rehabilitation is one method of supporting return to work. Although the best model has not been determined, there is evidence supporting early intervention. However, most vocational rehabilitation research focuses on return to work outcomes without considering why vocational rehabilitation works, for whom and under what circumstances. Given this knowledge gap, we detail a realist synthesis protocol aiming to explain how contextual factors trigger relevant mechanisms to facilitate return to work after SCI. Methods and analysis This study will use a realist synthesis approach, following Realist And MEta-narrative Evidence Synthesis: Evolving Standards (RAMESES) guidelines. First, we will undertake a realist review of existing published and grey literature. Second, to assist with theoretical conceptualisation, we will interview people with SCI who have received vocational rehabilitation. Finally, we will survey people with SCI who received early vocational rehabilitation for theoretical testing and refinement. Ethics and dissemination University of Otago Ethics Committee (Reference H19/170) has been obtained. A knowledge translation event will address issues relevant to wider implementation of the intervention and study findings. Findings will be also be disseminated through peer reviewed journals, conference presentations and formal reports.	[Dunn, Jennifer; Nunnerley, Joanne L.; Snell, Deborah] Univ Otago, Dept Orthopaed Surg & Musculoskeletal Med, Christchurch, New Zealand; [Martin, Rachelle A.] Univ Otago, Dept Med, Wellington, New Zealand; [Martin, Rachelle A.; Hackney, Jonathan J.; Nunnerley, Joanne L.; Bourke, John A.] Burwood Acad Independent Living, Christchurch, New Zealand; [Bourke, John A.] Griffith Univ, Menzies Hlth Inst, Gold Coast, NSW, Australia; [Hall, Andrew] New Zealand Spinal Trust, Christchurch, New Zealand; [Derrett, Sarah] Univ Otago, Preventat & Social Med, Dunedin, New Zealand		Dunn, J (corresponding author), Univ Otago, Dept Orthopaed Surg & Musculoskeletal Med, Christchurch, New Zealand.	jennifer.dunn@otago.ac.nz	Dunn, Jennifer/ABA-7400-2021	Dunn, Jennifer/0000-0002-2894-7533; Nunnerley, Joanne/0000-0002-3378-2702	Health Research Council of New ZealandHealth Research Council of New Zealand; Ministry of Social Development [HRC 19-834]	This work is supported by the Health Research Council of New Zealand and Ministry of Social Development (HRC 19-834).	Astbury B, 2010, AM J EVAL, V31, P363, DOI 10.1177/1098214010371972; Burton A.K., 2006, IS WORK GOOD YOUR HL; Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; Chan Simon K K, 2005, Work, V25, P325; Colella A, 2001, ACAD MANAGE REV, V26, P100, DOI 10.5465/AMR.2001.4011984; Dalkin SM, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0237-x; Dunn DS, 2008, REHABIL PSYCHOL, V53, P413, DOI 10.1037/a0013749; Dunstan DA, 2013, J OCCUP REHABIL, V23, P44, DOI 10.1007/s10926-012-9380-2; Emmel N., 2018, DOING REALIST RES; Fadyl JK, 2010, DISABIL REHABIL, V32, P1173, DOI 10.3109/09638281003653302; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Giaquinto S, 2007, DISABIL REHABIL, V29, P1313, DOI 10.1080/09638280701415282; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Kelly M., 2017, AUSTR NZ SPIN CORD S; Kelly M, 2014, P NZ OCC HLTH C; MacEachen E, 2010, J OCCUP REHABIL, V20, P349, DOI 10.1007/s10926-010-9229-5; Middleton JW, 2015, J REHABIL MED, V47, P626, DOI 10.2340/16501977-1980; Ministry of Education, 2020, RET STUD SEN 2 SCH; Murphy GC, 2003, J REHABIL MED, V35, P276, DOI 10.1080/16501970310015209; New Zealand Spinal Cord Injury Registry, 2020, NZ SPIN CORD INJ REG; Nunnerley J, 2016, DISABIL REHABIL, V38, P987, DOI 10.3109/09638288.2015.1070299; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Pawson R., 2004, REALIST SYNTHESIS IN; Pawson R., 1997, REALISTIC EVALUATION; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Salter KL, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0115-y; Schonherr MC, 2004, SPINAL CORD, V42, P177, DOI 10.1038/sj.sc.3101581; Schoppen T, 2001, ARCH PHYS MED REHAB, V82, P239, DOI 10.1053/apmr.2001.18231; Schoppen T, 2001, ARCH PHYS MED REHAB, V82, P1425, DOI 10.1053/apmr.2001.26074; Statistics New Zealand , 2017, LAB FORC SURV; The Royal Australasian College of Physicians, 2011, AUSTR FAC OCC ENV ME; Tjulin A, 2010, J OCCUP REHABIL, V20, P311, DOI 10.1007/s10926-009-9209-9; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Waddell G, 2008, VOCATIONAL REHABILIT; Watson TJ., 2008, SOCIOLOGY WORK IND E; Wong G., 2017, HEAL SERV DELIV RES, V5, P1, DOI DOI 10.3310/HSDR05280; Wong G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-21; Yasuda S, 2002, NEUROREHABILITATION, V17, P177	42	3	3	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	5							e048753	10.1136/bmjopen-2021-048753			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RX9UH	WOS:000647561000033	33941637	gold, Green Published			2022-02-06	
J	Gabrieli, D; Schumm, SN; Vigilante, NF; Meaney, DF				Gabrieli, David; Schumm, Samantha N.; Vigilante, Nicholas F.; Meaney, David F.			NMDA Receptor Alterations After Mild Traumatic Brain Injury Induce Deficits in Memory Acquisition and Recall	NEURAL COMPUTATION			English	Article							UNITED-STATES; SYNAPTIC PLASTICITY; NETWORK; MODEL; OSCILLATIONS; DAMAGE; HIPPOCAMPUS; DEPENDENCE; PATTERNS; TIME	Mild traumatic brain injury (mTBI) presents a significant health concern with potential persisting deficits that can last decades. Although a growing body of literature improves our understanding of the brain network response and corresponding underlying cellular alterations after injury, the effects of cellular disruptions on local circuitry after mTBI are poorly understood. Our group recently reported how mTBI in neuronal networks affects the functional wiring of neural circuits and how neuronal inactivation influences the synchrony of coupled microcircuits. Here, we utilized a computational neural network model to investigate the circuit-level effects of N-methyl D-aspartate receptor dysfunction. The initial increase in activity in injured neurons spreads to downstream neurons, but this increase was partially reduced by restructuring the network with spike-timing-dependent plasticity. As a model of network-based learning, we also investigated how injury alters pattern acquisition, recall, and maintenance of a conditioned response to stimulus. Although pattern acquisition and maintenance were impaired in injured networks, the greatest deficits arose in recall of previously trained patterns. These results demonstrate how one specific mechanism of cellular-level damage in mTBI affects the overall function of a neural network and point to the importance of reversing cellular-level changes to recover important properties of learning and memory in a microcircuit.	[Gabrieli, David; Schumm, Samantha N.; Vigilante, Nicholas F.; Meaney, David F.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Gabrieli, D (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.	davidjgabrieli@gmail.com; schumms@seas.upenn.edu; nfvigilante@gmail.com		Schumm, Samantha/0000-0003-4399-5362; Vigilante, Nicholas/0000-0003-0540-4816	Paul G. Allen Frontiers Group [12347]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS088176]	This study was funded by the Paul G. Allen Frontiers Group grant 12347 and by the National Institutes of Health, grant number RO1 NS088176.	Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bracci S, 2017, NEUROPSYCHOLOGIA, V105, P153, DOI 10.1016/j.neuropsychologia.2017.06.010; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Chavlis S, 2017, HIPPOCAMPUS, V27, P89, DOI 10.1002/hipo.22675; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Christen Y., 1994, TEMPORAL CODING BRAI; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Clayton MS, 2015, TRENDS COGN SCI, V19, P188, DOI 10.1016/j.tics.2015.02.004; Connor CE, 2017, NAT NEUROSCI, V20, P1493, DOI 10.1038/nn.4657; Corbetta M, 2012, DEV PSYCHOBIOL, V54, P239, DOI 10.1002/dev.20507; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Enoka RM, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029702; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; Garcia NVD, 2011, NATURE, V472, P351, DOI 10.1038/nature09865; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Hanslmayr S, 2016, TRENDS NEUROSCI, V39, P16, DOI 10.1016/j.tins.2015.11.004; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Ismail FY, 2017, EUR J PAEDIATR NEURO, V21, P23, DOI 10.1016/j.ejpn.2016.07.007; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; JAHR CE, 1990, J NEUROSCI, V10, P1830; JAHR CE, 1990, J NEUROSCI, V10, P3178; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kraus BJ, 2013, NEURON, V78, P1090, DOI 10.1016/j.neuron.2013.04.015; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Moser MB, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021808; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Papadopoulos L, 2017, CHAOS, V27, DOI 10.1063/1.4994819; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Patel TP, 2014, J NEUROSCI, V34, P4200, DOI 10.1523/JNEUROSCI.4172-13.2014; Plack CJ, 2014, HEARING RES, V307, P53, DOI 10.1016/j.heares.2013.07.020; Rajasethupathy P, 2016, CELL, V165, P524, DOI 10.1016/j.cell.2016.03.047; Rebola N, 2017, NAT REV NEUROSCI, V18, P209, DOI 10.1038/nrn.2017.10; Richards BA, 2017, NEURON, V94, P1071, DOI 10.1016/j.neuron.2017.04.037; Rolls ET, 2018, CELL TISSUE RES, V373, P577, DOI 10.1007/s00441-017-2744-3; RUPPIN E, 1995, NEURAL COMPUT, V7, P1105, DOI 10.1162/neco.1995.7.5.1105; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schumm SN, 2020, FRONT COMPUT NEUROSC, V14, DOI 10.3389/fncom.2020.00018; Sharpee TO, 2017, NEURON, V94, P954, DOI 10.1016/j.neuron.2017.04.044; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Terada S, 2017, NEURON, V94, P1248, DOI 10.1016/j.neuron.2017.05.024; Titley HK, 2017, NEURON, V95, P19, DOI 10.1016/j.neuron.2017.05.021; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Vertes PE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0531; Vertes PE, 2010, HFSP J, V4, P153, DOI 10.2976/1.3386761; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Victor JD, 2017, ANNU REV VIS SCI, V3, P275, DOI 10.1146/annurev-vision-102016-061316; Volman V, 2011, P NATL ACAD SCI USA, V108, P15402, DOI 10.1073/pnas.1112066108; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wiles L, 2017, SCI REP-UK, V7, DOI 10.1038/srep44006; Zenke F, 2017, CURR OPIN NEUROBIOL, V43, P166, DOI 10.1016/j.conb.2017.03.015; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	81	3	3	2	3	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	JAN	2021	33	1					67	95		10.1162/neco_a_01343			29	Computer Science, Artificial Intelligence; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Neurosciences & Neurology	PG7BO	WOS:000599886900002	33253030	Green Accepted			2022-02-06	
J	Gao, F; Wu, X; Mao, X; Niu, F; Zhang, B; Dong, JQ; Liu, BY				Gao, Fei; Wu, Xiao; Mao, Xiang; Niu, Fei; Zhang, Bin; Dong, Jinqian; Liu, Baiyun			Astaxanthin provides neuroprotection in an experimental model of traumatic brain injury via the Nrf2/HO-1 pathway	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Astaxanthin; traumatic brain injury; neuroprotection; Nrf2/HO-1 pathway	OXIDATIVE STRESS; NRF2; RATS; MICE; NEUROINFLAMMATION; DYSFUNCTION; EXPRESSION; PROTECTS; ADAPTER; LIGASE	Background: Astaxanthin (ATX) is a carotenoid pigment with effective antioxidant, anti-inflammatory, antitumor and immunomodulatory actions. ATX has been proposed to exert neuroprotective effects and attenuate oxidative stress in mice after traumatic brain injury (TBI). The nuclear factor erythroid 2-related factor 2 (Nrf2)-heme oxygenase 1 (HO-1) signaling pathway is stimulated after TBI and activates a compensatory mechanism against TBI. Nevertheless, the effect of ATX on the pathophysiology of TBI in mice is limited. Our present study evaluated the neuroprotection afforded by ATX and the possible role of the Nrf2/HO-1 pathway in experimental TBI. Materials and methods: Mice were casually separated into 3 groups: the sham, TBI + vehicle, and TBI + ATX (100 mg/kg, intraperitoneally administered) groups. Neurobehaviors of the mice were assessed using the neurological severity scores (NSSs), the forced swimming test (FST) and the rotarod test. Levels of the Nrf2, HO-1, NAD(P)H: quinine oxidoreductase-1 (NQO1), cleaved caspase3 (C-caspase3), and superoxide dismutase1 (SOD1) proteins and levels of the Nrf2 and HO-1 mRNAs were assessed. In addition, Nrf2 nuclear import and apoptosis were measured after TBI. Results: The ATX treatment significantly improved the neurological status, promoted Nrf2 activation, and upregulated the expression of the Nrf2 and HO-1 mRNAs and the levels of the Nrf2, HO-1, and NQO1 proteins after TBI. The level of the SOD1 protein was decreased after TBI and increased after ATX treatment; however, the difference was not significant. ATX markedly reduced the level of the C-caspase3 protein and the number of TUNEL-positive cells, indicating that it exerted an antiapoptotic effect. Immunofluorescence staining confirmed that ATX promoted Nrf2 nuclear import. Conclusions: Based on our study, ATX possibly affords neuroprotection by activating the Nrf2/HO-1 signaling pathway in mice after TBI.	[Gao, Fei; Zhang, Bin; Dong, Jinqian; Liu, Baiyun] Capital Med Univ, Beijing Tiantan Hosp, Beijing 100070, Peoples R China; [Wu, Xiao] Anhui Med Univ, Affiliated Hosp 1, Dept Emergency, Hefei 230022, Anhui, Peoples R China; [Mao, Xiang] Anhui Med Univ, Affiliated Hosp 1, Dept Neurosurg, Hefei 230022, Anhui, Peoples R China; [Mao, Xiang; Niu, Fei] Capital Med Univ, Beijing Neurosurg Inst, Beijing 100070, Peoples R China; [Mao, Xiang; Niu, Fei; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing 100070, Peoples R China; [Mao, Xiang; Niu, Fei; Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing 100070, Peoples R China; [Mao, Xiang; Niu, Fei; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing 100070, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing 100070, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing 100070, Peoples R China.; Liu, BY (corresponding author), Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing 100070, Peoples R China.; Liu, BY (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing 100070, Peoples R China.	liubaiyun1212@163.com	Dong, Jinqian/AAP-2298-2021				Ahmed SMU, 2017, BBA-MOL BASIS DIS, V1863, P585, DOI 10.1016/j.bbadis.2016.11.005; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Caglayan B, 2019, MOL BIOL REP, V46, P241, DOI 10.1007/s11033-018-4465-4; Chan KC, 2009, J FOOD SCI, V74, pH225, DOI 10.1111/j.1750-3841.2009.01274.x; Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Chen G, 2011, J NEUROSCI RES, V89, P515, DOI 10.1002/jnr.22577; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dai W, 2018, BRAIN RES BULL, V140, P65, DOI 10.1016/j.brainresbull.2018.03.020; Ernst IMA, 2011, PHARMACOL RES, V63, P233, DOI 10.1016/j.phrs.2010.11.005; Fakhri S, 2018, BRAIN RES BULL, V143, P217, DOI 10.1016/j.brainresbull.2018.09.011; Fassett RG, 2009, FUTUR CARDIOL, V5, P333, DOI 10.2217/FCA.09.19; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Funakohi-Tago M, 2018, EUR J PHARMACOL, V834, P246, DOI 10.1016/j.ejphar.2018.07.043; Higuera-Ciapara I, 2006, CRIT REV FOOD SCI, V46, P185, DOI 10.1080/10408690590957188; Hur W, 2011, CURR OPIN CHEM BIOL, V15, P162, DOI 10.1016/j.cbpa.2010.12.009; Hussein G, 2006, J NAT PROD, V69, P443, DOI 10.1021/np050354+; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Jiang L, 2017, BRAIN RES, V1660, P1, DOI 10.1016/j.brainres.2017.01.031; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kupcinskas L, 2008, PHYTOMEDICINE, V15, P391, DOI 10.1016/j.phymed.2008.04.004; Li FY, 2019, ANN CLIN TRANSL NEUR, V6, P1825, DOI 10.1002/acn3.50878; Li ZZ, 2018, BIOMED PHARMACOTHER, V106, P349, DOI 10.1016/j.biopha.2018.06.041; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; Lorenz RT, 2000, TRENDS BIOTECHNOL, V18, P160, DOI 10.1016/S0167-7799(00)01433-5; Lu XY, 2015, CELL MOL NEUROBIOL, V35, P713, DOI 10.1007/s10571-015-0167-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mao X, 2020, J NEUROTRAUM, V37, P1331, DOI 10.1089/neu.2019.6510; Mao X, 2016, WORLD NEUROSURG, V92, P552, DOI 10.1016/j.wneu.2016.04.096; Mao X, 2016, AM J TRANSL RES, V8, P133; Mao X, 2015, BRAIN INJURY, V29, P86, DOI 10.3109/02699052.2014.968621; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Niu TT, 2018, J AGR FOOD CHEM, V66, P1551, DOI 10.1021/acs.jafc.7b05493; Palozza P, 2009, CANCER LETT, V283, P108, DOI 10.1016/j.canlet.2009.03.031; Wang HQ, 2010, BRAIN RES, V1360, P159, DOI 10.1016/j.brainres.2010.08.100; Wu Q, 2014, MAR DRUGS, V12, P6125, DOI 10.3390/md12126125; Xue YG, 2019, N-S ARCH PHARMACOL, V392, P341, DOI 10.1007/s00210-018-1595-0; Yuan JP, 2011, MOL NUTR FOOD RES, V55, P150, DOI 10.1002/mnfr.201000414; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang M, 2018, NEUROCHEM RES, V43, P2435, DOI 10.1007/s11064-018-2671-z; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhang MK, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0295-2; Zheng B, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180892	45	3	3	4	6	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2021	13	3					1483	1493					11	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	RB0QF	WOS:000631821600014	33841672				2022-02-06	
J	Green, GA; Porter, KP; Conte, S; Valadka, AB; Soloff, L; Curriero, FC				Green, Gary Alan; Porter, Keshia Pollack; Conte, Stan; Valadka, Alex B.; Soloff, Lonnie; Curriero, Frank C.			Preventing Concussions From Foul Tips and Backswings in Professional Baseball: Catchers' Perceptions of and Experiences With Conventional and Hockey-Style Masks	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						baseball; catchers; protective equipment; injury surveillance; concussion	INJURY	Objective:To understand catchers' preferences for mask type and perceptions regarding safety, comfort, and fit, and determine whether mask type is correlated with self-reported concussion and related symptoms after impacts from foul tips or backswings. Design: Cross-sectional study. Setting: Survey of active baseball catchers. Participants: Professional baseball catchers. Intervention: From May 1, 2015, to June 30, 2015, an online survey was administered in English and Spanish to all Major and Minor League catchers (n = 836). Main Outcome Measures: Survey items addressed the type of mask routinely and previously used (conventional or hockey style); brand and material (steel or titanium); perceptions regarding safety, comfort, and fit; and experiences with concussions. Results: The sample consisted of 596 catchers of which 26% reported being diagnosed with a concussion. Some concussions occurred from non-baseball activities, such as car accidents or off the field incidents. For those that occurred playing baseball, 35% resulted from a foul tip. Once catchers entered professional baseball, the use of a conventional mask rose significantly: 71% of catchers reported wearing conventional-style masks, and 30% hockey-style masks at the time the survey was conducted (P < 0.05). Both conventional and hockey-style mask wearers significantly selected hockey-style masks as providing better overall safety and protection than conventional masks (P < 0.05). Conclusions: This research supports foul tips as an important cause of concussion in catchers and provides important information about preferences among catchers for masks that are not perceived as the safest and strongest. Future research should supplement these data by conducting laboratory testing to determine which masks are stronger and by collecting qualitative data to explore why some players are more likely to wear a mask type that they perceive as offering less safety or protection.	[Green, Gary Alan] UCLA, Div Sports Med, Pacific Palisades Med Grp, Pacific Palisades, CA USA; [Porter, Keshia Pollack] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Ctr Injury Res & Policy, Baltimore, MD USA; [Conte, Stan] Santa Clara Univ, Conte Injury Analyt, Baseball Med, Santa Clara, CA 95053 USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Soloff, Lonnie] Cleveland Indians Baseball, Med Serv, Cleveland, OH USA; [Curriero, Frank C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA		Green, GA (corresponding author), Pacific Palisades Med Grp, 15200 Sunset Blvd,Suite 107, Pacific Palisades, CA 90272 USA.	ggreen@mednet.ucla.edu			Office of the Commissioner, Major League Baseball	Supported by a contract from the Office of the Commissioner, Major League Baseball to the Johns Hopkins Bloomberg School of Public Health for epidemiological design, analysis, and statistical support.	Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Delaney JS, 2018, CLIN J SPORT MED, V28, P1, DOI 10.1097/JSM.0000000000000495; Donaldson A, 2016, AM J LIFESTYLE MED, V10, P120, DOI 10.1177/1559827614538751; Eddy M., 2017, MAKEUP MINORS; Finch CF, 2017, BRIT J SPORT MED, V51, P1734, DOI 10.1136/bjsports-2017-098212; Green GA., 2016, 5 INT CONS C CONC SP; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Kennedy P., 2013, NEW YORK TIMES; Kerr ZY, 2018, AM J SPORT MED, V46, P22, DOI 10.1177/0363546517728264; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pollack KM, 2016, AM J EPIDEMIOL, V183, P490, DOI 10.1093/aje/kwv348	13	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2021	31	1					E1	E7		10.1097/JSM.0000000000000679			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	PR5RY	WOS:000607294800001	30358617				2022-02-06	
J	Khan, RS; Ross, AG; Aravand, P; Dine, K; Selzer, EB; Shindler, KS				Khan, Reas S.; Ross, Ahmara G.; Aravand, Puya; Dine, Kimberly; Selzer, Evan B.; Shindler, Kenneth S.			RGC and Vision Loss From Traumatic Optic Neuropathy Induced by Repetitive Closed Head Trauma Is Dependent on Timing and Force of Impact and Kenneth S. Shindler',2,*	TRANSLATIONAL VISION SCIENCE & TECHNOLOGY			English	Article						traumatic optic neuropathy; retinal ganglion cell; traumatic head impact		Results: Five repetitive mild impacts significantly decreased OKR scores and RGC numbers compared with control mice 10 weeks after initial impact, with maximal pathology observed by 6 weeks and partial but significant loss present by 3 weeks. One severe impact induced similar TON. Three mild impacts also induced early OKR and RGC loss, but one mild impact did not. Equivalent degrees of TON were induced bilaterally, and a significant correlation was observed between OKR scores and RGC numbers. Conclusions: Repetitive, mild closed head trauma in mice induces progressive RGC and vision loss that worsens with increasing impacts. Translational Relevance: Results detail a reproducible model of TON that provides a reliable platform for studying potential treatments over a 3- to 6-week time course. ABSTRACT Purpose: Traumatic optic neuropathy (TON) is often caused by blunt head trauma and has no currently effective treatment. Common animal models of TON induced by surgical crush injury are plagued by variability and do not mimic typical mechanisms of TON injury. Traumatic head impact models have recently shown evidence of TON, but the degree of head impact necessary to consistently induce TON is not well characterized, and it is examined here. Methods: Traumatic skull impacts to C57BL/6J mice were induced using an electromagnetic controlled impact device. One impact performed at two depths (mild and severe), as well as three and five repetitive impacts with an interconcussion interval of 48 hours, were tested. Optokinetic responses (OKRs) and retinal ganglion cell (RGC) loss were measured. Results: Five repetitive mild impacts significantly decreased OKR scores and RGC numbers compared with control mice 10 weeks after initial impact, with maximal pathology observed by 6 weeks and partial but significant loss present by 3 weeks. One severe impact induced similar TON. Three mild impacts also induced early OKR and RGC loss, but one mild impact did not. Equivalent degrees of TON were induced bilaterally, and a significant correlation was observed between OKR scores and RGC numbers. Conclusions: Repetitive, mild closed head trauma in mice induces progressive RGC and vision loss that worsens with increasing impacts. Translational Relevance: Results detail a reproducible model of TON that provides a reliable platform for studying potential treatments over a 3-to 6-week time course.	[Khan, Reas S.; Ross, Ahmara G.; Aravand, Puya; Dine, Kimberly; Shindler, Kenneth S.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Ross, Ahmara G.; Shindler, Kenneth S.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Selzer, Evan B.] Thomas Jefferson Univ, Sch Med, Philadelphia, PA 19107 USA		Khan, RS; Shindler, KS (corresponding author), Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Dept Ophthalmol,Stellar Chance Labs, 3rd Floor,422 Curie Blvd, Philadelphia, PA 19104 USA.	reas@pennmedicine.upenn.edu; kenneth.shindler@uphs.upenn.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY019014, EY030163]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); F. M. Kirby Foundation; Robert Wood Johnson Harold Amos Faculty Development Award	Supported provided by grants from the National Institutes of Health (EY019014 and EY030163), by Research to Prevent Blindness and the F. M. Kirby Foundation, and by a Robert Wood Johnson Harold Amos Faculty Development Award.	ANDERSON RL, 1982, OPHTHALMOLOGY, V89, P445; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Bernardo-Colon A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00719; Bernardo-Colon A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1061-4; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Cansler SM, 2020, J NEUROSCI RES, V98, P571, DOI 10.1002/jnr.24543; Carta A, 2003, J NEUROL NEUROSUR PS, V74, P246, DOI 10.1136/jnnp.74.2.246; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Edwards P, 2005, LANCET, V365, P1957; Guley NM, 2019, EXP EYE RES, V182, P109, DOI 10.1016/j.exer.2019.03.013; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P4159, DOI 10.1167/iovs.19-27565; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Ibrahim AS, 2018, INVEST OPHTH VIS SCI, V59, P5548, DOI 10.1167/iovs.18-24773; Jha KA, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1436-1; Kanamori A, 2012, ARCH OPHTHALMOL-CHIC, V130, P1067, DOI 10.1001/archophthalmol.2012.470; Khan RS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48087-3; Khan RS, 2017, SCI REP-UK, V7, DOI 10.1038/srep41768; Kumaran AM, 2015, CRANIOMAX TRAUM REC, V8, P31, DOI 10.1055/s-0034-1393734; Lee KF, 2010, INT J OPHTHALMOL-CHI, V3, P175, DOI 10.3980/j.issn.2222-3959.2010.02.20; Lee V, 2010, EYE, V24, P240, DOI 10.1038/eye.2009.79; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Levin Leonard A, 2004, Ophthalmol Clin North Am, V17, P455, DOI 10.1016/j.ohc.2004.05.008; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Pirouzmand F, 2012, J CRANIOFAC SURG, V23, P516, DOI 10.1097/SCS.0b013e31824cd4a7; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Quinn Thomas A, 2011, Front Neurol, V2, P50, DOI 10.3389/fneur.2011.00050; Sappington RM, 2003, INVEST OPHTH VIS SCI, V44, P3725, DOI 10.1167/iovs.03-0039; Steinsapir KD, 2006, J NEURO-OPHTHALMOL, V26, P65, DOI 10.1097/01.wno.0000204646.94991.68; Tao WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12225-6; Templeton JP, 2012, MOL VIS, V18, P2147; Thomas CN, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121517; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Walsh FB, 1969, CLIN NEUROOPHTHALMOL, P2380; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Yang N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030677; Yu-Wai-Man P, 2011, COCHRANE DATABASE SY, V19; Zuo L, 2013, INVEST OPHTH VIS SCI, V54, P5097, DOI 10.1167/iovs.13-12157	47	3	3	1	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	2164-2591			TRANSL VIS SCI TECHN	Transl. Vis. Sci. Technol.	JAN	2021	10	1								10.1167/tvst.10.1.8			13	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	RF6JV	WOS:000634949300008	33505775	Green Published, gold			2022-02-06	
J	Lange, RT; Lippa, SM; Brickell, TA; Yeh, PH; Ollinger, J; Wright, M; Driscoll, A; Sullivan, J; Braatz, S; Gartner, R; Barnhart, E; French, LM				Lange, Rael T.; Lippa, Sara M.; Brickell, Tracey A.; Yeh, Ping-Hong; Ollinger, John; Wright, Megan; Driscoll, Angela; Sullivan, Jamie; Braatz, Samantha; Gartner, Rachel; Barnhart, Elizabeth; French, Louis M.			Post-Traumatic Stress Disorder Is Associated with Neuropsychological Outcome but Not White Matter Integrity after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; mild traumatic brain injury; neuropsychological assessment; post-traumatic stress	QUALITY-OF-LIFE; OPERATIONS ENDURING FREEDOM; PSYCHOMETRIC PROPERTIES; UNCOMPLICATED MILD; SERVICE MEMBERS; RESPONSE BIAS; PTSD SYMPTOMS; BASE RATES; IRAQ; AFGHANISTAN	The aim of this study was to examine neuropsychological functioning and white matter integrity, in service members and veterans (SMVs) after mild traumatic brain injury (MTBI), with versus without post-traumatic stress disorder (PTSD). Participants were 116 U.S. military SMVs, prospectively enrolled from the Walter Reed National Military Medical Center (Bethesda, MD), who had sustained an MTBI (n = 86) or an injury without TBI (i.e., Injured Control [IC]; n = 30). Participants completed a battery of neuropsychological measures (neurobehavioral and -cognitive), as well as diffusion tensor imaging (DTI) of the brain, on average 6 years post-injury. Based on diagnostic criteria for PTSD, participants in the MTBI group were classified into two subgroups: MTBI/PTSD-Present (n = 21) and MTBI/PTSD-Absent (n = 65). Participants in the IC group were included only if they were classified as PTSD-Absent. The MTBI/PTSD-Present group had a significantly higher number of self-reported symptoms on all neurobehavioral measures (e.g., depression), and lower scores on more than half of the neurocognitive domains (e.g., processing speed), compared to the MTBI/PTSD-Absent and IC/PTSD-Absent groups. There were no significant group differences for the vast majority of DTI measures, with the exception of a handful of regions (i.e., superior longitudinal fascicle and superior thalamic radiation). These results suggest that there is 1) a strong relationship between PTSD and poor neuropsychological outcome after MTBI and 2) a lack of a relationship between PTSD and white matter integrity, as measured by DTI, after MTBI. Concurrent PTSD and MTBI should be considered a risk factor for poor neuropsychological outcome that requires early intervention.	[Lange, Rael T.; Brickell, Tracey A.; Wright, Megan; Driscoll, Angela; Sullivan, Jamie; Braatz, Samantha; Barnhart, Elizabeth; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 5003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA; [Lange, Rael T.; Lippa, Sara M.; Brickell, Tracey A.; Yeh, Ping-Hong; Ollinger, John; Wright, Megan; Driscoll, Angela; Sullivan, Jamie; Braatz, Samantha; Barnhart, Elizabeth; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Gartner, Rachel] Georgetown Univ, Med Ctr, Dept Rehabil Med, Ctr Brain Plast & Recovery, Washington, DC 20007 USA		Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 5003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rlange@dvbic.org		french, louis/0000-0002-9451-0604			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Avants B, 2004, NEUROIMAGE, V23, pS139, DOI 10.1016/j.neuroimage.2004.07.010; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bolzenius JD, 2018, J HEAD TRAUMA REHAB, V33, P393, DOI 10.1097/HTR.0000000000000378; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; CHANG MCJ, 1985, NEUROCHEM RES, V10, P1231, DOI 10.1007/BF00964842; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen GH, 2015, EPIDEMIOL REV, V37, P7, DOI 10.1093/epirev/mxu007; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Conners K., 2002, CONNERS CONTINUOUS P; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Fan YT, 2019, AGING MENT HEALTH, V23, P831, DOI 10.1080/13607863.2018.1455804; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Green P, 2004, GREENS MED SYMPTOM V; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holdnack J. A., 2009, ADV CLIN SOLUTIONS W; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Lange RT, 2016, J HEAD TRAUMA REHAB, V31, P62, DOI 10.1097/HTR.0000000000000149; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Lopez KC, 2017, J NEUROTRAUM, V34, P16, DOI 10.1089/neu.2015.4323; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nenonen M, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2047981614546795; O'Doherty DCM, 2018, HUM BRAIN MAPP, V39, P1327, DOI 10.1002/hbm.23920; Olatunji BO, 2007, CLIN PSYCHOL REV, V27, P572, DOI 10.1016/j.cpr.2007.01.015; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Reitan RM, 1992, TRAIL MAKING TEST MA; Santhanam P, 2019, J NEUROTRAUM, V36, P1093, DOI 10.1089/neu.2017.5541; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Sekiguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083967; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wasserthal J, 2018, NEUROIMAGE, V183, P239, DOI 10.1016/j.neuroimage.2018.07.070; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; White T, 2003, NEUROPSYCHOLOGICAL A; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	75	3	3	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2021	38	1					63	73		10.1089/neu.2019.6852			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PN6IA	WOS:000604579500004	33395374				2022-02-06	
J	Liu, T; Liao, XZ; Zhou, MT				Liu, Ting; Liao, Xing-Zhi; Zhou, Mai-Tao			Ulinastatin alleviates traumatic brain injury by reducing endothelin-1	TRANSLATIONAL NEUROSCIENCE			English	Article						ulinastatin; traumatic brain injury; brain edema; astrocyte; endothelin-1	URINARY TRYPSIN-INHIBITOR; SIGNALING PATHWAY; CEREBRAL EDEMA; NITRIC-OXIDE; EXPRESSION; AQP4; MIGRATION; RATS	Background - Brain edema is one of the major causes of fatality and disability associated with injury and neurosurgical procedures. The goal of this study was to evaluate the effect of ulinastatin (UTI), a protease inhibitor, on astrocytes in a rat model of traumatic brain injury (TBI). Methodology - A rat model of TBI was established. Animals were randomly divided into 2 groups - one group was treated with normal saline and the second group was treated with UTI (50,000 U/kg). The brain water content and permeability of the blood-brain barrier were assessed in the two groups along with a sham group (no TBI). Expression of the glial fibrillary acidic protein, endthelin-1 (ET-1), vascular endothelial growth factor (VEGF), and matrix metalloproteinase 9 (MMP-9) were measured by immunohistochemistry and western blot. Effect of UTI on ERK and PI3K/AKT signaling pathways was measured by western blot. Results - UTI significantly decreased the brain water content and extravasation of the Evans blue dye. This attenuation was associated with decreased activation of the astrocytes and ET-1. UTI treatment decreased ERK and Akt activation and inhibited the expression of proinflammatory VEGF and MMP-9. Conclusion - UTI can alleviate brain edema resulting from TBI by inhibiting astrocyte activation and ET-1 production.	[Liu, Ting; Liao, Xing-Zhi; Zhou, Mai-Tao] 904th Hosp Joint Logist Support Force PLA, Wuxi, Jiangsu, Peoples R China; [Liu, Ting] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China		Liao, XZ; Zhou, MT (corresponding author), 904th Hosp Joint Logist Support Force PLA, Wuxi, Jiangsu, Peoples R China.	617396382@qq.com; liaoxingzhi@aliyun.com; zhoumaitao_904h@126.com			Project on Scientific Research of Wuxi Municipal Health and Family Planning Commission [MS201810]	This study was supported by the Project on Scientific Research of Wuxi Municipal Health and Family Planning Commission [MS201810].	Belaidi E, 2016, PHARMACOL THERAPEUT, V168, P1, DOI [10.10166/j.pharmthera.2016.07.010, 10.1016/j.pharmthera.2016.07.010]; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Chen HM, 2014, INT J CLIN EXP MED, V7, P1483; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; Cheng X, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1597-y; Cui T, 2015, CELL BIOCHEM BIOPHYS, V71, P595, DOI 10.1007/s12013-014-0239-3; D'Antoni S, 2017, NEUROTOX RES, V32, P58, DOI 10.1007/s12640-017-9711-3; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Hayman EG, 2017, NEUROCRIT CARE, V26, P301, DOI 10.1007/s12028-016-0354-7; He JT, 2019, CELL MOL NEUROBIOL, V39, P671, DOI 10.1007/s10571-019-00670-y; He WJ, 2015, INT J CLIN EXP PATHO, V8, P10792; Hostenbach S, 2016, PROG NEUROBIOL, V144, P88, DOI 10.1016/j.pneurobio.2016.04.009; Ikeshima-Kataoka H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081306; Jung KT, 2013, KOREAN J PAIN, V26, P356, DOI 10.3344/kjp.2013.26.4.356; Kanazawa F, 2005, BRAIN RES, V1036, P145, DOI 10.1016/j.brainres.2004.12.019; Kansanen E, 2017, MOL PHARMACOL, V92, P481, DOI 10.1124/mol.117.109751; Katoozi S, 2017, BRAIN STRUCT FUNCT, V222, P3959, DOI 10.1007/s00429-017-1448-5; Krueger M, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0671-0; Lehmann LH, 2014, LIFE SCI, V118, P165, DOI 10.1016/j.lfs.2014.03.005; Li ST, 2018, ACTA PHARMACOL SIN, V39, P1294, DOI 10.1038/aps.2017.143; Li WY, 2019, J BIOL REG HOMEOS AG, V33, P919; Nasser M, 2016, CNS NEUROL DISORD-DR, V15, P1030, DOI 10.2174/1871527315666160815093525; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Rempe RG, 2018, J NEUROSCI, V38, P4301, DOI 10.1523/JNEUROSCI.2751-17.2018; Robinson BD, 2018, J TRAUMA ACUTE CARE, V85, P968, DOI 10.1097/TA.0000000000002011; Sakai K, 2003, J CLIN NEUROSCI, V10, P677, DOI 10.1016/S0967-5868(03)00073-0; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sonar SA, 2018, J LEUKOCYTE BIOL, V103, P839, DOI 10.1002/JLB.1RU1117-428R; Sun J, 2018, THERANOSTICS, V8, P4695, DOI 10.7150/thno.26203; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Wang HH, 2011, J CELL PHYSIOL, V226, P2244, DOI 10.1002/jcp.22560; Wang HH, 2010, J NEUROCHEM, V113, P1133, DOI 10.1111/j.1471-4159.2010.06680.x; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Yasui Masato, 2019, Folia Pharmacologica Japonica, V153, P231, DOI 10.1254/fpj.153.231; Zhu JJ, 2018, J CEREBR BLOOD F MET, V38, P1979, DOI 10.1177/0271678X17726062	37	3	3	1	1	DE GRUYTER POLAND SP Z O O	WARSAW	BOGUMILA ZUGA 32A STR, 01-811 WARSAW, MAZOVIA, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2021	12	1					1	8		10.1515/tnsci-2021-0001			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU3LO	WOS:000609207000001	33505713	Green Published, gold			2022-02-06	
J	Longworth, T; McDonald, A; Cunningham, C; Khan, H; Fitzpatrick, J				Longworth, Thomas; McDonald, Andrew; Cunningham, Corey; Khan, Hussain; Fitzpatrick, Jane			Do rugby league players under-report concussion symptoms? A cross-sectional study of elite teams based in Australia	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						concussion; rugby; epidemiology	FOOTBALL PLAYERS; EPIDEMIOLOGY; HISTORY; SPORTS; UNION	Objective To determine the rate of under-reporting of concussion and its symptoms in elite rugby league players in Australia. Methods The study was conducted in the preseason of the 2020 National Rugby League (NRL) competition. A total of 151 male, NRL club contracted rugby league players across three professional clubs participated. The participants completed a voluntary, anonymous survey exploring player demographics, concussion data, under-reporting instances and reasons for under-reporting over the 2018 and 2019 rugby league seasons. Results 17.2% of surveyed players reported sustaining a likely concussion over the past 2 years and not reporting to medical staff. 22% of NRL first grade players admitted to not reporting at least one concussion during the 2018 and 2019 seasons. The most common reason not to report was the player 'not wanting to be ruled out of the game or training session' (57.7%), followed by 'not wanting to let down the coaches or teammates' (23.1%). 85.4% of surveyed players reported having concussion education by their club in the previous two seasons. Conclusions 17.2 % of elite rugby league players in Australia chose not to report likely concussive episodes and concussion-related symptoms during the 2018 and 2019 seasons. Clinicians need to be aware of under-reporting in athletes when assessing players following head injuries. The findings highlight the need for development of validated, objective testing for concussion following sports-associated head injury.	[Longworth, Thomas] Australasian Coll Sport & Exercise Phys, Melbourne, Vic, Australia; [Longworth, Thomas; McDonald, Andrew] Eastern Suburbs Sports Med Ctr, Sports Med, Sydney, NSW, Australia; [Cunningham, Corey] New South Wales Inst Sport, Med, Sydney Olympic Pk, NSW, Australia; [Khan, Hussain] Olymp Pk Sports Med Ctr, Sports Med, Melbourne, Vic, Australia; [Fitzpatrick, Jane] Univ Melbourne, Fac Med Dent & Hlth Sci, Ctr Hlth & Exercise Sports Med, Melbourne, Vic, Australia; [Fitzpatrick, Jane] Australasian Coll Sport & Exercise Phys, Res Comm, Melbourne, Vic, Australia		Fitzpatrick, J (corresponding author), Univ Melbourne, Fac Med Dent & Hlth Sci, Ctr Hlth & Exercise Sports Med, Melbourne, Vic, Australia.; Fitzpatrick, J (corresponding author), Australasian Coll Sport & Exercise Phys, Res Comm, Melbourne, Vic, Australia.	jane.fitzpatrick@unimelb.edu.au	Fitzpatrick, Jane/F-5161-2013	Fitzpatrick, Jane/0000-0002-9578-026X	Australian Institute of Sport Ethics Committee [20191105]	This project had ethics approval granted on 12 November 2019 by the Australian Institute of Sport Ethics Committee (project number: 20191105). The project was endorsed by The Rugby League Research Committee.	Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Cosgrave M, 2019, PHYS THER SPORT, V35, P99, DOI 10.1016/j.ptsp.2018.11.010; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Delaney JS, 2018, CLIN J SPORT MED, V28, P1, DOI 10.1097/JSM.0000000000000495; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; O'Connor D, 2020, NRL INJURY SURVEILLA; O'Connor S, 2020, CLIN J SPORT MED, V30, P578, DOI 10.1097/JSM.0000000000000658; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Saw R, 2018, SPORTS HEALTH, V10, P208, DOI 10.1177/1941738117726070; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	20	3	3	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2021	7	1							e000860	10.1136/bmjsem-2020-000860			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PZ0MM	WOS:000612435200002	33520253	Green Published, gold			2022-02-06	
J	Lubart, A; Benbenishty, A; Har-Gil, H; Laufer, H; Gdalyahu, A; Assaf, Y; Blinder, P				Lubart, Alisa; Benbenishty, Amit; Har-Gil, Hagai; Laufer, Hadas; Gdalyahu, Amos; Assaf, Yaniv; Blinder, Pablo			Single Cortical Microinfarcts Lead to Widespread Microglia/Macrophage Migration Along the White Matter	CEREBRAL CORTEX			English	Article						cortical microinfarct; diffusion tensor imaging; microglia/macrophages; myelin; targeted photothrombotic occlusion	ISCHEMIC BRAIN-INJURY; TRAUMATIC BRAIN; PENETRATING ARTERIOLES; FRACTALKINE-RECEPTOR; MOUSE MODEL; BLOOD-FLOW; RECOVERY; PLASTICITY; REORGANIZATION; OCCLUSION	Loss of cognitive function with aging is a complex and poorly understood process. Recently, clinical research has linked the occurrence of cortical microinfarcts to cognitive decline. Cortical microinfarcts form following the occlusion of penetrating vessels and are considered to be restricted to the proximity of the occluded vessel. Whether and how such local events propagate and affect remote brain regions remain unknown. To this end, we combined histological analysis and longitudinal diffusion tensor imaging (DTI), following the targeted-photothrombotic occlusion of single cortical penetrating vessels. Occlusions resulted in distant tissue reorganization across the mouse brain. This remodeling co-occurred with the formation of a microglia/macrophage migratory path along subcortical white matter tracts, reaching the contralateral hemisphere through the corpus callosum and leaving a microstructural signature detected by DTI-tractography. CX3CR1-deficient mice exhibited shorter trail lengths, differential remodeling, and only ipsilateral white matter tract changes. We concluded that microinfarcts lead to brain-wide remodeling in a microglial CX3CR1-dependent manner.	[Lubart, Alisa; Benbenishty, Amit; Har-Gil, Hagai; Laufer, Hadas; Assaf, Yaniv; Blinder, Pablo] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Gdalyahu, Amos; Assaf, Yaniv; Blinder, Pablo] Tel Aviv Univ, Neurobiol Biochem & Biophys Sch, Tel Aviv, Israel; [Benbenishty, Amit] Weizmann Inst Sci, Biol Regulat Dept, Rehovot, Israel		Blinder, P (corresponding author), Tel Aviv Univ, Neurobiol Biochem & Biophys Sch, Tel Aviv, Israel.	pb@tauex.tau.ac.il		Benbenishty, Amit/0000-0003-4559-5821; Blinder, Pablo/0000-0002-4042-214X	FP7-CIG Marie Curie Action [618251]; Israeli Science FoundationIsrael Science Foundation [1019/15]; Leducq FoundationLeducq Foundation [FDNLEDQ-15CVD-02]; Foundation Judaism Francais; Dante family	The FP7-CIG Marie Curie Action (project 618251 to P.B.); the Israeli Science Foundation (1019/15 to P.B.) and the Leducq Foundation (FDNLEDQ-15CVD-02 to P.B.). A.L. thanks the Foundation Judaism Francais for doctoral scholarship support. A.B. is grateful to the Dante family for the award of a doctoral fellowship.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Cotrina ML, 2017, NEUROSCIENCE, V343, P483, DOI 10.1016/j.neuroscience.2016.12.012; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Dijkhuizen RM, 2012, TRANSL STROKE RES, V3, P36, DOI 10.1007/s12975-011-0143-8; Drew PJ, 2010, NAT METHODS, V7, P981, DOI [10.1038/nmeth.1530, 10.1038/NMETH.1530]; Feldman HM, 2010, J DEV BEHAV PEDIATR, V31, P346, DOI 10.1097/DBP.0b013e3181dcaa8b; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Hill RA, 2018, NAT NEUROSCI, V21, P683, DOI 10.1038/s41593-018-0120-6; Hinman JD, 2014, CURR OPIN NEUROL, V27, P615, DOI 10.1097/WCO.0000000000000149; Hui ES, 2012, BRAIN RES, V1451, P100, DOI 10.1016/j.brainres.2012.02.044; Iadecola C, 2009, STROKE, V40, pS40, DOI 10.1161/STROKEAHA.108.533638; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Johnston DG, 2013, CEREB CORTEX, V23, P751, DOI 10.1093/cercor/bhs092; Jung WB, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3704; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Lampron A, 2015, J EXP MED, V212, P481, DOI 10.1084/jem.20141656; Lee JK, 2009, GENESIS, V47, P751, DOI 10.1002/dvg.20557; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Li HL, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-58; Li T, 2013, BRAIN, V136, P3578, DOI 10.1093/brain/awt287; Lim DH, 2014, J NEUROSCI, V34, P16455, DOI 10.1523/JNEUROSCI.3384-14.2014; Lloyd AF, 2019, NAT REV NEUROL, V15, P447, DOI 10.1038/s41582-019-0184-2; Nguyen QT, 2006, J NEUROSCI METH, V156, P351, DOI 10.1016/j.jneumeth.2006.03.001; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Nishimura N., 2006, NATURE METHODS, V3, P5; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Nishimura N, 2013, STROKE, V44, pS90, DOI 10.1161/STROKEAHA.112.679621; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Raman MR, 2014, NEUROLOGY, V82, P1951, DOI 10.1212/WNL.0000000000000471; Rungta RL, 2018, NEURON; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Schaechter JD, 2006, BRAIN, V129, P2722, DOI 10.1093/brain/awl214; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Shen ZM, 2012, NAT METHODS, V9, P273, DOI [10.1038/NMETH.1857, 10.1038/nmeth.1857]; Sheridan GK, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130181; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278; Shih AY, 2013, OPTICALLY INDUCED OC; Silasi G, 2015, J CEREBR BLOOD F MET, V35, P734, DOI 10.1038/jcbfm.2015.8; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Sokolowski JD, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00360; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Summers PM, 2017, J CEREBR BLOOD F MET, V37, P3599, DOI 10.1177/0271678X16685573; Taylor ZJ, 2016, J CEREBR BLOOD F MET, V36, P1357, DOI 10.1177/0271678X15608388; Taylor ZJ, 2013, BIO PROTOC, V3, pe897; Thiel A, 2011, STROKE, V42, P507, DOI 10.1161/STROKEAHA.110.598821; Valmianski I, 2010, J NEUROPHYSIOL, V104, P1803, DOI 10.1152/jn.00484.2010; van der Maten G, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-016-0325-0; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; van Rooden S, 2014, RADIOLOGY, V270, P205, DOI 10.1148/radiol.13130743; van Veluw SJ, 2017, LANCET NEUROL, V16, P730, DOI 10.1016/S1474-4422(17)30196-5; van Veluw SJ, 2013, J CEREBR BLOOD F MET, V33, P322, DOI 10.1038/jcbfm.2012.196; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang MH, 2012, J NEUROSCI, V32, P17948, DOI 10.1523/JNEUROSCI.1860-12.2012; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yu CS, 2009, NEUROIMAGE, V47, P451, DOI 10.1016/j.neuroimage.2009.04.066; Zhang JY, 2012, TRENDS NEUROSCI, V35, P412, DOI 10.1016/j.tins.2012.04.010; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	72	3	3	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	JAN	2021	31	1					248	266		10.1093/cercor/bhaa223			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PT1SX	WOS:000608401000019	32954425				2022-02-06	
J	Neumane, S; Camara-Costa, H; Francillette, L; Araujo, M; Toure, H; Brugel, D; Laurent-Vannier, A; Ewing-Cobbs, L; Meyer, P; Dellatolas, G; Watier, L; Chevignard, M				Neumane, Sara; Camara-Costa, Hugo; Francillette, Leila; Araujo, Melanie; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Ewing-Cobbs, Linda; Meyer, Philippe; Dellatolas, Georges; Watier, Laurence; Chevignard, Mathilde			Functional outcome after severe childhood traumatic brain injury: Results of the TGE prospective longitudinal study	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Severe traumatic brain injury; Child; Functional outcome; Longitudinal cohort study; Overall disability; Long-term follow-up	EXECUTIVE FUNCTION; CHILDREN; RECOVERY; PREDICTORS; TERM; VULNERABILITY; DISABILITY; SCORE; SCALE; COMA	Background: Childhood severe traumatic brain injury (TBI) is a leading cause of long-lasting acquired disability, but little is known about functional outcome. Objective: We aimed to 1) study clinical recovery and functional outcome over 24 months after severe childhood TBI, 2) identify early sociodemographic and severity factors influencing outcome, and 3) examine the clinical utility of the Pediatric Injury Functional Outcome Scale (PIFOS) to assess functional outcome. Methods: Children (0-15 years) consecutively admitted in a trauma centre after accidental severe TBI over 3 years were included in a prospective longitudinal study (Traumatisme Grave de l'Enfant cohort). We measured clinical/neurological recovery, functional status (Pediatric Injury Functional Outcome Scale, [PIFOS]), overall disability (pediatric Glasgow Outcome Scale [GOS-Peds]) as well as intellectual ability (Wechsler scales) and educational outcome (mainstream school vs special education) of survivors at 1, 3, 12 and 24 months post-injury. Results: For 45 children (aged 3 to 15 years at injury), functional impairments were severe within the first 3 months. Despite the initial rapid clinical recovery and significant improvement over the first year, substantial alterations persisted for most children at 12 months post-TBI, with no significant improvement up to 2 years. Up to 80% of children still had moderate or severe overall disability (GOS-Peds) at 24 months. The severity of functional impairments (PIFOS) at 12 and 24 months was mostly related to socio-emotional, cognitive and physical impairments, and was significantly correlated with clinical/neurological deficits and cognitive (intellectual, executive) and behavioural disorders. Initial TBI severity was the main prognostic factor associated with functional status over the first 2 years post-injury. Conclusions: Our results confirm the significant impact of severe childhood TBI on shortand medium term functional outcomes and overall disability. All patients should benefit from systematic follow-up. The PIFOS appeared to be an accurate and reliable tool to assess functional impairment evolution and clinically meaningful outcomes over the first 2 years post-injury. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Neumane, Sara; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Brain Injury, St Maurice, France; [Neumane, Sara] Sorbonne Univ, Fac Med, Paris, France; [Camara-Costa, Hugo; Dellatolas, Georges] Univ Paris SUD, Univ Paris Saclay, INSERM, CESP,UVSQ, Paris, France; [Camara-Costa, Hugo; Francillette, Leila; Chevignard, Mathilde] Sorbonne Univ, Lab Imagerie Biomed, Paris, France; [Araujo, Melanie] Univ Toulouse, Lab Pharmacol Med & Clin, INSERM UMR 1027, Ctr Hosp, Toulouse, France; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Childrens Learning Inst, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat, Houston, TX 77030 USA; [Meyer, Philippe] Hop Necker Enfants Malad, Pediat Anesthesiol Dept, Paris, France; [Meyer, Philippe] Paris Descartes Univ, Fac Med, Paris, France; [Watier, Laurence] Univ Paris Saclay, Biostat Biomath Pharmacoepidemiol & Infect Dis B2, INSERM, Inst Pasteur,UVSQ, Paris, France; [Dellatolas, Georges; Chevignard, Mathilde] Sorbonne Univ, GRC Handicap Moteur & Cognitif & Readaptat HaMCRe, Paris, France		Camara-Costa, H (corresponding author), CESP INSERM U1018, 97 Blvd Port Royal, F-75014 Paris, France.	hugocamaracosta@gmail.com	Dellatolas, Georges/AAW-1377-2021	Camara-Costa, Hugo/0000-0002-3739-7190; Neumane, Sara/0000-0002-3131-5369; Meyer, Philippe G/0000-0002-3829-6631	French Ministry of Health's general direction of health; national fund for health insurance of salaried workers; national fund for health insurance of independent workers; national fund for solidarity and autonomy; national institute for prevention and education for health; French Speaking Society of Research in Children with Disabilities (SFERHE); French Traumatic Brain Injury Society (France Traumatisme Cranien -FTC); French Speaking Society of Physical Medicine and Rehabilitation (SOFMER); French Ministry of Health's general direction of health (Direction Generale de la Sante); French Ministry of Health's general direction of research, studies, assessment and statistics"; French Ministry of Health's general direction of research, studies, assessment and statistics	In depth analyses and manuscript preparation were funded thanks to a co-funding by the French Ministry of Health's general direction of health and direction of research, studies, assessment and statistics, by the national fund for health insurance of salaried workers, the national fund for health insurance of independent workers, by the national fund for solidarity and autonomy and by the national institute for prevention and education for health, in the call for research projects launched by the IReSP in 2011, and by two grant(s) awarded to Hugo Camara-Costa: one grant from the French Speaking Society of Research in Children with Disabilities (SFERHE, www.sferhe.org) and one joint grant from the French Traumatic Brain Injury Society (France Traumatisme Cranien -FTC) and the French Speaking Society of Physical Medicine and Rehabilitation (SOFMER, www.sofmer.com).Thus, the "French Ministry of Health's general direction of health (Direction Generale de la Sante) and direction of research, studies, assessment and statistics" is a funding body on its own, that co-funded the study in this joint call.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; Camara-Costa H, 2020, DISABIL REHABIL, V42, P2402, DOI 10.1080/09638288.2019.1594398; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chevignard M, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000295; Chevignard MP, 2010, CURR OPIN NEUROL, V23, P695, DOI 10.1097/WCO.0b013e328340296f; Clark A, 2019, J PEDIATR SURG, DOI [10.1016/j.jpedsurg.2019.06.022.S002234681930449X, DOI 10.1016/J.JPEDSURG.2019.06.022.S002234681930449X]; Crichton A, 2018, J INT NEUROPSYCH SOC, V24, P224, DOI 10.1017/S1355617717000893; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Gioia GA, 2014, ADAPTATION FRANCAISE; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JENNETT B, 1975, LANCET, V1, P480; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; Le Fur C, 2020, ANN PHYS REHABIL MED, V63, P270, DOI 10.1016/j.rehab.2019.09.003; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Toure H, 2019, QUAL LIFE RES, DOI [10.1007/s11136-019-02305, DOI 10.1007/S11136-019-02305]; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Viot S, 2019, BRAIN INJURY, V33, P1208, DOI 10.1080/02699052.2019.1631485; Wechsler D., 2002, ECHELLE INTELLIGENCE; Wechsler D., 1996, ECHELLE INTELLIGENCE; Wilkinson AA, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0925-6; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	45	3	3	0	3	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	JAN	2021	64	1							101375	10.1016/j.rehab.2020.01.008			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	QL9UY	WOS:000621427100005	32275965	Bronze			2022-02-06	
J	Pierpoint, LA; Collins, C				Pierpoint, Lauren A.; Collins, Christy			Epidemiology of Sport-Related Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; High school; College; Sport; Epidemiology; Traumatic brain injury	SURVEILLANCE DESCRIPTIVE EPIDEMIOLOGY; ATHLETIC ASSOCIATION MENS; STATES EMERGENCY-DEPARTMENTS; TRAUMATIC BRAIN-INJURIES; HIGH-SCHOOL; 1ST DECADE; UNITED-STATES; LACROSSE INJURIES; HEAD-INJURIES; BASKETBALL 2004-2005		[Pierpoint, Lauren A.] Steadman Philippon Res Inst, 181 West Meadow Dr,Suite 100, Vail, CO 81657 USA; [Collins, Christy] Datalys Ctr Sports Injury Res & Prevent, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA		Pierpoint, LA (corresponding author), Steadman Philippon Res Inst, 181 West Meadow Dr,Suite 100, Vail, CO 81657 USA.	lpierpoint@sprivail.org					Bailly N, 2017, MED SCI SPORT EXER, V49, P1, DOI 10.1249/MSS.0000000000001078; Bleakley C, 2011, J ATHL TRAINING, V46, P555; Centers for Disease Control and Prevention, BRAIN INJ BAS WHAT C; Centers for Disease Control and prevention, CONC PLAY OPP RESH C; Centers for Disease Control and Prevention, NAT CONC SURV SYST; Centers for Disease Control and Prevention, BRAIN INJ BAS REC CO; Chrisman SPD, 2019, J PEDIATR-US, V207, P176, DOI 10.1016/j.jpeds.2018.11.003; Clifton DR, 2018, J ATHL TRAINING, V53, P1037, DOI 10.4085/1062-6050-150-17; Clifton DR, 2018, J ATHL TRAINING, V53, P1025, DOI 10.4085/1062-6050-148-17; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Currie DW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2447; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Dick R, 2007, J ATHL TRAINING, V42, P255; DiStefano LJ, 2018, J ATHL TRAINING, V53, P880, DOI 10.4085/1062-6050-156-17; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Gil JA, 2017, CLIN J SPORT MED, V27, P499, DOI 10.1097/JSM.0000000000000395; Graves JM, 2013, INJURY PREV, V19, P399, DOI 10.1136/injuryprev-2012-040727; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3482; Kerr ZY, 2019, AM J SPORT MED, V47, P933, DOI 10.1177/0363546518825361; Kerr ZY, 2018, J ATHL TRAINING, V53, P926, DOI 10.4085/1062-6050-162-17; Kerr ZY, 2021, CLIN J SPORT MED, V31, pE21, DOI 10.1097/JSM.0000000000000697; Kerr ZY, 2018, J ATHL TRAINING, V53, P893, DOI 10.4085/1062-6050-166-17; Kerr ZY, 2018, J ATHL TRAINING, V53, P738, DOI 10.4085/1062-6050-144-17; Kerr ZY, 2018, MED SCI SPORT EXER, V50, P284, DOI 10.1249/MSS.0000000000001422; Kerr ZY, 2017, J ATHL TRAINING, V52, P955, DOI 10.4085/1062-6050-52.7.06; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr Zachary Y, 2017, Inj Epidemiol, V4, P6, DOI 10.1186/s40621-017-0104-0; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kroshus E, 2018, J ATHL TRAINING, V53, P1143, DOI 10.4085/1062-6050-154-17; Kucera KL, CATASTROPHIC SPORT I; Lawson BR, 2009, PEDIATRICS, V123, pE1028, DOI 10.1542/peds.2007-3796; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lopez V, 2016, MED SCI SPORT EXER, V48, P1320, DOI 10.1249/MSS.0000000000000892; Lynall RC, 2018, J ATHL TRAINING, V53, P1129, DOI 10.4085/1062-6050-176-17; Lynall RC, 2018, J ATHL TRAINING, V53, P938, DOI 10.4085/1062-6050-173-17; Major DH, 2014, BRIT J SPORT MED, V48, P18, DOI 10.1136/bjsports-2013-092573; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Marshall SW, 2001, J ATHL TRAINING, V36, P334; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCulloch PC, 2007, ORTHOPEDICS, V30, P29, DOI 10.3928/01477447-20070101-05; Myers RJ, 2010, WEST J EMERG MED, V11, P442; Naiyer N, 2017, CLIN PEDIATR, V56, P985, DOI 10.1177/0009922817702938; National Collegiate Athletic Association, 2019, NCAA SPORTS SPONS PA; National Federation of State High School Associations, 2019, 2018 19 HIGH SCH ATH; National Public Radio Robert Wood Johnson Foundation Harvard T.H. Chan School of Public Health, 2015, SPORTS HLTH AM; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Pierpoint LA, 2019, J ATHL TRAINING, V54, P42, DOI 10.4085/1062-6050-201-17; Pierpoint LA, 2019, J ATHL TRAINING, V54, P30, DOI 10.4085/1062-6050-200-17; Rasberry CN, 2011, PREV MED, V52, pS10, DOI 10.1016/j.ypmed.2011.01.027; Russell K, 2018, RES SPORTS MED, V26, P166, DOI 10.1080/15438627.2018.1438277; Sabesan V, 2016, OPEN ACCESS J SPORTS, V7, P135, DOI 10.2147/OAJSM.S114019; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Schneider KJ, 2021, CLIN J SPORT MED, V31, P70, DOI 10.1097/JSM.0000000000000673; Steenstrup SE, 2014, BRIT J SPORT MED, V48, P41, DOI 10.1136/bjsports-2013-093145; Summers Z, 2017, J PEDIATR SURG, V52, P2038, DOI 10.1016/j.jpedsurg.2017.08.038; The Aspen Institute Project Play, 2019, STAT PLAY 2019 TREND; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; USA Rugby, 2019, YEAR REV 2019; Wasserman EB, 2019, J ATHL TRAINING, V54, P198, DOI 10.4085/1062-6050-239-17; Wasserman EB, 2019, J ATHL TRAINING, V54, P212, DOI 10.4085/1062-6050-206-17; Wasserman EB, 2018, CLIN SPORT MED, V37, P387, DOI 10.1016/j.csm.2018.03.007; Woods RA, 2017, SPOT LIGHT STAT SPOR; Xiang H, 2004, INJURY PREV, V10, P99, DOI 10.1136/ip.2003.004655; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Yard EE, 2006, J ATHL TRAINING, V41, P441; Yard EE, 2006, J ATHL TRAINING, V41, P325; Yau RK, 2019, SPORTS HEALTH, V11, P32, DOI 10.1177/1941738118807122; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	77	3	3	11	24	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					1	18		10.1016/j.csm.2020.08.013			18	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	PE8NO	WOS:000598618400001	33187601				2022-02-06	
J	Riegler, KE; Guty, ET; Thomas, GA; Arnett, PA				Riegler, Kaitlin E.; Guty, Erin T.; Thomas, Garrett A.; Arnett, Peter A.			Sleep Deprived or Concussed? The Acute Impact of Self-Reported Insufficient Sleep in College Athletes	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Cognition function; Post-concussion symptoms; Concussion; Mild; Sports injuries; Self report; Sports	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE FUNCTION; BASE-LINE; RECOMMENDATIONS; PERFORMANCE; COMPLAINTS; DISORDERS; CHILDREN; RECOVERY	Objective: Sleep deprivation is common among both college students and athletes and has been correlated with negative health outcomes, including worse cognition. As such, the current study sought to examine the relationship between sleep difficulties and self-reported symptoms and objective neuropsychological performance at baseline and post-concussion in collegiate athletes. Method: Seven hundred seventy-two collegiate athletes completed a comprehensive neuropsychological test battery at baseline and/or post-concussion. Athletes were separated into two groups based on the amount of sleep the night prior to testing. The sleep duration cutoffs for these group were empirically determined by sample mean and standard deviation (M = 7.07, SD = 1.29). Results: Compared with athletes getting sufficient sleep, those getting insufficient sleep the night prior to baseline reported significantly more overall symptoms and more symptoms from each of the five symptom clusters of the Post-Concussion Symptom Scale. However, there were no significant differences on objective performance indices. Secondly, there were no significant differences on any of the outcome measures, except for sleep symptoms and headache, between athletes getting insufficient sleep at baseline and those getting sufficient sleep post-concussion. Conclusion: Overall, the effect of insufficient sleep at baseline can make an athlete appear similar to a concussed athlete with sufficient sleep. As such, athletes completing a baseline assessment following insufficient sleep could be underperforming cognitively and reporting elevated symptoms that would skew post-concussion comparisons. Therefore, there may need to be consideration of prior night's sleep when determining whether a baseline can be used as a valid comparison.	[Riegler, Kaitlin E.; Guty, Erin T.; Thomas, Garrett A.; Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Riegler, KE (corresponding author), Penn State Univ, 372 Moore Bldg, University Pk, PA 16802 USA.	kriegler25@gmail.com		Riegler, Kaitlin/0000-0002-3939-4751; Guty, Erin/0000-0002-6599-2173			American College Health Association, 2015, NCHA ACHA II SPRING; [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; [Anonymous], 2018, BANGLADESH TEXTILE T, V11, P37, DOI DOI 10.5935/1984-0063.20180009; Baglioni C, 2016, PSYCHOL BULL, V142, P969, DOI 10.1037/bul0000053; Bailey CM, 2009, J HEAD TRAUMA REHAB, V24, P123, DOI 10.1097/HTR.0b013e31819c1caa; Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; BUYSSE DJ, 1991, SLEEP, V14, P331; Cegalis J.A., 1994, VIGIL W CONTINUOUS P; Dosi C, 2015, SEMIN PEDIATR NEUROL, V22, P105, DOI 10.1016/j.spen.2015.04.005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Girschik J, 2012, J EPIDEMIOL, V22, P462, DOI 10.2188/jea.JE20120012; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lim J., 2012, PSYCHOL BULL, V136, P375, DOI [10.1037/a0018883.A, DOI 10.1037/A0018883.A]; Lo JC, 2016, SLEEP MED, V17, P87, DOI 10.1016/j.sleep.2015.08.021; Lovell M, 2000, IMPACT IMMEDIATE POS; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Mastin DF, 2006, J BEHAV MED, V29, P223, DOI 10.1007/s10865-006-9047-6; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; MCCRORY P, 2017, BRIT J SPORT MED, V51, P838, DOI DOI 10.1136/BJSPORTS-2017-097699; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Na CL, 2007, J SYST ENG ELECTRON, V18, P622; O'Brien LM, 2011, SLEEP MED CLIN, V6, P109, DOI 10.1016/j.jsmc.2010.12.007; Parsons J.T., 2014, 2014 2015 NCAA SPORT, P56; Parsons J.T., 2014, 2014 2015 NCAA SPORT, DOI [10.1136/bmj.319.7224.1582, DOI 10.1136/BMJ.319.7224.1582]; Protection I. I. C. O. R., 2008, ANN ICRP, V38, P53, DOI DOI 10.2165/00007256-200838010-00005; Putukian M, 2021, CLIN J SPORT MED, V31, P15, DOI 10.1097/JSM.0000000000000705; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Riegler KE, 2020, NEUROPSYCHOLOGY, V34, P63, DOI 10.1037/neu0000582; Riemann D, 2009, SLEEP MED REV, V13, P205, DOI 10.1016/j.smrv.2008.06.001; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Smith A., 1991, SYMBOL DIGIT MODALIT; Stocker RPJ, 2017, ARCH CLIN NEUROPSYCH, V32, P349, DOI 10.1093/arclin/acx003; Taheri Morteza, 2012, Asian J Sports Med, V3, P15; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Vaessen TJA, 2015, SLEEP MED REV, V19, P51, DOI 10.1016/j.smrv.2014.03.008; Valovich McLeod T. C., 2017, ATHLETIC TRAINING SP, V9, P271, DOI [10.3928/19425864-20171010-03, DOI 10.3928/19425864-20171010-03]; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Weschler D., 1997, WESCHLER ADULT INTEL	55	3	3	2	5	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2021	27	1					35	46	PII S135561772000065X	10.1017/S135561772000065X			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	PY4ML	WOS:000612019900004	32641197				2022-02-06	
J	Teah, MK; Chan, GK; Wong, MTF; Yeap, TB				Teah, Ming Kai; Chan, Guan Keng; Wong, Melvin Teck Fui; Yeap, Tat Boon			Treatment of benzodiazepine withdrawal syndrome in a severe traumatic brain injury patient	BMJ CASE REPORTS			English	Article						adult intensive care; mechanical ventilation; intensive care	DEXMEDETOMIDINE; MIDAZOLAM; SEDATION	Prolonged exposure to benzodiazepines (BDZ) may contribute towards physical dependence, which is manifested by iatrogenic Benzodiazepine Withdrawal Syndrome (BWS), a condition often underdiagnosed. Current evidence recommends precluding BDZ infusion as sedation in the intensive care unit to avoid possible withdrawal and delirium issues. Administration of dexmedetomidine should be considered to facilitate weaning in patients with BWS.	[Teah, Ming Kai; Chan, Guan Keng; Wong, Melvin Teck Fui] Queen Elizabeth Hosp, Dept Anaesthesia, Kota Kinabalu, Sabah, Malaysia; [Teah, Ming Kai; Chan, Guan Keng; Wong, Melvin Teck Fui] Queen Elizabeth Hosp, Intens Care Unit, Kota Kinabalu, Sabah, Malaysia; [Yeap, Tat Boon] Univ Malaysia Sabah, Fac Med & Hlth Sci, Med Based Disciplines Dept, Kota Kinabalu, Sabah, Malaysia		Yeap, TB (corresponding author), Univ Malaysia Sabah, Fac Med & Hlth Sci, Med Based Disciplines Dept, Kota Kinabalu, Sabah, Malaysia.	boontat@ums.edu.my		Teah, Kai Ming/0000-0002-3076-2116			Arroyo-Novoa Carmen Mabel, 2020, Crit Care Explor, V2, pe0089, DOI 10.1097/CCE.0000000000000089; Best Kaitlin M, 2017, Crit Care Med, V45, pe7; Chen K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010269.pub2; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Fonsmark L, 1999, CRIT CARE MED, V27, P196, DOI 10.1097/00003246-199901000-00052; Garcia-Sanchez M, 2019, MED INTENSIVA, V43, P225, DOI 10.1016/j.medin.2018.12.003; HUGHES J, 1994, ACTA PAEDIATR, V83, P1194; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Klompas M, 2016, CHEST, V149, P1373, DOI 10.1378/chest.15-1389; Maccioli GA, 2003, ANESTHESIOLOGY, V98, P575, DOI 10.1097/00000542-200302000-00041; Multz AS, 2003, ANESTH ANALG, V96, P1054, DOI 10.1213/01.ANE.0000050773.70232.08; Treggiari MM, 2009, CRIT CARE MED, V37, P2527, DOI 10.1097/CCM.0b013e3181a5689f; Urkmez S, 2019, TURK J ANAESTHESIOL, V47, P220, DOI 10.5152/TJAR.2019.49799; ZIEGLER WH, 1983, BRIT J CLIN PHARMACO, V16, pS63, DOI 10.1111/j.1365-2125.1983.tb02272.x	14	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	JAN	2021	14	1							e238318	10.1136/bcr-2020-238318			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SS2MC	WOS:000661574500179	33419751				2022-02-06	
J	ter Avest, E; Taylor, S; Wilson, M; Lyon, RL				ter Avest, Ewoud; Taylor, Sam; Wilson, Mark; Lyon, Richard L.			Prehospital clinical signs are a poor predictor of raised intracranial pressure following traumatic brain injury	EMERGENCY MEDICINE JOURNAL			English	Article							HYPERTONIC SALINE; MANAGEMENT; GUIDELINES	Background For the prehospital diagnosis of raised intracranial pressure (ICP), clinicians are reliant on clinical signs such as the Glasgow Coma Score (GCS), pupillary response and/or Cushing's triad (hypertension, bradycardia and an irregular breathing pattern). This study aimed to explore the diagnostic accuracy of these signs as indicators of a raised ICP. Methods We performed a retrospective cohort study of adult patients attended by a Helicopter Emergency Medical Service (Air Ambulance Kent, Surrey Sussex), who had sustained a traumatic brain injury (TBI), requiring prehospital anaesthesia between 1 January 2016 and 1 January 2018. We established optimal cut-off values for clinical signs to identify patients with a raised ICP and investigated diagnostic accuracy for combinations of these values. Results Outcome data for 249 patients with TBI were available, of which 87 (35%) had a raised ICP. Optimal cut-off points for systolic blood pressure (SBP), heart rate (HR) and pupil diameter to discriminate patients with a raised ICP were, respectively, >160 mm Hg,<60 bpm and >5 mm. Cushing criteria (SBP >160 mm Hg and HR <60 bpm) and pupillary response and size were complimentary in their ability to detect patients with a raised ICP. The presence of a fixed blown pupil or a Cushing's response had a specificity of 93.2 (88.2-96.6)%, and a positive likelihood ratio (LR+) of 5.4 (2.9-10.2), whereas sensitivity and LR- were only 36.8 (26.7-47.8)% and 0.7 (0.6-0.8), respectively, (Area Under the Curve (AUC) 0.65 (0.57-0.73)). Sensitivity analysis revealed that optimal cut-off values and resultant accuracy were dependent on injury pattern. Conclusion Traditional clinical signs of raised ICP may under triage patients to prehospital treatment with hyperosmolar drugs. Further research should identify more accurate clinical signs or alternative non-invasive diagnostic aids in the prehospital environment.	[ter Avest, Ewoud; Taylor, Sam; Wilson, Mark; Lyon, Richard L.] Air Ambulance Kent Surrey & Sussex, Redhill RH1 5YP, Surrey, England; [ter Avest, Ewoud] Univ Groningen, Univ Med Ctr Groningen, Dept Emergency Med, Groningen, Netherlands; [Wilson, Mark] Imperial Coll London, Neurotrauma Ctr, London, England; [Lyon, Richard L.] Univ Surrey, Sch Hlth Sci, Guildford, Surrey, England		ter Avest, E (corresponding author), Air Ambulance Kent Surrey & Sussex, Redhill RH1 5YP, Surrey, England.	Ewoudteravest@aakss.org.uk		ter Avest, Ewoud/0000-0002-1462-6130			Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen H, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010904.pub3; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clark A, 2006, EMERG MED J, V23, P440, DOI 10.1136/emj.2005.030247; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Fodstad H, 2006, NEUROSURGERY, V59, P1132, DOI 10.1227/01.NEU.0000245582.08532.7C; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Hoogmartens O, 2014, PREHOSP EMERG CARE, V18, P265, DOI 10.3109/10903127.2013.856506; Kebapci A, 2020, INTENS CRIT CARE NUR, V58, DOI 10.1016/j.iccn.2020.102801; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kim AL, 2015, MIL MED, V180, P597, DOI 10.7205/MILMED-D-14-00670; Lee SH, 2020, J CRIT CARE, V56, P182, DOI 10.1016/j.jcrc.2020.01.006; Lyon RM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0872-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McMahon N, 2012, ANAESTHESIA, V67, P1343, DOI 10.1111/j.1365-2044.2012.07302.x; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Peters J, 2017, PREHOSP DISASTER MED, V32, P414, DOI 10.1017/S1049023X17006367; Smith M, 2015, BRIT J ANAESTH, V115, P488, DOI 10.1093/bja/aev230; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Yumoto T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0341-1	24	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN	2021	38	1					21	26		10.1136/emermed-2020-209635			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	PT2VG	WOS:000608475700006	32948620	Green Published, hybrid			2022-02-06	
J	Vartiainen, MV; Peltonen, K; Holm, A; Koskinen, S; Iverson, GL; Hokkanen, L				Vartiainen, Matti V.; Peltonen, Kati; Holm, Anu; Koskinen, Sanna; Iverson, Grant L.; Hokkanen, Laura			Preliminary normative study of ImPACTVR in Finnish professional male ice hockey players	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Baseline; cognition; cultural differences; norms; sport concussion	DEMOGRAPHICALLY CORRECTED NORMS; MULTIPLE PAST CONCUSSIONS; TEST-RETEST RELIABILITY; NEUROCOGNITIVE PERFORMANCE; TEST BATTERY; SPANISH SPEAKERS; SPORT; EPIDEMIOLOGY; INJURY; TESTS	Assessment of cognition is an important part of concussion management. The common paradigm of baseline and postinjury evaluations is recommended but due to the often lacking baseline data, reliable normative values are needed. The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACTVR) battery is a widely used method of cognitive assessment offering several language options. There are few comparative studies between language groups on this test battery. ImPACT was administered at baseline to 184 Finnish male Professional Ice Hockey league players. The performance of the Finnish sample differed from previously published English and Czech language samples on the Visual Motor Speed and Reaction Time composites with medium effect-sizes (d = 0.38-0.52). Age, but not education or prior concussions, was associated with ImPACT performance. ImPACT performance is not uniform across language and culture groups and the findings highlight the need for language-specific norms. Finnish reference values for ImPACT for ages <20, 20-26, and >26 are presented. A similar approach is encouraged for other languages.	[Vartiainen, Matti V.; Peltonen, Kati; Koskinen, Sanna; Hokkanen, Laura] Univ Helsinki, Fac Med, Depat Psychol & Logoped, POB 21, Helsinki 00014 HY, Finland; [Holm, Anu] Satakunta Univ Appl Sci, Fac Hlth & Welf, Pori, Finland; [Holm, Anu] Satakunta Cent Hosp, Dept Clin Neurophysiol, Pori, Finland; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] MassGen Hosp ChildrenTM, Sport Concuss Program, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA		Vartiainen, MV (corresponding author), Univ Helsinki, Fac Med, Depat Psychol & Logoped, POB 21, Helsinki 00014 HY, Finland.	m.vartiainen@kolumbus.fi		Koskinen, Sanna/0000-0002-3453-5084; Holm, Anu/0000-0003-4282-6479			Agranovich AV, 2007, ARCH CLIN NEUROPSYCH, V22, P273, DOI 10.1016/j.acn.2007.01.003; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Bure-Reyes A, 2013, J CLIN EXP NEUROPSYC, V35, P404, DOI 10.1080/13803395.2013.778232; Cherner M, 2007, ARCH CLIN NEUROPSYCH, V22, P343, DOI 10.1016/j.acn.2007.01.009; Cohen J., 2013, STAT POWER ANAL BEHA; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Echemendia RJ, 2016, CLIN NEUROPSYCHOL, V30, P311, DOI 10.1080/13854046.2016.1158320; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P287; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckay CD, 2014, ARCH CLIN NEUROPSYCH, V29, P141, DOI 10.1093/arclin/act116; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; Norman MA, 2011, J CLIN EXP NEUROPSYC, V33, P793, DOI 10.1080/13803395.2011.559157; Ott S, 2014, ARCH CLIN NEUROPSYCH, V29, P152, DOI 10.1093/arclin/act091; Peltonen K., 2018, CHILD NEUROPSYCHOL, V21, P1, DOI [10.1080/09297049.2018, DOI 10.1080/09297049.2018]; Putukian M, 2011, PM&R, V3, pS425, DOI 10.1016/j.pmrj.2011.08.003; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Tsushima William T, 2014, Hawaii J Med Public Health, V73, P208; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	43	3	3	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 1	2021	28	1					53	59		10.1080/23279095.2019.1592175			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	RA5JR	WOS:000631455100001	31043082	Green Accepted			2022-02-06	
J	Vu, PA; McNamara, EH; Liu, J; Tucker, LB; Fu, AH; McCabe, JT				Vu, Patricia A.; McNamara, Eileen H.; Liu, Jiong; Tucker, Laura B.; Fu, Amanda H.; McCabe, Joseph T.			Behavioral responses following repeated bilateral frontal region closed head impacts and fear conditioning in male and female mice	BRAIN RESEARCH			English	Article						Traumatic brain injury; Concussion; Fear conditioning; Frontal cortex; Microglia; Activity; Locomotor function; Mouse; Female; Sex factors	TRAUMATIC BRAIN-INJURY; INDUCED AXONAL INJURY; UNITED-STATES; MOUSE MODEL; COGNITIVE PERFORMANCE; GENDER-DIFFERENCES; SEX-DIFFERENCES; RISK-FACTORS; OPTIC-NERVE; MILD	The frontal lobes are among the most vulnerable sites in traumatic brain injuries. In the current study, a balanced 2 x 2 x 2 design (n = 18 mice/group), female and male C57Bl/6J mice received repeated bilateral frontal concussive brain injury (frCBI) and underwent fear conditioning (FC) to assess how injured mice respond to adverse conditions. Shocks received during FC impacted behavior on all subsequent tests except the tail suspension test. FC resulted in more freezing behavior in all mice that received foot shocks when evaluated in subsequent context and cue tests and induced hypoactivity in the open field (OF) and elevated zero maze (EZM). Mice that sustained frCBI learned the FC association between tone and shock. Injured mice froze less than sham controls during context and cue tests, which could indicate memory impairment, but could also suggest that frCBI resulted in hyperactivity that overrode the rodent's natural freezing response to threat, as injured mice were also more active in the OF and EZM. There were notable sex differences, where female mice exhibited more freezing behavior than male mice during FC context and cue tests. The findings suggest frCBI impaired, but did not eliminate, FC retention and resulted in an overall increase in general activity. The injury was characterized pathologically by increased inflammation (CD11b staining) in cortical regions underlying the injury site and in the optic tracts. The performance of male and female mice after injury suggested the complexity of possible sex differences for neuropsychiatric symptoms.	[Vu, Patricia A.; McNamara, Eileen H.; Liu, Jiong; Tucker, Laura B.; Fu, Amanda H.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, FE Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Vu, Patricia A.; McNamara, Eileen H.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, FE Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Tucker, Laura B.; Fu, Amanda H.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Preclin Studies Core, Ctr Neurosci & Regenerat Med, FE Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, FE Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Joseph.McCabe@usuhs.edu	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442; Tucker, Laura/0000-0002-5984-6399	Center for Neuroscience and Regenerative Medicine (Department of Defense)United States Department of Defense [310185-6.01-65310]; Defense Health Agency [64682-307877-2.00]	This work was supported by The Center for Neuroscience and Regenerative Medicine (Department of Defense), 310185-6.01-65310, and The Defense Health Agency [64682-307877-2.00] to JTM. The opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army, Department of Defense, the U.S. Government or the Uniformed Services University of the Health Sciences. The use of trade names does not constitute an official endorsement or approval of the use of reagents or commercial hardware or software. This document may not be cited for purposes of advertisement.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Algamal M, 2019, J NEUROTRAUM, V36, P2590, DOI 10.1089/neu.2018.6314; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Chou A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151418; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Czosnyka M, 2008, ACTA NEUROCHIR SUPPL, V102, P25, DOI 10.1007/978-3-211-85578-2_5; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Esposito G, 1996, J NUCL MED, V37, P559; Faul M, 2010, TRAUMATIC BRAIN INJU; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Grin'kina NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161053; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kim JY, 2016, STEM CELLS, V34, P888, DOI 10.1002/stem.2276; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Le Prieult F, 2017, J NEUROTRAUM, V34, P1097, DOI 10.1089/neu.2016.4575; Leung LS, 2014, PROG NEUROBIOL, V122, P24, DOI 10.1016/j.pneurobio.2014.08.001; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LINDAL E, 1993, ACTA PSYCHIAT SCAND, V88, P29, DOI 10.1111/j.1600-0447.1993.tb03410.x; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Maguen S, 2012, WOMEN HEALTH ISS, V22, pE61, DOI 10.1016/j.whi.2011.07.010; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marek R, 2019, PSYCHOPHARMACOLOGY, V236, P313, DOI 10.1007/s00213-018-5033-2; McAllister BB, 2015, BEHAV BRAIN RES, V290, P102, DOI 10.1016/j.bbr.2015.04.049; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Ouyang W, 2018, J NEUROSCI RES, V96, P1412, DOI 10.1002/jnr.24261; Ouyang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171976; Paxinos G., 2008, MOUSE BRAIN STEREOTA; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Sawyer Q, 2016, J ATHL TRAINING, V51, P739, DOI 10.4085/1062-6050-51.12.01; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Shimogawa T, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0075-6; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Song SJ, 2016, J NEUROSCI RES, V94, P409, DOI 10.1002/jnr.23714; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Tucker LB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222153; Tucker LB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00509; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Ueno M, 2011, EXP NEUROL, V230, P280, DOI 10.1016/j.expneurol.2011.05.006; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Vu PA, 2018, BRAIN RES, V1700, P138, DOI 10.1016/j.brainres.2018.08.034; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569	89	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 1	2021	1750								147147	10.1016/j.brainres.2020.147147			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PC1CA	WOS:000596745500009	33091394	hybrid			2022-02-06	
J	Wang, RR; He, M; Gui, XY; Kang, Y				Wang, Ruo Ran; He, Min; Gui, Xiying; Kang, Yan			A nomogram based on serum cystatin C for predicting acute kidney injury in patients with traumatic brain injury	RENAL FAILURE			English	Article						Cystatin C; acute kidney injury; traumatic brain injury; biomarker	ANGIOTENSIN-ALDOSTERONE SYSTEM; GLOMERULAR-FILTRATION-RATE; SUBARACHNOID HEMORRHAGE; ORGAN DYSFUNCTION; PROGNOSTIC VALUE; RISK-FACTORS; MORTALITY; CARE; ASSOCIATION; CREATININE	Background: Acute kidney injury (AKI) is a common complication in traumatic brain injury (TBI) patients and is associated with unfavorable outcome of these patients. We designed this study to explore the value of serum cystatin C, an indicator of renal function, on predicting AKI after suffering TBI. Methods: Patients confirmed with TBI and hospitalized in the West China Hospital of Sichuan University between January 2015 and December 2019 were included. Patients were divided into two groups according to occurrence of AKI. Univariate and multivariate logistic regression analyses were sequentially utilized to find risk factors of AKI in included TBI patients. Nomogram composed of discovered risk factors for predicting AKI was constructed. Receiver operating characteristics (ROC) curves were drawn and area under the ROC curve (AUC) were calculated to evaluate the predictive value of cystatin C alone and the constructed nomogram. Results: Among 234 included TBI patients, 55 were divided into AKI group. AKI group had shorter length of stay (p < 0.001) and higher in-hospital mortality (p < 0.001). Multivariate logistic regression analysis showed absolute lymphocyte count (p = 0.034), serum creatinine (p < 0.001), serum cystatin C (p = 0.017) and transfusion of red blood cell (p = 0.005) were independently associated with development of AKI after TBI. While hypertonic saline use was not associated with the development of AKI (p = 0.067). The AUC of single cystatin C and predictive nomogram were 0.804 and 0.925, respectively. Conclusion: Higher serum cystatin C is associated with development of AKI in TBI patients. Predictive nomogram incorporating cystatin C is beneficial for physicians to evaluate possibilities of AKI and consequently adjust treatment strategies to avoid occurrence of AKI.	[Wang, Ruo Ran; He, Min; Kang, Yan] Sichuan Univ, West China Hosp, Dept Crit Care Med, Chengdu, Peoples R China; [Gui, Xiying] Tibet Autonomous Reg Peoples Hosp, Dept Crit Care Med, Lhasa, Peoples R China		Kang, Y (corresponding author), West China Hosp, Dept Crit Care Med, 37 Guo Xue Xiang, Chengdu, Peoples R China.	kangyan@scu.edu.cn			1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University [19HXFH012]	The study was financially supported by the 1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University [19HXFH012].	An S, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.01.60; Angeli F, 2015, EUROINTERVENTION, V11, P757, DOI 10.4244/EIJY14M08_02; Bell M, 2009, NEPHROL DIAL TRANSPL, V24, P3096, DOI 10.1093/ndt/gfp196; Bi JB, 2020, WORLD J GASTRO SURG, V12, DOI 10.4240/wjgs.v12.i7.326; Bouma HR, 2009, AM J TRANSPLANT, V9, P989, DOI 10.1111/j.1600-6143.2009.02587.x; Bu X, 2019, INT IMMUNOPHARMACOL, V70, P372, DOI 10.1016/j.intimp.2019.02.043; Buttner S, 2020, J INTENSIVE CARE MED, V35, P338, DOI 10.1177/0885066617748596; Chen YT, 2021, J FORMOS MED ASSOC, V120, P641, DOI 10.1016/j.jfma.2020.07.022; Chowdhury AH, 2012, ANN SURG, V256, P18, DOI 10.1097/SLA.0b013e318256be72; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Delanaye P, 2004, INTENS CARE MED, V30, P980, DOI 10.1007/s00134-004-2189-5; Deng YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04627-3; Deng YJ, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1626-0; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Dudoignon E, 2020, ANAESTH CRIT CARE PA, V39, P453, DOI 10.1016/j.accpm.2020.06.006; El-Sadek AE, 2020, J PEDIATR UROL, V16, DOI 10.1016/j.jpurol.2019.12.001; Gameiro J, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0561-4; Giannoudis PV, 2008, J TRAUMA, V65, P646, DOI 10.1097/TA.0b013e3181820d48; Goksu E, 2014, TURK NEUROSURG, V24, P391, DOI 10.5137/1019-5149.JTN.8953-13.1; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Hendrickson CM, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03111-1; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Inaba A, 2020, J IMMUNOL, V205, P1376, DOI 10.4049/jimmunol.2000454; Jiang SY, 2017, CRIT CARE MED, V45, pE1099, DOI 10.1097/CCM.0000000000002566; Karkouti K, 2015, CAN J ANESTH, V62, P377, DOI 10.1007/s12630-014-0302-y; Karkouti K, 2011, ANESTHESIOLOGY, V115, P523, DOI 10.1097/ALN.0b013e318229a7e8; Krawczeski CD, 2010, CLIN J AM SOC NEPHRO, V5, P1552, DOI 10.2215/CJN.02040310; Kumar AB, 2015, NEUROCRIT CARE, V22, P184, DOI 10.1007/s12028-014-0067-8; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Liu YZ, 2014, MOL NEUROBIOL, V49, P1043, DOI 10.1007/s12035-013-8579-3; Liu YZ, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-21; Luo J, 2015, CLIN CHIM ACTA, V450, P39, DOI 10.1016/j.cca.2015.07.016; Maaranen P, 2019, J CARDIOTHOR VASC AN, V33, P2949, DOI 10.1053/j.jvca.2019.06.038; Maiwall R, 2016, DIGEST DIS SCI, V61, P920, DOI 10.1007/s10620-015-3921-4; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Nejat M, 2010, NEPHROL DIAL TRANSPL, V25, P3283, DOI 10.1093/ndt/gfq176; Nguyen MT, 2008, PEDIATR NEPHROL, V23, P2151, DOI 10.1007/s00467-007-0470-x; Nilsson CU, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00727-y; Odutayo A, 2012, CLIN NEPHROL, V78, P64, DOI 10.5414/CN107324; Rickli H, 2004, CLIN NEPHROL, V61, P98; Sadan O, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00449-0; Seo YS, 2018, J GASTROEN HEPATOL, V33, P910, DOI 10.1111/jgh.13983; Shi JJ, 2019, CURR NEUROVASC RES, V16, P301, DOI 10.2174/1567202616666190906110204; Shlipak MG, 2005, J AM COLL CARDIOL, V45, P268, DOI 10.1016/j.jacc.2004.09.061; Sigmon J, 2020, ANN PHARMACOTHER, V54, P541, DOI 10.1177/1060028019891986; Sjostrom P, 2004, CLIN NEPHROL, V62, P241; Skrifvars MB, 2019, ACTA ANAESTH SCAND, V63, P200, DOI 10.1111/aas.13244; Staubli SM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54910-8; Swaminathan M, 2003, ANN THORAC SURG, V76, P784, DOI 10.1016/S0003-4975(03)00558-7; Volpon LC, 2015, PEDIATR CRIT CARE ME, V16, pE125, DOI 10.1097/PCC.0000000000000403; Wang XD, 2020, BIOMARKERS, V25, P20, DOI 10.1080/1354750X.2019.1688865; Weller S, 2017, NEPHRON, V137, P287, DOI 10.1159/000478538; Yamane DP., 2020, J INTENS CARE MED; Yang BH, 2019, ACTA NEUROCHIR, V161, P1783, DOI 10.1007/s00701-019-04006-z; Yang B, 2020, J NEUROCHEM, V153, P413, DOI 10.1111/jnc.14894; Zappitelli M, 2015, JAMA PEDIATR, V169, P583, DOI 10.1001/jamapediatrics.2015.54; Zeng Q, 2015, CURR NEUROVASC RES, V12, P40, DOI 10.2174/1567202612666150102150941; Zhang JB, 2014, J CLIN NEUROSCI, V21, P268, DOI 10.1016/j.jocn.2013.04.014; Zhang JY, 2020, SPINAL CORD, V58, P341, DOI 10.1038/s41393-019-0360-7; Zhang WR, 2015, J AM SOC NEPHROL, V26, P3123, DOI 10.1681/ASN.2014080764; Zheng CF, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1821-z; Zheng L, 2019, CURR PROTEIN PEPT SC, V20, P770, DOI 10.2174/1389203720666190507102529; Zhu ZB, 2018, ATHEROSCLEROSIS, V274, P146, DOI 10.1016/j.atherosclerosis.2018.05.015; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	69	3	3	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0886-022X	1525-6049		RENAL FAILURE	Ren. Fail.	JAN 1	2021	43	1					206	215		10.1080/0886022X.2021.1871919			10	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	PU8JW	WOS:000609546500001	33478333	Green Published, gold			2022-02-06	
J	Yang, LD; Dong, Y; Wu, CY; Youngblood, H; Li, Y; Zong, XM; Li, L; Xu, TD; Zhang, QG				Yang, Luodan; Dong, Yan; Wu, Chongyun; Youngblood, Hannah; Li, Yong; Zong, Xuemei; Li, Lei; Xu, Tongda; Zhang, Quanguang			Effects of prenatal photobiomodulation treatment on neonatal hypoxic ischemia in rat offspring	THERANOSTICS			English	Article						Prenatal photobiomodulation; Neonatal hypoxic-ischemic encephalopathy; Mitochondria; Neuroinflammation; Oxidative stress	TRAUMATIC BRAIN-INJURY; LEVEL LASER THERAPY; MITOCHONDRIAL DYSFUNCTION; MICROGLIAL ACTIVATION; OXIDATIVE STRESS; EMBOLIC STROKES; HYPOTHERMIA; ENCEPHALOPATHY; LIGHT; INFANTS	Neonatal hypoxic-ischemic (HI) injury is a severe complication often leading to neonatal death and long-term neurobehavioral deficits in children. Currently, the only treatment option available for neonatal HI injury is therapeutic hypothermia. However, the necessary specialized equipment, possible adverse side effects, and limited effectiveness of this therapy creates an urgent need for the development of new HI treatment methods. Photobiomodulation (PBM) has been shown to be neuroprotective against multiple brain disorders in animal models, as well as limited human studies. However, the effects of PBM treatment on neonatal HI injury remain unclear. Methods: Two-minutes PBM (808 nm continuous wave laser, 8 mW/cm(2) on neonatal brain) was applied three times weekly on the abdomen of pregnant rats from gestation day 1 (GD1) to GD21. After neonatal right common carotid artery ligation, cortexand hippocampus-related behavioral deficits due to HI insult were measured using a battery of behavioral tests. The effects of HI insult and PBM pretreatment on infarct size; synaptic, dendritic, and white matter damage; neuronal degeneration; apoptosis; mitochondrial function; mitochondrial fragmentation; oxidative stress; and gliosis were then assessed. Results: Prenatal PBM treatment significantly improved the survival rate of neonatal rats and decreased infarct size after HI insult. Behavioral tests revealed that prenatal PBM treatment significantly alleviated cortex-related motor deficits and hippocampus-related memory and learning dysfunction. In addition, mitochondrial function and integrity were protected in HI animals treated with PBM. Additional studies revealed that prenatal PBM treatment significantly alleviated HI-induced neuroinflammation, oxidative stress, and myeloid cell/astrocyte activation. Conclusion: Prenatal PBM treatment exerts neuroprotective effects on neonatal HI rats. Underlying mechanisms for this neuroprotection may include preservation of mitochondrial function, reduction of inflammation, and decreased oxidative stress. Our findings support the possible use of PBM treatment in high-risk pregnancies to alleviate or prevent HI-induced brain injury in the perinatal period.	[Yang, Luodan; Dong, Yan; Wu, Chongyun; Li, Yong; Zong, Xuemei; Li, Lei; Xu, Tongda; Zhang, Quanguang] Augusta Univ, Dept Neurosci & Regenerat Med, Med Coll Georgia, 1120 15th St, Augusta, GA 30912 USA; [Youngblood, Hannah] Augusta Univ, Dept Cellular Biol & Anat, Med Coll Georgia, 1120 15th St, Augusta, GA 30912 USA		Zhang, QG (corresponding author), Augusta Univ, Dept Neurosci & Regenerat Med, Med Coll Georgia, 1120 15th St, Augusta, GA 30912 USA.	qzhang@augusta.edu	Yang, Luodan/AAB-8891-2022		United States of America: National Institute of Neurological Disorders and Stroke [NS086929]; United States of America: National Institute of Aging, National Institutes of Health [NIA00051]; United States of America: American Heart Association [AHA00169]	This study was supported by research grants from the United States of America: NS086929 from the National Institute of Neurological Disorders and Stroke; NIA00051 from National Institute of Aging, National Institutes of Health; AHA00169 from American Heart Association.	Agrawal T, 2014, DOSE-RESPONSE, V12, P619, DOI 10.2203/dose-response.14-032.Agrawal; Ahmed ME, 2016, NEUROSCIENCE, V336, P39, DOI 10.1016/j.neuroscience.2016.08.036; Aly H, 2006, BRAIN DEV-JPN, V28, P178, DOI 10.1016/j.braindev.2005.06.006; Amaroli A, 2019, PHOTOCHEM PHOTOBIOL, V95, P455, DOI 10.1111/php.13032; Andrabi SS, 2017, DIS MODEL MECH, V10, P787, DOI 10.1242/dmm.025692; Argibay B, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00911; Askalsky P, 2019, NEUROPSYCH DIS TREAT, V15, P3255, DOI 10.2147/NDT.S188906; Aslami H, 2018, MITOCHONDRIAL DNA A, V29, P525, DOI 10.1080/24701394.2017.1315568; Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Biswas SK, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5698931; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Boo NY, 2016, SINGAP MED J, V57, P456, DOI 10.11622/smedj.2016137; Borjini N, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1595-0; Chang SY, 2020, MOL THER-METH CLIN D, V17, P556, DOI 10.1016/j.omtm.2020.03.010; Chang SY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55711-9; Charriaut-Marlangue C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00650; Chen WQ, 2011, STROKE, V42, P764, DOI 10.1161/STROKEAHA.110.599118; Chen YZ, 2013, BRAIN RES, V1495, P11, DOI 10.1016/j.brainres.2012.12.006; Chen YM, 2013, NEUROSCI LETT, V553, P99, DOI 10.1016/j.neulet.2013.07.049; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Cooke R, 2005, LANCET, V365, P632; Cornette L, 2012, FACTS VIEWS VIS OBGY, V4, P133; Cunha C, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6986175; CURRIE RW, 1987, J MOL CELL CARDIOL, V19, P795; Cury V, 2013, J PHOTOCH PHOTOBIO B, V125, P164, DOI 10.1016/j.jphotobiol.2013.06.004; Davidson JO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00198; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; Diaz J, 2017, DEV NEUROSCI-BASEL, V39, P257, DOI 10.1159/000454949; Dixon BJ, 2015, INT J MOL SCI, V16, P22368, DOI 10.3390/ijms160922368; Dompe C, 2020, J CLIN MED, V9; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Dumont U, 2020, BRAIN RES, V1738, DOI 10.1016/j.brainres.2020.146798; Escobar-Henriques M, 2014, CELL RES, V24, P387, DOI 10.1038/cr.2014.23; Eshaghi E, 2019, LASER SURG MED, V51, P634, DOI 10.1002/lsm.23082; Ferraresi C, 2015, LASER MED SCI, V30, P1259, DOI 10.1007/s10103-015-1723-8; Fisch U, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1706-y; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Fung THW, 2020, THERANOSTICS, V10, P8924, DOI 10.7150/thno.47118; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Ham PB, 2017, PROG NEUROBIOL, V157, P92, DOI 10.1016/j.pneurobio.2016.06.006; Hamblin MR, 2019, PHOTONICS-BASEL, V6, DOI 10.3390/photonics6030077; Hamblin MR, 2018, PHOTOCHEM PHOTOBIOL, V94, P199, DOI 10.1111/php.12864; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hankins GDV, 2003, OBSTET GYNECOL, V102, P628, DOI 10.1016/S0029-7844(03)00574-X; Harding B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010017; Henderson TA, 2015, NEUROPSYCH DIS TREAT, V11, P2191, DOI 10.2147/NDT.S78182; Hopkins JT, 2004, J ATHL TRAINING, V39, P223; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jantzie LL, 2005, J CEREBR BLOOD F MET, V25, P314, DOI 10.1038/sj.jcbfm.9600025; Jarlestedt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010397; Jonas EA, 2005, J BIOL CHEM, V280, P4491, DOI 10.1074/jbc.M410661200; Joshi AU, 2019, NAT NEUROSCI, V22, P1635, DOI 10.1038/s41593-019-0486-0; Kim H, 2017, EXP THER MED, V13, P2775, DOI 10.3892/etm.2017.4371; Kim YM, 2012, RESUSCITATION, V83, P188, DOI 10.1016/j.resuscitation.2011.07.031; Koch S, 2014, J CEREBR BLOOD F MET, V34, P933, DOI 10.1038/jcbfm.2014.42; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak PA, 2008, STROKE, V39, P3073, DOI 10.1161/STROKEAHA.108.516393; Lapchak PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127580; Laptook AR, 2017, JAMA-J AM MED ASSOC, V318, P1550, DOI 10.1001/jama.2017.14972; Leaw B, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00199; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Leviton A, 2004, PEDIATR RES, V55, P541, DOI 10.1203/01.PDR.0000121197.24154.82; Li B, 2019, CELL MOL IMMUNOL; Li T, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2280-z; Li T, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1524-2; Li Y, 2012, STROKE, V43, P2483, DOI 10.1161/STROKEAHA.112.664698; Li Y, 2012, PROG NEUROBIOL, V98, P145, DOI 10.1016/j.pneurobio.2012.05.010; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu JL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020191; Liu N, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5249675; Liu YQ, 2002, PEDIATR RES, V51, P25, DOI 10.1203/00006450-200201000-00007; Silveira PCL, 2019, MED ENG PHYS, V71, P108, DOI 10.1016/j.medengphy.2019.05.008; Lu YJ, 2017, NEUROBIOL AGING, V49, P165, DOI 10.1016/j.neurobiolaging.2016.10.003; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Mallard C, 2015, STROKE, V46, P3006, DOI 10.1161/STROKEAHA.115.007776; Martinez-Biarge M, 2011, NEUROLOGY, V76, P2055, DOI 10.1212/WNL.0b013e31821f442d; MCRAE A, 1995, DEV BRAIN RES, V84, P245, DOI 10.1016/0165-3806(94)00177-2; Millar LJ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00078; Mosalli R, 2012, J CLIN NEONATOL, V1, P101, DOI 10.4103/2249-4847.96777; Muntsant A, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00007; Nelson KB, 1998, AM J OBSTET GYNECOL, V179, P507, DOI 10.1016/S0002-9378(98)70387-4; O'Neill LAJ, 2016, CELL REP, V17, P625, DOI 10.1016/j.celrep.2016.09.085; Parker SJ, 2018, J PEDIATR-US, V203, P163, DOI 10.1016/j.jpeds.2018.08.028; Pauly JR, 2008, ACTA PAEDIATR, V97, P1331, DOI 10.1111/j.1651-2227.2008.00852.x; Pegoraro M, 1990, Minerva Cardioangiol, V38, P219; Perez M, 2019, FREE RADICAL BIO MED, V142, P61, DOI 10.1016/j.freeradbiomed.2019.03.035; Pfister RH, 2010, J PERINATOL, V30, pS82, DOI 10.1038/jp.2010.91; Qin XP, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00088; Rhee YH, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0499-3; Salehpour F, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040610; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Serdar M, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00237; Sharma A, 2018, THERANOSTICS, V8, P5529, DOI 10.7150/thno.29039; Sheldon RA, 2019, DEV NEUROSCI-BASEL, V40, P490, DOI 10.1159/000495880; Silachev DN, 2018, MOLECULES, V23; Smith AL, 2014, BRAIN SCI, V4, P240, DOI 10.3390/brainsci4020240; Stetler RA, 2014, PROG NEUROBIOL, V114, P58, DOI 10.1016/j.pneurobio.2013.11.005; Sun JK, 2020, CELL MOL NEUROBIOL, V40, P141, DOI 10.1007/s10571-019-00728-x; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Ten VS, 2003, BEHAV BRAIN RES, V145, P209, DOI 10.1016/S0166-4328(03)00146-3; Teo JD, 2015, PEDIATR RES, V77, P757, DOI 10.1038/pr.2015.47; Tissier R, 2013, RESUSCITATION, V84, P249, DOI 10.1016/j.resuscitation.2012.06.030; Tucker LD, 2018, J MOL NEUROSCI, V65, P514, DOI 10.1007/s12031-018-1121-3; Van den Bossche J, 2016, CELL REP, V17, P684, DOI 10.1016/j.celrep.2016.09.008; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; von Leden RE, 2013, LASER SURG MED, V45, P253, DOI 10.1002/lsm.22133; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wang RM, 2019, MOL NEUROBIOL, V56, P1852, DOI 10.1007/s12035-018-1191-9; Weis SN, 2011, INT J DEV NEUROSCI, V29, P115, DOI 10.1016/j.ijdevneu.2010.12.005; Wickstrom R, 2007, CURR NEUROPHARMACOL, V5, P213, DOI 10.2174/157015907781695955; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Winter R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35474-5; Wu C, 2020, MED SCI SPORTS EXERC; Wu CY, 2018, MED SCI SPORT EXER, V50, P945, DOI 10.1249/MSS.0000000000001519; Yang BC, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.201960117; Yang LD, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00197-z; Yang LD, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201800359; Yang LD, 2018, EXP NEUROL, V299, P86, DOI 10.1016/j.expneurol.2017.10.013; Yang XL, 2010, CARDIOVASC DRUG THER, V24, P225, DOI 10.1007/s10557-010-6236-x; Young K, 2018, JOVE-J VIS EXP, DOI 10.3791/57648; Yu SB, 2018, J MOL BIOL, V430, P3922, DOI 10.1016/j.jmb.2018.07.027; Zhang CY, 2020, THERANOSTICS, V10, P10908, DOI 10.7150/thno.48264; Zhang J, 2018, NEUROCHEM INT, V116, P1, DOI 10.1016/j.neuint.2018.03.004; Zhao NJ, 2017, MOL NEUROBIOL, V54, P4936, DOI 10.1007/s12035-016-0034-9; Zhao YD, 2013, J NEUROSCI RES, V91, P1165, DOI 10.1002/jnr.23247; Zhou KL, 2020, THERANOSTICS, V10, P9280, DOI 10.7150/thno.46566; Zong XM, 2020, TRANSL STROKE RES, V11, P450, DOI 10.1007/s12975-019-00731-w	134	3	3	1	1	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1838-7640			THERANOSTICS	Theranostics		2021	11	3					1269	1294		10.7150/thno.49672			26	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	OV7CN	WOS:000592363200001	33391534	Green Published, gold			2022-02-06	
J	Yoen, H; Yoo, RE; Choi, SH; Kim, E; Oh, BM; Yang, DJ; Hwang, I; Kang, KM; Yun, TJ; Kim, JH; Sohn, CH				Yoen, Heera; Yoo, Roh Eul; Choi, Seung Hong; Kim, Eunkyung; Oh, Byung-Mo; Yang, Dongjin; Hwang, Inpyeong; Kang, Koung Mi; Yun, Tae Jin; Kim, Ji Hoon; Sohn, Chul-Ho			Blood-Brain Barrier Disruption in Mild Traumatic Brain Injury Patients with Post-Concussion Syndrome: Evaluation with Region-Based Quantification of Dynamic Contrast-Enhanced MR Imaging Parameters Using Automatic Whole-Brain Segmentation	KOREAN JOURNAL OF RADIOLOGY			English	Article						Blood-brain barrier; Magnetic resonance imaging; Perfusion; Permeability; Post-concussion syndrome	WHITE-MATTER ABNORMALITIES; DCE-MRI; PERMEABILITY; DYSFUNCTION; SYMPTOMS	Objective: This study aimed to investigate the blood-brain barrier (BBB) disruption in mild traumatic brain injury (mTBI) patients with post-concussion syndrome (PCS) using dynamic contrast-enhanced (DCE) magnetic resonance (MR) imaging and automatic whole brain segmentation. Materials and Methods: Forty-two consecutive mTBI patients with PCS who had undergone post-traumatic MR imaging, including DCE MR imaging, between October 2016 and April 2018, and 29 controls with DCE MR imaging were included in this retrospective study. After performing three-dimensional T1-based brain segmentation with FreeSurfer software (Laboratory for Computational Neuroimaging), the mean Ktrans and vp from DCE MR imaging (derived using the Patlak model and extended Tofts and Kermode model) were analyzed in the bilateral cerebral/cerebellar cortex, bilateral cerebral/cerebellar white matter (WM), and brainstem. Ktrans values of the mTBI patients and controls were calculated using both models to identify the model that better reflected the increased permeability owing to mTBI (tendency toward higher Ktrans values in mTBI patients than in controls). The Mann-Whitney U test and Spearman rank correlation test were performed to compare the mean Ktrans and vp between the two groups and correlate Ktrans and vp with neuropsychological tests for mTBI patients. Results: Increased permeability owing to mTBI was observed in the Patlak model but not in the extended Tofts and Kermode model. In the Patlak model, the mean Ktrans in the bilateral cerebral cortex was significantly higher in mTBI patients than in controls (p = 0.042). The mean vp values in the bilateral cerebellar WM and brainstem were significantly lower in mTBI patients than in controls (p = 0.009 and p = 0.011, respectively). The mean Ktrans of the bilateral cerebral cortex was significantly higher in patients with atypical performance in the auditory continuous performance test (commission errors) than in average or good performers (p = 0.041). Conclusion: BBB disruption, as reflected by the increased Ktrans and decreased vp values from the Patlak model, was observed throughout the bilateral cerebral cortex, bilateral cerebellar WM, and brainstem in mTBI patients with PCS.	[Yoen, Heera; Yoo, Roh Eul; Choi, Seung Hong; Yang, Dongjin; Hwang, Inpyeong; Kang, Koung Mi; Yun, Tae Jin; Kim, Ji Hoon; Sohn, Chul-Ho] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Eunkyung; Oh, Byung-Mo] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Rehabil Med, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Ctr Nanoparticle Res, Inst Basic Sci IBS, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Oh, Byung-Mo] Seoul Natl Univ, Coll Med, Dept Rehabil Med, Seoul, South Korea; [Oh, Byung-Mo] Natl Traff Injury Rehabil Hosp, Yangpyeong, South Korea; [Oh, Byung-Mo] Seoul Natl Univ, Neurosci Res Inst, Coll Med, Seoul, South Korea		Yoo, RE (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, 101 Daehak Ro, Seoul 03080, South Korea.	roheul7@gmail.com	Sohn, ChulHo/AAV-4565-2021; Kim, Ji-hoon/D-5754-2012	Kim, Ji-hoon/0000-0002-6349-6950; Hwang, Inpyeong/0000-0002-1291-8973; Yang, Dongjin/0000-0003-1993-9053; Choi, Seung Hong/0000-0002-0412-2270; Yoen, Heera/0000-0001-5583-6065; Yun, Tae Jin/0000-0001-8441-4574; Kim, Eunkyung/0000-0001-6264-722X; Oh, Byung-Mo/0000-0001-9353-7541			Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cramer SP, 2014, J CEREBR BLOOD F MET, V34, P1655, DOI 10.1038/jcbfm.2014.126; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Heye AK, 2016, NEUROIMAGE, V125, P446, DOI 10.1016/j.neuroimage.2015.10.018; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kim YS, 2019, RADIOLOGY, V292, P713, DOI 10.1148/radiol.2019182566; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kwon JS, 2002, J KOREAN NEUROPSYCHI, V41, P347; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Liu GB, 2015, ACTA RADIOL, V56, P1256, DOI 10.1177/0284185114552883; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Payne-James J, 2015, ENCY FORENSIC LEGAL, V2nd; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Sourbron SP, 2013, NMR BIOMED, V26, P1004, DOI 10.1002/nbm.2940; Taheri S, 2011, STROKE, V42, P2158, DOI 10.1161/STROKEAHA.110.611731; Thornhill RE, 2010, AM J NEURORADIOL, V31, P1015, DOI 10.3174/ajnr.A2003; TODD NV, 1990, ACT NEUR S, V51, P296; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Winter C, 2015, NEUROL RES, V37, P599, DOI 10.1179/1743132815Y.0000000018; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yoo RE, 2019, EUR RADIOL, V29, P1308, DOI 10.1007/s00330-018-5656-z; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yun TJ, 2015, RADIOLOGY, V274, P830, DOI 10.1148/radiol.14132632	38	3	3	3	8	KOREAN RADIOLOGICAL SOC	SEOUL	121-8 YANGJAE-DONG, SEOCHO-GU, SEOUL 137-130, SOUTH KOREA	1229-6929	2005-8330		KOREAN J RADIOL	Korean J. Radiol.	JAN	2021	22	1					118	130		10.3348/kjr.2020.0016			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	PN6CU	WOS:000604565600010	32783413	Green Published			2022-02-06	
J	Yu, J; Zhu, H; Taheri, S; Mondy, W; Perry, S; Kirstein, C; Kindy, MS				Yu, Jin; Zhu, Hong; Taheri, Saeid; Mondy, William; Perry, Stephen; Kirstein, Cheryl; Kindy, Mark S.			Effects of GrandFusion Diet on Cognitive Impairment in Transgenic Mouse Model of Alzheimer's Disease	NUTRIENTS			English	Article						diet; Alzheimer&#8217; s disease; inflammation; behavior; amyloid		Alzheimer's disease (AD) is the result of the deposition of amyloid beta (A beta) peptide into amyloid fibrils and tau into neurofibrillary tangles. At the present time, there are no possible treatments for the disease. We have recently shown that diets enriched in phytonutrients show protection or limit the extent of damage in a number of neurological disorders. GrandFusion (GF) diets have attenuated the outcomes in animal models of traumatic brain injury, cerebral ischemia, and chronic traumatic encephalopathy. In this study, we investigated the effect of GF diets in a mouse model of AD prior to the development of amyloid plaques to show how this treatment paradigm would alter the accumulation of A beta peptide and related pathologic changes (i.e., inflammation, cathepsin B, and memory impairment). Administration of GF diets (2-4%) over a period of four months in APP/Delta PS1 double-transgenic mice resulted in attenuation in A beta peptide levels, reduction of amyloid load, and inflammation, increased cathepsin B expression, and improved spatial orientation. Additionally, treatment with GF diets increased nerve growth factor (NGF) levels in the brain and tempered the memory impairment in the animal model. These data suggest that GF diets may alter the development and progression of the mechanisms associated with the disease process to effectively modify AD pathogenesis.	[Yu, Jin; Zhu, Hong; Taheri, Saeid; Mondy, William; Kindy, Mark S.] Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA; [Perry, Stephen] NutriFusion LLC, Naples, FL 34109 USA; [Kirstein, Cheryl; Kindy, Mark S.] Univ S Florida, Dept Psychol, Coll Arts & Sci, Tampa, FL 33620 USA; [Kindy, Mark S.] James A Haley Vet Adm Med Ctr, Res, Tampa, FL 33612 USA; [Kindy, Mark S.] Shriners Hosp Children, Res, Tampa, FL 33612 USA		Kindy, MS (corresponding author), Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA.; Kindy, MS (corresponding author), Univ S Florida, Dept Psychol, Coll Arts & Sci, Tampa, FL 33620 USA.; Kindy, MS (corresponding author), James A Haley Vet Adm Med Ctr, Res, Tampa, FL 33612 USA.; Kindy, MS (corresponding author), Shriners Hosp Children, Res, Tampa, FL 33612 USA.	jinyu@usf.edu; hongzhu@usf.edu; taheris@usf.edu; wmondy@usf.edu; sperry@consealint.com; kirstein@usf.edu; kindym@usf.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21AG043718, R01 ES016774-01, 1P20GM109091, 2P20GM103444, 5P30GM103342]; VA Merit AwardUS Department of Veterans Affairs [1I01RX001450-01A1]; National Science Foundation (NSF)National Science Foundation (NSF) [IIP-0903795]; AHA SFRNAmerican Heart Association [15SFDRN25710468]	This work was in part supported by funding from the National Institutes of Health (NIH) (R21AG043718, R01 ES016774-01, 1P20GM109091, 2P20GM103444, and 5P30GM103342), VA Merit Award (1I01RX001450-01A1), funding from the National Science Foundation (NSF) (IIP-0903795), and an AHA SFRN (15SFDRN25710468) grant (M.S.K.). Kindy is a Senior Research Career Scientist in the VA. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Akiyama H, 2000, ALZ DIS ASSOC DIS, V14, pS47, DOI 10.1097/00002093-200000001-00008; Alkhouli MF, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2451-6; Atri A, 2019, MED CLIN N AM, V103, P263, DOI 10.1016/j.mcna.2018.10.009; Broom GM, 2019, NUTRITION, V60, P118, DOI 10.1016/j.nut.2018.10.003; Castellani RJ, 2019, LAB INVEST, V99, P958, DOI 10.1038/s41374-019-0231-z; Dennis J, 2013, ANN NEUROL, V74, P328, DOI 10.1002/ana.24001; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Elvington A, 2012, J IMMUNOL, V189, P4640, DOI 10.4049/jimmunol.1201904; Guarino A, 2019, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00437; Hill E, 2019, NEUROBIOL AGING, V76, P45, DOI 10.1016/j.neurobiolaging.2018.12.008; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011585; Hook G, 2014, J ALZHEIMERS DIS, V41, P129, DOI 10.3233/JAD-131370; Hook V, 2010, BIOL CHEM, V391, P861, DOI 10.1515/BC.2010.110; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Hung SY, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0355-7; Imbimbo BP, 2009, EXPERT OPIN INV DRUG, V18, P1147, DOI 10.1517/13543780903066780; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; Li SM, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00005; Liang JH, 2018, CLIN INTERV AGING, V13, P2061, DOI 10.2147/CIA.S184968; Mayeux R, 2010, NEW ENGL J MED, V362, P2194, DOI 10.1056/NEJMcp0910236; Fernandez SSM, 2018, CLIN GERIATR MED, V34, P677, DOI 10.1016/j.cger.2018.06.012; Nordengen K, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1399-2; Olsen I, 2016, J ALZHEIMERS DIS, V54, P45, DOI 10.3233/JAD-160197; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Scarmeas N, 2018, LANCET NEUROL, V17, P1006, DOI 10.1016/S1474-4422(18)30338-7; Selkoe DJ, 2007, NUTR REV, V65, pS239, DOI [10.1111/j.1753-4887.2007.tb00370.x, 10.1301/nr.2007.dec.S239-S243]; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Serrano-Pozo A, 2019, J ALZHEIMERS DIS, V67, P795, DOI 10.3233/JAD181028; Sharma P, 2019, EUR J MED CHEM, V167, P510, DOI 10.1016/j.ejmech.2019.02.030; Solfrizzi V, 2018, NEUROSCI BIOBEHAV R, V95, P480, DOI 10.1016/j.neubiorev.2018.10.022; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Su C, 2019, PSYCHOGERIATRICS, V19, P300, DOI 10.1111/psyg.12403; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yu J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020299; Yu J, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1312-4; Yu J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081101; Yu J, 2017, AGING-US, V9, P1041, DOI 10.18632/aging.101209; Yu J, 2016, NUTR NEUROSCI, V19, P290, DOI 10.1179/1476830515Y.0000000021; Yu J, 2011, J ALZHEIMERS DIS, V25, P295, DOI 10.3233/JAD-2011-101986; Zhang L, 2015, LAB INVEST, V95, P65, DOI 10.1038/labinvest.2014.135	44	3	3	5	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6643		NUTRIENTS	Nutrients	JAN	2021	13	1							117	10.3390/nu13010117			13	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	PW4JP	WOS:000610637700001	33396967	Green Published, gold			2022-02-06	
J	Hunfalvay, M; Murray, NP; Carrick, FR				Hunfalvay, Melissa; Murray, Nicholas P.; Carrick, Frederick Robert			Fixation stability as a biomarker for differentiating mild traumatic brain injury from age matched controls in pediatrics	BRAIN INJURY			English	Article						Eye tracking; fixation; TBI		Objectives: Traumatic brain injury (TBI) is an increasingly significant health concern worldwide, compounded by the difficultly in detection and diagnosis. Fortunately, a growing body of research has identified oculomotor behavior, specifically fixations, saccades and smooth pursuit eye movements as a promising endophenotype for neurotrauma. To date, limited research exists using fixation stability in a comparative study to indicate the presence of a mild TBI (mTBI), especially in the pediatric population.Methods: The present study examined data from 91 individuals clinically diagnosed with mTBI and a further 140 age- and gender-matched controls. They all completed the RightEye fixation stability test using a remote eye tracker. Participants were compared on five fixation metrics: Bivariate Contour Ellipse Area (BCEA), Convergence Point, Depth, Disassociated Phoria, and Targeting Displacement.Results: Results were analyzed using one-way univariate ANOVAs, ROC analysis, and stepwise logistic regression. BCEA results revealed significant differences between groups with the mTBI group showing a larger gaze spread, indicative of less ability to keep the eyes close to the target without deviating.Conclusions: Fixation stability is detrimentally impacted by mTBI in pediatric patients, and the oculomotor test can be used to differentiate between those with and without an mTBI.	[Hunfalvay, Melissa] Righteye, Bethesda, MD USA; [Murray, Nicholas P.] East Carolina Univ, Dept Kinesiol, Greensville, NC 27858 USA; [Carrick, Frederick Robert] Univ Cambridge, Ctr Mental Hlth Res Assoc, Cambridge, England; [Carrick, Frederick Robert] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Carrick, Frederick Robert] MGH Inst Hlth Profess, Boston, MA USA		Murray, NP (corresponding author), East Carolina Univ, Dept Kinesiol, Greensville, NC 27858 USA.	MURRAYNI@ECU.EDU		Carrick, Frederick/0000-0002-2818-6551; Murray, Nicholas/0000-0001-9968-2109; Hunfalvay, Melissa/0000-0002-6770-4956			Amore FM, 2013, OPHTHAL PHYSL OPT, V33, P611, DOI 10.1111/opo.12048; Arbour C, 2016, CRIT CARE MED, V44, pE1186, DOI 10.1097/CCM.0000000000001960; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; BARR W, 2001, JINS, V7; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bedell HE, 2013, VISION RES, V90, P32, DOI 10.1016/j.visres.2013.02.001; Bellmann C, 2004, OPHTHALMOLOGY, V111, P2265, DOI 10.1016/j.ophtha.2004.06.019; BRAHM K, 2019, OPTOM VIS SCI, V86; Cho HJ, 2008, CEREBROVASC DIS, V26, P178, DOI 10.1159/000145325; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Ciuffreda KJ, 2012, OPTOMETRY, V83, P10; Contreras R, 2011, BRAIN RES, V1398, P55, DOI 10.1016/j.brainres.2011.05.004; CROSSLAND M, 2004, OPHTHALMIC PHYSL OPT, V24; Diaz-Arrastia R., 2015, TRAUMATIC BRAIN INJU; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; Duchowski A., 2007, EYE TRACKING METHODO; Fragiotta S, 2018, OPTOMETRY VISION SCI, V95, P384, DOI 10.1097/OPX.0000000000001201; Ghaffarpasand Fariborz, 2013, Bull Emerg Trauma, V1, P135; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Hunfalvay M, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.581819; Hunfalvay Melissa, 2020, Concussion, V5, pCNC69, DOI 10.2217/cnc-2019-0013; Hunfalvay Melissa, 2019, Concussion, V4, pCNC60, DOI 10.2217/cnc-2019-0001; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KELLY J, 1991, JAMA-J AM MED ASSOC, V266; Komogortsev OV, 2013, BEHAV RES METHODS, V45, P203, DOI 10.3758/s13428-012-0234-9; LAND M, 2009, LOOKING ACTING VISIO; Leigh RJ, 2015, NEUROLOGY EYE MOVEME; Lemke S, 2016, OPHTHALMOLOGY, V123, P415, DOI 10.1016/j.ophtha.2015.10.003; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Miller LJ, 1999, ARCH CLIN NEUROPSYCH, V14, P537; Mollenbach E, 2013, J EYE MOVEMENT RES, V6; Morales MU, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.6.6; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Poole A., 2005, ENCY HUMAN COMPUTER; RUTLANDBROWN W, 2006, J HEAD TRAUMA REHAB, V21; SEO S, 2004, ARCH NEUROL-CHICAGO, V61; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tyagi A., VISION DEV REHABIL; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Wong AMF., 2008, EYE MOVEMENT DISORDE	47	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 18	2021	35	2					209	214		10.1080/02699052.2020.1865566		DEC 2020	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QW7IZ	WOS:000604020700001	33356610				2022-02-06	
J	Donders, J; Hayden, A				Donders, Jacobus; Hayden, Ashley			Utility of the D-KEFS color word interference test as an embedded measure of performance validity after traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						Assessment; performance validity; specificity	RESPONSE BIAS; MEMORY TEST; MMPI-2-RF; ISSUES	Objective We sought to determine the accuracy of embedded performance measures for the D-KEFS Color Word Interference Test that were recently proposed by Eglit et al. In particular, we wanted to determine if these indices would be associated with a specificity of at least .90, an Area Under the Curve of at least .70 and a positive likelihood ratio of at least 2. Method: We used logistic regression to investigate how well these indices could distinguish persons with traumatic brain injury (n = 169) who were evaluated within 1-12 months after injury. All participants had been classified on the basis of at least three independent performance validity tests as valid performance (n = 145) or invalid performance (n = 24). Results: None of the three indices that Eglit et al. had proposed as embedded performance measures for the D-KEFS Color Word Interference Test achieved the a priori defined minimally acceptable level of specificity. One of them did meet the criteria for Area Under the Curve as well as positive likelihood ratio. Conclusion: The current results do not support the application of the Eglit et al. embedded performance validity measures for the D-KEFS Color Word Interference Test in the clinical evaluation of patients with traumatic brain injury.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Dept Psychol, 235 Wealthy St SE, Grand Rapids, MI 49503 USA; [Hayden, Ashley] Hope Coll, Dept Psychol, Holland, MI 49423 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Dept Psychol, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	Jacobus.Donders@maryfreebed.com					American Educational Research Association American Psychological Association & National Council on Measurement in Education, 2014, STAND ED PSYCH TEST; Anderson LB, 2017, J CLIN EXP NEUROPSYC, V39, P890, DOI 10.1080/13803395.2016.1277513; Austin PC, 2017, STAT METHODS MED RES, V26, P796, DOI 10.1177/0962280214558972; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Boone K.B., 2013, CLIN PRACTICE FORENS; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Clark LR, 2012, J INT NEUROPSYCH SOC, V18, P118, DOI 10.1017/S1355617711001524; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Edmundson M, 2016, PSYCHOL INJ LAW, V9, P121, DOI 10.1007/s12207-015-9236-0; Eglit GML, 2020, CLIN NEUROPSYCHOL, V34, P332, DOI 10.1080/13854046.2019.1643923; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P155, DOI 10.1007/s12207-019-09356-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Galioto R, 2020, J INT NEUROPSYCH SOC, V26, P1028, DOI 10.1017/S1355617720000466; Golden CJ., 2002, STROOP COLOR WORD TE; Green P., 2004, MED SYMPTOM VALIDITY; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Guise BJ, 2014, J NEUROPSYCHOL, V8, P20, DOI 10.1111/jnp.12002; Hegedish O, 2013, EUR J PSYCHOL ASSESS, V29, P253, DOI 10.1027/1015-5759/a000154; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Johnson-Greene D, 2013, CLIN NEUROPSYCHOL, V27, P148, DOI 10.1080/13854046.2012.733732; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Larrabee GJ, 2019, CLIN NEUROPSYCHOL, V33, P1354, DOI 10.1080/13854046.2019.1614227; Locke DEC, 2008, NEUROREHABILITATION, V23, P273; Martin PK, 2020, CLIN NEUROPSYCHOL, V34, P88, DOI 10.1080/13854046.2019.1637027; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Sherer M, 2015, CLIN NEUROPSYCHOL, V29, P522, DOI 10.1080/13854046.2015.1052763; Smith K, 2014, CLIN NEUROPSYCHOL, V28, P1048, DOI 10.1080/13854046.2014.931465; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Sweet JJ, 2013, BEHAV SCI LAW, V31, P756, DOI 10.1002/bsl.2088; Tarescavage AM, 2013, CLIN NEUROPSYCHOL, V27, P313, DOI 10.1080/13854046.2012.744099; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Whiteside DM, 2019, APPL NEUROPSYCH-ADUL, V26, P472, DOI 10.1080/23279095.2018.1443935; Whiteside DM, 2015, CLIN NEUROPSYCHOL, V29, P788, DOI 10.1080/13854046.2015.1093660	40	3	3	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2020.1861659		DEC 2020	11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	PF9PY	WOS:000599379500001	33327855				2022-02-06	
J	Schindler, AG; Terry, GE; Wolden-Hanson, T; Cline, M; Park, M; Lee, J; Yagi, M; Meabon, JS; Peskind, ER; Raskind, MM; Phillips, PE; Cook, DG				Schindler, Abigail G.; Terry, Garth E.; Wolden-Hanson, Tami; Cline, Marcella; Park, Michael; Lee, Janet; Yagi, Mayumi; Meabon, James S.; Peskind, Elaine R.; Raskind, Murray M.; Phillips, Paul Em; Cook, David G.			Repetitive Blast Promotes Chronic Aversion to Neutral Cues Encountered in the Peri-Blast Environment	JOURNAL OF NEUROTRAUMA			English	Article						blast; post-traumatic stress disorder; stress; traumatic brain injury; veteran	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; SHELL SHOCK; MOUSE MODEL; ACTIVATION; PTSD; TBI	Repetitive mild traumatic brain injury (mTBI) has been called the "signature injury" of military service members in the Iraq and Afghanistan wars and is highly comorbid with post-traumatic stress disorder (PTSD). Correct attribution of adverse blast-induced mTBI and/or PTSD remains challenging. Pre-clinical research using animal models can provide important insight into the mechanisms by which blast produces injury and dysfunction-but only to the degree by which such models reflect the human experience. Avoidance of trauma reminders is a hallmark of PTSD. Here, we sought to understand whether a mouse model of blast reproduces this phenomenon, in addition to blast-induced physical injuries. Drawing on well-established work from the chronic stress and Pavlovian conditioning literature, we hypothesized that even while one is anesthetized during blast exposure, environmental cues encountered in the peri-blast environment could be conditioned to evoke aversion/dysphoria and re-experiencing of traumatic stress. Using a pneumatic shock tube that recapitulates battlefield-relevant open-field blast forces, we provide direct evidence that stress is inherent to repetitive blast exposure, resulting in chronic aversive/dysphoric-like responses to previous blast-paired cues. The results in this report demonstrate that, although both single and repetitive blast exposures produce acute stress responses (weight loss, corticosterone increase), only repetitive blast exposure also results in co-occurring aversive/dysphoric-like stress responses. These results extend appreciation of the highly complex nature of repetitive blast exposure; and lend further support for the potential translational relevance of animal modeling approaches currently used by multiple laboratories aimed at elucidating the mechanisms (both molecular and behavioral) of repetitive blast exposure.	[Schindler, Abigail G.; Terry, Garth E.; Park, Michael; Meabon, James S.; Peskind, Elaine R.; Raskind, Murray M.; Phillips, Paul Em] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Schindler, Abigail G.; Phillips, Paul Em; Cook, David G.] Univ Washington, Grad Program Neurosci, Seattle, WA 98195 USA; [Phillips, Paul Em; Cook, David G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Dept Med, Seattle, WA USA; [Schindler, Abigail G.; Wolden-Hanson, Tami; Cline, Marcella; Lee, Janet; Yagi, Mayumi; Cook, David G.] VA Puget Sound Hlth Care Syst, VA Northwest Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Terry, Garth E.; Meabon, James S.; Peskind, Elaine R.; Raskind, Murray M.] VA Puget Sound Hlth Care Syst, VA Northwest Mental Illness Res Educ & Clin Ctr, Seattle, WA 98108 USA		Schindler, AG (corresponding author), VA Puget Sound Hlth Care Syst, S182,1660 South Columbian Way, Seattle, WA 98108 USA.	aschind@u.washington.edu	Terry, Garth/AAI-2749-2021		Department of Veteran Affairs (VA) Basic Laboratory Research and Development (BLR&D) Career Development AwardUS Department of Veterans Affairs [1IK2BX003258]; VA BLR&D Merit Review Award [5I01BX002311]; VA Clinical Science Research and Development Career Development Award [CX-001787]; VA Rehabilitation Research and Development Service Merit Review Award [B77421]; University of Washington Friends of Alzheimer's Research; UW Royalty Research Fund; VA Northwest Mental Illness Research Education and Clinical Center	This work was supported by Department of Veteran Affairs (VA) Basic Laboratory Research and Development (BLR&D) Career Development Award 1IK2BX003258 (A.G.S.), VA BLR&D Merit Review Award 5I01BX002311 (D.G.C.), VA Clinical Science Research and Development Career Development Award #CX-001787 (G.E.T.), VA Rehabilitation Research and Development Service Merit Review Award #B77421 (E.R.P.), University of Washington Friends of Alzheimer's Research (D.G.C., E.R.P.), UW Royalty Research Fund (D.G.C.), and the VA Northwest Mental Illness Research Education and Clinical Center (J.S.M., M.M.R., E.R.P.).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bonasera SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142906; Bruchas MR, 2010, BRAIN RES, V1314, P44, DOI 10.1016/j.brainres.2009.08.062; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chavkin C, 2006, NEUROPSYCHOPHARMACOL, V31, pS40; Crocq M A, 2000, Dialogues Clin Neurosci, V2, P47; Defense and Veterans Brain Injury Center (DVBIC), 2019, DOD NUMB TRAUM BRAIN; Edwards S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.70; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Gewirtz JC, 2000, LEARN MEMORY, V7, P257, DOI 10.1101/lm.35200; Grimsley JMS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00038; Heinrichs SC, 2004, J PHARMACOL EXP THER, V311, P427, DOI 10.1124/jpet.103.052092; Hendrickson RC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0908-5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jaffe AE, 2019, EUR J PSYCHOTRAUMATO, V10, DOI 10.1080/20008198.2019.1634939; Jaffe AE, 2017, VIOLENCE VICTIMS, V32, P642, DOI 10.1891/0886-6708.VV-D-16-00045; Jones E, 2006, PHILOS T R SOC B, V361, P533, DOI 10.1098/rstb.2006.1814; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kansagara D., 2013, COMPLICATIONS MILD T; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Li SSY, 2014, NEUROBIOL LEARN MEM, V108, P14, DOI 10.1016/j.nlm.2013.05.002; Lin JY, 2017, PHYSIOL BEHAV, V177, P247, DOI 10.1016/j.physbeh.2017.05.010; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mott FW, 1916, LANCET, V1, P441; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Perez-Garcia G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00176; Rawal G, 2017, J TRANSL INTERN MED, V5, P90, DOI 10.1515/jtim-2016-0016; Richter-Levin G, 2019, MOL PSYCHIATR, V24, P1135, DOI 10.1038/s41380-018-0272-5; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Schindler AG, 2010, NEUROPSYCHOPHARMACOL, V35, P1932, DOI 10.1038/npp.2010.67; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Simola N, 2019, NEUROPHARMACOLOGY, V159, DOI 10.1016/j.neuropharm.2018.11.008; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wessa M, 2007, PSYCHOPHYSIOLOGY, V44, pS8	47	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2021	38	7					940	948		10.1089/neu.2020.7061		DEC 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	RI3KN	WOS:000599951800001	33138684	Green Submitted			2022-02-06	
J	Neuss, F; von Podewils, F; Wang, ZI; Susse, M; Zettl, UK; Grothe, M				Neuss, Friederike; von Podewils, Felix; Wang, Zhong Irene; Suesse, Marie; Zettl, Uwe Klaus; Grothe, Matthias			Epileptic seizures in multiple sclerosis: prevalence, competing causes and diagnostic accuracy	JOURNAL OF NEUROLOGY			English	Article						Multiple sclerosis; Epilepsy; Seizures; Comorbidity; Epidemiology	UNPROVOKED SEIZURES; CLASSIFICATION; FREQUENCY; RISK	Background Multiple sclerosis (MS) is accompanied by an increased risk of epileptic seizures, but data with a detailed description of the competing causes are lacking. Methods We aimed to describe a cohort of patients with both MS and epileptic seizures in a retrospective, population-based study. Results We included 59 out of 2285 MS patients who had at least one epileptic seizure. Out of them, 22 had seizures before the diagnosis of MS, whereas epileptic seizures occurred after MS diagnosis in 37 patients, resulting in a total prevalence of epileptic seizures in MS of 2.6%. Competing causes could be found in 50.8% (30/59) of all patients, with 40.9% (9/22) compared to 56.8% (21/37) of the MS patients with seizures before vs after MS diagnosis. The main alternative causes were traumatic brain injury and cerebral ischemia accounting for more than 30% of the patients, with no difference between the subgroups. 33.3% and 55.6% of MS patients with seizures before/after MS diagnosis had documented pathological EEG alterations. Conclusion A remarkable percentage of MS patients with epileptic seizures do have alternative competing causes at the time of the first seizure. A detailed diagnostic setup including patient history, EEG and MRI is recommended in the evaluation and choice for the best treatment.	[Neuss, Friederike; von Podewils, Felix; Suesse, Marie; Grothe, Matthias] Univ Med Greifswald, Dept Neurol, Ferdinand Sauerbruchstr, D-17475 Greifswald, Germany; [Wang, Zhong Irene] Cleveland Clin Fdn, Neurol Inst, Epilepsy Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Zettl, Uwe Klaus] Univ Rostock, Neuroimmunol Sect, Dept Neurol, Rostock, Germany		Grothe, M (corresponding author), Univ Med Greifswald, Dept Neurol, Ferdinand Sauerbruchstr, D-17475 Greifswald, Germany.	matthias.grothe@med.uni-greifswald.de		von Podewils, Felix/0000-0002-3134-8697; Grothe, Matthias/0000-0002-7998-5310	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.. This research received no specific Grant from any funding agency.	Adelow C, 2009, EPILEPSIA, V50, P1094, DOI 10.1111/j.1528-1167.2008.01726.x; Allen AN, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-189; Benjaminsen E, 2017, SEIZURE-EUR J EPILEP, V52, P131, DOI 10.1016/j.seizure.2017.09.022; Burman J, 2017, NEUROLOGY, V89, P2462, DOI 10.1212/WNL.0000000000004740; Calabrese M, 2017, MULT SCLER J, V23, P473, DOI 10.1177/1352458516651502; Calabrese M, 2012, J NEUROL NEUROSUR PS, V83, P49, DOI 10.1136/jnnp-2011-300414; Calabrese M, 2008, J NEUROL, V255, P581, DOI 10.1007/s00415-008-0752-7; Catenoix H, 2011, MULT SCLER J, V17, P96, DOI 10.1177/1352458510382246; Dericioglu N, 1999, SEIZURE-EUR J EPILEP, V8, P152, DOI 10.1053/seiz.1999.0277; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Filippi M, 2019, BRAIN, V142, P1858, DOI 10.1093/brain/awz144; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Gasparini S, 2017, NEUROL SCI, V38, P399, DOI 10.1007/s10072-016-2803-7; KINNUNEN E, 1986, EPILEPSIA, V27, P729, DOI 10.1111/j.1528-1157.1986.tb03602.x; KINNUNEN E, 1984, NEUROLOGY, V34, P457, DOI 10.1212/WNL.34.4.457; Langenbruch L, 2019, J NEUROL, V266, P1789, DOI 10.1007/s00415-019-09332-x; Marrie RA, 2015, MULT SCLER J, V21, P342, DOI 10.1177/1352458514564486; Nye BL, 2015, HEADACHE, V55, P359, DOI 10.1111/head.12536; Olafsson E, 2005, LANCET NEUROL, V4, P627, DOI 10.1016/S1474-4422(05)70172-1; Olafsson E, 1999, EPILEPSIA, V40, P745, DOI 10.1111/j.1528-1157.1999.tb00772.x; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Poser CM, 2003, EPILEPSY BEHAV, V4, P6, DOI 10.1016/S1525-5050(02)00646-7; Rommer PS, 2019, MULT SCLER J, V25, P1641, DOI 10.1177/1352458518799580; Sanai SA, 2016, MULT SCLER J, V22, P717, DOI 10.1177/1352458516634871; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Sokic DV, 2001, EPILEPSIA, V42, P72, DOI 10.1046/j.1528-1157.2001.48699.x; Spatt J, 2001, J NEUROL, V248, P2, DOI 10.1007/s004150170262; Syvertsen M, 2015, EPILEPSIA, V56, P699, DOI 10.1111/epi.12972; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; World Health Organization, 2004, ICD 10 INT STAT CLAS; Xu Y, 2016, SEIZURE-EUR J EPILEP, V41, P167, DOI 10.1016/j.seizure.2016.08.005	32	3	3	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	MAY	2021	268	5					1721	1727		10.1007/s00415-020-10346-z		DEC 2020	7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RR7EJ	WOS:000599109400001	33324995	Green Published, hybrid			2022-02-06	
J	Adil, SM; Elahi, C; Gramer, R; Spears, CA; Fuller, AT; Haglund, MM; Dunn, TW				Adil, Syed M.; Elahi, Cyrus; Gramer, Robert; Spears, Charis A.; Fuller, Anthony T.; Haglund, Michael M.; Dunn, Timothy W.			Predicting the Individual Treatment Effect of Neurosurgery for Patients with Traumatic Brain Injury in the Low-Resource Setting: A Machine Learning Approach in Uganda	JOURNAL OF NEUROTRAUMA			English	Article						individual treatment effect; machine learning; neurosurgery; prognosis; traumatic brain injury	MODELS; PROGNOSIS; SELECTION; SURGERY; HEALTH	Traumatic brain injury (TBI) disproportionately affects low- and middle-income countries (LMICs). In these low-resource settings, effective triage of patients with TBI-including the decision of whether or not to perform neurosurgery-is critical in optimizing patient outcomes and healthcare resource utilization. Machine learning may allow for effective predictions of patient outcomes both with and without surgery. Data from patients with TBI was collected prospectively at Mulago National Referral Hospital in Kampala, Uganda, from 2016 to 2019. One linear and six non-linear machine learning models were designed to predict good versus poor outcome near hospital discharge and internally validated using nested five-fold cross-validation. The 13 predictors included clinical variables easily acquired on admission and whether or not the patient received surgery. Using an elastic-net regularized logistic regression model (GLMnet), with predictions calibrated using Platt scaling, the probability of poor outcome was calculated for each patient both with and without surgery (with the difference quantifying the "individual treatment effect," ITE). Relative ITE represents the percent reduction in chance of poor outcome, equaling this ITE divided by the probability of poor outcome with no surgery. Ultimately, 1766 patients were included. Areas under the receiver operating characteristic curve (AUROCs) ranged from 83.1% (single C5.0 ruleset) to 88.5% (random forest), with the GLMnet at 87.5%. The two variables promoting good outcomes in the GLMnet model were high Glasgow Coma Scale score and receiving surgery. For the subgroup not receiving surgery, the median relative ITE was 42.9% (interquartile range [IQR], 32.7% to 53.5%); similarly, in those receiving surgery, it was 43.2% (IQR, 32.9% to 54.3%). We provide the first machine learning-based model to predict TBI outcomes with and without surgery in LMICs, thus enabling more effective surgical decision making in the resource-limited setting. Predicted ITE similarity between surgical and non-surgical groups suggests that, currently, patients are not being chosen optimally for neurosurgical intervention. Our clinical decision aid has the potential to improve outcomes.	[Adil, Syed M.; Elahi, Cyrus; Gramer, Robert; Spears, Charis A.; Fuller, Anthony T.; Haglund, Michael M.; Dunn, Timothy W.] Duke Univ, Med Ctr, Div Global Neurosurg & Neurol, Durham, NC USA; [Dunn, Timothy W.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA; [Dunn, Timothy W.] Duke Univ, Med Ctr, Dept Stat Sci, Durham, NC USA; [Fuller, Anthony T.; Haglund, Michael M.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA		Dunn, TW (corresponding author), Duke Univ, Med Ctr, Davison Bldg,Room 427,40 Duke Med Circle, Durham, NC 27710 USA.	timothy.dunn@duke.edu					Abdelgadir J, 2018, J CLIN NEUROSCI, V47, P79, DOI 10.1016/j.jocn.2017.10.004; Amorim RL, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01366; [Anonymous], 2019, R LANG ENV STAT COMP; Buchlak QD, 2020, NEUROSURG REV, V43, P1235, DOI 10.1007/s10143-019-01163-8; Chattopadhyay A., 2019, ICML, P981; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Corley J, 2019, WORLD NEUROSURG, V123, P295, DOI 10.1016/j.wneu.2018.12.042; Darcy AM, 2016, JAMA-J AM MED ASSOC, V315, P551, DOI 10.1001/jama.2015.18421; Desautels T, 2017, BIOMED INFORM INSIGH, V9, DOI 10.1177/1178222617712994; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Eisinga R, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1486-2; Haglund MM, 2019, J NEUROSURG, V131, P993, DOI 10.3171/2019.4.JNS181747; Haglund MM, 2017, NEUROSURGERY, V80, P656, DOI 10.1093/neuros/nyw159; JENNETT B, 1975, LANCET, V1, P480; Lee JD, 2016, ANN STAT, V44, P907, DOI 10.1214/15-AOS1371; Lu M, 2018, J COMPUT GRAPH STAT, V27, P209, DOI 10.1080/10618600.2017.1356325; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; Matsuo K, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6276; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Raj R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53889-6; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rocha TAH, 2020, J NEUROSURG, V132, P1961, DOI 10.3171/2019.2.JNS182098; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Senders JT, 2018, NEUROSURGERY, V83, P181, DOI 10.1093/neuros/nyx384; Senders JT, 2018, WORLD NEUROSURG, V109, P476, DOI 10.1016/j.wneu.2017.09.149; Shalit U., 2017, ESTIMATING INDIVIDUA, V25, P2020; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Steyerberg EW, 2018, J CLIN EPIDEMIOL, V103, P131, DOI 10.1016/j.jclinepi.2018.07.010; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Tropeano MP, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19507; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Calster B, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1466-7; Walsh CG, 2017, J BIOMED INFORM, V76, P9, DOI 10.1016/j.jbi.2017.10.008; Weiss Jeremy, 2015, AMIA Annu Symp Proc, V2015, P1306; Weiss P, 2020, ADV MATER TECHNOL-US, V5, DOI 10.1002/admt.202000028; who.int, 2014, UG HOSP HLTH CTR 4 C, V25, P2020; WHO. World Health Organization, 2018, GLOBAL STATUS REPORT; Winters N, 2020, J MED ETHICS, V46, P259, DOI 10.1136/medethics-2019-105468; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	46	3	3	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2021	38	7					928	939		10.1089/neu.2020.7262		DEC 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RI3KN	WOS:000599320500001	33054545				2022-02-06	
J	Walsh, DR; Lynch, JJ; O' Connor, DT; Newport, DT; Mulvihill, JJE				Walsh, Darragh R.; Lynch, James J.; O' Connor, David T.; Newport, David T.; Mulvihill, John J. E.			Mechanical and structural characterisation of the dural venous sinuses	SCIENTIFIC REPORTS			English	Article							SUPERIOR SAGITTAL SINUS; TRAUMATIC BRAIN-INJURY; BRIDGING VEINS; BIOMECHANICAL PROPERTIES; TISSUE; HEAD; BEHAVIOR; ANATOMY; QUANTIFICATION; ADOLESCENT	The dural venous sinuses play an integral role in draining venous blood from the cranial cavity. As a result of the sinuses anatomical location, they are of significant importance when evaluating the mechanopathology of traumatic brain injury (TBI). Despite the importance of the dural venous sinuses in normal neurophysiology, no mechanical analyses have been conducted on the tissues. In this study, we conduct mechanical and structural analysis on porcine dural venous sinus tissue to help elucidate the tissues' function in healthy and diseased conditions. With longitudinal elastic moduli values ranging from 33 to 58 MPa, we demonstrate that the sinuses exhibit higher mechanical stiffness than that of native dural tissue, which may be of interest to the field of TBI modelling. Furthermore, by employing histological staining and a colour deconvolution protocol, we show that the sinuses have a collagen-dominant extracellular matrix, with collagen area fractions ranging from 84 to 94%, which likely explains the tissue's large mechanical stiffness. In summary, we provide the first investigation of the dural venous sinus mechanical behaviour with accompanying structural analysis, which may aid in understanding TBI mechanopathology.	[Walsh, Darragh R.; Lynch, James J.; O' Connor, David T.; Newport, David T.; Mulvihill, John J. E.] Univ Limerick, Bernal Inst, Limerick, Ireland; [Walsh, Darragh R.; Lynch, James J.; O' Connor, David T.; Newport, David T.; Mulvihill, John J. E.] Univ Limerick, Sch Engn, Limerick, Ireland; [O' Connor, David T.; Mulvihill, John J. E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland		Mulvihill, JJE (corresponding author), Univ Limerick, Bernal Inst, Limerick, Ireland.; Mulvihill, JJE (corresponding author), Univ Limerick, Sch Engn, Limerick, Ireland.; Mulvihill, JJE (corresponding author), Univ Limerick, Hlth Res Inst, Limerick, Ireland.	john.mulvihill@ul.ie			Irish Research CouncilIrish Research Council for Science, Engineering and Technology [GOIPG/2017/1816]	Fundng was provided by the Irish Research Council (Grant No. GOIPG/2017/1816).	Akintunde AR, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4042014; ANDREWS BT, 1989, NEUROSURGERY, V24, P514, DOI 10.1227/00006123-198904000-00005; Anssari-Benam A, 2012, J BIOMECH, V45, P2481, DOI 10.1016/j.jbiomech.2012.07.016; Arsalan M, 2017, EUR HEART J, V38, P634, DOI 10.1093/eurheartj/ehv487; Assoul N, 2008, J BIOMECH, V41, P2227, DOI 10.1016/j.jbiomech.2008.04.017; Aydin HE, 2019, J KOREAN NEUROSURG S, V62, P382, DOI 10.3340/jkns.2018.0130; Baker MD, 2001, NEUROSURGERY, V48, P487, DOI 10.1097/00006123-200103000-00005; Balik V, 2019, OPER NEUROSURG, V17, P88, DOI 10.1093/ons/opy287; Bayarogullari H, 2018, CHILD NERV SYST, V34, P1183, DOI 10.1007/s00381-018-3763-4; Behera Sanjay K, 2015, Asian J Neurosurg, V10, P17, DOI 10.4103/1793-5482.151503; Brockmann C, 2012, CLIN IMAG, V36, P85, DOI 10.1016/j.clinimag.2011.05.003; Capone DJ, 2019, J BIOMECH, V82, P299, DOI 10.1016/j.jbiomech.2018.11.001; Caro-Bretelle AS, 2015, J BIOMECH, V48, P3135, DOI 10.1016/j.jbiomech.2015.07.014; CHAN PDS, 1995, J NEUROSURG, V83, P522, DOI 10.3171/jns.1995.83.3.0522; Chen Y, 2017, INT J CLIN EXP MED, V10, P14927; Clark GL, 2019, INTERFACE FOCUS, V9, DOI 10.1098/rsfs.2019.0025; Converse MI, 2018, ACTA BIOMATER, V67, P307, DOI 10.1016/j.actbio.2017.11.052; Cooney GM, 2015, J MECH BEHAV BIOMED, V41, P68, DOI 10.1016/j.jmbbm.2014.09.026; CURE JK, 1994, SEMIN ULTRASOUND CT, V15, P499, DOI 10.1016/S0887-2171(05)80019-8; Davidson AS, 2011, J CLIN NEUROSCI, V18, P464, DOI 10.1016/j.jocn.2010.12.004; Davis NF, 2018, UROLOGY, V113, P235, DOI 10.1016/j.urology.2017.11.028; de Bruijn SFTM, 2001, J NEUROL NEUROSUR PS, V70, P105, DOI 10.1136/jnnp.70.1.105; De Kegel D, 2018, J MECH BEHAV BIOMED, V79, P122, DOI 10.1016/j.jmbbm.2017.12.023; Delye Hans, 2006, Stapp Car Crash J, V50, P625; Dolan EB, 2017, J MECH BEHAV BIOMED, V71, P23, DOI 10.1016/j.jmbbm.2017.02.012; Egemen E., 2017, PRIMER CEREBROVASCUL, VSecond, P32; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Habib CA, 2013, J MAGN RESON IMAGING, V38, P641, DOI 10.1002/jmri.24003; Hamedani BA, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-59; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hoefer IE, 2013, CARDIOVASC RES, V99, P276, DOI 10.1093/cvr/cvt089; Hoffmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092990; Horie K, 2018, J ENDOVASC THER, V25, P683, DOI 10.1177/1526602818799733; Kashi AM, 2014, GALEN MED J, V3, P63; Khanafer K, 2013, EUR J VASC ENDOVASC, V45, P332, DOI 10.1016/j.ejvs.2012.12.015; Kimber J, 2002, QJM-INT J MED, V95, P137, DOI 10.1093/qjmed/95.3.137; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Li WG, 2018, PROG BIOPHYS MOL BIO, V133, P56, DOI 10.1016/j.pbiomolbio.2017.11.004; Liao WH, 2015, NEURORADIOL J, V28, P177, DOI 10.1177/1971400915576633; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; MacManus DB, 2017, ACTA BIOMATER, V57, P384, DOI 10.1016/j.actbio.2017.05.022; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Maxeiner H, 1997, FORENSIC SCI INT, V89, P103, DOI 10.1016/S0379-0738(97)00124-2; McGilvray KC, 2010, J BIOMECH, V43, P2941, DOI 10.1016/j.jbiomech.2010.07.012; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Amato MCM, 2016, J NEUROSURG, V125, P494, DOI 10.3171/2015.6.JNS15584; Mortazavi M. M, 2020, ANATOMY, P231; Muller-Schweinitzer E, 2009, ORGANOGENESIS, V5, P97, DOI 10.4161/org.5.3.9495; Mulvihill JJ, 2013, ACTA BIOMATER, V9, P9027, DOI 10.1016/j.actbio.2013.07.012; Mulvihill JJ, 2013, BIOMECH MODEL MECHAN, V12, P975, DOI 10.1007/s10237-012-0457-9; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Pasquesi SA, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00016; Pasquesi SA, 2017, ANN BIOMED ENG, V45, P1877, DOI 10.1007/s10439-017-1833-5; Patchana T, 2019, CUREUS, V11, DOI 10.7759/cureus.4597; Protasoni M, 2011, J NEUROSURG, V114, P1723, DOI 10.3171/2010.12.JNS101732; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; ROLAND J, 1987, SURG RADIOL ANAT, V9, P43, DOI 10.1007/BF02116853; Ruifrok AC, 2003, APPL IMMUNOHISTO M M, V11, P85, DOI 10.1097/00022744-200303000-00014; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sangiorgi S, 2005, ANN ANAT, V187, P13, DOI 10.1016/j.aanat.2004.06.001; Schmidt V., 2015, COMP ANATOMY PIG BRA; Scott GG, 2016, BIOMECH MODEL MECHAN, V15, P1101, DOI 10.1007/s10237-015-0747-0; Scott GG, 2015, IEEE T MED IMAGING, V34, P1452, DOI 10.1109/TMI.2015.2396527; Shazly T, 2015, EXP MECH, V55, P41, DOI 10.1007/s11340-014-9910-2; Silver FH, 2003, ANN BIOMED ENG, V31, P793, DOI 10.1114/1.1581287; Sindou M, 2000, ADV TECH STAND NEUR, V26, P131; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Tubbs R.S., 2020, ANATOMY, P9; van Noort R, 1981, Clin Phys Physiol Meas, V2, P197, DOI 10.1088/0143-0815/2/3/003; Walsh DR, 2018, ACTA BIOMATER, V80, P237, DOI 10.1016/j.actbio.2018.09.004; Walsh MT, 2014, J BIOMECH, V47, P793, DOI 10.1016/j.jbiomech.2014.01.017; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zhou B, 2016, JOVE, V1, P53625; ZOUAOUI A, 1988, ACTA ANAT, V133, P318; Zwirner J, 2019, J MECH BEHAV BIOMED, V96, P38, DOI 10.1016/j.jmbbm.2019.04.035; Zwirner J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52836-9	83	3	3	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	DEC 10	2020	10	1							21763	10.1038/s41598-020-78694-4			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PU3HK	WOS:000609195000119	33303894	Green Published, gold			2022-02-06	
J	Balasubramanian, N; Sagarkar, S; Jadhav, M; Shahi, N; Sirmaur, R; Sakharkar, AJ				Balasubramanian, Nagalakshmi; Sagarkar, Sneha; Jadhav, Meha; Shahi, Navneet; Sirmaur, Richa; Sakharkar, Amul J.			Role for Histone Deacetylation in Traumatic Brain Injury-Induced Deficits in Neuropeptide Y in Arcuate Nucleus: Possible Implications in Feeding Behavior	NEUROENDOCRINOLOGY			English	Article						Histone deacetylases; Neuropeptide Y; Arcuate nucleus; Food intake; cAMP response element-binding protein-binding protein	ANXIETY-LIKE; STRESS; MODEL; ACETYLATION; NPY; AMYGDALA; HYPOTHALAMUS; DYSFUNCTION; EXPRESSION; DISORDERS	Introduction: Repeated traumatic events result in long-lasting neuropsychiatric ailments, including neuroendocrine imbalances. Neuropeptide Y (NPY) in the arcuate nucleus (Arc) is an important orexigenic peptide. However, the molecular underpinnings of its dysregulation owing to traumatic brain injury remain unknown. Methods: Rats were subjected to repeated mild traumatic brain injury (rMTBI) using the closed head weight-drop model. Feeding behavior and the regulatory epigenetic parameters of NPY expression were measured at 48 h and 30 days post-rMTBI. Further, sodium butyrate (SB), a pan-histone deacetylase (HDAC) inhibitor, was administered to examine whether histone deacetylation is involved in NPY expression post-rMTBI. Results: The rMTBI attenuated food intake, which was coincident with a decrease in NPY mRNA and protein levels in the Arc post-rMTBI. Further, rMTBI also reduced the mRNA levels of the cAMP response element-binding protein (CREB) and CREB-binding protein (CBP) and altered the mRNA levels of the various isoforms of the HDACs. Concurrently, the acetylated histone 3-lysine 9 (H3-K9) levels and the binding of CBP at the NPY promoter in the Arc of the rMTBI-exposed rats were reduced. However, the treatment with SB corrected the rMTBI-induced deficits in the H3-K9 acetylation levels and CBP occupancy at the NPY promoter, restoring both NPY expression and food intake. Conclusions: These findings suggest that histone deacetylation at the NPY promoter persistently controls NPY function in the Arc after rMTBI. This study also demonstrates the efficacy of HDAC inhibitors in mitigating trauma-induced neuroendocrine maladaptations in the hypothalamus.	[Balasubramanian, Nagalakshmi; Sagarkar, Sneha; Jadhav, Meha; Shahi, Navneet; Sirmaur, Richa; Sakharkar, Amul J.] Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India; [Sagarkar, Sneha] Savitribai Phule Pune Univ, Dept Zool, Pune, Maharashtra, India		Sakharkar, AJ (corresponding author), Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India.	amul.sakharkar@unipune.ac.in		Jadhav, Meha/0000-0002-8898-1434	University Grants Commission (UGC), government of India (GOI) [F.4-5/151FRP/2014/BSR]; Science and Engineering Research Board (SERB), GOI [EMR/2017/000621]; Council for Scientific and Industrial Research (CSIR), GOI [37 [1718]/18/EMR-II]; DST INSPIRE-Faculty Program [DST/INSPIRE/04/2018/000529]; UGC, GOI for the award of a Senior Research Fellowship (UGC-SRF) [2061330923]; Rashtriya Uchchatar Shiksha Abhiyan (RUSA), GOI	This work was supported by grants from the University Grants Commission (UGC), government of India (GOI) (F.4-5/151FRP/2014/BSR), Science and Engineering Research Board (SERB), GOI (EMR/2017/000621), Council for Scientific and Industrial Research (CSIR), GOI (37 [1718]/18/EMR-II), and Rashtriya Uchchatar Shiksha Abhiyan (RUSA), GOI to AJS. SS acknowledges financial support through the DST INSPIRE-Faculty Program DST/INSPIRE/04/2018/000529). NB thanks UGC, GOI for the award of a Senior Research Fellowship (UGC-SRF; file no. 2061330923).	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Bannon AW, 2000, BRAIN RES, V868, P79, DOI 10.1016/S0006-8993(00)02285-X; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bonnavion P, 2016, J PHYSIOL-LONDON, V594, P6443, DOI 10.1113/JP271946; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Carr JA, 2002, INTEGR COMP BIOL, V42, P582, DOI 10.1093/icb/42.3.582; Castano B, 2010, NEUROREHABILITATION, V27, P113, DOI 10.3233/NRE-2010-0586; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Chen YM, 2019, ELIFE, V8, DOI 10.7554/eLife.46348; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cifani C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00187; Comeras LB, 2019, ANN NY ACAD SCI, V1455, P59, DOI 10.1111/nyas.14179; Das A, 2017, INDIAN J PSYCHOL MED, V39, P205, DOI 10.4103/0253-7176.203112; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Dreer LE, 2018, J HEAD TRAUMA REHAB, V33, P246, DOI 10.1097/HTR.0000000000000408; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fujii M, 1998, BRAIN INJURY, V12, P709, DOI 10.1080/026990598122278; Funato H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018950; Gehlert DR, 1999, NEUROPEPTIDES, V33, P329, DOI 10.1054/npep.1999.0057; HANSON ES, 1995, J NEUROENDOCRINOL, V7, P273, DOI 10.1111/j.1365-2826.1995.tb00757.x; Henson Martha B., 1993, Brain Injury, V7, P169, DOI 10.3109/02699059309008170; Hsieh YS, 2007, AM J PHYSIOL-ENDOC M, V292, pE123, DOI 10.1152/ajpendo.00195.2006; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Kabra DG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10782; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kim H, 2003, BRAIN RES, V983, P201, DOI 10.1016/S0006-8993(03)03087-7; Kokare DM, 2017, INT J NEUROPSYCHOPH, V20, P758, DOI 10.1093/ijnp/pyx041; Kokare DM, 2006, NEUROPHARMACOLOGY, V50, P16, DOI 10.1016/j.neuropharm.2005.07.019; Kormos V, 2013, NEUROPEPTIDES, V47, P401, DOI 10.1016/j.npep.2013.10.014; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Langley B, 2009, STROKE, V40, P2899, DOI 10.1161/STROKEAHA.108.540229; Laukova M, 2014, ENDOCRINOLOGY, V155, P3920, DOI 10.1210/en.2014-1192; LEWIN J, 1992, Brain Injury, V6, P199, DOI 10.3109/02699059209029660; Loh K, 2015, TRENDS ENDOCRIN MET, V26, P125, DOI 10.1016/j.tem.2015.01.003; Lomazzo E, 2017, NEUROPHARMACOLOGY, V113, P301, DOI 10.1016/j.neuropharm.2016.10.008; Melas PA, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.31; Mendez-Couz M, 2021, BEHAV BRAIN RES, V396, DOI 10.1016/j.bbr.2020.112864; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Miller SC, 2015, OCCUP ENVIRON MED, V72, P560, DOI 10.1136/oemed-2014-102646; Moreno CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166381; MYCHASIUK R, 2014, JOVE-J VIS EXP, V94, DOI [10.3791/51820, DOI 10.3791/51820]; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; Pandey SC, 2004, J NEUROSCI, V24, P5022, DOI 10.1523/JNEUROSCI.5557-03.2004; Pandey SC, 2008, J NEUROSCI, V28, P2589, DOI 10.1523/JNEUROSCI.4752-07.2008; Quirk SE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-175; Reddy Doodipala Samba, 2018, Curr Protoc Pharmacol, V81, pe41, DOI 10.1002/cpph.41; Reichmann F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28182; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Sagarkar S, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13074; Sagarkar S, 2019, BRAIN RES, V1711, P183, DOI 10.1016/j.brainres.2019.01.022; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Sah R, 2013, MOL PSYCHIATR, V18, P646, DOI 10.1038/mp.2012.101; Sakharkar AJ, 2019, NEUROPHARMACOLOGY, V157, DOI 10.1016/j.neuropharm.2019.107679; Sakharkar AJ, 2016, BRAIN STRUCT FUNCT, V221, P4691, DOI 10.1007/s00429-016-1196-y; Sakharkar AJ, 2014, INT J NEUROPSYCHOPH, V17, P1207, DOI 10.1017/S1461145714000054; Sakharkar AJ, 2012, ALCOHOL CLIN EXP RES, V36, P61, DOI 10.1111/j.1530-0277.2011.01581.x; Schmeltzer SN, 2016, EXP NEUROL, V284, P196, DOI 10.1016/j.expneurol.2016.06.020; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Shimizu-Albergine M, 2001, J NEUROSCI, V21, P1238; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Suchecki D, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00210; Tai YT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/980657; Taksande BG, 2011, BRIT J PHARMACOL, V164, P704, DOI 10.1111/j.1476-5381.2011.01484.x; Tan CMJ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01281; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Trummer M, 2002, ACTA NEUROCHIR, V144, P797, DOI 10.1007/s00701-002-0934-5; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Volmar CH., 2015, NEUROEPIGENETICS, V1, P20, DOI DOI 10.1016/J.NEPIG.2014.10.002; Wang B, 2010, ARTERIOSCL THROM VAS, V30, P536, DOI 10.1161/ATVBAHA.109.193821; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; West TA, 2014, J FAM PRACTICE, V63, P11; Wilkinson Charles W, 2012, Front Neurol, V3, P11, DOI 10.3389/fneur.2012.00011; Wu J, 2017, MOL MED REP, V16, P1846, DOI 10.3892/mmr.2017.6840; Xie L, 2013, J NEUROCHEM, V125, P457, DOI 10.1111/jnc.12210; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu JY, 2018, FOLIA NEUROPATHOL, V56, P179, DOI 10.5114/fn.2018.78697; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yang WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32987; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang L, 2019, ENDOCRINOLOGY, V160, P1411, DOI 10.1210/en.2019-00056; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	87	3	3	3	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-3835	1423-0194		NEUROENDOCRINOLOGY	Neuroendocrinology	NOV	2021	111	12					1187	1200		10.1159/000513638		DEC 2020	14	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	XK8DZ	WOS:000699994700001	33291119				2022-02-06	
J	Liu, LY; Bush, WS; Koyuturk, M; Karakurt, G				Liu, Larry Y.; Bush, William S.; Koyuturk, Mehmet; Karakurt, Gunnur			Interplay between traumatic brain injury and intimate partner violence: data driven analysis utilizing electronic health records	BMC WOMENS HEALTH			English	Article						Electronic health records; Intimate partner violence; Traumatic brain injury; Domestic violence; Cohort study; Blunt force; Data mining	DOMESTIC VIOLENCE; HEAD-INJURY; ALCOHOL-USE; THROMBOCYTOPENIA; MECHANISM; NEED	Background It is estimated that a majority of intimate partner violence (IPV) victims suffer from blunt force to the head, neck and the face area. Injuries to head and neck are among the major causes for traumatic brain injury (TBI). Methods In this interdisciplinary study, we aimed to characterize the key associations between IPV and TBI by mining de-identified electronic health records data with more than 12 M records between 1999 to 2017 from the IBM Explorys platform. For this purpose, we formulated a data-driven analytical framework to identify significant health correlates among IPV, TBI and six control cohorts. Using this framework, we assessed the co-morbidity, shared prevalence, and synergy between pairs of conditions. Results Our findings suggested that health effects attributed to malnutrition, acquired thrombocytopenia, post-traumatic wound infection, local infection of wound, poisoning by cardiovascular drug, alcoholic cirrhosis, alcoholic fatty liver, and drug-induced cirrhosis were highly significant at the joint presence of IPV and TBI. Conclusion To develop a better understanding of how IPV is related to negative health effects, it is potentially useful to determine the interactions and relationships between symptom categories. Our results can potentially improve the accuracy and confidence of existing clinical screening techniques on determining IPV-induced TBI diagnoses.	[Liu, Larry Y.] Case Western Reserve Univ, Syst Biol & Bioinformat Program, Cleveland, OH 44106 USA; [Bush, William S.] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Koyuturk, Mehmet] Case Western Reserve Univ, Dept Comp & Data Sci, Cleveland, OH 44106 USA; [Karakurt, Gunnur] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA		Karakurt, G (corresponding author), Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA.	gkk6@case.edu		Karakurt, Gunnur/0000-0003-1983-4518	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-LM012518]; National Libraries of Medicine	This study was supported in part by US National Institutes of Health Grant R01-LM012518 from the National Libraries of Medicine.	Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Black MC, 2011, AM J LIFESTYLE MED, V5, P428, DOI 10.1177/1559827611410265; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Brain Injury Association of America, 2020, BRAIN INJ BRAIN INJ; Breiding MJ., 2015, INTIMATE PARTNER VIO; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Cheng CY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001468; Choonthar MM, 2016, J CLIN DIAGN RES, V10, pZE1, DOI 10.7860/JCDR/2016/16112.7122; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Erdos B, 2015, AM J PHYSIOL-HEART C, V309, pH634, DOI 10.1152/ajpheart.00207.2015; Higgins D, 2015, J PRIM HEALTH CARE, V7, P102, DOI 10.1071/HC15102; Hill E, 2019, MULT SCLER RELAT DIS, V28, P69, DOI 10.1016/j.msard.2018.12.012; IBM Explorys Analytics & Informatics, 2017, IBM EXPL SEC DAT PRO; IVANY A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI DOI 10.1097/FCH.0000000000000094; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P434; Karakurt G, 2017, J FAM VIOLENCE, V32, P79, DOI 10.1007/s10896-016-9872-5; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kaysen D, 2007, ADDICT BEHAV, V32, P1272, DOI 10.1016/j.addbeh.2006.09.007; Klostermann KC, 2006, AGGRESS VIOLENT BEH, V11, P587, DOI 10.1016/j.avb.2005.08.008; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Leland K, 2008, AM J EPIDEMIOL, V167, P1186; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; MCCRAE KR, 1992, BLOOD, V80, P2697; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Niemela M, 2014, GEN HOSP PSYCHIAT, V36, P337, DOI 10.1016/j.genhosppsych.2013.12.012; Overstreet NM, 2013, BASIC APPL SOC PSYCH, V35, P109, DOI 10.1080/01973533.2012.746599; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Rodrigo AH, 2016, SOC COGN AFFECT NEUR, V11, P55, DOI 10.1093/scan/nsv091; Saukko P, 2004, KNIGHTS FORENSIC PAT, DOI [10.1201/b13642, DOI 10.1201/B13642]; Sauvageau A, 2010, J FORENSIC SCI, V55, P1259, DOI 10.1111/j.1556-4029.2010.01459.x; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; Silva Anderson Soares da, 2006, Acta Cir. Bras., V21, P79, DOI 10.1590/S0102-86502006000700018; Smith S. G., 2018, NATL INTIMATE PARTNE; Suffla S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-363; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; TEASDALE G, 1974, LANCET, V2, P81; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Whiting K, 2017, BIOCOMPUT-PAC SYM, P324, DOI 10.1142/9789813207813_0031; [吴俭 Wu Jian], 2018, [环境监测管理与技术, The Administration and Technique of Environmental Monitoring], V30, P1; Zilberman ML, 2005, REV BRAS PSIQUIATR, V27, pS51, DOI 10.1590/S1516-44462005000600004	42	3	3	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6874		BMC WOMENS HEALTH	BMC Womens Health	DEC 7	2020	20	1							269	10.1186/s12905-020-01104-4			16	Public, Environmental & Occupational Health; Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Obstetrics & Gynecology	PD8RH	WOS:000597944700002	33287806	gold, Green Published			2022-02-06	
J	Biesterveld, B; Pumiglia, L; Iancu, A; Shamshad, AA; Remmer, HA; Siddiqui, AZ; O'Connell, RL; Wakam, GK; Kemp, MT; Williams, AM; Pai, MP; Alam, HB				Biesterveld, Ben E.; Pumiglia, Luke; Iancu, Ariella; Shamshad, Alizeh A.; Remmer, Henriette A.; Siddiqui, Ali Z.; O'Connell, Rachel L.; Wakam, Glenn K.; Kemp, Michael T.; Williams, Aaron M.; Pai, Manjunath P.; Alam, Hasan B.			Valproic acid treatment rescues injured tissues after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						VPA; TBI; histone deacetylase; HDACI; swine	TRANSCRIPTOMIC CHANGES; EXPRESSION PROFILES; PORCINE MODEL; LESION SIZE; RESUSCITATION; PROTEOME; SERUM; GFAP	BACKGROUND No agents that are specifically neuroprotective are currently approved to emergently treat patients with traumatic brain injury (TBI). The histone deacetylase inhibitor, high-dose valproic acid (VPA) has been shown to have cytoprotective potential in models of combined TBI and hemorrhagic shock, but it has not been tested in an isolated TBI model. We hypothesized that VPA, administered after isolated TBI, will penetrate the injured brain, attenuate the lesion size, and activate prosurvival pathways. METHODS Yorkshire swine were subjected to severe TBI by cortical impact. One hour later, animals were randomized to VPA treatment (150 mg/kg delivered intravenously for 1 hour; n = 4) or control (saline vehicle; n = 4) groups. Seven hours after injury, animals were sacrificed, and brain lesion size was measured. Mass spectrometry imaging was used to visualize and quantitate brain tissue distribution of VPA. Sequential serum samples were assayed for key biomarkers and subjected to proteomic and pathway analysis. RESULTS Brain lesion size was 50% smaller (p = 0.01) in the VPA-treated animals (3,837 +/- 948 mm(3)) compared with the controls (1,900 +/- 614 mm(3)). Endothelial regions had eightfold higher VPA concentrations than perivascular regions by mass spectrometry imaging, and it readily penetrated the injured brain tissues. Serum glial fibrillary acid protein was significantly lower in the VPA-treated compared with the control animals (p < 0.05). More than 500 proteins were differentially expressed in the brain, and pathway analysis revealed that VPA affected critical modulators of TBI response including calcium signaling pathways, mitochondria metabolism, and biosynthetic machinery. CONCLUSION Valproic acid penetrates injured brain tissues and exerts neuroprotective and prosurvival effects that resulted in a significant reduction in brain lesion size after isolated TBI. Levels of serum biomarkers reflect these changes, which could be useful for monitoring the response of TBI patients during clinical studies.	[Biesterveld, Ben E.; Pumiglia, Luke; Iancu, Ariella; Shamshad, Alizeh A.; Remmer, Henriette A.; Siddiqui, Ali Z.; O'Connell, Rachel L.; Wakam, Glenn K.; Kemp, Michael T.; Williams, Aaron M.; Pai, Manjunath P.; Alam, Hasan B.] Univ Michigan, Dept Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Remmer, Henriette A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Pai, Manjunath P.] Univ Michigan, Dept Clin Pharm, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan, Dept Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Biesterveld, Ben/AAM-1087-2021		National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM130010]; Joyce and Don Massey TBI Foundation	For all authors, no conflicts are declared. B.E.B. is supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number F32GM130010. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was supported by the Joyce and Don Massey TBI Foundation.	Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; [Anonymous], 2008, BIOTECHNOLOGY-PAKIST; Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; Bhatti UF, 2019, PROTEOM CLIN APPL, V13, DOI 10.1002/prca.201900068; Biesterveld B, 2019, J TRAUMA ACUTE CARE, V87, P1133, DOI 10.1097/TA.0000000000002460; Bonenfant D, 2006, MOL CELL PROTEOMICS, V5, P541, DOI 10.1074/mcp.M500288-MCP200; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang PP, 2019, J AM COLL SURGEONS, V228, P265, DOI 10.1016/j.jamcollsurg.2018.12.026; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Difede J, 2010, ANN NY ACAD SCI, V1208, P1, DOI 10.1111/j.1749-6632.2010.05795.x; Du Y, 2019, AM J PHYSIOL-LUNG C, V317, pL347, DOI 10.1152/ajplung.00475.2018; Gaudet P, 2011, BRIEF BIOINFORM, V12, P449, DOI 10.1093/bib/bbr042; Georgoff PE, 2018, J TRAUMA ACUTE CARE, V84, P642, DOI 10.1097/TA.0000000000001763; Georgoff PE, 2018, CLIN PHARMACOKINET, V57, P209, DOI 10.1007/s40262-017-0553-1; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Higgins GA, 2019, PHARMACOL REV, V71, P520, DOI 10.1124/pr.119.017681; Higgins GA, 2017, PHARM RES-DORDR, V34, P1658, DOI 10.1007/s11095-017-2130-6; Jepsen CH, 2014, J TRAUMA ACUTE CARE, V77, P292, DOI 10.1097/TA.0000000000000333; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Lamade AM, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113307; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Lo EH, 2001, BRAIN RES REV, V38, P140, DOI 10.1016/S0165-0173(01)00083-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Meenu M, 2019, EPILEPSY RES, V158, DOI 10.1016/j.eplepsyres.2019.106219; Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100; Moore DF, 2005, CIRCULATION, V111, P212, DOI 10.1161/01.CIR.0000152105.79665.C6; Nikolian VC, 2018, J TRAUMA ACUTE CARE, V84, P459, DOI 10.1097/TA.0000000000001765; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; O'Sullivan F, 2017, WORLD J GASTROENTERO, V23, P7369, DOI 10.3748/wjg.v23.i41.7369; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Pasinetti GM, 2010, PSYCHIAT CLIN N AM, V33, P905, DOI 10.1016/j.psc.2010.09.003; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Peterson AB, 2019, SURVEILLANCE REPORT; Rogers S, 2008, BIOINFORMATICS, V24, P2894, DOI 10.1093/bioinformatics/btn553; Russo R, 2020, J TRAUMA ACUTE CARE, V89, pS69, DOI 10.1097/TA.0000000000002721; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Weykamp M, 2018, J SURG RES, V228, P84, DOI 10.1016/j.jss.2018.02.046; Williams AM, 2019, J TRAUMA ACUTE CARE, V87, P393, DOI 10.1097/TA.0000000000002281; Williams AM, 2019, SHOCK, V52, P300, DOI 10.1097/SHK.0000000000001308; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	52	3	3	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2020	89	6					1156	1165		10.1097/TA.0000000000002918			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	OZ3WN	WOS:000594860700036	32890344	Green Accepted			2022-02-06	
J	Blackwell, LS; Martinez, M; Fournier-Goodnight, A; Figueroa, J; Appert, A; Vats, A; Wali, B; Sayeed, I; Reisner, A				Blackwell, Laura S.; Martinez, Margaret; Fournier-Goodnight, Ashley; Figueroa, Janet; Appert, Andrew; Vats, Atul; Wali, Bushra; Sayeed, Iqbal; Reisner, Andrew			Patterns of Osteopontin Expression in Abusive Head Trauma Compared with Other Causes of Pediatric Traumatic Brain Injury	JOURNAL OF PEDIATRICS			English	Article							SERUM BIOMARKER CONCENTRATIONS; CHILDREN; OUTCOMES; INFANTS; MARKERS; MACROPHAGE	Objective To examine levels of plasma osteopontin (OPN), a recently described neuroinflammatory biomarker, in children with abusive head trauma (AHT) compared with children with other types of traumatic brain injury (TBI). Study design The study cohort comprised children aged <4 years diagnosed with TBI and seen in the intensive care unit in a tertiary children's hospital. Patients were classified as having confirmed or suspected AHT or TBI by other mechanisms (eg, motor vehicle accidents), as identified by a Child Protection Team clinician. Serial blood samples were collected at admission and at 24, 48, and 72 hours after admission. Levels of OPN were compared across groups. Results Of 77 patients identified, 24 had confirmed AHT, 12 had suspected AHT, and 41 had TBI. There were no differences in the Glasgow Coma Scale score between the patients with confirmed AHT and those with suspected AHT and those with TBI (median score, 4.5 vs 4 and 7; P = .39). At admission to the emergency department, OPN levels were significantly higher in children with confirmed AHT compared with the other 2 groups (mean confirmed AHT, 471.5 ng/mL; median suspected AHT, 322.3 ng/mL; mean TBI, 278.0 ng/mL; P = .03). Furthermore, the adjusted mean trajectory levels of OPN were significantly higher in the confirmed AHT group compared with the other 2 groups across all subsequent time points (P = <. 01). Conclusions OPN is significantly elevated in children with confirmed AHT compared with those with suspected AHT and those with other types of TBI. OPN expression may help identify children with suspected AHT to aid resource stratification and triage of appropriate interventions for children who are potential victims of abuse.	[Blackwell, Laura S.; Fournier-Goodnight, Ashley; Appert, Andrew; Vats, Atul; Reisner, Andrew] Childrens Healthcare Atlanta, Dept Neuropsychol, 5461 Meridian Mark Rd,Suite 180, Atlanta, GA 30342 USA; [Martinez, Margaret] Rowan Sch Osteopath Med, Stratford, NJ USA; [Figueroa, Janet] Emory Univ, Sch Med, Atlanta, GA USA; [Vats, Atul] Emory Sch Med, Dept Pediat, Atlanta, GA USA; [Wali, Bushra; Sayeed, Iqbal] Emory Sch Med, Dept Emergency Med, Atlanta, GA USA		Blackwell, LS (corresponding author), Childrens Healthcare Atlanta, Dept Neuropsychol, 5461 Meridian Mark Rd,Suite 180, Atlanta, GA 30342 USA.	laura.blackwell@choa.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R21NS103507-02]	Funded by the National Institutes of Health (5R21NS103507-02). The data in this article are the basis for patent 62/742,011, Blood Biomarkers for Severe Traumatic Brain Injury, filed on October 5, 2018. The authors declare no conflicts of interest.	Acker SN, 2015, J PEDIATR SURG, V50, P604, DOI 10.1016/j.jpedsurg.2014.05.030; Alvarez HAO, 2018, NEUROSCI BIOBEHAV R, V92, P226, DOI 10.1016/j.neubiorev.2018.06.002; Amagasa S, 2018, ACUTE MED SURG, V5, P265, DOI 10.1002/ams2.341; Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Chan JL, 2014, EXP NEUROL, V261, P757, DOI 10.1016/j.expneurol.2014.08.015; Chen WQ, 2011, STROKE, V42, P764, DOI 10.1161/STROKEAHA.110.599118; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Coelho R, 2014, ACTA PSYCHIAT SCAND, V129, P180, DOI 10.1111/acps.12217; Danese A, 2011, MOL PSYCHIATR, V16, P244, DOI 10.1038/mp.2010.5; Gao N, 2020, J CEREBR BLOOD F MET, V40, P35, DOI 10.1177/0271678X19836412; O'Meara AMI, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00118; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Lanteri P, 2012, CLIN CHEM LAB MED, V50, P1979, DOI 10.1515/cclm-2012-0177; Li Y, 2017, ENVIRON SCI POLLUT R, V4:1-8, DOI DOI 10.1080/1461670X.2017.1397531; Lind K, 2016, CHILD ABUSE NEGLECT, V51, P358, DOI 10.1016/j.chiabu.2015.08.001; Liu YZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00316; Matschke J, 2015, INT J LEGAL MED, V129, P105, DOI 10.1007/s00414-014-1060-7; Narang SK, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0203; Neigh GN, 2009, TRAUMA VIOLENCE ABUS, V10, P389, DOI 10.1177/1524838009339758; Newell E, 2015, PEDIATR CRIT CARE ME, V16, P549, DOI 10.1097/PCC.0000000000000400; Nuno M, 2015, J NEUROSURG-PEDIATR, V16, P515, DOI 10.3171/2015.3.PEDS14544; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Pittayakanchit W, 2018, ELIFE, V7, DOI 10.7554/eLife.37624; Rentsendorj A, 2018, BRAIN BEHAV IMMUN, V67, P163, DOI 10.1016/j.bbi.2017.08.019; Selassie AW, 2014, J TRAUMA NURS, V21, P72, DOI 10.1097/JTN.0000000000000038; Shalev I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0221310; Shin T, 2012, ACTA HISTOCHEM, V114, P749, DOI 10.1016/j.acthis.2012.08.004; Spies EL, 2016, MMWR-MORBID MORTAL W, V65, P505, DOI 10.15585/mmwr.mm6520a1; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016	35	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	DEC	2020	227						170	175		10.1016/j.jpeds.2020.06.080			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	OV0QU	WOS:000591926500032	32622673	Green Accepted			2022-02-06	
J	Li, Y; Zhang, W; Lu, YC; Wu, CW				Li, Y.; Zhang, W.; Lu, Y. -C.; Wu, C. W.			Hyper-viscoelastic mechanical behavior of cranial pia mater in tension	CLINICAL BIOMECHANICS			English	Article						Cranial pia mater; Tension; Stress-relaxation; Ogden model; Strain rate	SPINAL-CORD; BRAIN-TISSUE; HEAD; DEFORMATION; ACCELERATIONS; ELASTICITY; RESPONSES; SPACE	Background: Cranial pia mater, the innermost layer of the meninges, protects the central nervous system by tightly wrapping the brain and damping the external impact force to the brain. Accurate experimental data of the mechanical property of the cranial pia mater can enhance the theoretical prediction of traumatic brain injury or the scientific surgery design for brain disease. The aim of this study is to characterize the mechanical behavior of the cranial pia mater. Methods: In vitro tensile and stress-relaxation experiments of ovine cranial pia mater specimens were conducted at eight strain rates to characterize the rate-dependent viscoelastic property. The tensile and stress-relaxation experimental data were fitted by an Ogden hyper-viscoelastic model with a strain rate function to describe the mechanical behavior of the cranial pia mater. Findings: The elastic modulus and the ultimate stress are significantly increased from 5.545 MPa and 0.535 MPa at 0.00167 s(-1) to 18.345 MPa and 2.547 MPa at 0.83 s(-1) (p < .0001), respectively. The initial stress and the long-term stress (300 s) are also increased significantly with the increasing strain rates (p .0001). A good fit of the experimental data with the Ogden hyper-viscoelastic model incorporated with a strain rate function was achieved (R-2 > 0.93). Interpretation: The cranial pia mater exhibits as a rate-dependent hyper-viscoelastic material in the tensile and stress-relaxation experiments. Compared with the brain, the stiffer nature of the cranial pia mater indicates its essential role in brain protection. The rate-dependent constitutive model provides a proper description of the hyper-viscoelastic characteristics of the cranial pia mater in tension and may provide a basic constitutive relationship for numerical simulations of traumatic brain injury.	[Li, Y.; Zhang, W.; Wu, C. W.] Dalian Univ Technol, Fac Vehicle Engn & Mech, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China; [Lu, Y. -C.] Natl Childrens Hosp, Div Diagnost Imaging & Radiol, Washington, DC 20010 USA		Wu, CW (corresponding author), Dalian Univ Technol, Fac Vehicle Engn & Mech, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China.	cwwu@dlut.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51775541, U1908233,11772086]	This work was supported by the National Natural Science Foundation of China (Grant Nos. 51775541, U1908233,11772086). The authors would like to thank Dr. Shengbo Yu for helpful suggestions in dissecting the cranial pia mater.	Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; ALCOLADO R, 1988, NEUROPATH APPL NEURO, V14, P1, DOI 10.1111/j.1365-2990.1988.tb00862.x; ALLEN DJ, 1975, J COMP NEUROL, V161, P515, DOI 10.1002/cne.901610404; Bilston LE, 1996, ANN BIOMED ENG, V24, P67; Breig, 1960, BIOMECHANICS CENTRAL; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Dalley I.I., 2015, ESSENTIAL CLIN ANATO; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Feola AJ, 2016, INVEST OPHTH VIS SCI, V57, P1901, DOI 10.1167/iovs.15-17573; Gu LX, 2012, COMPOS PART B-ENG, V43, P3160, DOI 10.1016/j.compositesb.2012.04.014; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hiscox LV, 2016, PHYS MED BIOL, V61, pR401, DOI 10.1088/0031-9155/61/24/R401; Hosseini Farid M, 2017, ASME 2017 INT MECH E; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2014, ANN BIOMED ENG, V42, P812, DOI 10.1007/s10439-013-0948-6; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Lippert SA, 2004, BIORHEOLOGY, V41, P681; Lu YC, 2019, ANN BIOMED ENG, V47, P1923, DOI 10.1007/s10439-019-02226-z; Mazuchowski E.L., 2003, SUMM BIOENG C SON BE; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Ozawa H, 2004, J NEUROSURG-SPINE, V1, P122, DOI 10.3171/spi.2004.1.1.0122; Park SW, 1999, INT J SOLIDS STRUCT, V36, P1653, DOI 10.1016/S0020-7683(98)00055-9; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid Badar, 2012, IRCOBI C 2012 12 14; Reina MA, 2004, ANESTH ANALG, V98, P1479, DOI 10.1213/01.ANE.0000113240.09354.E9; Saboori Parisa, 2019, ANN BIOMED ENG, P1; Shetye SS, 2014, J MECH BEHAV BIOMED, V34, P146, DOI 10.1016/j.jmbbm.2014.02.014; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Takhounts Erik G, 2003, SAE TECHNICAL PAPER; TUNTURI AR, 1978, J NEUROSURG, V48, P975, DOI 10.3171/jns.1978.48.6.0975; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Yasuki T., 2006, AUTOTECHNOL, V6, P44; Zhang W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19687-2; Zhang W, 2016, J APPL MECH-T ASME, V83, DOI 10.1115/1.4033890	42	3	3	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	DEC	2020	80								105108	10.1016/j.clinbiomech.2020.105108			9	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	PK3FJ	WOS:000602335100030	32736277				2022-02-06	
J	McNabb, C; Reha, T; Georgieva, J; Jacques, A; Netto, K; Lavender, AP				McNabb, Colm; Reha, Tahere; Georgieva, Julia; Jacques, Angela; Netto, Kevin; Lavender, Andrew P.			The Effect of Sub-Concussive Impacts during a Rugby Tackling Drill on Brain Function	BRAIN SCIENCES			English	Article						balance; brain function; concussion; sub-concussion; rugby; transcranial magnetic stimulation	TRANSCRANIAL MAGNETIC STIMULATION; INTRACORTICAL INHIBITION; LONG-TERM; SPORTS CONCUSSION; SOCCER; INJURY; PLAYERS; UNION	Concussion is known to detrimentally affect brain health. Rugby tackles commonly occur with high collision force between tackler and ball carrier, and low impact head contact is not uncommon. Cognitive deficits following a bout of soccer ball heading has been attributed to the impact and termed sub-concussion. Although soccer ball heading studies provide evidence for acute effects of sub-concussion, it is unknown whether this phenomenon occurs following rugby tackles. This study investigates the acute effects of rugby tackles on brain function and balance in rugby players. Twenty-six volunteers were assigned to either the ball carrier (9), tackler (9) or control (8) group. Controls performed running without the tackle. Outcome measures included corticomotor function using transcranial magnetic brain stimulation (TMS) and balance was assessed by a series of tasks performed on a NeuroCom Balance Master before and immediately after a tackle training drill. Following the tackling bout, the cortical silent period (cSP) increased for the tacklers with no change for ball carrier and control groups, and no differences between groups for balance measures were observed. Lengthening of cSP observed in the tacklers following the bout has been reported in studies of concussion and may indicate long term detrimental effects.	[McNabb, Colm; Reha, Tahere; Georgieva, Julia; Jacques, Angela; Netto, Kevin; Lavender, Andrew P.] Curtin Univ, Sch Physiotherapy & Exercise Sci, Bentley, WA 6102, Australia; [Lavender, Andrew P.] Federat Univ Australia, Sch Sci Psychol & Sport, Ballarat, Vic 3350, Australia		Lavender, AP (corresponding author), Curtin Univ, Sch Physiotherapy & Exercise Sci, Bentley, WA 6102, Australia.; Lavender, AP (corresponding author), Federat Univ Australia, Sch Sci Psychol & Sport, Ballarat, Vic 3350, Australia.	colm.mcnabb@student.curtin.edu.au; tahere.reha@student.curtin.edu.au; julia.georgieva@postgrad.curtin.edu.au; Angela.jacques@curtin.edu.au; kevin.netto@curtin.edu.au; a.lavender@federation.edu.au	Lavender, Andrew/AAH-9570-2021	Jacques, Angela/0000-0002-0461-681X; Netto, Kevin/0000-0002-3680-3548; Lavender, Andrew/0000-0001-6222-880X; Georgieva, Julia/0000-0003-1843-2672			Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Agarwal S, 2019, J NEUROL NEUROSUR PS, V90, P47, DOI 10.1136/jnnp-2017-317371; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Daneshjoo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051568; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V564, P661, DOI 10.1113/jphysiol.2004.061747; Di Virgilio TG, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00294; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Dierijck JK, 2018, INT J PSYCHOPHYSIOL, V132, P74, DOI 10.1016/j.ijpsycho.2018.03.005; Erlanger DM, 2015, BRAIN INJURY, V29, P171, DOI 10.3109/02699052.2014.965211; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hammami R, 2014, J HUM KINET, V41, P33, DOI 10.2478/hukin-2014-0030; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Kellar D, 2018, NEUROIMAGE-CLIN, V18, P413, DOI 10.1016/j.nicl.2018.01.025; King R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00451; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Major BP, 2015, CLIN EXP PHARMACOL P, V42, P394, DOI 10.1111/1440-1681.12363; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Pearce AJ, 2016, EBIOMEDICINE, V13, P3, DOI 10.1016/j.ebiom.2016.10.043; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Piecha M, 2013, ACTA BIOENG BIOMECH, V15, P29, DOI 10.5277/abb130304; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Ras MJ, 2014, PAK J MED SCI, V30, P1346, DOI 10.12669/pjms.306.5648; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Sale MV, 2016, CLIN NEUROPHYSIOL, V127, P635, DOI 10.1016/j.clinph.2015.04.062; Shuttleworth-Edwards AB, 2008, J CLIN EXP NEUROPSYC, V30, P870, DOI 10.1080/13803390701846914; Subasi SS, 2008, J SPORT REHABIL, V17, P186, DOI 10.1123/jsr.17.2.186; Suzuki K, 2020, SCAND J MED SCI SPOR, V30, P185, DOI 10.1111/sms.13553; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615	38	3	3	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	DEC	2020	10	12							960	10.3390/brainsci10120960			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PK2CZ	WOS:000602260100001	33321843	Green Published, gold			2022-02-06	
J	O'Neill, KM; Jean, RA; Gross, CP; Becher, RD; Khera, R; Elizondo, JV; Nasir, K				O'Neill, Kathleen M.; Jean, Raymond A.; Gross, Cary P.; Becher, Robert D.; Khera, Rohan; Elizondo, Javier Valero; Nasir, Khurram			Financial Hardship After Traumatic Injury: Risk Factors and Drivers of Out-of-Pocket Health Expenses	JOURNAL OF SURGICAL RESEARCH			English	Article						Out-of-pocket expenses; Financial hardship; Insurance; Trauma; Cost	SPINAL-CORD-INJURY; CANCER SURVIVORS; MEDICAL-DEBT; BANKRUPTCY; INSURANCE; BRAIN	Background: Trauma-related disorders rank among the top five most costly medical conditions to the health care system. However, the impact of out-of-pocket (OOP) health expenses for traumatic conditions is not known. In this cross-sectional study, we use nationally representative data to investigate whether patients with a traumatic injury experienced financial hardship from OOP health expenses. Methods: Using data from the Medical Expenditure Panel Survey from 2010 to 2015, we analyzed the financial burden associated with a traumatic injury. Primary outcomes were excess financial burden (OOP>20% of annual income) and catastrophic medical expenses (OOP>40% of annual income). A multivariable logistic regression analysis evaluated whether these outcomes were associated with traumatic injury, adjusting for demographic, socioeconomic, and health care factors. We then completed a descriptive analysis to elucidate drivers of total OOP expenses. Results: Of the 90,964 families in the cohort, 6434 families had a traumatic injury requiring a visit to the emergency room and 668 families had a traumatic injury requiring hospitalization. Overall 1 in 8 households with an injured family member requiring hospitalization experienced financial hardship. These families were more likely to experience excess financial burden (OR: 2.04, 95% CI: 1.13-3.64) and catastrophic medical expenses (OR: 3.08, 95% CI: 1.37-6.9). The largest burden of OOP expenses was due to prescription drug costs, with inpatient costs as a major driver of OOP expenses for those requiring hospitalization. Conclusions: Households with an injured family member requiring hospitalization are significantly more vulnerable to financial hardship from OOP health expenses than the noninjured population. Prescription drug and inpatient costs were the most significant drivers of OOP health expenses. (C) 2020 Elsevier Inc. All rights reserved.	[O'Neill, Kathleen M.; Jean, Raymond A.] Yale Sch Med, Dept Surg, New Haven, CT USA; [O'Neill, Kathleen M.; Jean, Raymond A.; Gross, Cary P.] Yale Sch Med, Natl Clinician Scholars Program, New Haven, CT USA; [Gross, Cary P.] Yale Canc Ctr, Yale Sch Med, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA; [Gross, Cary P.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Becher, Robert D.] Yale Sch Med, Sect Gen Surg Trauma & Surg Crit Care, New Haven, CT USA; [Khera, Rohan] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT USA; [Khera, Rohan] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA; [Elizondo, Javier Valero; Nasir, Khurram] Houston Methodist DeBakey Heart & Vasc Ctr, Dept Cardiol, Div Cardiovasc Prevent & Wellness, Houston, TX USA; [Elizondo, Javier Valero; Nasir, Khurram] Houston Methodist, Ctr Outcomes Res, Houston, TX USA		O'Neill, KM (corresponding author), Yale New Haven Med Ctr, 330 Cedar St,FMB 107, New Haven, CT 06510 USA.	kathleen.oneill@yale.edu	Khera, Rohan/AAQ-6838-2021	Khera, Rohan/0000-0001-9467-6199; Jean, Raymond/0000-0001-5421-0386; Valero-Elizondo, Javier/0000-0002-9136-5093	CTSA grant from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1 TR001863]	Dr O'Neill is a PhD student in the Investigative Medicine Program at Yale which is supported by CTSA grant number TL1 TR001863 from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NIH.	Abutaleb Y, 2018, US HEALTHCARE SPENDI; Alba AC, 2017, JAMA-J AM MED ASSOC, V318, P1377, DOI 10.1001/jama.2017.12126; Alghnam S, 2016, QUAL LIFE RES, V25, P987, DOI 10.1007/s11136-015-1126-0; Annapureddy A, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.005180; [Anonymous], 2015, METHODOLOGY REPORT 3; [Anonymous], 2010, MED EXPENDITURE PANE; [Anonymous], 2013, METHODOLOGY REPORT 2; Arozullah Ahsan M, 2004, J Support Oncol, V2, P271; Banegas MP, 2016, HEALTH AFFAIR, V35, P54, DOI 10.1377/hlthaff.2015.0830; Bernard DSM, 2011, J CLIN ONCOL, V29, P2821, DOI 10.1200/JCO.2010.33.0522; Cutshaw CA, 2016, INT J HEALTH SERV, V46, P36, DOI 10.1177/0020731415614249; Goldman AL, 2018, JAMA INTERN MED, V178, P347, DOI 10.1001/jamainternmed.2017.8060; Gordon LG, 2017, PATIENT, V10, P295, DOI 10.1007/s40271-016-0204-x; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Hollingworth W, 2007, MED CARE, V45, P702, DOI 10.1097/MLR.0b013e318041f765; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Khera R, 2018, JAMA CARDIOL, V3, P729, DOI 10.1001/jamacardio.2018.1813; Ku L, 2008, HEALTH AFFAIR, V27, pW318, DOI 10.1377/hlthaff.27.4.w318; Liu C, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17696; Maddox KEJ, 2020, JAMA-J AM MED ASSOC, V323, P547, DOI 10.1001/jama.2019.21461; Ramsey S, 2013, HEALTH AFFAIR, V32, P1143, DOI 10.1377/hlthaff.2012.1263; Reeves R., 2016, 5 EVILS MULTIDIMENSI; Relyea-Chew A, 2009, ARCH PHYS MED REHAB, V90, P413, DOI 10.1016/j.apmr.2008.07.031; Roemer MI, 2001, STAT BRIEF MED EXPEN; Scott JW, 2018, ANN SURG, V267, P1093, DOI 10.1097/SLA.0000000000002254; Seifert RW, 2006, HEALTH AFFAIR, V25, pW89, DOI 10.1377/hlthaff.25.w89; Sun EC, 2019, JAMA INTERN MED, V179, P1543, DOI 10.1001/jamainternmed.2019.3451; Thorpe KE, 2015, HEALTH AFFAIR, V34, P1695, DOI 10.1377/hlthaff.2015.0323	29	3	3	1	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2020	256						1	12		10.1016/j.jss.2020.05.095			12	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	OH5EJ	WOS:000582602700001	32663705				2022-02-06	
J	Schiavo, S; Richardson, D; Santa Mina, D; Buryk-Iggers, S; Uehling, J; Carroll, J; Clarke, H; Djaiani, C; Gershinsky, M; Katznelson, R				Schiavo, S.; Richardson, D.; Santa Mina, D.; Buryk-Iggers, S.; Uehling, J.; Carroll, J.; Clarke, H.; Djaiani, C.; Gershinsky, M.; Katznelson, R.			Hyperbaric oxygen and focused rehabilitation program: a feasibility study in improving upper limb motor function after stroke	APPLIED PHYSIOLOGY NUTRITION AND METABOLISM			English	Article						hyperbaric oxygen therapy; stroke rehabilitation; stroke; rehabilitation; GRASP; exercise therapy; motor function	MONTREAL COGNITIVE ASSESSMENT; ISCHEMIA-REPERFUSION INJURY; POST-CONCUSSION SYNDROME; NITRIC-OXIDE; ARM FUNCTION; SAMPLE-SIZE; BLOCK TEST; THERAPY; NEUROPLASTICITY; ANGIOGENESIS	Neuroplasticity and recovery after stroke can be enhanced by a rehabilitation program pertinent to upper limb motor function exercise and mental imagery (EMI) as well as lryperbaric oxygen therapy (HBOT). We assessed feasibility and safety of the combined approach utilizing both HBOT and EMI, and to derive preliminary estimates of its efficacy. In this randomized controlled trial, 27 patients with upper extremity hemiparesis at 3-48 months after stroke were randomized to receive either a complementary rehabilitation program of HBOT-EMI (intervention group), or EMI alone (control group). Feasibility and safety were assessed as total session attendance, duration of sessions, attrition rates, missing data, and intervention-related adverse events. Secondary clinical outcomes were assessed with both objective tools and self-reported measures at baseline, 8 weeks (end of treatment), and 12-weeks thllow-up. Session attendance, duration, and attrition rate did not differ between the groups; there were no serious adverse events. Compared with baseline, there were significant sustained improvements of objective and subjective outcomes' measures in the intervention group, and a single improvement in an objective measure in the control group. Between-group outcome comparisons were not statistically significant. This study demonstrated that the combination HBOT-EMI was a safe and feasible approach in patients recovering from chronic stroke. There were also trends for improved motor function of the affected upper limb after the treatments. Novelty HBOT combined with an upper limb exercise and mental imagery rehabilitation program is feasible and safe in chronic stroke patients. This combined approach showed trends for improved functional recovery.	[Schiavo, S.; Uehling, J.; Carroll, J.; Clarke, H.; Djaiani, C.; Gershinsky, M.; Katznelson, R.] Univ Hlth Network, Toronto Gen Hosp, Dept Anesthesia & Pain Management, Hyperbar Med Unit, Toronto, ON M5G 2C4, Canada; [Richardson, D.] Toronto Rehabil Inst, Stroke Rehabil Clin, Toronto, ON M5G 2C4, Canada; [Santa Mina, D.; Buryk-Iggers, S.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON M5G 2C1, Canada; [Santa Mina, D.] Univ Toronto, Fac Med, Dept Surg, Toronto, ON M5G 2C1, Canada; [Santa Mina, D.] Princess Margaret Canc Ctr Toronto, Dept Support Care, Toronto, ON M5G 2C1, Canada		Katznelson, R (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Dept Anesthesia & Pain Management, Hyperbar Med Unit, Toronto, ON M5G 2C4, Canada.	rita.katznelson@uhn.ca		Santa Mina, Daniel/0000-0003-4361-1656; Schiavo, Simone/0000-0003-3609-9201	Mount Sinai Hospital-University Health Network Academic Medical Organization (MSHUHN AMO) Alternate Funding Plan (AFP) Innovation Fund	We want to acknowledge Sukhvinder Kalsi-Ryan, BScPT MSc PhD, Fatima Quraishi, OT, and Nadia Iannetta, BSc, MScPT, for their contribution and support in organizing and conducting the trial. The study was supported by the Mount Sinai Hospital-University Health Network Academic Medical Organization (MSHUHN AMO) Alternate Funding Plan (AFP) Innovation Fund.	Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bour A, 2010, J NEUROL, V257, P630, DOI 10.1007/s00415-009-5387-9; Boussi-Gross R, 2015, NEUROPSYCHOLOGY, V29, P610, DOI 10.1037/neu0000149; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; BROWNE RH, 1995, STAT MED, V14, P1933, DOI 10.1002/sim.4780141709; Carey L, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/5232374; DESROSIERS J, 1994, ARCH PHYS MED REHAB, V75, P751; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Faralli A, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/854597; Francis A, 2017, DIVING HYPERB MED, V47, P110; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; GOWLAND C, 1993, STROKE, V24, P58, DOI 10.1161/01.STR.24.1.58; Hadanny A, 2015, RESTOR NEUROL NEUROS, V33, P471, DOI 10.3233/RNN-150517; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harris JE, 2009, STROKE, V40, P2123, DOI 10.1161/STROKEAHA.108.544585; Hentia C, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.959; Heyboer M, 2017, ADV WOUND CARE, V6, P210, DOI 10.1089/wound.2016.0718; Heyboer M, 2014, UNDERSEA HYPERBAR M, V41, P393; Jain K.K., 2017, TXB HYPERBARIC MED, P79, DOI [10.1007/978-3-319-47140-2_8, DOI 10.1007/978-3-319-47140-2_8]; Jokinen-Gordon H, 2017, ADV SKIN WOUND CARE, V30, P125, DOI 10.1097/01.ASW.0000508712.86959.c9; Jones SR, 2010, PLAST RECONSTR SURG, V126, P403, DOI 10.1097/PRS.0b013e3181df64a5; Jorgensen H S, 1996, J Stroke Cerebrovasc Dis, V6, P5, DOI 10.1016/S1052-3057(96)80020-6; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lee YS, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/512978; Li JS, 2009, NEUROSCIENCE, V159, P1309, DOI 10.1016/j.neuroscience.2009.01.011; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Miljkovic-Lolic M, 2003, BRAIN RES, V971, P90, DOI 10.1016/S0006-8993(03)02364-3; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427; Pang MY, 2006, ARCH PHYS MED REHAB, V87, P1, DOI 10.1016/j.apmr.2005.08.113; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Ploughman M, 2015, TRANSL STROKE RES, V6, P13, DOI 10.1007/s12975-014-0357-7; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010820.pub2; Quinn TJ, 2018, STROKE, V49, P483, DOI 10.1161/STROKEAHA.117.016994; Riccio I, 2010, EUR J PHYS REHAB MED, V46, P19; Rosario ER, 2018, NEUROL RES INT, V2018, DOI 10.1155/2018/3172679; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Shupak A., 2008, PHYSL MED HYPERBARIC, P513; Tal S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00508; Tal S, 2015, RESTOR NEUROL NEUROS, V33, P943, DOI 10.3233/RNN-150585; Veltkamp R, 2005, STROKE, V36, P1679, DOI 10.1161/01.STR.0000173408.94728.79; Venetsanou K, 2012, EUR J APPL PHYSIOL, V112, P677, DOI 10.1007/s00421-011-2027-8; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Yang YJ, 2008, UNDERSEA HYPERBAR M, V35, P113; Zhai WW, 2016, MED GAS RES, V6, P111, DOI 10.4103/2045-9912.184721; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003; Zimmermann-Schlatter A, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-8	52	3	3	2	5	CANADIAN SCIENCE PUBLISHING	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1715-5312	1715-5320		APPL PHYSIOL NUTR ME	Appl. Physiol. Nutr. Metab.	DEC	2020	45	12					1345	1352		10.1139/apnm-2020-0124			8	Nutrition & Dietetics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics; Physiology; Sport Sciences	PB8VG	WOS:000596591500005	32574506				2022-02-06	
J	Wallace, J; Affagato, R; Brooke, M; McAllister-Deitrick, J; Moran, RN; Covassin, T				Wallace, Jessica; Affagato, Rachel; Brooke, Maxwell; McAllister-Deitrick, Jamie; Moran, Ryan N.; Covassin, Tracey			Racial disparities in parent knowledge of concussion and recognition of signs and symptoms	JOURNAL OF SAFETY RESEARCH			English	Article						Concussion; Traumatic brain injury; Race; Health disparities; Concussion knowledge	SCHOOL FOOTBALL PLAYERS; AMERICAN; ATTITUDES; EDUCATION; BEHAVIORS; AWARENESS; INJURY	Introduction: Concussion is a type of traumatic brain injury that can be sustained through participation in different sports. It is important that a parent be able to identify common and uncommon symptoms of a concussion to ensure the safety and good health of their child. The purpose of this study was to compare knowledge of concussion scores among White and African American parents and guardians. Methodology: This cross-sectional study consisted of a single survey of 53 questions that was given to parents/guardians of high school athletes at a preseason parent meeting. Parent and guardian knowledge of concussion was assessed through a series of 45 questions. Participants were asked to correctly identify signs and symptoms of concussion, answer questions regarding the anatomy of a concussion (i.e. a concussion is an injury to the brain), answer true/false questions about general concussion knowledge, select from a list the consequences of multiple concussions and select from a list the consequences of returning to play too soon from a concussion. Knowledge of concussion was calculated by summing correct responses for the 45 knowledge questions. Racial differences were calculated using an ANCOVA, controlling for socioeconomic school type. The statistical significance level was set a priori p <= 0.05 for all analyses. Results: Participants of this study consisted of 176 [115 (65.3%) White, 61 (34.7%) African American] parents/guardians of high school athletes. Significant differences in knowledge of concussion scores between White parents/guardians [38.50 +/- 4.55 (85.6% correct)], and African American parents/guardians [35.15 +/- 4.97, 78.1% correct)] were identified (F(1,172) = 4.82, p = 0.03). Conclusion: Knowledge of concussion disparities exist between African American and White parents/guardians. This disparity could cause complications from concussion to surface among children and adolescents participating in sport as their parents/guardians may not be able to correctly identify the signs and symptoms in order to seek proper medical care. Practical Application: Findings from this study highlight quantitative differences in concussion knowledge of parents from different demographics. These findings underline disparities and inequities in access to concussion-health resources that need to be addressed. (C) 2020 National Safety Council and Elsevier Ltd. All rights reserved.	[Wallace, Jessica; Moran, Ryan N.] Univ Alabama, Dept Hlth Sci, Tuscaloosa, AL 35401 USA; [Affagato, Rachel; Brooke, Maxwell] Youngstown State Univ, Dept Kinesiol & Sport Sci, Youngstown, OH 44555 USA; [McAllister-Deitrick, Jamie] Coastal Carolina Univ, Dept Kinesiol, Conway, SC 29528 USA; [Covassin, Tracey] Michigan State Univ, Athlet Training Program, 105 IM Circle, E Lansing, MI 48840 USA		Wallace, J (corresponding author), Univ Alabama, Dept Hlth Sci, Tuscaloosa, AL 35401 USA.	jswallace1@ua.edu; Mbrooke@student.ysu.edu; jdeitrick@coastal.edu; rnmoran@ua.edu; covassin@msu.edu					Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; [Anonymous], 2018, HIGH SCH SPORTS PART; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bergeron GL, 2019, CAN J NEUROL SCI, V46, P443, DOI 10.1017/cjn.2019.58; Bey T, 2009, WEST J EMERG MED, V10, P6; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; Chinn NR, 2016, BMJ OPEN SPORT EXERC, V2; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Donnell Z, 2018, J SAFETY RES, V64, P163, DOI 10.1016/j.jsr.2017.12.001; Johnston LD, 2007, AM J PREV MED, V33, pS195, DOI 10.1016/j.amepre.2007.07.015; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kay MC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117742370; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kroshus E, 2018, CLIN J SPORT MED; Kroshus E, 2019, SOC SCI MED, V222, P359, DOI 10.1016/j.socscimed.2018.12.037; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lininger M, 2017, ATHLETIC TRAIN SPORT, V9, P71, DOI DOI 10.3928/19425864-20161116-01; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Popescu I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193222; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; Richmond TK, 2006, PEDIATRICS, V117, P2158, DOI 10.1542/peds.2005-1920; Rieger B, 2018, CUREUS, V10, DOI 10.7759/cureus.2268; Sarmiento K., 2019, J ATHL DEV EXP, V1, P1; Shea JA, 2004, FAM MED, V36, P575; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Sullivan L., 2018, INT J ADOLESCENT MED; Thomas DG, 2018, J EMERG NURS, V44, P52, DOI 10.1016/j.jen.2017.04.012; Turner RW, 2017, BRAIN INJURY, V31, P1124, DOI 10.1080/02699052.2017.1298003; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543	39	3	3	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	DEC	2020	75						166	172		10.1016/j.jsr.2020.09.007			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	PH6UN	WOS:000600545200019	33334474				2022-02-06	
J	Zhou, C; Chen, H; Zheng, JF; Guo, ZD; Huang, ZJ; Wu, Y; Zhong, JJ; Sun, XC; Cheng, CJ				Zhou, Chao; Chen, Hong; Zheng, Jian-Feng; Guo, Zong-Duo; Huang, Zhi-Jian; Wu, Yue; Zhong, Jian-Jun; Sun, Xiao-Chuan; Cheng, Chong-Jie			Pentraxin 3 contributes to neurogenesis after traumatic brain injury in mice	NEURAL REGENERATION RESEARCH			English	Article						brain injury; brain trauma; cells; neurogenesis; plasticity; protein; recovery; regeneration	LONG NONCODING RNA; REACTIVE ASTROCYTES; EXPRESSION; CELLS; PTX3	Emerging evidence indicates that pentraxin 3 is an acute-phase protein that is linked with the immune response to inflammation. It is also a newly discovered marker of anti-inflammatory A2 reactive astrocytes, and potentially has multiple protective effects in stroke; however, its role in the adult brain after traumatic brain injury is unknown. In the present study, a moderate model of traumatic brain injury in mice was established using controlled cortical impact. The models were intraventricularly injected with recombinant pentraxin 3 (the recombinant pentraxin 3 group) or an equal volume of vehicle (the control group). The sham-operated mice underwent craniotomy, but did not undergo the controlled cortical impact. The potential neuroprotective and neuroregenerative roles of pentraxin 3 were investigated on days 14 and 21 after traumatic brain injury. Western blot assay showed that the expression of endogenous pentraxin 3 was increased after traumatic brain injury in mice. Furthermore, the neurological severity test and wire grip test revealed that recombinant pentraxin 3 treatment reduced the neurological severity score and increased the wire grip score, suggesting an improved recovery of sensory-motor functions. The Morris water maze results demonstrated that recombinant pentraxin 3 treatment reduced the latency to the platform, increased the time spent in the correct quadrant, and increased the number of times traveled across the platform, thus suggesting an improved recovery of cognitive function. In addition, to investigate the effects of pentraxin 3 on astrocytes, specific markers of A2 astrocytes were detected in primary astrocyte cultures in vitro using western blot assay. The results demonstrated that pentraxin 3 administration activates A2 astrocytes. To explore the protective mechanisms of pentraxin 3, immunofluorescence staining was used. Intraventricular injection of recombinant pentraxin 3 increased neuronal maintenance in the peri-injured cortex and ipsilateral hippocampus, increased the number of doublecortin-positive neural progenitor cells in the subventricular and subgranular zones, and increased the number of bromodeoxyuridine (proliferation) and neuronal nuclear antigen (mature neuron) double-labeled cells in the hippocampus and peri-injured cortex. Pentraxin 3 administration also increased the number of neurospheres and the number of bromodeoxyuridine and doublecortin double-labeled cells in neurospheres, and enhanced the proliferation of neural progenitor cells in primary neural progenitor cell cultures in vitro. In conclusion, recombinant pentraxin 3 administration activated A2 astrocytes, and consequently improved the recovery of neural function by increasing neuronal survival and enhancing neurogenesis. All experiments were approved by the Animal Ethics Committee of the First Affiliated Hospital of Chongqing Medical University, China on March 1, 2016.	[Zhou, Chao; Chen, Hong; Zheng, Jian-Feng; Guo, Zong-Duo; Huang, Zhi-Jian; Wu, Yue; Zhong, Jian-Jun; Sun, Xiao-Chuan; Cheng, Chong-Jie] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing, Peoples R China		Sun, XC; Cheng, CJ (corresponding author), Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing, Peoples R China.	sunxiaochuan@cqmu.edu.cn; 358187887@qq.com		Reis, AlessanRSS/0000-0001-8486-7469	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81601072, 81801230, 81901210]	This work was supported by the National Natural Science Foundation of China, No. 81571159 (to XCS); the National Natural Science Foundation for Youth of China, Nos. 81601072 (to CJC), 81801230 (to JJZ), and 81901210 (to YW).; This work was supported by the National Natural Science Foundation of China, No. 81571159 (to XCS); the National Natural Science Foundation for Youth of China, Nos. 81601072 (to CJC), 81801230 (to JJZ), and 81901210 (to YW). The funding sources had no role in study conception and design, data analysis or interpretation, paper writing or deciding to submit this paper for publication.	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Azari Hassan, 2010, J Vis Exp, DOI 10.3791/2393; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cheng CJ, 2017, INT J MED SCI, V14, P927, DOI 10.7150/ijms.18812; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Cui YQ, 2019, NEURAL REGEN RES, V14, P913, DOI 10.4103/1673-5374.249240; Cui ZW, 2016, J BIOCHEM MOL TOXIC, V30, P396, DOI 10.1002/jbt.21803; Datta I, 2018, MOL NEUROBIOL, V55, P5505, DOI 10.1007/s12035-017-0767-0; Dillen Y, 2020, TRANSL STROKE RES, V11, P60, DOI 10.1007/s12975-019-00717-8; Ding S, 2014, NEURAL REGEN RES, V9, P2048, DOI 10.4103/1673-5374.147929; Erreni M, 2017, IMMUNOL REV, V280, P112, DOI 10.1111/imr.12570; Fornai F, 2015, INT J BIOCHEM CELL B, V69, P70, DOI 10.1016/j.biocel.2015.10.017; Fossati G, 2019, EMBO J, V38, DOI 10.15252/embj.201899529; Grafman J, 2016, NEW ENGL J MED, V375, P1597, DOI 10.1056/NEJMc1610498; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; He JC, 2018, NEUROBIOL DIS, V117, P114, DOI 10.1016/j.nbd.2018.06.003; Huang ZJ, 2016, J NEUROCHEM, V136, P1017, DOI 10.1111/jnc.13491; Ishii T, 2019, FREE RADICAL BIO MED, V133, P169, DOI 10.1016/j.freeradbiomed.2018.09.002; Jeon H, 2010, J NEUROIMMUNOL, V229, P63, DOI 10.1016/j.jneuroim.2010.07.001; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin Y, 2015, BIOMATERIALS, V69, P148, DOI 10.1016/j.biomaterials.2015.08.010; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Ma YJ, 2013, J IMMUNOL, V191, P1324, DOI 10.4049/jimmunol.1300382; Martinez B, 2017, NEURAL REGEN RES, V12, P1749, DOI 10.4103/1673-5374.219025; Moreno-Jimenez EP, 2019, NAT MED, V25, P554, DOI 10.1038/s41591-019-0375-9; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Neal M, 2018, GLIA, V66, P2137, DOI 10.1002/glia.23467; Ngwenya LB, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01014; Oliveira MS, 2019, INT IMMUNOPHARMACOL, V70, P302, DOI 10.1016/j.intimp.2019.02.055; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Rajkovic I, 2018, J MOL MED, V96, P1319, DOI 10.1007/s00109-018-1698-6; Redmond SA, 2019, CELL REP, V27, P429, DOI 10.1016/j.celrep.2019.01.088; Rodriguez-Grande B, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0227-y; Shindo A, 2016, STROKE, V47, P1094, DOI 10.1161/STROKEAHA.115.012133; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Yu ZY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1007-x; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang ZS, 2019, CELL TRANSPLANT, V28, P1161, DOI 10.1177/0963689719842161; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002	45	3	3	1	32	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	DEC	2020	15	12					2318	2326		10.4103/1673-5374.285001			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	MG0WP	WOS:000545755700028	32594056	Green Published, gold			2022-02-06	
J	La Rocca, M; Garner, R; Amoroso, N; Lutkenhoff, ES; Monti, MM; Vespa, P; Toga, AW; Duncan, D				La Rocca, Marianna; Garner, Rachael; Amoroso, Nicola; Lutkenhoff, Evan S.; Monti, Martin M.; Vespa, Paul; Toga, Arthur W.; Duncan, Dominique			Multiplex Networks to Characterize Seizure Development in Traumatic Brain Injury Patients	FRONTIERS IN NEUROSCIENCE			English	Article						post-traumatic epilepsy; traumatic brain injury; structural magnetic resonance imaging; multiplex networks; random forest; machine learning; complex networks	POSTTRAUMATIC EPILEPSY; MRI	Traumatic brain injury (TBI) may cause secondary debilitating problems, such as post-traumatic epilepsy (PTE), which occurs with unprovoked recurrent seizures, months or even years after TBI. Currently, the Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) has been enrolling moderate-severe TBI patients with the goal to identify biomarkers of epileptogenesis that may help to prevent seizure occurrence and better understand the mechanism underlying PTE. In this work, we used a novel complex network approach based on segmenting T1-weighted Magnetic Resonance Imaging (MRI) scans in patches of the same dimension (network nodes) and measured pairwise patch similarities using Pearson's correlation (network connections). This network model allowed us to obtain a series of single and multiplex network metrics to comprehensively analyze the different interactions between brain components and capture structural MRI alterations related to seizure development. We used these complex network features to train a Random Forest (RF) classifier and predict, with an accuracy of 70 and a 95% confidence interval of [67, 73%], which subjects from EpiBioS4Rx have had at least one seizure after a TBI. This complex network approach also allowed the identification of the most informative scales and brain areas for the discrimination between the two clinical groups: seizure-free and seizure-affected subjects, demonstrating to be a promising pilot study which, in the future, may serve to identify and validate biomarkers of PTE.	[La Rocca, Marianna; Garner, Rachael; Toga, Arthur W.; Duncan, Dominique] Univ Southern Calif, Keck Sch Med, USC Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging, Los Angeles, CA 90007 USA; [Amoroso, Nicola] Univ Bari A Moro, Dipartimento Farm Sci Farmaco, Bari, Italy; [Lutkenhoff, Evan S.; Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Vespa, Paul] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA		La Rocca, M (corresponding author), Univ Southern Calif, Keck Sch Med, USC Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging, Los Angeles, CA 90007 USA.	marianna.larocca@loni.usc.edu	La Rocca, Marianna/ABG-1214-2021	La Rocca, Marianna/0000-0002-2254-1583; Duncan, Dominique/0000-0002-6154-9262	National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54 NS100064, R01NS111744]	This study was conducted with the support of the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) under award numbers U54 NS100064 (EpiBioS4Rx) and R01NS111744.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Amoroso N, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00365; Amoroso N, 2018, MED IMAGE ANAL, V48, P12, DOI 10.1016/j.media.2018.05.004; Amoroso N, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0439-y; Bharath RD, 2019, EUR RADIOL, V29, P3496, DOI 10.1007/s00330-019-5997-2; Bianconi G, 2018, MULTILAYER NETWORKS: STRUCTURE AND FUNCTION, DOI 10.1093/oso/9780198753919.001.0001; Biau G, 2016, TEST-SPAIN, V25, P197, DOI 10.1007/s11749-016-0481-7; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Figueroa RL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-8; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Floares A., 2017, INT J ONCOL CANC THE, V2, P13; Garner R, 2019, 2019 SPRING SIMULATION CONFERENCE (SPRINGSIM); Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Immonen R, 2019, NEUROBIOL DIS, V123, P75, DOI 10.1016/j.nbd.2018.10.008; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; La Rocca M., 2019, MED IMAGING DEEP LEA; La Rocca M, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aacf1f; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lutkenhoff ES, 2020, J NEUROL NEUROSUR PS, V91, P1154, DOI 10.1136/jnnp-2020-322780; Lutkenhoff ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115551; Messori A, 2005, EPILEPSIA, V46, P1472, DOI 10.1111/j.1528-1167.2005.34004.x; Mukaka MM, 2012, MALAWI MED J, V24, P69; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Norden AD, 2002, EPILEPSY BEHAV, V3, P219, DOI 10.1016/S1525-5050(02)00029-X; Shah P, 2019, HUM BRAIN MAPP, V40, P2390, DOI 10.1002/hbm.24530; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Suk HI, 2014, NEUROIMAGE, V101, P569, DOI 10.1016/j.neuroimage.2014.06.077; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Vabalas A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224365; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036733	37	3	3	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	NOV 30	2020	14								591662	10.3389/fnins.2020.591662			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PE1QS	WOS:000598146300001	33328863	gold, Green Published			2022-02-06	
J	Chary, K; Nissi, MJ; Nykanen, O; Manninen, E; Rey, RI; Shmueli, K; Sierra, A; Grohn, O				Chary, Karthik; Nissi, Mikko J.; Nykanen, Olli; Manninen, Eppu; Rey, Ramon, I; Shmueli, Karin; Sierra, Alejandra; Grohn, Olli			Quantitative susceptibility mapping of the rat brain after traumatic brain injury	NMR IN BIOMEDICINE			English	Article						animal models; iron; microbleeds; myelin; quantitative susceptibility mapping; traumatic brain injury	HIGH-FIELD MRI; MAGNETIC-SUSCEPTIBILITY; MICROSTRUCTURAL CHANGES; ORIENTATION-DEPENDENCE; CEREBRAL MICROBLEEDS; GRAY-MATTER; IN-VIVO; WHITE; IRON; DIFFUSION	The primary lesion arising from the initial insult after traumatic brain injury (TBI) triggers a cascade of secondary tissue damage, which may also progress to connected brain areas in the chronic phase. The aim of this study was, therefore, to investigate variations in the susceptibility distribution related to these secondary tissue changes in a rat model after severe lateral fluid percussion injury. We compared quantitative susceptibility mapping (QSM) and R-2* measurements with histological analyses in white and grey matter areas outside the primary lesion but connected to the lesion site. We demonstrate that susceptibility variations in white and grey matter areas could be attributed to reduction in myelin, accumulation of iron and calcium, and gliosis. QSM showed quantitative changes attributed to secondary damage in areas located rostral to the lesion site that appeared normal in R-2* maps. However, combination of QSM and R-2* was informative in disentangling the underlying tissue changes such as iron accumulation, demyelination, or calcifications. Therefore, combining QSM with R-2* measurement can provide a more detailed assessment of tissue changes and may pave the way for improved diagnosis of TBI, and several other complex neurodegenerative diseases.	[Chary, Karthik; Manninen, Eppu; Sierra, Alejandra; Grohn, Olli] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Nissi, Mikko J.; Nykanen, Olli] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Nissi, Mikko J.] Univ Oulu, Res Unit Med Imaging Phys & Technol, Oulu, Finland; [Rey, Ramon, I] Univ Santiago de Compostela, Hlth Res Inst Santiago de Compostela, Dept Neurol, Clin Neurosci Res Lab, Santiago De Compostela, Spain; [Shmueli, Karin] UCL, Dept Med Phys & Biomed Engn, London, England		Grohn, O (corresponding author), Univ Eastern Finland, Biomed Imaging Unit, AI Virtanen Inst Mol Sci, POB 1627 Neulaniementie 2, FI-70211 Kuopio, Finland.	olli.grohn@uef.fi		Chary, Karthik Sampath Kumar/0000-0002-1539-3463; Manninen, Eppu/0000-0002-9353-6079	Academy of FinlandAcademy of FinlandEuropean Commission [285909, 293970, 275453, 284544, 312686, 298007]	Academy of Finland, Grant/Award Numbers: #285909, #293970, #275453, #284544, #312686, #298007	Acosta-Cabronero J, 2018, NEUROIMAGE, V183, P7, DOI 10.1016/j.neuroimage.2018.07.065; Aggarwal M, 2018, J MAGN RESON IMAGING, V47, P554, DOI 10.1002/jmri.25777; Argyridis L, 2014, NEUROIMAGE, V88, P134, DOI 10.1016/j.neuroimage.2013.11.026; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Chappell KE, 2004, AM J NEURORADIOL, V25, P431; Cherubini A, 2009, MAGN RESON MED, V61, P1066, DOI 10.1002/mrm.21978; Cohen-Adad J, 2012, NEUROIMAGE, V60, P1006, DOI 10.1016/j.neuroimage.2012.01.053; Conti AC, 1998, J NEUROSCI, V18, P5663; Deistung A, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3569; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Dymerska B, 2019, P INT SOC MAGN RESON, V27, P2993; Eskreis-Winkler S, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3668; Fukunaga M, 2010, P NATL ACAD SCI USA, V107, P3834, DOI 10.1073/pnas.0911177107; Gayoso MJ, 2003, HISTOL HISTOPATHOL, V18, P855, DOI 10.14670/HH-18.855; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; He NY, 2015, HUM BRAIN MAPP, V36, P4407, DOI 10.1002/hbm.22928; Huttunen JK, 2018, J NEUROTRAUM, V35, P2708, DOI 10.1089/neu.2017.5308; Immonen RJ, 2008, NEUROIMAGE, V40, P1718, DOI 10.1016/j.neuroimage.2008.01.042; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karsa A, 2020, THESIS; Karsa A, 2020, MAGN RESON MED, V84, P3206, DOI 10.1002/mrm.28377; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim HG, 2017, NEUROIMAGE-CLIN, V16, P429, DOI 10.1016/j.nicl.2017.08.019; Klohs J, 2011, J CEREBR BLOOD F MET, V31, P2282, DOI 10.1038/jcbfm.2011.118; Kressler B, 2010, IEEE T MED IMAGING, V29, P273, DOI 10.1109/TMI.2009.2023787; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Langkammer C, 2018, MAGN RESON MED, V79, P1661, DOI 10.1002/mrm.26830; Langkammer C, 2013, RADIOLOGY, V267, P551, DOI 10.1148/radiol.12120707; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; Langkammer C, 2012, NEUROIMAGE, V59, P1413, DOI 10.1016/j.neuroimage.2011.08.045; Lee Bruce, 2005, NeuroRx, V2, P372; Lee J, 2012, NEUROIMAGE, V59, P3967, DOI 10.1016/j.neuroimage.2011.10.076; Lehto LJ, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3678; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Li W, 2016, NMR BIOMED, V29, P896, DOI 10.1002/nbm.3536; Li W, 2012, NEUROIMAGE, V59, P2088, DOI 10.1016/j.neuroimage.2011.10.038; Liu CL, 2015, TOMOGRAPHY, V1, P3, DOI 10.18383/j.tom.2015.00136; Liu CL, 2011, NEUROIMAGE, V56, P930, DOI 10.1016/j.neuroimage.2011.02.024; Liu J, 2012, NEUROIMAGE, V59, P2560, DOI 10.1016/j.neuroimage.2011.08.082; Liu T, 2011, NMR BIOMED, V24, P1129, DOI 10.1002/nbm.1670; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; Murakami Y, 2015, AM J NEURORADIOL, V36, P1102, DOI 10.3174/ajnr.A4260; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Nissi MJ, 2015, PLOS ONE, V10, P1; Okubo Shuichi, 2013, Acta Neurochir Suppl, V118, P83, DOI 10.1007/978-3-7091-1434-6_14; Barbosa JHO, 2015, MAGN RESON IMAGING, V33, P559, DOI 10.1016/j.mri.2015.02.021; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Rudko DA, 2014, P NATL ACAD SCI USA, V111, pE159, DOI 10.1073/pnas.1306516111; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Schofield MA, 2003, OPT LETT, V28, P1194, DOI 10.1364/OL.28.001194; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Schweser F, 2019, NEUROIMAGE, V200, P250, DOI 10.1016/j.neuroimage.2019.06.024; Schweser F, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3604; Schweser F, 2013, MAGN RESON MED, V69, P1581, DOI 10.1002/mrm.24405; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Shmueli K, 2009, P INT SOC MAGN RESON, V17, P466; Shoamanesh A, 2011, CEREBROVASC DIS, V32, P528, DOI 10.1159/000331466; Soman S, 2018, AM J NEURORADIOL, V39, P648, DOI 10.3174/ajnr.A5550; Sun HF, 2018, RADIOLOGY, V288, P830, DOI 10.1148/radiol.2018171918; Sun HF, 2015, NEUROIMAGE, V105, P486, DOI 10.1016/j.neuroimage.2014.11.010; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Wisnieff C, 2015, MAGN RESON MED, V74, P564, DOI 10.1002/mrm.25420; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Yamada N, 1996, RADIOLOGY, V198, P171, DOI 10.1148/radiology.198.1.8539373	77	3	3	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	FEB	2021	34	2							e4438	10.1002/nbm.4438		NOV 2020	15	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	PS7MX	WOS:000590837000001	33219598	Green Submitted			2022-02-06	
J	Kupats, E; Stelfa, G; Zvejniece, B; Grinberga, S; Vavers, E; Makrecka-Kuka, M; Svalbe, B; Zvejniece, L; Dambrova, M				Kupats, Einars; Stelfa, Gundega; Zvejniece, Baiba; Grinberga, Solveiga; Vavers, Edijs; Makrecka-Kuka, Marina; Svalbe, Baiba; Zvejniece, Liga; Dambrova, Maija			Mitochondrial-Protective Effects of R-Phenibut after Experimental Traumatic Brain Injury	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							CORTICAL IMPACT INJURY; CLOSED-HEAD INJURY; SPINAL-CORD-INJURY; PERMEABILITY TRANSITION; ALPHA(2)DELTA SUBUNITS; ANTIOXIDANT THERAPIES; OPTICAL ISOMERS; ANIMAL-MODELS; CALCIUM; INTERLEUKIN-1	Altered neuronal Ca2+ homeostasis and mitochondrial dysfunction play a central role in the pathogenesis of traumatic brain injury (TBI). R-Phenibut ((3R)-phenyl-4-aminobutyric acid) is an antagonist of the alpha(2)delta subunit of voltage-dependent calcium channels (VDCC) and an agonist of gamma-aminobutyric acid B (GABA-B) receptors. The aim of this study was to evaluate the potential therapeutic effects of R-phenibut following the lateral fluid percussion injury (latFPI) model of TBI in mice and the impact of R- and S-phenibut on mitochondrial functionality in vitro. By determining the bioavailability of R-phenibut in the mouse brain tissue and plasma, we found that R-phenibut (50 mg/kg) reached the brain tissue 15 min after intraperitoneal (i.p.) and peroral (p.o.) injections. The maximal concentration of R-phenibut in the brain tissues was 0.6 mu g/g and 0.2 mu g/g tissue after i.p. and p.o. administration, respectively. Male Swiss-Webster mice received i.p. injections of R-phenibut at doses of 10 or 50 mg/kg 2 h after TBI and then once daily for 7 days. R-Phenibut treatment at the dose of 50 mg/kg significantly ameliorated functional deficits after TBI on postinjury days 1, 4, and 7. Seven days after TBI, the number of Nissl-stained dark neurons (N-DNs) and interleukin-1beta (IL-1 beta) expression in the cerebral neocortex in the area of cortical impact were reduced. Moreover, the addition of R- and S-phenibut at a concentration of 0.5 mu g/ml inhibited calcium-induced mitochondrial swelling in the brain homogenate and prevented anoxia-reoxygenation-induced increases in mitochondrial H2O2 production and the H2O2/O ratio. Taken together, these results suggest that R-phenibut could serve as a neuroprotective agent and promising drug candidate for treating TBI.	[Kupats, Einars; Stelfa, Gundega; Zvejniece, Baiba; Grinberga, Solveiga; Vavers, Edijs; Makrecka-Kuka, Marina; Svalbe, Baiba; Zvejniece, Liga; Dambrova, Maija] Latvian Inst Organ Synth, Riga, Latvia; [Kupats, Einars] Riga Stradins Univ, Dept Neurol & Neurosurg, Riga, Latvia; [Stelfa, Gundega] Latvia Univ Life Sci & Technol, Jelgava, Latvia; [Dambrova, Maija] Riga Stradins Univ, Dept Pharmaceut Chem, Riga, Latvia		Kupats, E (corresponding author), Latvian Inst Organ Synth, Riga, Latvia.; Kupats, E (corresponding author), Riga Stradins Univ, Dept Neurol & Neurosurg, Riga, Latvia.	einars.kupats@farm.osi.lv; gundega@farm.osi.lv; baiba.zvejniece@farm.osi.lv; solveiga@osi.lv; edijs.vavers@farm.osi.lv; makrecka@farm.osi.lv; baibas@farm.osi.lv; liga@farm.osi.lv; maija.dambrova@farm.osi.lv	Vavers, Edijs/AAW-5840-2021	Makrecka-Kuka, Marina/0000-0003-4549-1993; Vavers, Edijs/0000-0003-1322-1307; Stelfa, Gundega/0000-0001-7520-142X; Svalbe, Baiba/0000-0001-8390-773X; Kupats, Einars/0000-0003-3597-0093	EU-ERA-NET NEURON project TRAINS; EU-ERA-NET NEURON project CnsAflame	This study was supported by the framework of the EU-ERA-NET NEURON projects TRAINS and CnsAflame.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Belozertseva I, 2016, PHARMACOL REP, V68, P550, DOI 10.1016/j.pharep.2015.12.004; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Burtscher J, 2015, MITOCHONDRION, V25, P104, DOI 10.1016/j.mito.2015.10.007; Calikoglu C, 2015, MED SCI MONITOR, V21; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; D'Arco M, 2015, J NEUROSCI, V35, P5891, DOI 10.1523/JNEUROSCI.3997-14.2015; Dambrova M, 2008, EUR J PHARMACOL, V583, P128, DOI 10.1016/j.ejphar.2008.01.015; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; Flygt J, 2018, J NEUROTRAUM, V35, P2837, DOI 10.1089/neu.2018.5660; Genrikhs EE, 2015, J DRUG TARGET, V23, P347, DOI 10.3109/1061186X.2014.997736; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Ha KY, 2008, EUR SPINE J, V17, P864, DOI 10.1007/s00586-008-0653-6; Ha KY, 2011, J KOREAN MED SCI, V26, P404, DOI 10.3346/jkms.2011.26.3.404; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Huynh D, 2012, FASEB J, V26; Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473; Kinjo T, 2018, NEUROCHEM RES, V43, P79, DOI 10.1007/s11064-017-2311-z; Kobayashi T, 2003, BRAIN RES, V960, P62, DOI 10.1016/S0006-8993(02)03767-8; Kristian T, 2000, J NEUROCHEM, V74, P1999, DOI 10.1046/j.1471-4159.2000.0741999.x; Krumschnabel Gerhard, 2015, Methods Mol Biol, V1264, P245, DOI 10.1007/978-1-4939-2257-4_22; Kupats E, 2020, PHARMACOPSYCHIATRY, V53, P201, DOI 10.1055/a-1151-5017; Lapin I, 2001, CNS DRUG REV, V7, P471; Lazovic J, 2005, STROKE, V36, P2226, DOI 10.1161/01.STR.0000182255.08162.6a; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Makrecka M, 2014, EUR J PHARMACOL, V723, P55, DOI 10.1016/j.ejphar.2013.12.006; Makrecka-Kuka M, 2015, BIOMOLECULES, V5, P1319, DOI 10.3390/biom5031319; Marais E, 2001, MOL PHARMACOL, V59, P1243, DOI 10.1124/mol.59.5.1243; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Meymandi MS, 2018, BRAIN RES BULL, V140, P169, DOI 10.1016/j.brainresbull.2018.05.001; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Newell EA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0385-17.2018; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Perfilova VN, 2017, B EXP BIOL MED+, V163, P226, DOI 10.1007/s10517-017-3772-4; Posmantur RM, 2000, EXP NEUROL, V161, P15, DOI 10.1006/exnr.1999.7244; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qin N, 2002, MOL PHARMACOL, V62, P485, DOI 10.1124/mol.62.3.485; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Schmidt RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045186; Schurman LD, 2017, NEUROSCI LETT, V653, P31, DOI 10.1016/j.neulet.2017.05.032; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Taylor CP, 2008, NEUROSCIENCE, V155, P510, DOI 10.1016/j.neuroscience.2008.05.053; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Vavers E, 2016, PHARMACOL RES, V113, P796, DOI 10.1016/j.phrs.2015.11.013; Veech RL, 2012, IUBMB LIFE, V64, P203, DOI 10.1002/iub.590; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhou J, 2018, AM J TRANSL RES, V10, P1887; Zvejniece L, 2020, INFLAMMOPHARMACOLOGY, V28, P1283, DOI 10.1007/s10787-020-00705-7; Zvejniece L, 2020, J NEUROTRAUM, V37, P295, DOI 10.1089/neu.2019.6524; Zvejniece L, 2015, PHARMACOL BIOCHEM BE, V137, P23, DOI 10.1016/j.pbb.2015.07.014	65	3	3	1	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.	NOV 21	2020	2020								9364598	10.1155/2020/9364598			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	PB6SI	WOS:000596447900002	33274011	Green Published, gold			2022-02-06	
J	Creutzfeldt, CJ; Schutz, REC; Zahuranec, DB; Lutz, BJ; Curtis, JR; Engelberg, RA				Creutzfeldt, Claire J.; Schutz, Rachael E. C.; Zahuranec, Darin B.; Lutz, Barbara J.; Curtis, J. Randall; Engelberg, Ruth A.			Family Presence for Patients with Severe Acute Brain Injury and the Influence of the COVID-19 Pandemic	JOURNAL OF PALLIATIVE MEDICINE			English	Article						communication; COVID-19; critical illness; family; palliative care; severe acute brain injury		Objectives: The global COVID-19 pandemic made strict visitation policies necessary. We explored the experiences of family members of patients with severe acute brain injury focusing on the impact of family presence in the hospital. Methods: Semistructured interviews (February 2018-April 2020) were audiotaped, transcribed, and analyzed using thematic analysis. Results: We interviewed family members of 19 patients with stroke, traumatic brain injury, or cardiac arrest; five interviews occurred after initiation of restrictive visitation policies. Four key themes highlight the role of visitation on family's ability to (1) cope by being at the bedside, (2) protect and advocate for the patient, (3) build trust with clinicians, and (4) receive emotional support in the intensive care unit. After visitation restrictions, families found ways to communicate and support virtually and wished for proactive communication from clinicians. Conclusions: Family presence at patient's bedside fulfills important needs. Visitation restrictions require hospitals to be creative and inclusive to help maintain these connections.	[Creutzfeldt, Claire J.; Schutz, Rachael E. C.] Univ Washington, Harborview Med Ctr, Dept Neurol, 325 Ninth Ave, Seattle, WA 98104 USA; [Curtis, J. Randall; Engelberg, Ruth A.] Univ Washington, Harborview Med Ctr, Div Pulm Crit Care & Sleep Med, 325 9Th Ave, Seattle, WA 98104 USA; [Creutzfeldt, Claire J.; Curtis, J. Randall; Engelberg, Ruth A.] Univ Washington, Harborview Med Ctr, Cambia Palliat Care Ctr Excellence, 325 9Th Ave, Seattle, WA 98104 USA; [Zahuranec, Darin B.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Lutz, Barbara J.] Univ N Carolina, Sch Nursing, Wilmington, NC USA		Creutzfeldt, CJ (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol, 325 Ninth Ave, Seattle, WA 98104 USA.	clairejc@uw.edu	Schutz, Rachael/AAV-6164-2021		NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS099421]	This article was funded by a career development award from the NINDS (Grant No. K23 NS099421).	[Anonymous], 2020, VITALTALK COVID READ; Boyd EA, 2010, CRIT CARE MED, V38, P1270, DOI 10.1097/CCM.0b013e3181d8a217; Chua IS, 2020, J PALLIAT MED, V23, P1507, DOI 10.1089/jpm.2020.0298; Lamas D, 2020, IM FRONT LINES I HAV; Sandelowski M, 2012, QUAL HEALTH RES, V22, P1404, DOI 10.1177/1049732312450368; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Zahuranec DB, 2018, J PALLIAT MED, V21, P956, DOI 10.1089/jpm.2017.0604	7	3	3	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-6218	1557-7740		J PALLIAT MED	J. Palliat. Med.	MAY 1	2021	24	5					743	746		10.1089/jpm.2020.0520		NOV 2020	4	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	RW9AV	WOS:000592686800001	33210984				2022-02-06	
J	Wu, E; Marthi, S; Asaad, WF				Wu, Esther; Marthi, Siddharth; Asaad, Wael F.			Predictors of Mortality in Traumatic Intracranial Hemorrhage: A National Trauma Data Bank Study	FRONTIERS IN NEUROLOGY			English	Article						national trauma data bank; support vector machine; traumatic brain injury; traumatic intracranial hemorrhage; mortality predictors	BRAIN-INJURY; ALCOHOL	Background/Objective: Traumatic intracranial hemorrhage (tICH) accounts for significant trauma morbidity and mortality. Several studies have developed prognostic models for tICH outcomes, but previous models face limitations, including poor generalizability and limited accuracy. The objective was to develop a prognostic model and determine predictors of mortality using the largest trauma database in the U.S., applying rigorous analytical methodology with true hold-out-set model validation. Methods: We identified 248,536 patients in the National Trauma Data Bank (NTDB) from 2012 to 2016 with a diagnosis code associated with tICH. For each admission, we collected demographic information, systolic blood pressure, blood alcohol level (BAL), Glasgow Coma Score (GCS), Injury Severity Score (ISS), presence of epidural/subdural/subarachnoid/intraparenchymal hemorrhage, comorbidities, complications, trauma center level, and trauma center region. Our final study population was 212,666 patients following exclusion of records with missing data. The dependent variable was patient death. Linear support vector machine (SVM) classification was carried out with recursive feature selection. Model performance was assessed using holdout 10-fold cross-validation. Results: Cross-validation demonstrated a mean accuracy of 0.792 (95% CI 0.783-0.799). Accuracy, precision, recall, and AUC were 0.827, 0.309, 0.750, and 0.791, respectively. In the final model, high ISS, advanced age, subdural hemorrhage, and subarachnoid hemorrhage were associated with increased mortality, while high GCS verbal and motor subscores, current smoker, BAL beyond the legal limit, and level 1 trauma center were associated with decreased mortality. Conclusions: A linear SVM model was developed for tICH, with nine features selected as predictors of mortality. These findings are applicable to multiple hemorrhage subtypes and may benefit the triage of high risk patients upon admission. While many studies have attempted to create models to predict mortality in TBI, we sought to confirm those predictors using modern modeling approaches, machine learning, and true hold-out test sets, using the largest available TBI database in the U.S. We find that while the predictors we identify are consistent with prior reports, overall prediction accuracy is somewhat lower than prior reports when assessed more rigorously.	[Wu, Esther; Marthi, Siddharth; Asaad, Wael F.] Brown Univ, Dept Neurosurg, Warren Alpert Med Sch, Providence, RI 02912 USA; [Asaad, Wael F.] Brown Univ, Carney Inst Brain Sci, Providence, RI 02912 USA; [Asaad, Wael F.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Asaad, Wael F.] Rhode Isl Hosp, Norman Prince Neurosci Inst, Providence, RI USA; [Asaad, Wael F.] Rhode Isl Hosp, Dept Neurosurg, Providence, RI USA		Wu, E (corresponding author), Brown Univ, Dept Neurosurg, Warren Alpert Med Sch, Providence, RI 02912 USA.	esther_wu@brown.edu	Asaad, Wael/I-8485-2012	Asaad, Wael/0000-0003-4406-9096			[Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Caruana R, 2005, P 21 C UNC ART INT, P413; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1994, RADIOLOGY, V191, P1; Han JLXG, 2017, WORLD NEUROSURG, V108, P885, DOI 10.1016/j.wneu.2017.08.147; Hijioka M, 2012, NEUROSCIENCE, V222, P10, DOI 10.1016/j.neuroscience.2012.07.024; Hijioka M, 2011, J PHARMACOL EXP THER, V338, P741, DOI 10.1124/jpet.111.182519; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Keerthi SS, 2006, J MACH LEARN RES, V7, P1493; Lilley EJ, 2018, JAMA SURG, V153, P44, DOI 10.1001/jamasurg.2017.3148; Modi NJ, 2016, NEUROL INDIA, V64, P8, DOI 10.4103/0028-3886.178030; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Ostberg A, 2014, BRAIN INJURY, V28, P155, DOI 10.3109/02699052.2013.860468; Powers AY, 2020, J NEUROSURG, V132, P552, DOI 10.3171/2018.11.JNS182199; Raschka S., 2018, MODEL EVALUATION MOD; Rau CS, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234787; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111420; Shivasabesan G, 2018, INJURY, V49, P1641, DOI 10.1016/j.injury.2018.03.035; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491	28	3	3	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 17	2020	11								587587	10.3389/fneur.2020.587587			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OY6UK	WOS:000594379700001	33281725	Green Published, gold			2022-02-06	
J	Kawata, K; Steinfeldt, JA; Huibregtse, ME; Nowak, MK; Macy, JT; Kercher, K; Rettke, DJ; Shin, A; Chen, ZX; Ejima, K; Newman, SD; Cheng, H				Kawata, Keisuke; Steinfeldt, Jesse A.; Huibregtse, Megan E.; Nowak, Madeleine K.; Macy, Jonathan T.; Kercher, Kyle; Rettke, Devin J.; Shin, Andrea; Chen, Zhongxue; Ejima, Keisuke; Newman, Sharlene D.; Cheng, Hu			Association Between Proteomic Blood Biomarkers and DTI/NODDI Metrics in Adolescent Football Players: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						brain injury; diffusion tensor imaging; neurite orientation dispersion and density imaging; blood biomarker; football; youth; concussion; subconcussion	SERUM NEUROFILAMENT LIGHT; TRAUMATIC BRAIN-INJURY; NEURITE ORIENTATION DISPERSION; DIFFUSION TENSOR; WHITE-MATTER; FRACTIONAL ANISOTROPY; ALZHEIMERS-DISEASE; CONCUSSION; IMMUNOASSAY; PROTEIN	While neuroimaging and blood biomarker have been two of the most active areas of research in the neurotrauma community, these fields rarely intersect to delineate subconcussive brain injury. The aim of the study was to examine the association between diffusion MRI techniques [diffusion tensor imaging (DTI) and neurite orientation/dispersion density imaging (NODDI)] and brain-injury blood biomarker levels [tau, neurofilament-light (NfL), glial-fibrillary-acidic-protein (GFAP)] in high-school football players at their baseline, aiming to detect cumulative neuronal damage from prior seasons. Twenty-five football players were enrolled in the study. MRI measures and blood samples were obtained during preseason data collection. The whole-brain, tract-based spatial statistics was conducted for six diffusion metrics: fractional anisotropy (FA), mean diffusivity (MD), axial/radial diffusivity (AD, RD), neurite density index (NDI), and orientation dispersion index (ODI). Five players were ineligible for MRIs, and three serum samples were excluded due to hemolysis, resulting in 17 completed set of diffusion metrics and blood biomarker levels for association analysis. Our permutation-based regression model revealed that serum tau levels were significantly associated with MD and NDI in various axonal tracts; specifically, elevated serum tau levels correlated to elevated MD (p = 0.0044) and reduced NDI (p = 0.016) in the corpus callosum and surrounding white matter tracts (e.g., longitudinal fasciculus). Additionally, there was a negative association between NfL and ODI in the focal area of the longitudinal fasciculus. Our data suggest that high school football players may develop axonal microstructural abnormality in the corpus callosum and surrounding white matter tracts, such as longitudinal fasciculus. A future study is warranted to determine the longitudinal multimodal relationship in response to repetitive exposure to sports-related head impacts.	[Kawata, Keisuke; Huibregtse, Megan E.; Nowak, Madeleine K.; Rettke, Devin J.] Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Kawata, Keisuke; Cheng, Hu] Indiana Univ, Coll Arts & Sci, Program Neurosci, Bloomington, IN 47405 USA; [Steinfeldt, Jesse A.] Indiana Univ, Sch Educ, Dept Counseling & Educ Psychol, Bloomington, IN 47405 USA; [Macy, Jonathan T.; Kercher, Kyle] Indiana Univ, Dept Appl Hlth Sci, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Shin, Andrea] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA; [Chen, Zhongxue; Ejima, Keisuke] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth Bloomington, Bloomington, IN USA; [Newman, Sharlene D.; Cheng, Hu] Indiana Univ, Coll Arts & Sci, Dept Psychol & Brain Sci, Bloomington, IN USA; [Newman, Sharlene D.] Univ Alabama, Alabama Life Res Inst, Tuscaloosa, AL USA		Kawata, K (corresponding author), Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA.; Kawata, K (corresponding author), Indiana Univ, Coll Arts & Sci, Program Neurosci, Bloomington, IN 47405 USA.	kkawata@indiana.edu		Kercher, Kyle/0000-0002-4092-7113	Indiana University Office of Vice President for Research; Indiana University Women's Philanthropy Council; Indiana CTSI pilot core fund	This manuscript has been released as a pre-print at bioRxiv [Kawata et al. (71)]. This work was partly supported by the Research Funds from the Indiana University Office of Vice President for Research (to KKa), Indiana University Women's Philanthropy Council (to KKa), and Indiana CTSI pilot core fund (to KKa and SN). Sponsors had no role in the design or execution of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Chen Y, 2019, ARXIV191202901V1, V1912, p02901v1; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fu XW, 2020, CLIN NEURORADIOL, V30, P569, DOI 10.1007/s00062-019-00805-0; Gao WY, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022363; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Genc S, 2017, NEUROIMAGE, V148, P373, DOI 10.1016/j.neuroimage.2017.01.023; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Goldstein A, 2020, NEUROANATOMY CORPUS; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hermesdorf M, 2017, NEUROIMAGE-CLIN, V14, P151, DOI 10.1016/j.nicl.2017.01.013; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Jin M, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00254; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Joseph JR, 2019, J NEUROSURG, V130, P1642, DOI 10.3171/2017.12.JNS172386; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kawata K, 2020, BIORXIV PREPRINT, DOI [10.1101/2020.02.20.958694, DOI 10.1101/2020.02.20.958694]; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kuhle J, 2017, NEUROLOGY, V88, P826, DOI 10.1212/WNL.0000000000003653; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Lombardi V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67914-6; Lubsen J, 2011, SEMIN PERINATOL, V35, P34, DOI 10.1053/j.semperi.2010.10.006; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Oliver JM, 2019, J NEUROSURG, V130, P1655, DOI 10.3171/2017.12.JNS172035; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; Palacios EM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6892; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2017, J NEUROTRAUM, V34, P2132, DOI 10.1089/neu.2016.4806; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Rubin LH, 2019, BRAIN INJURY, V33, P456, DOI 10.1080/02699052.2019.1565895; Schneider DK, 2019, J NEUROTRAUM, V36, P2831, DOI 10.1089/neu.2019.6398; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Strauss SB, 2021, BRAIN IMAGING BEHAV, V15, P882, DOI 10.1007/s11682-020-00297-4; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wang SY, 2019, J ALZHEIMERS DIS, V72, P1353, DOI 10.3233/JAD-190615; Warbrick T, 2017, NEUROIMAGE, V153, P369, DOI 10.1016/j.neuroimage.2016.12.075; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Wirsching A, 2019, J NEUROTRAUM, V36, P548, DOI 10.1089/neu.2018.5836; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zonner SW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00327	71	3	3	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 16	2020	11								581781	10.3389/fneur.2020.581781			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OY0LB	WOS:000593944600001	33304306	gold, Green Submitted, Green Published			2022-02-06	
J	Rosenbaum, PE; Locandro, C; Chrisman, SPD; Choe, MC; Richards, R; Pacchia, C; Cook, LJ; Rivara, FP; Gioia, GA; Giza, CC				Rosenbaum, Philip E.; Locandro, Christopher; Chrisman, Sara P. D.; Choe, Meeryo C.; Richards, Rachel; Pacchia, Christina; Cook, Lawrence J.; Rivara, Frederick P.; Gioia, Gerard A.; Giza, Christopher C.			Characteristics of Pediatric Mild Traumatic Brain Injury and Recovery in a Concussion Clinic Population	JAMA NETWORK OPEN			English	Article							EMERGENCY-DEPARTMENT VISITS; COMMON DATA ELEMENTS; POSTCONCUSSION SYNDROME; LIFETIME PREVALENCE; UNITED-STATES; EPIDEMIOLOGY; DISORDERS; SYMPTOMS; SEX; AGE	Question What factors are associated with recovery in pediatric patients with mild traumatic brain injury or concussion? Findings In this cohort study of 600 pediatric patients presenting to concussion clinics in 3 centers, girls and women experienced slower recovery and were more likely to have preexisting anxiety compared with boys and men. Independent of sex, patients with anxiety or depression or migraine recovered more slowly than those without these comorbidities. Meaning These findings suggest that factors, such as sex and comorbidities, in pediatric patients with mild traumatic brain injury are essential for accurate prognostic estimates and identifying targets for treatment. This cohort study examines patient characteristics associated with recovery time in pediatric patients with mild traumatic brain injury treated at concussion specialty clinics. Importance Pediatric mild traumatic brain injury (TBI) and concussion are a public health challenge with up to 30% of patients experiencing prolonged recovery. Pediatric patients presenting to concussion clinics often have ongoing impairments and may be at increased risk for persistent symptoms. Understanding this population is critical for improved prognostic estimates and optimal treatment. Objective To describe pediatric patients presenting to concussion clinics and characterize factors associated with their recovery. Design, Setting, and Participants This prospective cohort study included patients enrolled at multicenter concussion specialty clinics from the Four Corners Youth Consortium from December 2017 to July 2019, with up to 12-month follow-up. Patients were eligible if they were aged 5 to 18.99 years with a diagnosis of mild TBI or concussion presenting to participating clinics within 8 weeks of injury. Patients were excluded if the patient or their parents were unable to read or sign the consent document, or if the patient had a Glasgow Coma Scale score less than 13 or a penetrating injury. Data were analyzed from February 2019 to April 2020. Exposures Diagnosis of mild TBI or concussion. Main Outcomes and Measures This study used National Institute of Neurological Disorders and Stroke common data elements, including data on demographic characteristics, injury details, history, neurological and neuropsychological assessments, and treatment. Results A total of 600 patients were consecutively enrolled, among whom 324 (54.0%) were female and 435 (72.5%) were adolescents (ie, aged 13-18 years). A higher proportion of girls and women (248 patients [76.5%]) were adolescents compared with boys and men (187 patients [67.8%]) (P = .02), and girls and women reported significantly more preexisting anxiety compared with boys and men (80 patients [26.7%] vs 46 patients [18.7%]; P = .03). Significantly more adolescents reported preexisting migraines compared with preadolescents (82 patients [20.9%] vs 15 patients [10.9%]; P = .01). Girls and women recovered more slowly than boys and men (persistent symptoms after injury: week 4, 217 patients [81.6%] vs 156 patients [71.2%]; week 8, 146 patients [58.9%] vs 89 patients [44.3%]; week 12, 103 patients [42.6%] vs 58 patients [30.2%]; P = .01). Patients with history of migraine or anxiety or depression recovered more slowly than those without, regardless of sex. Conclusions and Relevance These findings suggest that identification of subgroups of pediatric patients with mild TBI or concussion at risk for prolonged recovery could aid in better prognostic estimates and more targeted treatment interventions.	[Choe, Meeryo C.; Giza, Christopher C.] UCLA Mattel Childrens Hosp, David Geffen Sch Med, Dept Pediat, 300 Stein Plaza Driveway,Ste 531, Los Angeles, CA 90095 USA; [Rosenbaum, Philip E.; Giza, Christopher C.] Univ Calif Los Angeles, Dept Neurosurg, David Geffen Sch Med, Los Angeles, CA USA; [Rosenbaum, Philip E.; Choe, Meeryo C.; Giza, Christopher C.] Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Locandro, Christopher; Richards, Rachel; Pacchia, Christina; Cook, Lawrence J.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Chrisman, Sara P. D.; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Chrisman, Sara P. D.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Chrisman, Sara P. D.; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Dept Psychiat, Washington, DC 20052 USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Dept Behav Sci, Washington, DC 20052 USA; [Gioia, Gerard A.] Natl Childrens Hosp, Rockville, MD USA		Giza, CC (corresponding author), UCLA Mattel Childrens Hosp, David Geffen Sch Med, Dept Pediat, 300 Stein Plaza Driveway,Ste 531, Los Angeles, CA 90095 USA.	cgiza@mednet.ucla.edu		Chrisman, Sara/0000-0001-5373-7223	UCLA Steve Tisch BrainSPORT Program; Easton Clinic for Brain Health; UCLA Brain Injury Research Center; Stan and Patti Silver; Satterberg Foundation; Sports Institute at UW Medicine	This study was supported by funds from the UCLA Steve Tisch BrainSPORT Program, the Easton Clinic for Brain Health, the UCLA Brain Injury Research Center, Stan and Patti Silver, the Satterberg Foundation, and the Sports Institute at UW Medicine.	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control and Prevention, 2018, C MAN TRAUM BRAIN IN; Choe MC, 2020, PEDIATR NEUROL, V107, P84, DOI 10.1016/j.pediatrneurol.2020.01.008; Copley M, 2020, J RACIAL ETHN HEALTH, V7, P571, DOI 10.1007/s40615-019-00686-6; Cyranowski JM, 2000, ARCH GEN PSYCHIAT, V57, P21, DOI 10.1001/archpsyc.57.1.21; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; de Lijster JM, 2017, CAN J PSYCHIAT, V62, P237, DOI 10.1177/0706743716640757; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Ghandour RM, 2019, J PEDIATR-US, V206, P256, DOI 10.1016/j.jpeds.2018.09.021; Howell DR, 2019, CLIN PEDIATR, V58, P42, DOI 10.1177/0009922818806308; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kessler RC, 2011, ARCH GEN PSYCHIAT, V68, P90, DOI 10.1001/archgenpsychiatry.2010.180; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lagman-Bartolome AM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0551-3; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mayer AR, 2020, J NEUROTRAUM, V37, P1504, DOI 10.1089/neu.2019.6805; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Mojtabai R, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1878; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; STEWART WF, 1991, AM J EPIDEMIOL, V134, P1111, DOI 10.1093/oxfordjournals.aje.a116014; Vetvik KG, 2017, LANCET NEUROL, V16, P76, DOI 10.1016/S1474-4422(16)30293-9; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; Yumul JN, 2020, J HEAD TRAUMA REHAB, V35, P279, DOI 10.1097/HTR.0000000000000565; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	44	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	NOV 16	2020	3	11							e2021463	10.1001/jamanetworkopen.2020.21463			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	PA5FZ	WOS:000595662700001	33196804	Green Published, gold			2022-02-06	
J	Ashton, J; Coyles, G; Malone, JJ; Roberts, JW				Ashton, Jake; Coyles, Ginny; Malone, James J.; Roberts, James W.			Immediate effects of an acute bout of repeated soccer heading on cognitive performance	SCIENCE AND MEDICINE IN FOOTBALL			English	Article						Head impact; concussion; cognitive function; working memory	NEUROPSYCHOLOGICAL IMPAIRMENT; HIGH-SCHOOL; FOOTBALL; YOUTH; INJURIES; BRAIN; CONCUSSIONS; SYMPTOMS; TRAIL; PLAY	Purpose: There isgrowing concern surrounding the harmful effects of soccer heading on cognitive function. The present study aims to examine the immediate effects of heading. Methods: 30 recreational male soccer players were divided into three groups that undertook 20 consecutive headers with a soft (8.8 psi), hard (16.2 psi), or no (control) ball. A battery of neuropsychological tests was completed before and after heading: King-Devick, trail-making (TM) (A, B), digit span (DS) and spatial span (SS) (forward, backward). Results: Significant increase in the time (M = 4.44 s) and errors (M = 1.45) for the King-Devick test within the hard and soft groups, although there was no significant difference for TM-A and TM-B. Significant decline for SS forward within the hard and soft groups (M= -16%), although the declines for SS backward (M = -16%), DS forward (M= -23%) and DS backward (M = -25%) were present only for the hard group (ps <.05). Discussion: While outside of regular match-play, this study showed that heading negatively influenced one indicator of a suspected concussion (King-Devick), as well as working memory (DS, SS) that is essential for daily life. These findings contribute to the growing debate surrounding heading safety.	[Ashton, Jake; Coyles, Ginny; Malone, James J.; Roberts, James W.] Liverpool Hope Univ, Sch Hlth Sci, Hope Pk, Liverpool L16 9JD, Merseyside, England; [Roberts, James W.] Liverpool John Moores Univ, Brain & Behav Lab, Res Inst Sport & Exercise Sci, Tom Reilly Bldg,Byrom St, Liverpool L3 5AF, Merseyside, England		Roberts, JW (corresponding author), Liverpool Hope Univ, Sch Hlth Sci, Hope Pk, Liverpool L16 9JD, Merseyside, England.	J.W.Roberts@ljmu.ac.uk	Roberts, James/AAA-4182-2021; Malone, James/AAQ-6686-2021	Roberts, James/0000-0001-6204-5325; Malone, James/0000-0003-4593-3974			Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Beaudouin F, 2020, SCAND J MED SCI SPOR, V30, P1506, DOI 10.1111/sms.13694; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Caccese JB, 2021, CLIN J SPORT MED, V31, P266, DOI 10.1097/JSM.0000000000000709; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Chiampas GT, 2018, SCI MED FOOTBALL, V2, P80, DOI 10.1080/24733938.2017.1421771; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Howitt Scott, 2016, J Can Chiropr Assoc, V60, P322; International Football Association Board, 2019, LAWS GAM; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kaminski TW, 2020, SCI MED FOOTBALL, V4, P93, DOI 10.1080/24733938.2019.1677937; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; KESSELS RPC, 2000, APPL NEUROPSYCHOL, V7, P4, DOI DOI https://doi.org/10.1207/S15324826AN0704_8; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lo AHY, 2012, J NEUROPSYCHOL, V6, P212, DOI 10.1111/j.1748-6653.2011.02023.x; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Meyer T, 2018, SCI MED FOOTBALL, V2, P1, DOI 10.1080/24733938.2017.1416950; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Radeborg K, 1999, ERGONOMICS, V42, P767, DOI 10.1080/001401399185441; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sandmo SB, 2020, SCAND J MED SCI SPOR, V30, P193, DOI 10.1111/sms.13562; Scheunemann J, 2019, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00542; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI33, DOI 10.1136/bjsm.2005.019059; Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tierney GJ, 2021, SCAND J MED SCI SPOR, V31, P124, DOI 10.1111/sms.13816; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; UEFA, 2020, UEFA HEAD GUID YOUTH; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Wiechmann A, 2010, AGING NEUROPSYCHOL C, V18, P56, DOI 10.1080/13825585.2010.510556; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	45	3	3	4	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2473-3938	2473-4446		SCI MED FOOTBALL	Sci. Med. Football	JUL 3	2021	5	3					181	187		10.1080/24733938.2020.1846769		NOV 2020	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TC0ZF	WOS:000592656300001	35077295	Green Accepted			2022-02-06	
J	Komisarow, JM; Chen, FY; Vavilala, MS; Laskowitz, D; James, ML; Krishnamoorthy, V				Komisarow, Jordan M.; Chen, Fangyu; Vavilala, Monica S.; Laskowitz, Daniel; James, Michael L.; Krishnamoorthy, Vijay			Epidemiology and Outcomes of Acute Respiratory Distress Syndrome Following Isolated Severe Traumatic Brain Injury	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						traumatic brain injury; ARDS; critical care; multi-organ dysfunction		Patients with traumatic brain injury (TBI) are at risk for extra-cranial complications, such as the acute respiratory distress syndrome (ARDS). We conducted an analysis of risk factors, mortality, and healthcare utilization associated with ARDS following isolated severe TBI. The National Trauma Data Bank (NTDB) dataset files from 2007-2014 were used to identify adult patients who suffered isolated [other body region-specific Abbreviated Injury Scale (AIS) < 3] severe TBI [admission total Glasgow Coma Scale (GCS) from 3 to 8 and head region-specific AIS >3]. In-hospital mortality was compared between patients who developed ARDS and those who did not. Utilization of healthcare resources (ICU length of stay, hospital length of stay, duration of mechanical ventilation, and frequency of tracheostomy and gastrostomy tube placement) was also examined. This retrospective cohort study included 38,213 patients with an overall ARDS occurrence of 7.5%. Younger age, admission tachycardia, pre-existing vascular and respiratory diseases, and pneumonia were associated with the development of ARDS. Compared to patients without ARDS, patients that developed ARDS experienced increased in-hospital mortality (OR 1.13, 95% CI 1.01-1.26), length of stay (p = <0.001), duration of mechanical ventilation (p = < 0.001), and placement of tracheostomy (OR 2.70, 95% CI 2.34-3.13) and gastrostomy (OR 2.42, 95% CI 2.06-2.84). After isolated severe TBI, ARDS is associated with increased mortality and healthcare utilization. Future studies should focus on both prevention and management strategies specific to TBI-associated ARDS.	[Komisarow, Jordan M.] Duke Univ, Dept Neurosurg, DUMC Box 3807, Durham, NC 27710 USA; [Chen, Fangyu] Duke Univ, Sch Med, Durham, NC USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Laskowitz, Daniel; James, Michael L.] Duke Univ, Dept Neurol, Durham, NC USA; [James, Michael L.; Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, Durham, NC USA		Komisarow, JM (corresponding author), Duke Univ, Dept Neurosurg, DUMC Box 3807, Durham, NC 27710 USA.	jordan.komisarow@duke.edu		Komisarow, Jordan/0000-0003-3919-7931	NIH NINDS via K award [5K23NS109274-02]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr. Vijay Krishnamoorthy has received funding from the NIH NINDS via K award 5K23NS109274-02.	Aisiku IP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1470-7; Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Busl KM, 2015, CRIT CARE MED, V43, P1710, DOI 10.1097/CCM.0000000000001101; Chang MC., 2016, NATL TRAUMA DATABANK; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cox SR, 2019, EUR HEART J, V40, P2290, DOI 10.1093/eurheartj/ehz100; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; Davison DL, 2012, CHEST, V141, P793, DOI 10.1378/chest.11-0789; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; Eberhard LW, 2000, CRIT CARE MED, V28, P125, DOI 10.1097/00003246-200001000-00021; Esnault P, 2019, NEUROCRIT CARE, V30, P405, DOI 10.1007/s12028-018-0639-0; Ferguson ND, 2005, CRIT CARE MED, V33, P2228, DOI 10.1097/01.CCM.0000181529.08630.49; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Hoffman H, 2020, J NEUROSURG, V133, P875, DOI 10.3171/2019.5.JNS19459; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Jacome T, 2018, NEUROCRIT CARE, V28, P110, DOI 10.1007/s12028-017-0410-y; Jenkins R, 2019, NEUROCRIT CARE, V30, P387, DOI 10.1007/s12028-018-0624-7; Killien EY, 2019, CRIT CARE MED, V47, pE112, DOI 10.1097/CCM.0000000000003525; Krishnamoorthy V, 2019, NEUROCRIT CARE, V30, P546, DOI 10.1007/s12028-019-00697-5; Krishnamoorthy V, 2018, CRIT CARE MED, V46, P965, DOI 10.1097/CCM.0000000000003052; Li YT, 2020, NEUROCRIT CARE, V32, P272, DOI 10.1007/s12028-019-00773-w; MACKERSIE RC, 1983, J TRAUMA, V23, P968, DOI 10.1097/00005373-198311000-00002; Mascia L, 1998, INTENS CARE MED, V24, P1115, DOI 10.1007/s001340050727; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; RANIERI VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI [10.1001/jama.2012.5669, DOI 10.1001/JAMA.2012.5669]; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Salim A, 2008, INJURY, V39, P30, DOI 10.1016/j.injury.2007.06.015; SIMMONS RL, 1969, ANN SURG, V170, P39, DOI 10.1097/00000658-196907000-00005; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; van Dijck JTJM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216743; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	41	3	3	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	JAN	2022	37	1					68	74	0885066620972001	10.1177/0885066620972001		NOV 2020	7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XB5LH	WOS:000624866800001	33191844				2022-02-06	
J	Yan, CL; Yan, HY; Mao, JN; Liu, YT; Xu, L; Zhao, HT; Shen, JQ; Cao, Y; Gao, YY; Li, KY; Jin, W				Yan, Chaolong; Yan, Huiying; Mao, Jiannan; Liu, Yutong; Xu, Li; Zhao, Hongting; Shen, Jiaqi; Cao, Yan; Gao, Yongyue; Li, Kuanyu; Jin, Wei			Neuroprotective Effect of Oridonin on Traumatic Brain Injury via Inhibiting NLRP3 Inflammasome in Experimental Mice	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; NLRP3 inflammasome; oridonin; neuroprotection; anti-inflammation	NEUROINFLAMMATION; PROTECTS; RAT; INTERLEUKIN-1-BETA; MENINGITIS; APOPTOSIS	NLRP3 inflammasome has been considered as an important contributor to inflammation and neuronal death after traumatic brain injury (TBI). Oridonin (Ori), the major active ingredient of Chinese herbal medicine Rabdosia rubescens, has been proved to be a covalent NLRP3 inhibitor with strong anti-inflammation activity. The purpose of this study was to investigate the effect of Ori on inflammation and brain injury induced by TBI. Adult male C57BL/6 mice were subjected to closed-head injury using Hall's weight-dropping method. Ori was injected directly intraperitoneally at a dose of 10 mg/kg within 30 min after TBI and injected once daily until the experiments ended. Our results showed that NLRP3 inflammasome was activated within 24 h post-TBI. The expression of NLRP3 inflammasome components (NLRP3, ASC, and caspase-1) was significantly decreased after treatment with Ori. Besides, the secretion of IL-1 beta and IL-18, downstream inflammatory factors of activated caspase-1, was reduced by Ori treatment. Importantly, Ori administration further protected the blood-brain barrier, alleviated brain edema, reduced cortical lesion volume, decreased cell death, and attenuated neurological deficits after TBI. Our findings indicate that NLRP3 inflammasome participated in the secondary injury after TBI and the application of Ori may provide neuroprotection via inhibiting NLRP3 inflammasome in animal models, suggesting that Ori might be a promising candidate for patients with TBI.	[Yan, Chaolong; Jin, Wei] Nanjing Med Univ, Nanjing Drum Tower Hosp, Dept Neurosurg, Clin Coll, Nanjing, Peoples R China; [Yan, Huiying; Mao, Jiannan; Gao, Yongyue; Jin, Wei] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Neurosurg,Nanjing Drum Tower Hosp, Nanjing, Peoples R China; [Liu, Yutong; Xu, Li; Zhao, Hongting; Shen, Jiaqi; Cao, Yan; Li, Kuanyu] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Peoples R China		Jin, W (corresponding author), Nanjing Med Univ, Nanjing Drum Tower Hosp, Dept Neurosurg, Clin Coll, Nanjing, Peoples R China.; Jin, W (corresponding author), Nanjing Univ, Sch Med, Affiliated Hosp, Dept Neurosurg,Nanjing Drum Tower Hosp, Nanjing, Peoples R China.; Li, KY (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Peoples R China.	likuanyu@nju.edu.cn; njneurosurgery@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571192]; Scientific Research Fund of Jiangsu Health Commission [Z2018025]	This work was supported by the National Natural Science Foundation of China (No. 81571192) and the Scientific Research Fund of Jiangsu Health Commission (Z2018025).	Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Garcia JM, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00386; He HB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04947-6; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; Jin W, 2014, ANN CLIN LAB SCI, V44, P151; Jin W, 2011, INJURY, V42, P714, DOI 10.1016/j.injury.2011.03.009; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu QQ, 2016, J DIGEST DIS, V17, P104, DOI 10.1111/1751-2980.12314; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Shang CH, 2016, INFLAMMATION, V39, P873, DOI 10.1007/s10753-016-0318-2; Shao BZ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00262; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tan MS, 2013, MOL NEUROBIOL, V48, P875, DOI 10.1007/s12035-013-8475-x; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Wallisch JS, 2017, NEUROCRIT CARE, V27, P44, DOI 10.1007/s12028-017-0378-7; Wang S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089848, 10.1371/journal.pone.0091357, 10.1371/journal.pone.0104745]; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yan HD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03435-z; Yan HY, 2015, MOL NEUROBIOL, V52, P1637, DOI 10.1007/s12035-014-8942-z; Yang Y., 2019, CELL DEATH DIS, V10; Zhou KR, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9238290	41	3	3	7	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	NOV 13	2020	14								557170	10.3389/fnins.2020.557170			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OV8HO	WOS:000592443900001	33281541	Green Published, gold			2022-02-06	
J	Zhang, MH; He, QP; Chen, GS; Li, PA				Zhang, Minghao; He, Qingping; Chen, Guisheng; Li, P. Andy			Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease	NEURODEGENERATIVE DISEASES			English	Article						Caspase-1; Inflammasome; NIM811; NLRP3; Rotenone; Parkinson&#8217; s disease; Pyroptosis	PERMEABILITY TRANSITION PORE; TRAUMATIC BRAIN-INJURY; CYCLOSPORINE-A; MITOCHONDRIAL DYSFUNCTION; GASDERMIN D; MECHANISM; MICROGLIA; APOPTOSIS; GSDMD; NEUROINFLAMMATION	Background: Parkinson's disease (PD) is characterized by the selective death of dopaminergic neurons in the substantia nigra. Recently, NLRP3 inflammasome and pyroptosis were found to be associated with PD. Cyclosporine A (CsA), an immunosuppressant, reduces neuronal death in PD. However, CsA could hardly pass through the blood-brain barrier (BBB) and high dose is associated with severe side effects and toxicity. N-methyl-4-isoleucine-cyclosporine (NIM811) is a CsA derivate that can pass through the BBB. However, little is known about its effect on PD. Objective: The objectives of this study were to explore the mechanism of rotenone-induced cell damage and to examine the protective effects of NIM811 on the neurotoxicity of a Parkinson-like in vitro model induced by rotenone. Methods: Murine hippocampal HT22 cells were cultured with the mitochondrial complex I inhibitor rotenone, a widely used pesticide that has been used for many years as a tool to induce a PD model in vitro and in vivo and proven to be reproducible. NIM811 was added to the culture media 3 h prior to the rotenone incubation. Cell viability was determined by resazurin assay, reactive oxygen species (ROS) production by dihydroethidine (DHE), and mitochondrial membrane potential by tetramethyl rhodamine methyl ester (TMRM). TUNEL and caspase-1 immunofluorescent double staining was used to detect pyroptosis. NLRP3, caspase-1, pro-caspase-1, GSDMD, and interleukin-18 (IL-18) were measured using Western blotting after 24 h of rotenone incubation. The reactivity of interleukin-1 beta (IL-1 beta) was determined by ELISA. Results: Our results demonstrated that rotenone caused more than 40% of cell death, increased ROS production, and reduced mitochondrial membrane potential, while NIM811 reversed these alterations. Immunofluorescent double staining showed that rotenone increased the percentage of caspase-1 and TUNEL double-labelled cells, an indication of pyroptosis, after 24 h of incubation. The protein expression of NLRP3, caspase-1, pro-caspase-1, GSDMD, IL-18, and IL-1 beta was significantly increased after 24 h of rotenone incubation. NIM811 suppressed rotenone-induced pyroptosis and downregulated the protein expression of NLRP3, caspase-1, pro-caspase-1, GSDMD, IL-1 beta, and IL-18. Conclusion: These results provide evidence that rotenone activates the NLRP3 inflammomere and induces pyroptosis. NIM811 protects the cell from rotenone-induced damage and inhibits NLRP3 inflammasome and pyroptosis. NIM811 might serve as a potential therapeutic drug in the treatment of PD.	[Zhang, Minghao] Ningxia Med Univ, Sch Basic Med Sci, Dept Pathophysiol, Yinchuan, Ningxia, Peoples R China; [Zhang, Minghao; He, Qingping; Li, P. Andy] North Carolina Cent Univ, Coll Arts & Sci, Biomfg Res Inst Biotechnol Enterprise BRITE, Dept Pharmaceut Sci, 1801 Fayetteville St, Durham, NC 27707 USA; [Zhang, Minghao] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pharmacol, Hlth Sci Ctr, Xian, Peoples R China; [Chen, Guisheng] Ningxia Med Univ, Neurosci Ctr, Dept Neurol, Key Lab Craniocerebral Dis,Gen Hosp, Yinchuan, Ningxia, Peoples R China		Li, PA (corresponding author), North Carolina Cent Univ, Coll Arts & Sci, Biomfg Res Inst Biotechnol Enterprise BRITE, Dept Pharmaceut Sci, 1801 Fayetteville St, Durham, NC 27707 USA.	pli@nccu.edu			China Scholarship CouncilChina Scholarship Council; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [8156050251]	This work was supported by grants from the China Scholarship Council (to M.Z.) and National Natural Science Foundation of China (8156050251) to G.C.	Antony PMA, 2013, FEBS J, V280, P5981, DOI 10.1111/febs.12335; Bauer TM, 2020, CIRC RES, V126, P280, DOI 10.1161/CIRCRESAHA.119.316306; Cho DH, 2020, MOL CELLS, V43, P10, DOI 10.14348/molcells.2020.2329; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Gaidt MM, 2016, EMBO J, V35, P2167, DOI 10.15252/embj.201695415; Garabadu D, 2020, NEUROMOL MED, V22, P314, DOI 10.1007/s12017-019-08590-2; He H, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01531; Hedya SA, 2018, MOL NEUROBIOL, V55, P7579, DOI 10.1007/s12035-018-0923-1; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Javed H, 2020, INT IMMUNOPHARMACOL, V83, DOI 10.1016/j.intimp.2020.106441; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Li HN, 2014, INT J MOL SCI, V15, P13388, DOI 10.3390/ijms150813388; Li ZY, 2019, AGING-US, V11, P1226, DOI 10.18632/aging.101831; Liang FQ, 2020, INFLAMM RES, V69, P159, DOI 10.1007/s00011-020-01315-3; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Matsumoto S, 2018, ACUTE MED SURG, V5, P213, DOI 10.1002/ams2.343; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; McEwen ML, 2011, NEUROTHERAPEUTICS, V8, P168, DOI 10.1007/s13311-011-0031-7; Melnikov S, 2011, EUR J CLIN INVEST, V41, P1113, DOI 10.1111/j.1365-2362.2011.02517.x; Mizuma A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00467; Mou YH, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0720-y; Mursaleen L, 2020, J PARKINSON DIS, V10, P99, DOI 10.3233/JPD-191754; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nighoghossian N, 2016, CEREBROVASC DIS, V42, P309, DOI 10.1159/000446850; Ouchi Y, 2009, PARKINSONISM RELAT D, V15, pS200, DOI 10.1016/S1353-8020(09)70814-4; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Sangiuliano B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/821043; Sasaoka M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57638-y; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; [佘颜 She Yan], 2019, [中国病理生理杂志, Chinese Journal of Pathophysiology], V35, P1379; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Springer JE, 2018, J NEUROTRAUM, V35, P492, DOI 10.1089/neu.2017.5167; Springer JE, 2018, NEURAL REGEN RES, V13, P1338, DOI 10.4103/1673-5374.235218; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Tsuchiya K, 2020, MICROBIOL IMMUNOL, V64, P252, DOI 10.1111/1348-0421.12771; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009; Vorobjeva N, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165664; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Walker JE, 2020, P NATL ACAD SCI USA, V117, P2745, DOI 10.1073/pnas.1921409117; Walker OS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229332; Wang S, 2019, INT IMMUNOPHARMACOL, V67, P458, DOI 10.1016/j.intimp.2018.12.019; Wang Y, 2019, CNS NEUROSCI THER, V25, P859, DOI 10.1111/cns.13140; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Yang J, 2020, RADIAT ONCOL, V15, DOI 10.1186/s13014-020-01525-3; Yoo SM, 2020, BMB REP, V53, P35, DOI 10.5483/BMBRep.2020.53.1.274; Youn Y, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12999; Yu SJ, 2019, BRAIN RES, V1719, P124, DOI 10.1016/j.brainres.2019.05.040; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	63	3	3	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1660-2854	1660-2862		NEURODEGENER DIS	Neurodegener. Dis.	FEB	2021	20	2-3					73	83		10.1159/000511207		NOV 2020	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QF6SR	WOS:000588751200001	33176317				2022-02-06	
J	McMurry, HS; Tsang, DC; Lin, N; Symes, SN; Dong, CH; Monteith, TS				McMurry, Hannah S.; Tsang, Darren C.; Lin, Nicole; Symes, Stephen N.; Dong, Chuanhui; Monteith, Teshamae S.			Head injury and neuropsychiatric sequelae in asylum seekers	NEUROLOGY			English	Article								Objective Asylum seekers experience a high burden of physical and psychological trauma, yet there is a scarcity of literature regarding the epidemiology and sequelae of head injury (HI) in asylum seekers. We examined HI prevalence and association with neuropsychiatric comorbidities in asylum seekers. Methods A retrospective cross-sectional study was performed through review of 139 medical affidavits from an affidavit database. Affidavits written from 2010 to 2018 were included. Demographic and case-related data were collected and classified based on the presence of HI. For neuropsychiatric sequelae, the primary study outcome was headache and the secondary outcomes were depression, posttraumatic stress disorder, and anxiety. Multivariable logistic regression was performed to examine the association between HI and neuropsychiatric sequelae, adjusted for demographic and clinical characteristics. Results A total of 139 medical affidavits of asylum seekers were included. The mean age was 27.4 +/- 12.1 years, 56.8% were female, and 38.8% were <19 years. Almost half (42.5%) explicitly self-reported history of HI. Compared to clients who did not report HI, clients with HI were older and more likely to report a history of headache, physical abuse, physical trauma, concussion, and loss of consciousness. After adjustment for demographic and clinical characteristics, clients with HI had greater odds for neuropsychological sequelae such as headache (odds ratio [OR] 4.2, 95% confidence interval [CI] 2.0-8.7) and depression (OR 2.5, 95% CI 1.1-5.7). Conclusions We observed a high prevalence of HI in asylum seekers. Comprehensive screening for HI and neuropsychiatric comorbidities is encouraged when evaluating asylum seekers.	[Symes, Stephen N.] Univ Miami, Miller Sch Med, Div Infect Dis & Immunol Allergy, Coral Gables, FL 33124 USA; [Dong, Chuanhui] Univ Miami, Miller Sch Med, Clin Translat Res Div, Coral Gables, FL 33124 USA; [Monteith, Teshamae S.] Univ Miami, Miller Sch Med, Headache Div, Coral Gables, FL 33124 USA; [McMurry, Hannah S.; Tsang, Darren C.; Lin, Nicole; Symes, Stephen N.; Dong, Chuanhui; Monteith, Teshamae S.] Univ Miami, Miller Sch Med, Dept Neurol, Coral Gables, FL 33124 USA		Monteith, TS (corresponding author), Univ Miami, Miller Sch Med, Headache Div, Coral Gables, FL 33124 USA.; Monteith, TS (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Coral Gables, FL 33124 USA.	tmonteith@med.miami.edu					Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Doherty SM, 2016, GLOB MENT HEALTH, V3, DOI 10.1017/gmh.2016.23; Evans RW, 2014, NEUROL CLIN, V32, P283, DOI 10.1016/j.ncl.2013.11.010; Herlihy J, 2007, BRIT J PSYCHIAT, V191, P3, DOI 10.1192/bjp.bp.106.034439; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Mollica RF, 2014, COMPR PSYCHIAT, V55, P1626, DOI 10.1016/j.comppsych.2014.04.014; Mossaad Nadwa., 2016, ANN FLOW REPORT REFU; Physicians forHuman Rights, 2012, EX AS SEEK CLIN GUID; Vaughan J., 2016, BORDER ASYLUM CLAIMS; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	10	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 10	2020	95	19					E2605	E2609		10.1212/WNL.0000000000010929			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QI9BV	WOS:000619282800001	33004606				2022-02-06	
J	Xiao, K; Zhao, F; Liu, Q; Jiang, JL; Chen, ZY; Gong, W; Zheng, ZW; Le, AP				Xiao, Kun; Zhao, Fei; Liu, Qiang; Jiang, Jinliang; Chen, Zhiyong; Gong, Wei; Zheng, Zengwang; Le, Aiping			Effect of Red Blood Cell Storage Duration on Outcomes of Isolated Traumatic Brain Injury	MEDICAL SCIENCE MONITOR			English	Article						Brain Injuries; Erythrocytes; Mortality	RESTRICTIVE TRANSFUSION; MORTALITY; AGE; HEMOGLOBIN; EPIDEMIOLOGY; ASSOCIATION; IMPACT; LESS	Background: The aim of this study was to investigate the effects of red blood cell (RBC) storage duration on the outcomes of adult isolated traumatic brain injury (iTBI) patients after transfusion. Material/Methods: A total of 1252 adult iTBI patients who received the fresh RBCs (stored for <= 14 days) or old RBCs (stored for >14 days) were finally enrolled in this study. The primary outcome was 90-day mortality. The secondary outcomes were in-hospital mortality, nosocomial infection, and complications. Results: By 90 days after RBC transfusion, 89 patients (17.0%) had died in the fresh RBC group, and 107 had died (14.7%) in the old RBC group, with no significant difference in 90-day mortality between the 2 groups (OR=1.192, 95% CI: 0.877-1.620, P=0.261). According to ISS score, no differences were discovered in mild injury (OR=1.079, 95% CI: 0.682-1.707, P=0.746), severe injury (OR=1.055, 95% CI: 0.634-1.755, P=0.838), and more severe injury (OR=1.940, 95% CI: 0.955-3.943, P=0.064). For GCS score, there were no differences in mild injury (OR=1.546, 95% CI: 0.893-2.676, P=0.118), moderate injury (OR=0.965, 95% CI: 0.616-1.513, P=0.877), and severe injury (OR=1.332, 95% CI: 0.677-2.620, P=0.406). We also observed no significant differences in secondary outcomes. Conclusions: Use of old RBCs did not increase the 90-day mortality in adult iTBI patients.	[Xiao, Kun; Le, Aiping] Nanchang Univ, Dept Blood Transfus, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Zhao, Fei] Nanchang Univ, Dept Neurol, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Liu, Qiang] Nanchang Univ, Dept Informat, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Jiang, Jinliang] Nanchang Univ, Dept Sci & Technol, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Chen, Zhiyong] Nanchang Univ, Dept Personnel, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Gong, Wei] Nanchang Univ, Presidents Off, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Zheng, Zengwang] Nanchang Univ, Dept Med Adm, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China		Le, AP (corresponding author), Nanchang Univ, Dept Blood Transfus, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.	aipingledoctor@163.com					Bishnoi AK, 2019, HEART LUNG CIRC, V28, P784, DOI 10.1016/j.hlc.2018.03.012; Borgstrom L, 2010, ACTA PHYSL, V93, P505; Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Cooper DJ, 2017, NEW ENGL J MED, V377, P1858, DOI 10.1056/NEJMoa1707572; Desjardins P, 2012, CRIT CARE, V16, DOI 10.1186/cc11293; Dhar R, 2012, J NEUROSURG, V116, P648, DOI 10.3171/2011.9.JNS11691; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Heddle NM, 2016, NEW ENGL J MED, V375, P1937, DOI 10.1056/NEJMoa1609014; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kellert L, 2014, J CRIT CARE, V29, P236, DOI 10.1016/j.jcrc.2013.11.008; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kramer AH, 2012, CURR TREAT OPTION NE, V14, P150, DOI 10.1007/s11940-012-0167-8; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Kuramatsu JB, 2013, CRIT CARE, V17, DOI 10.1186/cc12827; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Rincon F, 2014, J NEUROSURG, V121, P950, DOI 10.3171/2014.7.JNS132470; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruel-Laliberte J, 2019, CAN J ANESTH, V66, P696, DOI 10.1007/s12630-019-01326-7; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Spinella PC, 2009, CRIT CARE, V13, DOI 10.1186/cc8050; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; van de Watering L, 2011, VOX SANG, V100, P36, DOI 10.1111/j.1423-0410.2010.01441.x; Weinberg JA, 2008, J TRAUMA, V65, P794, DOI 10.1097/TA.0b013e318184aa11; Weinberg JA, 2008, J TRAUMA, V65, P279, DOI 10.1097/TA.0b013e31817c9687; Weinberg JA, 2010, J TRAUMA, V69, P1427, DOI 10.1097/TA.0b013e3181fa0019; Yamal JM, 2015, J TRAUMA ACUTE CARE, V79, P843, DOI 10.1097/TA.0000000000000834	35	3	3	3	3	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	NOV 7	2020	26								e923448	10.12659/MSM.923448			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	OO3OR	WOS:000587292700001	33159032	Green Published			2022-02-06	
J	Bloom, GA; Trbovich, AM; Caron, JG; Kontos, AP				Bloom, Gordon A.; Trbovich, Alicia M.; Caron, Jeffrey G.; Kontos, Anthony P.			Psychological aspects of sport-related concussion: An evidence-based position paper	JOURNAL OF APPLIED SPORT PSYCHOLOGY			English	Article; Early Access							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; RECOVERY TRAJECTORIES; AGREEMENT STATEMENT; ORTHOPEDIC INJURIES; CURRENT ISSUES; SYMPTOMS; DEPRESSION; BEHAVIOR	The field of sport-related concussion (SRC) is evolving quickly, and psychological aspects affecting athletes' recovery and well-being are now recognized as an important component for research and clinical practice. There has been considerable recent emphasis on empirical research into the psychological implications of SRC. This emphasis reflects trends from clinical research that indicate anxiety and mood-related issues may represent the primary symptoms in nearly 30% of concussions. In short, SRC and its psychological aspects is a major issue that influences not only athletes' performance, but also their physical and mental health. The purpose of this position paper is to provide a concise yet comprehensive review of the current state of research and evidence-based practice as it relates to the psychological aspects of SRC. More specifically, we present five postulates that are intended to stimulate discussion among researchers and allied health professionals who are interested in psychological aspects of SRC. Our intent in writing this position paper is to advance this subdiscipline within the area of SRC by discussing areas for growth in theory, research, and practice. Lay Summary: Sport-related concussions (SRC) have become a public health issue, however little research has focused on the the psychological aspects of this injury. This position paper identifies five postulates that are intended to stimulate research and practice on psychological aspects of SRC. Implications for Practice Multidisciplinary concussion care teams should include a sport psychology professional to assist with psychosocial recovery and well-being. Identify psychological factors that detract athletes from feeling ready to return to sport following a concussion (e.g., confidence, fear), and work with them to develop coping strategies to assist their return. Appropriately trained sport psychology professionals could deliver effective concussion education interventions that involve behavior change techniques.	[Bloom, Gordon A.] McGill Univ, Dept Kinesiol & Phys Educ, 475 Pine Ave West, Montreal, PQ H2W 1S4, Canada; [Trbovich, Alicia M.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA USA; [Caron, Jeffrey G.] Univ Montreal, Sch Kinesiol & Phys Act Sci, Montreal, PQ, Canada		Bloom, GA (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, 475 Pine Ave West, Montreal, PQ H2W 1S4, Canada.	gordon.bloom@mcgill.ca		Caron, Jeff/0000-0002-4972-2704			Ahmed OH, 2016, PHYS THER SPORT, V21, P82, DOI 10.1016/j.ptsp.2016.03.001; Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Anderson MN, 2019, DEV NEUROPSYCHOL, V44, P443, DOI 10.1080/87565641.2019.1667995; Andre-Morin D, 2017, SPORT EXERC PERFORM, V6, P289, DOI 10.1037/spy0000106; Ardern CL, 2014, BRIT J SPORT MED, V48, P1613, DOI 10.1136/bjsports-2014-093842; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Beck A. T., 2000, MANUAL BECK DEPRESSI; Bender SD, 2013, PSYCHOL INJ LAW, V6, P113, DOI 10.1007/s12207-013-9156-9; Bloom G., 2019, PSYCHOL ASPECTS SPOR; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Bunt SC, 2019, ARCH CLIN NEUROPSYCH, V34, P773, DOI 10.1093/arclin/acz026.43; Caron J. G., 2019, PSYCHOL ASPECTS SPOR; Caron J. G., 2017, J SPORT EXERCISE PSY, V39; Caron JG, 2018, BRIT J SPORT MED, V52, P1, DOI 10.1136/bjsports-2017-098319; Caron JG, 2017, J LOSS TRAUMA, V22, P501, DOI 10.1080/15325024.2017.1335150; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Caron JG., 2019, PSYCHOL ASPECTS SPOR, P66; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Clement D, 2011, J SPORT REHABIL, V20, P457, DOI 10.1123/jsr.20.4.457; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Conder R, 2015, BRAIN INJURY, V29, P249, DOI 10.3109/02699052.2014.965209; Conner M, 2017, PSYCHOL HEALTH, V32, P895, DOI 10.1080/08870446.2017.1336240; Cote J, 2009, INT J SPORT EXERC PS, V7, P7, DOI 10.1080/1612197X.2009.9671889; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Covassin T, 2013, SPORT PSYCHOL, V27, P372, DOI 10.1123/tsp.27.4.372; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Delaney JS, 2018, CLIN J SPORT MED, V28, P1, DOI 10.1097/JSM.0000000000000495; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Durish CL, 2019, J INT NEUROPSYCH SOC, V25, P346, DOI 10.1017/S1355617718001169; Gardner A. J., 2017, BRIT J SPORT MED, V51, DOI https://doi.org/10.1136/bjsports-2016-097270.176; GILLIE BL, 2020, APPL NEUROPSYCH 0728, DOI DOI https://doi.org/10.1080/21622965.2020.1799790; GRUDNIEWICZ A, 2015, IMPLEMENT SCI, V10, DOI DOI https://doi.org/10.1186/s13012-015-0347-5; Harwood CG, 2015, PSYCHOL SPORT EXERC, V16, P24, DOI 10.1016/j.psychsport.2014.03.001; Heil J., 1993, PSYCHOL SPORT INJURY; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Iverson GL, 2020, J NEUROPSYCH CLIN N, V32, P139, DOI 10.1176/appi.neuropsych.19010021; Kelly MP, 2016, PUBLIC HEALTH, V136, P109, DOI 10.1016/j.puhe.2016.03.030; Kontos A. P., 2018, CONCUSSION CLIN PROF; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Kontos AP, 2017, SPORT EXERC PERFORM, V6, P215, DOI 10.1037/spy0000108; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kontos AP, 2013, RES SPORTS MED, V21, P367, DOI 10.1080/15438627.2013.825801; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kontos AP, 2004, J APPL SPORT PSYCHOL, V16, P220, DOI 10.1080/10413200490485568; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kunnen M, 2020, ANN LEIS RES, V23, P447, DOI 10.1080/11745398.2019.1647789; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Lintunen T, 2020, HDB BEHAV CHANGE, DOI 10:9781108677318; Madrigal L, 2015, SPORT PSYCHOL, V29, P310, DOI 10.1123/tsp.2014-0139; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Malcolm D., 2019, CONCUSSION CRISIS SP; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; MCCRORY P, 2017, BRIT J SPORT MED, V51, P838, DOI DOI 10.1136/BJSPORTS-2017-097699; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Merritt VC, 2015, DEV NEUROPSYCHOL, V40, P45, DOI 10.1080/87565641.2014.979928; Michie S., 2014, BEHAV CHANGE WHEEL G, V2nd; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morse AM, 2018, HAND CLINIC, V158, P127, DOI 10.1016/B978-0-444-63954-7.00013-6; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; O'Connor S, 2020, PHYSICIAN SPORTSMED, V48, P186, DOI 10.1080/00913847.2019.1671141; Parachute Canada, 2020, CONC AW IN; Podlog L, 2006, J APPL SPORT PSYCHOL, V18, P44, DOI 10.1080/10413200500471319; Podlog L, 2015, SPORT PSYCHOL, V29, P1, DOI 10.1123/tsp.2014-0063; Poll H., 2015, KNOWLEDGEABLE ARE AM; POPOVICH M, 2018, NEUROLOGY S1, V91, DOI DOI https://doi.org/10.1212/01.wnl.0000550601.73235.b4; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Reese LMS, 2012, J SPORT HEALTH SCI, V1, P71, DOI 10.1016/j.jshs.2012.06.003; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Schatz P, 2017, SPORT EXERC PERFORM, V6, P243, DOI 10.1037/spy0000100; SCHWARZER R, 2008, APPL PSYCHOL INT REV, V0057, P00001, DOI DOI https://doi.org/10.1111/j.1464-0597.2007.00325.x; Seguin C.M., 2019, PSYCHOL ASPECTS SPOR, P83, DOI [https://doi.org/10.4324/9781351200516-7, DOI 10.4324/9781351200516-7]; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Sniehotta FF, 2014, HEALTH PSYCHOL REV, V8, P1, DOI 10.1080/17437199.2013.869710; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Sufrinko AM, 2017, J PEDIATR-US, V185, P167, DOI 10.1016/j.jpeds.2017.02.072; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; TJONG VK, 2017, JAAOS GLOB RES REV, V1, DOI DOI https://doi.org/10.5435/JAAOSGlobal-D-17-00070; Turner S, 2017, SPORT EXERC PERFORM, V6, P277, DOI 10.1037/spy0000099; Tynan R, 2017, QUAL RES SPORT EXERC, V9, P469, DOI 10.1080/2159676X.2017.1323778; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2018, J ALZHEIMERS DIS, V66, P37, DOI 10.3233/JAD-180218	107	3	3	4	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1041-3200	1533-1571		J APPL SPORT PSYCHOL	J. Appl. Sport Psychol.												10.1080/10413200.2020.1843200		NOV 2020	23	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	OP6CF	WOS:000588171700001					2022-02-06	
J	Tuerk, C; Anderson, V; Bernier, A; Beauchamp, MH				Tuerk, Carola; Anderson, Vicki; Bernier, Annie; Beauchamp, Miriam H.			Social competence in early childhood: An empirical validation of the SOCIAL model	JOURNAL OF NEUROPSYCHOLOGY			English	Article						social competence; preschoolers; social development; social cognition; validation	TRAUMATIC BRAIN-INJURY; CHILDRENS COMMUNICATION CHECKLIST; GENERIC CORE SCALES; EXECUTIVE FUNCTION; INDIVIDUAL-DIFFERENCES; GENDER-DIFFERENCES; SEX-DIFFERENCES; YOUNG-CHILDREN; MILD TBI; BEHAVIOR	Social skills are the basis of human interactions and functioning in society. Social competence (SC) is thought to evolve gradually during childhood and adolescence via the interplay of multiple factors. In particular, the early years of life are marked by the emergence of basic social abilities and constitute the foundation for successful social development. The biopsychosocial SOcio-Cognitive Integration of Abilities modeL (SOCIAL) posits that internal (child-based), external (environment), and cognitive factors are critical to SC in the context of normal brain maturation; but this has yet to be shown empirically and comprehensively. This study tested the SOCIAL model in a sample of typically developing preschool children. Parents of 103 children (M = 67.59 months, SD = 11.65) completed questionnaires and children underwent neuropsychological assessment of executive functioning (EF), communication skills and social cognition. Three-step hierarchical regression analyses (1) Internal factors, 2) External factors, 3) Cognitive factors) confirmed that each step of the regression model significantly predicted SC. In the final model, general cognitive and socio-cognitive factors significantly predicted SC above and beyond internal and external factors: children with lower temperamental negative affect and less parent-reported executive dysfunction, as well as better non-verbal communication and theory of mind had better SC. Our findings support the conceptual SOCIAL model, and highlight the importance of internal, external, and cognitive factors for SC in the preschool years. Identification of factors associated with early social development can inform both normative and clinical approaches to identifying intervention loci and optimizing SC in those at risk for maladaptive social functioning.	[Tuerk, Carola; Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca		Anderson, Vicki/0000-0001-5233-3147; Tuerk, Carola/0000-0002-0910-846X; Beauchamp, Miriam/0000-0002-8637-6361; Bernier, Annie/0000-0002-2359-9808	Canadian Health Research Fund [MOP111036]; Fonds de recherche du Quebec - Nature et technologies (FRQNT) [261327]	The authors declare that they have no conflict of interest that might have influenced the performance or presentation of the work described in this article. The authors thank all participants who were involved in the study and all members of the LION project. This work was supported by the Canadian Health Research Fund (grant number MOP111036). C.T. received a doctoral scholarship (261327) from the Fonds de recherche du Quebec -Nature et technologies (FRQNT).	Abdi B, 2010, PROCD SOC BEHV, V5, P1175, DOI 10.1016/j.sbspro.2010.07.256; Ackerman BP, 2006, ADV CHILD DEV BEHAV, V34, P91, DOI 10.1016/S0065-2407(06)80005-4; Adams C, 2012, INT J LANG COMM DIS, V47, P233, DOI 10.1111/j.1460-6984.2011.00146.x; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Aksan N, 2006, DEV PSYCHOL, V42, P833, DOI 10.1037/0012-1649.42.5.833; Anderson PJ, 2012, NEUROPSYCHOL REV, V22, P345, DOI 10.1007/s11065-012-9220-3; Anderson SE, 2015, EAT BEHAV, V19, P110, DOI 10.1016/j.eatbeh.2015.07.006; Angeleri R, 2014, CAN J EXP PSYCHOL, V68, P133, DOI 10.1037/cep0000011; Beauchamp MH, 2017, NEUROPSYCHOLOGY, V31, P981, DOI 10.1037/neu0000395; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beaudoin C, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02905; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Bennett S, 2005, AGGRESS VIOLENT BEH, V10, P263, DOI 10.1016/j.avb.2004.07.001; Besag FMC, 2019, EPILEPSY BEHAV, V100, DOI 10.1016/j.yebeh.2019.03.015; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Brown CS, 2010, SEX ROLES, V63, P860, DOI 10.1007/s11199-010-9856-5; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P437, DOI 10.1016/j.neubiorev.2005.08.001; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Cacioppo JT, 2002, AM PSYCHOL, V57, P819, DOI 10.1037/0003-066X.57.11.819; Cambridge Cognition, 2006, NEUR TEST AUT BATT C; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Chmait HR, 2021, J DEV BEHAV PEDIATR, V42, P41, DOI 10.1097/DBP.0000000000000851; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Cummins A, 2005, DEV MED CHILD NEUROL, V47, P437, DOI 10.1017/S001216220500085X; Dadds MR, 2008, CHILD PSYCHIAT HUM D, V39, P111, DOI 10.1007/s10578-007-0075-4; Degeilh F, 2018, DEV PSYCHOBIOL, V60, P1037, DOI 10.1002/dev.21786; Desai AD, 2014, JAMA PEDIATR, V168, P1114, DOI 10.1001/jamapediatrics.2014.1600; Deschamps PK, 2018, AM J ORTHOPSYCHIAT, V88, P346, DOI 10.1037/ort0000319; Devine RT, 2016, DEV PSYCHOL, V52, P758, DOI 10.1037/dev0000105; Eadie P, 2018, INT J LANG COMM DIS, V53, P799, DOI 10.1111/1460-6984.12385; Enders C. K., 2010, APPL MISSING DATA AN; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fabes R.A., 1998, HDB CHILD PSYCHOL, V3, P1; Fernandes C, 2020, ATTACH HUM DEV, V22, P687, DOI 10.1080/14616734.2019.1692045; Franco MD, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01376; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Gagner C, 2020, J PEDIATR PSYCHOL, V45, P50, DOI 10.1093/jpepsy/jsz071; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Geurts H, 2010, INT J LANG COMM DIS, V45, P436, DOI 10.3109/13682820903165685; Gioia G. A., 2003, BEHAV RATING INVENTO; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Greco LA, 2001, CLIN CHILD FAM PSYCH, V4, P299, DOI 10.1023/A:1013543320648; Haigh SM, 2018, J AUTISM DEV DISORD, V48, P2653, DOI 10.1007/s10803-018-3515-z; Hall JA, 2019, ANNU REV PSYCHOL, V70, P271, DOI 10.1146/annurev-psych-010418-103145; Hedgecock JB, 2018, PHYS THER, V98, P251, DOI 10.1093/ptj/pzy006; Heijligers M, 2018, HUM REPROD, V33, P2150, DOI 10.1093/humrep/dey302; Hughes C, 2011, J EXP CHILD PSYCHOL, V108, P663, DOI 10.1016/j.jecp.2010.06.005; Hughes C, 2011, J EXP CHILD PSYCHOL, V108, P96, DOI 10.1016/j.jecp.2010.07.012; Hughes SO, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-64; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Izard CE, 2009, ANNU REV PSYCHOL, V60, P1, DOI 10.1146/annurev.psych.60.110707.163539; Korkman M., 2007, NEPSY 2 DEV NEUROPSY; Laible D, 2014, SOC DEV, V23, P734, DOI 10.1111/sode.12072; Lalonde G, 2020, J NEUROPSYCHOL, V14, P98, DOI 10.1111/jnp.12179; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Landa RJ, 2005, MENT RETARD DEV D R, V11, P247, DOI 10.1002/mrdd.20079; Landry-Roy C, 2018, J INT NEUROPSYCH SOC, V24, P769, DOI 10.1017/S1355617718000401; Landry-Roy C, 2017, J HEAD TRAUMA REHAB, V32, pE13, DOI 10.1097/HTR.0000000000000303; Leeman J, 2016, RES NURS HEALTH, V39, P229, DOI 10.1002/nur.21725; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Muscara F, 2010, BRAIN IMPAIR, V11, P162, DOI 10.1375/brim.11.2.162; Putnam S. P., 2010, INT C INF STUD BALT; Putnam SP, 2006, J PERS ASSESS, V87, P102, DOI 10.1207/s15327752jpa8701_09; Putnam SP, 2006, INFANT BEHAV DEV, V29, P386, DOI 10.1016/j.infbeh.2006.01.004; Rothbart M.K., 2019, ENCY EARLY CHILDHOOD, V2nd rev. e; Rothbart MK., 2011, BECOMING WHO WE ARE; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; Ryan NP, 2019, J NEUROTRAUM, V36, P2895, DOI 10.1089/neu.2018.6308; Seguin M, 2020, NEUROPSYCHOLOGY, V34, P375, DOI 10.1037/neu0000618; SIMON HA, 1975, COGNITIVE PSYCHOL, V7, P268, DOI 10.1016/0010-0285(75)90012-2; Smidts DP, 2004, DEV NEUROPSYCHOL, V26, P385, DOI 10.1207/s15326942dn2601_2; Sokol BW, 2004, NEW DIR CHILD ADOLES, V103, P19, DOI 10.1002/cd.95; Soto EF, 2020, NEUROPSYCHOLOGY, V34, P605, DOI 10.1037/neu0000681; Soto-Icaza P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00333; Spinrad TL, 2018, CURR OPIN PSYCHOL, V20, P40, DOI 10.1016/j.copsyc.2017.08.004; Thompson EJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016633; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Vaisanen R, 2014, LOGOP PHONIATR VOCO, V39, P179, DOI 10.3109/14015439.2013.784802; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Vera-Estay E, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00227; Vezina M, 2011, CAN J SPEECH-LANG PA, V35, P244; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th; Wechsler D., 2002, WECHSLER PRESCHOOL P; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	91	3	3	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	SEP	2021	15	3					477	499		10.1111/jnp.12230		NOV 2020	23	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	UO6UE	WOS:000585965000001	33155418				2022-02-06	
J	Tomaiuolo, F; Cerasa, A; Lerch, JP; Bivona, U; Carlesimo, GA; Ciurli, P; Raffa, G; Quattropani, MC; Germano, A; Caltagirone, C; Formisano, R; Nigro, S				Tomaiuolo, Francesco; Cerasa, Antonio; Lerch, Jason P.; Bivona, Umberto; Carlesimo, Giovanni Augusto; Ciurli, Paola; Raffa, Giovanni; Quattropani, Marina Catena; Germano, Antonino; Caltagirone, Carlo; Formisano, Rita; Nigro, Salvatore			Brain Neurodegeneration in the Chronic Stage of the Survivors from Severe Non-Missile Traumatic Brain Injury: A Voxel-Based Morphometry Within-Group at One versus Nine Years from a Head Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; neuropsychology; other tools of modern imaging; outcome measures; traumatic brain injury	EXECUTIVE FUNCTION; DIFFUSION-TENSOR; CORPUS-CALLOSUM; SELF-AWARENESS; FOCAL LESIONS; WHITE-MATTER; ATROPHY; MILD; DEGENERATION; FORNIX	The long-term time course of neuropathological changes occurring in survivors from severe traumatic brain injury (TBI) remains uncertain. We investigated the brain morphometry and memory performance modifications within the same group of severe non-missile traumatic brain injury patients (nmTBI) after about similar to one year and at similar to nine years from injury. Brain magnetic resonance imaging (MRI) measurements were performed with voxel-based morphometry (VBM) to determine specific changes in the gray matter (GM) and white matter (WM) and the overall gray matter volume modifications (GMV) and white matter volume modifications (WMV). Contemporarily, memory-tests were also administered. In comparison with healthy control subjects (HC), those with nmTBI showed a significant change and volume reduction in the GM and WM and also in the GMV and WMV after similar to one year; conversely, similar to nine years after injury, neurodegenerative changes spared the GM and GMV, but a prominent loss was detected in WMV and in WM sites, such as the superior longitudinal fasciculi, the body of the corpus callosum, the optic radiation, and the uncinate fasciculus. Memory performance at similar to one year in comparison with similar to nine years was stable with a subtle but significant trend toward recovery. These data demonstrate that patients with nmTBI undergo neurodegenerative processes during the chronic stage affecting mainly the cerebral WM rather than GM. Despite these anatomical brain parenchyma losses, memory performance tends to be stable or even slightly recovered. These results suggest possible correlations between progressive demyelinization and/or neuropsychiatric changes other than memory performance, and support possible treatments to prevent long-term WM degeneration of the examined nmTBI.	[Tomaiuolo, Francesco; Quattropani, Marina Catena] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Raffa, Giovanni; Germano, Antonino] Univ Messina, Dept BIOMORF, Div Neurosurg, Messina, Italy; [Cerasa, Antonio] CNR, IRIB, Cosenza, Italy; [Cerasa, Antonio] S Anna Inst & Res Adv Neurorehabil RAN, Crotone, Italy; [Lerch, Jason P.] Univ Oxford, Nuffield Dept Clin Neurosci, FMRIB, Wellcome Ctr Integrat Neuroimaging, Oxford, England; [Bivona, Umberto; Carlesimo, Giovanni Augusto; Ciurli, Paola; Caltagirone, Carlo; Formisano, Rita] IRCCS Fdn Santa Lucia, Rome, Italy; [Carlesimo, Giovanni Augusto] Univ Tor Vergata, Dipartimento Med Sistemi, Rome, Italy; [Nigro, Salvatore] CNR, Inst Nanotechnol NANOTEC, Lecce, Italy		Tomaiuolo, F (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.; Nigro, S (corresponding author), CNR, Inst Nanotechnol NANOTEC, Lecce, Italy.	ftomaiuolo@unime.it; salvatore.nigro@nanotec.cnr.it	Quattropani, Maria C./G-3504-2015; cerasa, antonio/E-8614-2011; Raffa, Giovanni/K-7972-2016	Quattropani, Maria C./0000-0003-0711-6412; cerasa, antonio/0000-0002-8022-4770; Raffa, Giovanni/0000-0001-8623-4964; Nigro, Salvatore/0000-0001-7566-7983	European Union's Horizon 2020 programme (Marie Sklodowska-Curie grant) [778234-DoCMA]	Rita Formisano has been funded for this project by European Union's Horizon 2020 programme (Marie Sklodowska-Curie grant 778234-DoCMA project).	Adams J.H., 1994, INTRO NEUROPATHOLOGY, P133; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Carlesimo G, 2002, NUOVA RIV NEUROLOGIA, V12, P1; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Formisano R, 2017, INTERN EMERG MED, V12, P187, DOI 10.1007/s11739-016-1536-1; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Henry-Feugeas MC, 2000, BRAIN INJURY, V14, P597; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Koliatsos VE, 2019, CURR OPIN NEUROL, V32, P786, DOI 10.1097/WCO.0000000000000763; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Peru A, 2003, NEUROPSYCHOLOGIA, V41, P634, DOI 10.1016/S0028-3932(02)00203-8; Petrides M., 2002, PRINCIPLES FRONTAL L, V1, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Petrides M, 2007, ANN NY ACAD SCI, V1121, P33, DOI 10.1196/annals.1401.035; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Tomaiuolo F, 2001, NEUROREPORT, V12, P1469, DOI 10.1097/00001756-200105250-00035; Tomaiuolo F, 2007, DEMENT GERIATR COGN, V23, P96, DOI 10.1159/000097371; Tomaiuolo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107871; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	57	3	3	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2021	38	2					283	290		10.1089/neu.2020.7203		NOV 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PP0TL	WOS:000590806800001	32962533				2022-02-06	
J	Mihalik, JP; Chandran, A; Powell, JR; Roby, PR; Guskiewicz, KM; Stemper, BD; Shah, AS; Rowson, S; Duma, S; Harezlak, J; Riggen, L; Broglio, SP; McAllister, TW; McCrea, M				Mihalik, Jason P.; Chandran, Avinash; Powell, Jacob R.; Roby, Patricia R.; Guskiewicz, Kevin M.; Stemper, Brian D.; Shah, Alok S.; Rowson, Steven; Duma, Stefan; Harezlak, Jaroslaw; Riggen, Larry; Broglio, Steven P.; McAllister, Thomas W.; McCrea, Michael		CARE Consortium Investigators	Do Head Injury Biomechanics Predict Concussion Clinical Recovery in College American Football Players?	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Angular; Injury severity; Mechanics; NCAA-DOD CARE Consortium; Head impact sensors	IMPACT BIOMECHANICS; POSTURAL STABILITY; ACCELERATION; VALIDATION; KINEMATICS	Identifying the associations between head impact biomechanics and clinical recovery may inform better head impact monitoring procedures and identify athletes who may benefit from early treatments aimed to enhance recovery. The purpose of this study was to test whether head injury biomechanics are associated with clinical recovery of symptom severity, balance, and mental status, as well as symptom resolution time (SRT) and return-to-participation (RTP) time. We studied 45 college American football players (n = 51 concussions) who sustained an incident concussion while participating in a multi-site study. Player race/ethnicity, prior concussion, medical history, position, body mass index, event type, and impact location were covariates in our multivariable analyses. Multivariable negative binomial regression models analyzed associations between our study outcomes and (1) injury-causing linear and rotational head impact severity, (2) season repetitive head impact exposure (RHIE), and (3) injury day RHIE. Median SRT was 6.1 days (IQR 5.8 days, n = 45) and median RTP time was 12.3 days (IQR 7.8 days, n = 36) across our study sample. RTP time was 86% (Ratio 1.86, 95% CI [1.05, 3.28]) longer in athletes with a concussion history. Offensive players had SRTs 49% shorter than defensive players (Ratio 0.51, 95% CI [0.29, 0.92]). Per-unit increases in season RHIE were associated with 22% longer SRT (Ratio 1.22, 95% CI [1.09, 1.36]) but 28% shorter RTP time (Ratio 0.72, 95% CI [0.56, 0.93]). No other head injury biomechanics predicted injury recovery.	[Mihalik, Jason P.; Chandran, Avinash; Powell, Jacob R.; Roby, Patricia R.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, 2207 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27515 USA; [Mihalik, Jason P.; Powell, Jacob R.; Roby, Patricia R.; Guskiewicz, Kevin M.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Human Movement Sci Curriculum, Chapel Hill, NC 27515 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Roby, Patricia R.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Stemper, Brian D.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Stemper, Brian D.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Shah, Alok S.; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Rowson, Steven; Duma, Stefan] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Harezlak, Jaroslaw] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Riggen, Larry] Indiana Univ, Sch Med, Dept Biostat, Indianapolis, IN USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Mihalik, JP (corresponding author), Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, 2207 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27515 USA.	jmihalik@email.unc.edu	Rowson, Steven/B-1270-2012; Harezlak, Jaroslaw/P-8557-2014	Rowson, Steven/0000-0002-3227-0596; Powell, Jacob/0000-0002-3899-9433; Roby, Patricia/0000-0003-0166-4274; Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DoD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This investigation was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds).	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Kerr ZY, 2021, J SPORT HEALTH SCI, V10, P113, DOI 10.1016/j.jshs.2020.09.001; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2017, MED SCI SPORT EXER, V49, P247, DOI 10.1249/MSS.0000000000001089; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rowson S, 2019, ANN BIOMED ENG, V47, P2048, DOI 10.1007/s10439-019-02329-7; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stemper BD, 2020, MED SCI SPORT EXER, V52, P1629, DOI 10.1249/MSS.0000000000002283; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Wallace J, 2020, J EMERG MED, V59, P783, DOI 10.1016/j.jemermed.2020.07.002; Wallace J, 2020, AM J SPORT MED, V48, P2774, DOI 10.1177/0363546520946753	36	3	3	1	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2555	2565		10.1007/s10439-020-02658-y		NOV 2020	11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000586356800001	33136240				2022-02-06	
J	Newton, A; Yang, JZ; Shi, JX; Sullivan, L; Huang, LH; Singichetti, B; Zhu, MT; Felix, AS				Newton, Alison; Yang, Jingzhen; Shi, Junxin; Sullivan, Lindsay; Huang, Lihong; Singichetti, Bhavna; Zhu, Motao; Felix, Ashley S.			Sports and non-sports-related concussions among Medicaid-insured children: health care utilization before and after Ohio's concussion law	INJURY EPIDEMIOLOGY			English	Article						Pediatric; Traumatic brain injury; Legislation; Non-sports related injury	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT VISITS; UNITED-STATES; EPIDEMIOLOGY; LEGISLATION; MANAGEMENT	ObjectiveTo evaluate patterns of health care utilization for sports-related concussions (SRCs) and non-sports-related concussions (NSRCs) among Medicaid-insured children before and after the enactment of Ohio's concussion law in April 2013.MethodsWe analyzed claim data from the Partners For Kids (PFK) Ohio Medicaid database. Concussion diagnoses were identified between April 1, 2008 and June 30, 2017. We compared frequency of concussions by age and sex across the law period. We evaluated type of health care utilization before and after law enactment using multinomial logistic regression.ResultsOver the 9year study period, 6157 concussions were included, most of which (70.4%) were NSRCs. The proportion of SRCs increased with age. Among children younger than 5years old, the majority (96.1%) of concussions were NSRCs. During the post-law period, greater odds of primary care visits than emergency department (ED) visits were observed for both SRCs (OR=1.53; 95% CI 1.34, 1.75) and NSRCs (OR=1.73; 95% CI 1.58, 1.90) compared to the pre-law period.ConclusionsWe observed higher proportions of health care utilization for NSRCs than SRCs in Medicaid insured children and a shift in health care utilization from the ED to primary care in the post-law period. SRCs and NSRCs are likely to have different patterns of health care utilization before and after the enactment of Ohio's concussion law. Our results demonstrate that Ohio's youth concussion law had a quantifiable impact on health care utilization.	[Newton, Alison; Yang, Jingzhen; Sullivan, Lindsay; Huang, Lihong; Singichetti, Bhavna; Zhu, Motao] Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr RBIII, Columbus, OH 43205 USA; [Newton, Alison; Yang, Jingzhen; Zhu, Motao; Felix, Ashley S.] Ohio State Univ, Dept Epidemiol, Coll Publ Hlth, Columbus, OH 43205 USA; [Shi, Junxin] Nationwide Childrens Hosp, Biostatist Resource, Columbus, OH USA		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr RBIII, Columbus, OH 43205 USA.; Yang, JZ (corresponding author), Ohio State Univ, Dept Epidemiol, Coll Publ Hlth, Columbus, OH 43205 USA.	Ginger.Yang@nationwidechildrens.org			Centers for Disease Control PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [3 R49 CE002106-05S1]	This work was supported in part by funding from the Centers for Disease Control & Prevention (3 R49 CE002106-05S1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Centers for Disease Control & Prevention.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; Dillard C, 2017, DISABIL REHABIL, V39, P544, DOI 10.3109/09638288.2016.1152602; Eime RM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1796-0; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gonzalez L, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-019-0228-5; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Harrold GK, 2017, J NEUROL SCI, V379, P312, DOI 10.1016/j.jns.2017.06.038; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kerr ZY, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00261-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marsh AM, 2013, J PEDIATR HEALTH CAR, V27, P499, DOI 10.1016/j.pedhc.2012.12.014; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Patel Dilip R, 2002, Adolesc Med, V13, P569; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sullivan L, 2021, J RURAL HEALTH, V37, P479, DOI 10.1111/jrh.12484; Tarimala A, 2019, J PEDIATR-US, V206, P178, DOI 10.1016/j.jpeds.2018.10.021; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Trojian Thomas, 2015, Inj Epidemiol, V2, P2; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Zogg CK, 2018, EPIDEMIOLOGY, V29, P269, DOI 10.1097/EDE.0000000000000791	32	3	3	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	NOV 2	2020	7	1							55	10.1186/s40621-020-00283-w			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TD5QP	WOS:000669381600001	33131503	Green Published, gold			2022-02-06	
J	Banbury, C; Styles, I; Eisenstein, N; Zanier, ER; Vegliante, G; Belli, A; Logan, A; Oppenheimer, PG				Banbury, Carl; Styles, Iain; Eisenstein, Neil; Zanier, Elisa R.; Vegliante, Gloria; Belli, Antonio; Logan, Ann; Oppenheimer, Pola Goldberg			Spectroscopic detection of traumatic brain injury severity and biochemistry from the retina	BIOMEDICAL OPTICS EXPRESS			English	Article							RAMAN-SPECTROSCOPY	Traumatic brain injury (TBI) is a major burden on healthcare services worldwide, where scientific and clinical innovation is needed to provide better understanding of biochemical damage to improve both pre-hospital assessment and intensive care monitoring. Here, we present an unconventional concept of using Raman spectroscopy to measure the biochemical response to the retina in an ex-vivo murine model of TBI. Through comparison to spectra from the brain and retina following injury, we elicit subtle spectral changes through the use of multivariate analysis, linked to a decrease in cardiolipin and indicating metabolic disruption. The ability to classify injury severity via spectra of the retina is demonstrated for severe TBI (82.0 %), moderate TBI (75.1 %) and sham groups (69.4 %). By showing that optical spectroscopy can be used to explore the eye as the window to the brain, we lay the groundwork for further exploitation of Raman spectroscopy for indirect, non-invasive assessment of brain chemistry. Published by The Optical Society under the terms of the Creative Commons Attribution 4.0 License.	[Banbury, Carl; Eisenstein, Neil; Oppenheimer, Pola Goldberg] Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England; [Styles, Iain] Univ Birmingham, Comp Sci, Birmingham B15 2TT, W Midlands, England; [Zanier, Elisa R.; Vegliante, Gloria] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Milan, Italy; [Belli, Antonio; Logan, Ann] Univ Birmingham, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England		Oppenheimer, PG (corresponding author), Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England.	P.GoldhergOppenheimer@bham.acuk	Belli, Antonio/I-3799-2015; Vegliante, Gloria/ABF-9054-2021	Belli, Antonio/0000-0002-3211-9933; Vegliante, Gloria/0000-0002-7563-0889; Goldberg Oppenheimer, Pola/0000-0002-1014-4724; Styles, Iain/0000-0002-6755-0299	Royal Academy of EngineeringRoyal Academy of Engineering - UK [RF1415/14/28]; Wellcome TrustWellcome TrustEuropean Commission [174ISSFPP]; Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/L016346/1]	Royal Academy of Engineering (RF1415/14/28); Wellcome Trust (174ISSFPP); Engineering and Physical Sciences Research Council (EP/L016346/1).	Banbury C., 2020, RAMAN TOOLKIT ANAL D; Banbury C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47205-5; Chang Chia-Yu, 2009, Acta Neurol Taiwan, V18, P231; Chao HL, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97677; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Erckens RJ, 2001, LASER MED SCI, V16, P236, DOI 10.1007/PL00011360; Geeraerts T, 2008, CRIT CARE, V12, DOI [10.1186/cc6893, 10.1186/cc7006]; HAYREH S S, 1964, Br J Ophthalmol, V48, P522, DOI 10.1136/bjo.48.10.522; Krafft C, 2005, SPECTROCHIM ACTA A, V61, P1529, DOI 10.1016/j.saa.2004.11.017; KRISHNAN RS, 1981, J RAMAN SPECTROSC, V10, P1, DOI 10.1002/jrs.1250100103; Larkin P, 2011, INFRARED AND RAMAN SPECTROSCOPY: PRINCIPLES AND SPECTRAL INTERPRETATION, P73; Lloyd GR, 2009, CHEMOMETR INTELL LAB, V98, P149, DOI 10.1016/j.chemolab.2009.06.002; Marro M, 2014, J BIOPHOTONICS, V7, P724, DOI 10.1002/jbio.201300101; MEYERSCHWICKERATH R, 1995, GRAEF ARCH CLIN EXP, V233, P783, DOI 10.1007/BF00184090; Obana A, 2008, OPHTHALMOLOGY, V115, P147, DOI 10.1016/j.ophtha.2007.02.028; Pearn M. L., 2017, PATHOPHYSIOLOGY ASS; Purve D., 2001, NEUROSCIENCE; Rygula A, 2013, J RAMAN SPECTROSC, V44, P1061, DOI 10.1002/jrs.4335; Scheeren TWL, 2012, J CLIN MONIT COMPUT, V26, P279, DOI 10.1007/s10877-012-9348-y; Stiebing C, 2019, NEUROPHOTONICS, V6, DOI 10.1117/1.NPh.6.4.041106; Surmacki JM, 2017, ANALYST, V142, P132, DOI 10.1039/c6an02238c; Talari ACS, 2015, APPL SPECTROSC REV, V50, P46, DOI 10.1080/05704928.2014.923902; Tay LL, 2011, ANALYST, V136, P1620, DOI 10.1039/c0an00897d; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Zanier E. R., 2018, BRAIN; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]	26	3	3	3	5	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	NOV 1	2020	11	11					6249	6261		10.1364/BOE.399473			13	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	OI6HG	WOS:000583376400014	33282487	Green Published, gold			2022-02-06	
J	Carabias, CS; Castano-Leon, AM; Navarro, BB; Panero, I; Eiriz, C; Gomez, PA; Egea, J; Lagares, A				Carabias, Cristina Sanchez; Castano-Leon, Ana Maria; Blanca Navarro, B.; Panero, Irene; Eiriz, Carla; Gomez, Pedro A.; Egea, Javier; Lagares, Alfonso			Serum Amyloid A1 as a Potential Intracranial and Extracranial Clinical Severity Biomarker in Traumatic Brain Injury	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						traumatic brain injury (TBI); biomarkers; serum amyloid A1 (SAA1); secondary insults; inflammation; outcome	ACUTE-PHASE RESPONSE; HEAD-INJURY; INFLAMMATORY MARKERS; SECONDARY INSULTS; PROGNOSTIC VALUE; MORTALITY; DAMAGE; BLOOD; SCORE; IDENTIFICATION	Extracranial injury is frequently present in patients with traumatic brain injury (TBI). However, no reliable biomarker exists nowadays to evaluate the magnitude and extension of extracranial injury as well as the identification of patients who are at risk of developing secondary injuries. The purpose of this study was to identify new possible peptide biomarkers by mass spectrometry analysis in patients with TBI and ascertain whether the novel biomarker discovered by peptide mass fingerprinting, serum amyloid A1 (SAA1), is capable of reflecting the condition of the patient and both intracranial and extracranial injury extension. Demographic characteristics, clinical data, and serum samples were prospectively collected from 120 patients with TBI (Glasgow Coma Scale [GCS] score 3-15) on admission. Biomarkers were quantified by enzyme-linked immunosorbent assay. Intracranial lesion volume was measured from the semiautomatic segmentation of hematoma on computed tomography (CT) using Analyze software. Functional outcome was evaluated using the Glasgow Outcome Scale (GOS) at hospital discharge and GOS extended scores at 6 months. The SAA1 levels were significantly associated with intracranial (GCS score at admission, lesion load measured with cranial CT, and pupil responsiveness) and extracranial clinical severity (all Abbreviated Injury Scale regions, Injury Severity Score, major extracranial injury, polytrauma, and orthopedic fractures presence), along with systemic secondary insults and functional outcome. SAA1 was is associated with the volume of traumatic intracranial lesions. The SAA1 levels were correlated with astroglial S100 beta and glial fibrillary acidic protein (GFAP), neuronal neuron-specific enolase (NSE), and axonal total tau (T-tau) and phosphorylated neurofilament heavy chain (pNF-H) injury markers. SAA1 predicts unfavorable outcome and mortality at hospital discharge (area under the curve [AUC] = 0.90, 0.82) and 6 months (AUC = 0.89). SAA1 can be established as a marker for the overall patient condition due to its involvement in the neuroendocrine axis of the systemic response to craniocerebral trauma.	[Carabias, Cristina Sanchez; Lagares, Alfonso] Inst Invest Hosp 12 Octubre I 12, Neurotraumatol & Subarachnoid Hemorrhage Res Unit, Dept Neurosurg, Madrid, Spain; [Castano-Leon, Ana Maria; Blanca Navarro, B.; Panero, Irene; Eiriz, Carla; Gomez, Pedro A.; Lagares, Alfonso] Hosp Univ 12 Octubre, Dept Neurosurg, Madrid, Spain; [Egea, Javier] Inst Invest Sanitaria Hosp Univ La Princesa, Hosp Univ Santa Cristina, Mol Neuroinflammat & Neuronal Plast Res Unit, Madrid, Spain		Carabias, CS (corresponding author), Inst Invest Hosp 12 Octubre I 12, Dept Neurosurg, Neurotraumatol & Subarachnoid Hemorrhage Res Unit, Area 8 Neurosci & Mental Hlth, Av Cordoba S-N, Madrid 28041, Spain.	csanchezcarabias@gmail.com	Lagares, Alfonso/B-2969-2011; Castano-Leon, Ana M/ABF-6322-2020; Gomez, Pedro/E-2411-2014; Egea, Javier/A-1694-2008	Lagares, Alfonso/0000-0003-3996-0554; Castano-Leon, Ana M/0000-0002-7918-5049; Gomez, Pedro/0000-0002-4185-5238; Egea, Javier/0000-0003-4704-3019			Adams CA, 2011, CRIT CARE CLIN, V27, P345, DOI 10.1016/j.ccc.2010.12.002; Aly H, 2011, J PERINATOL, V31, P263, DOI 10.1038/jp.2010.130; Azar S, 2017, METHODS MOL BIOL, V1598, P45, DOI 10.1007/978-1-4939-6952-4_3; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; Ciriello V, 2013, INJURY, V44, P1680, DOI 10.1016/j.injury.2013.09.024; Deepika A, 2018, J NEUROTRAUM, V35, P1124, DOI 10.1089/neu.2017.5151; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; FASSBENDER K, 1994, J NEUROL SCI, V122, P135, DOI 10.1016/0022-510X(94)90289-5; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gao WM, 2014, PEDIATR RES, V76, P280, DOI 10.1038/pr.2014.86; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Joanna Izecka ZS, 2000, ACTA CLIN CROAT, V39, P139; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kosuge M, 2007, CIRC J, V71, P186, DOI 10.1253/circj.71.186; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Morrow DA, 2000, J AM COLL CARDIOL, V35, P358, DOI 10.1016/S0735-1097(99)00574-4; MOZES G, 1989, J TRAUMA, V29, P71, DOI 10.1097/00005373-198901000-00014; Onda H, 1999, J CEREBR BLOOD F MET, V19, P1279, DOI 10.1097/00004647-199911000-00013; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rallidis LS, 2006, ATHEROSCLEROSIS, V189, P193, DOI 10.1016/j.atherosclerosis.2005.11.032; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; SMITH CJ, 2004, BMC NEUROL, V4; Smith CJ, 2006, J NEUROL SCI, V251, P77, DOI 10.1016/j.jns.2006.09.011; SYRJANEN J, 1989, J CLIN PATHOL, V42, P63, DOI 10.1136/jcp.42.1.63; TEASDALE G, 1974, LANCET, V2, P81; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Villapol S, 2016, NEURAL REGEN RES, V11, P226, DOI 10.4103/1673-5374.177720; Villapol S, 2015, AM J PATHOL, V185, P2641, DOI 10.1016/j.ajpath.2015.06.016; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263	55	3	3	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	NOV	2020	35	11					1180	1195		10.1177/0885066619837913			16	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NV7TU	WOS:000574519800005	30961443				2022-02-06	
J	Carlozzi, NE; Kallen, MA; Brickell, TA; Lange, RT; Boileau, NR; Tulsky, D; Hanks, RA; Massengale, JP; Nakase-Richardson, R; Ianni, PA; Miner, JA; French, LM; Sander, AM				Carlozzi, Noelle E.; Kallen, Michael A.; Brickell, Tracey A.; Lange, Rael T.; Boileau, Nicholas R.; Tulsky, David; Hanks, Robin A.; Massengale, Jill P.; Nakase-Richardson, Risa; Ianni, Phillip A.; Miner, Jennifer A.; French, Louis M.; Sander, Angelle M.			Measuring Emotional Suppression in Caregivers of Adults With Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						health-related quality of life; TBI-CareQOL; traumatic brain injury; caregiver; patient-reported outcome	QUALITY-OF-LIFE; INDIVIDUAL-DIFFERENCES; RESPONSE THEORY; ITEM BANKS; HEALTH; SELF; OUTCOMES; REHABILITATION; CRITERIA; DISTRESS	Objective: Caregivers of individuals with traumatic brain injury (TBI) often feel pressure to maintain the appearance that they are emotionally well adjusted, despite feelings to the contrary. Because there are currently no measures examining this construct, this article focuses on the development of a new measure that is specific to caregivers of people with TBI. Design: A total of 533 caregivers of civilians with TB1 (n = 218) or service members/veterans (SMVs) with TBI (n = 315) completed 43 emotional suppression items, as well as other patient-reported outcomes and an estimate of the functional ability of the person with TBI. Results: Exploratory and confirmatory factor analyses supported the retention of 25 items. Graded response model (GRM) analyses and differential item functioning (DIF) studies supported the retention of 21 items in the final measure. Expert review and GRM calibration data were used to develop a 6-item static short form (SF) and program a computer adaptive test (CAT). Internal consistency was excellent for both the CAT and SF (reliabilities >= 0.91); 3-week test-retest stability was good (all intraclass correlations >= 0.89). Convergent validity was supported by moderate associations between TBI-CareQOL Emotional Suppression and related measures (rs from 0.47 to 0.59); discriminant validity was supported by small correlations between Emotional Suppression and positive aspects of caregiving and physical health (rs from 0.14 to 0.28). Known-groups validity was also supported. Conclusions: The new TBI-CareQOL Emotional Suppression CAT and 6-item short form is the first self-report measure of this construct in this population. Our findings suggest this new measure has strong psychometric properties.	[Carlozzi, Noelle E.; Boileau, Nicholas R.; Miner, Jennifer A.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Kallen, Michael A.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Evanston, IL 60208 USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Tulsky, David] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19716 USA; [Tulsky, David] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA; [Tulsky, David] Univ Delaware, Dept Psychol Brain Sci, Newark, DE 19716 USA; [Hanks, Robin A.] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI 48202 USA; [Massengale, Jill P.] James A Haley Vet Hosp, Nursing Serv, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBS, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Morsani Coll Med, Dept Internal Med, Tampa, FL 33620 USA; [Ianni, Phillip A.] Univ Michigan, Michigan Inst Clin & Hlth Res, Ann Arbor, MI 48109 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	Boileau, Nicholas/V-4832-2019	french, louis/0000-0002-9451-0604; Tulsky, David/0000-0002-4335-4509; Boileau, Nicholas/0000-0002-4056-4404	National Institutes of Health (NIH), National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; General Dynamics Information Technology, Inc. [DVBIC-SC-14-003, W91YTZ-13-C-0015]	Work on this article was supported by Grant R01NR013658 from the National Institutes of Health (NIH), National Institute of Nursing Research, the National Center for Advancing Translational Sciences (UL1TR000433), as well as contract funding from General Dynamics Information Technology, Inc., subcontractor for the Defense and Veterans Brain Injury Center (DVBIC; DVBIC-SC-14-003; W91YTZ-13-C-0015). We thank the investigators and research associates/coordinators who worked on the study, the study participants, and the organizations that supported recruitment efforts. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Abler B, 2010, PSYCHIAT RES-NEUROIM, V183, P105, DOI 10.1016/j.pscychresns.2010.05.010; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bjorner JB, 2014, J CLIN EPIDEMIOL, V67, P108, DOI 10.1016/j.jclinepi.2013.07.016; Brickell TA, 2018, BRAIN INJURY, V32, P1541, DOI 10.1080/02699052.2018.1503328; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Cai L, 2015, IRTPRO FOR WINDOWS; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS110, DOI 10.1016/j.apmr.2018.06.026; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Choi SW, 2011, J STAT SOFTW, V39, P1; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; CLAUSER BE, 1994, J EDUC MEAS, V31, P88; Cohen J., 2013, STAT POWER ANAL BEHA; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Cramer D, 2004, SAGE DICT STAT PRACT, DOI [10.4135/9780857020123, DOI 10.4135/9780857020123]; Crane PK, 2006, MED CARE, V44, pS115, DOI 10.1097/01.mlr.0000245183.28384.ed; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; DeVellis R.F., 2017, SCALE DEV THEORY APP; Egloff B, 2006, EMOTION, V6, P356, DOI 10.1037/1528-3542.6.3.356; EVERITT BS, 1975, BRIT J PSYCHIAT, V126, P237, DOI 10.1192/bjp.126.3.237; Gorsuch R.L., 1983, FACTOR ANAL; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Grimm L.G., 1995, READING UNDERSTANDIN, P99; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Hayes JP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00230; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Heaton R. K., 2004, REVISED COMPREHENSIV; HELKALA EL, 1995, NEUROSCI LETT, V191, P141, DOI 10.1016/0304-3940(95)11575-H; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hubley AM., 2014, ENCY QUALITY LIFE WE, DOI DOI 10.1007/978-94-007-0753-5_751; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; Kisala PA, 2019, HEALTH PSYCHOL, V38, P435, DOI 10.1037/hea0000685; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kwon H, 2019, INT J PSYCHOL, V54, P448, DOI 10.1002/ijop.12486; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; Larsen JK, 2012, J YOUTH ADOLESCENCE, V41, P1628, DOI 10.1007/s10964-012-9782-7; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lazarus R.S., 1991, EMOTION ADAPTATION; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; Magnus BE, 2016, QUAL LIFE RES, V25, P1655, DOI 10.1007/s11136-015-1221-2; Malec J., 2005, MAYO PORTLAND ADAPTA; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; McDonald R, 1999, TEST THEORY UNIFIED; Moore Sally A, 2012, J Exp Psychopathol, V3, P368; Mosier CI, 1943, PSYCHOMETRIKA, V8, P161, DOI 10.1007/BF02288700; Muthen L.K., 2011, MPLUS USERS GUIDE, V6th ed.; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; R Core Team, 2014, R LANG ENV STAT COMP; Ramsay J., 2000, TESTGRAF; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Roberts NA, 2008, INT J PSYCHOPHYSIOL, V70, P82, DOI 10.1016/j.ijpsycho.2008.06.003; Salsman JM, 2019, QUAL LIFE RES, V28, P2513, DOI 10.1007/s11136-019-02198-6; Samejima F., 1969, PSYCHOMETRIC MONOGRA; Samejima F., 1997, HDB MODERN ITEM RESP, P85, DOI [10.1007/978-1-4757-2691-6_5, DOI 10.1007/978-1-4757-2691-6_5]; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Sheldon KM, 1997, J PERS SOC PSYCHOL, V73, P1380, DOI 10.1037/0022-3514.73.6.1380; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Stucky BD, 2016, NICOTINE TOB RES, V18, P361, DOI 10.1093/ntr/ntv083; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Troy AS, 2019, EMOTION, V19, P751, DOI 10.1037/emo0000486; Wang M, 2017, QUAL LIFE RES, V26, P2973, DOI 10.1007/s11136-017-1640-3; Whittaker TA, 2012, J EXP EDUC, V80, P26, DOI 10.1080/00220973.2010.531299; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001	78	3	3	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2020	65	4					455	470		10.1037/rep0000291			16	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	OW5SF	WOS:000592945400013	31580109	Green Accepted, Bronze			2022-02-06	
J	de Oliveira, AJM; Solari, PN				de Oliveira, Adilson J. M.; Solari, Paulo N.			First Report of Traumatic Brain Injury in Luanda, Angola	WORLD NEUROSURGERY			English	Article						Angola; Neurosurgery; Road accidents; Traumatic brain injury	TERTIARY REFERRAL CENTER; HEAD-INJURY; EPIDEMIOLOGY; TANZANIA	BACKGROUND: Traumatic brain injury (TBI) is a global problem and is the greatest contributor to death and disability among all trauma-related injuries worldwide. Road traffic accidents are an important cause of TBI. The purpose of this paper is to present the first data on TBI in Angola. METHODS: This was a retrospective study of the clinical and radiologic profile of patients admitted to the intensive care unit of a tertiary hospital in Luanda, Angola, from January 2018 to December 2018. The medical records of patients with moderate and severe TBI admitted to the intensive care unit were reviewed. The inclusion criteria were adult patients who suffered from TBI. The exclusion criteria were incomplete medical records, pediatric age, and mild TBI. RESULTS: We included 29 patients (6 female) with a mean age of 31 years. Of them, 31% visited the hospital without an ambulance (using private or commercial vehicles), 58.6% suffered from severe TBI, and the mortality rate in our sample was 34.5%. Road accident was the most frequent cause of trauma. CONCLUSIONS: This first report of TBI in Angola reveals major problems with TBI management, road accident prevention, prehospital management, and loss of lives of young patients.	[de Oliveira, Adilson J. M.; Solari, Paulo N.] Agostinho Neto Univ, Clin Girassol, Neurosurg Serv, Luanda, Angola; [de Oliveira, Adilson J. M.] Agostinho Neto Univ, Nucleo Insvest Estudantes Saude, Luanda, Angola		de Oliveira, AJM (corresponding author), Agostinho Neto Univ, Clin Girassol, Neurosurg Serv, Luanda, Angola.; de Oliveira, AJM (corresponding author), Agostinho Neto Univ, Nucleo Insvest Estudantes Saude, Luanda, Angola.	adilsonvalmont@gmail.com		de Oliveira, Adilson/0000-0002-2876-6521			Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Coburger J, 2014, WORLD NEUROSURG, V82, pE1, DOI 10.1016/j.wneu.2012.09.019; DE Oliveira Adilson Jose Manuel, 2020, J Adv Med Educ Prof, V8, P50, DOI 10.30476/jamp.2019.81744.1030; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Prata MA, THESIS, P68; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Servadei F, 2018, WORLD NEUROSURG, V112, P315, DOI 10.1016/j.wneu.2018.01.047; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101	13	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2020	143						E362	E364		10.1016/j.wneu.2020.07.152			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OS2GK	WOS:000589984400040	32730976				2022-02-06	
J	Godoy, DA; Videtta, W; Santa Cruz, R; Silva, X; Aguilera-Rodriguez, S; Carreno-Rodriguez, JN; Ciccioli, F; Pinero, G; Ciro, JD; Re-Gutierrez, S; Domeniconi, G; Fischer, D; Hernandez, O; Lacerda-Gallardo, A; Mejia, J; Panhke, P; Romero, C; Lora, FS; Soler-Morejon, C; Sufan, JL; Montes, JM; Fuenzalida, LC; Parahnos, JL; Jibaja, M				Godoy, D. A.; Videtta, W.; Santa Cruz, R.; Silva, X.; Aguilera-Rodriguez, S.; Carreno-Rodriguez, J. N.; Ciccioli, F.; Pinero, G.; Ciro, J. D.; Re-Gutierrez, S.; Domeniconi, G.; Fischer, D.; Hernandez, O.; Lacerda-Gallardo, A.; Mejia, J.; Panhke, P.; Romero, C.; Lora, F. S.; Soler-Morejon, C.; Sufan, J. L.; Montes, J. M.; Fuenzalida, L. C.; Parahnos, J. L.; Jibaja, M.		Consorcio Latinoamericano Injuria	General care in the management of severe traumatic brain injury: Latin American consensus	MEDICINA INTENSIVA			Spanish	Article						Traumatic brain injury; Consensus; Secondary injury; General care; Homeostasis; Physiological neuroprotection	GUIDELINES; MEDICINE; QUALITY	Severe traumatic brain injury (sTBI) remains prevalent in the young adult population. Indeed, far from descending, the incidence of sTBI remains high. One of the key bases of treatment is to avoid, detect and correct secondary injuries of systemic origin, which aggravate the primary lesion. Much of this can be achieved by maintaining an adequate physiological microenvironment allowing recovery of the damaged brain tissue. General care measures are nonspecific actions designed to meet that objective. The available guidelines on the management of sTBI have not included the topics contemplated in this consensus. In this regard, a group of members of the Latin American Brain Injury Consortium (LABIC), involved in the different aspects of the acute management of sTBI (neurosurgeons, intensivists, anesthesiologists, neurologists, nurses and physiotherapists) were gathered. An exhaustive literature search was made of selected topics in the LILACS, PubMed, Embase, Scopus, Cochrane Controlled Register of Trials and Web of Science databases. To establish recommendations or suggestions with their respective strength or weakness, the GRADE methodology (Grading of Recommendations, Assessment, Development and Evaluation) was applied. Additionally, certain recommendations (included in complementary material) were not assessed by GRADE, because they constitute a set of therapeutic actions of effective compliance, in which it was not possible to apply the said methodology. Thirty-two recommendations were established, 16 strong and 16 weak, with their respective levels of evidence. This consensus attempts to standardize and establish basic general care measures in this particular patient population. (c) 2020 Elsevier Espana, S.L.U. y SEMICYUC. All rights reserved.	[Godoy, D. A.] Sanatorio Pasteur, Unidad Cuidados Neurointensivos, San Fernando Del Valle D, Catamarca, Argentina; [Godoy, D. A.] Hosp San Juan Bautista, Unidad Cuidados Intensivos, San Fernando Del Valle D, Catamarca, Argentina; [Videtta, W.] Hosp Nacl Alejandro Posadas, Unidad Cuidados Intensivos, Unidad Cuidados Intensivos Hosp Eva Peron, Merlo, Buenos Aires, Argentina; [Santa Cruz, R.] Hosp Reg Rio Gallegos, Unidad Terapia Intens, Santa Cruz, Argentina; [Silva, X.] Univ Magallanes, Escuela Med, Punta Arenas, Magallanes, Chile; [Aguilera-Rodriguez, S.] Hosp Naval Almirante Nef Vina del Mar, Serv Neurocirugia, Valparaiso, Chile; [Carreno-Rodriguez, J. N.] Univ Rosario, Fdn Santa Fe Bogota, Unidad Cuidados Intensivos, Bogota, Colombia; [Carreno-Rodriguez, J. N.] Univ Rosario, Fdn Santa Fe Bogota, Serv Neurocirugia, Bogota, Colombia; [Ciccioli, F.; Pinero, G.] Univ Nacl Sur, Hosp Municipal Agudos Dr Leonidas Lucero, Unidad Terapia Intens, Bahia Blanca, Buenos Aires, Argentina; [Ciro, J. D.] Clin Las Amer Auna, Anestesia & Cuidados Intensivos, Medellin, Antioquia, Colombia; [Re-Gutierrez, S.] Hosp Materno Infantil CNS0, Unidad Terapia Intens Adultos, La Paz, Bolivia; [Domeniconi, G.] Sanatorio Trinidad San Isidro, Unidad Cuidados Intensivos, San Isidro, Buenos Aires, Argentina; [Fischer, D.] Clin Univ los Andes, Unidad Paciente Crit Adulto, Santiago, Chile; [Hernandez, O.] Clin Medellin, Unidad Cuidados Intensivos, Medellin, Antioquia, Colombia; [Lacerda-Gallardo, A.] Hosp Gen Docente Roberto Rodriguez, Dept Neurocirugia, Moron, Ciego De Avila, Cuba; [Mejia, J.] Fdn Valle del Lili, Unidad Cuidados Neurointensivos, Cali, Valle Del Cauca, Colombia; [Panhke, P.] Hosp Municipal Urgencias, Shock Room, Cordoba, Argentina; [Romero, C.] Hosp Clin Univ Chile, Unidad Pacientes Crit, Dept Med, Santiago, Chile; [Lora, F. S.] Univ Mayor San Andres, La Paz, Bolivia; [Soler-Morejon, C.] Hosp Clin Quirurg Hermanos Ameijeiras, Havana, Cuba; [Sufan, J. L.] Univ Andres Bello, Fac Ciencias Rehabil, Escuela Kinesiol, Unidad Paciente Neurocrit,Clin Indisa, Santiago, Chile; [Montes, J. M.] Clin Alemana, Unidad Paciente Crit, Santiago, Chile; [Fuenzalida, L. C.] Pontificia Univ Catolica Chile, Complejo Hosp Barros Luco Trudeau, Ctr Pacientes Crit, Dept Med, Santiago, Chile; [Parahnos, J. L.] Hosp Santa Casa, Unidad Terapia Intens & Serv Neurocirugia, Sao Joao Del Rei, MG, Brazil; [Jibaja, M.] Univ Int Ecuador, Escuela Med, Hosp Eugenio Espejo, Unidad Cuidados Intensivos, Quito, Ecuador		Godoy, DA (corresponding author), Sanatorio Pasteur, Unidad Cuidados Neurointensivos, San Fernando Del Valle D, Catamarca, Argentina.; Godoy, DA (corresponding author), Hosp San Juan Bautista, Unidad Cuidados Intensivos, San Fernando Del Valle D, Catamarca, Argentina.	dagodoytorres@yahoo.com.ar	Santa Cruz, Roberto/AAK-8322-2021; Gallardo, Angel Jesus Lacerda/AAZ-9478-2020	Gallardo, Angel Jesus Lacerda/0000-0001-9171-2000			Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P99, DOI 10.1111/nyas.12483; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; GLASER EM, 1980, J APPL BEHAV SCI, V16, P79, DOI 10.1177/002188638001600107; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Nedelmann M, 2009, STROKE, V40, P3238, DOI 10.1161/STROKEAHA.109.555169; Oddo M, 2018, INTENS CARE MED, V44, P449, DOI 10.1007/s00134-018-5086-z; Pedersen Carsten M, 2009, Intensive Crit Care Nurs, V25, P21, DOI 10.1016/j.iccn.2008.05.004; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rotondi AJ, 1997, CRIT CARE CLIN, V13, P417, DOI 10.1016/S0749-0704(05)70319-5; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7	19	3	3	2	5	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	NOV	2020	44	8					500	508		10.1016/j.medin.2020.01.014			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OM6CY	WOS:000586111500006	32376092				2022-02-06	
J	June, D; Williams, OA; Huang, CW; An, Y; Landman, BA; Davatzikos, C; Bagel, M; Resnick, SM; Beason-Held, LL				June, Danielle; Williams, Owen A.; Huang, Chiung-Wei; An, Yang; Landman, Bennett A.; Davatzikos, Christos; Bagel, Murat; Resnick, Susan M.; Beason-Held, Lori L.			Lasting consequences of concussion on the aging brain: Findings from the Baltimore Longitudinal Study of Aging	NEUROIMAGE			English	Article						Concussion; Aging; Longitudinal neuroimaging; MRI; DTI; PET	WHITE-MATTER; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; HEAD-INJURY; BLOOD-FLOW; TASK-FORCE; REGISTRATION; HISTORY; ADULTS; VOLUME	Studies suggest that concussions may be related to increased risk of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy and Alzheimer's Disease. Most neuroimaging studies show effects of concussions in frontal and temporal lobes of the brain, yet the long-term impacts of concussions on the aging brain have not been well studied. We examined neuroimaging data from 51 participants (mean age at first imaging visit= 65.1 +/- 11.23) in the Baltimore Longitudinal Study of Aging (BLSA) who reported a concussion in their medical history an average of 23 years prior to the first imaging visit, and compared them to 150 participants (mean age at first imaging visit= 66.6 +/- 10.97) with no history of concussion. Participants underwent serial structural MRI over a mean of 5.17 +/- 6.14 years and DTI over a mean of 2.92 +/- 2.22 years to measure brain structure, as well as O-15-water PET over a mean of 5.33 +/- 2.19 years to measure brain function. A battery of neuropsychological tests was also administered over a mean of 11.62 +/- 7.41 years. Analyses of frontal and temporal lobe regions were performed to examine differences in these measures between the concussion and control groups at first imaging visit and in change over time. Compared to those without concussion, participants with a prior concussion had greater brain atrophy in temporal lobe white matter and hippocampus at first imaging visit, which remained stable throughout the follow-up visits. Those with prior concussion also showed differences in white matter microstructure using DTI, including increased radial and axial diffusivity in the fornix/stria terminalis, anterior corona radiata, and superior longitudinal fasciculus at first imaging visit. In O-15-water PET, higher resting cerebral blood flow was seen at first imaging visit in orbitofrontal and lateral temporal regions, and both increases and decreases were seen in prefrontal, cingulate, insular, hippocampal, and ventral temporal regions with longitudinal follow-up. There were no significant differences in neuropsychological performance between groups. Most of the differences observed between the concussed and non-concussed groups were seen at the first imaging visit, suggesting that concussions can produce long-lasting structural and functional alterations in temporal and frontal regions of the brain in older individuals. These results also suggest that many of the reported short-term effects of concussion may still be apparent later in life.	[June, Danielle; Williams, Owen A.; Huang, Chiung-Wei; An, Yang; Bagel, Murat; Resnick, Susan M.; Beason-Held, Lori L.] NIA, Lab Behav Neurosci, 251 Bayview Blvd, Baltimore, MD 21224 USA; [Landman, Bennett A.] Vanderbilt Univ, Dept Elect Engn & Comp Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Davatzikos, Christos] Univ Penn, Ctr Biomed Image Comp & Analyt, Philadelphia, PA 19104 USA		Beason-Held, LL (corresponding author), NIA, Lab Behav Neurosci, 251 Bayview Blvd, Baltimore, MD 21224 USA.	heldlo@mail.nih.gov	Davatzikos, Christos/ABE-2057-2021		Intramural Research Program of the National Institutes of Health, National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)	Intramural Research Program of the National Institutes of Health, National Institute on Aging.	Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Bates D., 2007, NLME LINEAR NONLINEA; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bender AR, 2015, NEUROBIOL AGING, V36, P1834, DOI 10.1016/j.neurobiolaging.2015.02.001; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BLACKBURN HL, 1957, J CONSULT PSYCHOL, V21, P139, DOI 10.1037/h0047235; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chu RX, 2016, J NEUROIMAGING, V26, P62, DOI 10.1111/jon.12271; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Cook P., 2006, 14 SCI M INT SOC MAG; Delis DC, 1987, CALIFORNIA VERBAL LE; Doshi J, 2016, NEUROIMAGE, V127, P186, DOI 10.1016/j.neuroimage.2015.11.073; Erus G, 2018, NEUROIMAGE, V166, P71, DOI 10.1016/j.neuroimage.2017.10.026; Freedman M. I., 1994, CLOCK DRAWING; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klein A., 2010, 16 ANN M ORG HUM BRA; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Lauzon CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061737; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Newcombe F., 1969, MISSILE WOUNDS BRAIN; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Ou YM, 2011, MED IMAGE ANAL, V15, P622, DOI 10.1016/j.media.2010.07.002; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Reitan RM, 1992, TRAIL MAKING TEST MA; Resnick SM, 2003, J NEUROSCI, V23, P3295; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sachdev PS, 2014, NAT REV NEUROL, V10, P634, DOI 10.1038/nrneurol.2014.181; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Shock NW., 1984, NORMAL HUMAN AGING B; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Wilde EA, 2016, J NEUROTRAUM, V33, P672, DOI 10.1089/neu.2015.4035; Williams OA, 2019, NEUROIMAGE, V188, P572, DOI 10.1016/j.neuroimage.2018.12.009; WILSON JR, 1975, INT J AGING HUM DEV, V6, P261, DOI 10.2190/BBJP-XKUG-C6EW-KYB7; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028	58	3	3	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	NOV 1	2020	221								117182	10.1016/j.neuroimage.2020.117182			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	PI0MO	WOS:000600795000047	32702483	Green Accepted, gold			2022-02-06	
J	Lesniak, MM; Iwanski, S; Szutkowska-Hoser, J; Seniow, J				Lesniak, Marcin M.; Iwanski, Szczepan; Szutkowska-Hoser, Joanna; Seniow, Joanna			Comprehensive cognitive training improves attention and memory in patients with severe or moderate traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Attention; cognitive training; memory; traumatic brain injury	WORKING-MEMORY; INCOG RECOMMENDATIONS; SUSTAINED-ATTENTION; GROUP-THERAPY; REHABILITATION; MANAGEMENT; DEFICITS; IMPAIRMENTS; REMEDIATION; STRATEGIES	Traumatic brain injury (TBI) leads to cognitive disorders, the most frequently affected functions being attention and memory. The present study aimed to investigate the effects of a cognitive rehabilitation program, consisting of individual and group interventions, on attention and memory in patients with TBI. Fifteen patients-in the postacute phase of recovery from moderate-to-severe TBI and subsequent cognitive disorders-were enrolled on a three-week waiting list and then underwent a three-week cognitive rehabilitation program. The patients were assessed using a set of five neuropsychological attention and memory tests. The patients and their caregivers were questioned to assess subjective changes in the everyday functioning of the former. The introduction of cognitive training was associated with improvement in one memory test and in two measures of attention. Mean effect size across all tests was higher over the period with treatment compared to the period without (d = 0.36 vs. 0.03). Both patients and caregivers reported significant improvements in everyday functioning (p< .05). There were no further improvements at the four-month follow-up assessment. A comprehensive program of cognitive rehabilitation may improve attention and memory, as well as everyday cognitive functioning, in patients with severe or moderate TBI.	[Lesniak, Marcin M.] Univ Wroclaw, Inst Psychol, 1 Dawida Str, PL-50527 Wroclaw, Poland; [Iwanski, Szczepan; Szutkowska-Hoser, Joanna; Seniow, Joanna] Inst Psychiat & Neurol, Dept Neurol 2, Warsaw, Poland		Lesniak, MM (corresponding author), Univ Wroclaw, Inst Psychol, 1 Dawida Str, PL-50527 Wroclaw, Poland.	marcin.lesniak@uwr.edu.pl		Lesniak, Marcin/0000-0001-9924-9620; Seniow, Joanna Seniow/0000-0002-1017-4819; Iwanski, Szczepan/0000-0002-9939-290X			Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Backhaus S, 2011, ENCY CLIN NEUROPSYCH; Barnes M, 2006, TXB NEURAL REPAIR RE; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Cappa SF, 2005, EUR J NEUROL, V12, P665; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Chi RP, 2010, BRAIN RES, V1353, P168, DOI 10.1016/j.brainres.2010.07.062; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Colantonio A, 2012, WORK, V43, P195, DOI 10.3233/WOR-2012-1377; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Duff K, 2005, ARCH CLIN NEUROPSYCH, V20, P111, DOI 10.1016/j.acn.2004.03.003; Dymowski AR, 2016, NEUROPSYCHOL REHABIL, V26, P866, DOI 10.1080/09602011.2015.1102746; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Goncalves MM, 2016, APPL NEUROPSYCH-ADUL, V23, P251, DOI 10.1080/23279095.2015.1053889; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI DOI 10.1080/09602019208401399; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS282, DOI 10.1016/j.apmr.2014.11.029; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; Jo JM, 2009, AM J PHYS MED REHAB, V88, P404, DOI 10.1097/PHM.0b013e3181a0e4cb; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Lannoo E, 1998, ACTA NEUROCHIR, V140, P245, DOI 10.1007/s007010050091; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Lesniak MM, 2018, J CLIN EXP NEUROPSYC, V40, P853, DOI 10.1080/13803395.2018.1441379; Livengood M, 2010, BRAIN INJURY, V24, P598, DOI 10.3109/02699051003652815; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Miller LA, 2014, NEUROPSYCHOL REHABIL, V24, P721, DOI 10.1080/09602011.2014.894479; Nash S., 2014, Annals of Physical and Rehabilitation Medicine, V57, P600, DOI 10.1016/j.rehab.2014.08.010; Neale C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138994; O'Neil-Pirozzi TM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000181; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; Orman JA, 2011, TXB TRAUMATIC BRAIN, V2nd, P3; Parente R., 2002, RETRAINING COGNITION, P131; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Park NW, 1999, NEUROPSYCHOL REHABIL, V9, P135, DOI 10.1080/713755595; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Rigon J, 2017, RESTOR NEUROL NEUROS, V35, P115, DOI 10.3233/RNN-150538; Roessler-Gorecka M, 2013, PSYCHIATR POL, V47, P465; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Sander A. M., 2014, HDB NEUROPSYCHOLOGY; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Stringer AY, 2011, BRAIN INJURY, V25, P169, DOI 10.3109/02699052.2010.541894; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Thickpenny-Davis KL, 2007, J HEAD TRAUMA REHAB, V22, P303, DOI 10.1097/01.HTR.0000290975.09496.93; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Vestri A, 2014, BRAIN INJURY, V28, P1102, DOI 10.3109/02699052.2014.910698; Virk S, 2015, NEUROREHABILITATION, V36, P367, DOI 10.3233/NRE-151225; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Wilson B, 2009, MEMORY REHABILITATIO; Wilson BA, 2003, NEUROPSYCHOLOG REHAB, P1	61	3	4	3	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 1	2020	27	6					570	579		10.1080/23279095.2019.1576691			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	NR9QH	WOS:000571896700010	30884968				2022-02-06	
J	Pape, TLB; Herrold, AA; Livengood, SL; Guernon, A; Weaver, JA; Higgins, JP; Rosenow, JM; Walsh, E; Bhaumik, R; Pacheco, M; Patil, VK; Kletzel, S; Conneely, M; Bhaumik, DK; Mallinson, T; Parrish, T				Pape, Theresa L. Bender; Herrold, Amy A.; Livengood, Sherri L.; Guernon, Ann; Weaver, Jennifer A.; Higgins, James P.; Rosenow, Joshua M.; Walsh, Elyse; Bhaumik, Runa; Pacheco, Marilyn; Patil, Vijaya K.; Kletzel, Sandra; Conneely, Mark; Bhaumik, Dulal K.; Mallinson, Trudy; Parrish, Todd			A Pilot Trial Examining the Merits of Combining Amantadine and Repetitive Transcranial Magnetic Stimulation as an Intervention for Persons With Disordered Consciousness After TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						amantadine; clinical trial; default mode network; disorders of consciousness; functional MRI; intervention; neurobehavioral; transcranial magnetic stimulation; traumatic brain injury; vegetative state	TRAUMATIC BRAIN-INJURY; RESTING-STATE NETWORKS; DEFAULT MODE NETWORK; COGNITIVE DYSFUNCTION; NATIONAL INSTITUTE; STRIATAL DOPAMINE; VEGETATIVE STATE; CONNECTIVITY; ATTENTION; REHABILITATION	Objective: Report pilot findings of neurobehavioral gains and network changes observed in persons with disordered consciousness (DoC) who received repetitive transcranial magnetic stimulation (rTMS) or amantadine (AMA), and then rTMS+AMA. Participants: Four persons with DoC 1 to 15 years after traumatic brain injury (TBI). Design: Alternate treatment-order, within-subject, baseline-controlled trial. Main Measures: For group and individual neurobehavioral analyses, predetermined thresholds, based on mixed linear-effects models and conditional minimally detectable change, were used to define meaningful neurobehavioral change for the Disorders of Consciousness Scale-25 (DOCS) total and Auditory-Language measures. Resting-state functional connectivity (rsFC) of the default mode and 6 other networks was examined. Results: Meaningful gains in DOCS total measures were observed for 75% of treatment segments and auditory-language gains were observed after rTMS, which doubled when rTMS preceded rTMS+AMA. Neurobehavioral changes were reflected in rsFC for language, salience, and sensorimotor networks. Between networks interactions were modulated, globally, after all treatments. Conclusions: For persons with DoC 1 to 15 years after TBI, meaningful neurobehavioral gains were observed after provision of rTMS, AMA, and rTMS+AMA. Sequencing and combining of treatments to modulate broad-scale neural activity, via differing mechanisms, merits investigation in a future study powered to determine efficacy of this approach to enabling neurobehavioral recovery.	[Pape, Theresa L. Bender; Herrold, Amy A.; Livengood, Sherri L.; Guernon, Ann; Walsh, Elyse; Pacheco, Marilyn; Kletzel, Sandra] Edward Hines Jr VA Hosp, Dept Vet Affairs VA Ctr, Ctr Innovat Complex Chron Healthcare & Res Serv, Hines, IL USA; [Pape, Theresa L. Bender; Livengood, Sherri L.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Rosenow, Joshua M.] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Higgins, James P.; Parrish, Todd] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Herrold, Amy A.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Guernon, Ann] Marianjoy Rehabil Hosp, Northwestern Med, Res Dept, Wheaton, IL USA; [Bhaumik, Runa; Bhaumik, Dulal K.] Univ Illinois, Dept Psychiat, Div Epidemiol & Biostat, Biostatat Res Ctr, Chicago, IL 60612 USA; [Bhaumik, Dulal K.] Edward Hines Jr VA Hosp, Cooperat Studies Program Coordinating Ctr, Res Serv, Hines, IL USA; [Weaver, Jennifer A.; Mallinson, Trudy] George Washington Univ, Sch Med & Hlth Sci, Dept Clin Res & Leadership, Washington, DC USA; [Patil, Vijaya K.] Edward Hines Jr VA Hosp, Dept Neurol, Hines, IL USA; [Patil, Vijaya K.] Loyola Univ, Chicago Stritch Sch Med, Dept Neurol, Maywood, IL 60153 USA; [Conneely, Mark] Rosalind Franklin Univ Sci & Med, Chicago Med Sch, N Chicago, IL USA; [Conneely, Mark] Captain James A Lovell Fed Hlth Care Ctr, Dept Radiol & Nucl Med, N Chicago, IL USA		Pape, TLB (corresponding author), Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Ctr Innovat Complex Chron Healthcare & Res Serv, PO 5000 S 5th Ave,Bldg 1,M-C 151H, Hines, IL 60141 USA.	Theresa.BenderPape@va.gov	Mallinson, Trudy/S-7381-2019; Weaver, Jennifer/M-1478-2017	Mallinson, Trudy/0000-0002-4888-5579; Parrish, Todd/0000-0002-1184-1572; Higgins, James/0000-0002-7916-8468; Weaver, Jennifer/0000-0002-3964-1441	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21HD075192-01A1]	The work reported here was supported by NIH 1R21HD075192-01A1 to Dr Bender Pape.	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Banerjee J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170528; Bayne T, 2017, ANN NEUROL, V82, P866, DOI 10.1002/ana.25088; Beynel L, 2020, NEUROIMAGE, V211, DOI 10.1016/j.neuroimage.2020.116596; Bond T.G., 2015, APPL RASCH MODEL FUN, V3rd ed; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Cole DM, 2013, NEUROIMAGE, V78, P59, DOI 10.1016/j.neuroimage.2013.04.034; Cole DM, 2012, CEREB CORTEX, V22, P2784, DOI 10.1093/cercor/bhr354; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coull JT, 2012, J NEUROSCI, V32, P16704, DOI 10.1523/JNEUROSCI.1258-12.2012; Croarkin PE, 2016, PSYCHIAT RES-NEUROIM, V247, P25, DOI 10.1016/j.pscychresns.2015.11.005; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Diana M, 2017, NAT REV NEUROSCI, V18, P685, DOI 10.1038/nrn.2017.113; Eckes T., 2009, REFERENCE SUPPLEMENT; Farrokhi F., 2012, JALT J, V34, P79; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox MD, 2012, NEUROIMAGE, V62, P2232, DOI 10.1016/j.neuroimage.2012.03.035; GEORGE MS, 1995, NEUROREPORT, V6, P1853, DOI 10.1097/00001756-199510020-00008; Giacino JT, 2020, ARCH PHYS MED REHAB, V101, P1072, DOI 10.1016/j.apmr.2020.01.013; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gollo LL, 2015, PHILOS T R SOC B, V370, P54, DOI 10.1098/rstb.2014.0165; Granger C., 2008, RASCH MEAS T, V21, P1122; Gruber AJ, 2006, J COMPUT NEUROSCI, V20, P153, DOI 10.1007/s10827-005-5705-x; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199708000-00003; JENNETT B, 2002, VEGETATIVE STATE MED; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Keck ME, 2002, NEUROPHARMACOLOGY, V43, P101, DOI 10.1016/S0028-3908(02)00069-2; Kozlakowsky-Hayner S, 2000, NEUROREHABILITATION, V14, P151; Lan YL, 2019, AM J TRANSL RES, V11, P2616; Mallinson T, 2020, J HEAD TRAUMA REHAB, V35, P363, DOI 10.1097/HTR.0000000000000577; Mallinson T, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000184; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mura E, 2014, CURR PHARM DESIGN, V20, P4121; Myford Carol M, 2003, J Appl Meas, V4, P386; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Palmiter RD, 2011, NEUROSCIENCE, V198, P213, DOI 10.1016/j.neuroscience.2011.06.089; Pape TLB, 2006, J HEAD TRAUMA REHAB, V21, P437, DOI 10.1097/00001199-200609000-00063; Pape TLB, 2014, ARCH PHYS MED REHAB, V95, P1672, DOI 10.1016/j.apmr.2014.04.015; Pape TLB, 2014, BRAIN STIMUL, V7, P620, DOI 10.1016/j.brs.2014.03.007; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Pogarell O, 2007, PSYCHIAT RES-NEUROIM, V156, P251, DOI 10.1016/j.pscychresns.2007.05.002; Pogarell O, 2006, J PSYCHIATR RES, V40, P307, DOI 10.1016/j.jpsychires.2005.09.001; Rosazza C, 2016, ANN NEUROL, V79, P841, DOI 10.1002/ana.24634; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; SALAMONE JD, 1992, PSYCHOPHARMACOLOGY, V107, P160, DOI 10.1007/BF02245133; Shafiei G, 2019, CEREB CORTEX, V29, P397, DOI 10.1093/cercor/bhy264; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Siddiqi SH, 2019, J NEUROPSYCH CLIN N, V31, P254, DOI 10.1176/appi.neuropsych.18100230; Siddiqi SH, 2019, J NEUROTRAUM, V36, P1361, DOI 10.1089/neu.2018.5889; Smyser CD, 2011, NEUROIMAGE, V56, P1437, DOI 10.1016/j.neuroimage.2011.02.073; Stelmaschuk S, 2015, J TRAUMA NURS, V22, P194, DOI 10.1097/JTN.0000000000000138; Wassermann EM, 2012, PHARMACOL THERAPEUT, V133, P98, DOI 10.1016/j.pharmthera.2011.09.003; Weaver J, 2019, ARCH PHYS MED REHAB, V100, P1385, DOI 10.1016/j.apmr.2019.03.006; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zafonte R, 2009, PROG BRAIN RES, V177, P293, DOI 10.1016/S0079-6123(09)17720-8; Zanto TP, 2013, TRENDS COGN SCI, V17, P602, DOI 10.1016/j.tics.2013.10.001	77	3	3	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2020	35	6			SI		371	387		10.1097/HTR.0000000000000634			17	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OP5PJ	WOS:000588138300002	33165151	hybrid			2022-02-06	
J	Piatt, J				Piatt, Joseph			Mediators of racial disparities in mortality rates after traumatic brain injury in childhood: data from the Trauma Quality Improvement Program	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						disparities; outcome; race; trauma; traumatic brain injury; mortality	ETHNIC DISPARITIES; INSURANCE STATUS; SOCIOECONOMIC-STATUS; CHILDREN; OUTCOMES; RACE; ABUSE; RESTRAINTS; INFANTS; TRENDS	OBJECTIVE Social disparities in healthcare outcomes are almost ubiquitous, and trauma care is no exception. Because social factors cannot cause a trauma outcome directly, there must exist mediating causal factors related to the nature and severity of the injury, the robustness of the victim, access to care, or processes of care. Identification of these causal factors is the first step in the movement toward health equity. METHODS A noninferiority analysis was undertaken to compare mortality rates between Black children and White children after traumatic brain injury (TBI). Data were derived from the Trauma Quality Improvement Program (TQIP) registries for the years 2014 through 2017. Inclusion criteria were age younger than 19 years and head Abbreviated Injury Scale scores of 4, 5, or 6. A noninferiority margin of 10% was preselected. A logistic regression propensity score model was developed to distinguish Black and White children based on all available covariates associated with race at p < 0.10. Stabilized inverse probability weighting and a one-tailed 95% CI were used to test the noninferiority hypothesis. RESULTS There were 7273 observations of White children and 2320 observations of Black children. The raw mortality rates were 15.6% and 22.8% for White and Black children, respectively. The final propensity score model included 31 covariates. It had good fit (Hosmer-Lemeshow chi(2) = 7.1604, df = 8; p = 0.5194) and good discrimination (c-statistic = 0.752). The adjusted mortality rates were 17.82% and 17.79% for White and Black children, respectively. The relative risk was 0.9986, with a confidence interval upper limit of 1.0865. The relative risk corresponding to the noninferiority margin was 1.1. The hypothesis of noninferiority was supported. CONCLUSIONS Data captured in the TQIP registries are sufficient to explain the observed racial disparities in mortality after TBI in childhood. Speculations about genetic or epigenetic factors are not supported by this analysis. Discriminatory care may still be a factor in TBI mortality disparities, but it is not occult. If it exists, evidence for it can be sought among the data included in the TQIP registries.	[Piatt, Joseph] Alfred I duPont Hosp Children, Div Neurosurg, Delaware, OH USA; [Piatt, Joseph] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Piatt, Joseph] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pediat, Philadelphia, PA 19107 USA		Piatt, J (corresponding author), Alfred I duPont Hosp Children, Nemours, Wilmington, DE 19803 USA.	jpiatt@nemours.org					Bechard LJ, 2016, CRIT CARE MED, V44, P1530, DOI 10.1097/CCM.0000000000001713; Chaudhary MA, 2018, SURGERY, V163, P651, DOI 10.1016/j.surg.2017.09.045; Costa DL, 2018, P NATL ACAD SCI USA, V115, P11215, DOI 10.1073/pnas.1803630115; Curtis LH, 2007, MED CARE, V45, pS103, DOI 10.1097/MLR.0b013e31806518ac; Falcone RA, 2008, J PEDIATR SURG, V43, P1858, DOI 10.1016/j.jpedsurg.2008.01.058; Falcone RA, 2007, J PEDIATR SURG, V42, P1031, DOI 10.1016/j.jpedsurg.2007.01.038; Falcone RA, 2007, J PEDIATR SURG, V42, P172, DOI 10.1016/j.jpedsurg.2006.09.015; Gerry JM, 2016, INJURY, V47, P197, DOI 10.1016/j.injury.2015.09.003; Glance LG, 2013, HEALTH SERV RES, V48, P1684, DOI 10.1111/1475-6773.12064; GOINS WA, 1993, J NATL MED ASSOC, V85, P601; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Haider AH, 2013, ANN SURG, V258, P572, DOI 10.1097/SLA.0b013e3182a50148; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; Hicks CW, 2015, ANN SURG, V262, P179, DOI 10.1097/SLA.0000000000000809; Howard M, 2005, TLS-TIMES LIT SUPPL, P15; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Le-Scherban F, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-4274; Lee Felecia A, 2017, Hosp Pediatr, V7, P171, DOI 10.1542/hpeds.2016-0123; Lee SL, 2012, J PEDIATR SURG, V47, P1192, DOI 10.1016/j.jpedsurg.2012.03.022; Leow JJ, 2014, WORLD J SURG, V38, P1694, DOI 10.1007/s00268-014-2459-5; Marcin JP, 2003, AM J PUBLIC HEALTH, V93, P461, DOI 10.2105/AJPH.93.3.461; Martin CA, 2010, AM J SURG, V199, P210, DOI 10.1016/j.amjsurg.2009.05.001; McNally JD, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1875-y; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Moore L, 2011, J AM COLL SURGEONS, V213, P402, DOI 10.1016/j.jamcollsurg.2011.05.007; Nirula R, 2009, J TRAUMA S5, V66; Oh DL, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1037-7; Osier ND, 2018, J NEUROTRAUM, V35, P2684, DOI 10.1089/neu.2017.5268; Osler T, 2015, J TRAUMA ACUTE CARE, V79, P516, DOI 10.1097/TA.0000000000000779; Rangel EL, 2009, J PEDIATR SURG, V44, P1229, DOI 10.1016/j.jpedsurg.2009.02.044; Rangel SJ, 2008, J PEDIATR SURG, V43, P200, DOI 10.1016/j.jpedsurg.2007.09.045; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Salim A, 2010, J TRAUMA, V68, P211, DOI 10.1097/TA.0b013e3181a0e659; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; Youssef NA, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8050083; Yue JK, 2017, NEUROGENETICS, V18, P29, DOI 10.1007/s10048-016-0500-6; Zhang P, 2010, I C CONT AUTOMAT ROB, P13, DOI 10.1109/ICARCV.2010.5707953	40	3	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2020	26	5					476	482		10.3171/2020.5.PEDS20336			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	OI1OU	WOS:000583057700002	32736354	Bronze			2022-02-06	
J	Ratliff, WA; Delic, V; Pick, CG; Citron, BA				Ratliff, Whitney A.; Delic, Vedad; Pick, Chaim G.; Citron, Bruce A.			Dendritic arbor complexity and spine density changes after repetitive mild traumatic brain injury and neuroprotective treatments	BRAIN RESEARCH			English	Article						Mild traumatic brain injury; Transcription factors; Mouse models; TBHQ; Pioglitazone; Dendritic arbor; Sholl analysis	COGNITIVE DEFICITS; SEQUELAE; MORPHOLOGY; RECOVERY; IMMATURE; STRESS; IMPACT; MEMORY; MICE	Traumatic brain injury has been described as the signature affliction of recent military conflicts and repetitive TBIs, particularly associated with military and athletic activities, typically result in more severe clinical effects. The majority of TBIs are mild, but they can result in long term cognitive deficits for which there is no effective treatment. One of the most significant deficits observed in TBI patients is memory loss, which suggests that TBI can induce pathological changes within the hippocampus. tert-butylhydroquinone (tBHQ) and pioglitazone activate the Nrf2 and PPAR-gamma transcription factors, respectively, and both have been shown to be neuroprotective in model systems. We examined the morphological changes within the hippocampus following repetitive mild TBI and simultaneous treatment with both factors. We utilized a closed head injury mouse model with five injuries over 5 weeks. Our results showed marked morphological changes among the dendrites and dendritic spines of the neurons of the dentate gyrus of the hippocampus. We observed decreases in overall dendritic length, as well as in the quantity and density of dendritic spines. Our treatment partially ameliorated these effects, suggesting that the Nrf2 and PPAR-gamma transcription factors may be important targets for future drug development in the treatment of TBI in humans.	[Delic, Vedad; Citron, Bruce A.] VA New Jersey Hlth Care Syst, Lab Mol Biol, Res & Dev 15, Bldg 16,Rm 16-176,385 Tremont Ave, E Orange, NJ 07018 USA; [Ratliff, Whitney A.; Citron, Bruce A.] Bay Pines VA Healthcare Syst, Lab Mol Biol, Res & Dev 151, Bldg 22 Rm 123,10000 Bay Pines Blvd, Bay Pines, FL 33744 USA; [Citron, Bruce A.] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, Tel Aviv, Israel		Citron, BA (corresponding author), VA New Jersey Hlth Care Syst, Lab Mol Biol, Res & Dev, Bldg 16 Room 16-176,385 Tremt Ave, E Orange, NJ 07018 USA.	bruce.citron@va.gov			Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development)US Department of Veterans Affairs [I01RX001520]; Assistant Secretary of Defense for Health Affairs through the Congressionally Directed Gulf War Illness Research Program [W81XWH-16-1-0626]; Florida Department of Health James and Esther King Biomedical Research Program [4KB14]; Bay Pines Foundation; Veterans Bio-Medical Research Institute	We thank Andrea Smith for expert animal assistance. We also thank Courtney Smith and Tanya Michaels for experimental assistance. This study was supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development (I01RX001520)), the Assistant Secretary of Defense for Health Affairs through the Congressionally Directed Gulf War Illness Research Program (W81XWH-16-1-0626), the Florida Department of Health James and Esther King Biomedical Research Program (4KB14), The Bay Pines Foundation, and the Veterans Bio-Medical Research Institute.	Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI, P1; Deng YB, 2020, GENES DIS, V7, P253, DOI 10.1016/j.gendis.2019.05.002; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrante M, 2013, J NEUROSCI, V33, P2156, DOI 10.1523/JNEUROSCI.3495-12.2013; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Peterson A., 2015, SURVEILLANCE REPORT; Pilipovic K, 2015, PROG NEURO-PSYCHOPH, V59, P8, DOI 10.1016/j.pnpbp.2015.01.003; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Ratliff W.A., 2020, J HEAD TRAUMA REHAB; Ratliff WA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59252-4; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Saykally JN, 2018, J NEUROTRAUM, V35, P139, DOI 10.1089/neu.2017.5070; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Semchenko V V, 2006, Neurosci Behav Physiol, V36, P613, DOI 10.1007/s11055-006-0065-1; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Shim SS, 2013, INT J NEUROPSYCHOPH, V16, P1373, DOI 10.1017/S1461145712001423; Shingo AS, 2015, BEHAV BRAIN RES, V280, P78, DOI 10.1016/j.bbr.2014.11.041; SHOLL DA, 1953, J ANAT, V87, P387; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wu CC, 2004, P NATL ACAD SCI USA, V101, P7141, DOI 10.1073/pnas.0402147101; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	42	3	3	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 1	2020	1746								147019	10.1016/j.brainres.2020.147019			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NK4XE	WOS:000566735000005	32681835	Bronze			2022-02-06	
J	Serpell, BG; Waddington, G; McGrath, B; Cook, CJ				SERPELL, B. E. N. J. A. M. I. N. G.; WADDINGTON, G. O. R. D. O. N.; MCGRATH, B. R. A. D. E. N.; COOK, C. H. R. I. S. T. I. A. N. J.			Is There a Link between Stress and Cognition, and Capacity to Execute Motor Skill?	MEDICINE & SCIENCE IN SPORTS & EXERCISE			English	Article						HORMONES; TESTOSTERONE; CORTISOL; SOMATOSENSORY PROCESSING; PUPILLOMETRY	AFFERENT PUPILLARY DEFECTS; SALIVARY TESTOSTERONE; RESPONSES; PERFORMANCE; DISCRIMINATION; PROPRIOCEPTION; INTERVENTIONS; CONCUSSION; DILATION; STRENGTH	Purpose This study aimed to examine the link between stress (measured via salivary cortisol and testosterone), cognition (measured via pupillometry, with greater pupil constriction and reduced pupil constriction latency associated with increased attention and improved information processing), and motor skill capacity (measured via somatosensory processing). Methods Twenty-five professional rugby players participated in this study. Saliva samples were collected upon waking, before pupillometry and somatosensory processing testing, and after testing. Testing times varied for participants; however, it was always in the morning, and the order of testing was randomized. Results Very small differences in hormone concentrations were seen across the morning (effect size = 0.01). Moderate to large differences in left eye pupil constriction for direct (left eye) versus consensual (right eye) stimulus were also seen (P< 0.01; effect size = 0.51 to 1.04). No differences for pupil constriction latency were seen for direct versus consensual stimulus. Some positive weak to moderate relationships were seen for testosterone and pupil constriction latency (r= 0.37 to 0.39,P< 0.05). Moderate to strong inverse relationships were seen for hormones with left eye pupil constriction difference between direct and consensual stimulus, and for pre- to posttest testosterone-to-cortisol ratio decline with left eye pupil constriction for direct and consensual stimulus (r= 0.41 to 0.52,P< 0.05). Weak to moderate inverse relationships for testosterone-to-cortisol ratio decline and somatosensory processing were seen (r= 0.36 to 0.47,P< 0.05). Conclusion Stress may affect ability to receive information and ability to execute motor tasks. Thus, stress may compromise ability to make appropriate objective decisions and consequently execute skill/task behavior. Strategies to help mitigate negative stress responses are noted.	[SERPELL, B. E. N. J. A. M. I. N. G.; WADDINGTON, G. O. R. D. O. N.] Univ Canberra, Univ Canberra Res Inst Sport & Exercise UCRISE, Bruce, Australia; [SERPELL, B. E. N. J. A. M. I. N. G.] Brumbies Rugby, Bruce, Australia; [SERPELL, B. E. N. J. A. M. I. N. G.] Australian Inst Sport, Performance People & Teams, Bruce, ACT 2617, Australia; [WADDINGTON, G. O. R. D. O. N.] Australian Inst Sport, Sports Med, Bruce, Australia; [MCGRATH, B. R. A. D. E. N.] Embry Riddle Aeronaut Univ, Human Factors & Behav Neurobiol Dept, Daytona Beach, FL USA; [COOK, C. H. R. I. S. T. I. A. N. J.] Univ New England, Sch Sci & Technol, Sport & Physiol Grp, Brain Behav Res Grp,Biomed Discipline,Human Perfo, Armidale, NSW, Australia		Serpell, BG (corresponding author), Australian Inst Sport, Performance People & Teams, Bruce, ACT 2617, Australia.	ben.serpell@gmail.com		Waddington, Gordon/0000-0002-4306-9193; Serpell, Benjamin/0000-0002-9067-2948; Cook, Christian/0000-0001-9677-0306	University of Canberra Research Institute of Sport and Exercise external collaboration grant	The authors thank Stratech Scientific Asia-Pacific for their assistance with saliva analysis. Funding for this project was awarded via the University of Canberra Research Institute of Sport and Exercise external collaboration grant. Funding for this project was awarded via the University of Canberra Research Institute of Sport and Exercise external collaboration grant.r The authors have no conflicts of interests, and the results of the present study do not constitute endorsement by the American College of Sports Medicine. The results of this study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation.	Bicalho LEA, 2019, HUM MOVEMENT SCI, V64, P142, DOI 10.1016/j.humov.2019.02.001; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Cabrera-Mino C, 2019, CLIN SIMUL NURS, V31, P21, DOI 10.1016/j.ecns.2019.03.009; Capo-Aponte J.E., 2013, J SPINE, V4, DOI [10.4172/2165-7939.S4-004, DOI 10.4172/2165-7939.S4-004]; Cook CJ, 2012, PHYSIOL BEHAV, V106, P683, DOI 10.1016/j.physbeh.2012.05.009; COX TA, 1981, AM J OPHTHALMOL, V92, P685, DOI 10.1016/S0002-9394(14)74662-8; Crewther BT, 2017, EUR J SPORT SCI, V17, P188, DOI 10.1080/17461391.2016.1220628; Crewther BT, 2013, J STRENGTH COND RES, V27, P471, DOI 10.1519/JSC.0b013e3182577010; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Frank BS, 2019, J SCI MED SPORT, V22, P35, DOI 10.1016/j.jsams.2018.05.017; Gaviglio CM, 2015, EUR J SPORT SCI, V15, P497, DOI 10.1080/17461391.2015.1017012; Gaviglio CM, 2014, INT J SPORT PHYSIOL, V9, P324, DOI [10.1123/ijspp.2013-0106, 10.1123/IJSPP.2013-0106]; Han J, 2016, J SPORT HEALTH SCI, V5, P80, DOI 10.1016/j.jshs.2014.10.004; HARTMANN G, 1986, J AUTONOM NERV SYST, V17, P85, DOI 10.1016/0165-1838(86)90084-6; Hayes LD, 2016, INT J SPORTS MED, V37, P1007, DOI 10.1055/s-0042-105649; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; JEZOVA D, 1981, HORM RES, V15, P141; Johnston M, 2015, EUR J SPORT SCI, V15, P550, DOI 10.1080/17461391.2015.1010107; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Lynch G, 2018, BEHAV SCI-BASEL, V8, DOI 10.3390/bs8110108; McGrath LB, 2019, NEUROSURGERY, V66, P181; Mehta PH, 2010, HORM BEHAV, V58, P898, DOI 10.1016/j.yhbeh.2010.08.020; Papacosta E, 2016, J SPORT SCI, V34, P1281, DOI 10.1080/02640414.2015.1111521; Peterson R A, 2000, J Health Psychol, V5, P255, DOI 10.1177/135910530000500215; Serpell BG, 2019, INT J SPORT PHYSIOL, V14, P125, DOI 10.1123/ijspp.2018-0177; Serpell BG, 2019, TEAM PERFORM MANAG, V26, P197, DOI 10.1108/TPM-06-2019-0059; Serpell BG, 2019, INT J SPORT PHYSIOL, V14, P796, DOI 10.1123/ijspp.2018-0600; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Strahorn J, 2017, J STRENGTH COND RES, V31, P3158, DOI 10.1519/JSC.0000000000002067; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; THOMPSON HS, 1966, AM J OPHTHALMOL, V62, P860; Waddington G, 1999, AUST J PHYSIOTHER, V45, P7, DOI 10.1016/S0004-9514(14)60335-4; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Witchalls J, 2012, J ATHL TRAINING, V47, P627, DOI 10.4085/1062-6050-47.6.12; Witchalls JB, 2014, PHYS THER SPORT, V15, P106, DOI 10.1016/j.ptsp.2013.04.002; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	36	3	3	3	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2020	52	11					2365	2372		10.1249/MSS.0000000000002397			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	OA3UT	WOS:000577715400011	33064410				2022-02-06	
J	Martin, A; McMillan, A				Martin, Aryn; McMillan, Alasdair			Concussion killjoys: CTE, violence and the brain's becoming	BIOSOCIETIES			English	Article; Early Access						Critical neuroscience; Biosocial; Chronic traumatic encephalopathy (CTE); Violence; Masculinity; Concussion; Feminism	HEAD-INJURY; NEUROSCIENCE; SCIENCE	CTE, or chronic traumatic encephalopathy, is caused by repetitive head trauma and detected by a distinctive stain for a protein called 'tau' in autopsied brain tissue. While the number of diagnosed patients is only in the hundreds, the cultural footprint of the disease in North America is huge, both because those diagnosed are often celebrity-athletes and because millions of children, adolescents and young men and women play collision sports like football and hockey. We argue that the widespread attention to CTE provides a useful wedge to crack open another, heretofore neglected public health concern: repetitive acts of violence in and around hypermasculine sports create subjects whose brains-and characters-are materially shaped by that violence. Brains change materially when delivering blows as well as receiving them, when participating in degrading hazing rituals as victim or assailant, when belittled or assaulted by a coach, when approaching an upcoming game riddled with fear. We adopt a biosocial model of the brain's becoming to intervene in a linear discourse around CTE that medicalizes and oversimplifies violence, a story that prematurely dissects one slice of the problem from a noxious whole.	[Martin, Aryn; McMillan, Alasdair] York Univ, Dept Sociol, 4700 Keele St, Toronto, ON M3J 1P3, Canada		Martin, A (corresponding author), York Univ, Dept Sociol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	aryn@yorku.ca		Martin, Aryn/0000-0003-1516-3219	York University's Faculty of Liberal Arts and Professional Studies	We thank audiences and interlocutors who heard versions of this paper at the University of Copenhagen's Centre for Medical STS; the Science History Institute in Philadelphia; McMaster University and at the Society for the Social Studies of Science annual meeting, 2019. Research for this paper was supported by York University's Faculty of Liberal Arts and Professional Studies. We are especially grateful to Asher and Max (Aryn) and Elspeth (Alasdair) who teach us daily that there are all kinds of ways to become.	Abi- Rached Joelle M., 2013, NEURO NEW BRAIN SCI; Ahmed S, 2010, SCHOLAR FEMINIST ONL, V8, P3; Anderson J, 2014, CONVERSATION; Bates D, 2016, BERKELEY FORUM HUMAN, P194; Blair RJR, 2019, AGGRESS VIOLENT BEH, V46, P158, DOI 10.1016/j.avb.2019.02.008; Branch J, 2015, BOY ICE LIFE DEATH D; Branch J, 2011, NY TIMES; Coates Ta-Nehisi, 2014, ATLANTIC; Coates Ta-Nehisi, 2012, ATLANTIC; Conway, 2011, MERCHANTS DOUBT HAND; Craig R.O, 2019, HYPERMASCULINITY ENC; Dumit J, 2004, PICTURING PERSONHOOD; Fainaru Steve, 2013, FRONTLINE; Fainaru-Wada M., 2014, LEAGUE DENIAL NFL CO; Fausto-Sterling A., 2000, SEXING BODY GENDER P; Fitzgerald D, 2015, THEOR CULT SOC, V32, P3, DOI 10.1177/0263276414537319; Gladwell M., 2009, NEW YORKER; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Hasan S, 2011, TRANSPORT RES REC, P1, DOI 10.3141/2260-01; Henne K, 2020, CRIME MEDIA CULT, V16, P395, DOI 10.1177/1741659019879888; James S, 2012, HEAD GAMES; Johnson LR, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00024; Landesman P., 2015, CONCUSSION; Laskas J.M., 2009, GQ              0915; Latour B, 2004, CRIT INQUIRY, V30, P225, DOI 10.1086/421123; Latour B., 1993, PASTEURIZATION FRANC; Leavy J, 2012, GRANTLAND       0817; Malabou Catherine, 2008, WHAT SHOULD WE DO OU; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Meloni M., 2018, PALGRAVE HDB BIOL SO; Messner M. A., 1990, International Review for the Sociology of Sport, V25, P203, DOI 10.1177/101269029002500303; Messner MA, 2005, TRANSFORMING RAPE CU, P23; Moffitt TE, 2013, DEV PSYCHOPATHOL, V25, P1619, DOI 10.1017/S0954579413000801; Niewohner J, 2018, BIOSOCIETIES, V13, P681, DOI 10.1057/s41292-017-0089-5; Oates T.P., 2017, FOOTBALL MANLINESS U; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pitts-Taylor V., 2016, BRAINS BODY NEUROSCI; Semuels A., 2019, ATLANTIC; SHAPIN S., 1985, LEVIATHAN AIR PUMP H; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Vaillancourt T, 2013, THEOR PRACT, V52, P241, DOI 10.1080/00405841.2013.829726; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Whitehead A.N., 1929, PROCESS REALITY; Young K, 2019, SPORT VIOLENCE SOC	44	3	3	14	18	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	1745-8552	1745-8560		BIOSOCIETIES	BioSocieties												10.1057/s41292-020-00209-1		OCT 2020	22	Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Biomedical Social Sciences	OI0SZ	WOS:000582998100001		hybrid			2022-02-06	
J	Posti, JP; Takala, RSK; Raj, R; Luoto, TM; Azurmendi, L; Lagerstedt, L; Mohammadian, M; Hossain, I; Gill, J; Frantzen, J; van Gils, M; Hutchinson, PJ; Katila, AJ; Koivikko, P; Maanpaa, HR; Menon, DK; Newcombe, VF; Tallus, J; Blennow, K; Tenovuo, O; Zetterberg, H; Sanchez, JC				Posti, Jussi P.; Takala, Riikka S. K.; Raj, Rahul; Luoto, Teemu M.; Azurmendi, Leire; Lagerstedt, Linnea; Mohammadian, Mehrbod; Hossain, Iftakher; Gill, Jessica; Frantzen, Janek; van Gils, Mark; Hutchinson, Peter J.; Katila, Ari J.; Koivikko, Pia; Maanpaa, Henna-Riikka; Menon, David K.; Newcombe, Virginia F.; Tallus, Jussi; Blennow, Kaj; Tenovuo, Olli; Zetterberg, Henrik; Sanchez, Jean-Charles			Admission Levels of Interleukin 10 and Amyloid beta 1-40 Improve the Outcome Prediction Performance of the Helsinki Computed Tomography Score in Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; biomarkers; outcome prediction; Helsinki CT score; interleukin 10 (IL10); beta amyloid 1&#8211; 40; panel analysis	FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE-L1; SERUM NEUROFILAMENT LIGHT; EXTERNAL VALIDATION; PLASMA-LEVELS; BIOMARKERS; S100B; CLASSIFICATION; TAU; INCREASES	Background: Blood biomarkers may enhance outcome prediction performance of head computed tomography scores in traumatic brain injury (TBI). Objective: To investigate whether admission levels of eight different protein biomarkers can improve the outcome prediction performance of the Helsinki computed tomography score (HCTS) without clinical covariates in TBI. Materials and methods: Eighty-two patients with computed tomography positive TBIs were included in this study. Plasma levels of beta-amyloid isoforms 1-40 (A beta 40) and 1-42 (A beta 42), glial fibrillary acidic protein, heart fatty acid-binding protein, interleukin 10 (IL-10), neurofilament light, S100 calcium-binding protein B, and total tau were measured within 24 h from admission. The patients were divided into favorable (Glasgow Outcome Scale-Extended 5-8, n = 49) and unfavorable (Glasgow Outcome Scale-Extended 1-4, n = 33) groups. The outcome was assessed 6-12 months after injury. An optimal predictive panel was investigated with the sensitivity set at 90-100%. Results: The HCTS alone yielded a sensitivity of 97.0% (95% CI: 90.9-100) and specificity of 22.4% (95% CI: 10.2-32.7) and partial area under the curve of the receiver operating characteristic of 2.5% (95% CI: 1.1-4.7), in discriminating patients with favorable and unfavorable outcomes. The threshold to detect a patient with unfavorable outcome was an HCTS > 1. The three best individually performing biomarkers in outcome prediction were A beta 40, A beta 42, and neurofilament light. The optimal panel included IL-10, A beta 40, and the HCTS reaching a partial area under the curve of the receiver operating characteristic of 3.4% (95% CI: 1.7-6.2) with a sensitivity of 90.9% (95% CI: 81.8-100) and specificity of 59.2% (95% CI: 40.8-69.4). Conclusion: Admission plasma levels of IL-10 and A beta 40 significantly improve the prognostication ability of the HCTS after TBI.	[Posti, Jussi P.; Frantzen, Janek; Maanpaa, Henna-Riikka] Univ Turku, Clin Neurosci, Dept Neurosurg, Turku Brain Injury Ctr,Turku Univ Hosp, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari J.; Koivikko, Pia] Univ Turku, Perioperat Serv Intens Care Med & Pain Management, Dept Anesthesiol & Intens Care, Turku Univ Hosp, Turku, Finland; [Raj, Rahul] Univ Helsinki, Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland; [Luoto, Teemu M.] Tampere Univ, Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Azurmendi, Leire; Lagerstedt, Linnea; Sanchez, Jean-Charles] Univ Geneva, Dept Special Internal Med, Fac Med, Geneva, Switzerland; [Mohammadian, Mehrbod; Hossain, Iftakher; Tallus, Jussi; Tenovuo, Olli] Univ Turku, Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Hossain, Iftakher; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Neurosurg Unit, Cambridge, England; [Gill, Jessica] NIH, NINR, Bldg 10, Bethesda, MD 20892 USA; [van Gils, Mark] VTT Tech Res Ctr Finland Ltd, Tampere, Finland; [Menon, David K.; Newcombe, Virginia F.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Gothenburg, Sweden; [Zetterberg, Henrik] UCL, Dept Neurodegenerat Dis, Inst Neurol, London, England; [Zetterberg, Henrik] UCL, United Kingdom Dementia Res Inst, London, England		Posti, JP (corresponding author), Univ Turku, Clin Neurosci, Dept Neurosurg, Turku Brain Injury Ctr,Turku Univ Hosp, Turku, Finland.	jussi.posti@utu.fi	Posti, Jussi P./Y-2908-2019; Luoto, Teemu/W-6468-2018; Raj, Rahul/K-7693-2012	Posti, Jussi P./0000-0002-5925-5193; Luoto, Teemu/0000-0002-7329-3284; Newcombe, Virginia/0000-0001-6044-9035; van Gils, Mark/0000-0002-0029-1771; Raj, Rahul/0000-0003-4243-9591; Hossain, Iftakher/0000-0003-4836-1158	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [FP7-270259-TBIcare]; Academy of Finland-GrantAcademy of Finland [17379]; Maire Taponen foundation; Integra EANS Research Grant; Finnish Medical Foundation; University of Turku Graduate School; Royal College of Surgeons; NIHR Research Professorship; NIHR Cambridge BRC; NIHR Research UK; Cambridge Biomedical Research CentreGeneral Electric; Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2017-00915]; Alzheimer Drug Discovery Foundation (ADDF) [RDAPB-201809-2016615]; Swedish Alzheimer Foundation [AF-742881]; Hjarnfonden, Sweden [FO2017-0243]; European Union Joint Program for Neurodegenerative Disorders [JPND2019-466-236]; Wallenberg Academy Fellowship; European Research Councils	This work was partially funded by the European Commission under the 7th Framework Programme (FP7-270259-TBIcare), Academy of Finland-Grant #17379, Government's Special Financial Transfer tied to academic research in Health Sciences (Finland) (JP), the Maire Taponen foundation (JP), the Integra EANS Research Grant (IH), the Finnish Medical Foundation (IH), University of Turku Graduate School funding (MM), the Royal College of Surgeons (PH), NIHR Research Professorship and the NIHR Cambridge BRC (PH), NIHR Research UK (through a Senior Investigator Award and the Cambridge Biomedical Research Centre) (DM), Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship (VN), Swedish Research Council (#2017-00915) (KB), the Alzheimer Drug Discovery Foundation (ADDF) (KB), USA (#RDAPB-201809-2016615) (KB), the Swedish Alzheimer Foundation (#AF-742881) (KB), Hjarnfonden, Sweden (#FO2017-0243) (KB), the Swedish state under the agreement between the Swedish government and the County Councils (KB), the ALF-Agreement (#ALFGBG-715986) (KB), and European Union Joint Program for Neurodegenerative Disorders (JPND2019-466-236) (KB), and Wallenberg Academy Fellowship and grants from the Swedish and European Research Councils (HZ).	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Azurmendi L, 2015, J PROTEOME RES, V14, P3948, DOI 10.1021/acs.jproteome.5b00391; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Hainard A, 2013, TRANSLANT PROTEOMICS, V1, P57, DOI [10.1016/J.TRPROT.2013.04.003, DOI 10.1016/J.TRPROT.2013.04.003, 10.1016/j.trprot.2013.04.003]; Hale AT, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS17773; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lagerstedt L, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00376; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193278; Lagerstedt L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175572; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Lindfors M, 2019, ACTA NEUROCHIR, V161, P2467, DOI 10.1007/s00701-019-04074-1; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Ma H, 2013, STAT MED, V32, P3449, DOI 10.1002/sim.5777; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Missler U, 1999, CLIN CHEM, V45, P138; National Institute for Health and Care Excellence, 2019, HEAD INJ ASS EARL MA; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Pargaonkar R, 2019, J CLIN NEUROSCI, V66, P100, DOI 10.1016/j.jocn.2019.05.011; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Robin X, 2009, EXPERT REV PROTEOMIC, V6, P675, DOI 10.1586/EPR.09.83; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2011, J CLIN EPIDEMIOL, V64, P1464, DOI 10.1016/j.jclinepi.2011.06.016; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; TEASDALE G, 1974, LANCET, V2, P81; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yao S, 2017, WORLD NEUROSURG, V101, P528, DOI 10.1016/j.wneu.2017.02.072; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	64	3	3	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 30	2020	11								549527	10.3389/fneur.2020.549527			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OQ3EQ	WOS:000588670900001	33192979	Green Published, gold			2022-02-06	
J	Baschera, D; Lawless, A; Roeters, R; Frysch, CWS; Zellweger, R				Baschera, Dominik; Lawless, Adam; Roeters, Robin; Frysch, Christian W. S.; Zellweger, Rene			Severity and predictors of head injury due to bicycle accidents in Western Australia	ACTA NEUROCHIRURGICA			English	Article						Bicycle accidents; Head trauma; Helmet; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; HELMET USE	Background Head and face injuries are the second most frequently reported injuries among bicyclists. Recently, helmet usage has increased, and in some countries, helmet laws have been introduced. However, subsequent changes in the incidence and severity of traumatic brain injury (TBI) are unknown, and data on neurosurgical interventions are lacking. Therefore, we analyzed a cohort of bicyclists with TBI, in a state with an enforced helmet law, and compared our results with the available literature. Methods Patient data of bicycle accidents that occurred between January 2008 and January 2015 were extracted from the state trauma registry, and the corresponding patient files and CT scans were comprehensively reviewed. Results Of the 1019 patients admitted due to bicycle accidents, 187 patients suffered from TBI. Most cases were mild; however, 72 involved intracranial hemorrhages. Of the TBI patients, 113 were wearing helmets. CT scans were performed on 168 TBI patients, 120 of whom had a Rotterdam CT score of 1, with no difference between helmeted and non-helmeted patients. Open head injury (p < 0.05) and epidural hematomas were significantly less frequent among helmet wearers (p = 0.03). Ten patients required surgery; helmet use and neurosurgical involvement were not significantly correlated. Conclusions Patients who wore helmets were significantly less likely to suffer from epidural hematomas and open head injuries. While TBI severity was not significantly different between helmeted and non-helmeted bicyclists, the overall occurrence of TBI and moderate to severe TBI among all admissions was lower than that seen in comparable studies from countries without helmet laws.	[Baschera, Dominik] Luzerner Kantonsspital, Dept Neurosurg, CH-6004 Luzern, Switzerland; [Lawless, Adam; Roeters, Robin; Zellweger, Rene] Royal Perth Hosp, Dept Orthopaed & Trauma Surg, Perth, WA, Australia; [Lawless, Adam] Fiona Stanley Hosp, Dept Orthoped & Trauma, Murdoch, WA, Australia; [Frysch, Christian W. S.] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany		Baschera, D (corresponding author), Luzerner Kantonsspital, Dept Neurosurg, CH-6004 Luzern, Switzerland.	dominik.baschera@luks.ch	Dominik, Baschera/AAI-1953-2021	Dominik, Baschera/0000-0002-9634-9922			Airaksinen N., 2010, ANN ADV AUTOMOTIVE M, V54, P267; Amoros Emmanuelle, 2011, BMC Public Health, V11, P653, DOI 10.1186/1471-2458-11-653; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Baschera D, 2019, WORLD NEUROSURG, V126, pE1023, DOI 10.1016/j.wneu.2019.03.032; Chen WS, 2013, ACAD EMERG MED, V20, P570, DOI 10.1111/acem.12146; Curnow WJ, 2008, HEALTH PROMOT J AUST, V19, P10, DOI 10.1071/HE08010; Dagher JH, 2016, CAN J NEUROL SCI, V43, P56, DOI 10.1017/cjn.2015.281; Debnath AK, 2016, ACCIDENT ANAL PREV, V97, P146, DOI 10.1016/j.aap.2016.09.010; Dinh MM, 2015, EMERG MED AUSTRALAS, V27, P323, DOI 10.1111/1742-6723.12407; Forbes AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185367; Hefny AF, 2012, INJURY, V43, P1547, DOI 10.1016/j.injury.2011.05.016; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; JENNETT B, 1975, LANCET, V1, P480; Joseph B, 2014, EUR J TRAUMA EMERG S, V40, P729, DOI 10.1007/s00068-014-0453-0; Joseph B, 2017, AM J SURG, V213, P413, DOI 10.1016/j.amjsurg.2016.05.021; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; Melo N, 2014, TRAUMA, V16, P183, DOI 10.1177/1460408614530953; Neumann MV, 2016, EMERG MED AUSTRALAS, V28, P90, DOI 10.1111/1742-6723.12495; Olivier J, 2019, INT J EPIDEMIOL, V48, P1197, DOI 10.1093/ije/dyz003; Olivier J, 2013, ACCIDENT ANAL PREV, V50, P1128, DOI 10.1016/j.aap.2012.09.003; Scholten AC, 2015, ACCIDENT ANAL PREV, V81, P51, DOI 10.1016/j.aap.2015.04.022; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; TEASDALE G, 1974, LANCET, V2, P81; Teschke K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008052; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Yilmaz P, 2013, INJURY, V44, P848, DOI 10.1016/j.injury.2013.03.007; Zentner J, 1996, CLIN NEUROL NEUROSUR, V98, P281, DOI 10.1016/0303-8467(96)00036-4; Zibung E, 2015, EUR J TRAUMA EMERG S, V41, P517, DOI 10.1007/s00068-014-0471-y	30	3	3	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2021	163	1					49	56		10.1007/s00701-020-04626-w		OCT 2020	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	PN3QX	WOS:000584921700001	33113011				2022-02-06	
J	Mercurio, D; Oggioni, M; Fumagalli, S; Lynch, NJ; Roscher, S; Minuta, D; Perego, C; Ippati, S; Wallis, R; Schwaeble, WJ; De Simoni, MG				Mercurio, D.; Oggioni, M.; Fumagalli, S.; Lynch, N. J.; Roscher, S.; Minuta, D.; Perego, C.; Ippati, S.; Wallis, R.; Schwaeble, W. J.; De Simoni, M. -G.			Targeted deletions of complement lectin pathway genes improve outcome in traumatic brain injury, with MASP-2 playing a major role	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Neuroinflammation; Lectin pathway; Complement cascade; MBL-associated serine protease; Neurological deficits; Pharmacological target	MANNOSE-BINDING LECTIN; INHIBITION; MICE; NEUROINFLAMMATION; DYSFUNCTION; ACTIVATION; EXPRESSION; PROTECTION; PHENOTYPE; ABSENCE	The lectin pathway (LP) of complement activation is believed to contribute to brain inflammation. The study aims to identify the key components of the LP contributing to TBI outcome as possible novel pharmacological targets. We compared the long-term neurological deficits and neuropathology of wild-type mice (WT) to that of mice carrying gene deletions of key LP components after experimental TBI. WT or MASP-2 (Masp2(-/-)), ficolin-A (Fcna(-/-)), CL-11 (Colec11(-/-)), MASP-1/3 (Masp1(-/-)), MBL-C (Mbl2(-/-)), MBL-A (Mbl1(-/-)) or MBL-/- (Mbl1(-/-)/Mbl2(-/-)) deficient male C57BL/6J mice were used. Mice underwent sham surgery or TBI by controlled cortical impact. The sensorimotor response was evaluated by neuroscore and beam walk tests weekly for 4 weeks. To obtain a comparative analysis of the functional outcome each transgenic line was rated according to a health score calculated on sensorimotor performance. For selected genotypes, brains were harvested 6 weeks after injury for histopathological analysis. MASP-2(-/-), MBL-/- and FCN-A(-/-) mice had better outcome scores compared to WT. Of these, MASP-2(-/-) mice had the best recovery after TBI, showing reduced sensorimotor deficits (by 33% at 3 weeks and by 36% at 4 weeks). They also showed higher neuronal density in the lesioned cortex with a 31.5% increase compared to WT. Measurement of LP functional activity in plasma from MASP-2(-/-) mice revealed the absence of LP functional activity using a C4b deposition assay. The LP critically contributes to the post-traumatic inflammatory pathology following TBI with the highest degree of protection achieved through the absence of the LP key enzyme MASP-2, underlining a therapeutic utility of MASP-2 targeting in TBI.	[Mercurio, D.; Oggioni, M.; Fumagalli, S.; Lynch, N. J.; Minuta, D.; Perego, C.; Ippati, S.; De Simoni, M. -G.] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Via Mario Negri 2, I-20156 Milan, Italy; [Roscher, S.; Wallis, R.] Univ Leicester, Dept Resp Sci, Univ Rd, Leicester LE1 9HN, Leics, England; [Lynch, N. J.; Schwaeble, W. J.] Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England; [Minuta, D.] Osped San Raffaele, San Raffaele Sci Inst, I-20132 Milan, Italy; [Ippati, S.] Natl Res Council CNR, Inst Neurosci, I-20129 Milan, Italy		De Simoni, MG (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Via Mario Negri 2, I-20156 Milan, Italy.	desimoni@marionegri.it	De Simoni, Maria Grazia/I-6021-2012; Mercurio, Domenico/ABH-6795-2020	De Simoni, Maria Grazia/0000-0001-6695-5297; Mercurio, Domenico/0000-0001-5101-7222; Fumagalli, Stefano/0000-0003-3598-6263	Italian Ministry of Health (Ministero della Salute): LEAP [NEURON9-FP-044]; ERA-NETNEURON, JTC 2016; Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/R002983/1]	DM, MO, SF, NJL, DM, CP, SI and MGDS received grant support from ERA-NETNEURON, JTC 2016 and Italian Ministry of Health (Ministero della Salute): LEAP (grant number: NEURON9-FP-044). SR and RW received grant support from ERA-NET-NEURON, JTC 2016 and Medical Research Council (MRC), and from Grant MR/R002983/1, MRC.	Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Dantzer R, 2001, BRAIN BEHAV IMMUN, V15, P7, DOI 10.1006/brbi.2000.0613; Das M, 2012, FUNGAL ECOL, V5, P236, DOI 10.1016/j.funeco.2011.10.002; De Blasio D, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X18758881; De Blasio D, 2017, J CEREBR BLOOD F MET, V37, P938, DOI 10.1177/0271678X16647397; Degn SE, 2014, P NATL ACAD SCI USA, V111, P13445, DOI 10.1073/pnas.1406849111; DODDS AW, 1993, METHOD ENZYMOL, V223, P46; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Fumagalli S, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1401-z; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Klein RS, 2020, NEW ENGL J MED, V382, P2056, DOI 10.1056/NEJMcibr2002480; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Lynch NJ, 2005, J IMMUNOL, V174, P4998, DOI 10.4049/jimmunol.174.8.4998; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Neglia L, 2020, J CEREBR BLOOD F MET, V40, P1608, DOI 10.1177/0271678X19874509; Neglia L, 2020, CELL MOL IMMUNOL, V17, P218, DOI 10.1038/s41423-019-0225-1; Orsini F, 2018, ARTERIOSCL THROM VAS, V38, P2678, DOI 10.1161/ATVBAHA.118.311058; Orsini F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0684-6; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Osthoff M, 2017, J NEUROTRAUM, V34, P2560, DOI 10.1089/neu.2016.4941; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Petersen SV, 2001, MOL IMMUNOL, V38, P133; Pischiutta F, 2014, NEUROPHARMACOLOGY, V79, P119, DOI 10.1016/j.neuropharm.2013.11.001; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; van der Pol P, 2012, AM J TRANSPLANT, V12, P877, DOI 10.1111/j.1600-6143.2011.03887.x; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; Yaseen S, 2017, FASEB J, V31, P2210, DOI 10.1096/fj.201601306R; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zanier Elisa R, 2015, Intensive Care Med Exp, V3, P39, DOI 10.1186/s40635-015-0039-0; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba	57	3	3	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	OCT 28	2020	8	1							174	10.1186/s40478-020-01041-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OP3VN	WOS:000588009700002	33115535	Green Published, gold			2022-02-06	
J	Karimi, SA; Hosseinmardi, N; Sayyah, M; Hajisoltani, R; Janahmadi, M				Karimi, Seyed Asaad; Hosseinmardi, Narges; Sayyah, Mohammad; Hajisoltani, Razieh; Janahmadi, Mahyar			Enhancement of intrinsic neuronal excitability-mediated by a reduction in hyperpolarization-activated cation current (I-h) in hippocampal CA1 neurons in a rat model of traumatic brain injury	HIPPOCAMPUS			English	Article						CA1 pyramidal neurons; controlled cortical impact; I-h channel current; intrinsic neuronal excitability; traumatic brain injury	LONG-TERM POTENTIATION; CORTICAL IMPACT MODEL; PYRAMIDAL NEURONS; DENTATE GYRUS; HCN1 CHANNELS; HYPEREXCITABILITY; CELLS; INVOLVEMENT; INHIBITION; INCREASES	Traumatic brain injury (TBI) is associated with epileptiform activity in the hippocampus; however, the underlying mechanisms have not been fully determined. The goal was to understand what changes take place in intrinsic neuronal physiology in the hippocampus after blunt force trauma to the cortex. In this context, hyperpolarization-activated cation current (I-h) currents may have a critical role in modulating the neuronal intrinsic membrane excitability; therefore, its contribution to the TBI-induced hyperexcitability was assessed. In a model of TBI caused by controlled cortical impact (CCI), the intrinsic electrophysiological properties of pyramidal neurons were examined 1 week after TBI induction in rats. Whole-cell patch-clamp recordings were performed under current- and voltage-clamp conditions following ionotropic receptors blockade. Induction of TBI caused changes in the intrinsic excitability of pyramidal neurons, as shown by a significant increase and decrease in firing frequency and in the rheobase current, respectively (p < .05). The evoked firing rate and the action potential time to peak were also significantly increased and decreased, respectively (p < .05). In the TBI group, the amplitude of instantaneous and steady-state I-h currents was both significantly smaller than those in the control group (p < .05). The I-h current density was also significantly decreased (p < .001). Findings indicated that TBI led to an increase in the intrinsic excitability in CA1 pyramidal neurons and changes in I-h current could be, in part, one of the underlying mechanisms involved in this hyperexcitability.	[Karimi, Seyed Asaad; Janahmadi, Mahyar] Shahid Beheshti Univ Med Sci, Sch Med, Neurosci Res Ctr, Tehran, Iran; [Karimi, Seyed Asaad; Hosseinmardi, Narges; Hajisoltani, Razieh; Janahmadi, Mahyar] Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran; [Karimi, Seyed Asaad] Hamadan Univ Med Sci, Neurophysiol Res Ctr, Hamadan, Hamadan, Iran; [Karimi, Seyed Asaad] Hamadan Univ Med Sci, Sch Sci & Adv Technol Med, Dept Neurosci, Hamadan, Hamadan, Iran; [Sayyah, Mohammad] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran		Janahmadi, M (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Neurosci Res Ctr, Tehran, Iran.	janahmadi@sbmu.ac.ir	Janahmadi, Mahyar/AAU-6425-2021; Karimi, Seyed Asaad/V-9287-2018	Karimi, Seyed Asaad/0000-0002-8663-6485	Shahid Beheshti University of Medical Sciences and Pasteur Institute	Shahid Beheshti University of Medical Sciences and Pasteur Institute	Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Balakrishnan S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195094; BANKS MI, 1993, J NEUROPHYSIOL, V70, P1420, DOI 10.1152/jn.1993.70.4.1420; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Berger T, 2003, J NEUROPHYSIOL, V90, P2428, DOI 10.1152/jn.00377.2003; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brauer AU, 2001, FASEB J, V15, P2689, DOI 10.1096/fj.01-0235com; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Chen WQ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0847-0; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Deng P, 2008, J CEREBR BLOOD F MET, V28, P939, DOI 10.1038/sj.jcbfm.9600583; Deng P, 2011, J NEUROTRAUM, V28, P1173, DOI 10.1089/neu.2010.1683; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Eslamizade MJ, 2015, NEUROSCIENCE, V305, P279, DOI 10.1016/j.neuroscience.2015.07.087; Fan Y, 2008, EXP NEUROL, V212, P415, DOI 10.1016/j.expneurol.2008.04.032; FAROOQUI AA, 1994, J NEUROSCI RES, V38, P6, DOI 10.1002/jnr.490380103; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Golowasch J, 2009, J NEUROPHYSIOL, V102, P2161, DOI 10.1152/jn.00160.2009; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Hosseini-Zare MS, 2017, EXP NEUROL, V295, P155, DOI 10.1016/j.expneurol.2017.05.002; Howard AL, 2007, J NEUROPHYSIOL, V97, P2394, DOI 10.1152/jn.00509.2006; Hu T, 2016, ANESTH ANALG, V122, P1048, DOI 10.1213/ANE.0000000000001140; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Janigro D, 1997, J MEMBRANE BIOL, V160, P101, DOI 10.1007/s002329900299; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Jung S, 2010, J NEUROSCI, V30, P6678, DOI 10.1523/JNEUROSCI.1290-10.2010; Kaczorowski CC, 2011, NEUROBIOL AGING, V32, P1452, DOI 10.1016/j.neurobiolaging.2009.09.003; Karimi SA, 2017, BRAIN RES BULL, V134, P177, DOI 10.1016/j.brainresbull.2017.07.014; Kochanek PM, 2017, CHILD NERV SYST, V33, P1693, DOI 10.1007/s00381-017-3474-2; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Magee JC, 1998, J NEUROSCI, V18, P7613; MATSUMOTO G, 1977, BIOPHYS J, V20, P1, DOI 10.1016/S0006-3495(77)85532-X; McClelland S, 2011, ANN NEUROL, V70, P454, DOI 10.1002/ana.22479; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/j.cell.2004.11.020; Ortiz F, 2015, EXP NEUROL, V271, P319, DOI 10.1016/j.expneurol.2015.06.009; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; PEDARZANI P, 1995, P NATL ACAD SCI USA, V92, P11716, DOI 10.1073/pnas.92.25.11716; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Reid CA, 2014, BRAIN, V137, P1701, DOI 10.1093/brain/awu077; Reinert M., 2000, NEUROSURG FOCUS, V8, P1; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Shah MM, 2013, NEUROPHARMACOLOGY, V69, P75, DOI 10.1016/j.neuropharm.2012.03.005; Shah MM, 2010, TRENDS NEUROSCI, V33, P307, DOI 10.1016/j.tins.2010.03.002; Siskova Z, 2014, NEURON, V84, P1023, DOI 10.1016/j.neuron.2014.10.024; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; STREIT J, 1987, PFLUG ARCH EUR J PHY, V408, P634, DOI 10.1007/BF00581167; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; Surges R, 2003, EPILEPSIA, V44, P150, DOI 10.1046/j.1528-1157.2003.36802.x; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Sweatt JD, 2004, PSYCHOPHARMACOLOGY, V174, P99, DOI 10.1007/s00213-004-1795-9; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Toth Z, 1997, J NEUROSCI, V17, P8106; van Ooyen A, 2002, NETWORK-COMP NEURAL, V13, P311, DOI 10.1088/0954-898X/13/3/304; Vigil FA, 2020, J CEREBR BLOOD F MET, V40, P1256, DOI 10.1177/0271678X19857818; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xiong Y, 2019, NEURAL REGEN RES, V14, P1477, DOI 10.4103/1673-5374.255957; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	86	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	FEB	2021	31	2					156	169		10.1002/hipo.23270		OCT 2020	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PV5KJ	WOS:000583678200001	33107111				2022-02-06	
J	Mishra, J; Vishwakarma, J; Malik, R; Gupta, K; Pandey, R; Maurya, SK; Garg, A; Shukla, M; Chattopadhyay, N; Bandyopadhyay, S				Mishra, Juhi; Vishwakarma, Jitendra; Malik, Rafat; Gupta, Keerti; Pandey, Rukmani; Maurya, Shailendra Kumar; Garg, Asmita; Shukla, Manoj; Chattopadhyay, Naibedya; Bandyopadhyay, Sanghamitra			Hypothyroidism Induces Interleukin-1-Dependent Autophagy Mechanism as a Key Mediator of Hippocampal Neuronal Apoptosis and Cognitive Decline in Postnatal Rats	MOLECULAR NEUROBIOLOGY			English	Article						Thyroid hormone deficiency; Inflammation; Autophagy; Hippocampus; Memory loss	NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; HORMONE STIMULATION; MEMORY IMPAIRMENT; THYROID-HORMONES; OXIDATIVE STRESS; EARLY-PREGNANCY; GROWTH-FACTOR; A-BETA; HB-EGF	Thyroid hormone (TH) is essential for brain development, and hypothyroidism induces cognitive deficits in children and young adults. However, the participating mechanisms remain less explored. Here, we examined the molecular mechanism, hypothesizing the involvement of a deregulated autophagy and apoptosis pathway in hippocampal neurons that regulate cognitive functions. Therefore, we used a rat model of developmental hypothyroidism, generated through methimazole treatment from gestation until young adulthood. We detected that methimazole stimulated the autophagy mechanism, characterized by increased LC3B-II, Beclin-1, ATG7, and ATG5-12 conjugate and decreased p-mTOR/mTOR and p-ULK1/ULK1 autophagy regulators in the hippocampus of developing and young adult rats. This methimazole-induced hippocampal autophagy could be inhibited by thyroxine treatment. Subsequently, probing the upstream mediators of autophagy revealed an increased hippocampal neuroinflammation, marked by upregulated interleukin (IL)-1alpha and beta and activated microglial marker, Iba1, promoting neuronal IL-1 receptor-1 expression. Hence, IL-1R-antagonist (IL-1Ra), which reduced hippocampal neuronal IL-1R1, also inhibited the enhanced autophagy in hypothyroid rats. We then linked these events with hypothyroidism-induced apoptosis and loss of hippocampal neurons, where we observed that like thyroxine, IL-1Ra and autophagy inhibitor, 3-methyladenine, reduced the cleaved caspase-3 and TUNEL-stained apoptotic neurons and enhanced Nissl-stained neuronal count in methimazole-treated rats. We further related these molecular results with cognition through Y-maze and passive avoidance tests, demonstrating an IL-1Ra and 3-methyladenine-mediated improvement in learning-memory performances of the hypothyroid rats. Taken together, our study enlightens the critical role of neuroinflammation-dependent autophagy mechanism in TH-regulated hippocampal functions, disrupted in developmental hypothyroidism.	[Mishra, Juhi; Vishwakarma, Jitendra; Malik, Rafat; Gupta, Keerti; Pandey, Rukmani; Garg, Asmita; Bandyopadhyay, Sanghamitra] CSIR Indian Inst Toxicol Res CSIR IITR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, Lucknow 226001, Uttar Pradesh, India; [Mishra, Juhi] Babu Banarasi Das Univ, Dept Biochem, Faizabad Rd, Lucknow, Uttar Pradesh, India; [Vishwakarma, Jitendra; Gupta, Keerti; Pandey, Rukmani; Garg, Asmita; Bandyopadhyay, Sanghamitra] Acad Sci & Innovat Res AcSIR, Ghaziabad, Uttar Pradesh, India; [Pandey, Rukmani] Icahn Sch Med Mt Sinai, Dept Psychiat, Ctr Mol Biol & Genet Neurodegenerat, New York, NY 10029 USA; [Maurya, Shailendra Kumar; Chattopadhyay, Naibedya] CSIR Cent Drug Res Inst CSIR CDRI, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Maurya, Shailendra Kumar] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Shukla, Manoj] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow, Uttar Pradesh, India		Bandyopadhyay, S (corresponding author), CSIR Indian Inst Toxicol Res CSIR IITR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, Lucknow 226001, Uttar Pradesh, India.; Bandyopadhyay, S (corresponding author), Acad Sci & Innovat Res AcSIR, Ghaziabad, Uttar Pradesh, India.	sanghmitra@iitr.res.in	Pandey, Rukmani/AAQ-7264-2021; Chattopadhyay, Naibedya/AAQ-3213-2021	Chattopadhyay, Naibedya/0000-0003-2473-0246; Bandyopadhyay, Sanghamitra/0000-0002-1490-3599	Council of Scientific and Industrial Research (CSIR), New DelhiCouncil of Scientific & Industrial Research (CSIR) - India	The first author was supported by the fellowship from Council of Scientific and Industrial Research (CSIR), New Delhi. Dr. Rohit A. Sinha, Assistant Prof & Wellcome Trust/DBT Fellow, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, provided valuable suggestions for the autophagy experiments. CSIR-IITR manuscript number is 3640.	Accorroni A, 2017, CURR DRUG METAB, V18, P225, DOI 10.2174/1389200218666170116112407; Alvarez-Arellano L, 2018, J NEUROSCI RES, V96, P234, DOI 10.1002/jnr.24130; Ashok A, 2015, TOXICOL SCI, V143, P64, DOI 10.1093/toxsci/kfu208; Baek SH, 2009, AUTOPHAGY, V5, P277, DOI 10.4161/auto.5.2.7641; Bernal J., 2000, THYROID HORMONES BRA; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Bossy B, 2008, CURR NEUROPHARMACOL, V6, P97, DOI 10.2174/157015908784533897; Chaalal A, 2019, MOL NEUROBIOL, V56, P722, DOI 10.1007/s12035-018-1111-z; Chaalal A, 2014, HIPPOCAMPUS, V24, P1381, DOI 10.1002/hipo.22319; Chi HC, 2016, AUTOPHAGY, V12, P2271, DOI 10.1080/15548627.2016.1230583; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Chung H, 2018, ENDOCR J, V65, P63, DOI 10.1507/endocrj.EJ17-0281; Chung KM, 2015, STEM CELLS, V33, P3052, DOI 10.1002/stem.2082; Chung Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1229-y; Cui CM, 2015, MOL MED REP, V12, P2323, DOI 10.3892/mmr.2015.3611; Doherty J, 2018, NAT CELL BIOL, V20, P1110, DOI 10.1038/s41556-018-0201-5; Dong J, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-149; Dong YL, 2018, EUR J NUTR, V57, P1781, DOI 10.1007/s00394-017-1462-7; Fan L, 2019, ACTA PHARMACOL SIN, V40, P1279, DOI 10.1038/s41401-019-0220-1; Friedman WJ, 2001, EXP NEUROL, V168, P23, DOI 10.1006/exnr.2000.7595; Ghenimi N, 2010, J NEUROENDOCRINOL, V22, P951, DOI 10.1111/j.1365-2826.2010.02002.x; Ginet V, 2014, AUTOPHAGY, V10, P846, DOI 10.4161/auto.28264; Glatigny M, 2019, CURR BIOL, V29, P435, DOI 10.1016/j.cub.2018.12.021; Guo HD, 2016, ACUPUNCT MED, V34, P449, DOI 10.1136/acupmed-2015-010894; Guo LL, 2018, EUR REV MED PHARMACO, V22, P6042, DOI 10.26355/eurrev_201809_15941; Ha S, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0119-9; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Ho YH, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0157-8; Huang XW, 2008, J ENDOCRINOL INVEST, V31, P8, DOI 10.1007/BF03345560; Huang Xin-wen, 2005, Zhejiang Da Xue Xue Bao Yi Xue Ban, V34, P298; Huang Xin-Wen, 2005, Zhonghua Er Ke Za Zhi, V43, P48; Jiang HS, 2018, CELL MOL NEUROBIOL, V38, P1009, DOI 10.1007/s10571-017-0570-5; Jonas P, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00107; Khazipov R, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00161; Kocaturk NM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00128; Korevaar TIM, 2016, LANCET DIABETES ENDO, V4, P35, DOI 10.1016/S2213-8587(15)00327-7; Kumar A, 2006, ENDOCRINOLOGY, V147, P4893, DOI 10.1210/en.2006-0027; Kushwaha R, 2019, J NEUROCHEM, V149, P679, DOI 10.1111/jnc.14610; Kushwaha R, 2018, MOL NEUROBIOL, V55, P2125, DOI 10.1007/s12035-017-0469-7; Lazarus JH, 2002, THYROID, V12, P861, DOI 10.1089/105072502761016485; Lesmana R, 2016, ENDOCRINOLOGY, V157, P23, DOI 10.1210/en.2015-1632; Li JX, 2015, BRAIN RES, V1610, P80, DOI 10.1016/j.brainres.2015.03.051; Li LL, 2014, SLEEP BREATH, V18, P243, DOI 10.1007/s11325-013-0930-4; Li ZG, 2016, BEHAV BRAIN RES, V305, P265, DOI 10.1016/j.bbr.2016.03.023; Ma C, 2009, NUCL MED COMMUN, V30, P586, DOI 10.1097/MNM.0b013e32832c79e0; Maurya SK, 2016, MOL NEUROBIOL, V53, P968, DOI 10.1007/s12035-014-9061-6; Maurya SK, 2012, TOXICOL SCI, V125, P473, DOI 10.1093/toxsci/kfr303; Modesto T, 2015, JAMA PEDIATR, V169, P838, DOI 10.1001/jamapediatrics.2015.0498; Nam SM, 2018, MOL MED REP, V17, P5782, DOI 10.3892/mmr.2018.8605; Napolitano F, 2018, NEUROSCIENCE, V384, P419, DOI 10.1016/j.neuroscience.2018.05.027; Ohyama K, 1997, J BONE MINER RES, V12, P1647, DOI 10.1359/jbmr.1997.12.10.1647; Pan JR, 2017, MOL NEUROBIOL, V54, P1710, DOI 10.1007/s12035-016-9735-3; Pandey R, 2020, J ENDOCRINOL, V244, P53, DOI 10.1530/JOE-19-0197; Pandey R, 2017, TOXICOL SCI, V159, P137, DOI 10.1093/toxsci/kfx124; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Plaza-Zabala A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030598; Raymaekers SR, 2017, GEN COMP ENDOCR, V247, P26, DOI 10.1016/j.ygcen.2017.04.001; Rothaug M, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-014-0182-y; Salazar P, 2019, MOL NEUROBIOL, V56, P2952, DOI 10.1007/s12035-018-1270-y; Salazar P, 2017, BBA-MOL BASIS DIS, V1863, P870, DOI 10.1016/j.bbadis.2017.01.002; Sangun O, 2015, J CLIN RES PEDIATR E, V7, P102, DOI 10.4274/jcrpe.1684; Shao ZQ, 2015, J NEUROL SCI, V349, P65, DOI 10.1016/j.jns.2014.12.027; Sinha RA, 2009, INT J DEV NEUROSCI, V27, P377, DOI 10.1016/j.ijdevneu.2009.02.003; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Srivastava IN, 2016, NEUROBIOL DIS, V85, P144, DOI 10.1016/j.nbd.2015.10.001; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Sweatt JD, 2004, PSYCHOPHARMACOLOGY, V174, P99, DOI 10.1007/s00213-004-1795-9; Tripathi S, 2017, J NEUROCHEM, V140, P96, DOI 10.1111/jnc.13879; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; Videla LA, 2019, IUBMB LIFE, V71, P1211, DOI 10.1002/iub.2067; Wang YF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.120; Wesselborg S, 2015, CELL MOL LIFE SCI, V72, P4721, DOI 10.1007/s00018-015-2034-8; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Woo H, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0381-8; Xilouri M, 2013, BRAIN, V136, P2130, DOI 10.1093/brain/awt131; Xin W, 2017, ENDOCR J, V64, P749, DOI 10.1507/endocrj.EJ16-0534; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Yu SW, 2008, STEM CELLS, V26, P2602, DOI 10.1634/stemcells.2008-0153; Yu Y, 2017, BEHAV BRAIN RES, V334, P155, DOI 10.1016/j.bbr.2017.07.003; Zhang K, 2013, BRAIN RES, V1490, P193, DOI 10.1016/j.brainres.2012.10.025; Zhou J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01363; Zhu JJ, 2016, LIFE SCI, V151, P115, DOI 10.1016/j.lfs.2016.02.014; Zhu YL, 2019, INFLAMMATION, V42, P2181, DOI 10.1007/s10753-019-01082-2; Zou WY, 2018, MOL NEUROBIOL, V55, P776, DOI 10.1007/s12035-016-0351-z	84	3	3	0	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2021	58	3					1196	1211		10.1007/s12035-020-02178-9		OCT 2020	16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QG0KD	WOS:000584000900001	33106949				2022-02-06	
J	Balasubramanian, N; Sagarkar, S; Choudhary, AG; Kokare, DM; Sakharkar, AJ				Balasubramanian, Nagalakshmi; Sagarkar, Sneha; Choudhary, Amit G.; Kokare, Dadasaheb M.; Sakharkar, Amul J.			Epigenetic Blockade of Hippocampal SOD2 Via DNMT3b-Mediated DNA Methylation: Implications in Mild Traumatic Brain Injury-Induced Persistent Oxidative Damage	MOLECULAR NEUROBIOLOGY			English	Article						Mild traumatic brain injury; DNA methylation; Superoxide dismutase 2; Hippocampus; Neurodegeneration	POSTTRAUMATIC-STRESS-DISORDER; MOUSE MODEL; HEAD-INJURY; MITOCHONDRIAL DYSFUNCTION; MEMORY DEFICITS; SUPEROXIDE; MECHANISMS; DISEASE; NEURODEGENERATION; RISK	The recurrent events of mild trauma exacerbate the vulnerability for post-traumatic stress disorder; however, the underlying molecular mechanisms are scarcely known. The repeated mild traumatic brain injury (rMTBI) perturbs redox homeostasis which is primarily managed by superoxide dismutase 2 (SOD2). The current study investigates the role of DNA methylation in SOD2 gene regulation and its involvement in rMTBI-induced persistent neuropathology inflicted by weight drop injury paradigm. The oxidative damage, neurodegenerative indicators, and SOD2 function and its regulation in the hippocampus were analyzed after 48 h and 30 days of rMTBI. The temporal and episodic increase in ROS levels (oxidative stress) heightened 8-hydroxyguanosine levels indicating oxidative damage after rMTBI that was concomitant with decline in SOD2 function. In parallel, occupancy of DNMT3b at SOD2 promoter was higher post 30 days of the first episode of rMTBI causing hypermethylation at SOD2 promoter. This epigenetic silencing of SOD2 promoter was sustained after the second episode of rMTBI causing permanent blockade in SOD2 response. The resultant oxidative stress further culminated into the increasing number of degenerating neurons. The treatment with 5-azacytidine, a pan DNMT inhibitor, normalized DNA methylation levels and revived SOD2 function after the second episode of rMTBI. The release of blockade in SOD2 expression by DNMT inhibition also normalized the post-traumatic oxidative consequences and relieved the neurodegeneration and deficits in learning and memory as measured by novel object recognition test. In conclusion, DNMT3b-mediated DNA methylation plays a critical role in SOD2 gene regulation in the hippocampus, and the perturbations therein post rMTBI are detrimental to redox homeostasis manifesting into neurological consequences.	[Balasubramanian, Nagalakshmi; Sagarkar, Sneha; Sakharkar, Amul J.] Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India; [Sagarkar, Sneha] Savitribai Phule Pune Univ, Dept Zool, Pune 411007, Maharashtra, India; [Choudhary, Amit G.; Kokare, Dadasaheb M.] Rashtrasant Tukadoji Maharaj Nagpur Univ, Dept Pharmaceut Sci, Nagpur 440033, Maharashtra, India		Sakharkar, AJ (corresponding author), Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India.	amul.sakharkar@unipune.ac.in			University Grants Commission, Government of India (UGC-GOI) [F.4-5/151-FRP/2014/BSR]; Science and Engineering Research Board (SERB), GOI [EMR/2017/000621]; Council for Scientific and Industrial Research (CSIR), GOI [37[1718]/18/EMR-II]; Department Research and Development Program of the Department of Biotechnology, Savitribai Phule Pune University, Pune, India; UGC-GOIUniversity Grants Commission, India [2061330923]; DST INSPIREFaculty program [DST/INSPIRE/04/2018/000529]; Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur [Dev./RTMNURP/AH/2115]	This work was supported by the grants from the University Grants Commission, Government of India (UGC-GOI; F.4-5/151-FRP/2014/BSR); Science and Engineering Research Board (SERB), GOI (EMR/2017/000621); and Council for Scientific and Industrial Research (CSIR), GOI (37[1718]/18/EMR-II) to AJS. AJS also acknowledges funds received through the Department Research and Development Program of the Department of Biotechnology, Savitribai Phule Pune University, Pune, India. NB thanks the UGC-GOI for the award of Senior Research Fellowship (File No. 2061330923). SS acknowledges DST INSPIREFaculty program (DST/INSPIRE/04/2018/000529) for the funding support. DMK acknowledges the grants from the University Research Project Scheme (URPS; Dev./RTMNURP/AH/2115) from Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Aggleton JP, 2010, BEHAV NEUROSCI, V124, P55, DOI 10.1037/a0018320; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bailey ZS, 2015, NEUROSCI LETT, V604, P119, DOI 10.1016/j.neulet.2015.07.035; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Balasubramanian N, 2020, NEUROSCI RES, V155, P34, DOI 10.1016/j.neures.2019.06.003; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bharne AP, 2016, HIPPOCAMPUS, V26, P1313, DOI 10.1002/hipo.22608; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Burke SN, 2010, BEHAV NEUROSCI, V124, P559, DOI 10.1037/a0020893; Carvajal FJ, 2018, BBA-MOL BASIS DIS, V1864, P2010, DOI 10.1016/j.bbadis.2018.03.019; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cowan K, 2019, CNS NEUROSCI THER, V25, P825, DOI 10.1111/cns.13105; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Demarest TG, 2015, J BIOENERG BIOMEMBR, V47, P173, DOI 10.1007/s10863-014-9583-7; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fernandes MYD, 2019, EUR J PHARMACOL, V842, P270, DOI 10.1016/j.ejphar.2018.09.036; Ehara A, 2009, ACTA HISTOCHEM CYTOC, V42, P171, DOI 10.1267/ahc.09018; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Flynn JM, 2013, FREE RADICAL BIO MED, V62, P4, DOI 10.1016/j.freeradbiomed.2013.05.027; Gaignard P, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12497; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gayet O, 2015, ONCOTARGET, V6, P746, DOI 10.18632/oncotarget.2685; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grinan-Ferre C, 2016, AGING-US, V8, P664, DOI 10.18632/aging.100906; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jaillard T, 2009, DIABETES, V58, P1544, DOI 10.2337/db08-1039; Jia J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4202437; Khalifa ARM, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13125; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kondo N, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201708547; Kotloski R, 2002, PROG BRAIN RES, V135, P95; Kuehner JN, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00268; Laskowitz DT., 2016, TRANSLATIONAL RES TR, P97; Lee B, 2016, BIOMOL THER, V24, P328, DOI 10.4062/biomolther.2015.152; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Liang LP, 2012, NEUROBIOL DIS, V45, P1068, DOI 10.1016/j.nbd.2011.12.025; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lovell MA, 2001, ARCH NEUROL-CHICAGO, V58, P392, DOI 10.1001/archneur.58.3.392; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marchi Saverio, 2012, J Signal Transduct, V2012, P329635, DOI 10.1155/2012/329635; Massaad CA, 2009, P NATL ACAD SCI USA, V106, P13576, DOI 10.1073/pnas.0902714106; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Min DY, 2012, NEUROSCI LETT, V510, P29, DOI 10.1016/j.neulet.2011.12.064; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Nanduri J, 2012, P NATL ACAD SCI USA, V109, P2515, DOI 10.1073/pnas.1120600109; Nobili A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14727; Oh SS, 2012, NEUROSCIENCE, V212, P201, DOI 10.1016/j.neuroscience.2012.03.026; Oliveira AMM, 2010, LEARN MEMORY, V17, P155, DOI 10.1101/lm.1625310; Parabucki AB, 2012, CROAT MED J, V53, P586, DOI 10.3325/cmj.2012.53.586; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Quick KL, 2008, NEUROBIOL AGING, V29, P117, DOI 10.1016/j.neurobiolaging.2006.09.014; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Sagarkar S, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13074; Sagarkar S, 2019, BRAIN RES, V1711, P183, DOI 10.1016/j.brainres.2019.01.022; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Stricker SH, 2018, FRONT NEUROSCI, V12, P2018, DOI [10.3389/fnins.2018.00005.eCollection, DOI 10.3389/FNINS.2018.00005.ECOLLECTION]; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vincent AM, 2007, EXP NEUROL, V208, P216, DOI 10.1016/j.expneurol.2007.07.017; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2005, J NEUROCHEM, V95, P732, DOI 10.1111/j.1471-4159.2005.03412.x; Yan H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6353845; Yang LY, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113135; Yang PM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03219; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061; Zhao H, 2019, BIOCHEM BIOPH RES CO, V508, P1209, DOI 10.1016/j.bbrc.2018.12.058; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	97	3	3	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2021	58	3					1162	1184		10.1007/s12035-020-02166-z		OCT 2020	23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	QG0KD	WOS:000582325800001	33099744				2022-02-06	
J	Khirug, S; Soni, S; Garcia, MS; Tessier, M; Zhou, L; Kulesskaya, N; Rauvala, H; Lindholm, D; Ludwig, A; Molinari, F; Rivera, C				Khirug, Stanislav; Soni, Shetal; Saez Garcia, Marta; Tessier, Marine; Zhou, Liang; Kulesskaya, Natalia; Rauvala, Heikki; Lindholm, Dan; Ludwig, Anastasia; Molinari, Florence; Rivera, Claudio			Protective Role of Low Ethanol Administration Following Ischemic Stroke via Recovery of KCC2 and p75(NTR) Expression	MOLECULAR NEUROBIOLOGY			English	Article						Apoptosis; Trauma; Chloride homeostasis; GABA(A) transmission; Neurotrophines	COTRANSPORTER KCC2; HIPPOCAMPAL-NEURONS; ALCOHOL-CONSUMPTION; DOWN-REGULATION; UP-REGULATION; BDNF; ACTIVATION; NEOCORTEX; MORTALITY; INJURY	A striking result from epidemiological studies show a correlation between low alcohol intake and lower incidence for ischemic stroke and severity of derived brain injury. Although reduced apoptosis and inflammation has been suggested to be involved, little is known about the mechanism mediating this effect in vivo. Increase in intracellular chloride concentration and derived depolarizing GABA(A)R-mediated transmission are common consequences following various brain injuries and are caused by the abnormal expression levels of the chloride cotransporters NKCC1 and KCC2. Downstream pro-apoptotic signaling through p75(NTR) may link GABA(A) depolarization with post-injury neuronal apoptosis. Here, we show that changes in GABAergic signaling, Cl- homeostasis, and expression of chloride cotransporters in the post-traumatic mouse brain can be significantly reduced by administration of 3% ethanol to the drinking water. Ethanol-induced upregulation of KCC2 has a positive impact on neuronal survival, preserving a large part of the cortical peri-infarct zone, as well as preventing the massive post-ischemic upregulation of the pro-apoptotic protein p75(NTR). Importantly, intracortical multisite in vivo recordings showed that ethanol treatment could significantly ameliorate stroke-induced reduction in cortical activity. This surprising finding discloses a pathway triggered by low concentration of ethanol as a novel therapeutically relevant target.	[Khirug, Stanislav; Soni, Shetal; Saez Garcia, Marta; Zhou, Liang; Kulesskaya, Natalia; Rauvala, Heikki; Ludwig, Anastasia; Rivera, Claudio] Univ Helsinki, Neurosci Ctr HiLIFE, Helsinki 00014, Finland; [Tessier, Marine; Molinari, Florence; Rivera, Claudio] Aix Marseille Univ, INSERM, U1249, INMED, Marseille, France; [Lindholm, Dan] Univ Helsinki, Fac Med, Dept Biochem & Dev Biol, Med, Helsinki, Finland; [Lindholm, Dan] Biomed Helsinki 2U, Minerva Fdn Inst Med Res, Helsinki, Finland		Khirug, S; Rivera, C (corresponding author), Univ Helsinki, Neurosci Ctr HiLIFE, Helsinki 00014, Finland.; Rivera, C (corresponding author), Aix Marseille Univ, INSERM, U1249, INMED, Marseille, France.	stanislav.khirug@helsinki.fi; claudio.rivera@helsinki.fi	Molinari, Florence/M-7683-2016; Rivera, Claudio/ABE-2499-2021; Ludwig, Anastasia/N-1837-2016	Molinari, Florence/0000-0001-5111-7215; Rivera, Claudio/0000-0003-2462-6561; Ludwig, Anastasia/0000-0003-4849-8074; Kulesskaya, Natalia/0000-0001-5517-8525; Tessier, Marine/0000-0001-8753-829X; Saez Garcia, Marta/0000-0001-7031-875X	University of Helsinki; Helsinki University Central Hospital; Academy of FinlandAcademy of FinlandEuropean Commission [250742, 259799, 308265]; French National Agency for Research (ANR)French National Research Agency (ANR) [ANR-Traumep-13-BSV4-0012-01]; Eranet Neuron III program project Acrobat; Doctoral Program in Biomedicine (DPBM), Helsinki University; La Fondation des Gueules Casees [83-2020]	Open access funding provided by University of Helsinki including Helsinki University Central Hospital. This work was supported by funding to AL from the Academy of Finland (250742), to CR from the Academy of Finland (259799 and 308265), the French National Agency for Research (ANR), ANR-Traumep-13-BSV4-0012-01, Eranet Neuron III program project Acrobat, and to SS from the Doctoral Program in Biomedicine (DPBM), Helsinki University, as well as La Fondation des Gueules Casees (N degrees 83-2020) to Marine Tessier.	Bansal S, 2013, AM J CARDIOVASC DRUG, V13, P57, DOI 10.1007/s40256-013-0007-6; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Begum G, 2015, STROKE, V46, P1956, DOI 10.1161/STROKEAHA.115.008939; Carmichael ST, 2016, ANN NEUROL, V79, P895, DOI 10.1002/ana.24653; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Pham DD, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1758-z; Ducroquet A, 2013, STROKE, V44, P2324, DOI 10.1161/STROKEAHA.113.001355; Feigin VL, 2013, NEUROEPIDEMIOLOGY, V45, P161, DOI DOI 10.1159/000441085; Ge Y, 2004, DEV BRAIN RES, V151, P99, DOI 10.1016/j.devbrainres.2004.04.002; Goubert E, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00012; HANSAGI H, 1995, STROKE, V26, P1768, DOI 10.1161/01.STR.26.10.1768; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Ikehara S, 2008, STROKE, V39, P2936, DOI 10.1161/STROKEAHA.108.520288; Jaenisch N, 2016, SCI REP-UK, V6, DOI 10.1038/srep26173; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Khiroug L, 2003, J NEUROSCI, V23, P9024; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Khirug S, 2010, J NEUROSCI, V30, P12028, DOI 10.1523/JNEUROSCI.3154-10.2010; Kislin M, 2017, J NEUROSCI, V37, P333, DOI [10.1523/JNEUROSCI.1510-16.2017, 10.1523/JNEUROSCI.1510-16.2016]; Kourdougli N, 2017, ANN NEUROL, V81, P251, DOI 10.1002/ana.24870; Labat-gest V, 2013, JOVE-J VIS EXP, DOI 10.3791/50370; Li C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63213-2; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; Medina I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00027; MESSING RO, 1991, BRAIN RES, V565, P301, DOI 10.1016/0006-8993(91)91662-K; Mihic SJ, 1999, NEUROCHEM INT, V35, P115, DOI 10.1016/S0197-0186(99)00053-4; Munakata M, 2007, EPILEPSIA, V48, P837, DOI 10.1111/j.1528-1167.2006.00954.x; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Pellegrino C, 2011, J PHYSIOL-LONDON, V589, P2475, DOI 10.1113/jphysiol.2010.203703; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Pin-Barre C, 2017, STROKE, V48, P2855, DOI 10.1161/STROKEAHA.117.017962; Riffault B, 2018, CEREB CORTEX, V28, P510, DOI 10.1093/cercor/bhw385; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Saito M, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030031; Schwamm LH, 2013, CIRC-CARDIOVASC QUAL, V6, P543, DOI 10.1161/CIRCOUTCOMES.111.000303; Shibasaki M, 2014, SYNAPSE, V68, P39, DOI 10.1002/syn.21688; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Sorensen B, 2003, J COMP NEUROL, V459, P242, DOI 10.1002/cne.10625; Toda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114328; Toth A, 2008, BRAIN RES, V1226, P99, DOI 10.1016/j.brainres.2008.05.068; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Xu GD, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00006; Zagrean AM, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9120360; Zhang C, 2014, INT J CARDIOL, V174, P669, DOI 10.1016/j.ijcard.2014.04.225	56	3	3	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2021	58	3					1145	1161		10.1007/s12035-020-02176-x		OCT 2020	17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QG0KD	WOS:000582326000002	33099743	hybrid, Green Published, Green Submitted			2022-02-06	
J	Lan, ZG; Richard, SA; Li, Q; Wu, C; Zhang, Q; Chen, RQ; Yang, CH				Lan, Zhigang; Richard, Seidu A.; Li, Qiang; Wu, Cong; Zhang, Qiao; Chen, Ruiqi; Yang, Chaohua			Outcomes of patients undergoing craniotomy and decompressive craniectomy for severe traumatic brain injury with brain herniation A retrospective study	MEDICINE			English	Article						craniectomy; decompressive; herniation; intracranial pressure; outcome; traumatic brain injury	ACUTE SUBDURAL-HEMATOMA; HEAD-INJURY; MANAGEMENT; MORTALITY; GUIDELINES; MORBIDITY; SURGERY; LESIONS; SCORE	The treatment of severe traumatic brain injury (TBI) with brain herniation is challenging because outcomes are often associated with high mortality and morbidity. Our aim was to identity factors contributing to decompressive craniectomy (DC) and evaluate treatment outcomes in patients with severe TBI with brain herniation. In this retrospective study, we analyzed medical records of severe TBI with brain herniation from May 2009 to December 2013. We reviewed their demographic data, mechanism of injury, Glasgow Coma Scale (GCS) score, pupil status, computed tomography findings, surgical treatment methods, time interval between brain herniation and surgery, as well as outcomes. GCS and pupil status are clinical parameters for detecting increase intracranial pressure while brain parenchyma bulged above the inner plate of the skull during operation indicated brain swelling as well as increased intracranial pressure on which basis the decision to perform DC or craniotomy was determined intraoperatively. One hundred ninety-four patients were included in the study. We performed DC in 143 of the patients while 51 of them we performed craniotomy. There were no statistically significant differences in the age, gender, or injury mechanism between the 2 groups. GCS, pupillary dilation, midline shift, hematoma type and timing of surgery were associated with DC. Nevertheless, logistic regression analysis revealed that hematoma type and timing of surgery were significantly associated with favorable DC outcomes (P < .001 and P = .023). Subdural hematoma and timing of surgery >1 hour were both identified as risk factors for DC. Six months after TBI, 34.0% of patients exhibited favorable outcomes. Overall mortality rate was 30.4%. Age, GCS, pupil dilation, hematoma type, and timing of surgery were all associated with patient outcomes. Further logistic regression analysis revealed that, lower GCS, bilateral pupil dilation, timing of surgery >1 hour, and advanced age were independent risk factors for poor outcomes (P = .001, P = .037, P = .028, and P = .001, respectively). Our study revealed that, DC is not mandatory for all TBI patients with brain herniation. Nevertheless, DC decreases mortality rate in severe TBI patients with brain herniation. Subdural hematoma and timing of surgery >1 hour are key indicators for DC. Lower GCS, bilateral pupil dilation, delayed timing of surgery and advance age are indicators of poor outcomes.	[Lan, Zhigang; Richard, Seidu A.; Li, Qiang; Wu, Cong; Zhang, Qiao; Chen, Ruiqi; Yang, Chaohua] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Peoples R China; [Richard, Seidu A.] Princefield Univ, Dept Med, Accra, Ghana		Yang, CH (corresponding author), Sichuan Univ, West China Hosp, Post Grad Training Ctr, Dept Neurosurg, 37 Guo Xue Xiang Rd, Chengdu 610041, Sichuan, Peoples R China.	yangchaohua999@126.com	Richard, Seidu A./H-7590-2017	Richard, Seidu A./0000-0003-3475-0363	Natural Science Foundation of Sichuan Province of China [0040205302272]	This work was supported by the Natural Science Foundation of Sichuan Province of China (Grant Number: 0040205302272).	Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Goker B, 2020, TURK NEUROSURG, V30, P225, DOI 10.5137/1019-5149.JTN.27576-19.3; Grandhi R, 2014, J NEUROSURG SCI, V58, P249; Grille Pedro, 2015, Rev. bras. ter. intensiva, V27, P113, DOI 10.5935/0103-507X.20150021; Honeybul S, 2017, J CLIN NEUROSCI, V43, P11, DOI 10.1016/j.jocn.2017.04.032; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hu Y, 2015, BMC SURG, V15, DOI 10.1186/1471-2482-15-6; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kochanek PM, 2019, NEUROSURGERY, V84, P1169, DOI 10.1093/neuros/nyz051; Lee JJ, 2018, J NEUROSURG, V128, P236, DOI 10.3171/2016.5.JNS16255; Liang Q, 2018, J BRAIN NEUROLOGY, V1; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Manfiotto M, 2019, WORLD NEUROSURG, V129, pE56, DOI 10.1016/j.wneu.2019.04.215; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Park Jun-Hee, 2014, Korean J Neurotrauma, V10, P112, DOI 10.13004/kjnt.2014.10.2.112; Phan K, 2017, WORLD NEUROSURG, V101, P677, DOI 10.1016/j.wneu.2017.03.024; Quintard H, 2015, ANAESTH CRIT CARE PA, V34, P79, DOI 10.1016/j.accpm.2014.09.002; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sauvigny T, 2016, WORLD NEUROSURG, V88, P519, DOI 10.1016/j.wneu.2015.10.072; Shah A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00011; Sharma R, 2017, NEUROSURGERY, V81, pE58, DOI 10.1093/neuros/nyx398; Shim Hyuk Ki, 2018, Korean J Neurotrauma, V14, P99, DOI 10.13004/kjnt.2018.14.2.99; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019	40	3	3	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	OCT 23	2020	99	43							e22742	10.1097/MD.0000000000022742			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OP6IA	WOS:000588186800051	33120775	Green Published, gold			2022-02-06	
J	Andersen, CR; Wolf, J; Jennings, K; Prough, DS; Hawkins, BE				Andersen, Clark R.; Wolf, Jordan; Jennings, Kristofer; Prough, Donald S.; Hawkins, Bridget E.			Accelerated Failure Time Survival Model to Analyze Morris Water Maze Latency Data	JOURNAL OF NEUROTRAUMA			English	Article						latency; learning and memory; Morris water maze; survival analysis; traumatic brain injury	TRAUMATIC BRAIN-INJURY; DEFICITS	Traumatic brain injury (TBI) induces cognitive deficits clinically and in animal models. Learning and memory testing is critical when evaluating potential therapeutic strategies and treatments to manage the effects of TBI. We evaluated three data analysis methods for the Morris water maze (MWM), a learning and memory assessment widely used in the neurotrauma field, to determine which statistical tool is optimal for MWM data. Hidden platform spatial MWM data aggregated from three separate experiments from the same laboratory were analyzed using 1) a logistic regression model, 2) an analysis of variance (ANOVA) model, and 3) an accelerated failure time (AFT) time-to-event model. The logistic regression model showed no significant evidence of differences between treatments among any swims over all days of the study,p > 0.11. Although the ANOVA model found significant evidence of differences between sham and TBI groups on three out of four swims on the third day, results are potentially biased due to the failure of this model to account for censoring. The time-to-event AFT model showed significant differences between sham and TBI over all swims on the third day,p < 0.045, taking censoring into account. We suggest AFT models should be the preferred analytical methodology for latency to platform associated with MWM studies.	[Andersen, Clark R.; Wolf, Jordan; Prough, Donald S.; Hawkins, Bridget E.] Univ Texas Med Branch, Moody Project Translat Traumat Brain Injury Res, Galveston, TX 77555 USA; [Andersen, Clark R.; Jennings, Kristofer] Univ Texas Med Branch, Off Biostat, Dept Prevent Med & Populat Hlth, Galveston, TX 77555 USA; [Wolf, Jordan; Prough, Donald S.; Hawkins, Bridget E.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Hawkins, Bridget E.] Univ Texas Med Branch, Sch Nursing, Galveston, TX 77555 USA		Hawkins, BE (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Moody Project Translat Traumat Brain Injury Res, Galveston, TX 77555 USA.	behawkin@utmb.edu	Hawkins, Bridget/H-4933-2015	Hawkins, Bridget/0000-0002-1887-3657; Jennings, Kristofer/0000-0002-5442-9326	Darrell K. Royal Research Fund for Alzheimer's Disease; Mission Connect, a Program of TIRR; Moody Project for Translational TBI Research; National Institutes of Health BD2K TCC Data Science RoAD-Trip FellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5U24ES026465-02]	Authors were supported in part by the Darrell K. Royal Research Fund for Alzheimer's Disease (B.E.H.); Mission Connect, a Program of TIRR (B.E.H.); The Moody Project for Translational TBI Research (D.S.P.); and a National Institutes of Health BD2K TCC Data Science RoAD-Trip Fellowship (to B.E.H. from Parent Grant 5U24ES026465-02 to John Darrell VanHorn PI).	Andersen C.R., 2019, CATSEYES CREATE CATS; Andersen CR, 2019, CRIT CARE MED, V47, P480, DOI 10.1097/CCM.0000000000003611; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; COX DR, 1972, J R STAT SOC B, V34, P187; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hausser N, 2018, JOVE-J VIS EXP, DOI 10.3791/56044; Hawkins BE, 2020, J NEUROTRAUM, V37, P2414, DOI 10.1089/neu.2018.6192; Hess K, 2019, MUHAZ HAZARD FUNCTIO; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Jahn-Eimermacher A, 2011, BEHAV BRAIN RES, V221, P271, DOI 10.1016/j.bbr.2011.03.007; Jenks KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084492; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lenth RV., 2018, PACKAGE EMMEANS ESTI; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MULLER HG, 1994, BIOMETRICS, V50, P61, DOI 10.2307/2533197; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; R Core Team, 2019, R LANG ENV STAT COMP; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Therneau T.M., 2000, STAT BIOL HEALTH; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027	28	3	3	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					435	445		10.1089/neu.2020.7089		OCT 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000582176800001	32829672	hybrid, Green Published			2022-02-06	
J	Ryan, NP; Anderson, VA; Bigler, ED; Dennis, M; Taylor, HG; Rubin, KH; Vannatta, K; Gerhardt, CA; Stancin, T; Beauchamp, MH; Hearps, S; Catroppa, C; Yeates, KO				Ryan, Nicholas P.; Anderson, Vicki A.; Bigler, Erin D.; Dennis, Maureen; Taylor, H. Gerry; Rubin, Kenneth H.; Vannatta, Kathryn; Gerhardt, Cynthia A.; Stancin, Terry; Beauchamp, Miriam H.; Hearps, Stephen; Catroppa, Cathy; Yeates, Keith Owen			Delineating the Nature and Correlates of Social Dysfunction after Childhood Traumatic Brain Injury Using Common Data Elements: Evidence from an International Multi-Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						childhood; outcome; predictors; social skills; traumatic brain injury	BEHAVIOR PROBLEMS; NEUROCOGNITIVE OUTCOMES; PEDIATRIC TBI; CHILDREN; MIND; COMPETENCE; RECOVERY; REHABILITATION; COMMUNICATION; ADOLESCENTS	Although childhood traumatic brain injury (TBI) has been linked to heightened risk of impaired social skills and behavior, current evidence is weakened by small studies of variable methodological quality. To address these weaknesses, this international multi-cohort study involved synthesis of data from two large observational cohort studies of complicated mild-severe child TBI in Australia and North America. Both studies adopted a unified approach to data collection and coding procedures, providing the opportunity to merge datasets from multiple, well-characterized cohorts for which gold standard measures of social outcomes were collected during the chronic recovery phase. The study involved 218 children, including 33 children with severe TBI, 83 children with complicated mild-moderate TBI, 59 children with orthopedic injury, and 43 age- and sex-matched typically developing control children. All injured children were recruited from academic children's hospitals and underwent direct cognitive assessments including measures of theory of mind (ToM) at least 1-year post- injury. Parents rated their child's social adjustment using standardized measures of social skills, communication and behavior. Results showed a brain-injury specific effect on ToM abilities, such that children with both complicated mild to moderate and severe TBI displayed significantly poorer ToM than children without TBI. In mediator models, poorer ToM predicted poorer parent-rated self-direction and social skills, as well as more frequent behavioral symptoms. The ToM mediated the effect of severe TBI on parent ratings of communication and social skills, as well as on overall behavior symptoms. The findings suggest that deficits in ToM are evident across the spectrum of TBI severity and represent one mechanism linking severe child TBI to long-term social adjustment difficulties. The findings underscore the value of large-scale data harmonization projects to increase the quality of evidence regarding the outcomes of TBI. Clinical and scientific implications are discussed.	[Ryan, Nicholas P.; Anderson, Vicki A.; Hearps, Stephen; Catroppa, Cathy] Murdoch Childrens Res Inst, Brain & Mind Res Clin Sci, Melbourne, Vic, Australia; Deakin Univ, Cognit Neurosci Unit, Geelong, Vic, Australia; [Ryan, Nicholas P.; Anderson, Vicki A.; Catroppa, Cathy] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Anderson, Vicki A.] Royal Childrens Hosp, Psychol, Melbourne, Vic, Australia; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Taylor, H. Gerry; Vannatta, Kathryn; Gerhardt, Cynthia A.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Vannatta, Kathryn; Gerhardt, Cynthia A.] Ohio State Univ, Dept Pediat & Psychol, Columbus, OH 43210 USA; Univ Hosp Cleveland, Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Rubin, Kenneth H.] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Pediat, Cleveland, OH USA; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Ryan, NP (corresponding author), Deakin Univ, Sch Psychol, 221 Burwood Highway, Burwood, Vic 3125, Australia.	nicholas.ryan@deakin.edu.au	Catroppa, Cathy/AAX-9458-2021; Yeates, Keith/AAJ-4223-2020	Catroppa, Cathy/0000-0002-9750-0436; Rubin, Kenneth/0000-0002-2608-2484; Ryan, Nicholas/0000-0002-0878-8889; Hearps, Stephen/0000-0003-2984-1172	Victoria Neurotrauma Initiative in Australia [CO6E1]; National Institute of Child Health and Human Development in the United States [5R01HD048946]; NR via the Rebecca Hotchkiss International Exchange Program; Hotchkiss Brain Institute at the University of Calgary, Alberta, Canada	The data analyzed in this study were drawn from studies supported by grants from the Victoria Neurotrauma Initiative (CO6E1) in Australia (to VA), and from the National Institute of Child Health and Human Development (5R01HD048946) in the United States (to KOY). We also wish to acknowledge the financial support received by NR via the Rebecca Hotchkiss International Exchange Program and the Hotchkiss Brain Institute at the University of Calgary, Alberta, Canada. The funding bodies did not play a role in the design of the study, analysis and interpretation of the data, or writing of the article.	Anderson V, 2017, J NEUROTRAUM, V34, P2261, DOI 10.1089/neu.2016.4692; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Crothers IR, 2007, BRAIN INJURY, V21, P47, DOI 10.1080/02699050601149054; Crowe LM, 2011, CLIN PSYCHOL REV, V31, P767, DOI 10.1016/j.cpr.2011.03.008; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Gilmore R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029587; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Heverly-Fitt S, 2016, J PEDIATR PSYCHOL, V41, P235, DOI 10.1093/jpepsy/jsv085; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hoskinson KR, 2019, SOC COGN AFFECT NEUR, V14, P1285, DOI 10.1093/scan/nsaa006; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Root AE, 2016, J APPL DEV PSYCHOL, V42, P1, DOI 10.1016/j.appdev.2015.10.002; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2017, BRAIN IMPAIR, V18, P88, DOI 10.1017/BrImp.2016.20; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P1132, DOI 10.1017/S1355617711001202; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	61	3	3	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2021	38	2					252	260		10.1089/neu.2020.7057		OCT 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PP0TL	WOS:000581641000001	32883163	Green Submitted, Green Published			2022-02-06	
J	Kang, DH; Choi, BY; Lee, SH; Kho, AR; Jeong, JH; Hong, DK; Kang, BS; Park, MK; Song, HK; Choi, HC; Lim, MS; Suh, SW				Kang, Dong Hyeon; Choi, Bo Young; Lee, Song Hee; Kho, A. Ra; Jeong, Jeong Hyun; Hong, Dae Ki; Kang, Beom Seok; Park, Min Kyu; Song, Hong Ki; Choi, Hui Chul; Lim, Man-Sup; Suh, Sang Won			Effects of Cerebrolysin on Hippocampal Neuronal Death After Pilocarpine-Induced Seizure	FRONTIERS IN NEUROSCIENCE			English	Article						epileptic seizure; pilocarpine; cerebrolysin; neurotropic; neuroprotective; neuropeptide; brain-derived neurotrophic factor	NEUROTROPHIC FACTOR; FUNCTIONAL RECOVERY; TRANSGENIC MODEL; NA+ CHANNELS; BRAIN-INJURY; BDNF; INFLAMMATION; APOPTOSIS; ROLES; RATS	Epilepsy is one of the most common and severe brain diseases. The exact cause of epilepsy is unclear. Epilepsy often occurs following brain damage, such as traumatic brain injury (TBI) and ischemia. Cerebrolysin is a porcine brain peptide that is a unique neurotropic and neuroprotective agent. Cerebrolysin has been reported to increase neuroprotective effects after TBI, ischemia, and other CNS diseases. However, the effects of cerebrolysin on seizures are not known. Therefore, this study aimed to investigate the effects of neuropeptide cerebrolysin on neuronal death in the hippocampus after a seizure. To confirm the effects of cerebrolysin, we used a pilocarpine-induced seizure animal model. Cerebrolysin (2.5 ml/kg, i.p., once per day for 7 days) was immediately injected after a seizure induction. After 1 week, we obtained brain tissues and performed staining to histologically evaluate the potentially protective effects of cerebrolysin on seizure-induced neuronal death in the hippocampus. We found that cerebrolysin decreased hippocampal neuronal death after a seizure. In addition, an increase in brain-derived neurotrophic factor (BDNF) was confirmed through Western blot analysis to further support our hypothesis. Therefore, the present study suggests that the administration of cerebrolysin can be a useful therapeutic tool for preventing neuronal death after a seizure.	[Kang, Dong Hyeon; Choi, Bo Young; Lee, Song Hee; Kho, A. Ra; Jeong, Jeong Hyun; Hong, Dae Ki; Kang, Beom Seok; Park, Min Kyu; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea; [Kang, Dong Hyeon; Song, Hong Ki; Choi, Hui Chul] Hallym Univ, Coll Med, Neurol, Chunchon, South Korea; [Song, Hong Ki; Choi, Hui Chul] Hallym Inst Epilepsy Res, Chunchon, South Korea; [Lim, Man-Sup] Hallym Univ, Dept Med Educ, Coll Med, Chunchon, South Korea		Suh, SW (corresponding author), Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea.; Song, HK; Choi, HC (corresponding author), Hallym Univ, Coll Med, Neurol, Chunchon, South Korea.; Song, HK; Choi, HC (corresponding author), Hallym Inst Epilepsy Res, Chunchon, South Korea.; Lim, MS (corresponding author), Hallym Univ, Dept Med Educ, Coll Med, Chunchon, South Korea.	hksong0@hanmail.net; dohchi@naver.com; ellemes@hallym.ac.kr; swsuh@hallym.ac.kr		Hong, Dae-Ki/0000-0003-3769-3456; Hong, Dae Ki/0000-0002-8937-1064	National Research Foundation of Korea (NRF)National Research Foundation of Korea [NRF-2019R1A2C4004912, NRF-2017M3C7A1028937, 2020R1A2C2008480]; Hallym University Research Fund [HRF-201901-008]	This study was supported by funding from the National Research Foundation of Korea (NRF; NRF-2019R1A2C4004912 to BC; NRF-2017M3C7A1028937 and 2020R1A2C2008480 to SS). This work was also supported by the Hallym University Research Fund (HRF-201901-008). The content of this manuscript was presented as an abstract at the CONFERENCE/International Brain Research Organization (IBRO) 2019, Society for Neuroscience (SFN) 2019 (Kang et al., 2019).	ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; Alvarez XA, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw024; Babb T L, 1999, Adv Neurol, V79, P763; Biagini G, 2001, NEUROBIOL DIS, V8, P45, DOI 10.1006/nbdi.2000.0331; Biagini G, 2009, EPILEPSIA, V50, P53, DOI 10.1111/j.1528-1167.2008.01971.x; Bornstein NM, 2018, NEUROL SCI, V39, P629, DOI 10.1007/s10072-017-3214-0; Budni J, 2015, AGING DIS, V6, P331, DOI 10.14336/AD.2015.0825; Chapkin RS, 2009, PROSTAG LEUKOTR ESS, V81, P187, DOI 10.1016/j.plefa.2009.05.010; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Da Penha Berzaghi Maria, 1993, Journal of Neuroscience, V13, P3818; Lima IVDA, 2015, EXP NEUROL, V267, P123, DOI 10.1016/j.expneurol.2015.02.021; Decourt B, 2017, CURR ALZHEIMER RES, V14, P412, DOI 10.2174/1567205013666160930110551; Fontana L, 2009, EXP GERONTOL, V44, P41, DOI 10.1016/j.exger.2008.04.005; Geral Claire, 2013, Pharmaceutics, V5, P127, DOI 10.3390/pharmaceutics5010127; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Haut SR, 2004, LANCET NEUROL, V3, P608, DOI 10.1016/S1474-4422(04)00881-6; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOLMES GL, 1991, EPILEPSIA, V32, pS14; Hong DK, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120231; Jeong JH, 2017, INT J MOL SCI, V18; Kang D. H., 2019, IBRO REP, V6, DOI 10.1016/j.ibror.2019.07.686; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Khalili H, 2017, CLIN NEUROL NEUROSUR, V152, P34, DOI 10.1016/j.clineuro.2016.11.011; Kho AR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050405; Kim JH, 2015, BRAIN RES, V1595, P156, DOI 10.1016/j.brainres.2014.11.011; Kim JH, 2013, BRAIN RES, V1499, P163, DOI 10.1016/j.brainres.2013.01.007; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048543; KNUSEL B, 1991, J NEUROCHEM, V57, P955, DOI 10.1111/j.1471-4159.1991.tb08243.x; Korte M, 1996, J PHYSIOLOGY-PARIS, V90, P157, DOI 10.1016/S0928-4257(97)81415-5; Lee HJ, 2019, ANIM CELLS SYST, V23, P246, DOI 10.1080/19768354.2019.1620853; Lee JM, 2018, J EXERC REHABIL, V14, P713, DOI 10.12965/jer.36394.197; Lee M, 2018, CURR NEUROPHARMACOL, V16, P51, DOI 10.2174/1570159X15666170518150053; Lee S.H., 2018, INT J MOL SCI, V19; Lee SH, 2017, BRAIN RES, V1654, P66, DOI 10.1016/j.brainres.2016.10.011; LEITE JP, 1990, NEUROSCI BIOBEHAV R, V14, P511, DOI 10.1016/S0149-7634(05)80076-4; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Li T, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/5403045; Li XD, 2019, BIOCHEM BIOPH RES CO, V512, P79, DOI 10.1016/j.bbrc.2019.03.019; Liang JD, 2019, EXP THER MED, V17, P1688, DOI 10.3892/etm.2018.7109; Liu ZJ, 2017, NEUROSCI LETT, V651, P72, DOI 10.1016/j.neulet.2017.04.022; Lommatzsch M, 1999, AM J PATHOL, V155, P1183, DOI 10.1016/S0002-9440(10)65221-2; Lukoyanov NV, 2004, EXP BRAIN RES, V154, P192, DOI 10.1007/s00221-003-1658-3; MENDES NF, 2019, FRONT NEUROL, V0010; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; Muresanu DF, 2015, CNS NEUROL DISORD-DR, V14, P587, DOI 10.2174/1871527314666150430162531; Najm IM, 1998, EPILEPSIA, V39, P244, DOI 10.1111/j.1528-1157.1998.tb01368.x; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Papathanassoglou EDE, 2015, BIOL RES NURS, V17, P521, DOI 10.1177/1099800414555411; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Peng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125902; PERSINGER MA, 1988, PHYSIOL BEHAV, V44, P27, DOI 10.1016/0031-9384(88)90342-3; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Plosker GL, 2009, DRUG AGING, V26, P893, DOI 10.2165/11203320-000000000-00000; Remy S, 2003, EUR J NEUROSCI, V17, P2648, DOI 10.1046/j.1460-9568.2003.02710.x; Riazi K, 2010, EPILEPSY RES, V89, P34, DOI 10.1016/j.eplepsyres.2009.09.004; Rockenstein E, 2005, J NEURAL TRANSM, V112, P269, DOI 10.1007/s00702-004-0181-4; Rockenstein E, 2015, STEM CELL RES, V15, P54, DOI 10.1016/j.scr.2015.04.008; Sanna MD, 2017, BRAIN RES, V1659, P55, DOI 10.1016/j.brainres.2017.01.019; SchmidtKastner R, 1996, EXP BRAIN RES, V107, P331; Scorza FA, 2009, AN ACAD BRAS CIENC, V81, P345, DOI 10.1590/S0001-37652009000300003; SEGAL M, 1988, BRAIN RES, V452, P79, DOI 10.1016/0006-8993(88)90011-X; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Sharma HS, 2012, INT REV NEUROBIOL, V102, P249, DOI 10.1016/B978-0-12-386986-9.00010-7; Shishkova V N, 2015, Zh Nevrol Psikhiatr Im S S Korsakova, V115, P57, DOI 10.17116/jnevro20151155157-63; Smolders I, 2002, NAT NEUROSCI, V5, P796, DOI 10.1038/nn880; Stein DJ, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00207; Tanila H, 2017, NEUROBIOL DIS, V97, P114, DOI 10.1016/j.nbd.2016.05.008; Thijs RD, 2019, LANCET, V393, P689, DOI 10.1016/S0140-6736(18)32596-0; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vinet J, 2016, GLIA, V64, P1350, DOI 10.1002/glia.23008; Vingerhoets G, 2006, SEIZURE-EUR J EPILEP, V15, P221, DOI 10.1016/j.seizure.2006.02.012; VonDran MW, 2014, ASN NEURO, V6, DOI 10.1177/1759091414552185; Wada K, 2003, STROKE, V34, P2722, DOI 10.1161/01.STR.0000094421.61917.71; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wang AH, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00971; Watkins CC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.119; Wu SY, 2017, FRONT BIOSCI-LANDMRK, V22, P1805; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; XIE XM, 1995, PFLUG ARCH EUR J PHY, V430, P437, DOI 10.1007/BF00373920; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Zhang YL, 2019, NEUROREHAB NEURAL RE, V33, P15, DOI 10.1177/1545968318809916; Zhang YL, 2013, J NEUROSURG, V118, P1343, DOI 10.3171/2013.3.JNS122061	84	3	3	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	OCT 16	2020	14								568813	10.3389/fnins.2020.568813			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OK6FD	WOS:000584743100001	33177978	gold, Green Published			2022-02-06	
J	Lukewich, MK; Schlenker, MB; Micieli, JA				Lukewich, Mark K.; Schlenker, Matthew B.; Micieli, Jonathan A.			Homonymous hemi-macular atrophy of the ganglion cell-inner plexiform layer with preserved visual function	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Homonymous hemiatrophy; Macular ganglion cell complex; Multiple sclerosis; Traumatic brain injury	RETROCHIASMAL LESIONS; MULTIPLE-SCLEROSIS; DEGENERATION; PERIMETRY	Homonymous hemimacular thinning of the retinal ganglion cell-inner plexiform layer (GCIPL) on optical coherence tomography (OCT) in the absence of significant visual field defects may be identified in the workup of patients with visual complaints, but the causes of this finding remain unknown. We retrospectively reviewed 1425 consecutive patients referred for neuro-ophthalmic assessment who had high quality OCT scans and reliable Humphrey 24-2 SITA-Fast testing. A total of 7 patients, 3 females and 4 males, with a mean age of 39.4 +/- 10.5 years that had homonymous thinning of the OCT macular-GCIPL without significant visual field defects were included in the study. Four patients had demyelinating disease and 3 patients had traumatic brain injury. Three patients with demyelinating disease had a documented prior homonymous visual field defect that resolved. The differential diagnosis of homonymous hemimacular thinning of the GCIPL without obvious visual field defects includes previous retrochiasmal demyelination and traumatic brain injury. OCT GCIPL provides a permanent objective way of documenting previous retrochiasmal disease including demyelination and may be helpful in establishing dissemination in time and space in patients being evaluated for multiple sclerosis.	[Lukewich, Mark K.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Schlenker, Matthew B.; Micieli, Jonathan A.] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Micieli, Jonathan A.] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Schlenker, Matthew B.; Micieli, Jonathan A.] Kensington Vis & Res Ctr, 340 Coll St,Suite 501, Toronto, ON M5T 3A9, Canada		Micieli, JA (corresponding author), Kensington Vis & Res Ctr, 340 Coll St,Suite 501, Toronto, ON M5T 3A9, Canada.	jmicieli@kensingtonhealth.org					Al-Louzi O, 2017, MULT SCLER J, V23, P1035, DOI 10.1177/1352458516679035; Blanch RJ, 2018, PITUITARY, V21, P515, DOI 10.1007/s11102-018-0906-2; Costello F, 2015, J NEUROL NEUROSUR PS, V86, P1369, DOI 10.1136/jnnp-2014-309704; Decramer T, 2018, J NEUROL, V265, P41, DOI 10.1007/s00415-017-8661-2; Horton JC, 2017, J NEURO-OPHTHALMOL, V37, P13, DOI 10.1097/WNO.0000000000000489; Keltner JL, 2007, J GLAUCOMA, V16, P665, DOI 10.1097/IJG.0b013e318057526d; Micieli JA, 2019, CURR OPIN NEUROL, V32, P115, DOI 10.1097/WCO.0000000000000636; Mitchell JR, 2015, J NEURO-OPHTHALMOL, V35, P353, DOI 10.1097/WNO.0000000000000268; Muhlemann F, 2020, NEUROLOGY, V94, pE323, DOI 10.1212/WNL.0000000000008738; PLANT GT, 1992, NEUROLOGY, V42, P68, DOI 10.1212/WNL.42.1.68; Saunders LJ, 2015, JAMA OPHTHALMOL, V133, P74, DOI 10.1001/jamaophthalmol.2014.4237; Shandra O, 2020, JOVE-J VIS EXP, DOI 10.3791/60360; Szatmary G, 2002, ARCH OPHTHALMOL-CHIC, V120, P1162; VanStavern G.P., 2001, J NEUROOPHTHALMOL, V21; Vien L, 2017, OPTOMETRY VISION SCI, V94, P125, DOI 10.1097/OPX.0000000000000899; Wall M, 2002, INVEST OPHTH VIS SCI, V43, P1277; Zangerl B, 2017, CLIN EXP OPTOM, V100, P214, DOI 10.1111/cxo.12478; Zehnder S, 2018, J NEURO-OPHTHALMOL, V38, P172, DOI 10.1097/WNO.0000000000000589; Zhang X., 2006, NEUROLOGY, V66	19	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	OCT 15	2020	417								117072	10.1016/j.jns.2020.117072			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NP6HG	WOS:000570274600039	32763512				2022-02-06	
J	Choudhury, R; Kolstad, A; Prajapati, V; Samuel, G; Yeates, K				Choudhury, Romita; Kolstad, Ash; Prajapati, Vishvesh; Samuel, Gina; Yeates, Keith			Loss and recovery after concussion: Adolescent patients give voice to their concussion experience	HEALTH EXPECTATIONS			English	Article						adolescent health; concussion; coping; mental health; patient education; patient engagement; patient experience; recovery; resilience	SPORT-RELATED CONCUSSION	Background Most concussion studies have focused on the perspectives and expertise of health-care providers and caregivers. Very little qualitative research has been done, engaging the adolescents who have suffered concussion and continue to experience the consequences in their everyday life. Objective To understand the experiences of recovery from the perspective of adolescent patients of concussion and to present the findings through their voices. Methods Two semi-structured focus groups and two narrative interviews were conducted with a small group of 7 adolescents. Grounded theory was used to analyse the data. Results Participants experience continuing difficulty 1-5 years after treatment with cognitive, emotional, social and mental well-being. The overriding experience among older adolescents (17-20) is a sense of irreversibility of the impact of concussion in all these areas. Conclusion There is a significant gap between the medical determination of recovery and what patients understand as recovery. Adolescents do not feel 'recovered' more than a year after they are clinically assessed as 'good to go'. Systematic follow-up and support from a multi-disciplinary health-care team would strengthen youths' coping and resilience.	[Choudhury, Romita; Kolstad, Ash; Prajapati, Vishvesh; Samuel, Gina] Univ Calgary, Cumming Sch Med, OBrien Inst Publ Hlth, Patient & Community Engagement Res Program, 3280 Hosp Dr,TRW 3rd Floor, Calgary, AB T2N 4Z6, Canada; [Kolstad, Ash] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Yeates, Keith] Univ Calgary, Dept Psychol, Ronald & Irene Ward Chair Pediat Brain Injury, Calgary, AB, Canada		Choudhury, R (corresponding author), Univ Calgary, Cumming Sch Med, OBrien Inst Publ Hlth, Patient & Community Engagement Res Program, 3280 Hosp Dr,TRW 3rd Floor, Calgary, AB T2N 4Z6, Canada.	romitac@athabascau.ca	Yeates, Keith/AAJ-4223-2020	Choudhury, Romita/0000-0002-4284-6616	Integrated Concussion Research Program, University of Calgary	Integrated Concussion Research Program, University of Calgary	[Anonymous], 2019, 158 MIN ED; [Anonymous], CONC SPORT; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council Social Sciences and Humanities Research Council of Canada, 2014, TRIC POL STAT ETH CO; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; DeMatteo CA, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00792; Glaser Barney., 1992, BASICS GROUNDED THEO; Glaser BG., 2017, DISCOVERY GROUNDED T; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Hachem Laureen D, 2016, CAN J NEUROL SCI, P1; Haidar MN, 2019, BR J SPORTS MED, V52, P1179; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kimbler DE, 2011, J NEUROSCI NURS, V43, P286, DOI 10.1097/JNN.0b013e31823858a6; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Leipold B, 2009, EUR PSYCHOL, V14, P40, DOI 10.1027/1016-9040.14.1.40; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Mainwaring L, 1999, CAN J REHABIL, V12, P145; Manzanero S., 2017, J CONCUSSION, DOI [10.1177/2059700217726874, DOI 10.1177/2059700217726874]; Marlett N., 2010, GREY MATTERS GUIDE C; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McFaull S, 2016, Health Promot Chronic Dis Prev Can, V36, P13; Moore RD, 2018, INT J PSYCHOPHYSIOL, V132, P14, DOI 10.1016/j.ijpsycho.2018.04.003; Office for Human Subject Protection, 2014, GUID INF CONS; Putukian M, 2016, BRIT J SPORT MED, V50, P145, DOI 10.1136/bjsports-2015-095586; Riessman C.K., 1993, NARRATIVE ANAL; Ryan T, 2018, PLOS ONE, V13, P1; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Valovich McLeod TC, 2017, ORTHOP J SPORTS MED, V5, P1	30	3	3	8	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1369-6513	1369-7625		HEALTH EXPECT	Health Expect.	DEC	2020	23	6					1533	1542		10.1111/hex.13138		OCT 2020	10	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	PH6PR	WOS:000575799300001	33029859	gold, Green Published			2022-02-06	
J	Turner, NE; Cook, S; Shi, J; Elton-Marshall, T; Hamilton, H; Ilie, G; Wickens, CM; McDonald, AJ; Trajtenberg, N; Cusimano, MD; Mann, RE				Turner, Nigel E.; Cook, Steven; Shi, Jing; Elton-Marshall, Tara; Hamilton, Hayley; Ilie, Gabriela; Wickens, Christine M.; McDonald, Andre J.; Trajtenberg, Nico; Cusimano, Michael D.; Mann, Robert E.			Traumatic brain injuries and problem gambling in youth: Evidence from a population-based study of secondary students in Ontario, Canada	PLOS ONE			English	Article							DECISION-MAKING; SUBSTANCE USE; ALCOHOL-USE; HEALTH-PROBLEMS; MENTAL-HEALTH; ASSOCIATIONS; IMPULSIVITY; SEVERITY; DISORDER; HISTORY	Traumatic brain injury (TBI) is characterized by a change in brain function after an external force or sudden movement to the head. TBI is associated with risk-taking, impulsivity, psychological distress, substance abuse, and violent crime. Previous studies have also linked problem gambling to TBI, but these studies have not controlled for possible confounding variables such as mental health problems and hazardous drinking which are also linked to TBI. This study examines the relationship between problem gambling and TBI among adolescents. Data were obtained from the 2011, 2013 and 2015 cycles of the OSDUHS, a biennial cross-sectional school-based study of children in grades 7 to 12 (N= 9,198). Logistic regression was used to estimate adjusted odds ratios (AOR) in controlled and uncontrolled analyses. Adjusting for sex and grade only, problem gambling was associated with a history of TBI (AOR = 2.8). This association remained significant after adjusting for hazardous drinking and suicidality (AOR = 2.0). In addition, problem gambling had a statistically significant relationship with being male (AOR = 4.7), hazardous drinking (AOR = 4.5), and suicidality (AOR = 3.1). This study provides further data to suggest a link between TBI and problem gambling. However, research is needed on the causal relationship between these variables and the potential implications for treatment and prevention.	[Turner, Nigel E.; Shi, Jing; Elton-Marshall, Tara; Hamilton, Hayley; Wickens, Christine M.; McDonald, Andre J.; Mann, Robert E.] Inst Mental Hlth Policy Res, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Turner, Nigel E.; Elton-Marshall, Tara; Hamilton, Hayley; Wickens, Christine M.; McDonald, Andre J.; Cusimano, Michael D.; Mann, Robert E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Turner, Nigel E.; Elton-Marshall, Tara; Mann, Robert E.] Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Cook, Steven] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Shi, Jing] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Ilie, Gabriela] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Wickens, Christine M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Trajtenberg, Nico] Cardiff Univ, Sch Social Sci, Cardiff, Wales; [Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada		Turner, NE (corresponding author), Inst Mental Hlth Policy Res, Ctr Addict & Mental Hlth, Toronto, ON, Canada.; Turner, NE (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	Nigel.Turner@camh.ca	Wickens, Christine M./Q-2014-2017; McDonald, Andre/AAZ-9353-2021; Ilie, Gabriela/AAM-9122-2021; Shi, Jing/F-7268-2019	Wickens, Christine M./0000-0002-9865-850X; McDonald, Andre/0000-0003-1734-5067; Shi, Jing/0000-0001-7156-8128	Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario [06703]; Centre for Addiction and Mental Health, the University of Toronto	This research is based on the Ontario Student Drug Use and Health Survey, a Centre for Addiction and Mental Health initiative funded in part through ongoing support from the Ontario Ministry of Health and Long-Term Care, as well as targeted funding from several provincial agencies. Additional funding was provided by the Ministry of Health and Long Term Care as grant number 06703. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The ideas expressed are those of the authors and do not necessarily reflect those of the Centre for Addiction and Mental Health, the University of Toronto, or the funder of this research project. The authors acknowledge the Institute for Social Research at York University for administering the data collection.	Adlaf EM, 2003, DEV SHORTENED VERSIO; Adlam ALR, 2017, BRAIN IMPAIR, V18, P62, DOI 10.1017/BrImp.2016.30; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Babor TF, 2001, AUDIT ALCOHOL USE DI; Bhatti JA, 2018, SOC PSYCH PSYCH EPID, V54, P517; Blaszczynski A, 2002, ADDICTION, V97, P487, DOI 10.1046/j.1360-0443.2002.00015.x; Boak A., 2015, CAMH RES DOCUMENT SE; Boak A., 2014, MENTAL HLTH WELL BEI; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burge AN, 2004, PSYCHIAT SERV, V55, P1437, DOI 10.1176/appi.ps.55.12.1437; Centers for Disease Control and Prevention, 2014, TRAUMATIC BRAIN INJU; Chan V, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027534; Ciccarelli M, 2020, J GAMBL STUD, V36, P243, DOI 10.1007/s10899-019-09872-x; Ciccarelli M, 2016, J GAMBL STUD, V32, P1203, DOI 10.1007/s10899-016-9597-7; Cook S, 2015, J GAMBL STUD, V31, P1121, DOI 10.1007/s10899-014-9483-0; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Elton-Marshall T, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2933-0; Farhat LC, 2020, J PSYCHIAT RES; Grant JE, 2002, ALCOHOL RES HEALTH, V26, P143; Guercio JM, 2012, J APPL BEHAV ANAL, V45, P485, DOI 10.1901/jaba.2012.45-485; Gupta Rina, 1998, J Gambl Stud, V14, P17, DOI 10.1023/A:1023046509031; Gupta Rina, 1998, J Gambl Stud, V14, P319, DOI 10.1023/A:1023068925328; Heeringa SG, 2017, APPL SURVEY DATA ANA, V2nd; Hodgins DC, 2015, INT J MENT HEALTH AD, V13, P699, DOI 10.1007/s11469-015-9572-z; Ilie G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229489; Ilie G, 2019, PSYCHIAT RES, V272, P458, DOI 10.1016/j.psychres.2018.12.069; Ilie G, 2017, PSYCHIAT RES, V258, P184, DOI 10.1016/j.psychres.2017.08.011; Ilie G, 2017, VIOLENCE VICTIMS, V32, P869, DOI 10.1891/0886-6708.VV-D-16-00027; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Korman LM, 2008, J GAMBL STUD, V24, P13, DOI 10.1007/s10899-007-9077-1; Korn DA, 2000, CAN MED ASSOC J, V163, P61; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Loxton NJ, 2008, PERS INDIV DIFFER, V45, P167, DOI 10.1016/j.paid.2008.03.017; Maccallum F, 2007, PERS INDIV DIFFER, V43, P1829, DOI 10.1016/j.paid.2007.06.002; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Molinaro S, 2018, ADDICTION, V113, P1862, DOI 10.1111/add.14275; Nower L., 2004, INT GAMBL STUD, V4, P69, DOI [DOI 10.1080/1445979042000224412, 10.1080/1445979042000224412]; Paglia-Boak A, 2011, CAMH RES DOCUMENT SE, V32; Parke A., 2005, INT J MENT HEALTH AD, V2, P50; Rahman AS, 2014, SUBST ABUS, V35, P426, DOI 10.1080/08897077.2014.951754; Raisamo S, 2013, J GAMBL STUD, V29, P151, DOI 10.1007/s10899-012-9298-9; Rash CJ, 2016, SUBST ABUSE REHABIL, V7, P3, DOI 10.2147/SAR.S83460; Rennert L, 2014, EXP CLIN PSYCHOPHARM, V22, P50, DOI 10.1037/a0034518; Roberts KJ, 2017, INT GAMBL STUD, V17, P51, DOI 10.1080/14459795.2016.1257648; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schachar RJ, 2015, J CANADIAN ACAD CHIL; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Shaver TK, 2019, BRAIN RES, V1704, P103, DOI 10.1016/j.brainres.2018.10.004; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; StataCorp, 2019, STATA STAT SOFTWARE; Sundqvist K, 2019, J GAMBL STUD, V35, P757, DOI 10.1007/s10899-019-09851-2; Turner N., 2008, INT J MENT HEALTH AD, V6, P238, DOI [10.1007/s11469-007-9121-5, DOI 10.1007/S11469-007-9117-1, 10.1007/s11469-007-9117-1]; Turner N.E., 2008, INT GAMBL STUD, V8, P281, DOI [DOI 10.1080/14459790802405905, https://doi.org/10.1080/14459790802405905]; Turner NE., 2006, INT GAMBL STUD, V6, P237, DOI [DOI 10.1080/14459790600928793, 10.1080/14459790600928793]; Turner NE, 2008, J GAMBL STUD, V24, P367, DOI 10.1007/s10899-007-9085-1; Turner NE, 2019, PSYCHIAT RES, V272, P692, DOI 10.1016/j.psychres.2018.12.170; Turner N, 2018, J GAMBL STUD, V34, P521, DOI 10.1007/s10899-017-9731-1; Turner NE, 2011, J GAMBL ISSUES, P88, DOI 10.4309/jgi.2011.25.7; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Whiting SW, 2016, J BEHAV ADDICT, V5, P213, DOI 10.1556/2006.5.2016.027; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Winters K C, 2000, J Gambl Stud, V16, P175, DOI 10.1023/A:1009480930810; Winters KC., 1993, J GAMBL STUD, V9, P63, DOI [DOI 10.1007/BF01019925, 10.1007/BF01019925]; Zangeneh M, 2010, INT J MENT HEALTH AD, V8, P51, DOI 10.1007/s11469-009-9220-6	74	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2020	15	10							e0239661	10.1371/journal.pone.0239661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NZ4YX	WOS:000577103500042	33007032	gold, Green Published, Green Accepted			2022-02-06	
J	Abdullah, A; Mobilio, F; Crack, PJ; Taylor, JM				Abdullah, Amar; Mobilio, Frank; Crack, Peter J.; Taylor, Juliet M.			STING-Mediated Autophagy Is Protective against H2O2-Induced Cell Death	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						STING; interferon; autophagy; oxidative stress	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; DISEASE; DAMAGE; MORTALITY; SEVERITY; SCORE; AGE; INTOXICATION; INFLAMMATION	Stimulator of interferon genes (STING)-mediated type-I interferon signaling is a well characterized instigator of the innate immune response following bacterial or viral infections in the periphery. Emerging evidence has recently linked STING to various neuropathological conditions, however, both protective and deleterious effects of the pathway have been reported. Elevated oxidative stress, such as neuroinflammation, is a feature of a number of neuropathologies, therefore, this study investigated the role of the STING pathway in cell death induced by elevated oxidative stress. Here, we report that the H2O2-induced activation of the STING pathway is protective against cell death in wildtype (WT) MEFSV40 cells as compared to STING(-/-) MEF SV40 cells. This protective effect of STING can be attributed, in part, to an increase in autophagy flux with an increased LC3II/I ratio identified in H2O2-treated WT cells as compared to STING(-/-) cells. STING(-/-) cells also exhibited impaired autophagic flux as indicated by p62, LC3-II and LAMP2 accumulation following H2O2 treatment, suggestive of an impairment at the autophagosome-lysosomal fusion step. This indicates a previously unrecognized role for STING in maintaining efficient autophagy flux and protecting against H2O2-induced cell death. This finding supports a multifaceted role for the STING pathway in the underlying cellular mechanisms contributing to the pathogenesis of neurological disorders.	[Abdullah, Amar; Mobilio, Frank; Crack, Peter J.; Taylor, Juliet M.] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia		Taylor, JM (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia.	amar.abdullah@unimelb.edu.au; mobiliof@unimelb.edu.au; pcrack@unimelb.edu.au; juliett@unimelb.edu.au		Taylor, Juliet/0000-0002-4596-6760	Melbourne International Research Scholarship from the University of Melbourne	A.A. was the recipient of a Melbourne International Research Scholarship from the University of Melbourne.	Abdullah A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1354-7; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Diller KR, 2009, ANNU REV BIOMED ENG, V11, P135, DOI 10.1146/annurev-bioeng-061008-124908; Feng X, 2012, J NEUROL SCI, V313, P48, DOI 10.1016/j.jns.2011.09.032; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Khormi YH, 2018, J NEUROTRAUM, V35, P1407, DOI 10.1089/neu.2017.5345; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Lazaridis C, 2012, NEUROCRIT CARE, V16, P478, DOI 10.1007/s12028-012-9685-1; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lecky F, 2014, BRIT J ANAESTH, V113, P286, DOI 10.1093/bja/aeu242; Lei Z, 2018, AM J PHYSIOL-GASTR L, V314, pG655, DOI 10.1152/ajpgi.00326.2017; Li Wei, 2017, Alzheimers Dement (Amst), V6, P196, DOI 10.1016/j.dadm.2017.01.008; Liu D, 2019, CELL DEATH DIFFER, V26, P1735, DOI 10.1038/s41418-018-0251-z; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Maekawa H, 2019, CELL REP, V29, P1261, DOI 10.1016/j.celrep.2019.09.050; Main BS, 2016, GLIA, V64, P1590, DOI 10.1002/glia.23028; Marion DW, 2006, NEUROSURGERY, V58, P655; Matis G, 2008, ACTA NEUROL BELG, V108, P75; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Nazmi A, 2019, GLIA, V67, P1254, DOI 10.1002/glia.23592; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Petrasek J, 2013, P NATL ACAD SCI USA, V110, P16544, DOI 10.1073/pnas.1308331110; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Prabakaran T, 2018, EMBO J, V37, DOI 10.15252/embj.201797858; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Qin HP, 2019, EXP CELL RES, V384, DOI 10.1016/j.yexcr.2019.111545; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Roy ER, 2020, J CLIN INVEST, V130, P1912, DOI 10.1172/JCI133737; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Soderstrom C A, 1988, Md Med J, V37, P541; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor JM, 2014, NEUROBIOL AGING, V35, P1012, DOI 10.1016/j.neurobiolaging.2013.10.089; TEASDALE G, 1974, LANCET, V2, P81; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Tohira H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-63; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Vidal RL, 2014, TRENDS PHARMACOL SCI, V35, P39, DOI 10.1016/j.tips.2014.09.002; Vitner EB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0570-2; Wu XQ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00051; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	70	3	3	6	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	OCT	2020	21	19							7059	10.3390/ijms21197059			17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	OO1RU	WOS:000587164500001	32992769	Green Published, gold			2022-02-06	
J	Abdullah, MI; Ahmad, A; Wafa, SWWSST; Latif, AZA; Yusoff, NAM; Jasmiad, MK; Udin, N; Karim, KA				Abdullah, Mohd Ibrahim; Ahmad, Aryati; Wafa, Sharifah Wajihah Wafa Syed Saadun Tarek; Latif, Ahmad Zubaidi Abdul; Yusoff, Noor Aini Mohd; Jasmiad, Muhammad Khalis; Udin, Nujaimin; Karim, Kartini Abdul			Determination of calorie and protein intake among acute and sub-acute traumatic brain injury patients	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Malnutrition; Calorie intake; Protein intake; Traumatic brain injury	CRITICALLY-ILL PATIENTS; ENTERAL NUTRITION; CRITICAL ILLNESS; ENERGY; REHABILITATION; OUTCOMES; THERAPY; IDENTIFICATION; REQUIREMENTS; PROVISION	Purpose: Malnutrition is a common problem among hospitalized patients, especially among traumatic brain injury (TBI) patients. It is developed from hypermetabolism and the condition may worsen under the circumstance of underfeeding or incompatible dietary management. However, the data of nutrient intake especially calorie and protein among TBI patients were scarce. Hence, this study aimed to determine the calorie and protein intake among acute and sub-acute TBI patients receiving medical nutrition therapy in hospital Sultanah Nur Zahirah, Terengganu. Methods: This observational study involved 50 patients recruited from the neurosurgical ward. Method of 24 h dietary recall was utilized and combined with self-administered food diaries for 2-8 days. Food consumptions including calorie intake and protein intake were analyzed using Nutritionist PRO (TM) (Woodinville, USA) and manual calculation based on the Malaysian food composition database (2015). Results: Patients consisted of 56% males and 44% females with the median age of 28.0 (IQR = 22.8-36.5) years, of which 92% were diagnosed as mild TBI and the remaining (8%) as moderate TBI. The Glasgow coma scale (GCS) was adopted to classify TBI severity with the score 13-15 being mild and 9-12 being moderate. The median length of hospital stay was 2 (IQR = 2.0-3.3) days. Calorie and protein intake improved significantly from day 1 to discharge day. However, the intake during discharge day was still considered as suboptimal, i.e. 75% of calorie requirement, whilst the median protein intake was only 61.3% relative to protein requirement. Moreover, the average percentages of calorie and protein intakes throughout hospitalization were remarkably lower, i.e. 52.2% and 41.0%, respectively. Conclusion: Although the calorie and protein intakes had increased from baseline, hospitalized TBI patients were still at a risk to develop malnutrition as the average intakes were considerably low as compared to their requirements. Optimum nutrient intakes especially calorie and protein are crucial to ensure optimum recovery process as well as to minimize risks of infection and complications. (C) 2020 Chinese Medical Association. Production and hosting by Elsevier B.V.	[Abdullah, Mohd Ibrahim; Ahmad, Aryati; Wafa, Sharifah Wajihah Wafa Syed Saadun Tarek; Yusoff, Noor Aini Mohd; Jasmiad, Muhammad Khalis] Univ Sultan Zainal Abidin, Fac Hlth Sci, Gong Badak Campus, Terengganu 21300, Malaysia; [Latif, Ahmad Zubaidi Abdul] Univ Sultan Zainal Abidin, Fac Med, Gong Badak Campus, Terengganu 21300, Malaysia; [Udin, Nujaimin] Hosp Sultanah Nur Zahirah, Minist Hlth Malaysia, Neurosurg Dept, Jalan Sultan Mahmud, Terengganu 20400, Malaysia; [Karim, Kartini Abdul] Hosp Sultanah Nur Zahirah, Minist Hlth Malaysia, Dietet & Food Serv Dept, Jalan Sultan Mahmud, Terengganu 20400, Malaysia		Ahmad, A (corresponding author), Univ Sultan Zainal Abidin, Fac Hlth Sci, Gong Badak Campus, Terengganu 21300, Malaysia.	aryatiahmad@unisza.edu.my		Syed Saadun Tarek Wafa, Sharifah Wajihah Wafa/0000-0002-1791-2714; ABDULLAH, MOHD IBRAHIM/0000-0002-2089-3788	Fundamental Research Grant Scheme (FRGS) [FRGS/1/2016/SKK02/UNISZA/02/1]; Ministry of Education, MalaysiaMinistry of Education, Malaysia	All authors made significant contributions to the study design, recruitment of patients, data collection, data analysis, preparing and revising of the manuscript for submission. This research was funded by the Fundamental Research Grant Scheme (FRGS)(FRGS/1/2016/SKK02/UNISZA/02/1) Ministry of Education, Malaysia.	Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; Allard JP, 2016, CLIN NUTR, V35, P144, DOI 10.1016/j.clnu.2015.01.009; Bailey N., 2007, CALORIC INTAKE FOLLO; Barker LA, 2011, INT J ENV RES PUB HE, V8, P514, DOI 10.3390/ijerph8020514; Barr J, 2004, CHEST, V125, P1446, DOI 10.1378/chest.125.4.1446; Bratton S, 2007, J NEUROTRAUM, V24, P59, DOI DOI 10.1089/neu.2007.9987; Cahill NE, 2010, CRIT CARE MED, V38, P395, DOI 10.1097/CCM.0b013e3181c0263d; Chapple LA, 2018, JPEN-PARENTER ENTER, V42, P318, DOI 10.1177/0148607116687498; Chapple LAS, 2016, CLIN NUTR, V35, P1315, DOI 10.1016/j.clnu.2016.02.009; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Daradkeh GA, 2016, SCREENING STATUS NUT; Dey R, 2011, CRIT CARE S1, V15, pP382; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Elmadfa I, 2008, ANN NUTR METAB, V52, P2, DOI 10.1159/000115339; Epstein LH, 2007, BEHAV NEUROSCI, V121, P877, DOI 10.1037/0735-7044.121.5.877; Erdman J., 2011, NUTR TRAUMATIC BRAIN, DOI [10.17226/13121, DOI 10.17226/13121]; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gano Benedict Francis, 1919, BIOMETRIC STUDY BASA, DOI [10.1016/S0045-7949(95)00118-2, DOI 10.1016/S0045-7949(95)00118-2]; Gouick J, 2004, TRAUMA, V6, P285, DOI DOI 10.1191/1460408604TA3230A; Gout BS, 2009, NUTR DIET, V66, P206, DOI 10.1111/j.1747-0080.2009.01372.x; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; Hoffer LJ, 2012, AM J CLIN NUTR, V96, P591, DOI 10.3945/ajcn.111.032078; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS245, DOI 10.1016/j.apmr.2014.06.024; Imoberdorf R, 2010, CLIN NUTR, V29, P38, DOI 10.1016/j.clnu.2009.06.005; Kabir A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198801; Kang MC, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e10; Kochanek PM, 2019, NEUROSURGERY, V84, P1169, DOI 10.1093/neuros/nyz051; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Lazarus C., 2005, Nutrition & Dietetics, V62, P41, DOI 10.1111/j.1747-0080.2005.tb00008.x; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Marshall AP, 2019, INT J NURS SCI, V6, P162, DOI 10.1016/j.ijnss.2019.03.008; Mashaal D., 2016, CHANGE NUTR STATUS T; Massanet PL, 2015, JPEN-PARENTER ENTER, V39, P391, DOI 10.1177/0148607114567901; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Moreira PA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-58; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Morgan Laurie M, 2004, Nutr Clin Pract, V19, P511, DOI 10.1177/0115426504019005511; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; O'Meara D, 2008, AM J CRIT CARE, V17, P53; Pirlich M, 2005, NUTRITION, V21, P295, DOI 10.1016/j.nut.2004.06.023; Samadi M, 2016, INT J PREVENTIVE MED, V7, DOI 10.4103/2008-7802.186224; Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037; Singh R, 2018, J REHABIL MED, V50, P673, DOI 10.2340/16501977-2364; Stewart ML, 2017, INTENS CRIT CARE NUR, V38, P24, DOI 10.1016/j.iccn.2016.05.004; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; van den Broek PWJH, 2009, BRIT J NUTR, V101, P68, DOI 10.1017/S0007114508986852; Yeh D, 2016, AM J CRIT CARE, V25, P318, DOI 10.4037/ajcc2016584	52	3	3	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	OCT	2020	23	5					290	294		10.1016/j.cjtee.2020.04.004			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	OA0GX	WOS:000577476500008	32423779	gold, Green Published			2022-02-06	
J	Adams, WK; Levesque, DL; Cocker, PJ; Kaur, S; Bodnar, TS; Young, AH; Winstanley, CA				Adams, Wendy K.; Levesque, Dominique L.; Cocker, Paul J.; Kaur, Sukhbir; Bodnar, Tamara S.; Young, Allan H.; Winstanley, Catharine A.			Decreased motor impulsivity following chronic lithium treatment in male rats is associated with reduced levels of pro-inflammatory cytokines in the orbitofrontal cortex	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Lithium; Five-choice serial reaction time task; Impulsivity; Neuroinflammation; IL-1 ss; IL-6; RANTES; Orbitofrontal cortex; Prefrontal cortex; Striatum	TRAUMATIC BRAIN-INJURY; REACTION-TIME-TASK; BIPOLAR DISORDER; WAITING IMPULSIVITY; CHEMOKINE RECEPTORS; DENDRITIC CELLS; MOOD DISORDERS; DEFENSIVE RAGE; MESSENGER-RNA; MALE SUICIDE	Lithium's efficacy in reducing both symptom severity in bipolar disorder (BD) and suicide risk across clinical populations may reflect its ability to reduce impulsivity. Changes in immune markers are associated with BD and suicidality yet their exact role in symptom expression remains unknown. Evidence also suggests that lithium may decrease levels of pro-inflammatory cytokines in the periphery and central nervous system, and that such changes are related to its therapeutic efficacy. However, issues of cause and effect are hard to infer from clinical data alone. Here, we investigated the effects of chronic dietary lithium treatment on rats' performance of the 5-Choice Serial Reaction Time Task (5CSRTT), a well-validated operant behavioural task measuring aspects of impulsivity, attention and motivation. Male Long-Evans rats received a diet supplemented with 0.3% LiCl (n = 13), or the equivalent control diet (n = 16), during behavioural testing. Blood and brain tissue samples were assayed for a wide range of cytokines once any changes in impulsivity became significant. After 12 weeks, chronic lithium treatment reduced levels of motor impulsivity, as indexed by premature responses in the 5CSRTT; measures of sustained attention and motivation were unaffected. Plasma levels of IL-1 beta, IL-10 and RANTES (CCL-5) were reduced in lithium-treated rats at this time point. IL-1 beta, IL-6 and RANTES were also reduced selectively within the orbitofrontal cortex of lithium-treated rats, whereas cytokine levels in the medial prefrontal cortex and nucleus accumbens were comparable with control subjects. These results are consistent with the hypothesis that lithium may improve impulse control deficits in clinical populations by minimising the effects of pro-inflammatory signalling on neuronal activity, particularly within the orbitofrontal cortex.	[Adams, Wendy K.; Levesque, Dominique L.; Cocker, Paul J.; Kaur, Sukhbir; Winstanley, Catharine A.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Psychol, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Adams, Wendy K.; Young, Allan H.; Winstanley, Catharine A.] Univ British Columbia, UBC Inst Mental Hlth, Vancouver, BC, Canada; [Bodnar, Tamara S.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada; [Young, Allan H.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Affect Disorders, London, England		Winstanley, CA (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Psychol, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	cwinstanley@psych.ubc.ca			Coast Capital Savings Depression Research Fund through the UBC Institute of Mental Health	This work was supported by a grant awarded to CAW from the Coast Capital Savings Depression Research Fund through the UBC Institute of Mental Health. CAW received salary support through the Michael Smith Foundation for Health Research and the Canadian Institutes of Health Research New Investigator Program during this time. WKA was supported by philanthropic donations provided by Paul and Diane Erickson and the Gillespie Family. In the past three years, CAW has consulted for Shire, and been retained as an expert witness by Hogan Lovells LLP, on unrelated matters, and received due compensation. The authors confirm they have no other conflicts of interest or financial disclosures to make. We gratefully acknowledge Prof. Joanne Weinberg and Prof. Timothy J. Kieffer for access to their resources to conduct cytokine assays.	Adams WK, 2018, PHYSIOL BEHAV, V192, P134, DOI 10.1016/j.physbeh.2018.03.027; Adams WK, 2017, BEHAV BRAIN RES, V328, P19, DOI 10.1016/j.bbr.2017.03.034; Adams WK, 2015, EUR J NEUROSCI, V42, P3095, DOI 10.1111/ejn.13117; Agrawal S, 2013, EXP GERONTOL, V48, P1285, DOI 10.1016/j.exger.2013.08.006; Alda M, 2015, MOL PSYCHIATR, V20, P661, DOI 10.1038/mp.2015.4; Amado I, 2005, PHARMACOPSYCHIATRY, V38, P321, DOI 10.1055/s-2005-916188; Ayorech Z, 2015, J AFFECT DISORDERS, V174, P467, DOI 10.1016/j.jad.2014.12.015; BANDTLOW CE, 1990, J CELL BIOL, V111, P1701, DOI 10.1083/jcb.111.4.1701; Barkus C, 2018, J PSYCHOPHARMACOL, V32, P1018, DOI 10.1177/0269881118784876; Bastos JR, 2018, J PSYCHIATR RES, V102, P142, DOI 10.1016/j.jpsychires.2018.04.004; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Blumberg HP, 1999, AM J PSYCHIAT, V156, P1986; Boufidou F, 2004, J AFFECT DISORDERS, V82, P309, DOI 10.1016/j.jad.2004.01.007; Brundin L, 2017, NEUROPSYCHOPHARMACOL, V42, P271, DOI 10.1038/npp.2016.116; CAPPELIEZ P, 1981, PSYCHOPHARMACOLOGY, V73, P34, DOI 10.1007/BF00431097; Caprioli D, 2015, J NEUROSCI, V35, P3747, DOI 10.1523/JNEUROSCI.3890-14.2015; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; Cerullo MA, 2009, INT REV PSYCHIATR, V21, P314, DOI 10.1080/09540260902962107; Clark L, 2004, EUR ARCH PSY CLIN N, V254, P61, DOI 10.1007/s00406-004-0460-y; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; Coant N, 2011, J HEPATOL, V55, P784, DOI 10.1016/j.jhep.2010.12.039; Coccaro EF, 2014, JAMA PSYCHIAT, V71, P158, DOI 10.1001/jamapsychiatry.2013.3297; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Diflorio A, 2010, INT REV PSYCHIATR, V22, P437, DOI 10.3109/09540261.2010.514601; Donegan JJ, 2015, MOL PHARMACOL, V87, P492, DOI 10.1124/mol.114.096289; Donegan JJ, 2014, J NEUROSCI, V34, P953, DOI 10.1523/JNEUROSCI.3968-13.2014; Einat H, 2003, J NEUROSCI, V23, P7311; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fernando ABP, 2012, PSYCHOPHARMACOLOGY, V219, P341, DOI 10.1007/s00213-011-2408-z; Furr A, 2012, INT J NEUROPSYCHOPH, V15, P1295, DOI 10.1017/S1461145711001441; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Gruol DL, 2015, NEUROPHARMACOLOGY, V96, P42, DOI 10.1016/j.neuropharm.2014.10.023; Gundersen V, 2015, PHYSIOL REV, V95, P695, DOI 10.1152/physrev.00024.2014; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Hassanain M, 2005, BRAIN RES, V1048, P1, DOI 10.1016/j.brainres.2005.04.086; Hassanain M, 2003, NEUROSCIENCE, V120, P227, DOI 10.1016/S0306-4522(03)00264-1; Hayley S, 2013, BRAIN BEHAV IMMUN, V31, P115, DOI 10.1016/j.bbi.2012.07.023; Higgins GA, 2003, PSYCHOPHARMACOLOGY, V170, P309, DOI 10.1007/s00213-003-1549-0; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Howerton AR, 2014, J NEUROSCI, V34, P7113, DOI 10.1523/JNEUROSCI.0118-14.2014; Huang Y, 2008, NEUROBIOL AGING, V29, P1744, DOI 10.1016/j.neurobiolaging.2007.04.012; Ishii N, 2015, J CLIN PSYCHIAT, V76, P319, DOI 10.4088/JCP.14m09218; Isung J, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.113; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Kato T, 2017, SCHIZOPHR RES, V187, P62, DOI 10.1016/j.schres.2016.10.037; Keck PE, 1996, J CLIN PSYCHIAT, V57, P13; Kristensen M, 2018, MOL PSYCHIATR, V23, P70, DOI 10.1038/mp.2017.192; Lanfranco MF, 2018, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00137; Lauterbach Edward C, 2016, Am J Neurodegener Dis, V5, P29; Lenox RH, 2003, MOL PSYCHIATR, V8, P135, DOI 10.1038/sj.mp.4001306; Levesque D.L., 2013, CHRONIC LITHIUM TREA; Lewitus GM, 2016, NEURON, V90, P483, DOI 10.1016/j.neuron.2016.03.030; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Liu KJ, 2011, J CELL PHYSIOL, V226, P424, DOI 10.1002/jcp.22348; Ma J, 2018, NEUROCHEM RES, V43, P1624, DOI 10.1007/s11064-018-2577-9; Maddu N, 2015, IMMUNOPHARM IMMUNOT, V37, P111, DOI 10.3109/08923973.2014.998369; Maes M, 1999, PSYCHOPHARMACOLOGY, V143, P401, DOI 10.1007/s002130050965; MALETZKY BM, 1978, WESTERN J MED, V128, P488; Manji HK, 1999, BIOL PSYCHIAT, V46, P1328, DOI 10.1016/S0006-3223(99)00235-8; Manji HK, 2000, BIOL PSYCHIAT, V48, P518, DOI 10.1016/S0006-3223(00)00929-X; MANJI HK, 1995, ARCH GEN PSYCHIAT, V52, P531; Manzardo AM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040472; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Munkholm K, 2015, BRAIN BEHAV IMMUN, V43, P205, DOI 10.1016/j.bbi.2014.09.021; Munkholm K, 2013, J PSYCHIATR RES, V47, P1119, DOI 10.1016/j.jpsychires.2013.05.018; Nassar A, 2014, ACS CHEM NEUROSCI, V5, P451, DOI 10.1021/cn500038f; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; O'Donnell KC, 2007, NEUROSCI BIOBEHAV R, V31, P932, DOI 10.1016/j.neubiorev.2007.04.002; Oglodek EA, 2014, PHARMACOL REP, V66, P920, DOI 10.1016/j.pharep.2014.06.001; Ohmura Y, 2012, PSYCHOPHARMACOLOGY, V219, P421, DOI 10.1007/s00213-011-2496-9; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Qian ZM, 2014, MOL NEUROBIOL, V50, P811, DOI 10.1007/s12035-014-8671-3; Quraishi S, 2002, J AFFECT DISORDERS, V72, P209, DOI 10.1016/S0165-0327(02)00091-5; Raghavendra PB, 2014, J NEUROIMMUNE PHARM, V9, P277, DOI 10.1007/s11481-013-9516-y; Rainville JR, 2019, NEUROPSYCHOPHARMACOL, V44, P184, DOI 10.1038/s41386-018-0124-7; Rapaport MH, 1999, J PSYCHIAT RES, V33, P335, DOI 10.1016/S0022-3956(99)00007-2; Rapaport MH, 2001, BIOL PSYCHIAT, V50, P217, DOI 10.1016/S0006-3223(01)01144-1; Ringheim GE, 1995, J NEUROIMMUNOL, V63, P113, DOI 10.1016/0165-5728(95)00134-4; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Sanchez-Roige S, 2014, NEUROPSYCHOPHARMACOL, V39, P2919, DOI 10.1038/npp.2014.151; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; SHEARD MH, 1976, AM J PSYCHIAT, V133, P1409; Shiotsuki I, 2016, J AFFECT DISORDERS, V189, P282, DOI 10.1016/j.jad.2015.09.070; SMITH DF, 1983, ACTA PHARMACOL TOX, V52, P81; Soderlund J, 2011, J PSYCHIATR NEUROSCI, V36, P114, DOI 10.1503/jpn.100080; Song C, 2006, PHARMACOPSYCHIATRY, V39, P88, DOI 10.1055/s-2006-941557; Strakowski SM, 2010, BIPOLAR DISORD, V12, P285, DOI 10.1111/j.1399-5618.2010.00806.x; Strakowski SM, 2009, BIPOLAR DISORD, V11, P41, DOI 10.1111/j.1399-5618.2008.00658.x; Stuart MJ, 2014, NEUROSCI BIOBEHAV R, V42, P93, DOI 10.1016/j.neubiorev.2014.02.001; Sutin AR, 2010, PSYCHOL MED, V40, P1485, DOI 10.1017/S0033291709992029; Sutin AR, 2012, J BEHAV MED, V35, P616, DOI 10.1007/s10865-011-9390-0; Swann AC, 2004, BIPOLAR DISORD, V6, P204, DOI 10.1111/j.1399-5618.2004.00110.x; Swann AC, 2003, J AFFECT DISORDERS, V73, P105, DOI 10.1016/S0165-0327(02)00328-2; Swann Alan C, 2010, Epidemiol Psichiatr Soc, V19, P120; Swann AC, 2009, CURR PSYCHIAT REP, V11, P481, DOI 10.1007/s11920-009-0073-2; Szuster-Ciesielska A, 2003, POL J PHARMACOL, V55, P353; Tay TF, 2012, TROP BIOMED, V29, P551; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; van Enkhuizen J, 2013, PSYCHOPHARMACOLOGY, V225, P661, DOI 10.1007/s00213-012-2854-2; van Enkhuizen J, 2015, NEUROSCI BIOBEHAV R, V58, P4, DOI 10.1016/j.neubiorev.2015.08.008; Viguera AC, 2000, AM J PSYCHIAT, V157, P1509, DOI 10.1176/appi.ajp.157.9.1509; Vonder Haar C, 2019, EUR J NEUROSCI, V50, P2134, DOI 10.1111/ejn.14123; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Voon V, 2014, BIOL PSYCHIAT, V75, P148, DOI 10.1016/j.biopsych.2013.05.013; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Winstanley CA, 2003, PSYCHOPHARMACOLOGY, V170, P320, DOI 10.1007/s00213-003-1546-3; Winstanley CA, 2003, PSYCHOPHARMACOLOGY, V167, P304, DOI 10.1007/s00213-003-1398-x; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Winstanley CA, 2011, BRIT J PHARMACOL, V164, P1301, DOI 10.1111/j.1476-5381.2011.01323.x; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Young AH, 2007, BRIT J PSYCHIAT, V191, P474, DOI 10.1192/bjp.bp.107.043133; Young JW, 2020, BIPOLAR DISORD, V22, P46, DOI 10.1111/bdi.12786; Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251; Zhang P, 2009, MOL IMMUNOL, V46, P677, DOI 10.1016/j.molimm.2008.08.281; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	123	3	3	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2020	89						339	349		10.1016/j.bbi.2020.07.018			11	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	OH9GJ	WOS:000582897600033	32688024				2022-02-06	
J	Alsalaheen, B; Carender, W; Grzesiak, M; Munday, C; Almeida, A; Lorincz, M; Marchetti, GF				Alsalaheen, Bara; Carender, Wendy; Grzesiak, Melissa; Munday, Cindy; Almeida, Andrea; Lorincz, Matthew; Marchetti, Gregory F.			Changes in Vestibular/Ocular-Motor Screen Scores in Adolescents Treated With Vestibular Therapy After Concussion	PEDIATRIC PHYSICAL THERAPY			English	Article						convergence; false positive; mTBI; Physical Therapy; vestibular rehabilitation; VOMS	SPORT-RELATED CONCUSSION; INSUFFICIENCY SYMPTOM SURVEY; CONVERGENCE INSUFFICIENCY; RELIABILITY; RECOVERY; VALIDITY; VOMS; REHABILITATION; IMPAIRMENT; CHILDREN	Purpose: To examine interrelationships among Vestibular/Ocular-Motor Screen (VOMS) items and to characterize the recovery of VOMS performance in a sample of adolescents treated with vestibular physical therapy (VPT) after concussion. Methods: Seventy-seven patients with concussion and 77 participants without concussion completed the study. Adolescents with concussion received an individualized VPT intervention consisting of targeted exercises for gaze stability, postural stability, ocular-motor control, habituation, and aerobic activities. The exercises were performed during a weekly clinic visit and via a home exercise program. Results: Except for near-point convergence distance, all VOMS items were significantly interrelated. Over the course of VPT, significant improvements in VOMS performance were observed, and discharge scores were similar to scores observed in adolescents without concussion. Conclusions: The VOMS measured moderately related functions and captured changes over the course of VPT. Clinicians should consider the contextual risk of "false positive" in their interpretation of VOMS.	[Alsalaheen, Bara] Univ Michigan Flint, Dept Phys Therapy, Flint, MI 48502 USA; [Alsalaheen, Bara; Almeida, Andrea; Lorincz, Matthew] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Alsalaheen, Bara; Carender, Wendy; Grzesiak, Melissa; Munday, Cindy; Almeida, Andrea; Lorincz, Matthew] Michigan Med, Michigan NeuroSport, Ann Arbor, MI USA; [Marchetti, Gregory F.] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA		Alsalaheen, B (corresponding author), Univ Michigan Flint, 303 E Kearsley St, Flint, MI 48502 USA.	Alsalahe@umich.edu			College of Health Sciences, University of Michigan-Flint	Interdisciplinary research awards, College of Health Sciences, University of Michigan-Flint.	Alkathiry AA, 2019, SPORTS HEALTH, V11, P479, DOI 10.1177/1941738119865262; Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P829, DOI 10.2519/jospt.2019.8869; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alshehri MM, 2016, J VESTIBUL RES-EQUIL, V26, P439, DOI 10.3233/VES-160598; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Christy JB, 2019, J NEUROL PHYS THER, V43, P153, DOI 10.1097/NPT.0000000000000280; Cohen J., 2013, STAT POWER ANAL BEHA; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; D'Amico NR, 2019, CLIN J SPORT MED; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lavrich JB, 2019, J AAPOS, V23, P32, DOI 10.1016/j.jaapos.2018.09.008; MAHTO RS, 1972, BRIT MED J, V2, P564, DOI 10.1136/bmj.2.5813.564; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Trbovich AM, 2019, BRAIN INJURY, V33, P1545, DOI 10.1080/02699052.2019.1658131; Whitney SL, 2005, OTOL NEUROTOL, V26, P1027, DOI 10.1097/01.mao.0000185066.04834.4e; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	35	3	3	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-5669	1538-005X		PEDIATR PHYS THER	Pediatr. Phys. Ther.	OCT	2020	32	4					331	337		10.1097/PEP.0000000000000729			7	Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Rehabilitation	OC5LR	WOS:000579198200010	32773522				2022-02-06	
J	Borns, J; Ersch, J; Dobrovoljac, M; Staubli, G; Brotschi, B				Borns, Julia; Ersch, Joerg; Dobrovoljac, Milana; Staubli, Georg; Brotschi, Barbara			Video Recordings to Analyze Preventable Management Errors in Pediatric Resuscitation Bay	PEDIATRIC EMERGENCY CARE			English	Article						pediatric resuscitation bay; management errors; video recording	LIFE-SUPPORT; TRAUMA; CLASSIFICATION; EPIDEMIOLOGY; GUIDELINES	Objective In treating patients of different ages and diseases in the pediatric resuscitation bay, management errors are common. This study aimed to analyze the adherence to advanced trauma life support and pediatric advanced life support guidelines and identify management errors in the pediatric resuscitation bay by using video recordings. Methods Video recording of all patients admitted to the pediatric resuscitation bay at University Children's Hospital Zurich during a 13-month period was performed. Treatment adherence to advanced trauma life support guidelines and pediatric advanced life support guidelines and errors per patient were identified. Results During the study period, 128 patients were recorded (65.6% with surgical, 34.4% with medical diseases). The most common causes for admission were traumatic brain injury (21.1%), multiple trauma (20.3%), and seizures (14.8%). There was a statistically significant correlation between accurate handover from emergency medical service to hospital physicians and adherence to airway, breathing, circulation, and disability sequence (correlation coefficient [CC], 0.205;P= 0.021), existence of a defined team leader and adherence to airway, breathing, circulation, and disability sequence (CC, 0.856;P< 0.001), and accurate hand over and existence of a defined team leader (CC, 0.186;P= 0.037). Unexpected errors were revealed. Cervical spine examination/stabilization was omitted in 40% of admitted surgical patients, even in 20% of patients with an injury of spine/limbs. Conclusions Video recording is a useful tool to evaluate patient management in the pediatric resuscitation bay. Analyzing errors of missing the adherence to the guidelines helps to pay attention and focus on specific items to improve patient care.	[Borns, Julia] Univ Childrens Hosp Zurich, Dept Cardiol, Zurich, Switzerland; [Ersch, Joerg; Brotschi, Barbara] Univ Childrens Hosp Zurich, Dept Pediat & Neonatal Intens Care, Zurich, Switzerland; [Dobrovoljac, Milana; Staubli, Georg] Univ Childrens Hosp Zurich, Dept Accid & Emergency, Zurich, Switzerland		Borns, J (corresponding author), Univ Childrens Hosp Zurich, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	julia.borns@kispi.uzh.ch					Chavez H, 2018, PEDIATR EMERG CARE, V34, P6, DOI 10.1097/PEC.0000000000000682; Claudet I, 2009, PEDIATR EMERG CARE, V25, P312, DOI 10.1097/PEC.0b013e3181a341ac; Fitzgerald M, 2006, CAN J SURG, V49, P208; Hoff WS, 1997, J TRAUMA, V43, P772, DOI 10.1097/00005373-199711000-00007; Hunziker S, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-3; Kelleher DC, 2013, J TRAUMA ACUTE CARE, V74, P622, DOI 10.1097/TA.0b013e31827d5f9e; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Larsen GY, 2011, PEDIATRICS, V127, pE1585, DOI 10.1542/peds.2010-3513; Oakley E, 2006, PEDIATRICS, V117, P658, DOI 10.1542/peds.2004-1803; Paul R, 2012, PEDIATRICS, V130, pE273, DOI 10.1542/peds.2012-0094; Pucher PH, 2013, WORLD J SURG, V37, P752, DOI 10.1007/s00268-013-1917-9; Webman RB, 2016, J TRAUMA ACUTE CARE, V81, P666, DOI 10.1097/TA.0000000000001196; Yamada NK, 2015, RESUSCITATION, V96, P109, DOI 10.1016/j.resuscitation.2015.07.048	14	3	3	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	2020	36	10					E558	E563		10.1097/PEC.0000000000001403			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	NX3NV	WOS:000575619900014	29346233	Green Accepted			2022-02-06	
J	Champahom, T; Jomnonkwao, S; Satiennam, T; Suesat, N; Ratanavaraha, V				Champahom, Thanapong; Jomnonkwao, Sajjakaj; Satiennam, Thaned; Suesat, Nattapong; Ratanavaraha, Vatanavongs			Modeling of safety helmet use intention among students in urban and rural Thailand based on the theory of planned behavior and Locus of Control	SOCIAL SCIENCE JOURNAL			English	Article						Motorcycle helmet use intention; Theory of planned behavior (TPB); Locus of Control (LOC); Structural equation modeling (SEM); Multi-group analysis	BICYCLE HELMET; MOTORCYCLISTS; DETERMINANTS; RISK; HEAD; FATALITIES; TEENAGERS; INJURIES; CYCLISTS; AREAS	Wearing a helmet has been widely recognized as a factor in reducing motorcycle accident fatalities. Establishing a campaign to increase helmet use is therefore essential. When considering differences between residential areas, there are differences in attitudes or motivations toward helmet wearing. This study analyzed the factors affecting the intention to wear a helmet to determine appropriate policies and guidelines. The theory of planned behavior (TPB) and Locus of Control (LOC) were applied, with the given socioeconomic background, basic attitude, and other characteristics being investigated, to assess the different behaviors or intentions in urban and rural areas. Structural equation modeling (SEM) segmented urban and rural areas to be used for the multi-group analysis, from which it was found that the attitudes in the two areas were significantly different. For latent variables that significantly affected helmet use intention in the urban locale, it was found that the most impactful factors were positive attitude and internality. In rural society, positive attitude was the most important factor, followed by internality and subjective norms. Indicating factors can be summarized in the following policies: it was concluded that promoting motorcycle helmet use and a positive attitude toward the wearing of helmets, by making riders realize how they could act to decrease injuries, should be emphasized in both urban and rural areas. However, in the rural community, the value of wearing a helmet should also include the impacts on people close to riders, such as friends or parents.	[Champahom, Thanapong; Jomnonkwao, Sajjakaj; Suesat, Nattapong; Ratanavaraha, Vatanavongs] Suranaree Univ Technol, Inst Engn, Sch Transportat Engn, 111 Univ Ave, Muang Dist 30000, Nakhon Ratchasi, Thailand; [Satiennam, Thaned] Khon Kaen Univ, Fac Engn, Khon Kaen, Thailand		Ratanavaraha, V (corresponding author), Suranaree Univ Technol, Inst Engn, Sch Transportat Engn, 111 Univ Ave, Muang Dist 30000, Nakhon Ratchasi, Thailand.	vatanavongs@g.sut.ac.th		Champahom, Thanapong/0000-0001-6258-496X; Jomnonkwao, Sajjakaj/0000-0002-9369-2741	Suranaree University of Technology; Higher Education Commission under NRU Project of Thailand	This work was supported by Suranaree University of Technology and by the Higher Education Commission under NRU Project of Thailand. And would like to thank Enago (http://www.enago.com) for the English language review.	Abbas AK, 2012, ACCIDENT ANAL PREV, V49, P249, DOI 10.1016/j.aap.2011.09.033; Aghamolaei T, 2011, TRAFFIC INJ PREV, V12, P239, DOI 10.1080/15389588.2011.557757; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ali M, 2011, INJURY, V42, P864, DOI 10.1016/j.injury.2010.08.030; Alm LR, 1997, SOC SCI J, V34, P271, DOI 10.1016/S0362-3319(97)90028-8; Brijs K, 2014, TRANSPORT RES F-TRAF, V26, P273, DOI 10.1016/j.trf.2014.08.002; Brijs K, 2011, TRANSPORT RES F-TRAF, V14, P600, DOI 10.1016/j.trf.2011.07.003; Chi GQ, 2013, SAFETY SCI, V59, P154, DOI 10.1016/j.ssci.2013.05.012; Cristea M, 2013, TRANSPORT RES F-TRAF, V21, P122, DOI 10.1016/j.trf.2013.09.009; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; de Gomez W, 2012, SOC SCI J, V49, P202, DOI 10.1016/j.soscij.2011.08.014; DeMarco AL, 2010, ACCIDENT ANAL PREV, V42, P1778, DOI 10.1016/j.aap.2010.04.019; Donate-Lopez C, 2010, ACCIDENT ANAL PREV, V42, P297, DOI 10.1016/j.aap.2009.08.007; Erhardt T, 2016, ACCIDENT ANAL PREV, V86, P23, DOI 10.1016/j.aap.2015.10.004; Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231; Fogarty GJ, 2010, ACCIDENT ANAL PREV, V42, P1455, DOI 10.1016/j.aap.2009.08.008; Forward SE, 2009, TRANSPORT RES F-TRAF, V12, P225, DOI 10.1016/j.trf.2008.12.003; Francis J., 2004, ACCOUNTING REV; Ghasemzadeh S, 2017, J TRANSP HEALTH, V6, P548, DOI 10.1016/j.jth.2017.04.007; Hair J. F, 2014, PRIMER PARTIAL LEAST; Hair JF., 2014, MULTIVARIATE DATA AN, V7; Holland C, 2010, PERS INDIV DIFFER, V48, P821, DOI 10.1016/j.paid.2010.02.003; Ichikawa M, 2003, ACCIDENT ANAL PREV, V35, P183, DOI 10.1016/S0001-4575(01)00102-6; Iversen H, 2002, PERS INDIV DIFFER, V33, P1251, DOI 10.1016/S0191-8869(02)00010-7; Jomnonkwao S, 2016, TRANSPORT POLICY, V45, P240, DOI 10.1016/j.tranpol.2015.04.001; Jomnonkwao S, 2015, TRANSPORTMETRICA A, V11, P659, DOI 10.1080/23249935.2015.1060274; Karl L. W., 2014, INTRO STRUCTURAL EQU; Keng SH, 2005, ACCIDENT ANAL PREV, V37, P349, DOI 10.1016/j.aap.2004.09.006; Kidwell B, 2008, PSYCHOL MARKET, V25, P1151, DOI 10.1002/mar.20258; Kline R.B., 2011, PRINCIPLES PRACTICE, V3rd; Lajunen T, 2004, J SAFETY RES, V35, P115, DOI 10.1016/j.jsr.2003.09.020; Lajunen T, 2001, J SAFETY RES, V32, P323, DOI 10.1016/S0022-4375(01)00056-1; Lajunen T, 2016, TRANSPORT RES F-TRAF, V41, P294, DOI 10.1016/j.trf.2015.03.005; Maskey R, 2018, ASIAN J SHIPPING LOG, V34, P91, DOI 10.1016/j.ajsl.2018.06.006; Nakahara S, 2005, ACCIDENT ANAL PREV, V37, P833, DOI 10.1016/j.aap.2005.04.001; O'Callaghan FV, 2006, J SAFETY RES, V37, P425, DOI 10.1016/j.jsr.2006.08.001; Ozkan T, 2005, PERS INDIV DIFFER, V38, P533, DOI 10.1016/j.paid.2004.05.007; Ozkan T, 2012, ACCIDENT ANAL PREV, V49, P124, DOI 10.1016/j.aap.2011.03.009; Peek-Asa C, 1999, ACCIDENT ANAL PREV, V31, P229, DOI 10.1016/S0001-4575(98)00071-2; Quine L, 2001, BRIT J HEALTH PSYCH, V6, P327, DOI 10.1348/135910701169241; Quine L, 1998, PSYCHOL HEALTH, V13, P251, DOI 10.1080/08870449808406750; Raju NS, 2002, J APPL PSYCHOL, V87, P517, DOI 10.1037/0021-9010.87.3.517; Ratanavaraha V, 2014, TRANSPORT POLICY, V36, P253, DOI 10.1016/j.tranpol.2014.09.004; Ratanavaraha V, 2013, TRANSPORT POLICY, V25, P111, DOI 10.1016/j.tranpol.2012.11.002; Rice TM, 2016, ACCIDENT ANAL PREV, V91, P200, DOI 10.1016/j.aap.2016.03.002; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Sanitin D., 2015, CZASOPISMO TECHNICZN, P245; Simsekoglu O, 2008, TRANSPORT RES F-TRAF, V11, P181, DOI 10.1016/j.trf.2007.10.001; Susilo YO, 2015, ACCIDENT ANAL PREV, V75, P272, DOI 10.1016/j.aap.2014.12.016; Tavafian SS, 2011, TRAFFIC INJ PREV, V12, P48, DOI 10.1080/15389588.2010.532523; Thailand Department of Land Transport, 2016, THAIL TRANSP STAT RE; Thailand National Statistical Office, 2014, STAT ROAD ACC THAIL; Thailand Office of Transport and Traffic Policy and Planning, 2015, AB ROAD ACC THAI 255; ThaiRoads Foundation, 2017, THAIL MOT HELM US; ThaiRoads Foundation, 2014, RAT HELM US THAI 255; Tornros J, 2006, TRANSPORT RES F-TRAF, V9, P298, DOI 10.1016/j.trf.2006.01.008; Tull ES, 2013, SOC SCI J, V50, P583, DOI 10.1016/j.soscij.2013.10.007; Velloso MS, 2012, TRANSPORT RES F-TRAF, V15, P588, DOI 10.1016/j.trf.2012.06.001; Washington SP, 2011, STAT ECONOMETRIC MET; World Health Organization, 2006, HELM ROAD SAF MAN DE; World Health Organization, 2015, GLOB STAT REP ROAD S; World Health Organization, 2015, MOT HELM FACT; Zhou HM, 2016, ACCIDENT ANAL PREV, V95, P417, DOI 10.1016/j.aap.2015.09.009	63	3	3	2	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0362-3319	1873-5355		SOC SCI J	Soc. Sci. J.	OCT 1	2020	57	4					508	529		10.1016/j.soscij.2019.02.003			22	Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Social Sciences - Other Topics	PG2QR	WOS:000599585700007					2022-02-06	
J	Dufour, SC; Adams, RS; Brody, DL; Puente, AN; Gray, JC				Dufour, Steven C.; Adams, Rachel Sayko; Brody, David L.; Puente, Antonio N.; Gray, Joshua C.			Prevalence and correlates of concussion in children: Data from the Adolescent Brain Cognitive Development study	CORTEX			English	Article						Concussion; Pediatrics; mTBI; Neurocognition	SLEEP DISTURBANCE SCALE; NEUROCOGNITIVE OUTCOMES; SOMATIC SYMPTOMS; MILD; PREDICTORS; INJURY; ASSOCIATION; CHILDHOOD; RECOVERY; ANXIETY	Introduction: Concussions are one of the most common causes for emergency room use in the United States (US) among youth and adolescents; however, prevalence data on concussion in this population are inconsistent. A growing body of literature has explored associations of a range of variables with pediatric concussion, but they have not been explored simultaneously in a well-powered sample in the US. The present study aimed to present lifetime concussion prevalence, evaluate demographic, psychological, and cognitive correlates of concussion, and assess for differences across these variables based on age of first concussion in a large sample of US children. Methods: We analyzed the Adolescent Brain Cognitive Development (ABCD) sample, which monitors biopsychosocial development in 11,875 children at 21 sites across the US between ages 9 and 10. Along with presenting rates of concussion, we also evaluated the association of demographics, sleep disturbance, cognitive functioning, and externalizing and internalizing symptoms with concussion history using backwards binary logistic regression. We further conducted univariate comparisons of all variables between those who experienced their first concussion before and after age 5. Significance was based on alpha = .02, with Benjamini-Hochberg FDR adjustments for multiple comparisons. Results: We found approximately 4% of the sample had experienced a concussion, and significant correlates of experiencing a concussion were male sex, increased family income, and higher somatic symptoms after FDR correction. Symptoms of ADHD were also noted as nominally significant. No differences based on age of first concussion were found. Discussion: Our analyses provided updated prevalence estimates of pediatric concussion in the US that aligns with many hospital records-based studies. Our findings largely mirrored those in the literature with the exception of somatic symptoms. Limitations of findings and implications of individual findings are discussed. Published by Elsevier Ltd.	[Dufour, Steven C.; Brody, David L.; Gray, Joshua C.] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Adams, Rachel Sayko] Brandeis Univ, Heller Sch Social Policy & Management, 415 South St, Waltham, MA USA; [Adams, Rachel Sayko] Rocky Mt Mental Illness Res Educ & Clin Ctr, Vet Hlth Adm, 1700 N Wheeling St, Aurora, CO 80045 USA; [Puente, Antonio N.] George Washington Univ, Sch Med & Hlth Sci, 2120 L St NW,Suite 600, Washington, DC 20052 USA		Dufour, SC (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	steven.dufour@usuhs.edu		Dufour, Steven/0000-0001-5370-1343	National InstitutesofHealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA;  [U01DA041022];  [U01DA041028];  [U01DA041048];  [U01DA041089];  [U01DA041106];  [U01DA041117];  [U01DA041120];  [U01DA041134];  [U01DA041148];  [U01DA041156];  [U01DA041174];  [U24DA041123];  [U24DA041147];  [U01DA041093];  [U01DA041025]	Data used in the preparation of this article were obtained from the Adolescent Brain Cognitive Development (ABCD) Study (https://abcdstudy.org), held in the NIMH Data Archive (NDA). This is amultisite, longitudinal study designed to recruit more than 10,000 children age 9e10 and follow them over 10 years into early adulthood. The ABCD Study is supported by the National InstitutesofHealthandadditional federalpartnersunder award numbers U01DA041022, U01DA041028, U01DA041048, U01DA041089, U01DA041106, U01DA041117, U01DA041120, U01DA041134, U01DA041148, U01DA041156, U01DA041174, U24DA041123, U24DA041147, U01DA041093, and U01DA041025. A full list of supporters is available at https://abcdstudy.org/federal-partners.html.A listing of participating sites and a complete listing of the study investigators can be found at https://abcdstudy.org/scientists/workgroups/.ABCD consortiuminvestigators designedandimplemented the study and/or provided data but did not necessarily participate in analysis or writing of this report. This manuscript reflects the viewsoftheauthorsandmaynotreflecttheopinionsorviewsof the NIH or ABCD consortiuminvestigators.	Achenbach T. M., 1991, CHILD BEHAV CHECKLIS; Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; Achenbach TM., 2003, MANUAL ASEBA ADULT F; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barch DM, 2018, DEV COGN NEUROS-NETH, V32, P55, DOI 10.1016/j.dcn.2017.10.010; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beauchamp MH, 2018, NEUROPSYCHOLOGY, V32, P495, DOI 10.1037/neu0000419; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bewick V, 2005, CRIT CARE, V9, P112, DOI 10.1186/cc3045; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Brooks BL, 2019, J NEUROTRAUM, V36, P679, DOI 10.1089/neu.2018.5792; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Ebesutani C, 2010, J PSYCHOPATHOL BEHAV, V32, P373, DOI 10.1007/s10862-009-9174-9; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fitzpatrick J, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116675272; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Garavan H, 2018, DEV COGN NEUROS-NETH, V32, P16, DOI 10.1016/j.dcn.2018.04.004; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gilmore RO, 2018, ADV METH PRACT PSYCH, V1, P121, DOI 10.1177/2515245917746500; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; Heinze G, 2017, TRANSPL INT, V30, P6, DOI 10.1111/tri.12895; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Ivanova MY, 2015, J PSYCHOPATHOL BEHAV, V37, P171, DOI 10.1007/s10862-014-9448-8; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Marriner AM, 2017, J SLEEP RES, V26, P587, DOI 10.1111/jsr.12526; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Masi G, 2000, PSYCHIATRY, V63, P140, DOI 10.1080/00332747.2000.11024905; Mayou R, 2002, BRIT MED J, V325, P265, DOI 10.1136/bmj.325.7358.265; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McKinlay A, 2014, AUST PSYCHOL, V49, P323, DOI 10.1111/ap.12084; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Nabi H, 2010, BIOL PSYCHIAT, V67, P378, DOI 10.1016/j.biopsych.2009.07.040; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Raikes AC, 2019, SLEEP MED, V58, P66, DOI 10.1016/j.sleep.2019.03.008; Rausa VC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0881-z; Rhodes SM, 2012, J CHILD PSYCHOL PSYC, V53, P128, DOI 10.1111/j.1469-7610.2011.02436.x; Rosenthal JA, 1996, J SOC SERV RES, V21, P37, DOI 10.1300/J079v21n04_02; Rubin D.B., 2004, MULTIPLE IMPUTATION; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schmidt NB, 2016, BEHAV RES THER, V77, P138, DOI 10.1016/j.brat.2015.12.011; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Thompson WK, 2019, DEV COGN NEUROS-NETH, V36, DOI 10.1016/j.dcn.2018.12.004; van Buuren S, 2011, J STAT SOFTW, V45, P1; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Volkow ND, 2018, DEV COGN NEUROS-NETH, V32, P4, DOI 10.1016/j.dcn.2017.10.002; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220; Zhou Y, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8120223; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	62	3	3	3	3	ELSEVIER MASSON, CORP OFF	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	OCT	2020	131						237	250		10.1016/j.cortex.2020.07.003			14	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	OA0SQ	WOS:000577507100018	32814618				2022-02-06	
J	Hoffman, JM; Lucas, S; Dikmen, S; Temkin, N				Hoffman, Jeanne M.; Lucas, Sylvia; Dikmen, Sureyya; Temkin, Nancy			Clinical Perspectives on Headache After Traumatic Brain Injury	PM&R			English	Article							CHRONIC POSTTRAUMATIC HEADACHES; US SOLDIERS; DEPRESSION; PREVALENCE; VETERANS; OUTCOMES; RATES; CLASSIFICATION; MODERATE; COHORT	Background Headache after traumatic brain injury (TBI) is frequent and persistent over the first year after injury. Providers may need to focus on different symptom presentations depending on their patient's TBI severity. Objective We evaluated headache symptoms in patients with moderate-to-severe TBI compared to patients with mild TBI and examined our data from two perspectives: (1) from providers who treat individuals after TBI and manage multiple postinjury symptoms including headache, and (2) from headache specialists who see individuals after TBI to manage headache. Design Prospective enrollment of individuals after TBI with telephone follow-up at 1-year postinjury. Setting Enrollment from hospital and then community followup. Participants Three hundred forty-six individuals with moderate-to-severe TBI were enrolled during acute inpatient rehabilitation across seven TBI Model System Centers. One hundred eighty-nine individuals with mild TBI were enrolled within 1 week of injury at a single center. Intervention None. Main Outcome Measurements Headache frequency, headache type, pain intensity, Headache Impact Test-6 (HIT-6), and depressive symptoms measured 1 year after injury. Results Headache prevalence is high in both TBI groups. TBI providers are more likely to evaluate and treat headache from individuals sustaining a mild TBI versus moderate-to-severe TBI. Patients with mild TBI are most likely to report tension-type headache followed by migraine-type headache. The migraine-type headache has higher impact (HIT-6) and greater pain intensity. Headache specialists may encounter patients with moderate-to-severe TBI who report more frequent headache and higher average pain scores compared to patients with mild TBI. The severity of TBI was unrelated to depressive symptoms 1 year after injury, but patients with headache were significantly more likely to have higher scores. Conclusions TBI providers versus headache specialists should be aware of differences in patient symptom presentation to their respective clinics. Ongoing assessment of headache and depression over time is important following TBI of any severity.	[Hoffman, Jeanne M.] Univ Washington, Sch Med, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA; [Lucas, Sylvia] Univ Washington, Sch Med, Dept Neurol Neurol Surg & Rehabil Med, Seattle, WA USA; [Dikmen, Sureyya] Univ Washington, Sch Med, Dept Rehabil Med Neurol Surg & Psychiat & Behav M, Seattle, WA USA; [Temkin, Nancy] Univ Washington, Sch Med, Dept Neurol Surg & Biostat, Seattle, WA USA		Hoffman, JM (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA.	jeanneh@uw.edu		Hoffman, Jeanne/0000-0002-3525-3839	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133A070032, H133G090022] Funding Source: Medline; ACL HHS [90DP0031] Funding Source: Medline		Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Finkel AG, 2017, HEADACHE, V57, P719, DOI 10.1111/head.13056; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Keidel M, 1997, NERVENARZT, V68, P769, DOI 10.1007/s001150050193; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Kumar RG, 2018, BRAIN INJURY, V32, P383, DOI 10.1080/02699052.2018.1427888; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; McMurtray AM, 2013, INT J PSYCHIAT MED, V45, P227, DOI 10.2190/PM.45.3.b; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Prevention CfDCa, 2015, C TRAUM BRAIN INJ US; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Smitherman TA, 2013, HEADACHE, V53, P427, DOI 10.1111/head.12074; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429	36	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2020	12	10					967	974		10.1002/pmrj.12338			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	OF7NA	WOS:000581388200002	32003524				2022-02-06	
J	Hogan, C; Cornwell, P; Fleming, J; Shum, DHK				Hogan, Christy; Cornwell, Petrea; Fleming, Jennifer; Shum, David H. K.			The Assessment and Prediction of Prospective Memory after Stroke	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Humans; Memory; Intention; Cognition; Stroke; Surveys and Questionnaires	TRAUMATIC BRAIN-INJURY; RETROSPECTIVE MEMORY; NORMATIVE DATA; QUESTIONNAIRE PRMQ; LATENT STRUCTURE; AGE; PERFORMANCE; REHABILITATION; VERSION; PEOPLE	Objective: Prospective memory (PM) is the memory used when intentions are to be carried out in the future. Little research has been conducted examining PM after stroke. This study aimed to determine if PM is impaired after stroke through comparison of individuals with stroke to healthy controls. Additionally, it aimed to explore the predictors of PM performance post-stroke. Method: Twenty-eight individuals with stroke and 27 neurologically healthy controls completed the Cambridge Prospective Memory Test (CAMPROMPT), 2 self-report PM questionnaires, and multiple cognitive measures. Results: Individuals with stroke performed significantly lower on both event- and time-based PM than controls on the CAMPROMPT, indicating PM impairment. Event-based PM after stroke was significantly predicted by age, retrospective memory (RM), and global cognitive function, whereas time-based PM was only predicted by the metacognitive skill of note-taking. Age and note-taking predicted time-based PM for controls, whereas only age predicted event-based PM for control participants. Conclusions: The findings of this study have helped to confirm that PM impairment does exist after stroke, particularly when using a standardised PM measure. Furthermore, PM impairment may be predicted by variables, such as age, strategy use, RM, and cognitive ability.	[Hogan, Christy] Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld, Australia; [Hogan, Christy; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Sch Allied Hlth Sci, Menzies Hlth Inst Queensland, Nathan, Qld, Australia; [Cornwell, Petrea] Prince Charles Hosp, Metro North Hosp & Hlth Serv, Chermside, Qld, Australia; [Shum, David H. K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Peoples R China; [Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Gold Coast, Australia		Shum, DHK (corresponding author), Hong Kong Polytech Univ, Fac Hlth & Social Sci, Hung Hom, Kowloon, Hong Kong, Peoples R China.	david.shum@polyu.edu.hk	Cornwell, Petrea/AAE-5547-2019; Shum, David H. K./A-3914-2008	Hogan, Christy/0000-0001-7325-9695; Shum, David H. K./0000-0002-4810-9262; Fleming, Jennifer/0000-0002-5603-2410	Griffith University Postgraduate ScholarshipGriffith University	This work was supported by a Griffith University Postgraduate Scholarship.	AIHW. Australian Institute of Health and Welfare, 2016, AUSTR HLTH SER, V15; Al Banna M, 2016, J NEUROL NEUROSUR PS, V87, P161, DOI 10.1136/jnnp-2015-310305; Andrews G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01032; Andrews G, 2014, BRAIN INJURY, V28, P442, DOI 10.3109/02699052.2014.888758; [Anonymous], 2009, J INTERDISCIPLINARY, VXL, P145, DOI DOI 10.1080/13554790802709039; [Anonymous], 1998, INT J POLITICS CULTU, V12, P43; Barr A.C., 2011, THESIS; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Crawford JR, 2006, BRIT J CLIN PSYCHOL, V45, P83, DOI 10.1348/014466505X28748; d'Ydewalle G, 1999, EUR J COGN PSYCHOL, V11, P219, DOI 10.1080/713752309; Dickson D, 2002, NAT MED, V8, P645, DOI 10.1038/nm0702-645a; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Hogan C, 2016, BRAIN IMPAIR, V17, P123, DOI 10.1017/BrImp.2016.12; IBM Corp, 2017, IBM SPSS STAT VERS 2; IOS Press, 2011, J E GOVERNANCE, V34, P187, DOI DOI 10.1097/MRR.0B013E3283487F31; Kant N, 2014, NEUROPSYCHOLOGIA, V60, P77, DOI 10.1016/j.neuropsychologia.2014.05.015; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Kvavilashvili L, 2009, MEMORY, V17, P180, DOI 10.1080/09658210802194366; Livingston J. A., 2003, METACOGNITION OVERVI; Man D, 2015, BRAIN INJURY, V29, P329, DOI 10.3109/02699052.2014.974672; Man DWK, 2015, NEUROPSYCHOL REHABIL, V25, P895, DOI 10.1080/09602011.2014.997253; Man DWK, 2011, NEUROPSYCHOL REHABIL, V21, P884, DOI 10.1080/09602011.2011.627270; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Miller LA, 2014, NEUROPSYCHOL REHABIL, V24, P721, DOI 10.1080/09602011.2014.894479; Mitrovic A, 2016, J APPL RES MEM COGN, V5, P204, DOI 10.1016/j.jarmac.2016.03.006; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neulinger K., 2002, BRAIN IMPAIR, V3, P1, DOI [10.1375/brim.3.1.1, DOI 10.1375/BRIM.3.1.1]; Niedzwienska A, 2012, AGING NEUROPSYCHOL C, V19, P58, DOI 10.1080/13825585.2011.628374; Nouri F. M., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Otani H, 1997, MEMORY, V5, P343, DOI 10.1080/741941393; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; RANKIN J, 1957, Scott Med J, V2, P200; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Schnitzspahn KM, 2013, DEV PSYCHOL, V49, P1544, DOI 10.1037/a0030579; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Uttl B, 2011, CAN J EXP PSYCHOL, V65, P57, DOI 10.1037/a0022843; Wilson~ BA, 2005, CAMBRIDGE TEST PROSP; Zuber S, 2016, MEM COGNITION, V44, P1192, DOI 10.3758/s13421-016-0628-5	50	3	3	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2020	26	9					873	882	PII S1355617720000405	10.1017/S1355617720000405			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	OB7LG	WOS:000578648000004	32527336	hybrid, Green Published			2022-02-06	
J	Holden, J; Francisco, E; Tommerdahl, A; Lensch, R; Kirsch, B; Zai, LL; Pearce, AJ; Favorov, OV; Dennis, RG; Tommerdahl, M				Holden, Jameson; Francisco, Eric; Tommerdahl, Anna; Lensch, Rachel; Kirsch, Bryan; Zai, Laila; Pearce, Alan J.; Favorov, Oleg, V; Dennis, Robert G.; Tommerdahl, Mark			Methodological Problems With Online Concussion Testing	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						reaction time; reaction time variability; online cognitive testing; online concussion testing; intraindividual reaction time variability; concussion; concussion testing	TRAUMATIC BRAIN-INJURY; SIMPLE REACTION-TIME; NEUROPSYCHOLOGICAL PERFORMANCE; ATTENTION DEFICITS; SPORTS CONCUSSION; TIMING ACCURACY; LONG-TERM; MILD; VARIABILITY; MOTOR	Reaction time testing is widely used in online computerized concussion assessments, and most concussion studies utilizing the metric have demonstrated varying degrees of difference between concussed and non-concussed individuals. The problem with most of these online concussion assessments is that they predominantly rely on consumer grade technology. Typical administration of these reaction time tests involves presenting a visual stimulus on a computer monitor and prompting the test subject to respond as quickly as possible via keypad or computer mouse. However, inherent delays and variabilities are introduced to the reaction time measure by both computer and associated operating systems that the concussion assessment tool is installed on. The authors hypothesized systems that are typically used to collect concussion reaction time data would demonstrate significant errors in reaction time measurements. To remove human bias, a series of experiments was conducted robotically to assess timing errors introduced by reaction time tests under four different conditions. In the first condition, a visual reaction time test was conducted by flashing a visual stimulus on a computer monitor. Detection was via photodiode and mechanical response was delivered via computer mouse. The second condition employed a mobile device for the visual stimulus, and the mechanical response was delivered to the mobile device's touchscreen. The third condition simulated a tactile reaction time test, and mechanical response was delivered via computer mouse. The fourth condition also simulated a tactile reaction time test, but response was delivered to a dedicated device designed to store the interval between stimulus delivery and response, thus bypassing any problems hypothesized to be introduced by computer and/or computer software. There were significant differences in the range of responses recorded from the four different conditions with the reaction time collected from visual stimulus on a mobile device being the worst and the device with dedicated hardware designed for the task being the best. The results suggest that some of the commonly used visual tasks on consumer grade computers could be (and have been) introducing significant errors for reaction time testing and that dedicated hardware designed for the reaction time task is needed to minimize testing errors.	[Holden, Jameson; Francisco, Eric; Tommerdahl, Anna; Lensch, Rachel; Kirsch, Bryan; Dennis, Robert G.; Tommerdahl, Mark] Cort Metr LLC, Carrboro, NC 27510 USA; [Zai, Laila] Lucent Res, Denver, CO USA; [Pearce, Alan J.] La Trobe Univ, Coll Hlth Sci & Engn, Melbourne, Vic, Australia; [Favorov, Oleg, V; Dennis, Robert G.; Tommerdahl, Mark] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27515 USA		Tommerdahl, M (corresponding author), Cort Metr LLC, Carrboro, NC 27510 USA.; Tommerdahl, M (corresponding author), Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27515 USA.	mark_tommerdahi@med.unc.edu		Favorov, Oleg V./0000-0002-8963-8339	Office of Naval ResearchOffice of Naval Research	Partial support for this work was provided by the Office of Naval Research. A previous version of thismanuscript has been released as a Pre-Print at Biology Archives (Holden et al., 2019).	Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; BENTON AL, 1977, ARCH NEUROL-CHICAGO, V34, P369, DOI 10.1001/archneur.1977.00500180063013; BERINGER J, 1992, BEHAV RES METH INSTR, V24, P486, DOI 10.3758/BF03203585; Bolte, 2018, OPTOM VIS PERFORM, V6, P119; CHENEY RALPH HOLT, 1934, JOUR AMER PHARM ASSOC, V23, P143; Cole WR, 2018, J INT NEUROPSYCH SOC, V24, P156, DOI 10.1017/S1355617717001187; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Danna-Dos-Santos A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22825-5; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Donders F. C., 1868, ONDERZOEKINGEN GEDAA, VII, P92; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Eckner JT, 2015, PERCEPT MOTOR SKILL, V120, P841, DOI 10.2466/25.15.PMS.120v19x6; EDWARDS AE, 1961, PSYCHOPHARMACOLOGIA, V2, P297, DOI 10.1007/BF00404117; EVARTS EV, 1981, BRAIN, V104, P167, DOI 10.1093/brain/104.1.167; Favorov OV, 2019, MIL MED, V184, P228, DOI 10.1093/milmed/usy411; Ferraro FR, 2016, AUTISM, V20, P116, DOI 10.1177/1362361314559986; FOZARD JL, 1994, J GERONTOL, V49, pP179, DOI 10.1093/geronj/49.4.P179; GOODRICH S, 1989, COGNITIVE NEUROPSYCH, V6, P309, DOI 10.1080/02643298908253422; Gould JA, 2013, BRAIN INJURY, V27, P1643, DOI 10.3109/02699052.2013.831124; Hernandez OH, 2006, PSYCHOPHARMACOLOGY, V184, P75, DOI 10.1007/s00213-005-0237-7; Holden J., 2019, BIORXIV, DOI [10.1101/726364, DOI 10.1101/726364]; Hsiao SS, 1998, ADV PSYCHOL, V127, P131; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2020, ARCH CLIN NEUROPSYCH, V35, P56, DOI 10.1093/arclin/acz021; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kim J., 2020, J SCI MED, V2, P1, DOI [10.37714/josam.v2i2.39, DOI 10.37714/JOSAM.V2I2.39]; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; LEONARD JA, 1959, Q J EXP PSYCHOL, V11, P76, DOI 10.1080/17470215908416294; LORENZO I, 1995, SLEEP, V18, P346; Lynall RC, 2018, ARCH PHYS MED REHAB, V99, P880, DOI 10.1016/j.apmr.2017.12.011; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MacDonald SWS, 2003, PSYCHOL AGING, V18, P510, DOI 10.1037/0882-7974.18.3.510; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Merkel J., 1885, PHILOS STUD, V2, P73; Neath I, 2011, BEHAV RES METHODS, V43, P353, DOI 10.3758/s13428-011-0069-9; Ng A, 2012, UIST'12: PROCEEDINGS OF THE 25TH ANNUAL ACM SYMPOSIUM ON USER INTERFACE SOFTWARE AND TECHNOLOGY, P453; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Norman RS, 2019, BRAIN INJURY, V33, P1173, DOI 10.1080/02699052.2019.1632487; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Patil S., 2015, INT J HLTH SCI RES, V5, P141; Pearce AJ, 2020, SOMATOSENS MOT RES, V37, P14, DOI 10.1080/08990220.2019.1699045; Pearce AJ, 2019, NEUROSCIENCE, V408, P272, DOI 10.1016/j.neuroscience.2019.04.019; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Plant RR, 2016, BEHAV RES METHODS, V48, P408, DOI 10.3758/s13428-015-0577-0; Plant RR, 2009, BEHAV RES METHODS, V41, P598, DOI 10.3758/BRM.41.3.598; Plant RR, 2004, BEHAV RES METH INS C, V36, P291, DOI 10.3758/BF03195575; Plant RR, 2003, BEHAV RES METH INS C, V35, P276, DOI 10.3758/BF03202553; Plant RR, 2002, BEHAV RES METH INS C, V34, P218, DOI 10.3758/BF03195446; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Puts NAJ, 2017, J NEUROPHYSIOL, V118, P2568, DOI 10.1152/jn.00087.2017; Puts NAJ, 2014, J NEUROPHYSIOL, V111, P1803, DOI 10.1152/jn.00890.2013; Ruesch J, 1944, J NEUROSURG, V1, P243, DOI 10.3171/jns.1944.1.4.0243; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; SCHWARTZ F, 1989, BIOL PSYCHIAT, V25, P540, DOI 10.1016/0006-3223(89)90214-X; SHERWOOD DE, 1979, MED SCI SPORT EXER, V11, P186; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tamm L, 2012, NEUROTHERAPEUTICS, V9, P500, DOI 10.1007/s13311-012-0138-5; Tommerdahl M., 2020, J SCI MED, V2, P1, DOI [10.37714/JOSAM.V2I2.31, DOI 10.37714/JOSAM.V2I2.31]; ULRICH R, 1989, BRIT J MATH STAT PSY, V42, P1, DOI 10.1111/j.2044-8317.1989.tb01111.x; VANDERMEERE J, 1992, J CHILD PSYCHOL PSYC, V33, P1347; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Woodley MA, 2013, INTELLIGENCE, V41, P843, DOI 10.1016/j.intell.2013.04.006; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924; Zhang Z, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00018	78	3	3	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	OCT 1	2020	14								509091	10.3389/fnhum.2020.509091			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	OC0MJ	WOS:000578856900001	33132870	gold, Green Published			2022-02-06	
J	Iverson, GL; Jones, PJ; Karr, JE; Maxwell, B; Zafonte, R; Berkner, PD; McNally, RJ				Iverson, Grant L.; Jones, Payton J.; Karr, Justin E.; Maxwell, Bruce; Zafonte, Ross; Berkner, Paul D.; McNally, Richard J.			Network Structure of Physical, Cognitive, and Emotional Symptoms at Preseason Baseline in Student Athletes with Attention-Deficit/Hyperactivity Disorder	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Child; Adolescent; Brain concussion; Sports; ADHD; Rehabilitation; Statistical methods	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; DEPRESSION; CHILDREN; ASSOCIATION; COMORBIDITY; HISTORY; ADHD	Objective: Preexisting attention-deficit/hyperactivity disorder (ADHD) may be a risk factor for worse outcome following sport-related concussion. We used a statistical and psychometric approach known as network analysis to examine the architecture of physical, cognitive, and emotional symptoms at preseason baseline among student athletes with ADHD. Method: A cohort of 44,527 adolescent student athletes completed baseline preseason testing with ImPACT (R) between 2009 and 2015. A subsample of athletes reporting a diagnosis of ADHD and at least one symptom were included in this study (N = 3,074; 14-18 years old, 32.7% girls). All participants completed the 22-item Post-Concussion Symptom Scale at preseason baseline. Results: Student athletes reported high frequencies of difficulty concentrating (boys/girls = 50.7%/59.4%), emotional symptoms (nervousness: boys/girls = 30.2%/51.0%; irritability: boys/girls = 23.6%/34.8%; sadness: boys/girls = 21.4%/39.7%), sleep/arousal-related symptoms (trouble falling asleep: boys/girls = 39.5%/49.4%; sleeping less than usual: boys/girls = 36.2%/ 43.4%; and fatigue: boys/girls = 29.8%/36.4%), and headaches (boys/girls = 27.6%/39.0%) during preseason baseline testing. The most central symptoms included dizziness, which was related to multiple somatic symptoms, and increased emotionality, which was related to a cluster of emotional symptoms. Girls reported symptoms at a greater frequency than boys, and there was evidence for variance in the global strength of the symptom network across gender, but not specific intersymptom relationships. Conclusion: In the absence of injury, symptoms that commonly occur after concussion interact and potentially reinforce each other among student athletes with ADHD at preseason. Symptoms common in ADHD (i.e., difficulty concentrating) are not necessarily the most central within the symptom network. These findings may inform more precise interventions for athletes with ADHD and prolonged recovery following concussion.	[Iverson, Grant L.; Karr, Justin E.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Karr, Justin E.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.; Karr, Justin E.] Spaulding Res Inst, Boston, MA USA; [Iverson, Grant L.; Karr, Justin E.; Zafonte, Ross] Home Base, Boston, MA USA; [Iverson, Grant L.; Karr, Justin E.] MassGen Hosp ChildrenTM, Sports Concuss Program, Boston, MA USA; [Jones, Payton J.; McNally, Richard J.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Karr, Justin E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA		Iverson, GL (corresponding author), Ctr Hlth & Rehabil Res, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu			National Football League	This study was funded in part by the National Football League for a program of research entitled "The Spectrum of Concussion: Predictors of Clinical Recovery, Treatment and Rehabilitation, and Possible Long-Term Effects" (Iverson, PI). Grant Iverson, PhD acknowledges unrestricted philanthropic support from ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, Boston Bolts, Heinz Family Foundation, and Spaulding Research Institute.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Beard C, 2016, PSYCHOL MED, V46, P3359, DOI 10.1017/S0033291716002300; Borsboom D, 2016, PSYCHOL MED, V46, P1567, DOI 10.1017/S0033291715001944; Borsboom D, 2019, MODELING PSYCHOPATHO; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Boschloo L, 2016, J ABNORM PSYCHOL, V125, P599, DOI 10.1037/abn0000150; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Cook NE, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00002; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Cramer AOJ, 2012, PSYCHOL MED, V42, P957, DOI 10.1017/S003329171100211X; Cramer AOJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167490; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Curtiss J, 2016, J AFFECT DISORDERS, V199, P99, DOI 10.1016/j.jad.2016.04.007; Dalege J, 2017, SOC PSYCHOL PERS SCI, V8, P528, DOI 10.1177/1948550617709827; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Epskamp S, 2018, PSYCHOL METHODS, V23, P617, DOI 10.1037/met0000167; Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fried EI, 2017, SOC PSYCH PSYCH EPID, V52, P1, DOI 10.1007/s00127-016-1319-z; Fried EI, 2016, J AFFECT DISORDERS, V189, P314, DOI 10.1016/j.jad.2015.09.005; Friedman J., 2014, GRAPHICAL LASSOESTIO; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; ImPACT Applications Inc., 2011, IMM POSTC ASS COGN T; Iverson GL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00175; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Jones P. J., 2018, R PACKAGE VERSION, V1, P2; Jones P. J., 2019, NETWORK TREES METHOD, DOI [10.31219/osf.io/ha4cw, DOI 10.31219/OSF.IO/HA4CW]; Jones PJ, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01742; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Levinson CA, 2018, INT J EAT DISORDER, V51, P693, DOI 10.1002/eat.22890; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Mair P, 2016, MULTIVAR BEHAV RES, V51, P772, DOI 10.1080/00273171.2016.1235966; McElroy E, 2018, J AM ACAD CHILD PSY, V57, P964, DOI 10.1016/j.jaac.2018.05.027; McWilliams LA, 2017, CLIN J PAIN, V33, P899, DOI 10.1097/AJP.0000000000000477; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; R Core Team, 2012, R LANG ENV STAT COMP; Reale L, 2017, EUR CHILD ADOLES PSY, V26, P1443, DOI 10.1007/s00787-017-1005-z; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Robinaugh DJ, 2016, J ABNORM PSYCHOL, V125, P747, DOI 10.1037/abn0000181; Terluin B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155205; Thompson EL, 2019, INT J BEHAV MED, V26, P59, DOI 10.1007/s12529-018-9754-8; van Borkulo C. D., 2019, VEGAN COMMUNITY ECOL; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079; van Loo HM, 2018, J AFFECT DISORDERS, V227, P313, DOI 10.1016/j.jad.2017.10.038; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Waldorp, 2016, COMP NETWORK S UNPUB, P34, DOI [DOI 10.13140/RG.2.2.29455.38569, 10.13140/RG.2.2.29455.38569]; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	65	3	3	1	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	OCT	2020	35	7					1109	1122		10.1093/arclin/acaa030			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	PA2TQ	WOS:000595486600005	32619228	Bronze			2022-02-06	
J	Khan, IR; Saulle, M; Oldham, MA; Weber, MT; Schifitto, G; Lee, HCB				Khan, Imad R.; Saulle, Michael; Oldham, Mark A.; Weber, Miriam T.; Schifitto, Giovanni; Lee, Hochang B.			Cognitive, Psychiatric, and Quality of Life Outcomes in Adult Survivors of Extracorporeal Membrane Oxygenation Therapy: A Scoping Review of the Literature	CRITICAL CARE MEDICINE			English	Article						acute heart failure; acute respiratory distress syndrome; cognitive outcomes; extracorporeal membrane oxygenation; psychiatric outcomes; quality of life	LONG-TERM OUTCOMES; MORTALITY RISK SCORE; NEUROLOGIC COMPLICATIONS; SUPPORT; REHABILITATION; PREDICTORS; DEPRESSION; INJURY; PREVALENCE; DISORDERS	Objectives: To perform a scoping literature review of cognitive, psychiatric, and quality of life outcomes in adults undergoing extracorporeal membrane oxygenation for any indication. Data Sources: We searched PubMed, EMBASE, Cochrane Library, Web of Science, CINAHL, and PsycINFO from inception to June 2019. Study Selection: Observational studies, clinical trials, qualitative studies, and case series with at least 10 adult subjects were included for analysis. Outcomes of interest consisted of general or domain-specific cognition, psychiatric illness, and quality of life measures that included both mental and physical health. Data Extraction: Study selection, data quality assessment, and interpretation of results were performed by two independent investigators in accordance with the PRISMA statement. Data Synthesis: Twenty-two articles were included in this review. Six described cognitive outcomes, 12 described psychiatric outcomes of which two were qualitative studies, and 16 described quality of life outcomes. Cognitive impairment was detected in varying degrees in every study that measured it. Three studies examined neuroimaging results and found neurologic injury to be more frequent in venoarterial versus venovenous extracorporeal membrane oxygenation, but described a variable correlation with cognitive impairment. Rates of depression, anxiety, and post-traumatic stress disorder were similar to other critically ill populations and were related to physical disability after extracorporeal membrane oxygenation. Extracorporeal membrane oxygenation survivors' physical quality of life was worse than population norms but tended to improve with time, while mental quality of life did not differ significantly from the general population. Most studies did not include matched controls and instead compared outcomes to previously published values. Conclusions: Extracorporeal membrane oxygenation survivors experience cognitive impairment, psychiatric morbidity, and worse quality of life compared with the general population and similar to other survivors of critical illness. Physical disability in extracorporeal membrane oxygenation patients plays a significant role in psychiatric morbidity. However, it remains unclear if structural brain injury plays a role in these outcomes and whether extracorporeal membrane oxygenation causes secondary brain injury.	[Khan, Imad R.] Univ Rochester, Med Ctr, Dept Neurol, Div Neurocrit Care, Rochester, NY 14642 USA; [Saulle, Michael] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Oldham, Mark A.; Lee, Hochang B.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Weber, Miriam T.; Schifitto, Giovanni] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA		Khan, IR (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Div Neurocrit Care, Rochester, NY 14642 USA.	imad_khan@urmc.rochester.edu	Khan, Ilyas/C-8770-2019	Khan, Ilyas/0000-0002-2056-9371	National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)	Dr. Weber has received funding from the National Institute on Aging. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Anselmi A, 2015, J THORAC CARDIOV SUR, V150, P947, DOI 10.1016/j.jtcvs.2015.05.070; Biscotti M, 2017, ANN THORAC SURG, V104, P412, DOI 10.1016/j.athoracsur.2016.11.056; Boyle K, 2018, PEDIATR CRIT CARE ME, V19, P760, DOI 10.1097/PCC.0000000000001612; Brodie D, 2018, CHEST, V153, P788, DOI 10.1016/j.chest.2017.12.024; Chen KH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196778; Chen KH, 2016, HEART LUNG, V45, P147, DOI 10.1016/j.hrtlng.2015.12.005; Cho SM, 2019, CRIT CARE MED, V47, P1773, DOI 10.1097/CCM.0000000000004060; Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385; Combes A, 2008, CRIT CARE MED, V36, P1404, DOI 10.1097/CCM.0b013e31816f7cf7; Combes A, 2017, INTENS CARE MED, V43, P1306, DOI 10.1007/s00134-017-4803-3; Corsi F, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1655-8; Cove ME, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0997-3; Dzierba AL, 2019, J CRIT CARE, V53, P98, DOI 10.1016/j.jcrc.2019.05.014; ELSO, 2017, ELSO GEN GUID ALL EC; Extracorporeal Life Support Organization (ELSO), 2020, INT SUMM ELS ECMO RE; Garcia JP, 2011, J THORAC CARDIOV SUR, V142, P755, DOI 10.1016/j.jtcvs.2011.07.029; Hodgson CL, 2019, CRIT CARE MED, V47, P1557, DOI 10.1097/CCM.0000000000003954; Hodgson CL, 2012, CRIT CARE, V16, DOI 10.1186/cc11811; Holzgraefe B, 2017, EUR J ANAESTH, V34, P98, DOI 10.1097/EJA.0000000000000544; Hrobjartsson A, 2019, COCHRANE HDB SYSTEMA; Hsieh FT, 2016, J ADV NURS, V72, P1626, DOI 10.1111/jan.12943; Jackson JC, 2014, LANCET RESP MED, V2, P369, DOI 10.1016/S2213-2600(14)70051-7; Karnatovskaia LV, 2015, J CRIT CARE, V30, P130, DOI 10.1016/j.jcrc.2014.09.024; Knudson KA, 2019, HEART LUNG, V49, P538, DOI 10.1016/j.hrtlng.2019.08.016; Kolaitis NA, 2018, J THORAC CARDIOV SUR, V156, P440, DOI 10.1016/j.jtcvs.2018.01.101; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Langer T, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1329-y; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lorusso R, 2017, J THORAC DIS, V9, pE954, DOI 10.21037/jtd.2017.09.30; Lorusso R, 2017, CRIT CARE MED, V45, P1389, DOI 10.1097/CCM.0000000000002502; Lorusso R, 2016, CRIT CARE MED, V44, pE964, DOI 10.1097/CCM.0000000000001865; Luyt CE, 2012, CHEST, V142, P583, DOI 10.1378/chest.11-2196; Marra A, 2018, CRIT CARE MED, V46, P1393, DOI 10.1097/CCM.0000000000003218; Mehta Amit, 2013, World J Crit Care Med, V2, P40, DOI 10.5492/wjccm.v2.i4.40; Mirabel M, 2011, CRIT CARE MED, V39, P1029, DOI 10.1097/CCM.0b013e31820ead45; Mitchell AJ, 2017, GEN HOSP PSYCHIAT, V47, P48, DOI 10.1016/j.genhosppsych.2017.04.001; Montisci A, 2015, ASAIO J, V61, P227, DOI 10.1097/MAT.0000000000000207; Muller G, 2016, INTENS CARE MED, V42, P370, DOI 10.1007/s00134-016-4223-9; Myhren H, 2010, CRIT CARE, V14, DOI 10.1186/cc8870; Myhren H, 2009, INTENS CARE MED, V35, P2078, DOI 10.1007/s00134-009-1614-1; Nasr DM, 2015, J CLIN NEUROL, V11, P383, DOI 10.3988/jcn.2015.11.4.383; Pappalardo F, 2017, J THORAC DIS, V9, P2774, DOI 10.21037/jtd.2017.08.62; Rahimi RA, 2013, PHYS THER, V93, P248, DOI 10.2522/ptj.20120336; Rehder KJ, 2013, RESP CARE, V58, P1291, DOI 10.4187/respcare.02155; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Risnes I, 2006, ANN THORAC SURG, V81, P1401, DOI 10.1016/j.athoracsur.2005.10.008; Risnes I, 2013, PSYCHOSOMATICS, V54, P418, DOI 10.1016/j.psym.2013.02.008; Roll MA, 2019, HEART LUNG CIRC, V28, P1090, DOI 10.1016/j.hlc.2018.06.1044; Ruckert F, 2017, INTERACT CARDIOV TH, V24, P542, DOI 10.1093/icvts/ivw398; Schmidt M, 2013, INTENS CARE MED, V39, P1704, DOI 10.1007/s00134-013-3037-2; Sutter R, 2018, CRIT CARE MED, V46, P1506, DOI 10.1097/CCM.0000000000003223; Sylvestre A, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0556-1; Tramm R, 2017, AM J CRIT CARE, V26, P311, DOI 10.4037/ajcc2017707; Tramm R, 2016, HEART LUNG, V45, P220, DOI 10.1016/j.hrtlng.2016.01.010; Tramm R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010381.pub2; Tramm R, 2015, AUST CRIT CARE, V28, P31, DOI 10.1016/j.aucc.2014.04.005; von Bahr V, 2018, CRIT CARE MED, V46, pE351, DOI 10.1097/CCM.0000000000002992; Wang JG, 2009, ANN THORAC SURG, V88, P1897, DOI 10.1016/j.athoracsur.2009.08.009; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wilcox ME, 2013, CRIT CARE MED, V41, pS81, DOI 10.1097/CCM.0b013e3182a16946	60	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2020	48	10					E959	E970		10.1097/CCM.0000000000004488			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NU4MF	WOS:000573616600015	32886470				2022-02-06	
J	Menichetti, A; MacManus, DB; Gilchrist, MD; Depreitere, B; Vander Sloten, J; Famaey, N				Menichetti, Andrea; MacManus, David B.; Gilchrist, Michael D.; Depreitere, Bart; Vander Sloten, Jos; Famaey, Nele			Regional characterization of the dynamic mechanical properties of human brain tissue by microindentation	INTERNATIONAL JOURNAL OF ENGINEERING SCIENCE			English	Article						Brain biomechanics; Traumatic brain injury; Soft tissue; Mechanical characterization; Indentation	FINITE-ELEMENT-ANALYSIS; IN-VIVO; CONSTITUTIVE MODEL; INJURY; INDENTATION; EPIDEMIOLOGY; STRAIN; IMPLEMENTATION; IDENTIFICATION; VERIFICATION	Traumatic brain injury (TBI) is an important cause of mortality and morbidity worldwide. Finite element models of the human head are used widely to simulate TBI loading scenarios, to improve the understanding of the mechanical pathogenesis of head trauma. The reliability of such computational models depends strongly on the accuracy of the mechanical properties of the different components of the brain. Here, we address the shortage of highquality data on the region-specific properties of human brain tissue at dynamic rates and under large deformation. We mechanically characterized 12 different regions of the human brain including cerebrum, cerebellum and brainstem through n=595 force-relaxation experiments with a custom-built micro-indentation apparatus. We imposed up to 35% strain at 10/s strain rate, i.e. values representative for TBI. Pronounced differences in mechanical response were observed across the brain. This work both highlights and addresses the need to assign accurate, region-specific viscoelastic properties to different brain regions in finite element head models. (C) 2020 Elsevier Ltd. All rights reserved.	[Menichetti, Andrea; Vander Sloten, Jos; Famaey, Nele] Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Celestijnenlaan 300,Box 2419, B-3001 Leuven, Belgium; [MacManus, David B.] Dublin City Univ, Sch Mech & Mfg Engn, Dublin, Ireland; [MacManus, David B.; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Depreitere, Bart] Univ Hosp, Dept Neurosurg, Leuven, Belgium		Menichetti, A (corresponding author), Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Celestijnenlaan 300,Box 2419, B-3001 Leuven, Belgium.	andrea.menichetti@kuleuven.be; david.macmanus@dcu.ie; michael.gilchrist@ucd.ie; bart.depreitere@uzleuven.be; jos.vandersloten@kuleuven.be; nele.famaey@kuleuven.be		MacManus, David/0000-0003-2959-698X; Famaey, Nele/0000-0002-7374-8912; Menichetti, Andrea/0000-0001-8042-0344	Research Foundation Flanders (FWO)FWO [1S25918N]; Science Foundation IrelandScience Foundation IrelandEuropean Commission [12/IP/1732]	This research was made possible through pre-doctoral fellowship of the Research Foundation Flanders (FWO) (Project no. 1S25918N) and funding from Science Foundation Ireland (Grant No. 12/IP/1732). The authors would like to acknowledge Jo Verbinnen from the Anatomy Department - Vesalius Institute of KU Leuven (Leuven, Belgium) for collecting and preserving the brain specimens, as well as Rebeca Alejandra Gavrila Laic and Paulien Vandemaele from the Biomechanics Section, Dept. of Mechanical Engineering of KU Leuven for the help in sectioning and obtaining the regional brain samples. The authors would also like to thank Dr. Kris Bogaerts, from the Leuven Biostatistics and statistical Bioinformatics Centre (Leuven, Belgium) for the help in the statistical analyses.	Amunts K, 2015, NEURON, V88, P1086, DOI 10.1016/j.neuron.2015.12.001; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bear M. F., 2016, J NEUROTRAUM, V33, P1, DOI [10.1089/neu.2015.4126, DOI 10.1089/NEU.2015.4126]; Budday S, 2020, ACTA BIOMATER, V104, P53, DOI 10.1016/j.actbio.2019.12.030; Budday S, 2017, J MECH BEHAV BIOMED, V74, P463, DOI 10.1016/j.jmbbm.2017.07.014; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; Chatelin S, 2012, J MECH BEHAV BIOMED, V6, P166, DOI 10.1016/j.jmbbm.2011.09.013; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Finan JD, 2014, BIOMECH MODEL MECHAN, V13, P573, DOI 10.1007/s10237-013-0519-7; Forte AE, 2017, BIOMECH MODEL MECHAN, V16, P907, DOI 10.1007/s10237-016-0860-8; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hosseini-Farid M, 2019, INT J NONLIN MECH, V116, P147, DOI 10.1016/j.ijnonlinmec.2019.06.008; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Johnson KL., 1985, CONTACT MECH, DOI [10.1017/CBO9781139171731, DOI 10.1017/CBO9781139171731]; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; [李仲平 Li Zhongping], 2020, [中国软科学, China Soft Science], P1; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; MacManus DB, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170894; MacManus DB, 2019, J MECH BEHAV BIOMED, V99, P240, DOI 10.1016/j.jmbbm.2019.07.028; MacManus DB, 2018, J MECH BEHAV BIOMED, V87, P256, DOI 10.1016/j.jmbbm.2018.07.025; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Mihai LA, 2017, J MECH PHYS SOLIDS, V106, P60, DOI 10.1016/j.jmps.2017.05.015; Montanino A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00643; Moran R, 2014, J BIOMECH, V47, P3762, DOI 10.1016/j.jbiomech.2014.09.030; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Pierrat B, 2018, J MECH BEHAV BIOMED, V78, P515, DOI 10.1016/j.jmbbm.2017.03.033; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prasad D, 2020, J MECH PHYS SOLIDS, V134, DOI 10.1016/j.jmps.2019.103752; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Puso MA, 1998, J BIOMECH ENG-T ASME, V120, P62, DOI 10.1115/1.2834308; Rajagopal K. R., 2020, AORTA, DOI [10.1055/s-0040-1715588., DOI 10.1055/S-0040-1715588]; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Samadi-Dooki A, 2018, J MECH BEHAV BIOMED, V77, P24, DOI 10.1016/j.jmbbm.2017.08.037; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Trexler MM, 2011, J MECH BEHAV BIOMED, V4, P1920, DOI 10.1016/j.jmbbm.2011.06.008; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; World Health Organization, 2018, AG HLTH; Yates K., 2016, P 14 INT LS DYNA US, P1; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005	68	3	3	7	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7225	1879-2197		INT J ENG SCI	Int. J. Eng. Sci.	OCT	2020	155								103355	10.1016/j.ijengsci.2020.103355			17	Engineering, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	NL7QD	WOS:000567604500003		Green Accepted, Green Published			2022-02-06	
J	Panwar, A; Jhun, M; Rentsendorj, A; Mardiros, A; Cordner, R; Birch, K; Yeager, N; Duvall, G; Golchian, D; Koronyo-Hamaoui, M; Cohen, RM; Ley, E; Black, KL; Wheeler, CJ				Panwar, Akanksha; Jhun, Michelle; Rentsendorj, Altan; Mardiros, Armen; Cordner, Ryan; Birch, Kurtis; Yeager, Nicole; Duvall, Gretchen; Golchian, David; Koronyo-Hamaoui, Maya; Cohen, Robert M.; Ley, Eric; Black, Keith L.; Wheeler, Christopher J.			Functional recreation of age-related CD8 T cells in young mice identifies drivers of aging- and human-specific tissue pathology	MECHANISMS OF AGEING AND DEVELOPMENT			English	Article						CD8 T cell; Resident memory T cell; Cellular immunity; Homeostatic expansion; Neurodegeneration; Immune aging	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; CLONAL EXPANSIONS; ALLELIC EXCLUSION; IMMUNE-SYSTEM; DIFFERENTIATION; REPERTOIRE; RECEPTOR; CD4(+)	Mitigating effects of aging on human health remains elusive because aging impacts multiple systems simultaneously, and because experimental animals exhibit critical aging differences relative to humans. Separation of aging into discrete processes may identify targetable drivers of pathology, particularly when applied to human-specific features. Gradual homeostatic expansion of CD8 T cells dominantly alters their function in aging humans but not in mice. Injecting T cells into athymic mice induces rapid homeostatic expansion, but its relevance to aging remains uncertain. We hypothesized that homeostatic expansion of T cells injected into T-deficient hosts models physiologically relevant CD8 T cell aging in young mice, and aimed to analyze age-related T cell phenotype and tissue pathology in such animals. Indeed, we found that such injection conferred uniform age-related phenotype, genotype, and function to mouse CD8 T cells, heightened age-associated tissue pathology in young athymic hosts, and humanized amyloidosis after brain injury in secondary wild-type recipients. This validates a model conferring a human-specific aging feature to mice that identifies targetable drivers of tissue pathology. Similar examination of independent aging features should promote systematic understanding of aging and identify additional targets to mitigate its effects on human health.	[Panwar, Akanksha; Jhun, Michelle; Rentsendorj, Altan; Mardiros, Armen; Cordner, Ryan; Birch, Kurtis; Yeager, Nicole; Duvall, Gretchen; Golchian, David; Koronyo-Hamaoui, Maya; Black, Keith L.; Wheeler, Christopher J.] Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Cordner, Ryan; Yeager, Nicole; Koronyo-Hamaoui, Maya] Dept Biomed Sci, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Cohen, Robert M.] Emory Univ, GDBBS, Dept Psychiat, 201 Dowman Dr, Atlanta, GA 30322 USA; [Cohen, Robert M.] Emory Univ, GDBBS, Behav Sci & Neurosci Program, 201 Dowman Dr, Atlanta, GA 30322 USA; [Ley, Eric] Dept Surg, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Wheeler, Christopher J.] Brain Mapping Fdn, Soc Brain Mapping & Therapeut, 860 Via Paz,Suite E-1, Pacific Palisades, CA 90272 USA; [Wheeler, Christopher J.] T Neuro Pharma, 1451 Innovat Pkwy SE,Suite 600, Albuquerque, NM 87123 USA; [Wheeler, Christopher J.] POB 781, Aptos, CA 95001 USA; [Mardiros, Armen; Ley, Eric] Kite Pharma, 2400 Broadway, Santa Monica, CA 90404 USA		Wheeler, CJ (corresponding author), POB 781, Aptos, CA 95001 USA.	Chris@TNeuroPharma.com	Koronyo-Hamaoui, Maya/AAG-2040-2021	Koronyo-Hamaoui, Maya/0000-0003-2864-8442; Black, Keith/0000-0002-0546-4934; Panwar, Akanksha/0000-0003-1537-9837	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS054162, R21AG033394]; Joseph Drown Foundation; Maxine Dunitz Neurosurgical Institute	This research was supported in part by NIH grants to RC and CW (R21NS054162 and R21AG033394, respectively), a grant from the Joseph Drown Foundation (CJW), and the Maxine Dunitz Neurosurgical Institute.	Ahmed M, 2009, J IMMUNOL, V182, P784, DOI 10.4049/jimmunol.182.2.784; Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; Armenta AM, 2019, DRUG AGING, V36, P235, DOI 10.1007/s40266-018-00633-w; Buchholz VR, 2011, CURR OPIN IMMUNOL, V23, P549, DOI 10.1016/j.coi.2011.05.002; Clambey ET, 2005, IMMUNOL REV, V205, P170, DOI 10.1111/j.0105-2896.2005.00265.x; Clamby ET, 2008, P NATL ACAD SCI USA, V105, P12997, DOI 10.1073/pnas.0805465105; Cupovic J, 2016, IMMUNITY, V44, P622, DOI 10.1016/j.immuni.2015.12.022; DATTA G, 2016, NEUROLOGY S16, V86; Degauque N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021240; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Duong H, 2013, J NEUROSCI METH, V220, P46, DOI 10.1016/j.jneumeth.2013.08.018; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; Gebhardt T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00340; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jurgens HA, 2012, EXP NEUROL, V233, P40, DOI 10.1016/j.expneurol.2010.11.014; LeMaoult J, 2000, J IMMUNOL, V165, P2367, DOI 10.4049/jimmunol.165.5.2367; Lourbopoulos A., 2015, FRONT CELL NEUROSCI, V9; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Messaoudi I, 2006, J IMMUNOL, V176, P301, DOI 10.4049/jimmunol.176.1.301; Messaoudi I, 2004, J EXP MED, V200, P1347, DOI 10.1084/jem.20040437; MORLEY JK, 1995, J IMMUNOL, V154, P6182; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Nikolich-Zugich J, 2012, SEMIN IMMUNOL, V24, P356, DOI 10.1016/j.smim.2012.04.009; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Onyema OO, 2012, BIOGERONTOLOGY, V13, P169, DOI 10.1007/s10522-011-9366-z; Pannese E, 2011, BRAIN STRUCT FUNCT, V216, P85, DOI 10.1007/s00429-011-0308-y; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Posnett DN, 2003, ANN NY ACAD SCI, V987, P274, DOI 10.1111/j.1749-6632.2003.tb06061.x; POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609; Puig KL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43725; Puig KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030378; Ramos GC, 2017, P NATL ACAD SCI USA, V114, pE2420, DOI 10.1073/pnas.1621047114; RHEINS LA, 1986, J INVEST DERMATOL, V86, P539, DOI 10.1111/1523-1747.ep12354989; Ricalton NS, 1998, J GERONTOL A-BIOL, V53, pB196, DOI 10.1093/gerona/53A.3.B196; Ritzel RM, 2016, J IMMUNOL, V196, P3318, DOI 10.4049/jimmunol.1502021; Rodriguez-Garcia M, 2018, AGING CELL, V17, DOI 10.1111/acel.12733; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schwab R, 1997, J IMMUNOL, V158, P4493; Smolders J, 2013, ACTA NEUROPATHOL, V126, P525, DOI 10.1007/s00401-013-1155-0; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Zlamy M, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0058-z	44	3	3	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0047-6374	1872-6216		MECH AGEING DEV	Mech. Ageing Dev.	OCT	2020	191								111351	10.1016/j.mad.2020.111351			11	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	OC9WT	WOS:000579507600020	32910956	hybrid, Green Accepted			2022-02-06	
J	Rasmussen, MS; Arango-Lasprilla, JC; Andelic, N; Nordenmark, TH; Soberg, HL				Rasmussen, Mari S.; Arango-Lasprilla, Juan Carlos; Andelic, Nada; Nordenmark, Tonje H.; Soberg, Helene L.			Mental Health and Family Functioning in Patients and Their Family Members after Traumatic Brain Injury: A Cross-Sectional Study	BRAIN SCIENCES			English	Article						traumatic brain injury; quality of life; family functioning; rehabilitation	QUALITY-OF-LIFE; POST-CONCUSSION SYMPTOMS; CAREGIVER BURDEN; HEAD-INJURY; INDIVIDUALS; OUTCOMES; TBI; SATISFACTION; RESILIENCE; PREDICTORS	Traumatic brain injury (TBI) affects the family as a whole. This study aimed to describe and compare mental health and family functioning in TBI patients and their family members, and to identify individual and family-related factors that were associated with mental health. It was conducted at an urban, specialized, TBI outpatient clinic and included 61 patients with mild to severe TBI and 63 family members. Baseline demographics and injury-related data were collected, and the participants answered standardized, self-reported questionnaires 6-18 months post-injury that assessed mental health; general health; family functioning, communication, and satisfaction; depression and anxiety; self-efficacy; resilience; and condition-specific quality of life. The patients reported significantly worse mental health, depression, resilience, self-efficacy, and general health compared with the family members. Patients and family members had similar perceptions, showing balanced family functioning, high family communication levels, and moderate family satisfaction. Factors significantly associated with mental health in patients and family members were depression, anxiety, and resilience, explaining 56% of the variance (p < 0.001). Family-related factors were not associated with mental health. The disease burden was mainly on the patients; however, the family members also reported emotional distress. Family-targeted interventions across the TBI continuum should be considered.	[Rasmussen, Mari S.; Andelic, Nada; Nordenmark, Tonje H.; Soberg, Helene L.] Oslo Univ Hosp, Dept Phys Med & Rehabil, PB 4950 Nydalen, N-0424 Oslo, Norway; [Rasmussen, Mari S.; Andelic, Nada] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, N-0318 Oslo, Norway; [Arango-Lasprilla, Juan Carlos] Biocruces Bizkaia Hlth Res Inst, Baracaldo 48903, Spain; [Arango-Lasprilla, Juan Carlos] Ikerbasque, Basque Fdn Sci, Bilbao 48009, Spain; [Arango-Lasprilla, Juan Carlos] Univ Basque Country, UPV EHU, Dept Cell Biol & Histol, Leioa 48940, Spain; [Nordenmark, Tonje H.] Univ Oslo, Dept Psychol, N-0317 Oslo, Norway; [Soberg, Helene L.] OsloMet Oslo Metropolitan Univ, Fac Hlth Sci, Dept Physiotherapy, N-0130 Oslo, Norway		Rasmussen, MS (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, PB 4950 Nydalen, N-0424 Oslo, Norway.; Rasmussen, MS (corresponding author), Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, N-0318 Oslo, Norway.	m.s.rasmussen@studmed.uio.no; jcalasprilla@gmail.com; nadand@ous-hf.no; tofoss@ous-hf.no; h.l.soberg@medisin.uio.no		Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311	DAM Foundation [2016/FO77196]	This work was supported by the DAM Foundation under Grant (2016/FO77196). The trial funders played no role in the study design, data collection, analysis or interpretation, manuscript writing, or decision to submit the article for publication.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Anderson MI, 2020, NEUROPSYCHOL REHABIL, V30, P1925, DOI 10.1080/09602011.2019.1620787; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Association for the Advancement of Automotive Medicine, ABBR INJ SCAL AIS 20; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bermejo-Toro L, 2020, BRAIN INJURY, V34, P480, DOI 10.1080/02699052.2020.1725127; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Friborg O, 2005, INT J METH PSYCH RES, V14, P29, DOI 10.1002/mpr.15; GARRATT AM, 2017, HEALTH QUAL LIFE OUT, V0015; Gulin SL, 2014, FAM SYST HEALTH, V32, P53, DOI 10.1037/a0032623; Hagen C, 1979, LEVELS COGNITIVE FUN; Hamilton E, 2016, FAM PROCESS, V55, P16, DOI 10.1111/famp.12200; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; JENNETT B, 1975, LANCET, V1, P480; Jones K, 2020, BRAIN IMPAIR, V21, P154, DOI 10.1017/BrImp.2019.27; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kreitzer N, 2018, ARCH PHYS MED REHAB, V99, P2342, DOI 10.1016/j.apmr.2018.04.016; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Lehan TJ, 2012, NEUROREHABILITATION, V30, P75, DOI 10.3233/NRE-2012-0729; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Norup A, 2017, NEUROPSYCHOL REHABIL, V27, P196, DOI 10.1080/09602011.2015.1076484; Norup A, 2013, AUST J REHABIL COUNS, V19, P71, DOI 10.1017/jrc.2013.12; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Perrin PB, 2013, PM&R, V5, P839, DOI 10.1016/j.pmrj.2013.05.018; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Quinn Christina, 2010, Appl Nurs Res, V23, pe15, DOI 10.1016/j.apnr.2008.10.001; Rasmussen M.S., 2019, COGENT MED, V6, DOI [10.1080/2331205X.2019.1607433, DOI 10.1080/2331205X.2019.1607433]; Reher DS, 1998, POPUL DEV REV, V24, P203, DOI 10.2307/2807972; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Sibley LM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-20; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Soberg HL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0589-9; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stevens LF, 2013, NEUROREHABILITATION, V33, P273, DOI 10.3233/NRE-130955; Stevens Lillian Flores, 2016, Top Spinal Cord Inj Rehabil, V22, P49, DOI 10.1310/sci2201-49; Stevens LF, 2012, NEUROREHABILITATION, V31, P443, DOI 10.3233/NRE-2012-00815; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Tsyben A, 2018, ACTA NEUROCHIR, V160, P107, DOI 10.1007/s00701-017-3334-6; Turner-Bowker, 2007, USERS MANUAL SF 36V2; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Vogler J, 2014, BRAIN INJURY, V28, P1381, DOI 10.3109/02699052.2014.919536; von Steinbuchel N, 2020, J NEUROTRAUM, V37, P1242, DOI 10.1089/neu.2019.6627; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287	68	3	3	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	OCT	2020	10	10							670	10.3390/brainsci10100670			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OJ7HQ	WOS:000584127900001	32992808	gold, Green Published			2022-02-06	
J	Sherer, M; Sander, AM; Ponsford, J; Vos, L; Poritz, JMP; Ngan, E; Novelo, LL				Sherer, Mark; Sander, Angelle M.; Ponsford, Jennie; Vos, Leia; Poritz, Julia M. P.; Ngan, Esther; Novelo, Luis Leon			Patterns of Cognitive Test Scores and Symptom Complaints in Persons with TBI Who Failed Performance Validity Testing	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Performance validity; Traumatic brain injury; Cognitive tests; Self-report questionnaires; Subgroups	TRAUMATIC BRAIN-INJURY; AMERICAN ACADEMY; POLICY	Objective: To determine clinically meaningful subgroups of persons with traumatic brain injury (TBI) who have failed performance validity testing. Method: Study participants were selected from a cohort of 674 participants with definitive medical evidence of TBI. Participants were those who failed performance validity testing (the Word Memory Test, using the standard cutoffs). Participants were administered cognitive tests and self-report questionnaires. Test and questionnaire results were summarized as 12 dimension scores. Cluster analysis using the k-means method was performed. Results: Cluster analysis for the 143 retained participants indicated three subgroups. These subgroups differed on patterns of scores. Subgroup 1 was impaired for memory and had no excessive complaints. Subgroup 2 had impaired memory and processing speed as well as concern regarding cognition function. Subgroup 3 showed impairment on all cognitive tests and excess complaints in multiple areas. Conclusions: These results provide a preliminary basis for improved understanding of poor performance validity.	[Sherer, Mark; Sander, Angelle M.] TIRR Mem Hermann, Houston, TX USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Ponsford, Jennie] Monash Univ, Monash Epworth Rehabil Res Ctr, Sch Psychol Sci, Turner Inst Brain & Mental Hlth,Epworth Healthcar, Melbourne, Vic, Australia; [Vos, Leia] Zablocki Milwaukee VA Med Ctr, Acute Mental Hlth, Neuropsychol, Milwaukee, WI USA; [Vos, Leia] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA; [Poritz, Julia M. P.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Ngan, Esther; Novelo, Luis Leon] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA		Sherer, M (corresponding author), TIRR Res Ctr, 1333 Moursund, Houston, TX 77030 USA.	Mark.Sherer@memorialhermann.org		Sherer, Mark/0000-0003-1784-7008	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant)United States Department of Health & Human Services [90DPTB0016]	This research was partially supported by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DPTB0016). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	[Anonymous], 2007, IEEE T ENERGY CONVER, V22, P197; [Anonymous], 1995, LA VENTANA, V10, P1; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Calinski TT., 1974, COMMUN STAT, V3, P1, DOI 10.1080/03610927408827101; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Cohen J., 2013, STAT POWER ANAL BEHA; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greher MR, 2017, J PSYCHIATR PRACT, V23, P134, DOI 10.1097/PRA.0000000000000218; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry GK, 2018, J INT NEUROPSYCH SOC, V24, P735, DOI 10.1017/S1355617718000218; Larrabee G.J., 2014, FORENSIC NEUROPSYCHO, P116; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Morin RT, 2017, CLIN NEUROPSYCHOL, V31, P1087, DOI 10.1080/13854046.2017.1341550; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A, 1958, EXAMIN CLIN PSYCHOL; Schmidt M., 1996, REY AUDITORY VERBAL; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, pE17, DOI 10.1097/HTR.0000000000000290; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tulsky DS, 2015, ARCH PHYS MED REHAB, V96, P604, DOI 10.1016/j.apmr.2014.02.030; Wechsler D., 2008, WECHSLER ADULT INTEL	31	3	3	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2020	26	9					932	938	PII S1355617720000351	10.1017/S1355617720000351			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	OB7LG	WOS:000578648000010	32456725	Green Accepted			2022-02-06	
J	Thompson, HJ; Rivara, F; Becker, KJ; Maier, R; Temkin, N				Thompson, Hilaire J.; Rivara, Frederick; Becker, Kyra J.; Maier, Ronald; Temkin, Nancy			Impact of aging on the immune response to traumatic brain injury (AIm:TBI) study protocol	INJURY PREVENTION			English	Article						brain injury; older adult; cohort study; disability; biomarkers; immune function	HEAD-INJURY; TNF-ALPHA; RELIABILITY; AGE; QUESTIONNAIRE; INDIVIDUALS; BIOMARKERS; GUIDELINES; SEVERITY; VALIDITY	Background Traumatic brain injury (TBI) in older adults leads to considerable morbidity and mortality. Outcomes among older adults with TBI are disparately worse than in younger adults. Differences in immunological response to injury may account for at least some of this disparity. Understanding how ageing differentially affects the immune response to TBI and how older age and these immunological changes affect the natural history of recovery following TBI are the goals of this study. Design/methods A prospective multiple cohort design is being used to assess the effects of ageing and TBI on immune makers and to test predictors of impairment and disability in older adults following mild TBI. Older adults (>55 years) with mild TBI are enrolled with three comparison groups: younger adults (21-54 years) with mild TBI, non-injured older adults (>55 years) and non-injured young adults (21-54 years). For the primary analysis, we will assess the association between immune markers and Glasgow Outcome Scale-Extended at 6 months, using logistic regression. Predictors of interest will be inflammatory biomarkers. Multivariate linear regression will be used to evaluate associations between biomarkers and other outcomes (symptoms, function and quality of life) at 3 and 6 months. Exploratory analyses will investigate the utility of biomarkers to predict outcome using receiver-operating characteristic curves. Discussion A better understanding of the recovery trajectory and biological rationale for disparate outcomes following TBI in older adults could allow for development of specific interventions aimed at reducing or eliminating symptoms. Such interventions could reduce impairment and healthcare costs.	[Thompson, Hilaire J.] Univ Washington, Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA; [Thompson, Hilaire J.; Rivara, Frederick; Maier, Ronald] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Rivara, Frederick] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Becker, Kyra J.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Becker, Kyra J.; Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Maier, Ronald] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA		Thompson, HJ (corresponding author), Univ Washington, Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA.	hilairet@uw.edu		Thompson, Hilaire/0000-0002-5472-478X	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077913]	This work was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS077913.	Agarwal S, 2010, ANN ALLERG ASTHMA IM, V104, P183, DOI 10.1016/j.anai.2009.11.009; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Brandt EN, 1997, ENABLING AM ASSESSIN; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Centers for Disease Control, 2001, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention, 2005, REC FRAM E COD GROUP; CoI S, 2008, ABBR INJ SCAL 2005 U; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diggle P., 2002, ANAL LONGITUDINAL DA; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Gosain A, 2005, J BURN CARE REHABIL, V26, P7, DOI 10.1097/01.BCR.0000150214.72984.44; Grossman KJ, 2011, BEHAV BRAIN RES, V217, P202, DOI 10.1016/j.bbr.2010.09.029; HAGIWARA E, 1995, CYTOKINE, V7, P815, DOI 10.1006/cyto.1995.0098; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Jacoby SF, 2006, J NURS SCHOLARSHIP, V38, P133, DOI 10.1111/j.1547-5069.2006.00090.x; Jurgens HA, 2012, EXP NEUROL, V233, P40, DOI 10.1016/j.expneurol.2010.11.014; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; MILLER J D, 1989, Neurosurgical Review, V12, P441; MITRUSHINA M, 1991, J CLIN PSYCHOL, V47, P790, DOI 10.1002/1097-4679(199111)47:6<790::AID-JCLP2270470610>3.0.CO;2-C; MITRUSHINA M, 1991, J CLIN PSYCHOL, V47, P351, DOI 10.1002/1097-4679(199105)47:3<351::AID-JCLP2270470305>3.0.CO;2-S; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pope AM, 1991, DISABILITY AM NATL A; Rue T, 2008, J NURS SCHOLARSHIP, V40, P373, DOI 10.1111/j.1547-5069.2008.00252.x; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; Thompson HJ, 2010, J NEUROTRAUM, V27; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; von Wild KRH, 2008, ACT NEUR S, V101, P55; Ware J., 2000, SCORE VERSION 2 SF 3; Ware JE, 1994, SF 36R PHYS MENTAL H; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	63	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	OCT	2020	26	5					471	477		10.1136/injuryprev-2019-043325			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	NY3IY	WOS:000576288900011	31481600	Green Accepted			2022-02-06	
J	Tunthanathip, T; Duangsuwan, J; Wattanakitrungroj, N; Tongman, S; Phuenpathom, N				Tunthanathip, Thara; Duangsuwan, Jarunee; Wattanakitrungroj, Niwan; Tongman, Sasiporn; Phuenpathom, Nakornchai			Clinical nomogram predicting intracranial injury in pediatric traumatic brain injury	JOURNAL OF PEDIATRIC NEUROSCIENCES			English	Article						Nomogram; pediatric traumatic brain injury; road traffic accident; traumatic brain injury	HEAD-INJURY; CHILDREN	Background: There are differences in injured mechanisms among pediatric traumatic brain injury (TBI) in developing countries. This study aimed to develop and validate clinical nomogram for predicting intracranial injury in pediatric TBI that will be implicated in balancing the unnecessary investigation in the general practice. Materials and Methods: The retrospective study was conducted in all patients who were younger than 15 years old and underwent computed tomography (CT) of the brain after TBI in southern Thailand. Injured mechanisms and clinical characteristics were identified and analyzed with binary logistic regression for predicting intracranial injury. Using random sampling without replacement, the total data was split into nomogram developing dataset (80%) and testing dataset (20%). Therefore, a nomogram was constructed and applied via the web-based application from the developing dataset. Using testing dataset, validation as binary classifiers was performed by various probabilities levels. Results: A total of 900 victims were enrolled. The mean age was 87.2 (standard deviation [SD] 57.4) months, and 65.3% of all patients injured were from road traffic accidents. The rate of positive findings in CT of the brain was 32.8%. A nomogram was developed from the significant variables, including age groups, road traffic accidents, loss of consciousness, scalp hematoma/laceration, motor weakness, signs of basilar skull fraction, low Glasgow Coma Scale score, and pupillary light reflex.Therefore, a nomogram was developed from 80% of data and was validated from 20% of data. The accuracy, sensitivity, specificity, positive, and negative predictive values of the nomogram were 0.83, 0.42, 1.00, 1.00, and 0.81 at a cutoff value of 0.5 probability. Conclusion: This study provides a clinical nomogram that will be applied to making decisions in general practice as a diagnostic tool from high specificity.	[Tunthanathip, Thara; Phuenpathom, Nakornchai] Prince Songkla Univ, Fac Med, Dept Surg, Div Neurosurg, Hat Yai 90110, Songkhla, Thailand; [Duangsuwan, Jarunee; Wattanakitrungroj, Niwan] Prince Songkla Univ, Fac Sci, Dept Comp Sci, Hat Yai, Thailand; [Tongman, Sasiporn] Thammasat Univ, Fac Sci & Technol, Dept Biotechnol, Rangsit Campus, Khlong Luang, Thailand		Tunthanathip, T (corresponding author), Prince Songkla Univ, Fac Med, Dept Surg, Div Neurosurg, Hat Yai 90110, Songkhla, Thailand.	tsus4@hotmail.com	Tongman, Sasiporn/ABF-4966-2021; Wattanakitrungroj, Niwan/T-4130-2019	Tongman, Sasiporn/0000-0001-9445-2179; Wattanakitrungroj, Niwan/0000-0003-4616-5970; Tunthanathip, Thara/0000-0002-6303-836X	Targeted Research Gants, Faculty of Medicine, Prince of Songkla University [62-065-10-1]	This study was funded by Targeted Research Gants, Faculty of Medicine, Prince of Songkla University (Grant no. 62-065-10-1).	Chang W, WEB APPL FRAMEWORK R; Chaudhuri K, 2009, INJURY, V40, P28, DOI 10.1016/j.injury.2008.09.004; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Devin CJ, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS18326; Dogan HS, 2015, J PEDIAT UROL, V11, p[84, e1], DOI DOI 10.1016/J.JPUR0L.2015.01.004; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Liang WH, 2015, J CLIN ONCOL, V33, P861, DOI 10.1200/JCO.2014.56.6661; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; Moghaddam MFT, 2020, GENE REP, V21, DOI 10.1016/j.genrep.2020.100771; Osifo OD, 2012, PREHOSP DISASTER MED, V27, P136, DOI 10.1017/S1049023X12000465; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Owlia M, 2014, AM J MED, V127, P406, DOI 10.1016/j.amjmed.2014.01.023; Panesar Sandip S, 2019, World Neurosurg X, V2, P100012, DOI 10.1016/j.wnsx.2019.100012; Parma C, 2014, AM SURGEON, V80, P664; Pontarelli EM, 2014, PEDIATR EMERG CARE, V30, P677, DOI 10.1097/PEC.0000000000000226; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Singal AG, 2013, AM J GASTROENTEROL, V108, P1723, DOI 10.1038/ajg.2013.332; Stevens RD, 2015, NEUROCRIT CARE, V23, pS76, DOI 10.1007/s12028-015-0168-z; SWETS JA, 1979, INVEST RADIOL, V14, P109, DOI 10.1097/00004424-197903000-00002; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; Tunthanathip Thara, 2019, Bull Emerg Trauma, V7, P347, DOI 10.29252/beat-070402; Tunthanathip T, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19382; Tunthanathip T, 2017, J NEUROSCI RURAL PRA, V8, P601, DOI 10.4103/jnrp.jnrp_381_17; Wong NC, 2019, BJU INT, V123, P51, DOI 10.1111/bju.14477; World Health Organization, GLOB STAT REP ROAD S	28	3	3	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1817-1745	1998-3948		J PEDIATR NEUROSCI	J. Pediatr. Neurosci.	OCT-DEC	2020	15	4					409	415		10.4103/JPN.JPN_11_20			7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	QA4LS	WOS:000613417100011	33936306	Green Published			2022-02-06	
J	Xue, YH; Li, ZK; Wang, Y; Zhu, XD; Hu, RX; Xu, W				Xue, Yonghua; Li, Zhikun; Wang, Yi; Zhu, Xiaodong; Hu, Ruixi; Xu, Wei			Role of the HIF-1 alpha/SDF-1/CXCR4 signaling axis in accelerated fracture healing after craniocerebral injury	MOLECULAR MEDICINE REPORTS			English	Article						craniocerebral injury; mesenchymal stem cells; HIF-1 alpha; stromal cell-derived factor 1; C-X-C chemokine receptor type 4 axis	MESENCHYMAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; BONE-MARROW; SDF-1-ALPHA; HIF-1-ALPHA; PROMOTES; DIFFERENTIATION; OSSIFICATION; EXPRESSION; MIGRATION	The hypoxic state of the brain tissue surrounding craniocerebral injury induces an increase in the secretion of HIF-1 alpha during the healing process. HIF-1 alpha can promote mesenchymal stem cell (MSC) migration to ischemic and hypoxic sites by regulating the expression levels of molecules such as stromal cell-derived factor-1 (SDF-1) in the microenvironment. Stem cells express the SDF-1 receptor C-X-C chemokine receptor type 4 (CXCR4) and serve a key role in tissue repair, as well as a number of physiological and pathological processes. The present study aimed to determine the role of HIF-1 alpha /SDF-1/CXCR4 signaling in the process of accelerated fracture healing during craniocerebral injury. Cultured MSCs underwent HIF-1 alpha knockdown to elucidate its effect on the proliferative ability of MSCs, and the effect of SDF-1 in MSCs was investigated. It was also determined whether HIF-1 alpha could promote osteogenesis via SDF-1/CXCR4 signaling and recruit MSCs. The results indicated that HIF-1 alpha knockdown suppressed MSC proliferation in vitro, and SDF-1 promoted cell migration via binding to CXCR4. Furthermore, HIF-1 alpha knockdown inhibited MSC migration via SDF-1/CXCR4 signaling. Considering the wide distribution and diversity of roles of SDF-1 and CXCR4, the present results may form a basis for the development of novel strategies for the treatment of craniocerebral injury.	[Xue, Yonghua] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Neurosurg, Shanghai 200062, Peoples R China; [Li, Zhikun; Wang, Yi; Zhu, Xiaodong; Hu, Ruixi; Xu, Wei] Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, Dept Orthoped Surg, 1111 Xianxia Rd, Shanghai 200331, Peoples R China		Xu, W (corresponding author), Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, Dept Orthoped Surg, 1111 Xianxia Rd, Shanghai 200331, Peoples R China.	xw2107@shtrhospital.com			Shanghai Excellent Young Medical Talents Training Program [2018YQ46]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501897]; Shanghai Municipal Commission of Health and Family Planning of Science and Research Fund [20154Y0070]; K.C. Wong Education Foundation	The present study was supported by the Shanghai Excellent Young Medical Talents Training Program (grant no. 2018YQ46), the National Natural Science Foundation of China (grant no. 81501897), the Shanghai Municipal Commission of Health and Family Planning of Science and Research Fund (grant no. 20154Y0070) and K.C. Wong Education Foundation.	Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Hankenson KD, 2014, INJURY, V45, pS8, DOI 10.1016/j.injury.2014.04.003; Hara Y, 2017, J NIPPON MED SCH, V84, P12, DOI 10.1272/jnms.84.12; Huang H, 2018, J ORTHOP TRANSL, V12, P16, DOI 10.1016/j.jot.2017.10.002; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Merino JJ, 2011, INT J STROKE, V6, P466, DOI 10.1111/j.1747-4949.2011.00651.x; Johnson RW, 2015, PHARMACOL THERAPEUT, V150, P169, DOI 10.1016/j.pharmthera.2015.02.002; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Kim A, 2018, INT J ONCOL, V53, P1160, DOI 10.3892/ijo.2018.4479; Knerlich-Lukoschus F, 2011, J NEUROSURG-SPINE, V14, P583, DOI 10.3171/2010.12.SPINE10480; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Kristocheck M, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1520-9; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Lampert FM, 2016, J CELL BIOCHEM, V117, P760, DOI 10.1002/jcb.25361; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Liu SH, 2019, BIOMATER SCI-UK, V7, P362, DOI 10.1039/c8bm00846a; Liu XG, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00087; Liu XQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054077, 10.1371/journal.pone.0077367, 10.1371/journal.pone.0058489]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo YQ, 2005, J NEUROCHEM, V93, P452, DOI 10.1111/j.1471-4159.2005.03049.x; Maes C, 2017, SEMIN CELL DEV BIOL, V62, P16, DOI 10.1016/j.semcdb.2016.05.007; Manzano-Moreno FJ, 2015, J CRANIO MAXILL SURG, V43, P1926, DOI 10.1016/j.jcms.2015.08.026; Periyasamy-Thandavan S, 2019, J GERONTOL A-BIOL, V74, P1368, DOI 10.1093/gerona/gly186; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Quarles LD, 2019, CURR OPIN NEPHROL HY, V28, P16, DOI 10.1097/MNH.0000000000000467; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Seemann R, 2018, J MUSCULOSKEL NEURON, V18, P32; Sun J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26683; Sun XJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-17; Tirpe AA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246140; van Baardewijk LJ, 2013, INT ORTHOP, V37, P523, DOI 10.1007/s00264-012-1750-z; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wang T, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3516463; Wen J, 2012, AM J CARDIOVASC DIS, V2, P20; Yu Q, 2015, CELL J, V16, P440; Yuan GX, 2013, P NATL ACAD SCI USA, V110, pE1788, DOI 10.1073/pnas.1305961110; Zhou NA, 2015, CELL PHYSIOL BIOCHEM, V36, P44, DOI 10.1159/000374052	39	3	3	2	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2020	22	4					2767	2774		10.3892/mmr.2020.11361			8	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	NW4US	WOS:000575004300018	32945380	Green Published, hybrid			2022-02-06	
J	Buckley, NA; Baskaya, MK; Darsie, ME				Buckley, Niall A.; Baskaya, Mustafa K.; Darsie, Marin E.			Intravenous Immunoglobulin (IVIG) in Severe Heparin-Induced Thrombocytopenia (HIT) in a Traumatic Brain Injury (TBI) Patient with Cerebral Venous Sinus Thrombosis (CVST)	NEUROCRITICAL CARE			English	Article							RISK		[Buckley, Niall A.; Baskaya, Mustafa K.; Darsie, Marin E.] Univ Wisconsin Hosp & Clin, Dept Neurol Surg, 600 Highland Ave, Madison, WI 53792 USA; [Darsie, Marin E.] Univ Wisconsin Hosp & Clin, Dept Emergency Med, 600 Highland Ave, Madison, WI 53792 USA		Buckley, NA (corresponding author), Univ Wisconsin Hosp & Clin, Dept Neurol Surg, 600 Highland Ave, Madison, WI 53792 USA.	niall.a.buckley@gmail.com					Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Ammann EM, 2016, AM J HEMATOL, V91, P594, DOI 10.1002/ajh.24358; Arepally GM, 2010, ANNU REV MED, V61, P77, DOI 10.1146/annurev.med.042808.171814; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Filippidis A, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09167; Irani M, 2019, TRANSFUSION, V59, P931, DOI 10.1111/trf.15105; Joppa SA, 2018, J CLIN MED, V7, DOI 10.3390/jcm7020029; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Lee CJ, 2011, BRIT J CLIN PHARMACO, V72, P581, DOI 10.1111/j.1365-2125.2011.03916.x; Martel N, 2005, BLOOD, V106, P2710, DOI 10.1182/blood-2005-04-1546; Mohanty E, 2019, J THROMB HAEMOST, V17, P841, DOI 10.1111/jth.14411; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ning SY, 2017, CHEST, V152, P453, DOI 10.1016/j.chest.2017.05.042; Park BD, 2018, TRANSFUS APHER SCI, V57, P561, DOI 10.1016/j.transci.2018.06.007; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Smythe MA, 2007, CHEST, V131, P1644, DOI 10.1378/chest.06-2109; Thomas S, 2018, CLIN MED, V18, P314, DOI 10.7861/clinmedicine.18-4-314; Warkentin TE, 2002, CAN J ANAESTH, V49, pS11	18	3	3	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2021	34	3					1103	1107		10.1007/s12028-020-01101-3		SEP 2020	5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN4OZ	WOS:000574076000002	33000379				2022-02-06	
J	Haider, MN; Johnson, BD; Horn, EC; Leddy, JJ; Wilber, CG; Reed, EL; O'Leary, M; Bloomfield, A; Decezaro, LL; Willer, BS				Haider, Mohammad Nadir; Johnson, Blair D.; Horn, Emily C.; Leddy, John J.; Wilber, Charles G.; Reed, Emma L.; O'Leary, Morgan; Bloomfield, Adam; Decezaro, Larissa L.; Willer, Barry S.			Blunted Cardiac Parasympathetic Activation in Student Athletes With a Remote History of Concussion: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						concussion; autonomic nervous system; sport; heart rate vaiability; face cooling	HEART-RATE-VARIABILITY; CEREBRAL-BLOOD-FLOW; POSTCONCUSSION SYNDROME; EXERCISE TREATMENT	Introduction:Blunted cardiac autonomic nervous system (ANS) responses, quantified using heart rate variability (HRV), have been reported after sport-related concussion (SRC). Research suggests this persists beyond clinical recovery. This study compared cardiac parasympathetic responses in student athletes with a remote history of SRC (> 1-year ago, Concussion History: CH) with those who reported no lifetime history of SRC (Concussion Naive: CN). Design:Retrospective nested case-control. Setting:University laboratory. Patients or Other Participants:CH (n= 9, 18.3 +/- 2 years, 44% male, median 2 years since injury) were student athletes with a remote history of concussion(s) from more than 1 year ago. CN (n= 21, 16.7 +/- 3 years, 67% male) were student athletes with no lifetime history of concussion. Exclusion criteria included taking medications that could affect ANS function, history of concussion within the past year, persistent concussion symptoms, lifetime history of moderate to severe brain injury, and lifetime history of more than 3 concussions. Material and Methods:Participants performed the Face Cooling (FC) test for 3-min after 10-min of supine rest while wearing a 3-lead electrocardiogram in a controlled environment. Outcome Measures:Heart rate (HR), R-R interval (RRI), root mean square of the successive differences (RMSSD) of RRI, high frequency (HF) and low frequency to HF (LF:HF) ratios. Results:At baseline, CH had a lower resting HR than CN (62.3 +/- 11 bpm vs. 72.9 +/- 12,p= 0.034). CH had a different HR response to FC than CN (+8.9% change from baseline in CH vs. -7.5% in CN,p= 0.010). CH also had a smaller RMSSD increase to FC than CN (+31.8% change from baseline in CH vs. +121.8% in CN,p= 0.048). There were no significant group differences over time in RRI (p= 0.106), HF (p= 0.550) or LF:HF ratio (p= 0.053). Conclusion:Asymptomatic student athletes with a remote history of concussion had a blunted cardiac parasympathetic response to FC when compared with athletes with no lifetime history of concussion. These data suggest that an impaired autonomic response to a physiological stressor persists after clinical recovery from SRC for longer than previously reported.	[Haider, Mohammad Nadir; Horn, Emily C.; Leddy, John J.; Wilber, Charles G.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Dept Orthopaed & Sports Med, Buffalo, NY USA; [Haider, Mohammad Nadir] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurosci, Buffalo, NY USA; [Haider, Mohammad Nadir] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Biostat, Buffalo, NY USA; [Johnson, Blair D.; Reed, Emma L.; O'Leary, Morgan; Bloomfield, Adam] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Exercise & Nutr Sci, Buffalo, NY 14214 USA; [Decezaro, Larissa L.] Fac Med Jundiai FMJ, Jundiai Med Sch, Jundiai, Brazil; [Willer, Barry S.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Johnson, BD (corresponding author), SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Exercise & Nutr Sci, Buffalo, NY 14214 USA.	bj33@indiana.edu		DECEZARO, LARISSA/0000-0002-8439-6852; Johnson, Blair/0000-0002-1731-4415	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number 1R01NS094444 and by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Acharya U Rajendra, 2007, ADV CARDIAC SIGNAL P; Bazarian JJ, 2010, J HEAD TRAUMA REHAB, V25, P225, DOI 10.1097/HTR.0b013e3181e7f784; Beakey M, 2020, CLIN J SPORT MED, V30, pS75, DOI 10.1097/JSM.0000000000000597; Bernard C, 2017, BRAIN INJURY, V31, P1414, DOI 10.1080/02699052.2017.1350999; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Fatisson J, 2016, HEART INT, V11, pE32, DOI 10.5301/heartint.5000232; Fisher JP, 2015, AM J PHYSIOL-HEART C, V308, pH367, DOI 10.1152/ajpheart.00728.2014; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Godek D, 2019, PHYSL DIVING REFLEX; Haider M, 2019, NEUROLOGY, V93, pS8, DOI 10.1212/01.wnl.0000580900.09715.8d; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hinds A, 2016, J NEUROL NEUROPHYSIO, V7, P388, DOI DOI 10.4172/2155-9562.1000388; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Johnson BD, 2020, J ATHL TRAINING, V55, P124, DOI 10.4085/1062-6050-573-18; Johnson BD, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13694; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Liao KH, 2016, PSYCHIAT RES, V243, P349, DOI 10.1016/j.psychres.2016.07.001; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MARTIN CE, 1974, J CLIN INVEST, V54, P104, DOI 10.1172/JCI107731; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKeag DB, 2009, CLIN J SPORT MED, V19, P343, DOI 10.1097/JSM.0b013e3181b2c114; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Polak P, 2015, J HEAD TRAUMA REHAB, V30, pE32, DOI 10.1097/HTR.0000000000000037; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Stillman A, 2016, NEUROLOGY, V86; Sztajzel J, 2004, SWISS MED WKLY, V134, P514; Truong JQ, 2016, BRAIN INJURY, V30, P1378, DOI 10.1080/02699052.2016.1195922; Zhang J, 2007, J MANIP PHYSIOL THER, V30, P374, DOI 10.1016/j.jmpt.2007.04.001	35	3	3	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 30	2020	11								547126	10.3389/fneur.2020.547126			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OC1NC	WOS:000578928200001	33101172	Green Published, gold			2022-02-06	
J	Reilly, N; Prebor, J; Moxey, J; Schussler, E				Reilly, Nicholas; Prebor, Jessica; Moxey, Jacquelyn; Schussler, Eric			Chronic impairments of static postural stability associated with history of concussion	EXPERIMENTAL BRAIN RESEARCH			English	Article						Concussion; Concussion history; Postural stability; Center-of-pressure; Dual-task	DUAL-TASK GAIT; LONG-TERM CONSEQUENCES; TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; CEREBRAL CONCUSSION; ATTENTIONAL DEMANDS; COGNITIVE TASK; BALANCE; FALLS; TIME	Postural stability deficits are commonly observed in cases of concussion. However, the objective duration in which impairments of standing postural stability remain following a concussion is often inconclusive. The present study was conducted to determine if prior history of concussion is associated with deficits in postural stability beyond the clinical determination of recovery. It was hypothesized that concussion history would be associated with decreases in static stability compared to individuals that have never sustained a concussion. Fifty-four healthy adults were recruited based on whether they reported sustaining one or more prior concussions (n = 27) or no history of concussion (n = 27). Participants were instructed to stand on a force platform to track center-of-pressure (CoP) during standing for thirty seconds under four conditions based on stance and number of tasks: (1) bipedal, single-task, (2) bipedal, dual-task, (3) unipedal, single-task, and (4) unipedal, dual-task. Results revealed that individuals with a history of concussion demonstrate significantly reduced postural stability under dual-task conditions as evidenced by increases in average displacements and elliptical area of postural sway as well as reductions in CoP sample entropy. However, there were no significant differences in CoP displacement or elliptical area between groups under single task conditions. Overall, these findings indicate that concussion is associated with impairments of maintaining standing postural stability that remain evident approximately 7 years following clinical resolution of the initial injury. The exacerbation of these impairments under dual-task conditions indicate that concussion can result in a reduced capacity to allocate proper attention resources to multiple concurrent objectives.	[Reilly, Nicholas; Prebor, Jessica; Moxey, Jacquelyn; Schussler, Eric] Old Dominion Univ, Sch Rehabil Sci, 4211 Monarch Way,Suite 275, Norfolk, VA 23529 USA		Reilly, N (corresponding author), Old Dominion Univ, Sch Rehabil Sci, 4211 Monarch Way,Suite 275, Norfolk, VA 23529 USA.	nreil001@odu.edu		Schussler, Eric/0000-0002-0101-0986; Reilly, Nicholas/0000-0001-6052-324X			Allum JHJ, 2001, GAIT POSTURE, V14, P227, DOI 10.1016/S0966-6362(01)00132-1; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; [Anonymous], 1995, GAIT POSTURE; Beretta VS, 2018, MOTOR CONTROL, V22, P449, DOI 10.1123/mc.2017-0033; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Blaszczyk JW, 2007, EXP BRAIN RES, V183, P107, DOI 10.1007/s00221-007-1024-y; Blaszczyk JW, 2011, HUM MOVEMENT SCI, V30, P396, DOI 10.1016/j.humov.2010.07.017; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2010, MED SCI SPORT EXER, V42, P492, DOI 10.1249/01.MSS.0000385107.79185.43; Busa MA, 2016, J SPORT HEALTH SCI, V5, P44, DOI 10.1016/j.jshs.2016.01.018; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Cavanaugh J, 2004, THESIS; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen YJ, 2017, J NEUROIMAGING, V27, P272, DOI 10.1111/jon.12404; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davceva N, 2017, J FORENSIC LEG MED, V48, P35, DOI 10.1016/j.jflm.2017.04.004; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Eagle SR, 2021, CLIN J SPORT MED, V31, P273, DOI 10.1097/JSM.0000000000000731; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ferguson B, 2014, J CAN CHIROPR ASS, V58, P328; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Hugentobler JA, 2016, CLIN J SPORT MED, V26, P510, DOI 10.1097/JSM.0000000000000286; Hurtubise Johanna, 2016, Concussion, V1, pCNC17, DOI 10.2217/cnc-2016-0006; Jacobson GP, 2011, EAR HEARING, V32, pE1, DOI 10.1097/AUD.0b013e31822802bb; Kalron A, 2013, J NEUROL SCI, V335, P186, DOI 10.1016/j.jns.2013.09.029; Ko JH, 2016, NEUROSCI LETT, V610, P104, DOI 10.1016/j.neulet.2015.10.069; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lynall RC, 2018, ARCH PHYS MED REHAB, V99, P880, DOI 10.1016/j.apmr.2017.12.011; Matinolli M, 2007, MOVEMENT DISORD, V22, P1927, DOI 10.1002/mds.21633; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; Merritt ED, 2017, J SPORT REHABIL, V26, P518, DOI 10.1123/jsr.2016-0119; Moran RN, 2020, BRAIN INJURY, V34, P20, DOI 10.1080/02699052.2019.1669824; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Murray NG, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aafcd8; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Nashner LM, 1989, PROG BRAIN RES, V80, P395; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Purkayastha S, 2019, PM&R, V11, P1184, DOI 10.1002/pmrj.12129; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roerdink M, 2011, HUM MOVEMENT SCI, V30, P203, DOI 10.1016/j.humov.2010.04.005; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Takakusaki K, 2017, ADV ROBOTICS, V31, P2, DOI 10.1080/01691864.2016.1252690; Vuillerme N, 2000, NEUROSCI LETT, V291, P77, DOI 10.1016/S0304-3940(00)01374-4; Westwood C, 2020, J SPORT REHABIL, V29, P131, DOI 10.1123/jsr.2018-0358; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Young CC, 1997, CLIN J SPORT MED, V7, P196, DOI 10.1097/00042752-199707000-00008	73	3	3	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	DEC	2020	238	12					2783	2793		10.1007/s00221-020-05934-4		SEP 2020	11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ON7HM	WOS:000574132200001	33000293				2022-02-06	
J	Amitay, N; Zlotnik, Y; Coreanu, T; Zeller, L; Abu-Salameh, I; Novack, V; Ifergane, G				Amitay, Nadav; Zlotnik, Yair; Coreanu, Tara; Zeller, Lior; Abu-Salameh, Ibrahim; Novack, Victor; Ifergane, Gal			Soccer heading and subclinical neuropsychiatric symptomatology in professional soccer players	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CONCUSSION SYMPTOMS QUESTIONNAIRE; INVENTORY; ENCEPHALOPATHY; PERFORMANCE; VALIDATION; AVOIDANCE; EXPOSURE; ANXIETY; IMPACT	Objectives To evaluate the association between postconcussive symptomatology and heading in professional soccer players, overcoming the bias of self-reported exposure, we evaluated several clinical neuropsychiatric symptoms using questionnaires after a thorough objective follow-up of players' heading exposure throughout an entire season. Methods We collected heading data for all Israeli Premier League players for an entire season using a web-based platform for performance analysis, which enabled us to quantify the exact number of headers per player. Players filled out questionnaires regarding postconcussion symptoms, depression, anxiety, and sleep disorders. We tested the association between the number of headers and each outcome using a negative binomial regression corrected for the hours played. Results A total of 159 players were included, of whom 79 were considered in the high heading exposure group (49%), defined as more than median number of headings (1.34 per game hour). Among players without any past head injury, those with higher heading exposure were less likely to have postconcussion symptoms compared with players with low heading exposure (relative risk [RR] per heading per hour 0.94, 95% confidence interval [CI] 0.912-0.963). Players with high heading exposure had fewer depression symptoms (RR 0.98, 95% CI 0.961-0.997), anxiety (RR 0.98, 95% CI 0.958-0.997), and sleep disorders (RR 0.98, 95% CI 0.961-0.996). Conclusion Professional soccer players with high heading rate do not display higher postconcussive symptomatology severity. Symptoms among players with low heading exposure might be explained by low resilience, possibly associated with an inferior heading technique. Alternatively, it can reflect heading-avoidant behavior.	[Amitay, Nadav; Zlotnik, Yair; Abu-Salameh, Ibrahim; Ifergane, Gal] Soroka Univ, Med Ctr, Dept Neurol, Beer Sheva, Israel; [Coreanu, Tara; Novack, Victor] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel; [Zeller, Lior] Soroka Univ, Med Ctr, Dept Internal Med, Beer Sheva, Israel		Amitay, N (corresponding author), Soroka Univ, Med Ctr, Dept Neurol, Beer Sheva, Israel.	Naduv22@gmail.com					Agot K, 2015, AIDS BEHAV, V19, P743, DOI 10.1007/s10461-014-0859-z; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; de Guise E, 2016, APPL NEUROPSYCH-ADUL, V23, P213, DOI 10.1080/23279095.2015.1038747; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Kartal A, 2004, EUR SPINE J, V13, P76, DOI 10.1007/s00586-003-0623-y; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Leyfer OT, 2006, J ANXIETY DISORD, V20, P444, DOI 10.1016/j.janxdis.2005.05.004; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Natale V, 2014, PSYCHIAT CLIN NEUROS, V68, P568, DOI 10.1111/pcn.12161; Ozoh OB, 2014, J PUBLIC HEALTH AFR, V5, P47, DOI 10.4081/jphia.2014.316; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rutherford A, 2009, J CLIN EXP NEUROPSYC, V31, P664, DOI 10.1080/13803390802484755; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Seijo M, 2018, ACTA OBSTET GYN SCAN, V97, P429, DOI 10.1111/aogs.13326; Silverberg ND, 2019, J NEUROTRAUM, V36, P1544, DOI 10.1089/neu.2018.6025; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Stalnacke BM, 2008, BIOMARK INSIGHTS, V3, P87; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Veale D, 2014, J SEX MED, V11, P84, DOI 10.1111/jsm.12294; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Zhang MR, 2013, PLOS ONE, V8, P8	46	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 29	2020	95	13					E1776	E1783		10.1212/WNL.0000000000010244			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NX9JO	WOS:000576018200013	32651295				2022-02-06	
J	Chen, X; Qiu, N; Chen, C; Wang, DX; Zhang, GD; Zhai, L				Chen, Xin; Qiu, Nan; Chen, Chao; Wang, Dexin; Zhang, Guodong; Zhai, Liang			Self-Efficacy and Depression in Boxers: A Mediation Model	FRONTIERS IN PSYCHIATRY			English	Article						self-efficacy; self-control; depression; mediating effect; boxers	SOCIAL COGNITIVE THEORY; PEER VICTIMIZATION; HEALTH-PROMOTION; SPORT PSYCHOLOGY; CONTROL BEHAVIOR; MENTAL-HEALTH; SYMPTOMS; PERFORMANCE; PREVALENCE; CONCUSSION	Background Depression has become one of the most common problems faced by athletes. In many mental health problems, its production and development mechanisms and influencing factors have received full attention from researchers, whereas boxers' depression has received limited attention. This study explored the relationship between boxers' self-efficacy and depression, as well as the effect of self-control as a mediating factor. Methods This study used the athlete self-efficacy scale (ASES), the self-control scale (SCS), and the Center for Epidemiologic Studies depression scale (CES-D). Using a large number of randomly selected samples, a total ofN=231 boxers (age:M=20.28,SD= 2.60, ages around 18 to 32; the total number of years of exercise:M= 6.07 years,SD= 2.90, years around 1 to 15; 144 male) of Chinese national athletes participated the study. Results Self-efficacy and self-control were negatively correlated with depression; self-efficacy was positively correlated with self-control. In addition, self-control played a partial mediation role between self-efficacy and depression among boxers. Conclusion Above all, an important way to improve and prevent the depression of Chinese boxers maybe enhance their level of self-efficacy and self-control.	[Chen, Xin] Tech Univ Munich, Dept Sport & Hlth Sci, Munich, Germany; [Qiu, Nan] Ludwig Maximilians Univ Munchen, Dept Psychol, Gen & Expt Psychol, Munich, Germany; [Chen, Chao; Wang, Dexin] Shanghai Univ Sport, Shanghai, Peoples R China; [Zhang, Guodong] Southwest Univ, Coll Phys Educ, Inst Sport Sci, Chongqing, Peoples R China; [Zhai, Liang] Sichuan Agr Univ, Coll Phys Educ, Yaan, Peoples R China		Chen, X (corresponding author), Tech Univ Munich, Dept Sport & Hlth Sci, Munich, Germany.; Zhang, GD (corresponding author), Southwest Univ, Coll Phys Educ, Inst Sport Sci, Chongqing, Peoples R China.	cx18996401842@163.com; lygd777@swu.edu.cn	zhang, guodong/G-2634-2011		China Scholarship CouncilChina Scholarship Council [202008080341]	This work was partly supported by the China Scholarship Council (No. 202008080341).	ALLOY LB, 1992, J ABNORM PSYCHOL, V101, P234, DOI 10.1037/0021-843X.101.2.234; Arenella K, 2020, INT PSYCHOGERIATR, V32, P229, DOI 10.1017/S1041610219000565; Bandura A, 1996, CHILD DEV, V67, P1206, DOI 10.2307/1131888; Bandura A, 2006, STAUFFER SYMP APPL P, P53; Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bandura A, 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI; Bandura A., 1994, SELF EFFICACY, P71; Bandura A, 2012, J MANAGE, V38, P9, DOI 10.1177/0149206311410606; Barchia K, 2010, J ADOLESCENCE, V33, P615, DOI 10.1016/j.adolescence.2009.12.002; Beable S, 2017, J SCI MED SPORT, V20, P1047, DOI 10.1016/j.jsams.2017.04.018; Blackburn L, 2015, J CLIN PSYCHOL, V71, P219, DOI 10.1002/jclp.22133; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Bradley DE, 2004, J SMALL BUS MANAGE, V42, P37, DOI 10.1111/j.1540-627X.2004.00096.x; Byl M, 2017, J COUNS PSYCHOL, V1, P2; Caprara GV, 2012, J PERS SOC PSYCHOL, V102, P1289, DOI 10.1037/a0025626; Carver CS, 2008, PSYCHOL BULL, V134, P912, DOI 10.1037/a0013740; Cataldo MG, 2005, PSYCHIAT RES, V136, P123, DOI 10.1016/j.psychres.2004.12.012; Chang CW, 2018, CHILD YOUTH SERV REV, V88, P128, DOI 10.1016/j.childyouth.2018.03.001; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen X, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00212; DeWall CN, 2012, PERS INDIV DIFFER, V53, P832, DOI 10.1016/j.paid.2012.05.025; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; DOHERTY S, 2016, FRONT PSYCHOL, V0007, DOI DOI 10.3389/fpsyg.2016.01609; Ein-Gar D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01788; Ein-Gar D, 2015, J CONSUM PSYCHOL, V25, P268, DOI 10.1016/j.jcps.2014.08.006; Englert C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00314; Francis SE, 2012, PSYCHOTHER RES, V22, P220, DOI 10.1080/10503307.2011.637990; FUCHS CZ, 1977, J CONSULT CLIN PSYCH, V45, P206, DOI 10.1037/0022-006X.45.2.206; Galatzer-Levy IR, 2014, PSYCHOL SCI, V25, P2177, DOI 10.1177/0956797614551750; GERBING DW, 1988, J MARKETING RES, V25, P186, DOI 10.2307/3172650; Gouttebarge V, 2015, J SPORT SCI MED, V14, P811; Gulliver A, 2015, J SCI MED SPORT, V18, P255, DOI 10.1016/j.jsams.2014.04.006; Hall CJ, 2001, BRIT J SPORT MED, V35, P390, DOI 10.1136/bjsm.35.6.390; Hammond T, 2013, CLIN J SPORT MED, V23, P273, DOI 10.1097/JSM.0b013e318287b870; Herrman H, 2019, LANCET, V393, pE42, DOI 10.1016/S0140-6736(18)32408-5; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jun MH, 2013, CHILD YOUTH SERV REV, V35, P1327, DOI 10.1016/j.childyouth.2013.05.004; KASLOW NJ, 1988, J ABNORM CHILD PSYCH, V16, P163, DOI 10.1007/BF00913592; Kendler KS, 1998, PHARMACOPSYCHIATRY, V31, P5, DOI 10.1055/s-2007-979287; Khan ZH, 2008, J BELIEFS VALUES, V29, P213, DOI 10.1080/13617670802289734; Kontos AP, 2004, J APPL SPORT PSYCHOL, V16, P220, DOI 10.1080/10413200490485568; Lebrun F, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02062; Lee B, 2019, J HEAD TRAUMA REHAB, V34, pE29, DOI 10.1097/HTR.0000000000000495; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Liu CL, 2019, PSYCHOL RES BEHAV MA, V12, P195, DOI 10.2147/PRBM.S195131; [刘文俐 Liu Wenli], 2016, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V24, P841; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Milanovic M, 2018, J NERV MENT DIS, V206, P350, DOI 10.1097/NMD.0000000000000804; Moritz SE, 2000, RES Q EXERCISE SPORT, V71, P280, DOI 10.1080/02701367.2000.10608908; Nixdorf I, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00893; Orth U, 2016, J PERS SOC PSYCHOL, V110, P133, DOI 10.1037/pspp0000038; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Przepiorka A, 2019, CHRONOBIOL INT, V36, P1025, DOI 10.1080/07420528.2019.1607370; Pu J, 2017, CURR PSYCHOL, V36, P410, DOI 10.1007/s12144-016-9429-z; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reardon CL, 2010, SPORTS MED, V40, P961, DOI 10.2165/11536580-000000000-00000; REHM LP, 1977, BEHAV THER, V8, P787, DOI 10.1016/S0005-7894(77)80150-0; Rice SM, 2016, SPORTS MED, V46, P1333, DOI 10.1007/s40279-016-0492-2; Roberts CM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01067; Ryba TV, 2005, QUEST, V57, P192, DOI 10.1080/00336297.2005.10491853; Schaal K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019007; Schunk DH., 1995, SELF EFFICACY ADAPTA, P281, DOI [10.1007/978-1-4419-6868-5_10, DOI 10.1007/978-1-4419-6868-5_10]; Semple SJ, 2007, J PSYCHOACTIVE DRUGS, P353; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Simpson D, 2013, SPORT PSYCHOL, V27, P109, DOI 10.1123/tsp.27.2.109; Singh P, 2011, J RES ADOLESCENCE, V21, P420, DOI 10.1111/j.1532-7795.2010.00680.x; Son YJ, 2017, INT J NURS PRACT, V23, DOI 10.1111/ijn.12525; Sun X., 2017, STUD PSYCHOL BEHAV, V15, P169; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Treasure DC, 1996, SPORT PSYCHOL, V10, P73, DOI 10.1123/tsp.10.1.73; Wang N, 2019, AIDS CARE, V31, P629, DOI 10.1080/09540121.2018.1549721; Wei P., 2008, J XIAN PHYS ED U, V25, P128, DOI [10.16063/j.cnki.issn1001-747x.2008.04.030, DOI 10.16063/J.CNKI.ISSN1001-747X.2008.04.030]; Xu Y., 2014, OPT EXPRESS, V22, pA259, DOI DOI 10.16128/j.cnki.1005-3611.2014.05.069; Yang CY, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00388; Yang XL, 2018, J AFFECT DISORDERS, V226, P251, DOI 10.1016/j.jad.2017.10.014; [周浩 Zhou Hao], 2004, [心理科学进展, ADVANCES IN PSYCHOLOGICAL SCIENCE], V12, P942	81	3	3	5	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	SEP 29	2020	11								00791	10.3389/fpsyt.2020.00791			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	OB6ZI	WOS:000578617000001	33132920	gold, Green Published			2022-02-06	
J	Kristjansdottir, H; Brynjarsdottir, RM; Kristensen, ISU; Sigurjonsdottir, HA; Claessen, LOE; Jonsdottir, MK				Kristjansdottir, Hafrun; Brynjarsdottir, Ragna Margret; Kristensen, Ingunn S. U.; Sigurjonsdottir, Helga A.; Claessen, Lara Osk Eggertsdottir; Jonsdottir, Maria K.			Self-reported concussion history among Icelandic female athletes with and without a definition of concussion	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion knowledge; sport-related concussions; self-report; contact sports; high-concussion risk sports	TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SEX-DIFFERENCES; HEALTH CONCERN; SPORT HELD; EPIDEMIOLOGY; GUIDELINES; KNOWLEDGE; ZURICH	Objective This study examined whether Icelandic female athletes in contact sports, based their self-reported concussion history on adequate medical definitions, by assessing self-reported concussion history with and without a definition of concussion. Another aim was to examine whether currently active athletes were more knowledgeable of concussions than retired athletes. Methods Participants (age = 26.9, SD = 7.1) were 508 former (34.5%) and current (65.5%) elite female athletes in soccer (41%), handball (30.6%), basketball (19.1%), ice hockey (4.5%) and combat sports (4.7%). An online questionnaire (QuestionPro) was distributed to females in contact sports (snowball sampling). Participants later came for an in-person interview where the authenticity of previous responses was confirmed. In the questionnaire, participants answered background questions and questions about concussion history. First, they reported the total number of sustained concussions without a prompt. They reported the number of sustained concussions again after reading a definition of concussion. Participants could not correct their previous answers. Pearson's Chi-square was used for group comparisons. Results The prevalence of reported concussions increased from 40.2% to 64.8% following a definition. There was no significant difference in how many participants changed their answer when asked about sustaining SRCs before and after reading the definition based on whether the participants were still competitive or retiredX(2)(1) = 0.69,p = 0.41. Conclusions Our data suggest that understanding of concussions is inadequate among female athletes. Self-report will continue to be an essential source of clinical information and prompting with a definition can increase the reliability of self-reported concussions.	[Kristjansdottir, Hafrun] Reykjavik Univ, Phys Act Phys Educ Sport & Hlth PAPESH Res Ctr, Sch Social Sci, Sports Sci Dept, Reykjavik, Iceland; [Brynjarsdottir, Ragna Margret; Kristensen, Ingunn S. U.; Jonsdottir, Maria K.] Reykjavik Univ, Sch Social Sci, Psychol Dept, Reykjavik, Iceland; [Sigurjonsdottir, Helga A.; Claessen, Lara Osk Eggertsdottir] Univ Iceland, Fac Med, Sch Hlth Sci, Reykjavik, Iceland; [Sigurjonsdottir, Helga A.; Claessen, Lara Osk Eggertsdottir; Jonsdottir, Maria K.] Landspitali Natl Hosp Iceland, Reykjavik, Iceland		Jonsdottir, MK (corresponding author), Reykjavik Univ, Dept Psychol, Menntavegur 1, IS-102 Reykjavik, Iceland.	mariakj@ru.is		Jonsdottir, Maria K./0000-0003-0383-007X			Alosco ML, 2017, BRAIN INJURY, V31, P1116, DOI 10.1080/02699052.2017.1294709; Barry NC, 2015, J CLIN EXP NEUROPSYC, V37, P994, DOI 10.1080/13803395.2015.1038981; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Benson B., 2018, SPORT RELATED CONCUS; Bjornsson R., 2017, HEILAHRISTINGUR HEIL; Bodin D., 2012, PEDIAT ADOLESCENT CO; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu R, 2006, Foundations of Sport-Related Brain Injuries, P87, DOI 10.1007/0-387-32565-4_5; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Denny-Brown D, 1943, Bull N Y Acad Med, V19, P3; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Halldorsson JG, 2012, BRAIN INJURY, V26, P1, DOI 10.3109/02699052.2011.635359; Hermannsson R. H., 2014, THESIS; Hootman J.M., 2007, J ATHL TRAINING, V42, P311; ithornrotta- og olympiusamband islands, HEIL; Johnson LSM, 2015, NEUROETHICS-NETH, V8, P1, DOI 10.1007/s12152-015-9233-8; Jonsson G., 2013, THESIS; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Krutsch W, 2018, SPORTVERLETZ SPORTSC, V32, P111, DOI 10.1055/s-0583-3792; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MEANS B, 1989, VITAL HLTH STAT, V6, P1; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mistry DA, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000445; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298	44	3	3	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	SEP 28	2020	34			1			70	82		10.1080/13854046.2020.1814873		SEP 2020	13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	OU3GK	WOS:000573317600001	32990154				2022-02-06	
J	Diekfuss, JA; Yuan, WH; Foss, KDB; Dudley, JA; DiCesare, CA; Reddington, DL; Zhong, W; Nissen, KS; Shafer, JL; Leach, JL; Bonnette, S; Logan, K; Epstein, JN; Clark, J; Altaye, M; Myer, GD				Diekfuss, Jed A.; Yuan, Weihong; Barber Foss, Kim D.; Dudley, Jonathan A.; DiCesare, Christopher A.; Reddington, Danielle L.; Zhong, Wen; Nissen, Katharine S.; Shafer, Jessica L.; Leach, James L.; Bonnette, Scott; Logan, Kelsey; Epstein, Jeffery N.; Clark, Joseph; Altaye, Mekibib; Myer, Gregory D.			The effects of internal jugular vein compression for modulating and preserving white matter following a season of American tackle football: A prospective longitudinal evaluation of differential head impact exposure	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						accelerometry; diffusion tensor imaging; injury prevention; sub-concussive head impacts; tract-based spatial statistics	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; AXONAL INJURY; PROFESSIONAL FOOTBALL; WORKING-MEMORY; SINGLE SEASON; RAT MODEL; COLLAR; PLAYERS; ENCEPHALOPATHY	The purpose of this clinical trial was to examine whether internal jugular vein compression (JVC)-using an externally worn neck collar-modulated the relationships between differential head impact exposure levels and pre- to postseason changes in diffusion tensor imaging (DTI)-derived diffusivity and anisotropy metrics of white matter following a season of American tackle football. Male high-school athletes (n = 284) were prospectively assigned to a non-collar group or a collar group. Magnetic resonance imaging data were collected from participants pre- and postseason and head impact exposure was monitored by accelerometers during every practice and game throughout the competitive season. Athletes' accumulated head impact exposure was systematically thresholded based on the frequency of impacts of progressively higher magnitudes (10 g intervals between 20 to 150 g) and modeled with pre- to postseason changes in DTI measures of white matter as a function of JVC neck collar wear. The findings revealed that the JVC neck collar modulated the relationships between greater high-magnitude head impact exposure (110 to 140 g) and longitudinal changes to white matter, with each group showing associations that varied in directionality. Results also revealed that the JVC neck collar group partially preserved longitudinal changes in DTI metrics. Collectively, these data indicate that a JVC neck collar can provide a mechanistic response to the diffusion and anisotropic properties of brain white matter following the highly diverse exposure to repetitive head impacts in American tackle football. Clinicaltrials.gov: NCT# 04068883.	[Diekfuss, Jed A.; Barber Foss, Kim D.; DiCesare, Christopher A.; Reddington, Danielle L.; Zhong, Wen; Nissen, Katharine S.; Shafer, Jessica L.; Bonnette, Scott; Logan, Kelsey; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, SPORT Ctr, Div Sports Med, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA; [Yuan, Weihong; Dudley, Jonathan A.] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Yuan, Weihong; Zhong, Wen; Epstein, Jeffery N.; Clark, Joseph; Altaye, Mekibib] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Yuan, Weihong; Zhong, Wen; Epstein, Jeffery N.; Clark, Joseph; Altaye, Mekibib] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH USA; [Leach, James L.] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Cincinnati, OH 45229 USA; [Epstein, Jeffery N.] Cincinnati Childrens Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH USA; [Altaye, Mekibib] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Myer, Gregory D.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Diekfuss, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, SPORT Ctr, Div Sports Med, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	jed.diekfuss@gmail.com	DiCesare, Christopher/AAA-3327-2021; Diekfuss, Jed/ABD-7372-2020; DiCesare, Christopher/ABH-9573-2020; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Diekfuss, Jed/0000-0003-3835-363X; Dudley, Jonathan/0000-0002-5189-9568; Zhong, Wen/0000-0002-7568-3112; Myer, Gregory/0000-0002-9983-8422	Q30 Sports Innovations, LLC	Q30 Sports Innovations, LLC	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; American College of Radiology, 2019, ACR ASNR SPR PRACT G; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bonnette S, 2018, EXP BRAIN RES, V236, P2691, DOI 10.1007/s00221-018-5328-x; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bussey MD, 2019, PHYS THER SPORT, V37, P105, DOI 10.1016/j.ptsp.2019.03.012; Chamard E, 2018, BRAIN INJURY, V32, P816, DOI 10.1080/02699052.2018.1463106; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Danielle S., 2017, BRIT J SPORT MED, V51, pA4, DOI [10.1136/bjsports-2016-097270.8, DOI 10.1136/BJSP0RTS-2016-097270.8]; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dudley J, 2020, BRAIN CONNECT, V10, P292, DOI 10.1089/brain.2019.0729; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Foss KDB, 2019, CLIN J SPORT MED, V29, P442, DOI 10.1097/JSM.0000000000000753; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GILLAND O, 1969, AMER J ROENTGENOL RA, V106, P369, DOI 10.2214/ajr.106.2.369; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hatt A, 2015, AM J NEURORADIOL, V36, P1971, DOI 10.3174/ajnr.A4361; Helwig NE, 2019, WIRES COMPUT STAT, V11, DOI 10.1002/wics.1457; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jbabdi S, 2010, NEUROIMAGE, V49, P247, DOI 10.1016/j.neuroimage.2009.08.039; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kelley ME, 2019, J NEUROSURG-PEDIATR, V23, P381, DOI 10.3171/2018.9.PEDS18314; Koretsky AP, 2012, NEUROIMAGE, V62, P602, DOI 10.1016/j.neuroimage.2012.01.005; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mannix R, 2020, NEUROSCIENCE, V437, P132, DOI 10.1016/j.neuroscience.2020.04.009; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McGuine T, 2020, BRIT J SPORT MED, V54, P408, DOI 10.1136/bjsports-2018-100238; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Miller LE, 2019, J NEUROTRAUM, V36, P1561, DOI 10.1089/neu.2018.6037; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Nevins D, 2016, PROCEDIA ENGINEER, V147, P186, DOI 10.1016/j.proeng.2016.06.211; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; NFHS, 2018, 2017 2018 HIGH SCH A; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oliver JM, 2019, J NEUROSURG, V130, P1655, DOI 10.3171/2017.12.JNS172035; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Ranzenberger LR, 2020, STATPEARLS; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Schneider DK, 2019, J NEUROTRAUM, V36, P2831, DOI 10.1089/neu.2019.6398; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Stewart GW, 2012, INT J SPORTS PHYS TH, V7, P433; Stojanovski S, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102102; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Tae WS, 2018, J CLIN NEUROL, V14, P129, DOI 10.3988/jcn.2018.14.2.129; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; USA_Football, HEADS FOOTB; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Yuan WH, 2018, J NEUROTRAUM, V35, P1248, DOI 10.1089/neu.2017.5262; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	114	3	3	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB	2021	99	2					423	445		10.1002/jnr.24727		SEP 2020	23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PG9PI	WOS:000572776700001	32981154				2022-02-06	
J	McClure, J; Leah, C				McClure, John; Leah, Caspian			Is independence enough? Rehabilitation should include autonomy and social engagement to achieve quality of life	CLINICAL REHABILITATION			English	Article						Independence; autonomy; social engagement; quality of life; functioning effectively	TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX; HEALTH; INTERDEPENDENCE; MISCONCEPTIONS; PARTICIPATION; ATTRIBUTIONS; MODEL; TIME	Purpose: This discussion paper argues that holding independence as the central goal for rehabilitation has limitations that hinder successful outcomes. It shows why autonomy and social engagement should also serve as goals of rehabilitation, in order to achieve quality of life and effective functioning. Methods: The paper reviews problems arising from the over-emphasis on independence in rehabilitation. Although independence is a valuable goal on some tasks, it is sometimes not possible or desirable and is best complimented by autonomy and social engagement. Autonomy recognises that enacting some goals requires the support of other people. Autonomy is thus linked to social engagement (connectivity) in the workplace and personal relationships. The paper applies this framework to motor and cognitive disabilities. Results: The inclusion of autonomy and social engagement as goals for rehabilitation addresses the limitations of independence and can serve the unifying aim of enhancing the person's quality of life. These goals apply equally to motor disabilities and the cognitive and behavioural effects of injuries which affect personal and work relationships. Conclusions: Rehabilitation is likely to be more effective if it aims at a combination of independence, autonomy and social engagement, in service of the goal of a good quality of life.	[McClure, John; Leah, Caspian] Victoria Univ Wellington, Sch Psychol, POB 600, Wellington 6140, New Zealand		McClure, J (corresponding author), Victoria Univ Wellington, Sch Psychol, POB 600, Wellington 6140, New Zealand.	john.mcclure@vuw.ac.nz	McClure, John/O-9060-2015	McClure, John/0000-0002-9261-4995			Agich G. J., 2003, DEPENDENCE AUTONOMY; Barnes C., 2014, REV DISAB STUD, V1, P4; Barskova T, 2007, DISABIL REHABIL, V29, P1481, DOI 10.1080/09638280601029399; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Bodhit A, 2014, NEUROLOGY, V82, P10; Brain Injury association of America, TREATM; Cardol M, 2002, DISABIL REHABIL, V24, P970, DOI 10.1080/09638280210151996; Chesnel C, 2018, CLIN REHABIL, V32, P692, DOI 10.1177/0269215517734294; Clapton J, 2002, DISABIL REHABIL, V24, P987, DOI 10.1080/09638280210152058; Condeluci A., 1998, INTERDEPENDENCE ROUT; Conly S, 2014, AUTONOMY JUSTIFYING; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; DEJONG G, 1979, ARCH PHYS MED REHAB, V60, P435; Diener E, 2018, NAT HUM BEHAV, V2, P253, DOI 10.1038/s41562-018-0307-6; Dunn D., 2015, SOCIAL PSYCHOL DISAB; Esser I, 2010, INT J SOC WELF, V19, pS103, DOI 10.1111/j.1468-2397.2010.00737.x; GAWANDE A, 2015, BEING MORTAL ILLNESS; Gibson B.E., 2016, REHABILITATION POSTC; Gibson BE, 2014, DISABIL REHABIL, V36, P1328, DOI 10.3109/09638288.2014.891661; Gooden-Ledbetter MJ, 2007, J VOCAT REHABIL, V27, P153; Haas S, 2018, JAMA-J AM MED ASSOC, V319, P1765, DOI 10.1001/jama.2018.2074; Harvey J, 2018, DISABIL SOC, V33, P78, DOI 10.1080/09687599.2017.1382322; Hilberink SR, 2013, DISABIL SOC, V28, P569, DOI 10.1080/09687599.2013.790616; Hoofien D, 2001, BRAIN INJURY, V15, P189; Irdesel J, 2007, NEUROCIRUGIA, V18, P5; Johns Hopkins Medicine, TRAUMATIC BRAIN INJU; Krahn T.M., 2015, HDB NEUROETHICS, P1501, DOI [10.1007/978-94-007-4707-4_126, DOI 10.1007/978-94-007-4707-4_126]; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; McClure J., 2020, DAY LIFE BRAIN INJUR; McClure J, 2008, BRAIN INJURY, V22, P639, DOI 10.1080/02699050802255585; McClure J, 2006, BRAIN INJURY, V20, P1029, DOI 10.1080/02699050600909870; McClure J, 2011, REHABIL PSYCHOL, V56, P85, DOI 10.1037/a0023354; Meyer LH, 1998, MAKING FRIENDS INFLU; Putnam RD., 2000, BOWLING ALONE COLLAP; Remnant J, 2015, APPETITE, V92, P36, DOI 10.1016/j.appet.2015.04.069; Rusch FR, 1991, CRITICAL ISSUES LIVE, P145; Saadah MA, 2002, DISABIL REHABIL, V24, P977, DOI 10.1080/09638280210152021; Seitz RJ, 2006, NEUROPSYCHOLOGY, V20, P743, DOI 10.1037/0894-4105.20.6.743; Siegert RJ, 2007, DISABIL REHABIL, V29, P1604, DOI 10.1080/09638280701618794; Sim J, 1998, CLIN REHABIL, V12, P3, DOI 10.1191/026921598670782549; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Triandis HC, 2001, J PERS, V69, P907, DOI 10.1111/1467-6494.696169; Van Lange PAM, 2015, APA HDB PERSONALITY; Wade D, 2015, CLIN REHABIL, V29, P1145, DOI 10.1177/0269215515601175; Wadeson N, 2013, J INST THEOR ECON, V169, P253, DOI 10.1628/093245613X13620416111326; White GW, 2010, J DISABIL POLICY STU, V20, P233, DOI 10.1177/1044207309350561; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wrosch C, 2003, PERS SOC PSYCHOL B, V29, P1494, DOI 10.1177/0146167203256921; Wyse JJ, 2020, PSYCHOL SERV, V17, P65, DOI 10.1037/ser0000283	54	3	3	1	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JAN	2021	35	1					3	12	0269215520954344	10.1177/0269215520954344		SEP 2020	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	PT7IB	WOS:000572760200001	32959679				2022-02-06	
J	Hurtado, JE; Heusel-Gillig, L; Risk, BB; Trofimova, A; Abidi, SA; Allen, JW; Gore, RK				Hurtado, Julia E.; Heusel-Gillig, Lisa; Risk, Benjamin B.; Trofimova, Anna; Abidi, Syed A.; Allen, Jason W.; Gore, Russell K.			Technology-enhanced visual desensitization home exercise program for post-concussive visually induced dizziness: a case series	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article; Early Access						Concussion; vestibular rehabilitation; visually induced dizziness	TRAUMATIC BRAIN-INJURY; VESTIBULAR REHABILITATION; PHYSICAL-THERAPY; DYSFUNCTION; DISORDERS; PRESCRIPTION; MIGRAINE; VERTIGO; SPEED	Purpose:Post-concussive visually induced dizziness (VID), in which symptoms are provoked by exposure to complex visual motion, is associated with protracted recovery. Although vestibular rehabilitation therapy (VRT) is recommended to treat post-concussive dizziness, there is sparse literature reporting on specific VRT interventions treating VID. Methods: A consecutive series of 26 individuals referred for VRT post-concussion were retrospectively assessed for inclusion in this case series. Each participant underwent a combination of conventional VRT and a technology-enhanced visual desensitization home exercise program (HEP). Self-report and objective measures were recorded from initial and discharge therapy evaluations. Twenty-three individuals (mean age 23.1 +/- 12.4) with post-concussive dizziness (mean 109 +/- 56 days post-injury) and no evidence for peripheral vestibular dysfunction were included. Treatment duration averaged 6.9 +/- 2.5 weeks. Results: There were significant improvements in post-intervention on subjective and objective measures of dizziness and gait (p < .05). The response to intervention was independent of pre-injury migraine history but pre-injury depression/anxiety increased self-report of post-treatment anxiety. Concurrent treatment with medications did not influence response to treatment. Conclusions: The combination therapy intervention improved outcome measures consistent with VRT treatment outcomes in both concussion and non-traumatic vestibular conditions. Individuals referred for VRT post-concussion warrant assessment for VID and may benefit from the addition of technology-enhanced visual desensitization.	[Hurtado, Julia E.; Gore, Russell K.] Complex Concuss Clin, Shepherd Ctr, Atlanta, GA 30309 USA; [Heusel-Gillig, Lisa] Emory Dizziness & Balance Ctr, Dept Rehabil Med, Atlanta, GA USA; [Risk, Benjamin B.] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Trofimova, Anna; Allen, Jason W.] Emory Univ, Dept Radiol & Imaging Sci, Neuroradiol Div, Diagnost Radiol,Sch Med, Atlanta, GA USA; [Abidi, Syed A.] Emory Univ, Sch Med, Atlanta, GA USA; [Allen, Jason W.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Gore, Russell K.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Gore, Russell K.] Emory Univ, Atlanta, GA 30322 USA		Hurtado, JE (corresponding author), Complex Concuss Clin, Shepherd Ctr, Atlanta, GA 30309 USA.	julia.hurtado@shepherd.org	Risk, Benjamin/AAO-1020-2020	Risk, Benjamin/0000-0003-1090-0777			Alahmari KA, 2014, IEEE T NEUR SYS REH, V22, P389, DOI 10.1109/TNSRE.2013.2294904; Aligene K, 2013, NEUROREHABILITATION, V32, P543, DOI 10.3233/NRE-130876; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron Mathieu, 2015, Adv Med, V2015, P916735, DOI 10.1155/2015/916735; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Bronstein AM, 2013, SEMIN NEUROL, V33, P219, DOI 10.1055/s-0033-1354602; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dannenbaum E, 2011, J VESTIBUL RES-EQUIL, V21, P153, DOI 10.3233/VES-2011-0412; Faul M, 2010, TRAUMATIC BRAIN INJU; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; Kleffelgaard I, 2017, BRAIN INJURY, V31, P1436, DOI 10.1080/02699052.2017.1377348; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Moaty AS, 2017, HEARING BALANC COMMU, V15, P127, DOI 10.1080/21695717.2017.1347367; Morris AE, 2008, INT J AUDIOL, V47, P169, DOI 10.1080/14992020701843129; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Park K, 2018, J SPORT REHABIL, V27, P485, DOI 10.1123/jsr.2016-0222; Pavlou M, 2013, NEUROREHAB NEURAL RE, V27, P208, DOI 10.1177/1545968312461715; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Quatman-Yates C, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI DOI 10.2519/jospt.2020.0601; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sessoms PH, 2015, MIL MED, V180, P143, DOI 10.7205/MILMED-D-14-00385; Staab JP, 2017, J VESTIBUL RES-EQUIL, V27, P191, DOI 10.3233/VES-170622; Whitney SL, 2000, LARYNGOSCOPE, V110, P1528, DOI 10.1097/00005537-200009000-00022; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	35	3	3	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.												10.1080/09593985.2020.1815259		SEP 2020	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	NT2TJ	WOS:000572799400001	32955968				2022-02-06	
J	Huang, XC; Yang, LL; Ye, JP; He, SK; Wang, BP				Huang, Xuecai; Yang, Lingling; Ye, Jinping; He, Shike; Wang, Baoping			Equimolar doses of hypertonic agents (saline or mannitol) in the treatment of intracranial hypertension after severe traumatic brain injury	MEDICINE			English	Article						efficacy; hypertonic saline; intracranial hypertension; mannitol; traumatic brain injury	PRESSURE; GUIDELINES; MANAGEMENT; EQUIOSMOLAR	Background: Mannitol and hypertonic saline (HTS) are effective in reducing intracranial pressure (ICP) after severe traumatic brain injury (TBI). However, their efficacy on the ICP has not been evaluated rigorously. Objective: To evaluate the efficacy of repeated bolus dosing of HTS and mannitol in similar osmotic burdens to treat intracranial hypertension (ICH) in patients with severe TBI. Methods: The authors used an alternating treatment protocol to evaluate the efficacy of HTS with that of mannitol given for ICH episodes in patients treated for severe TBI at their hospital during 2017 to 2019. Doses of similar osmotic burdens (20% mannitol, 2 ml/kg, or 10% HTS, 0.63 ml/kg, administered as a bolus via a central venous catheter, infused over 15 minutes) were given alternately to the individual patient with severe TBI during ICH episodes. The choice of osmotic agents for the treatment of the initial ICH episode was determined on a randomized basis; osmotic agents were alternated for every subsequent ICH episode in each individual patient. intracranial pressure (ICP), mean arterial pressure (MAP), and cerebral perfusion pressure (CPP) were continuously monitored between the beginning of each osmotherapy and the return of ICP to 20 mm Hg. The duration of the effect of ICP reduction (between the beginning of osmotherapy and the return of ICP to 20 mm Hg), the maximum reduction of ICP and its time was recorded after each dose. Serum sodium and plasma osmolality were measured before, 0.5 hours and 3 hours after each dose. Adverse effects such as central pontine myelinolysis (CPM), severe fluctuations of serum sodium and plasma osmolality were assessed to evaluate the safety of repeated dosing of HTS and mannitol. Results: Eighty three patients with severe TBI were assessed, including 437 ICH episodes, receiving 236 doses of HTS and 221 doses of mannitol totally. There was no significant difference between equimolar HTS and mannitol boluses on the magnitude of ICP reduction, the duration of effect, and the time to lowest ICP achieved (P > .05). The proportion of efficacious boluses was higher for HTS than for mannitol (P = .016), as was the increase in serum sodium (P = .038). The serum osmolality increased immediately after osmotherapy with a significant difference (P = .017). No cases of CPM were detected. Conclusion: Repeat bolus dosing of 10% HTS and 20% mannitol appears to be significantly and similarly effective for treating ICH in patients with severe TBI. The proportion of efficacious doses of HTS on ICP reduction may be higher than mannitol.	[Huang, Xuecai; Ye, Jinping; He, Shike; Wang, Baoping] Zhejiang Univ, Lishui Hosp, Dept Neurosurg, Sch Med, Lishui, Zhejiang, Peoples R China; [Huang, Xuecai; Ye, Jinping; He, Shike; Wang, Baoping] Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 5, Lishui, Zhejiang, Peoples R China; [Huang, Xuecai; Ye, Jinping; He, Shike; Wang, Baoping] Lishui Municipal Cent Hosp, Dept Neurosurg, Lishui, Zhejiang, Peoples R China; [Yang, Lingling] Zhejiang Univ, Lishui Hosp, Hlth Examinat Ctr, Sch Med, Lishui 323000, Zhejiang, Peoples R China; [Yang, Lingling] Wenzhou Med Univ, Hlth Examinat Ctr, Affiliated Hosp 5, Lishui 323000, Zhejiang, Peoples R China; [Yang, Lingling] Lishui Municipal Cent Hosp, Hlth Examinat Ctr, Lishui 323000, Zhejiang, Peoples R China		Yang, LL (corresponding author), Zhejiang Univ, Lishui Hosp, Hlth Examinat Ctr, Sch Med, Lishui 323000, Zhejiang, Peoples R China.; Yang, LL (corresponding author), Wenzhou Med Univ, Hlth Examinat Ctr, Affiliated Hosp 5, Lishui 323000, Zhejiang, Peoples R China.; Yang, LL (corresponding author), Lishui Municipal Cent Hosp, Hlth Examinat Ctr, Lishui 323000, Zhejiang, Peoples R China.	neuro-mo@hotmail.com	huang, xuecai/K-5280-2013				Anstey JR, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6399; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; DORMAN HR, 1990, MEDICINE, V69, P153, DOI 10.1097/00005792-199005000-00003; Fink Matthew E, 2012, Continuum (Minneap Minn), V18, P640, DOI 10.1212/01.CON.0000415432.84147.1e; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jagannatha AT, 2016, J CLIN NEUROSCI, V27, P68, DOI 10.1016/j.jocn.2015.08.035; JAMES HE, 1980, ACTA NEUROCHIR, V51, P161, DOI 10.1007/BF01406742; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Kim MY, 2014, J NEUROSURG, V120, P1340, DOI 10.3171/2013.12.JNS13888; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Lewandowski-Belfer JJ, 2014, NEUROCRIT CARE, V20, P436, DOI 10.1007/s12028-013-9907-1; Mangat HS, 2020, NEUROSURGERY, V86, P221, DOI 10.1093/neuros/nyz046; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; McManus ML, 1998, ANESTHESIOLOGY, V88, P1586, DOI 10.1097/00000542-199806000-00023; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Norenberg MD, 2010, METAB BRAIN DIS, V25, P97, DOI 10.1007/s11011-010-9175-0; Palma L, 2006, J Neurosurg Sci, V50, P63; Poole D, 2020, NEUROCRIT CARE, V32, P252, DOI 10.1007/s12028-019-00771-y; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Sankar T, 2008, J NEUROSURG, V108, P1010, DOI 10.3171/JNS/2008/108/5/1010; Santacruz CA, 2016, MINERVA ANESTESIOL, V82, P186; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Visweswaran P, 1997, J AM SOC NEPHROL, V8, P1028; WEAVER A, 1987, NEPHRON, V45, P233, DOI 10.1159/000184124; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478	35	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	SEP 18	2020	99	38							e22004	10.1097/MD.0000000000022004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OC6WV	WOS:000579298600015	32957318	gold, Green Published			2022-02-06	
J	Maurer, GE; Mathews, NM; Schleich, KT; Slayman, TG; Marcussen, BL				Maurer, Gretchen E.; Mathews, Neilson M.; Schleich, Kevin T.; Slayman, Tyler G.; Marcussen, Britt L.			Understanding Cannabis-Based Therapeutics in Sports Medicine	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						cannabinoids; THC; CBD; cannabis; medical marijuana; endocannabinoid system	PAIN; ENDOCANNABINOIDS; HYPERALGESIA; PHARMACOLOGY; PERFORMANCE; CB1	Context: With increased use of cannabis-based products by the public for both recreational and medical use, sports medicine clinicians should be informed of historical context, current legal considerations, and existing evidence with regard to efficacy, safety, and risks in the athletic community. Evidence Acquisition: A review of ClinicalTrials.gov, MEDLINE, and CINAHL from 2015 to present was conducted with emphasis on the most recent literature using search terms,cannabis, nabiximols, cannabinoids, pain management, THC, CBD, and marijuana. Bibliographies based on original search were utilized to pursue further literature search. Study Design: Clinical review. Results: At present, limited high-quality studies exist for use of cannabinoids for acute pain, chronic pain, or concussion. None of the trials involving cannabinoids included the athletic population. Thus, results from this clinical review are extrapolated to conditions of the sports medicine population. For acute pain, 2 small-randomized double-blinded crossover trials concluded no immediate effect of cannabinoid therapy. More robust evidence exists for treatment of chronic pain conditions through meta-analysis and systemic reviews. Cannabinoid therapy exhibits moderate efficacy as a treatment for some chronic pain conditions. Investigations included a broad spectrum of chronic pain conditions, including neuropathic, musculoskeletal, inflammatory, and central pain conditions, and reveal reduction in pain and improvement of quality of life with limited adverse effects. For concussion, evidence is based on preclinical in vitro and animal models revealing possible neuroprotective effects as well as 2 clinical studies involving the presence of cannabinoids for concussion (some sports-related), but there are no high-quality trials evaluating efficacy for treatment with cannabinoids at this time. Conclusion: Although various biochemical explanations exist on the use of cannabinoid therapy through modulation of the endocannabinoid system for several medical issues affecting athletes, recommendations from clinicians must be extrapolated from a majority of research done in the nonathletic population. Lack of strong-quality clinical evidence, coupled with inconsistent federal and state law as well as purity issues with cannabis-based products, make it difficult for the sports medicine clinician to widely recommend cannabinoid therapeutics at present. Future larger, higher quality clinical research studies with standardized pure extracts will better guide appropriate medical use going forward. At present, evidence for a multitude of therapeutic applications is emerging for cannabinoid treatment approaches. With emphasis placed on patient-centered clinical decisions, cannabinoids hold promise of treatment for athletes with chronic pain conditions. Clinicians who treat the athletic community must consider legal and ethical issues when discussing and recommending the use of cannabinoids, with acknowledgment of inconsistencies in purity of various formulations and concerns of drug testing.	[Maurer, Gretchen E.; Mathews, Neilson M.] Lehigh Valley Hlth Network, Allentown, PA USA; [Schleich, Kevin T.; Slayman, Tyler G.; Marcussen, Britt L.] Univ Iowa, Carver Coll Med, Iowa City, IA USA		Maurer, GE (corresponding author), Lehigh Valley Hlth Network, Dept Family Med, 707 Hamilton St,8th Floor, Allentown, PA 18105 USA.	gretchen.maurer@lvhn.org		Marcussen, Britt/0000-0001-9723-6682			[Anonymous], 2006, PLOS MED, V3, pe252; Babson KA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0775-9; Boehnke KF, 2016, J PAIN, V17, P739, DOI 10.1016/j.jpain.2016.03.002; Bonn-Miller MO, 2017, JAMA-J AM MED ASSOC, V318, P1708, DOI 10.1001/jama.2017.11909; Booz GW, 2011, FREE RADICAL BIO MED, V51, P1054, DOI 10.1016/j.freeradbiomed.2011.01.007; Consumer Reports, CBD IS LEG IS IT SAF; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Dietrich A, 2004, BRIT J SPORT MED, V38, P536, DOI 10.1136/bjsm.2004.011718; Dupuy O, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00403; Electronic Medicines Compendium, NAB; Elikkottil Jaseena, 2009, J Opioid Manag, V5, P341; ESPN, MLB UN AGR OP TEST M; Food and Drug Administration, REG CANN CANN DER PR; Food and Drug Administration, WARN LETT TEST RES C; Food and Drug Administration, FDA CANN RES DRUG AP; Food and Drug Administration, 2019, WHAT YOU NEED KNOW W; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; GW Pharmaceuticals, SAT HEALTHC PROF; Knapik JJ, 2016, SPORTS MED, V46, P103, DOI 10.1007/s40279-015-0387-7; Kraft B, 2008, ANESTHESIOLOGY, V109, P101, DOI 10.1097/ALN.0b013e31817881e1; Kroshus E, 2019, BRIT J SPORT MED, V53, P731, DOI 10.1136/bjsports-2019-100590; La Porta C, 2015, PAIN, V156, P2001, DOI 10.1097/j.pain.0000000000000260; Laprairie RB, 2015, BRIT J PHARMACOL, V172, P4790, DOI 10.1111/bph.13250; Lawrence DW, 2020, BRAIN INJURY, V34, P42, DOI 10.1080/02699052.2019.1679885; Lynch ME, 2011, BRIT J CLIN PHARMACO, V72, P735, DOI 10.1111/j.1365-2125.2011.03970.x; MacCallum CA, 2018, EUR J INTERN MED, V49, P12, DOI 10.1016/j.ejim.2018.01.004; Major League Baseball, MAJ LEAG BAS JOINT D; Malek N, 2019, BRIT J PHARMACOL, V176, P1412, DOI 10.1111/bph.14204; McPartland JM, 2015, BRIT J PHARMACOL, V172, P737, DOI 10.1111/bph.12944; National Academies of Sciences Engineering and Medicine, 2017, HLTH EFF CANN CANN C; National Basketball Association, CBA 101 HIGHL COLL B; National Collegiate Athletic Association, 2019, NCAA INCR THC TEST T; National Conference of State Legislatures, STAT MED MAR LAWS; National Football League, 2020, POL PROGR SUBST AB 2; National Hockey League, NHL NHLPA TEAM PERF; Nguyen BM, 2014, AM SURGEON, V80, P979; Nielsen S, 2017, NEUROPSYCHOPHARMACOL, V42, P1752, DOI 10.1038/npp.2017.51; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Russo EB, 2017, ADV PHARMACOL, V80, P67, DOI 10.1016/bs.apha.2017.03.004; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; United States Anti-Doping Agency, ATHL 6 THINGS KNOW C; United States Anti-Doping Agency, US TRIATHL ATHL LAUR; United States Food and Drug Administration, 2018, EP CANN PACK INS; United States Food and Drug Administration, 18651S021 NDA USFDA; Wallace M, 2007, ANESTHESIOLOGY, V107, P785, DOI 10.1097/01.anes.0000286986.92475.b7; Ware MA, 2018, CLIN J SPORT MED, V28, P480, DOI 10.1097/JSM.0000000000000650; Watkins BA, 2018, MOL ASPECTS MED, V64, P68, DOI 10.1016/j.mam.2018.10.001; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; World Anti-Doping Aagency, PROH LIST DOC; Zeiger JS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218998	51	3	3	1	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	NOV	2020	12	6					540	546	1941738120956604	10.1177/1941738120956604		SEP 2020	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	OM5SW	WOS:000570694300001	32936058	Green Published			2022-02-06	
J	Keymoradzadeh, A; Hedayati, CM; Abedinzade, M; Gazor, R; Rostampour, M; Taleghani, BK				Keymoradzadeh, Arman; Hedayati, Mojtaba Ch; Abedinzade, Mahmood; Gazor, Rohollah; Rostampour, Mohammad; Taleghani, Behrooz Khakpour			Enriched environment effect on lipopolysaccharide-induced spatial learning, memory impairment and hippocampal inflammatory cytokine levels in male rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Alzheimer; Cytokine; Enrich environment; Learning; Memory; Neuroinflammation	TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; NEUROINFLAMMATION; PLASTICITY; ACTIVATION; MICROGLIA; C57BL/6; DISEASE; ANXIETY; BALB/C	Neuro-inflammation is responsible for cognitive impairments and neurodegenerative diseases such as Alzheimer's disease. In this study, we aimed to investigate the enriched environment (EE) effect on learning and memory impairment as well as on pro-inflammatory cytokines changes induced by lipopolysaccharide (LPS). LPS injection (1 mg/kg/i.p, days 1, 3, 5, and 7) was used to develop the animal model of neuro-inflammation. Twenty-eight male Wistar rats were used in the experiment and randomly divided into 4 groups: 1) sham (S), 2) sham + enriched environment (SE), 3) LPS (L), and 4) LPS + EE (LE). Two different housing conditions, including standard environment (SE) and enriched environment, were used. The Morris Water Maze (MWM) test was used to examine animals learning and memory. IL-1 beta, IL-10, and TNF-alpha levels were measured in the brain using ELISA. We found that LPS significantly impaired learning and memory (p < 0.05) in the MWM task, but EE could significantly improve learning and memory impairment (p < 0.05). IL-1 and IL-10 levels dramatically increased in the LPS group (P < 0.05), whereas EE could decrease and increase IL-1 beta and IL-10 values in the LPS + EE group (P < 0.05), respectively. TNF-alpha levels were traced but had not detectable values in the hippocampus. Thus, we can conclude that EE has healing effects on LPS induced neuro-inflammation and can improve learning and memory deficit; however, further studies are needed to support the findings of our study.	[Keymoradzadeh, Arman] Guilan Univ Med Sci, Sch Med, Student Res Comm, Rasht, Iran; [Hedayati, Mojtaba Ch] Guilan Univ Med Sci, Fac Med, Dept Microbiol, Rasht, Iran; [Abedinzade, Mahmood] Guilan Univ Med Sci, Med Biotechnol Res Ctr, Sch Nursing Midwifery & Paramed, Rasht, Iran; [Gazor, Rohollah] Guilan Univ Med Sci, Sch Med, Dept Anat Sci, Rasht, Iran; [Rostampour, Mohammad; Taleghani, Behrooz Khakpour] Guilan Univ Med Sci, Cellular & Mol Res Ctr, Sch Med, Rasht, Iran; [Rostampour, Mohammad; Taleghani, Behrooz Khakpour] Guilan Univ Med Sci, Sch Med, Dept Physiol, Rasht, Iran		Taleghani, BK (corresponding author), Guilan Univ Med Sci, Cellular & Mol Res Ctr, Sch Med, Rasht, Iran.	khakpour_b@yahoo.com	Abedinzade, Mahmood/O-2081-2019	Abedinzade, Mahmood/0000-0002-9216-7216	Guilan University of Medical Sciences [96103007]	This work was supported by Guilan University of Medical Sciences [grant numbers 96103007].	Abadi AHA, 2016, BEHAV PHARMACOL, V27, P270, DOI 10.1097/FBP.0000000000000197; Abramov U, 2008, NEUROSCI LETT, V443, P223, DOI 10.1016/j.neulet.2008.07.075; Batista CRA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092293; Aminyavari S, 2019, PROG NEURO-PSYCHOPH, V89, P322, DOI 10.1016/j.pnpbp.2018.10.005; Anaeigoudari A, 2015, ARQ NEURO-PSIQUIAT, V73, P784, DOI 10.1590/0004-282X20150121; Ball NJ, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00466; Baroncelli L, 2010, CELL DEATH DIFFER, V17, P1092, DOI 10.1038/cdd.2009.193; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Chanteux H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-71; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; d'Avila JC, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1059-y; Da Re C, 2020, BEHAV BRAIN RES, V379, DOI 10.1016/j.bbr.2019.112360; Engelhardt KR, 2014, CURR TOP MICROBIOL, V380, P1, DOI 10.1007/978-3-662-43492-5_1; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Frick KM, 2003, NEUROBIOL AGING, V24, P615, DOI 10.1016/S0197-4580(02)00138-0; Gong XR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1301-7; Goshen I, 2009, J NEUROSCI, V29, P3395, DOI 10.1523/JNEUROSCI.5352-08.2009; Harvey D, 2006, PHYSIOL BEHAV, V87, P842, DOI 10.1016/j.physbeh.2006.03.002; Herring A, 2010, BRAIN PATHOL, V20, P166, DOI 10.1111/j.1750-3639.2008.00257.x; Holbrook Jonathan, 2019, F1000Res, V8, DOI 10.12688/f1000research.17023.1; Huang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039656; Huttenrauch M, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00062; Ilin Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004329; Jahangiri Z, 2019, J PHYSIOL SCI, V69, P993, DOI 10.1007/s12576-019-00719-z; Ji MH, 2017, ONCOTARGET, V8, P82376, DOI 10.18632/oncotarget.19595; Jin XH, 2017, MED SCI MONITOR, V23, P207, DOI 10.12659/MSM.902728; Khakpour-Taleghani B, 2009, NEUROSCIENCE, V158, P1284, DOI 10.1016/j.neuroscience.2008.11.001; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Konkle ATM, 2010, J AM ASSOC LAB ANIM, V49, P427; Korn L, 2016, MED SCI MONITOR, V22, P3043, DOI 10.12659/MSM.898810; Laber K, 2008, J AM ASSOC LAB ANIM, V47, P16; Lee B, 2018, ANIM CELLS SYST, V22, P305, DOI 10.1080/19768354.2018.1517825; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; Lee YJ, 2013, J NUTR BIOCHEM, V24, P298, DOI 10.1016/j.jnutbio.2012.06.011; Liu Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1141-5; Lobo-Silva D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0763-8; Manickavasagam D, 2020, NANOMED-NANOTECHNOL, V23, DOI 10.1016/j.nano.2019.102107; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Mirahmadi SMS, 2018, CYTOKINE, V104, P151, DOI 10.1016/j.cyto.2017.10.008; Mora-Gallegos A, 2015, NEUROBIOL LEARN MEM, V118, P96, DOI 10.1016/j.nlm.2014.11.012; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Noorbakhshnia M, 2015, PHARMACOL REP, V67, P370, DOI 10.1016/j.pharep.2014.10.014; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Lima MGP, 2018, P NATL ACAD SCI USA, V115, pE2403, DOI 10.1073/pnas.1718435115; Singhal G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00097; Smith MA, 2009, BEHAV PHARMACOL, V20, P312, DOI 10.1097/FBP.0b013e32832ec568; Swanson A, 2018, BEHAV BRAIN RES, V347, P49, DOI 10.1016/j.bbr.2018.02.015; Talvani A, 2011, ADV PARASIT, V76, P171, DOI 10.1016/B978-0-12-385895-5.00008-6; Tanaka S, 2011, J NEUROSCI RES, V89, P506, DOI 10.1002/jnr.22582; Ugalde-Muniz P, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4807179; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vukovic J, 2012, J NEUROSCI, V32, P6435, DOI 10.1523/JNEUROSCI.5925-11.2012; Wassenaar TM, 2018, EUR J MICROBIOL IMMU, V8, P63, DOI 10.1556/1886.2018.00017; Williamson LL, 2012, BRAIN BEHAV IMMUN, V26, P500, DOI 10.1016/j.bbi.2012.01.003; Williamson LL, 2011, J NEUROSCI, V31, P15511, DOI 10.1523/JNEUROSCI.3688-11.2011; Zhan XH, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00042; Zhang R, 2009, J NEUROIMMUNOL, V206, P121, DOI 10.1016/j.jneuroim.2008.09.017; Zhang SH, 2017, EUR J INFLAMM, V15, P200, DOI 10.1177/1721727X17730471; Zhao JY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42286-8; Ziv Y, 2008, BRAIN BEHAV IMMUN, V22, P167, DOI 10.1016/j.bbi.2007.08.006	62	3	3	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	SEP 15	2020	394								112814	10.1016/j.bbr.2020.112814			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	NP3KS	WOS:000570078600013	32707137				2022-02-06	
J	Iyer, KK; Zalesky, A; Cocchi, L; Barlow, KM				Iyer, Kartik K.; Zalesky, Andrew; Cocchi, Luca; Barlow, Karen M.			Neural Correlates of Sleep Recovery following Melatonin Treatment for Pediatric Concussion: A Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						brain connectivity; concussion; melatonin; mild traumatic brain injury; sleep	TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; CHILDREN; DISTURBANCE; NETWORKS; DISRUPTION	Evidence-based treatments for children with persistent post-concussion symptoms (PPCS) are few and limited. Common PPCS complaints such as sleep disturbance and fatigue could be ameliorated via the supplementation of melatonin, which has significant neuroprotective and anti-inflammatory properties. This study aims to identify neural correlates of melatonin treatment with changes in sleep disturbances and clinical recovery in a pediatric cohort with PPCS. We examined structural and functional neuroimaging (fMRI) in 62 children with PPCS in a randomized, double-blind, placebo-controlled trial of 3 mg or 10 mg of melatonin (NCT01874847). The primary outcome was the total youth self-report Post-Concussion Symptom Inventory (PCSI) score after 28 days of treatment. Secondary outcomes included the change in the sleep domain PCSI score and sleep-wake behavior (assessed using wrist-worn actigraphy). Whole-brain analyses of (1) functional connectivity (FC) of resting-state fMRI, and (2) structural gray matter volumes via voxel-based morphometry were assessed immediately before and after melatonin treatment and compared with placebo to identify neural effects of melatonin treatment. Increased FC of posterior default mode network (DMN) regions with visual, somatosensory, and dorsal networks was detected in the melatonin groups over time. The FC increases also corresponded with reduced wake periods (r = -0.27,p = 0.01). Children who did not recover (n = 39) demonstrated significant FC increases within anterior DMN and limbic regions compared with those who did recover (i.e., PCSI scores returned to pre-injury level,n = 23) over time, (p = 0.026). Increases in GM volume within the posterior cingulate cortex were found to correlate with reduced wakefulness after sleep onset (r = -0.32, p = 0.001) and sleep symptom improvement (r = 0.29, p = 0.02). Although the melatonin treatment trial was negative and did not result in PPCS recovery (with or without sleep problems), the relationship between melatonin and improvement in sleep parameters was linked to changes in function-structure within and between brain regions interacting with the DMN.	[Iyer, Kartik K.; Barlow, Karen M.] Univ Queensland, Child Hlth Res Ctr, Fac Med, Brisbane, Qld, Australia; [Zalesky, Andrew] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Zalesky, Andrew] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia; [Cocchi, Luca] QIMR Berghofer Med Res Inst, Clin Brain Networks Grp, Brisbane, Qld, Australia; [Barlow, Karen M.] Queensland Childrens Hosp, Dept Neurol, Brisbane, Qld, Australia; [Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Barlow, Karen M.] Univ Calgary, Calgary, AB, Canada		Iyer, KK (corresponding author), Univ Queensland, Child Hlth Res Ctr, Fac Med, Brisbane, Qld, Australia.	k.iyer@uq.edu.au	Barlow, Karen/C-1323-2014; Cocchi, Luca/G-7611-2011	Barlow, Karen/0000-0003-2612-8507; ZALESKY, ANDREW/0000-0003-2298-9908; Cocchi, Luca/0000-0003-3651-2676	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293375]; Motor Accident Insurance Commission (MAIC, Queensland, Australia); Australian National Health Medical Research CouncilNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [1099082, 1138711]	K.M.B. acknowledges funding support from the Canadian Institutes of Health Research (grant number: 293375) and Motor Accident Insurance Commission (MAIC, Queensland, Australia). L.C. is supported by the Australian National Health Medical Research Council (L.C. 1099082 and 1138711).	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Barlow KM, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-2812; Barlow KM, 2020, PEDIATR NEUROL, V105, P27, DOI 10.1016/j.pediatrneurol.2019.11.006; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Cirelli C, 2019, SCIENCE, V366, P189, DOI 10.1126/science.aay5304; Cohen R, 2013, PEDIATR NEUROL, V49, P465, DOI 10.1016/j.pediatrneurol.2013.06.010; Dagys N, 2012, J CHILD PSYCHOL PSYC, V53, P660, DOI 10.1111/j.1469-7610.2011.02502.x; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Facer-Childs ER, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz033; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Gorfine T, 2006, NEUROIMAGE, V31, P410, DOI 10.1016/j.neuroimage.2005.11.024; Gorfine T, 2009, HUM BRAIN MAPP, V30, P541, DOI 10.1002/hbm.20525; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Horne CM, 2018, J PSYCHIATR RES, V102, P223, DOI 10.1016/j.jpsychires.2018.04.013; Iyer KK, 2019, ANN CLIN TRANSL NEUR, DOI 10.1002/acn3.50951; Iyer KK, 2019, ANN CLIN TRANSL NEUR, V6, P954, DOI 10.1002/acn3.764; Janusz JA, 2012, MILD TRAUMATIC BRAIN, DOI [10.1249/JSR.0b013-31819c7-87, DOI 10.1249/JSR.0B013-31819C7-87]; Killgore WDS, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104679; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Kurth S, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx121; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Mantua J, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx062; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Plourde V, 2020, ARCH CLIN NEUROPSYCH, V35, P302, DOI 10.1093/arclin/acz073; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Puentes-Mestril C, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00061; Robinson JL, 2018, DEV COGN NEUROS-NETH, V31, P1, DOI 10.1016/j.dcn.2018.03.012; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schaefer A, 2018, CEREB CORTEX, V28, P3095, DOI 10.1093/cercor/bhx179; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Szeinberg A, 2006, CLIN PEDIATR, V45, P809, DOI 10.1177/0009922806294218; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tashjian SM, 2018, SOC COGN AFFECT NEUR, V13, P290, DOI 10.1093/scan/nsy009; Tian Y, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.12948; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhou YX, 2017, J MAGN RESON IMAGING, V45, P1105, DOI 10.1002/jmri.25413; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zisapel N, 2018, BRIT J PHARMACOL, V175, P3190, DOI 10.1111/bph.14116	50	3	4	2	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2020	37	24					2647	2655		10.1089/neu.2020.7200		SEP 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PF0CR	WOS:000572089100001	32772826				2022-02-06	
J	Lewis, LM; Papa, L; Bazarian, JJ; Weber, A; Howard, R; Welch, RD				Lewis, Lawrence M.; Papa, Linda; Bazarian, Jeffrey J.; Weber, Art; Howard, Rob; Welch, Robert D.			Biomarkers May Predict Unfavorable Neurological Outcome after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; mild traumatic brain injury; neurological deterioration	FIBRILLARY ACIDIC PROTEIN; COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; TERMINAL HYDROLASE-L1; DECISION INSTRUMENT; ADULT PATIENTS; HEAD-INJURY; LOW-RISK; S100B; ADMISSION	The objective of this study was to determine if initial or repeat measurements of serum concentrations of glial fibrillary acidic protein (GFAP) or ubiquitin C-terminal hydrolase L1 (UCH-L1) are predictive of an acute unfavorable neurological outcome in patients who present to the emergency department (ED) with brain injury and an initial Glasgow Coma Scale Score (GCS) of 14-15. This multi-center observational trial included brain-injured adults presenting to the ED, receiving a head computed tomography (CT) and venipuncture for biomarker concentration measurements within 6 h of injury. Subjects had repeat serum sampling and GCS scores every 4 h for the first 24 h, if available for assessment. We analyzed blood samples using an enzyme-linked immunosorbent assay approved by the Food and Drug Administration (FDA). Wilcoxin two-sample test was used to compare initial and repeat serum concentrations for both biomarkers between CT-positive patients who did not have an acute unfavorable neurological outcome and those patients who did. A total of 145 enrolled subjects had adequate data for analysis; 69 were CT-positive, 74 were CT-negative, and 2 were CT-inconclusive. Five subjects developed an acute unfavorable neurological outcome, defined as need for intracranial pressure monitoring, craniotomy, persistent neurological deficits, or death resulting from brain injury. Initial median serum concentrations of GFAP and UCH-L1 (obtained <6 h from injury) were significantly greater in CT-positive patients who had an acute unfavorable neurological outcome than in CT-positive patients who did not (GFAP: 5237 pg/mL [IQR 4511, 8180] versus 283.5 pg/mL [IQR 107, 1123];p = 0.026; UCH-L1: 3329 pg/mL [QR 1423, 5010] versus 679.5 pg/mL [IQR 363, 1100]p = 0.014). Repeat serum testing (6- < 12 h from injury) showed that UCH-L1 serum concentration, but not GFAP, was also significantly greater in the acute unfavorable neurological outcome group than in those without an unfavorable outcome: 1088 pg/mL versus 374 pg/mL;p = 0.041.	[Lewis, Lawrence M.] Washington Univ, Dept Emergency Med, 660 S Euclid Ave, St Louis, MO 63110 USA; [Papa, Linda] Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL USA; [Bazarian, Jeffrey J.] Univ Rochester, Emergency Med Res, Rochester, NY USA; [Weber, Art] Banyan Biomarkers Inc, San Diego, CA USA; [Howard, Rob] Verid Solut, Del Mar, CA USA; [Welch, Robert D.] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit Receiving Hosp, Detroit, MI USA		Lewis, LM (corresponding author), Washington Univ, Dept Emergency Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	lewisl@wustl.edu			Banyan Biomarkers, Inc.; United States Department of DefenseUnited States Department of Defense; United States Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division [W911QY-15-c-0019]	This study was sponsored through Banyan Biomarkers, Inc. in collaboration with the United States Department of Defense, and was supported by the United States Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, under contract No. W911QY-15-c-0019. The views, opinions and/or findings contained in this report are those of the authors and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation. VIGILANT Clinical Trial Identifier: NCT02541123.	Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Javidi E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00686; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Schwed AC, 2016, AM SURGEON, V82, P898; Shih FY, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0069-2; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sweeney T.E., 2015, WORLD J EMERG SURG, V23, P1; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; von Elm E., 2017, ANN INTERN MED, V147, P573; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Yun BJ, 2018, ACAD EMERG MED, V25, P769, DOI 10.1111/acem.13350; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	25	3	3	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2020	37	24					2624	2631		10.1089/neu.2020.7071		SEP 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PF0CR	WOS:000570776700001	32821007	Green Submitted			2022-02-06	
J	Wallace, J; Bretzin, A; Beidler, E; Hibbler, T; Delfin, D; Gray, H; Covassin, T				Wallace, Jessica; Bretzin, Abigail; Beidler, Erica; Hibbler, Tamaria; Delfin, Danae; Gray, Haleigh; Covassin, Tracey			The Underreporting of Concussion: Differences Between Black and White High School Athletes Likely Stemming from Inequities	JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES			English	Article						Concussion; Race; Reporting behaviors; Underreporting; Health equity; Inequities	RACIAL DISPARITIES; REPORTING BEHAVIOR; HEALTH-CARE; KNOWLEDGE; ACCESS; URBAN	Previous studies have found that Black high school athletes have poorer knowledge about concussions and have fewer sports medicine healthcare resources than White athletes, but research on concussion disclosure by race is still needed. Therefore, the purpose of this study was to examine racial differences in concussion reporting behaviors between Black and White high school athletes. This cross-sectional study administered surveys to 577 high school athletes (64.5% Black; 72.3% males; 16.02 +/- 1.2 years) from 14 schools (title I,n = 9; non-title I,n = 5). The survey included self-reported items on concussions and bell-ringers experienced during games and practices and the number of these episodes that were reported to an authoritative figure. Reasons for reporting and not reporting were also assessed. Results found that White athletes were more likely to recall experiencing a bell-ringer in games compared with Black athletes. They were also more likely to report a bell-ringer or concussion that occurred in a game. There was a significantly higher proportion of Black athletes compared with White athletes that did not report their bell-ringer experienced in games and concussions experienced in practices. White athletes were more likely than Black athletes to disclose a concussion because they thought they had a concussion, while there were no racial differences in the reasons for not reporting. The findings of this study highlight the critical role that race, as a social determinant of health, may play in concussion reporting in high school athletes. Future public health efforts should seek to further understand and overcome inequities in healthcare resources for concussion education and management.	[Wallace, Jessica; Delfin, Danae; Gray, Haleigh] Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane,2106 Capital Hall, Tuscaloosa, AL 35487 USA; [Bretzin, Abigail] Univ Penn, Dept Biostat Epidemiol & Informat, Blockley Hall,Room 937,423 Guardian Dr, Philadelphia, PA 19104 USA; [Beidler, Erica] Duquesne Univ, Dept Athlet Training, 600 Forbes Ave,118 Hlth Sci Bldg, Pittsburgh, PA 15282 USA; [Hibbler, Tamaria; Covassin, Tracey] Michigan State Univ, Dept Kinesiol, Athlet Training, E Lansing, MI 48840 USA		Wallace, J (corresponding author), Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane,2106 Capital Hall, Tuscaloosa, AL 35487 USA.	jswallace1@ua.edu; Abigail.Bretzin@Pennmedicine.upenn.edu; Johnsone1@duq.edu; Hollis22@ath.msu.edu; ddelfin@crimson.ua.edu; hmgray@crimson.ua.edu; covassin@msu.edu		Bretzin, Abigail/0000-0003-3730-2849	Blue Cross Blue Shield of Michigan Foundation; Pentacost Foundation; Michigan State University College of Education	This research endeavor was supported by the Blue Cross Blue Shield of Michigan Foundation, the Pentacost Foundation, and the Michigan State University College of Education.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2015, 2014 NAT HEALTHC QUA; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Beakey M, 2020, CLIN J SPORT MED, V30, pS75, DOI 10.1097/JSM.0000000000000597; Beidler E, 2018, J ATHL TRAINING, V53, P866, DOI 10.4085/1062-6050-266-17; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Clark R, 2019, J TRAUMA NURS, V26, P297, DOI 10.1097/JTN.0000000000000468; Conway F, CLIN J SPORT MED; Donnell Z, 2018, J SAFETY RES, V64, P163, DOI 10.1016/j.jsr.2017.12.001; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Graham H, 2004, MILBANK Q, V82, P101, DOI 10.1111/j.0887-378X.2004.00303.x; Griffith DM, 2007, AM J COMMUN PSYCHOL, V39, P381, DOI 10.1007/s10464-007-9117-0; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kreiger N, 1993, RACIAL EC SCI, P161; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Leachman M, 2014, CENT BUDGET POLICY P, V16, P1; Lyons TW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00690; Maina IW, 2018, SOC SCI MED, V199, P219, DOI 10.1016/j.socscimed.2017.05.009; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; McAllister-Deitrick J, 2020, CLIN J SPORT MED; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Miller GF, 2021, SPORTS HEALTH, V13, P187, DOI 10.1177/1941738120939913; Nelson A, 2002, J NATL MED ASSOC, V94, P666; Popescu I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193222; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; WATSON BC, 1989, J NEGRO EDUC, V58, P309, DOI 10.2307/2295664; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Yearby R, 2018, AM J ECON SOCIOL, V77, P1113, DOI 10.1111/ajes.12230	40	3	3	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2197-3792	2196-8837		J RACIAL ETHN HEALTH	J. Racial Ethn. Health Disparities	AUG	2021	8	4					1079	1088		10.1007/s40615-020-00864-x		SEP 2020	10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TJ1UI	WOS:000569878700001	32926391				2022-02-06	
J	Keller, J; Stetkarova, I; Macri, V; Kuhn, S; Petioky, J; Gualeni, S; Simmons, CD; Arthanat, S; Zilber, P				Keller, Jiri; Stetkarova, Ivana; Macri, Vince; Kuehn, Simone; Petioky, Jakub; Gualeni, Stefano; Simmons, C. Douglas; Arthanat, Sajay; Zilber, Paul			Virtual reality-based treatment for regaining upper extremity function induces cortex grey matter changes in persons with acquired brain injury	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Acquired brain injury (ABI); Virtual anatomical interactivity (VAI); Brain plasticity; Magnetic resonance imaging (MRI); Rehabilitation; Stroke; Traumatic brain injury (TBI); Virtual world; Therapeutic games; Video-observation-feedback therapy	MODIFIED ASHWORTH SCALE; UPPER-LIMB; MOTOR IMAGERY; GLOBAL BURDEN; STROKE; REHABILITATION; PLASTICITY; THERAPY; DISEASE; INDIVIDUALS	Background Individuals with acquired brain injuries (ABI) are in need of neurorehabilitation and neurorepair. Virtual anatomical interactivity (VAI) presents a digital game-like format in which ABI survivors with upper limb paresis use an unaffected limb to control a standard input device and a commonplace computer mouse to control virtual limb movements and tasks in a virtual world. Methods In a prospective cohort study, 35 ambulatory survivors of ABI (25/71% stroke, 10/29% traumatic brain injury) were enrolled. The subjects were divided into three groups: group A received VAI therapy only, group B received VAI and physical/occupational therapy (P/OT), and group C received P/OT only. Motor skills were evaluated by muscle strength (hand key pinch strength, grasp, and three-jaw chuck pinch) and active range of motion (AROM) of the shoulder, elbow, and wrist. Changes were analyzed by ANOVA, ANCOVA, and one-tailed Pearson correlation analysis. MRI data was acquired for group A, and volumetric changes in grey matter were analyzed using voxel-based morphometry (VBM) and correlated with quantified motor skills. Results AROM of the shoulder, elbow, and wrist improved in all three groups. VBM revealed grey matter increases in five brain areas: the tail of the hippocampus, the left caudate, the rostral cingulate zone, the depth of the central sulcus, and the visual cortex. A positive correlation between the grey matter volumes in three cortical regions (motor and premotor and supplementary motor areas) and motor test results (power and AROM) was detected. Conclusions Our findings suggest that the VAI rehabilitation program significantly improved motor function and skills in the affected upper extremities of subjects with acquired brain injuries. Significant increases in grey matter volume in the motor and premotor regions of affected hemisphere and correlations of motor skills and volume in nonaffected brain regions were present, suggesting marked changes in structural brain plasticity.	[Keller, Jiri] Na Homolce Hosp, Dept Radiol, Prague, Czech Republic; [Keller, Jiri; Stetkarova, Ivana] Charles Univ Prague, Fac Med 3, Dept Neurol, Prague, Czech Republic; [Macri, Vince; Zilber, Paul] 3D PreMotorSkill Technol LLC, Tallahassee, FL USA; [Kuehn, Simone] Univ Clin Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany; [Petioky, Jakub] REGIBASE, Prague, Czech Republic; [Petioky, Jakub] Rehabil Ctr, Kladruby, Czech Republic; [Gualeni, Stefano] Univ Malta, Inst Digital Games, Msida, Malta; [Simmons, C. Douglas] MCPHS Univ, Sch Occupat Therapy, Manchester, NH USA; [Arthanat, Sajay] Univ New Hampshire, Dept Occupat Therapy, Durham, NH 03824 USA		Keller, J (corresponding author), Na Homolce Hosp, Dept Radiol, Prague, Czech Republic.; Keller, J (corresponding author), Charles Univ Prague, Fac Med 3, Dept Neurol, Prague, Czech Republic.	keller.public+jner@gmail.com	Keller, Jiri/AAE-4791-2019; Kuehn, Simone/P-6145-2014	Keller, Jiri/0000-0002-6799-7840; Petioky, Jakub/0000-0003-2619-765X	Research Projects of Charles University PROGRES Q 35 and Q 38; Ministry of Health of the Czech Republic DRO (NHH) [00023884]	Supported by the Research Projects of Charles University PROGRES Q 35 and Q 38 and by a grant from the Ministry of Health of the Czech Republic DRO (NHH, 00023884).	BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Coleman ER, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0686-6; Dickstein R, 2014, NEUROREHABILITATION, V34, P267, DOI 10.3233/NRE-131035; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Filevich E, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0383-y; Gori M, 2017, J NEUROENG REHABIL, V14, P23, DOI DOI 10.1186/s12984-017-0231-4; Gualeni S, 2015, VIRTUAL WORLDS PHILO; Karamians R, 2020, ARCH PHYS MED REHAB, V101, P885, DOI 10.1016/j.apmr.2019.10.195; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Kuhn S, 2014, MOL PSYCHIATR, V19, P842, DOI 10.1038/mp.2013.100; Kuhn S, 2014, MOL PSYCHIATR, V19, P265, DOI 10.1038/mp.2013.120; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Kwon JS, 2012, NEUROREHABILITATION, V31, P379, DOI 10.3233/NRE-2012-00807; Lacourse MG, 2004, J REHABIL RES DEV, V41, P505, DOI 10.1682/JRRD.2004.04.0505; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Levin MF, 2015, PHYS THER, V95, P415, DOI 10.2522/ptj.20130579; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Morris JH, 2013, DISABIL REHABIL, V35, P291, DOI 10.3109/09638288.2012.691942; Muller P, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00056; Nijboer T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00182; Orihuela-Espina F, 2013, TOP STROKE REHABIL, V20, P197, DOI 10.1310/tsr2003-197; Pandyan AD, 2003, CLIN REHABIL, V17, P290, DOI 10.1191/0269215503cr610oa; Perez-Marcos D, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0328-9; Proffitt R, 2015, INT J TELEREHABILITA, V7, P23, DOI 10.5195/ijt.2015.6177; Rasova K, 2015, INT J REHABIL RES, V38, P49, DOI 10.1097/MRR.0000000000000090; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sampson M, 2012, DISABIL REHABIL-ASSI, V7, P55, DOI 10.3109/17483107.2011.562959; Shin JH, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0125-x; Simmons CD, 2014, J REHABIL RES DEV, V51, P377, DOI 10.1682/JRRD.2013.05.0103; Tanaka S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066998; Vromen A, 2011, BRAIN INJURY, V25, P387, DOI 10.3109/02699052.2011.558041; Wille D, 2009, DEV NEUROREHABIL, V12, P44, DOI 10.1080/17518420902773117; You SH, 2005, DEV MED CHILD NEUROL, V47, P628, DOI 10.1017/S0012162205001234; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	35	3	3	5	19	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	SEP 12	2020	17	1							127	10.1186/s12984-020-00754-7			11	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology; Rehabilitation	NQ2VL	WOS:000570723100001	32919473	Green Published, gold			2022-02-06	
J	Dzreyan, V; Rodkin, S; Nikul, V; Pitinova, M; Uzdensky, A				Dzreyan, Valentina; Rodkin, Stanislav; Nikul, Viktor; Pitinova, Maria; Uzdensky, Anatoly			The Expression of E2F1, p53, and Caspase 3 in the Rat Dorsal Root Ganglia After Sciatic Nerve Transection	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Dorsal root ganglion; Nerve injury; Satellite glia; Apoptosis; Nerve and ganglion visualization	AMYLOID PRECURSOR PROTEIN; AXOTOMY-INDUCED NECROSIS; SATELLITE GLIAL-CELLS; AXONAL INJURY; APOPTOSIS; PATHWAYS; NEURONS; REMOTE; SITE; SECTIONS	Neurotrauma is among the main causes of human disability and mortality. Nerve injury impairs not only neurons but also causes death of satellite glial cells remote from the injury site. We studied the dynamics of expression of different proapoptotic proteins (E2F1, p53, caspase 3) in the dorsal root ganglia (DRG) of a rat after sciatic nerve transection. TUNEL staining and immunoblotting were used for analysis of cell apoptosis and axotomy-induced biochemical changes. Apoptosis of glial cells was observed at 24 h after sciatic nerve transection and increased on day 7, when apoptosis of some neurons only started. The earliest proapoptotic event in the injured DRG was overexpression of transcription factor E2F1 at 4 h after sciatic nerve transection. This preceded the induction of p53 and cleavage of caspase 3 at 24-h post-axotomy. The nerve injury marker amyloid precursor protein and the nerve regeneration marker GAP-43 were overexpressed in DRG on day 7 after sciatic nerve transection. We also developed a novel fluorescence method for differential visualization of the rat DRG and nerves by means of double staining with propidium iodide and Hoechst 33342 that impart red and blue-green fluorescence, respectively. The present experiments showed that glial cells remote from the nerve transection site were more vulnerable to axotomy than DRG neurons. E2F1 and p53 may be considered promising molecular targets for development of potential neuroprotective agents.	[Dzreyan, Valentina; Rodkin, Stanislav; Nikul, Viktor; Pitinova, Maria; Uzdensky, Anatoly] Southern Fed Univ, Mol Neurobiol Lab, 194-1 Stachky Ave, Rostov Na Donu 344090, Russia		Uzdensky, A (corresponding author), Southern Fed Univ, Mol Neurobiol Lab, 194-1 Stachky Ave, Rostov Na Donu 344090, Russia.	auzd@yandex.ru	Dzreyan, Valentina/ABD-3530-2020; Pitinova, Maria/ABD-2882-2020; Uzdensky, Anatoly/E-2900-2014	Dzreyan, Valentina/0000-0003-3249-5020; Uzdensky, Anatoly/0000-0002-0344-434X; Rodkin, Stanislav/0000-0003-4036-5410	Ministry of Science and Higher Education of Russian Federation [0852-2020-0028]	The work was supported by the Ministry of Science and Higher Education of Russian Federation; grant #0852-2020-0028.	Atlasi Mohammad Ali, 2009, Iranian Biomedical Journal, V13, P65; Aubrey BJ, 2018, CELL DEATH DIFFER, V25, P104, DOI 10.1038/cdd.2017.169; Barron KD, 2004, J NEUROL SCI, V220, P119, DOI 10.1016/j.jns.2004.03.009; Berezhnaya EV, 2017, MOL CELL NEUROSCI, V83, P1, DOI 10.1016/j.mcn.2017.06.003; Bornstein N, 2012, DRUG TODAY, V48, P43, DOI 10.1358/dot.2012.48(Suppl.A).1739723; Casas C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09185; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Demyanenko S, 2019, J MOL NEUROSCI, V68, P667, DOI 10.1007/s12031-019-01329-5; Dubovy P, 2018, ANAT REC, V301, P1618, DOI 10.1002/ar.23843; Engelmann D, 2010, DRUG RESIST UPDATE, V13, P119, DOI 10.1016/j.drup.2010.06.001; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fedorenko GM, 2009, J INTEGR NEUROSCI, V8, P433, DOI 10.1142/S0219635209002290; Hart AM, 2002, EXP BRAIN RES, V142, P308, DOI 10.1007/s00221-001-0929-0; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hughes PE, 1999, PROG NEUROBIOL, V57, P421, DOI 10.1016/S0301-0082(98)00057-4; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Khaitin AM, 2015, INVERTEBR NEUROSCI, V15, DOI 10.1007/s10158-014-0176-2; Khaitin A, 2018, MOL CELL NEUROSCI, V88, P7, DOI 10.1016/j.mcn.2017.12.004; Kiryu-Seo S, 2005, J NEUROSCI, V25, P1442, DOI 10.1523/JNEUROSCI.4041-04.2005; Kolosov M, 2006, BRAIN RES BULL, V69, P495, DOI 10.1016/j.brainresbull.2006.02.018; Laskowitz D., 2016, TRANSLATIONAL RES TR; LAWSON SN, 1979, J NEUROCYTOL, V8, P275, DOI 10.1007/BF01236123; Lebrun-Julien F, 2015, ASN NEURO, V7, DOI 10.1177/1759091415593066; Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112; Liu BH, 2017, J NEUROSCI RES, V95, P2126, DOI 10.1002/jnr.24140; Liu XZ, 1997, J NEUROSCI, V17, P5395; Ma L, 2017, NEUROSCI LETT, V644, P55, DOI 10.1016/j.neulet.2017.02.038; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; Melle C, 2009, J NEUROSCI METH, V185, P23, DOI 10.1016/j.jneumeth.2009.09.003; Meng P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.326; Momeni HR, 2013, CELL J, V15, P212; Mulder J, 2007, NEUROSCIENCE, V146, P1689, DOI 10.1016/j.neuroscience.2007.02.054; Muresan V, 2015, EXP CELL RES, V334, P45, DOI 10.1016/j.yexcr.2014.12.014; Niu JF, 2015, ACTA HISTOCHEM, V117, P182, DOI 10.1016/j.acthis.2014.12.001; Patodia S, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00008; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Perlson E, 2004, J NEUROBIOL, V58, P287, DOI 10.1002/neu.10316; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Savastano LE, 2014, J NEUROSCI METH, V227, P166, DOI 10.1016/j.jneumeth.2014.01.020; Schaeffer V, 2010, GLIA, V58, P169, DOI 10.1002/glia.20910; Uzdensky AB, 2018, NEURAL REGEN RES, V13, P639, DOI 10.4103/1673-5374.230285; Verkhratsky A, 2019, ADV EXPT MED BIOL BO, V1175; Wan CH, 2014, TOXICOL APPL PHARM, V281, P294, DOI 10.1016/j.taap.2014.10.013; Wang DB, 2014, BBA-MOL BASIS DIS, V1842, P1186, DOI 10.1016/j.bbadis.2013.12.015; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Whiteside G, 1998, BRAIN RES PROTOC, V3, P52, DOI 10.1016/S1385-299X(98)00020-8; Whiteside G, 1998, EUR J NEUROSCI, V10, P3400, DOI 10.1046/j.1460-9568.1998.00346.x; Witiw CD, 2015, J SPINAL DISORD TECH, V28, P202, DOI 10.1097/BSD.0000000000000287; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131	51	3	3	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	APR	2021	71	4					826	835		10.1007/s12031-020-01705-6		SEP 2020	10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	QY5FP	WOS:000568472600001	32918240				2022-02-06	
J	Fickling, SD; Greene, T; Greene, D; Frehlick, Z; Campbell, N; Etheridge, T; Smith, CJ; Bollinger, F; Danilov, Y; Rizzotti, R; Livingstone, AC; Lakhani, B; D'Arcy, RCN				Fickling, Shaun D.; Greene, Trevor; Greene, Debbie; Frehlick, Zack; Campbell, Natasha; Etheridge, Tori; Smith, Christopher J.; Bollinger, Fabio; Danilov, Yuri; Rizzotti, Rowena; Livingstone, Ashley C.; Lakhani, Bimal; D'Arcy, Ryan C. N.			Brain Vital Signs Detect Cognitive Improvements During Combined Physical Therapy and Neuromodulation in Rehabilitation From Severe Traumatic Brain Injury: A Case Report	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						traumatic brain injury (TBI); translingual neurostimulation (TLNS); electroencephalography (EEG); brain vital signs; neuroplasticity; post-traumatic stress disorder (PTSD); case report	POSTTRAUMATIC-STRESS-DISORDER; EVENT-RELATED POTENTIALS; FALSE DISCOVERY RATE; STIMULATION; BALANCE; NUCLEI; P300	Using a longitudinal case study design, we have tracked the recovery of motor function following severe traumatic brain injury (TBI) through a multimodal neuroimaging approach. In 2006, Canadian Soldier Captain (retired) Trevor Greene (TG) was attacked with an axe to the head while on tour in Afghanistan. TG continues intensive daily rehabilitation, which recently included the integration of physical therapy (PT) with neuromodulation using translingual neurostimulation (TLNS) to facilitate neuroplasticity. Recent findings with PT + TLNS demonstrated that recovery of motor function occurred beyond conventional time limits, currently extending past 14-years post-injury. To investigate whether PT + TLNS similarly resulted in associated cognitive function improvements, we examined event-related potentials (ERPs) with the brain vital signs framework. In parallel with motor function improvements, brain vital signs detected significant increases in basic attention (as measured by P300 response amplitude) and cognitive processing (as measured by contextual N400 response amplitude). These objective cognitive improvements corresponded with TG's self-reported improvements, including a noteworthy and consistent reduction in ongoing symptoms of post-traumatic stress disorder (PTSD). The findings provide valuable insight into the potential importance of non-invasive neuromodulation in cognitive rehabilitation, in addition to initial indications for physical rehabilitation.	[Fickling, Shaun D.; Greene, Trevor; Greene, Debbie; Frehlick, Zack; Campbell, Natasha; Etheridge, Tori; Smith, Christopher J.; Bollinger, Fabio; Rizzotti, Rowena; Livingstone, Ashley C.; Lakhani, Bimal; D'Arcy, Ryan C. N.] HealthTech Connex Inc, Ctr Neurol Studies, Vancouver, BC, Canada; [Fickling, Shaun D.; Greene, Trevor; Greene, Debbie; Frehlick, Zack; Campbell, Natasha; Etheridge, Tori; Smith, Christopher J.; Bollinger, Fabio; Rizzotti, Rowena; Livingstone, Ashley C.; Lakhani, Bimal; D'Arcy, Ryan C. N.] BrainNET, Hlth & Technol Dist, Vancouver, BC, Canada; [Fickling, Shaun D.; D'Arcy, Ryan C. N.] Simon Fraser Univ, Appl Sci & Sci, Vancouver, BC, Canada; [Danilov, Yuri] Univ Wisconsin, Dept Kinesiol, Madison, AL USA; [Danilov, Yuri] Russian Acad Sci, Pavlov Inst Physiol, St Petersburg, Russia; [Rizzotti, Rowena] Ctr Excellence Mental & Phys Rehabil, Leg Vet Village, Surrey, BC, Canada; [D'Arcy, Ryan C. N.] Univ British Columbia, Ctr Brain Hlth Radiol, Vancouver, BC, Canada		Lakhani, B; D'Arcy, RCN (corresponding author), HealthTech Connex Inc, Ctr Neurol Studies, Vancouver, BC, Canada.; Lakhani, B; D'Arcy, RCN (corresponding author), BrainNET, Hlth & Technol Dist, Vancouver, BC, Canada.; D'Arcy, RCN (corresponding author), Simon Fraser Univ, Appl Sci & Sci, Vancouver, BC, Canada.; D'Arcy, RCN (corresponding author), Univ British Columbia, Ctr Brain Hlth Radiol, Vancouver, BC, Canada.	ryan@healthtechconnex.com; bimallakhani@healthtechconnex.com	Danilov, Yuri/P-7917-2018	Danilov, Yuri/0000-0002-3123-4016	National Research Council of Canada (NRC); Natural Sciences and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); BC Leading Edge Endowment Fund; Surrey Hospital Foundation	This work was funded by the National Research Council of Canada (NRC), the Natural Sciences and Engineering Research Council (NSERC), BC Leading Edge Endowment Fund, and the Surrey Hospital Foundation.	Araki T, 2005, NEUROIMAGE, V25, P43, DOI 10.1016/j.neuroimage.2004.11.039; Bastani Andisheh, 2018, Cerebellum Ataxias, V5, P6, DOI 10.1186/s40673-018-0084-z; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black RD, 2020, FRONT SYST NEUROSCI, V14, DOI 10.3389/fnsys.2020.00012; Boudarene M, 1997, ANN NY ACAD SCI, V821, P494, DOI 10.1111/j.1749-6632.1997.tb48314.x; Buisseret-Delmas C, 1999, J COMP NEUROL, V409, P153, DOI 10.1002/(SICI)1096-9861(19990621)409:1<153::AID-CNE11>3.0.CO;2-#; Chiluwal A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07219-3; Curran OE, 2021, EUR J NEUROSCI, V54, P6864, DOI 10.1111/ejn.14846; D'Arcy R. C. N., 2020, RES SQUARE; D'Arcy RCN, 2016, J HEAD TRAUMA REHAB, V31, pE50, DOI 10.1097/HTR.0000000000000185; Danilov Y, 2015, BRAIN NEUROTRAUMA MO, P605, DOI DOI 10.1201/B18126-51; Danilov Y, 2018, NEUROMETHODS, V139, P307, DOI 10.1007/978-1-4939-8564-7_19; Davis PA, 1939, J NEUROPHYSIOL, V2, P494, DOI 10.1152/jn.1939.2.6.494; Di Nocera F, 2000, BEHAV RES METH INS C, V32, P111, DOI 10.3758/BF03200793; Doidge Norman, 2007, BRAIN CHANGES ITSELF; El-Sayes J, 2019, NEUROSCIENTIST, V25, P65, DOI 10.1177/1073858418771538; Epps C. T., 2019, BRAIN DISORD THER, V8, P255, DOI [10.35248/2168-975X.19.8.255, DOI 10.35248/2168-975X.19.8.255]; Felmingham KL, 2002, PSYCHIAT RES, V109, P171, DOI 10.1016/S0165-1781(02)00003-3; Fickling SD, 2019, BRAIN, V142, P255, DOI 10.1093/brain/awy317; Frehlick Z, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0538-4; Gattu R, 2016, BRAIN INJURY, V30, P1501, DOI 10.1080/02699052.2016.1219056; Gawryluk J. R., 2010, HDB PHYS MED BIOL; Greene T., 2012, MARCH FORTH INSPIRIN; Hajra SG, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00211; Hajra SG, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/aae91e; Hajra SG, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1527-2; He P, 2004, MED BIOL ENG COMPUT, V42, P407, DOI 10.1007/BF02344717; Herrick JL, 1998, BRAIN BEHAV EVOLUT, V51, P183; Javanbakht A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-5; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leonard Gabriel, 2017, Mult Scler J Exp Transl Clin, V3, p2055217317690561, DOI 10.1177/2055217317690561; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Marano E, 2005, HEADACHE, V45, P325, DOI 10.1111/j.1526-4610.2005.05069.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ptito A, 2021, NEUROMODULATION, V24, P1412, DOI 10.1111/ner.13159; Quiroga RQ, 2003, CLIN NEUROPHYSIOL, V114, P376, DOI 10.1016/S1388-2457(02)00365-6; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; SUTTON S, 1967, SCIENCE, V155, P1436, DOI 10.1126/science.155.3768.1436; Tyler Mitchell, 2019, Arch Rehabil Res Clin Transl, V1, P100026, DOI 10.1016/j.arrct.2019.100026; Wilcox R, 2012, INTRODUCTION TO ROBUST ESTIMATION AND HYPOTHESIS TESTING, 3RD EDITION, P103, DOI 10.1016/B978-0-12-386983-8.00004-4; Wildenberg JC, 2011, NEUROIMAGE, V56, P2129, DOI 10.1016/j.neuroimage.2011.03.074; Wildenberg JC, 2010, BRAIN IMAGING BEHAV, V4, P199, DOI 10.1007/s11682-010-9099-7; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5	45	3	3	2	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	SEP 10	2020	14								347	10.3389/fnhum.2020.00347			8	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	NW9QG	WOS:000575352300001	33132868	Green Published, gold			2022-02-06	
J	Li, YT; Lv, WY; Cheng, G; Wang, SW; Liu, BX; Zhao, HL; Wang, HW; Zhang, LM; Dong, C; Zhang, JN				Li, Yanteng; Lv, Wenying; Cheng, Gang; Wang, Shuwei; Liu, Bangxin; Zhao, Hulin; Wang, Hongwei; Zhang, Leiming; Dong, Chao; Zhang, Jianning			Effect of Early Normobaric Hyperoxia on Blast-Induced Traumatic Brain Injury in Rats	NEUROCHEMICAL RESEARCH			English	Article						Normobaric hyperoxia; Brain injuries; Blast injuries; Rat; Brain edema	INTRACRANIAL-PRESSURE; CEREBRAL METABOLISM; BARRIER DAMAGE; OXYGEN; EDEMA; TIME	Blast-induced traumatic brain injury (bTBI) is a leading cause of disability and mortality in soldiers during the conflicts in Iraq and Afghanistan. Although substantial clinical and animal studies have investigated the pathophysiology and treatments of bTBI, few effective therapies have been found, especially for the early rescue in the battlefield. The aim of this study is to evaluate neuroprotective effects of early normobaric hyperoxia (NBO) on bTBI. We established a rat model of bTBI caused by explosion in the cabin. It exhibited typical changes of mild bTBI, like impaired neurological function, brain edema, minor intracranial hemorrhage and neuron necrosis. The rats were divided into 4 groups (n = 12): Sham, Vehicle, hyperbaric oxygen (HBO) and NBO. Neurological function of the rats was assessed by the Neurological Severity Scores (NSS) at 24 h and 72 h after explosion. Serum interleukin-6 (IL-6), neuron specific enolase (NSE) and tau protein were measured at 24 h and 72 h after explosion. Brain water content was measured and Aquaporin-4 (AQP4) immunostaining was performed. Neuronal apoptosis was analyzed by TUNEL staining. NBO demonstrated curative effects on protecting the neurological function. Serum levels of NSE and tau protein were reduced at 24 h and 72 h after explosion. But the levels of IL-6 were not reduced significantly at both time points. Cerebral edema was alleviated. Simultaneously, AQP4 immunostaining of the hippocampus showed remarkably decreased expression after treatment. The number of apoptotic cells in hippocampus was also decreased. Compared with HBO, NBO is simple and convenient, and can be administered in remote areas. It may be a promising therapy for early rescue of bTBI in the battlefield.	[Li, Yanteng; Lv, Wenying; Cheng, Gang; Wang, Shuwei; Zhao, Hulin; Wang, Hongwei; Zhang, Leiming; Dong, Chao; Zhang, Jianning] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Neurosurg, 6 Fucheng Rd, Beijing 100048, Peoples R China; [Liu, Bangxin] PLA, Cent War Zone Gen Hosp, Dept Neurosurg, Wuhan 430070, Peoples R China		Zhang, JN (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Neurosurg, 6 Fucheng Rd, Beijing 100048, Peoples R China.	jianningzhang2008@163.com			Major Projects of PLA Logistics [AHJ14J001]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372128]	This work was supported in part by the Major Projects of PLA Logistics (AHJ14J001) and the National Natural Science Foundation of China (81372128). The funding agencies had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Cai L, 2016, NEUROSCIENCE, V318, P45, DOI 10.1016/j.neuroscience.2016.01.010; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen ZY, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00050; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Keene DD, 2016, J ROY ARMY MED CORPS, V162, P355, DOI 10.1136/jramc-2015-000490; Lang M, 2018, ACTA ANAESTH SCAND, V62, P801, DOI 10.1111/aas.13093; Liang J, 2015, STROKE, V46, P1344, DOI 10.1161/STROKEAHA.114.008599; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Martin Laurie T, 2013, Rand Health Q, V3, P4; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Quintard H, 2015, NEUROCRIT CARE, V22, P243, DOI 10.1007/s12028-014-0062-0; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Shi SH, 2017, STROKE, V48, P2848, DOI 10.1161/STROKEAHA.117.017713; Sjoberg F, 2013, J INTERN MED, V274, P505, DOI 10.1111/joim.12139; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Tomura S, 2020, NEUROSCI LETT, V721, DOI 10.1016/j.neulet.2020.134827; Vandebroek A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051603; Veltkamp R, 2005, STROKE, V36, P1679, DOI 10.1161/01.STR.0000173408.94728.79; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Weaver J, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0032-4; You PD, 2016, NEUROREPORT, V27, P329, DOI 10.1097/WNR.0000000000000542; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4	25	3	3	5	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	NOV	2020	45	11					2723	2731		10.1007/s11064-020-03123-x		SEP 2020	9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	NX7WY	WOS:000567770600001	32902742				2022-02-06	
J	Chao, LL; Barlow, C; Karimpoor, M; Lim, L				Chao, Linda L.; Barlow, Cody; Karimpoor, Mahta; Lim, Lew			Changes in Brain Function and Structure After Self-Administered Home Photobiomodulation Treatment in a Concussion Case	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury (TBI); photobiomodulation; home treatment; cognition; neuroimaging	LEVEL LASER THERAPY; VERBAL-LEARNING TEST; DEFAULT-MODE NETWORK; NEAR-INFRARED LIGHT; CEREBRAL-BLOOD-FLOW; CLOSED-HEAD-INJURY; CORTICAL-NEURONS; IN-VITRO; CONNECTIVITY; IRRADIATION	Traumatic brain injury (TBI) is a common neurological disorder among athletes. Although there are no widely accepted treatments for TBI, new investigational approaches, such as photobiomodulation (PBM), are being tested. PBM is a light therapy that uses red to near-infrared (NIR) light to stimulate, heal, and protect tissue that has been injured or is at risk of dying. Benefits following transcranial PBM treatments in animal models of acute TBI and a small number of chronic TBI patients have been reported. However, the human PBM TBI studies published to date have been based on behavioral assessments. This report describes changes in behavioral and neuroimaging measures after 8 weeks of PBM treatments. The subject was a 23-year professional hockey player with a history of concussions, presumed to have caused his symptoms of headaches, mild anxiety, and difficulty concentrating. He treated himself at home with commercially available, low-risk PBM devices that used light-emitting diodes (LEDs) to emit 810-nm light pulsing at 10 or 40Hz delivered by an intranasal and four transcranial modules that targeted nodes of the default mode network (DMN) with a maximum power density of 100 mW/cm(2). After 8 weeks of PBM treatments, increased brain volumes, improved functional connectivity, and increased cerebral perfusion and improvements on neuropsychological test scores were observed. Although this is a single, sport-related case with a history of concussions, these positive findings encourage replication studies that could provide further validation for this non-invasive, non-pharmacological modality as a viable treatment option for TBI.	[Chao, Linda L.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Chao, Linda L.] Univ Calif San Francisco, Dept Biomed Imaging, San Francisco, CA USA; [Chao, Linda L.] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94143 USA; [Chao, Linda L.; Barlow, Cody] San Francisco VA Hlth Care Syst, VA Adv Imaging Res Ctr, San Francisco, CA 94121 USA; [Karimpoor, Mahta; Lim, Lew] Vielight Inc, Toronto, ON, Canada		Chao, LL (corresponding author), Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA.; Chao, LL (corresponding author), Univ Calif San Francisco, Dept Biomed Imaging, San Francisco, CA USA.; Chao, LL (corresponding author), Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94143 USA.; Chao, LL (corresponding author), San Francisco VA Hlth Care Syst, VA Adv Imaging Res Ctr, San Francisco, CA 94121 USA.	linda.chao@ucsf.edu			Vielight, Inc.	Funds for the Vielight Neuro Alpha and Gamma devices and to the 3T research MRI scans were provided by Vielight, Inc.	Alexandratou E, 2002, PHOTOCH PHOTOBIO SCI, V1, P547, DOI 10.1039/b110213n; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bjordal JM, 2006, PHOTOMED LASER SURG, V24, P158, DOI 10.1089/pho.2006.24.158; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Chao LL, 2019, PHOTOBIOMODULATION P, V37, P133, DOI 10.1089/photob.2018.4555; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; de Lima FM, 2013, LASER MED SCI, V28, P551, DOI 10.1007/s10103-012-1088-1; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Duan R, 2003, LASER SURG MED, V33, P199, DOI 10.1002/lsm.10216; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giuliani A, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-8; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hamblin MR, 2017, AIMS BIOPHYS, V4, P337, DOI 10.3934/biophy.2017.3.337; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Hou JF, 2008, LASER SURG MED, V40, P726, DOI 10.1002/lsm.20709; Huang YY, 2014, J BIOPHOTONICS, V7, P656, DOI 10.1002/jbio.201300125; ICHISE M, 1994, J NUCL MED, V35, P217; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kandolf-Sekulovic L, 2003, PHOTODERMATOL PHOTO, V19, P203, DOI 10.1034/j.1600-0781.2003.00040.x; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; KARU T, 1995, J PHOTOCH PHOTOBIO B, V27, P219, DOI 10.1016/1011-1344(94)07078-3; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Liang HL, 2006, NEUROSCIENCE, V139, P639, DOI 10.1016/j.neuroscience.2005.12.047; LIEVENS P C, 1991, Lasers in Medical Science, V6, P189, DOI 10.1007/BF02032547; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meng CB, 2013, J NEUROSCI, V33, P13505, DOI 10.1523/JNEUROSCI.0918-13.2013; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 1997, ANN M INT NEUR SOC B; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nawashiro H, 2012, PHOTOMED LASER SURG, V30, P231, DOI 10.1089/pho.2011.3044; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; PASSARELLA S, 1984, FEBS LETT, V175, P95, DOI 10.1016/0014-5793(84)80577-3; Pessoa ES, 2004, PHOTOMED LASER SURG, V22, P199, DOI 10.1089/1549541041438533; PRAYER L, 1993, ACTA RADIOL, V34, P593; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Reitan R, 1985, HALSTEAD REITAN NEUR; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Ridner SH, 2013, ONCOL NURS FORUM, V40, P383, DOI 10.1188/13.ONF.383-393; Rojas JC, 2012, J ALZHEIMERS DIS, V32, P741, DOI 10.3233/JAD-2012-120817; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Salehpour F, 2018, MOL NEUROBIOL, V55, P6601, DOI 10.1007/s12035-017-0852-4; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Silva TC, 2010, PHOTOMED LASER SURG, V28, P63, DOI 10.1089/pho.2008.2403; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stergioulas A, 2004, J CLIN LASER MED SUR, V22, P125, DOI 10.1089/104454704774076181; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Tian FH, 2016, LASER SURG MED, V48, P343, DOI 10.1002/lsm.22471; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Uozumi Y, 2010, LASER SURG MED, V42, P566, DOI 10.1002/lsm.20938; Waypa GB, 2016, MOL ASPECTS MED, V47-48, P76, DOI 10.1016/j.mam.2016.01.002; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Zhang L, 2000, J NEUROL SCI, V174, P141, DOI 10.1016/S0022-510X(00)00268-9; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zomorrodi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42693-x	91	3	3	2	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 8	2020	11								952	10.3389/fneur.2020.00952			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NV7JK	WOS:000574492800001	33013635	Green Published, gold			2022-02-06	
J	Zhao, YL; Wei, X; Li, WM; Shan, CY; Song, JN; Zhang, M				Zhao, Yonglin; Wei, Xing; Li, Weimiao; Shan, Changyou; Song, Jinning; Zhang, Ming			Inhibition of Macrophage Migration Inhibitory Factor Protects against Inflammation through a Toll-like Receptor-Related Pathway after Diffuse Axonal Injury in Rats	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN; MIF	Objective. We have previously demonstrated that inflammation induced by toll-like receptors (TLRs) 2/4 exert cerebral deleterious effects after diffuse axonal injury (DAI); however, the underlying mechanisms are not fully understood. Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine involved in inflammatory responses. The purpose of this study was to investigate the role of MIF in inflammation induced by TLRs in the cortices of DAI rats.Methods. The rat DAI model was established by head rotational acceleration and confirmed by beta-APP, HE, and silver staining. MIF protein expression at 3 h, 6 h, 12 h, 1 d, and 3 d after DAI was measured by western blot. The localization of MIF was measured by immunofluorescence. MIF antagonist ISO-1 was intracerebroventricularly injected to inhibit MIF. Neuronal and axonal injury and glial responses were assessed by TUNEL, immunohistochemistry, and TEM. Expression of TLR2, TLR4, ERK, phospho-ERK, NF-kappa B, and phospho-NF-kappa B was examined by western blot. The level of IL-1 beta, IL-6, and TNF-alpha was measured by ELISA.Results. MIF expression was significantly increased, peaking at 1 day after DAI, and MIF was mainly localized in microglial cells and neurons. ISO-1 suppressed neuronal apoptosis, axonal injury, and glial responses and decreased the expression of downstream signaling molecules related to TLR2/4, including ERK, phospho-ERK, NF-kappa B, phospho-NF-kappa B, IL-1 beta, IL-6, and TNF-alpha.Conclusion. MIF was involved in the neuronal and axonal damage through a TLR-related pathway following DAI.	[Zhao, Yonglin; Li, Weimiao; Shan, Changyou] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Oncol, Xian 710004, Peoples R China; [Wei, Xing] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Gynecol & Obstet, Xian 710004, Peoples R China; [Song, Jinning] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, Xian 710061, Peoples R China; [Zhang, Ming] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Neurosurg, 157 Xiwu Rd, Xian 710004, Peoples R China		Zhang, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Neurosurg, 157 Xiwu Rd, Xian 710004, Peoples R China.	zhaoyonglinlin@163.com; sharpay0731@163.com; liweimiao6229@126.com; shanchangyou1986@163.com; jinningsong@126.com; phoenixzhang@126.com		Zhao, Yonglin/0000-0001-7326-7249	Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [xjj2015018, szy012019083]; special research fund for personnel training of the Second Affiliated Hospital of Xi'an Jiaotong University [RC (XM) 201603]; special research fund for the Youth Sciences Foundation of the Second Affiliated Hospital of Xi'an Jiaotong University [YJ (QN) 201402]	This work was supported by the Fundamental Research Funds for the Central Universities (grant numbers xjj2015018 and szy012019083), the special research fund for personnel training of the Second Affiliated Hospital of Xi'an Jiaotong University (grant number RC (XM) 201603), and a special research fund for the Youth Sciences Foundation of the Second Affiliated Hospital of Xi'an Jiaotong University (grant number YJ (QN) 201402).	Bae SH, 2020, NEURAL REGEN RES, V15, P1483, DOI 10.4103/1673-5374.274340; Bank M, 2015, ARCH PHYS MED REHAB, V96, P633, DOI 10.1016/j.apmr.2014.10.021; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Cavalli E, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9100284; Chang MC, 2019, NEURAL REGEN RES, V14, P1230, DOI 10.4103/1673-5374.251330; Cho MK, 2015, PARASITE IMMUNOL, V37, P180, DOI 10.1111/pim.12172; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Huang TQ, 2018, NEUROREPORT, V29, P661, DOI [10.1097/WNR.0000000000001015, 10.1097/wnr.0000000000001015]; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Li JH, 2019, J CELL MOL MED, V23, P3867, DOI 10.1111/jcmm.14234; Liu YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-16927-9; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; Pang HG, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4569521; Paudel YN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00628; Tirado MDR, 2018, AM J FOREN MED PATH, V39, P201, DOI 10.1097/PAF.0000000000000412; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Yang DB, 2017, CLIN CHIM ACTA, V469, P99, DOI 10.1016/j.cca.2017.03.030; Yang H, 2016, CLIN EXP IMMUNOL, V183, P280, DOI 10.1111/cei.12710; Zhang J, 2014, IMMUNOL LETT, V162, P101, DOI 10.1016/j.imlet.2014.07.013; Zhang S, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0508-x; Zhao Y. S., 2016, SENSORS, V16, P2, DOI DOI 10.1155/2016/4706915; Zhao YL, 2019, INFLAMMATION, V42, P841, DOI 10.1007/s10753-018-0940-2; Zhao YL, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/1570917	24	3	3	1	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.	SEP 7	2020	2020								5946205	10.1155/2020/5946205			10	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	NW0KU	WOS:000574699200006	32964038	Green Published, gold			2022-02-06	
J	Singh, R; Sahu, A; Singh, K; Prasad, RS; Pandey, N; Singh, RC				Singh, Rahul; Sahu, Anurag; Singh, Kulwant; Prasad, Ravi Shankar; Pandey, Nityanand; Singh, Ramit Chandra			Impact of COVID-19 Pandemic on Neurosurgical Practice in a Tertiary Care Center in India	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						COVID-19; neurosurgical practice; pandemic; virtual learning; neurosurgical emergency; neurosurgical training	CORONAVIRUS	Objectives The aim of the study is to determine the magnitude of repercussions of coronavirus disease 2019 (COVID-19) pandemic on neurosurgical specialty and formulate a management approach. Materials and Methods This combined retrospective and prospective study was done in neurosurgical specialty of IMS-BHU, Varanasi, India, a tertiary care center, between January 1, 2020 and May 31, 2020. Analysis of impact on neurosurgical emergency and electives was done over before pandemic, during lockdown 1 and 2 and during lockdown 3 and 4 timelines. Effects of COVID-19 pandemic on psychology of neurosurgical team (50 members) and on patient party (88) were also evaluated. Virtual learning and webinars as a substitute to residential neurosurgical training were analyzed by a questionnaire given to 13 neurosurgeons of our department. Statistical Analysis Ordinary one-way ANOVA (analysis of variance) and unpaired t-test were used according to data analyzed. p < 0.05 was considered statistically significant. GraphPad Prism software was used for this analysis. Results On an average 8.22 admissions per day were done in neurosurgical emergency before pandemic. After lockdown these figures reduced to 3.2 admissions per day during lockdown 1 and 2 and to 5.36 admissions per day during lockdown 3 and 4. There was significant reduction in neurotrauma admission rate during lockdown (p < 0.0001) at our center. There was 76% reduction in emergency neurosurgical operated cases during pandemic. There was significant reduction in outpatient department (OPD) attendance per day, OPD admissions per day (p < 0.0001), and total elective surgeries (p < 0.0001) during lockdown. Of 50 neurosurgical team members (neurosurgeons, nursing, and ground staff) interviewed, 90% of them had the fear of contacting the COVID-19 disease, fear of well-being of family and children, and difficulty in transport. Three out of 13 neurosurgeons (23.1%) agreed on change in practice based on what they learned from virtual teaching and webinars and only two of them (15.4%) accepted improvement of skills based on virtual learning. Conclusion The COVID-19 pandemic is causing a significant impact on health care systems worldwide. For conserving resources elective surgical procedures should be limited. This pandemic has a negative impact on neurosurgical resident training program and psychology of both neurosurgical unit and patients.	[Singh, Rahul; Sahu, Anurag; Singh, Kulwant; Prasad, Ravi Shankar; Pandey, Nityanand; Singh, Ramit Chandra] Banaras Hindu Univ, Inst Med Sci, Dept Neurosurg, Varanasi 221005, Uttar Pradesh, India		Sahu, A (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Neurosurg, Varanasi 221005, Uttar Pradesh, India.	anuragsahubhuneurosurgery@gmail.com					[Anonymous], 2020, LANCET, V395, P1315, DOI 10.1016/S0140-6736(20)30938-7; Chang D, 2020, LANCET RESP MED, V8, pE13, DOI 10.1016/S2213-2600(20)30066-7; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen ZM, 2020, WORLD J PEDIATR, V16, P240, DOI 10.1007/s12519-020-00345-5; Cheng ZJ, 2019, INFECTION, V2020, P1, DOI DOI 10.1007/S15010-020-01401-Y; European Centre for Disease Prevention and Control (EADC), DIS ENV HLTH NON HLT; Global Neuro Foundation, 2020, GLOB NEUR NEURO SPEC; Home | Ministry of Health and Family Welfare | GOI, HOME; Huang PK, 2020, RADIOLOGY, V295, P22, DOI 10.1148/radiol.2020200330; Jean WC, 2020, ACTA NEUROCHIR, V162, P1229, DOI 10.1007/s00701-020-04342-5; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022; NIH, COVID 19 TREATM GUID; Patel ZM., PRECAUTIONS ENDOSCOP; Richman DD, 2016, CLIN VIROLOGY, V4th; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; Tsermoulas G, 2020, WORLD NEUROSURG, V139, P519, DOI 10.1016/j.wneu.2020.05.108; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; World Health Organization, SIT REP	20	3	3	1	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JAN	2021	12	01					24	32		10.1055/s-0040-1716455		SEP 2020	9	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RM2BQ	WOS:000565888500007	33531756	gold, Green Published			2022-02-06	
J	Spreij, LA; Gosselt, IK; Visser-Meily, JMA; Nijboer, TCW				Spreij, Lauriane A.; Gosselt, Isabel K.; Visser-Meily, Johanna M. A.; Nijboer, Tanja C. W.			Digital neuropsychological assessment: Feasibility and applicability in patients with acquired brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychological assessment; computerized assessment; acquired brain injury; traumatic brain injury; stroke	COGNITIVE ASSESSMENT; LARGE-SAMPLE; COMPUTER; BATTERY; TESTS; DEVICES; TECHNOLOGY; VALIDITY; CANTAB; TIME	Introduction Digital neuropsychological assessment (d-NPA) has several advantages over paper-and-pencil tests in neuropsychological assessment, such as a more standardized stimulus presentation and response acquisition. We investigated (1) the feasibility and user-experience of a d-NPA in patients with acquired brain injury (ABI) and healthy controls; (2) the applicability of conventional paper-and-pencil norms on digital tests; and (3) whether familiarity with a tablet would affect test performance on a tablet. Method We administered a d-NPA in stroke patients (n= 59), traumatic brain injury patients (n= 61) and healthy controls (n= 159). The neuropsychological tests were presented on a tablet and participants used a pencil stylus to respond. We examined the completion rate to assess the feasibility, and a semi-structured interview was conducted to examine the user-experience. The applicability of conventional norms was examined by the number of healthy controls performing <10(th)percentile, which was expected to be no more than 10%. The effect of tablet familiarity on test performance was examined with a regression-based model. Results Overall, 94% of patients completed the d-NPA. The d-NPA was considered pleasant by patients and healthy controls. Conventional norms that exist for paper-and-pencil tests were not applicable on the digital version of the tests, as up to 34% of healthy controls showed an abnormal performance on half of the tests. Tablet familiarity did not affect test performance on a tablet, indicating that participants who were more experienced with working with a tablet did not perform better on digital tests. Conclusions The administration of a d-NPA is feasible in patients with ABI. Familiarity with a tablet did not impact test performance, which is particularly important in neuropsychological assessment. Future research should focus on developing norms in order to implement a d-NPA in clinical practice.	[Spreij, Lauriane A.; Gosselt, Isabel K.; Visser-Meily, Johanna M. A.; Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, UMC Utrecht Brain Ctr, NL-3584 CX Utrecht, Netherlands; [Spreij, Lauriane A.; Gosselt, Isabel K.; Visser-Meily, Johanna M. A.; Nijboer, Tanja C. W.] de Hoogstr Rehabil, Utrecht, Netherlands; [Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Rehabil Phys Therapy Sci & Sports, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands		Nijboer, TCW (corresponding author), Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, UMC Utrecht Brain Ctr, NL-3584 CX Utrecht, Netherlands.	t.c.w.nijboer@uu.nl			Philips Research	This work was supported by Philips Research.	*AM PSYCH ASS, 1986, GUID COMP BAS TESTS; BAKER EL, 1985, NEUROBEH TOXICOL TER, V7, P369; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilder RM, 2019, CLIN NEUROPSYCHOL, V33, P220, DOI 10.1080/13854046.2018.1521993; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Canini M, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/804723; CARR AC, 1986, BRIT J CLIN PSYCHOL, V25, P305, DOI 10.1111/j.2044-8260.1986.tb00711.x; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Davis R, 2015, AI MAG, V36, P49, DOI 10.1609/aimag.v36i3.2602; Deelman BG., 1986, 15 WOORDENTEST A B V; Diaz-Orueta U, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00361; Dickinson MD, 2011, APPL NEUROPSYCHOL, V18, P136, DOI 10.1080/09084282.2010.547785; Elwood RW, 2001, NEUROPSYCHOL REV, V11, P89, DOI 10.1023/A:1016671201211; Findlater L., 2013, P SIGCHI C HUM FACT, V2013, P343, DOI DOI 10.1145/2470654.2470703; Germine L, 2019, CLIN NEUROPSYCHOL, V33, P271, DOI 10.1080/13854046.2018.1535662; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Gerth S, 2016, HUM MOVEMENT SCI, V48, P62, DOI 10.1016/j.humov.2016.04.006; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guilbert J, 2019, HUM MOVEMENT SCI, V65, P30, DOI 10.1016/j.humov.2018.09.001; Hammes J., 1973, STROOP KLEUR WOORD T; Harvey Philip D, 2012, Dialogues Clin Neurosci, V14, P91; Hazan E, 2018, INT J GERIATR PSYCH, V33, pE22, DOI 10.1002/gps.4731; Heaton R., 1993, WISCONSIN CARD SORTI; HEATON RK, 1986, NEUROPSYCHOLOGICAL A, P100; Holzinger A, 2003, LECT NOTES COMPUT SC, V2615, P387; International Test Commission, 2001, INT J TEST, V1, P93, DOI DOI 10.1207/S15327574IJT0102_1; Iverson GL, 2009, J CLIN EXP NEUROPSYC, V31, P594, DOI 10.1080/13803390802372125; Jenkins A, 2016, J ALZHEIMERS DIS, V54, P1169, DOI 10.3233/JAD-160545; Joddrell Phil, 2016, JMIR Rehabil Assist Technol, V3, pe10, DOI 10.2196/rehab.5788; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kane R. L., 1997, NEUROPSYCHOLOGY HDB; KANE RL, 1992, NEUROPSYCHOL REV, V3, P1, DOI 10.1007/BF01108787; KAPLAN E, 1988, APHASIOLOGY, V2, P309, DOI 10.1080/02687038808248930; Kim HJ, 2011, NUTR RES PRACT, V5, P11, DOI 10.4162/nrp.2011.5.1.11; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Messer, 2010, MMSE 2 MINI MENTAL S; Meyers JE, 1995, PSYCHOL ASSESSMENT R; Muniz J, 2007, EUR PSYCHOL, V12, P206, DOI 10.1027/1016-9040.12.3.206; Murata A, 2005, HUM FACTORS, V47, P767, DOI 10.1518/001872005775570952; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Olson R, 2010, CAN J NEUROL SCI, V37, P264, DOI 10.1017/S0317167100010039; Parsey CM, 2013, CLIN NEUROPSYCHOL, V27, P1328, DOI 10.1080/13854046.2013.834971; Paul RH, 2005, INT J NEUROSCI, V115, P1549, DOI 10.1080/00207450590957890; Powell D. H., 1993, MICROCOG ASSESSMENT; Rabin LA, 2014, PROF PSYCHOL-RES PR, V45, P368, DOI 10.1037/a0037987; Rasquin S, 2009, TIJDSCHRIFT NEUROPSY, V3, P44; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Scheydt S, 2017, INT J MENT HEALTH NU, V26, P110, DOI 10.1111/inm.12303; Schlegel RE, 2007, ARCH CLIN NEUROPSYCH, V22, pS49, DOI 10.1016/j.acn.2006.10.005; Schmand B, 2008, Tijdschr Gerontol Geriatr, V39, P64; Schwarz N., 2007, SCI REAL TIME DATA C, P11; Selverstein SM, 2007, BEHAV RES METHODS, V39, P940, DOI 10.3758/BF03192989; Shah SGS, 2007, INT J TECHNOL ASSESS, V23, P131, DOI 10.1017/S0266462307051677; Shuhfried G., 2013, VIENNA TEST SYSTEM P; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Spreij L. A., JOURNEY IS JUST IMPO; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tun PA, 2010, PSYCHOL AGING, V25, P560, DOI 10.1037/a0019543; UNESCO Institute for Statistics, 2012, INT STAND CLASS ED I; Van der Stoep N, 2013, J CLIN EXP NEUROPSYC, V35, P799, DOI 10.1080/13803395.2013.824555; VERHAGE F, 1965, HUM DEV, V8, P238, DOI 10.1159/000270308; Vermeent S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00770; Wallace SE, 2019, NEUROREHABILITATION, V45, P25, DOI 10.3233/NRE-192725; Wechsler D., 2004, WAIS 3; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; Witt JA, 2013, SEIZURE-EUR J EPILEP, V22, P416, DOI 10.1016/j.seizure.2013.04.004; Wood E, 2005, J APPL GERONTOL, V24, P419, DOI 10.1177/0733464805278378	74	3	3	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	SEP 13	2020	42	8					781	793		10.1080/13803395.2020.1808595		SEP 2020	13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	OA2EN	WOS:000566927600001	32878561	Green Published, hybrid			2022-02-06	
J	Jaywant, A; Steinberg, C; Lee, A; Toglia, J				Jaywant, Abhishek; Steinberg, Chelsea; Lee, Alyson; Toglia, Joan			Feasibility and acceptability of the multicontext approach for individuals with acquired brain injury in acute inpatient rehabilitation: A single case series	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Neurologic rehabilitation; Stroke; Brain tumour; Traumatic brain injury; Cognitive rehabilitation	EXECUTIVE DYSFUNCTION; SELF-REGULATION; STROKE; AWARENESS; RECOVERY; DEFICITS; THERAPY; PEOPLE; TOOL	The Multicontext (MC) approach, a metacognitive intervention designed to improve awareness, strategy use, and executive functioning, may be beneficial for individuals with acquired brain injury (ABI) undergoing acute inpatient rehabilitation. The goal of this study was to provide evidence of feasibility and acceptability of the MC approach and to explore clinical outcomes. A case series of eight individuals with acquired brain injury and at least mild executive functioning impairment were recruited from an acute inpatient rehabilitation unit. The MC approach - involving guided questioning and patient self-generation of strategies practiced across everyday functional cognitive tasks - was implemented within routine occupational therapy. Occupational therapists implemented the MC approach with high adherence to the treatment protocol. Therapists' perceived challenges were the time constraints of inpatient rehabilitation as well as client factors. Participants rated the MC approach as highly satisfying and engaging. They described subjective improvements in their ability to use executive functioning strategies. The MC approach was associated with improvement in awareness, strategy use, and executive functioning at the conclusion of treatment. The MC approach may be a beneficial intervention for individuals with acquired brain injury and executive dysfunction undergoing acute inpatient rehabilitation. Further evaluation with larger samples in controlled trials is warranted.	[Jaywant, Abhishek; Toglia, Joan] Weill Cornell Med, Dept Rehabil Med, 525 East 68th St, New York, NY 10065 USA; [Jaywant, Abhishek] Weill Cornell Med, Dept Psychiat, New York, NY USA; [Jaywant, Abhishek; Steinberg, Chelsea; Lee, Alyson; Toglia, Joan] NewYork Presbyterian Hosp, New York, NY USA; [Toglia, Joan] Mercy Coll, Sch Hlth & Nat Sci, 555 Broadway, Dobbs Ferry, NY 10522 USA		Toglia, J (corresponding author), Weill Cornell Med, Dept Rehabil Med, 525 East 68th St, New York, NY 10065 USA.; Toglia, J (corresponding author), Mercy Coll, Sch Hlth & Nat Sci, 555 Broadway, Dobbs Ferry, NY 10522 USA.	jtoglia@mercy.edu	Jaywant, Abhishek/AAK-4727-2021; Toglia, Joan/AAN-6674-2021	Jaywant, Abhishek/0000-0003-4307-5742; Toglia, Joan/0000-0002-6902-6853			Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Braun JD, 2015, BEHAV RES THER, V70, P32, DOI 10.1016/j.brat.2015.05.004; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Correa DD, 2010, CURR NEUROL NEUROSCI, V10, P232, DOI 10.1007/s11910-010-0108-4; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Engel L, 2019, NEUROPSYCHOL REHABIL, V29, P163, DOI 10.1080/09602011.2017.1292923; Fong KNK, 2009, AM J OCCUP THER, V63, P525, DOI 10.5014/ajot.63.5.525; Foster, MULTICONTEXT APPROAC; Foster ER, 2018, DISABIL REHABIL, V40, P1127, DOI 10.1080/09638288.2017.1288275; Giles G.M., 2019, FUNCTIONAL COGNITION, P219, DOI https://doi.org/10.1080/09602011.2020.1810710; Insel K, 2006, J GERONTOL B-PSYCHOL, V61, pP102, DOI 10.1093/geronb/61.2.P102; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kersey J, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.031450; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Rose D, 2008, AM J PSYCHIATR REHAB, V11, P181, DOI 10.1080/15487760801963694; Sheline YI, 2010, ARCH GEN PSYCHIAT, V67, P277, DOI 10.1001/archgenpsychiatry.2009.204; Shevil E, 2009, PATIENT EDUC COUNS, V76, P77, DOI 10.1016/j.pec.2008.11.007; Skidmore ER, 2015, NEUROREHAB NEURAL RE, V29, P668, DOI 10.1177/1545968314562113; Skidmore ER, 2015, PM&R, V7, P562, DOI 10.1016/j.pmrj.2014.12.010; Skidmore ER, 2014, CLIN REHABIL, V28, P378, DOI 10.1177/0269215513502799; Skidmore ER, 2011, NEUROPSYCHOL REHABIL, V21, P208, DOI 10.1080/09602011.2011.552559; Smith A., 1991, SYMBOL DIGIT MODALIT; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Toglia J., 2018, COGNITION OCCUPATION, P355; Toglia J, 2015, WEEKLY CALENDAR PLAN; Toglia J., 2018, COGNITION OCCUPATION, V4th ed., P143; Toglia J.P., 2017, SCHEDULE ACTIVITY MO; Toglia J, 2020, BRIT J OCCUP THER, V83, P363, DOI 10.1177/0308022619898091; Toglia J, 2017, AM J OCCUP THER, V71, DOI 10.5014/ajot.2016.020073; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; Tsapekos D, 2019, NEUROPSYCHOL REHABIL, V29, P361, DOI 10.1080/09602011.2017.1301263; Turunen KEA, 2018, J INT NEUROPSYCH SOC, V24, P117, DOI 10.1017/S1355617717000728; Vossel S, 2013, CORTEX, V49, P1782, DOI 10.1016/j.cortex.2012.12.011; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015	40	3	3	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2020.1810710		SEP 2020	20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	NH9GG	WOS:000564969100001	32873157	hybrid			2022-02-06	
J	Metcalf, K; Sabaz, M; Daher, M; Simpson, G				Metcalf, Kasey; Sabaz, Mark; Daher, Maysaa; Simpson, Grahame			Measuring reliable change in traumatic brain injury (TBI): The pitfalls of using readily available formulae	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Traumatic brain injury; neuropsychological assessment; practice effects; reliable change	TEST-RETEST RELIABILITY; SEVERE HEAD-INJURY; CLINICAL NEUROPSYCHOLOGY; INTERPRETING CHANGE; RECOVERY; SCORES; ACADEMY; MODELS; IMPACT	Individuals with a traumatic brain injury (TBI) frequently undergo repeat neuropsychological assessments. Reliable change (RC) methodologies based on general population normative data are often used to assess for clinically significant change. The consequence of applying such methodologies to an individual with a TBI needs investigation. The current study tested the validity of readily available formulae in moderate to severe TBI participants who were >2 years postinjury. Participants were administered the Wechsler Adult Intelligence Scale-IV/Wechsler Memory Scale-IV (WAIS/WMS-IV) battery on two occasions across an approximate 1 year interval. Index scores were entered into 10 RC formulae to assess their validity in individuals with a TBI. Findings revealed that the formulae used in the study are relatively interchangeable in regards to WAIS-IV assessment, but that many of the formulae identified statistically unexpected rates of RC change in memory tasks assessed by the WMS-IV. Two formulae that did not contain statistical manipulations for practice effects performed relatively well in regards to memory assessment. Therefore, indiscriminate use of RC formulae could lead to over identifying memory decline in the TBI populations. The results suggest that either Iverson or Jacobson and Truax formulae can be used to assess RC for memory in moderate to severe TBI populations.	[Metcalf, Kasey; Daher, Maysaa; Simpson, Grahame] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Sabaz, Mark] Sydney Childrens Hosp, Dept Psychol, Randwick, NSW, Australia		Metcalf, K (corresponding author), Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool Bc, NSW, Australia.	kasey.metcalf@health.nsw.gov.au		Simpson, Grahame/0000-0001-8156-9060			Access Economics, 2009, EC COST SPIN CORD IN, V31; Barr William B, 2002, CNS Spectr, V7, P300; Basso MR, 2002, CLIN NEUROPSYCHOL, V16, P57, DOI 10.1076/clin.16.1.57.8329; Bird CM, 2004, BRIT J CLIN PSYCHOL, V43, P197, DOI 10.1348/014466504323088051; Charter RA, 1996, PERCEPT MOTOR SKILL, V82, P1139, DOI 10.2466/pms.1996.82.3c.1139; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Crawford JR, 2006, NEUROPSYCHOLOGY, V20, P259, DOI 10.1037/0894-4105.20.3.259; Crawford JR, 1998, J CLIN EXP NEUROPSYC, V20, P755, DOI 10.1076/jcen.20.5.755.1132; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P624, DOI 10.1080/13803390490918589; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Duff K., 2000, PRACTITIONERS GUIDE; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gavett BE, 2015, J INT NEUROPSYCH SOC, V21, P558, DOI 10.1017/S1355617715000582; Greve KW, 2002, ASSESSMENT, V9, P271, DOI 10.1177/1073191102009003006; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Hinton-Bayre AD, 2016, ARCH CLIN NEUROPSYCH, V31, P754, DOI 10.1093/arclin/acw064; Hinton-Bayre AD, 2011, ARCH CLIN NEUROPSYCH, V26, P76, DOI 10.1093/arclin/acq084; Hinton-Bayre AD, 2010, ARCH CLIN NEUROPSYCH, V25, P244, DOI 10.1093/arclin/acq008; Holdnack J. A., 2009, ADV CLIN SOLUTIONS W; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson G, 1999, J COGNITIVE REHABILI, V17, P16; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Ivnik RJ, 1999, NEUROPSYCHOLOGY, V13, P121, DOI 10.1037/0894-4105.13.1.121; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jennett B, 1981, MANAGEMENT HEAD INJU; MAA, 2013, NEUR ASS CHILDR AD T; Maassen GH, 2006, BRIT J SPORT MED, V40, P829, DOI 10.1136/bjsm.2005.023713; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MCSWEENY AJ, 1993, CLIN NEUROPSYCHOL, V7, P460; Miller JB, 2012, CLIN NEUROPSYCHOL, V26, P599, DOI 10.1080/13854046.2012.677478; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; Schultz R, 2013, BRAIN IMPAIR, V14, P450, DOI 10.1017/BrImp.2013.24; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Thiruselvam I, 2015, ARCH CLIN NEUROPSYCH, V30, P248, DOI 10.1093/arclin/acv010; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Turner TH, 2016, APPL NEUROPSYCH-ADUL, V23, P399, DOI 10.1080/23279095.2016.1160907; Wechsler D., 2008, WAIS 4 WECHSLER ADUL; Wechsler D, 2009, WECHSLER MEMORY SCAL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wong PP, 2001, BRAIN INJURY, V15, P519, DOI 10.1080/02699050010005995; Zegers F. E., 1994, ULTIMATE RELIABLE CH	51	3	3	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	SEP 2	2020	27	5					421	430		10.1080/23279095.2018.1559166			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	NC2YP	WOS:000561082300004	30724584				2022-02-06	
J	Cariello, AN; Perrin, PB; Rodriguez-Agudelo, Y; Plaza, SLO; Quijano-Martinez, MC; Arango-Lasprilla, JC				Cariello, Annahir N.; Perrin, Paul B.; Rodriguez-Agudelo, Yaneth; Olivera Plaza, Silvia Leonor; Cristina Quijano-Martinez, Maria; Carlos Arango-Lasprilla, Juan			A Multi-Site Study of Traumatic Brain Injury in Mexico and Colombia: Longitudinal Mediational and Cross-Lagged Models of Family Dynamics, Coping, and Health-Related Quality of Life	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; health-related quality of life; family dynamics; coping	COHERENCE; SENSE; DISABILITY; REHABILITATION; INDIVIDUALS; CAREGIVERS; VALIDITY; NEEDS; SATISFACTION; RELIABILITY	Latin America has high rates of traumatic brain injury (TBI), yet reduced mental and physical health outcomes due to limited rehabilitation services. To understand the psychosocial adjustment process in TBI patients in Latin America, the incorporation of cultural values including family-based variables is imperative. The current study examined relations among healthy family dynamics, coping, and mental and physical health related quality of life (HRQL) among a sample of TBI patients across three sites and two countries over the first 4 months post-injury. A sample of 109 acute TBI patients from Mexico and Colombia were recruited, and a series of longitudinal mediation and cross-lag panel analyses were run. Mental and physical HRQL were positively associated with each other, as well as healthy family dynamics and coping. Coping partially mediated the effects of healthy family dynamics on both mental and physical HRQL. Family dynamics showed the strongest cross-lag relationships with coping going from 2 months to 4 months. Similarly, coping showed the strongest cross-lag relationships with both mental and physical HRQL going from baseline to 2 months. Results provide empirical support for the importance of a rehabilitation workforce that has been trained in and can effectively implement family-based interventions for individuals with TBI in Latin America.	[Cariello, Annahir N.; Perrin, Paul B.] Virginia Commonwealth Univ, 907 Floyd Ave, Richmond, VA 23284 USA; [Rodriguez-Agudelo, Yaneth] Natl Inst Neurol & Neurosurg, Neuropsychol Dept, Mexico City 14269, DF, Mexico; [Olivera Plaza, Silvia Leonor] Univ Surcolombiana, Grp Invest Carlos Finlay, Neiva, Huila, Colombia; [Cristina Quijano-Martinez, Maria] Pontificia Univ Javeriana Cali, Dept Social Sci, Cali, Colombia; [Carlos Arango-Lasprilla, Juan] Cruces Univ Hosp Barakaldo, BioCruces Bizkaia Hlth Res Inst, Baracaldo 48903, Spain; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain; [Carlos Arango-Lasprilla, Juan] Univ Basque Country, Dept Cell Biol & Histol, UPV EHU, Leioa 48940, Biscay, Spain		Arango-Lasprilla, JC (corresponding author), Cruces Univ Hosp Barakaldo, BioCruces Bizkaia Hlth Res Inst, Baracaldo 48903, Spain.; Arango-Lasprilla, JC (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain.; Arango-Lasprilla, JC (corresponding author), Univ Basque Country, Dept Cell Biol & Histol, UPV EHU, Leioa 48940, Biscay, Spain.	carielloa@mymail.vcu.edu; pperrin@vcu.edu; yaneth_r@hotmail.com; silvileo06@hotmail.com; mcquijano@javerianacaliedu.co; jcalasprilla@gmail.com	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X	Fogarty International Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R21TW009746]	This study was funded by grant #R21TW009746 from Fogarty International Center of the National Institutes of Health.	Aarons GA, 2007, FAM PROCESS, V46, P557, DOI 10.1111/j.1545-5300.2007.00232.x; Alvis-Miranda H R, 2013, PANAM J TRAUMA CRIT, V2, P134; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Andren S, 2008, J CLIN NURS, V17, P790, DOI 10.1111/j.1365-2702.2007.02066.x; [Anonymous], **NON-TRADITIONAL**; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Antonovsky A., 1987, UNRAVELING MYSTERY H; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Ayuso-Mateos JL, 1999, ACTA PSYCHIAT SCAND, V99, P26, DOI 10.1111/j.1600-0447.1999.tb05381.x; Briceno-Leon R., 1999, P WORKSH RIS VIOL CR, P6; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Coy AE, 2013, ARCH PHYS MED REHAB, V94, P362, DOI 10.1016/j.apmr.2012.08.210; Elnasseh Aaliah G, 2016, Int J Alzheimers Dis, V2016, P2386728, DOI 10.1155/2016/2386728; Feigin R, 1998, MARRIAGE FAM REV, V27, P71, DOI 10.1300/J002v27n01_06; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Garcia-Moya I, 2012, SCAND J PUBLIC HEALT, V40, P333, DOI 10.1177/1403494812449924; Gison A, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0193-0; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Hsieh MY, 2012, DISABIL REHABIL, V34, P408, DOI 10.3109/09638288.2011.607219; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Jurkovich GJ, 1999, J TRAUMA, V47, pS46, DOI 10.1097/00005373-199909001-00011; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kirchner T, 2010, EUR PSYCHIAT, V25, P479, DOI 10.1016/j.eurpsy.2010.04.003; Kitter B, 2015, BRAIN INJURY, V29, P1082, DOI 10.3109/02699052.2015.1018323; Kouneski E., 2002, TWIN CITIES MN U MIN, V1, P1; Kreutzer J.S., 1990, COMMUNITY INTEGR TRA, P249; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; LAMMEL JA, 2003, THESIS; Lehan TJ, 2012, NEUROREHABILITATION, V30, P75, DOI 10.3233/NRE-2012-0729; Lopez Rebecca A, 2005, J Immigr Health, V7, P23, DOI 10.1007/s10903-005-1387-8; Marin G, 1991, RES HISPANIC POPULAT; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; MINUCHIN S, 1975, ARCH GEN PSYCHIAT, V32, P1031; Niemann Y. F., 2004, HDB CHICANA PSYCHOL, P79; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Petersen C, 2005, PROG BRAIN RES, V150, P545, DOI 10.1016/S0079-6123(05)50038-4; POLINDER S, 2015, POPUL HEALTH METR, V0013; Ramachandran A, 2017, WORLD J SURG, V41, P2224, DOI 10.1007/s00268-017-4013-8; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Rena F, 1996, SOC SCI MED, V43, P163, DOI 10.1016/0277-9536(95)00358-4; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Snell DL, 2017, DISABIL REHABIL, V39, P1968, DOI 10.1080/09638288.2016.1213895; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Stalp M, 2002, J TRAUMA, V52, P1160, DOI 10.1097/00005373-200206000-00023; Stejskal TM, 2012, NEUROREHABILITATION, V31, P75, DOI 10.3233/NRE-2012-0776; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Virues-Ortega J, 2007, MED CLIN-BARCELONA, V128, P486, DOI 10.1157/13100935; Webster G, 1999, BRAIN INJURY, V13, P593; Williams J., 1990, J HEAD TRAUMA REHAB, V5, P9, DOI [https://doi.org/10.1097/00001199-199003000-00004, DOI 10.1097/00001199-199003000-00004]; Yody BB, 2000, J HEAD TRAUMA REHAB, V15, P1041, DOI 10.1097/00001199-200008000-00006; Zniga Carrasco, 2008, VIGILANCIA EPIDEMIOL, V26, P1	57	3	3	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	SEP	2020	17	17							6045	10.3390/ijerph17176045			16	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	NO9ML	WOS:000569810000001	32825253	Green Published, gold			2022-02-06	
J	Cevik, HB; Yuvaci, F; Eceviz, E; Bulut, G				Cevik, Huseyin Bilgehan; Yuvaci, Fatih; Eceviz, Engin; Bulut, Guven			Four different management strategies in missed Monteggia lesions in children	JOURNAL OF ORTHOPAEDICS			English	Article						Missed monteggia lesion; Children; Ulnar osteotomy; Radial head dislocation	RADIAL HEAD DISLOCATIONS; OPEN REDUCTION; ULNAR OSTEOTOMY; FRACTURE-DISLOCATIONS; ANTERIOR DISLOCATION; CLOSED REDUCTION; FIXATION; OUTCOMES	Objectives: Management of missed Monteggia lesions presents a challenging clinical scenario for pediatric orthopaedic surgeons as the patient may be exposed to possible morbidities and increased complications. There are several evidenced surgical strategies described. We aimed to present 18 patients diagnosed within 4 months of injury who were treated using 4 of the identified many surgical strategies. Methods: Eighteen consecutive cases of missed Monteggia lesions were treated in our institution between 2011 and 2014. The mean delay from injury to surgery was 8.3 weeks (range 4-16). Bilateral preoperative and postoperative radiographs, Oxford Elbow Score, the direction of radial head dislocation, Bado classification, ulnar pathology (plastic deformation or fracture), carrying angle, head-neck ratio, any abnormal bony architecture, and any related condition. Results: There were no major complications to surgery. All patients had regained painless range of motion of the forearm and elbow, and reduced radiocapitellar joint. Ligament reconstruction or transcapitellar k-wire fixation did not influence the radiographic or clinical outcome. Conclusions: Because conservative treatment of this injury may cause high morbidity, surgical management should be preferred in the foreground. The ulnar deformity is a key point in the reduction of the radiocapitellar joint. The preferred treatment strategy has no significant effect on the results as long as it provides radial head reduction.	[Cevik, Huseyin Bilgehan] Univ Hlth Sci, Diskapi Yildirim Beyazit Res & Training Hosp, Dept Orthopaed & Traumatol, Sehit Omer Halisdemir St Diskapi, TR-06110 Ankara, Turkey; [Yuvaci, Fatih; Eceviz, Engin; Bulut, Guven] Univ Hlth Sci, Kartal Dr Lutfi Kirdar Res & Training Hosp, Dept Orthopaed & Traumatol, Denizer St Cevizili, TR-34806 Istanbul, Turkey		Cevik, HB (corresponding author), Diskapi Yildirim Beyazit Training & Res Hosp, Sehit Omer Halisdemir St Diskapi, TR-06110 Ankara, Turkey.	bilgehancevik@gmail.com	Cevik, H. Bilgehan/T-3713-2019; eceviz, engin/N-3329-2014	Cevik, H. Bilgehan/0000-0003-1945-3715; eceviz, engin/0000-0003-2453-0869			Bado JL, 1967, CLIN ORTHOP RELAT R, V50, P71; Belangero WD, 2007, INT ORTHOP, V31, P151, DOI 10.1007/s00264-006-0153-4; Bell Tawse A J, 1965, J Bone Joint Surg Br, V47, P718; Bor N, 2015, J PEDIATR ORTHOPED, V35, P7, DOI 10.1097/BPO.0000000000000203; BOUYALA JM, 1988, REV CHIR ORTHOP, V74, P173; BOUYALA JM, 1978, CHIR PEDIATR, V19, P201; CHEN WS, 1992, ACTA ORTHOP SCAND, V63, P343, DOI 10.3109/17453679209154798; Dawson J, 2008, J BONE JOINT SURG BR, V90B, P466, DOI 10.1302/0301-620X.90B4.20290; Dawson J, 2008, QUAL LIFE RES, V17, P1257, DOI 10.1007/s11136-008-9409-3; DeBoeck H, 1997, CLIN ORTHOP RELAT R, P94; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; Devnani AS, 1997, INJURY, V28, P131, DOI 10.1016/S0020-1383(96)00160-X; Exner GU, 2001, J BONE JOINT SURG BR, V83B, P547, DOI 10.1302/0301-620X.83B4.11103; Goyal T, 2015, J PEDIATR ORTHOP B, V24, P191, DOI 10.1097/BPB.0000000000000147; Gyr BM, 2004, J PEDIATR ORTHOP B, V13, P402, DOI 10.1097/01202412-200411000-00011; Hasler CC, 2005, J BONE JOINT SURG BR, V87B, P88, DOI 10.1302/0301-620X.87B1.14669; Hubbard J, 2018, JBJS REV, V6, DOI 10.2106/JBJS.RVW.17.00116; Hui JHP, 2005, J PEDIATR ORTHOPED, V25, P501, DOI 10.1097/01.bpo.0000158812.37225.b3; Jacobsen K, 1998, Ugeskr Laeger, V160, P4222; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P583, DOI 10.1097/00004694-200209000-00004; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P591, DOI 10.1097/01.BPO.0000023140.69745.72; Ladermann A, 2007, J CHILD ORTHOP, V1, P237, DOI 10.1007/s11832-007-0039-z; Liao SJ, 2019, INJURY, V50, P1237, DOI 10.1016/j.injury.2019.04.017; Mehta SD, 1985, INDIAN J SURG, V47, P15; Nakamura K, 2009, J BONE JOINT SURG AM, V91A, P1394, DOI 10.2106/JBJS.H.00644; ONER FC, 1993, J BONE JOINT SURG BR, V75, P577, DOI 10.1302/0301-620X.75B4.8331112; Rahbek O, 2011, J CHILD ORTHOP, V5, P449, DOI 10.1007/s11832-011-0372-0; Ring D, 1996, J BONE JOINT SURG BR, V78B, P734, DOI 10.1302/0301-620X.78B5.0780734; Rodgers WB, 1996, J BONE JOINT SURG AM, V78A, P1322, DOI 10.2106/00004623-199609000-00005; STOLL TM, 1992, J BONE JOINT SURG BR, V74, P436, DOI 10.1302/0301-620X.74B3.1587897; TAJIMA T, 1995, J HAND SURG-AM, V20A, pS91, DOI 10.1016/S0363-5023(95)80177-4; VERNERET C, 1989, REV CHIR ORTHOP, V75, P77; Wang Q, 2019, ORTHOP SURG, V11, P102, DOI 10.1111/os.12426	33	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0972-978X			J ORTHOP	J. Orthop.	SEP-OCT	2020	21						207	212		10.1016/j.jor.2020.03.055			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	OE2WJ	WOS:000580396900037	32273658	Green Published			2022-02-06	
J	Corwin, DJ; Arbogast, KB; Swann, C; Haber, R; Grady, MF; Master, CL				Corwin, Daniel J.; Arbogast, Kristy B.; Swann, Casey; Haber, Rebecca; Grady, Matthew F.; Master, Christina L.			Reliability of the visio-vestibular examination for concussion among providers in a pediatric emergency department	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Pediatric concussion; Visio-vestibular examination; Vestibular and oculomotor deficits; Reliability	ASSOCIATIONS; OCULOMOTOR; ACCURACY; COMMON	Background: Visio-vestibular examination (VVE) deficits are common following pediatric concussion. Guidelines recommend assessing these deficits on all potentially concussed youth given their diagnostic and prognostic value, however test psychometrics of the VVE in the emergency department (ED) setting are unknown. Our objective was to determine the inter-rater (IRR) and test-retest reliability (TRR) of the VVE in a pediatric ED. Methods: We enrolled 155 patients (112 IRR; 43 TRR) age 6-18 years with head injury presenting to the ED of a tertiary care children's hospital. Exams were performed by a group of 65 attending/fellow physicians, pediatricians, and advanced practice providers. The VVE consisted of 9 maneuvers (smooth pursuits, horizontal/vertical saccades and gaze stability, binocular convergence, left/right monocular accommodation, complex tandemgait). Cohen's kappa was calculated for IRR and TRR for each element. Results: For IRR, 5/9 kappas (saccades, gaze stability, monocular accommodation) were in the moderate agreement range (0.40 to 0.60); remaining kappas showed fair agreement. For TRR, 6/9 maneuvers (saccades, horizontal gaze stability, monocular accommodation, tandem gait) showed substantial agreement (0.60 to 0.80). Kappas of 7/9 elements for subjects age 15-18 showed improved IRR and TRR. Conclusions: The individual elements of the VVE show fair to moderate agreement between providers and moderate to substantial agreement among the same provider in the ED setting. These findings suggest a role in the VVE in evaluating concussion acutely, particularly given its previously demonstrated ability to assist in risk stratification of concussed youth and the importance of early diagnosis for improved outcomes. (c) 2020 Elsevier Inc. All rights reserved.	[Corwin, Daniel J.; Arbogast, Kristy B.; Swann, Casey; Haber, Rebecca; Master, Christina L.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19103 USA; [Corwin, Daniel J.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19103 USA; [Grady, Matthew F.; Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19103 USA; [Corwin, Daniel J.; Arbogast, Kristy B.; Grady, Matthew F.; Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA		Corwin, DJ (corresponding author), Childrens Hosp Philadelphia, Roberts Ctr Pediat Res, 2716 South St, Philadelphia, PA 19103 USA.	corwind@email.chop.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097549]; internal Nicholas Crognale Chair Divisional Research Grant from the Division of Emergency Medicine of Children's Hospital of Philadelphia	Research reported in this publicationwas also supported by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS097549. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study was also supported by an internal Nicholas Crognale Chair Divisional Research Grant from the Division of Emergency Medicine of Children's Hospital of Philadelphia.	Anderson M, 2015, INT J EXERC SCI C P, V11, P30; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bourne CL, 2014, WEST J EMERG MED, V15, P889, DOI 10.5811/westjem.2014.9.22691; Boutis K, 2018, J EMERG MED, V54, P757, DOI 10.1016/j.jemermed.2018.02.041; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Corwin DJ, 2020, MED SCI SPORT EXER, V52, P542, DOI 10.1249/MSS.0000000000002163; Corwin DJ, 2019, AM J EMERG MED, V37, P1219, DOI 10.1016/j.ajem.2018.09.008; Corwin DJ, 2018, BRAIN INJURY, V32, P794, DOI 10.1080/02699052.2018.1458150; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Howell DR, 2019, J ATHL TRAINING, V54, P1254, DOI 10.4085/1062-6050-525-18; Iverson GL, 2019, CLIN J SPORTS MED; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Lavrich JB, 2010, CURR OPIN OPHTHALMOL, V21, P356, DOI 10.1097/ICU.0b013e32833cf03a; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nunes AF, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1061-x; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955; Viera AJ, 2005, FAM MED, V37, P360; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zonfrillo M, ED PATHWAY EVALUATIO; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	37	3	3	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2020	38	9					1847	1853		10.1016/j.ajem.2020.06.020			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	OE6OI	WOS:000580647500027	32745919	Green Accepted			2022-02-06	
J	Dobran, M; Nasi, D; Polonara, G; Paracino, R; Mancini, F; Della Costanza, M; Jonis, G; Campa, S; Lattanzi, S; Iacoangeli, M				Dobran, Mauro; Nasi, Davide; Polonara, Gabriele; Paracino, Riccardo; Mancini, Fabrizio; Della Costanza, Martina; Jonis, Gjino; Campa, Serena; Lattanzi, Simona; Iacoangeli, Maurizio			Clinical and radiological risk factors of autograft cranioplasty resorption after decompressive craniectomy for traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Autologous bone flap resorption; Cranioplasty; Decompressive craniectomy; Traumatic brain injury; Neutrophil-to-lymphocyte ratio	BONE	Objective: The repositioning of an autologous bone flap after decompressive craniectomy (DC) for traumatic intracranial hypertension remains the first-line treatment for cranial reconstruction. Aseptic autologous bone flap resorption (BFR) is the most frequent complication. The identification of possible predictive parameters for BFR would help to improve the management of these patients. Patients and methods: Three hundred and nine patients undergoing autologous bone flap repositioning after previous DC for TBI between September 2003 and September 2017 were included in the study. Results: BFR was identified in 76 (24,59 %) of the 309 patients undergoing autologous CP. Age of <= 45 years and CP bone fragmentation were seen to be significant independent risk factors for BFR (p = 0.001 and p = 0.018, respectively) using multivariate logistic regression analysis. Of the radiologic predictors, CP size and the gap between CP and the skull defect were independently associated with BFR (p = 0.034 and p = 0.0003, respectively). The Youden index and ROC curve analysis were used to estimate the cut-off values for the continuous parameters and determine the sensitivity and specificity of the radiologic risk factors. The cut-off value for these two factors was found to be 114,98 cm2 and >= 578,5 mm2, respectively. The area under the ROC curve was 0.627 for bone flap size and 0.758 for the DC-CP gap. The DC-CP gap had greater sensitivity and specificity as a predictor of BFR, compared to bone flap size (p = 0.079 and p = <= 0.001, respectively). Conclusions: In this large cohort of patients with autologous cranioplasty, younger age, fragmented autologous bone flap and a wide gap between CP and cranial defect were predictive of bone flap resorption.	[Polonara, Gabriele; Campa, Serena] Univ Politecn Marche, Neuroradiol Dept, Osped Riuniti Ancona, Ancona, Italy; [Lattanzi, Simona] Univ Politecn Marche, Dept Neurol, Osped Riuniti Ancona, Ancona, Italy; [Dobran, Mauro; Nasi, Davide; Paracino, Riccardo; Mancini, Fabrizio; Della Costanza, Martina; Jonis, Gjino; Iacoangeli, Maurizio] Univ Politecn Marche, Dept Neurosurg, Osped Riuniti Ancona, Via Conca 71, I-60020 Ancona, Italy		Dobran, M (corresponding author), Univ Politecn Marche, Dept Neurosurg, Osped Riuniti Ancona, Via Conca 71, I-60020 Ancona, Italy.	dobran@libero.it		Lattanzi, Simona/0000-0001-8748-0083; Nasi, Davide/0000-0002-7357-7455; Mancini, Fabrizio/0000-0001-7077-4106			Corbett JM, 2020, J NEUROSURG, V132, P545, DOI 10.3171/2018.10.JNS182293; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Kim JH, 2018, WORLD NEUROSURG, V115, pE111, DOI 10.1016/j.wneu.2018.03.197; Liu LM, 2020, BRIT J NEUROSURG, V34, P388, DOI 10.1080/02688697.2020.1742291; Malcolm JG, 2018, WORLD NEUROSURG, V116, P60, DOI 10.1016/j.wneu.2018.05.009; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Nasi D., 2018, ACTA NEUROCHIR, V116, P406; Nasi D, 2018, ACTA NEUROCHIR, V160, P2127, DOI 10.1007/s00701-018-3688-4; Nasi D, 2018, WORLD NEUROSURG, V116, pE543, DOI 10.1016/j.wneu.2018.05.028; Nasi D, 2016, WORLD NEUROSURG, V91, DOI 10.1016/j.wneu.2016.04.041; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159	13	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	SEP	2020	196								105979	10.1016/j.clineuro.2020.105979			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NR3RZ	WOS:000571482200025	32544731				2022-02-06	
J	Frodsham, KM; Fair, JE; Frost, RB; Hopkins, RO; Bigler, ED; Majercik, S; Bledsoe, J; Ryser, D; MacDonald, J; Barrett, R; Horn, SD; Pisani, D; Stevens, M; Larson, MJ				Frodsham, Kayla M.; Fair, Joseph E.; Frost, R. Brock; Hopkins, Ramona O.; Bigler, Erin D.; Majercik, Sarah; Bledsoe, Joseph; Ryser, David; MacDonald, Joel; Barrett, Ryan; Horn, Susan D.; Pisani, David; Stevens, Mark; Larson, Michael J.			Day-of-Injury Computed Tomography and Longitudinal Rehabilitation Outcomes A Comparison of the Marshall and Rotterdam Computed Tomography Scoring Methods	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Traumatic Brain Injury; Rehabilitation; Computed Tomography	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; HEAD-INJURY; CT; CLASSIFICATION; PREDICTION; SEVERITY; SCORES; 1-YEAR; CARE	Objective The aim of the study was to compare the relative predictive value of Marshall Classification System and Rotterdam scores on long-term rehabilitation outcomes. This study hypothesized that Rotterdam would outperform Marshall Classification System. Design The study used an observational cohort design with a consecutive sample of 88 participants (25 females, mean age = 42.0 [SD= 21.3]) with moderate to severe traumatic brain injury who were admitted to trauma service with subsequent transfer to the rehabilitation unit between February 2009 and July 2011 and who had clearly readable computed tomography scans. Twenty-three participants did not return for the 9-mo postdischarge follow-up. Day-of-injury computed tomography images were scored using both Marshall Classification System and Rotterdam criteria by two independent raters, blind to outcomes. Functional outcomes were measured by length of stay in rehabilitation and the cognitive and motor subscales of the Functional Independence Measure at rehabilitation discharge and 9-mo postdischarge follow-up. Results Neither Marshall Classification System nor Rotterdam scales as a whole significantly predicted Functional Independence Measure motor or cognitive outcomes at discharge or 9-mo follow-up. Both scales, however, predicted length of stay in rehabilitation. Specific Marshall scores (3 and 6) and Rotterdam scores (5 and 6) significantly predicted subacute outcomes such as Functional Independence Measure cognitive at discharge from rehabilitation and length of stay. Conclusions Marshall Classification System and Rotterdam scales may have limited utility in predicting long-term functional outcome, but specific Marshall and Rotterdam scores, primarily linked to increased severity and intracranial pressure, may predict subacute outcomes.	[Frodsham, Kayla M.; Fair, Joseph E.; Frost, R. Brock; Hopkins, Ramona O.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84604 USA; [Fair, Joseph E.] Utah Valley Hosp, Utah Valley Orthoped & Sports Med, Provo, UT USA; [Fair, Joseph E.] Utah Valley Hosp, Dept Phys Med & Rehabil, Provo, UT USA; [Frost, R. Brock] Raymond G Murphy VA Med Ctr, Albuquerque, NM USA; [Frost, R. Brock] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Hopkins, Ramona O.] Intermt Med Ctr, Pulm & Crit Care Med, Murray, UT USA; [Hopkins, Ramona O.] Intermt Healthcare, Ctr Humanizing Crit Care, Murray, UT USA; [Hopkins, Ramona O.; Bigler, Erin D.; Larson, Michael J.] Brigham Young Univ, Neurosci Ctr, 244 TLRB, Provo, UT 84604 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat & Neurol, Salt Lake City, UT USA; [Majercik, Sarah; Stevens, Mark] Intermt Med Ctr, Div Trauma Serv & Surg Crit Care, Murray, UT USA; [Bledsoe, Joseph] Intermt Med Ctr, Dept Emergency Med, Murray, UT USA; [Ryser, David] Intermt Med Ctr, Dept Rehabil Med, Murray, UT USA; [MacDonald, Joel] Salt Lake Reg Med Ctr, Neurosurg, Salt Lake City, UT USA; [Barrett, Ryan; Horn, Susan D.] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Horn, Susan D.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Pisani, David] Intermt Med Ctr, Dept Radiol, Murray, UT USA		Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84604 USA.; Larson, MJ (corresponding author), Brigham Young Univ, Neurosci Ctr, 244 TLRB, Provo, UT 84604 USA.				Intermountain Research and Medical Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Ontario Neurotrauma Foundation; National Institute for Disability and Rehabilitation Research	This research was funded by a grant from the Intermountain Research and Medical Foundation and grants from National Institutes of Health, the Ontario Neurotrauma Foundation, and the National Institute for Disability and Rehabilitation Research.	Aldossary NM, 2019, J AFFECT DISORDERS, V243, P1, DOI 10.1016/j.jad.2018.09.001; Avesani R, 2011, EUR J PHYS REHAB MED, V47, P203; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Brown AW, 2019, BRAIN INJURY, V33, P610, DOI 10.1080/02699052.2019.1566970; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Ding J, 2012, BRAIN INJURY, V26, P1211, DOI 10.3109/02699052.2012.667591; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Horn SD, 2015, ARCH PHYS MED REHAB, V96; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS173, DOI 10.1016/j.apmr.2015.03.027; JOHNSTON MV, 1991, AM J PHYS MED REHAB, V70, P40, DOI 10.1097/00002060-199102000-00008; Lee Bruce, 2005, NeuroRx, V2, P372; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P199, DOI 10.1007/s00402-012-1652-y; Leon-Carrion J, 2013, BRAIN INJURY, V27, P1119, DOI 10.3109/02699052.2013.804204; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Majercik S, 2017, J TRAUMA ACUTE CARE, V82, P80, DOI 10.1097/TA.0000000000001263; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Munakomi S, 2016, CHIN J TRAUMATOL, V19, P25, DOI 10.1016/j.cjtee.2015.12.005; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; SCHEFFE H, 1953, BIOMETRIKA, V40, P87, DOI 10.1093/biomet/40.1-2.87; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402	45	3	3	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	SEP	2020	99	9					821	829		10.1097/PHM.0000000000001422			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	NF8PB	WOS:000563553900015	32195734	Green Accepted			2022-02-06	
J	Harriss, AB; Abbott, KC; Humphreys, D; Daley, M; Moir, ME; Woehrle, E; Balestrini, CS; Fischer, LK; Fraser, DD; Shoemaker, JK				Harriss, Alexandra B.; Abbott, Kolten C.; Humphreys, David; Daley, Mark; Moir, Marci Erin; Woehrle, Emilie; Balestrini, Christopher S.; Fischer, Lisa K.; Fraser, Douglas D.; Shoemaker, Joel Kevin			Concussion Symptoms Predictive of Adolescent Sport-Related Concussion Injury	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; youth; SCAT III; symptom; postconcussion; self-report		Objective: To assess the predictive capability of the postconcussion symptom scale (PCSS) of the sport concussion assessment tool (SCAT) III to differentiate concussed and nonconcussed adolescents. Design: Retrospective. Setting: Tertiary. Participants: Sixty-nine concussed (15.2 +/- 1.6 years old) and 55 control (14.4 +/- 1.7 years old) adolescents. Independent Variables: Postconcussion symptom scale. Main Outcome Measure: Two-proportion z-test determined differences in symptom endorsement between groups. To assess the predictive power of the PCSS, we trained an ensemble classifier composed of a forest of 1000 decision trees to classify subjects as concussed, or not concussed, based on PCSS responses. The initial classifier was trained on all 22-concussion symptoms addressed in the PCSS, whereas the second classifier removed concussion symptoms that were not statistically significant between groups. Results: Concussion symptoms common between groups were trouble falling asleep, more emotional, irritability, sadness, and anxious. After removal, analysis of the second classifier indicated that the 5 leading feature rankings of symptoms were headache, head pressure, light sensitivity, noise sensitivity, and "don't feel right," which accounted for 52% of the variance between groups. Conclusions: Collectively, self-reported symptoms through the PCSS can differentiate concussed and nonconcussed adolescents. However, predictability for adolescent patients may be improved by removing emotional and sleep domain symptoms.	[Harriss, Alexandra B.; Abbott, Kolten C.; Humphreys, David; Moir, Marci Erin; Woehrle, Emilie; Shoemaker, Joel Kevin] Western Univ, Sch Kinesiol, 1151 Richmond St, London, ON N6A 5B9, Canada; [Harriss, Alexandra B.] Western Univ, Dept Hlth & Rehabil Sci, London, ON, Canada; [Daley, Mark] Western Univ, Dept Comp Sci, London, ON, Canada; [Daley, Mark] Western Univ, Dept Biol, London, ON, Canada; [Daley, Mark] Western Univ, Dept Stat & Actuarial Sci, London, ON, Canada; [Balestrini, Christopher S.] Western Univ, Dept Anat & Cell Biol, London, ON, Canada; [Fischer, Lisa K.] Western Univ, Dept Family Med, London, ON, Canada; [Fischer, Lisa K.] Western Univ, Fowler Kennedy Sports Med Clin, London, ON, Canada; [Fraser, Douglas D.] Western Univ, Dept Paediat, London, ON, Canada; [Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Shoemaker, Joel Kevin] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada		Shoemaker, JK (corresponding author), Western Univ, Sch Kinesiol, 1151 Richmond St, London, ON N6A 5B9, Canada.	kshoemak@uwo.ca	Daley, Mark/AAS-7366-2020; Fischer, Lisa K/H-3999-2015; Shoemaker, Joel Kevin/L-2682-2013	Daley, Mark/0000-0002-6939-9772; Fischer, Lisa K/0000-0001-5992-0176; Shoemaker, Joel Kevin/0000-0002-6794-5979	Children's Health Foundation	This study was funded by the Children's Health Foundation.	Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Bishop C., 2006, PATTERN RECOGN; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Smith-Seemiller L, 2009, BRAIN INJURY, V17, P199	6	3	3	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2020	30	5					E147	E149		10.1097/JSM.0000000000000714			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NX9CH	WOS:000575999300008	30969186				2022-02-06	
J	Kheirabadi, BS; Miranda, N; Terrazas, IB; Voelker, AN; de Guzman, R; Wienandt, NA; Brown, AW; Dubick, MA				Kheirabadi, Bijan S.; Miranda, Nahir; Terrazas, Irasema B.; Voelker, Amber N.; de Guzman, Rodolfo; Wienandt, Nathan A.; Brown, Ammon W.; Dubick, Michael A.			SHOULD ALBUMIN BE CONSIDERED FOR PREHOSPITAL RESUSCITATION IN AUSTERE ENVIRONMENTS? A PROSPECTIVE RANDOMIZED SURVIVAL STUDY IN RABBITS	SHOCK			English	Article						Albumin; blood; hemorrhagic shock; plasma; prehospital resuscitation; rabbits	TRAUMATIC BRAIN-INJURY; FLUID RESUSCITATION; COMBAT CASUALTIES; AFGHANISTAN; SALINE; BLOOD; TRANSFUSION; MILITARY	Background: The new guidelines for prehospital care of combat casualties in shock recommend administration of whole blood or blood components to increase blood pressure to a permissible hypotensive level (i.e., hypotensive resuscitation [HR]). We investigated if 2 h of HR using limited volumes of whole blood, plasma, or albumin would lead to full recovery and long-term survival of rabbits subjected to severe hemorrhagic shock (HS). Methods: Following instrumentation, laparotomy was performed on IV-anesthetized spontaneously breathing New Zealand white rabbits (3.0 kg -3.5 kg). Next, similar to 40% of rabbits' blood volume was removed producing HS (mean arterial pressure [MAP]similar to 20 mm Hg). Fifteen minutes later, rabbits were resuscitated with a limited volume (12.5 mL/kg) of rabbit whole blood (fresh whole blood [FWB]), rabbit fresh frozen plasma (FFP), or 5% human albumin (ALB) to a target pressure (MAP) of 60 mm Hg (n=8/grp (n =6) was also included. Results: Following HS, lactate and base deficit levels were increased to 8.2 +/- 1.6 and 12.9 +/- 3.1mM respectively with no difference among groups. A lower volume of FWB volume was required to reach the target MAP (P< 0.05 vs. ALB) but MAP declined during the HR period (P< 0.01 vs. ALB). FWB provided higher hematocrit and platelets but it did not reduce lactate level faster than other fluids. Beside higher fibrinogen, no differenceswere found in hemostatic or resuscitative effects of FFP versus ALB. Bleeding time was prolonged with ALB and FFP fluids but unchanged with FWB. Untreated rabbits died during shock or shortly after. All treated rabbits except one recovered and lived for 8 days with normal blood tests and similar tissue histology. Conclusions: Two hours of HRusing a limited volume of FWB, FFP, or ALB led to full recovery and long-termsurvival of rabbits subjected to HS. Apart from bleeding time, no clinically significant differenceswere found among the three fluids. Five percent human albumin solutions are isotonic, iso-oncotic, ready-to-use, stable, and compatible with all blood types and should be considered for prehospital resuscitation where blood products are not available or not accepted.	[Kheirabadi, Bijan S.; Miranda, Nahir; Terrazas, Irasema B.; Voelker, Amber N.; de Guzman, Rodolfo; Wienandt, Nathan A.; Brown, Ammon W.; Dubick, Michael A.] US Army, Inst Surg Res, Ft Sam Houston, TX 78234 USA		Kheirabadi, BS (corresponding author), 3650 Chambers Pass,BHT2,Bldg 3610, Ft Sam Houston, TX 78234 USA.	Bijan.s.kheirabadi.civ@mail.mil			US Army Medical Research and Development Command	This manuscript is not an endorsement of any commercial products by the authors or the U.S. Army. The funding for this work was provided solely by the US Army Medical Research and Development Command.	Bailey JA, 2013, CURR OPIN CRIT CARE, V19, P569, DOI 10.1097/MCC.0000000000000037; Brohi K, 2019, INTENS CARE MED, V45, P709, DOI 10.1007/s00134-019-05560-x; Butler Frank K, 2014, J Spec Oper Med, V14, P13; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; CROWELL JW, 1964, AM J PHYSIOL, V206, P313, DOI 10.1152/ajplegacy.1964.206.2.313; Delellis SM, J SPECIAL OP MED, P2018; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Garner J, 2010, ANN SURG, V251, P1131, DOI 10.1097/SLA.0b013e3181e00fcb; Goforth CW, 2016, CRIT CARE NURSE, V36, P50, DOI 10.4037/ccn2016780; Hedin A, 2005, CLIN SCI, V108, P217, DOI 10.1042/CS20040303; Institute of Laboratory Animal Resources National Research Council, 1996, GUIDE CARE USE LAB A; Kheirabadi BS, 2015, J TRAUMA ACUTE CARE, V78, P752, DOI 10.1097/TA.0000000000000591; Kheirabadi BS, 2017, J TRAUMA ACUTE CARE, V82, P156, DOI 10.1097/TA.0000000000001285; Kheirabadi BS, 2016, J TRAUMA ACUTE CARE, V81, P42, DOI 10.1097/TA.0000000000001091; MORTON DB, 1993, LAB ANIM, V27, P1, DOI 10.1258/002367793780745633; Murdock AD, 2014, SHOCK, V41, P62, DOI 10.1097/SHK.0000000000000134; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Penn-Barwell JG, 2015, J TRAUMA ACUTE CARE, V78, P1014, DOI 10.1097/TA.0000000000000580; Pivalizza EG, 2018, ANESTH ANALG, V127, P157, DOI 10.1213/ANE.0000000000003427; Rixen D, 2005, CRIT CARE, V9, P441, DOI 10.1186/cc3526; Shackelford SA, 2017, JAMA-J AM MED ASSOC, V318, P1581, DOI 10.1001/jama.2017.15097; Siller-Matula JM, 2008, THROMB HAEMOSTASIS, V100, P397, DOI 10.1160/TH08-02-0103; Skarda DE, 2008, ACAD EMERG MED, V15, P845, DOI 10.1111/j.1553-2712.2008.00202.x; Smith IM, 2016, SHOCK, V46, P3, DOI 10.1097/SHK.0000000000000569; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Studer NM, 2017, J SPEC OPER MED, V17, P82; Torres LN, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1745-7; Van Aken HK, 2012, CURR OPIN ANESTHESIO, V25, P563, DOI 10.1097/ACO.0b013e3283572274; Vincent JL, 2014, CRIT CARE, V18, DOI 10.1186/cc13991; Yu YH, 2009, RESUSCITATION, V80, P1424, DOI 10.1016/j.resuscitation.2009.08.024	30	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	SEP	2020	54	3					358	367		10.1097/SHK.0000000000001480			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	QJ2DE	WOS:000619499200012	31743300	Bronze			2022-02-06	
J	Lazzarino, G; Amorini, AM; Barnes, NM; Bruce, L; Mordente, A; Lazzarino, G; Di Pietro, V; Tavazzi, B; Belli, A; Logan, A				Lazzarino, Giacomo; Amorini, Angela Maria; Barnes, Nicholas M.; Bruce, Lars; Mordente, Alvaro; Lazzarino, Giuseppe; Di Pietro, Valentina; Tavazzi, Barbara; Belli, Antonio; Logan, Ann			Low Molecular Weight Dextran Sulfate (ILB(R)) Administration Restores Brain Energy Metabolism Following Severe Traumatic Brain Injury in the Rat	ANTIOXIDANTS			English	Article						severe traumatic brain injury; low molecular weight dextran sulfate; mitochondrial dysfunction; energy metabolism; N-acetylaspartate; nicotinic coenzymes; oxidative; nitrosative stress; ascorbate; reduced glutathione (GSH); HPLC	MITOCHONDRIAL DYSFUNCTION; TEMPORAL WINDOW; LIPID-PEROXIDATION; CYCLOSPORINE-A; GROWTH-FACTOR; INFLAMMATION; MODEL; VULNERABILITY; NEUROINFLAMMATION; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) is the leading cause of death and disability in people less than 40 years of age in Western countries. Currently, there are no satisfying pharmacological treatments for TBI patients. In this study, we subjected rats to severe TBI (sTBI), testing the effects of a single subcutaneous administration, 30 min post-impact, of a new low molecular weight dextran sulfate, named ILB(R), at three different dose levels (1, 5, and 15 mg/kg body weight). A group of control sham-operated animals and one of untreated sTBI rats were used for comparison (each groupn= 12). On day 2 or 7 post-sTBI animals were sacrificed and the simultaneous HPLC analysis of energy metabolites,N-acetylaspartate (NAA), oxidized and reduced nicotinic coenzymes, water-soluble antioxidants, and biomarkers of oxidative/nitrosative stress was carried out on deproteinized cerebral homogenates. Compared to untreated sTBI rats, ILB(R)improved energy metabolism by increasing ATP, ATP/ adenosine diphosphate ratio (ATP/ADP ratio), and triphosphate nucleosides, dose-dependently increased NAA concentrations, protected nicotinic coenzyme levels and their oxidized over reduced ratios, prevented depletion of ascorbate and reduced glutathione (GSH), and decreased oxidative (malondialdehyde formation) and nitrosative stress (nitrite + nitrate production). Although needing further experiments, these data provide the first evidence that a single post-injury injection of a new low molecular weight dextran sulfate (ILB(R)) has beneficial effects on sTBI metabolic damages. Due to the absence of adverse effects in humans, ILB(R)represents a promising therapeutic agent for the treatment of sTBI patients.	[Lazzarino, Giacomo; Tavazzi, Barbara] UniCamillus St Camillus Int Univ Hlth Sci, Via St Alessandro 8, I-00131 Rome, Italy; [Amorini, Angela Maria; Lazzarino, Giuseppe] Univ Catania, Div Med Biochem, Dept Biomed & Biotechnol Sci, Via S Sofia 97, I-95123 Catania, Italy; [Barnes, Nicholas M.; Di Pietro, Valentina; Belli, Antonio] Queen Elizabeth Hosp, Natl Inst Hlth Res Surg Reconstruct & Microbiol R, Birmingham B15 2TH, W Midlands, England; [Barnes, Nicholas M.] Univ Birmingham, Inst Clin Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Bruce, Lars] Tikomed AB, S-26303 Viken, Sweden; [Mordente, Alvaro; Tavazzi, Barbara] Catholic Univ Sacred Heart Rome, Dept Basic Biotechnol Sci Intens & Perioperat Cli, Largo F Vito 1, I-00168 Rome, Italy; [Mordente, Alvaro; Tavazzi, Barbara] Fdn Policlin Univ A Gemelli IRCCS, Dept Lab Sci & Infect Dis, Largo A Gemelli 8, I-00168 Rome, Italy; [Di Pietro, Valentina; Belli, Antonio] Univ Birmingham, Neurotrauma & Ophthalmol Res Grp, Inst Inflammat & Ageing, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Logan, Ann] Axolotl Consulting Ltd, Droitwich WR9 0JS, Worcs, England		Tavazzi, B (corresponding author), UniCamillus St Camillus Int Univ Hlth Sci, Via St Alessandro 8, I-00131 Rome, Italy.; Lazzarino, G (corresponding author), Univ Catania, Div Med Biochem, Dept Biomed & Biotechnol Sci, Via S Sofia 97, I-95123 Catania, Italy.; Di Pietro, V (corresponding author), Queen Elizabeth Hosp, Natl Inst Hlth Res Surg Reconstruct & Microbiol R, Birmingham B15 2TH, W Midlands, England.; Tavazzi, B (corresponding author), Catholic Univ Sacred Heart Rome, Dept Basic Biotechnol Sci Intens & Perioperat Cli, Largo F Vito 1, I-00168 Rome, Italy.; Tavazzi, B (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, Dept Lab Sci & Infect Dis, Largo A Gemelli 8, I-00168 Rome, Italy.; Di Pietro, V (corresponding author), Univ Birmingham, Neurotrauma & Ophthalmol Res Grp, Inst Inflammat & Ageing, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.; Logan, A (corresponding author), Axolotl Consulting Ltd, Droitwich WR9 0JS, Worcs, England.	giacomo.lazzarino@unicamillus.org; amorini@unict.it; n.m.barnes@bham.ac.uk; lars.bruce@tikomed.com; alvaro.mordente@unicatt.it; lazzarig@unict.it; v.dipietro@bham.ac.uk; barbara.tavazzi@unicatt.it; a.belli@bham.ac.uk; a.logan@axolotlconsulting.com	TAVAZZI, BARBARA/AAB-9830-2019; Belli, Antonio/I-3799-2015; Barnes, Nicholas/ABE-6312-2020; Nagy, Zsuzsanna/L-8446-2013; lazzarino, giuseppe/K-2277-2015	TAVAZZI, BARBARA/0000-0001-8743-0895; Belli, Antonio/0000-0002-3211-9933; Nagy, Zsuzsanna/0000-0002-6700-4829; AMORINI, Angela Maria/0000-0003-3525-9955; lazzarino, giuseppe/0000-0002-5917-7279; Lazzarino, Giacomo/0000-0003-1639-0966	Tikomed AB, Sweden [78/2018-PR] Funding Source: Medline		Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Akella NM, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0671-3; Amorini AM, 2016, BBA-MOL BASIS DIS, V1862, P679, DOI 10.1016/j.bbadis.2016.01.023; Mejia SA, 2018, EUR J PHARMACOL, V818, P499, DOI 10.1016/j.ejphar.2017.10.048; Bakthavachalam P, 2017, J NEUROL SCI, V375, P417, DOI 10.1016/j.jns.2017.02.043; Bao ZY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00222; Barritault D, 2017, GLYCOCONJUGATE J, V34, P325, DOI 10.1007/s10719-016-9744-5; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carteri RB, 2019, J NEUROTRAUM, V36, P2246, DOI 10.1089/neu.2018.6266; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chen L, 2019, INT J BIOL MACROMOL, V126, P743, DOI 10.1016/j.ijbiomac.2018.12.261; Chen YH, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00202; Choi JJ, 2010, ULTRASOUND MED BIOL, V36, P58, DOI 10.1016/j.ultrasmedbio.2009.08.006; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Czigler A, 2019, J NEUROTRAUM, V36, P3309, DOI 10.1089/neu.2019.6439; Darwish RS, 2010, NEUROCRIT CARE, V12, P337, DOI 10.1007/s12028-009-9328-3; Devanney NA, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113310; Di Pietro V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030260; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; DIPIETRO V, 2017, SCI REP UK, V7; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Froese L, 2021, NEUROCRIT CARE, V34, P325, DOI 10.1007/s12028-020-01003-4; FUJISHIMA M, 1986, ANGIOLOGY, V37, P487, DOI 10.1177/000331978603700702; Hagiwara A, 1997, ANTI-CANCER DRUG, V8, P894, DOI 10.1097/00001813-199710000-00011; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Johansson H, 2006, AM J TRANSPLANT, V6, P305, DOI 10.1111/j.1600-6143.2005.01186.x; Josephine A, 2007, MOL NUTR FOOD RES, V51, P1413, DOI 10.1002/mnfr.200700127; Josephine A, 2006, MOL CELL BIOCHEM, V287, P101, DOI 10.1007/s11010-005-9081-7; Kerr N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210128; Kulikova VA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P800, DOI 10.1134/S0006297918070040; Kumar D, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2019.134347; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Lazzarino G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225774; Ley K, 1998, CIRC RES, V83, P287, DOI 10.1161/01.RES.83.3.287; Lorente L, 2021, MED INTENSIVA, V45, P131, DOI 10.1016/j.medin.2019.09.005; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Ma MW, 2018, FREE RADICAL BIO MED, V117, P66, DOI 10.1016/j.freeradbiomed.2018.01.031; Ma XT, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2542950; Maldonado EN, 2014, MITOCHONDRION, V19, P78, DOI 10.1016/j.mito.2014.09.002; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsumiya A, 1998, LIFE SCI, V64, pPL9, DOI 10.1016/S0024-3205(98)00546-3; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Perdomo G, 2008, J BIOL CHEM, V283, P13700, DOI 10.1074/jbc.M707551200; Presa FB, 2018, MAR DRUGS, V16, DOI 10.3390/md16040135; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Sacoman JL, 2017, J BIOL CHEM, V292, P4499, DOI 10.1074/jbc.M116.726752; Scerrati A, 2018, J NEUROSURG SCI, V62, P574, DOI 10.23736/S0390-5616.18.04462-4; Schmidt P, 2008, TRANSPLANTATION, V86, P1523, DOI 10.1097/TP.0b013e3181890593; Shi YJ, 2019, TOXICOL LETT, V315, P23, DOI 10.1016/j.toxlet.2019.08.012; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Sun W, 2002, J NEUROSCI, V22, P6537; Tahay G, 2012, BIOCHEM J, V441, P105, DOI 10.1042/BJ20111179; Tan DH, 2017, MOL MED REP, V16, P4235, DOI 10.3892/mmr.2017.7040; Tanaka T, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/658786; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vasantharaja R, 2019, INT J BIOL MACROMOL, V124, P50, DOI 10.1016/j.ijbiomac.2018.11.104; von Zur-Muhlen B, 2019, TRANSPLANTATION, V103, P630, DOI 10.1097/TP.0000000000002425; Wang QZ, 2016, PROTEIN EXPRES PURIF, V119, P11, DOI 10.1016/j.pep.2015.11.001; Wang T, 2016, CELL MOL NEUROBIOL, V36, P1257, DOI 10.1007/s10571-015-0323-2; Xiao WS, 2020, ANTIOXID REDOX SIGN, V32, P1330, DOI 10.1089/ars.2019.7803; Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014; Yassin M, 2019, IMMUNOLOGY, V158, P35, DOI 10.1111/imm.13093; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007	79	3	3	1	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	SEP	2020	9	9							850	10.3390/antiox9090850			18	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	OD6QX	WOS:000579977100001	32927770	Green Published, gold			2022-02-06	
J	Manohar, S; Adler, HJ; Chen, GD; Salvi, R				Manohar, Senthilvelan; Adler, Henry J.; Chen, Guang-Di; Salvi, Richard			Blast-induced hearing loss suppresses hippocampal neurogenesis and disrupts long term spatial memory	HEARING RESEARCH			English	Article						Neurogenesis; Memory; Blast wave; Hippocampus; Doublecortin	TRAUMATIC BRAIN-INJURY; ADULT NEUROGENESIS; AUDITORY-SYSTEM; GLUCOCORTICOID-RECEPTORS; FUNCTIONAL CONNECTIVITY; CELL-PROLIFERATION; COCHLEAR NUCLEUS; ACOUSTIC TRAUMA; COMBAT VETERANS; DENTATE GYRUS	Acoustic information transduced by cochlear hair cells is continuously relayed from the auditory pathway to other sensory, motor, emotional and cognitive centers in the central nervous system. Human epidemiological studies have suggested that hearing loss is a risk factor for dementia and cognitive decline, but the mechanisms contributing to these memory and cognitive impairments are poorly understood. To explore these issues in a controlled experimental setting, we exposed adult rats to a series of intense blast wave exposures that significantly reduced the neural output of the cochlea. Several weeks later, we used the Morris Water Maze test, a hippocampal-dependent memory task, to assess the ability of Blast Wave and Control rats to learn a spatial navigation task (memory acquisition) and to remember what they had learned (spatial memory retention) several weeks earlier. The elevated plus maze and open field arena were used to test for anxiety-like behaviors. Afterwards, hippocampal cell proliferation and neurogenesis were evaluated using bromodeoxyuridine (BrdU), doublecortin (DCX), and Neuronal Nuclei (NeuN) immunolabeling. The Blast Wave and Control rats learned the spatial navigation task equally well and showed no differences on tests of anxiety. However, the Blast Wave rats performed significantly worse on the spatial memory retention task, i.e., remembering where they had been two weeks earlier. Deficits on the spatial memory retention task were associated with significant decreases in hippocampal cell proliferation and neurogenesis. Our blast wave results are consistent with other experimental manipulations that link spatial memory retention deficits (long term memory) with decreased cell proliferation and neurogenesis in the hippocampus. These results add to the growing body of knowledge linking blast-induced cochlear hearing loss with the cognitive deficits often seen in combat personnel and provide mechanistic insights into these extra auditory disorders that could lead to therapeutic interventions. (C) 2020 Elsevier B.V. All rights reserved.	[Manohar, Senthilvelan; Adler, Henry J.; Chen, Guang-Di; Salvi, Richard] SUNY Buffalo, Ctr Hearing & Deafness, 137 Cary Hall,3435 Main St, Buffalo, NY 14214 USA		Salvi, R (corresponding author), SUNY Buffalo, Ctr Hearing & Deafness, 137 Cary Hall,3435 Main St, Buffalo, NY 14214 USA.	salvi@buffalo.edu			United States of America National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DC011808, R01DC014452]	Research supported in part by grants from the United States of America National Institutes of Health (R01DC011808 and R01DC014452). We gratefully acknowledgement the technical assistance of Kimberly Dahar and Robert Dingman.	Alattar AA, 2020, J GERONTOL A-BIOL, V75, P567, DOI 10.1093/gerona/glz035; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Anchan D, 2014, BRAIN BEHAV, V4, P51, DOI 10.1002/brb3.197; Aronov D, 2017, NATURE, V543, P719, DOI 10.1038/nature21692; Arslan Fatih, 2018, Ear Nose Throat J, V97, pE7; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Baizer JS, 2015, NEUROSCIENCE, V303, P299, DOI 10.1016/j.neuroscience.2015.07.004; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; CALFORD MB, 1993, NEUROSCIENCE, V55, P953, DOI 10.1016/0306-4522(93)90310-C; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Chan JNM, 2017, FRONT BEHAV NEUROSCI, V11, P1, DOI 10.3389/fnbeh.2017.00018; Chen GD, 2010, HEARING RES, V265, P63, DOI 10.1016/j.heares.2010.02.010; Chen YC, 2015, ELIFE, V4, DOI 10.7554/eLife.06576; CHURCH J, 1988, ANESTHESIOLOGY, V69, P702, DOI 10.1097/00000542-198811000-00011; Clarke M, 2017, NEUROPHARMACOLOGY, V112, P210, DOI 10.1016/j.neuropharm.2016.04.021; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Contrera KJ, 2017, J AGING HEALTH, V29, P172, DOI 10.1177/0898264316634571; Cooper CM, 2016, PSYCHIAT RES-NEUROIM, V250, P33, DOI 10.1016/j.pscychresns.2016.03.004; Cosh S, 2018, INT J GERIATR PSYCH, V33, P598, DOI 10.1002/gps.4827; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Eggermont JJ, 2015, EUR J NEUROSCI, V41, P665, DOI 10.1111/ejn.12759; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feng J, 2012, J NEUROSCI RES, V90, P831, DOI 10.1002/jnr.22793; Fenton AA, 2000, J GEN PHYSIOL, V116, P211, DOI 10.1085/jgp.116.2.211; Fontana X, 2006, CEREB CORTEX, V16, P301, DOI 10.1093/cercor/bhi120; GARINTHER GR, 1979, J ACOUST SOC AM, V65, pS29, DOI 10.1121/1.2017190; GEHRMANN J, 1991, ACTA NEUROPATHOL, V82, P442, DOI 10.1007/BF00293378; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Goble TJ, 2009, HEARING RES, V253, P52, DOI 10.1016/j.heares.2009.03.002; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313; HAMERNIK RP, 1984, HEARING RES, V13, P229, DOI 10.1016/0378-5955(84)90077-7; Hayes SH, 2019, HEARING RES, V379, P43, DOI 10.1016/j.heares.2019.04.013; Helfer TM, 2011, AM J AUDIOL, V20, P33, DOI 10.1044/1059-0889(2011/10-0033); Huang TT, 2012, FREE RADICAL RES, V46, P951, DOI 10.3109/10715762.2012.664770; Hufner K, 2011, ANN NY ACAD SCI, V1233, P177, DOI 10.1111/j.1749-6632.2011.06115.x; Jokel C, 2019, J ACOUST SOC AM, V146, P3832, DOI 10.1121/1.5134069; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kraus KS, 2012, HEARING RES, V288, P34, DOI 10.1016/j.heares.2012.02.009; Lesicko AMH, 2016, J NEUROSCI, V36, P11037, DOI 10.1523/JNEUROSCI.4134-15.2016; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Lin FR, 2011, NEUROPSYCHOLOGY, V25, P763, DOI 10.1037/a0024238; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Liu CM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8112; Liu LJ, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00035; Liu LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20374; Lucassen Paul J., 2006, CNS & Neurological Disorders-Drug Targets, V5, P531, DOI 10.2174/187152706778559273; Lucassen PJ, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021303; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Manohar S, 2012, NEUROSCIENCE, V202, P169, DOI 10.1016/j.neuroscience.2011.12.013; Manohar S., 2011, UNIPOLAR BRUSH CELLS, P431; McDermott TJ, 2016, J PSYCHIATR NEUROSCI, V41, P251, DOI 10.1503/jpn.150058; McIntosh AR, 1998, J NEUROPHYSIOL, V80, P3148, DOI 10.1152/jn.1998.80.6.3148; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; Michler SA, 2002, J COMP NEUROL, V451, P250, DOI 10.1002/cne.10348; Mohan A, 2018, EUR J NEUROSCI, V48, P1743, DOI 10.1111/ejn.13988; MOREST DK, 1983, HEARING RES, V9, P145, DOI 10.1016/0378-5955(83)90024-2; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moser EI, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0511; Mosnier I, 2015, JAMA OTOLARYNGOL, V141, P442, DOI 10.1001/jamaoto.2015.129; Munoz-Lopez MM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00129; Newman AJ, 2015, J NEUROSCI METH, V242, P82, DOI 10.1016/j.jneumeth.2015.01.009; Oitzl MS, 1998, EUR J NEUROSCI, V10, P3759, DOI 10.1046/j.1460-9568.1998.00381.x; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Paolone N.A., 2011, EXPRESSION NEURONAL; Pascual B, 2015, CEREB CORTEX, V25, P680, DOI 10.1093/cercor/bht260; Proescholdt M, 2001, BRAIN RES, V904, P245, DOI 10.1016/S0006-8993(01)02465-9; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Ravassard P, 2013, SCIENCE, V340, P1342, DOI 10.1126/science.1232655; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Robertson D, 2013, HEARING RES, V295, P124, DOI 10.1016/j.heares.2012.02.002; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Saaltink DJ, 2014, CELL MOL LIFE SCI, V71, P2499, DOI 10.1007/s00018-014-1568-5; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Scott BW, 2000, EXP NEUROL, V165, P231, DOI 10.1006/exnr.2000.7458; Scotto-Lomassese S, 2002, CURR BIOL, V12, P1001, DOI 10.1016/S0960-9822(02)00889-8; Sheppard AM, 2017, NEUROSCIENCE, V359, P159, DOI 10.1016/j.neuroscience.2017.07.005; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Shukla M, 2019, BRAIN RES BULL, V147, P47, DOI 10.1016/j.brainresbull.2019.02.006; Sidor MM, 2010, J NEUROSCI METH, V188, P7, DOI 10.1016/j.jneumeth.2010.01.021; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Sweatt JD, 2004, PSYCHOPHARMACOLOGY, V174, P99, DOI 10.1007/s00213-004-1795-9; Szczepaniak WS, 1996, EVOKED POTENTIAL, V100, P158, DOI 10.1016/0013-4694(95)00234-0; TAMURA R, 1992, HIPPOCAMPUS, V2, P307, DOI 10.1002/hipo.450020309; TAMURA R, 1992, HIPPOCAMPUS, V2, P287, DOI 10.1002/hipo.450020308; Tea J, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.194894; Tischler L, 2006, ANN NY ACAD SCI, V1071, P405, DOI 10.1196/annals.1364.031; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; Vetter DE, 2002, NAT GENET, V31, P363, DOI 10.1038/ng914; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Xu HB, 2016, HEARING RES, V335, P138, DOI 10.1016/j.heares.2016.02.016; Yang FC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00025; Zheng Y, 2001, NEUROSCIENCE, V105, P1, DOI 10.1016/S0306-4522(01)00217-2; Zuckerman A, 2019, J NEUROTRAUM, V36, P380, DOI 10.1089/neu.2018.5672; Zuo ZF, 2011, NEUROSCIENCE, V190, P156, DOI 10.1016/j.neuroscience.2011.06.025	104	3	3	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	SEP	2020	395								108022	10.1016/j.heares.2020.108022			12	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	NU1KV	WOS:000573400900016	32663733				2022-02-06	
J	Meyers, JE; Vincent, AS				Meyers, John E.; Vincent, Andrea S.			Automated Neuropsychological Assessment Metrics (v4) Military Battery: Military Normative Data	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; PERFORMANCE; TESTS; ANAM; RECOVERY; SCORES	Introduction The Automated Neuropsychological Assessment Metrics (ANAM (R)) is a validated computerized cognitive assessment battery that has been routinely used for cognitive health assessments for active duty service members. The purpose of the current study was to provide updated normative data for the ANAM Military-Expanded battery. Materials and Methods This study was a retrospective review of deidentified predeployment baseline data obtained for service members completing ANAM as part of the mandated Department of Defense clinical testing policy. The effects of age, gender, race/ethnicity, and education were examined for all subtests and descriptive measures of performance were computed. Rates of low scores were also examined. Results Data from 1,067,899 active duty service members (88% male) were analyzed and represented all services and the Coast Guard. The sample ranged in age from 17 to 65 years (mean = 28.1, standard deviation [SD] = 8.4) was 66% White with a majority having education of 12 years or less (72%). Generally, small effect sizes were observed for each of the demographic factors with the largest effects observed for age. Rates of low scores on two or more tests in the battery were 10.6% using a more conservative cutpoint (>= 1.3 SD below the mean) or 2.4% using the most stringent cutpoint (>= 2 SD below the mean). Conclusions The current norms provide an update to previously published normative data and represent the largest, most representative set of data currently available for military personnel. Enhancements over previous norms include an expanded sample size, stratification by age (5-year increments), gender, race/ethnicity and education, and inclusion of all 10 tests in the ANAM Military-Expanded battery. These data are provided to assist healthcare providers using ANAM to assess and manage service member health.	[Meyers, John E.] Neuro Cognit Assessment Branch NCAB, Falls Church, VA 22042 USA; [Vincent, Andrea S.] Vista LifeSci Inc, Denver, CO 80134 USA		Meyers, JE (corresponding author), Neuro Cognit Assessment Branch NCAB, Falls Church, VA 22042 USA.						Axelrod BN, 2007, INT J NEUROSCI, V117, P1591, DOI 10.1080/00207450600941189; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P14, DOI 10.1093/arclin/acp100; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Harris WC, 2005, MIL PSYCHOL, V17, P115, DOI 10.1207/s15327876mp1702_4; Heaton R. K., 2004, REVISED COMPREHENSIV; Ivins BJ, 2019, ARCH CLIN NEUROPSYCH, V34, P1392, DOI 10.1093/arclin/acz004; Jones WP, 2008, CLIN NEUROPSYCHOL, V22, P305, DOI 10.1080/13854040701281483; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; Meyers JE, 2020, ARCH CLIN NEUROPSYCH, V35, P70, DOI 10.1093/arclin/acz062; Meyers JE, 2015, APPL NEUROPSYCH-ADUL, V22, P427, DOI 10.1080/23279095.2014.968919; Proctor SP, 2015, MIL MED, V180, P660, DOI 10.7205/MILMED-D-14-00298; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Roebuck-Spencer TM, 2008, MIL PSYCHOL, V20, P187, DOI 10.1080/08995600802118825; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Spencer TMR, 2003, ARCH CLIN NEUROPSYCH, V18, P802; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; VLS, 2015, ANAM MIL BATT ADM MA; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilken JA, 2007, ARCH CLIN NEUROPSYCH, V22, pS127, DOI 10.1016/j.acn.2006.10.007	29	3	3	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2020	185	9-10					E1706	E1721		10.1093/milmed/usaa066			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NV3WN	WOS:000574256400065		hybrid			2022-02-06	
J	Mojahed, A; Abderezaei, J; Kurt, M; Bergman, LA; Vakakis, AF				Mojahed, Alireza; Abderezaei, Javid; Kurt, Mehmet; Bergman, Lawrence A.; Vakakis, Alexander F.			A Nonlinear Reduced-Order Model of the Corpus Callosum Under Planar Coronal Excitation	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						traumatic brain injury; deep white matter; geometric nonlinearity; dynamical reduced order model; coronal rotational excitation	BRAIN-INJURY; DEFORMATION; STRAIN; CONCUSSION; MECHANICS; RESPONSES; SPORTS	Traumatic brain injury (TBI) is often associated with microstructural tissue damage in the brain, which results from its complex biomechanical behavior. Recent studies have shown that the deep white matter (WM) region of the human brain is susceptible to being damaged due to strain localization in that region. Motivated by these studies, in this paper, we propose a geometrically nonlinear dynamical reduced order model (ROM) to model and study the dynamics of the deep WM region of the human brain under coronal excitation. In this model, the brain hemispheres were modeled as lumped masses connected via viscoelastic links, resembling the geometry of the corpus callosum (CC). Employing system identification techniques, we determined the unknown parameters of the ROM, and ensured the accuracy of the ROM by comparing its response against the response of an advanced finite element (FE) model. Next, utilizing modal analysis techniques, we determined the energy distribution among the governing modes of vibration of the ROM and concluded that the demonstrated nonlinear behavior of the FE model might be predominantly due to the special geometry of the brain deep WM region. Furthermore, we observed that, for sufficiently high input energies, high frequency harmonics at approximately 45Hz, were generated in the response of the CC, which, in turn, are associated with high-frequency oscillations of the CC. Such harmonics might potentially lead to strain localization in the CC. This work is a step toward understanding the brain dynamics during traumatic injury.	[Mojahed, Alireza; Vakakis, Alexander F.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Abderezaei, Javid; Kurt, Mehmet] Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA; [Kurt, Mehmet] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, New York, NY 10029 USA; [Bergman, Lawrence A.] Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA		Mojahed, A (corresponding author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.		Vakakis, Alexander/AAZ-3410-2021; Abderezaei, Javid/AAT-5749-2020; Kurt, Mehmet/AAX-3303-2021	Vakakis, Alexander/0000-0002-3919-432X; Kurt, Mehmet/0000-0002-5618-0296	National Science FoundationNational Science Foundation (NSF) [CMMI-17-1727761, CMMI-17-1728186, 10.13039/100000001]	National Science Foundation (Grant Nos. CMMI-17-1727761 and CMMI-17-1728186; Funder ID: 10.13039/100000001).	Abderezaei J, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.014058; Alem N. M., 1974, SIMULATION HEAD INJU; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; [Anonymous], 2018, WORLD NEUROSURG, V120, pe153; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Chatterjee A, 2000, CURR SCI INDIA, V78, P808; Fabris G, 2019, ACTA BIOMATER, V100, P29, DOI 10.1016/j.actbio.2019.09.044; Feeny BF, 1998, J SOUND VIB, V211, P607, DOI 10.1006/jsvi.1997.1386; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Giordano C., 2014, EVALUATION AXONAL ST; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1944, J NEUROSURG, V1, P190, DOI 10.3171/jns.1944.1.3.0190; Holbourn AHS, 1943, LANCET, V2, P438; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kerschen G, 2005, NONLINEAR DYNAM, V41, P147, DOI 10.1007/s11071-005-2803-2; Kleinberger M., 1998, NHTSA DOCKET, V4405, P12; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S., 2007, PREDICTORS TRAUMATIC; KORNHAUSER M, 1954, J APPL MECH-T ASME, V21, P371; Kurt M, 2019, J NEUROIMAGING, V29, P440, DOI 10.1111/jon.12619; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Low T, 1987, INT RES COUNCIL BIOK, V15, P203; Malone D., 2008, INVESTIGATION TRAUMA; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Suar Zeynep M, 2019, Curr Protoc Neurosci, V89, pe83, DOI 10.1002/cpns.83; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Terem I, 2018, MAGN RESON MED, V80, P2549, DOI 10.1002/mrm.27236; Versace J, 1971, REV SEVERITY INDEX; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3	44	3	3	1	1	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	SEP 1	2020	142	9							091009	10.1115/1.4046503			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	NC7YR	WOS:000561431000009	32110796				2022-02-06	
J	Ondek, K; Brevnova, O; Jimenez-Ornelas, C; Vergara, A; Zwienenberg, M; Gurkoff, G				Ondek, Katelynn; Brevnova, Olga; Jimenez-Ornelas, Consuelo; Vergara, Audrey; Zwienenberg, Marike; Gurkoff, Gene			A new model of repeat mTBI in adolescent rats	EXPERIMENTAL NEUROLOGY			English	Article						Mild TBI; Repeat TBI; Rodent models; Adolescent; Sports-related injury	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; WORKING-MEMORY; AXONAL INJURY; WATER-MAZE; CALPAIN ACTIVATION; FOOTBALL PLAYERS; MOUSE MODEL; MILD; DEFICITS	Sports-related injury is frequently associated with repeated diffuse and mild traumatic brain injury (mTBI). We combined two existing models for inducing TBI in rats, the Impact Acceleration and Controlled Cortical Impact models, to create a new method relevant to the study of cognitive sequelae of repeat mTBI in adolescent athletes. Repeated mTBI, such as those incurred in sports, can result in a wide range of outcomes, with many individuals experiencing no chronic sequela while others develop profound cognitive and behavioral impairments, typically in the absence of lasting motor symptoms or gross tissue loss appreciable antemortem. It is critical to develop models of mTBI and repeat mTBI that have the flexibility to assess multiple parameters related to injury (e.g. number and magnitude of impacts, inter-injury interval, etc) that are associated with brain vulnerability compared to normal recovery. We designed a 3D-printed plastic implant to permanently secure a metal disc to the skull of adolescent rats in order to induce multiple injuries without performing multiple survival surgeries and also to minimize pre-injury anesthesia time. Rats were randomly assigned to sham injury (n = 12), single injury (n = 12; injury on P41), or repeat injury (n = 14; injuries on P35, P38, and P41) groups. Compared to single injury and sham injury, repeat injuries caused increased toe pinch reflex latency (F-(2,F- 34) = 4.126, p < .05) and diminished weight gain (F-(2,F-34) = 4.767, p < .05). Spatial navigation was tested using Morris water maze, beginning one week after the final injury (P48). While there were no differences between groups during acquisition, both single and repeat injuries resulted in deficits on probe trial performance (p < .01 and p < .05 respectively). Single injury animals also exhibited a deficit in working memory deficit across three days of testing (p < .05). Neither injury group had neuronal loss in the hilus or CA3, according to stereological quantification of NeuN. Therefore, by implanting a helmet we have created a relevant model of sports-related injury and repeated mTBI that results in subtle but significant changes in cognitive outcome in the absence of significant hippocampal cell death.	[Ondek, Katelynn; Brevnova, Olga; Jimenez-Ornelas, Consuelo; Vergara, Audrey; Zwienenberg, Marike; Gurkoff, Gene] Univ Calif Davis, Davis Sch Med, Dept Neurol Surg, 4800 Y St Suite 3740, Sacramento, CA 95817 USA; [Ondek, Katelynn; Gurkoff, Gene] Univ Calif Davis, Ctr Neurosci, 1544 Newton Ct, Davis, CA 95818 USA		Gurkoff, G (corresponding author), 1515 Newton Ct, Davis, CA 95618 USA.	kondek@ucdavis.edu; ombrenova@ucdavis.edu; cojimenezornelas@ucdavis.edu; arvergara@ucdavis.edu; mzwien@ucdavis.edu; gggurkoff@ucdavis.edu		Ondek, Katelynn/0000-0002-9116-0805			Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Algattas H., 2013, TRAUMATIC BRAIN INJU; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Bolton-Hall AN, 2019, J NEUROTRAUM, V36, P1203, DOI 10.1089/neu.2018.6096; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Chen JQ, 2014, ASIAN PAC J TROP MED, V7, P991, DOI 10.1016/S1995-7645(14)60174-7; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gerberding JLBS, 2003, CTR DIS CONTR PREV, P9; Giza CC, 2017, NEURON, V94, P1051, DOI 10.1016/j.neuron.2017.05.003; GRONWALL D, 1975, LANCET, V2, P995; Guberman GI, 2020, BRAIN STRUCT FUNCT, V225, P441, DOI 10.1007/s00429-019-02002-8; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; HODGES H, 1995, PSYCHOPHARMACOLOGY, V117, P318, DOI 10.1007/BF02246107; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Huh JW, 2006, DEV NEUROSCI-BASEL, V28, P466, DOI 10.1159/000094172; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kolarik BS, 2018, HIPPOCAMPUS, V28, P31, DOI 10.1002/hipo.22801; Kolarik BS, 2016, NEUROPSYCHOLOGIA, V80, P90, DOI 10.1016/j.neuropsychologia.2015.11.013; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Lee JB, 2018, DEV NEUROSCI-BASEL, V40, P358, DOI 10.1159/000494134; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McCloskey DP, 2006, EUR J NEUROSCI, V24, P2203, DOI 10.1111/j.1460-9568.2006.05101.x; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2005, Clin J Sport Med, V15, P48; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nolan A, 2018, J NEUROTRAUM, V35, P2425, DOI 10.1089/neu.2018.5731; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Prabhu RK, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6020040; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Sponton LES, 2018, BEHAV BRAIN RES, V339, P286, DOI 10.1016/j.bbr.2017.10.033; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; XIAO ZX, 2011, J NEUROTRAUM, V29, P1165, DOI DOI 10.1089/NEU; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001	62	3	3	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2020	331								113360	10.1016/j.expneurol.2020.113360			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NK5RP	WOS:000566790500007	32442552				2022-02-06	
J	Rhon, DI; Snodgrass, SJ; Cleland, JA; Cook, CE				Rhon, Daniel I.; Snodgrass, Suzanne J.; Cleland, Joshua A.; Cook, Chad E.			The Risk of Prior Opioid Exposure on Future Opioid Use and Comorbidities in Individuals With Non-Acute Musculoskeletal Knee Pain	JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH			English	Article						opioids; opioid risk; opioid naive; patellofemoral pain; musculoskeletal pain; knee; comorbidities; health services research	SLEEP-APNEA; STATEMENT	Objectives: Due to their potentially deleterious effects, minimizing the use of opioids for musculoskeletal pain is a priority for healthcare systems. The objective of this study was to examine the risk of future opioid prescription use based on prior opioid use within a non-surgical cohort with musculoskeletal knee pain. We also examined the risk of pre-existing comorbidities on future opioid use, and the risk of prior opioid use on future comorbidities (sleep, mental health, cardiometabolic disorders). Methods: Data came from the Military Health System Data Repository for 80 290 consecutive beneficiaries with an initial episode of care for patellofemoral pain from January 1, 2010 through December 31, 2011. Risk was calculated using 2 x 2 tables based on pre- and post-opioid utilization and comorbid diagnosis. Risk ratios, relative and absolute risk increases, and numbers needed to harm were calculated, all with 95% confidence intervals. Results Prior opioid use resulted in a risk ratio of 18.0 (95 CI 17.1, 19.0) and an absolute risk increase of 61.6% for future opioid use (numbers needed to harm = 2). The presence of all comorbidities (except cardiometabolic syndrome) were associated with a significant relative risk for future opioid use (RR range 1.2-1.5), but the absolute risk increase was trivial (range 0.7%-2.2%). The relative risk for a chronic pain diagnosis, traumatic brain injury/concussion, insomnia, depression, and PTSD were all significantly higher in those with prior opioid use (1.3-1.6), but absolute risk increase was minimal (1.1%-6.5%). Discussion: Prior opioid use was a strong risk factor for future opioid use in non-surgical patients with knee pain. These findings show that history of prior opioid use is important when assessing the risk of future opioid use, whereas prior comorbidities may not be as important. Opioid history assessment should be standard practice for all patients with patellofemoral pain in whom an opioid prescription is considered.	[Rhon, Daniel I.] Brooke Army Med Ctr, JBSA Ft Sam Houston, TX USA; [Rhon, Daniel I.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Rhon, Daniel I.; Snodgrass, Suzanne J.] Univ Newcastle, Callaghan, NSW, Australia; [Cleland, Joshua A.] Tufts Univ, Sch Med, Boston, MA USA; [Cook, Chad E.] Duke Univ, Durham, NC USA		Rhon, DI (corresponding author), Brooke Army Med Ctr, Dept Rehab Med, 3551 Roger Brooke Dr, JBSA Ft Sam Houston, TX 78234 USA.	daniel_rhon@baylor.edu	Rhon, Daniel/C-9542-2011	Rhon, Daniel/0000-0002-4320-990X			[Anonymous], PHYS EV DAT PEDRO; Armaghani SJ, 2014, SPINE, V39, pE1524, DOI 10.1097/BRS.0000000000000622; Benchimol EI, 2016, Z EVIDENZ FORTBILD Q, V115, P33, DOI [10.1016/j.zefq.2016.07.010, 10.1371/journal.pmed.1001885]; Bertenthal D, 2018, BRAIN INJURY, V32, P1188, DOI 10.1080/02699052.2018.1493535; Chiu AS, 2019, SURGERY, V166, P758, DOI 10.1016/j.surg.2019.05.021; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; Collins NJ, 2018, BRIT J SPORT MED, V52, P1170, DOI 10.1136/bjsports-2018-099397; Cron DC, 2017, ANN SURG, V265, P695, DOI 10.1097/SLA.0000000000001901; Crossley KM, 2016, BRIT J SPORT MED, V50, P844, DOI 10.1136/bjsports-2016-096268; Crossley KM, 2016, BRIT J SPORT MED, V50, P247, DOI 10.1136/bjsports-2015-h3939rep; Daniell HW, 2008, J PAIN, V9, P28, DOI 10.1016/j.jpain.2007.08.005; Daniell HW, 2002, J PAIN, V3, P377, DOI 10.1054/jpai.2002.126790; Deyo RA, 2018, PAIN, V159, P1147, DOI 10.1097/j.pain.0000000000001202; DiMarco LA, 2019, PAIN PRACT, V19, P149, DOI 10.1111/papr.12728; Dimsdale JE, 2007, J CLIN SLEEP MED, V3, P33; Goplen CM, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2619-8; Guilleminault C, 2010, LUNG, V188, P459, DOI 10.1007/s00408-010-9254-3; Hah JM, 2015, PAIN RES TREAT, V2015, DOI 10.1155/2015/829696; Harbaugh CM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2439; Hills JM, 2019, SPINE, V44, P887, DOI 10.1097/BRS.0000000000002964; Kazanis W, 2018, MIL MED, V183, pE157, DOI 10.1093/milmed/usx014; Kim SC, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8061; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Mendes D, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0875-8; Noordzij M., 2017, NEPHROL DIAL TRAN S2, V32, pii13; Pappas E, 2012, SPORTS HEALTH, V4, P115, DOI 10.1177/1941738111432097; Ranganathan Priya, 2016, Perspect Clin Res, V7, P51, DOI 10.4103/2229-3485.173773; Rhee TG, 2019, AM J ADDICTION, V28, P92, DOI 10.1111/ajad.12861; Rhon DI, 2019, PAIN PHYSICIAN, V22, pE351; Rhon DI, 2018, PERIOPER MED-LONDON, V7, DOI 10.1186/s13741-018-0105-8; Rhon DI, 2019, BRIT J SPORT MED, V53, P547, DOI 10.1136/bjsports-2018-099294; Rhon DI, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0588-8; Scherrer JF, 2016, ANN FAM MED, V14, P54, DOI 10.1370/afm.1885; Speed TJ, 2018, INT REV PSYCHIATR, V30, P136, DOI 10.1080/09540261.2018.1514369; Stahlman Shauna, 2018, MSMR, V25, P2; Tong ST, 2019, ANN FAM MED, V17, P200, DOI 10.1370/afm.2357; Utting MR, 2005, KNEE, V12, P362, DOI 10.1016/j.knee.2004.12.006; Vallecillo G, 2018, SUBST ABUS, V39, P46, DOI 10.1080/08897077.2017.1363122; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI [10.2471/BLT.07.045120, 10.1371/journal.pmed.0040296]; Vowles KE, 2015, PAIN, V156, P569, DOI 10.1097/01.j.pain.0000460357.01998.f1; Wan Q, 2008, J NEUROIMMUNOL, V199, P1, DOI 10.1016/j.jneuroim.2008.04.026; Zywiel MG, 2011, J BONE JOINT SURG AM, V93A, P1988, DOI 10.2106/JBJS.J.01473	42	3	3	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2150-1319	2150-1327		J PRIM CARE COMMUNIT	J. Prim. Care Community Health	SEP	2020	11								2150132720957438	10.1177/2150132720957438			8	Primary Health Care	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NR7ON	WOS:000571750200001	32909510	gold, Green Published			2022-02-06	
J	Schwartzberg, L; Aslanyan, L; Angelo, N; Mancini, J; Kooyman, PS; Abu-Sbaih, R; Zwibel, H; Yao, SC				Schwartzberg, Lauren; Aslanyan, Lilit; Angelo, Nicole; Mancini, Jayme; Kooyman, Patricia S.; Abu-Sbaih, Reem; Zwibel, Hallie; Yao, Sheldon C.			Cranial Strain Patterns Associated With Concussions	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article						athlete; college sports; concussion; cranial strain; somatic dysfunction	OSTEOPATHIC MANIPULATIVE TREATMENT; SOMATIC DYSFUNCTION; IMPACT	Context: Concussions can cause cognitive impairment, somatic symptoms, and behavioral changes. Symptoms may vary in severity, depending on the degree of traumatic force. Due to the biomechanical nature of this trauma, cranial somatic dysfunctions may commonly be seen in patients with concussion. Objective: To determine whether patients were more likely to have nonphysiologic cranial somatic dysfunctions than physiologic cranial somatic dysfunctions after sustaining a concussion. Methods: College athletes who had a concussion based on the Immediate Post-Concussion Assessment and Cognitive test were evaluated by a physician within 1 week of the injury. Patients were evaluated for somatic dysfunctions of the cranium. Cranial somatic dysfunctions were documented; test scores and force vectors were compared with the type of strain pattern using SPSS, with P<.05 demonstrating statistical significance. Results: Sixteen patients were included in the study: 10 with nonphysiologic cranial strain somatic dysfunctions and 6 with physiologic dysfunctions. Compared with lateral forces, forces of impact with anterioposterior vectors were associated 1.5 times more often with nonphysiologic rather than physiologic cranial somatic dysfunctions (P=.697). An analysis of specific cranial strain patterns and impact force vectors showed no statistical significance (P=.096). Conclusion: There was no statistically significant association showing that concussion patients were more likely to have nonphysiologic cranial somatic dysfunctions compared with physiological cranial somatic dysfunctions. However, nonphysiologic cranial somatic dysfunctions did show a trend toward association with concussion. Further studies are needed to better understand the potential association between concussion and cranial somatic dysfunctions.	[Mancini, Jayme; Kooyman, Patricia S.; Abu-Sbaih, Reem; Yao, Sheldon C.] New York Inst Technol, Coll Osteopath Med, Dept Osteopath Manipulat Med, POB 8000 Northern Blvd,Serota Bldg Room 127, Old Westbury, NY 11568 USA; [Zwibel, Hallie] New York Inst Technol, Coll Osteopath Med, Dept Family Med, Old Westbury, NY 11568 USA; [Schwartzberg, Lauren; Aslanyan, Lilit; Angelo, Nicole] New York Inst Technol, Coll Osteopath Med, Old Westbury, NY 11568 USA		Yao, SC (corresponding author), New York Inst Technol, Coll Osteopath Med, Dept Osteopath Manipulat Med, POB 8000 Northern Blvd,Serota Bldg Room 127, Old Westbury, NY 11568 USA.	syao@nyit.edu		Mancini, Jayme/0000-0002-1445-9715			Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2014, Clin J Sport Med, V24, P89, DOI 10.1097/JSM.0000000000000062; Castillo I, 2016, J AM OSTEOPATH ASSOC, V116, P178, DOI 10.7556/jaoa.2016.034; Chappell C, 2015, OSTEOPATH FAM PHYS, V7, P30; Guernsey DT, 2016, J AM OSTEOPATH ASSOC, V116, pE13, DOI 10.7556/jaoa.2016.036; Hitscherich K, 2016, J AM OSTEOPATH ASSOC, V116, P170, DOI 10.7556/jaoa.2016.033; Jakel A, 2011, J AM OSTEOPATH ASSOC, V111, P685; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M.R.C.M., 2003, IMMEDIATE POSTCONCUS; Mazzeo S, 2020, J AM OSTEOPATH ASSOC, V120, P615, DOI 10.7556/jaoa.2020.100; McCallister A, 2016, J AM OSTEOPATH ASSOC, V116, P810, DOI 10.7556/jaoa.2016.157; Moy S., 2014, OSTEOPATH FAM PHYS, V2, P8; National Institute of Neurological Disorders and Stroke, 2002, NIH PUBLICATION, V02-158; Pizzolorusso G, 2013, J AM OSTEOPATH ASSOC, V113, P462; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Timoshkin EM, 2008, J AM OSTEOPATH ASSOC, V108, P652; Yao SC, 2020, J AM OSTEOPATH ASSOC, V120, P607, DOI 10.7556/jaoa.2020.099	20	3	3	0	0	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	SEP	2020	120	9					601	606		10.7556/jaoa.2020.098			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NU8WU	WOS:000573918900008	32766807	Bronze			2022-02-06	
J	Sohn, MN; Virani, S; Carlson, HL; MacPhail, S; Low, TA; Plourde, V; Yeates, KO; Lebel, C; Brooks, BL				Sohn, Maya N.; Virani, Shane; Carlson, Helen L.; MacPhail, Shelby; Low, Trevor A.; Plourde, Vickie; Yeates, Keith Owen; Lebel, Catherine; Brooks, Brian L.			Microstructure of the Corpus Callosum Long after Pediatric Concussion	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Mild traumatic brain injury; Adolescence; White matter; Long-term; Diffusion tensor imaging; Post-concussion syndrome	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; TENSOR IMAGING FINDINGS; NEUROIMAGING BIOMARKERS; AXONAL INJURY; MILD; DIFFUSION; ABNORMALITIES; SYMPTOMS; CHILDREN	Objective: The long-term effects of pediatric concussion on white matter microstructure are poorly understood. This study investigated long-term changes in white matter diffusion properties of the corpus callosum in youth several years after concussion. Methods: Participants were 8-19 years old with a history of concussion (n = 36) or orthopedic injury (OI) (n = 21). Mean time since injury for the sample was 2.6 years (SD = 1.6). Participants underwent diffusion magnetic resonance imaging, completed cognitive testing, and rated their post-concussion symptoms. Measures of diffusivity (fractional anisotropy, mean, axial, and radial diffusivity) were extracted from white matter tracts in the genu, body, and splenium regions of the corpus callosum. The genu and splenium tracts were further subdivided into 21 equally spaced regions along the tract and diffusion values were extracted from each of these smaller regions. Results: White matter tracts in the genu, body, and splenium did not differ in diffusivity properties between youth with a history of concussion and those with a history of OI. No significant group differences were found in subdivisions of the genu and splenium after correcting for multiple comparisons. Diffusion metrics did not significantly correlate with symptom reports or cognitive performance. Conclusions: These findings suggest that at approximately 2.5 years post-injury, youth with prior concussion do not have differences in their corpus callosum microstructure compared to youth with OI. Although these results are promising from the perspective of long-term recovery, further research utilizing longitudinal study designs is needed to confirm the long-term effects of pediatric concussion on white matter microstructure.	[Sohn, Maya N.] Univ Calgary, Dept Neurosci, Calgary, AB, Canada; [Virani, Shane; Carlson, Helen L.; Yeates, Keith Owen; Lebel, Catherine; Brooks, Brian L.] Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Virani, Shane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Virani, Shane; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neuropsychol Serv, Calgary, AB, Canada; [Carlson, Helen L.; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [MacPhail, Shelby] Muhlenberg Coll, Dept Neurosci, Allentown, PA 18104 USA; [Low, Trevor A.; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Plourde, Vickie] Univ Moncton, Fac Sci Sante & Serv Communautaires, Ecole Psychol, Moncton, NB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Carlson, Helen L.; Yeates, Keith Owen; Lebel, Catherine] Hotchkiss Brain Inst, Calgary, AB, Canada; [Lebel, Catherine] Univ Calgary, Dept Radiol, Calgary, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca	Yeates, Keith/AAJ-4223-2020	Plourde, Vickie/0000-0002-0098-5431; Low, Trevor/0000-0002-8564-845X	Shaikh Family Research Award by the Alberta Children's Hospital Research Institute; Ronald and Irene Ward Chair in Pediatric Brain Injury; Alberta Innovates-Health Solutions; Vi Riddell Children's Pain and Rehabilitation Program; Integrated Concussion Research Program; Alberta Children's Hospital Research Institute (University of Calgary); Integrated Concussion Research Program (University of Calgary); Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	This study ("NEURO-detect") was funded by the Shaikh Family Research Award (distributed by the Alberta Children's Hospital Research Institute) awarded to Brian Brooks (study PI), with additional support from the Ronald and Irene Ward Chair in Pediatric Brain Injury (awarded to Keith Yeates). Maya Sohn acknowledges summer studentship funding from Alberta Innovates-Health Solutions. Shane Virani acknowledges salary funding by the Vi Riddell Children's Pain and Rehabilitation Program and the Integrated Concussion Research Program. Trevor Low acknowledges summer studentship funding from the Alberta Children's Hospital Research Institute (University of Calgary), the Integrated Concussion Research Program (University of Calgary), and Alberta Innovates-Health Solutions. Brian Brooks acknowledges salary funding from the Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary Award.	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS1, DOI DOI 10.1542/PEDS.2009-0925; [Anonymous], 2017, LANCET HIV, V2, pe115, DOI DOI 10.2217/CNC-2016-0028; [Anonymous], 2012, TINEA, V22, P53; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Carlson HL, 2014, EPILEPSY BEHAV, V37, P116, DOI 10.1016/j.yebeh.2014.06.020; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Grohs MN, 2018, NEUROIMAGE, V183, P828, DOI 10.1016/j.neuroimage.2018.09.004; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Honce JM, 2016, PHYS MED REH CLIN N, V27, P411, DOI 10.1016/j.pmr.2016.01.002; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Moore RD, 2018, INT J PSYCHOPHYSIOL, V132, P14, DOI 10.1016/j.ijpsycho.2018.04.003; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Plourde V, 2018, ARCH CLIN NEUROPSYCH, V33, P247, DOI 10.1093/arclin/acx067; Plourde V, 2017, J INT NEUROPSYCH SOC, V23, P304, DOI 10.1017/S1355617717000066; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; TEASDALE G, 1974, LANCET, V2, P81; Terry DP, 2019, J INT NEUROPSYCH SOC, V25, P950, DOI 10.1017/S1355617719000754; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tracy R. A., 2016, ADV WOUND CARE, V5, P119; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Van Beek L, 2015, BRAIN INJURY, V29, P1701, DOI 10.3109/02699052.2015.1075172; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Womack KB, 2017, J NEUROTRAUM, V34, P1539, DOI 10.1089/neu.2016.4670; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang SW, 2018, NEUROIMAGE, V172, P40, DOI 10.1016/j.neuroimage.2018.01.046	71	3	3	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2020	26	8					763	775	PII S1355617720000223	10.1017/S1355617720000223			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	NH7ZI	WOS:000564883500003	32183917				2022-02-06	
J	Swanson, LC; Rimkus, SA; Ganetzky, B; Wassarman, DA				Swanson, Laura C.; Rimkus, Stacey A.; Ganetzky, Barry; Wassarman, David A.			Loss of the Antimicrobial Peptide Metchnikowin Protects Against Traumatic Brain Injury Outcomes in Drosophila melanogaster	G3-GENES GENOMES GENETICS			English	Article						antimicrobial peptide; Drosophila melanogaster; innate immune response; Metchnikowin; traumatic brain injury	INNATE IMMUNE-RESPONSE; LIFE-SPAN; MODEL; AGE; TBI; EXPRESSION; TOLL; GENE; NEUROINFLAMMATION; NEURODEGENERATION	Neuroinflammation is a major pathophysiological feature of traumatic brain injury (TBI). Early and persistent activation of innate immune response signaling pathways by primary injuries is associated with secondary cellular injuries that cause TBI outcomes to change over time. We used a Drosophila melanogaster model to investigate the role of antimicrobial peptides (AMPs) in acute and chronic outcomes of closed-head TBI. AMPs are effectors of pathogen and stress defense mechanisms mediated by the evolutionarily conserved Toll and Immune-deficiency (Imd) innate immune response pathways that activate Nuclear Factor kappa B (NF-kappa B) transcription factors. Here, we analyzed the effect of null mutations in 10 of the 14 known Drosophila AMP genes on TBI outcomes. We found that mutation of Metchnikowin (Mtk) was unique in protecting flies from mortality within the 24 h following TBI under two diet conditions that produce different levels of mortality. In addition, Mtk mutants had reduced behavioral deficits at 24 h following TBI and increased lifespan either in the absence or presence of TBI. Using a transcriptional reporter of gene expression, we found that TBI increased Mtk expression in the brain. Quantitative analysis of mRNA in whole flies revealed that expression of other AMPs in the Toll and Imd pathways as well as NF-kappa B transcription factors were not altered in Mtk mutants. Overall, these results demonstrate that Mtk plays an infection-independent role in the fly nervous system, and TBI-induced expression of Mtk in the brain activates acute and chronic secondary injury pathways that are also activated during normal aging.	[Swanson, Laura C.; Rimkus, Stacey A.; Wassarman, David A.] Univ Wisconsin, Coll Agr & Life Sci, Sch Med & Publ Hlth, Dept Med Genet, Madison, WI 53706 USA; [Swanson, Laura C.] Univ Wisconsin, Coll Agr & Life Sci, Cellular & Mol Biol Grad Program, Madison, WI 53706 USA; [Swanson, Laura C.] Univ Wisconsin, Coll Agr & Life Sci, Med Scientist Training Program, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Ganetzky, Barry] Univ Wisconsin, Coll Agr & Life Sci, Dept Genet, Madison, WI 53706 USA		Wassarman, DA (corresponding author), Room 4262,Genet Biotechnol Bldg,425-G Henry Mall, Madison, WI 53706 USA.	dawassarman@wisc.edu		Swanson, Laura/0000-0002-9438-7546; Wassarman, David/0000-0002-7042-9561; ganetzky, barry/0000-0001-5418-7577	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RF1 NS114359]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 AG000213]	We thank members of the Boekhoff-Falk, Perouansky, and Wassarman laboratories for their insights throughout the course of this research as well as Grace Boekhoff-Falk and Stanislava Chtarbanova for their thoughtful comments on this manuscript. We also thank Bruno Lemaitre for providing the AMP mutant fly lines and Ylva Engstrom for providing the AMP-GFP flies. L.C.S., B.G., and D.A.W. designed the project. L.C.S. and S.A.R. performed and analyzed the experiments. L.C.S., S.A.R., B.G., and D.A.W. wrote the manuscript. This work was supported by the National Institutes of Health (NIH) [RF1 NS114359 to D.A.W.] and a predoctoral fellowship from an NIH training grant [T32 AG000213 to L.C.S.].	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ali YO, 2011, JOVE-J VIS EXP, DOI 10.3791/2504; Alves JL, 2019, WORLD NEUROSURG, V130, P115, DOI 10.1016/j.wneu.2019.06.212; Badinloo M, 2018, ARCH INSECT BIOCHEM, V98, DOI 10.1002/arch.21464; Barajas-Azpeleta R, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007440; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bergman P, 2017, CURR TOP DEV BIOL, V121, P29, DOI 10.1016/bs.ctdb.2016.07.002; Bogart K., 2006, 200610 CGB, DOI [10.2506/cgbtr-200610, DOI 10.2506/CGBTR-200610]; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Diamond ML, 2015, EPILEPSIA, V56, P991, DOI 10.1111/epi.13100; Dissel S, 2015, BRAIN BEHAV IMMUN, V47, P75, DOI 10.1016/j.bbi.2014.09.019; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fischer JA, 2018, ANESTH ANALG, V126, P1979, DOI 10.1213/ANE.0000000000002906; Ganetzky B., 2016, CURR PHYS MED REHABI, V4, P1, DOI [10.1007/s40141-016-0107-8, DOI 10.1007/S40141-016-0107-8, 10.1007/s40141]; Hanson MA, 2020, CURR OPIN IMMUNOL, V62, P22, DOI 10.1016/j.coi.2019.11.008; Hanson MA, 2019, ELIFE, V8, DOI [10.7554/eLife.44341, 10.7554/eLife.44341.001]; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Jiang HS, 2018, CELL MOL NEUROBIOL, V38, P1009, DOI 10.1007/s10571-017-0570-5; Juengst SB, 2017, EPILEPSY BEHAV, V73, P240, DOI 10.1016/j.yebeh.2017.06.001; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Katzenberger RJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52905; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kounatidis I, 2017, CELL REP, V19, P836, DOI 10.1016/j.celrep.2017.04.007; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar D, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2019.134347; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lee S, 2016, DIS MODEL MECH, V9, P295, DOI 10.1242/dmm.018069; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LEVASHINA EA, 1995, EUR J BIOCHEM, V233, P694, DOI 10.1111/j.1432-1033.1995.694_2.x; Levashina EA, 1998, J MOL BIOL, V278, P515, DOI 10.1006/jmbi.1998.1705; Lezi E, 2018, NEURON, V97, P125, DOI 10.1016/j.neuron.2017.12.001; Liu H, 2017, AGEING RES REV, V34, P64, DOI 10.1016/j.arr.2016.11.006; Long XB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01761-0; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Moghaddam MRB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08407-x; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Petersen AJ, 2013, GENETICS, V194, P133, DOI 10.1534/genetics.113.150854; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Ratliff EP, 2016, AUTOPHAGY, V12, P2256, DOI 10.1080/15548627.2016.1221565; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sanuki R, 2019, BRAIN BEHAV IMMUN, V80, P427, DOI 10.1016/j.bbi.2019.04.023; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7; Sen AK, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00175; Shah EJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00409; Shi HJ, 2019, NEUROPHARMACOLOGY, V145, P259, DOI 10.1016/j.neuropharm.2018.07.022; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Shukla AK, 2019, CELL REP, V26, P131, DOI 10.1016/j.celrep.2018.12.025; Somayaji MR, 2018, CURR NEUROPHARMACOL, V16, P484, DOI 10.2174/1570159X15666170828165711; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Spitzer P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32228; Toda H, 2019, SCIENCE, V363, P509, DOI 10.1126/science.aat1650; Tortella FC, 2016, METHODS MOL BIOL, V1462, P735, DOI 10.1007/978-1-4939-3816-2_40; Tsuda L, 2018, ADV EXP MED BIOL, V1076, P25, DOI 10.1007/978-981-13-0529-0_3; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Van Vranken JG, 2014, CELL METAB, V20, P241, DOI 10.1016/j.cmet.2014.05.012; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Zu Z., 2012, ANN CLIN LAB SCI, V42, P25	85	3	3	0	1	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	SEP	2020	10	9					3109	3119		10.1534/g3.120.401377			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ8QF	WOS:000571131800020	32631949	gold, Green Published			2022-02-06	
J	Tverdal, C; Aarhus, M; Andelic, N; Skaansar, O; Skogen, K; Helseth, E				Tverdal, Cathrine; Aarhus, Mads; Andelic, Nada; Skaansar, Ola; Skogen, Karoline; Helseth, Eirik			Characteristics of traumatic brain injury patients with abnormal neuroimaging in Southeast Norway	INJURY EPIDEMIOLOGY			English	Article						Traumatic brain injury; Neurosurgery; Trauma center; Hospital admission	HEAD-INJURY; INTRACRANIAL HEMORRHAGE; EPIDEMIOLOGY; PATTERNS; CLASSIFICATION; SEVERITY; REGISTER; OUTCOMES; WEATHER; RISK	BackgroundThe vast majority of hospital admitted patients with traumatic brain injury (TBI) will have intracranial injury identified by neuroimaging, requiring qualified staff and hospital beds. Moreover, increased pressure in health care services is expected because of an aging population. Thus, a regular evaluation of characteristics of hospital admitted patients with TBI is needed. Oslo TBI Registry - Neurosurgery prospectively register all patients with TBI identified by neuroimaging admitted to a trauma center for southeast part of Norway. The purpose of this study is to describe this patient population with respect to case load, time of admission, age, comorbidity, injury mechanism, injury characteristics, length of stay, and 30-days survival.MethodsData for 5 years was extracted from Oslo TBI Registry - Neurosurgery. Case load, time of admission, age, sex, comorbidity, injury mechanism, injury characteristics, length of stay, and 30-days survival was compiled and compared.ResultsFrom January 1st, 2015 to December 31st, 2019, 2153 consecutive patients with TBI identified by neuroimaging were registered. The admission rate of TBI of all severities has been stable year-round since 2015. Mean age was 52years (standard deviation 25, range 0-99), and 68% were males. Comorbidities were common; 28% with pre-injury ASA score of >= 3 and 25% used antithrombotic medication. The dominating cause of injury in all ages was falls (55%) but increased with age. Upon admission, the head injury was classified as mild TBI in 46%, moderate in 28%, and severe (Glasgow coma score <= 8) in 26%. Case load was stable without seasonal variation. Majority of patients (68%) were admitted during evening, night or weekend. 68% was admitted to intensive care unit. Length of hospital stay was 4days (median, interquartile range 3-9). 30-day survival for mild, moderate and severe TBI was 98, 94 and 69%, respectively.ConclusionsThe typical TBI patients admitted to hospital with abnormal neuroimaging were aged 50-79years, often with significant comorbidity, and admitted outside ordinary working hours. This suggests the necessity for all-hour presence of competent health care professionals.	[Tverdal, Cathrine; Aarhus, Mads; Skaansar, Ola; Helseth, Eirik] Oslo Univ Hosp, Ulleval Hosp, Dept Neurosurg, POB 4956 Nydalen, N-0424 Oslo, Norway; [Tverdal, Cathrine; Skaansar, Ola; Helseth, Eirik] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Skogen, Karoline] Oslo Univ Hosp, Dept Neuroradiol, Oslo, Norway		Tverdal, C (corresponding author), Oslo Univ Hosp, Ulleval Hosp, Dept Neurosurg, POB 4956 Nydalen, N-0424 Oslo, Norway.; Tverdal, C (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.	uxtvec@ous-hf.no		Tverdal, Cathrine/0000-0002-1094-3825	Department of Neurosurgery, Oslo University Hospital	Founded by Department of Neurosurgery, Oslo University Hospital.	Ali AM, 2015, INJURY, V46, P945, DOI 10.1016/j.injury.2015.03.016; American Society of Anesthesiologists, 2014, ASA PHYS STAT CLASS; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; [Anonymous], 2017, PUBL HLTH REP HLTH S; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Bakke E, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0085-2; Berg CL, 2017, LEGEMIDDELSTATISTIKK, V2017, P2; Bjarko VV, 2019, WORLD NEUROSURG, V122, pE684, DOI 10.1016/j.wneu.2018.10.122; Borczuk P, 2019, WEST J EMERG MED, V20, P307, DOI 10.5811/westjem.2018.12.39337; Brain Trauma Foundation, 2016, GUID MAN SEV TBI; Bus S, 2019, BRIT J NEUROSURG, V33, P51, DOI 10.1080/02688697.2018.1522418; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gaastra B, 2016, BRIT J NEUROSURG, V30, P221, DOI 10.3109/02688697.2015.1119240; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Gale SC, 2018, ANN MED SURG, V27, P22, DOI 10.1016/j.amsu.2018.01.005; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gates M, 2017, WORLD NEUROSURG, V100, P417, DOI 10.1016/j.wneu.2017.01.046; Gulati S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202575; Haller CS, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14177; Harr ME, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-25; Helse og omsorgsdepartementet, 2017, KART NORG AK REG; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Huijben JA, 2020, INTENS CARE MED, V46, P995, DOI 10.1007/s00134-020-05965-z; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Julien J, 2017, J CLIN NEUROSCI, V38, P122, DOI 10.1016/j.jocn.2016.12.032; Kieffer WKM, 2016, ANN ROY COLL SURG, V98, P128, DOI 10.1308/rcsann.2016.0040; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Lenell S, 2019, ACTA NEUROCHIR, V161, P1243, DOI 10.1007/s00701-019-03893-6; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Narum S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0094-1; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Owens PW, 2018, BRAIN INJURY, V32, P900, DOI 10.1080/02699052.2018.1466366; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Pedersen K, 2015, NEUROEPIDEMIOLOGY, V45, P20, DOI 10.1159/000381780; Peeters G, 2019, OSTEOPOROSIS INT, V30, P2099, DOI 10.1007/s00198-019-05034-2; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Regional Committees for Medical and Health Research Ethics (REC), 2012, EX ACT THAT DO NOT R; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Rising WR, 2006, J TRAUMA, V60, P1096, DOI 10.1097/01.ta.0000197435.82141.27; Robertson A, 2004, INJURY, V35, P864, DOI 10.1016/j.injury.2003.10.022; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Roislien J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192568; Ronning P, 2019, J NEUROSURG, V131, P1896, DOI 10.3171/2018.7.JNS18270; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sollid Snorre, 2008, Tidsskr Nor Laegeforen, V128, P1524; Sovik S, 2014, INJURY, V45, P1722, DOI 10.1016/j.injury.2014.05.038; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stonko DP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207766; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z; Vaziri K, 2007, J TRAUMA, V62, P610, DOI 10.1097/TA.0b013e31803245c7; Volovici V, 2019, J CRIT CARE, V49, P158, DOI 10.1016/j.jcrc.2018.11.002; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	64	3	3	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	SEP 1	2020	7	1							45	10.1186/s40621-020-00269-8			13	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TD5MX	WOS:000669372000001	32867838	gold, Green Published			2022-02-06	
J	Woehrle, E; Harriss, AB; Abbott, KC; Moir, ME; Balestrini, CS; Fischer, LK; Fraser, DD; Shoemaker, JK				Woehrle, Emilie; Harriss, Alexandra B.; Abbott, Kolten C.; Moir, Marcy Erin; Balestrini, Christopher S.; Fischer, Lisa K.; Fraser, Douglas D.; Shoemaker, Joel Kevin			Concussion in Adolescents Impairs Heart Rate Response to Brief Handgrip Exercise	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; adolescents; heart rate; autonomic impairment	DYNAMIC EXERCISE; MECHANISMS	Objective: Test the hypotheses that (1) concussion in adolescents impairs autonomic neural control of heart rate (HR), and (2) HR reactivity improves with symptom resolution. Design: Observational, case-control. Participants: Nineteen concussed adolescents (8 female adolescents; age 15 +/- 2 years) and 16 healthy controls (6 female adolescents, age 15 +/- 2 years). Intervention: All participants performed an isometric handgrip (IHG) at 30% maximum voluntary contraction lasting 30 seconds. Heart rate (electrocardiogram) and hemodynamic responses (photoplethysmographic Finometer) were recorded from 30 seconds of baseline and the last 10 seconds of handgrip. Main Outcome Measures: The HR response (Delta HR) at the onset of moderate-intensity IHG using a mixed 1-way analysis of variance. Results: A group x time interaction (P< 0.005) indicated that handgrip evoked a greater Delta HR among control participants (13 +/- 10 beats/min) compared with concussed (6.4 +/- 6.3 beats/min; groupP= 0.63; timeP< 0.001;d= 0.77). Conclusion: These preliminary results suggest that a concussion impairs the ability to elevate HR at the exercise onset and, given the nature of the task, this could be interpreted to reflect reduced ability to withdraw cardiovagal control. Therefore, the data support the hypothesis of neural cardiac dysregulation in adolescents diagnosed with concussion.	[Woehrle, Emilie; Harriss, Alexandra B.; Abbott, Kolten C.; Moir, Marcy Erin; Balestrini, Christopher S.; Shoemaker, Joel Kevin] Western Univ, Sch Kinesiol, London, ON, Canada; [Harriss, Alexandra B.] Western Univ, Sch Phys Therapy, London, ON, Canada; [Balestrini, Christopher S.] Western Univ, Schulich Sch Med, London, ON, Canada; [Fischer, Lisa K.] Fowler Kennedy Sport Med Clin, London, ON, Canada; [Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Shoemaker, Joel Kevin] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada		Shoemaker, JK (corresponding author), Univ Western Ontario, Neurovasc Res Lab, Sch Kinesiol, Room 3159C Thames Hall, London, ON N6A 3K7, Canada.	kshoemak@uwo.ca			Children's Health Foundation, London, Ontario, Canada	This study was supported by the Children's Health Foundation, London, Ontario, Canada.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; MACIEL BC, 1986, CLIN SCI, V71, P457; MARTIN CE, 1974, J CLIN INVEST, V54, P104, DOI 10.1172/JCI107731; ROBINSON BF, 1966, CIRC RES, V19, P400, DOI 10.1161/01.RES.19.2.400; VICTOR RG, 1987, J CLIN INVEST, V79, P508, DOI 10.1172/JCI112841	8	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2020	30	5					E130	E133		10.1097/JSM.0000000000000635			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NX9CH	WOS:000575999300004	30113967				2022-02-06	
J	Yao, SC; Zwibel, H; Angelo, N; Leder, A; Mancini, J				Yao, Sheldon C.; Zwibel, Hallie; Angelo, Nicole; Leder, Adena; Mancini, Jayme			Effectiveness of Osteopathic Manipulative Medicine vs Concussion Education in Treating Student Athletes With Acute Concussion Symptoms	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article						athletes; concussion; osteopathic manipulative medicine	MANUAL LYMPHATIC DRAINAGE; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; MANAGEMENT; DURATION; IMPACT; REST	Context: Concussion, a type of mild traumatic brain injury, is a disruption in normal brain function due to head injury. New-onset symptoms from concussion vary, likely depending on the areas of the head and neck affected; they can be severe and debilitating. Current treatment options are limited and difficult to individualize. Osteopathic manipulative medicine (OMM) can aid musculoskeletal restrictions that can potentially improve concussion symptoms. Objective: To assess concussion symptom number and severity in participants with concussion who received either OMM or an educational intervention. Methods: A randomized controlled trial was conducted at the New York Institute of Technology Academic Health Care Center. Patients presenting to the center with concussion-like symptoms due to recent head injury within the previous 7 days provided consent and were randomized into 2 intervention groups, receiving either 1 OMM treatment (n=16) or 1 concussion education intervention (n=15). Participants were assessed before and after the intervention with the validated Symptom Concussion Assessment Tool fifth edition (SCAT-5) for quantification of number of symptoms and their severity. Collected data were analyzed using the Mann-Whitney U test and the repeated-measures analysis of variance. Results: Thirty-one participants were enrolled in the study; after 1 control participant was excluded due to incomplete data, 30 patient records were analyzed. The OMM intervention group had a significant decrease in symptom number (P=.002) and symptom severity (P=.001) compared with the concussion education group. Conclusion: When used in the acute setting, OMM significantly decreased concussion symptom number and severity compared with concussion education. This study demonstrates that integration of OMM using a physical examination-guided, individualized approach is safe and effective in the management of new-onset symptoms of uncomplicated concussions.	[Yao, Sheldon C.; Leder, Adena; Mancini, Jayme] New York Inst Technol, Coll Osteopath Med, Dept Osteopath Manipulat Med, POB 8000 Northern Blvd,Serota Bldg Room 127, Old Westbury, NY 11568 USA; [Zwibel, Hallie] New York Inst Technol, Coll Osteopath Med, Dept Family Med, Old Westbury, NY 11568 USA; [Angelo, Nicole] New York Inst Technol, Coll Osteopath Med, Old Westbury, NY 11568 USA		Yao, SC (corresponding author), New York Inst Technol, Coll Osteopath Med, Dept Osteopath Manipulat Med, POB 8000 Northern Blvd,Serota Bldg Room 127, Old Westbury, NY 11568 USA.	sheldon.yao@nyit.edu		Mancini, Jayme/0000-0002-1445-9715			Benveniste H, 2019, GERONTOLOGY, V65, P106, DOI 10.1159/000490349; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brolinson P Gunnar, 2014, Clin J Sport Med, V24, P89, DOI 10.1097/JSM.0000000000000062; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Cerritelli F, 2017, J PAIN RES, V10, P601, DOI 10.2147/JPR.S130501; Chappell C, 2015, OSTEOPATH FAM PHYS, V7, P30; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Faul M, 2010, TRAUMATIC BRAIN INJU; Garcia JD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00040; Giles PD, 2013, J ALTERN COMPLEM MED, V19, P92, DOI 10.1089/acm.2011.0031; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guernsey DT, 2016, J AM OSTEOPATH ASSOC, V116, pE13, DOI 10.7556/jaoa.2016.036; Hitscherich K, 2016, J AM OSTEOPATH ASSOC, V116, P170, DOI 10.7556/jaoa.2016.033; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Jull G, 2007, J ORTHOP RES, V25, P404, DOI 10.1002/jor.20220; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lee-Wong M, 2011, J ALLER THER, V2, P109, DOI [10.4172/2155-6121.1000109, DOI 10.4172/2155-6121.1000109]; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lunghi C, 2016, J BODYW MOV THER, V20, P784, DOI 10.1016/j.jbmt.2016.01.004; Majewski-Schrage T, 2016, J SPORT REHABIL, V25, P91, DOI [10.1123/jsr.2014-0222, 10-1123/jsr.2014-0222]; Mazzeo S, 2020, J AM OSTEOPATH ASSOC, V120, P615, DOI 10.7556/jaoa.2020.100; McCombs TM, 2006, J AM OSTEOPATH ASSOC, V106, P379; McCorry LK, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710478; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rose SC, 2016, SPORTS HEALTH, V8, P37, DOI 10.1177/1941738115591948; Saggio G, 2011, J AM OSTEOPATH ASSOC, V111, P143; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schwartzberg L, 2020, J AM OSTEOPATH ASSOC, V120, P601, DOI 10.7556/jaoa.2020.098; Stewart GW, 2012, INT J SPORTS PHYS TH, V7, P433; Vairo GL, 2009, J MAN MANIP THER, V17, pE80, DOI 10.1179/jmt.2009.17.3.80E	40	3	3	1	3	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	SEP	2020	120	9					607	614		10.7556/jaoa.2020.099			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NU8WU	WOS:000573918900009	32766808				2022-02-06	
J	Zhu, ZD; Chuckowree, JA; Dickson, TC; Musgrove, R; Blizzard, CA				Zhu, Zhendan; Chuckowree, Jyoti A.; Dickson, Tracey C.; Musgrove, Ruth; Blizzard, Catherine A.			The pathologic outcomes and ef ficacy of epothilone treatment following traumatic brain injury is determined by age	NEUROBIOLOGY OF AGING			English	Article							MICROTUBULE-STABILIZING AGENT; AXON REGENERATION; COGNITIVE DEFICITS; TRANSGENIC MICE; CNS INJURY; INTEGRITY; RECOVERY; TAXOL; NEUROINFLAMMATION; DYSFUNCTION		[Zhu, Zhendan; Chuckowree, Jyoti A.; Dickson, Tracey C.; Musgrove, Ruth; Blizzard, Catherine A.] Univ Tasmania, Menzies Inst Med Res, Private Bag 23, Hobart, Tas 7000, Australia		Blizzard, CA (corresponding author), Univ Tasmania, Menzies Inst Med Res, Private Bag 23, Hobart, Tas 7000, Australia.	Catherine.Blizzard@utas.eclu.au			National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Australian Research CouncilAustralian Research Council; Tasmanian Masonic Medical Research Foundation	This research was supported by the National Health and Medical Research Council of Australia, Australian Research Council, and Tasmanian Masonic Medical Research Foundation.	Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2017, J NEUROTRAUM, V34, P2261, DOI 10.1089/neu.2016.4692; Antona-Makoshi J, 2015, TRAFFIC INJ PREV, V16, pS91, DOI 10.1080/15389588.2015.1021416; Baas PW, 2014, NEURAL REGEN RES, V9, P1265, DOI 10.4103/1673-5374.137572; Ballatore C, 2017, ACS CHEM NEUROSCI, V8, P5, DOI 10.1021/acschemneuro.6b00384; Barten DM, 2012, J NEUROSCI, V32, P7137, DOI 10.1523/JNEUROSCI.0188-12.2012; Brizuela M, 2015, MOL CELL NEUROSCI, V66, P129, DOI 10.1016/j.mcn.2015.02.006; Brunden KR, 2012, BIOCHEM SOC T, V40, P661, DOI 10.1042/BST20120010; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cartelli D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01837; Chen D.Y., 2015, RADIOLOGY, V278, P854; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Chong CD, 2018, HEADACHE, V58, P827, DOI 10.1111/head.13269; Chuckowree JA, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00223; Clark JA, 2018, NEUROPATH APPL NEURO, V44, P590, DOI 10.1111/nan.12473; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Cross DJ, 2015, BRAIN RES, V1618, P299, DOI 10.1016/j.brainres.2015.06.006; Dent EW, 2017, MOL BIOL CELL, V28, P1, DOI 10.1091/mbc.E15-11-0769; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fan YJ, 2014, BIOL OPEN, V3, P494, DOI 10.1242/bio.20147641; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Gamble S, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6616a1; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hellstrom T., 2017, SCI REP, V7, P54; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hoffer ME, 2015, CURR OPIN NEUROL, V28, P74, DOI 10.1097/WCO.0000000000000164; Hur EM, 2014, INT NEUROUROL J, V18, P171, DOI 10.5213/inj.2014.18.4.171; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jang EH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5056418; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Keenan H. T., 2018, J NEUROTRAUM, V36, P282; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lichte P, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0159-8; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Luoto TM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00652; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Penazzi L, 2016, NEUROPHARMACOLOGY, V105, P84, DOI 10.1016/j.neuropharm.2016.01.002; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Popovich PG, 2014, EXP NEUROL, V261, P97, DOI 10.1016/j.expneurol.2014.06.020; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Rahimian R, 2019, NEUROSCIENCE, V405, P14, DOI 10.1016/j.neuroscience.2018.02.048; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Ruschel J, 2018, EXP NEUROL, V306, P243, DOI 10.1016/j.expneurol.2017.12.001; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Rusconi R, 2018, AGING CELL, V17, DOI 10.1111/acel.12727; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandner B, 2018, EXP NEUROL, V306, P250, DOI 10.1016/j.expneurol.2018.01.018; Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sinha SP, 2017, BRAIN BEHAV IMMUN, V61, P353, DOI 10.1016/j.bbi.2017.01.006; Sun M, 2020, NEUROSCI BIOBEHAV R, V109, P114, DOI 10.1016/j.neubiorev.2019.12.027; Sun MJ, 2019, BRAIN BEHAV IMMUN, V80, P536, DOI 10.1016/j.bbi.2019.04.038; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Teuber H., 1971, NEUROPSYCHOLOGIA, V17, P557; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Webster KM, 2019, J COMP NEUROL, V527, P1102, DOI 10.1002/cne.24589; Woodcock T., 2015, FRONT NEUROL, V4, P21; Yap YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176997; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012; Zhang YM, 2017, DESTECH TRANS COMP, P9; Zhao Y, 2009, EXPERT OPIN THER PAT, V19, P607, DOI 10.1517/13543770902775713	97	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	SEP	2020	93						85	96		10.1016/j.neurobiolaging.2020.03.023			12	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology	LY3UH	WOS:000540453200012	32480164				2022-02-06	
J	Irimia, A				Irimia, Andrei			Cross-Sectional Volumes and Trajectories of the Human Brain, Gray Matter, White Matter and Cerebrospinal Fluid in 9473 Typically Aging Adults	NEUROINFORMATICS			English	Article						Brain volume; Gray matter; White matter; Cerebrospinal fluid; Meta-analysis	VOXEL-BASED MORPHOMETRY; SEX-DIFFERENCES; AGE; MRI; METAANALYSIS; DECLINE; SEGMENTATION; THICKNESS; SHAPE; SIZE	Accurate knowledge of adult human brain volume (BV) is critical for studies of aging- and disease-related brain alterations, and for monitoring the trajectories of neural and cognitive functions in conditions like Alzheimer's disease and traumatic brain injury. This scoping meta-analysis aggregates normative reference values for BV and three related volumetrics-gray matter volume (GMV), white matter volume (WMV) and cerebrospinal fluid volume (CSFV)-from typically-aging adults studied cross-sectionally using magnetic resonance imaging (MRI). Drawing from an aggregate sample of 9473 adults, this study provides (A) regression coefficients beta describing the age-dependent trajectories of volumetric measures by sex within the range from 20 to 70 years based on both linear and quadratic models, and (B) average values for BV, GMV, WMV and CSFV at the representative ages of 20 (young age), 45 (middle age) and 70 (old age). The results provided synthesize similar to 20 years of brain volumetrics research and allow one to estimate BV at any age between 20 and 70. Importantly, however, such estimates should be used and interpreted with caution because they depend on MRI hardware specifications (e.g. scanner manufacturer, magnetic field strength), data acquisition parameters (e.g. spatial resolution, weighting), and brain segmentation algorithms. Guidelines are proposed to facilitate future meta- and mega-analyses of brain volumetrics.	[Irimia, Andrei] Univ Southern Calif, Ethel Percy Andrus Gerontol Ctr, Leonard Davis Sch Gerontol, 3715 McClintock Ave, Los Angeles, CA 90089 USA; [Irimia, Andrei] Univ Southern Calif, Denney Res Ctr, Dept Biomed Engn, Viterbi Sch Engn, 1042 Downey Way, Los Angeles, CA 90089 USA		Irimia, A (corresponding author), Univ Southern Calif, Ethel Percy Andrus Gerontol Ctr, Leonard Davis Sch Gerontol, 3715 McClintock Ave, Los Angeles, CA 90089 USA.; Irimia, A (corresponding author), Univ Southern Calif, Denney Res Ctr, Dept Biomed Engn, Viterbi Sch Engn, 1042 Downey Way, Los Angeles, CA 90089 USA.	irimia@usc.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RF1 AG 054442, R01 NS 100973]; US Department of DefenseUnited States Department of Defense [W81XWH-18-1-0413]	This work was supported by the National Institutes of Health under Award Numbers RF1 AG 054442 and R01 NS 100973, and by the US Department of Defense under contract W81XWH-18-1-0413. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health or of the Department of Defense.	Abe O, 2008, NEUROBIOL AGING, V29, P102, DOI 10.1016/j.neurobiolaging.2006.09.003; Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Balafar MA, 2010, ARTIF INTELL REV, V33, P261, DOI 10.1007/s10462-010-9155-0; Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benedetti B, 2006, NEUROLOGY, V66, P535, DOI 10.1212/01.wnl.0000198510.73363.c6; Bigler ED, 2001, INVEST RADIOL, V36, P539, DOI 10.1097/00004424-200109000-00006; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Burnham KA., 2002, MODEL SELECTION MULT, V2; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; de Boer R, 2010, NEUROIMAGE, V51, P1047, DOI 10.1016/j.neuroimage.2010.03.012; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Despotovic I, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/450341; Doherty CP, 2000, MAGN RESON IMAGING, V18, P1017, DOI 10.1016/S0730-725X(00)00185-5; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Fjell AM, 2010, NEUROIMAGE, V50, P1376, DOI 10.1016/j.neuroimage.2010.01.061; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Gazzaniga MS, 2009, HUMAN SCI WHAT MAKES; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Gur RC, 2002, AM J GERIAT PSYCHIAT, V10, P72, DOI 10.1176/appi.ajgp.10.1.72; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Guttmann CRG, 1998, NEUROLOGY, V50, P972, DOI 10.1212/WNL.50.4.972; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; HECKMAN J, 1990, AM ECON REV, V80, P313; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hodos, 1996, COMP VERTEBRATE NEUR; Iimia A, 2013, NEUROIMAGE, V66, P489, DOI 10.1016/j.neuroimage.2012.10.066; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Irimia A, 2019, FRONT NEUROINFORM, V13, DOI 10.3389/fninf.2019.00009; Irimia A, 2015, BRAIN IMAGING BEHAV, V9, P678, DOI 10.1007/s11682-014-9321-0; Jancke L, 2015, HUM BRAIN MAPP, V36, P150, DOI 10.1002/hbm.22619; Jantz RL, 2016, HUM BIOL, V88, P56; Jantz RL, 2000, AM J HUM BIOL, V12, P327, DOI 10.1002/(SICI)1520-6300(200005/06)12:3<327::AID-AJHB3>3.0.CO;2-1; JERNIGAN TL, 1991, BIOL PSYCHIAT, V29, P55, DOI 10.1016/0006-3223(91)90210-D; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Kaplan H, 2017, LANCET, V389, P1730, DOI 10.1016/S0140-6736(17)30752-3; Lemaitre H, 2005, NEUROIMAGE, V26, P900, DOI 10.1016/j.neuroimage.2005.02.042; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Lenroot RK, 2008, DEV PSYCHOPATHOL, V20, P1161, DOI 10.1017/S0954579408000552; Liu RSN, 2003, NEUROIMAGE, V20, P22, DOI 10.1016/S1053-8119(03)00219-2; Lorio S, 2016, HUM BRAIN MAPP, V37, P1801, DOI 10.1002/hbm.23137; Matsumae M, 1996, J NEUROSURG, V84, P982, DOI 10.3171/jns.1996.84.6.0982; Michielse S, 2010, NEUROIMAGE, V52, P1190, DOI 10.1016/j.neuroimage.2010.05.019; Natu VS, 2019, P NATL ACAD SCI USA, V116, P20750, DOI 10.1073/pnas.1904931116; Nieminen P., 2013, EPIDEMIOLOGY BIOSTAT, V10, P1, DOI DOI 10.2427/8854; NUNNEY L, 1991, P ROY SOC B-BIOL SCI, V246, P71, DOI 10.1098/rspb.1991.0126; Peelle JE, 2012, NEUROIMAGE, V60, P1503, DOI 10.1016/j.neuroimage.2011.12.086; Prothero D., 2007, EVOLUTION WHAT FOSSI; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Rossi RJ., 2018, MATH STAT INTRO LIKE; Rushton JP, 1996, PSYCHON B REV, V3, P21, DOI 10.3758/BF03210739; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Shiavi R, 2006, INTRO APPL STAT SIGN; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sutton A, 2004, METHODS METAANALYSIS; Taki Y, 2004, NEUROBIOL AGING, V25, P455, DOI 10.1016/j.neurobiolaging.2003.09.002; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; USPENSKII SI, 1964, AM J PHYS ANTHROPOL, V22, P115, DOI 10.1002/ajpa.1330220123; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Voevodskaya O, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00264; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013	74	3	3	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1539-2791	1559-0089		NEUROINFORMATICS	Neuroinformatics	APR	2021	19	2					347	366		10.1007/s12021-020-09480-w		AUG 2020	20	Computer Science, Interdisciplinary Applications; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Neurosciences & Neurology	RD9SN	WOS:000565517800001	32856237	Green Submitted			2022-02-06	
J	Yeatts, SD; Martin, RH; Meurer, W; Silbergleit, R; Rockswold, GL; Barsan, WG; Korley, FK; Wright, DW; Gajewski, BJ				Yeatts, Sharon D.; Martin, Renee' H.; Meurer, William; Silbergleit, Robert; Rockswold, Gaylan L.; Barsan, William G.; Korley, Frederick K.; Wright, David W.; Gajewski, Byron J.			Sliding Scoring of the Glasgow Outcome Scale-Extended as Primary Outcome in Traumatic Brain Injury Trials	JOURNAL OF NEUROTRAUMA			English	Article						Glasgow Outcome Scale-Extended; sliding score; statistical analysis		The Glasgow Outcome Scale-Extended (GOS-E), an ordinal scale measuring global outcome, is used commonly as the primary outcome measure in clinical trials of traumatic brain injury. Analysis is often based on a dichotomization and thus has inherent statistical limitations, including loss of information related to the collapse of adjacent categories. A fixed dichotomization defines favorable outcome consistently for all subjects, whereas a sliding dichotomy tailors the definition of favorable outcome according to baseline prognosis/severity. Literature indicates that the sliding dichotomy is more statistically efficient than the fixed dichotomy; however, the sliding dichotomy still collapses categories and therefore discards information. We propose an alternative, a sliding scoring system for the GOS-E, intended to address the limitations of the sliding dichotomy. The score is assigned based on the number of levels between the achieved score and the favorable cut-point. The proposed scoring system reflects the magnitude of change, where change is defined according to each subject's baseline prognosis. Because the score is approximately continuous, statistical methods can rely on the normal distribution, both for analysis and study design. Two examples show the corresponding potential for improved power. A sliding score approach allows for quantification of the magnitude of change while still accounting for prognosis. Scientific advantages include increased power and an intuitive interpretation.	[Yeatts, Sharon D.; Martin, Renee' H.] Med Univ South Carolina, Dept Publ Hlth Sci, 135 Cannon St,Suite 303,MSC 835, Charleston, SC 29425 USA; [Meurer, William; Silbergleit, Robert; Barsan, William G.; Korley, Frederick K.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Meurer, William] Berry Consultants, Austin, TX USA; [Rockswold, Gaylan L.] Univ Minnesota, Hennepin Cty Med Ctr, Dept Neurosurg, Minneapolis, MN 55415 USA; [Wright, David W.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Gajewski, Byron J.] Univ Kansas, Med Ctr, Dept Biostat & Data Sci, Kansas City, KS 66103 USA		Yeatts, SD (corresponding author), Med Univ South Carolina, Dept Publ Hlth Sci, 135 Cannon St,Suite 303,MSC 835, Charleston, SC 29425 USA.	yeatts@musc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NIH (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF)	During the conduct of the study, Dr. Yeatts and Dr. Martin report grants to the Medical University of South Carolina from National Institutes of Health, Dr. Meurer and Dr. Silbergleit report grants to the University of Michigan from National Institutes of Health, Dr. Barsan reports grants to the University of Michigan from NIH (NINDS, NHLBI), Dr. Korley reports grants to the University of Michigan from the National Institutes of Health and the Robert Wood Johnson Foundation, Dr. Gajewski reports grants to the University of Kansas Medical Center from National Institutes of Health.	Alali AS, 2015, J NEUROTRAUM, V32, P581, DOI 10.1089/neu.2014.3495; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Dijkland SA, 2018, STROKE, V49, P965, DOI 10.1161/STROKEAHA.117.020194; Gajewski BJ, 2019, STAT MED, V38, P3123, DOI 10.1002/sim.8167; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	11	3	4	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2020	37	24					2674	2679		10.1089/neu.2019.6969		AUG 2020	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PF0CR	WOS:000566011600001	32664792	Green Published			2022-02-06	
J	O'Connell, GC; Alder, ML; Smothers, CG; Chang, JHC				O'Connell, Grant C.; Alder, Megan L.; Smothers, Christine G.; Chang, Julia H. C.			Large-scale informatic analysis to algorithmically identify blood biomarkers of neurological damage	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						molecular diagnostics; stroke; multiple sclerosis; traumatic brain injury; Alzheimer's disease	TRAUMATIC BRAIN-INJURY; MYELIN BASIC-PROTEIN; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; ISCHEMIC-STROKE; EARLY-DIAGNOSIS; ACIDIC PROTEIN; EXPRESSION; SERUM; CSF	The identification of precision blood biomarkers which can accurately indicate damage to brain tissue could yield molecular diagnostics with the potential to improve how we detect and treat neurological pathologies. However, a majority of candidate blood biomarkers for neurological damage that are studied today are proteins which were arbitrarily proposed several decades before the advent of high-throughput omic techniques, and it is unclear whether they represent the best possible targets relative to the remainder of the human proteome. Here, we leveraged mRNA expression data generated from nearly 12,000 human specimens to algorithmically evaluate over 17,000 protein-coding genes in terms of their potential to produce blood biomarkers for neurological damage based on their expression profiles both across the body and within the brain. The circulating levels of proteins associated with the top-ranked genes were then measured in blood sampled from a diverse cohort of patients diagnosed with a variety of acute and chronic neurological disorders, including ischemic stroke, hemorrhagic stroke, traumatic brain injury, Alzheimer's disease, and multiple sclerosis, and evaluated for their diagnostic performance. Our analysis identifies several previously unexplored candidate blood biomarkers of neurological damage with possible clinical utility, many of which whose presence in blood is likely linked to specific cell-level pathologic processes. Furthermore, our findings also suggest that many frequently cited previously proposed blood biomarkers exhibit expression profiles which could limit their diagnostic efficacy.	[O'Connell, Grant C.; Alder, Megan L.; Smothers, Christine G.; Chang, Julia H. C.] Case Western Reserve Univ, Sch Nursing, Cleveland, OH 44106 USA		O'Connell, GC (corresponding author), Case Western Reserve Univ, Sch Nursing, Cleveland, OH 44106 USA.	grant.oconnell@case.edu	Alder, Megan/L-6112-2016	Alder, Megan/0000-0002-7817-3476; Smothers, Christine/0000-0002-8269-2375; O'Connell, Grant/0000-0002-2642-6670	Case Western Reserve University Frances Payne Bolton School of Nursing	We thank Dr. Paul D. Chantler of West Virginia University, and Dr. Taura L. Barr, formerly of West Virginia University, for providing access to stroke and traumatic brain injury blood samples. We also thank Dr. Mary E. Kerr and Ali L. Clark for critical review of the manuscript. Work was financially supported by Case Western Reserve University Frances Payne Bolton School of Nursing start-up funds issued to G.C.O.	Arch AE, 2016, STROKE, V47, P668, DOI 10.1161/STROKEAHA.115.010613; BARKHOF F, 1992, NEUROLOGY, V42, P63, DOI 10.1212/WNL.42.1.63; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012; Briard JN, 2018, J STROKE CEREBROVASC, V27, P2738, DOI 10.1016/j.jstrokecerebrovasdis.2018.05.046; Bustamante A, 2017, STROKE, V48, P2419, DOI 10.1161/STROKEAHA.117.017076; Comabella M, 2014, LANCET NEUROL, V13, P113, DOI 10.1016/S1474-4422(13)70233-3; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Fuller G, 2016, EUR J EMERG MED, V23, P61, DOI 10.1097/MEJ.0000000000000327; Fuller G, 2014, EMERG MED J, V31, P914, DOI 10.1136/emermed-2013-202575; Gallacher KI, 2019, STROKE, V50, P1919, DOI 10.1161/STROKEAHA.118.020376; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Glushakova Olena Y, 2016, Brain Circ, V2, P28, DOI 10.4103/2394-8108.178546; Goyal N, 2015, J STROKE CEREBROVASC, V24, P828, DOI 10.1016/j.jstrokecerebrovasdis.2014.11.023; Hampel H, 2018, NAT REV NEUROL, V14, P639, DOI 10.1038/s41582-018-0079-7; Hiskens MI, 2020, BIOMARKERS, V25, P213, DOI 10.1080/1354750X.2020.1735521; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; Jiang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep29795; Jickling GC, 2015, STROKE, V46, P915, DOI 10.1161/STROKEAHA.114.005604; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Kamtchum-Tatuene J, 2019, NEUROMOL MED, V21, P344, DOI 10.1007/s12017-019-08530-0; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Kernagis DN, 2012, ANN NEUROL, V71, P289, DOI 10.1002/ana.22553; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Koch MW, 2015, J NEUROL SCI, V350, P46, DOI 10.1016/j.jns.2015.02.009; LAATSCH RH, 1962, J EXP MED, V115, P777, DOI 10.1084/jem.115.4.777; Lambert J, 2019, J IMMUNOL, V202; Lamers KJB, 1998, MULT SCLER, V4, P124; Lees Kennedy R, 2010, Lancet, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lever NM, 2013, J EMERG NURS, V39, P434, DOI 10.1016/j.jen.2012.02.011; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Lim Ee Tuan, 1800, J Negat Results Biomed, V3, P4, DOI 10.1186/1477-5751-3-4; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; MOORE BW, 1965, J BIOL CHEM, V240, P1647; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; O'Connell GC, 2020, BRAIN INJURY, V34, P965, DOI 10.1080/02699052.2020.1764102; O'Connell GC, 2020, BRAIN RES, V1739, DOI 10.1016/j.brainres.2020.146861; O'Connell GC, 2020, NEUROL RES, V42, P346, DOI 10.1080/01616412.2020.1726588; O'Connell GC, 2019, NEUROTHERAPEUTICS, V16, P868, DOI 10.1007/s13311-019-00720-9; O'Hagan S, 2018, CELL SYST, V6, P230, DOI 10.1016/j.cels.2018.01.003; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Ren CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24588; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Shen EH, 2012, TRENDS NEUROSCI, V35, P711, DOI 10.1016/j.tins.2012.09.005; Solomon AJ, 2017, NAT REV NEUROL, V13, P567, DOI 10.1038/nrneurol.2017.106; Tanji K, 2003, BRAIN RES, V976, P125, DOI 10.1016/S0006-8993(03)02633-7; THOMAS D G T, 1978, Lancet, V1, P113; THOMAS DGT, 1984, J NEUROL NEUROSUR PS, V47, P173, DOI 10.1136/jnnp.47.2.173; Wasik N, 2020, ACTA NEUROCHIR, V162, P545, DOI 10.1007/s00701-019-04185-9; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WHITAKER JN, 1977, NEUROLOGY, V27, P911, DOI 10.1212/WNL.27.10.911; Yanagitani S, 1999, LIFE SCI, V64, P707, DOI 10.1016/S0024-3205(98)00612-2; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yuguchi T, 1997, J CEREBR BLOOD F MET, V17, P745; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhelev Z, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011427.pub2	64	3	3	3	5	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 25	2020	117	34					20764	20775		10.1073/pnas.2007719117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5TE	WOS:000572322600008	32764143	Green Published, Bronze			2022-02-06	
J	Osumi, R; Wang, ZY; Ishihara, Y; Odagaki, N; Iimura, T; Kamioka, H				Osumi, Ryuta; Wang, Ziyi; Ishihara, Yoshihito; Odagaki, Naoya; Iimura, Tadahiro; Kamioka, Hiroshi			Changes in the intra- and peri-cellular sclerostin distribution in lacuno-canalicular system induced by mechanical unloading	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Sclerostin distribution; Lacuno-canalicular system; Mechanical unloading	SOLUTE TRANSPORT; BONE-DEVELOPMENT; LOADED BONE; OSTEOCYTES; MICE; ACTIVATION; GENETICS; MODEL	Introduction Mechanical stimuli regulate Sclerostin (Scl), a negative regulator of bone formation, expression in osteocytes. However, the detailed Scl distribution in osteocytes in response to mechanical unloading remains unclear. Materials and methods Twelve-week-old male rats were used. The sciatic and femoral nerves on the right side were excised as mechanical unloading treatment. A sham operation was performed on the left side. One week after neurotrauma, the bone density of the femora was evaluated by peripheral quantitative computed tomography, and immunofluorescence was performed in coronal sections of the femoral diaphysis. The mean fluorescence intensity and fluorescent profile of Scl from the marrow to the periosteal side were analyzed to estimate the Scl expression and determine to which side (marrow or periosteal) the Scl prefers to distribute in response to mechanical unloading. The most sensitive region indicated by the immunofluorescence results was further investigated by transmission electron microscopy (TEM) with immunogold staining to show the Scl expression changes in different subcellular structures. Results In femur distal metaphysis, neurotrauma-induced mechanical unloading significantly decreased the bone density, made the distribution of Scl closer to the marrow on the anterior and medial side, and increased the Scl expression only on the lateral side. TEM findings showed that only the expression of Scl in canaliculi was increased by mechanical unloading. Conclusions Our results showed that even short-term mechanical unloading is enough to decrease bone density, and mechanical unloading not only regulated the Scl expression but also changed the Scl distribution in both the osteocyte network and subcellular structures.	[Osumi, Ryuta; Ishihara, Yoshihito; Odagaki, Naoya] Okayama Univ Hosp, Dept Orthodont, Okayama, Japan; [Wang, Ziyi; Kamioka, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthodont, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan; [Wang, Ziyi] Japan Soc Promot Sci, Tokyo, Japan; [Iimura, Tadahiro] Hokkaido Univ, Grad Sch Dent Med, Dept Pharmacol, Sapporo, Hokkaido, Japan		Kamioka, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthodont, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	kamioka@md.okayama-u.ac.jp	Wang, Ziyi/AAW-6082-2020; ISHIHARA, Yoshihito/B-2345-2011	Wang, Ziyi/0000-0003-1884-8053; ISHIHARA, Yoshihito/0000-0002-5999-8253	Japan Society for the Promotion of Science, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [18H02983, 17H04413, 19J11906, 16H05549, 19H03859]	The authors would like to thank Masumi Furutani and Megumi Tsukano, Central Research Laboratory, Okayama University Medical School, for their technical assistance in this study. This work was supported by a Grant-in-Aid for Scientific Research (to T. Iimura [18H02983], Y. Ishihara [17H04413], Z. Wang [19J11906] and H. Kamioka [16H05549, 19H03859]) from the Japan Society for the Promotion of Science, Japan.	Adachi T, 2009, J BIOMECH, V42, P1989, DOI 10.1016/j.jbiomech.2009.04.034; Albiol L, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0012; Anagnostis P, 2018, HAEMOPHILIA, V24, P316, DOI 10.1111/hae.13384; Birkhold AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep23480; Blaber EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061372; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Brodt MD, 2010, J BONE MINER RES, V25, P2006, DOI 10.1002/jbmr.96; Delgado-Calle J, 2017, BONE, V96, P29, DOI 10.1016/j.bone.2016.10.007; EJIRI S, 1982, ARCH HISTOL JAPON, V45, P399, DOI 10.1679/aohc.45.399; Elefteriou F, 2018, PHYSIOL REV, V98, P1083, DOI 10.1152/physrev.00014.2017; Fu SQ, 2019, J ENDOCRINOL, V241, P161, DOI 10.1530/JOE-19-0022; Galea GL, 2017, BONE, V96, P38, DOI 10.1016/j.bone.2016.10.008; Grimston SK, 2008, J BONE MINER RES, V23, P879, DOI 10.1359/JBMR.080222; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Irie K, 2008, J HISTOCHEM CYTOCHEM, V56, P561, DOI 10.1369/jhc.2008.950527; Ishihara Y, 2008, J BONE MINER RES, V23, P350, DOI 10.1359/JBMR.071102; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Kamioka H, 2012, INTEGR BIOL-UK, V4, P1198, DOI 10.1039/c2ib20092a; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Keune JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep18671; Kogawa M, 2018, AM J PHYSIOL-CELL PH, V314, pC53, DOI 10.1152/ajpcell.00175.2017; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Li W, 2009, BONE, V45, P1017, DOI 10.1016/j.bone.2009.07.076; Lloyd SA, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-122; Lv JW, 2015, BIOCHEM BIOPH RES CO, V468, P587, DOI 10.1016/j.bbrc.2015.10.152; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; MURAKAMI H, 1994, J BONE MINER RES, V9, P1355; Neu CM, 2001, OSTEOPOROSIS INT, V12, P538, DOI 10.1007/s001980170074; Nicol L, 2018, J BONE MINER RES, V33, P307, DOI 10.1002/jbmr.3312; Nishiyama Y, 2015, ARCH ORAL BIOL, V60, P45, DOI 10.1016/j.archoralbio.2014.08.013; Odagaki N, 2018, J DENT RES, V97, P1374, DOI 10.1177/0022034518771331; PIEKARSKI K, 1977, NATURE, V269, P80, DOI 10.1038/269080a0; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Price C, 2011, J BONE MINER RES, V26, P277, DOI 10.1002/jbmr.211; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Sebastian A, 2018, METABOLISM, V80, P38, DOI 10.1016/j.metabol.2017.10.005; Sebastian A, 2017, BONE, V96, P76, DOI 10.1016/j.bone.2016.10.009; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Sugawara Y, 2013, BONE, V52, P189, DOI 10.1016/j.bone.2012.09.033; Suzuki N, 2016, BIOMECH MODEL MECHAN, V15, P1091, DOI 10.1007/s10237-015-0746-1; Tami AE, 2003, BIORHEOLOGY, V40, P577; Tate MLK, 1998, BONE, V22, P107; Tezuka K, 2005, J BONE MINER METAB, V23, P1, DOI 10.1007/s00774-004-0533-z; Vatsa A, 2008, BONE, V43, P452, DOI 10.1016/j.bone.2008.01.030; Wang B, 2013, J BONE MINER RES, V28, P1075, DOI 10.1002/jbmr.1804; Wang LY, 2005, P NATL ACAD SCI USA, V102, P11911, DOI 10.1073/pnas.0505193102; Watanabe T, 2012, BONE, V51, P447, DOI 10.1016/j.bone.2012.06.019; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; Williams Diarra K, 2018, JBMR Plus, V2, P47, DOI 10.1002/jbm4.10025; Yavropoulou MP, 2014, HORM-INT J ENDOCRINO, V13, P476	51	3	3	1	4	SPRINGER JAPAN KK	TOKYO	SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	MAR	2021	39	2					148	159		10.1007/s00774-020-01135-9		AUG 2020	12	Endocrinology & Metabolism; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Research & Experimental Medicine	QT9BJ	WOS:000562686600001	32844318	Green Submitted			2022-02-06	
J	LeBlanc, J; Seresova, A; Laberge-Poirier, A; Tabet, S; Correa, JA; Alturki, AY; Feyz, M; de Guise, E				LeBlanc, Joanne; Seresova, Alena; Laberge-Poirier, Andreanne; Tabet, Sabrina; Correa, Jose A.; Alturki, Abdulrahman Y.; Feyz, Mitra; de Guise, Elaine			Cognitive-communication skills and acute outcome following mild traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; communication; language; acute care; outcome	SOCIAL INTEGRATION; DISCOURSE; ABILITIES; SEQUELAE; DEFICITS; MODERATE; QUALITY; ADULTS; SCALE	Purpose Little is known about cognitive-communication skills post mild traumatic brain injury (mTBI). We aimed to determine how performance on cognitive-communication measures in the acute recovery period relates to early outcome following complicated mTBI. Method Results of language and communication skill measures, demographic and accident-related data, length of stay (LOS), Glasgow Outcome Scale-Extended (GOSE) scores and discharge destinations were retrospectively gathered for 128 admitted patients with complicated mTBI. Results More than half of the individuals required rehabilitation services post discharge from hospital with over a third needing in-patient rehabilitation. Patients with poorer skills in auditory comprehension, verbal reasoning, confrontation naming, verbal fluency and conversational discourse were more likely to require in-patient rehabilitation. Subjects with worse skills in naming, conversational discourse and letter-category verbal fluency had a greater chance of being referred to out-patient rehabilitation services. Thus patients with both auditory comprehension and oral expression deficits were more likely to require in-patient services whereas those who had oral expression deficits but no significant difficulty in auditory comprehension were more often referred to out-patient services. Also, worse conversational discourse skills and semantic-category naming ability were related to lower GOSE scores and the chance of a longer LOS was greater when letter-category naming was poorer. Conclusion The likelihood of individuals requiring rehabilitation services post mTBI was related to performance on several oral expression and auditory comprehension measures. It is therefore important to evaluate cognitive-communication skills early to determine rehabilitation needs.	[LeBlanc, Joanne; Seresova, Alena; Laberge-Poirier, Andreanne; Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ, Canada; [Tabet, Sabrina; de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Correa, Jose A.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Alturki, Abdulrahman Y.; de Guise, Elaine] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Alturki, Abdulrahman Y.] King Fahad Med City, Natl Neurosci Inst, Adult Neurosurg Dept, Riyadh, Saudi Arabia; [de Guise, Elaine] Montreal Metropolitain CRIR, Ctr Rech Interdisciplinaire Readaptat, Montreal, PQ, Canada; [de Guise, Elaine] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada		LeBlanc, J (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada.	joanne.leblanc@mcgill.ca			Research Institute of the McGill University Health Center	We thank the Research Institute of the McGill University Health Center for their support.	[Anonymous], 1988, CAN AD ACH TEST; [Anonymous], 1995, TEST REND FRANC; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Baker H. J., 1965, DETROIT TEST LEARNIN; Barrow IM, 2003, J TRAUMA, V54, P888, DOI 10.1097/01.TA.0000057150.60668.7C; Benton A., 1976, MULTILINGUAL APHASIA; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Brown J, 2019, TOP LANG DISORD, V39, P239, DOI 10.1097/TLD.0000000000000186; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Cote H, 2004, REEDUCATION ORTHOPHO, V219, P107; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Fonseca RP, 2008, SPAN J PSYCHOL, V11, P678, DOI 10.1017/S1138741600004686; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gauthier S, 2018, J COMMUN DISORD, V73, P77, DOI 10.1016/j.jcomdis.2018.04.003; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Isaki E, 2000, BRAIN INJURY, V14, P441; Joanette Y, 2004, PROTOCOLE MONTREAL E; Kaplan E., 2001, BOSTON NAMING TEST; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; LeBlanc J, 2014, BRAIN INJURY, V28, P951, DOI 10.3109/02699052.2014.888760; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; McHugh T, 2006, BRAIN COGNITION, V60, P209; McMillan TM, 2013, J NEUROTRAUM, V30, P970, DOI 10.1089/neu.2012.2703; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prigatano GP, 1995, BNI Q, V9, P2; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Snow M, 1998, BRAIN INJURY, V12, P911, DOI [10.1080/026990598121981, DOI 10.1080/026990598121981]; Steel J, 2015, NEUROREHABILITATION, V37, P221, DOI 10.3233/NRE-151255; Stockbridge MD, 2019, AM J SPEECH-LANG PAT, V28, P1554, DOI 10.1044/2019_AJSLP-18-0196; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Tran S, 2018, BRAIN INJURY, V32, P1700, DOI 10.1080/02699052.2018.1537006; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Ylvisaker M., 2008, LANGUAGE INTERVENTIO; Yue JK, 2017, BRAIN INJ, V31, P1820	45	3	3	3	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 18	2020	34	11					1472	1479		10.1080/02699052.2020.1802669		AUG 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NR9QK	WOS:000564120500001	32857623				2022-02-06	
J	Hayakwa, M; Ooyasu, T; Sadamoto, Y; Saito, T; Yoshida, T; Katabami, K; Wada, T; Maekawa, K; Ieko, M				Hayakwa, Mineji; Ooyasu, Takayoshi; Sadamoto, Yoshihiro; Saito, Tomoyo; Yoshida, Tomonao; Katabami, Kenichi; Wada, Takeshi; Maekawa, Kunihiko; Ieko, Masahiro			Microparticles and Nucleosomes Are Released From Parenchymal Cells Destroyed After Injury in a Rat Model of Blunt Trauma	CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS			English	Article						blunt trauma; coagulopathy; microparticle; nucleosome; thrombin	DISSEMINATED INTRAVASCULAR COAGULATION; NEUTROPHIL EXTRACELLULAR TRAPS; INDUCED COAGULOPATHY; THROMBIN GENERATION; EARLY PHASE; PLASMA DNA; PROCOAGULANT; BRAIN; PATHOPHYSIOLOGY; INFLAMMATION	We investigated the relationships between circulating procoagulants and trauma severity, including cellular destruction, and the effects of thrombin generation on procoagulants in a rat blunt trauma model. The rats were subjected to tumbling blunt trauma, where they were tumbled for 0, 250, 500, or 1000 revolutions. Creatine kinase, nucleosome, and microparticle plasma levels increased gradually with trauma severity. Strong interrelationships were observed among creatine kinase, nucleosome, and microparticle levels. Time to initiation of thrombin generation shortened with increasing trauma severity. In accordance with trauma severity, prothrombin activity decreased, but the thrombin generation ratio increased. Time to initiation of thrombin generation and the thrombin generation ratio correlated with creatine kinase levels. In anin vitrostudy, a homogenized muscle solution, which included massive nucleosomes and microparticles, showed accelerated thrombin generation of plasma from healthy subjects. Procoagulants, such as microparticles and nucleosomes, are released from destroyed parenchymal cells immediately after external traumatic force, activating the coagulation cascade. The procoagulants shorten the time to initiation of thrombin generation. Furthermore, although coagulation factors are consumed, the thrombin generation ratio increases.	[Hayakwa, Mineji; Ooyasu, Takayoshi; Sadamoto, Yoshihiro; Saito, Tomoyo; Yoshida, Tomonao; Katabami, Kenichi; Wada, Takeshi; Maekawa, Kunihiko] Hokkaido Univ Hosp, Dept Emergency Med, Sapporo, Hokkaido, Japan; [Ieko, Masahiro] Hlth Sci Univ Hokkaido, Sch Dent, Dept Internal Med, Ishikari, Hokkaido, Japan		Hayakwa, M (corresponding author), Hokkaido Univ Hosp, Dept Emergency Med, Kita Ku, N14W5, Sapporo, Hokkaido 0608648, Japan.	mineji@dream.com	Hayakawa, Mineji/G-2263-2012		JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP 18K08905]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by JSPS KAKENHI grant number JP 18K08905.	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Floccard B, 2012, INJURY, V43, P26, DOI 10.1016/j.injury.2010.11.003; Frohlich M, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0499-9; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943, DOI 10.1055/s-0037-1613338; Gando S, 2016, SEMIN THROMB HEMOST, V42, P155, DOI 10.1055/s-0035-1564831; Hayakawa M, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1811-1; Hayakawa M, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0200-1; Hayakawa M, 2016, SHOCK, V45, P308, DOI 10.1097/SHK.0000000000000542; Hayakawa M, 2015, SHOCK, V43, P261, DOI 10.1097/SHK.0000000000000281; Hayakawa M, 2015, SEMIN THROMB HEMOST, V41, P35, DOI 10.1055/s-0034-1398379; Hayakawa M, 2011, SURGERY, V149, P221, DOI 10.1016/j.surg.2010.06.010; Johansson PI, 2012, J THROMB HAEMOST, V10, P207, DOI 10.1111/j.1538-7836.2011.04589.x; Johansson Par I, 2013, J Emerg Trauma Shock, V6, P171, DOI 10.4103/0974-2700.115327; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kutcher ME, 2014, ANN SURG, V260, P1103, DOI 10.1097/SLA.0000000000000366; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P1389, DOI 10.1097/TA.0b013e318270d595; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; Liaw PC, 2016, BLOOD REV, V30, P257, DOI 10.1016/j.blre.2015.12.004; Lo YMD, 2000, CLIN CHEM, V46, P319; Marsman G, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.410; Matijevic N, 2014, THROMB RES, V134, P652, DOI 10.1016/j.thromres.2014.07.023; Miyazaki Y, 1996, BLOOD, V88, P3456, DOI 10.1182/blood.V88.9.3456.bloodjournal8893456; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Noble RL, 1942, Q J EXP PHYSIOL CMS, V31, P187, DOI 10.1113/expphysiol.1942.sp000856; Nomura S, 2008, THROMB RES, V123, P8, DOI 10.1016/j.thromres.2008.06.006; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Park MS, 2015, J TRAUMA ACUTE CARE, V79, P726, DOI 10.1097/TA.0000000000000839; Park MS, 2012, SURGERY, V151, P831, DOI 10.1016/j.surg.2011.12.022; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Pfeiler S, 2017, HAEMATOLOGICA, V102, P206, DOI 10.3324/haematol.2016.142471; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Silk E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.52; Swystun LL, 2011, J THROMB HAEMOST, V9, P2313, DOI 10.1111/j.1538-7836.2011.04465.x; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Yanagida Y, 2013, SURGERY, V154, P48, DOI 10.1016/j.surg.2013.02.004; Yasui H, 2016, AM J PHYSIOL-LUNG C, V311, pL74, DOI 10.1152/ajplung.00429.2015	40	3	3	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1076-0296	1938-2723		CLIN APPL THROMB-HEM	Clin. Appl. Thromb.-Hemost.	AUG 20	2020	26								1076029620950825	10.1177/1076029620950825			8	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	NH0JV	WOS:000564366800001	32833555	gold, Green Published			2022-02-06	
J	Lesman-Segev, OH; Edwards, L; Rabinovici, GD				Lesman-Segev, Orit H.; Edwards, Lauren; Rabinovici, Gil D.			Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia	SEMINARS IN NEUROLOGY			English	Article						chronic traumatic encephalopathy; differential diagnosis; Alzheimer's disease; frontotemporal dementia	MILD COGNITIVE IMPAIRMENT; PROGRESSIVE SUPRANUCLEAR PALSY; ENVIRONMENTAL RISK-FACTORS; SMALLER THALAMIC VOLUMES; BRAIN-INJURY; BEHAVIORAL VARIANT; LOBAR DEGENERATION; APOLIPOPROTEIN-E; DIAGNOSTIC-CRITERIA; AMYLOID-PET	The clinical diagnosis of chronic traumatic encephalopathy (CTE) is challenging due to heterogeneous clinical presentations and overlap with other neurodegenerative dementias. Depending on the clinical presentation, the differential diagnosis of CTE includes Alzheimer's disease (AD), behavioral variant frontotemporal dementia (bvFTD), Parkinson's disease, amyotrophic lateral sclerosis, primary mood disorders, posttraumatic stress disorder, and psychotic disorders. The aim of this article is to compare the clinical aspects, genetics, fluid biomarkers, imaging, treatment, and pathology of CTE to those of AD and bvFTD. A detailed clinical evaluation, neurocognitive assessment, and structural brain imaging can inform the differential diagnosis, while molecular biomarkers can help exclude underlying AD pathology. Prospective studies that include clinicopathological correlations are needed to establish tools that can more accurately determine the cause of neuropsychiatric decline in patients at risk for CTE.	[Lesman-Segev, Orit H.; Edwards, Lauren; Rabinovici, Gil D.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Rabinovici, Gil D.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA; [Rabinovici, Gil D.] Univ Calif San Francisco, Weill Neurosci Inst, San Francisco, CA 94158 USA		Rabinovici, GD (corresponding author), Univ Calif San Francisco UCSF, Dept Neurol, Memory & Aging Ctr MC 1207,675 Nelson Rising Lane, San Francisco, CA 94158 USA.; Rabinovici, GD (corresponding author), Univ Calif San Francisco UCSF, Dept Radiol & Biomed Imaging, Memory & Aging Ctr MC 1207,675 Nelson Rising Lane, San Francisco, CA 94158 USA.	Gil.Rabinovici@ucsf.edu		Edwards, Lauren/0000-0002-8434-9669	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG062422] Funding Source: Medline		Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Aisen PS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006395; Albuquerque FN, 2010, J AM COLL CARDIOL, V56, P1432, DOI 10.1016/j.jacc.2010.03.099; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Aziz AL, 2017, NEUROBIOL AGING, V54, P22, DOI 10.1016/j.neurobiolaging.2017.02.010; Baker SL, 2019, J NUCL MED, V60, P1444, DOI 10.2967/jnumed.118.224113; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; Bang SA, 2016, J NEUROTRAUM, V33, P1005, DOI 10.1089/neu.2015.4051; Barrio JR, 2018, J NUCL MED, V59, P115, DOI 10.2967/jnumed.117.198960; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Bejanin A, 2017, BRAIN, V140, P3286, DOI 10.1093/brain/awx243; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bondi MW, 2017, J INT NEUROPSYCH SOC, V23, P818, DOI 10.1017/S135561771700100X; Borroni B, 2009, NEUROBIOL AGING, V30, P34, DOI 10.1016/j.neurobiolaging.2007.05.009; Borroni B, 2018, J ALZHEIMERS DIS, V62, P1113, DOI 10.3233/JAD-170584; Borroni B, 2015, AMYOTROPH LAT SCL FR, V16, P86, DOI 10.3109/21678421.2014.971812; Boxer AL, 2013, LANCET NEUROL, V12, P149, DOI 10.1016/S1474-4422(12)70320-4; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; Carmona Susana, 2018, Handb Clin Neurol, V148, P395, DOI 10.1016/B978-0-444-64076-5.00026-0; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Desikan RS, 2013, AM J NEURORADIOL, V34, P2075, DOI 10.3174/ajnr.A3644; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Dugger BN, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028035; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Erkkinen MG, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033118; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Finger Elizabeth C, 2016, Continuum (Minneap Minn), V22, P464, DOI 10.1212/CON.0000000000000300; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frisoni GB, 2007, BRAIN, V130, P720, DOI 10.1093/brain/awl377; Frisoni GB, 2013, NEUROLOGY, V81, P487, DOI 10.1212/WNL.0b013e31829d86e8; Galimberti Daniela, 2012, Curr Top Behav Neurosci, V12, P615; Gardner Raquel C, 2015, Neurol Clin Pract, V5, P285; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; George CFP, 2003, SLEEP MED, V4, P317, DOI 10.1016/S1389-9457(03)00113-8; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goldstein L, 2018, JAMA-J AM MED ASSOC, V320, P554, DOI 10.1001/jama.2018.10825; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Janelidze S, 2016, ANN CLIN TRANSL NEUR, V3, P154, DOI 10.1002/acn3.274; Jeong Y, 2005, J NUCL MED, V46, P233; Jicha Gregory A, 2019, Continuum (Minneap Minn), V25, P208, DOI 10.1212/CON.0000000000000697; Johnson JK, 2005, ARCH NEUROL-CHICAGO, V62, P925, DOI 10.1001/archneur.62.6.925; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Knopman DS, 2004, NEUROLOGY, V62, P506, DOI 10.1212/01.WNL.0000106827.39764.7E; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lee JK, 2017, AM J NEURORADIOL, V38, P1303, DOI 10.3174/ajnr.A5175; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Ljubenkov Peter A, 2016, Focus (Am Psychiatr Publ), V14, P448, DOI 10.1176/appi.focus.20160018; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Makaretz SJ, 2018, J NEUROL NEUROSUR PS, V89, P1024, DOI 10.1136/jnnp-2017-316409; Markowitsch HJ, 2012, LANCET, V380, P1429, DOI 10.1016/S0140-6736(11)61304-4; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Mattsson N, 2017, NEUROBIOL AGING, V52, P196, DOI 10.1016/j.neurobiolaging.2016.02.034; MAWDSLEY C, 1963, LANCET, V2, P795; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MCLATCHIE G, 1987, J NEUROL NEUROSUR PS, V50, P96, DOI 10.1136/jnnp.50.1.96; Mendez MF, 2007, AM J GERIAT PSYCHIAT, V15, P84, DOI 10.1097/01.JGP.0000231744.69631.33; Mendez MF, 2012, AM J ALZHEIMERS DIS, V27, P413, DOI 10.1177/1533317512454711; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mielke MM, 2018, ALZHEIMERS DEMENT, V14, P989, DOI 10.1016/j.jalz.2018.02.013; Mielke MM, 2017, JAMA NEUROL, V74, P1073, DOI 10.1001/jamaneurol.2017.1359; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; Niemantsverdriet E, 2017, J ALZHEIMERS DIS, V60, P561, DOI 10.3233/JAD-170327; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; Ossenkoppele R, 2016, BRAIN, V139, P1551, DOI 10.1093/brain/aww027; Ossenkoppele R, 2015, BRAIN, V138, P2732, DOI 10.1093/brain/awv191; Ossenkoppele R, 2015, JAMA-J AM MED ASSOC, V313, P1939, DOI 10.1001/jama.2015.4669; Ossenkoppele R, 2012, EUR J NUCL MED MOL I, V39, P990, DOI 10.1007/s00259-012-2102-3; Ovod V, 2017, ALZHEIMERS DEMENT, V13, P841, DOI 10.1016/j.jalz.2017.06.2266; Pedersen HA, 2014, AM J ALZHEIMERS DIS, V29, P201, DOI 10.1177/1533317513517036; Perry DC, 2017, BRAIN, V140, P3329, DOI 10.1093/brain/awx254; Perry DC, 2013, SEMIN NEUROL, V33, P336, DOI 10.1055/s-0033-1359316; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petersen RC, 2018, NEUROLOGY, V90, P126, DOI 10.1212/WNL.0000000000004826; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Podcasy JL, 2016, DIALOGUES CLIN NEURO, V18, P437; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Rabinovici Gil D, 2019, Continuum (Minneap Minn), V25, P14, DOI 10.1212/CON.0000000000000700; Rabinovici GD, 2010, CNS DRUGS, V24, P375, DOI 10.2165/11533100-000000000-00000; Ranasinghe KG, 2016, NEUROLOGY, V86, P600, DOI 10.1212/WNL.0000000000002373; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Rice TB, 2010, SLEEP, V33, P819, DOI 10.1093/sleep/33.6.819; Ridge PG, 2016, NEUROBIOL AGING, V41, DOI 10.1016/j.neurobiolaging.2016.02.024; Rogers April J, 2017, J Sleep Disord Ther, V6, DOI 10.4172/2167-0277.1000278; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Rubin LH, 2019, BRAIN INJURY, V33, P456, DOI 10.1080/02699052.2019.1565895; Salmon DP, 2009, ANNU REV PSYCHOL, V60, P257, DOI 10.1146/annurev.psych.57.102904.190024; Schneider B, 2001, FORTSCHR NEUROL PSYC, V69, P164, DOI 10.1055/s-2001-12693; Schonhaut DR, 2017, ANN NEUROL, V82, P622, DOI 10.1002/ana.25060; Schroeter ML, 2007, NEUROIMAGE, V36, P497, DOI 10.1016/j.neuroimage.2007.03.024; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Seeley William W, 2019, Continuum (Minneap Minn), V25, P76, DOI 10.1212/CON.0000000000000698; Sha S J, 2016, NONALZHEIMERS ATYPIC, P17; Shivamurthy VKN, 2015, AM J ROENTGENOL, V204, pW76, DOI 10.2214/AJR.13.12363; Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith R, 2017, NEUROLOGY, V89, P845, DOI 10.1212/WNL.0000000000004264; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Steinacker P, 2018, NEUROLOGY, V91, pE1390, DOI 10.1212/WNL.0000000000006318; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Suzuki H, 2016, J BIOL CHEM, V291, P21448, DOI 10.1074/jbc.M116.737171; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Terrell TR, 2018, BRIT J SPORT MED, V52, P192, DOI 10.1136/bjsports-2016-097419; Utianski RL, 2018, CORTEX, V99, P358, DOI 10.1016/j.cortex.2017.12.021; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Zetterberg H, 2018, HAND CLINIC, V158, P323, DOI 10.1016/B978-0-444-63954-7.00030-6	151	3	3	1	16	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	AUG	2020	40	04					394	410		10.1055/s-0040-1715134		AUG 2020	17	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NL6KK	WOS:000561069900001	32820492				2022-02-06	
J	Zauszniewski, JA; Herbell, K; Lekhak, N; Badr, H				Zauszniewski, Jaclene A.; Herbell, Kayla; Lekhak, Nirmala; Badr, Hanan			Differences among Caregivers on Coping Resources and Mental Health	ISSUES IN MENTAL HEALTH NURSING			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; STROKE SURVIVORS; PHYSICAL HEALTH; CANCER-PATIENTS; BURDEN; NEED; SPIRITUALITY; INDIVIDUALS; DEPRESSION	Given the growing number of family members who provide care to adults with a disability or illness, this study examined differences in coping resources and mental health among family caregivers of persons with various health conditions. Within the context of Ensel and Lin's stress paradigm, 234 family caregivers participated in an online study by completing validated measures of resourcefulness, spiritual practices, caregiver burden, anxiety, and depression. Caregivers were categorized into nine groups according to their care recipient's condition. The groups differed significantly on burden and resourcefulness. Greatest burden and lowest resourcefulness were found in caregivers of persons with traumatic brain injury, stroke, and dementia. Caregivers across all groups were found to be at a similarly high risk for anxiety and depression. These results provide insights for tailoring interventions for caregivers, particularly those whose care recipients have traumatic brain injury, stroke, or dementia, who may benefit from resourcefulness training.	[Zauszniewski, Jaclene A.] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 2120 Cornell Rd, Cleveland, OH 44106 USA; [Herbell, Kayla] Ohio State Univ, Nursing, Columbus, OH 43210 USA; [Lekhak, Nirmala] Univ Nevada, Nursing, Las Vegas, NV 89154 USA; [Badr, Hanan] King Abdulaziz Univ, Nursing, Jeddah, Saudi Arabia		Zauszniewski, JA (corresponding author), Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 2120 Cornell Rd, Cleveland, OH 44106 USA.	jaz@case.edu	Badr, Hanan/AAS-6027-2021	Badr, Hanan/0000-0002-2163-290X	Frances Payne Bolton School of Nursing research fund	Funding for the study was provided by the Frances Payne Bolton School of Nursing research fund to Dr. Jaclene A. Zauszniewski.	Adams D, 2016, NEUROREHABILITATION, V39, P223, DOI 10.3233/NRE-161353; Barrow S, 2005, J PUBLIC HEALTH, V27, P292, DOI 10.1093/pubmed/fdi038; Byun E, 2015, CLIN NURS RES, V24, P468, DOI 10.1177/1054773814537060; Chronister J, 2016, REHABIL COUNS BULL, V59, P235, DOI 10.1177/0034355215601072; Clery A, 2020, STROKE, V51, P179, DOI 10.1161/STROKEAHA.119.026618; del-Pino-Casado R, 2011, J ADV NURS, V67, P2311, DOI 10.1111/j.1365-2648.2011.05725.x; Delaney C, 2005, J HOLIST NURS, V23, P145, DOI 10.1177/0898010105276180; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Douglas SL, 2013, PALLIAT SUPPORT CARE, V11, P389, DOI 10.1017/S1478951512000570; Dutta D, 2018, CLIN REHABIL, V32, P1108, DOI 10.1177/0269215517748715; ENSEL WM, 1991, J HEALTH SOC BEHAV, V32, P321, DOI 10.2307/2137101; Fauth E, 2012, AGING MENT HEALTH, V16, P699, DOI 10.1080/13607863.2012.678482; FEINBERG L., 2011, VALUING INVALUABLE 2; Folkman S., 1984, STRESS; Geng HM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011863; Given BA, 2011, CANCER EPIDEM BIOMAR, V20, P2015, DOI 10.1158/1055-9965.EPI-11-0611; GRAESSEL E, 2014, BMC GERIATR, V14, DOI DOI https://doi.org/10.1186/1471-2318-14-23; Guevara AB, 2016, J HEAD TRAUMA REHAB, V31, pE48, DOI 10.1097/HTR.0000000000000151; Health Measures, 2020, PROMIS DEPR; Health Measures, 2020, PROMIS ANX; Herbell K, 2018, APPL NURS RES, V41, P1, DOI 10.1016/j.apnr.2018.02.004; Hung Jen-Wen, 2012, Chang Gung Med J, V35, P392; Jaracz K, 2015, PATIENT EDUC COUNS, V98, P1011, DOI 10.1016/j.pec.2015.04.008; Kershaw T, 2015, ANN BEHAV MED, V49, P901, DOI 10.1007/s12160-015-9743-y; Kreutzer JS, 2016, J FAM THEOR REV, V8, P386, DOI 10.1111/jftr.12150; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Mosher CE, 2017, PSYCHOL HEALTH, V31, P94, DOI 10.1080/08870446.2016.1247839; National Alliance for Caregiving (NAC) & the AARP Public Policy Institute, 2015, 2015 REP CAR US; PENDERGRASS A, 2018, BMC HEALTH SERV RES, V18, DOI DOI https://doi.org/10.1186/s12913-018-3047-4; Peters M, 2011, PARKINSONISM RELAT D, V17, P348, DOI 10.1016/j.parkreldis.2011.02.009; Pinquart M, 2011, PSYCHOL AGING, V26, P1, DOI 10.1037/a0021863; Rigby H, 2009, INT J STROKE, V4, P285, DOI 10.1111/j.1747-4949.2009.00289.x; Sklenarova H, 2015, CANCER-AM CANCER SOC, V121, P1513, DOI 10.1002/cncr.29223; Smith A., 2018, SOCIAL MEDIA USE 201; Smith ER, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/1396572; Smith TO, 2019, J AM GERIATR SOC, V67, P1960, DOI 10.1111/jgs.16048; Snyder CM, 2015, AGING MENT HEALTH, V19, P390, DOI 10.1080/13607863.2014.939610; Tanuseputro P, 2017, J AM MED DIR ASSOC, V18, P616, DOI 10.1016/j.jamda.2017.02.008; Ugalde A, 2019, PSYCHO-ONCOLOGY, V28, P687, DOI 10.1002/pon.5018; Walke SC, 2018, J NEUROSCI RURAL PRA, V9, P180, DOI 10.4103/jnrp.jnrp_312_17; Walshe C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169071; Zauszniewski J A, 1996, J Holist Nurs, V14, P223, DOI 10.1177/089801019601400305; Zauszniewski J.A., 2006, ENCY NURSING RES, P256; Zauszniewski JA, 2006, J NURS MEAS, V14, P57, DOI 10.1891/jnum.14.1.57; Zauszniewski JA, 2021, WESTERN J NURS RES, V43, P316, DOI 10.1177/0193945920948469; Zauszniewski JA, 2015, ISSUES MENT HEALTH N, V36, P1007, DOI 10.3109/01612840.2015.1075236	46	3	3	4	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0161-2840	1096-4673		ISSUES MENT HEALTH N	Issues Ment. Health Nurs.	SEP 30	2020	42	3					280	286		10.1080/01612840.2020.1800876		AUG 2020	7	Nursing; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Psychiatry	QR8YM	WOS:000561909100001	32822243				2022-02-06	
J	Sada, N; Fujita, Y; Mizuta, N; Ueno, M; Furukawa, T; Yamashita, T				Sada, Naoki; Fujita, Yuki; Mizuta, Nanano; Ueno, Masaki; Furukawa, Takahisa; Yamashita, Toshihide			Inhibition of HDAC increases BDNF expression and promotes neuronal rewiring and functional recovery after brain injury	CELL DEATH & DISEASE			English	Article							SPINAL-CORD; HISTONE DEACETYLASES; GENE-EXPRESSION; STROKE RECOVERY; CIRCUITS; FORELIMB; PLASTICITY; REORGANIZATION; ORGANIZATION; ACETYLATION	Brain injury causes serious motor, sensory, and cognitive disabilities. Accumulating evidence has demonstrated that histone deacetylase (HDAC) inhibitors exert neuroprotective effects against various insults to the central nervous system (CNS). In this study, we investigated the effects of the HDAC inhibition on the expression of brain-derived neurotrophic factor (BDNF) and functional recovery after traumatic brain injury (TBI) in mice. Administration of class I HDAC inhibitor increased the number of synaptic boutons in rewiring corticospinal fibers and improved the recovery of motor functions after TBI. Immunohistochemistry results showed that HDAC2 is mainly expressed in the neurons of the mouse spinal cord under normal conditions. After TBI, HDAC2 expression was increased in the spinal cord after 35 days, whereas BDNF expression was decreased after 42 days. Administration of CI-994 increased BDNF expression after TBI. Knockdown of HDAC2 elevated H4K5ac enrichment at the BDNF promoter, which was decreased following TBI. Together, our findings suggest that HDAC inhibition increases expression of neurotrophic factors, and promote neuronal rewiring and functional recovery following TBI.	[Sada, Naoki; Fujita, Yuki; Mizuta, Nanano; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Ueno, Masaki] Niigata Univ, Brain Res Inst, Dept Syst Pathol Neurol Disorders, Niigata 9518585, Japan; [Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Neuromed Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan		Fujita, Y; Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yuki-fujita@molneu.med.osaka-u.ac.jp; yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Ueno, Masaki/0000-0003-1484-9921; Yamashita, Toshihide/0000-0003-4559-7018	AMED-CREST [18gm1210005h0001]; Japan Society for the Promotion of Science (JSPS)/Ministry of Education, Culture, Sports, Science and Technology (MEXT)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [19H04779]; JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [18H02593]; Takeda Science FoundationTakeda Science Foundation (TSF)	The authors would like to thank Dr. Hongkui Zeng for the AAV phSyn1(S)-FLEXtdTomato-T2A-SypEGFP-WPRE plasmid (Addgene plasmid #51509). This work was supported by AMED-CREST (18gm1210005h0001) to T.Y., Japan Society for the Promotion of Science (JSPS)/Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant Number 19H04779 to Y.F., and JSPS KAKENHI Grant Number 18H02593 to T.F., and grant from the Takeda Science Foundation.	Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Asboth L, 2018, NAT NEUROSCI, V21, P576, DOI 10.1038/s41593-018-0093-5; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Bikoff JB, 2016, CELL, V165, P207, DOI 10.1016/j.cell.2016.01.027; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Chen J, 2016, EXP NEUROL, V280, P50, DOI 10.1016/j.expneurol.2016.04.001; Cramer SC, 2006, STROKE, V37, P111, DOI 10.1161/01.STR.0000195135.70379.1f; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dougherty KJ, 2010, ANN NY ACAD SCI, V1198, P85, DOI 10.1111/j.1749-6632.2010.05502.x; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fujita Y, 2017, J EXP MED, V214, P1431, DOI 10.1084/jem.20161517; Fujita Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139616; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Harrison IF, 2013, PHARMACOL THERAPEUT, V140, P34, DOI 10.1016/j.pharmthera.2013.05.010; Hayashi M, 2018, NEURON, V97, P869, DOI 10.1016/j.neuron.2018.01.023; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Ishida A, 2016, J NEUROSCI, V36, P455, DOI 10.1523/JNEUROSCI.2399-15.2016; Jang M, 2019, ELIFE, V8, DOI 10.7554/eLife.42156; Jones TA, 2017, NAT REV NEUROSCI, V18, P267, DOI 10.1038/nrn.2017.26; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kiehn O, 2016, NAT REV NEUROSCI, V17, P224, DOI 10.1038/nrn.2016.9; Klein Alexander, 1800, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0828s58; Kumamaru H, 2019, CELL REP, V26, P2329, DOI 10.1016/j.celrep.2019.01.099; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lai HC, 2016, DEVELOPMENT, V143, P3434, DOI 10.1242/dev.139592; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Levine AJ, 2014, NAT NEUROSCI, V17, P586, DOI 10.1038/nn.3675; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Liu ZW, 2009, STROKE, V40, P2546, DOI 10.1161/STROKEAHA.109.547265; Lu DC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00025; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Mochizuki H, 2001, P NATL ACAD SCI USA, V98, P10918, DOI 10.1073/pnas.191107398; MORI M, 1990, J COMP NEUROL, V299, P167, DOI 10.1002/cne.902990204; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nakanishi T, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1338-2; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Sathyamurthy A, 2018, CELL REP, V22, P2216, DOI 10.1016/j.celrep.2018.02.003; Stoeckel MC, 2010, EXP NEUROL, V221, P13, DOI 10.1016/j.expneurol.2009.10.021; Tabuse M, 2010, J CLIN NEUROSCI, V17, P1412, DOI 10.1016/j.jocn.2010.01.056; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tanaka T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.102; Ueno M, 2018, CELL REP, V23, P1286, DOI 10.1016/j.celrep.2018.03.137; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Ueno M, 2011, EXP NEUROL, V230, P280, DOI 10.1016/j.expneurol.2011.05.006; Umeda T, 2010, J NEUROPHYSIOL, V104, P1707, DOI 10.1152/jn.00968.2009; Ward NS, 2017, NAT REV NEUROL, V13, P244, DOI 10.1038/nrneurol.2017.34; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H; Whishaw IQ, 1996, BEHAV BRAIN RES, V77, P135, DOI 10.1016/0166-4328(95)00209-X; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yamakawa H, 2017, CELL REP, V20, P1319, DOI 10.1016/j.celrep.2017.07.044; Zai LL, 2009, J NEUROSCI, V29, P8187, DOI 10.1523/JNEUROSCI.0414-09.2009; Zhang SL, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/ctg.2018.1; Zholudeva LV, 2018, J NEUROTRAUM, V35, P2883, DOI 10.1089/neu.2017.5439	70	3	3	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	AUG 18	2020	11	8							655	10.1038/s41419-020-02897-w			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	OD4IL	WOS:000579816000001	32811822	gold, Green Published			2022-02-06	
J	Mohammadian, M; Roine, T; Hirvonen, J; Kurki, T; Posti, JP; Katila, AJ; Takala, RSK; Tallus, J; Maanpaa, HR; Frantzen, J; Hutchinson, PJ; Newcombe, VF; Menon, DK; Tenovuo, O				Mohammadian, Mehrbod; Roine, Timo; Hirvonen, Jussi; Kurki, Timo; Posti, Jussi P.; Katila, Ari J.; Takala, Riikka S. K.; Tallus, Jussi; Maanpaa, Henna-Riikka; Frantzen, Janek; Hutchinson, Peter J.; Newcombe, Virginia F.; Menon, David K.; Tenovuo, Olli			Alterations in Microstructure and Local Fiber Orientation of White Matter Are Associated with Outcome after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; mild traumatic brain injury; outcome; tract-based spatial statistics	DIFFUSE AXONAL INJURY; CONSTRAINED SPHERICAL DECONVOLUTION; TENSOR IMAGING DETECTS; SPATIAL STATISTICS; CORPUS-CALLOSUM; WATER DIFFUSION; DTI; MRI; ABNORMALITIES; DYSMYELINATION	Mild traumatic brain injury (mTBI) can have long-lasting consequences. We investigated white matter (WM) alterations at 6-12 months following mTBI using diffusion tensor imaging (DTI) and assessed if the alterations associate with outcome. Eighty-five patients with mTBI underwent diffusion-weighted magnetic resonance imaging (MRI) on average 8 months post-injury and patients' outcome was assessed at the time of imaging using the Glasgow Outcome Scale-Extended (GOS-E). Additionally, 30 age-matched patients with extracranial orthopedic injuries were used as control subjects. Voxel-wise analysis of the data was performed using a tract-based spatial statistics (TBSS) approach and differences in microstructural metrics between groups were investigated. Further, the susceptibility of the abnormalities to specific fiber orientations was investigated by analyzing the first eigenvector of the diffusion tensor in the voxels with significant differences. We found significantly lower fractional anisotropy (FA) and higher mean diffusivity (MD) and radial diffusivity (RD) in patients with mTBI compared with control subjects, whereas no significant differences were observed in axial diffusivity (AD) between the groups. The differences were present bilaterally in several WM regions and correlated with outcome. Moreover, multiple clusters were found in the principal fiber orientations of the significant voxels in anisotropy, and similar orientation patterns were found for the diffusivity metrics. These directional clusters correlated with patients' functional outcome. Our study showed that mTBI is associated with WM changes at the chronic stage and these alterations occur in several WM regions. In addition, several significant clusters of WM alterations in specific fiber orientations were found and these clusters were associated with outcome.	[Mohammadian, Mehrbod; Kurki, Timo; Posti, Jussi P.; Tallus, Jussi; Frantzen, Janek; Tenovuo, Olli] Univ Turku, Dept Clin Neurosci, Vaha Hameenkatu 1, FI-20500 Turku, Finland; [Roine, Timo] Univ Turku, Turku Brain & Mind Ctr, Turku, Finland; [Hirvonen, Jussi; Kurki, Timo] Univ Turku, Dept Radiol, Turku, Finland; [Katila, Ari J.; Takala, Riikka S. K.] Univ Turku, Anesthesiol Intens Care Emergency Care & Pain Med, Turku, Finland; [Mohammadian, Mehrbod; Kurki, Timo; Posti, Jussi P.; Tallus, Jussi; Maanpaa, Henna-Riikka; Tenovuo, Olli] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Posti, Jussi P.; Maanpaa, Henna-Riikka; Frantzen, Janek] Turku Univ Hosp, Div Clin Neurosci, Dept Neurosurg, Turku, Finland; [Katila, Ari J.; Takala, Riikka S. K.] Turku Univ Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Roine, Timo] Aalto Univ, Dept Neurosci & Biomed Engn, Sch Sci, Espoo, Finland; [Hutchinson, Peter J.] Addenbrookes Hosp, Dept Clin Neurosci, Neurosurg Unit, Cambridge, England; [Newcombe, Virginia F.; Menon, David K.] Addenbrookes Hosp, Div Anesthesia, Cambridge, England		Mohammadian, M (corresponding author), Univ Turku, Dept Clin Neurosci, Vaha Hameenkatu 1, FI-20500 Turku, Finland.	mehmoh@utu.fi	Hirvonen, Jussi/H-2521-2012; Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Newcombe, Virginia/0000-0001-6044-9035	TBICare FP7 project under the European Commission 7th Framework Program [FP7-270259-TBICare]; University of Turku; TYKS Foundation; Maud Kuistila Memorial Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation, FinlandFinnish Cultural Foundation; Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Finnish Brain Foundation; MaireTaponen Foundation; Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship; NIHR research professorship; NIHR Cambridge BRC	This study was partially funded by the TBICare FP7 project under the European Commission 7th Framework Program (FP7-270259-TBICare). M.M. received funding fromUniversity of Turku and the TYKS Foundation. T.R. received support from the Maud Kuistila Memorial Foundation, the Emil Aaltonen Foundation, and the Finnish Cultural Foundation, Finland. J.P.P. received funding from the Academy of Finland (Grant #17379), the Government's Special Financial Transfer tied to academic research in Health Sciences (Finland), the Emil Aaltonen Foundation, the Finnish Brain Foundation, and the MaireTaponen Foundation. V.F.J.N. is supported by an Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship. P.J.H. is supported by an NIHR research professorship and the NIHR Cambridge BRC.	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Descoteaux M, 2011, MED IMAGE ANAL, V15, P603, DOI 10.1016/j.media.2010.07.001; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jbabdi S, 2012, MAGN RESON MED, V68, P1846, DOI 10.1002/mrm.24204; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mohammadian M, 2017, NEUROIMAGE-CLIN, V13, P174, DOI 10.1016/j.nicl.2016.11.016; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; Roine T, 2015, MED IMAGE ANAL, V24, P269, DOI 10.1016/j.media.2015.01.001; Roine T, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00028; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shetty T, 2016, SPORTS HEALTH, V8, P26, DOI 10.1177/1941738115588745; Shiramizu H, 2008, NEUROL MED-CHIR, V48, P1, DOI 10.2176/nmc.48.1; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Thomas AW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178360; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tsitsopoulos PP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00599; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yeh P.-H., 2012, OPEN J MED IMAGING, V2, P137, DOI [10.4236/ojmi.2012.24025, DOI 10.4236/OJMI.2012.24025]; Yuh E.L., 2014, J NEUROTRAUM, V21, P1	80	3	4	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2020	37	24					2616	2623		10.1089/neu.2020.7081		AUG 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PF0CR	WOS:000564401300001	32689872	Green Accepted			2022-02-06	
J	Mills, BD; Goubran, M; Parivash, SN; Dennis, EL; Rezaii, P; Akers, C; Bian, W; Mitchell, LA; Boldt, B; Douglas, D; Sami, S; Mouchawar, N; Wilson, EW; DiGiacomo, P; Parekh, M; Do, H; Lopez, J; Rosenberg, J; Camarillo, D; Grant, G; Wintermark, M; Zeineh, M				Mills, Brian D.; Goubran, Maged; Parivash, Sherveen N.; Dennis, Emily L.; Rezaii, Paymon; Akers, Carolyn; Bian, Wei; Mitchell, Lex A.; Boldt, Brian; Douglas, David; Sami, Sohrab; Mouchawar, Nicole; Wilson, Eugene W.; DiGiacomo, Phil; Parekh, Mansi; Do, Huy; Lopez, Jaime; Rosenberg, Jarrett; Camarillo, David; Grant, Gerald; Wintermark, Max; Zeineh, Michael			Longitudinal alteration of cortical thickness and volume in high -impact sports	NEUROIMAGE			English	Article							TRAUMATIC BRAIN-INJURY; CONCUSSION; COLLEGIATE		[Mills, Brian D.; Goubran, Maged; Parivash, Sherveen N.; Akers, Carolyn; Bian, Wei; Mitchell, Lex A.; Douglas, David; Mouchawar, Nicole; Wilson, Eugene W.; DiGiacomo, Phil; Parekh, Mansi; Do, Huy; Rosenberg, Jarrett; Wintermark, Max; Zeineh, Michael] Stanford Univ, Dept Radiol, Stanford, CA 94035 USA; [Camarillo, David] Stanford Univ, Dept Bioengn, Stanford, CA 94035 USA; [Rezaii, Paymon; Grant, Gerald] Stanford Univ, Dept Neurosurg, Stanford, CA 94035 USA; [Boldt, Brian] Uniformed Serv Univ Hlth Sci, Dept Radiol, Bethesda, MD 20814 USA; [Boldt, Brian] Madigan Army Med Ctr, Dept Radiol, Tacoma, WA 98431 USA; [Sami, Sohrab] Stanford Ctr Clin Res, Stanford, CA 94304 USA; [Lopez, Jaime] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94035 USA; [Dennis, Emily L.] Univ Utah, Dept Neurol, Sch Med, Salt Lake City, UT 84132 USA; [Goubran, Maged] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Goubran, Maged] Univ Toronto, Sunnybrook Res Inst, Hurvitz Brain Sci Program, Toronto, ON, Canada; [Goubran, Maged] Univ Toronto, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada		Zeineh, M (corresponding author), Lucas Ctr Imaging, Rm P271,1201 Welch Rd, Stanford, CA 94305 USA.	millsb@stanford.edu; mgoubran@stanford.edu; parivash@stanford.edu; Emily.Dennis@hsc.utah.edu; prezaii@stanford.edu; cakers@stanford.edu; wei.bian@stanford.edu; lexflex5235@gmail.com; boldtb@hotmail.com; ddouglas@stanford.edu; ssami@stanford.edu; nmouchaw@stanford.edu; eugene.wilson303@gmail.com; pdigiaco@stanford.edu; mansibparekh@gmail.com; huymdo@stanford.edu; lopezjr@stanford.edu; Jarrett.Rosenberg@Stanford.EDU; dcamarillo@stanford.edu; ggrant2@stanford.edu; max.wintermark@gmail.com; mzeineh@stanford.edu	Dennis, Emily/AAD-5223-2021	Dennis, Emily/0000-0001-7112-4009; Douglas, David/0000-0003-1021-534X; Akers, Carolyn/0000-0001-9367-6795; Goubran, Maged/0000-0001-5880-0818; Rezaii, Paymon/0000-0002-4803-0853	Radiology Society of North America; American Society for Neuroradiology; General Electric HealthcareGeneral ElectricGE Healthcare; Pac-12 Conference's StudentAthlete Health and Well-Being Initiative; Center for Biological Imaging at Stanford	This research was conducted with funding from the Radiology Society of North America, the American Society for Neuroradiology, the Center for Biological Imaging at Stanford, and General Electric Healthcare. This publication was also supported by the Pac-12 Conference's StudentAthlete Health and Well-Being Initiative. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the Pac-12 Conference or its members. We thank Dr. Andrew Hoffman, Dr. Tony Wyss-Coray, Steven Bartlinsky, Scott Anderson, Christopher Barrett, Lexie Ross, Eitan Gelber, and Anthony Pass for their assistance with study design, recruitment, and evaluation.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Adler CM, 2018, CLIN J SPORT MED, V28, P100, DOI 10.1097/JSM.0000000000000391; Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian J.J., 2014, PLOS ONE, DOI [10.1371/journal.pone.0094734.t001, DOI 10.1371/J0URNAL.P0NE.0094734.T001]; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler E.D., 2018, INT J PSYCHOPHYSIOL, DOI [10.1016/j.ijpsycho.2017.09.006, DOI 10.1016/J.IJPSYCH0.2017.09.006]; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Champagne AA, 2020, J CEREBR BLOOD F MET, V40, P1453, DOI 10.1177/0271678X19862861; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Dennis E.L., 2013, DIALOGUES CLIN NEURO; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Ham SA, 2009, J PHYS ACT HEALTH, V6, P6, DOI 10.1123/jpah.6.1.6; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Koerte I.K., 2016, BRAIN INJURY, DOI [10.3109/02699052.2016.1162060, DOI 10.3109/02699052.2016.1162060]; Lee SH, 2010, GENET EPIDEMIOL, V34, P854, DOI 10.1002/gepi.20541; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P., 2009, NIH CONSENSUS STATE, DOI [10.3810/psm.2009.06.1721, DOI 10.3810/PSM.2009.06.1721.]; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Moore D.R., 2016, INT J PSYCHOPHYSIOL, DOI [10.1016/j.ijpsycho.2015.11.010, DOI 10.1016/J.IJPSYCH0.2015.11.010]; Narvacan K, 2017, HUM BRAIN MAPP, V38, P3771, DOI 10.1002/hbm.23604; Natu VS, 2019, P NATL ACAD SCI USA, V116, P20750, DOI 10.1073/pnas.1904931116; Parivash SN, 2019, J NEUROTRAUM, V36, P2762, DOI 10.1089/neu.2018.6357; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Reuter M., 2012, P MICCAI NOV NEUR BI; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Selemon LD, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.115; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tamnes CK, 2017, J NEUROSCI, V37, P3402, DOI 10.1523/JNEUROSCI.3302-16.2017; Tremblay Sara, 2018, INT J PSYCHOPHYSIOL, DOI [10.1016/j.ijpsycho.2017.09.005, DOI 10.1016/J.IJPSYCH0.2017.09.005]; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Whitaker KJ, 2016, P NATL ACAD SCI USA, V113, P9105, DOI 10.1073/pnas.1601745113; Wierenga LM, 2014, NEUROIMAGE, V87, P120, DOI 10.1016/j.neuroimage.2013.11.010; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Yakovlev PI, 1967, REGIONAL DEV BRAIN E; Zhou T, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00077	65	3	3	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	AUG 15	2020	217								116864	10.1016/j.neuroimage.2020.116864			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	MB1LY	WOS:000542369500006	32360690	gold			2022-02-06	
J	Tucker, R; Brown, J; Falvey, E; Fuller, G; Raftery, M				Tucker, Ross; Brown, James; Falvey, Eanna; Fuller, Gordon; Raftery, Martin			The effect of exercise on baseline SCAT5 performance in male professional Rugby players	SPORTS MEDICINE-OPEN			English	Article						Concussion; SCAT; Rugby union; Neurological screening; Concussion management	SELF-REPORTED SYMPTOMS; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; CONCUSSION SYMPTOMS; AEROBIC EXERCISE; SEX-DIFFERENCES; SPORT; AGREEMENT; HISTORY	Background: Rugby Union requires annual baseline testing using the Sports Concussion Assessment Tool (SCAT5) as part of its head injury assessment protocols. Scores achieved during baseline testing are used to guide return-to-play decisions at the time of head impact events during matches, and concussion diagnosis during subsequent diagnostic screens. Baseline values must be valid, accurate representations of a player's capability in the various SCAT5 sub-modes, including symptom report, cognitive function and balance. The extent to which prior exercise may affect performance is an important consideration, and the present cross-sectional study aimed to explore how SCAT5 performance differs when assessed at rest (RSCAT) compared to after 30 min of exercise (EXSCAT) in 698 male professional rugby players for whom paired exercise and rest SCAT5 data were available. Results: Symptom endorsement was greater when assessed after exercise than at rest. Fatigue/Low energy was 1.5 times more likely to be reported when assessed during EXSCAT. Orientation score was improved during SCAT5s performed after exercise, but only when rest and exercise SCAT5s were conducted on the same day, suggesting a learning effect. Concentration score was impaired during EXSCAT. No other cognitive sub-modes were affected by exercise. Total errors during Modified Balance Error Scoring System (MBESS) increased during EXSCAT, as a result of increased errors made during single leg balance, irrespective of testing sequence, with 42% of players making more errors in EXSCAT, compared to 28% making more errors in RSCAT. Conclusions: Symptoms, cognitive sub-modes and balance sub-modes are all affected by exercise. These may be the result of learning effects that improve cognitive performance, and the direct effects of exercise on sub-mode performance. The clinical implications of these changes may be assessed in the future through a study of diagnostic screens in players after head impact events, to confirm whether an exercise baseline screen is required annually, or whether specific sub-modes of the SCAT5 should be obtained at rest and after exercise.	[Tucker, Ross; Raftery, Martin] World Rugby, World Rugby House 8-10 Lower Pembroke St, Dublin 2, Ireland; [Brown, James] Stellenbosch Univ, Inst Sport & Exercise Med, Dept Orthopaed, ZA-7500 Tygerberg, South Africa; [Falvey, Eanna] Univ Coll Cork, Dept Med, Cork, Ireland; [Fuller, Gordon] Univ Sheffield, Ctr Urgent & Emergency Care Res, Sch Hlth & Related Res, Sheffield, S Yorkshire, England		Tucker, R (corresponding author), World Rugby, World Rugby House 8-10 Lower Pembroke St, Dublin 2, Ireland.	Ross.tucker@mweb.co.za		Fuller, Gordon Ward/0000-0001-8532-3500; Falvey, Eanna/0000-0003-3961-1805	World Rugby	There was no specific funding for the research study, though the research was supported by World Rugby, which employs some of the author group, as described in Competing Interests.	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Bruce JM, 2004, NEUROLOGY, V63, P1516; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Fuller GW, 2018, CLIN J SPORT MED; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Lee H, 2015, J SCI MED SPORT, V18, P245, DOI 10.1016/j.jsams.2014.04.003; Lee JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727261; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Susco TM, 2004, J ATHL TRAINING, V39, P241; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	22	3	3	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open	AUG 15	2020	6	1							37	10.1186/s40798-020-00265-8			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NF8PM	WOS:000563555000001	32803645	Green Accepted, Green Published, gold			2022-02-06	
J	Zhao, JL; Lai, ST; Du, ZY; Xu, J; Sun, YR; Yuan, Q; Wu, X; Li, ZQ; Hu, J; Xie, R				Zhao, Jian-Lan; Lai, Song-Tao; Du, Zhuo-Ying; Xu, Jian; Sun, Yi-Rui; Yuan, Qiang; Wu, Xing; Li, Zhi-Qi; Hu, Jin; Xie, Rong			Circulating neutrophil-to-lymphocyte ratio at admission predicts the long-term outcome in acute traumatic cervical spinal cord injury patients	BMC MUSCULOSKELETAL DISORDERS			English	Article						Acute traumatic cervical spinal cord injury; Neutrophil-to-lymphocyte ratio; Prediction model; Prognostic value; 6-months outcome	BRAIN; INFLAMMATION	BackgroundThe prognostic value of Neutrophil-to-Lymphocyte Ratio (NLR) for the outcome of acute cervical traumatic spinal cord injury (tSCI) patients has rarely been studied by now throughout the world.MethodsWe performed a single-center retrospective cohort study to evaluate the prognostic value of NLR from peripheral whole blood count in patients with acute cervical tSCI. Patients within 6h of acute cervical tSCI treated between Dec 2008 and May 2018 in Huashan Hospital of Fudan University were enrolled. Outcomes of patients with tSCI were assessed using American spinal injury association Impairment Scale (AIS). 6-month outcomes were dichotomized into poor outcome group (AIS A to C) and good outcome group (AIS D and E). Uni- and multivariate analyses were performed to assess the independent predictors of 6-month outcome. Two prediction models based on admission characteristics were built to evaluate the prognostic value of NLR. The discriminative ability of predictive models was evaluated using the area under the curve (AUC).ResultsA total of 377 patients were identified from our single center in China PR. Multivariate analysis showed that age, AIS grade at admission, NLR (p<0.001) and coagulopathy (p=0.003) were independent predictors of the 6-months outcome for acute cervical tSCI patients. The model combing NLR and standard variables (AUC=0.944; 95% CI, 0.923-0.964) showed a more favorable prognostic value than that without NLR (AUC=0.841; 95% CI, 0.798-0.885) in terms of 6-month outcome.ConclusionsNLR is firstly identified as an independent predictor of the 6-month outcome in acute cervical tSCI patients worldwide. The prognostic value of NLR is favorable, and a high NLR is associated with poor outcome in patients with acute cervical tSCI.	[Zhao, Jian-Lan; Du, Zhuo-Ying; Sun, Yi-Rui; Yuan, Qiang; Wu, Xing; Li, Zhi-Qi; Hu, Jin; Xie, Rong] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, 12 Wulumuqi Rd M, Shanghai 200040, Peoples R China; [Zhao, Jian-Lan; Du, Zhuo-Ying; Sun, Yi-Rui; Yuan, Qiang; Wu, Xing; Li, Zhi-Qi; Hu, Jin; Xie, Rong] Fudan Univ, Neurosurg Inst, 12 Wulumuqi Rd M, Shanghai 200040, Peoples R China; [Zhao, Jian-Lan; Du, Zhuo-Ying; Sun, Yi-Rui; Yuan, Qiang; Wu, Xing; Li, Zhi-Qi; Hu, Jin; Xie, Rong] Shanghai Clin Med Ctr Neurosurg, 12 Wulumuqi Rd M, Shanghai 200040, Peoples R China; [Zhao, Jian-Lan; Du, Zhuo-Ying; Sun, Yi-Rui; Yuan, Qiang; Wu, Xing; Li, Zhi-Qi; Hu, Jin; Xie, Rong] Shanghai Key Lab Brain Funct & Restorat & Neural, 12 Wulumuqi Rd M, Shanghai 200040, Peoples R China; [Lai, Song-Tao] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Oncol,Dept Radiat Oncol, Shanghai 200032, Peoples R China; [Xu, Jian] SUN Yat Sen Univ, Affiliated Hosp 7, Dept Gen Surg, Shenzhen 518000, Peoples R China		Hu, J; Xie, R (corresponding author), Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, 12 Wulumuqi Rd M, Shanghai 200040, Peoples R China.; Hu, J; Xie, R (corresponding author), Fudan Univ, Neurosurg Inst, 12 Wulumuqi Rd M, Shanghai 200040, Peoples R China.; Hu, J; Xie, R (corresponding author), Shanghai Clin Med Ctr Neurosurg, 12 Wulumuqi Rd M, Shanghai 200040, Peoples R China.; Hu, J; Xie, R (corresponding author), Shanghai Key Lab Brain Funct & Restorat & Neural, 12 Wulumuqi Rd M, Shanghai 200040, Peoples R China.	286644104@qq.com; hujin_dana@126.cn; rongxie@fudan.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471241, 81271375, 81701206, 81671200, 81571111, 81870909, 81870968, 81171133]; Shanghai Municipal Science and Technology Commission project [16411955300, 18441903300, 18695841300]; Shanghai Municipal Commission of Health and Family Planning project [201840063, 201801075]; Major and Develop Project of Chinese Ministry of Science and Technology [2017ZX09304005]; Shanghai Minhang Natural Science Foundation [2018MHZ001]; Public Medical Artificial Intelligence Training Platform [XX-RGZN-01-17-4684]	This work was supported by the National Natural Science Foundation of China (81471241, 81271375, 81701206, 81671200, 81571111, 81870909, 81870968 and 81171133), Shanghai Municipal Science and Technology Commission project (16411955300, 18441903300 and 18695841300), Shanghai Municipal Commission of Health and Family Planning project (201840063, 201801075), The Major and Develop Project of Chinese Ministry of Science and Technology (2017ZX09304005), the Public Medical Artificial Intelligence Training Platform (XX-RGZN-01-17-4684), and Shanghai Minhang Natural Science Foundation (2018MHZ001).	BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Guerra JCD, 2014, SPINAL CORD, V52, P327, DOI 10.1038/sc.2013.170; Diong J, 2012, SPINAL CORD, V50, P579, DOI 10.1038/sc.2012.25; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; Hasler RM, 2011, EUR SPINE J, V20, P2174, DOI 10.1007/s00586-011-1866-7; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Lattanzi S, 2016, STROKE, V47, P1654, DOI 10.1161/STROKEAHA.116.013627; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Neirinckx V, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0150-2; Qiu Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep38909; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sun YM, 2017, AM J EMERG MED, V35, P429, DOI 10.1016/j.ajem.2016.11.037; Sun Y, 2010, CURR BLADDER DYSFUNC, V5, P219, DOI 10.1007/s11884-010-0063-6; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Wang F, 2018, NEUROTOX RES; You SJ, 2017, J NEUROL SCI, V372, P157, DOI 10.1016/j.jns.2016.11.022; You SJ, 2016, NEUROL RES, V38, P903, DOI 10.1080/01616412.2016.1204797; Younan D, 2016, SHOCK, V45, P502, DOI 10.1097/SHK.0000000000000531; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0; Zhang N, 2012, INDIAN J MED RES, V135, P287; Zhao JL, 2019, CLIN NEUROL NEUROSUR, V180, P1, DOI 10.1016/j.clineuro.2019.02.021; Zhao JL, 2019, WORLD NEUROSURG	28	3	3	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2474		BMC MUSCULOSKEL DIS	BMC Musculoskelet. Disord.	AUG 15	2020	21	1							548	10.1186/s12891-020-03556-z			7	Orthopedics; Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rheumatology	NF8CY	WOS:000563521900002	32799840	gold, Green Submitted, Green Published			2022-02-06	
J	Post, A; Karton, C; Thevenot, O; Hoshizaki, TB; Robidoux, M; Gilchrist, MD				Post, Andrew; Karton, Clara; Thevenot, Odette; Hoshizaki, T. Blaine; Robidoux, Michael; Gilchrist, Michael D.			Comparison of frequency and magnitude of head impacts experienced by Peewee boys and girls in games of youth ice hockey	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Brain trauma; concussion; brain trauma profile; sport	DIFFUSE AXONAL INJURY; WHITE-MATTER; RISK; CONCUSSION; MECHANISMS; ACCURACY; EXPOSURE; CRITERIA; MENS	In youth ice hockey, girls are reported to suffer more concussions than boys, peaking around 13-14 years old, which may be related to differences in the level of brain trauma experienced by the players. The purpose of this research was to describe the differences in brain trauma characteristics, specifically the magnitude and frequency of head impacts between Peewee boys and girls from playing ice hockey. Thirty games of Peewee boys and Peewee girl's ice hockey were recorded to document the head impact events. These events were reconstructed using physical and computational techniques to estimate the strain to the brain tissue. The results found that Peewee boys experienced more head impacts than girls, specifically from the shoulder, ice, boards, and fist/punches (p < 0.05). The boys also experienced more medium strain category impacts (p < 0.05). These results identify that Peewee boys and girls engage in ice hockey differently, which affects the risk of brain trauma likely to be encountered while during game play, suggesting that the increased rate of concussion for girls may not be related to impact magnitudes within the sport but increased reporting of symptoms of concussion or gender differences in brain tissue response to an impact.	[Post, Andrew; Karton, Clara; Thevenot, Odette; Hoshizaki, T. Blaine; Robidoux, Michael; Gilchrist, Michael D.] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Post, Andrew; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Ottawa, Human Kinet, Ottawa, ON, Canada.; Post, A (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552	Natural Sciences and Engineering Research Council of Canada Collaborative Research and Development GrantNatural Sciences and Engineering Research Council of Canada (NSERC)	This research was supported by a Natural Sciences and Engineering Research Council of Canada Collaborative Research and Development Grant.	Agel J, 2010, CAN J SURG, V53, P319; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen W, 2020, STRUCT CONCRETE, DOI 10.1002/suco.201900389; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; DICK R, 2009, BR J SPORTS MED S1, V43; Eckner JT, 2018, AM J SPORT MED, V46, P2253, DOI 10.1177/0363546518777244; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Forward KE, 2014, PAED CHILD HEALT-CAN, V19, P418, DOI 10.1093/pch/19.8.418; Fryar Cheryl D, 2012, Vital Health Stat 11, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Karton C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54874-9; Karton C, 2018, HAND CLINIC, V158, P39, DOI 10.1016/B978-0-444-63954-7.00005-7; Kendall M., 2016, COMP CHARACTERIZATIO; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Mennes M, 2014, NEUROIMAGE, V98, P513, DOI 10.1016/j.neuroimage.2014.04.030; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Oeur A., 2018, EFFECT RECONSTRUCTED; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A., 2019, 42 CAN MED BIOL ENG; Post A., 2016, INT RES COUNC BIOM I; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Robidoux MA, 2020, J CONCUSSION, V4; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rousseau Philippe, 2010, Stapp Car Crash J, V54, P37; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	49	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	MAY 20	2021	24	1					1	13		10.1080/10255842.2020.1805442		AUG 2020	13	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	SD8KE	WOS:000559559300001	32787715				2022-02-06	
J	Deng, HS; Zusman, BE; Nwachuku, EL; Yue, JK; Chang, YF; Conley, YP; Okonkwo, DO; Puccio, AM				Deng, Hansen; Zusman, Benjamin E.; Nwachuku, Enyinna L.; Yue, John K.; Chang, Yue-Fang; Conley, Yvette P.; Okonkwo, David O.; Puccio, Ava M.			B-Cell Lymphoma 2 (Bcl-2) Gene Is Associated with Intracranial Hypertension after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; Bcl-2; genotype; intracranial hypertension; traumatic brain injury	CEREBROSPINAL-FLUID; UNITED-STATES; DEATH; APOPTOSIS; PRESSURE; OUTCOMES; EXPRESSION; GUIDELINES; MANAGEMENT; INCREASES	Severe traumatic brain injury (TBI) activates the apoptotic cascade in neurons and glia as part of secondary cellular injury. B-cell lymphoma 2 (Bcl-2) gene encodes a pro-survival protein to suppress programmed cell death, and variation in this gene has potential to affect intracranial pressure (ICP). Participants were recruited from a single clinical center using a prospective observational study design. Inclusion criteria were: age 16-80 years; Glasgow Coma Scale (GCS) score 4-8; and at least 24 h of ICP monitoring treated between 2000-2014. Outcomes were mean ICP, spikes >20 and >25 mm Hg, edema, and surgical intervention. Odds ratios (OR), mean increases/decreases (B), and 95% confidence intervals (CIs) were reported. In 264 patients, average age was 39.2 years old and 78% of patients were male. Mean ICPs were 11.4 +/- 0.4 mm Hg for patients with homozygous wild-type (AA), 12.8 +/- 0.6 mm Hg for heterozygous (AG), and 14.3 +/- 1.2 mm Hg for homozygous variant (GG;p = 0.023).Rs17759659GG genotype was associated with more ICP spikes >20 mm Hg (p = 0.017) and >25 mm Hg (p = 0.048). Multi-variate analysis showed that GG relative to AA genotype had higher ICP (B = 2.7 mm Hg, 95% CI [0.5,4.9],p = 0.015), edema (OR = 2.5 [1.0, 6.0],p = 0.049) and need for decompression (OR = 3.7 [1.5-9.3],p = 0.004). In this prospective severe TBI cohort,Bcl-2 rs17759659was associated with increased risk of intracranial hypertension, cerebral edema, and need for surgical intervention. The variant allele may impact programmed cell death of injured neurons, resulting in elevated ICP and post-traumatic secondary insults. Further risk stratification and targeted genotype-based therapies could improve outcomes after severe TBI.	[Deng, Hansen; Zusman, Benjamin E.; Nwachuku, Enyinna L.; Chang, Yue-Fang; Okonkwo, David O.; Puccio, Ava M.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA; [Chang, Yue-Fang] Univ Pittsburgh, Med Ctr, Dept Biostat & Epidemiol, Pittsburgh, PA 15213 USA; [Okonkwo, David O.; Puccio, Ava M.] Univ Pittsburgh, Med Ctr, Neurotrauma Clin Trials Ctr, Pittsburgh, PA 15213 USA; [Yue, John K.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA		Puccio, AM (corresponding author), Univ Pittsburgh, Med Ctr, Dept Neurol Surg, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	puccioam@upmc.edu			 [R00NR013176];  [R01NR008424];  [R01NR013342];  [5P50NS30318]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013342] Funding Source: NIH RePORTER	This study was supported by the federally funded grants R00NR013176, R01NR008424, R01NR013342, and 5P50NS30318.	Badr R, 2016, BRATISL MED J, V117, P358, DOI 10.4149/BLL_2016_071; Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Bennett E.R., 2015, TRANSLATIONAL RES TR; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Deng H., 2018, MED SCI BASEL, P6; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; Geifman N, 2013, AGE, V35, P2357, DOI 10.1007/s11357-013-9510-6; Graham SH, 2000, J NEUROTRAUM, V17, P831, DOI 10.1089/neu.2000.17.831; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jha RM, 2018, CRIT CARE MED, V46, P1792, DOI 10.1097/CCM.0000000000003361; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Shah S, 2016, SEMIN NEUROL, V36, P502, DOI 10.1055/s-0036-1592109; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Yue JK, 2017, NEUROGENETICS, V18, P29, DOI 10.1007/s10048-016-0500-6; Zhang HM, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01874-18; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	47	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2021	38	2					291	299		10.1089/neu.2020.7028		AUG 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PP0TL	WOS:000558942600001	32515262	Green Published			2022-02-06	
J	Lin, C; Li, N; Chang, HX; Shen, YQ; Li, Z; Wei, W; Chen, H; Lu, H; Ji, J; Liu, N				Lin, Chao; Li, Nan; Chang, Hanxiao; Shen, Yuqi; Li, Zheng; Wei, Wu; Chen, Hua; Lu, Hua; Ji, Jing; Liu, Ning			Dual effects of thyroid hormone on neurons and neurogenesis in traumatic brain injury	CELL DEATH & DISEASE			English	Article							ADULT; MITOCHONDRIA; MITOPHAGY; MODELS	Thyroid hormone (TH) plays a crucial role in neurodevelopment, but its function and specific mechanisms remain unclear after traumatic brain injury (TBI). Here we found that treatment with triiodothyronine (T3) ameliorated the progression of neurological deficits in mice subjected to TBI. The data showed that T3 reduced neural death and promoted the elimination of damaged mitochondria via mitophagy. However, T3 did not prevent TBI-induced cell death in phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (Pink1) knockout mice suggesting the involvement of mitophagy. Moreover, we also found that T3 promoted neurogenesis via crosstalk between mature neurons and neural stem cells (NSCs) after TBI. In neuron cultures undergoing oxygen and glucose deprivation (OGD), conditioned neuron culture medium collected after T3 treatment enhanced the in vitro differentiation of NSCs into mature neurons, a process in which mitophagy was required. Taken together, these data suggested that T3 treatment could provide a therapeutic approach for TBI by preventing neuronal death via mitophagy and promoting neurogenesis via neuron-NSC crosstalk.	[Lin, Chao; Chang, Hanxiao; Shen, Yuqi; Li, Zheng; Wei, Wu; Chen, Hua; Lu, Hua; Ji, Jing; Liu, Ning] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing 210029, Peoples R China; [Lin, Chao; Chang, Hanxiao; Shen, Yuqi; Li, Zheng; Wei, Wu; Chen, Hua; Lu, Hua; Ji, Jing; Liu, Ning] Jiangsu Prov Hosp, Dept Neurosurg, Nanjing 210029, Peoples R China; [Li, Nan] Drum Tower Hosp, Dept Nephrol, Nanjing 210029, Peoples R China		Lin, C; Ji, J; Liu, N (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing 210029, Peoples R China.; Lin, C; Ji, J; Liu, N (corresponding author), Jiangsu Prov Hosp, Dept Neurosurg, Nanjing 210029, Peoples R China.	linchao@njmu.edu.cn; jijing@njmu.edu.cn; liuning_0853@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81901258, 81972153]	This work was supported by a grant from the National Natural Science Foundation of China (81901258 to C.L. and 81972153 J.J.).	Bloise FF, 2018, J ENDOCRINOL, V236, pR57, DOI 10.1530/JOE-16-0611; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chao HL, 2019, J NEUROSCI, V39, P1930, DOI 10.1523/JNEUROSCI.3415-17.2018; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Flamant F, 2017, CURR TOP DEV BIOL, V125, P303, DOI 10.1016/bs.ctdb.2017.01.001; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gothie JD, 2017, MOL METAB, V6, P1551, DOI 10.1016/j.molmet.2017.08.003; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Katsimpardi L, 2018, CURR OPIN NEUROBIOL, V53, P131, DOI 10.1016/j.conb.2018.07.006; Li JR, 2017, MOL CELL ENDOCRINOL, V452, P120, DOI 10.1016/j.mce.2017.05.023; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Lin C, 2013, J NEUROSURG, V118, P364, DOI 10.3171/2012.9.JNS12702; Liu XY, 2020, J NEUROCHEM, V153, P230, DOI 10.1111/jnc.14859; Liu YY, 2018, PHARMACOL THERAPEUT, V186, P176, DOI 10.1016/j.pharmthera.2018.01.007; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Malekpour Babak, 2012, Acta Med Iran, V50, P113; Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Rastogi L, 2018, BIOCHEM BIOPH RES CO, V506, P597, DOI 10.1016/j.bbrc.2018.10.031; Sinha RA, 2015, AUTOPHAGY, V11, P1341, DOI 10.1080/15548627.2015.1061849; Stromme P, 2018, THYROID, V28, P1406, DOI 10.1089/thy.2018.0595; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yau WW, 2019, AUTOPHAGY, V15, P131, DOI 10.1080/15548627.2018.1511263; Yu GY, 2018, NAT MED, V24, P39, DOI 10.1038/nm.4447	25	3	3	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	AUG 9	2020	11	8							671	10.1038/s41419-020-02836-9			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	NH9YF	WOS:000565015800001	32826870	Green Published, gold			2022-02-06	
J	Jacob, L; Cogne, M; Tenovuo, O; Roe, C; Andelic, N; Majdan, M; Ranta, J; Ylen, P; Dawes, H; Azouvi, P				Jacob, Louis; Cogne, Melanie; Tenovuo, Olli; Roe, Cecilie; Andelic, Nada; Majdan, Marek; Ranta, Jukka; Ylen, Peter; Dawes, Helen; Azouvi, Philippe		CTR-TBI Participants Investigators	Predictors of Access to Rehabilitation in the Year Following Traumatic Brain Injury: A European Prospective and Multicenter Study	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; rehabilitation; predictive factors; international prospective study; Europe	CENTER-TBI; CARE; EPIDEMIOLOGY; MODERATE; HEALTH; MORTALITY; PATHWAYS; RECOVERY; OUTCOMES; IMPACT	Background Although rehabilitation is beneficial for individuals with traumatic brain injury (TBI), a significant proportion of them do not receive adequate rehabilitation after acute care. Objective Therefore, the goal of this prospective and multicenter study was to investigate predictors of access to rehabilitation in the year following injury in patients with TBI. Methods Data from a large European study (CENTER-TBI), including TBIs of all severities between December 2014 and December 2017 were used (N = 4498 patients). Participants were dichotomized into those who had and those who did not have access to rehabilitation in the year following TBI. Potential predictors included sociodemographic factors, psychoactive substance use, preinjury medical history, injury-related factors, and factors related to medical care, complications, and discharge. Results In the year following traumatic injury, 31.4% of patients received rehabilitation services. Access to rehabilitation was positively and significantly predicted by female sex (odds ratio [OR] = 1.50), increased number of years of education completed (OR = 1.05), living in Northern (OR = 1.62; reference: Western Europe) or Southern Europe (OR = 1.74), lower prehospital Glasgow Coma Scale score (OR = 1.03), higher Injury Severity Score (OR = 1.01), intracranial (OR = 1.33) and extracranial (OR = 1.99) surgery, and extracranial complication (OR = 1.75). On contrast, significant negative predictors were lack of preinjury employment (OR = 0.80), living in Central and Eastern Europe (OR = 0.42), and admission to hospital ward (OR = 0.47; reference: admission to intensive care unit) or direct discharge from emergency room (OR = 0.24). Conclusions Based on these findings, there is an urgent need to implement national and international guidelines and strategies for access to rehabilitation after TBI.	[Jacob, Louis] Univ Versailles St Quentin En Yvelines, Montigny Le Bretonneux, France; [Jacob, Louis] CIBERSAM Dr Antoni Pujadas, Parc Sanit St Joan de Deu, Barcelona, Spain; [Cogne, Melanie] Univ Hosp Rennes, Rennes, Bretagne, France; [Tenovuo, Olli] Turku Univ Hosp, Turku, Finland; [Tenovuo, Olli] Univ Turku, Turku, Finland; [Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Oslo, Norway; [Roe, Cecilie; Andelic, Nada] Univ Oslo, Oslo, Norway; [Majdan, Marek] Trnava Univ, Dept Publ Hlth, Inst Global Hlth & Epidemiol, Trnava, Slovakia; [Ranta, Jukka; Ylen, Peter] VTT Tech Res Ctr Finland Ltd, Espoo, Uusimaa, Finland; [Dawes, Helen] Oxford Brookes Univ, Oxford, England; [Azouvi, Philippe] Hop Raymond Poincare, AP HP, Garches, France; [Azouvi, Philippe] Univ Paris Saclay, UVSQ, Versailles, France		Jacob, L (corresponding author), Univ Versailles St Quentin En Yvelines, Fac Med, 2 Ave Source Bievre, F-78180 Montigny Le Bretonneux, France.	louis.jacob.contacts@gmail.com	Lagares, Alfonso/B-2969-2011; Vande Vyvere, Thijs/AAB-5180-2022; Castano-Leon, Ana M/ABF-6322-2020; Ledoux, Didier/ABA-8401-2021; Posti, Jussi P./Y-2908-2019; Sahuquillo, Juan/B-3577-2008; Jacob, Louis/AAL-3956-2020; van der Jagt, Mathieu/G-1905-2017; Gomez, Pedro/E-2411-2014; Raj, Rahul/K-7693-2012	Lagares, Alfonso/0000-0003-3996-0554; Vande Vyvere, Thijs/0000-0003-4032-5443; Castano-Leon, Ana M/0000-0002-7918-5049; Ledoux, Didier/0000-0002-9314-6564; Posti, Jussi P./0000-0002-5925-5193; Sahuquillo, Juan/0000-0003-0713-5875; Jacob, Louis/0000-0003-1071-1239; van der Naalt, Joukje/0000-0001-9873-2418; Stewart, William/0000-0003-2199-2582; Coles, Jonathan/0000-0003-4013-679X; Sanchez-Porras, Renan/0000-0002-9084-8114; Van Essen, Thomas/0000-0003-4657-5283; van der Jagt, Mathieu/0000-0003-2566-8325; Newcombe, Virginia/0000-0001-6044-9035; Parizel, Paul M./0000-0002-0221-2854; Kondziella, Daniel/0000-0001-5562-9808; Gratz, Johannes/0000-0001-8717-0544; Gomez, Pedro/0000-0002-4185-5238; Radoi, Andreea/0000-0002-0677-3544; Raj, Rahul/0000-0003-4243-9591; Rossi, Sandra/0000-0002-9963-8121; Dark, Paul/0000-0003-3309-0164; Della Corte, Francesco/0000-0003-1736-2318; Sakowitz, Oliver/0000-0003-3248-6335; Zeiler, Frederick/0000-0003-1737-0510	European Union 7th Framework program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Data used in preparation of this article were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC Grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), and from Integra LifeSciences Corporation (USA). Data for the CENTER-TBI study were collected through the Quesgen e-CRF (Quesgen Systems Inc, USA), hosted on the INCF platform and extracted via the INCF Neurobot tool (INCF, Sweden). The funder had no role in the study design, collection, analysis, and interpretation of the data; writing of the report; and the decision to submit the article for publication.	Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bolt M, 2019, PRIM HEALTH CARE RES, V20, DOI 10.1017/S1463423618000452; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Cnossen MC, 2017, J REHABIL MED, V49, P395, DOI 10.2340/16501977-2216; Corti C, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/1346987; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Daabiss M, 2011, INDIAN J ANAESTH, V55, P111, DOI 10.4103/0019-5049.79879; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; DITTMER DK, 1993, CAN FAM PHYSICIAN, V39, P1428; Doig E, 2011, BRAIN INJURY, V25, P1114, DOI 10.3109/02699052.2011.607788; Eldar R, 2008, DISABIL REHABIL, V30, P134, DOI 10.1080/09638280701191776; Elliott L, 2005, NEUROPSYCHOL REHABIL, V15, P480, DOI 10.1080/09602010443000506; Eurostat, HEALTHC PERS STAT DE; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gimigliano F, 2017, EUR J PHYS REHAB MED, V53, P155, DOI 10.23736/S1973-9087.17.04746-3; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Ilie G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188908; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; KONG FY, 1993, COMMUNITY MENT HLT J, V29, P205, DOI 10.1007/BF00778807; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Morris T, 2016, RESTOR NEUROL NEUROS, V34, P977, DOI 10.3233/RNN-160687; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; Ownsworth T, 2018, J HEAD TRAUMA REHAB, V33, pE33, DOI 10.1097/HTR.0000000000000350; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Publications Office European Union, EUROVOC THES; R Core Team, 2019, R LANG ENV STAT COMP; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Song SY, 2016, J KOREAN NEUROSURG S, V59, P485, DOI 10.3340/jkns.2016.59.5.485; Stenberg M, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/680308; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Strohmeier H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205333; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Tverdal CB, 2018, J REHABIL MED, V50, P505, DOI 10.2340/16501977-2332; Vadlamani A, 2019, ARCH PHYS MED REHAB, V100, P1622, DOI 10.1016/j.apmr.2019.03.008; Walter S, 2009, EUR J EPIDEMIOL, V24, P733, DOI 10.1007/s10654-009-9411-2; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1	53	3	3	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	SEP	2020	34	9					814	830	1545968320946038	10.1177/1545968320946038		AUG 2020	17	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NQ2IX	WOS:000557530500001	32762407	Green Accepted, Green Submitted			2022-02-06	
J	Galaz, A; Cortes-Molina, F; Arce-Molina, R; Romero-Gomez, I; Mardones, GA; Barros, LF; San Martin, A				Galaz, Alex; Cortes-Molina, Francisca; Arce-Molina, Robinson; Romero-Gomez, Ignacio; Antonio Mardones, Gonzalo; Barros, L. Felipe; San Martin, Alejandro			Imaging of the Lactate/Pyruvate Ratio Using a Genetically Encoded Forster Resonance Energy Transfer Indicator	ANALYTICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; BACILLUS-SUBTILIS; PYRUVATE RATIO; LACTATE; CELLS; VISUALIZATION; DIAGNOSIS; LUTR	The ratio between the cytosolic concentrations of lactate and pyruvate is a direct readout of the balance between glycolysis and mitochondrial oxidative metabolism. Current approaches do not allow detection of the lactate/pyruvate ratio in a single readout with high spatial/temporal resolution in living systems. Using a Forster resonance energy transfer (FRET)-based screening strategy, we found that the orphan transcriptional factor LutR from Bacillus licheniformis is an endogenous sensor of the lactate/pyruvate ratio, suitable for use as a binding moiety to develop a lactate/pyruvate ratio FRET-based genetically encoded indicator, Lapronic. The sensitivity of the indicator to lactate and pyruvate was characterized through changes in the fluorescence FRET ratio and validated with isothermal titration calorimetry. Lapronic was insensitive to physiological pH and temperature and did not respond to structurally related molecules acetate and beta-hydroxybutyrate or cofactors NAD+ and NADH. Lapronic was expressed in HEK 293 cells showing a homogeneous cytosolic localization and was also targeted to the mitochondrial matrix. A calibration protocol was designed to quantitatively assess the lactate/pyruvate ratio in intact mammalian cells. Purified protein from Escherichia coli showed robust stability over time and was found suitable for lactate/pyruvate ratio detection in biological samples. We envision that Lapronic will be of practical interest for basic and applied research.	[Galaz, Alex; Cortes-Molina, Francisca; Arce-Molina, Robinson; Romero-Gomez, Ignacio; Barros, L. Felipe; San Martin, Alejandro] Ctr Estudios Cient, Valdivia 5110466, Chile; [Antonio Mardones, Gonzalo] Univ Austral Chile UACh, Fac Med, Inst Fisiol, Valdivia 5110566, Chile		San Martin, A (corresponding author), Ctr Estudios Cient, Valdivia 5110466, Chile.	aalejo@cecs.cl		San Martin, Alejandro/0000-0002-5608-5117	FONDECYT grant Initiation into Research [11150930]; FONDEQUIP [EQM140116]; Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	This work was supported by FONDECYT grant Initiation into Research No. 11150930 and FONDEQUIP EQM140116. The Centro de Estudios Cientifi ' cos (CECs) is funded by the Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT.	ARTUCH R, 1995, EUR J CLIN CHEM CLIN, V33, P529; Carpenter KLH, 2017, CURR OPIN CRIT CARE, V23, P103, DOI 10.1097/MCC.0000000000000400; Chai YR, 2009, J BACTERIOL, V191, P2423, DOI 10.1128/JB.01464-08; CHARIOT P, 1994, ARTHRITIS RHEUM, V37, P583, DOI 10.1002/art.1780370421; Chiu KC, 2014, MICROBIOL-SGM, V160, P2178, DOI 10.1099/mic.0.079806-0; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Irigul-Sonmez O, 2014, MICROBIOL-SGM, V160, P243, DOI 10.1099/mic.0.064675-0; Jones AM, 2013, CURR OPIN PLANT BIOL, V16, P389, DOI 10.1016/j.pbi.2013.02.010; Kaper T, 2007, PLOS BIOL, V5, P2201, DOI 10.1371/journal.pbio.0050257; Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054; Levy B, 2000, CRIT CARE MED, V28, P114, DOI 10.1097/00003246-200001000-00019; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177; Rimachi R, 2012, ANAESTH INTENS CARE, V40, P427, DOI 10.1177/0310057X1204000307; Ross BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087357; San Martin A, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011004; San Martin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085780; San Martin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057712; Suistomaa M, 2000, SHOCK, V14, P8, DOI 10.1097/00024382-200014010-00002; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhao YZ, 2015, CELL METAB, V21, P777, DOI 10.1016/j.cmet.2015.04.009; Zou YJ, 2020, DEV CELL, V53, P240, DOI 10.1016/j.devcel.2020.02.017	27	3	3	1	21	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	AUG 4	2020	92	15					10643	10650		10.1021/acs.analchem.0c01741			8	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	MY9SH	WOS:000558761500059	32600029				2022-02-06	
J	Chang, MC; Seo, JP				Chang, Min Cheol; Seo, Jeong Pyo			Injury of the dentato-rubro-thalamic tract in a patient with intentional tremor after mild traumatic brain injury: a case report	BRAIN INJURY			English	Article						Traumatic brain injury; diffuse axonal injury; tremor; dentato-rubro-thalamic tract; cortico-ponto-cerebellar tract	PROPRANOLOL	Objectives We imaged the dentato-rubro-thalamic tract (DRTT) and cortico-ponto-cerebellar tract (CPCT) using diffusion tensor tractography (DTT) to evaluate the cortico-cerebellar-cortical circuit in a patient with tremor in both hands after mild TBI. We found bilateral DRTT injury in the DTT. Method A 50-year-old male presented with action tremor in both hands 1 week after mild TBI. One month before the visit, the patient had a head injury from a fall on a bus. The patient lost consciousness for 1 min and experienced post-traumatic amnesia for approximately 5 min after the accident. His Glasgow Coma Scale score was 15. The action tremor presented with a frequency of 3 Hz in both hands. No specific lesion was observed with a conventional brain MRI. Results DTT, performed 1.5 months after TBI, showed that the right DRTT was not reconstructed and the left DRTT had thinned. However, CPCT integrity was well-preserved in both hemispheres. The tremor disappeared after oral treatment with 30 mg/day indenol. The patient's tremor would have been caused by disruption of the bilateral DRTT following mild TBI. Conclusion DRTT and CPCT analysis using DTT would be useful for diagnosing abnormal movement problems, including tremor and ataxia, in patients following mild TBI.	[Chang, Min Cheol; Seo, Jeong Pyo] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea		Chang, MC (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea.	wheel633@gmail.com			National Research Foundation of Korea - Korean governmentNational Research Foundation of KoreaKorean Government [NRF-2019R1F1A1061348]	The present study was supported by a National Research Foundation of Korea grant funded by the Korean government (Grain No. NRF-2019R1F1A1061348).	ABILA B, 1985, BRIT J CLIN PHARMACO, V20, P369, DOI 10.1111/j.1365-2125.1985.tb05079.x; Choi SM, 2016, J MOV DISORD, V9, P80, DOI 10.14802/jmd.16004; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; DUPONT E, 1973, ACTA NEUROL SCAND, V49, P75; Hedera P, 2013, J CENT NERV SYST DIS, V5, P43, DOI [10.4137/JCNSD.S6561, 10.4137/JCNSNSD.S6561]; Hong JH, 2011, NEURAL REGEN RES, V6; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008749; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008253; Jang SH, 2017, BRAIN INJURY, V31, P416, DOI 10.1080/02699052.2016.1239274; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005590; Jang SH, 2015, BRAIN INJURY, V29, P1725, DOI 10.3109/02699052.2015.1075170; Kitamura K, 2008, NEURORADIOLOGY, V50, P285, DOI 10.1007/s00234-007-0351-9; Kwon HG, 2011, NEURORADIOLOGY, V53, P787, DOI 10.1007/s00234-011-0878-7; MARSDEN CD, 1982, ANN NEUROL, V11, P107, DOI 10.1002/ana.410110124; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Min Y, 2012, ANN REHABIL MED-ARM, V36, P887, DOI 10.5535/arm.2012.36.6.887; Ripoll MA, 2004, NEURORADIOLOGY, V46, P435, DOI 10.1007/s00234-004-1191-5; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Schulz R, 2017, CEREB CORTEX, V27, P635, DOI 10.1093/cercor/bhv251; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; TERAVAINEN H, 1976, NEUROLOGY, V26, P27, DOI 10.1212/WNL.26.1.27; TOLOSA ES, 1975, NEUROLOGY, V25, P177, DOI 10.1212/WNL.25.2.177	23	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 28	2020	34	9					1283	1286		10.1080/02699052.2020.1802656		AUG 2020	4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ND6FI	WOS:000555135600001	32735460				2022-02-06	
J	Irimia, A; Maher, AS; Chaudhari, NN; Chowdhury, NF; Jacobs, EB				Irimia, Andrei; Maher, Alexander S.; Chaudhari, Nikhil N.; Chowdhury, Nahian F.; Jacobs, Elliot B.		Alzheimers Dis Neuroimaging Initia	Acute cognitive deficits after traumatic brain injury predict Alzheimer's disease-like degradation of the human default mode network	GEROSCIENCE			English	Article						Alzheimer's disease; Traumatic brain injury; Default mode network; Resting state; Geriatrics; Functional connectome	STATE FUNCTIONAL CONNECTIVITY; NEUROIMAGING INITIATIVE ADNI; INDEPENDENT COMPONENT; EQUIVALENCE; AGE; DEMENTIA	Traumatic brain injury (TBI) and Alzheimer's disease (AD) are prominent neurological conditions whose neural and cognitive commonalities are poorly understood. The extent of TBI-related neurophysiological abnormalities has been hypothesized to reflect AD-like neurodegeneration because TBI can increase vulnerability to AD. However, it remains challenging to prognosticate AD risk partly because the functional relationship between acute posttraumatic sequelae and chronic AD-like degradation remains elusive. Here, functional magnetic resonance imaging (fMRI), network theory, and machine learning (ML) are leveraged to study the extent to which geriatric mild TBI (mTBI) can lead to AD-like alteration of resting-state activity in the default mode network (DMN). This network is found to contain modules whose extent of AD-like, posttraumatic degradation can be accurately prognosticated based on the acute cognitive deficits of geriatric mTBI patients with cerebral microbleeds. Aside from establishing a predictive physiological association between geriatric mTBI, cognitive impairment, and AD-like functional degradation, these findings advance the goal of acutely forecasting mTBI patients' chronic deviations from normality along AD-like functional trajectories. The association of geriatric mTBI with AD-like changes in functional brain connectivity as early as similar to 6 months post-injury carries substantial implications for public health because TBI has relatively high prevalence in the elderly.	[Irimia, Andrei; Maher, Alexander S.; Chaudhari, Nikhil N.; Chowdhury, Nahian F.; Jacobs, Elliot B.] Univ Southern Calif, Ethel Percy Andrus Gerontol Ctr, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA; [Irimia, Andrei] Univ Southern Calif, Dept Biomed Engn, Denney Res Ctr, Viterbi Sch Engn, Los Angeles, CA 90007 USA		Irimia, A (corresponding author), Univ Southern Calif, Dept Biomed Engn, Denney Res Ctr, Viterbi Sch Engn, Los Angeles, CA 90007 USA.	irimia@usc.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Maher, Alexander/0000-0003-4140-6085	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 100973]; DoDUnited States Department of Defense [W81-XWH-1810413]; Hanson-Thorell Research Scholarship; Undergraduate Research Associate Program (URAP) at the University of Southern California; Alzheimer's Disease Neuroimaging Initiative (ADNI, NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 AG024904]; DoD ADNIUnited States Department of Defense [W81XWH-12-2-0012]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); AbbVieAbbVie; Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; BiogenBiogen; Bristol-Myers Squibb CompanyBristol-Myers Squibb; CereSpir, Inc.; CogstateCogState Limited; Eisai Inc.Eisai Co Ltd; Elan Pharmaceuticals, Inc.; Eli Lilly and CompanyEli Lilly; EuroImmun; F. Hoffmann-La Roche Ltd.Hoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech; Fujirebio; GE HealthcareGeneral ElectricGE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research& Development, LLC.; Johnson& Johnson Pharmaceutical Research & Development LLC.Johnson & JohnsonJohnson & Johnson USA; Lumosity; LundbeckLundbeck Corporation; Merck Co., Inc.Merck & Company; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals CorporationNovartis; Pfizer Inc.Pfizer; Piramal Imaging; ServierServier; Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company Ltd; Transition Therapeutics; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This work was supported by NIH grant R01 NS 100973 to A.I., by DoD award W81-XWH-1810413 to A.I., by a Hanson-Thorell Research Scholarship to A.I., and by the Undergraduate Research Associate Program (URAP) at the University of Southern California. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI, NIH Grant U01 AG024904) and DoD ADNI (DoD award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research& Development, LLC.; Johnson& Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.Data availabilityMRI data acquired from HC and AD participants are publicly available from the ADNI database (http://adni.loni.usc.edu).For TBI participants, primary data generated during and/or analyzed during the current study are available subject to a data transfer agreement. At the request of some participants, their written permission is additionally required in a limited number of cases.	Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Anderson V, 2010, STUD NEUROPSYCHOL NE, pXXVII; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bradshaw LA, 2009, NEUROGASTROENT MOTIL, V21, P778, DOI 10.1111/j.1365-2982.2009.01265.x; Bronstein AM, 2006, P NATL ACAD SCI USA, V103, P1168, DOI 10.1073/pnas.0508601103; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calvillo M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01423; Cuthill E, 1969, NEW YORK 24 NAT C AC; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fan D, 2019, IEEE ENG MED BIO, P198, DOI 10.1109/EMBC.2019.8857921; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gibson DB, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00126; Goh SYM, 2016, PROC SPIE, V9789, DOI 10.1117/12.2216150; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; HAUCK WW, 1984, J PHARMACOKINET BIOP, V12, P83, DOI 10.1007/BF01063612; Heringa SM, 2014, J ALZHEIMERS DIS, V38, P211, DOI 10.3233/JAD-130542; Hilger K, 2020, HUM BRAIN MAPP, V41, P362, DOI 10.1002/hbm.24807; Hoffelder T, 2015, J BIOPHARM STAT, V25, P417, DOI 10.1080/10543406.2014.920344; Hout MC, 2013, WIRES COGN SCI, V4, P93, DOI 10.1002/wcs.1203; Iimia A, 2013, NEUROIMAGE, V66, P489, DOI 10.1016/j.neuroimage.2012.10.066; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Irimia A, 2006, PHYS MED BIOL, V51, P1347, DOI 10.1088/0031-9155/51/5/022; Irimia A, 2005, PHYSIOL MEAS, V26, P1059, DOI 10.1088/0967-3334/26/6/015; Irimia A, 2005, PHYS MED BIOL, V50, P4429, DOI 10.1088/0031-9155/50/18/012; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Irimia A, 2018, NEUROBIOL AGING, V66, P158, DOI 10.1016/j.neurobiolaging.2018.02.026; Irimia A, 2016, BRAIN CONNECT, V6, P152, DOI 10.1089/brain.2015.0360; Irimia A, 2015, BRAIN IMAGING BEHAV, V9, P678, DOI 10.1007/s11682-014-9321-0; Irimia A, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S79174; Irimia A, 2015, J CLIN NEUROSCI, V22, P627, DOI 10.1016/j.jocn.2014.09.019; Irimia A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00051; Irimia A, 2013, CLIN NEUROPHYSIOL, V124, P2129, DOI 10.1016/j.clinph.2013.04.336; Irimia A, 2013, CLIN NEUROL NEUROSUR, V115, P2159, DOI 10.1016/j.clineuro.2013.08.003; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Khazaee A, 2015, CLIN NEUROPHYSIOL, V126, P2132, DOI 10.1016/j.clinph.2015.02.060; Lima EA, 2006, SQUID HDB APPL SQUID; Lima EA, 2008, SQUID HDB, V2, P139; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maher AS, 2018, ACM-BCB'18: PROCEEDINGS OF THE 2018 ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, P165, DOI 10.1145/3233547.3233598; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Pasquini L, 2015, ALZHEIMERS DEMENT, V11, P475, DOI 10.1016/j.jalz.2014.02.007; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Rencher Alvan C., 2002, METHODS MULTIVARIATE; Rostowsky KA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00948; Tripodis Y, 2017, J ALZHEIMERS DIS, V59, P251, DOI 10.3233/JAD-160585; Van Horn JD, 2018, J NEUROSCI RES, V96, P652, DOI 10.1002/jnr.24084; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Wellek S, 1996, BIOMETRICAL J, V38, P695, DOI 10.1002/bimj.4710380608; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zverova M, 2018, NEUROPSYCH DIS TREAT, V14, P1877, DOI 10.2147/NDT.S172285	64	3	4	0	9	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	2509-2715	2509-2723		GEROSCIENCE	GeroScience	OCT	2020	42	5			SI		1411	1429		10.1007/s11357-020-00245-6		AUG 2020	19	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	NV4AK	WOS:000554853300001	32743786	Green Published, Green Submitted			2022-02-06	
J	Abdolmohammadi, B; Dupre, A; Evers, L; Mez, J				Abdolmohammadi, Bobak; Dupre, Alicia; Evers, Laney; Mez, Jesse			Genetics of Chronic Traumatic Encephalopathy	SEMINARS IN NEUROLOGY			English	Article						chronic traumatic encephalopathy; genetics; APOE; MAPT; TMEM106B	FRONTOTEMPORAL LOBAR DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISMS; BRAIN-INJURY; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; TAU-GENE; HEAD-INJURY; COGNITIVE PERFORMANCE; EPIGENETIC REGULATION; IDENTIFIES VARIANTS	Although chronic traumatic encephalopathy (CTE) garners substantial attention in the media and there have been marked scientific advances in the last few years, much remains unclear about the role of genetic risk in CTE. Two athletes with comparable contact-sport exposure may have varying amounts of CTE neuropathology, suggesting that other factors, including genetics, may contribute to CTE risk and severity. In this review, we explore reasons why genetics may be important for CTE, concepts in genetic study design for CTE (including choosing controls, endophenotypes, gene by environment interaction, and epigenetics), implicated genes in CTE (including APOE , MAPT , and TMEM106B ), and whether predictive genetic testing for CTE should be considered.	[Abdolmohammadi, Bobak; Dupre, Alicia; Evers, Laney; Mez, Jesse] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Abdolmohammadi, Bobak; Dupre, Alicia; Evers, Laney; Mez, Jesse] Boston Univ, Sch Med, Chron Traumat Encephalopathy Ctr, Boston, MA 02118 USA; [Abdolmohammadi, Bobak; Dupre, Alicia; Evers, Laney; Mez, Jesse] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA		Mez, J (corresponding author), Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis Ctr,Chron Traumat Encephalopathy C, Boston, MA 02118 USA.	jessemez@bu.edu			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23 AG046377, P30 AG013846, R01 AG061028] Funding Source: Medline		Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Beason-Held LL, 2013, J NEUROSCI, V33, P18008, DOI 10.1523/JNEUROSCI.1402-13.2013; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bis JC, 2020, MOL PSYCHIATR, V25, P1859, DOI 10.1038/s41380-018-0112-7; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Chen JA, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0270-8; Cherry C, 2018, ONE HEALTH-AMSTERDAM, V6, P1, DOI 10.1016/j.onehlt.2018.05.003; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Chuang PY, 2010, J NEUROTRAUM, V27, P999, DOI 10.1089/neu.2009.1129; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cousar JL, 2013, NEUROCRIT CARE, V19, P192, DOI 10.1007/s12028-013-9881-7; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Dardiotis E, 2015, PHARMACOGENET GENOM, V25, P485, DOI 10.1097/FPC.0000000000000161; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; De Jager PL, 2013, JAMA NEUROL, V70, P719, DOI 10.1001/jamaneurol.2013.275; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Dickson DW, 2018, NEUROLOGY, V91, pE1182, DOI 10.1212/WNL.0000000000006212; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jabbari E, 2018, ANN NEUROL, V84, P485, DOI 10.1002/ana.25308; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jakobsdottir J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006327; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jun G, 2016, MOL PSYCHIATR, V21, P108, DOI 10.1038/mp.2015.23; Jun GR, 2017, ALZHEIMERS DEMENT, V13, P727, DOI 10.1016/j.jalz.2016.12.012; Koch R, 2002, J INHERIT METAB DIS, V25, P333, DOI 10.1023/A:1020158631102; Kunkle BW, 2018, BIORXIV, DOI [10.1101/294629, DOI 10.1101/294629]; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lanoiselee HM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002270; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Liu JZ, 2017, NAT GENET, V49, P325, DOI 10.1038/ng.3766; Logue MW, 2014, ALZHEIMERS DEMENT, V10, P609, DOI 10.1016/j.jalz.2014.06.010; Markos SM, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000224; Martinez-Lucas P, 2005, INTENS CARE MED, V31, P1168, DOI 10.1007/s00134-005-2715-0; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2017, ALZHEIMERS DEMENT, V13, P119, DOI 10.1016/j.jalz.2016.09.002; Munoz MJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00044; Murray ME, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt231; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Nelson PT, 2015, J NEUROPATH EXP NEUR, V74, P75, DOI 10.1097/NEN.0000000000000151; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Osier ND, 2017, J NEUROTRAUM, V34, P86, DOI 10.1089/neu.2015.4343; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Rademakers R, 2005, HUM MOL GENET, V14, P3281, DOI 10.1093/hmg/ddi361; REBECK GW, 1993, NEURON, V11, P575; Reed LA, 2001, NEUROBIOL AGING, V22, P89, DOI 10.1016/S0197-4580(00)00202-5; Reitz C, 2009, NEUROSCIENCE, V164, P174, DOI 10.1016/j.neuroscience.2009.04.006; Rhinn H, 2017, CELL SYST, V4, P404, DOI 10.1016/j.cels.2017.02.009; Roberts JS, 2013, PROG NEUROBIOL, V110, P89, DOI 10.1016/j.pneurobio.2013.02.005; Rubino E, 2013, ALZHEIMERS DEMENT, V9, P706, DOI 10.1016/j.jalz.2012.10.013; Ruiz A, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.2; Sanchez-Contreras MY, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0267-3; Santa-Maria I, 2012, ACTA NEUROPATHOL, V124, P693, DOI 10.1007/s00401-012-1017-1; Sarnaik AA, 2010, J NEUROTRAUM, V27, P465, DOI 10.1089/neu.2009.1171; SFIA, 2018, SPORTS FITN LEIS ACT; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Sinha S., 2015, J NEUROTRAUM, V112, P673; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Surtees R, 2000, EUR J PEDIATR, V159, pS109, DOI 10.1007/PL00014370; Suzuki H, 2016, J BIOL CHEM, V291, P21448, DOI 10.1074/jbc.M116.737171; Tammen SA, 2013, MOL ASPECTS MED, V34, P753, DOI 10.1016/j.mam.2012.07.018; Tanriverdi T, 2006, SURG NEUROL, V65, P7, DOI 10.1016/j.surneu.2005.05.024; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Tzioras M, 2019, NEUROPATH APPL NEURO, V45, P327, DOI 10.1111/nan.12529; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Vass R, 2011, ACTA NEUROPATHOL, V121, P373, DOI 10.1007/s00401-010-0782-y; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang ZL, 2015, GENET MOL RES, V14, P10948, DOI 10.4238/2015.September.21.6; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; White CC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002287; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Zeiler FA, 2021, J NEUROTRAUM, V38, P1107, DOI 10.1089/neu.2017.5583; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zhao N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06783-0; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	105	3	3	5	12	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	AUG	2020	40	04					420	429		10.1055/s-0040-1713631			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NL6KK	WOS:000567521900009	32712945				2022-02-06	
J	Benko, N; Luke, E; Alsanea, Y; Coats, B				Benko, Nikolaus; Luke, Emma; Alsanea, Yousef; Coats, Brittany			Spatial distribution of human arachnoid trabeculae	JOURNAL OF ANATOMY			English	Article						cadaver; imaging; optical coherence tomography; pia-arachnoid complex; traumatic brain injury	SUBARACHNOID SPACE; BRAIN-INJURY; OPTIC-NERVE; ANATOMY; DIRECTION; MENINGES; SEPTA	Traumatic brain injury (TBI) is a common injury modality affecting a diverse patient population. Axonal injury occurs when the brain experiences excessive deformation as a result of head impact. Previous studies have shown that the arachnoid trabeculae (AT) in the subarachnoid space significantly influence the magnitude and distribution of brain deformation during impact. However, the quantity and spatial distribution of cranial AT in humans is unknown. Quantification of these microstructural features will improve understanding of force transfer during TBI, and may be a valuable dataset for microneurosurgical procedures. In this study, we quantify the spatial distribution of cranial AT in seven post-mortem human subjects. Optical coherence tomography (OCT) was used to conduct in situ imaging of AT microstructure across the surface of the human brain. OCT images were segmented to quantify the relative amounts of trabecular structures through a volume fraction (VF) measurement. The average VF for each brain ranged from 22.0% to 29.2%. Across all brains, there was a positive spatial correlation, with VF significantly greater by 12% near the superior aspect of the brain (p < .005), and significantly greater by 5%-10% in the frontal lobes (p < .005). These findings suggest that the distribution of AT between the brain and skull is heterogeneous, region-dependent, and likely contributes to brain deformation patterns. This study is the first to image and quantify human AT across the cerebrum and identify region-dependencies. Incorporation of this spatial heterogeneity may improve the accuracy of computational models of human TBI and enhance understanding of brain dynamics.	[Benko, Nikolaus; Alsanea, Yousef; Coats, Brittany] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA; [Luke, Emma] Univ Rochester, Dept Biomed Engn, Rochester, NY USA		Coats, B (corresponding author), Univ Utah, 1495 E 100 S 1550 MEK, Salt Lake City, UT 84112 USA.	brittany.coats@utah.edu	Coats, Brittany/A-4523-2009	Benko, Nikolaus/0000-0002-7852-8775			ALCOLADO R, 1988, NEUROPATH APPL NEURO, V14, P1, DOI 10.1111/j.1365-2990.1988.tb00862.x; AURENHAMMER F, 1991, COMPUT SURV, V23, P345; Buades A, 2011, IMAGE PROCESS ON LIN, V1, P208, DOI 10.5201/ipol.2011.bcm_nlm; Chen YG, 2012, LETT SPAT RESOUR SCI, V5, P65, DOI 10.1007/s12076-011-0076-6; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Darbon J, 2008, I S BIOMED IMAGING, P1331, DOI 10.1109/ISBI.2008.4541250; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GETIS A, 1995, PROG HUM GEOG, V19, P245, DOI 10.1177/030913259501900205; Ghaffari M., 2014, J MODERN ENG, V14, P54; Gupta S, 2010, J R SOC INTERFACE, V7, P1195, DOI 10.1098/rsif.2010.0033; Haines D.E., 2002, FUNDAMENTAL NEUROSCI; HAINES DE, 1991, ANAT RECORD, V230, P3, DOI 10.1002/ar.1092300103; Hartmann K, 2019, THER ADV NEUROL DISO, V12, DOI 10.1177/1756286419843040; Key A., 1873, ARCH MIKROSK ANAT, V9, P308; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Killer HE, 1999, J NEURO-OPHTHALMOL, V19, P222; LIU D, 1993, AM J OPHTHALMOL, V116, P548, DOI 10.1016/S0002-9394(14)73195-2; Mortazavi MM, 2018, WORLD NEUROSURG, V111, P279, DOI 10.1016/j.wneu.2017.12.041; NAUTA HJW, 1983, SURG NEUROL, V19, P431, DOI 10.1016/0090-3019(83)90141-6; NICHOLAS DS, 1988, J NEUROSURG, V69, P276, DOI 10.3171/jns.1988.69.2.0276; PARKINSON D, 1991, AM J ANAT, V192, P498, DOI 10.1002/aja.1001920414; Petroni S, 2003, CELLS TISSUES ORGANS, V173, P122, DOI 10.1159/000068943; Rickenbacher J., 1985, APPL ANATOMY BACK AP; Saboori P, 2011, SCI IRAN, V18, P1492, DOI 10.1016/j.scient.2011.11.032; Saboori Parisa, 2015, Anat Res Int, V2015, P279814, DOI 10.1155/2015/279814; Scott GG, 2016, BIOMECH MODEL MECHAN, V15, P1101, DOI 10.1007/s10237-015-0747-0; Scott GG, 2015, IEEE T MED IMAGING, V34, P1452, DOI 10.1109/TMI.2015.2396527; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Talbert D.G., 2016, J TRAUMA TREATMENT, V4, P1; Weller R. O., 2005, Morphologie, V89, P22, DOI 10.1016/S1286-0115(05)83235-7; WRIGLEY N, 1982, GEOGR J, V148, P383, DOI 10.2307/633177	32	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	AUG	2020	237	2					275	284		10.1111/joa.13186			10	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	ML9FI	WOS:000549765800006	32202332	Bronze			2022-02-06	
J	Brown, J; Knollman-Porter, K				Brown, Jessica; Knollman-Porter, Kelly			Continuum of Care Following Sports-Related Concussion	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; REPORTING BEHAVIORS; SERVICE MEMBERS; SYMPTOMS; MANAGEMENT; CHILDREN; COLLEGIATE; RISK; RECOMMENDATIONS; EPIDEMIOLOGY	Purpose: Although guidelines have changed regarding federally mandated concussion practices since their inception, little is known regarding the implementation of such guidelines and the resultant continuum of care for youth athletes participating in recreational or organized sports who incur concussions. Furthermore, data regarding the role of speech-language pathologists in the historic postconcussion care are lacking. Therefore, the purpose of this retrospective study was to investigate the experiences of young adults with history of sports-related concussion as it related to injury reporting and received follow-up care. Method: Participants included 13 young adults with history of at least one sports-related concussion across their life span. We implemented a mixed-methods design to collect both quantitative and qualitative information through structured interviews. Participants reported experiencing 42 concussions across the life span-26 subsequent to sports injuries. Results: Twenty-three concussions were reported to a parent or medical professional, 14 resulted in a formal diagnosis, and participants received initial medical care for only 10 of the incidents and treatment or services on only two occasions. Participants reported concussions to an athletic trainer least frequently and to parents most frequently. Participants commented that previous experience with concussion reduced the need for seeking treatment or that they were unaware treatments or supports existed postconcussion. Only one concussion incident resulted in the care from a speech-language pathologist. Conclusion: The results of the study reported herein shed light on the fidelity of sports-related concussion care management across time. Subsequently, we suggest guidelines related to continuum of care from injury to individualized therapy.	[Brown, Jessica] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA; [Knollman-Porter, Kelly] Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA		Brown, J (corresponding author), Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA.	jessicabrown@email.arizona.edu					Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; American Speech-Language-Hearing Association, 2016, SCOP PRACT SPEECH LA; [Anonymous], 2018, SPORTS CONCUSSIONS; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Brannen J., 2005, INT J SOC RES METHOD, V8, P173, DOI 10.1080/13645570500154642; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown J., 2015, AM SPEECH LANG HEAR; Brown J., 2018, POSTCONCUSSION UNPUB; Brown J, 2019, AM J SPEECH-LANG PAT, V28, P1363, DOI 10.1044/2019_AJSLP-18-0296; Brown J, 2019, DISABIL REHABIL-ASSI, V14, P255, DOI 10.1080/17483107.2018.1428371; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Centers for Disease Control and Prevention, 2018, TRAUM BRAIN INJ CONC; Claiborne T, 2007, ATHLET THER TODAY, V12, P34; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Emery CA, 2011, BRIT J SPORT MED, V45, P1289, DOI 10.1136/bjsports-2011-090538; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Green J., 2018, STATE LEGISLATURES C; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Hux K., 2017, CURRENT RES CONCUSSI, V4, pE14, DOI [10.1055/s-0037-1606578, DOI 10.1055/S-0037-1606578]; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Knollman-Porter K, 2019, TOP LANG DISORD, V39, P257, DOI 10.1097/TLD.0000000000000187; Knollman-Porter K, 2019, SEMIN SPEECH LANG, V40, P3, DOI 10.1055/s-0038-1676363; Knollman-Porter K, 2018, AM J SPEECH-LANG PAT, V27, P778, DOI 10.1044/2018_AJSLP-17-0108; Kramer NA, 2017, MED SCI SPORT EXER, V49, P414, DOI 10.1249/01.mss.0000518014.16336.43; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lundine JP, 2019, AM J SPEECH-LANG PAT, V28, P1371, DOI 10.1044/2019_AJSLP-18-0295; Mann A., 2017, BRIT J SPORT MED, V51, P53, DOI [10.1136/bjsports-2016-097270.138, DOI 10.1136/BJSPORTS-2016-097270.138]; Martella R. C., 2013, UNDERSTANDING INTERP; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNally KA, 2018, CHILD NEUROPSYCHOL, V24, P396, DOI 10.1080/09297049.2017.1280143; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Moser RS, 2018, ARCH CLIN NEUROPSYCH, V33, P417, DOI 10.1093/arclin/acx070; Musille A., 2016, AM SPEECH LANG HEAR; National Athletic Trainer's Association, 2018, GROWTH TOT NUMB MEMB; Ontario Neurotrauma Foundation, GUID MILD TRAUM BRAI; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Radomski MV, 2009, AM J OCCUP THER, V63, P646, DOI 10.5014/ajot.63.5.646; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Roth C., 2016, COGNITIVE COMMUNICAT; Stephensen S, 1996, BRIT J SPORT MED, V30, P331, DOI 10.1136/bjsm.30.4.331; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	61	3	3	0	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	AUG	2020	29	3					1389	1403		10.1044/2020_AJSLP-19-00131			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	MY6LO	WOS:000558526500019	32379485				2022-02-06	
J	Buckley, TA; Munkasy, BA; Krazeise, DA; Oldham, JR; Evans, KM; Clouse, B				Buckley, Thomas A.; Munkasy, Barry A.; Krazeise, David A.; Oldham, Jessie R.; Evans, Kelsey M.; Clouse, Brandy			Differential Effects of Acute and Multiple Concussions on Gait Initiation Performance	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Mild traumatic brain injuries; Posture; Rehabilitation	ERROR SCORING SYSTEM; CHRONIC TRAUMATIC ENCEPHALOPATHY; POSTURAL CONTROL; INTERNATIONAL-CONFERENCE; RECURRENT CONCUSSION; CONSENSUS STATEMENT; ATHLETIC TRAINERS; CONTROL DEFICITS; SPORT HELD; ASSOCIATION	Objective: To identify the effect of acute and multiple concussions on gait initiation performance. Design: Cohort study. Setting: University research center. Participants: A population-based sample of participants (N=45) divided into 3 groups: No Prior Concussion, >= 3 Prior Concussions, and Acute Concussion. The Acute Concussion participants were assessed within 24 hours of their concussion. Participants were matched based on (1) sport, (2) position, and (3) anthropometric measures. Interventions: Participants were tested on a single occasion and performed 5 trials of gait initiation on 4 force plates. The No Prior Concussion and >= 3 Prior Concussions groups were tested out of their primary athletic season. Main Outcome Measures: The dependent variables were the posterior and lateral displacement and velocity of the center of pressure (COP) during the anticipatory postural adjustment phase and initial step kinematics (step length and step velocity). Comparisons between groups used a 1-way analysis of variance with Tukey post hoc when significant effects were identified and effect sizes were calculated. Results: There were significant effects for group for all 6 outcome measures with large effect sizes. Post hoc tests identified differences between Acute Concussion and No Prior Concussion groups for all measures. The >= 3 Prior Concussions group and No Prior Concussion group were different for COP posterior displacement (4.91 +/- 1.09 and 4.91 +/- 1.09cm, respectively, P=.032, d=0.91) and velocity (0.18 +/- 0.06 and 0.27 +/- 0.08m/s, respectively, P=.002, d=1.27). Conclusion: There was continuum of performance identified whereby the Acute Concussion participants performed worse and the No Prior Concussion participants performed the best. The >= 3 Prior Concussions generally fell between these 2 groups, but only statistical significance on COP posterior displacement and velocity. These results suggest there may be subtle neurophysiological deficits present in collegiate student-athletes with >= 3 Prior Concussions group, and further investigation over the lifespan is warranted. (C) 2020 by the American Congress of Rehabilitation Medicine	[Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, 349 STAR Tower,100 Discovery Blvd, Newark, DE 19716 USA; [Buckley, Thomas A.] Univ Delaware, Interdisciplinaty Program Biomech & Movement Sci, Newark, DE 19716 USA; [Munkasy, Barry A.] Georgia Southern Univ, Sch Hlth & Kinesiol, Statesboro, GA USA; [Krazeise, David A.] Zimmer Biomet Orthoped, Warsaw, IN USA; [Oldham, Jessie R.] Boston Childrens Hosp, Michell Ctr Sports Injury Prevent, Waltham, MA USA; [Evans, Kelsey M.] Each Carolina Univ, Brody Sch Med, Greenville, NC USA; [Clouse, Brandy] Georgia Southern Univ, Dept Intercollegiate Athlet, Statesboro, GA USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 349 STAR Tower,100 Discovery Blvd, Newark, DE 19716 USA.	TBuckley@UDel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150	National Institute of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R15NS070744]	Supported in part by the National Institute of Health/National Institute of Neurological Disorders and Stroke (grant no. 1R15NS070744).	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brunt D, 1999, GAIT POSTURE, V10, P121, DOI 10.1016/S0966-6362(99)00020-X; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Buckley TA, 2017, ARCH PHYS MED REHAB, V98, P1962, DOI 10.1016/j.apmr.2017.05.002; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Carlson CD, 2019, ATHL TRAIN SPORTS HL, V12, P67; Chang HA, 1999, ARCH PHYS MED REHAB, V80, P490; Chastan N, 2009, MOVEMENT DISORD, V24, P188, DOI 10.1002/mds.22269; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Dierijck JK, 2018, INT J PSYCHOPHYSIOL, V132, P74, DOI 10.1016/j.ijpsycho.2018.03.005; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gantchev N, 1996, ELECTROMYOGR MOTOR C, V101, P110, DOI 10.1016/0924-980X(95)00253-H; Garcia GGP, 2019, J NEUROTRAUM, V36, P1571, DOI 10.1089/neu.2018.6098; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Halliday SE, 1998, GAIT POSTURE, V8, P8, DOI 10.1016/S0966-6362(98)00020-4; Hass CJ, 2008, CLIN BIOMECH, V23, P743, DOI 10.1016/j.clinbiomech.2008.02.012; Hass CJ, 2012, GAIT POSTURE, V35, P669, DOI 10.1016/j.gaitpost.2011.12.022; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Iverson G, 2019, BRAIN INJURY, V33, P258; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Manaseer TS, 2020, CLIN J SPORT MED S1, V30, pS11; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mitchell KM, 2019, CLIN BIOMECH, V67, P142, DOI 10.1016/j.clinbiomech.2019.05.006; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Murray NG, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aafcd8; Nocera JR, 2013, J REHABIL RES DEV, V50, P699, DOI 10.1682/JRRD.2012.06.0114; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Papa EV, 2019, J BIOMECH, V87, P197, DOI 10.1016/j.jbiomech.2019.03.009; Polcyn AF, 1998, ARCH PHYS MED REHAB, V79, P1582, DOI 10.1016/S0003-9993(98)90425-7; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Shumway-Cook A, 2012, MOTOR CONTROL TRANSL; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Turner S, 2017, SPORT EXERC PERFORM, V6, P277, DOI 10.1037/spy0000099; Vallabhajosula S, 2013, GAIT POSTURE, V37, P280, DOI 10.1016/j.gaitpost.2012.07.018; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Weber ML, 2019, ANN BIOMED ENG, V47, P2136, DOI 10.1007/s10439-018-02151-7; Zhang YJ, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9080199	64	3	3	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2020	101	8					1347	1354		10.1016/j.apmr.2020.03.018			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	MT3YW	WOS:000554905500009	32343972	Green Accepted			2022-02-06	
J	Choi, I; Kwon, GH; Lee, S; Nam, CS				Choi, Inchul; Kwon, Gyu Hyun; Lee, Sangwon; Nam, Chang S.			Functional Electrical Stimulation Controlled by Motor Imagery Brain-Computer Interface for Rehabilitation	BRAIN SCIENCES			English	Article						brain-computer interface (BCI); functional electrical stimulation (FES); sensorimotor rhythm (SMR); adaptive learning; rehabilitation	STROKE REHABILITATION; RECOVERY; PATIENT; BCI; DESYNCHRONIZATION; SYNCHRONIZATION; IMPROVEMENT; FEASIBILITY; RESTORATION; ALGORITHMS	Sensorimotor rhythm (SMR)-based brain-computer interface (BCI) controlled Functional Electrical Stimulation (FES) has gained importance in recent years for the rehabilitation of motor deficits. However, there still remain many research questions to be addressed, such as unstructured Motor Imagery (MI) training procedures; a lack of methods to classify different MI tasks in a single hand, such as grasping and opening; and difficulty in decoding voluntary MI-evoked SMRs compared to FES-driven passive-movement-evoked SMRs. To address these issues, a study that is composed of two phases was conducted to develop and validate an SMR-based BCI-FES system with 2-class MI tasks in a single hand (Phase 1), and investigate the feasibility of the system with stroke and traumatic brain injury (TBI) patients (Phase 2). The results of Phase 1 showed that the accuracy of classifying 2-class MIs (approximately 71.25%) was significantly higher than the true chance level, while that of distinguishing voluntary and passive SMRs was not. In Phase 2, where the patients performed goal-oriented tasks in a semi-asynchronous mode, the effects of the FES existence type and adaptive learning on task performance were evaluated. The results showed that adaptive learning significantly increased the accuracy, and the accuracy after applying adaptive learning under the No-FES condition (61.9%) was significantly higher than the true chance level. The outcomes of the present research would provide insight into SMR-based BCI-controlled FES systems that can connect those with motor disabilities (e.g., stroke and TBI patients) to other people by greatly improving their quality of life. Recommendations for future work with a larger sample size and kinesthetic MI were also presented.	[Choi, Inchul; Nam, Chang S.] North Carolina State Univ, Dept Ind & Syst Engn 1, Raleigh, NC 27695 USA; [Kwon, Gyu Hyun] Hanyang Univ, Grad Sch Technol & Innovat Management, Seoul 04763, South Korea; [Lee, Sangwon] Sungkyunkwan Univ, Dept Interact Sci, Seoul 03063, South Korea		Nam, CS (corresponding author), North Carolina State Univ, Dept Ind & Syst Engn 1, Raleigh, NC 27695 USA.	ichoi3@ncsu.edu; ghkwon@hanyang.ac.kr; upcircle@skku.edu; csnam@ncsu.edu		Kwon, Gyu Hyun/0000-0003-1623-4867; Lee, Sangwon/0000-0002-9825-0854; nam, chang/0000-0001-9005-0703	National Science Foundation (NSF)National Science Foundation (NSF) [IIS-1421948]	This work was supported in part by the National Science Foundation (NSF) under Grant Number IIS-1421948. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF.	Ahlstrom V., 2007, HUMAN FACTORS CRITER; Amiri S, 2013, ADV HUM-COMPUT INTER, V2013, DOI 10.1155/2013/187024; Barsi GI, 2008, EXP BRAIN RES, V191, P57, DOI 10.1007/s00221-008-1495-5; Bashashati A, 2007, J NEURAL ENG, V4, pR32, DOI 10.1088/1741-2560/4/2/R03; BEISTEINER R, 1995, EVOKED POTENTIAL, V96, P183, DOI 10.1016/0168-5597(94)00226-5; Bhattacharyya S., 2015, MED IMAGING CONCETPS; Blokland Y, 2014, IEEE T NEUR SYS REH, V22, P222, DOI 10.1109/TNSRE.2013.2292995; Brouwer AM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00019; Chae J, 2008, TOP STROKE REHABIL, V15, P412, DOI 10.1310/tsr1505-412; Choi I., 2016, P 6 INT BRAIN COMP I; Da Silva HSVP, 2013, PESTICIDAS, V23, P1; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Daly JJ, 2009, J NEUROL PHYS THER, V33, P203, DOI 10.1097/NPT.0b013e3181c1fc0b; de Vries S, 2007, J REHABIL MED, V39, P5, DOI 10.2340/16501977-0020; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Duncan PW, 2005, STROKE, V36, pE100, DOI 10.1161/01.STR.0000180861.54180.FF; Fazel-Rezai Reza, 2012, Front Neuroeng, V5, P14, DOI 10.3389/fneng.2012.00014; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Gatti R, 2013, NEUROSCI LETT, V540, P37, DOI 10.1016/j.neulet.2012.11.039; Golub MD, 2016, CURR OPIN NEUROBIOL, V37, P53, DOI 10.1016/j.conb.2015.12.005; Gu Y, 2009, CLIN NEUROPHYSIOL, V120, P1596, DOI 10.1016/j.clinph.2009.05.006; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Hara Yukihiro, 2008, Journal of Nippon Medical School, V75, P4, DOI 10.1272/jnms.75.4; HART S G, 1988, P139; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Holz EM, 2015, BRAIN-COMPUT INTERFA, V2, P117, DOI 10.1080/2326263X.2015.1100048; Homer ML, 2013, ANNU REV BIOMED ENG, V15, P383, DOI 10.1146/annurev-bioeng-071910-124640; Huang DD, 2012, IEEE T NEUR SYS REH, V20, P379, DOI 10.1109/TNSRE.2012.2190299; Iosa M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/815814; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Johnson LA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/016009; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kathner I, 2013, CLIN NEUROPHYSIOL, V124, P327, DOI 10.1016/j.clinph.2012.08.006; Kawashima N, 2013, PHYSIOTHER CAN, V65, P20, DOI 10.3138/ptc.2011-36; Keller T., 2008, J AUTOM CONTROL, V18, P35, DOI [10.2298/JAC0802035K, DOI 10.2298/JAC0802035K]; Kim T, 2016, OCCUP THER INT, V23, P39, DOI 10.1002/oti.1403; Kohavi R., P 14 INT JOINT C ART, P1137; Kottink AIR, 2004, ARTIF ORGANS, V28, P577, DOI 10.1111/j.1525-1594.2004.07310.x; Krusienski DJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025002; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lawrence M, 2009, THESIS; LEVIN MF, 1992, ELECTROEN CLIN NEURO, V85, P131, DOI 10.1016/0168-5597(92)90079-Q; Li Y., 2015, P HUM FACT ERGO SOC, V59, P716, DOI DOI 10.1177/1541931215591169; Looned R, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-51; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lynch CL, 2008, IEEE CONTR SYST MAG, V28, P40, DOI 10.1109/MCS.2007.914689; Mak Joseph N, 2009, IEEE Rev Biomed Eng, V2, P187, DOI 10.1109/RBME.2009.2035356; Mangold S, 2005, SPINAL CORD, V43, P1, DOI 10.1038/sj.sc.3101644; Matsumoto S, 2010, INT J BIOMETEOROL, V54, P465, DOI 10.1007/s00484-009-0300-x; McGie SC, 2015, NEUROMODULATION, V18, P233, DOI 10.1111/ner.12185; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Mozaffarian D., 2015, CIRCULATION, V133; Muller GR, 2003, NEUROSCI LETT, V340, P143, DOI 10.1016/S0304-3940(03)00019-3; Nam C.S., 2014, P 5 INT BRAIN COMP I; Nam CS, 2015, ERGON DES, V23, P13, DOI 10.1177/1064804615572625; Nam CS, 2018, BRAIN-COMPUTER INTERFACES HANDBOOK: TECHNOLOGICAL AND THEORETICAL ADVANCES, P1; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; Novi Q, 2007, 2007 3RD INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, VOLS 1 AND 2, P204, DOI 10.1109/CNE.2007.369647; Ortner R, 2011, IEEE T NEUR SYS REH, V19, P1, DOI 10.1109/TNSRE.2010.2076364; Lourencao MIP, 2008, INT J REHABIL RES, V31, P33, DOI 10.1097/MRR.0b013e3282f4524c; PAPACHRISTOS A, 2014, TOPICS IN PARAPLEGIA; Peckham PH, 2005, ANNU REV BIOMED ENG, V7, P327, DOI 10.1146/annurev.bioeng.6.040803.140103; Perelmouter J, 2000, IEEE T REHABIL ENG, V8, P227, DOI 10.1109/86.847824; Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V43, P757, DOI 10.1016/0013-4694(77)90092-X; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2006, PROG BRAIN RES, V159, P433, DOI 10.1016/S0079-6123(06)59028-4; Pfurtscheller G, 2010, IEEE T NEUR SYS REH, V18, P409, DOI 10.1109/TNSRE.2010.2040837; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Popovic DB, 2014, J ELECTROMYOGR KINES, V24, P795, DOI 10.1016/j.jelekin.2014.09.008; Popovic MR, 2001, SPINAL CORD, V39, P403, DOI 10.1038/sj.sc.3101191; Quandt Fanny, 2014, Exp Transl Stroke Med, V6, P9, DOI 10.1186/2040-7378-6-9; Rohm M., 2010, BIOMED TECH, V55, P1, DOI [10.1515/bmt.2010.715, DOI 10.1515/BMT.2010.715]; Rohm M, 2013, ARTIF INTELL MED, V59, P133, DOI 10.1016/j.artmed.2013.07.004; Roset SA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00415; Sabut SK, 2011, NEUROREHABILITATION, V29, P393, DOI 10.3233/NRE-2011-0717; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Schalk G, 2010, PRACTICAL GUIDE TO BRAIN-COMPUTER INTERFACING WITH BCI2000, P1, DOI 10.1007/978-1-84996-092-2; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Sujith OK, 2008, EUR J NEUROL, V15, P437, DOI 10.1111/j.1468-1331.2008.02127.x; Takahashi M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-56; Teasell Robert, 2005, Top Stroke Rehabil, V12, P11; Tonet O., 2006, 056402 EUR SPAC AG A; Toriyama H, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00295; van Delden AEQ, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/972069; Vidaurre C, 2011, NEURAL COMPUT, V23, P791, DOI 10.1162/NECO_a_00089; Vidaurre C, 2010, BRAIN TOPOGR, V23, P194, DOI 10.1007/s10548-009-0121-6; Vuagnat H, 2003, J REHABIL MED, V35, P49, DOI 10.1080/16501970306111; Wissel J, 2010, J NEUROL, V257, P1067, DOI 10.1007/s00415-010-5463-1; Wodlinger B, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016011; Wolpaw J R, 1998, IEEE Trans Rehabil Eng, V6, P326, DOI 10.1109/86.712231; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Young Brittany M, 2014, Front Neuroeng, V7, P18, DOI 10.3389/fneng.2014.00018; Yu TY, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/750934; Yu TY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036012; Zhang D, 2007, P 1 INT CONV REH ENG, P221; Zhang Y, 2019, IEEE T CYBERNETICS, V49, P3322, DOI 10.1109/TCYB.2018.2841847	104	3	4	4	10	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	AUG	2020	10	8							512	10.3390/brainsci10080512			27	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NM5KA	WOS:000568134500001	32748888	gold, Green Published			2022-02-06	
J	Chong, AJ; Wee, HY; Chang, CH; Chio, CC; Kuo, JR; Lim, SW				Chong, Arng Jack; Wee, Hsiao-Yue; Chang, Chin-Hung; Chio, Chung-Ching; Kuo, Jinn-Rung; Lim, Sher-Wei			Effects of a High-Fat Diet on Neuroinflammation and Apoptosis in Acute Stage After Moderate Traumatic Brain Injury in Rats	NEUROCRITICAL CARE			English	Article						High-fat diet; Cholesterol; Triglycerides; Traumatic brain injury; Apoptosis; Tumor necrosis factor-alpha	EXPRESSION; DEFICITS; PROTEIN	Background A high-fat diet (HFD) is correlated with a higher risk of metabolic syndrome. The effect of HFD on neuroinflammation and apoptosis in acute stage after traumatic brain injury (TBI) in rats is not well known. Materials and Methods Five-week-old male Sprague-Dawley (SD) rats were fed a HFD or normal diet (ND) for 8 weeks. Anesthetized male SD rats were divided into two subgroups: sham-operated and TBI. Motor function was measured using an inclined plane. The numbers of apoptotic neurons (markers Neu-N, TUNEL, caspase-3), activated astrocytes (marker GFAP) and microglia (marker OX42), and TNF-alpha expression in microglia and astrocytes in the ischemic cortex were investigated using an immunofluorescence assay. All of the parameters were measured on the 3rd day after TBI. Results Rats fed a HFD for 8 weeks had higher body weight, serum cholesterol, and triglycerides. TBI-induced motor deficits, neuronal decrease, neuronal apoptosis, astrocyte and microglia activation, and TNF-alpha expression in microglia and astrocytes in the ischemia cortex were significantly increased in ND and HFD rats compared to sham rats. However, these parameters were not significantly different between the ND and HFD TBI groups, except motor deficit. Conclusions HFD has no significant effects on neuronal apoptosis or neuroinflammation in acute stage compared with ND for 8 weeks after moderate TBI in experimental rats.	[Chong, Arng Jack; Wee, Hsiao-Yue; Chang, Chin-Hung; Chio, Chung-Ching; Kuo, Jinn-Rung; Lim, Sher-Wei] Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan; [Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lim, Sher-Wei] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan		Kuo, JR; Lim, SW (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan.	kuojinnrung@gmail.com; slsw0219@gmail.com					Arvanitidis AP, 2009, BRAIN RES, V1252, P192, DOI 10.1016/j.brainres.2008.11.058; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Farr S, 2016, CURR OPIN LIPIDOL, V27, P1, DOI 10.1097/MOL.0000000000000254; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Herz J, 2014, NEUROBIOL DIS, V62, P456, DOI 10.1016/j.nbd.2013.10.022; Hoane MR, 2011, BEHAV BRAIN RES, V223, P119, DOI 10.1016/j.bbr.2011.04.028; Jia JX, 2010, MOL CELL BIOCHEM, V335, P127, DOI 10.1007/s11010-009-0249-4; Kang DH, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0202-2; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; Laaksonen DE, 2004, ANN MED, V36, P332, DOI 10.1080/07853890410031849; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Palmisano BT, 2018, MOL METAB, V15, P45, DOI 10.1016/j.molmet.2018.05.008; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Rosenson RS, 1998, ATHEROSCLEROSIS, V140, P271, DOI 10.1016/S0021-9150(98)00144-0; Salama A. A. A., 2015, African Journal of Pharmacy and Pharmacology, V9, P567; Spagnuolo MS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00479; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Wang CC, 2018, WORLD NEUROSURG, V112, pE719, DOI 10.1016/j.wneu.2018.01.140; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Xue QS, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-20; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3	32	3	3	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2020	33	1					230	240		10.1007/s12028-019-00891-5			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MT1KH	WOS:000554726700025	31828728				2022-02-06	
J	Dasari, R; Zhi, WB; Bonsack, F; Sukumari-Ramesh, S				Dasari, Rajaneekar; Zhi, Wenbo; Bonsack, Frederick; Sukumari-Ramesh, Sangeetha			A Combined Proteomics and Bioinformatics Approach Reveals Novel Signaling Pathways and Molecular Targets After Intracerebral Hemorrhage	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						ICH; Mass spectrometry; Proteomics; Bioinformatics	BRAIN-BARRIER PERMEABILITY; BLOOD; INTEGRINS; NEUROPROTECTION; ACTIVATION; EXPRESSION; ANGIOGENESIS; INHIBITION; APOPTOSIS; INJURY	Intracerebral hemorrhage (ICH) is a non-traumatic cerebrovascular disorder with very high morbidity and mortality and regarded as one of the deadliest stroke subtypes. Notably, there is no effective treatment for ICH. Despite an overall increase in preclinical studies, the pathophysiology of ICH is complex and remains enigmatic. To this end, ICH was induced in male CD-1 mice and the ipsilateral brain tissue was characterized in an unbiased manner using a combination of proteomics and bioinformatics approaches. A total of 4833 proteins were revealed by quantitative proteomic analysis. Of those, 207 proteins exhibited significantly altered expression after ICH in comparison to sham. It was found that 46 proteins were significantly upregulated and 161 proteins were significantly downregulated after ICH compared to sham. The quantitative proteomics approach combined with bioinformatics revealed several novel molecular targets (cyclin-dependent-like kinase 5, E3 ubiquitin-protein ligase, protein phosphatase 2A-alpha, protein phosphatase 2A-beta, serine/threonine-protein kinase PAK1, alpha-actinin-4, calpain-8, axin-1, NCK1, and septin-4), and related signaling pathways, which could play roles in secondary brain injury and long-term neurobehavioral outcomes after ICH warranting further investigation.	[Dasari, Rajaneekar; Bonsack, Frederick; Sukumari-Ramesh, Sangeetha] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, 1120 15th St,CB3618, Augusta, GA 30912 USA; [Zhi, Wenbo] Augusta Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Zhi, Wenbo] Augusta Univ, Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA USA		Sukumari-Ramesh, S (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, 1120 15th St,CB3618, Augusta, GA 30912 USA.	sramesh@augusta.edu			American Heart AssociationAmerican Heart Association [14SDG18730034] Funding Source: Medline; NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS107853, R01NS107853] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS107853] Funding Source: Medline		Agnihotri S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-160; Bonsack F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0619-2; Brooks PC, 1996, EUR J CANCER, V32A, P2423, DOI 10.1016/S0959-8049(96)00381-4; Cao SL, 2016, STROKE, V47, P1626, DOI 10.1161/STROKEAHA.116.013146; Chen L, 2015, BRAIN RES, V1606, P44, DOI 10.1016/j.brainres.2015.02.032; Clark W, 1998, STROKE, V29, P2136, DOI 10.1161/01.STR.29.10.2136; Ducruet AF, 2009, EXP NEUROL, V219, P398, DOI 10.1016/j.expneurol.2009.07.018; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Flaherty ML, 2006, NEUROLOGY, V66, P1182, DOI 10.1212/01.wnl.0000208400.08722.7c; Gonzalez-Forero D, 2012, J NEUROSCI, V32, P68, DOI 10.1523/JNEUROSCI.3215-11.2012; Guo Fu-qiang, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P290; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hua Y, 2000, J NEUROSURG, V92, P1016, DOI 10.3171/jns.2000.92.6.1016; Huang B, 2012, NEUROBIOL DIS, V46, P204, DOI 10.1016/j.nbd.2012.01.008; Huangfu Wei-Chun, 2010, Genes Cancer, V1, P725, DOI 10.1177/1947601910382901; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Jiang J, 2018, ONCOGENE, V37, P2992, DOI 10.1038/s41388-018-0166-7; Kang WF, 2014, P NATL ACAD SCI USA, V111, pE2987, DOI 10.1073/pnas.1320401111; Keep RF, 2008, ACT NEUR S, V105, P73; Langhauser F, 2012, BLOOD, V120, P4082, DOI 10.1182/blood-2012-06-440057; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; Li ZH, 2017, J MOL NEUROSCI, V61, P279, DOI 10.1007/s12031-017-0883-3; Lim T.C., 2019, TRANSL STROKE RES; Liu WJ, 2014, BRAIN RES, V1573, P17, DOI 10.1016/j.brainres.2014.05.022; Loftspring MC, 2009, J CEREBR BLOOD F MET, V29, P137, DOI 10.1038/jcbfm.2008.114; Ma Qiu-Lan, 2012, Cell Logist, V2, P117; Madangarli N, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9110316; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Mracsko E, 2014, STROKE, V45, P2107, DOI 10.1161/STROKEAHA.114.005801; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Pillai DR, 2013, J CEREBR BLOOD F MET, V33, P557, DOI 10.1038/jcbfm.2012.201; Rincon F, 2013, NEUROCRIT CARE, V19, P95, DOI 10.1007/s12028-012-9793-y; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Rowell JP, 2012, STRUCTURE, V20, P2014, DOI 10.1016/j.str.2012.09.004; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Schittenhelm L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01866; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Stromblad S, 1996, CHEM BIOL, V3, P881, DOI 10.1016/S1074-5521(96)90176-3; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; Sukumari-Ramesh S, 2016, J MOL NEUROSCI, V58, P525, DOI 10.1007/s12031-016-0722-y; Sukumari-Ramesh S, 2016, TRANSL STROKE RES, V7, P141, DOI 10.1007/s12975-015-0421-y; Sukumari-Ramesh S, 2012, J NEUROTRAUM, V29, P2798, DOI 10.1089/neu.2011.2243; Sukumari-Ramesh S, 2012, TRANSL STROKE RES, V3, pS80, DOI 10.1007/s12975-012-0165-x; Sukumari-Ramesh S, 2011, J NEUROSURG, V114, P1681, DOI 10.3171/2010.12.JNS10588; Sukumari-Ramesh S, 2010, GLIA, V58, P1858, DOI 10.1002/glia.21055; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang GQ, 2019, NEUROSCIENCE, V415, P135, DOI 10.1016/j.neuroscience.2019.06.038; Wang J, 2017, CELL MOL NEUROBIOL, V37, P251, DOI 10.1007/s10571-016-0365-0; Westlin WF, 2001, CANCER J, V7, pS139; Xue Mengzhou, 2003, J Stroke Cerebrovasc Dis, V12, P152, DOI 10.1016/S1052-3057(03)00036-3; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Yamada M, 1997, PROG NEUROBIOL, V51, P19, DOI 10.1016/S0301-0082(96)00046-9; Yang Z, 2014, INT IMMUNOPHARMACOL, V22, P522, DOI 10.1016/j.intimp.2014.06.037; Zhao YY, 2017, CELL TRANSPLANT, V26, P395, DOI 10.3727/096368916X694364; Zuo SL, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6138424	57	3	3	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	AUG	2020	70	8					1186	1197		10.1007/s12031-020-01526-7			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MJ2FR	WOS:000547908400004	32170712	Green Published, Green Accepted, hybrid			2022-02-06	
J	Gomez, A; Dian, J; Froese, L; Zeiler, FA				Gomez, Alwyn; Dian, Joshua; Froese, Logan; Zeiler, Frederick Adam			Near-Infrared Cerebrovascular Reactivity for Monitoring Cerebral Autoregulation and Predicting Outcomes in Moderate to Severe Traumatic Brain Injury: Proposal for a Pilot Observational Study	JMIR RESEARCH PROTOCOLS			English	Article						autoregulation; cerebrovascular reactivity; near-infrared spectroscopy; non-invasive; neurology; brain injury; trauma; protocol; outcome; invasive	PRESSURE REACTIVITY	Background: Impaired cerebrovascular reactivity after traumatic brain injury (TBI) in adults is emerging as an important prognostic factor, with strong independent association with 6-month outcomes. To date, it is unknown if impaired cerebrovascular reactivity during the acute phase is associated with ongoing impaired continuously measured cerebrovascular reactivity in the long-term, and if such measures are associated with clinical phenotype at those points in time. Objective: We describe a prospective pilot study to assess the use of near-infrared spectroscopy (NIRS) to derive continuous measures of cerebrovascular reactivity during the acute and long-term phases of TBI in adults. Methods: Over 2 years, we will recruit up to 80 adults with moderate/severe TBI admitted to the intensive care unit (ICU) with invasive intracranial pressure (ICP) monitoring. These patients will undergo high-frequency data capture of ICP, arterial blood pressure (ABP), and NIRS for the first 5 days of care. Patients will then have 30 minutes of noninvasive NIRS and ABP monitoring in the clinic at 3, 6, and 12 months post-injury. Outcomes will be assessed via the Glasgow Outcome Scale and Short Form-12 questionnaires. Various relationships between NIRS and ICP-derived cerebrovascular reactivity metrics and associated outcomes will be assessed using biomedical signal processing techniques and both multivariate and time-series statistical methodologies. Results: Study recruitment began at the end of February 2020, with data collection ongoing and three patients enrolled at the time of writing. The expected duration of data collection will be from February 2020 to January 2022, as per our local research ethics board approval (B2018:103). Support for this work has been obtained through the National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS) (R03NS114335), funded in January 2020. Conclusions: With the application of NIRS technology for monitoring of patients with TBI, we expect to be able to outline core relationships between noninvasively measured aspects of cerebral physiology and invasive measures, as well as patient outcomes. Documenting these relationships carries the potential to revolutionize the way we monitor patients with TBI, moving to more noninvasive techniques.	[Gomez, Alwyn; Dian, Joshua; Zeiler, Frederick Adam] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Froese, Logan; Zeiler, Frederick Adam] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Zeiler, Frederick Adam] Univ Manitoba, Rady Fac Hlth Sci, Dept Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick Adam] Univ Mantioba, Ctr Aging, Winnipeg, MB, Canada; [Zeiler, Frederick Adam] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge, England		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Hlth Sci Ctr GF231, Sect Neurosurg,Dept Surg, 820 Sherbrook St, Winnipeg, MB R3A1R9, Canada.	frederick.zeiler@umanitoba.ca		Gomez, Alwyn/0000-0002-3737-2065; Zeiler, Frederick/0000-0003-1737-0510; Froese, Logan/0000-0002-6076-0189	National Institute of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS114335]; Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment Fund; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; University of Manitoba Centre on Aging Fellowship; Health Sciences Centre Foundation (HSCF) Winnipeg; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); University of Manitoba Department of Surgery GFT Research Grant; University of Manitoba Office of Research Services (ORS) University Research Grant Program (URGP); University of Manitoba Clinician Investigator Program	The research reported in this publication was supported by the National Institute of Neurological Disorders And Stroke of the National Institutes of Health under Award Number R03NS114335. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; FAZ's research program is also supported by the Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment Fund, the University of Manitoba VPRI Research Investment Fund (RIF), University of Manitoba Rudy Falk Clinician-Scientist Professorship, the University of Manitoba Centre on Aging Fellowship, the Health Sciences Centre Foundation (HSCF) Winnipeg, and the Canadian Institutes of Health Research (CIHR).; LF is supported through the University of Manitoba Department of Surgery GFT Research Grant, and the University of Manitoba Office of Research Services (ORS) University Research Grant Program (URGP).; AG is supported through the University of Manitoba Clinician Investigator Program.	Cabella B, 2017, NEUROCRIT CARE, V27, P103, DOI 10.1007/s12028-016-0319-x; Cardona G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-3; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chatfield C., 2016, ANAL TIME SERIES INT; Crawley M.J., 2012, R BOOK; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Douc R., 2014, NONLINEAR TIME SERIE, V1st edn; Faraway J. J, 2005, EXTENDING LINEAR MOD; Finapres MS, 2020, N FINAPRES NOVA NANO; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; Gelman A., 2013, BAYESIAN DATA ANAL, DOI DOI 10.1201/B16018; Gomez A, 2021, J CLIN MONIT COMPUT, V35, P307, DOI 10.1007/s10877-020-00472-4; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Pandey M., 2015, BIOSTATISTICS BASIC; Smieleweski P, INTENSIVE CARE MONIT; Zeiler FA, 2018, J NEUROTRAUM, V35, P1559, DOI 10.1089/neu.2017.5596; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	20	3	3	1	1	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	AUG	2020	9	8							e18740	10.2196/18740			8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	NN3XP	WOS:000568724400049	32415822	gold, Green Published			2022-02-06	
J	Green-Hopkins, I; Monuteaux, MC; Lee, LK; Nigrovic, LE; Mannix, R; Schutzman, SA				Green-Hopkins, Israel; Monuteaux, Michael C.; Lee, Lois K.; Nigrovic, Lise E.; Mannix, Rebekah; Schutzman, Sara A.			Use of Ondansetron for Vomiting After Head Trauma Does It Mask Clinically Significant Traumatic Brain Injury?	PEDIATRIC EMERGENCY CARE			English	Article						head trauma; ondansetron; return visits; pediatric trauma	CHILDREN; MANAGEMENT	Objectives: We describe ondansetron use in children with head injury evaluated in pediatric emergency departments and its association with return visits and late diagnoses of intracranial injuries requiring intervention. Methods: Children ages 6 months to 18 years discharged without neuro-imaging from 35 pediatric emergency departments with a diagnosis of head injury from 2009 to 2013 were identified retrospectively from the Pediatric Health Information System. We evaluated the rates of ondansetron use during the study period and of the association of ondansetron treatment with the diagnosis of intracranial injury, skull fracture, and return visits within 72 hours requiring admission or operative intervention. Results: We identified 218,904 encounters during the study period. Of these, 5894 patients (2.8%) were given ondansetron. There was significant variation in the use of ondansetron during the index visit between hospitals (0.1%-5.7%), and ondansetron use significantly increased over the study period. Return visits within 72 hours were more likely for patients treated with ondansetron during the index visit (3.7% vs 1.9%; adjusted odds ratio, 1.99; 95% confidence interval, 1.7-2.4). These patients were more likely to be admitted than those not treated initially with ondansetron (7% vs 4%; adjusted odds ratio, 1.97; 95% confidence interval, 1.09-3.55). There were no significant differences in rates of skull fractures, intracranial injury, intensive care unit admission, or operative intervention between groups. Conclusions: Ondansetron use during an initial emergency department visit for head trauma in children not requiring neuroimaging is associated with a higher likelihood of return within 72 hours and subsequent admission. There were no differences in rates of missed skull fractures, intracranial injury, intensive care admission, or operative intervention for groups who were and were not treated with ondansetron; however, this study was underpowered to detect significant differences in these categories. Future investigations with greater numbers would be required to confidently assess these critical differences.	[Green-Hopkins, Israel] UCSF Benioff Childrens Hosp, Div Pediat Emergency Med, 550 16th St,5153,Box 0632, San Francisco, CA 94143 USA; [Monuteaux, Michael C.; Lee, Lois K.; Nigrovic, Lise E.; Mannix, Rebekah; Schutzman, Sara A.] Harvard Med Sch, Boston Childrens Hosp, Dept Emergency Med, Div Emergency Med, Boston, MA 02115 USA		Green-Hopkins, I (corresponding author), UCSF Benioff Childrens Hosp, Div Pediat Emergency Med, 550 16th St,5153,Box 0632, San Francisco, CA 94143 USA.	Israel.geen-hopkins@ucsf.edu	Monuteaux, Michael C/O-5032-2018				Carter B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000622; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Farrell C., 2013, MANAGEMENT PAEDIAT P; Feudtner C, 2002, PEDIATRICS, V109, P887, DOI 10.1542/peds.109.5.887; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Natale JE, 2012, ARCH PEDIAT ADOL MED, V166, P732, DOI 10.1001/archpediatrics.2012.307; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Sturm JJ, 2013, AM J EMERG MED, V31, P166, DOI 10.1016/j.ajem.2012.07.002; Svenson JE, 2001, AM J EMERG MED, V19, P19, DOI 10.1053/ajem.2001.18041	10	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	AUG	2020	36	8					E433	E437					5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	MZ8NJ	WOS:000559381400002	29040247				2022-02-06	
J	Hackman, H; Howland, J; Taylor, A; Brown, L; Gapinski, MA; Olshaker, J; Stern, RA				Hackman, Holly; Howland, Jonathan; Taylor, Alyssa; Brown, Linda; Gapinski, Mary Ann; Olshaker, Jonathan; Stern, Robert A.			Application of Components of the Massachusetts' Sports Concussion Regulations to All Students With Concussion: A Survey of School Nurses	JOURNAL OF SCHOOL NURSING			English	Article						traumatic brain injury; concussion; school nursing; policy; return-to-learn	TRAUMATIC BRAIN-INJURY; CHILDREN; VISITS; IMPACT; LAW	Appropriate management by schools of all students with a concussion, regardless of the cause, has not received the same attention as sports-related concussions. Focus groups conducted with Massachusetts School Nurses in 2015 found that some had applied protocols required in the state's sports concussion regulations to all students with concussion, not just student athletes. We surveyed high school nurses in Massachusetts to examine (1) the extent of this practice and (2) the extent to which protocols for all students with concussion are included in school policies. Of 168 (74%) responding, 94% applied the return-to-learn and play, and medical clearance requirements to all students with concussion, regardless of how or where the concussion occurred and 77% reported their school's policy required these protocols for all students with concussion. A significant association (odds ratio: 13.3, 95% confidence interval [2.4, 72.8],p<.01) existed between the two measures. These findings have important clinical and academic implications.	[Hackman, Holly; Howland, Jonathan; Olshaker, Jonathan] Boston Univ, Sch Med, Dept Emergency Med, Boston, MA 02118 USA; [Hackman, Holly; Howland, Jonathan; Taylor, Alyssa; Olshaker, Jonathan] Boston Med Ctr, Injury Prevent Ctr, Boston, MA 02118 USA; [Brown, Linda; Gapinski, Mary Ann] Massachusetts Dept Publ Hlth, Boston, MA USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol Neurosurg & Anat & Neurobiol, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Alzheimers Dis & Chron Traumat Encephalopathy Ctr, Boston, MA 02215 USA		Hackman, H (corresponding author), Boston Med Ctr, Dept Emergency Med, BCD Bldg Room 2013, Boston, MA 02118 USA.	holly.hackman@bmc.org	, Bob/ABA-8507-2020	Hackman, Holly/0000-0001-5021-3790			Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Centers for Disease Control and Prevention, WHAT IS CONC; Centers for Disease Control and Prevention, IMPL RET PLAY LEARN; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Flaherty MR, 2016, J PEDIATR-US, V178, P268, DOI 10.1016/j.jpeds.2016.08.025; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Howland J, 2018, J SCH NURS, V34, P344, DOI 10.1177/1059840517702697; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrory P., 2017, BRIT J SPORTS MED; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson LL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2151	18	3	3	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1059-8405	1546-8364		J SCH NURS	J. Sch. Nurs.	AUG	2020	36	4					265	271		10.1177/1059840518818709			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	MK2FA	WOS:000548600100006	30563410				2022-02-06	
J	Lust, CAC; Mountjoy, M; Robinson, LE; Oliver, JM; Ma, DWL				Lust, Cody A. C.; Mountjoy, Margo; Robinson, Lindsay E.; Oliver, Jonathan M.; Ma, David W. L.			Sports-related concussions and subconcussive impacts in athletes: incidence, diagnosis, and the emerging role of EPA and DHA	APPLIED PHYSIOLOGY NUTRITION AND METABOLISM			English	Article						n-3 fatty acids; nutrition; brain; sports; athletes; concussion; subconcussive	DOCOSAHEXAENOIC ACID DHA; COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; HEAD IMPACTS; FATTY-ACIDS; DIETARY SUPPLEMENTATION; CEREBROSPINAL-FLUID; WHITE-MATTER; EPIDEMIOLOGY; INFLAMMATION	Sports-related concussions (SRC) are traumatic brain injuries induced as the result of a biomechanical force to the body that temporarily impair neurological functions. Not all traumatic impacts reach the threshold necessary to produce concussive symptoms; however, the culmination of these events is known as a subconcussive impact (SCI). Athletes who have been diagnosed with a SRC or those who accumulate multiple SCI have exhibited structural damage to the brain, impairments to learning and memory, and an increase in depressive symptoms. This area is rapidly evolving, and current clinical definitions of injury, diagnosis, and treatment of SRC and SCI are reviewed. In tandem, there is also growing research examining the role of nutrition in brain injuries, focusing primarily on n-3 polyunsaturated fatty acids (PUFA). The potential role of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in reducing inflammation and promoting recovery following brain injury are also reviewed. Overall, advancements in the evaluation of SRC and SCI coupled with n-3 PUFA supplementation show promise in the management of brain injuries, leading to better long-term health outcomes for athletes. Novelty SRC have garnered widespread attention due to the growing body of reported prevalence in youth and professional sports. Current definitions and protocol(s) for diagnosing SRC and SCI have improved, but still require further evaluation. n-3, EPA and DHA, reduce inflammation and promote recovery following brain injuries in experimental models.	[Lust, Cody A. C.; Mountjoy, Margo; Robinson, Lindsay E.; Ma, David W. L.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Oliver, Jonathan M.] US Mil Acad, Athlet, West Point, NY 10996 USA		Ma, DWL (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	davidma@uoguelph.ca			Natural Sciences and Research Council of Canada Discovery Grant	Funding for this research was provided by the Natural Sciences and Research Council of Canada Discovery Grant to DWLM. A Heinz graduate scholarship was also provided to CL.	ADAMS R, 2018, CUREUS, V10, DOI DOI 10.7759/CUREUS; Allaire J, 2016, AM J CLIN NUTR, V104, P280, DOI 10.3945/ajcn.116.131896; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Anzalone A, 2019, J ATHL TRAINING, V54, P7, DOI 10.4085/1062-6050-387-18; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Bisicchia E, 2018, MOL NEUROBIOL, V55, P6894, DOI 10.1007/s12035-018-0889-z; Bradbury J, 2011, NUTRIENTS, V3, P529, DOI 10.3390/nu3050529; Brokaw EB, 2018, TECHNOL HEALTH CARE, V26, P109, DOI 10.3233/THC-171079; Broughton KS, 2002, J NUTR, V132, P88, DOI 10.1093/jn/132.1.88; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Chen CT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15791; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Desai AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085237; Devassy JG, 2016, ADV NUTR, V7, P905, DOI 10.3945/an.116.012187; Deyama S, 2018, PSYCHOPHARMACOLOGY, V235, P329, DOI 10.1007/s00213-017-4774-7; Dierijck JK, 2018, INT J PSYCHOPHYSIOL, V132, P74, DOI 10.1016/j.ijpsycho.2018.03.005; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echeverria F, 2017, PROSTAG LEUKOTR ESS, V124, P1, DOI 10.1016/j.plefa.2017.08.001; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Elmadfa I, 2009, ANN NUTR METAB, V55, P56, DOI 10.1159/000228996; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Guo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05446-2; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Heikkinen A, 2011, INT J SPORT NUTR EXE, V21, P271, DOI 10.1123/ijsnem.21.4.271; Hill K., 2014, AM J EMERG MED, V51, P618, DOI [10.1016/j.jemermed.2016.09.041., DOI 10.1016/J.JEMERMED.2016.09.041]; Hussein N, 2005, J LIPID RES, V46, P269, DOI 10.1194/jlr.M400225-JLR200; Innis SM, 2007, EARLY HUM DEV, V83, P761, DOI 10.1016/j.earlhumdev.2007.09.004; JENNETT B, 1975, LANCET, V1, P480; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kamolrat T, 2013, BIOCHEM BIOPH RES CO, V432, P593, DOI 10.1016/j.bbrc.2013.02.041; Kawata K, 2018, J NEUROTRAUM, V35, P260, DOI 10.1089/neu.2017.5376; Kawata K, 2018, HAND CLINIC, V158, P217, DOI 10.1016/B978-0-444-63954-7.00022-7; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kim HY, 2014, MIL MED, V179, P106, DOI 10.7205/MILMED-D-14-00162; Kitson AP, 2016, J NUTR BIOCHEM, V33, P91, DOI 10.1016/j.jnutbio.2016.02.009; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lacombe RJS, 2018, MOL ASPECTS MED, V64, P109, DOI 10.1016/j.mam.2017.12.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Langlois K, 2015, HEALTH REP, V26, P3; Lauritzen L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010006; Lo Van A, 2016, BIOCHIMIE, V130, P163, DOI 10.1016/j.biochi.2016.07.011; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miyashita TL, 2020, SPORT BIOMECH, V19, P180, DOI 10.1080/14763141.2018.1458892; Neselius S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099870; NFHS (National Federation of State High School Associations), 2015, 2014 15 HIGHSCH ATHL; NFL (National Football League), 2019, INJ DAT; NFL (National Football League), 2018, NFL HEAD NECK SPIN C; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; NHLPA (National Hockey League Players Association), 2016, CONC EV MAN PROT; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Public Health Agency of Canada, 2019, CONC SYMPT TREATM; Rey C, 2016, BRAIN BEHAV IMMUN, V55, P249, DOI 10.1016/j.bbi.2015.12.013; Richard C, 2016, ADV NUTR, V7, P1139, DOI 10.3945/an.116.012963; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Rubin LH, 2019, BRAIN INJURY, V33, P456, DOI 10.1080/02699052.2019.1565895; Russell KL, 2013, PROSTAG LEUKOTR ESS, V89, P97, DOI 10.1016/j.plefa.2013.05.004; Schuchardt JP, 2017, PROSTAG LEUKOTR ESS, V121, P76, DOI 10.1016/j.plefa.2017.06.007; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Snegireva N, 2020, PHYSICIAN SPORTSMED, V48, P165, DOI 10.1080/00913847.2019.1645577; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Weiser MJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020099; Wiktorowska-Owczarek A, 2015, ADV CLIN EXP MED, V24, P931, DOI 10.17219/acem/31243; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhu W, 2018, INFLAMMATION, V41, P1182, DOI 10.1007/s10753-018-0765-z; Zonner SW, 2019, JAMA OPHTHALMOL, V137, P265, DOI 10.1001/jamaophthalmol.2018.6193; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	87	3	3	1	8	CANADIAN SCIENCE PUBLISHING	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1715-5312	1715-5320		APPL PHYSIOL NUTR ME	Appl. Physiol. Nutr. Metab.	AUG	2020	45	8					886	892		10.1139/apnm-2019-0555			7	Nutrition & Dietetics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nutrition & Dietetics; Physiology; Sport Sciences	MY8EZ	WOS:000558650600011	32119565	hybrid			2022-02-06	
J	Oyemolade, TA; Balogun, JA; Akinkunmi, MA; Ogunyileka, OC; Arogundade, FM; Olusola, AJ				Oyemolade, Toyin Ayofe; Balogun, James Ayokunle; Akinkunmi, Mojirade Abiola; Ogunyileka, Oluwakemi Comfort; Arogundade, Folawemimo Mercy; Olusola, Ayodele Joy			The Burden of Neurosurgical Diseases in a Rural Southwestern Nigeria Setting	WORLD NEUROSURGERY			English	Article						Burden; Neurosurgery; Nigeria; Rural	GLOBAL NEUROSURGERY; EPIDEMIOLOGY; NEUROTRAUMA; PATTERN	BACKGROUND: Most of the few neurosurgeons in Nigeria are clustered in the urban centers. Consequently, a large proportion of the population who live in the rural areas have no direct access to neurosurgical care. This study aims to describe the burden of neurosurgical diseases in a rural neurosurgical service in Nigeria. METHODS: This was a prospective observational study of all neurosurgical patients managed at our center between August 2018 and July 2019. Data were analyzed with SPSS version 20 (IBM, Armonk, New York, USA). RESULTS: The study cohort comprised 379 patients, including 267 males and 112 females (male:female ratio 2.4:1). The mean age was 35.71 +/- 20.08 years (range, 35 hours to 100 years). More than one-half of the patients (55.6%) were age 20-49 years. Head injury was the most common presentation, occurring alone in 256 patients (67.55%) and in combination with spinal cord injury in 30 patients (7.92%). Brain tumors were present in 19 patients (5.01%), spinal cord injury in 15 patients (3.96%), degenerative spine disease in 9 patients (2.38%), and hydrocephalus in 5 patients (1.32%). Surgical intervention was performed in 21 patients (5.54%). The outcome of treatment was good in 251 patients (66.22%); 34 patients (8.97%) were referred to other facilities, 43 patients (11.35%) were discharged against medical advice, mostly because of economic reasons and poor medical insight, and 31 patients (8.18%) died. CONCLUSIONS: Trauma is the most common indication for neurosurgical care in our service. Poverty and poor medical insight remain formidable obstacles to maximizing the benefits of available neurosurgical care in developing countries.	[Oyemolade, Toyin Ayofe; Akinkunmi, Mojirade Abiola; Ogunyileka, Oluwakemi Comfort; Arogundade, Folawemimo Mercy; Olusola, Ayodele Joy] Fed Med Ctr, Dept Surg, Div Neurosurg, Owo, Nigeria; [Balogun, James Ayokunle] Univ Ibadan, Coll Med, Div Neurosurg, Dept Surg, Ibadan, Nigeria; [Balogun, James Ayokunle] Univ Coll Hosp, Dept Neurol Surg, Ibadan, Nigeria		Oyemolade, TA (corresponding author), Fed Med Ctr, Dept Surg, Div Neurosurg, Owo, Nigeria.	toyinmolade@yahoo.com		Oyemolade, Toyin/0000-0002-0545-527X; Balogun, James/0000-0002-0737-5265			Adeleye Amos Olufemi, 2009, Congenital Anomalies, V49, P258, DOI 10.1111/j.1741-4520.2009.00241.x; ADEM A, 2001, E CENTRAL AFRICAN J, V6, P31; Adeolu AA, 2004, INTERNET J EPIDEMIOL, V2; Adeolu AA, 2013, WORLD NEUROSURG, V80, P251, DOI 10.1016/j.wneu.2012.11.063; Agius S, 2012, BRIT J NEUROSURG, V26, P212, DOI 10.3109/02688697.2011.609920; Agrawal Deepak, 2012, J Emerg Trauma Shock, V5, P7, DOI 10.4103/0974-2700.93099; Andrews RJ, 2016, WORLD NEUROSURG, V85, P22, DOI 10.1016/j.wneu.2015.08.002; Beavogi K, 2011, Zh Vopr Neirokhir Im N N Burdenko, V75, P38; Bishop CV, 2006, ANZ J SURG, V76, P53, DOI 10.1111/j.1445-2197.2006.03642.x; Central Intelligence Agency, WORLD FACTBOOK; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Emejulu J K C, 2008, Afr J Med Med Sci, V37, P383; Emejulu JK, 2009, AJNS, V28; Idowu OE, 2008, ACTA NEUROCHIR, V150, P911, DOI 10.1007/s00701-008-0002-x; Kemp A, 1997, J ACCID EMERG MED, V14, P316; Kumar R, 2018, WORLD NEUROSURG, V113, pE345, DOI 10.1016/j.wneu.2018.02.033; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Park KB, 2016, WORLD NEUROSURG, V88, P32, DOI 10.1016/j.wneu.2015.12.048; Rabiu TB, 2016, J NEUROSCI RURAL PRA, V7, P485, DOI 10.4103/0976-3147.188624; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS8, DOI 10.1016/S2214-109X(14)70384-5; Warf BC, 2015, WORLD NEUROSURG, V84, P1547, DOI 10.1016/j.wneu.2015.07.052; Winkler AS, 2010, WORLD NEUROSURG, V73, P264, DOI 10.1016/j.wneu.2010.03.037	22	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2020	140						E148	E152		10.1016/j.wneu.2020.04.205			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NA8FH	WOS:000560052700020	32387403				2022-02-06	
J	Pagulayan, KF; Petrie, EC; Cook, DG; Hendrickson, RC; Rau, H; Reilly, M; Mayer, C; Meabon, JS; Raskind, MA; Peskind, ER; Kleinhans, N				Pagulayan, Kathleen F.; Petrie, Eric C.; Cook, David G.; Hendrickson, Rebecca C.; Rau, Holly; Reilly, Melissa; Mayer, Cindy; Meabon, James S.; Raskind, Murray A.; Peskind, Elaine R.; Kleinhans, Natalia			Effect of blast-related mTBI on the working memory system: a resting state fMRI study	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic brain injury; Resting state fMRI; Working memory; Auditory consonant trigrams test; Veterans; Blast injury; Neuropsychology	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE REHABILITATION; FUNCTIONAL CONNECTIVITY; MULTIPLE-SCLEROSIS; EXECUTIVE FUNCTION; ACTIVATION; CONCUSSION; VETERANS; DEFICITS	Reduced working memory is frequently reported by Veterans with a history of blast-related mild traumatic brain injury (mTBI), but can be difficult to quantify on neuropsychological measures. This study aimed to improve our understanding of the impact of blast-related mTBI on the working memory system by using resting state functional magnetic resonance imaging (fMRI) to explore differences in functional connectivity between OEF/OIF/OND Veterans with and without a history of mTBI. Participants were twenty-four Veterans with a history of blast-related mTBI and 17 Veterans who were deployed but had no lifetime history of TBI. Working memory ability was evaluated with the Auditory Consonants Trigrams (ACT) task. Resting state fMRI was used to evaluate intrinsic functional connectivity from frontal seed regions that are known components of the working memory network. No significant group differences were found on the ACT, but the imaging analyses revealed widespread hyper-connectivity from the frontal seed regions in the Veterans with a history of mTBI relative to the deployed control group. Further, within the mTBI group, but not the control group, better performance on the ACT was associated with increased functional connectivity to multiple brain regions, including cerebellar components of the working memory network. These results were present after controlling for age, PTSD symptoms, and estimated premorbid IQ, and suggest that long-term alterations in the functional connectivity of the working memory network following blast-related mTBI may reflect a compensatory change that contributes to intact performance on an objective measure of working memory.	[Pagulayan, Kathleen F.; Petrie, Eric C.; Hendrickson, Rebecca C.; Rau, Holly; Mayer, Cindy; Meabon, James S.; Raskind, Murray A.; Peskind, Elaine R.] VA Puget Sound Hlth Care Syst, VA Northwest Network Mental Illness Res Educ & Cl, 1660 S Columbian Way,S-116 MIRECC, Seattle, WA 98108 USA; [Pagulayan, Kathleen F.; Petrie, Eric C.; Meabon, James S.; Raskind, Murray A.; Peskind, Elaine R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Cook, David G.] VA Puget Sound Hlth Care Syst, Seattle Div, Geriatr Res Educ & Clin Ctr GRECC, Seattle, WA USA; [Reilly, Melissa; Kleinhans, Natalia] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA		Pagulayan, KF (corresponding author), VA Puget Sound Hlth Care Syst, VA Northwest Network Mental Illness Res Educ & Cl, 1660 S Columbian Way,S-116 MIRECC, Seattle, WA 98108 USA.; Pagulayan, KF (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	kathleen.pagulayan@va.gov	Hendrickson, Rebecca/I-4923-2017; Pagulayan, Kati/AAR-9225-2020	Hendrickson, Rebecca/0000-0003-2377-823X; Petrie, Eric/0000-0003-1188-6321	United States (U.S.) Department of Veterans Affairs Clinical Science Research and Development Service [IK2CX000516]; U.S. Department of Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [I01 RX000521]; U.S. Department of Veterans Affairs Medical Research ServiceUS Department of Veterans Affairs; VA Northwest NetworkMIRECC; University ofWashington Royalty Research Fund; Veterans AffairsUS Department of Veterans Affairs [I01RX001612, IK2CX000516] Funding Source: NIH RePORTER	This work was supported by Career Development Award #IK2CX000516 from the United States (U.S.) Department of Veterans Affairs Clinical Science Research and Development Service, Merit Review #I01 RX000521 from the U.S. Department of Veterans Affairs Rehabilitation Research and Development Service, the U.S. Department of Veterans Affairs Medical Research Service, as well as VA Northwest NetworkMIRECC and University ofWashington Royalty Research Fund.	Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Bonavita S, 2015, J NEUROL, V262, P91, DOI 10.1007/s00415-014-7528-z; Cerasa A, 2013, NEUROREHAB NEURAL RE, V27, P284, DOI 10.1177/1545968312465194; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen SHA, 2005, NEUROPSYCHOLOGIA, V43, P1227, DOI 10.1016/j.neuropsychologia.2004.12.015; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; De Giglio L, 2016, RADIOLOGY, V280, P202, DOI 10.1148/radiol.2016150710; Desmond JE, 1997, J NEUROSCI, V17, P9675; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Freeman M., 2014, J INT NEUROPSYCHOL S, V5, P1; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gathercole SE, 2008, LEARN INDIVID DIFFER, V18, P214, DOI 10.1016/j.lindif.2007.10.003; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Gorges M, 2015, NEUROBIOL AGING, V36, P1727, DOI 10.1016/j.neurobiolaging.2014.12.026; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Jao T, 2015, NEUROIMAGE, V122, P332, DOI 10.1016/j.neuroimage.2015.07.068; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Kirschen MP, 2005, NEUROIMAGE, V24, P462, DOI 10.1016/j.neuroimage.2004.08.036; Koso M, 2006, EUR PSYCHIAT, V21, P167, DOI 10.1016/j.eurpsy.2005.06.004; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Lemieux L, 2007, MAGN RESON IMAGING, V25, P894, DOI 10.1016/j.mri.2007.03.009; Louapre C, 2014, HUM BRAIN MAPP, V35, P4706, DOI 10.1002/hbm.22505; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Sacco R, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/857807; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Sastre-Garriga J, 2011, MULT SCLER J, V17, P457, DOI 10.1177/1352458510389219; Selnes OA, 2002, JAIDS-J ACQ IMM DEF, V31, pS132, DOI 10.1097/00126334-200212153-00009; Shaw ME, 2009, PSYCHIAT RES-NEUROIM, V172, P235, DOI 10.1016/j.pscychresns.2008.07.014; Shura RD, 2016, ARCH CLIN NEUROPSYCH, V31, P47, DOI 10.1093/arclin/acv083; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thames AD, 2011, J CLIN EXP NEUROPSYC, V33, P200, DOI 10.1080/13803395.2010.499357; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Weathers F., 1993, 9 ANN C ISTSS SAN AN; Weathers F. W., 1991, PCL M DSM IV; WechslerD, 2001, WECHSLER TEST ADULT; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	72	3	3	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	AUG	2020	14	4					949	960		10.1007/s11682-018-9987-9			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP2PQ	WOS:000552051500001	30519997				2022-02-06	
J	Russo, R; Kemp, M; Bhatti, UF; Pai, M; Wakam, G; Biesterveld, B; Alam, HB				Russo, Rachel; Kemp, Michael; Bhatti, Umar F.; Pai, Manjunath; Wakam, Glenn; Biesterveld, Ben; Alam, Hasan B.			Life on the battlefield: Valproic acid for combat applications	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	4th Annual Meeting of Cellular Therapies and Transfusion Medicine in Trauma and Critical Care	DEC 11-12, 2019	San Diego, CA			Valproic acid; hemorrhagic shock; traumatic brain injury; prolonged resuscitation; prosurvival strategies		The leading causes of death in military conflicts continue to be hemorrhagic shock (HS) and traumatic brain injury (TBI). Most of the mortality is a result of patients not surviving long enough to obtain surgical care. As a result, there is a significant unmet need for a therapy that stimulates a "prosurvival phenotype" that counteracts the cellular pathophysiology of HS and TBI to prolong survival. Valproic acid (VPA), a well-established antiepileptic therapy for more than 50 years, has shown potential as one such prosurvival therapy. This review details how VPA's role as a nonselective histone deacetylase inhibitor induces cellular changes that promote survival and decrease cellular pathways that lead to cell death. The review comprehensively covers more than two decades worth of studies ranging from preclinical (mice, swine) to recent human clinical trials of the use of VPA in HS and TBI. Furthermore, it details the different mechanisms in which VPA alters gene expression, induces cytoprotective changes, attenuates platelet dysfunction, provides neuroprotection, and enhances survival in HS and TBI. Valproic acid shows real promise as a therapy that can induce the prosurvival phenotype in those injured during military conflict.	[Russo, Rachel; Kemp, Michael; Bhatti, Umar F.; Wakam, Glenn; Biesterveld, Ben; Alam, Hasan B.] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI USA; [Russo, Rachel] US Air Force, David Grant Med Ctr, Med Corps, Travis AFB, CA USA; [Pai, Manjunath] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Hlth Syst, Dept Surg, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Biesterveld, Ben/AAM-1087-2021		U.S. Department of DefenseUnited States Department of Defense; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	For all authors, no conflicts are declared. H.B.A. has received numerous federal research grants from the National Institutes of Health, Office of Naval Research, Defense Advanced Research Projects Agency, and the U.S. Army Medical Research and Materiel Command to study the effects of VPA in combat injuries. The research included in this review was supported by numerous grants from the U.S. Department of Defense and the National Institutes of Health.	Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Alam HB, 2002, RESUSCITATION, V54, P195, DOI 10.1016/S0300-9572(02)00095-3; [Anonymous], 2011, CURR PROB SURG, V48, P531, DOI 10.1067/j.cpsurg.2011.04.002; Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; Bhatti UF, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000321; Bhatti UF, 2019, PROTEOM CLIN APPL, V13, DOI 10.1002/prca.201900068; Biesterveld B, 2019, J TRAUMA ACUTE CARE, V87, P1133, DOI 10.1097/TA.0000000000002460; Butt MU, 2009, J SURG RES, V156, P290, DOI 10.1016/j.jss.2009.04.012; Causey MW, 2013, J SURG RES, V184, P533, DOI 10.1016/j.jss.2013.03.087; Causey MW, 2012, J VASC SURG, V55, P1096, DOI 10.1016/j.jvs.2011.08.060; Chang PP, 2019, J AM COLL SURGEONS, V228, P265, DOI 10.1016/j.jamcollsurg.2018.12.026; Chang PP, 2018, J TRAUMA ACUTE CARE, V84, P795, DOI 10.1097/TA.0000000000001824; Chen HZ, 2006, J TRAUMA, V60, P701, DOI 10.1097/01.ta.0000203699.91475.f6; Connolly S, 2013, BRAIN INJURY, V27, P754, DOI 10.3109/02699052.2013.775503; CORNFORD EM, 1985, J NEUROCHEM, V44, P1541, DOI 10.1111/j.1471-4159.1985.tb08793.x; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; Darvishi M, 2014, NEUROCHEM RES, V39, P2319, DOI 10.1007/s11064-014-1429-5; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Dekker SE, 2018, J NEUROSCI RES, V96, P711, DOI 10.1002/jnr.24125; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Dekker SE, 2014, J SURG RES, V190, P312, DOI 10.1016/j.jss.2014.02.049; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Fukudome EY, 2012, SURGERY, V152, P254, DOI 10.1016/j.surg.2012.03.013; Georgoff PE, 2018, CLIN PHARMACOKINET, V57, P209, DOI 10.1007/s40262-017-0553-1; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Hamdeh S., 2018, SCI REP-UK, V8, P1; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Heers H, 2018, EUR J PHARMACOL, V835, P61, DOI 10.1016/j.ejphar.2018.07.057; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Li YQ, 2008, SURGERY, V144, P217, DOI 10.1016/j.surg.2008.03.037; Li YQ, 2015, J TRAUMA ACUTE CARE, V78, P378, DOI 10.1097/TA.0000000000000510; Li YQ, 2012, ADV EXP MED BIOL, V710, P107, DOI 10.1007/978-1-4419-5638-5_11; Li YQ, 2010, J SURG RES, V159, P474, DOI 10.1016/j.jss.2009.04.011; Limdi NA, 2007, EPILEPSIA, V48, P478, DOI 10.1111/j.1528-1167.2007.00989.x; Lin T, 2006, SURGERY, V139, P365, DOI 10.1016/j.surg.2005.08.022; Lin T, 2007, SURGERY, V141, P784, DOI 10.1016/j.surg.2007.01.014; Liu ZC, 2014, SHOCK, V41, P104, DOI 10.1097/SHK.0000000000000074; Luo HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077523; Mateen BA, 2017, J NEUROTRAUM, V34, P2379, DOI 10.1089/neu.2017.5007; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nikolian VC, 2016, J AM COLL SURGEONS, V223, pS82, DOI 10.1016/j.jamcollsurg.2016.06.158; Peterson GM, 2005, J CLIN PHARM THER, V30, P417, DOI 10.1111/j.1365-2710.2005.00671.x; Raja M, 2002, INT J PSYCHIAT CLIN, V6, P173, DOI 10.1080/136515002760276117; Sailhamer EA, 2008, SURGERY, V144, P204, DOI 10.1016/j.surg.2008.03.034; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Shults C, 2008, J TRAUMA, V64, P629, DOI 10.1097/TA.0b013e3181650ff3; Sillesen M, 2016, J TRAUMA ACUTE CARE, V80, P26, DOI 10.1097/TA.0000000000000896; Singh AK, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060731; Smith KT, 2009, NAT BIOTECHNOL, V27, P917, DOI 10.1038/nbt1009-917; Tai YT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/980657; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Tian S, 2019, EBIOMEDICINE, V39, P83, DOI 10.1016/j.ebiom.2018.12.003; Ye JS, 2016, TRANSPLANTATION, V100, P2342, DOI 10.1097/TP.0000000000001197; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Zhuo CJ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01262	63	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2020	89	2S		2			S69	S76		10.1097/TA.0000000000002721			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	QB5BE	WOS:000614154300011	32282756				2022-02-06	
J	Salman, M; Tabassum, H; Parvez, S				Salman, Mohd.; Tabassum, Heena; Parvez, Suhel			Nrf2/HO-1 mediates the neuroprotective effects of pramipexole by attenuating oxidative damage and mitochondrial perturbation after traumatic brain injury in rats	DISEASE MODELS & MECHANISMS			English	Article						Traumatic brain injury; Oxidative damage; Mitochondrial dysfunction; Nrf2; Pramipexole; Neuroprotection	DYSFUNCTION; MELATONIN; MODEL; NEUROTOXICITY; INFLAMMATION; EXPRESSION; APOPTOSIS; STRESS; ROS	Pramipexole (PPX), a D2-like receptor agonist, is generally used in the treatment of Parkinson's disease and restless leg syndrome. Its neuroprotective effects have been shown against various neurological disorders. Recent research work has demonstrated that PPX exerts neuroprotection through mitochondria. However, the neuromodulator-related effects of PPX against traumatic brain injury (TBI) remain unexplored. The present study, therefore, investigated the mechanism of neuroprotection by PPX against oxidative stress, mitochondrial dysfunction and neuronal damage following TBI in rats. We hypothesized that the neuroprotection by PPX in TBI-subjected rats might involve activation of the Nrf2/HO-1 (also known as Nfe2l2/Hmox1) signaling pathway. PPX was injected intraperitoneally (0.25 mg/kg body weight and 1.0 mg/kg body weight) at different time intervals post-TBI. Several neurobehavioral parameters were assessed at 48 h post-TBI, and the brain was isolated for molecular and biochemical analysis. The results demonstrated that PPX treatment significantly improved the behavioral deficits, decreased the lipid peroxidation rate, increased glutathione levels and decreased 4-hydroxynonenal levels in TBI-subjected rats. PPX also increased the activities of glutathione peroxidase and superoxide dismutase enzymes. In addition, PPX treatment inhibited mitochondrial reactive oxygen species production, restored mitochondrial membrane potential and increased ATP levels after a TBI. Further, PPX treatment reduced the Bax/Bcl2 ratio and translocation of Bax to mitochondria and cytochrome-c to the cytosol. Finally, PPX treatment greatly accelerated the translocation of Nrf2 to the nucleus and upregulated HO-1 protein expression. We conclude that the neuroprotective effects of PPX are mediated by activation of the Nrf2/HO-1 signaling pathway following TBI. This article has an associated First Person interview with the first author of the paper.	[Salman, Mohd.; Parvez, Suhel] Jamia Hamdard, Sch Chem & Life Sci, Dept Med Elementol & Toxicol, New Delhi 110062, India; [Tabassum, Heena] Govt India, Minist Hlth & Family Welf, Indian Council Med Res, Div Basic Med Sci, New Delhi 110029, India		Parvez, S (corresponding author), Jamia Hamdard, Sch Chem & Life Sci, Dept Med Elementol & Toxicol, New Delhi 110062, India.	sparvez@jamiahamdard.ac.in	Salman, Mohd/AAN-8924-2021	Salman, Mohd/0000-0002-7330-8108	Indian Council of Medical ResearchIndian Council of Medical Research (ICMR) [3/1/2/4/Trauma/2019-NCD-1]; Department of Science and Technology, Ministry of Science and Technology, IndiaDepartment of Science & Technology (India) [SR/FST/LS-I/2017/05(C), SR/PURSE Phase2/39 (C)]; Department of Biotechnology, Government of IndiaDepartment of Biotechnology (DBT) India [BT/Bio-CARe/01/10219/2013-14]	This work was supported by the Indian Council of Medical Research (3/1/2/4/Trauma/2019-NCD-1 to M.S.), the Department of Science and Technology, Ministry of Science and Technology, India [SR/FST/LS-I/2017/05(C) and SR/PURSE Phase2/39 (C) to S.P.] and the Department of Biotechnology, Government of India; (BT/Bio-CARe/01/10219/2013-14 to H.T.).	Andrabi SS, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.033860; Andrabi SS, 2017, DIS MODEL MECH, V10, P787, DOI 10.1242/dmm.025692; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Barrera G, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080102; Benbir Gulcin, 2006, Neuropsychiatr Dis Treat, V2, P393, DOI 10.2147/nedt.2006.2.4.393; Boscolo A, 2013, BRIT J ANAESTH, V110, P47, DOI 10.1093/bja/aet073; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cabral-Costa JV, 2020, MOL ASPECTS MED, V71, DOI 10.1016/j.mam.2019.10.003; Caglayan B, 2019, MOL BIOL REP, V46, P241, DOI 10.1007/s11033-018-4465-4; Chaudhary S, 2012, NEUROSCIENCE, V225, P258, DOI 10.1016/j.neuroscience.2012.08.060; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chu SF, 2019, ACTA PHARMACOL SIN, V40, P13, DOI 10.1038/s41401-018-0154-z; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dobrachinski F, 2017, J NEUROTRAUM, V34, P1318, DOI 10.1089/neu.2016.4563; Fujita Y, 2006, N-S ARCH PHARMACOL, V372, P257, DOI 10.1007/s00210-005-0025-2; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Inden M, 2009, NEUROCHEM INT, V55, P760, DOI 10.1016/j.neuint.2009.07.009; Krishna G, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801055; Lamade AM, 2019, NEUROPHARMACOLOGY, V145, P209, DOI 10.1016/j.neuropharm.2018.07.014; Li FY, 2019, ANN CLIN TRANSL NEUR, V6, P1825, DOI 10.1002/acn3.50878; Li FY, 2019, J CELL BIOCHEM, V120, P14899, DOI 10.1002/jcb.28751; Li X, 2018, J CELL MOL MED, V22, P883, DOI 10.1111/jcmm.13313; Li X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164237; Ma JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep23817; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Ndisang JF, 2017, CURR PHARM DESIGN, V23, P1465, DOI 10.2174/1381612823666170113153818; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Pich EM, 2015, EUR NEUROPSYCHOPHARM, V25, P1437, DOI 10.1016/j.euroneuro.2015.07.012; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rasheed MZ, 2018, J ENVIRON PATHOL TOX, V37, P139, DOI 10.1615/JEnvironPatholToxicolOncol.2018025666; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Sadeghi H, 2017, IMMUNOPHARM IMMUNOT, V39, P80, DOI 10.1080/08923973.2017.1284230; Sanderson TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078627; Sayeed I, 2006, FASEB J, V20, P556, DOI 10.1096/fj.05-4748fje; Shin DK, 2007, BIOORG MED CHEM LETT, V17, P5686, DOI 10.1016/j.bmcl.2007.07.056; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Wang YZ, 2018, J PHARMACOL SCI, V138, P31, DOI 10.1016/j.jphs.2018.08.008; Waseem M, 2016, MITOCHONDRION, V30, P168, DOI 10.1016/j.mito.2016.08.001; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Xia DY, 2019, J CELL MOL MED, V23, P4088, DOI 10.1111/jcmm.14296; Xie YZ, 2019, CNS NEUROSCI THER, V25, P1006, DOI 10.1111/cns.13146; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang XJ, 2017, BIOL PHARM BULL, V40, P1490, DOI 10.1248/bpb.b17-00313; Zhang YL, 2018, J NEUROTRAUM, V35, P661, DOI 10.1089/neu.2017.5284; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013; Zou LL, 2000, NEUROSCI LETT, V281, P167, DOI 10.1016/S0304-3940(00)00853-3	50	3	3	3	3	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	AUG	2020	13	8							dmm045021	10.1242/dmm.045021			11	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	NL5QZ	WOS:000567471400001	32540990	Green Published, gold			2022-02-06	
J	Zhu, W; Cui, GQ; Li, T; Chen, HG; Zhu, J; Ding, YX; Zhao, L				Zhu, Wei; Cui, Guangqiang; Li, Tuo; Chen, Hongguang; Zhu, Jian; Ding, Yuexia; Zhao, Li			Docosahexaenoic Acid Protects Traumatic Brain Injury by Regulating NOX2 Generation via Nrf2 Signaling Pathway	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury; Docosahexaenoic acid; NADPH oxidase; Nuclear factor erythroid 2-related factor 2; Reactive oxygen species	OXIDATIVE-STRESS; NEUROPROTECTION; NEURONS	Docosahexaenoic acid (DHA) is verified to have neuroprotective effects on traumatic brain injury (TBI) rats by activating Nrf2 signaling pathway, but the role of NOX2 in this effect has not been illuminated. So this study explored the role of NOX2 in TBI models treated with DHA, aiming to complete the mechanism of DHA. TBI rat models were constructed with or without DHA treatment, and H2O2-induced hippocampal neurons were pretreated with DHA alone or in combination with Nrf2 inhibitor brusatol. The neurological function, cognitive ability, and cerebral edema degree of rats were assessed. The apoptosis rate and viability of cells was measured. The generation of NOX2, Nrf2, HO-1 and NQO-1 expression levels, and ROS content in hippocampal CA1 region and hippocampal neurons were detected. DHA could not only improve the neurological function, brain edema and cognitive ability in TBI rats, but also decrease effectively the contents of NOX2 and ROS in hippocampal CA1 region and hippocampal neurons. DHA promoted the nuclear transposition of Nrf2 and the expression levels of HO-1 and NQO-1 in hippocampal CA1 region and hippocampal neurons. On the contrary, Nrf2 inhibitor brusatol inhibited the nuclear transposition of Nrf2 and the expression levels of HO-1 and NQO-1 in hippocampal neurons, promoted the generation of ROS and NOX2, and accelerated cell apoptosis. Both in vivo and in vitro experiments demonstrated that DHA treated TBI by reducing NOX2 generation that might function on Nrf2 signaling pathway, providing a potential evidence for its clinical application.	[Zhu, Wei; Cui, Guangqiang; Li, Tuo; Chen, Hongguang] Qingdao Univ, Dept Neurosurg, Affiliated Yantai Yuhuangding Hosp, Yantai, Shandong, Peoples R China; [Zhu, Jian] Qingdao Univ, Dept Med Engn, Affiliated Yantai Yuhuangding Hosp, Yantai, Shandong, Peoples R China; [Ding, Yuexia; Zhao, Li] Qingdao Univ, Dept Pharm, Affiliated Yantai Yuhuangding Hosp, 20 East Yuhuangding Rd, Yantai 264000, Shandong, Peoples R China		Ding, YX (corresponding author), Qingdao Univ, Dept Pharm, Affiliated Yantai Yuhuangding Hosp, 20 East Yuhuangding Rd, Yantai 264000, Shandong, Peoples R China.	dingyx_yuexd@163.com; oliver-zhao@163.com			Science and Technology Planning Project of Yantai [2018SFGY093]	This work was supported by the Science and Technology Planning Project of Yantai [Grant Number 2018SFGY093]. Thanks for the financial support.	Bang HY, 2017, MOLECULES, V22, DOI 10.3390/molecules22060969; Barnhart CD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124521; Calder PC, 2016, ANN NUTR METAB, V69, P8, DOI 10.1159/000448262; Chao XJ, 2014, CNS NEUROSCI THER, V20, P840, DOI 10.1111/cns.12286; Chaung HC, 2013, FOOD CHEM, V138, P342, DOI 10.1016/j.foodchem.2012.10.082; Chen XB, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3067-7; Cieslik M, 2013, NEUROCHEM INT, V62, P626, DOI 10.1016/j.neuint.2013.02.016; Cortese-Krott MM, 2016, PHARMACOL RES, V113, P490, DOI 10.1016/j.phrs.2016.09.022; Cui CM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9245702; Deshmukh Prashant, 2017, Biophys Rev, V9, P41, DOI 10.1007/s12551-016-0244-4; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kim HY, 2014, MIL MED, V179, P106, DOI 10.7205/MILMED-D-14-00162; Kovac S, 2015, BBA-GEN SUBJECTS, V1850, P794, DOI 10.1016/j.bbagen.2014.11.021; Li FY, 2019, ANN CLIN TRANSL NEUR, V6, P1825, DOI 10.1002/acn3.50878; Lin Y, 2015, NEUROSCIENCE, V301, P471, DOI 10.1016/j.neuroscience.2015.06.024; Lv DY, 2018, KIDNEY BLOOD PRESS R, V43, P191, DOI 10.1159/000487501; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Marrocco I, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6501046; Mioni G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00269; Pan WY, 2020, PHARMACOLOGY, V105, P47, DOI 10.1159/000502767; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Saw CLL, 2013, FOOD CHEM TOXICOL, V62, P869, DOI 10.1016/j.fct.2013.10.023; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Wang J, 2018, FREE RADICAL BIO MED, V123, P62, DOI 10.1016/j.freeradbiomed.2018.05.069; Wen Y, 2018, INT J BIOCHEM CELL B, V98, P43, DOI 10.1016/j.biocel.2018.02.015; Yu NN, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1979-6; Zgorzynska E, 2017, PHARMACOL REP, V69, P935, DOI 10.1016/j.pharep.2017.04.009; Zhao ZY, 2013, CNS NEUROSCI THER, V19, P163, DOI 10.1111/cns.12044; Zhu W, 2018, INFLAMMATION, V41, P1182, DOI 10.1007/s10753-018-0765-z; Zhu W, 2017, EXP THER MED, V14, P4411, DOI 10.3892/etm.2017.5054	36	3	4	1	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	AUG	2020	45	8					1839	1850		10.1007/s11064-020-03078-z			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MX1VI	WOS:000557514600001	32676950	Green Published, hybrid			2022-02-06	
J	Papadaki, E; Kavroulakis, E; Manolitsi, K; Makrakis, D; Papastefanakis, E; Tsagaraki, P; Papadopoulou, S; Zampetakis, A; Malliou, M; Vakis, A; Simos, P				Papadaki, Efrosini; Kavroulakis, Eleftherios; Manolitsi, Katina; Makrakis, Dimitrios; Papastefanakis, Emmanouil; Tsagaraki, Pelagia; Papadopoulou, Styliani; Zampetakis, Alexandros; Malliou, Margarita; Vakis, Antonios; Simos, Panagiotis			Cerebral perfusion disturbances in chronic mild traumatic brain injury correlate with psychoemotional outcomes	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic brain injury; Perfusion MRI; Cerebral blood flow; Depression; Anxiety	ANTERIOR CINGULATE CORTEX; BLOOD-FLOW; MAJOR DEPRESSION; HEAD-INJURY; COGNITIVE IMPAIRMENT; RISK-FACTORS; ABNORMALITIES; SYMPTOMS; EMOTION; SPECT	The study explored associations between hemodynamic changes and psychoemotional status in 32 patients with chronic mild traumatic brain injury (mTBI) and 31 age-matched healthy volunteers. Cerebral blood flow (CBF) and cerebral blood volume (CBV) values were obtained using Dynamic Susceptibility Contrast Magnetic Resonance Imaging in brain regions suspected to play a role in anxiety and depression. Patients were administered self-report measures of anxiety and depression symptoms and underwent neuropsychological assessment. As a group mTBI patients scored significantly below age- and education-adjusted population norms on multiple cognitive domains and reported high rates of anxiety and depression symptomatology. Significantly reduced CBF values were detected in the mTBI group compared to controls in dorsolateral prefrontal areas, putamen, and hippocampus, bilaterally. Within the mTBI group, depressive symptomatology was significantly associated with lower perfusion in the left anterior cingulate gyrus and higher perfusion in the putamen, bilaterally. The latter association was independent from verbal working memory capacity. Moreover, anxiety symptomatology was associated with lower perfusion in the hippocampus (after controlling for verbal episodic memory difficulties). Associations between regional perfusion and psychoemotional scores were specific to depression or anxiety, respectively, and independent of the presence of visible lesions on conventional MRI. Results are discussed in relation to the role of specific limbic and paralimbic regions in the pathogenesis of symptoms of depression and anxiety.	[Papadaki, Efrosini; Kavroulakis, Eleftherios; Makrakis, Dimitrios] Univ Crete, Univ Hosp Heraklion, Sch Med, Dept Radiol, Iraklion, Greece; [Papadaki, Efrosini; Simos, Panagiotis] Fdn Res & Technol Hellas, Inst Comp Sci, Iraklion, Greece; [Manolitsi, Katina; Vakis, Antonios] Univ Crete, Univ Hosp Heraklion, Sch Med, Dept Neurosurg, Iraklion, Greece; [Papastefanakis, Emmanouil; Tsagaraki, Pelagia; Papadopoulou, Styliani; Zampetakis, Alexandros; Malliou, Margarita; Simos, Panagiotis] Univ Crete, Univ Hosp Heraklion, Sch Med, Dept Psychiat, Iraklion, Greece		Papadaki, E (corresponding author), Univ Crete, Univ Hosp Heraklion, Sch Med, Dept Radiol, Iraklion, Greece.; Papadaki, E (corresponding author), Fdn Res & Technol Hellas, Inst Comp Sci, Iraklion, Greece.	fpapada@otenet.gr	PAPADAKI, EFROSINI/AAX-2602-2020; Papastefanakis, Emmanouil/ABC-3737-2021	PAPADAKI, EFROSINI/0000-0002-3428-8298; 			Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Arsalidou M, 2013, HUM BRAIN MAPP, V34, P3031, DOI 10.1002/hbm.22124; Aslan S, 2010, MAGN RESON IMAGING, V28, P928, DOI 10.1016/j.mri.2010.03.037; Barkai G, 2004, PSYCHIAT RES-NEUROIM, V132, P279, DOI 10.1016/j.pscychresns.2004.09.004; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Brody AL, 2001, ARCH GEN PSYCHIAT, V58, P631, DOI 10.1001/archpsyc.58.7.631; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Conca A, 2000, PSYCHIAT RES-NEUROIM, V98, P43, DOI 10.1016/S0925-4927(99)00051-7; Constantinidou F, 2014, J INT NEUROPSYCH SOC, V20, P822, DOI 10.1017/S1355617714000678; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Daou MAZ, 2018, J PSYCHIATR RES, V97, P1, DOI 10.1016/j.jpsychires.2017.11.005; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dolcos F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01867; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Duhameau B, 2010, PSYCHIAT RES-NEUROIM, V182, P111, DOI 10.1016/j.pscychresns.2010.01.009; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Fountoulakis K, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-3; Fountoulakis Konstantinos N, 2006, Ann Gen Psychiatry, V5, P2, DOI 10.1186/1744-859X-5-2; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Godsil BP, 2013, EUR NEUROPSYCHOPHARM, V23, P1165, DOI 10.1016/j.euroneuro.2012.10.018; Graham J, 2013, J AFFECT DISORDERS, V151, P423, DOI 10.1016/j.jad.2013.07.002; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Haacke WR, 2013, CEREBRAL BLOOD FLOW; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hubley AM, 2002, J CLIN EXP NEUROPSYC, V24, P370, DOI 10.1076/jcen.24.3.370.984; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Knutson KM, 2013, NEUROPSYCHOLOGIA, V51, P686, DOI 10.1016/j.neuropsychologia.2013.01.003; Knutsson L, 2004, MAGN RESON IMAGING, V22, P789, DOI 10.1016/j.mri.2003.12.002; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Koh KB, 2010, J CLIN PSYCHIAT, V71, P1576, DOI 10.4088/JCP.09m05061blu; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014; Kou Zhifeng, 2015, Top Magn Reson Imaging, V24, P253, DOI 10.1097/RMR.0000000000000064; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Levin, 1997, Semin Clin Neuropsychiatry, V2, P207; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Lui S, 2009, RADIOLOGY, V251, P476, DOI 10.1148/radiol.2512081548; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McGehee BE, 2012, J MAGN RESON IMAGING, V36, P1257, DOI 10.1002/jmri.23645; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Muller VI, 2017, JAMA PSYCHIAT, V74, P47, DOI 10.1001/jamapsychiatry.2016.2783; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Newsome MR, 2013, J INT NEUROPSYCH SOC, V19, P911, DOI 10.1017/S1355617713000817; Palmer SM, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01045; Panou, 2011, GREEK MEMORY SCALE; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; Rudebeck PH, 2008, COGN AFFECT BEHAV NE, V8, P485, DOI 10.3758/CABN.8.4.485; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; TEASDALE G, 1974, LANCET, V2, P81; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Vasic N, 2015, J PSYCHIATR NEUROSCI, V40, P412, DOI 10.1503/jpn.140246; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267; Zalonis I, 2008, CLIN NEUROPSYCHOL, V22, P842, DOI 10.1080/13854040701629301	87	3	4	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2021	15	3					1438	1449		10.1007/s11682-020-00343-1		JUL 2020	12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TJ9UM	WOS:000554054300001	32734434				2022-02-06	
J	Koerte, IK; Esopenko, C; Hinds, II; Shenton, ME; Bonke, EM; Bazarian, JJ; Bickart, KC; Bigler, ED; Bouix, S; Buckley, TA; Choe, MC; Echlin, PS; Gill, J; Giza, CC; Hayes, J; Hodges, CB; Irimia, A; Johnson, PK; Kenney, K; Levin, HS; Lin, AP; Lindsey, HM; Lipton, ML; Max, JE; Mayer, AR; Meier, TB; Merchant-Borna, K; Merkley, TL; Mills, BD; Newsome, MR; Porfido, T; Stephens, JA; Tartaglia, MC; Ware, AL; Zafonte, RD; Zeineh, MM; Thompson, PM; Tate, DF; Dennis, EL; Wilde, EA; Baron, D				Koerte, Inga K.; Esopenko, Carrie; Hinds, Sidney R., II; Shenton, Martha E.; Bonke, Elena M.; Bazarian, Jeffrey J.; Bickart, Kevin C.; Bigler, Erin D.; Bouix, Sylvain; Buckley, Thomas A.; Choe, Meeryo C.; Echlin, Paul S.; Gill, Jessica; Giza, Christopher C.; Hayes, Jasmeet; Hodges, Cooper B.; Irimia, Andrei; Johnson, Paula K.; Kenney, Kimbra; Levin, Harvey S.; Lin, Alexander P.; Lindsey, Hannah M.; Lipton, Michael L.; Max, Jeffrey E.; Mayer, Andrew R.; Meier, Timothy B.; Merchant-Borna, Kian; Merkley, Tricia L.; Mills, Brian D.; Newsome, Mary R.; Porfido, Tara; Stephens, Jaclyn A.; Tartaglia, Maria Carmela; Ware, Ashley L.; Zafonte, Ross D.; Zeineh, Michael M.; Thompson, Paul M.; Tate, David F.; Dennis, Emily L.; Wilde, Elisabeth A.; Baron, David			The ENIGMA sports injury working group:- an international collaboration to further our understanding of sport-related brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Concussion; ENIGMA; Repetitive head impacts; Sport-related brain injury	SEX-DIFFERENCES; CONCUSSION; EPIDEMIOLOGY; COLLEGIATE; SYMPTOMS; OUTCOMES; IMPACT	Sport-related brain injury is very common, and the potential long-term effects include a wide range of neurological and psychiatric symptoms, and potentially neurodegeneration. Around the globe, researchers are conducting neuroimaging studies on primarily homogenous samples of athletes. However, neuroimaging studies are expensive and time consuming, and thus current findings from studies of sport-related brain injury are often limited by small sample sizes. Further, current studies apply a variety of neuroimaging techniques and analysis tools which limit comparability among studies. The ENIGMA Sports Injury working group aims to provide a platform for data sharing and collaborative data analysis thereby leveraging existing data and expertise. By harmonizing data from a large number of studies from around the globe, we will work towards reproducibility of previously published findings and towards addressing important research questions with regard to diagnosis, prognosis, and efficacy of treatment for sport-related brain injury. Moreover, the ENIGMA Sports Injury working group is committed to providing recommendations for future prospective data acquisition to enhance data quality and scientific rigor.	[Koerte, Inga K.; Bonke, Elena M.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Waltherstr 23, D-80337 Munich, Germany; [Koerte, Inga K.; Shenton, Martha E.; Bouix, Sylvain] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Esopenko, Carrie] Rutgers Biomed Hlth Sci, Dept Rehabil & Movement Sci, Newark, NJ USA; [Esopenko, Carrie; Porfido, Tara] Rutgers Biomed Hlth Sci, Sch Grad Studies, Newark, NJ USA; [Hinds, Sidney R., II; Shenton, Martha E.; Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Hinds, Sidney R., II] VA Boston Healthcare Syst, Boston, MA USA; [Bonke, Elena M.] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci, Munich, Germany; [Bazarian, Jeffrey J.; Merchant-Borna, Kian] Univ Rochester, Sch Med, Dept Emergency Med & Neurol, Rochester, NY USA; [Bickart, Kevin C.; Choe, Meeryo C.; Giza, Christopher C.] Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Bickart, Kevin C.] Univ Calif Los Angeles, David Geffen Sch Med, Neurol & Neunapsychiat, Los Angeles, CA 90095 USA; [Bigler, Erin D.; Hodges, Cooper B.; Johnson, Paula K.; Lindsey, Hannah M.; Merkley, Tricia L.; Tate, David F.; Dennis, Emily L.; Wilde, Elisabeth A.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Bigler, Erin D.; Hodges, Cooper B.; Lindsey, Hannah M.; Merkley, Tricia L.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.; Johnson, Paula K.; Merkley, Tricia L.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Buckley, Thomas A.] Univ Delaware, Biomech & Movement Sci Program, Newark, DE USA; [Choe, Meeryo C.; Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat, Div Neurol, Mattel Childrens Hosp, Los Angeles, CA 90024 USA; [Echlin, Paul S.] Elliott Sports Med Clin, Burlington, ON, Canada; [Gill, Jessica] NIH, Dept Intramural Res, Bldg 10, Bethesda, MD 20892 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Hayes, Jasmeet] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Hayes, Jasmeet] Ohio State Univ, Chron Brain Injury Program, Columbus, OH 43210 USA; [Hodges, Cooper B.; Lindsey, Hannah M.; Tate, David F.; Dennis, Emily L.; Wilde, Elisabeth A.] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [Irimia, Andrei] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA; [Irimia, Andrei] Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA 90007 USA; [Kenney, Kimbra] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Levin, Harvey S.; Newsome, Mary R.; Wilde, Elisabeth A.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey S.; Newsome, Mary R.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Lin, Alexander P.] Harvard Med Sch, Ctr Clin Spect, Brigham & Womens Hosp, Boston, MA 02115 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, Gruss Magnet Resonance Res Ctr, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat, Gruss Magnet Resonance Res Ctr, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Behav Sci, Gruss Magnet Resonance Res Ctr, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Gruss Magnet Resonance Res Ctr, Bronx, NY 10467 USA; [Lipton, Michael L.] Montefiore Med, Dept Radiol, Bronx, NY USA; [Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Max, Jeffrey E.] Rady Childrens Hosp, Dept Psychiat, San Diego, CA USA; [Mayer, Andrew R.] Mind Res Network, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Mills, Brian D.; Zeineh, Michael M.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Stephens, Jaclyn A.] Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; [Tartaglia, Maria Carmela] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Tartaglia, Maria Carmela] Univ Hlth Network, Toronto, ON, Canada; [Tartaglia, Maria Carmela] Krembil Brain Inst, Toronto, ON, Canada; [Ware, Ashley L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Zafonte, Ross D.] Harvard Med Sch, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Thompson, Paul M.] Imaging Genet Ctr, Keck Sch Med USC, Stevens Neuroimaging & Informat Inst, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Los Angeles, CA USA; [Baron, David] Western Univ Hlth Sci, Pomona, CA USA		Koerte, IK (corresponding author), Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Waltherstr 23, D-80337 Munich, Germany.; Koerte, IK (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA 02115 USA.	Inga.Koerte@med.lmu.de	Thompson, Paul M/C-4194-2018; Dennis, Emily/AAD-5223-2021; Koerte, Inga Katharina/AAW-3031-2021; Buckley, Thomas A/B-7525-2016; Irimia, Andrei/B-8275-2008; Merkley, Tricia L./AAN-2989-2020; Tate, David/G-5166-2011	Thompson, Paul M/0000-0002-4720-8867; Dennis, Emily/0000-0001-7112-4009; Buckley, Thomas A/0000-0002-0515-0150; Irimia, Andrei/0000-0002-9254-9388; Koerte, Inga/0000-0003-1281-9286; Esopenko, Carrie/0000-0001-8607-5633; Porfido, Tara/0000-0003-0953-3594; Tate, David/0000-0003-0213-1920	Projekt DEAL	Open Access funding provided by Projekt DEAL.	Alosco ML, 2020, BRAIN IMAGING BEHAV, V14, P1419, DOI 10.1007/s11682-019-00060-4; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bartnik-Olson B., 2019, CLIN UTILITY MAGNETI, DOI [10.31234/osf.io/gesvh, DOI 10.31234/OSF.IO/GESVH]; Bigler ED, 2018, INT J PSYCHOPHYSIOL, V132, P105, DOI 10.1016/j.ijpsycho.2017.09.006; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Cheng H, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104683; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dennis EL, 2019, BRAIN IMAGING YOUNG, DOI [10.31234/osf.io/y2txh, DOI 10.31234/OSF.IO/Y2TXH]; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; ENIGMA, PROT ENIGMA; Esopenko C., 2019, STUDY INTIMATE PARTN, DOI [10.31234/osf.io/3xzwg, DOI 10.31234/OSF.IO/3XZWG]; Filipcik P, 2015, BBA-MOL BASIS DIS, V1852, P1219, DOI 10.1016/j.bbadis.2015.03.003; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hasan KM, 2018, NEUROIMAG CLIN N AM, V28, P31, DOI 10.1016/j.nic.2017.09.001; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holway FE, 2011, J SPORT SCI, V29, pS115, DOI 10.1080/02640414.2011.605459; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Karayumak SC, 2019, NEUROIMAGE, V184, P180, DOI 10.1016/j.neuroimage.2018.08.073; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Koerte IK, 2020, J NEUROIMAGING, V30, P387, DOI 10.1111/jon.12726; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Laker SR, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0510-3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nguyen VT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4223; Olsen A., 2019, GLOBAL REPROD SCI BR, DOI [10.31234/osf.io/jnsb2, DOI 10.31234/OSF.IO/JNSB2]; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schranz AL, 2018, HUM BRAIN MAPP, V39, P1489, DOI 10.1002/hbm.23919; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Tate D  F., 2019, COORDINATING GLOBAL, DOI [10.31234/osf.io/d4qs8, DOI 10.31234/OSF.IO/D4QS8]; Thompson PM, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0705-1; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wilde EA., 2019, ENIGMA BRAIN INJURY, DOI [10.31234/osf.io/t96xb, DOI 10.31234/OSF.IO/T96XB]; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	57	3	3	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	APR	2021	15	2					576	584		10.1007/s11682-020-00370-y		JUL 2020	9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RK3RJ	WOS:000552936300001	32720179	Green Published, hybrid			2022-02-06	
J	Strauss, SB; Fleysher, R; Ifrah, C; Hunter, L; Ye, K; Lipton, R; Zimmerman, M; Kim, M; Stewart, W; Lipton, ML				Strauss, Sara B.; Fleysher, Roman; Ifrah, Chloe; Hunter, Liane; Ye, Kenny; Lipton, Richard; Zimmerman, Molly; Kim, Mimi; Stewart, Walter; Lipton, Michael L.			Framing potential for adverse effects of repetitive subconcussive impacts in soccer in the context of athlete and non-athlete controls	BRAIN IMAGING AND BEHAVIOR			English	Article							COGNITIVE IMPAIRMENT; HEAD-IMPACT; NEUROPSYCHOLOGICAL IMPAIRMENT; EXERCISE; SYMPTOMS; EXPOSURE; BRAIN; NEUROPLASTICITY; CONSEQUENCE; PERFORMANCE	The benefits of athletic activity may be attenuated by sport-related head impacts, including soccer-related concussion and subconcussive events. The purpose of this study is to characterize the specific effects of soccer heading on white matter microstructure and cognitive function, independent of concussion, relative to non-athlete controls and relative to active athletes who are not involved in collision sports. 246 amateur soccer players, 72 non-contact/non-collision sports athletes and 110 healthy,non-athlete controls were included in the study, and underwent cognitive testing and 3T diffusion tensor imaging (DTI). Voxelwise linear regression, comparing soccer players and non-contact/non-collision sports athletes healthy,non-athlete controls, identified regions of abnormally low and high fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD) and mean diffusivity (MD) in athlete participants. Generalized estimating equations were used to examine the effects of 2 week and 1 year heading exposure quartile on cognitive performance and on the volume of each high and each low DTI parameter. Athletes with no or lower exposure to repetitive heading exhibited greater expression of low RD, greater expression of high FA and better performance on tasks of attention, processing speed, verbal memory, and working memory compared to non-athletes. Soccer players with the highest exposure to repetitive head impacts, however, did not differ significantly from healthy, non-athletes on either micro-structural features or cognitive performance, findings not explained by concussion history or demographic factors. These results are consistent with the notion that beneficial effects of athletic conditioning or training on brain structure and function may be attenuated by exposure to repeated subconcussive head impacts.	[Strauss, Sara B.; Fleysher, Roman; Ifrah, Chloe; Hunter, Liane; Ye, Kenny; Lipton, Richard; Zimmerman, Molly; Kim, Mimi; Stewart, Walter; Lipton, Michael L.] Weill Cornell Med Ctr, NY Presbyterian, New York, NY 10065 USA; [Strauss, Sara B.] Montefiore Med Ctr, Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA		Lipton, ML (corresponding author), Weill Cornell Med Ctr, NY Presbyterian, New York, NY 10065 USA.	Michael.lipton@einsteinmed.org	Lipton, Richard Bruce/AAY-2818-2021; Ye, Kenny/U-2341-2019	Ye, Kenny/0000-0002-1466-855X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS082432]; Dana Foundation	This study was funded by the National Institutes of Health (R01NS082432) and the Dana Foundation.	Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Bunc Gorazd, 2017, Med Arch, V71, P356, DOI 10.5455/medarh.2017.71.356-359; Callisaya M, 2017, J ALZHEIMERS DIS, V59, P503, DOI 10.3233/JAD-161154; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Davenport Elizabeth M, 2016, Concussion, V1, pCNC19, DOI 10.2217/cnc-2016-0003; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Forbes CR, 2016, APPL NEUROPSYCH-CHIL, V5, P14, DOI 10.1080/21622965.2014.933108; Forbes D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub3; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2005, GEN ESTIMATING EQUAT; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hotting K, 2013, NEUROSCI BIOBEHAV R, V37, P2243, DOI 10.1016/j.neubiorev.2013.04.005; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Jones S. A. V., 2013, BRIT J SPORTS MED; Khan Karim M, 2012, Lancet, V380, P59, DOI 10.1016/S0140-6736(12)60865-4; Kim TW, 2017, NEUROSCIENCE, V346, P173, DOI 10.1016/j.neuroscience.2017.01.016; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Kunz M, 2007, FIFA MAGAZINE, V7, P11, DOI [10.1080/13673882.2007.9680857, DOI 10.1080/13673882.2007.9680857]; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lipton ML, 2018, J SCI MED SPORT, V21, P363, DOI 10.1016/j.jsams.2017.08.008; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Nguyen VT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4223; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Sabia S, 2012, AM J PUBLIC HEALTH, V102, P698, DOI 10.2105/AJPH.2011.300257; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; Suri AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142288; Tarnutzer A. A., 2016, BRIT J SPORTS MED; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092	45	3	3	0	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	APR	2021	15	2					882	895		10.1007/s11682-020-00297-4		JUL 2020	14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RK3RJ	WOS:000552252000006	32712797				2022-02-06	
J	Johnson, LW; Lundgren, K; Henrich, V; Phillips, S				Johnson, Leslie Weaver; Lundgren, Kristine; Henrich, Vincent; Phillips, Susan			Factors influencing recovery from mild traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; APOE; cognitive impairment; recovery; prognosis	APOLIPOPROTEIN-E EPSILON-4; GLASGOW COMA SCALE; APOE GENOTYPE; HEAD-INJURY; COMPUTED-TOMOGRAPHY; E POLYMORPHISM; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PROGNOSTIC-FACTORS; EARLY-STAGE	Primary Objective This study determined whether initial GCS score, head CT results, cognitive performance on IMPACT testing, or APOE genotype most effectively predicted 1-month functional outcome after mild traumatic brain injury (mTBI). This study tested the hypotheses that participants with poor performance on initial cognitive testing and those with an APOEe4 genotype would exhibit a poorer 1-month recovery after mTBI. Research Design Regression analysis determined which independent variables were most effective in predicting 1-month GOS-E or DRS score. Independent t-test procedures determined whether cognitive recovery varied across APOEe4 carriers. Methods and Procedures 49 participants admitted to the hospital with mTBI received cognitive evaluation within 48 hours after injury and again one month later. DNA analysis provided participant APOE genotype. Main Outcomes and Results Results showed that no study variables significantly predicted GOS-E or DRS scores, however, differences were identified when APOE groups were compared. Participants who were noncarriers of APOEe4 had significantly slower reaction times compared to APOEe4 carriers. Participants who were homozygous APOEe4 carriers had significantly lower instances of impulsivity than noncarriers. Conclusions Further research is needed to understand how APOE allele status and performance on initial cognitive testing may influence short-term recovery after mTBI.	[Johnson, Leslie Weaver] North Carolina Cent Univ, Commun Disorders Program, Durham, NC USA; [Lundgren, Kristine; Phillips, Susan] Univ N Carolina, Dept Commun & Sci Disorders, Greensboro, NC USA; [Henrich, Vincent] Univ N Carolina, Dept Biol, Greensboro, NC USA		Johnson, LW (corresponding author), North Carolina Cent Univ, Sch Educ, Durham, NC 27707 USA.	ljohn169@nccu.edu		Johnson, Leslie/0000-0002-6651-4763			ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; [Anonymous], 2017, IMPACT ADM INTERPRET; Arendt T, 1997, J NEUROSCI, V17, P516; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Asihainen I, 1999, EPILEPSIA, V40; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bennett DA, 2003, NEUROLOGY, V60, P246, DOI 10.1212/01.WNL.0000042478.08543.F7; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Bretsky P, 2003, NEUROLOGY, V60, P1077, DOI 10.1212/01.WNL.0000055875.26908.24; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Caselli RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1306, DOI 10.1001/archneur.64.9.1306; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; Eisenstein M, 2011, NATURE, V475, pS20, DOI 10.1038/475S20a; Elias-Sonnenschein LS, 2011, J NEUROL NEUROSUR PS, V82, P1149, DOI 10.1136/jnnp.2010.231555; Farlow MR, 2004, NEUROLOGY, V63, P1898, DOI 10.1212/01.WNL.0000144279.21502.B7; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Faul M, 2010, TRAUMATIC BRAIN INJU; Fisher J, 2001, CRIT CARE NURS Q, V23; Guo L, 2004, J MOL NEUROSCI, V23, P205, DOI 10.1385/JMN:23:3:205; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hiekikanen H, 2007, BRAIN INJURY, V21, P1307, DOI 10.1080/02699050701739549; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Horsburgh K, 2000, NEUROPATH APPL NEURO, V26, P124, DOI 10.1046/j.1365-2990.2000.026002124.x; Houlden H, 2006, J NEUROL NEUROSUR PS, V77, P1106, DOI 10.1136/jnnp.2006.095513; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Jiang Y, 2008, ACTA NEUROCHIR SUPPL, V105, P233; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Jonker C, 1998, ARCH NEUROL-CHICAGO, V55, P1065, DOI 10.1001/archneur.55.8.1065; Kamboj SK, 2005, PAIN, V117, P388, DOI 10.1016/j.pain.2005.06.022; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lescai F, 2011, J ALZHEIMERS DIS, V24, P235, DOI 10.3233/JAD-2011-101764; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; McMorn S, 2011, J CLIN ONCOL, V29, P4342, DOI 10.1200/JCO.2011.38.2309; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Noe E, 2010, BRAIN INJURY, V24, P886, DOI 10.3109/02699051003724952; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Ramanan VK, 2014, MOL PSYCHIATR, V19, P351, DOI 10.1038/mp.2013.19; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	93	3	3	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 28	2020	34	9					1202	1212		10.1080/02699052.2020.1795719		JUL 2020	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ND6FI	WOS:000551623900001	32705914	Green Submitted			2022-02-06	
J	Remigio-Baker, RA; Kiser, S; Ferdosi, H; Gregory, E; Engel, S; Sebesta, S; Beauchamp, D; Malik, S; Scher, AI; Hinds, II				Remigio-Baker, Rosemay A.; Kiser, Seth; Ferdosi, Hamid; Gregory, Emma; Engel, Scot; Sebesta, Sean; Beauchamp, Daniel; Malik, Saafan; Scher, Ann, I; Hinds, Sidney R., II			Current patterns of primary care provider practices for the treatment of post-traumatic headache in active duty military settings	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PREVALENCE; CONCUSSION; SOLDIERS	Objective To provide a preliminary assessment of the current clinical practice for the treatment of post-traumatic headache following concussion in military primary health care settings. Background Headache is one of the most common symptoms post-concussion; however, little is known of the current clinical practices of primary care providers (on the treatment of post-traumatic headache), particularly in military settings. Methods Study participants were primary care providers (n = 65) who treated active duty Service members suffering from post-traumatic headache at two military installations. Qualitative data gathered via semi-structured interviews were used to describe provider practices and experience in treating patients with post-traumatic headache. Results Some patterns of care across primary care providers treating post-traumatic headache were consistent with the Department of Defense-recommended clinical recommendation (e.g., recommendation of both pharmacological and non-pharmacological treatment [89.4%]; engaging in follow-up care [100%]). Differences existed in timing of follow-up from initial visit [16.9% reporting within 24 hours; 21.5% reporting within 48-72 hours; and 26.2% reporting more than 1 week], the factors contributing to the type of care given (e.g., symptomatology [33.0%], injury characteristic [24.2%], patient characteristic [13.2%]) and the need for referral to higher level of care (e.g., symptomatology [44.6%], treatment failure [25.0%]). These variations may be indicative of individualized treatment which would be compliant with best clinical practice. Conclusion The results of this study demonstrate the current clinical practice in military primary care settings for the treatment of post-traumatic headache which can potentially inform and improve implementation of provider training and education.	[Remigio-Baker, Rosemay A.; Kiser, Seth; Ferdosi, Hamid; Gregory, Emma; Malik, Saafan] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Remigio-Baker, Rosemay A.] Henry Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Remigio-Baker, Rosemay A.] Naval Hosp Camp Pendleton, Camp Pendleton, CA 92055 USA; [Kiser, Seth; Ferdosi, Hamid] Gen Dynam Informat Technol, Falls Church, VA USA; [Engel, Scot] Intrepid Spirit Ctr, Ft Hood, TX USA; [Sebesta, Sean; Beauchamp, Daniel] Intrepid Spirit Ctr, Ft Bliss, TX USA; [Scher, Ann, I] Uniformed Serv Univ Hlth Sci, Prevent Med & Biostat, Bethesda, MD USA; [Hinds, Sidney R., II] Uniformed Serv Univ Hlth Sci, Neurol, Bethesda, MD USA		Remigio-Baker, RA (corresponding author), Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA.; Remigio-Baker, RA (corresponding author), Henry Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.; Remigio-Baker, RA (corresponding author), Naval Hosp Camp Pendleton, Camp Pendleton, CA 92055 USA.	rremigiobaker@gmail.com		Scher, Ann/0000-0003-4599-9834	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; MRMC JPC-6 Neurotrauma [NT160002]	This study was funded by the Defense and Veterans Brain Injury Center and MRMC JPC-6 Neurotrauma (award number NT160002). RR-B was employed by the Henry M. Jackson Foundation for the Advancement of Military Medicine; SK and HF were employed by the General Dynamics Information Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSARA, 2017, DIS EV SYST AN RES A; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Defense and Veterans Brain Injury Center, MAN HEAD FOLL CONC M; Defense and Veterans Brain Injury Center, 2019, CONC MAN TOOL PUID 4; Defense and Veterans Brain Injury Center, 2019, DOD WORLDW NUMB TBI; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Hinds Ii Sidney R, 2016, US Army Med Dep J, P97; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S., 2015, BRAIN NEUROTRAUMA; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Martins Hugo André de Lima, 2012, Dement. neuropsychol., V6, P53, DOI 10.1590/S1980-57642012DN06010009; Metti A, 2019, NEUROLOGY; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Tfelt-Hansen P, 2012, CEPHALALGIA, V32, P6, DOI 10.1177/0333102411417901; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042	21	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236762	10.1371/journal.pone.0236762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	WOS:000579931700061	32706834	Green Published, gold			2022-02-06	
J	Curt, A; Hsieh, J; Schubert, M; Hupp, M; Friedl, S; Freund, P; Huber, E; Pfyffer, D; Sutter, R; Jutzeler, C; Wuthrich, RP; Min, K; Casha, S; Fehlings, MG; Guzman, R				Curt, Armin; Hsieh, Jane; Schubert, Martin; Hupp, Markus; Friedl, Susanne; Freund, Patrick; Huber, Evenline; Pfyffer, Dario; Sutter, Reto; Jutzeler, Catherine; Wuthrich, Rudolf P.; Min, Kan; Casha, Steve; Fehlings, Michael G.; Guzman, Raphael			The Damaged Spinal Cord Is a Suitable Target for Stem Cell Transplantation	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						spinal cord injury; stem cell transplantation; neurorecovery	HEALTH CONDITIONS; INJURY; MULTICENTER; OUTCOMES; INSIGHTS; THERAPY; TRACT	Background. Given individuals with spinal cord injury (SCI) approaching 2 million, viable options for regenerative repair are desperately needed. Human central nervous system stem cells (HuCNS-SC) are self-renewing, multipotent adult stem cells that engraft, migrate, and differentiate in appropriate regions in multiple animal models of injured brain and spinal cord. Preclinical improved SCI locomotor function provided rationale for the first-in-human SCI clinical trial of HuCNS-SC cells. Evidence of feasibility and long-term safety of cell transplantation into damaged human cord is needed to foster translational progression of cellular therapies.Methods. A first-ever, multisite phase I/IIa trial involving surgical transplantation of 20 million HuCNS-SC cells into the thoracic cord in 12 AIS A or B subjects (traumatic, T2-T11 motor-complete, sensory-incomplete), aged 19 to 53 years, demonstrated safety and preliminary efficacy. Six-year follow-up data were collected (sensory thresholds and neuroimaging augmenting clinical assessments).Findings. The study revealed short- and long-term surgical and medical safety (well-tolerated immunosuppression in population susceptible to infections). Preliminary efficacy measures identified 5/12 with reliable sensory improvements. Unfortunately, without thoracic muscles available for manual muscle examination, thoracic motor changes could not be measured. Lower limb motor scores did not change during the study. Cervical cord imaging revealed, no tumor formation or malformation of the lesion area, and secondary supralesional structural changes similar to SCI control subjects.Interpretation. Short- and long-term safety and feasibility support the consideration of cell transplantation for patients with complete and incomplete SCI. This report is an important step to prepare, foster, and maintain the therapeutic development of cell transplantation for human SCI.	[Curt, Armin; Hsieh, Jane; Schubert, Martin; Hupp, Markus; Friedl, Susanne; Freund, Patrick; Huber, Evenline; Pfyffer, Dario; Sutter, Reto; Jutzeler, Catherine; Min, Kan] Balgrist Univ Hosp, Zurich, Switzerland; [Wuthrich, Rudolf P.] Univ Hosp Zurich, Zurich, Switzerland; [Casha, Steve] Univ Calgary, Calgary, AB, Canada; [Fehlings, Michael G.] Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada; [Guzman, Raphael] Univ Hosp Basel, Basel, Switzerland		Curt, A (corresponding author), Balgrist Univ Hosp, Spinal Cord Injury Ctr, Forchstr 340, CH-8008 Zurich, Switzerland.	armin.curt@balgrist.ch	Sutter, Reto/D-6783-2013	Sutter, Reto/0000-0001-6355-9838; Pfyffer, Dario/0000-0002-2406-9251; Hupp, Markus/0000-0003-0845-2514	Stem Cells Inc, Newark, California, USA; Wings for Life (WfL) [2016Q3]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The initial study (short-term follow-up of the first year; STFU) and part of the second study (long-term follow-up; LTFU) was funded by Stem Cells Inc, Newark, California, USA. After dissolution of Stem Cells Inc, 2016Q3 grants from Wings for Life (WfL), and the Bright Oceans Corporation (BOCO) enabled completion of the LTFU, compilation of the full set of monitored data (initial Phase I/IIa STFU trial and LTFU study), data analysis, and manuscript completion.	Adriaansen JJE, 2013, J REHABIL MED, V45, P1016, DOI 10.2340/16501977-1207; Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Aimetti AA, 2019, SPINAL CORD, V57, P753, DOI 10.1038/s41393-019-0299-8; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Brinkhof MWG, 2016, J REHABIL MED, V48, P197, DOI 10.2340/16501977-2039; Bulte JWM, 2018, RADIOLOGY, V289, P604, DOI 10.1148/radiol.2018180449; Cadotte DW, 2013, NAT REV NEUROL, V9, P546, DOI 10.1038/nrneurol.2013.190; Curt A, 2017, JAMA NEUROL, V74, P635, DOI 10.1001/jamaneurol.2017.0318; Curtis E, 2018, CELL STEM CELL, V22, P941, DOI 10.1016/j.stem.2018.05.014; David G, 2019, NAT REV NEUROL, V15, P718, DOI 10.1038/s41582-019-0270-5; Dikmen PY, 2013, J SPINAL CORD MED, V36, P672, DOI 10.1179/2045772313Y.0000000107; Eftekharpour E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E18; Fehlings MG, 2005, INJURY, V36, P113, DOI 10.1016/j.injury.2005.06.022; Freund P, 2019, LANCET NEUROL, V18, P1123, DOI 10.1016/S1474-4422(19)30138-3; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Freund P, 2013, NEUROSCIENTIST, V19, P116, DOI 10.1177/1073858412449192; Gao YL, 2017, UROLOGY, V104, P53, DOI 10.1016/j.urology.2017.03.006; Ghobrial GM, 2017, NEUROSURGERY, V64, P87, DOI 10.1093/neuros/nyx242; Grabher P, 2015, ANN NEUROL, V78, P751, DOI 10.1002/ana.24508; Hagen EM, 2015, PAIN THER, V4, P51, DOI 10.1007/s40122-015-0033-y; Huber E, 2018, NEUROLOGY, V90, pE1510, DOI 10.1212/WNL.0000000000005361; Huber E, 2017, ANN NEUROL, V81, P740, DOI 10.1002/ana.24932; Jin MC, 2019, NEUROSURG FOCUS, V46, DOI 10.3171/2018.12.FOCUS18602; Kwon BK, 2019, SPINAL CORD, V57, P819, DOI 10.1038/s41393-019-0319-8; Lad SP, 2013, J NEUROTRAUM, V30, P492, DOI 10.1089/neu.2012.2540; Lammertse DP, 2012, SPINAL CORD, V50, P661, DOI 10.1038/sc.2012.39; Levi AD, 2019, J NEUROTRAUM, V36, P891, DOI 10.1089/neu.2018.5843; Levi AD, 2018, NEUROSURGERY, V82, P562, DOI 10.1093/neuros/nyx250; Macklin RA, 2017, J NEUROTRAUM, V34, P1778, DOI 10.1089/neu.2016.4433; Middleton JW, 2004, SPINAL CORD, V42, P359, DOI 10.1038/sj.sc.3101601; Parasuraman R, 2013, AM J TRANSPLANT, V13, P327, DOI 10.1111/ajt.12124; Piltti KM, 2013, STEM CELL TRANSL MED, V2, P204, DOI 10.5966/sctm.2012-0110; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Tsukamoto A, 2013, STEM CELL RES THER, V4, DOI [10.1186/scrt313, 10.1186/1757-6512-4-102]; van Hedel HJA, 2012, NEUROREHAB NEURAL RE, V26, P497, DOI 10.1177/1545968311423669; Vaquero J, 2018, CYTOTHERAPY, V20, P806, DOI 10.1016/j.jcyt.2018.03.032; Vaquero J, 2016, CYTOTHERAPY, V18, P1025, DOI 10.1016/j.jcyt.2016.05.003; Zariffa J, 2011, SPINAL CORD, V49, P463, DOI 10.1038/sc.2010.140; Ziegler G, 2018, NEUROLOGY, V90, pE1257, DOI 10.1212/WNL.0000000000005258	39	3	3	2	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	AUG	2020	34	8					758	768	1545968320935815	10.1177/1545968320935815		JUL 2020	11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	NF1AY	WOS:000552072800001	32698674				2022-02-06	
J	Arnts, H; van Erp, WS; Sanz, LRD; Lavrijsen, JCM; Schuurman, R; Laureys, S; Vandertop, WP; van den Munckhof, P				Arnts, Hisse; van Erp, Willemijn S.; Sanz, Leandro R. D.; Lavrijsen, Jan C. M.; Schuurman, Rick; Laureys, Steven; Vandertop, William P.; van den Munckhof, Pepijn			The Dilemma of Hydrocephalus in Prolonged Disorders of Consciousness	JOURNAL OF NEUROTRAUMA			English	Article						cerebrospinal fluid disorders; disorders of consciousness; secondary normal pressure hydrocephalus; traumatic brain injury; ventriculoperitoneal shunt	NORMAL-PRESSURE HYDROCEPHALUS; LONG-TERM OUTCOMES; ANEURYSMAL SUBARACHNOID HEMORRHAGE; BRAIN-INJURY; POSTTRAUMATIC HYDROCEPHALUS; INPATIENT REHABILITATION; MEDICAL COMPLICATIONS; SHUNT IMPLANTATION; DIAGNOSIS; STATE	Prolonged disorders of consciousness (DOC) are considered to be among the most severe outcomes after acquired brain injury. Medical care for these patients is mainly focused on minimizing complications, given that treatment options for patients with unresponsive wakefulness or minimal consciousness remain scarce. The complication rate in patients with DOC is high, both in the acute hospital setting, as in the rehabilitation or long-term care phase. Hydrocephalus is one of these well-known complications and usually develops quickly after acute changes in cerebrospinal fluid (CSF) circulation after different types of brain damage. However, hydrocephalus may also develop with a significant delay, weeks, or even months after the initial injury, reducing the potential for natural recovery of consciousness. In this phase, hydrocephalus is likely to be missed in DOC patients, given that their limited behavioral responsiveness camouflages the classic signs of increased intracranial pressure or secondary normal-pressure hydrocephalus. Moreover, the development of late-onset hydrocephalus may exceed the period of regular outpatient follow-up. Several controversies remain about the diagnosis of clinical hydrocephalus in patients with ventricular enlargement after severe brain injury. In this article, we discuss both the difficulties in diagnosis and dilemmas in the treatment of CSF disorders in patients with prolonged DOC and review evidence from the literature to advance an active surveillance protocol for the detection of this late, but treatable, complication. Moreover, we advocate a low threshold for CSF diversion when hydrocephalus is suspected, even months or years after brain injury.	[Arnts, Hisse; Schuurman, Rick; Vandertop, William P.; van den Munckhof, Pepijn] Univ Amsterdam, Amsterdam Univ Med Ctr, Locat AMC, Dept Neurosurg, Amsterdam, Netherlands; [van Erp, Willemijn S.; Lavrijsen, Jan C. M.] Radboud Univ Nijmegen, Med Ctr, Ctr Family Med Geriatr Care & Publ Hlth, Dept Primary & Community Care, Nijmegen, Netherlands; [van Erp, Willemijn S.; Sanz, Leandro R. D.; Laureys, Steven] Univ Liege, GIGA Consciousness, Liege, Belgium; [van Erp, Willemijn S.; Sanz, Leandro R. D.; Laureys, Steven] Univ Hosp Liege, Coma Sci Grp, Liege, Belgium		Arnts, H (corresponding author), Univ Amsterdam, Med Ctr, Acad Med Ctr AMC, Dept Neurosurg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.arnts@amsterdamumc.nl	Sanz, Leandro R. D./AAL-6984-2021; Schuurman, Rick/ABE-9100-2021; Laureys, Steven/A-3349-2011; van Erp, Willemijn S/P-6195-2015; Lavrijsen, Jan/L-4477-2015; van den Munckhof, Pepijn/AAY-9259-2020; Laureys, Steven/AAN-2097-2021	Sanz, Leandro R. D./0000-0001-5054-2471; van Erp, Willemijn S/0000-0002-9167-4136; Laureys, Steven/0000-0002-3096-3807; Vandertop, William/0000-0001-5417-0265; van den Munckhof, Pepijn/0000-0001-5044-3705; Arnts, Hisse/0000-0003-4454-5056			Adams H, 2016, STROKE, V47, P2488, DOI 10.1161/STROKEAHA.116.013739; Agerskov S, 2019, AM J NEURORADIOL, V40, P74, DOI 10.3174/ajnr.A5910; Bhattathiri PS, 2006, ACTA NEUROCHIR SUPPL, V96, P65; Boon AJW, 1997, J NEUROSURG, V87, P687, DOI 10.3171/jns.1997.87.5.0687; Chen Z, 2014, J REHABIL MED, V46, P876, DOI 10.2340/16501977-1856; Daou B, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.6.FOCUS16189; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Eklund A, 2007, MED BIOL ENG COMPUT, V45, P719, DOI 10.1007/s11517-007-0199-5; Fattahian Reza, 2018, Med Arch, V72, P214, DOI 10.5455/medarh.2018.72.214-219; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Guyot LL, 2000, NEUROL RES, V22, P25; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Hashimoto M, 2010, FLUIDS BARRIERS CNS, V7, P2, DOI 10.1186/1743-8454-7-18; Hebb AO, 2001, NEUROSURGERY, V49, P1166, DOI 10.1097/00006123-200111000-00028; Hirashima Y, 2003, CEREBROVASC DIS, V16, P205, DOI 10.1159/000071117; Huang X, 2014, J CRANIOFAC SURG, V25, P1280, DOI 10.1097/SCS.0000000000000583; Jox RJ, 2012, LANCET NEUROL, V11, P732, DOI 10.1016/S1474-4422(12)70154-0; Kahlon B, 2002, J NEUROL NEUROSUR PS, V73, P721, DOI 10.1136/jnnp.73.6.721; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Khan QU, 2013, J NEUROSURG, V119, P1498, DOI 10.3171/2013.7.JNS13484; Kim JY, 2006, J KOR NEUROTRAUMATOL, V2, P101; Kowalsky RJ, 2018, J PHYS ACT HEALTH, V15, P788, DOI [10.1123/jpah.2017-0639, 10.3171/2017.7.JNS17555]; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Licata C, 2001, J Neurosurg Sci, V45, P141; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Marmarou A, 2005, NEUROSURGERY, V57, P1, DOI 10.1227/01.NEU.0000168188.25559.0E; Marmarou A, 2005, NEUROSURGERY, V57, P17, DOI 10.1227/01.NEU.0000168184.01002.60; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Merkler AE, 2017, WORLD NEUROSURG, V98, P654, DOI 10.1016/j.wneu.2016.10.136; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, pS10, DOI 10.1016/S0003-9993(98)90114-9; Perry A, 2017, WORLD NEUROSURG, V99, P695, DOI 10.1016/j.wneu.2016.12.121; Pfisterer WK, 2007, ACTA NEUROCHIR, V149, P983, DOI 10.1007/s00701-007-1240-z; Pickard JD, 2005, NEUROPSYCHOL REHABIL, V15, P224, DOI 10.1080/09602010443000614; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Reddy GK, 2014, WORLD NEUROSURG, V81, P404, DOI 10.1016/j.wneu.2013.01.096; Savolainen S, 2002, ACTA NEUROCHIR, V144, P515, DOI 10.1007/s00701-002-0936-3; SAZBON L, 1991, ACTA NEUROCHIR, V112, P110, DOI 10.1007/BF01405137; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sheehan JP, 1999, NEUROSURGERY, V45, P1120, DOI 10.1097/00006123-199911000-00021; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; Tribl G, 2000, BRAIN INJURY, V14, P345; van Erp WS, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.014; Walchenbach R, 2002, J NEUROL NEUROSUR PS, V72, P503; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Williams Michael A, 2013, Neurol Clin Pract, V3, P375; Yeom KW, 2014, AM J NEURORADIOL, V35, P1433, DOI 10.3174/ajnr.A3891	57	3	3	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2020	37	20					2150	2156		10.1089/neu.2020.7129		JUL 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	OA4HP	WOS:000556039900001	32484029				2022-02-06	
J	Rogers, JM; Jensen, J; Valderrama, JT; Johnstone, SJ; Wilson, PH				Rogers, Jeffrey M.; Jensen, Jenny; Valderrama, Joaquin T.; Johnstone, Stuart J.; Wilson, Peter H.			Single-channel EEG measurement of engagement in virtual rehabilitation: a validation study	VIRTUAL REALITY			English	Article						Engagement; Presence; Electroencephalogram; Rehabilitation; Virtual reality	FRONTAL-MIDLINE-THETA; TRAUMATIC BRAIN-INJURY; PATIENT ENGAGEMENT; DELTA/ALPHA RATIO; POSITIVE EMOTION; SPATIAL PRESENCE; MENTAL WORKLOAD; TASK ENGAGEMENT; VIDEO GAMES; REALITY	Stroke rehabilitation suffers from low levels of patient engagement, impeding recovery. Virtual rehabilitation (VR) approaches can improve patient outcomes; however, there is limited understanding of the participant's user experience and the field lacks a validated, objective measure of VR engagement. A neurophysiological measure of engagement in healthy adults was therefore examined, to inform future clinical studies. Twenty-four participants (M(age)26.7 years, range 18-47) interacted with a tabletop VR system (ElementsDNA, or EDNA), after which they rated their experience on the presence questionnaire (PQ). Separately, participants completed tasks eliciting low (restingeyes-open and -closed) and high (EDNA VR and roller coastersimulation) levels of engagement while continuous electroencephalogram (EEG) was recorded from a single, left pre-frontal electrode. EEG differences between therestingandsimulationconditions included an increase in theta power (p < 0.01) and a decrease in alpha power (p < 0.01). Importantly, theta power insimulationconditions correlated with PQ scores expressing the hands-on EDNA VR experience (r(s) = 0.38-0.48). In conclusion, the current results provide proof of concept that increased frontal theta power in healthy adults provides a valid measure of user engagement in VR simulation and participation. As the practical potential of VR is increasingly realised in stroke rehabilitation, objective EEG-based measures of engagement may provide a convenient and sensitive technique to assist in evaluating these interventions.	[Rogers, Jeffrey M.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Jensen, Jenny; Wilson, Peter H.] Australian Catholic Univ, Sch Behav & Hlth Sci, 115 Victoria Parade, Melbourne, Vic 3450, Australia; [Valderrama, Joaquin T.] Natl Acoust Labs, Sydney, NSW, Australia; [Valderrama, Joaquin T.] Macquarie Univ, Dept Linguist, Sydney, NSW, Australia; [Valderrama, Joaquin T.] HEARing CRC, Melbourne, Vic, Australia; [Johnstone, Stuart J.] Univ Wollongong, Sch Psychol & Brain & Behav Res Inst, Wollongong, NSW, Australia; [Wilson, Peter H.] Australian Catholic Univ, Ctr Disabil & Dev Res, 115 Victoria Parade, Melbourne, Vic 3450, Australia		Wilson, PH (corresponding author), Australian Catholic Univ, Sch Behav & Hlth Sci, 115 Victoria Parade, Melbourne, Vic 3450, Australia.; Wilson, PH (corresponding author), Australian Catholic Univ, Ctr Disabil & Dev Res, 115 Victoria Parade, Melbourne, Vic 3450, Australia.	peterh.wilson@acu.edu.au	Wilson, Peter H./E-2881-2018; Valderrama, Joaquin T/O-3394-2014	Wilson, Peter H./0000-0003-3747-0287; Valderrama, Joaquin T/0000-0002-5529-8620; Johnstone, Stuart/0000-0001-5380-9952			Aminov A, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0370-2; Badcock NA, 2013, PEERJ, V1, DOI 10.7717/peerj.38; Barello S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/905934; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Barry RJ, 2014, INT J PSYCHOPHYSIOL, V94, P236, DOI 10.1016/j.ijpsycho.2014.08.915; Bartur G, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9071568; Baumgartner T, 2006, CYBERPSYCHOL BEHAV, V9, P30, DOI 10.1089/cpb.2006.9.30; Baumgartner T, 2007, NEUROREPORT, V18, P261, DOI 10.1097/WNR.0b013e328012272e; Baumgartner T, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.008.2008; BEARDSELY M, 1982, AESTHETIC POINT VIEW; Berka C, 2007, AVIAT SPACE ENVIR MD, V78, pB231; Borghini G., 2011, ITALIAN J AEROSPACE, V5, P34, DOI DOI 10.1016/j.itjm.2010.07.009; Brackney DE, 2017, J NURS MEAS, V25, pE66, DOI 10.1891/1061-3749.25.2.E66; Brett CE, 2017, NEUROPSYCHOL REHABIL, V27, P959, DOI 10.1080/09602011.2015.1090459; Bright FAS, 2015, DISABIL REHABIL, V37, P643, DOI 10.3109/09638288.2014.933899; Burke JW, 2009, VISUAL COMPUT, V25, P1085, DOI 10.1007/s00371-009-0387-4; Calabro RS, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0268-4; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Csikszentmihalyi, 1990, FLOW PSYCHOL OPTIMAL; Deutsch JE, 2013, J NEUROL PHYS THER, V37, P118, DOI 10.1097/NPT.0b013e3182a0a078; Doppelmayr A, 2008, NEUROPSYCHOLOGIA, V46, P1463, DOI 10.1016/j.neuropsychologia.2007.12.026; Palma GCD, 2017, TOP STROKE REHABIL, V24, P269, DOI 10.1080/10749357.2016.1250373; Duckworth J, 2015, LECT NOTES COMPUT SC, V9177, P420, DOI 10.1007/978-3-319-20684-4_41; Dussault C, 2005, AVIAT SPACE ENVIR MD, V76, P344; Ekandem JI, 2012, ERGONOMICS, V55, P592, DOI 10.1080/00140139.2012.662527; Ewing KC, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00223; Fairclough SH, 2006, BIOL PSYCHOL, V71, P100, DOI 10.1016/j.biopsycho.2005.03.007; Fairclough SH, 2005, INT J PSYCHOPHYSIOL, V56, P171, DOI 10.1016/j.ijpsycho.2004.11.003; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Finnigan S, 2016, CLIN NEUROPHYSIOL, V127, P1452, DOI 10.1016/j.clinph.2015.07.014; Freeman J, 1999, PRESENCE-TELEOP VIRT, V8, P1, DOI 10.1162/105474699566017; Gamito P, 2010, STUD HEALTH TECHNOL, V154, P128, DOI 10.3233/978-1-60750-561-7-128; Green D, 2012, DISABIL REHABIL, V34, P593, DOI 10.3109/09638288.2011.613520; Green K, 2014, HISTORY OF WOMEN'S POLITICAL THOUGHT IN EUROPE, 1700-1800, P203; Gundel Alexander, 1992, Brain Topography, V5, P17, DOI 10.1007/BF01129966; Howard MC, 2017, COMPUT HUM BEHAV, V70, P317, DOI 10.1016/j.chb.2017.01.013; Hsieh LT, 2014, NEUROIMAGE, V85, P721, DOI 10.1016/j.neuroimage.2013.08.003; Imam B, 2014, REHABIL RES PRACT, V2014, DOI 10.1155/2014/594540; Imms C, 2017, DEV MED CHILD NEUROL, V59, P16, DOI 10.1111/dmcn.13237; Jancke L, 2009, FRONT NEUROSCI-SWITZ, V3, P52, DOI 10.3389/neuro.01.006.2009; Johnstone SJ, 2012, CLIN EEG NEUROSCI, V43, P112, DOI 10.1177/1550059411435857; Kao SC, 2013, J SPORT EXERCISE PSY, V35, P470, DOI 10.1123/jsep.35.5.470; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kober SE, 2012, INT J PSYCHOPHYSIOL, V83, P365, DOI 10.1016/j.ijpsycho.2011.12.003; Lalmas M., 2014, SYNTH LECT INF CONCE, V6, P1, DOI DOI 10.2200/S00605ED1V01Y201410ICR038; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Lee SH, 2015, J PHYS THER SCI, V27, P2285, DOI 10.1589/jpts.27.2285; Leiker AM, 2016, JMIR SERIOUS GAMES, V4, pE4, DOI 10.2196/games.5460; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P1599, DOI 10.1016/j.apmr.2004.03.027; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Lequerica AH, 2009, DISABIL REHABIL, V31, P753, DOI 10.1080/09638280802309095; Levin MF, 2011, EXPERT REV NEUROTHER, V11, P153, DOI 10.1586/ERN.10.201; Lewis GN, 2012, DISABIL REHABIL, V34, P1880, DOI 10.3109/09638288.2012.670036; Li C, 2016, ENG APPL ARTIF INTEL, V51, P182, DOI 10.1016/j.engappai.2016.01.021; Li C, 2014, INT J REHABIL RES, V37, P334, DOI 10.1097/MRR.0000000000000076; Lohse KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093318; Maclean N, 2000, BMJ-BRIT MED J, V321, P1051, DOI 10.1136/bmj.321.7268.1051; Maier M, 2019, NEUROREHAB NEURAL RE, V33, P112, DOI 10.1177/1545968318820169; McMahan T, 2015, PROCEDIA MANUF, V3, P2303, DOI 10.1016/j.promfg.2015.07.376; Miller BW, 2015, EDUC PSYCHOL-US, V50, P31, DOI 10.1080/00461520.2015.1004068; Mumford N, 2012, BRAIN INJURY, V26, P166, DOI 10.3109/02699052.2011.648706; Mumford N, 2010, BRAIN INJURY, V24, P780, DOI 10.3109/02699051003652807; Nagendra H, 2017, COGN SYST RES, V42, P42, DOI 10.1016/j.cogsys.2016.11.007; O'Brien HL, 2008, J AM SOC INF SCI TEC, V59, P938, DOI 10.1002/asi.20801; Ostir GV, 2008, PSYCHOSOM MED, V70, P404, DOI 10.1097/PSY.0b013e31816fd7d0; Perez MA, 2004, EXP BRAIN RES, V159, P197, DOI 10.1007/s00221-004-1947-5; POPE AT, 1995, BIOL PSYCHOL, V40, P187, DOI 10.1016/0301-0511(95)05116-3; Ratti E, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00398; Reinecke K, 2011, APPL PSYCHOPHYS BIOF, V36, P265, DOI 10.1007/s10484-011-9166-x; Rogers JM, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0531-y; Rogers JM, 2016, INT J PSYCHOPHYSIOL, V106, P87, DOI 10.1016/j.ijpsycho.2016.06.006; Ruffino C, 2017, NEUROSCIENCE, V341, P61, DOI 10.1016/j.neuroscience.2016.11.023; Salminen M, 2008, NEUROSCI LETT, V435, P69, DOI 10.1016/j.neulet.2008.02.009; Schleiger E, 2014, INT J PSYCHOPHYSIOL, V94, P19, DOI 10.1016/j.ijpsycho.2014.06.012; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; Seale GS, 2010, REHABIL PSYCHOL, V55, P33, DOI 10.1037/a0018744; de Oliveira SMS, 2018, NEUROL RES, V40, P160, DOI 10.1080/01616412.2017.1420584; Slobounov SM, 2015, INT J PSYCHOPHYSIOL, V95, P254, DOI 10.1016/j.ijpsycho.2014.11.003; Slobounov SM, 2000, COGNITIVE BRAIN RES, V9, P287, DOI 10.1016/S0926-6410(00)00009-4; Smith ME, 2001, HUM FACTORS, V43, P366, DOI 10.1518/001872001775898287; Stephenson W, 1967, PLAY THEORY MASS COM, P45; Toms EG, 2002, J AM SOC INF SCI TEC, V53, P855, DOI 10.1002/asi.10094; Triberti S, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02052; Valderrama JT, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aa8d95; Witmer BG, 2005, PRESENCE-TELEOP VIRT, V14, P298, DOI 10.1162/105474605323384654; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Wright RA, 2008, SOC PERSONAL PSYCHOL, V2, P682, DOI 10.1111/j.1751-9004.2008.00093.x; Yamada F, 1998, ERGONOMICS, V41, P678, DOI 10.1080/001401398186847; Zappasodi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141995; Zimmerli L, 2013, ARCH PHYS MED REHAB, V94, P1737, DOI 10.1016/j.apmr.2013.01.029	91	3	3	3	15	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1359-4338	1434-9957		VIRTUAL REAL-LONDON	Virtual Real.	JUN	2021	25	2					357	366		10.1007/s10055-020-00460-8		JUL 2020	10	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering; Imaging Science & Photographic Technology	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Imaging Science & Photographic Technology	SE2QO	WOS:000551380500001					2022-02-06	
J	Yuan, JY; Botchway, BOA; Zhang, Y; Wang, XZ; Liu, XH				Yuan, Jiaying; Botchway, Benson O. A.; Zhang, Yong; Wang, Xizhi; Liu, Xuehong			Role of Circular Ribonucleic Acids in the Treatment of Traumatic Brain and Spinal Cord Injury	MOLECULAR NEUROBIOLOGY			English	Article						Circular RNAs; Stem cells; Exosomes; Traumatic brain injury; Spinal cord injury; MicroRNAs	NEURAL STEM-CELLS; ISCHEMIC-STROKE; EXPRESSION ALTERATION; RNA; INFLAMMATION; AUTOPHAGY; EXOSOMES; RATS; DIFFERENTIATION; REGENERATION	The causal and pathogenetic factors linked to traumatic brain injury (TBI) and spinal cord injury (SCI) are complex. This complexity is a contributive factor in the minimal improvement outcomes of injured individuals. Several studies have demonstrated the potentiality of stem cells in facilitating neuronal growth and improve outcome in various neurological conditions, including TBI and SCI. However, the efficiency concerning stem cell delivery at injured sites is open to question. Circular ribonucleic acids (circular RNAs) have recently been the focus of attention owing to their disparate functions and features in vivo. Exosomes have close relationship with circular RNAs and might have a significant impact on circular RNA expressions. Herein, we reviewed the specific functions of circular RNAs, exosomes, and stem cells in central nervous system conditions, particularly TBI and SCI, and attempted to show the connection among them. Our analyses showed the role of circular RNAs in brain/spinal cord injuries to be multifaceted, as they can modulate several signaling mechanisms while also acting as sponges for microRNAs and binding to their sites. Additionally, circular RNAs can activate several biological, molecular, and cellular activities in the wake of brain/spinal cord injuries. Thus, both non-pharmacological and pharmacological interventions centered on the regulation of circular RNAs could be promising for TBI and SCI.	[Yuan, Jiaying; Zhang, Yong; Wang, Xizhi; Liu, Xuehong] Shaoxing Univ, Dept Histol & Embryol, Coll Med, Shaoxing 312000, Zhejiang, Peoples R China; [Botchway, Benson O. A.] Zhejiang Univ, Sch Med, Inst Neurosci, Hangzhou, Peoples R China		Liu, XH (corresponding author), Shaoxing Univ, Dept Histol & Embryol, Coll Med, Shaoxing 312000, Zhejiang, Peoples R China.	liuxueh6588@126.com	Botchway, Benson/ABD-3436-2021	Botchway, Benson/0000-0001-9732-7904; Liu, Xuehong/0000-0003-4325-6762	Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY19H170001]	This work was supported by the Natural Science Foundation of Zhejiang Province (Grant No. LY19H170001).	Akhter R, 2018, ADV EXP MED BIOL, V1087, P239, DOI 10.1007/978-981-13-1426-1_19; Bach DH, 2019, MOL THER-NUCL ACIDS, V16, P118, DOI 10.1016/j.omtn.2019.02.005; Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Barilani M, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102848; Braicu C, 2019, CELL MOL LIFE SCI, V76, P1559, DOI 10.1007/s00018-019-03016-5; Cao YQ, 2020, ARTIF CELL NANOMED B, V48, P594, DOI 10.1080/21691401.2020.1725536; Chen LL, 2015, RNA BIOL, V12, P381, DOI 10.1080/15476286.2015.1020271; Chen XL, 2018, INT IMMUNOPHARMACOL, V59, P287, DOI 10.1016/j.intimp.2018.04.020; Chen ZH, 2019, EXP NEUROL, V313, P37, DOI 10.1016/j.expneurol.2018.12.003; Cherubini A, 2019, NUCLEIC ACIDS RES, V47, P5325, DOI 10.1093/nar/gkz199; Clark DPQ, 2019, NEUROCHEM RES, V44, P1410, DOI 10.1007/s11064-019-02721-8; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Dey M, 2012, CURR NEUROL NEUROSCI, V12, P24, DOI 10.1007/s11910-011-0231-x; Errichelli L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14741; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Furlan JC, 2016, WORLD NEUROSURG, V88, P166, DOI 10.1016/j.wneu.2015.12.072; Gomes-Osman J, 2016, J NEUROTRAUM, V33, P425, DOI 10.1089/neu.2014.3812; Guo S, 2019, EUR J PHARMACOL, V849, P50, DOI 10.1016/j.ejphar.2019.01.057; Guo Y, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1003-5; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Huang HR, 2019, CANCER BIOL THER, V20, P73, DOI 10.1080/15384047.2018.1507254; Huang X, 2018, EXP CELL RES, V371, P269, DOI 10.1016/j.yexcr.2018.08.021; Jeong SI, 2016, NEUROBIOL AGING, V44, P74, DOI 10.1016/j.neurobiolaging.2016.04.007; Jiang YJ, 2019, J NEUROTRAUM, V36, P1018, DOI 10.1089/neu.2018.5647; Kaka G, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3389/fnins.7016.00025, 10.3389/fnins.2016.00025]; Katoh H, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00248; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kim JY, 2015, CNS NEUROSCI THER, V21, P309, DOI 10.1111/cns.12360; Li XB, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0976-0; Li X, 2017, BIOMATERIALS, V137, P73, DOI 10.1016/j.biomaterials.2017.05.027; Lien BV, 2019, EXP NEUROL, V314, P46, DOI 10.1016/j.expneurol.2019.01.006; Liu XH, 2018, ANAT REC, V301, P686, DOI 10.1002/ar.23729; Liu YD, 2020, J MOL NEUROSCI, V70, P1894, DOI 10.1007/s12031-020-01586-9; Lu YH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00209; Luo ML, 2019, NEUROCHEM RES, V44, P2765, DOI 10.1007/s11064-019-02897-z; Luo YJ, 2019, BRAIN RES BULL, V146, P320, DOI 10.1016/j.brainresbull.2019.01.027; Lv T, 2018, CANCER MED-US, V7, P6147, DOI 10.1002/cam4.1613; Mao SS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2027-x; Mietto BS, 2015, J NEUROSCI, V35, P16431, DOI 10.1523/JNEUROSCI.2119-15.2015; Mohammadshirazi A, 2019, J CELL PHYSIOL, V234, P20742, DOI 10.1002/jcp.28680; Pacurari M, 2019, NEUROSCIENCE, V398, P263, DOI 10.1016/j.neuroscience.2018.12.010; Pan ZQ, 2019, J NEUROSCI, V39, P2125, DOI 10.1523/JNEUROSCI.1631-18.2018; Qin C, 2019, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00497; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Qu XL, 2020, J NEUROSCI RES, V98, P1485, DOI 10.1002/jnr.24591; Qu Y, 2017, J CELL MOL MED, V21, P2491, DOI 10.1111/jcmm.13170; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shao AW, 2016, MOL NEUROBIOL, V53, P18, DOI 10.1007/s12035-014-8986-0; Su YJ, 2019, J CELL PHYSIOL, V234, P14259, DOI 10.1002/jcp.28124; Sun BL, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1046-3; Theus MH, 2017, J IMMUNOL, V199, P3547, DOI 10.4049/jimmunol.1700251; Vinukonda G, 2013, EXP NEUROL, V247, P630, DOI 10.1016/j.expneurol.2013.02.018; Wang CX, 2017, J BIOMATER TISS ENG, V7, P655, DOI 10.1166/jbt.2017.1611; Wang GT, 2020, EBIOMEDICINE, V52, DOI 10.1016/j.ebiom.2020.102660; Wang H, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0056-7; Wang Y, 2020, DIFFERENTIATION, V113, P10, DOI 10.1016/j.diff.2020.03.001; Wu FF, 2019, J NEUROSCI, V39, P7369, DOI 10.1523/JNEUROSCI.0299-19.2019; Xie BS, 2018, J NEUROTRAUM, V35, P1659, DOI 10.1089/neu.2017.5468; Xie F, 2019, J CELL BIOCHEM, V120, P3428, DOI 10.1002/jcb.27614; Yang J, 2018, ADV EXP MED BIOL, V1087, P309, DOI 10.1007/978-981-13-1426-1_25; Yang L, 2020, CIRCULATION, V142, P556, DOI 10.1161/CIRCULATIONAHA.120.045765; Yang QC, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0651-1; Yang XL, 2018, BIOCHEM BIOPH RES CO, V499, P758, DOI 10.1016/j.bbrc.2018.03.218; Yang YB, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx166; Yokota K, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-018-0422-3; Yorke AM, 2016, PHYS THER, V96, P1018, DOI 10.2522/ptj.20140598; Yuan JY, 2020, STEM CELL REV REP, V16, P323, DOI 10.1007/s12015-019-09927-x; Zhang X, 2019, BIOCHEM BIOPH RES CO, V511, P551, DOI 10.1016/j.bbrc.2019.02.082; Zhang Y, 2019, J CELL BIOCHEM, V120, P14372, DOI 10.1002/jcb.28693; Zhang ZK, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4689-7; Zhao RT, 2018, J NEUROTRAUM, V35, P2056, DOI 10.1089/neu.2017.5502; Zhou J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00091; Zhou ZB, 2019, J NEUROTRAUM, V36, P2287, DOI 10.1089/neu.2018.6366; Zhou ZB, 2018, MOL THER-NUCL ACIDS, V12, P718, DOI 10.1016/j.omtn.2018.07.011; Zhu LH, 2018, CELL PHYSIOL BIOCHEM, V49, P2264, DOI 10.1159/000493829; Zhu N, 2020, CELL BIOL INT, V44, P785, DOI 10.1002/cbin.11273	79	3	3	3	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	OCT	2020	57	10					4296	4304		10.1007/s12035-020-02027-9		JUL 2020	9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NJ1KR	WOS:000551396900002	32700251				2022-02-06	
J	Knell, G; Burkhart, SO; Caze, TJ; Polousky, JD; Kohl, HW; Messiah, SE				Knell, Gregory; Burkhart, Scott O.; Caze, Todd J.; Polousky, John D.; Kohl, Harold W., III; Messiah, Sarah E.			Association Between Concussion History and Factors Relating to Cognitive, Behavioral, and Emotional Health Among American High School Athletes: A Cross-sectional Analysis	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; epidemiology; adolescent; athlete	TRAUMATIC BRAIN-INJURY; UNITED-STATES; SPORTS; PREVALENCE; OUTCOMES; ADOLESCENTS; POPULATION; RECOVERY; CHILDREN; RISK	Background: The cognitive, behavioral, and emotional deficits that may be associated with sports-related concussions among adolescents are unclear. Purpose: We examined the association between reported concussion history and factors relating to cognitive, behavioral, and emotional health among a population-based sample of US high school-aged adolescents. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Participants included a representative sample of US high school student-athletes who reported a concussion history (in the past 12 months) and relevant behaviors/outcomes within 3 domains: cognitive (academics, difficulty concentrating), behavioral (drinking and driving, carrying a weapon, physically fighting, tobacco use, marijuana use, binge drinking), and emotional (symptoms of depression, suicidal thoughts/actions). The adjusted relative odds of experiencing 0 and at least 1, 2, 3, or >= 4 concussions were modeled while mutually adjusting for the behaviors of interest in addition to age, race/ethnicity, and sleep problems. Data were reported in sex stratum. Results: A total of 13,268 participants were included in the unweighted data set. Overall, 14.5% (95% CI, 12.9%-16.2%) of female and 18.1% (95% CI, 16.4%-19.8%) of male student-athletes had at least 1 concussion in the past 12 months. As compared with those who reported not engaging in any of the behaviors deleterious to health or having had any of the negative health outcomes (composite score of 0), female athletes with composite scores of 1 to 4, 5 to 7, and 8 to 11 were 1.94 (95% CI, 1.55-2.43), 3.13 (95% CI, 2.30-4.33), and 6.05 (95% CI, 3.75-9.75) times more likely to have a recent history of concussions after accounting for relevant factors. As compared with those having a composite score of 0, male athletes with composite scores of 1 to 4, 5 to 7, and 8 to 11 were 2.03 (95% CI, 1.58-2.59), 3.80 (95% CI, 2.71-5.34), and 8.23 (95% CI, 4.91-13.77) times more likely to have a recent history of concussions after accounting for relevant factors. Conclusion: Self-reported concussions among US high school athletes is related to several deleterious health behaviors and outcomes. These associations should be confirmed in longitudinal analyses.	[Knell, Gregory; Burkhart, Scott O.; Caze, Todd J.; Polousky, John D.; Kohl, Harold W., III; Messiah, Sarah E.] Univ Texas Hlth Sci Ctr Houston, Ctr Pediat Populat Hlth, Dallas, TX 75390 USA; [Knell, Gregory; Kohl, Harold W., III; Messiah, Sarah E.] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Dallas, TX 75390 USA; [Knell, Gregory; Burkhart, Scott O.; Caze, Todd J.; Polousky, John D.] Childrens Hlth Andrews Inst Orthopaed & Sports Me, Plano, TX USA; [Caze, Todd J.] Univ Texas Southwestern Med Ctr Dallas, Peter ODonnell Jr Brain Inst, Dallas, TX 75390 USA; [Kohl, Harold W., III] Univ Texas Hlth Sci Ctr Houston, Michael & Susan Ctr Hlth Living, Austin, TX USA; [Kohl, Harold W., III] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA		Knell, G (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Dallas, TX 75390 USA.	Gregory.Knell@uth.tmc.edu		Messiah, Sarah/0000-0001-6685-2175			Andrade C, 2015, J CLIN PSYCHIAT, V76, pE857, DOI 10.4088/JCP.15f10150; Buckley L, 2017, J PUBLIC HEALTH-UK, V39, P52, DOI 10.1093/pubmed/fdw009; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Diehl K, 2012, J SPORT SCI MED, V11, P201; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Enders CK, 2011, REHABIL PSYCHOL, V56, P267, DOI 10.1037/a0025579; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Gadbury G L, 2003, Obes Rev, V4, P175, DOI 10.1046/j.1467-789X.2003.00109.x; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Gornall A, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6235; Grossner EC, 2019, NEUROPSYCHOLOGY SPOR, V2019, P119; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Ilie G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135860; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1; Koh JO, 2004, BRAIN INJURY, V18, P1287, DOI 10.1080/02699050410001719907; Kontos A. P., 2018, CONCUSSION CLIN PROF; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lisha NE, 2010, ADDICT BEHAV, V35, P399, DOI 10.1016/j.addbeh.2009.12.032; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrea MA, 2017, NEUROL CLIN, V35, P487, DOI 10.1016/j.ncl.2017.03.005; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Rosenbaum JE, 2009, AM J EPIDEMIOL, V169, P1388, DOI 10.1093/aje/kwp049; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Veliz P, 2021, SUBST ABUS, V42, P183, DOI 10.1080/08897077.2019.1671938; Veliz P, 2019, JAMA PEDIATR, V173, P399, DOI 10.1001/jamapediatrics.2019.0001; Wangnoo T, 2020, J NEUROTRAUM, V37, P1401, DOI 10.1089/neu.2018.5721; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Yang MN, 2019, AM J HEALTH BEHAV, V43, P258, DOI 10.5993/AJHB.43.2.3	45	3	3	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	AUG	2020	48	10					2534	2543	0363546520938776	10.1177/0363546520938776		JUL 2020	10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	MS8TC	WOS:000552003200001	32692937				2022-02-06	
J	Torres, AC; Bebarta, VS; April, MD; Maddry, JK; Herson, PS; Bebarta, EK; Schauer, S				Torres, Allee C.; Bebarta, Vikhyat S.; April, Michael D.; Maddry, Joseph K.; Herson, Paco S.; Bebarta, Emma K.; Schauer, Steven			Ketamine Administration in Prehospital Combat Injured Patients With Traumatic Brain Injury: A 10-Year Report of Survival	CUREUS			English	Article						ketamine; head; trauma; military; prehospital; tccc	RAPID-SEQUENCE INTUBATION; IRAQ; PRESSURE; MANAGEMENT; ANESTHESIA; ETOMIDATE; SEDATION; INCREASE	Background The Tactical Combat Casualty Care (TCCC) guidelines recommend ketamine as the primary battlefield analgesic in the setting of moderate-to-severe pain and hemodynamic compromise. However, despite recent studies failing to support the association between ketamine and worse outcomes in head trauma, TCCC guidelines state that ketamine may worsen severe traumatic brain injury. We compared mortality outcomes following head trauma sustained in a combat setting between ketamine recipients and non-recipients. Methods This is a secondary analysis of previously published data in the Department of Defense Trauma Registry from January 2007 to August 2016. We isolated patients with an abbreviated injury scale of 3 or greater for the head body region. We compared mortality between prehospital ketamine recipients and non-recipients. Results Our initial search yielded 28,222 patients, of which 4,183 met the inclusion criteria: 209 were ketamine-recipients and 3,974 were non-recipients. The ketamine group had a higher percentage injured by explosives (59.81% vs. 53.57%, p<0.001) and gunshot wounds (28.71% vs. 22.07%, p<0.001) and were more frequently located in Afghanistan (100% vs. 68.0%, p<0.001). The ketamine group had higher rates of tourniquet application (24.4% vs. 8.5%, p<0.001) and had lower survival proportion (75.1% alive vs. 83.0%, p=0.003). All differences were significant. On univariable analysis, the ketamine group had worse odds of survival with (OR: 0.62; 95%CI: 0.45 0.86). When controlling for the presence of an airway intervention and mechanism of injury, the finding was non-significant (OR: 1.09; 95% CI: 0.76 1.55). Conclusions In our prehospital combat study, after controlling for confounders, we found no association between administration of prehospital ketamine and worse survival outcomes for casualties with head injuries. However, despite the lack of difference in overall survival noted, those who received ketamine and died had a higher risk ratio for time to death.	[Torres, Allee C.] Univ Colorado, Sch Med, Emergency Med, Aurora, CO 80045 USA; [Bebarta, Vikhyat S.; Bebarta, Emma K.] Univ Colorado, Emergency Med, Anschutz Med Campus, Aurora, CO USA; [April, Michael D.] San Antonio Uniformed Serv Hlth Educ Consortium S, Emergency Med, Ft Sam Houston, TX USA; [Maddry, Joseph K.] Brooke Army Med Ctr, Emergency Med, Ft Sam Houston, TX 78234 USA; [Maddry, Joseph K.] Uniformed Serv Univ Hlth Sci, Mil & Emergency Med, Bethesda, MD USA; [Herson, Paco S.] Univ Colorado, Sch Med, Anesthesiol, Aurora, CO USA; [Bebarta, Emma K.] Cherry Creek High Sch, Other, Greenwood Village, CO USA; [Schauer, Steven] US Army, Inst Surg Res, Off Senior Scientist, San Antonio, TX USA; [Schauer, Steven] US Army, Inst Surg Res, Joint Base Sam Houston, San Antonio, TX USA		Torres, AC (corresponding author), Univ Colorado, Sch Med, Emergency Med, Aurora, CO 80045 USA.	allee.torres@cuanschutz.edu					Benov A, 2017, J TRAUMA ACUTE CARE, V83, pS150, DOI 10.1097/TA.0000000000001481; Blackburn MB, 2018, J TRAUMA ACUTE CARE, V85, pS154, DOI 10.1097/TA.0000000000001866; Butler FK, 2017, MIL MED, V182, pE1563, DOI 10.7205/MILMED-D-16-00214; Butler Frank K, 2014, J Spec Oper Med, V14, P13; Chang LC, 2013, CNS NEUROSCI THER, V19, P390, DOI 10.1111/cns.12077; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; Committee on the Assessment of the Readjustment Needs of Military Personnel Veterans and Their Families; Board on the Health of Select Populations; Institute of Medicine, 2013, RET HOM IR AFGH ASS; Farrell Deacon, 2018, Curr Anesthesiol Rep, V8, P279, DOI 10.1007/s40140-018-0286-1; Grathwohl KW, 2008, ANESTHESIOLOGY, V109, P44, DOI 10.1097/ALN.0b013e31817c02e3; Green SM, 1998, ANN EMERG MED, V31, P688, DOI 10.1016/S0196-0644(98)70226-4; Green SM, 2015, ANN EMERG MED, V65, P52, DOI 10.1016/j.annemergmed.2014.08.025; Green SM, 2011, ANN EMERG MED, V57, P449, DOI 10.1016/j.annemergmed.2010.11.030; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Li LD, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00612; McGhee LL, 2008, J TRAUMA, V64, pS195, DOI 10.1097/TA.0b013e318160ba1d; McGhee LL, 2014, MIL MED, V179, P41, DOI 10.7205/MILMED-D-13-00481; Robinson John B, 2016, US Army Med Dep J, P87; Schauer Stephen G, 2017, US Army Med Dep J, P92; Schauer SG, 2018, SOUTH MED J, V111, P707, DOI 10.14423/SMJ.0000000000000906; Schauer SG, 2018, PREHOSP EMERG CARE, V22, P624, DOI 10.1080/10903127.2018.1439130; Schauer SG, 2019, PREHOSP EMERG CARE, V23, P271, DOI 10.1080/10903127.2018.1489022; Schauer SG, 2018, AM J EMERG MED, V36, P1540, DOI 10.1016/j.ajem.2018.01.014; Schauer SG, 2019, AM J EMERG MED, V37, P94, DOI 10.1016/j.ajem.2018.04.068; Schauer Steven G, 2015, J Spec Oper Med, V15, P85; Upchurch CP, 2017, ANN EMERG MED, V69, P24, DOI 10.1016/j.annemergmed.2016.08.009; Wang X, 2014, J ANESTH, V28, P821, DOI 10.1007/s00540-014-1845-3; Wedmore IS, 2017, WILD ENVIRON MED, V28, pS109, DOI 10.1016/j.wem.2017.04.001; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y	29	3	3	1	3	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL 17	2020	12	7							e9248	10.7759/cureus.9248			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	MM0MY	WOS:000549855600015	32821594	gold, Green Published			2022-02-06	
J	Zhang, EW; Wan, XD; Yang, LJ; Wang, D; Chen, ZS; Chen, Y; Liu, MH; Zhang, GS; Wu, JL; Han, HE; Fan, ZZ				Zhang, Erwei; Wan, Xiangdong; Yang, Lijun; Wang, Dong; Chen, Zeshang; Chen, Yan; Liu, Minghao; Zhang, Gengshen; Wu, Jianliang; Han, Haie; Fan, Zhenzeng			Omega-3 Polyunsaturated Fatty Acids Alleviate Traumatic Brain Injury by Regulating the Glymphatic Pathway in Mice	FRONTIERS IN NEUROLOGY			English	Article						omega-3 polyunsaturated fatty acid; traumatic brain injury; glymphatic system; aquaporin-4; blood-brain barrier; epilepsy	PREVENTION; RECOVERY	Background:The glymphatic pathway has been shown to be impaired in traumatic brain injury (TBI). Omega-3 polysaturated fatty acids (Omega-3, PUFAs) are involved in the clearance of amyloid-ss through the glymphatic system and this effect is Aquaporin-4 (AQP4) dependent. We hypothesize that Omega-3 PUFAs can alleviate neurological impairment in TBI by protecting the glymphatic pathway. Methods:We pretreated mice with Omega-3 PUFAs rich fish oil and introduced TBI in the mice. Neurological functions were assessed through the modified neurological severity score (mNSS) system and Rota-rod test. Ass42 levels and radioisotope clearance were examined to determine the function of glymphatic system. AQP4 protein and mRNA expressions and its polarity were examined in fish oil treated TBI mice or control mice. Finally, the integrity of blood-brain barrier was determined by Evans blue extravasation and measurement of tight junction proteins (ZO-1 and Occludin) levels. Results:TBI surgery induced significant neurological functional impairment, Omega-3 PUFAs attenuated TBI-induced neurological impairment, as evidenced by reduced mNSS, improved performance in the Rota-rod test. Furthermore, Omega-3 PUFAs improved glymphatic clearance after induction of TBI in mice, reduced Ass42 accumulation, partially restored the clearance of both(3)H-mannitol and(14)C-Inulin. Omega-3 PUFAs also suppressed AQP4 expression and partially prevented loss of AQP4 polarity in mice undergoing TBI. Finally, Omega-3 PUFAs protected mice from TBI induced blood-brain barrier disruption. Conclusion:Omaga-3 PUFAs attenuate neurological function by partially restoring the AQP4 dependent glymphatic system in mice with TBI.	[Zhang, Erwei; Wan, Xiangdong; Yang, Lijun; Chen, Zeshang; Chen, Yan; Liu, Minghao; Zhang, Gengshen; Wu, Jianliang; Han, Haie; Fan, Zhenzeng] Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang, Hebei, Peoples R China; [Wang, Dong] Hebei Med Univ, Dept Neurol, Hosp 2, Shijiazhuang, Hebei, Peoples R China		Fan, ZZ (corresponding author), Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang, Hebei, Peoples R China.	fanzhenzeng@126.com			Natural Science Foundation of Hebei Province, ChinaNatural Science Foundation of Hebei Province [H2018206325]; foundation of 2019 clinical medicine training program of Hebei Province	This project was supported by Natural Science Foundation of Hebei Province, China. (Grant No. H2018206325) and foundation of 2019 clinical medicine training program of Hebei Province.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Cai MF, 2017, AGING DIS, V8, P531, DOI 10.14336/AD.2017.0520; Calon F, 2007, PROSTAG LEUKOTR ESS, V77, P287, DOI 10.1016/j.plefa.2007.10.019; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dyall SC, 2008, NEUROMOL MED, V10, P219, DOI 10.1007/s12017-008-8036-z; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Gundersen GA, 2014, BRAIN STRUCT FUNCT, V219, P2181, DOI 10.1007/s00429-013-0629-0; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Johnson EJ, 2006, AM J CLIN NUTR, V83, p1494S, DOI 10.1093/ajcn/83.6.1494S; Keaney J, 2015, FEBS J, V282, P4067, DOI 10.1111/febs.13412; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Mader S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020090; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Ren HX, 2017, FASEB J, V31, P282, DOI 10.1096/fj.201600896; Salberg S, 2017, NEUROSCIENCE, V365, P146, DOI 10.1016/j.neuroscience.2017.09.053; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016; Verheggen ICM, 2018, NEUROSCI BIOBEHAV R, V90, P26, DOI 10.1016/j.neubiorev.2018.03.028; Wei F, 2019, PSYCHOPHARMACOLOGY, V236, P1367, DOI 10.1007/s00213-018-5147-6; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Xu ZQ, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0056-1; Zhang MK, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0295-2	28	3	3	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 17	2020	11								707	10.3389/fneur.2020.00707			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MW3IC	WOS:000556934100001	32765412	Green Published, gold			2022-02-06	
J	Hampson, N; King, L; Eriksson, LM; Smee, H				Hampson, Natalie; King, Lorraine; Eriksson, Linda-Mary; Smee, Hannah			The effects of relaxation training on depression and anxiety in people living with long-term neurological conditions	DISABILITY AND REHABILITATION			English	Article						Relaxation training; rehabilitation; anxiety; depression; long-term neurological conditions	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; HOSPITAL ANXIETY; PARKINSONS-DISEASE; THERAPY; NEUROPSYCHIATRY; REHABILITATION; MANAGEMENT; DISORDERS	Purpose:The present study investigated the effects of a relaxation training program on self-reported depression and anxiety in participants living with long-term neurological conditions, including acquired brain injury, stroke, Parkinson's disease, and multiple sclerosis. Materials and methods: A five-session relaxation training program, plus a follow-up session was offered to people living with a long-term neurological condition as part of routine clinical practice, and was delivered in their own homes. A self-report measure (Hospital Anxiety and Depression Scale) was administered at the pre- and post-intervention time points and at follow-up, around 5 weeks after the final session. Participants also completed an individual assessment of change questionnaire at follow-up, reporting on subjective views of observed changes. Results:Statistically significant improvements were found on measures of both anxiety and depression following completion of the relaxation program. Scores at follow-up (mean = 5 weeks) revealed the improvement was maintained for anxiety, and there was further significant improvement for depression. Reliable change analyses from pre- to post-intervention demonstrated a clinically significant decrease in anxiety scores for 47% of participants and in depression scores for 30% of participants. No clinically significant increase in depression and anxiety was identified from pre- to post-intervention, and this was generally maintained at follow-up. Conclusion:Relaxation training is proposed as a clinically effective treatment for anxiety and depression in people living with long-term neurological conditions, which could in turn lead to better functional outcomes of neurorehabilitation. The program investigated here has additional benefits of being delivered in people's own homes, which overcomes barriers to attending hospital, and is consistent with trends towards home as opposed to hospital care. This program may also be less costly to administer as it can be delivered as part of a stepped-care program by therapy assistants under supervision from qualified staff, and encourages self-management over the longer term. Design limitations may reduce the generalisability of these findings, but are clinically encouraging and should stimulate further research.	[Hampson, Natalie] Sheffield Childrens Hosp, Dept Paediat Clin Psychol, Sheffield, S Yorkshire, England; [King, Lorraine] Salford Royal NHS Fdn Trust, Dept Clin Neuropsychol, Clin Sci Bldg,Stott Lane, Salford M6 8HD, Lancs, England; [Eriksson, Linda-Mary] Alternat Futures Grp, Manchester, Lancs, England; [Smee, Hannah] Greater Manchester Mental Hlth NHS Fdn Trust, Manchester, Lancs, England		King, L (corresponding author), Salford Royal NHS Fdn Trust, Dept Clin Neuropsychol, Clin Sci Bldg,Stott Lane, Salford M6 8HD, Lancs, England.	lorraine.king@srft.nhs.uk					Arnold SD, 2008, NEURO-ONCOLOGY, V10, P171, DOI 10.1215/15228517-2007-057; Ayis SA, 2018, J AFFECT DISORDERS, V228, P33, DOI 10.1016/j.jad.2017.11.037; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Bertisch HC, 2013, REHABIL PSYCHOL, V58, P429, DOI 10.1037/a0034554; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Brookmann F, 2016, CLIN PSYCHOL FORUM, V288, P17; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; CHRISTENSEN L, 1986, BEHAV THER, V17, P305, DOI 10.1016/S0005-7894(86)80060-0; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Davies F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014575; Dayapoglu N, 2012, J ALTERN COMPLEM MED, V18, P983, DOI 10.1089/acm.2011.0390; Dehdari T, 2009, INDIAN J MED RES, V129, P603; Dobkin Roseanne DeFronzo, 2008, Expert Rev Neurother, V8, P27, DOI 10.1586/14737175.8.1.27; Esch Tobias, 2003, Med Sci Monit, V9, pRA23; Feinstein A, 2004, CAN J PSYCHIAT, V49, P157, DOI 10.1177/070674370404900302; Ferreri F, 2006, CAN MED ASSOC J, V175, P1545, DOI 10.1503/cmaj.060542; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Gage H, 2004, CLIN REHABIL, V18, P463, DOI 10.1191/0269215504cr764oa; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Golding K, 2016, CLIN REHABIL, V30, P174, DOI 10.1177/0269215515575746; Hahn VC, 2011, J OCCUP HEALTH PSYCH, V16, P202, DOI 10.1037/a0022169; Halstead JE, 2014, STRUCTURED REHABILIT, P6; Hampson NE, 2014, STRUCTURED REHABILIT; Honarmand K, 2009, MULT SCLER J, V15, P1518, DOI 10.1177/1352458509347150; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Kanji N, 2004, AM HEART J, V147, pK1, DOI 10.1016/j.ahj.2003.10.011; Kesselring J, 2005, LANCET NEUROL, V4, P643, DOI 10.1016/S1474-4422(05)70193-9; Lobentanz IS, 2004, ACTA NEUROL SCAND, V110, P6, DOI 10.1111/j.1600-0404.2004.00257.x; Manzoni GM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-41; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Mishra K, 2012, ANN INDIAN ACAD NEUR, V15, P247, DOI 10.4103/0972-2327.104328; Mohr DC, 2001, J CONSULT CLIN PSYCH, V69, P942, DOI 10.1037//0022-006X.69.6.942; Neuendorf R, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/902708; Rickards H, 2005, J NEUROL NEUROSUR PS, V76, pI48, DOI 10.1136/jnnp.2004.060426; Royal College of Physicians National Council for Palliative Care British Society of Rehabilitation Medicine, 2008, CONCISE GUIDANCE GOO, V10; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Snaith RP, 1994, HADS HOSP ANXIETY DE; Steptoe A, 2005, NEUROBIOL AGING, V26, pS108, DOI 10.1016/j.neurobiolaging.2005.08.016; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	3	3	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUL 16	2020	42	15					2100	2105		10.1080/09638288.2018.1554009			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	MN6GG	WOS:000550936800003	30653375				2022-02-06	
J	Dickerson, MR; Bailey, ZS; Murphy, SF; Urban, MJ; VandeVord, PJ				Dickerson, Michelle R.; Bailey, Zachary Stephen; Murphy, Susan F.; Urban, Michael J.; VandeVord, Pamela J.			Glial Activation in the Thalamus Contributes to Vestibulomotor Deficits Following Blast-Induced Neurotrauma	FRONTIERS IN NEUROLOGY			English	Article						thalamus; amygdala; blast; vestibulomotor; microglia; astrocytes; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; OXIDATIVE STRESS; EXPOSURE; MECHANISMS; ANXIETY; MODEL; CONSEQUENCES; MACROPHAGES; IMPAIRMENT	Vestibular impairment has become a frequent consequence following blast-related traumatic brain injury (bTBI) in military personnel and Veterans. Behavioral outcomes such as depression, fear and anxiety are also common comorbidities of bTBI. To accelerate pre-clinical research and therapy developments, there is a need to study the link between behavioral patterns and neuropathology. The transmission of neurosensory information often involves a pathway from the cerebral cortex to the thalamus, and the thalamus serves crucial integrative functions within vestibular processing. Pathways from the thalamus also connect with the amygdala, suggesting thalamic and amygdalar contributions to anxiolytic behavior. Here we used behavioral assays and immunohistochemistry to determine the sub-acute and early chronic effects of repeated blast exposure on the thalamic and amygdala nuclei. Behavioral results indicated vestibulomotor deficits at 1 and 3 weeks following repeated blast events. Anxiety-like behavior assessments depicted trending increases in the blast group. Astrogliosis and microglia activation were observed upon post-mortem pathological examination in the thalamic region, along with a limited glia response in the amygdala at 4 weeks. These findings are consistent with a diffuse glia response associated with bTBI and support the premise that dysfunction within the thalamic nuclei following repeated blast exposures contribute to vestibulomotor impairment.	[Dickerson, Michelle R.; Bailey, Zachary Stephen; Murphy, Susan F.; Urban, Michael J.; VandeVord, Pamela J.] Virginia Tech, Coll Engn, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [VandeVord, Pamela J.] Salem VA Med Ctr, Salem, VA USA		VandeVord, PJ (corresponding author), Virginia Tech, Coll Engn, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.; VandeVord, PJ (corresponding author), Salem VA Med Ctr, Salem, VA USA.	pvord@vt.edu			Merit Review Award from United States Department of Veterans Affairs Rehabilitation Research and Development Service Program [RX001104-01]	This work was supported by Merit Review Award number RX001104-01 from the United States Department of Veterans Affairs Rehabilitation Research and Development Service Program (PI: PV).	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Arun P, 2020, J NEUROTRAUM, V37, P647, DOI 10.1089/neu.2019.6591; Bailey ZS, 2016, METHODS MOL BIOL, V1462, P119, DOI 10.1007/978-1-4939-3816-2_8; Bailey ZS, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00064; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Baldwin SA, 1996, GLIA, V16, P266; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bohne P, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00051; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Denby E, 2020, J HEAD TRAUMA REHAB, V35, P57, DOI 10.1097/HTR.0000000000000468; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fang WR, 2018, THERANOSTICS, V8, P3530, DOI 10.7150/thno.24475; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Franco-Bocanegra DK, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060639; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Han K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00231; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hitier M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00059; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lien S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00297; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lopez J, 2009, J NEUROSCI, V29, P3302, DOI 10.1523/JNEUROSCI.5576-08.2009; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mikkelsen HB, 2017, ANAT REC, V300, P1114, DOI 10.1002/ar.23517; Miller AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173167; Mitchell AS, 2005, EUR J NEUROSCI, V22, P973, DOI 10.1111/j.1460-9568.2005.04199.x; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Phillips Y., 1991, CONVENTIONAL WARFARE, V1, P271; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Rajagopalan Archana, 2017, J Nat Sci Biol Med, V8, P11, DOI 10.4103/0976-9668.198350; Rao KVR, 2018, J NEUROTRAUM, V35, P2077, DOI 10.1089/neu.2017.5358; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Robel S, 2016, NAT NEUROSCI, V19, P28, DOI 10.1038/nn.4184; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Rushby JA, 2016, NEUROIMAGE-CLIN, V12, P607, DOI 10.1016/j.nicl.2016.09.017; Rusiecki J, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1624-z; SAGGAR M, 2019, NEUROBIOL PAIN, V6; Sajja Venkata Siva Sai S, 2012, Biomed Sci Instrum, V48, P374; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2015, SHOCK, V44, P71, DOI 10.1097/SHK.0000000000000311; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Sharp BM, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.161; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Studlack PE, 2018, BRAIN INJURY, V32, P1866, DOI 10.1080/02699052.2018.1536282; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; van Groen T, 2002, BEHAV BRAIN RES, V132, P19, DOI 10.1016/S0166-4328(01)00390-4; van Wageningen TA, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0850-z; Vertes RP, 2012, NEUROSCIENCE, V219, P120, DOI 10.1016/j.neuroscience.2012.04.067; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Wijesinghe R, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00079; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	77	3	3	6	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 15	2020	11								618	10.3389/fneur.2020.00618			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MX0YZ	WOS:000557455400001	32760340	Green Published, gold			2022-02-06	
J	Lewis, JM; Dhawan, S; Obirieze, AC; Sarno, B; Akers, J; Heller, MJ; Chen, CC				Lewis, Jean M.; Dhawan, Sanjay; Obirieze, Augustine C.; Sarno, Benjamin; Akers, Johnny; Heller, Michael J.; Chen, Clark C.			Plasma Biomarker for Post-concussive Syndrome: A Pilot Study Using an Alternating Current Electro-Kinetic Platform	FRONTIERS IN NEUROLOGY			English	Article						alternating current electrokinetics; traumatic brain injury; biomarkers; extracellular vesicles; concussion	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE; CELL-FREE DNA; MARKER; CLASSIFICATION; SYSTEM; DAMAGE; GFAP	Background:Technology platforms that afford biomarker discovery in patients suffering from traumatic brain injury (TBI) remain an unmet medical need. Here, we describe an observational pilot study to explore the utility of an alternating current electrokinetic (ACE) microchip device in this context. Methods:Blood samples were collected from participating subjects with and without minor TBI. Plasma levels of glial fibrillary acidic protein (GFAP), Tau, ubiquitin C-terminal hydrolase L1 (UCH-L1), and cell-free DNA (cfDNA) were determined in subjects with and without minor TBI using ACE microchip device followed by on-chip immunofluorescent analysis. Post-concussive symptoms were assessed using the Rivermead Post Concussion Symptoms Questionnaire (RPCSQ) at one-month follow-up. Results:Highest levels of GFAP, UCH-L1, and Tau were seen in two minor TBI subjects with abnormality on head computed tomography (CT). In patients without abnormal head CT, Tau and GFAP levels discriminated between plasma from minor-TBI and non-TBI patients, with sensitivity and specificity of 64-72 and 50%, respectively. Plasma GFAP, UCH-L1, and Tau strongly correlated with the cumulative RPCSQ score. Plasma UCH-L1 and GFAP exhibited highest correlation to sensitivity to noise and light (r= 0.96 and 0.91, respectively,p< 0.001). Plasma UCH-L1 and Tau showed highest correlation with headache (r= 0.74 and 0.78, respectively,p< 0.001), sleep disturbance (r= 0.69 and 0.84, respectively,p< 0.001), and cognitive symptoms, including forgetfulness (r= 0.76 and 0.74, respectively,p< 0.001), poor concentration (r= 0.68 and 0.76, respectively,p< 0.001), and time required for information processing (r= 0.77 and 0.81, respectively,p< 0.001). cfDNA exhibited a strong correlation with depression (r= 0.79,p< 0.01) and dizziness (r= 0.69,p< 0.01). While cfDNA demonstrated positive correlation with dizziness and depression (r= 0.69 and 0.79, respectively,p< 0.001), no significant correlation was observed between cumulative RPCSQ and cfDNA (r= 0.07,p= 0.81). Conclusion:We provide proof-of-principle results supporting the utility of ACE microchip for plasma biomarker analysis in patients with minor TBI.	[Lewis, Jean M.; Obirieze, Augustine C.; Sarno, Benjamin; Heller, Michael J.] Univ Calif San Diego, Dept Nanoengn, San Diego, CA 92103 USA; [Dhawan, Sanjay; Chen, Clark C.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Akers, Johnny] VisiCELL Med Inc, San Diego, CA USA; [Heller, Michael J.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA		Chen, CC (corresponding author), Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.	ccchen@umn.edu		Lewis, Jean/0000-0001-6978-5166	DOD grant [W81XWH-14-20192]; National Science Foundation (NSF) Graduate Research Fellowship Program (GRFP) award [DGE-1650112]	This work was supported by DOD grant #W81XWH-14-20192 to MH and CC. Fellowship support was provided to AO by a National Science Foundation (NSF) Graduate Research Fellowship Program (GRFP) award under Grant #DGE-1650112.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Bishop P, 2016, BIOCHEM J, V473, P2453, DOI 10.1042/BCJ20160082; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Brenner M, 2014, NEUROSCI LETT, V565, P7, DOI 10.1016/j.neulet.2014.01.055; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Ibsen SD, 2017, ACS NANO, V11, P6641, DOI 10.1021/acsnano.7b00549; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; Kanmert D, 2015, J NEUROSCI, V35, P10851, DOI 10.1523/JNEUROSCI.0387-15.2015; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lee Bruce, 2005, NeuroRx, V2, P372; Lewis J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46311-8; Lewis JM, 2018, ACS NANO, V12, P3311, DOI 10.1021/acsnano.7b08199; Liu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178049; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mouliere F, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809323; Notturno F, 2008, MUSCLE NERVE, V38, P899, DOI 10.1002/mus.20983; Notturno F, 2009, MUSCLE NERVE, V40, P50, DOI 10.1002/mus.21323; Ohayon S, 2012, J NEUROTRAUM, V29, P261, DOI 10.1089/neu.2011.1938; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rodrigues EM, 2014, J NEUROTRAUM, V31, P1639, DOI 10.1089/neu.2013.3178; Rogg Jeffrey, 2014, R I Med J (2013), V97, P22; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sonnenberg A, 2014, ELECTROPHORESIS, V35, P1828, DOI 10.1002/elps.201400016; TEASDALE G, 1974, LANCET, V2, P81; Tomita K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214381	42	3	3	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 14	2020	11								685	10.3389/fneur.2020.00685			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MV4CT	WOS:000556308500001	32760343	Green Published, gold			2022-02-06	
J	Ayala, N; Heath, M				Ayala, Naila; Heath, Matthew			Executive Dysfunction after a Sport-Related Concussion Is Independent of Task-Based Symptom Burden	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; behavioral assessments; cognitive function; human studies	EXPRESS SACCADES; REACTION-TIMES; SWITCH-COST; OCULOMOTOR; DEFICITS; ANTISACCADES; HISTORY	A sport-related concussion (SRC) results in short- and long-term deficits in oculomotor control; however, it is unclear whether this change reflects executive dysfunction and/or a performance decrement caused by an increase in task-based symptom burden. Here, individuals with a SRC - and age- and sex-matched controls - completed an antisaccade task (i.e., saccade mirror-symmetrical to a target) during the early (initial assessment <= 12 days) and later (follow-up assessment <30 days) stages of recovery. Antisaccades were used because they require top-down executive control and exhibit performance decrements following an SRC. Reaction time (RT) and directional errors were included with pupillometry, because pupil size in the antisaccade task has been shown to provide a neural proxy for executive control. In addition, the Sport-Concussion Assessment Tool (SCAT-5) symptom checklist was completed prior to and after each oculomotor assessment to identify a possible task-based increase in symptomology. The SRC group yielded longer initial assessment RTs, more directional errors, and larger task-evoked pupil dilations (TEPD) than the control group. At the follow-up assessment, RTs for the SRC and control group did not reliably differ; however, the former demonstrated more directional errors and larger TEPDs. SCAT-5 symptom severity scores did not vary from the pre- to post-oculomotor evaluation for either initial or follow-up assessments. Accordingly, an SRC imparts a persistent executive dysfunction to oculomotor planning independent of a task-based increase in symptom burden. These findings evince that antisaccades serve as an effective tool to identify subtle executive deficits during the early and later stages of SRC recovery.	[Ayala, Naila; Heath, Matthew] Univ Western Ontario, Sch Kinesiol, London, ON N6A 3K7, Canada; [Ayala, Naila; Heath, Matthew] Univ Western Ontario, Grad Program Neurosci, London, ON N6A 3K7, Canada		Heath, M (corresponding author), Univ Western Ontario, Sch Kinesiol, London, ON N6A 3K7, Canada.; Heath, M (corresponding author), Univ Western Ontario, Grad Program Neurosci, London, ON N6A 3K7, Canada.	mheath2@uwo.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; University of Western Ontario	This research was supported by the Natural Sciences and Engineering Research Council of Canada, and Academic Development Fund and Faculty Scholar Awards from the University of Western Ontario.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chan JL, 2013, EXP BRAIN RES, V227, P301, DOI 10.1007/s00221-013-3452-1; Clough M, 2018, J NEUROTRAUM, V35, P730, DOI 10.1089/neu.2017.5204; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Covassin T, 2013, BRAIN INJURY, V27, P1589, DOI 10.3109/02699052.2013.823656; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; DeSimone JC, 2014, VISION RES, V96, P17, DOI 10.1016/j.visres.2013.12.005; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Edelman JA, 2006, VISION RES, V46, P1411, DOI 10.1016/j.visres.2005.09.013; Everling S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0068; FISCHER B, 1984, EXP BRAIN RES, V57, P191; FISCHER B, 1992, EXP BRAIN RES, V89, P415; Fischer TD, 2016, J NEUROTRAUM, V33, P1237, DOI 10.1089/neu.2015.3990; Gezeck S, 1997, VISION RES, V37, P2119, DOI 10.1016/S0042-6989(97)00022-9; Gillen C, 2014, EXP BRAIN RES, V232, P3201, DOI 10.1007/s00221-014-4010-1; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Heath M, 2017, J ALZHEIMERS DIS, V56, P167, DOI 10.3233/JAD-160627; Heath M, 2011, EXP BRAIN RES, V209, P117, DOI 10.1007/s00221-010-2525-7; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Karatekin C, 2010, SCHIZOPHRENIA BULL, V36, P1167, DOI 10.1093/schbul/sbp035; Kleiner M, 2007, PERCEPTION, V36, P14; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Lakens D, 2018, ADV METH PRACT PSYCH, V1, P259, DOI 10.1177/2515245918770963; Lehmann SJ, 2016, J NEUROSCI, V36, P3765, DOI 10.1523/JNEUROSCI.4264-15.2016; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Mathot Sebastiaan, 2018, J Cogn, V1, P16, DOI 10.5334/joc.18; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDowell JE, 2002, BIOL PSYCHIAT, V51, P216, DOI 10.1016/S0006-3223(01)01204-5; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Peltsch A, 2014, EUR J NEUROSCI, V39, P2000, DOI 10.1111/ejn.12617; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wang CA, 2016, NEUROPSYCHOLOGIA, V80, P176, DOI 10.1016/j.neuropsychologia.2015.11.019; Wang CA, 2015, EUR J NEUROSCI, V41, P1102, DOI 10.1111/ejn.12883; Webb B, 2018, J NEUROTRAUM, V35, P1874, DOI 10.1089/neu.2018.5673; Weiler J, 2015, BEHAV BRAIN RES, V278, P323, DOI 10.1016/j.bbr.2014.10.012; Weiler J, 2014, J NEUROPHYSIOL, V112, P2176, DOI 10.1152/jn.00352.2014; Weiler J, 2012, NEUROSCI LETT, V530, P150, DOI 10.1016/j.neulet.2012.10.007; WENBANSMITH MG, 1991, EXP BRAIN RES, V87, P218; Winn MB, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518800869; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	46	3	3	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2558	2568		10.1089/neu.2019.6865		JUL 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000547888200001	32438897				2022-02-06	
J	Garland, J; Ondruschka, B; Stables, S; Morrow, P; Kesha, K; Glenn, C; Tse, R				Garland, Jack; Ondruschka, Benjamin; Stables, Simon; Morrow, Paul; Kesha, Kilak; Glenn, Charley; Tse, Rexson			Identifying Fatal Head Injuries on Postmortem Computed Tomography Using Convolutional Neural Network/Deep Learning: A Feasibility Study	JOURNAL OF FORENSIC SCIENCES			English	Article						head; injuries; traumatic brain injury; postmortem computed tomography; convoluted neural network; deep learning; subarachnoid hemorrhage; SAH; autopsy; forensic radiology	ARTIFICIAL-INTELLIGENCE; FORENSIC AUTOPSY; PMCT	Postmortem computed tomography (PMCT) is a relatively recent advancement in forensic pathology practice that has been increasingly used as an ancillary investigation and screening tool. One area of clinical CT imaging that has garnered a lot of research interest recently is the area of "artificial intelligence" (AI), such as in screening and computer-assisted diagnostics. This feasibility study investigated the application of convolutional neural network, a form of deep learning AI, to PMCT head imaging in differentiating fatal head injury from controls. PMCT images of a transverse section of the head at the level of the frontal sinus from 25 cases of fatal head injury were combined with 25 nonhead-injury controls and divided into training and testing datasets. A convolutional neural network was constructed using Keras and was trained against the training data before being assessed against the testing dataset. The results of this study demonstrated an accuracy of between 70% and 92.5%, with difficulties in recognizing subarachnoid hemorrhage and in distinguishing congested vessels and prominent falx from head injury. These results are promising for potential applications as a screening tool or in computer-assisted diagnostics in the future.	[Garland, Jack] Forens & Analyt Sci Serv, 480 Weeroona Rd, Lidcombe, NSW 2141, Australia; [Ondruschka, Benjamin] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, Martinistr 52, D-20251 Hamburg, Germany; [Stables, Simon; Morrow, Paul; Kesha, Kilak; Glenn, Charley; Tse, Rexson] Auckland City Hosp, Dept Forens Pathol, LabPLUS, 2 Pk Rd, Auckland 1023, New Zealand; [Tse, Rexson] Univ Auckland, Fac Med & Hlth Sci, 85 Pk Rd, Auckland 1023, New Zealand		Tse, R (corresponding author), Auckland City Hosp, Dept Forens Pathol, LabPLUS, 2 Pk Rd, Auckland 1023, New Zealand.; Tse, R (corresponding author), Univ Auckland, Fac Med & Hlth Sci, 85 Pk Rd, Auckland 1023, New Zealand.	rexsont@adhb.govt.nz	Tse, Rexson/Y-1939-2019	Tse, Rexson/0000-0002-1388-9537			Chan S, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20180416; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Chollet F., 2015, KERAS; Ebert LC, 2017, FORENSIC SCI MED PAT, V13, P426, DOI 10.1007/s12024-017-9906-1; Flach PM, 2014, FORENSIC SCI MED PAT, V10, P583, DOI 10.1007/s12024-014-9555-6; Grabherr S, 2017, FOREN SCI RES, V2, P52, DOI 10.1080/20961790.2017.1330738; Hosny A, 2018, NAT REV CANCER, V18, P500, DOI 10.1038/s41568-018-0016-5; Le Blanc-Louvry I, 2013, EUR RADIOL, V23, P1829, DOI 10.1007/s00330-013-2779-0; Lefevre T, 2018, J FORENSIC LEG MED, V57, P1, DOI 10.1016/j.jflm.2017.08.001; Legrand L, 2020, J NEURORADIOLOGY, V47, P5, DOI 10.1016/j.neurad.2019.03.008; Miller DD, 2018, AM J MED, V131, P129, DOI 10.1016/j.amjmed.2017.10.035; Moskala A, 2016, LEGAL MED-TOKYO, V18, P25, DOI 10.1016/j.legalmed.2015.11.005; O'Sullivan Shane, 2019, Brain Inform, V6, P3, DOI 10.1186/s40708-019-0096-3; O'Sullivan Shane, 2017, Autops Case Rep, V7, P3, DOI 10.4322/acr.2017.037; Prevedello LM, 2017, RADIOLOGY, V285, P923, DOI 10.1148/radiol.2017162664; Schmitt-Sody M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0231-6; Shirota G, 2017, INT J LEGAL MED, V131, P1647, DOI 10.1007/s00414-017-1651-1; Thomsen AH, 2009, FORENSIC SCI INT, V183, P87, DOI 10.1016/j.forsciint.2008.10.019; Yasaka K, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002707; Zhu GM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00869	20	3	3	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	NOV	2020	65	6					2019	2022		10.1111/1556-4029.14502		JUL 2020	4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	OL9KU	WOS:000546143200001	32639630				2022-02-06	
J	Hammond, FM; Ketchum, J; Dams-O'Connor, K; Corrigan, JD; Miller, C; Haarbauer-Krupa, J; Faul, M; Trexler, LE; Harrison-Felix, C				Hammond, Flora M.; Ketchum, Jessica; Dams-O'Connor, Kristen; Corrigan, John D.; Miller, Cate; Haarbauer-Krupa, Juliet; Faul, Mark; Trexler, Lance E.; Harrison-Felix, Cynthia			Mortality Secondary to Unintentional Poisoning after Inpatient Rehabilitation among Individuals with Moderate to Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						accidental poisoning; mortality; narcotics; opioids; rehabilitation; traumatic brain injury; unintentional poisoning	DRUG OVERDOSE DEATHS; HEAD-INJURY; RATING-SCALE; CHRONIC PAIN; UNITED-STATES; VALIDITY; HISTORY; COMPLETION; DISABILITY; ACCURACY	Studies have shown reduced life expectancy following moderate-severe traumatic brain injury (TBI) with death from unintentional poisoning (UP) being 11 times higher following TBI than in the general population. The characteristics of those who die of unintentional poisoning are compared with the characteristics of those who die of other causes (OC) in a retrospective cohort who received inpatient rehabilitation following TBI and enrolled in the TBI Model Systems National Database between 1989 and 2017 (n = 15,835 cases with 2,238 deaths recorded). Seventy-eight cases (3.5%) of deaths were the result of UP, 76% were the result of OC, and 20.5% were from an unknown cause. Among the UP deaths, 90% involved drugs (of these, 67% involved narcotic drugs and 14% involved psychostimulants), and 8% involved alcohol. Age-adjusted risk for UP death was associated with: white/non-Hispanic race/ethnicity, living alone, non-institutionalization, pre- and post-injury illicit drug use and alcohol/drug problem use, any alcohol use at last follow-up, better Functional Independence Measure(TM)(FIM) scores, history of arrest, moderate disability (vs. severe disability or good recovery), less supervision needed, and greater anxiety. Adults who receive inpatient rehabilitation for TBI who die from UP are distinguishable from those who die of OC. Factors such as pre-injury substance use in the context of functional independence may be regarded as targets for prevention and/or intervention to reduce substance use and substance-related mortality among survivors of moderate-severe TBI. The current findings may have implications for medical care, surveillance, prevention, and health promotion.	[Hammond, Flora M.; Trexler, Lance E.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Hammond, Flora M.; Trexler, Lance E.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Ketchum, Jessica; Harrison-Felix, Cynthia] Craig Hosp, Res Dept, Englewood, CO USA; [Ketchum, Jessica; Harrison-Felix, Cynthia] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, Dept Rehabil Med, New York, NY 10029 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Miller, Cate] Natl Inst Disabil Independent Living & Rehabil Re, Adm Community Living, Dept Hlth & Human Serv, Washington, DC USA; [Haarbauer-Krupa, Juliet; Faul, Mark] Ctr Dis Control & Prevent, Traumat Brain Injury Team, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	Flora.hammond@rhin.com		Faul, Mark/0000-0002-7683-0348	United States Department of Health and Human Services (HHS), CDCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [90DP0013, 90DP0084]; United States Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR) [90DP0013, 90DP0084]; NIDILRR: Indiana University School of Medicine/Rehabilitation Hospital of Indiana [90DP0036, 90DRTB0002]; NIDILRR: Icahn School of Medicine at Mount Sinai [90DP0038, 90DPTB0009]; NIDILRR: Ohio State University [90DP0040]; NIDILRR: Traumatic Brain Injury Model Systems National Data and Statistical Center at Craig Hospital [90DP0013, 90DP0084]; National Institutes of Health, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [K01HD074651-01A1]; CDCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [5 NU17CE002721-03-00]	This research was supported by an interagency agreement between the United States Department of Health and Human Services (HHS), CDC, and the United States Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR) with supplemental funding to the NIDRR-funded Traumatic Brain Injury Model Systems National Data and Statistical Center (Grant Numbers 90DP0013 and 90DP0084). In 2014, NIDRR was moved to the Administration for Community Living (ACL) within HHS, and renamed the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDLRR). The contents of this publication were developed under grants from the NIDILRR: Indiana University School of Medicine/Rehabilitation Hospital of Indiana (Grant Numbers 90DP0036 and 90DRTB0002), Icahn School of Medicine at Mount Sinai (Grant Numbers 90DP0038 and 90DPTB0009), Ohio State University (Grant Number 90DP0040), and Traumatic Brain Injury Model Systems National Data and Statistical Center at Craig Hospital (Grant Numbers 90DP0013 and #90DP0084), by a grant from the National Institutes of Health, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (Grant Number K01HD074651-01A1), and by a grant from the CDC (Grant Number 5 NU17CE002721-03-00). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, CDC, or HHS, and endorsement by the federal government should not be assumed.	Alexandridis AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227350; [Anonymous], 2019, TRAUM BRAIN INJ MOD; Beaulieu-Bonneau S, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000341; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Centers for Disease Control and Prevention Behavioral, 2013, RISK FACT SURV SYST; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Finkelman MD, 2017, DRUG ALCOHOL DEPEN, V178, P94, DOI 10.1016/j.drugalcdep.2017.04.016; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Hedegaard Holly, 2018, Natl Vital Stat Rep, V67, P1; KIRCHER T, 1987, JAMA-J AM MED ASSOC, V258, P349, DOI 10.1001/jama.258.3.349; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; McHugo GJ, 2017, J HEAD TRAUMA REHAB, V32, pE65, DOI 10.1097/HTR.0000000000000249; Mertz KJ, 2014, J FORENSIC SCI, V59, P1583, DOI 10.1111/1556-4029.12541; Messite J, 1996, JAMA-J AM MED ASSOC, V275, P794, DOI 10.1001/jama.275.10.794; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Opioid Therapy for Chronic Pain Work Group (US), 2017, VA DOD CLIN PRACT GU; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; SAS Institute Inc, 2002, SAS V 9 4; Scholl L, 2019, MMWR-MORBID MORTAL W, V67, P1419; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Shaw E, 2018, PM&R, V10, P681, DOI 10.1016/j.pmrj.2018.05.004; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Slavova S, 2015, PUBLIC HEALTH REP, V130, P339, DOI 10.1177/003335491513000411; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Substance Abuse and Mental Health Services Administration, 2019, NSDUH SER H, VPEP19-5068; U. S. Department of Health and Human Services and U. S. Department of Agriculture, 2015 2020 DIET GUID; United States Department of Health and Human Services, 2017, DET NAT PUBL HLTH EM; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Winstanley EL, 2018, DRUG ALCOHOL DEPEN, V188, P169, DOI 10.1016/j.drugalcdep.2018.03.036; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007	53	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2507	2516		10.1089/neu.2020.7038		JUL 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000547886400001	32438850	Green Published			2022-02-06	
J	Johnston, W; Heiderscheit, B; Coughlan, G; McLoughlin, R; Liston, M; Brooks, MA; Caulfield, B				Johnston, William; Heiderscheit, Bryan; Coughlan, Garrett; McLoughlin, Rod; Liston, Mairead; Brooks, M. Alison; Caulfield, Brian			Concussion Recovery Evaluation Using the Inertial Sensor Instrumented Y Balance Test	JOURNAL OF NEUROTRAUMA			English	Article						digital health; mild traumatic brain injury; postural control; rehabilitation; sports medicine	POSTURAL-CONTROL; NEUROMUSCULAR CONTROL; CEREBRAL CONCUSSION; CONTROL DEFICITS; INJURY; RISK; RETURN	The current sports concussion assessment paradigm lacks reliability, has learning effects, and is not sufficiently challenging for athletes. As a result, subtle deficits in sensorimotor function may be unidentified, increasing the risk of future injury. This study examined if the inertial-sensor instrumented Y Balance test could capture concussion-induced alterations in dynamic movement control. A cohort of 226 elite Rugby Union, American football, and ice hockey athletes were evaluated using the inertial-sensor instrumented Y balance test. Dynamic balance performance was quantified using normalized reach distance, jerk magnitude root-mean-squared (Jerk Mag RMS), and gyroscope magnitude sample entropy (Gyro Mag SEn). Concussed athletes who consented to follow-up were evaluated 24 to 48 h post-injury, and at the point of return to full contact training (RTP). Seventeen athletes sustained a concussion and consented to both the 24- to 48-h and RTP follow-up testing. Twenty uninjured control athletes were re-tested 6 months following initial screening. Concussed athletes had reductions in normalized reach distance (Cohens D = 0.66-1.16) and Jerk Mag (Cohens D = 0.57-1.14) 24 to 48 h post-injury, which returned to pre-injury levels by the point of RTP. There was no significant difference in performance between the baseline and 6-month follow-up in the 20 uninjured athletes (Cohens D = 0.06-0.51). There was a statistically significant linear association between Jerk Mag RMS 24 to 48 h post-injury and the natural log of RTP duration (R-2 = 0.27 to 0.33). These results indicate that concussed athletes possessed alterations in dynamic movement control 24 to 48 h post-concussion, which typically returns to pre-injury levels by the point of RTP. Further, evaluation of dynamic movement control 24 to 48 h post-injury may aid in the evaluation of recovery prognosis.	[Johnston, William; Caulfield, Brian] Univ Coll Dublin, Insight Ctr Data Analyt, Dublin, Ireland; [Johnston, William; Caulfield, Brian] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Heiderscheit, Bryan; Brooks, M. Alison] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI USA; [Heiderscheit, Bryan; Brooks, M. Alison] Univ Wisconsin, Badger Athlet Performance, Madison, WI USA; [McLoughlin, Rod; Liston, Mairead] Irish Rugby Football Union, Dublin, Ireland; [Coughlan, Garrett] Connacht Rugby, Galway, Ireland		Johnston, W (corresponding author), Univ Coll Dublin, Insight Ctr Data Analyt, Dublin, Ireland.	william.johnston@insight-centre.org			Science Foundation of IrelandScience Foundation Ireland [12/RC/2289_P2]	This study was supported by the Science Foundation of Ireland (12/RC/2289_P2).	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Howell DR, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab3552; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Johnston W., 2017, CONCUSSION, V2, P28; Johnston W., 2018, 6 INT C SPORTS SCI R, P63; Johnston W., 2019, THESIS; Johnston W, 2019, IEEE ENG MED BIO, P2063, DOI 10.1109/EMBC.2019.8857628; Johnston W, 2019, SPORTS MED, V49, P783, DOI 10.1007/s40279-019-01095-9; Johnston William, 2017, Digit Biomark, V1, P106, DOI 10.1159/000485470; Johnston W, 2017, QJM-INT J MED, V110, P779, DOI 10.1093/qjmed/hcw228; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGeown JP, 2020, SPORTS MED, V50, P1191, DOI 10.1007/s40279-019-01240-4; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Pantall A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01044; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Rugby Football Union, 2015, ENGL PROF RUGB INJ S; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; World Rugby, 2015, HEAD INJ ASS HIA PRO	33	3	3	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2549	2557		10.1089/neu.2020.7040		JUL 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000556941500001	32394801	Green Submitted			2022-02-06	
J	Zhong, YH; Zheng, BE; He, RH; Zhou, Z; Zhang, SQ; Wei, Y; Fan, JZ				Zhong, Yu H.; Zheng, Bi E.; He, Ren H.; Zhou, Zhou; Zhang, Sheng Q.; Wei, Yi; Fan, Jian Z.			Serum Levels of HDL Cholesterol are Associated with Diffuse Axonal Injury in Patients with Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Diffuse axonal injury; HDL cholesterol	DENSITY-LIPOPROTEIN CHOLESTEROL; IN-VITRO; TRANSPORT; STATINS; COMA	Background It is well known that lipids are vital for axonal myelin repair. Diffuse axonal injury (DAI) is characterized by widespread axonal injury. The association between serum lipids and DAI is not well known. The purpose of this study was to investigate the associations of serum lipid profile variables (triglycerides, high- and low-density lipoproteins, and total cholesterol) with DAI detected by magnetic resonance imaging (MRI) and with clinical outcome for patients suffering from traumatic brain injury (TBI). Methods This study included 176 patients with a history of TBI who had undergone initial serum lipid measurements within 1 week and brain MRIs within 30 days. Based on MRI findings, patients were divided into negative and positive DAI groups. Results Of the 176 patients, 70 (39.8%) were assigned to DAI group and 106 (60.2%) patients to non-DAI group. Compared with the non-DAI group, patients with DAI had significantly lower levels of high-density lipoprotein cholesterol (HDL-C) in serum during the first week following TBI. Multivariate analysis identified HDL-C as an independent predictor of DAI. Patients with lower serum HDL-C levels were less likely to regain consciousness within 6 months in TBI patients with DAI lesions identified by MRI. Conclusions Plasma levels of HDL-C may be a viable addition to biomarker panels for predicting the presence and prognosis of DAI on subsequent MRI following TBI.	[Zhong, Yu H.; Zheng, Bi E.; He, Ren H.; Zhou, Zhou; Zhang, Sheng Q.; Wei, Yi; Fan, Jian Z.] Southern Med Univ, Nanfang Hosp, Dept Rehabil Med, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China		Zhong, YH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Rehabil Med, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China.	zhongbinyue@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81802250]; Presidential Foundation of Nanfang Hospital [2017C031]	This study was supported by the National Natural Science Foundation of China (Grant No. 81802250) and the Presidential Foundation of Nanfang Hospital (Grant No. 2017C031).	Abu Hamdeh S, 2018, J NEUROSURG, V14, P1; Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Balazs Z, 2004, J NEUROCHEM, V89, P939, DOI 10.1111/j.1471-4159.2004.02373.x; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; BORGHINI I, 1995, BBA-LIPID LIPID MET, V1255, P192, DOI 10.1016/0005-2760(94)00232-N; Burger Danielle, 2002, Autoimmunity Reviews, V1, P111, DOI 10.1016/S1568-9972(01)00018-0; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Fellows K, 2015, J LIPID RES, V56, P2010, DOI 10.1194/jlr.M060970; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Haley RW, 2000, ARCH NEUROL-CHICAGO, V57, P1410, DOI 10.1001/archneur.57.10.1410; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Hottman DA, 2014, NEUROBIOL DIS, V72, P22, DOI 10.1016/j.nbd.2014.07.015; Jang SH, 2015, NEUROSCI LETT, V590, P58, DOI 10.1016/j.neulet.2015.01.071; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Klopfleisch S, 2008, J NEUROSCI, V28, P13609, DOI 10.1523/JNEUROSCI.2765-08.2008; Li L, 2019, NEURAL REGEN RES, V14, P1573, DOI 10.4103/1673-5374.255972; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mu J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00217; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Ohno N, 2019, NEUROSCI RES, V139, P48, DOI 10.1016/j.neures.2018.08.013; ROHEIM PS, 1979, P NATL ACAD SCI USA, V76, P4646, DOI 10.1073/pnas.76.9.4646; Rosenson RS, 1996, ARCH INTERN MED, V156, P1278, DOI 10.1001/archinte.156.12.1278; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tang CH, 2017, J CRIT CARE, V39, P267, DOI 10.1016/j.jcrc.2016.12.012; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Yoo RE, 2019, EUR RADIOL, V29, P1308, DOI 10.1007/s00330-018-5656-z; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050; Zhong YH, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00261	40	3	3	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2021	34	2					465	472		10.1007/s12028-020-01043-w		JUL 2020	8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SD6RK	WOS:000546516400001	32642967				2022-02-06	
J	Weeden, M; Bailey, M; Gabbe, B; Pilcher, D; Bellomo, R; Udy, A				Weeden, M.; Bailey, M.; Gabbe, B.; Pilcher, D.; Bellomo, R.; Udy, A.			Functional Outcomes in Patients Admitted to the Intensive Care Unit with Traumatic Brain Injury and Exposed to Hyperoxia: A Retrospective Multicentre Cohort Study	NEUROCRITICAL CARE			English	Article						Hyperoxia; Critical care; Traumatic brain injury; Functional neurological outcome; Glasgow Outcome Score-Extended; Oxygen toxicity	VENTILATED PATIENTS; OXYGEN-THERAPY; MAJOR TRAUMA; MORTALITY; ILL	Background Supplemental oxygen administration to critically ill patients is ubiquitous in the intensive care unit (ICU). Uncertainty persists as to whether hyperoxia is benign in patients with traumatic brain injury (TBI), particularly in regard to their long-term functional neurological outcomes. Methods We conducted a retrospective multicenter cohort study of invasively ventilated patients with TBI admitted to the ICU. A database linkage between the Australian and New Zealand Intensive Care Society Adult Patient Database (ANZICS-APD) and the Victorian State Trauma Registry (VSTR) was utilized. The primary exposure variable was minimum acute physiology and chronic health evaluation (APACHE) III P(a)O(2)in the first 24 h of ICU. We defined hypoxia as PaO2 < 60 mmHg, normoxia as 60-299 mmHg, and hyperoxia as >= 300 mmHg. The primary outcome was a Glasgow Outcome Scale-Extended (GOSE) < 5 at 6 months while secondary outcomes included 12 and 24 months GOSE and mortality at each of these timepoints. Additional sensitivity analyses were undertaken in the following subgroups: isolated head injury, patients with operative intervention, head injury severity, and P(a)O(2)either subcategorized by increments of 60 mmHg or treated as a continuous variable. Results A total of 3699 patients met the inclusion criteria. The mean age was 42.8 years, 77.7% were male and the mean acute physiology and chronic health evaluation (APACHE) III score was 60.1 (26.3). 2842 patients experienced normoxia, and 783 hyperoxia. The primary outcome occurred in 1470 (47.1%) of patients overall with 1123 (47.1%) from the normoxia group and 312 (45.9%) from the hyperoxia group-odds ratio 0.99 (0.78-1.25). No significant differences in outcomes between groups at 6, 12, and 24 months were observed. Sensitivity analyses did not identify subgroups that were adversely affected by exposure to hyperoxia. Conclusions No associations were observed between hyperoxia in ICU during the first 24 h and adverse neurological outcome at 6 months in ventilated TBI patients.	[Weeden, M.; Pilcher, D.; Udy, A.] Alfred, Dept Intens Care & Hyperbar Med, 55 Commercial Rd, Melbourne, Vic 3004, Australia; [Bailey, M.; Pilcher, D.; Bellomo, R.; Udy, A.] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia; [Gabbe, B.] Monash Univ, Dept Epidemiol & Prevent Med, Victorian State Trauma Registry, 553 St Kilda Rd, Melbourne, Vic 3004, Australia; [Pilcher, D.] Australian & New Zealand Intens Care Soc Ctr Outc, 10 Levers Terrace, Melbourne, Vic 3053, Australia; [Bellomo, R.] Austin Hosp, Dept Intens Care Med, 145 Studley Rd, Melbourne, Vic 3084, Australia		Weeden, M (corresponding author), Alfred, Dept Intens Care & Hyperbar Med, 55 Commercial Rd, Melbourne, Vic 3004, Australia.	weeden.mark.c@gmail.com			National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [GNT1124532]; State Health Department of Australia; Territory Health Department of Australia; New Zealand Ministry of Health; Department of Health and Human Services, State Government of Victoria; Transport Accident Commission	Professor Andrew Udy gratefully acknowledges salary support from the National Health and Medical Research Council of Australia (Early Career Fellowship; GNT1124532). ANZICS CORE is funded by the State and Territory Health Departments of Australia and the New Zealand Ministry of Health to monitor performance and provide benchmarking services to ICUs and Health Departments throughout both countries. The VSTR is a Department of Health and Human Services, State Government of Victoria and Transport Accident Commission funded project.	Asfar P, 2017, LANCET RESP MED, V5, P180, DOI 10.1016/S2213-2600(17)30046-2; Asfar P, 2015, INTENS CARE MED, V41, P1118, DOI 10.1007/s00134-015-3670-z; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Briain DO, 2018, NEUROCRIT CARE, V29, P443, DOI 10.1007/s12028-018-0553-5; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; de Jonge E, 2008, CRIT CARE, V12, DOI 10.1186/cc7150; Ekegren CL, 2016, INJURY, V47, P130, DOI 10.1016/j.injury.2015.08.002; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Jeong JH, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021758; Lang M, 2018, ACTA ANAESTH SCAND, V62, P801, DOI 10.1111/aas.13093; Mackle D, 2020, NEW ENGL J MED, V382, P989, DOI 10.1056/NEJMoa1903297; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003; Palmer E, 2019, AM J RESP CRIT CARE, V200, P1373, DOI 10.1164/rccm.201904-0849OC; Panwar R, 2013, ANAESTH INTENS CARE, V41, P505, DOI 10.1177/0310057X1304100412; Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; Russell DW, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0370-1; Suzuki S, 2013, J CRIT CARE, V28, P647, DOI 10.1016/j.jcrc.2013.03.010; Taher A, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.26772; Tarnow-Mordi W, 2016, NEW ENGL J MED, V374, P749, DOI 10.1056/NEJMoa1514212; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Young PJ, 2015, CRIT CARE RESUSC, V17, P202	28	3	3	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2021	34	2					441	448		10.1007/s12028-020-01033-y		JUL 2020	8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SD6RK	WOS:000545877800001	32632905	Green Published, Bronze			2022-02-06	
J	Albicini, M; Eggleston, M; McKinlay, A				Albicini, Michelle; Eggleston, Matthew; McKinlay, Audrey			The prevalence of traumatic brain injury, comorbid anxiety and other psychiatric disorders in an outpatient child and adolescent mental health service	JOURNAL OF MENTAL HEALTH			English	Article						Head injury; children; youth; psychiatric disorders; assessment	TERM BEHAVIOR PROBLEMS; CLOSED-HEAD INJURY; 1ST 6 MONTHS; LONG-TERM; MILD; PREDICTORS; SYMPTOMS; OUTCOMES; RELIABILITY; POPULATION	Background: A history of traumatic brain injury (TBI) is prevalent in children and adolescents within the health system, which may be accompanied with higher rates of poor mental health outcomes including anxiety and other psychiatric disorders. Aims: To explore rates of TBI and associated anxiety and other psychiatric diagnoses in children and adolescents aged 5-18 years within the mental health system. Methods: Participants were recruited from an outpatient mental health service in Canterbury, New Zealand. The Ohio State University TBI Identification method was utilised to ascertain TBI history. Anxiety and other diagnoses were identified by a mental health file review. Results: Over 28% of children in this study reported a history of TBI, the majority of which were mild. Review of mental health files revealed no significant differences between participants with and without TBI for anxiety and psychiatric diagnoses. Conclusions: A proportionately high number of children and adolescents within the mental health system reported a previous TBI. However, anxiety and other psychiatric problems were not over-represented in this group. Further research is essential for examining the characteristics of children and adolescents with TBI within the mental health system, particularly those with more severe injuries, who may present a subgroup.	[Albicini, Michelle] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Psychol Sci, Clayton, Vic, Australia; [Albicini, Michelle; McKinlay, Audrey] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Eggleston, Matthew] Canterbury Dist Hlth Board, Child & Family Specialty Serv, Christchurch, New Zealand		Albicini, M (corresponding author), Monash Univ, Sch Psychol Sci, 18 Innovat Walk,Clayton Campus,Wellington Rd, Clayton, Vic 3800, Australia.	michelle.albicini@monash.edu		McKinlay, Audrey/0000-0001-9846-8514			Albicini M., 2015, FRESH LOOK ANXIETY D, P199, DOI [10.5772/57353, DOI 10.5772/57353, DOI 10.5772/60426]; Albicini M., 2014, TRAUMATIC BRAIN INJU, P3; Albicini M, 2015, J CLIN EXP NEUROPSYC, V37, P776, DOI 10.1080/13803395.2015.1053843; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Bennett S, 2016, ANXIETY DISORDERS CH; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brinks V, 2007, PROG BRAIN RES, V167, P257, DOI 10.1016/S0079-6123(07)67019-8; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kurowski BG, 2013, PM&R, V5, P1026, DOI 10.1016/j.pmrj.2013.08.589; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; Max JE, 2015, J PEDIATR REHAB MED, V8, P345, DOI 10.3233/PRM-150352; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P187, DOI 10.1176/appi.neuropsych.12010011; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2014, INCIDENCE RATES TRAU; McKinlay A, 2017, DISABIL REHABIL, V39, P1296, DOI 10.1080/09638288.2016.1193905; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Seeman M., 1997, AJP, V154, P4501; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wittchen HU, 1998, PSYCHOL MED, V28, P109, DOI 10.1017/S0033291797005928; Zubrick, 2015, MENTAL HLTH CHILDREN	47	3	3	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0963-8237	1360-0567		J MENT HEALTH	J. Ment. Heal.	JUL 3	2020	29	4					439	445		10.1080/09638237.2017.1385733			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	MU5AW	WOS:000555684400010	28980490				2022-02-06	
J	Meyers, JE; Miller, RM; Rohling, ML; Kalat, SS				Meyers, John E.; Miller, Ronald M.; Rohling, Martin L.; Kalat, Stephen S.			Premorbid estimates of neuropsychological functioning for diverse groups	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Adulthood; child; clinical; pediatric; learning; tests; premorbid estimation	WAIS-R IQ; TRAUMATIC BRAIN-INJURY; DEMOGRAPHIC-VARIABLES; COMBINED PERFORMANCE; INTELLIGENCE; ABILITY; VALIDATION; REGRESSION; SCORES; BATTERY	One of the basic tasks performed by a neuropsychologist is to identify the difference between current performance and the premorbid expected performance. Baseline expected performance for Intellectually Impaired (n = 21), Developmentally Delayed (n = 40), Attention Deficit Disorder (n = 98), Learning Disability (n = 42), and "Normal" groups (n = 75) were developed along with a demographically corrected prediction of premorbid functioning and a word reading based prediction of premorbid functioning. We utilized a subset of this data pool for development (n = 107) and validation (n = 108) of premorbid functioning estimates. Findings show that a combination of three methods (baseline, demographic, and reading) were superior to any individual method. The effect size (Cohen's d) calculations show that differences in the prediction of domain level performances were small and likely not clinically meaningful, indicating that the premorbid estimates would be usable as a prediction of expected performance at the domain level. However, the motor domains were not well predicted.	[Meyers, John E.] Meyers Neuropsychol Serv, 412 W Rossetti Dr, Nokomis, FL 34275 USA; [Miller, Ronald M.] Utah Valley Univ, Woodbury Sch Business, Orem, UT USA; [Rohling, Martin L.] Univ S Alabama, Psychol, Mobile, AL USA; [Kalat, Stephen S.] Colorado Neuropsychol Consulting, Denver, CO USA		Meyers, JE (corresponding author), Meyers Neuropsychol Serv, 412 W Rossetti Dr, Nokomis, FL 34275 USA.	jmeyersneuro@yahoo.com					Axelrod BN, 1999, ARCH CLIN NEUROPSYCH, V14, P341, DOI 10.1016/S0887-6177(98)00028-6; Axelrod BN, 2007, INT J NEUROSCI, V117, P1591, DOI 10.1080/00207450600941189; Ball JD, 2007, CLIN NEUROPSYCHOL, V21, P422, DOI 10.1080/13854040600582577; BARONA A, 1986, INT J CLIN NEUROPSYC, V8, P169; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Basso MR, 2000, CLIN NEUROPSYCHOL, V14, P325, DOI 10.1076/1385-4046(200008)14:3;1-P;FT325; Berk R. A, 1984, SCREENING DIAGNOSIS; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Cohen J., 2013, STAT POWER ANAL BEHA; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P793, DOI 10.1016/0191-8869(89)90126-8; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P97, DOI 10.1348/014466501163517; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Hamsher K. D., 1984, HDB PSYCHOL ASSESSME, P235; Holdnack J. A., 2009, ADV CLIN SOLUTIONS W; Holdnack JA, 2013, PRACT RESOUR MENT, P217, DOI 10.1016/B978-0-12-386934-0.00005-5; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Langeluddecke PM, 2004, CLIN NEUROPSYCHOL, V18, P423, DOI 10.1080/1385404049052422; Larrabee G. J, 2017, APA HDB FORENSIC NEU, P57; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P139, DOI 10.1076/1385-4046(200002)14:1;1-8;FT139; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lowe DA, 2011, J AGING RES, V2011; Matarazzo JD, 1972, WECHSLERS MEASUREMEN; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers J, 2011, CLIN NEUROPSYCHOL, V25, P477, DOI 10.1080/13854046.2011.554442; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Meyers JE, 2013, APPL NEUROPSYCH-ADUL, V20, P249, DOI 10.1080/09084282.2012.710180; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Miller JB, 2010, CLIN NEUROPSYCHOL, V24, P678, DOI 10.1080/13854041003601493; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Nelson H.E., 1982, NATL ADULT READING T; Nelson HE, 1991, REVISED NATL ADULT R; PAOLO AM, 1992, ARCH CLIN NEUROPSYCH, V7, P135; Rohling ML, 2015, ARCH CLIN NEUROPSYCH, V30, P611, DOI 10.1093/arclin/acv039; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Schoenberg MR, 2008, PSYCHOL ASSESSMENT, V20, P377, DOI 10.1037/a0014010; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Spinks R, 2009, J INT NEUROPSYCH SOC, V15, P590, DOI 10.1017/S1355617709090766; Spreen O., 1998, COMPENDIUM NEUROPSYC, p[45, 75]; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Taylor M. J., 2001, J INT NEUROPSYCH SOC, V7, P867874; VANDERPLOEG RD, 1995, ARCH CLIN NEUROPSYCH, V10, P225, DOI 10.1016/0887-6177(94)00042-O; Vanderploeg RD, 1996, PSYCHOL ASSESSMENT, V8, P404, DOI 10.1037/1040-3590.8.4.404; Veiel HOF, 2001, PSYCHOL ASSESSMENT, V13, P356, DOI 10.1037/1040-3590.13.3.356; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Williamson D. J., 1996, 16 ANN M NAT AC NEUR; WILSON R S, 1979, Journal of Clinical Neuropsychology, V1, P49, DOI 10.1080/01688637908401097	54	3	3	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JUL 3	2020	27	4					364	375		10.1080/23279095.2018.1550412			12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	LO3FE	WOS:000533513700007	30773042				2022-02-06	
J	Rietdijk, R; Power, E; Brunner, M; Togher, L				Rietdijk, Rachael; Power, Emma; Brunner, Melissa; Togher, Leanne			The reliability of evaluating conversations between people with traumatic brain injury and their communication partners via videoconferencing	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Conversation; Assessment; Telehealth; Reliability	SPEECH-LANGUAGE PATHOLOGISTS; PARENTING SKILLS; ADULTS; INDIVIDUALS; TELEHEALTH; APHASIA; PERSPECTIVES; DISCOURSE; PROTOCOL; OUTCOMES	There is growing interest in using telehealth to work with people with traumatic brain injury (TBI). This study investigated whether established rating scales for evaluating conversations of people with TBI are reliable for use over videoconferencing. Nineteen participants with TBI and their communication partners completed two conversation samples during both in-person (IP) and videoconferencing-based (VC) assessment, with randomised order of assessment. Independent clinicians evaluated the conversations using the Adapted Measure of Participation in Conversation (MPC), the Adapted Measure of Support in Conversation (MSC) and the Global Impression scales. Comparisons between IP and VC ratings identified no significant differences on the MPC, MSC, and four out of five of the Global Impression scales. There was a significant difference between IP and VC recordings for "Task Completion" (p = .047), with participants performing significantly better in VC ratings. Inter-rater reliability was fair to excellent for the MPC and Global Impression scales for both IP and VC recordings. For the MSC scale, inter-rater reliability was poor to excellent. This study confirms the potential for using videoconferencing for evaluating conversations of people with TBI. Further development of training and rating procedures for these scales could facilitate more frequent and reliable use of these measures.	[Rietdijk, Rachael; Power, Emma; Brunner, Melissa; Togher, Leanne] Univ Sydney, Fac Hlth Sci, POB 170, Sydney, NSW, Australia; [Power, Emma; Brunner, Melissa] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia		Rietdijk, R (corresponding author), Univ Sydney, Fac Hlth Sci, POB 170, Sydney, NSW, Australia.	rman7827@uni.sydney.edu.au	Togher, Leanne/AAC-7083-2019; Brunner, Melissa/AAS-5965-2020; Rietdijk, Rachael/J-6573-2012; Power, Emma/A-9263-2015	Rietdijk, Rachael/0000-0003-4343-4039; Brunner, Melissa/0000-0001-6823-5189; Power, Emma/0000-0002-2638-0406	Transport Accident Commission (TAC) through the Institute for Safety Compensation and Recovery Research [NGE-E-13-073]; Australian Postgraduate AwardAustralian Government; NHMRC CRE Moving Ahead Seed GrantNational Health and Medical Research Council of Australia	This work was supported by the Transport Accident Commission (TAC) through the Institute for Safety Compensation and Recovery Research [grant number NGE-E-13-073]; Australian Postgraduate Award (This funding is currently called an Australian Government Research Training Program Scholarship); NHMRC CRE Moving Ahead Seed Grant.	[Anonymous], 2015, PASS 14 POW AN SAMPL; [Anonymous], 2011, WORLD REP DIS; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Cohn ER, 2011, SIG 18 PERSPECT TELE, V1, P26, DOI DOI 10.1044/tele1.1.26; Eriksson K, 2016, INT J LANG COMM DIS, V51, P402, DOI 10.1111/1460-6984.12216; Eriksson K, 2014, J INTERACT RES COM D, V5, P245, DOI 10.1558/jircd.v5i2.245; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Georgeadis AC, 2004, APHASIOLOGY, V18, P639, DOI 10.1080/02687030444000075; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Horton S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011207; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Luxton DD, 2014, PROF PSYCHOL-RES PR, V45, P27, DOI 10.1037/a0034547; Mast JE, 2014, CHILD ABUSE NEGLECT, V38, P1487, DOI 10.1016/j.chiabu.2014.04.012; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Murphy A, 2015, APHASIOLOGY, V29, P151, DOI 10.1080/02687038.2014.959411; Rietdijk R, 2019, BRAIN INJURY, V33, P94, DOI 10.1080/02699052.2018.1531313; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Sabesan S, 2015, MED J AUSTRALIA, V202, P231, DOI 10.5694/mja14.01021; Saldert C, 2018, APHASIOLOGY, V32, P1167, DOI 10.1080/02687038.2018.1470317; Saldert C, 2013, APHASIOLOGY, V27, P271, DOI 10.1080/02687038.2012.710317; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Speech Pathology Australia, 2014, TEL SPEECH PATH POS; Steel J, 2019, BRAIN INJURY, V33, P48, DOI 10.1080/02699052.2018.1531304; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Tucker JK, 2012, INT J TELEREHABILITA, V4, P61, DOI 10.5195/ijt.2012.6100; Turkstra LS, 2012, J HEAD TRAUMA REHAB, V27, P424, DOI 10.1097/HTR.0b013e31823346fc; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wiltshire GE, 2014, J SOC INCL, V5, P9, DOI 10.36251/josi.73; World Health Organization, 2006, NEUROLOGICAL DISORDE, P164	43	3	3	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 2	2020	30	6					1074	1091		10.1080/09602011.2018.1554533			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	LU7DF	WOS:000537910900006	30520702				2022-02-06	
J	Albrecht, JS; Abariga, SA; Rao, VI; Wickwire, EM				Albrecht, Jennifer S.; Abariga, Samuel A.; Rao, Vani; Wickwire, Emerson M.			Incidence of New Neuropsychiatric Disorder Diagnoses Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						administrative claims; neuropsychiatric disorders; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; AXIS-I; MAJOR DEPRESSION; UNITED-STATES; ALCOHOL-USE; PSYCHOPATHOLOGY; INDIVIDUALS; ASSOCIATION; DISABILITY	Background: Neuropsychiatric disturbances (NPDs) are common following traumatic brain injury (TBI) and associated with poor recovery. Prior estimates of NPD following TBI failed to account for preexisting NPDs or potential confounding. Methods: We estimated the risk of anxiety, posttraumatic stress disorder (PTSD), bipolar disorder, and alcohol and substance dependence disorder diagnoses associated with TBI using administrative claims data from a large insurer in the United States, 2008-2014. We calculated rates of new NPD diagnoses during the 12 months before and 24 months after TBI and estimated the risk of NPD following TBI using a difference-in-difference approach and adjusting for confounders. Results: Before the TBI occurred, rates of NPD diagnoses were more than double in the TBI cohort (n= 207 354) relative to the no-TBI cohort (n= 414 708). TBI was associated with an increased risk of anxiety (rate ratio [RtR] = 1.08; 95% confidence interval [CI], 1.05-1.12) and PTSD (RtR = 1.41; 95% CI, 1.24-1.60) diagnoses. Rates of alcohol (RtR = 0.32; 95% CI, 0.30-0.34) and substance use disorder (RtR = 0.57; 95% CI, 0.55-0.59) diagnoses decreased following TBI. Conclusions: In this large national study, rates of NPD were much higher among individuals with TBI than those in a non-TBI cohort, even before the TBI took place. TBI was associated with an increased risk of anxiety and PTSD diagnoses. Results from this study also suggest that individuals who sustain TBI have increased contact with the healthcare system during the months prior to injury, providing a window for intervention, especially for individuals diagnosed with alcohol dependence disorder.	[Albrecht, Jennifer S.; Abariga, Samuel A.] Univ Maryland Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA; [Wickwire, Emerson M.] Univ Maryland Sch Med, Dept Psychiat, Baltimore, MD USA; [Albrecht, Jennifer S.] OptumLabs, Cambridge, MA USA; [Rao, Vani] Johns Hopkins Univ Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA		Albrecht, JS (corresponding author), Univ Maryland Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA.	jalbrecht@som.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274	Agency for Healthcare Quality and ResearchUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1K01HS024560]; DODUnited States Department of Defense [W81XWH-13-1-0469]	Dr Albrecht was supported by Agency for Healthcare Quality and Research grant 1K01HS024560. Dr Rao was supported by DOD grant W81XWH-13-1-0469. The authors thank Susan dosReis, PhD, University of Maryland School of Pharmacy, for her thorough review of the manuscript.	Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Albrecht JS, 2017, J HEAD TRAUMA REHAB, V32, P178, DOI 10.1097/HTR.0000000000000266; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Deb S, 1999, AM J PSYCHIAT, V156, P374; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Epstein EL, 2019, PSYCHIAT RES, V274, P105, DOI 10.1016/j.psychres.2019.01.097; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Grossbard J, 2017, PSYCHIAT SERV, V68, P48, DOI 10.1176/appi.ps.201500290; Hayward RD, 2018, BRAIN INJURY, V32, P1373, DOI 10.1080/02699052.2018.1487584; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lechner M., 2010, ECONOMETRICS, V4, P165, DOI DOI 10.1561/0800000014; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Marr A., 2004, CENTRAL NERVOUS SYST; OptumLabs, 2019, OPT OPT DAT WAR OLDW; Pagulayan KF, 2016, J NEUROTRAUM, V33, P1390, DOI 10.1089/neu.2015.4071; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ., 1995, GUIDELINES SURVEILLA; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	40	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		E352	E360		10.1097/HTR.0000000000000551			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300010	31996603				2022-02-06	
J	Gagnon, I; Teel, E; Gioia, G; Aglipay, M; Barrowman, N; Sady, M; Vaughan, C; Zemek, R				Gagnon, Isabelle; Teel, Elizabeth; Gioia, Gerard; Aglipay, Mary; Barrowman, Nick; Sady, Maegan; Vaughan, Christopher; Zemek, Roger		Pediat Emergency Res Canada PERC	Parent-Child Agreement on Postconcussion Symptoms in the Acute Postinjury Period	PEDIATRICS			English	Article							SPORT-RELATED CONCUSSION; QUALITY-OF-LIFE; SELF-REPORT; RECOVERY; HEALTH; INSTRUMENTS	In this study, we establish parent-child agreement for postconcussion symptom reports and examine the predictive power of a previously derived clinical rule when using child-reported symptoms. OBJECTIVES:To evaluate parent-child agreement on postconcussion symptom severity within 48 hours of injury and examine the comparative predictive power of a clinical prediction rule when using parent or child symptom reporting.METHODS:Both patients and parents quantified preinjury and current symptoms using the Postconcussion Symptom Inventory (PCSI) in the pediatric emergency department. Two-way mixed, absolute measure intraclass correlation coefficients were calculated to evaluate the agreement between patient and parent reports. A multiple logistic regression was run with 9 items to determine the predictive power of the Predicting and Preventing Postconcussive Problems in Pediatrics clinical prediction rule when using the child-reported PCSI. Delong's receiver operating characteristic curve analysis was used to compare the area under the curve (AUC) for the child-report models versus previously published parent-report models.RESULTS:Overall parent-child agreement for the total PCSI score was fair (intraclass correlation coefficient = 0.66). Parent-child agreement was greater for (1) postinjury (versus preinjury) ratings, (2) physical (versus emotional) symptoms, and (3) older (versus younger) children. Applying the clinical prediction rule by using the child-reported PCSI maintained similar predictive power to parent-reported PCSI (child AUC = 0.70 [95% confidence interval: 0.67-0.72]; parent AUC = 0.71 [95% confidence interval: 0.68-0.74]; P = .23).CONCLUSIONS:Overall parent-child agreement on postconcussion symptoms is fair but varies according to several factors. The findings for physical symptoms and the clinical prediction rule have high agreement; information in these domains are likely to be similar regardless of whether they are provided by either the parent or child. Younger children and emotional symptoms show poorer agreement; interviewing both the child and the parent would provide more comprehensive information in these instances.	[Gagnon, Isabelle; Teel, Elizabeth] McGill Univ, Sch Phys & Occupat Therapy, 5252 Boul Maisonneuve,Off 3E-17, Montreal, PQ H4A 3S5, Canada; [Gagnon, Isabelle] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ, Canada; [Gioia, Gerard; Sady, Maegan; Vaughan, Christopher] Childrens Natl Med Ctr, Div Pediat Neuropsychol, Washington, DC 20010 USA; [Aglipay, Mary; Barrowman, Nick; Zemek, Roger] Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Pediat, Div Emergency Med, Ottawa, ON, Canada		Teel, E (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, 5252 Boul Maisonneuve,Off 3E-17, Montreal, PQ H4A 3S5, Canada.	elizabeth.teel@mail.mcgill.ca		Gagnon, Isabelle/0000-0003-2043-1644; Burns, Emma/0000-0001-8042-7124; Teel, Elizabeth/0000-0002-2846-5884	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 126197]; CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury team grant [TM1 127047]; CIHR planning grantCanadian Institutes of Health Research (CIHR) [MRP 119829]	Supported by a Canadian Institutes of Health Research (CIHR) operating grant (MOP 126197), a CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury team grant (TM1 127047), and a CIHR planning grant (MRP 119829).	Berman AH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150545; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chan JYC, 2016, PAIN, V157, P997, DOI 10.1097/j.pain.0000000000000476; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; KALNINS I, 1982, HEALTH EDUC QUART, V9, P104; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Matza LS, 2013, VALUE HEALTH, V16, P461, DOI 10.1016/j.jval.2013.04.004; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Patel BJ, 2017, CARDIOL YOUNG, V27, P713, DOI 10.1017/S1047951116001141; Patsimas T, 2020, J ATHL TRAIN, V55; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Steindel SJ, 2010, J AM MED INFORM ASSN, V17, P274, DOI 10.1136/jamia.2009.001230; Tingskull S, 2015, CHILD ABUSE REV, V24, P170, DOI 10.1002/car.2287; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Vollmer BL, 2018, CLIN PEDIATR, V57, P146, DOI 10.1177/0009922817693300; Waters E, 2003, CHILD CARE HLTH DEV, V29, P501, DOI 10.1046/j.1365-2214.2003.00370.x; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550corr1; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	29	3	3	1	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUL 1	2020	146	1							e20192317	10.1542/peds.2019-2317			11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	NF0FX	WOS:000562980500003	32499388	Bronze			2022-02-06	
J	Gorbunova, A; Zeldovich, M; Voormolen, DC; Krenz, U; Polinder, S; Haagsma, JA; Hagmayer, Y; Covic, A; Real, RGL; Asendorf, T; von Steinbuechel, N				Gorbunova, Anastasia; Zeldovich, Marina; Voormolen, Daphne C.; Krenz, Ugne; Polinder, Suzanne; Haagsma, Juanita A.; Hagmayer, York; Covic, Amra; Real, Ruben G. L.; Asendorf, Thomas; von Steinbuechel, Nicole		CTR-TBI Participants Investigators	Reference Values of the QOLIBRI from General Population Samples in the United Kingdom and The Netherlands	JOURNAL OF CLINICAL MEDICINE			English	Article						QOLIBRI; disease-specific; health-related quality of life; traumatic brain injury; measurement invariance; reference values; healthy individuals; chronic health condition	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CONFIRMATORY FACTOR-ANALYSIS; SF-36 HEALTH SURVEY; CENTER-TBI; EPIDEMIOLOGY; IMPACT; SCALE; INVARIANCE; CRITERIA	The Quality of Life after Traumatic Brain Injury (QOLIBRI) instrument is an internationally validated patient-reported outcome measure for assessing disease-specific health-related quality of life (HRQoL) in individuals after traumatic brain injury (TBI). However, no reference values for general populations are available yet for use in clinical practice and research in the field of TBI. The aim of the present study was, therefore, to establish these reference values for the United Kingdom (UK) and the Netherlands (NL). For this purpose, an online survey with a reworded version of the QOLIBRI for general populations was used to collect data on 4403 individuals in the UK and 3399 in the NL. This QOLIBRI version was validated by inspecting descriptive statistics, psychometric criteria, and comparability of the translations to the original version. In particular, measurement invariance (MI) was tested to examine whether the items of the instrument were understood in the same way by different individuals in the general population samples and in the TBI sample across the two countries, which is necessary in order to establish reference values. In the general population samples, the reworded QOLIBRI displayed good psychometric properties, including MI across countries and in the non-TBI and TBI samples. Therefore, differences in the QOLIBRI scores can be attributed to real differences in HRQoL. Individuals with and without a chronic health condition did differ significantly, with the latter reporting lower HRQoL. In conclusion, we provided reference values for healthy individuals and individuals with at least one chronic condition from general population samples in the UK and the NL. These can be used in the interpretation of disease-specific HRQoL assessments after TBI applying the QOLIBRI on the individual level in clinical as well as research contexts.	[Gorbunova, Anastasia; Zeldovich, Marina; Krenz, Ugne; Covic, Amra; Real, Ruben G. L.; Asendorf, Thomas; von Steinbuechel, Nicole] Univ Med Ctr Gottingen UMG, Inst Med Psychol & Med Sociol, Waldweg 37, D-37073 Gottingen, Germany; [Voormolen, Daphne C.; Polinder, Suzanne; Haagsma, Juanita A.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Haagsma, Juanita A.] Univ Med Ctr Rotterdam, Dept Emergency Med, Erasmus MC, NL-3000 CA Rotterdam, Netherlands; [Hagmayer, York] Georg August Univ, Inst Psychol, Gosslerstr 14, D-37073 Gottingen, Germany		von Steinbuechel, N (corresponding author), Univ Med Ctr Gottingen UMG, Inst Med Psychol & Med Sociol, Waldweg 37, D-37073 Gottingen, Germany.	Anastasia.Gorbunova@med.uni-goettingen.de; marina.zeldovich@med.uni-goettingen.de; d.voormolen@erasmusmc.nl; ugne.krenz@med.uni-goettingen.de; s.polinder@erasmusmc.nl; j.haagsma@erasmusmc.nl; york.hagmayer@bio.uni-goettingen.de; amra.covic@med.uni-goettingen.de; real.ruben@gmail.com; thomas.asendorf@med.uni-goettingen.de; nvsteinbuechel@med.uni-goettingen.de	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Bonn, Germany); OneMind (Napa, CA, USA); Integra LifeSciences Corporation (Princeton, NJ, USA); Neurotrauma Sciences (Alpharetta, GA, USA)	CENTER-TBI was supported by the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Bonn, Germany), from OneMind (Napa, CA, USA), from Integra LifeSciences Corporation (Princeton, NJ, USA) and from Neurotrauma Sciences (Alpharetta, GA, USA).	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Bridges AJ, 2007, CHILD NEUROPSYCHOL, V13, P528, DOI 10.1080/09297040701233875; Brown T., 2015, CONFIRMATORY FACTOR, VSecond; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Fischer F, 2018, QUAL LIFE RES, V27, P999, DOI 10.1007/s11136-018-1785-8; Garratt AM, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0625-9; Gliem JA, 2003, 2003 MIDW RES TO PRA; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Koh KH, 2008, J MOD APPL STAT METH, V7, P471; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu Y, 2017, PSYCHOL METHODS, V22, P486, DOI 10.1037/met0000075; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Oort FJ, 2005, QUAL LIFE RES, V14, P587, DOI 10.1007/s11136-004-0830-y; Oosterhuis HEM, 2016, ASSESSMENT, V23, P191, DOI 10.1177/1073191115580638; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; R Core Team, 2019, R LANG ENV STAT COMP; Saarni SI, 2007, J CLIN EPIDEMIOL, V60, P1288, DOI 10.1016/j.jclinepi.2007.03.004; Sax LJ, 2003, RES HIGH EDUC, V44, P409, DOI 10.1023/A:1024232915870; Schmidt S, 2006, J CLIN EPIDEMIOL, V59, P587, DOI 10.1016/j.jclinepi.2005.09.012; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Strack F., 1991, SUBJECTIVE WELL BEIN, V1st ed.; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; TEASDALE G, 1974, LANCET, V2, P81; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Turner-Bowker, 2007, USERS MANUAL SF 36V2; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; von Steinbuchel N, 2020, J NEUROTRAUM, V37, P1242, DOI 10.1089/neu.2019.6627; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10; Wu H, 2016, PSYCHOMETRIKA, V81, P1014, DOI 10.1007/s11336-016-9506-0; Xia Y, 2019, BEHAV RES METHODS, V51, P409, DOI 10.3758/s13428-018-1055-2	45	3	3	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUL	2020	9	7							2100	10.3390/jcm9072100			29	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MX3SM	WOS:000557645000001	32635328	Green Published, gold, Green Submitted			2022-02-06	
J	Ketchum, JM; Sevigny, M; Hart, T; O'Neil-Pirozzi, TM; Sander, AM; Juengst, SB; Bergquist, TF; Dreer, LE; Whiteneck, GG				Ketchum, Jessica M.; Sevigny, Mitch; Hart, Tessa; O'Neil-Pirozzi, Therese M.; Sander, Angelle M.; Juengst, Shannon B.; Bergquist, Thomas F.; Dreer, Laura E.; Whiteneck, Gale G.			The Association Between Community Participation and Social Internet Use Among Adults With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Internet; participation; social media; traumatic brain injury	MEDIA USE; ALTERNATIVE COMMUNICATION; INDIVIDUALS; BARRIERS; PEOPLE	Objective: To examine the association between social Internet use and real-world societal participation in survivors of moderate-severe traumatic brain injury. Design: Prospective cross-sectional observational study. Setting: Ten Traumatic Brain Injury Model Systems Centers. Participants: A total of 331 participants in the Traumatic Brain Injury Model Systems, interviewed at any follow-up year between April 2014 and March 2015. Main Measures: Survey on Internet use, including social media and other online socialization; Participation Assessment with Recombined Tools-Objective with separate analyses of Productivity, Social Relations, Out and About subscales; covariates included demographics, injury variables, and functional and emotional status at follow-up. Results: Participants were classified as social Internet users (N= 232) or nonusers (N= 99). Users had significantly higher Participation Assessment with Recombined Tools-Objective Social Relations scores than nonusers. A similar finding pertained to Out and About scores, with the between-group difference significantly greater for those with greater depressive symptoms severity. Users and nonusers did not differ significantly on Productivity subscale. Conclusions: The positive association between social Internet use and real-world social participation suggests that people with traumatic brain injury do not use social media as an alternative to real-world socialization. Rather, it is likely that similar barriers and facilitators affect both online and real-world social participation following traumatic brain injury. Emotional function should be considered as a moderating factor in further studies.	[Ketchum, Jessica M.; Sevigny, Mitch; Whiteneck, Gale G.] Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA; [Ketchum, Jessica M.; Sevigny, Mitch; Whiteneck, Gale G.] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [O'Neil-Pirozzi, Therese M.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Bergquist, Thomas F.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol & Visual Sci, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA		Ketchum, JM (corresponding author), Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA.	JKetchum@craighospital.org			National Institute of Disability, Independent Living, and Rehabilitation Research (NIDILRR) [90DPTB0007, 90DPTB0004, 90DPTB0011, 90DPT0016, 90DPTB0013, 90DPTB0012, 90DPTB0015, 90DP0084]	The contents of this article were developed under grants from the National Institute of Disability, Independent Living, and Rehabilitation Research (NIDILRR) to Craig (90DPTB0007), Moss (90DPTB0004), Spaulding/Harvard (90DPTB0011), TIRR (90DPT0016), North Texas (90DPTB0013), Mayo (90DPTB0012), Alabama (90DPTB0015), and the Traumatic Brain Injury National Data and Statistical Center (90DP0084). NIDILRR is a Center within the Administration for Community Living ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government.	Baker-Sparr C, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000305; Barclay L, 2016, AUST OCCUP THER J, V63, P19, DOI 10.1111/1440-1630.12241; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brunner M, 2019, INT J LANG COMM DIS, V54, P221, DOI 10.1111/1460-6984.12405; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Caron J, 2015, AM J SPEECH-LANG PAT, V24, P680, DOI 10.1044/2015_AJSLP-15-0010; Center for Disease Control and Prevention, FREQ ASK QUEST; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Eghdam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159362; GRANGER CV, 1986, GUIDE USE UNIFORM DA; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hynan A, 2015, DISABIL REHABIL, V37, P1559, DOI 10.3109/09638288.2015.1056387; Kim Y, 2016, CYBERPSYCH BEH SOC N, V19, P264, DOI 10.1089/cyber.2015.0408; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Patel R, 2015, AM J MED, V128, P1335, DOI 10.1016/j.amjmed.2015.06.015; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roach MJ, 2011, ARCH PHYS MED REHAB, V92, P472, DOI 10.1016/j.apmr.2010.09.030; Sharifian N, 2019, INT J AGING HUM DEV, V88, P107, DOI 10.1177/0091415018757213; Tsai IH, 2017, REHABIL PSYCHOL, V62, P36, DOI 10.1037/rep0000117; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434; World Health Organization, 2007, INT CLASS FUNCT DIS	24	3	3	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		254	261		10.1097/HTR.0000000000000566			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300002	32108716	Green Accepted			2022-02-06	
J	Kupnicka, P; Kojder, K; Metryka, E; Kapczuk, P; Jezewski, D; Gutowska, I; Goschorska, M; Chlubek, D; Baranowska-Bosiacka, I				Kupnicka, Patrycja; Kojder, Klaudyna; Metryka, Emilia; Kapczuk, Patrycja; Jezewski, Dariusz; Gutowska, Izabela; Goschorska, Marta; Chlubek, Dariusz; Baranowska-Bosiacka, Irena			Morphine-element interactions - The influence of selected chemical elements on neural pathways associated with addiction	JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY			English	Article						Morphine; Dependence; Elements; Neurotransmission	PERINATAL LEAD-EXPOSURE; VENTRAL TEGMENTAL AREA; TRAUMATIC BRAIN-INJURY; CONDITIONED PLACE PREFERENCE; METHYL-D-ASPARTATE; RAT-BRAIN; MANGANESE EXPOSURE; NMDA RECEPTOR; SYNAPTIC-TRANSMISSION; CHROMIUM PICOLINATE	Addiction is a pressing social problem worldwide and opioid dependence can be considered the strongest and most difficult addiction to treat. Mesolimbic and mesocortical dopaminergic pathways play an important role in modulation of cognitive processes and decision making and, therefore, changes in dopamine metabolism are considered the central basis for the development of dependence. Disturbances caused by excesses or deficiency of certain elements have a significant impact on the functioning of the central nervous system (CNS) both in physiological conditions and in pathology and can affect the cerebral reward system and therefore, may modulate processes associated with the development of addiction. In this paper we review the mechanisms of interactions between morphine and zinc, manganese, chromium, cadmium, lead, fluoride, their impact on neural pathways associated with addiction, and on antinociception and morphine tolerance and dependence.	[Kupnicka, Patrycja; Metryka, Emilia; Kapczuk, Patrycja; Goschorska, Marta; Chlubek, Dariusz; Baranowska-Bosiacka, Irena] Pomeranian Med Univ, Dept Biochem & Med Chem, Powstancow Wlkp 72, PL-70111 Szczecin, Poland; [Kojder, Klaudyna] Pomeranian Med Univ, Dept Anaesthesiol & Intens Care, Unii Lubelskiej 1, PL-71252 Szczecin, Poland; [Jezewski, Dariusz] Pomeranian Med Univ, Dept Appl Neurocognit Sci, Unii Lubelskiej 1, PL-71252 Szczecin, Poland; [Gutowska, Izabela] Pomeranian Med Univ, Dept Biochem & Human Nutr, Broniewskiego 24, PL-71460 Szczecin, Poland		Baranowska-Bosiacka, I (corresponding author), Pomeranian Med Univ, Dept Biochem & Med Chem, Powstancow Wlkp 72, PL-70111 Szczecin, Poland.	kkojder@pum.edu.pl	Chlubek, Dariusz/J-6310-2014	Chlubek, Dariusz/0000-0003-4497-4395; Metryka, Emilia/0000-0002-9196-9057; Kapczuk, Patrycja/0000-0002-2766-7783; Jezewski, Dariusz/0000-0002-2179-3367	Department of Biochemistry and Medical Chemistry Pomeranian Medical University in Szczecin, Poland	This study was supported by the statutory budget of the Department of Biochemistry and Medical Chemistry Pomeranian Medical University in Szczecin, Poland.	Amico-Ruvio SA, 2011, BIOPHYS J, V100, P1910, DOI 10.1016/j.bpj.2011.02.042; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Anderson JG, 2007, ENVIRON TOXICOL PHAR, V23, P179, DOI 10.1016/j.etap.2006.08.006; Anderson JG, 2007, TOXICOL SCI, V95, P188, DOI 10.1093/toxsci/kfl130; Anderson RA, 1997, REGUL TOXICOL PHARM, V26, pS35, DOI 10.1006/rtph.1997.1136; Antonilli L, 2003, J PHARMACOL EXP THER, V307, P651, DOI 10.1124/jpet.103.055467; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Aschner M, 2005, CRIT REV TOXICOL, V35, P1, DOI 10.1080/10408440590905920; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Baranowska-Bosiacka I, 2011, TOXICOLOGY, V280, P24, DOI 10.1016/j.tox.2010.11.004; Baranowska-Bosiacka I, 2016, BIOL TRACE ELEM RES, V170, P279, DOI 10.1007/s12011-015-0482-5; Baranowska-Bosiacka I, 2016, TOXICOLOGY, V339, P19, DOI 10.1016/j.tox.2015.10.003; Baranowska-Bosiacka I, 2011, TOXICOLOGY, V279, P100, DOI 10.1016/j.tox.2010.09.016; Barton HJ, 2011, BIOL TRACE ELEM RES, V143, P637, DOI 10.1007/s12011-010-8896-6; Basha DC, 2012, INT J DEV NEUROSCI, V30, P343, DOI 10.1016/j.ijdevneu.2012.01.004; Beaulieu JM, 2015, BRIT J PHARMACOL, V172, P1, DOI 10.1111/bph.12906; Belatar B, 2018, J TOXICOL-US, V2018, DOI 10.1155/2018/7252606; Berridge KC, 2015, NEURON, V86, P646, DOI 10.1016/j.neuron.2015.02.018; Bihaqi SW, 2018, CURR ALZHEIMER RES, V15, P1114, DOI 10.2174/1567205015666180801095925; Borsook D, 2016, NEUROSCI BIOBEHAV R, V68, P282, DOI 10.1016/j.neubiorev.2016.05.033; Branca JJV, 2018, NEURAL REGEN RES, V13, P1879, DOI 10.4103/1673-5374.239434; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Cannino G, 2009, MITOCHONDRION, V9, P377, DOI 10.1016/j.mito.2009.08.009; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Carta F, 2019, SCIENCE, V363, P248, DOI 10.1126/science.aav0581; CHANDRA SV, 1982, ACTA PHARMACOL TOX, V51, P456; Chen ML, 2012, J PAIN, V13, P945, DOI 10.1016/j.jpain.2012.06.007; CHEN ZR, 1991, LIFE SCI, V48, P2165, DOI 10.1016/0024-3205(91)90150-A; Cherasse Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112334; Cherian I, 2018, J NEUROSCI RES, V96, P744, DOI 10.1002/jnr.24145; Chibowska K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122140; Chioca LR, 2008, EUR J PHARMACOL, V579, P196, DOI 10.1016/j.ejphar.2007.10.019; Chirumari K, 2007, FLUORIDE, V40, P101; Choi AL, 2012, ENVIRON HEALTH PERSP, V120, P1362, DOI 10.1289/ehp.1104912; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Ciubotariu D., 2007, REV MED CHIRURG SOC, V111, P9815; Ciubotariu D, 2018, J TRACE ELEM MED BIO, V50, P676, DOI 10.1016/j.jtemb.2018.06.025; Ciubotariu D, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/s13011-015-0025-2; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Cordova FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033057; CORYSLECHTA DA, 1995, ANNU REV PHARMACOL, V35, P391, DOI 10.1146/annurev.pharmtox.35.1.391; COTZIAS GC, 1972, SCIENCE, V176, P410, DOI 10.1126/science.176.4033.410; COTZIAS GC, 1976, MED CLIN N AM, V60, P729, DOI 10.1016/S0025-7125(16)31856-9; Cui YS, 2018, ECOTOX ENVIRON SAFE, V165, P270, DOI 10.1016/j.ecoenv.2018.09.018; Davidson JRT, 2003, BIOL PSYCHIAT, V53, P261, DOI 10.1016/S0006-3223(02)01500-7; De Vries TJ, 2002, J NEUROSCI, V22, P3321; Dec K, 2017, BIOL TRACE ELEM RES, V177, P224, DOI 10.1007/s12011-016-0871-4; Dobson AW, 2003, BIOL TRACE ELEM RES, V93, P113, DOI 10.1385/BTER:93:1-3:113; Dorman DC, 2004, INHAL TOXICOL, V16, P481, DOI 10.1080/08958370490439687; Dorman DC, 2002, J TOXICOL ENV HEAL A, V65, P1493, DOI 10.1080/00984100290071630; Dubey VK, 2015, J TRACE ELEM MED BIO, V29, P222, DOI 10.1016/j.jtemb.2014.06.014; DURSUN N, 1995, RES COMMUN ALCOHOL S, V16, P47; ELLIOTT K, 1994, PAIN, V56, P69, DOI 10.1016/0304-3959(94)90151-1; Fitsanakis VA, 2006, NEUROTOXICOLOGY, V27, P798, DOI 10.1016/j.neuro.2006.03.001; FORSYTHE ID, 1988, J NEUROSCI, V8, P3733; Franklin M, 2003, PHARMACOPSYCHIATRY, V36, P176; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FREDERICKSON CJ, 1982, BRAIN RES, V246, P338, DOI 10.1016/0006-8993(82)91188-X; Gedeon Y, 2001, TOXICOL LETT, V123, P217, DOI 10.1016/S0378-4274(01)00408-8; Glass MJ, 2011, ILAR J, V52, P342, DOI 10.1093/ilar.52.3.342; Glass MJ, 2010, VITAM HORM, V82, P145, DOI 10.1016/S0083-6729(10)82008-4; Gluskin BS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.22; GONG QL, 1991, EUR J PHARMACOL, V193, P47, DOI 10.1016/0014-2999(91)90199-Z; Goodman A, 2008, BIOCHEM PHARMACOL, V75, P266, DOI 10.1016/j.bcp.2007.07.030; Grall-Bronnec M, 2014, NEUROSCI BIOBEHAV R, V47, P592, DOI 10.1016/j.neubiorev.2014.10.013; Grover H, 2018, AM J NEURORADIOL, V39, P2200, DOI 10.3174/ajnr.A5903; Gupta R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20342-z; Gutowska I, 2015, TOXICOL IN VITRO, V29, P1661, DOI 10.1016/j.tiv.2015.06.024; Gutowska I, 2010, TOXICOL LETT, V196, P74, DOI 10.1016/j.toxlet.2010.03.1167; Gwiazda RH, 2002, NEUROTOXICOLOGY, V23, P69, DOI 10.1016/S0161-813X(02)00002-5; HANISSIAN SH, 1988, NEUROPHARMACOLOGY, V27, P1145, DOI 10.1016/0028-3908(88)90010-X; Henderson G, 1997, TRENDS PHARMACOL SCI, V18, P293, DOI 10.1016/S0165-6147(97)90645-3; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Horvath RJ, 2010, PAIN, V150, P401, DOI 10.1016/j.pain.2010.02.042; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Hsieh CT, 2007, PEDIATR NEUROL, V36, P181, DOI 10.1016/j.pediatrneurol.2006.10.005; HURLEY LS, 1959, P SOC EXP BIOL MED, V102, P360, DOI 10.3181/00379727-102-25248; Iovieno N, 2011, J AFFECT DISORDERS, V130, P343, DOI 10.1016/j.jad.2010.06.010; Jakubowski P., 1995, MED PR, V46, P109; Jones DC, 2008, BIOCHEM PHARMACOL, V76, P569, DOI 10.1016/j.bcp.2008.05.010; Jones EA, 2010, ENVIRON INT, V36, P649, DOI 10.1016/j.envint.2010.04.007; KALA SV, 1995, NEUROTOXICOLOGY, V16, P297; Kalisinska E, 2014, ENVIRON GEOCHEM HLTH, V36, P1063, DOI 10.1007/s10653-014-9615-6; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kawasaki Y, 2005, BRIT J PHARMACOL, V145, P751, DOI 10.1038/sj.bjp.0706228; Keen CL, 2005, ENCY HUMAN NUTR, P217; KITCHEN I, 1993, NEUROTOXICOLOGY, V14, P125; Kleber Herbert D, 2007, Dialogues Clin Neurosci, V9, P455; Kobeissy FH, 2008, ADDICT BIOL, V13, P15, DOI 10.1111/j.1369-1600.2007.00083.x; KOH JY, 1988, J NEUROSCI, V8, P2164; Koob GF, 2009, J DRUG ISSUES, V39, P115, DOI 10.1177/002204260903900110; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Kopnisky S., 2002, NEUROPSYCHOPHARMACOL, P1369; Kordas K, 2011, J PEDIATR-US, V159, P638, DOI 10.1016/j.jpeds.2011.03.043; Kosten TR, 2018, JAMA PSYCHIAT, V75, P649, DOI 10.1001/jamapsychiatry.2018.0098; Kosten TR, 2018, JAMA PSYCHIAT, V75, P642, DOI 10.1001/jamapsychiatry.2018.0101; Krikorian R, 2010, NUTR NEUROSCI, V13, P116, DOI 10.1179/147683010X12611460764084; Lafuente A, 2000, BIOMETALS, V13, P47, DOI 10.1023/A:1009286709935; Lang UE, 2015, CELL PHYSIOL BIOCHEM, V37, P1029, DOI 10.1159/000430229; Larson AA, 2000, EUR J PHARMACOL, V407, P267, DOI 10.1016/S0014-2999(00)00715-9; LASLEY SM, 1984, NEUROCHEM RES, V9, P1675, DOI 10.1007/BF00968078; LAWRENCE AJ, 1992, BIOCHEM PHARMACOL, V43, P2335, DOI 10.1016/0006-2952(92)90311-6; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lee J, 2016, EXP NEUROBIOL, V25, P72, DOI 10.5607/en.2016.25.2.72; Lee Kim Mai, 2015, World J Virol, V4, P42, DOI 10.5501/wjv.v4.i2.42; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; Leret ML, 2002, BRAIN RES BULL, V58, P469, DOI 10.1016/S0361-9230(02)00819-5; Lipe GW, 1999, J ENVIRON SCI HEAL B, V34, P119, DOI 10.1080/03601239909373187; Listos J, 2013, TOXICOLOGY, V310, P73, DOI 10.1016/j.tox.2013.05.007; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Liu XH, 2006, TOXICOL SCI, V91, P521, DOI 10.1093/toxsci/kfj150; Lucchini RG, 2007, AM J IND MED, V50, P788, DOI 10.1002/ajim.20494; Luo ZC, 2011, J NEUROSCI, V31, P13180, DOI 10.1523/JNEUROSCI.2369-11.2011; Malenka S.E., 2009, MOL NEUROPHARMACOLOG, P117; McDonagh MS, 2000, BRIT MED J, V321, P855, DOI 10.1136/bmj.321.7265.855; McLemore GL, 1997, BRAIN RES, V778, P120, DOI 10.1016/S0006-8993(97)00985-2; Medvedeva YV, 2017, J NEUROSCI, V37, P726, DOI [10.1523/JNEUROSCI.3270-16.2016, 10.1523/JNEUROSCI.3270-16.2017]; Merkel SF, 2017, NEUROSCI BIOBEHAV R, V77, P209, DOI 10.1016/j.neubiorev.2017.03.015; Mesbahzadeh Behzad, 2019, BioMolecular Concepts, V10, P51, DOI 10.1515/bmc-2019-0006; Metryka E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061813; Mika J., 2009, PALLIAT MED PRACT, V3, P28; Miller DK, 1997, BRAIN RES, V776, P162, DOI 10.1016/S0006-8993(97)01013-5; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Mlyniec K, 2014, PHARMACOL REP, V66, P534, DOI 10.1016/j.pharep.2014.03.001; Montes S, 2001, BRAIN RES, V891, P123, DOI 10.1016/S0006-8993(00)03208-X; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; MURPHY JV, 1970, J AMER MED ASSOC, V212, P2119, DOI 10.1001/jama.212.12.2119; Mystek P, 2015, BBA-MOL CELL RES, V1853, P594, DOI 10.1016/j.bbamcr.2014.12.015; Nakashima A, 2003, MOL BRAIN RES, V112, P61, DOI 10.1016/S0169-328X(03)00047-0; Nation JR, 2003, PSYCHOPHARMACOLOGY, V168, P236, DOI 10.1007/s00213-003-1405-2; Nechifor M, 2017, FARMACIA, V65, P257; Nechifor M, 2016, FARMACIA, V64, P48; NEFF NH, 1969, EXPERIENTIA, V25, P1140, DOI 10.1007/BF01900234; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Nymberg C, 2014, NEUROPSYCHOPHARMACOL, V39, P2357, DOI 10.1038/npp.2014.83; O'Neal Stefanie L, 2015, Curr Environ Health Rep, V2, P315, DOI 10.1007/s40572-015-0056-x; OGAWA N, 1985, PEPTIDES, V6, P23, DOI 10.1016/0196-9781(85)90008-7; Olivier V, 1999, NEUROCHEM INT, V35, P431, DOI 10.1016/S0197-0186(99)00094-7; Ostrowska P, 2008, GOSPOD SUROWCAMI MIN, V24, P255; PACIFICI GM, 1982, EUR J CLIN PHARMACOL, V22, P553, DOI 10.1007/BF00609630; PASTERNAK GW, 1975, MOL PHARMACOL, V11, P735; Pereira M, 2011, NEUROTOX RES, V19, P55, DOI 10.1007/s12640-009-9139-5; PERT CB, 1973, SCIENCE, V182, P1359, DOI 10.1126/science.182.4119.1359; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Piotrowska A, 2013, J PHYSIOL PHARMACOL, V64, P493; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Portbury SD, 2018, METALLOMICS, V10, P846, DOI 10.1039/c8mt00068a; Prakash A, 2015, FUND CLIN PHARMACOL, V29, P131, DOI 10.1111/fcp.12110; Previc FH, 1999, BRAIN COGNITION, V41, P299, DOI 10.1006/brcg.1999.1129; Prus J., 2009, METHODS BEHAV ANAL N, DOI [10.1201/9781420041811, DOI 10.1201/9781420041811]; Rainnie DG, 2004, J NEUROSCI, V24, P3471, DOI 10.1523/JNEUROSCI.5740-03.2004; Reisi Z, 2014, PHARMACOL BIOCHEM BE, V118, P16, DOI 10.1016/j.pbb.2013.12.023; Richard JM, 2013, NEUROSCI BIOBEHAV R, V37, P1919, DOI 10.1016/j.neubiorev.2012.12.008; Roberts BR, 2015, METALLOMICS, V7, P124, DOI 10.1039/c4mt00258j; Rocha A, 2005, NEUROPSYCHOPHARMACOL, V30, P2058, DOI 10.1038/sj.npp.1300729; Roy A, 2011, ENVIRON HEALTH PERSP, V119, P144, DOI 10.1289/ehp.0901878; Sadlik J, 2000, Przegl Lek, V57, P563; Sahin K, 2013, LIFE SCI, V93, P1039, DOI 10.1016/j.lfs.2013.10.009; Sahin K, 2012, BIOL TRACE ELEM RES, V150, P291, DOI 10.1007/s12011-012-9475-9; Satarug S, 2003, TOXICOL LETT, V137, P65, DOI 10.1016/S0378-4274(02)00381-8; SCHRODER HD, 1979, J COMP NEUROL, V186, P439; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Schultz W, 2015, PHYSIOL REV, V95, P853, DOI 10.1152/physrev.00023.2014; Scott L, 2009, NEUROSCIENCE, V158, P62, DOI 10.1016/j.neuroscience.2008.10.020; Scrimgeour AG, 2018, J NEUROTRAUM, V35, P2495, DOI 10.1089/neu.2017.5614; Sharfstein JM, 2019, JAMA-J AM MED ASSOC, V321, P1446, DOI 10.1001/jama.2019.3505; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Shivarajashankara YM, 2002, FLUORIDE, V35, P12; SIMANTOV R, 1976, MOL PHARMACOL, V12, P977; SIMANTOV R, 1976, P NATL ACAD SCI USA, V73, P2515, DOI 10.1073/pnas.73.7.2515; Sindreu C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00068; Singla Amit, 2015, Acta Neurochir Suppl, V120, P63, DOI 10.1007/978-3-319-04981-6_11; Smith KR, 2002, PHARMACOL BIOCHEM BE, V72, P581, DOI 10.1016/S0091-3057(02)00729-3; Solinas M, 2019, J NEURAL TRANSM, V126, P481, DOI 10.1007/s00702-018-1957-2; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; STENGAARDPEDERSEN K, 1981, PEPTIDES, V2, P27, DOI 10.1016/0196-9781(81)90052-8; Struzynska L, 2007, TOXICOL SCI, V95, P156, DOI 10.1093/toxsci/kfl134; Sylvia LG, 2013, PSYCHOTHER PSYCHOSOM, V82, P10, DOI 10.1159/000341309; Szczerbak G, 2007, NEUROCHEM RES, V32, P1791, DOI 10.1007/s11064-007-9306-0; Takagi Y, 2001, JPEN-PARENTER ENTER, V25, P87, DOI 10.1177/014860710102500287; Takeda A, 2018, MOL NEUROBIOL, V55, P1498, DOI 10.1007/s12035-017-0428-3; Takeda A, 2016, ARCH BIOCHEM BIOPHYS, V611, P93, DOI 10.1016/j.abb.2016.06.021; Tamano H, 2018, NEUROTOXICOLOGY, V69, P23, DOI 10.1016/j.neuro.2018.08.008; TEJWANI GA, 1990, NEUROPHARMACOLOGY, V29, P445, DOI 10.1016/0028-3908(90)90166-O; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; TRESCOT AM, 2008, CLIN J PAIN, V11, pS133; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Tsunoda M, 2005, FLUORIDE, V38, P284; Tyszka-Czochara M, 2014, ACTA POL PHARM, V71, P369; Tzschentke TM, 1999, EUR J NEUROSCI, V11, P4099, DOI 10.1046/j.1460-9568.1999.00834.x; Ungless MA, 2003, NEURON, V39, P401, DOI 10.1016/S0896-6273(03)00461-6; Valles R, 2005, PHARMACOL BIOCHEM BE, V80, P611, DOI 10.1016/j.pbb.2005.01.011; VANDERKOOY D, 1982, BRAIN RES, V243, P107, DOI 10.1016/0006-8993(82)91124-6; VANDERKOOY D, 1983, BRAIN RES, V259, P111, DOI 10.1016/0006-8993(83)91071-5; Ventura R, 2005, CEREB CORTEX, V15, P1877, DOI 10.1093/cercor/bhi066; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; Verstraeten S, 2008, ARCH TOXICOL, V82, P789, DOI 10.1007/s00204-008-0345-3; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Wang L, 2015, ENVIRON SCI POLLUT R, V22, P16441, DOI 10.1007/s11356-015-5273-1; Wang YD, 2004, FREE RADICAL BIO MED, V36, P1434, DOI 10.1016/j.freeradbiomed.2004.03.010; Weisskopf MG, 2010, ENVIRON HEALTH PERSP, V118, P1609, DOI 10.1289/ehp.1002339; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Williams BB, 2010, TOXICOL SCI, V117, P169, DOI 10.1093/toxsci/kfq174; Winston AE, 1998, J AM DENT ASSOC, V129, P1579, DOI 10.14219/jada.archive.1998.0104; Witholt R, 2000, NEUROTOXICOL TERATOL, V22, P851, DOI 10.1016/S0892-0362(00)00108-2; Wolf Marina E, 2003, Mol Interv, V3, P248, DOI 10.1124/mi.3.5.248; Wu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29989; Yager LM, 2015, NEUROSCIENCE, V301, P529, DOI 10.1016/j.neuroscience.2015.06.033; YANO I, 1977, RES COMMUN CHEM PATH, V16, P721; Yazdi SM, 2011, FLUORIDE, V44, P158; YEH SY, 1975, J PHARMACOL EXP THER, V192, P201; Zarepour L, 2014, NEUROPEPTIDES, V48, P179, DOI 10.1016/j.npep.2014.04.003; Zhang DQ, 2004, NEUROREPORT, V15, P1761, DOI 10.1097/01.wnr.0000135699.75775.41; Zhang S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01865; Zhang S, 2015, TOXICOL SCI, V144, P238, DOI 10.1093/toxsci/kfu311; Zhang S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00216; Zhou BR, 2014, FLUORIDE, V47, P191; Zuch CL, 1998, TOXICOL APPL PHARM, V150, P174, DOI 10.1006/taap.1998.8396	224	3	3	0	11	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	0946-672X			J TRACE ELEM MED BIO	J. Trace Elem. Med. Biol.	JUL	2020	60								126495	10.1016/j.jtemb.2020.126495			16	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	LB1SC	WOS:000524414400014	32179426	hybrid			2022-02-06	
J	Lee, JJ; Thompson, ZS; Piccirillo, JF; Klatt-Cromwell, CN; Orlowski, HLP; Kallogjeri, D; Pipkorn, P; Schneider, JS				Lee, Jake J.; Thompson, Zindzi S.; Piccirillo, Jay F.; Klatt-Cromwell, Cristine N.; Orlowski, Hilary L. P.; Kallogjeri, Dorina; Pipkorn, Patrik; Schneider, John S.			Risk Factors for Patient-Reported Olfactory Dysfunction After Endoscopic Transsphenoidal Hypophysectomy	JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY			English	Article							FLAP RECONSTRUCTION; PITUITARY SURGERY; OUTCOMES; IMPAIRMENT; PREVALENCE; DISORDERS; TUMORS; SMELL	Question What are demographic, comorbidity, cephalometric, intraoperative, histological, and postoperative risk factors for patient-reported olfactory dysfunction after endoscopic transsphenoidal hypophysectomy? Findings In this cohort study of 147 patients with primary sellar lesions who underwent endoscopic transsphenoidal hypophysectomy, smoking history, acute angle between the planum sphenoidale and face of the sella turcica on sagittal imaging, and abdominal fat grafting were associated with patient-reported olfactory dysfunction. Increased number of months after the surgical procedure was associated with patient-reported normosmia. Meaning These findings suggest that smoking cessation counseling, cephalometric measurements of preoperative imaging, and judicious use of abdominal fat grafting may improve patient-reported olfactory outcomes after a transsphenoidal surgical procedure. Importance Iatrogenic olfactory dysfunction after endoscopic transsphenoidal hypophysectomy (ETSH) is an overlooked complication without elucidated risk factors. Objective To assess the independent prognostic role of demographic, comorbidity, cephalometric, intraoperative, histological, and postoperative parameters in patient-reported postoperative olfactory dysfunction, and to explore the association between anatomical measurements of the skull base and sinonasal cavity and postoperative olfactory dysfunction. Design, Setting, and Participants This retrospective cohort study in a tertiary care medical center enrolled consecutive patients with primary sellar lesions who underwent ETSH between January 1, 2015, and January 31, 2019. Patients were excluded if they underwent multiple sinonasal surgical procedures, presented with a sellar malignant neoplasm, required an expanded transsphenoidal approach, had nasal polyposis or a neurodegenerative disease, or sustained traumatic brain injury. After undergoing medical record review and telephone screening, patients were asked to participate in a 3-item telephone survey. Main Outcomes and Measures The primary outcome was the Clinical Global Impressions change in smell rating, a validated transitional patient-reported outcome measure. Patients rated their change in smell before and after ETSH on a 7-point Likert scale, with the following response options: (1) much better, (2) somewhat better, (3) slightly better, (4) neither better nor worse, (5) slightly worse, (6) somewhat worse, or (7) much worse. Responses of slightly worse, somewhat worse, and much worse were surrogates for postoperative olfactory dysfunction status. Patient medical records, preoperative imaging scans, operative notes, and pathology reports were reviewed. Results Of the 147 patients (mean [SD] age, 54 [15] years; 79 women [54%]) who responded to the telephone survey, 42 (29%) reported olfactory dysfunction after ETSH. Median (interquartile range [IQR]) time between the ETSH completion and survey response was 31.1 (21-43) months. On multivariable analysis, abdominal fat grafting (adjusted relative risk [aRR], 2.95; 95% CI, 1.89-4.60) was associated with postoperative olfactory dysfunction, whereas smoking history (aRR, 1.54; 95% CI, 0.95-2.51) demonstrated a clinically meaningful but imprecise effect size. A more obtuse angle between the planum sphenoidale and face of the sella turcica on sagittal imaging was protective (aRR, 0.98; 95% CI, 0.96-0.99). Increased number of months after the ETSH was associated with patient-reported normosmia (aRR, 0.93; 95% CI, 0.91-0.95). In contrast, other comorbidities; intraoperative variables such as turbinate resection, nasoseptal flap, and mucosal or bone grafting; histological variables such as pathology and proliferative index; and postoperative variables such as adjuvant radiotherapy were not associated with postoperative olfactory dysfunction. Conclusions and Relevance This study found that abdominal fat grafting, acute skull base angle, and smoking history appeared to be clinically significant risk factors for patient-reported postoperative olfactory dysfunction. Increased time after ETSH may be associated with better olfactory outcomes. This cohort study analyzes the association between postsurgical hyposmia and/or anosmia and a variety of patient, disease, and treatment factors among patients with primary sellar lesions.	[Lee, Jake J.; Thompson, Zindzi S.; Piccirillo, Jay F.; Klatt-Cromwell, Cristine N.; Kallogjeri, Dorina; Pipkorn, Patrik; Schneider, John S.] Washington Univ, Sch Med St Louis, Dept Otolaryngol Head & Neck Surg, 660 S Euclid Ave,Campus Box 8115, St Louis, MO 63110 USA; [Thompson, Zindzi S.] Meharry Med Coll, Sch Med, Nashville, TN 37208 USA; [Orlowski, Hilary L. P.] Washington Univ, Sch Med St Louis, Dept Radiol, St Louis, MO 63110 USA		Lee, JJ (corresponding author), Washington Univ, Sch Med St Louis, Dept Otolaryngol Head & Neck Surg, 660 S Euclid Ave,Campus Box 8115, St Louis, MO 63110 USA.	jakejlee@wustl.edu		Lee, Jake/0000-0002-8175-9486	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32DC000022-30]; National Center for Advancing Translational Sciences of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002345]	This study was funded by grant 5T32DC000022-30 from the National Institutes of Health (NIH) and by grant UL1TR002345 from the National Center for Advancing Translational Sciences of the NIH (Dr Lee).	Al-Dahmani K, 2016, CAN J NEUROL SCI, V43, P291, DOI 10.1017/cjn.2015.301; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Chaaban MR, 2015, AM J RHINOL ALLERGY, V29, P365, DOI 10.2500/ajra.2015.29.4206; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Dusick JR, 2006, SURG NEUROL, V65, P332, DOI 10.1016/j.surneu.2005.12.010; FEINSTEIN AR, 1977, CLIN PHARMACOL THER, V22, P485; Gallagher MJ, 2014, BRIT J NEUROSURG, V28, P622, DOI 10.3109/02688697.2014.887656; Hanson M, 2015, J LARYNGOL OTOL, V129, pS41, DOI 10.1017/S002221511500047X; Hart CK, 2010, OTOLARYNG HEAD NECK, V142, P95, DOI 10.1016/j.otohns.2009.09.032; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Kahilogullari G, 2013, LARYNGOSCOPE, V123, P2112, DOI 10.1002/lary.24037; Keller A, 2013, BMC EAR NOSE THROAT, V13, DOI 10.1186/1472-6815-13-8; Kim DH, 2018, J CRANIOFAC SURG, V29, P543, DOI 10.1097/SCS.0000000000004193; Kiraz M, 2018, TURK NEUROSURG, V28, P915, DOI 10.5137/1019-5149.JTN.21588-17.1; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Liu G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013246; Liu JK, 2001, J NEUROSURG, V95, P1083, DOI 10.3171/jns.2001.95.6.1083; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Neuland C, 2011, LARYNGOSCOPE, V121, P867, DOI 10.1002/lary.21387; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Patel ZM, 2016, CURR OPIN OTOLARYNGO, V24, P70, DOI 10.1097/MOO.0000000000000216; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; Pinto JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107541; Rotenberg BW, 2011, LARYNGOSCOPE, V121, P1611, DOI 10.1002/lary.21890; Saeger W, 2007, EUR J ENDOCRINOL, V156, P203, DOI 10.1530/eje.1.02326; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Schubert CR, 2011, LARYNGOSCOPE, V121, P873, DOI 10.1002/lary.21416; Soyka MB, 2017, AM J RHINOL ALLERGY, V31, P334, DOI 10.2500/ajra.2017.31.4463; Taha ANM, 2011, WORLD NEUROSURG, V75, P692, DOI 10.1016/j.wneu.2011.01.023; Tam S, 2013, INT FORUM ALLERGY RH, V3, P62, DOI 10.1002/alr.21069; Thompson CF, 2015, OTOLARYNG CLIN N AM, V48, P795, DOI 10.1016/j.otc.2015.05.007; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Yin LDX, 2019, LARYNGOSCOPE, V129, P1998, DOI 10.1002/lary.28003	34	3	3	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6181	2168-619X		JAMA OTOLARYNGOL	JAMA Otolaryngol-Head Neck Surg.	JUL	2020	146	7					621	629		10.1001/jamaoto.2020.0673			9	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	MQ8PQ	WOS:000553155200006	32379292	Bronze, Green Published			2022-02-06	
J	Li, FF; Lu, LY; Shang, SA; Chen, HY; Wang, P; Haidari, NA; Chen, YC; Yin, XD				Li, Fengfang; Lu, Liyan; Shang, Song'an; Chen, Huiyou; Wang, Peng; Haidari, Nasir Ahmad; Chen, Yu-Chen; Yin, Xindao			Cerebral Blood Flow and Its Connectivity Deficits in Mild Traumatic Brain Injury at the Acute Stage	NEURAL PLASTICITY			English	Article							MONTREAL COGNITIVE ASSESSMENT; FUNCTIONAL CONNECTIVITY; PERFUSION MRI; ABNORMALITIES; TBI	Objective. The influence of cognitive impairment after mild traumatic brain injury (mTBI) on cerebral vascular perfusion has been widely concerned, yet the resting-state cerebral blood flow (CBF) connectivity alterations based on arterial spin labeling (ASL) in mild traumatic brain injury (mTBI) remain unclear. This study investigated region CBF and CBF connectivity features in acute mTBI patients, as well as the associations between CBF changes and cognitive impairment. Materials and Methods. Forty-five acute mTBI patients and 42 health controls underwent pseudocontinuous arterial spin labeling (pCASL) perfusion magnetic resonance imaging (MRI). The alterations in regional CBF and relationship between the CBF changes and cognitive impairment were detected. The ASL-CBF connectivity of the brain regions with regional CBF significant differences was also compared between two groups. Neuropsychological tests covered seven cognitive domains. Associations between the CBF changes and cognitive impairment were further investigated. Results. Compared with the healthy controls, the acute mTBI patients exhibited increased CBF in the bilateral inferior temporal gyrus (ITG) and decreased CBF in the right middle frontal gyrus (MFG), the bilateral superior frontal gyrus (SFG), and the right cerebellum posterior lobe (CPL). In the mTBI patients, significant correlations were identified between the CBF changes and cognitive impairment. Importantly, the acute mTBI patients exhibited CBF disconnections between the right CPL and right fusiform gyrus (FG) as well as bilateral ITG, between the left SFG and left middle occipital gyrus (MOG), and between the right SFG and right FG as well as right parahippocampal gyrus. Conclusion. Our results suggest that acute mTBI patients exhibit both regional CBF abnormalities and CBF connectivity deficits, which may underlie the cognitive impairment of the acute mTBI patients.	[Li, Fengfang; Lu, Liyan; Shang, Song'an; Chen, Huiyou; Wang, Peng; Haidari, Nasir Ahmad; Chen, Yu-Chen; Yin, Xindao] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, Nanjing, Peoples R China		Chen, YC; Yin, XD (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, Nanjing, Peoples R China.	li_ff51@163.com; luliyan.ok@163.com; shangsongan0601@163.com; chenchenxiaoyou@163.com; wangpengtygl@163.com; nasirahmadhaidari@outlook.com; chenyuchen1989@126.com; y.163yy@163.com		Chen, Yu-Chen/0000-0002-8539-7224	Jiangsu Provincial Special Program of Medical Science [BE2017614]; Youth Medical Talents of Jiangsu Province [QNRC2016062]; 333 High-Level Talents Training Project of Jiangsu Province [BRA2019122]	This work was supported by the Jiangsu Provincial Special Program of Medical Science (No. BE2017614), Youth Medical Talents of Jiangsu Province (No. QNRC2016062), and the 333 High-Level Talents Training Project of Jiangsu Province (No. BRA2019122).	Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; Andre Jalal B, 2015, Top Magn Reson Imaging, V24, P275, DOI 10.1097/RMR.0000000000000065; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aslan S, 2010, MAGN RESON IMAGING, V28, P928, DOI 10.1016/j.mri.2010.03.037; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Crider T, 2018, CLIN NEUROL NEUROSUR, V170, P159, DOI 10.1016/j.clineuro.2018.05.019; Cui LB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14343-7; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; De Pauw R, 2019, HUM BRAIN MAPP, V40, P4266, DOI 10.1002/hbm.24700; Diedrichsen J, 2019, NEURON, V102, P918, DOI 10.1016/j.neuron.2019.04.021; Dodd AB, 2020, J CEREBR BLOOD F MET, V40, P2491, DOI 10.1177/0271678X19896883; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Haber M, 2018, J NEUROTRAUM, V35, P2250, DOI 10.1089/neu.2018.5684; Hamer J, 2020, J NEUROTRAUM, V37, P1197, DOI 10.1089/neu.2019.6800; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Havsteen I, 2018, ACTA RADIOL, V59, P1232, DOI 10.1177/0284185117752552; Herweg NA, 2020, J NEUROSCI, V40, P2119, DOI 10.1523/JNEUROSCI.1640-19.2019; Ho ML, 2018, J NEURORADIOLOGY, V45, P276, DOI 10.1016/j.neurad.2018.06.003; Jann K, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00371; Jezzard P, 2018, J CEREBR BLOOD F MET, V38, P603, DOI 10.1177/0271678X17743240; Keil VC, 2019, PEDIATR RADIOL, V49, P245, DOI 10.1007/s00247-018-4269-7; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Lancaster K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00825; Leeuwis AE, 2017, ALZHEIMERS DEMENT, V13, P531, DOI 10.1016/j.jalz.2016.08.013; Li FF, 2019, AGING-US, V11, P10684, DOI 10.18632/aging.102484; Melie-Garcia L, 2013, NEUROIMAGE, V64, P173, DOI 10.1016/j.neuroimage.2012.08.082; Micarelli A, 2013, ACTA PHYSIOL, V209, P69, DOI 10.1111/apha.12116; Moller MC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00496; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newberg AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087009; Newsome MR, 2016, J INT NEUROPSYCH SOC, V22, P631, DOI 10.1017/S1355617716000448; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Rockswold SB, 2019, J NEUROTRAUM, V36, P1099, DOI 10.1089/neu.2018.5796; Santhanam P, 2019, BRAIN RES, V1711, P77, DOI 10.1016/j.brainres.2019.01.015; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Wang S, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00107; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wang Z, 2012, MAGN RESON IMAGING, V30, P1409, DOI 10.1016/j.mri.2012.05.004; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462; Zhu JJ, 2015, J PSYCHIATR RES, V63, P28, DOI 10.1016/j.jpsychires.2015.03.002	44	3	3	3	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.	JUL 1	2020	2020								2174371	10.1155/2020/2174371			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MQ3LR	WOS:000552798800005	32684919	Green Published, gold			2022-02-06	
J	Lois, N; Gardner, E; McFarland, M; Armstrong, D; McNally, C; Lavery, NJ; Campbell, C; Kirk, RI; Bajorunas, D; Dunne, A; Cerami, A; Brines, M				Lois, Noemi; Gardner, Evie; McFarland, Margaret; Armstrong, David; McNally, Christine; Lavery, Nuala Jane; Campbell, Christina; Kirk, Rita, I; Bajorunas, Daiva; Dunne, Ann; Cerami, Anthony; Brines, Michael			A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema	JOURNAL OF CLINICAL MEDICINE			English	Article						ARA 290; cibinetide; diabetes; diabetic macular edema; diabetic retinopathy; DME; erythropoietin; helix B surface peptide	TRAUMATIC BRAIN-INJURY; PEPTIDE PHBSP; ERYTHROPOIETIN; RANIBIZUMAB; PROTECTS; WEIGHT; ANALOG; FGF21; FGF19	Purpose: Evaluating the effects of cibinetide in diabetic macular edema (DME). Methods: Phase 2 trial. Naive patients with >400 mu m central retinal thickness (CRT) DME in one/both eyes were recruited (May 2016-April 2017) at the Belfast Health and Social Care Trust. The study eye was that with best vision and lowest CRT. Patients self-administered cibinetide 4 mg/day subcutaneously for 12 weeks. Primary and secondary outcomes: mean change from baseline to week 12 in best corrected visual acuity (BCVA), CRT, central retinal sensitivity, tear production, patient-reported outcomes, adverse events and antibodies to cibinetide. Descriptive statistics were used; exploratory analyses focused on non-study eyes, diabetic control, serum cytokines and albuminuria. Results: Nine patients were recruited; eight completed the study. There was no improvement in mean change baseline-week 12 in BCVA (-2.9 + 5.0), CRT (10 + 94.6 microns), central retinal sensitivity (-0.53 + 1.9 dB) or tear production (-0.13 + 7.7 mm), but there was an improvement in National Eye Institute Visual Function Questionnaire (NEI VFQ-25) composite scores (2.7 + 3.1). Some participants experienced improvements in CRT, tear production, diabetic control and albuminuria. No serious adverse events/reactions or anti-cibinetide antibodies were seen. Conclusions: The cibinetide 12-week course was safe. Improvements in NEI VFQ-25 scores, CRT, tear production, diabetic control and albuminuria, observed in some participants, warrant further investigation. Trial Registration: EudraCT number: 2015-001940-12. ISRCTN16962255-registration date 25.06.15.	[Lois, Noemi; Armstrong, David; Lavery, Nuala Jane] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Gardner, Evie; McNally, Christine; Campbell, Christina] Royal Hosp, Elliott Dynes Ctr, Northern Ireland Clin Trials Unit NICTU, 1st Floor, Belfast BT12 6BA, Antrim, North Ireland; [McFarland, Margaret] Royal Grp Hosp, Pharm Dept, Belfast BT12 6BA, Antrim, North Ireland; [Kirk, Rita, I; Bajorunas, Daiva; Dunne, Ann; Cerami, Anthony; Brines, Michael] Araim Pharmaceut, 580 White Plains Rd,Suite 210, Tarrytown, NY 10591 USA		Lois, N (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	n.lois@qub.ac.uk; evie.gardner@nictu.hscni.net; Margaret.McFarland@belfasttrust.hscni.net; David.Armstrong@belfasttrust.hscni.net; christine.mcnally@nictu.hscni.net; nualajane.lavery@belfasttrust.hscni.net; christinax.campbell@nictu.hscni.net; rkirk@araimpharma.com; dbajorunas@araimpharma.com; adunne@araimpharma.com; acerami@araimpharma.com; mbrines@araimpharma.com		Brines, Michael/0000-0003-4151-4449; Lois, Noemi/0000-0003-2666-2937	Araim Pharmaceuticals, Inc, Tarrytown, NY, USA; Chief Investigator own research fund	This research was funded in part by Araim Pharmaceuticals, Inc, 580 White Plains Road, Suite 210, Tarrytown, NY 10591 USA, and through the Chief Investigator own research fund.	Ahmet I, 2011, MOL MED, V17, P194, DOI 10.2119/molmed.2010.00235; Berg AH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005218; Bradshaw EM, 2009, J IMMUNOL, V183, P4432, DOI 10.4049/jimmunol.0900576; Bretz CA, 2020, AM J PATHOL, V190, P630, DOI 10.1016/j.ajpath.2019.11.009; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines M, 2014, MOL MED, V20, P658, DOI 10.2119/molmed.2014.00215; Chen CW, 2017, CLIN CHEM, V63, P477, DOI 10.1373/clinchem.2016.258319; Chibber R, 2007, CURR DIABETES REV, V3, P3, DOI 10.2174/157339907779802139; Collino M, 2014, BRIT J PHARMACOL, V171, P5802, DOI 10.1111/bph.12888; Collino M, 2015, PHARMACOL THERAPEUT, V151, P32, DOI 10.1016/j.pharmthera.2015.02.005; Culver DA, 2017, INVEST OPHTH VIS SCI, V58, pBIO52, DOI 10.1167/iovs.16-21291; Egan C, 2017, BRIT J OPHTHALMOL, V101, P75, DOI 10.1136/bjophthalmol-2016-309313; Elman MJ, 2015, OPHTHALMOLOGY, V122, P375, DOI 10.1016/j.ophtha.2014.08.047; Fiore T, 2013, CURR EYE RES, V38, P674, DOI 10.3109/02713683.2013.781191; Gomez-Ambrosi J, 2017, CLIN NUTR, V36, P861, DOI 10.1016/j.clnu.2016.04.027; Hernandez C, 2012, ENDOCRINE, V41, P220, DOI 10.1007/s12020-011-9579-6; Labbe A, 2013, INVEST OPHTH VIS SCI, V54, P5144, DOI 10.1167/iovs.13-12370; Lan T, 2017, CELL METAB, V26, P709, DOI 10.1016/j.cmet.2017.09.005; Lois N., 2018, ANN EYE SCI, V3, P2, DOI [10.21037/aes.2017.12.03, DOI 10.21037/AES.2017.12.03]; McVicar CM, 2011, DIABETES, V60, P2995, DOI 10.2337/db11-0026; Muller C, 2015, MOL MED, V21, P969, DOI 10.2119/molmed.2015.00267; National Eye Institute, VIS FUNCT QUEST 25; Niesters M, 2013, EXPERT OPIN ORPHAN D, V1, P77, DOI 10.1517/21678707.2013.719289; Olink, TARG 96 INFL; Patel NSA, 2012, MOL MED, V18, P719, DOI 10.2119/molmed.2012.00093; Petropoulos IN, 2018, DIABETES METAB J, V42, P255, DOI 10.4093/dmj.2018.0056; Polito A, 2006, RETINA-J RET VIT DIS, V26, P14, DOI 10.1097/00006982-200601000-00003; Reid G, 2017, VISION RES, V139, P237, DOI 10.1016/j.visres.2017.05.010; Robertson CS, 2013, J NEUROTRAUM, V30, P765, DOI 10.1089/neu.2012.2431; Robertson CS, 2012, J NEUROTRAUM, V29, P1156, DOI 10.1089/neu.2011.1827; Stitt AW, 2016, PROG RETIN EYE RES, V51, P156, DOI 10.1016/j.preteyeres.2015.08.001; Wells JA, 2016, OPHTHALMOLOGY, V123, P1351, DOI 10.1016/j.ophtha.2016.02.022; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhu B, 2008, EXP EYE RES, V86, P375, DOI 10.1016/j.exer.2007.11.010	34	3	3	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUL	2020	9	7							2225	10.3390/jcm9072225			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MS2UD	WOS:000554137000001	32674280	Green Published, gold			2022-02-06	
J	McCarty, JC; Kiwanuka, E; Gadkaree, S; Siu, JM; Caterson, EJ				McCarty, Justin C.; Kiwanuka, Elizabeth; Gadkaree, Shekhar; Siu, Jennifer M.; Caterson, Edward J.			Traumatic Brain Injury in Trauma Patients With Isolated Facial Fractures	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Concussion; facial fractures; head injury; traumatic brain injury	EMERGENCY-DEPARTMENT; DIAGNOSIS; PROTECT; BURDEN	Background: Diagnosis of traumatic brain injury (TBI), and specifically mild TBI (mTBI), is a diagnostic challenge which can delay diagnosis preventing early intervention and follow-up care. Facial fractures represent an objective surrogate marker for potential force transmission to the neural cavity. The authors' objective was to characterize the prevalence of TBI in trauma patients with isolated facial fractures stratified by injury severity. Methods: The authors performed a retrospective cross-sectional study of the National Trauma Databank (NTDB) from 2007 to 2014 assessing a total of 1,867,761 participants identified as having a TBI and 306,785(60.2%) had an isolated facial fracture using ICD-9 codes. TBI severity was subdivided using Glasgow Coma Scale into mTBI and moderate-to-severe TBI. Logistic regression assessed odds of mTBI and moderate-to-severe TBI with different isolated facial fractures adjusted for injury severity. Results: Trauma patients with isolated facial fractures of the nasal bone, mandible, malar region and maxilla, orbital floor, and alveolar and palate had a concomitant prevalence of mTBI ranging from 21.3% to 46.0% and moderate-to-severe TBI ranging from 7.3% to 18.4%. Mandibular fractures had the lowest odds of mTBI and moderate to severe TBI while alveolar and palate fractures had the highest odds of mTBI [OR3.20,95%CI (3.11-3.30)] and moderate to severe TBI [OR3.83,95%CI (3.65-4.01)]. Conclusions: Isolated facial fractures have a high prevalence of mTBI at all injury severity levels. Clinicians can use the presence of facial fractures in trauma patients to serve as clinical markers for TBI, without distracting from already existing trauma protocols and their focus on treatment of immediate life-threatening injuries raising both awareness and potential for early intervention.	[McCarty, Justin C.; Gadkaree, Shekhar; Siu, Jennifer M.; Caterson, Edward J.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [McCarty, Justin C.; Caterson, Edward J.] Harvard Med Sch, Brigham & Womens Hosp, Div Plast Surg, 75 Francis St, Boston, MA 02115 USA; [Kiwanuka, Elizabeth] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Plast Surg, Providence, RI 02903 USA; [Gadkaree, Shekhar] Harvard Med Sch, Dept Otolaryngol, Massachusetts Eye & Ear, Boston, MA 02115 USA; [Siu, Jennifer M.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada		McCarty, JC (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Plast Surg, 75 Francis St, Boston, MA 02115 USA.	justin.c.mccarty@gmail.com		K., Shekhar/0000-0003-3274-4488	Gillian Reny Stepping Strong Center for Plastic Surgery Trauma Innovation	Justin C. McCarty receives fellowship funding from the Gillian Reny Stepping Strong Center for Plastic Surgery Trauma Innovation. The remaining authors report no conflicts of interest.	Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Control NCfIPa, 2003, REP C MILD TRAUM BRA; Corrigan JD, 2014, J NEUROTRAUM, V31, P1000, DOI 10.1089/neu.2013.3145; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Grant AL, 2012, J CRANIOFAC SURG, V23, P1324, DOI 10.1097/SCS.0b013e31825e60ae; Hashmi ZG, 2018, JAMA SURG, V153, P852, DOI 10.1001/jamasurg.2018.0483; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Martin RCG, 2002, AM SURGEON, V68, P477; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mithani SK, 2009, PLAST RECONSTR SURG, V123, P1293, DOI 10.1097/PRS.0b013e31819e26f2; Mulligan RP, 2010, PLAST RECONSTR SURG, V126, P1648, DOI 10.1097/PRS.0b013e3181ef90e4; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Pappachan B, 2012, J MAXILLOFAC ORAL SU, V11, P224, DOI 10.1007/s12663-011-0289-7; Puljula J, 2012, INJURY, V43, P2100, DOI 10.1016/j.injury.2012.04.010; Rajandram RK, 2014, DENT TRAUMATOL, V30, P128, DOI 10.1111/edt.12052; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Zogg CK, 2016, J AM COLL SURGEONS, V223, pS158, DOI 10.1016/j.jamcollsurg.2016.06.343	26	3	3	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUL-AUG	2020	31	5					1182	1185		10.1097/SCS.0000000000006379			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PI0IJ	WOS:000600784100040	32282477				2022-02-06	
J	McLoughlin, RJ; Cournoyer, L; Hirsh, MP; Cleary, MA; Aidlen, JT				McLoughlin, Robert J.; Cournoyer, Lauren; Hirsh, Michael P.; Cleary, Muriel A.; Aidlen, Jeremy T.			Hospitalizations for pediatric dog bite injuries in the United States	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatric; Dog bite; Trauma	CHILDREN; EXPERIENCE; BEHAVIOR	Background: Dog bites are a common cause of pediatric trauma requiring hospital admission. We aim to describe pediatric bite victims, associated injuries and interventions. Methods: Children (18 years old) were identified with an ICD-9 diagnosis of dog bite in the Kids Inpatient Database for the years 2006, 2009 and 2012. National estimates were obtained using case weighting. Muliivariable logistic regression was performed. Results: We identified 6323 admissions for a dog bite with mean age of 6.63 years. Patients were predominately male (56.9%), non-Hispanic white (61.9%), resided in the South (35.1%), and in an urban environment (59.9%). Almost one third underwent a surgical procedure. Open wounds of the head, neck and trunk were the most common injury and decreased in prevalence with increasing age. Open wounds of the extremities were the second most common and the prevalence increased with increasing age. Children aged 1-4 and 5-10 years were both more than three times more likely to be admitted than those more than age 11. Conclusions: Dog bite injuries are common for pediatric patients. Children less than age 11 are at greatest risk, particularly in the summer. Dog safety training should be focused on elementary and middle school children close to the start of summer vacation. (C) 2019 Elsevier Inc. All rights reserved.	[McLoughlin, Robert J.] Univ Massachusetts, Med Sch, Dept Surg, 55 Lake Ave N, Worcester, MA 01655 USA; [Cournoyer, Lauren] Univ Massachusetts, Med Sch, 55 Lake Ave N, Worcester, MA 01655 USA; [Hirsh, Michael P.; Cleary, Muriel A.; Aidlen, Jeremy T.] Univ Massachusetts, Med Sch, Dept Surg, Div Pediat Surg, 55 Lake Ave N, Worcester, MA 01655 USA		McLoughlin, RJ (corresponding author), Univ Massachusetts, Med Sch, Dept Surg, 55 Lake Ave N, Worcester, MA 01655 USA.	Robert.McLoughlin@umassmemorial.org	McLoughlin, Robert/V-5812-2019	McLoughlin, Robert/0000-0003-1762-3215			Abraham JT, 2019, J PEDIATR SURG, V54, P1416, DOI 10.1016/j.jpedsurg.2018.09.022; AfHRa Quality, 2009, CLIN CLASS SOFTW CCS; AVNER JR, 1991, PEDIATRICS, V88, P55; BECK AM, 1985, PUBLIC HEALTH REP, V100, P315; Borg BA, 2018, PEDIATRICS, V142, P357; Borud LJ, 2000, PLAST RECONSTR SURG, V106, P987, DOI 10.1097/00006534-200010000-00004; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Bureau of Labor Statistics, CONS PRIC IND INFL C; CDC, 2018, PREV DOG BIT; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P605; Cohen-Manheim I, 2018, EPIDEMIOLOGY HOSP DU; Daniels DM, 2009, J TRAUMA, V66, pS17, DOI 10.1097/TA.0b013e3181937925; De Keuster T, 2006, VET J, V172, P482, DOI 10.1016/j.tvjl.2005.04.024; Dixon CA, 2012, J PEDIATR-US, V160, P337, DOI 10.1016/j.jpeds.2011.07.016; Essig Jr GF, 2019, OTORHINOLARYNGOL, V117, P182; FARMER JE, 1995, HEALTH PSYCHOL, V14, P325, DOI 10.1037/0278-6133.14.4.325; Fein J, 2018, INJ PREV; Gandhi RR, 1999, AM SURGEON, V65, P863; Garvey EM, 2015, J PEDIATR SURG, V50, P343, DOI 10.1016/j.jpedsurg.2014.09.051; GERSHMAN KA, 1994, PEDIATRICS, V93, P913; Holzer KJ, 2019, INJURY PREV, V25, P187, DOI 10.1136/injuryprev-2018-042890; InsuranceInformationInstitute, 2018, DOG BIT CLAIMS NAT I; Kaye AE, 2009, PLAST RECONSTR SURG, V124, P551, DOI 10.1097/PRS.0b013e3181addad9; Morgan M, 2007, BMJ-BRIT MED J, V334, P413, DOI 10.1136/bmj.39105.659919.BE; Nigg JT, 2013, CLIN PSYCHOL REV, V33, P215, DOI 10.1016/j.cpr.2012.11.005; Quality AfHRa, 2006, QUAL AFHRA; Quinlan KP, 1999, JAMA-J AM MED ASSOC, V281, P232, DOI 10.1001/jama.281.3.232; Sacks J J, 1996, Inj Prev, V2, P52, DOI 10.1136/ip.2.1.52; Schalamon J, 2006, PEDIATRICS, V117, pE374, DOI 10.1542/peds.2005-1451; van den Ban E, 2014, EUR CHILD ADOLES PSY, V23, P95, DOI 10.1007/s00787-013-0432-8; Weiss HB, 1998, JAMA-J AM MED ASSOC, V279, P51, DOI 10.1001/jama.279.1.51; Williams K, 2012, PEDIATRICS, V129, pS153, DOI 10.1542/peds.2012-0055I	32	3	3	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	JUL	2020	55	7					1228	1233		10.1016/j.jpedsurg.2019.06.025			6	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	NB4NR	WOS:000560491400009	31326111				2022-02-06	
J	Prado, GR; LaPlaca, MC				Prado, Gustavo R.; LaPlaca, Michelle C.			Neuronal Plasma Membrane Integrity is Transiently Disturbed by Traumatic Loading	NEUROSCIENCE INSIGHTS			English	Article						Cell injury; cortical neuron; calcium; neurotrauma; plasma membrane	SPINAL-CORD; BRAIN-INJURY; CELLULAR-DAMAGE; CELLS; PERMEABILITY; DISRUPTION; MECHANISMS; CALCIUM; STRETCH; MODEL	The acute response of neurons subjected to traumatic loading involves plasma membrane disruption, yet the mechanical tolerance for membrane compromise, time course, and mechanisms for resealing are not well understood. We have used an in vitro traumatic neuronal injury model to investigate plasma membrane integrity immediately following a high-rate shear injury. Cell-impermeant fluorescent molecules were added to cortical neuronal cultures prior to insult to assess membrane integrity. The percentage of cells containing the permeability marker was dependent on the molecular size of the marker, as smaller molecules gained access to a higher percentage of cells than larger ones. Permeability increases were positively correlated with insult loading rate. Membrane disruption was transient, evidenced by a membrane resealing within the first minute after the insult. In addition, chelation of either extracellular Ca(2+)or intracellular Ca(2+)limited membrane resealing. However, injury following chelation of both extracellular and intracellular Ca(2+)caused diminished permeability as well as a greater resealing ability compared to chelation of extracellular or intracellular Ca(2+)alone. Treatment of neuronal cultures with jasplakinolide, which stabilizes filamentous actin, reduced permeability increases, while latrunculin-B, an actin depolymerizing agent, both reduced the increase in plasma membrane permeability and promoted resealing. This study gives insight into the dynamics of neuronal membrane disruption and subsequent resealing, which was found to be calcium dependent and involve actin in a role that differs from non-neuronal cells. Taken together, these data will lead to a better understanding of the acute neuronal response to traumatic loading.	[LaPlaca, Michelle C.] Georgia Inst Technol, Translat Neurotrauma Lab, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA; [LaPlaca, Michelle C.] Emory Univ, Sch Med, 313 Ferst Dr, Atlanta, GA 30332 USA		LaPlaca, MC (corresponding author), Georgia Inst Technol, Translat Neurotrauma Lab, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.; LaPlaca, MC (corresponding author), Emory Univ, Sch Med, 313 Ferst Dr, Atlanta, GA 30332 USA.	michelle.laplaca@bme.gatech.edu			Whitaker Foundation; Institute for Bioengineering and Bioscience	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors received partial funding for this research from the Whitaker Foundation and the Institute for Bioengineering and Bioscience.	Andrews NW, 2014, TRENDS CELL BIOL, V24, P734, DOI 10.1016/j.tcb.2014.07.008; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; Boothe DL, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00236; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Draeger A, 2014, BIOCHIMIE, V107, P66, DOI 10.1016/j.biochi.2014.08.008; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Galle B, 2007, J BIOMECH, V40, P3029, DOI 10.1016/j.jbiomech.2007.03.014; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guzman HR, 2001, J ACOUST SOC AM, V110, P588, DOI 10.1121/1.1376131; Hallow DM, 2008, BIOTECHNOL BIOENG, V99, P846, DOI 10.1002/bit.21651; Howard MJ, 1999, NEUROSCIENCE, V93, P807, DOI 10.1016/S0306-4522(99)00195-5; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Ko KS, 2001, J CELL SCI, V114, P1155; Ko KS, 2000, J MEMBRANE BIOL, V174, P85, DOI 10.1007/s002320001034; Krassowska W, 2007, BIOPHYS J, V92, P404, DOI 10.1529/biophysj.106.094235; Kurtoglu E, 2017, J BIOMECH SCI ENG, V12; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; LaPlaca MC, 2019, CLIN BIOMECH, V64, P2, DOI 10.1016/j.clinbiomech.2018.05.016; LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; LaPlaca Michelle C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2384; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; McNeil PL, 2000, J CELL SCI, V113, P1891; McNeil PL, 2002, J CELL SCI, V115, P873; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Miyake K, 2001, J CELL SCI, V114, P3487; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Saito K, 1999, EXP EYE RES, V68, P431, DOI 10.1006/exer.1998.0626; Schlicher RK, 2006, ULTRASOUND MED BIOL, V32, P915, DOI 10.1016/j.ultrasmedbio.2006.02.1416; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Shi R, 2001, J NEUROCYTOL, V30, P829, DOI 10.1023/A:1019645505848; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Sliozberg YR, 2016, CHEM PHYS LETT, V651, P39, DOI 10.1016/j.cplett.2016.03.018; Spira ME, 1996, J NEUROSCI METH, V69, P91, DOI 10.1016/S0165-0270(96)00024-6; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Streppa L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26797-4; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Thompson GL, 2014, BIOELECTROMAGNETICS, V35, P262, DOI 10.1002/bem.21845; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Togo T, 1999, J CELL SCI, V112, P719; Togo T, 2000, ZYGOTE, V8, pS31; TSONG TY, 1991, BIOPHYS J, V60, P297, DOI 10.1016/S0006-3495(91)82054-9; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Zhou Y, 2008, J CONTROL RELEASE, V126, P34, DOI 10.1016/j.jconrel.2007.11.007	62	3	3	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND		2633-1055		NEUROSCI INSIGHTS	Neurosci. Insights	JUL	2020	15								2633105520946090	10.1177/2633105520946090			11	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	MW2IT	WOS:000556868100001	32783028	gold, Green Published			2022-02-06	
J	Reddy, AVC; Mani, R; Selvakumar, A; Hussaindeen, JR				Reddy, Ashwini V. C.; Mani, Revathy; Selvakumar, Ambika; Hussaindeen, Jameel Rizwana			Reading eye movements in traumatic brain injury	JOURNAL OF OPTOMETRY			English	Article						Oculomotor dysfunction; ReadAlyzer; Reading rate; Saccades	OCULOMOTOR REHABILITATION; RESPONSIVITY; DEFICITS; MTBI	Purpose: The aim of this study was to measure the reading eye movements in subjects with traumatic brain injury (TBI) using ReadAlyzer. ReadAlyzer is an objective eye movement recording device that tracks the eye movements while reading. Methods: Reading eye movements were measured using ReadAlyzer in 30 subjects with TBI (mild, moderate and severe) who had binocular vision and reading related symptoms and 60 asymptomatic controls. Results: There was a significant decrease in reading eye movement parameters in subjects with TBI compared to controls. Reading eye movement parameters are represented in median and interquartile range (IQR). Subjects with TBI presented with an increased number of fixations/100 words (median 137, IQR 106-159) and regressions/100 words (24, 12-36), and reduced reading rate (154, 128-173) words per minute. They also had a lesser grade level equivalent (4.0, 3.0-7.0) and reduced comprehension (70, 60-80) percentage compared to controls (Mann-Whitney U test, p < 0.05). Reading eye movement parameters were also significantly affected in mild and moderate-severe TBI subjects compared to controls (Kruskal-Wallis test, p < 0.05). Conclusion: Reading eye movement performance using ReadAlyzer was found to be decreased in traumatic brain injury. Reading assessment may serve as a clinical measure to understand the oculomotor system following TBI. (C) 2019 Spanish General Council of Optometry. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Reddy, Ashwini V. C.; Hussaindeen, Jameel Rizwana] Sankara Nethralaya, Elite Sch Optometry, Chennai, Tamil Nadu, India; [Reddy, Ashwini V. C.; Hussaindeen, Jameel Rizwana] Birla Inst Technol & Sci, Pilani, Rajasthan, India; [Reddy, Ashwini V. C.; Mani, Revathy; Hussaindeen, Jameel Rizwana] Sankara Nethralaya, Binocular Vis & Neurooptometry Clin, Chennai, Tamil Nadu, India; [Reddy, Ashwini V. C.; Mani, Revathy; Hussaindeen, Jameel Rizwana] Sankara Nethralaya, Srimathi Sundari Subramanian Dept Visual Psychoph, Chennai, Tamil Nadu, India; [Selvakumar, Ambika] Sankara Nethralaya, Dept Neuroophthalmol, Chennai, Tamil Nadu, India; [Mani, Revathy] Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia		Hussaindeen, JR (corresponding author), Sankara Nethralaya, Elite Sch Optometry, Chennai, Tamil Nadu, India.; Hussaindeen, JR (corresponding author), Birla Inst Technol & Sci, Pilani, Rajasthan, India.; Hussaindeen, JR (corresponding author), Sankara Nethralaya, Binocular Vis & Neurooptometry Clin, Chennai, Tamil Nadu, India.; Hussaindeen, JR (corresponding author), Sankara Nethralaya, Srimathi Sundari Subramanian Dept Visual Psychoph, Chennai, Tamil Nadu, India.	ashwini@snmail.org; revs.maruti@gmail.com; drsa@snmail.org; rizwana@snmail.org	Hussaindeen, Jameel Rizwana/AAN-5335-2021; Mani, Revathy/AAY-8313-2020	Hussaindeen, Jameel Rizwana/0000-0001-6569-5251; Mani, Revathy/0000-0002-2842-8979			[Anonymous], 2013, EYE MOVEMENT RECORDI; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda MA, 2003, J BEHAV OPTOM, V14, P60; Colby D, 1998, J Am Optom Assoc, V69, P22; Friedland D, 2013, ADV CLIN NEUROSCIENC; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hsiao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002621; Irving EL, 2006, INVEST OPHTH VIS SCI, V47, P2478, DOI 10.1167/iovs.05-1311; Lewallen S, 1998, Community Eye Health, V11, P57; Mani R, 2017, OPTOM VIS PERF, V5, P96; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; MOHAN Dinesh, 2002, J TRANSPORT INFRASTR, V9, P79; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; Tannen B., 1995, EYE MOVEMENT BASICS; TAYLOR SE, 1965, AM EDUC RES J, V2, P187, DOI 10.3102/00028312002004187; Thiagarajan P, 2014, J REHABIL RES DEV, V51, P175, DOI 10.1682/JRRD.2013.01.0027; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Webber A, 2011, OPTOMETRY VISION SCI, V88, P295, DOI 10.1097/OPX.0b013e31820846c0	22	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1888-4296	1989-1342		J OPTOM	J. Optom.	JUL-SEP	2020	13	3					155	162		10.1016/j.optom.2019.10.001			8	Ophthalmology	Emerging Sources Citation Index (ESCI)	Ophthalmology	LZ0BZ	WOS:000540896200004	31784207	Green Published, Green Submitted, gold			2022-02-06	
J	Ullah, S; Bin Ayaz, S; Moukais, IS; Qureshi, AZ; Alumri, T; Wani, TA; Aldajani, AA				Ullah, Sami; Bin Ayaz, Saeed; Moukais, Imad S.; Qureshi, Ahmad Z.; Alumri, Talal; Wani, Tariq A.; Aldajani, Adel A.			Factors affecting functional outcomes of traumatic brain injury rehabilitation at a rehabilitation facility in Saudi Arabia	NEUROSCIENCES			English	Article								Objectives: To identify the factors that affect disability after inpatient rehabilitation (IPR) in persons with traumatic brain injury (TBI). Methods: This retrospective study identified 140 patients aged >= 16 years who were admitted to the TBI rehabilitation unit at King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia between 2015 and 2017. The collected data included demographic variables, TBI cause, coma duration, time from injury to IPR, LOS, and Functional Independence Measure (FIM) scores at IPR admission and discharge. Results: Majority of the patients were young males. The TBI was caused by motor vehicle accidents (MVA) in 95% of patients. The mean coma duration, time from injury to IPR admission, and LOS were 47 +/- 38, 264 +/- 357, and 75 +/- 52 days, respectively. The factors that were found to have an association with FIM change were time from injury to IPR admission (p=0.003, r=-0.250), admission FIM score (p=0.003, r=-0.253), and discharge FIM score (p<0.001, r=0.390). Employed patients had high FIM scores at admission (p=0.029, r=0.184) and discharge (p=0.003, r=0.252). Conclusion: Reduction in disability at discharge was positively associated with the severity of disability at admission and negatively with the time duration from injury to IPR admission, indicating a need to reduce time before admittance to an IPR setup. The high incidence of MVA causing TBI in a young male population strongly points to a need for appropriate measures of prevention.	[Ullah, Sami; Moukais, Imad S.; Qureshi, Ahmad Z.; Aldajani, Adel A.] King Fahad Med City, Res Ctr, Res Serv Adm, Dept Phys Med & Rehabil, Riyadh, Saudi Arabia; [Wani, Tariq A.] King Fahad Med City, Res Ctr, Res Serv Adm, Dept Biostat, Riyadh, Saudi Arabia; [Alumri, Talal] Natl Guard Hosp, Riyadh, Saudi Arabia; [Bin Ayaz, Saeed] Combined Mil Hosp Jhelum, Dept Phys Med & Rehabil, Punjab, Pakistan		Ullah, S (corresponding author), King Fahad Med City, Dept Phys Med & Rehabil, Rehabil Hosp, Riyadh, Saudi Arabia.	drsamipmr@gmail.com	Qureshi, Ahmad Zaheer/AAW-2040-2021				Adeloye A, 1996, E AFR MED J, V73, P253; Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Al-Habib A, 2013, ANN SAUDI MED, V33, P351, DOI 10.5144/0256-4947.2013.351; Al-Jadid MS, 2012, SAUDI MED J, V33, P326; Al-Kuwaiti A, 2012, ULUS TRAVMA ACIL CER, V18, P213, DOI 10.5505/tjtes.2012.03710; Al-Naami I, 2019, NEUROSCI J, V2019; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Avesani R, 2012, EUR J PHYS REHAB MED, V48, P433; Bragge P, 2014, J HEAD TRAUMA REHAB, V29, P277, DOI 10.1097/HTR.0000000000000066; Chowdhury T, 2014, SAUDI J ANAESTH, V8, P114, DOI 10.4103/1658-354X.125971; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Demir Y, 2019, TURK J PH MED REHAB, V65, P67, DOI 10.5606/tftrd.2019.2281; DeNicola E, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00215; Downing M, 2019, BRAIN IMPAIR, V20, P24, DOI 10.1017/BrImp.2018.12; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; El-Menyar A, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0159-9; El-Siddig SM, 2017, BASIC RES J MED CLIN, V6, P93; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hawkins ML, 2005, AM SURGEON, V71, P920; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JAMAL A, 2019, INT J ENV RES PUB HE, V17, P1; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lee SY, 2019, BRAIN INJURY, V33, P1263, DOI 10.1080/02699052.2019.1641747; Mansuri FA, 2015, SAUDI MED J, V36, P418, DOI 10.15537/smj.2015.4.10003; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; Mazaux JM, 2001, J REHABIL MED, V33, P99; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Qannam H, 2017, BRAIN INJURY, V31, P702, DOI 10.1080/02699052.2017.1286386; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Taha MM, 2016, J SPINE NEUROSURG, V5, P6; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Valk-Kleibeuker L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087414; World Health Organization, 2016, INT STAT CLASS DIS R, V5TH; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358	51	3	3	1	1	RIYADH ARMED FORCES HOSPITAL	RIYADH	PO BOX 7897, RIYADH, KSA 11159, SAUDI ARABIA	1319-6138			NEUROSCIENCES	Neurosciences	JUL	2020	25	3					169	175		10.17712/nsj.2020.3.20190097			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RI1SV	WOS:000636691400002	32683395	Green Published, gold			2022-02-06	
J	Wang, YB; Liu, Y; Nham, A; Sherbaf, A; Quach, D; Yahya, E; Ranburger, D; Bi, XN; Baudry, M				Wang, Yubin; Liu, Yan; Nham, Amy; Sherbaf, Arash; Quach, Diana; Yahya, Emad; Ranburger, Davis; Bi, Xiaoning; Baudry, Michel			Calpain-2 as a therapeutic target in repeated concussion-induced neuropathy and behavioral impairment	SCIENCE ADVANCES			English	Article							TRAUMATIC BRAIN-INJURY; PHARMACOLOGICAL ANALYSIS; REACTIVE ASTROCYTES; INHIBITOR; EFFICACY; PROTEIN; DAMAGE; CELLS; MODEL	Repeated concussion represents a serious health problem as it can result in various brain pathologies, ranging from minor focal tissue injury to severe chronic traumatic encephalopathy. The calcium-dependent protease, calpain, participates in the development of neurodegeneration following concussion, but there is no information regarding the relative contribution of calpain-1 and calpain-2, the major calpain isoforms in the brain. We used a mouse model of repeated concussions, which reproduces most of the behavioral and neuropathological features of the human condition, to address this issue. Deletion of calpain-2 or treatment with a selective calpain-2 inhibitor for 2 weeks prevented most of these neuropathological features. Changes in TAR DNA binding protein 43 (TDP-43) subcellular localization similar to those found in human amyotrophic lateral sclerosis and frontotemporal dementia were also prevented by deletion of calpain-2 or treatment with calpain-2 inhibitor. Our results indicate that a selective calpain-2 inhibitor represents a therapeutic approach for concussion.	[Wang, Yubin; Liu, Yan; Nham, Amy; Sherbaf, Arash; Quach, Diana; Yahya, Emad; Ranburger, Davis; Baudry, Michel] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA; [Bi, Xiaoning] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA		Baudry, M (corresponding author), Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA.	mbaudry@westernu.edu		Wang, Yubin/0000-0002-8836-9632; Ranburger, Davis/0000-0001-9457-9049; Yahya, Emad/0000-0003-3397-3434; Baudry, Michel/0000-0002-5142-241X	Office of the Assistant Secretary of Defense for Health Affairs through The Defense Medical Research and Development Program [W81XWH-19-1-0329]; U.S. Department of DefenseUnited States Department of Defense [BA170606]; Daljit and Elaine Sarkaria Chair	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through The Defense Medical Research and Development Program under Award no. W81XWH-19-1-0329. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the U.S. Department of Defense. Grant no. BA170606. "Optimization of a selective calpain-2 inhibitor for prolonged field care in traumatic brain injury". X.B. is supported, in part, by funds from the Daljit and Elaine Sarkaria Chair.	Anagli J, 2009, BIOCHEM BIOPH RES CO, V385, P94, DOI 10.1016/j.bbrc.2009.04.141; Bains M, 2013, J NEUROCHEM, V125, P125, DOI 10.1111/jnc.12118; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Davis BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01747-8; Fesharaki-Zadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00713; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Gerson JE, 2017, METHODS MOL BIOL, V1523, P141, DOI 10.1007/978-1-4939-6598-4_9; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hiskens MI, 2019, J NEUROSCI RES, V97, P1194, DOI 10.1002/jnr.24472; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kobeissy FH, 2015, BRAIN NEUROTRAUMA MO; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Koumura A, 2008, NEUROSCIENCE, V157, P309, DOI 10.1016/j.neuroscience.2008.09.007; Li KY, 2019, AGING DIS, V10, P664, DOI 10.14336/AD.2018.0720; Liu S, 2014, BRAIN INJURY, V28, P133, DOI 10.3109/02699052.2013.860479; Liu Y, 2016, LEARN MEMORY, V23, P399, DOI 10.1101/lm.042721.116; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Perez EJ, 2017, J CLIN INVEST, V127, P3114, DOI 10.1172/JCI92300; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Puskarjov M, 2012, J NEUROSCI, V32, P11356, DOI 10.1523/JNEUROSCI.6265-11.2012; Schoch KM, 2013, J NEUROCHEM, V125, P909, DOI 10.1111/jnc.12144; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Siklos M, 2015, ACTA PHARM SIN B, V5, P506, DOI 10.1016/j.apsb.2015.08.001; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Wang YB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12236-3; Wang YB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4051; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yamashita T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2303; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yildiz-Unal A, 2015, NEUROPSYCH DIS TREAT, V11, P297, DOI 10.2147/NDT.S78226	43	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	JUL	2020	6	27							eaba5547	10.1126/sciadv.aba5547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MK4DR	WOS:000548735500028	32937436	Green Published, gold			2022-02-06	
J	Yadav, YR; Ratre, S; Parihar, V; Bajaj, J; Sinha, M; Kumar, A				Yadav, Yad Ram; Ratre, Shailendra; Parihar, Vijay; Bajaj, Jitin; Sinha, Mallika; Kumar, Ambuj			Endoscopic Management of Chronic Subdural Hematoma	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						chronic subdural hematoma; endoscopic surgical procedure; minimally invasive neurosurgery; neuroendoscopy; traumatic intracranial subdural hematoma	BURR-HOLE DRAINAGE; POSTOPERATIVE RECURRENCE; ASSISTED EVACUATION; REMOVAL; SURGERY; DECOMPRESSION; TREPANATION; CRANIOTOMY; SUBGALEAL; THERAPY	Background Twist drill evacuation, burr hole aspiration, mini-craniotomy, and craniotomy are some of the surgical methods to remove chronic subdural hematoma (CSDH). Endoscopic treatment was also recently found to be useful. Methods We conducted a prospective study of 72 hematomas in 68 patients. Computed tomography was performed in all cases. Endoscopic surgery was performed in all CSDH patients. Surgical procedure A 4-cm skin incision was performed at the most curved part of skull with the CSDH. A mini-craniotomy or enlarged burr hole was made. The inner and outer table of the burr hole margin was drilled to provide a straight trajectory to the hematoma cavity. An endoscope supported by a telescope holder was used. A modified silicone brain retractor was used in five patients. A subgaleal drain was left in all patients for 3 to 5 days. Results There were 42 male and 26 female patients. The age ranged from 45 to 79 years (average: 69 years). All patients had a history of head trauma. Preoperative average Glasgow Coma Scale Score was 14. The procedure was effective in hematoma evacuation and a good visualization of the whole cavity in all patients. The endoscopic technique helped in complete hematoma removal in organized/solid clot, septations, and bridging vessels in 17, 2, and 2 cases, respectively. Duration of surgery ranged from 35 to 80 minutes. One death occurred. There was no recurrence, infection, fresh bleed, or injury to the brain or membrane. Conclusion The endoscopic technique is an effective alternative technique for treating CSDH. Although the study has limitations because of the small number of patients with a short follow-up, the study indicated that thick and vascular membranes, septations, and organized and solid clots can be removed effectively using this technique.	[Yadav, Yad Ram; Ratre, Shailendra; Parihar, Vijay; Bajaj, Jitin; Sinha, Mallika; Kumar, Ambuj] Netaji Subhash Chandra Bose Med Coll & Hosp, Dept Neurosurg, Jabalpur, India		Ratre, S (corresponding author), Netaji Subhash Chandra Bose Med Coll Jabalpur, Dept Neurosurg, Jabalpur 482003, Madhya Pradesh, India.	drsratre@gmail.com	kumar, Ambuj/AAV-8328-2020; BAJAJ, JITIN/N-6601-2016	kumar, Ambuj/0000-0001-5606-6170; BAJAJ, JITIN/0000-0002-1638-0015			Alcala-Cerra G, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.012; Alcala-Cerra G, 2014, NEUROCIRUGIA, V25, P99, DOI 10.1016/j.neucir.2013.11.002; Battaglia F, 2012, NEUROCHIRURGIE, V58, P230, DOI 10.1016/j.neuchi.2012.04.002; BAUER BL, 1994, ACT NEUR S, V61, P1; Beez T, 2018, CUREUS, V10, DOI 10.7759/cureus.2258; Bellut D, 2012, WORLD NEUROSURG, V77, P111, DOI 10.1016/j.wneu.2011.05.036; Berhouma M, 2014, ACTA NEUROCHIR, V156, P2359, DOI 10.1007/s00701-014-2219-1; Boyaci S, 2016, TURK NEUROSURG, V26, P871, DOI 10.5137/1019-5149.JTN.14113-15.2; Chon KH, 2012, ACTA NEUROCHIR, V154, P1541, DOI 10.1007/s00701-012-1399-9; Dewanngan NK, 2017, J NEUROL SURG PART A, V78, P541, DOI 10.1055/s-0037-1599819; Dubey A, 2018, WORLD NEUROSURG, V113, pE612, DOI 10.1016/j.wneu.2018.02.108; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Gazzeri R, 2007, ACTA NEUROCHIR, V149, P487, DOI 10.1007/s00701-007-1139-8; Grobelny BT, 2009, J NEUROSURG, V111, P1257, DOI 10.3171/2009.6.JNS0928; Gruber DP, 1997, PEDIATR NEUROSURG, V27, P292, DOI 10.1159/000121273; Hellwig D, 1996, SURG NEUROL, V45, P272, DOI 10.1016/0090-3019(95)00417-3; Hellwig D, 2000, NEUROSURG CLIN N AM, V11, P525, DOI 10.1016/S1042-3680(18)30118-9; Huang YH, 2011, NEUROCRIT CARE, V14, P253, DOI 10.1007/s12028-011-9509-8; Ishikawa Toshihito, 2017, No Shinkei Geka, V45, P667, DOI 10.11477/mf.1436203572; Isobe N, 2008, NEUROL SURG TOKYO, V36, P1115; Jack A, 2015, CAN J NEUROL SCI, V42, P34, DOI 10.1017/cjn.2014.122; Jeong Seong Il, 2014, Korean J Neurotrauma, V10, P15, DOI 10.13004/kjnt.2014.10.1.15; Kale A, 2017, NEUROL RES, V39, P399, DOI 10.1080/01616412.2017.1296655; Kamenova M, 2017, WORLD NEUROSURG, V100, P594, DOI 10.1016/j.wneu.2017.01.065; Kamenova M, 2016, NEUROSURGERY, V79, P715, DOI 10.1227/NEU.0000000000001393; Kawasaki T, 2018, ACTA NEUROCHIR, V160, P241, DOI 10.1007/s00701-017-3399-2; Link TW, 2018, INTERV NEURORADIOL, V24, DOI 10.1177/1591019918769336; Mahmood SD, 2017, WORLD NEUROSURG, V106, P676, DOI 10.1016/j.wneu.2017.07.057; Majovsky M, 2016, ACTA NEUROCHIR, V158, P1987, DOI 10.1007/s00701-016-2902-5; Masopust V, 2003, MINIM INVAS NEUROSUR, V46, P374, DOI 10.1055/s-2003-812507; Matsumoto H, 2018, J CLIN NEUROSCI, V49, P40, DOI 10.1016/j.jocn.2017.11.009; Miki Koichi, 2016, No Shinkei Geka, V44, P747, DOI 10.11477/mf.1436203368; Mobbs R, 2009, J CLIN NEUROSCI, V16, P701, DOI 10.1016/j.jocn.2008.06.023; Motiei-Langroudi R, 2018, J NEUROSURG, V129, P1143, DOI 10.3171/2017.6.JNS17130; Nayil K, 2012, WORLD NEUROSURG, V77, P103, DOI 10.1016/j.wneu.2011.06.012; Oral S, 2015, NORTH CLIN ISTANB, V2, P115, DOI 10.14744/nci.2015.06977; Parihar VS, 2018, WORLD NEUROSURG, V115, pE599, DOI 10.1016/j.wneu.2018.04.107; Parihar VS, 2017, J NEUROL SURG PART A, V78, P219, DOI 10.1055/s-0036-1594014; Ratre S, 2018, J NEUROL SURG PART A, V79, P45, DOI 10.1055/s-0036-1594011; Ratre S, 2016, J NEUROL SURG PART A, V77, P312, DOI 10.1055/s-0036-1580595; RODZIEWICZ GS, 1995, SURG NEUROL, V43, P569, DOI 10.1016/0090-3019(95)00005-4; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Senturk S, 2010, SWISS MED WKLY, V140, P335, DOI smw-12867; Shin HS, 2016, J KOREAN NEUROSURG S, V59, P69, DOI 10.3340/jkns.2016.59.1.69; Shiomi N, 2005, NEUROL SURG TOKYO, V33, P785; Shiomi N, 2002, NEUROL SURG TOKYO, V30, P717; Shiomi N, 2002, NEUROL SURG TOKYO, V30, P823; Shrestha P, 2012, J NEPAL MED ASSOC, V52, P1; Singh AK, 2014, NEUROL INDIA, V62, P169, DOI 10.4103/0028-3886.132364; Song Dae Hyo, 2014, Korean J Neurotrauma, V10, P41, DOI 10.13004/kjnt.2014.10.2.41; Stavrinou P, 2017, WORLD NEUROSURG, V99, P465, DOI 10.1016/j.wneu.2016.12.058; Takahashi S, 2011, NEUROL MED-CHIR, V51, P515, DOI 10.2176/nmc.51.515; Tysiak EWN, 2012, EUR J PAEDIATR NEURO, V16, P736, DOI 10.1016/j.ejpn.2012.02.006; Wada M, 2014, CLIN NEUROL NEUROSUR, V120, P49, DOI 10.1016/j.clineuro.2014.02.007; Yadav YR, 2018, WORLD NEUROSURG, V114, P436, DOI 10.1016/j.wneu.2018.03.154; Yadav Yad R, 2016, Asian J Neurosurg, V11, P330; Yadav Yad Ram, 2016, Asian J Neurosurg, V11, P214, DOI 10.4103/1793-5482.145096; Yadav YR, 2016, J NEUROL SURG PART A, V77, P146, DOI 10.1055/s-0034-1376190; Yadav YR, 2015, J NEUROL SURG PART A, V76, P483, DOI 10.1055/s-0035-1551828; Yadav YR, 2014, J NEUROL SURG PART A, V75, P376, DOI 10.1055/s-0033-1343984; Yadav YR, 2013, J NEUROL SURG PART A, V74, P162, DOI 10.1055/s-0032-1327441; Yadav YR, 2013, J NEUROL SURG PART A, V74, P77, DOI 10.1055/s-0032-1333127; Yadav YR, 2013, TURK NEUROSURG, V23, P50, DOI 10.5137/1019-5149.JTN.6655-12.1; Yan KX, 2017, NEUROL RES, V39, P803, DOI 10.1080/01616412.2017.1321709; Yan KX, 2016, NEUROL RES, V38, P467, DOI 10.1080/01616412.2016.1139772; You WD, 2018, ACTA NEUROCHIR, V160, P893, DOI 10.1007/s00701-018-3513-0; Zhang JB, 2018, BRAIN RES, V1678, P245, DOI 10.1016/j.brainres.2017.10.017; Zumofen D, 2009, NEUROSURGERY, V64, P1116, DOI 10.1227/01.NEU.0000345633.45961.BB	68	3	5	1	7	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	JUL	2020	81	04					330	341		10.1055/s-0039-1698388			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MB5HA	WOS:000542632400008	32176925				2022-02-06	
J	Yue, JK; Satris, GG; Ore, CLD; Huie, JR; Deng, HS; Winkler, EA; Lee, YM; Vassar, MJ; Taylor, SR; Schnyer, DM; Lingsma, HF; Puccio, AM; Yuh, EL; Mukherjee, P; Valadka, AB; Ferguson, AR; Markowitz, AJ; Okonkwo, DO; Manley, GT				Yue, John K.; Satris, Gabriela G.; Ore, Cecilia L. Dalle; Huie, J. Russell; Deng, Hansen; Winkler, Ethan A.; Lee, Young M.; Vassar, Mary J.; Taylor, Sabrina R.; Schnyer, David M.; Lingsma, Hester F.; Puccio, Ava M.; Yuh, Esther L.; Mukherjee, Pratik; Valadka, Alex B.; Ferguson, Adam R.; Markowitz, Amy J.; Okonkwo, David O.; Manley, Geoffrey T.		RACK-TBI Investigators	Polytrauma Is Associated with Increased Three- and Six-Month Disability after Traumatic Brain Injury: A TRACK-TBI Pilot Study	NEUROTRAUMA REPORTS			English	Article						disability; functional outcome; outcome measure; polytrauma; traumatic brain injury	GLASGOW OUTCOME SCALE; COMMON DATA ELEMENTS; HEAD-INJURY; EXTERNAL VALIDATION; PREDICTORS; MILD; RECOMMENDATIONS; MORTALITY; ETIOLOGY; VALIDITY	Polytrauma and traumatic brain injury (TBI) frequently co-occur and outcomes are routinely measured by the Glasgow Outcome Scale-Extended (GOSE). Polytrauma may confound GOSE measurement of TBI-specific outcomes. Adult patients with TBI from the prospective Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study had presented to a Level 1 trauma center after injury, received head computed tomography (CT) within 24 h, and completed the GOSE at 3 months and 6 months post-injury. Polytrauma was defined as an Abbreviated Injury Score (AIS) >= 3 in any extracranial region. Univariate regressions were performed using known GOSE clinical cutoffs. Multi-variable regressions were performed for the 3- and 6-month GOSE, controlling for known demographic and injury predictors. Of 361 subjects (age 44.9 +/- 18.9 years, 69.8% male), 69 (19.1%) suffered polytrauma. By Glasgow Coma Scale (GCS) assessment, 80.1% had mild, 5.8% moderate, and 14.1% severe TBI. On univariate logistic regression, polytrauma was associated with increased odds of moderate disability or worse (GOSE <= 6; 3 month odds ratio [OR] = 2.57 [95% confidence interval (CI): 1.50-4.41; 6 month OR = 1.70 [95% CI: 1.01-2.88]) and death/severe disability (GOSE <= 4; 3 month OR = 3.80 [95% CI: 2.03-7.11]; 6 month OR = 3.33 [95% CI: 1.71-6.46]). Compared with patients with isolated TBI, more polytrauma patients experienced a decline in GOSE from 3 to 6 months (37.7 vs. 24.7%), and fewer improved (11.6 vs. 22.6%). Polytrauma was associated with greater univariate ordinal odds for poorer GOSE (3 month OR = 2.79 [95% CI: 1.73-4.49]; 6 month OR = 1.73 [95% CI: 1.07-2.79]), which was conserved on multi-variable ordinal regression (3 month OR = 3.05 [95% CI: 1.76-5.26]; 6 month OR = 2.04 [95% CI: 1.18-3.42]). Patients with TBI with polytrauma are at greater risk for 3- and 6-month disability compared with those with isolated TBI. Methodological improvements in assessing TBI-specific disability, versus disability attributable to all systemic injuries, will generate better TBI outcomes assessment tools.	[Yue, John K.; Satris, Gabriela G.; Ore, Cecilia L. Dalle; Huie, J. Russell; Winkler, Ethan A.; Lee, Young M.; Vassar, Mary J.; Taylor, Sabrina R.; Ferguson, Adam R.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94143 USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Yue, John K.; Satris, Gabriela G.; Ore, Cecilia L. Dalle; Huie, J. Russell; Winkler, Ethan A.; Lee, Young M.; Vassar, Mary J.; Taylor, Sabrina R.; Yuh, Esther L.; Mukherjee, Pratik; Ferguson, Adam R.; Markowitz, Amy J.; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Deng, Hansen; Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Schnyer, David M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA		Yue, JK; Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94143 USA.; Markowitz, AJ (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	john.yue@ucsf.edu; amymarkowitz@gmail.com; manleyg@neurosurg.ucsf.edu			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03]; U.S. Department of Defense (DOD)United States Department of Defense [W81XWH-13-1-0441]; U.S. DODUnited States Department of Defense [W81XWH-14-2-0176]	This work was supported by the following grants: National Institute of Neurological Disorders and Stroke (NINDS) 1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, and 5U01NS086090-03; U.S. Department of Defense (DOD) W81XWH-13-1-0441and U.S. DOD W81XWH-14-2-0176 (to G.T.M.)	Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Areas FZ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00432; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Belavic M, 2015, INJURY, V46, pS31, DOI 10.1016/j.injury.2015.10.057; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Chen CW, 2011, ACCIDENT ANAL PREV, V43, P823, DOI 10.1016/j.aap.2010.11.001; COTTINGTON EM, 1988, J TRAUMA, V28, P305, DOI 10.1097/00005373-198803000-00005; da Costa LGV, 2017, CLINICS, V72, P461, DOI 10.6061/clinics/2017(08)02; Dagher JH, 2010, BRAIN INJURY, V24, P1389, DOI 10.3109/02699052.2010.523042; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; El Mestoui Z, 2017, EUR J EMERG MED, V24, P49, DOI 10.1097/MEJ.0000000000000293; El-Menyar A, 2018, WORLD J SURG, V42, P1346, DOI 10.1007/s00268-017-4310-2; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hildebrand F, 2005, INJURY, V36, P293, DOI 10.1016/j.injury.2004.08.012; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Mkandawire NC, 2002, INJURY, V33, P111, DOI 10.1016/S0020-1383(01)00047-X; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Ranson J, 2019, J NEUROTRAUM, V36, P2493, DOI 10.1089/neu.2018.5998; Roberts I, 2002, NATL MED J INDIA, V15, P61; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; van der Vliet QMJ, 2019, CLIN ORTHOP RELAT R, V477, P2267, DOI 10.1097/CORR.0000000000000757; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Watanabe T, 2018, NEUROL MED-CHIR, V58, P393, DOI 10.2176/nmc.oa.2018-0116; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Yuan Q, 2012, INJURY, V43, P2094, DOI 10.1016/j.injury.2012.03.028; Yue JK, 2018, NEUROL RES, V40, P972, DOI 10.1080/01616412.2018.1505416; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zhao Xing-ji, 2007, Chin J Traumatol, V10, P53	50	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	JUL 1	2020	1	1					32	41		10.1089/neur.2020.0004			10	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WV1MY	WOS:000717002800006	34223528	Green Submitted, hybrid, Green Published			2022-02-06	
J	Buckley, CT; Van Matre, ET; Fischer, PE; Minard, G; Dickerson, RN				Buckley, Christopher T.; Van Matre, Edward T.; Fischer, Peter E.; Minard, Gayle; Dickerson, Roland N.			Improvement in Protein Delivery for Critically Ill Patients Requiring High-Dose Propofol Therapy and Enteral Nutrition	NUTRITION IN CLINICAL PRACTICE			English	Article						critical illness; calorie; enteral nutrition; propofol; protein; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEDATION; ENERGY; ADULTS; PROVISION; REQUIREMENTS; GUIDELINES; MORTALITY; CALORIES; SUPPORT	Background Patients with traumatic brain (TBI) injury often require a high dosage of propofol, which can provide an excessive caloric intake. We evaluated our strategy of using liquid protein supplement boluses concurrently with high protein-containing enteral nutrition (EN) formulas and formula rate reduction to avoid caloric overfeeding and inadequate protein intake. Methods Adult patients (aged >17 years) with TBI admitted to the trauma intensive care unit (TICU) who received concurrent propofol and EN were retrospectively reviewed. Caloric intakes from propofol and EN were obtained. Actual protein intake was compared with projected protein intakes from high protein content and standard protein content enteral formulas when given at an isocaloric intake. Results Fifty-one patients were enrolled. Average caloric intake from propofol was 356 +/- 243 kcal/d or 5 +/- 3 kcal/kg/d (range, <1-15 kcal/kg/d). Daily EN caloric intake ranged from 7 +/- 4 kcal/kg/d (day 2) to 16 +/- 9 kcal/kg/d (day 5;P< .001). Average protein intake ranged from 0.6 +/- 0.4 g/kg/d (day 2) to 1.5 +/- 0.7 g/kg/d (day 5;P< .001). The modified EN strategy resulted in daily delivery of 24%-38% more protein than an isocaloric regimen with a high protein-content formula and twice as much protein than the standard protein-content formula (P< .001). Conclusion The strategy of providing an EN regimen comprised liquid protein boluses, and high and very high protein-containing EN formulas at a reduced rate improved protein delivery without caloric overfeeding.	[Buckley, Christopher T.] Union Univ, Dept Pharm Practice, Coll Pharm, Jackson, TN 38305 USA; [Van Matre, Edward T.; Dickerson, Roland N.] Univ Tennessee, Dept Pharm & Translat Sci, Hlth Sci Ctr, 881 Madison Ave,Suite 345, Memphis, TN 38163 USA; [Fischer, Peter E.; Minard, Gayle] Univ Tennessee, Dept Surg, Hlth Sci Ctr, Memphis, TN 38163 USA		Dickerson, RN (corresponding author), Univ Tennessee, Dept Pharm & Translat Sci, Hlth Sci Ctr, 881 Madison Ave,Suite 345, Memphis, TN 38163 USA.	rdickerson@uthsc.edu		Van Matre, Edward/0000-0001-9125-9509; Buckley, Christopher/0000-0003-2398-2273; Dickerson, Roland/0000-0002-2086-6317			Allingstrup MJ, 2012, CLIN NUTR, V31, P462, DOI 10.1016/j.clnu.2011.12.006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bousie E, 2016, EUR J CLIN NUTR, V70, P1443, DOI 10.1038/ejcn.2016.167; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Charriere M, 2017, NUTRITION, V42, P64, DOI 10.1016/j.nut.2017.05.009; Cogle S. V., 2017, Journal of Pharmacy and Nutrition Sciences, V7, P106; Compher C, 2017, CRIT CARE MED, V45, P156, DOI [10.1097/CCM.0000000000002083, 10.1097/ccm.0000000000002083]; Dickerson RN, 2008, NUTRITION, V24, P536, DOI 10.1016/j.nut.2008.02.008; Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b; Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307; Dickerson RN, 2009, AM J HEALTH-SYST PH, V66, P796, DOI 10.2146/ajhp080574; Ferrie S, 2013, INTENS CARE MED, V39, P1989, DOI 10.1007/s00134-013-3053-2; Hastings J, 2018, JPEN-PARENTER ENTER, V42, P748, DOI 10.1177/0148607117721917; Klein CJ, 1998, J AM DIET ASSOC, V98, P795, DOI 10.1016/S0002-8223(98)00179-5; Krajcova A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1112-5; Levine M, 2014, J MED TOXICOL, V10, P10, DOI 10.1007/s13181-013-0356-1; Lowrey T S, 1996, Nutr Clin Pract, V11, P147, DOI 10.1177/0115426596011004147; Morgan Laurie M, 2004, Nutr Clin Pract, V19, P511, DOI 10.1177/0115426504019005511; Nicolo M, 2016, JPEN-PARENTER ENTER, V40, P45, DOI 10.1177/0148607115583675; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Rosmarin D K, 1996, Nutr Clin Pract, V11, P151, DOI 10.1177/0115426596011004151; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; SHELDON GF, 1978, ARCH SURG-CHICAGO, V113, P504; TALPERS SS, 1992, CHEST, V102, P551, DOI 10.1378/chest.102.2.551; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Taylor Stephen J, 2005, J Intensive Care Med, V20, P111, DOI 10.1177/0885066604273497; Weijs PJM, 2012, JPEN-PARENTER ENTER, V36, P60, DOI 10.1177/0148607111415109; Yeh DD, 2018, JPEN-PARENTER ENTER, V42, P212, DOI 10.1002/jpen.1033	30	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-5336	1941-2452		NUTR CLIN PRACT	Nutr. Clin. Pract.	FEB	2021	36	1			SI		212	218		10.1002/ncp.10546		JUN 2020	7	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	QG3UD	WOS:000543236100001	32589810	Bronze			2022-02-06	
J	Chihi, M; Gembruch, O; Oppong, MD; Helsper, M; Hutter, BO; Jabbarli, R; Wrede, KH; Sure, U; Maslehaty, H				Chihi, Mehdi; Gembruch, Oliver; Darkwah Oppong, Marvin; Helsper, Moritz; Huetter, Bernd-Otto; Jabbarli, Ramazan; Wrede, Karsten H.; Sure, Ulrich; Maslehaty, Homajoun			Analysis of Brain Natriuretic Peptide Serum Levels in Patients with Symptomatic Chronic Subdural Hematoma: A Potential Reliable Biomarker	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; brain natriuretic peptide; cardiac insufficiency; chronic subdural hematoma	ISCHEMIC-STROKE SUBTYPES; PLASMA-CONCENTRATION; BNP; DIAGNOSIS; SEVERITY; INJURY; HEART	The purpose of this study was to analyze brain natriuretic peptide (BNP) serum levels of patients with chronic subdural hematoma (cSDH) and their clinical implication. Patients with cSDH who underwent surgery in our department between November 2016 and October 2019 were eligible for enrollment in the study. Patients with recurrent bleedings, traumatic brain injury, cSDH associated with other intracranial pathologies, and those with a history of congestive heart failure, renal or endocrine disease were excluded. We measured BNP serum levels pre- and post-operatively and at discharge. The BNP values were analyzed with respect to patient medical history and neurological condition. The Glasgow Coma Scale score and the modified Rankin Scale score classified the clinical and neurological condition at the time of admission and discharge, respectively. The data of 100 surgically treated patients with cSDH (mean age 73.2, range 42 - 94 years, male/female 3.5:1) were analyzed. Pre-operative BNP serum levels (BNP-1) were elevated in 67% of the patients (n = 67; median = 101.6 pg/mL;p < 0.001). These serum levels increased after surgery (p < 0.001) and decreased thereafter (p < 0.001), reaching a level at discharge (day 7) that was not statistically different from BNP-1 (p > 0.05). In addition, elevated BNP-1 showed a significant statistical association with the presence of atrial fibrillation (p < 0.01) and antiplatelet and/or anticoagulant therapy (p < 0.01). This study provides new evidence regarding BNP serum levels and their secretion pattern in patients with cSDH. Whether BNP-1 can predict the long-term functional outcome of patients with cSDH is being investigated in this ongoing prospective study.	[Chihi, Mehdi; Gembruch, Oliver; Darkwah Oppong, Marvin; Helsper, Moritz; Huetter, Bernd-Otto; Jabbarli, Ramazan; Wrede, Karsten H.; Sure, Ulrich; Maslehaty, Homajoun] Univ Hosp Essen, Dept Neurosurg & Spine Surg, Essen, Germany; [Maslehaty, Homajoun] St Vinzenz Hosp, Dept Orthoped & Trauma Surg, Dinslaken, Germany		Chihi, M (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Neurosurg & Spine Surg, Hufelandstr 55, D-45147 Essen, Germany.	mehdi.chihi@uk-essen.de	Oppong, Marvin Darkwah/AAP-7231-2020; Wrede, Karsten/AAZ-2154-2020	Oppong, Marvin Darkwah/0000-0003-1021-5024; Wrede, Karsten/0000-0001-7076-3503; Gembruch, Oliver/0000-0002-0054-1611			Abdelalim EM, 2006, PEPTIDES, V27, P1886, DOI 10.1016/j.peptides.2006.01.001; ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; Belzberg H, 2007, J TRAUMA, V63, P1032, DOI 10.1097/01.ta.0000235995.86162.d2; Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; Chaudhuri JR, 2015, J STROKE CEREBROVASC, V24, P485, DOI 10.1016/j.jstrokecerebrovasdis.2014.09.025; Di Angelantonlo E, 2007, J NEUROL SCI, V260, P139, DOI 10.1016/j.jns.2007.04.018; Edlmann E, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0881-y; ESPINER EA, 1994, J INTERN MED, V235, P527, DOI 10.1111/j.1365-2796.1994.tb01261.x; Fukuhara K., 2019, ENEUROLOGICALSCI, V18, P100217; Galinier M, 2010, BNP NT PROBNP LEQUEL; Gregorio T, 2019, J NEUROL SCI, V399, P51, DOI 10.1016/j.jns.2019.02.014; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Gupta HV, 2019, NEUROLOGIST, V24, P6, DOI 10.1097/NRL.0000000000000214; Jabbarli R, 2020, NEUROSURG REV, V43, P825, DOI 10.1007/s10143-018-1037-y; Khalid F, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19517; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; Lee KS, 1998, BRAIN INJURY, V12, P901; Li F, 2018, J INTENSIVE CARE MED, V33, P663, DOI 10.1177/0885066616683677; McAteer A, 2017, BIOL RES NURS, V19, P531, DOI 10.1177/1099800417711584; McGirt MJ, 2004, NEUROSURGERY, V54, P1369, DOI 10.1227/01.NEU.0000125016.37332.50; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Nakagawa K, 2005, CEREBROVASC DIS, V19, P157, DOI 10.1159/000083249; Nosaka S, 1966, Jpn Circ J, V30, P509; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Porzionato A, 2010, INT REV CEL MOL BIO, V280, P1, DOI 10.1016/S1937-6448(10)80001-2; Stanisic M, 2017, NEUROSURGERY, V81, P752, DOI 10.1093/neuros/nyx090; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; TAKAHASHI K, 1992, PEPTIDES, V13, P121, DOI 10.1016/0196-9781(92)90149-W; Tsubokawa T, 2004, NEUROL RES, V26, P893, DOI 10.1179/016164104225017776; Tung PP, 2005, STROKE, V36, P1567, DOI 10.1161/01.STR.0000170699.59783.d6; Wei SG, 2013, HYPERTENSION, V62, P118, DOI 10.1161/HYPERTENSIONAHA.113.01404; Wu X, 2011, J TRAUMA, V71, P820, DOI 10.1097/TA.0b013e3182277b69	35	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2020	37	20					2211	2218		10.1089/neu.2020.7110		JUN 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	OA4HP	WOS:000546052200001	32524892	hybrid, Green Published			2022-02-06	
J	Zhao, PZ; Li, C; Chen, BL; Sun, GC; Chao, HL; Tu, YM; Bao, ZY; Fan, L; Du, XL; Ji, J				Zhao, Pengzhan; Li, Chong; Chen, Binglin; Sun, Guangchi; Chao, Honglu; Tu, Yiming; Bao, Zhongyuan; Fan, Liang; Du, Xiaoliu; Ji, Jing			Up-regulation of CHMP4B alleviates microglial necroptosis induced by traumatic brain injury	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						CHMP4B; FOXO1; microglia; necroptosis; traumatic brain injury	TRANSCRIPTION FACTOR FOXO1; TUMOR-NECROSIS-FACTOR; CELL-DEATH; MLKL; INFLAMMATION; DOWNSTREAM; MECHANISMS; APOPTOSIS; RIPK1	Microglial cells are key component of central nervous system (CNS) and mediate the immune response of the brain under physiological or pathological conditions. It tends to activate into a pro-inflammatory M1 phenotype after traumatic brain injury (TBI) and promote secondary brain damage. Recently, necroptosis was found to promote microglial activation and neuroinflammation after TBI. However, the mechanism and specific interventions of microglial necroptosis after TBI remain poorly investigated. Here, we reported that overexpress the charged multivesicular body protein 4b (CHMP4B) which is a core member of the endosomal sorting required for transport complex III (ESCRT-III) significantly decreased the level of necroptosis in microglia, improved neurological function recovery and protected against cell death after TBI. Further investigation showed that forkhead transcription factor O1 (FOXO1) was a crucial transcription factor that increased CHMP4B transcription by binding to the promoter region, thereby inhibiting necroptosis in microglia. Collectively, our findings demonstrated that CHMP4B relieved microglial necroptosis and neuroinflammation after TBI, and promote the recovery of nerve function. FOXO1 is an important factor in promoting CHMP4B expression. This study provides the novel viewpoint for TBI prevention and treatment.	[Zhao, Pengzhan; Li, Chong; Chen, Binglin; Sun, Guangchi; Chao, Honglu; Tu, Yiming; Bao, Zhongyuan; Ji, Jing] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Fan, Liang] Nanchang Univ, Affiliated Hosp 3, Dept Trauma Ctr, Nanjing, Jiangxi, Peoples R China; [Du, Xiaoliu] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Peoples R China		Ji, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	jijing@njmu.edu.cn			Jiangsu Province's Key Discipline of Medicine [XK201117]; Jiangsu Province's Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK20160047]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471269, 81972153, 81372709]; Priority Academic Program Development of Jiangsu Higher Education Institution [PAPD]; Jiangsu Province Medical Key Talent [ZDRCB2016002]	Jiangsu Province's Key Discipline of Medicine, Grant/Award Number: XK201117; Jiangsu Province's Natural Science Foundation, Grant/Award Number: BK20160047; National Natural Science Foundation of China, Grant/Award Number: 81471269, 81972153 and 81372709; Priority Academic Program Development of Jiangsu Higher Education Institution [PAPD]; Jiangsu Province Medical Key Talent, Grant/Award Number: ZDRCB2016002	Cheng FY, 2019, AGING-US, V11, P9875, DOI 10.18632/aging.102437; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Fan H, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0081-8; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Galluzzi L, 2014, CELL RES, V24, P139, DOI 10.1038/cr.2014.8; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Guo HY, 2017, CELL, V169, P186, DOI 10.1016/j.cell.2017.03.030; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Ichiyama K, 2016, IMMUNITY, V44, P1284, DOI 10.1016/j.immuni.2016.05.015; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Li Y, 2019, CELL DEATH DIFFER, V26, P2284, DOI 10.1038/s41418-019-0299-4; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Lu JN, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01360; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Maeda A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.277; Mahul-Mellier AL, 2006, J NEUROSCI, V26, P542, DOI 10.1523/JNEUROSCI.3069-05.2006; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Song SS, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01030; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Xu XP, 2017, CELL MOL NEUROBIOL, V37, P1359, DOI 10.1007/s10571-017-0466-4; Yang JP, 2018, CEREB CORTEX, V28, P2622, DOI 10.1093/cercor/bhy089; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2017, BRAIN INJURY, V31, P406, DOI 10.1080/02699052.2016.1225984; Zhang YY, 2018, CELL RES, V28, P9, DOI 10.1038/cr.2017.133	45	3	3	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	AUG	2020	24	15					8466	8479		10.1111/jcmm.15406		JUN 2020	14	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	MV5JV	WOS:000542909900001	32585748	Green Published, gold			2022-02-06	
J	Miyashita, TL; Cote, C; Terrone, D; Diakogeorgiou, E				Miyashita, Theresa L.; Cote, Christopher; Terrone, Douglas; Diakogeorgiou, Eleni			Detecting changes in postural sway	JOURNAL OF BIOMECHANICS			English	Article						Balance; Sway velocity; Baseline; Center of pressure; Instrumented	COLLEGIATE FOOTBALL PLAYERS; ANKLE INJURIES; CONCUSSION; BALANCE; STABILITY; MANAGEMENT; RECOVERY	Postural sway has been identified as a valid marker for assessing the presence of a concussion and monitoring return to activity progression. Instrumented balance assessments have shown to be more reliable in detecting postural sway. However, many sports medicine programs cannot afford to purchase a force plate system to objectively assess postural sway and changes, which may occur due to a head injury. The purpose of this study was to determine if the C3Logix (TM) application can detect postural sway with the same degree of accuracy as the VSR Sport (TM) by NeuroCom (R). Forty-five Division I Lacrosse players, consisting of 27 males and 18 females, participated in this study. Participants completed the Stability Evaluation Test (SET) on the VSR Sport (TM) while simultaneously completing the same balance assessment via the C3Logix (TM) application. The balance assessment consisted of three stances (double leg, single leg, tandem stance) on two surfaces (firm & foam) for a total of six trials. A Pearson correlation was used to determine the correlation between the postural sway velocity values from the VSR Sport (TM) and ellipse volume values from the C3Logix (TM) application. Each of the stances on both the firm and foam surface was found to have a strong correlation, suggesting the C3Logix (TM) application is a valid alternative to postural assessments on a force plate. (C) 2020 Elsevier Ltd. All rights reserved.	[Miyashita, Theresa L.] Concordia Univ Chicago, 7400 Augusta St, River Forest, IL 60305 USA; [Cote, Christopher] Bryant Univ, Smithfield, RI USA; [Terrone, Douglas] Sacred Heart Univ, Fairfield, CT USA; [Diakogeorgiou, Eleni] Univ Connecticut, Storrs, CT USA		Miyashita, TL (corresponding author), Concordia Univ Chicago, 7400 Augusta St, River Forest, IL 60305 USA.	Theresa.miyashita@cuchicago.edu					Bernstein JPK, 2019, APPL NEUROPSYCH-ADUL, V26, P275, DOI 10.1080/23279095.2017.1416471; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kleffelgaard I, 2018, EUR J PHYSIOTHER, V20, P25, DOI 10.1080/21679169.2017.1352020; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Mucha A, 2012, BRAIN INJURY PROFESS, V9, P12, DOI DOI 10.3109/02699052.2014.887144; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rochefort C, 2017, J SCI MED SPORT, V20, P970, DOI 10.1016/j.jsams.2017.04.008; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Wang HK, 2006, ARCH PHYS MED REHAB, V87, P821, DOI 10.1016/j.apmr.2006.02.024; Williams RM, 2017, J SPECTROSC, V2017, P1, DOI 10.1155/2017/6867507; Williams RM, 2017, INT J ATHL THER TRAI, V22, P39, DOI 10.1123/ijatt.2016-0095	22	3	3	2	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JUN 23	2020	107								109868	10.1016/j.jbiomech.2020.109868			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	LW9AU	WOS:000539435300017	32517863				2022-02-06	
J	Kalgudi, S; Ho, KM				Kalgudi, Shankar; Ho, Kwok M.			Incidence of Antithrombin Deficiency and Anti-Cardiolipin Antibodies After Severe Traumatic Brain Injury: A Prospective Cohort Study	NEUROCRITICAL CARE			English	Article						Anti-cardiolipin antibodies; Antithrombin; Prothrombotic state; Traumatic brain injury; Venous thromboembolism	CARDIOLIPIN; MITOCHONDRIA; COAGULOPATHY; PEROXIDATION; COAGULATION	Background Animal studies suggested that cerebral mitochondrial cardiolipin phospholipids were released after severe traumatic brain injury (TBI), contributing to the pathogenesis of thromboembolism. Objectives To determine the incidence of anti-cardiolipin antibodies after severe TBI and whether this was related to the severity of TBI and development of venous thromboembolism. Methods Serial anti-cardiolipin antibodies, antithrombin levels, viscoelastic testing, and coagulation parameters were measured on admission, day-1, and between day-5 and day-7 in patients with severe TBI requiring intracranial pressure monitoring. Results Of the 40 patients included (85% male and median age 42 years), 7 (18%) had a raised Ig-G or Ig-M anti-cardiolipin antibody titer after TBI. Antithrombin levels were below the normal level-especially on day-0 and day-1-in 15 patients (38%), and 14 patients (38%) developed an increase in maximum clot firmness on the viscoelastic test in conjunction with elevations in fibrinogen concentration and platelet count. Four patients (10%) developed deep vein thrombosis, and 10 patients (25%) died, both of which were not significantly related to the presence of anti-cardiolipin antibodies (P = 0.619 andP = 0.638, respectively). Conclusions A reduction in antithrombin level and development of anti-cardiolipin antibodies were not rare immediately after severe TBI; these abnormalities were followed by an increase in in vitro clot strength due to elevations in fibrinogen concentration and platelet count. The quantitative relationships between the development of anti-cardiolipin antibodies and severity of TBI or clinical thromboembolic events deserve further investigation.	[Kalgudi, Shankar; Ho, Kwok M.] Royal Perth Hosp, Dept Intens Care Med, ICU, 4th Floor,North Block,Wellington St, Perth, WA 6000, Australia; [Ho, Kwok M.] Univ Western Australia, Med Sch, Perth, WA, Australia; [Ho, Kwok M.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia		Ho, KM (corresponding author), Royal Perth Hosp, Dept Intens Care Med, ICU, 4th Floor,North Block,Wellington St, Perth, WA 6000, Australia.; Ho, KM (corresponding author), Univ Western Australia, Med Sch, Perth, WA, Australia.; Ho, KM (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia.	kwok.ho@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004	Department of Intensive Care Medicine, Royal Perth Hospital, Perth, Western Australia	This study was solely funded internally by the Department of Intensive Care Medicine, Royal Perth Hospital, Perth, Western Australia. The funder plays no role in the study design, in the collection, analysis and interpretation of the data, in the writing of the report, and the decision to submit the article for publication.	Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Devreese KMJ, 2018, J THROMB HAEMOST, V16, P809, DOI 10.1111/jth.13976; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Harahsheh Y, 2019, CRIT CARE MED, V47, P826, DOI 10.1097/CCM.0000000000003730; Harahsheh Y, 2018, EUR J HAEMATOL, V100, P113, DOI 10.1111/ejh.12992; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Hoots WK, 1997, SEMIN THROMB HEMOST, V23, P3; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Jessen KR, 2004, INT J BIOCHEM CELL B, V36, P1861, DOI 10.1016/j.biocel.2004.02.023; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; Lakos G, 2012, SEMIN THROMB HEMOST, V38, P353, DOI 10.1055/s-0032-1304714; Li XX, 2015, J HISTOCHEM CYTOCHEM, V63, P301, DOI 10.1369/0022155415574818; Lopez-Escribano H, 2002, ARTHRITIS RHEUM, V46, P3290, DOI 10.1002/art.10684; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Matsumoto H, 2018, THROMB J, V16, DOI 10.1186/s12959-018-0171-7; Mejia EM, 2014, CHEM PHYS LIPIDS, V179, P11, DOI 10.1016/j.chemphyslip.2013.10.001; Nomura H, 1998, STROKE, V29, P1014, DOI 10.1161/01.STR.29.5.1014; Ornaghi S, 2014, THROMB RES, V133, P972, DOI 10.1016/j.thromres.2014.02.014; Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016; Peyta L, 2016, BBA-BIOENERGETICS, V1857, P443, DOI 10.1016/j.bbabio.2016.01.002; Pointer CB, 2017, CELL MOL NEUROBIOL, V37, P1161, DOI 10.1007/s10571-016-0458-9; Pope S, 2008, BBA-BIOENERGETICS, V1777, P794, DOI 10.1016/j.bbabio.2008.03.011; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; RUGGIERO FM, 1992, J NEUROCHEM, V59, P487, DOI 10.1111/j.1471-4159.1992.tb09396.x; Saw MM, 2014, NEUROCRIT CARE, V20, P209, DOI 10.1007/s12028-013-9933-z; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]	38	3	3	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2021	34	1					227	235		10.1007/s12028-020-01026-x		JUN 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QT6MJ	WOS:000541215600002	32557110				2022-02-06	
J	Horan, B; Heckenberg, R; Maruff, P; Wright, B				Horan, Ben; Heckenberg, Rachael; Maruff, Paul; Wright, Bradley			Development of a new virtual reality test of cognition: assessing the test-retest reliability, convergent and ecological validity of CONVIRT	BMC PSYCHOLOGY			English	Article						VR; Eye-tracking; Concussion; Mild traumatic brain injury; Assessment	TRAUMATIC BRAIN-INJURY; EYE-MOVEMENTS; CONCUSSION; STRESS; TIME; TRACKING; SACCADES; PURSUIT	Background: Technological advances provide an opportunity to refine tools that assess central nervous system performance. This study aimed to assess the test-retest reliability and convergent and ecological validity of a newly developed, virtual-reality, concussion assessment tool, 'CONVIRT', which uses eye-tracking technology to assess visual processing speed, and manual reaction time (pushing a button on a riding crop) to assess attention and decision-making. CONVIRT was developed for horse jockeys, as of all sportspersons, they are most at risk of concussion. Methods: Participants (N=165), were assessed with CONVIRT, which uses virtual reality to give the user the experience of riding a horse during a horserace. Participants were also assessed with standard Cogstate computer-based concussion measures in-between two completions of the CONVIRT battery. The physiological arousal induced by the test batteries were assessed via measures of heart rate and heart rate variability (LF/HF ratio). Results: Satisfactory test-retest reliability and convergent validity with Cogstate attention and decision-making subtests and divergent validity in visual processing speed measures were observed. CONVIRT also increased heart rate and LF/HF ratio, which may better approximate participant arousal levels in their workplace. Conclusions: CONVIRT may be a reliable and valid tool to assess elements of cognition and CNS disruption. The increased ecological validity may also mean better informed 'return-to-play' decisions and stronger industry acceptance due to the real-world meaningfulness of the assessment. However, before this can be achieved, the sensitivity of the CONVIRT battery needs to be demonstrated.	[Horan, Ben] Deakin Univ, Sch Engn, Geelong, Vic 3216, Australia; [Heckenberg, Rachael] La Trobe Univ, Sch Psychol & Publ Hlth, Wodonga, Vic 3690, Australia; [Maruff, Paul] Univ Melbourne, Florey Inst, Parkville, Vic 3052, Australia; [Wright, Bradley] La Trobe Univ, Sch Psychol & Publ Hlth, Bundoora, Vic 3086, Australia		Wright, B (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Bundoora, Vic 3086, Australia.	b.wright@latrobe.edu.au	Maruff, Paul/AAD-2454-2021	Maruff, Paul/0000-0002-6947-9537; Wright, Bradley/0000-0002-6428-9128			Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Bott N, 2018, J MED INTERNET RES, V20, DOI 10.2196/11143; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Camm AJ, 1996, CIRCULATION, V93, P1043; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Cripps AE., 2015, J ATHL ENHANC, V4, P1; D'Amico NR., 2016, MED SCI SPORT EXERC, V48, P1; de Xivry JJO, 2007, J PHYSIOL-LONDON, V584, P11, DOI 10.1113/jphysiol.2007.139881; Delaney JPA, 2000, PERCEPT MOTOR SKILL, V91, P515, DOI 10.2466/PMS.91.6.515-524; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Evans J., 1996, STRAIGHTFORWARD STAT, P127; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hitchens PL, 2009, MED J AUSTRALIA, V190, P83, DOI 10.5694/j.1326-5377.2009.tb02284.x; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Kuhnell R, 2020, STRESS, V23, P136, DOI 10.1080/10253890.2019.1651285; Landolt K, 2017, PSYCHONEUROENDOCRINO, V84, P151, DOI 10.1016/j.psyneuen.2017.07.238; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Munafo J, 2017, EXP BRAIN RES, V235, P889, DOI 10.1007/s00221-016-4846-7; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Orchard J., 2014, AFL REPORTS, P1; Parsons T. D., 2012, ADV HUMAN COMPUTER I, V5, P1; Parsons TD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00660; Parsons TD, 2013, J CLIN EXP NEUROPSYC, V35, P812, DOI 10.1080/13803395.2013.824556; Porcino TM, 2017, IEEE INT CONF SERIOU; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Salomoni P, 2017, J MULTIMODAL USER IN, V11, P173, DOI 10.1007/s12193-016-0236-5; Semmelmann K, 2018, BEHAV RES METHODS, V50, P451, DOI 10.3758/s13428-017-0913-7; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Taghdiri F, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000286; Turner M, 2008, BRIT J SPORT MED, V42, P763, DOI 10.1136/bjsm.2007.040337; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; Urbina S, 1997, PSYCHOL TESTING; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wege N, 2017, J PSYCHOSOM RES, V94, P64, DOI 10.1016/j.jpsychores.2017.01.008; White SA, 2004, STAT MED, V23, P1603, DOI 10.1002/sim.1804	53	3	3	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2050-7283		BMC PSYCHOL	BMC Psychol.	JUN 12	2020	8	1							61	10.1186/s40359-020-00429-x			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	UX5IW	WOS:000700879500002	32532362	Green Published, gold			2022-02-06	
J	Tan, YZ; Levin, L; Guo, WW; Chen, YJ				Tan, Yi-zhou; Levin, Liran; Guo, Weiwei; Chen, Yongjin			Dental injuries at the Xi'an, China Stomatological Hospital: A Retrospective Study	DENTAL TRAUMATOLOGY			English	Article						avulsion; luxation; prevention; tooth fracture; trauma	SCHOOLCHILDREN; PREVALENCE; TRAUMA	Background/Aim In order to enrich epidemiological knowledge regarding traumatic dental injuries (TDI) in China, and to further improve the treatment, prevention and education of TDI, the aim of this study was to retrospectively analyze the TDI that presented to the emergency dental department at the Stomatological Hospital in Xi'an, China. Methods This retrospective study included all first-visit patients who presented with TDI at the Stomatological Hospital affiliated with the Fourth Military Medical University in Xi'an, China, between January 2013 and June 2019. Data were extracted using the terms of diagnosis of TDI from the hospital database. Results Overall, 965 (606 males and 359 females) files were reviewed. The average age was 22.8 +/- 13.4 years. Among the 2059 teeth injured (average of 2.1 teeth per patient), the maxillary incisors (1751; 85.0%) were the most prevalent teeth to present with injuries, while the main types of injuries were concussions (14.8%) enamel-dentin-fractures (14.50%) and enamel-dentin-pulp fractures (14.0%). After initial examination and diagnosis, 4.2% patients refused treatment. Conclusions The epidemiological statistics of TDI in Xi'an, China show consistency with other studies from around the world, but they also vary in diagnosis proportion and the choice of treatments. This information may further instruct treatment, prevention and emergency resources distribution to target the high-risk groups.	[Tan, Yi-zhou; Guo, Weiwei; Chen, Yongjin] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Sch Stomatol, Xian, Peoples R China; [Tan, Yi-zhou; Guo, Weiwei; Chen, Yongjin] Fourth Mil Med Univ, Natl Clin Res Ctr Oral Dis, Sch Stomatol, Xian, Peoples R China; [Tan, Yi-zhou; Guo, Weiwei; Chen, Yongjin] Fourth Mil Med Univ, Shaanxi Engn Res Ctr Dent Mat & Adv Manufacture, Sch Stomatol, Dept Periodontol, Xian, Peoples R China; [Levin, Liran] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada		Levin, L (corresponding author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Natl Clin Res Ctr Oral Dis, Dept Gen Dent & Emergency,Sch Stomatol, 145th West Chang Le Rd, Xian 710032, Peoples R China.	liran@ualberta.ca					Andreasen FM, 2007, TXB COLOR ATLAS TRAU, P197; Arheiam AA, 2020, DENT TRAUMATOL, V36, P185, DOI 10.1111/edt.12529; Chen Z, 2014, DENT TRAUMATOL, V30, P385, DOI 10.1111/edt.12110; da Silva AC, 2004, DENT TRAUMATOL, V20, P6, DOI 10.1111/j.1600-4469.2004.00212.x; Villalobos MIDEB, 2020, DENT TRAUMATOL, V36, P161, DOI 10.1111/edt.12514; Figueiredo R, 2018, DENT TRAUMATOL, V34, P421, DOI 10.1111/edt.12436; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Gong Y, 2011, DENT TRAUMATOL, V27, P203, DOI 10.1111/j.1600-9657.2010.00938.x; Hegde Rahul, 2017, Int J Clin Pediatr Dent, V10, P177, DOI 10.5005/jp-journals-10005-1430; Kaczmarek U, 2019, DENT MED PROBL, V56, P365, DOI 10.17219/dmp/112302; Liu F, 2020, DENT TRAUMATOL, V36, P489, DOI 10.1111/edt.12555; Ng L, 2020, DENT TRAUMATOL, V36, P360, DOI 10.1111/edt.12548; Petersson EE, 1997, SWED DENT J, V21, P55; Scott N, 2020, DENT TRAUMATOL, V36, P25, DOI 10.1111/edt.12505; Tumen EC, 2017, NIGER J CLIN PRACT, V20, P1259, DOI 10.4103/1119-3077.219518; Wood EB, 2002, AUST DENT J, V47, P142, DOI 10.1111/j.1834-7819.2002.tb00318.x; Zaror C, 2018, COMMUNITY DENT ORAL, V46, P88, DOI 10.1111/cdoe.12333; Zhang Y, 2014, DENT TRAUMATOL, V30, P211, DOI 10.1111/edt.12075	18	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	OCT	2020	36	5					505	509		10.1111/edt.12572		JUN 2020	5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	NK1LF	WOS:000539655100001	32450001				2022-02-06	
J	Torres, VA; Strack, JE; Dolan, S; Kruse, MI; Pennington, ML; Synett, SJ; Kimbrel, N; Gulliver, SB				Torres, Victoria A.; Strack, Jordan E.; Dolan, Sara; Kruse, Marc, I; Pennington, Michelle L.; Synett, Samantha J.; Kimbrel, Nathan; Gulliver, Suzy B.			Identifying Frequency of Mild Traumatic Brain Injury in Firefighters	WORKPLACE HEALTH & SAFETY			English	Article						head injury; mTBI; first responder; firefighter; post-concussive syndrome	BECK-DEPRESSION-INVENTORY; TBI IDENTIFICATION METHOD; ANXIETY STRESS SCALES; PSYCHOMETRIC PROPERTIES; CONSTRUCT-VALIDITY; RELIABILITY; CONCUSSION; SYMPTOMS; RECOMMENDATIONS	Background:Mild traumatic brain injury (mTBI) is a nationwide problem; yet, no firefighter mTBI data are available.Methods:In this cross-sectional study, we assessed retrospective head injuries using WHO guidelines. We captured mTBI frequency and examined firefighters' symptoms (e.g., using Ohio State University Traumatic Brain Injury Identification method, Brief Traumatic Brain Injury Screen, Warrior Administered Retrospective Causality Assessment Tool).Findings:Of 1,112 firefighters contacted, 60 responses were included. Most participants were White (80%), male (90%), former athletes (75%). 62% met mTBI symptom criteria. 75% reported at least one lifetime head injury. Number of head injuries and depression symptoms were associated (r = .36, p < .05).Conclusion/application to practice:Overall, it appears most firefighters have sustained at least one lifetime mTBI. Those with multiple head injuries may be at increased risk of depression. Occupational health professionals should be aware of firefighters' mTBI risk. Further research is warranted given findings.	[Torres, Victoria A.] Univ Mississippi, University, MS 38677 USA; [Strack, Jordan E.; Pennington, Michelle L.; Gulliver, Suzy B.] Baylor Scott & White Hlth, Waco, TX 76708 USA; [Dolan, Sara] Baylor Univ, Psychol & Neurosci Dept, Waco, TX 76798 USA; [Kruse, Marc, I] Austin Fire Dept, Austin, TX USA; [Kruse, Marc, I] Austin Travis Cty Emergency Med Serv, Bellville, TX USA; [Synett, Samantha J.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Kimbrel, Nathan] Duke Univ, Med Ctr, Durham Vet Affairs Med Ctr VAMC, Durham, NC 27706 USA; [Kimbrel, Nathan] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Gulliver, Suzy B.] Texas A&M Hlth Sci Ctr, Bryan, TX USA		Strack, JE (corresponding author), Baylor Scott & White Hlth, Warriors Res Inst, 2201 MacArthur Dr,Suite 2200, Waco, TX 76708 USA.	Jordan.strack@bswhealth.org			Research Mentorship Award (RMA) grant from Baylor Scott White [150278]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by a Research Mentorship Award (RMA) grant from Baylor Scott & White (150278) and approved by the Institutional Review Boards for the Protection of Human Research Subjects at Baylor Scott & White.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Barr DA, 2016, PREHOSP EMERG CARE, V20, P467, DOI 10.3109/10903127.2016.1139215; Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; Bedard M, 2018, CLIN NEUROPSYCHOL, V32, P1002, DOI 10.1080/13854046.2017.1404644; Billings J, 2016, J OCCUP ENVIRON MED, V58, P294, DOI 10.1097/JOM.0000000000000624; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brain Injury Alliance of Utah, TYP LEV BRAIN INJ; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryant RA, 2010, SLEEP, V33, P69, DOI 10.1093/sleep/33.1.69; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carpenter GSJ, 2015, AM J HEALTH BEHAV, V39, P191, DOI 10.5993/AJHB.39.2.5; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Evarts B., 2018, US FIREFIGHTER INJUR; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; GREENWALD BD, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/469475; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lovibond S.H., 1983, 18 ANN C AUSTR PSYCH; McKinlay A, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000284; Meyer EC, 2012, PSYCHOL SERV, V9, P1, DOI 10.1037/a0026414; Peterson AB, 2019, SURVEILLANCE REPORT; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Scandella F., 2012, FIREFIGHTERS FEELING; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Tanielian T.L., 2008, INVISIBLE WOUNDS WAR, V1; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Terry DP, 2019, CLIN NEUROPSYCHOL, V33, P124, DOI 10.1080/13854046.2018.1459853; U.S. Department of Labor Occupational Safety and Health Administration. (2016)., 2016, REC PRACT SAF HLTH P; U.S. Fire Administration, 2016, FIR REL FIR INJ REP; Weathers F.W., 1993, ANN CONV INT SOC TRA	37	3	3	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2165-0799	2165-0969		WORKPLACE HEALTH SAF	Workplace Health Saf.	OCT	2020	68	10					468	475	2165079920922576	10.1177/2165079920922576		JUN 2020	8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	NP3IZ	WOS:000540046800001	32525463				2022-02-06	
J	Osborne, CL; Kauvar, DS; Juengst, SB				Osborne, Candice L.; Kauvar, David S.; Juengst, Shannon B.			Linking the behavioral assessment screening tool to the international classification of functioning, disability, and health as a novel indicator of content validity	DISABILITY AND REHABILITATION			English	Article						Content validity; traumatic brain injury; behavior; assessment	OUTCOME MEASURES; CORE SETS; MODEL; ICF	Purpose:To use the International Classification of Functioning, Disability, and Health (ICF) to classify and describe the concepts of the Behavioral Assessment Screening Tool (BAST), a measure of behavioral disruptions after traumatic brain injury (TBI). Methods:Meaningful concepts in the BAST were linked to the International Classification of Functioning to (1) further explore the validity of the conceptual model of behavior; (2) demonstrate ICF linking as a novel indicator of the content validity; (3) identify International Classification of Functioning concepts that characterize behavior; (4) determine the comprehensiveness of the BAST. Results:The body functions component and the activities and participation component were most frequently addressed in the BAST. The majority of the TBI Core Set categories were included in the BAST and the manifest and latent coders agreed 85% of the time. Conclusions:Linking BAST concepts to the International Classification of Functioning demonstrated the BAST's content validity and comprehensiveness. This approach provides a model for how ICF coding could be used to assess content validity.	[Osborne, Candice L.; Juengst, Shannon B.] Univ Texas Southwest Med Ctr, Dept Phys Med & Rehabil, 5161 Harry Hines Blvd, Dallas, TX 75390 USA; [Kauvar, David S.] San Antonio Mil Med Ctr, Dept Surg, San Antonio, TX USA; [Kauvar, David S.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Osborne, CL (corresponding author), Univ Texas Southwest Med Ctr, Dept Phys Med & Rehabil, 5161 Harry Hines Blvd, Dallas, TX 75390 USA.	candice.osborne@utsouthwestern.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X			Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; Cieza A, 2008, EUR J PHYS REHAB MED, V44, P303; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Cieza A, 2019, DISABIL REHABIL, V41, P574, DOI 10.3109/09638288.2016.1145258; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Juengst SB, 2018, DISABIL REHABIL, P1; Juengst SB, 2019, DISABIL REHABIL, V41, P1200, DOI 10.1080/09638288.2017.1423403; Juengst SB, 2017, J CLIN EXP NEUROPSYC, V39, P513, DOI 10.1080/13803395.2016.1240758; Juengst ST, 2018, CURR TOP PHYS MED RE; Laxe S, 2013, BRAIN INJURY, V27, P379, DOI 10.3109/02699052.2012.750757; Offenbacher M, 2007, CLIN J PAIN, V23, P691, DOI 10.1097/AJP.0b013e318148b93d; Osborne CL, 2017, DISABIL REHABIL, V39, P2584, DOI 10.1080/09638288.2016.1239767; Osborne CL, 2019, DISABIL REHABIL, V41, P456, DOI 10.1080/09638288.2017.1390699; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Selb M, 2015, EUR J PHYS REHAB MED, V51, P105; Simeonsson RJ, 2014, DISABIL REHABIL, V36, P2187, DOI 10.3109/09638288.2014.892638; World Health Organization, 2007, INT CLASS FUNCT DIS	18	3	3	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUN 4	2020	42	12					1775	1782		10.1080/09638288.2018.1539128			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	ME1RS	WOS:000544439400015	30656977				2022-02-06	
J	Song, YB; Cao, CY; Xu, QY; Gu, SM; Wang, FS; Huang, X; Xu, SJ; Wu, EX; Huang, JH				Song, Yabei; Cao, Caiyun; Xu, Qiuyue; Gu, Simeng; Wang, Fushun; Huang, Xi; Xu, Shijun; Wu, Erxi; Huang, Jason H.			Piperine Attenuates TBI-Induced Seizures via Inhibiting Cytokine-Activated Reactive Astrogliosis	FRONTIERS IN NEUROLOGY			English	Article						piperine; traumatic brain injury; seizure; glial fibrillary acidic protein; astrocytes; glymphatic system	UP-REGULATION; BLACK PEPPER; RECEPTOR; ASTROCYTES; POTASSIUM; SEROTONIN; CA2+; GFAP	Peppers have been used in clinics for a long time and its major component, piperine (PPR), has been proven to be effective in the treatment of seizures. The purpose of this study was to investigate the effects of piperine on early seizures in mice after a traumatic brain injury (TBI) and to explore the mechanism of the drug against the development on TBI. Specific-pathogen-free-grade mice were randomly divided into six dietary groups for a week: control group, TBI group, three piperine groups (low PPR group with 10 mg/kg PPR, medium PPR group with 20 mg/kg PPR, and high PPR group with 40 mg/kg PPR), and a positive control group (200 mg/kg valproate). Except for the control group, all the other groups used Feeney free weight falling method to establish the TBI of closed brain injury in mice, and the corresponding drugs were continuously injected intraperitoneally for 7 days after the brain injury. The results from behavior and electroencephalogram showed that piperine attenuated the subthreshold dose of pentylenetetrazole-induced seizures compared with the TBI group. The western blot results showed that the expression levels of inflammatory factors tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) were reduced by piperine. The immunostaining results showed that the brain-derived neurotrophic factor (BDNF) was also reduced by piperine. In addition, positive cell counts of astrocytic fibrillary acidic protein (GFAP) in immuno-fluorescence showed that they were also reduced. Our data show that piperine treatment can reduce the degree of cerebral edema, down-regulate TNF-alpha, IL-1 beta, and BDNF, decrease the reactivity of GFAP in the hippocampus, and inhibit TBI-induced seizures.	[Song, Yabei; Cao, Caiyun; Xu, Qiuyue; Gu, Simeng; Wang, Fushun; Huang, Xi] Nanjing Univ Chinese Med, Dept Pharm, Nanjing, Peoples R China; [Gu, Simeng] Jiangsu Univ, Dept Psychol, Sch Med, Zhenjiang, Jiangsu, Peoples R China; [Gu, Simeng; Wang, Fushun] Sichuan Normal Univ, Inst Brain & Psychol Sci, Chengdu, Peoples R China; [Xu, Shijun] Chengdu Univ Tradit Chinese Med, Sch Pharm, Chengdu, Peoples R China; [Wu, Erxi; Huang, Jason H.] Baylor Scott & White Hlth, Dept Neurosurg, Temple, TX 76502 USA; [Wu, Erxi; Huang, Jason H.] Texas A&M Univ, Coll Med, Dept Surg, Temple, TX 76508 USA		Gu, SM; Wang, FS (corresponding author), Nanjing Univ Chinese Med, Dept Pharm, Nanjing, Peoples R China.; Gu, SM (corresponding author), Jiangsu Univ, Dept Psychol, Sch Med, Zhenjiang, Jiangsu, Peoples R China.; Gu, SM; Wang, FS (corresponding author), Sichuan Normal Univ, Inst Brain & Psychol Sci, Chengdu, Peoples R China.; Huang, JH (corresponding author), Baylor Scott & White Hlth, Dept Neurosurg, Temple, TX 76502 USA.; Huang, JH (corresponding author), Texas A&M Univ, Coll Med, Dept Surg, Temple, TX 76508 USA.	gsm_2007@126.com; 13814541138@163.com; jason.huang@bswhealth.org		XU, Qiuyue/0000-0002-2237-9790	Jiangsu Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK20151565]; Jiangsu Six Talent Peak [2015-YY-006]; priority academic program development of Jiangsu Higher Education Institute; Jiangsu Traditional Chinese Medicine Foundation [ZD201501]	This work was supported by the Jiangsu Natural Science Foundation (BK20151565) and the Jiangsu Six Talent Peak (2015-YY-006). The paper was also supported by the priority academic program development of Jiangsu Higher Education Institute (Integrated Chinese andWestern Medicine) and Jiangsu Traditional Chinese Medicine Foundation (ZD201501).	Avelar WM, 2015, INT J STROKE, V10, P1197, DOI 10.1111/ijs.12574; Chen CY, 2013, EUR J PHARMACOL, V714, P288, DOI 10.1016/j.ejphar.2013.07.041; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; CHU CY, 1994, FOOD CHEM TOXICOL, V32, P373, DOI 10.1016/0278-6915(94)90076-0; Dadas A, 2019, NEUROBIOL DIS, V123, P20, DOI 10.1016/j.nbd.2018.06.022; Derosa G, 2016, ADV EXP MED BIOL, V928, P173, DOI 10.1007/978-3-319-41334-1_8; DHooge R, 1996, ARZNEIMITTELFORSCH, V46, P557; Friedman D, 2016, NEW ENGL J MED, V374, P94, DOI 10.1056/NEJMc1512758; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Gharedaghi MH, 2014, EXP BRAIN RES, V232, P347, DOI 10.1007/s00221-013-3757-0; Gorgani L, 2017, COMPR REV FOOD SCI F, V16, P124, DOI 10.1111/1541-4337.12246; GU S, 2016, NEURAL PLAST, V2016, DOI DOI 10.1155/2016/2609128; Guo G, 2020, HUM EXP TOXICOL, V39, P477, DOI 10.1177/0960327119892042; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Liu MD, 2014, CHIN J TRAUMATOL, V17, P317, DOI 10.3760/cma.j.issn.1008-1275.2014.06.003; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Mestre H, 2020, SCIENCE, V367, P1211, DOI 10.1126/science.aax7171; MORI A, 1985, NEUROCHEM RES, V10, P1269, DOI 10.1007/BF00964845; Morita ME, 2012, NEUROLOGY, V79, P2349, DOI 10.1212/WNL.0b013e318278b63f; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; da Cruz GMP, 2013, PHARMACOL BIOCHEM BE, V104, P144, DOI 10.1016/j.pbb.2013.01.002; Rehman A, 2015, J FUNCT FOODS, V19, P126, DOI 10.1016/j.jff.2015.09.006; Ren TJ, 2019, EXPERT OPIN DRUG MET, V15, P849, DOI 10.1080/17425255.2019.1672658; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Sharma S, 2014, TUBERCULOSIS, V94, P389, DOI 10.1016/j.tube.2014.04.007; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wang FJ, 2011, J INT MED RES, V39, P1358, DOI 10.1177/147323001103900422; Wang FS, 2020, NEURAL REGEN RES, V15, P980, DOI 10.4103/1673-5374.270295; Wang FS, 2017, BRAIN STRUCT FUNCT, V222, P1543, DOI 10.1007/s00429-016-1292-z; Wang FS, 2013, J NEUROSCI, V33, P17404, DOI 10.1523/JNEUROSCI.2178-13.2013; Wang FS, 2012, P NATL ACAD SCI USA, V109, P7911, DOI 10.1073/pnas.1120380109; Wang FS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002334; Xia Y, 2015, MOL CELL BIOCHEM, V398, P147, DOI 10.1007/s11010-014-2214-0; Xu ZC, 2011, NEUROCHEM RES, V36, P2208, DOI 10.1007/s11064-011-0576-1; Yaffe PB, 2013, EXP MOL PATHOL, V94, P109, DOI 10.1016/j.yexmp.2012.10.008; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791	39	3	3	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 4	2020	11								431	10.3389/fneur.2020.00431			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MC3JF	WOS:000543186900001	32655468	gold, Green Published			2022-02-06	
J	Ozoner, B; Kilic, M; Aydin, L; Aydin, S; Arslan, YK; Musluman, AM; Yilmaz, A				Ozoner, Baris; Kilic, Mustafa; Aydin, Levent; Aydin, Seckin; Arslan, Yusuf Kemal; Musluman, Ahmet Murat; Yilmaz, Adem			Early cranioplasty associated with a lower rate of post-traumatic hydrocephalus after decompressive craniectomy for traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Post-traumatic hydrocephalus; Decompressive craniectomy; Early cranioplasty	GUIDELINES; MANAGEMENT	Background Post-traumatic hydrocephalus (PTH) is one of the primary complications during the course of traumatic brain injury (TBI). The aim of this study was to define factors associated with the development of PTH in patients who underwent unilateral decompressive craniectomy (DC) for TBI. Methods A total of 126 patients, who met the inclusion criteria of the study, were divided into two groups: patients with PTH (n = 25) and patients without PTH (n = 101). Their demographic, clinical, radiological, operative, and postoperative factors, which may be associated with the development of PTH, were compared. Results Multivariate logistic regression analysis revealed that cranioplasty performed later than 2 months following DC was significantly associated with the requirement for ventriculoperitoneal shunting due to PTH (p < 0.001). Also, a significant unfavorable outcome rate was observed in patients with PTH at 1-year follow-up according to the Glasgow Outcome Scale-Extended (p = 0.047). Conclusions Our results show that early cranioplasty within 2 months after DC was associated with a lower rate of PTH development after TBI.	[Ozoner, Baris] Bahcesehir Univ, Sch Med, Dept Neurosurg, Istanbul, Turkey; [Kilic, Mustafa; Aydin, Levent; Musluman, Ahmet Murat; Yilmaz, Adem] Univ Med Sci, Sisli Hamidiye Etfal Res & Educ Hosp, Dept Neurosurg, Istanbul, Turkey; [Aydin, Seckin] Univ Med Sci, Okmeydani Res & Educ Hosp, Dept Neurosurg, Istanbul, Turkey; [Arslan, Yusuf Kemal] Erzincan Binali Yildirim Univ, Sch Med, Dept Biostat, Erzincan, Turkey; [Ozoner, Baris] Erzincan Binali Yildirim Univ, Sch Med, Dept Neurosurg, Erzincan, Turkey		Ozoner, B (corresponding author), Bahcesehir Univ, Sch Med, Dept Neurosurg, Istanbul, Turkey.; Ozoner, B (corresponding author), Erzincan Binali Yildirim Univ, Sch Med, Dept Neurosurg, Erzincan, Turkey.	drbarisozoner@gmail.com	ARSLAN, YUSUF KEMAL/ABD-3311-2020	ARSLAN, YUSUF KEMAL/0000-0003-1308-8569; Ozoner, Baris/0000-0003-0534-2766; Aydin, Seckin/0000-0003-1195-9084; Yilmaz, Adem/0000-0002-3552-1442; Aydin, Levent/0000-0001-7015-4070	Turkish Neurosurgical Society	The language editing of this article is partly supported by the Turkish Neurosurgical Society.	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Bulat M, 2011, BRAIN RES REV, V65, P99, DOI 10.1016/j.brainresrev.2010.08.002; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Di GF, 2018, WORLD NEUROSURG, V116, pE406, DOI 10.1016/j.wneu.2018.04.216; El-Menyar A, 2017, WORLD NEUROSURG, V107, P6, DOI [10.1016/J.WNEU.2017.07.070, 10.1016/j.wneu.2017.07.070]; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giammattei L, 2018, WORLD NEUROSURG, V116, P322, DOI 10.1016/j.wneu.2018.05.176; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Hu QX, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00337; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kim JH, 2019, ACTA NEUROCHIR, V161, P25, DOI 10.1007/s00701-018-3749-8; Liao CC, 2018, INT J BIOMED IMAGING, V2018, DOI 10.1155/2018/4303161; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; MCCOMB JG, 1983, J NEUROSURG, V59, P369, DOI 10.3171/jns.1983.59.3.0369; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Nasi D, 2018, ACTA NEUROCHIR, V160, P1691, DOI 10.1007/s00701-018-3639-0; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2019, J CLIN NEUROSCI, V63, P62, DOI 10.1016/j.jocn.2019.02.006; Takahashi Y, 2001, CHILD NERV SYST, V17, P472, DOI 10.1007/s003810000424; UPTON ML, 1985, J NEUROSURG, V63, P867, DOI 10.3171/jns.1985.63.6.0867; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang NR, 2018, WORLD NEUROSURG, V110, pE160, DOI 10.1016/j.wneu.2017.10.117; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	42	3	3	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2020	46	4					919	926		10.1007/s00068-020-01409-x		JUN 2020	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	NA4ON	WOS:000537634200001	32494837				2022-02-06	
J	Ren, DB; Zheng, P; Feng, JG; Gong, YQ; Wang, Y; Duan, J; Zhao, L; Deng, J; Chen, HM; Zou, SF; Hong, T; Chen, W				Ren, Dabin; Zheng, Ping; Feng, Jiugeng; Gong, Yuqin; Wang, Yang; Duan, Jian; Zhao, Lin; Deng, Jun; Chen, Haiming; Zou, Shufeng; Hong, Tao; Chen, Wei			Overexpression of Astrocytes-Specific GJA1-20k Enhances the Viability and Recovery of the Neurons in a Rat Model of Traumatic Brain Injury	ACS CHEMICAL NEUROSCIENCE			English	Article						Craniocerebral trauma; astrocyte; gap junction alpha-1 protein (GJA1)-20k; apoptosis	CONNEXIN43; CX43; MITOCHONDRIA; EXPRESSION; PROTEIN	Traumatic brain injury (TBI) is a devastating actuality in clinics worldwide. It is estimated that approximately 10 million people among the world suffer from TBI each year, and a considerable number of patients will be temporarily or permanently disabled or even die due to this disease. Astrocytes play a very important role in the repair of brain tissue after TBI, including the formation of a neuroprotective barrier, inhibition of brain edema, and inhibition of normal nerve cell apoptosis. However, the detailed mechanism underlying this protective effect is still unclear. To investigate the regulatory factors of astrocytes to other neurons post-TBI, we established a TBI rat model and used the AAV to mediate the overexpression of GJA1-20k in astrocytes of rats. And functionally, the specific overexpression of GJA1-20k in astrocytes promoted the viability and recovery of neurons in TBI. Mechanistically, the astrocytes-specific upregulation of GJA1-20k protected the function of mitochondria in neurons of FPI rats, thus suppressing the apoptosis of the damaged neurons. We hereby reported that astrocytes-specific overexpression of GJA1-20k enhanced the viability and recovery of the neurons in TBI through regulating their mitochondrial function.	[Feng, Jiugeng; Wang, Yang; Duan, Jian; Zhao, Lin; Zou, Shufeng; Hong, Tao] Nanchang Univ, Dept Neurosurg, Affiliated Hosp 1, Nanchang 330008, Jiangxi, Peoples R China; [Ren, Dabin; Zheng, Ping; Chen, Wei] Shanghai Univ Med & Hlth Sci, Peoples Hosp Shanghai Pudong New Area, Dept Neurosurg, Shanghai 201299, Peoples R China; [Deng, Jun; Chen, Haiming; Chen, Wei] Nanchang Univ, Affiliated Hosp 1, Dept Emergency, Trauma Ctr, Nanchang 330008, Jiangxi, Peoples R China; [Gong, Yuqin] Nanchang Univ, Affiliated Hosp 2, Dept Operat Room, Nanchang 330009, Jiangxi, Peoples R China		Zou, SF; Hong, T (corresponding author), Nanchang Univ, Dept Neurosurg, Affiliated Hosp 1, Nanchang 330008, Jiangxi, Peoples R China.; Chen, W (corresponding author), Shanghai Univ Med & Hlth Sci, Peoples Hosp Shanghai Pudong New Area, Dept Neurosurg, Shanghai 201299, Peoples R China.; Chen, W (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Emergency, Trauma Ctr, Nanchang 330008, Jiangxi, Peoples R China.	1812492699@qq.com; ht2000@vip.sina.com; weichen445@163.com		Chen, Wei/0000-0001-7438-3241	Shanghai Natural Science FoundationNatural Science Foundation of Shanghai [19ZR1447400]; Key Project of Jiangxi Education Department [GJJ190022]; Key Project of Jiangxi Science and Technology Department [20192BBGL70022]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81960236, 81701231]; Featured Clinical Discipline Project of Shanghai Pudong [PWYst2018-01]; Key Discipline Group Construction Project of Shanghai Pudong [PWZxq2017-02]	The study was supported by the Shanghai Natural Science Foundation (19ZR1447400), Key Project of Jiangxi Education Department (GJJ190022), Key Project of Jiangxi Science and Technology Department (20192BBGL70022), National Natural Science Foundation of China (81960236, 81701231), The Featured Clinical Discipline Project of Shanghai Pudong (PWYst2018-01), and Key Discipline Group Construction Project of Shanghai Pudong (PWZxq2017-02).	Akar FG, 2007, AM J PHYSIOL-HEART C, V293, pH1223, DOI 10.1152/ajpheart.00079.2007; Basheer WA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121900; Basheer WA, 2017, CIRC RES, V121, P1069, DOI 10.1161/CIRCRESAHA.117.311955; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Dardis G, 2017, DEV DYNAM, V246, P691, DOI [10.1002/DVDY.24531, 10.1002/dvdy.24531]; Ek-Vitorin JF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061659; FISHMAN GI, 1991, GENOMICS, V10, P250, DOI 10.1016/0888-7543(91)90507-B; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Fu Y., 2017, FRONT PHYSIOL, V8, P1; Greer K, 2017, BRAIN RES BULL, V134, P38, DOI 10.1016/j.brainresbull.2017.06.016; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Huang Jing-Lan, 2018, Zhongguo Dang Dai Er Ke Za Zhi, V20, P397; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jovicic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171418; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Lu HJ, 2017, CELL MOL NEUROBIOL, V37, P1131, DOI 10.1007/s10571-016-0446-0; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao HJ, 2018, J BIOMECH, V77, P228, DOI 10.1016/j.jbiomech.2018.07.004; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Rahimian P, 2016, J NEUROVIROL, V22, P774, DOI 10.1007/s13365-016-0451-6; Reyes A, 2002, GENE, V291, P223, DOI 10.1016/S0378-1119(02)00600-5; Rhett JM, 2017, AM J PHYSIOL-CELL PH, V313, pC314, DOI 10.1152/ajpcell.00229.2016; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salat-Canela C, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-31; Smyth JW, 2013, CELL REP, V5, P611, DOI 10.1016/j.celrep.2013.10.009; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Solan JL, 2012, J MEMBRANE BIOL, V245, P255, DOI 10.1007/s00232-012-9446-2; Srisakuldee W, 2014, CARDIOVASC RES, V103, P72, DOI 10.1093/cvr/cvu066; Ul-Hussain M, 2014, J BIOL CHEM, V289, P20979, DOI 10.1074/jbc.M113.540187; Zhao ZL, 2017, PROTEIN CELL, V8, P801, DOI 10.1007/s13238-017-0414-6	38	3	3	3	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JUN 3	2020	11	11					1643	1650		10.1021/acschemneuro.0c00142			8	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	LV6BU	WOS:000538519600014	32401478				2022-02-06	
J	Balasubramanian, N; Srivastava, A; Pawar, N; Sagarkar, S; Sakharkar, AJ				Balasubramanian, Nagalakshmi; Srivastava, Abhinav; Pawar, Namrata; Sagarkar, Sneha; Sakharkar, Amul J.			Repeated mild traumatic brain injury induces persistent variations in mitochondrial DNA copy number in mesocorticolimbic neurocircuitry of the rat	NEUROSCIENCE RESEARCH			English	Article						16S rRNA; Mesocorticolimbic circuitry; Mild traumatic brain injury; Mitochondrial DNA copy number	DYSFUNCTION; STRESS; IMPACT; HIPPOCAMPAL; HOMEOSTASIS; MECHANISMS; MITOPHAGY; GENOME; MODEL	Mild traumatic brain injury (MTBI) results in persistent deficits in the cognitive and emotive abilities governed by the mesocorticolimbic (MCL) neurocircuitry. In this study, we observed regional variations in the mitochondrial DNA copy number (mtDNAcn) in the MCL neurocircuitry. Although repeated MTBI (rMTBI) is known to cause mitochondrial dysfunction, the persistent changes in the mtDNAcn and its manifestations in 16S rRNA levels in the MCL neurocircuitry have not been investigated. Herein, we employed the closed head weight drop paradigm to induce rMTBI in rats. We analyzed the mtDNAcn and 16S rRNA levels in eight regions of the MCL neurocircuitry 48 h and 30 days after the rMTBI. The mtDNAcn in the prefrontal cortex, cortex, hippocampus, and ventral tegmental area (VTA) of the rMTBI-exposed rats was decreased at both the time points. Although the mtDNAcn was reduced in hypothalamus and amygdala at 48 h, it was increased at 30 days post rMTBI. The 16S rRNA levels and mtDNAcn were altered in all the regions, with the exception of bed nucleus of stria terminalis and the VTA. Moreover, the rMTBI did not affect the mtDNAcn and 16S rRNA levels in nucleus accumbens. These results suggest that the repetitive trauma induces persistent changes in the mtDNAcn which are manifested as aberrations in mitochondrial transcription in the brain areas crucial for emotion and cognition. (C) 2019 Published by Elsevier B.V.	[Balasubramanian, Nagalakshmi; Srivastava, Abhinav; Pawar, Namrata; Sakharkar, Amul J.] Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India; [Sagarkar, Sneha] Savitribai Phule Pune Univ, Dept Zool, Pune 411007, Maharashtra, India		Sakharkar, AJ (corresponding author), Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India.	amul.sakharkar@unipune.ac.in			University Grants Commission, Government of India (UGC-GOI) [F.4-5/151-FRP/2014/BSR]; University Research Grant Scheme, Savitribai Phule Pune University (SPPU); Science and Engineering Research Board (SERB), GOI [EMR/2017/000621]; Council for Scientific and Industrial Research (CSIR), GOI [37[1718]/18/EMR-II]; Department Research and Development Program of the Department of Biotechnology, SPPU; UGC-GOIUniversity Grants Commission, India [2061330923]	This work was supported by grants from the University Grants Commission, Government of India (UGC-GOI; F.4-5/151-FRP/2014/BSR); the University Research Grant Scheme, Savitribai Phule Pune University (SPPU); the Science and Engineering Research Board (SERB), GOI (EMR/2017/000621); and the Council for Scientific and Industrial Research (CSIR), GOI (37[1718]/18/EMR-II) to AJS. AJS also acknowledges funds received through the Department Research and Development Program of the Department of Biotechnology, SPPU. NB thanks to UGC-GOI for the award of Senior Research Fellowship (UGC-SRF; File No. 2061330923).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Anglin RES, 2012, AM J MED GENET B, V159B, P749, DOI 10.1002/ajmg.b.32086; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen YH, 2017, CELL TRANSPLANT, V26, P1156, DOI 10.1177/0963689717714105; Corral-Frias NS, 2013, NEUROPSYCHOPHARMACOL, V38, P350, DOI 10.1038/npp.2012.189; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Dubinsky JM, 2009, EXP NEUROL, V218, P293, DOI 10.1016/j.expneurol.2009.05.020; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Felmingham KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103653; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fuke S, 2011, BBA-BIOENERGETICS, V1807, P270, DOI 10.1016/j.bbabio.2010.11.016; Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002; Gordon-Weeks P.R., 2000, NEURONAL GROWTH CONE, P260; Harmon JL, 2017, J NEUROTRAUM, V34, P487, DOI 10.1089/neu.2015.4395; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Javed Zeeshan, 2015, Indian J Endocrinol Metab, V19, P753, DOI 10.4103/2230-8210.167561; Jin JJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00170; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li M., 2016, GEN MED, V4, pE275; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Morava E, 2010, MITOCHONDRION, V10, P528, DOI 10.1016/j.mito.2010.05.011; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Nagy NA, 2017, PEERJ, V5, DOI 10.7717/peerj.4047; Nawijn L, 2015, NEUROSCI BIOBEHAV R, V51, P189, DOI 10.1016/j.neubiorev.2015.01.019; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Oliva I, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00030; Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021; Phani S, 2010, BRAIN RES, V1343, P1, DOI 10.1016/j.brainres.2010.04.061; Picard M, 2015, P NATL ACAD SCI USA, V112, pE6614, DOI 10.1073/pnas.1515733112; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Ranaldi R, 2014, REV NEUROSCIENCE, V25, P621, DOI 10.1515/revneuro-2014-0019; Rice MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100054; Rydbirk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37116; Sadakierska-Chudy A, 2017, MOL NEUROBIOL, V54, P7460, DOI 10.1007/s12035-016-0153-3; Sagarkar S, 2019, BRAIN RES, V1711, P183, DOI 10.1016/j.brainres.2019.01.022; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Schulze F, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4356-4; Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Spielberg JM, 2008, SOC PERSONAL PSYCHOL, V2, P135, DOI 10.1111/j.1751-9004.2007.00064.x; Streck EL, 2014, REV BRAS PSIQUIATR, V36, P156, DOI 10.1590/1516-4446-2013-1224; Tyrka AR, 2016, BIOL PSYCHIAT, V79, P78, DOI 10.1016/j.biopsych.2014.12.025; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vyas A, 2002, J NEUROSCI, V22, P6810; Watson W.D., 2014, FRONT NEUROENERGETIC, V5, P12; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	69	3	3	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUN	2020	155						34	42		10.1016/j.neures.2019.06.003			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY0MA	WOS:000540217100005	31260697				2022-02-06	
J	Baugh, CM; Kerr, ZY; Kroshus, E; Lanser, BL; Lindley, TR; Meehan, WP				Baugh, Christine M.; Kerr, Zachary Y.; Kroshus, Emily; Lanser, Bailey L.; Lindley, Tory R.; Meehan, William P.			Sports Medicine Staffing Patterns and Incidence of Injury in Collegiate Men's Ice Hockey	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; collegiate athletics; epidemiology; health policy; skill mix	WORK-FAMILY CONFLICT; TIME-LOSS INJURIES; ATHLETIC TRAINERS; ASSOCIATION; QUALITY; BURNOUT; CARE; JOB; SATISFACTION; ANTECEDENTS	Context: The relative availability of clinicians as well as the types and training of health care providers have been associated with morbidity and mortality in non-athletic health care settings. Whether staffing variations are associated with injury incidence in collegiate athletes is unknown. Objective: To evaluate whether the institutional ratio of athletes to athletic trainers (patient load) or the ratio of staff to nonstaff (graduate assistant and certified intern) athletic trainers or both is associated with the incidence of injuries sustained by male ice hockey athletes at the school. Design: Descriptive epidemiology study. Setting: National Collegiate Athletic Association (NCAA) men's ice hockey teams. Patients or Other Participants: Collegiate men's ice hockey athletes. Main Outcome Measure(s): The NCAA Injury Surveillance Program collected data from collegiate men's ice hockey athletes. Staffing patterns were obtained through telephone interviews. Injury counts, injury rates per 1000 athlete-exposures, and injury rate ratios with 95% confidence intervals were calculated and compared between the following groups: (1) schools with high (versus low) patient load and (2) schools with high (versus low) ratio of staff to nonstaff (graduate assistant and certified intern) athletic trainers. Results: Both the patient load and relative number of staff athletic trainers were associated with variations in the incidences and types of diagnosed injuries in male ice hockey players. Specifically, fewer injuries were diagnosed by clinicians at institutions with high patient loads. The rates of injury overall and non-time-loss injuries were lower in the high patient-load group. Time-loss injury rates, severe injury rates, concussion rates, and overall rates of injury during competition were greater in the group with a higher proportion of staff athletic trainers, whereas non-time-loss injury rates were lower. Conclusions: In this study of collegiate men's ice hockey players, athlete health outcomes were directly related to the number and types of clinicians available. Future researchers should evaluate whether this finding extends beyond men's ice hockey.	[Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Boston, MA 02115 USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Lanser, Bailey L.] Cleveland Clin Rehabil & Sports Therapy, Cleveland, OH USA; [Lindley, Tory R.] Northwestern Univ, Intercoll Sports Med, Evanston, IL USA; [Meehan, William P.] Boston Childrens Hosp, Div Sports Med, Sports Concuss Clin, Boston, MA USA; [Meehan, William P.] Univ Colorado, Ctr Bioeth & Humanities, Sch Med, Dept Med,Div Gen Internal Med, Aurora, CO 80045 USA		Baugh, CM (corresponding author), Univ Colorado, 13080 East 19th Ave,CB B137, Aurora, CO 80045 USA.	christine.baugh@cuanschutz.edu			National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; National College Athletic Association (NCAA)	We thank the many athletic trainers who have volunteered their time and efforts to submit data to the NCAA Injury Surveillance Program. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate athletes. We would also like to thank the athletic trainers who participated in the telephone survey on sports medicine staffing. This work was supported by the National Institute of Mental Health Award Number T32MH019733. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This publication contains materials created, compiled or produced by the Datalys Center for Sports Injury Research and Prevention, Inc. on behalf of the National Collegiate Athletic Association. All rights reserved. The NCAA Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the National College Athletic Association (NCAA). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the Datalys Center or the NCAA.	Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2020, J ATHL TRAINING, V55, P573, DOI 10.4085/1062-6050-0463-19; Bekker S, 2016, BRIT J SPORT MED, V50, P1489, DOI 10.1136/bjsports-2016-096457; Blegen MA, 1998, NURS RES, V47, P43, DOI 10.1097/00006199-199801000-00008; Bower P, 2003, QUAL SAF HEALTH CARE, V12, P273, DOI 10.1136/qhc.12.4.273; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Burchinal M, 2002, EARLY CHILD RES Q, V17, P87, DOI 10.1016/S0885-2006(02)00132-1; Cantu RC, 2016, WORLD NEUROSURG, V95, P601, DOI 10.1016/j.wneu.2016.04.056; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; DeFreese JD, 2016, J ATHL TRAINING, V51, P28, DOI 10.4085/1062-6050-51.2.05; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Gallucci AR, 2017, J ATHL TRAINING, V52, P785, DOI 10.4085/1062-6050-52.3.16; Johnson TJ, 2016, ACAD EMERG MED, V23, P297, DOI 10.1111/acem.12901; Kajonius PJ, 2016, HEALTH SOC CARE COMM, V24, P699, DOI 10.1111/hsc.12230; Kania ML, 2009, J ATHL TRAINING, V44, P58, DOI 10.4085/1062-6050-44.1.58; Kerr ZY, 2017, J ATHL TRAINING, V52, P446, DOI 10.4085/1062-6050-52.2.15; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Koopmans L, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3812-4; Kovner C, 1998, Image J Nurs Sch, V30, P315, DOI 10.1111/j.1547-5069.1998.tb01326.x; Kroshus E, 2016, J ATHL TRAINING, V51, P389, DOI 10.4085/1062-6050-51.5.07; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Mazerolle SM, 2005, THESIS; Mazerolle SM, 2008, J ATHL TRAINING, V43, P513, DOI 10.4085/1062-6050-43.5.513; Mazerolle SM, 2008, J ATHL TRAINING, V43, P505, DOI 10.4085/1062-6050-43.5.505; Mazerolle SM, 2013, J ATHL TRAINING, V48, P668, DOI 10.4085/1062-6050-48.3.24; Mazerolle SM, 2012, J ATHL TRAINING, V47, P320, DOI 10.4085/1062-6050-47.3.02; Morita K, 2017, HEALTH SERV RES, V52, P1005, DOI 10.1111/1475-6773.12529; Needleman J, 2006, HEALTH AFFAIR, V25, P204, DOI 10.1377/hlthaff.25.1.204; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Pierpoint Lauren A, 2018, Inj Epidemiol, V5, P29, DOI 10.1186/s40621-018-0159-6; Powell JW, 2004, J ATHL TRAINING, V39, P56; Staggs VS, 2017, J GEN INTERN MED, V32, P35, DOI 10.1007/s11606-016-3830-z; Unruh L, 2014, NURS ECON, V32, P296	35	3	3	0	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUN	2020	55	6					587	593		10.4085/1062-6050-0464.19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	NK4ZE	WOS:000566740300005	32383984	gold, Green Published			2022-02-06	
J	Baugh, CM; Kroshus, E; Meehan, WP; Campbell, EG				Baugh, Christine M.; Kroshus, Emily; Meehan, William P., III; Campbell, Eric G.			Trust, Conflicts of Interest, and Concussion Reporting in College Football Players	JOURNAL OF LAW MEDICINE & ETHICS			English	Article							SPORTS-MEDICINE; ICE HOCKEY; MANAGEMENT; ETHICS; CARE; PRESSURE; INJURIES; COACHES; IMPACT; POLICY	Sports medicine clinicians face conflicts of interest in providing medical care to athletes. Using a survey of college football players, this study evaluates whether athletes are aware of these conflicts of interest, whether these conflicts affect athlete trust in their health care providers, or whether conflicts or athletes' trust in stakeholders are associated with athletes' injury reporting behaviors.	[Baugh, Christine M.; Campbell, Eric G.] Univ Colorado, Div Gen Internal Med, Med, Boulder, CO 80309 USA; [Baugh, Christine M.] Univ Colorado, Core Res Fac, Ctr Bioeth & Humanities, Boulder, CO 80309 USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98195 USA; [Meehan, William P., III] Harvard Med Sch, Pediat & Orthoped, Boston, MA 02115 USA; [Meehan, William P., III] Boston Childrens Hosp, Micheli Ctr Sports Injury Prevent, Boston, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Res Brain Injury Ctr, Boston, MA USA; [Campbell, Eric G.] Univ Colorado, Ctr Bioeth & Humanities, Boulder, CO 80309 USA		Baugh, CM (corresponding author), Univ Colorado, Div Gen Internal Med, Med, Boulder, CO 80309 USA.; Baugh, CM (corresponding author), Univ Colorado, Core Res Fac, Ctr Bioeth & Humanities, Boulder, CO 80309 USA.				Edmond J. Safra Center for Ethics at Harvard University; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; National Football League	Dr. Baugh reports grants from Edmond J. Safra Center for Ethics at Harvard University, during the conduct of the study. Dr. Kroshus reports grants from National Collegiate Athletic Association, grants from PAC-12 Athletic Conference/Student-Athlete Health and Wellbeing Initiative, outside the submitted work. Dr. Meehan reports receiving royalties from ABC-Clio publishing for the sale of the books, Kids, Sports, and Concussion: A Guide for Coaches and Parents, and Concussions; from Springer International for the book Head and Neck Injuries in Young Athlete; and from Wolters Kluwer for working as an author for UpToDate. Dr. Meehan's research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and a grant from the National Football League. Dr. Campbell serves as a paid expert witness in a law case related to financial conflicts of interest in medicine on behalf of the Attorney General of Arizona. This activity was approved by the University of Colorado School of Medicine.	Baugh CM, 2017, J LAW MED ETHICS, V45, P231, DOI 10.1177/1073110517720652; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Baugh CM, 2015, CONCUSSION, V1, P49; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Calandrillo S, 2005, SLU LAW J, V50, P185; Celorrio-Navarro M, 2019, J NEUROTRAUM, V36, pA2; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Deubert C.R., 2016, FOOTBALL PLAYERS HLT; Doescher MP, 2000, ARCH FAM MED, V9, P1156, DOI 10.1001/archfami.9.10.1156; Dunn WR, 2007, AM J SPORT MED, V35, P840, DOI 10.1177/0363546506295177; Hall MA, 2002, MED CARE RES REV, V59, P293, DOI 10.1177/1077558702059003004; Hanson SS, 2018, J PHILOS SPORT, V45, P215, DOI 10.1080/00948705.2018.1486199; Johnson R, 2004, CLIN SPORT MED, V23, P175, DOI 10.1016/j.csm.2004.01.003; Junge M., 2004, AMA J ETHICS, V6, P318; Keating NL, 2004, ARCH INTERN MED, V164, P1015, DOI 10.1001/archinte.164.9.1015; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; King NMP, 2013, AM J BIOETHICS, V13, P13, DOI 10.1080/15265161.2013.828126; Kroshus E., 2016, HEALTH EDUC BEHAV, V43, P66; Kroshus E., 2014, ANN BEHAV MED, V49, P1; Kroshus E, 2019, HEALTH EDUC BEHAV, V46, P916, DOI 10.1177/1090198119859414; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lo Bernard, 2009, CONFLICT INTEREST ME, V46; Lynch HF, 2016, HASTINGS CENT REP, V46, P4, DOI 10.1002/hast.528; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McNamee M, 2013, AM J BIOETHICS, V13, P15, DOI 10.1080/15265161.2013.828123; Mechanic D, 1996, JAMA-J AM MED ASSOC, V275, P1693, DOI 10.1001/jama.275.21.1693; Murray T.H., 1984, PHYSICIAN SPORTSMED, V12, P134; National Athletic Trainers' Association, 2019, ONL HALF COLL LEV SP; NCAA, 2019, DIV 1 MAN; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Piette JD, 2005, ARCH INTERN MED, V165, P1749, DOI 10.1001/archinte.165.15.1749; Polsky S, 1998, J Contemp Health Law Policy, V14, P503; Sailors PR, 2013, AM J BIOETHICS, V13, P22, DOI 10.1080/15265161.2013.828118; Testoni D, 2013, AM J BIOETHICS, V13, P4, DOI 10.1080/15265161.2013.828114; Waddington I, 2005, ETHICS SPORT, P182; Wolverton B, 2013, CHRONICLE HIGHER ED	49	3	3	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics	JUN	2020	48	2			SI		307	314		10.1177/1073110520935342			8	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	MG9FL	WOS:000546338400010	32631188				2022-02-06	
J	Caccese, JB; Eckner, JT; Franco-MacKendrick, L; Hazzard, JB; Ni, M; Broglio, SP; McAllister, TW; McCrea, M; Buckley, TA				Caccese, Jaclyn B.; Eckner, James T.; Franco-MacKendrick, Lea; Hazzard, Joseph B.; Ni, Meng; Broglio, Steven P.; McAllister, Thomas W.; McCrea, Michael; Buckley, Thomas A.			Clinical Reaction-Time Performance Factors in Healthy Collegiate Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; mild traumatic brain injury; sex; sport type	SEX-DIFFERENCES; CONCUSSION; RELIABILITY; TRAINERS; SYMPTOMS	Context: In the absence of baseline testing, normative data may be used to interpret postconcussion scores on the clinical reaction-time test (RTclin). However, to provide normative data, we must understand the performance factors associated with baseline testing. Objective: To explore performance factors associated with baseline RTclin from among candidate variables representing demographics, medical and concussion history, self-reported symptoms, sleep, and sport-related features. Design: Cross-sectional study. Setting: Clinical setting (eg, athletic training room). Patients or Other Participants: A total of 2584 National Collegiate Athletic Association student-athletes (n = 1206 females [47%], 1377 males [53%], and 1 unreported (<0.1%); mass = 76.7 +/- 18.7 kg; height -176.7 +/- 11.3 cm; age =19.0 +/- 1.3 years) from 3 institutions participated in this study as part of the Concussion Assessment, Research and Education Consortium. Main Outcome Measure(s): Potential performance factors were sex; race; ethnicity; dominant hand; sport type; number of prior concussions; presence of anxiety, learning disability, attention-deficit disorder or attention-deficit/hyperactivity disorder, depression, or migraine headache; self-reported sleep the night before the test; mass; height; age; total number of symptoms; and total symptom burden at baseline. The primary study outcome measure was mean baseline RTclin. Results: The overall RTclin was 202.0 +/- 25.0 milliseconds. Female sex (parameter estimate [B] = 8.6 milliseconds, P < .001, Cohen d = 0.54 relative to male sex), black or African American race (B = 5.3 milliseconds, P= .001, Cohen d = 0.08 relative to white race), and limited-contact (B =4.2 milliseconds, P < .001, Cohen d = 0.30 relative to contact) or noncontact (B = 5.9 milliseconds, P < .001, Cohen d = 0.38 relative to contact) sport participation were associated with slower RTclin. Being taller was associated with a faster RTclin, although this association was weak (B = -0.7 milliseconds, P < .001). No other predictors were significant. When adjustments are made for sex and sport type, the following normative data may be considered (mean +/- standard deviation): female, noncontact (211.5 +/- 25.8 milliseconds), limited contact (212.1 +/- 24.3 milliseconds), contact (203.7 +/- 21.5 milliseconds); male, noncontact (199.4 +/- 26.7 milliseconds), limited contact (196.3 +/- 23.9 milliseconds), contact (195.0 +/- 23.8 milliseconds). Conclusions: Potentially clinically relevant differences existed in RTclin for sex and sport type. These results provide normative data adjusting for these performance factors.	[Caccese, Jaclyn B.] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Eckner, James T.; Franco-MacKendrick, Lea] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Hazzard, Joseph B.] Bloomsburg Univ, Dept Exercise Sci, Bloomsburg, PA USA; [Ni, Meng] Bloomsburg Univ, Inst Concuss Res & Serv, Bloomsburg, PA USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg & Neurol, Milwaukee, WI 53226 USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19713 USA; [Buckley, Thomas A.] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE 19713 USA		Buckley, TA (corresponding author), Univ Delaware, 349 Tower & STAR,100 Discovery Blvd, Newark, DE 19713 USA.	tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016; Caccese, Jaclyn B./AAH-4571-2020	Buckley, Thomas A/0000-0002-0515-0150; Caccese, Jaclyn B./0000-0003-2329-3603	Grand Alliance CARE Consortium - National Collegiate Athletic Association; US Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This study was supported in part by the Grand Alliance CARE Consortium, funded by the National Collegiate Athletic Association and the US Department of Defense. The US Army Medical Research Acquisition Activity, Fort Detrick, Maryland, is the awarding and administering acquisition office. This study was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under award W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the US Department of Defense (Defense Health Program funds).	Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Eckner JT, 2015, PERCEPT MOTOR SKILL, V120, P841, DOI 10.2466/25.15.PMS.120v19x6; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2011, PM&R, V3, P1092, DOI 10.1016/j.pmrj.2011.04.022; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Heaton RK, 2009, NEUROPSYCHOLOGICAL A, P127; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Magill R. A., 2007, MOTOR LEARNING CONTR, V8th; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nikam Lalita H, 2012, Indian J Physiol Pharmacol, V56, P94; Van Den Berg J, 2006, PERCEPT MOTOR SKILL, V102, P589, DOI 10.2466/PMS.102.2.589-599; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131; Zelaznik H. N., 1996, ADV MOTOR LEARNING C	30	3	3	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUN	2020	55	6					601	607		10.4085/1062-6050-164-19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	NK4ZE	WOS:000566740300007	32320283	Green Published, gold			2022-02-06	
J	Emejulu, JK; Malomo, A; Oremakinde, A; Onyia, C; Nwaribe, E; Ekweogwu, O; Oseni, A; Opara, O; Iroegbu-Emeruem, L; Otorkpa, E; Komolafe, E; Bankole, O; Shehu, B				Emejulu, Jude-Kennedy; Malomo, Adefolarin; Oremakinde, Adetunji; Onyia, Chiazor; Nwaribe, Evaristus; Ekweogwu, Ofodile; Oseni, Abidemi; Opara, Oluwamayowa; Iroegbu-Emeruem, Linda; Otorkpa, Ega; Komolafe, Edward; Bankole, Olufemi; Shehu, Bello			Developing a Guideline for Neurotrauma in Nigeria	WORLD NEUROSURGERY			English	Article							TRAUMATIC BRAIN-INJURY; CERVICAL-SPINE; HEAD-INJURY; LOW-RISK; MANAGEMENT; NEUROSURGERY		[Emejulu, Jude-Kennedy] Nnamdi Azikiwe Univ, Dept Surg, Coll Hlth Sci, Fac Med, Awka, Nigeria; [Malomo, Adefolarin] Univ Coll Hosp, Dept Neurosurg, Ibadan, Nigeria; [Malomo, Adefolarin] Coll Med, Ibadan, Nigeria; [Oremakinde, Adetunji] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Onyia, Chiazor] Lagoon Hosp, Dept Surg, Lagos, Nigeria; [Nwaribe, Evaristus; Shehu, Bello] Natl Hosp, Dept Surg, Abuja, Nigeria; [Ekweogwu, Ofodile] Nnamdi Azikiwe Univ, Teaching Hosp, Dept Surg, Nnewi, Nigeria; [Oseni, Abidemi; Bankole, Olufemi] Lagos Univ, Teaching Hosp, Dept Surg, Lagos, Nigeria; [Opara, Oluwamayowa] Reg Stroke & Neurosci Hosp, Neurosurg Unit, Owerri, Nigeria; [Iroegbu-Emeruem, Linda] Univ Port Harcourt, Teaching Hosp, Dept Surg, Choba, Nigeria; [Otorkpa, Ega] Univ Abuja, Teaching Hosp, Dept Surg, Abuja, Nigeria; [Komolafe, Edward] Obafemi Awolowo Univ, Dept Surg, Ife, Nigeria		Oremakinde, A (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	adetunji.oremakinde@mail.utoronto.ca		Onyia, Chiazor/0000-0002-4264-6876; komolafe, edward/0000-0003-1261-3501			Adeloye A, 1975, J Natl Med Assoc, V67, P319; Agrawal A, 2014, ROM NEUROSURG, V21, P307; Alex BV, 1996, NEUROTRAUMA, P119; Arienta C, 1997, SURG NEUROL, V48, P213, DOI 10.1016/S0090-3019(97)00019-0; BACHULIS BL, 1987, AM J SURG, V153, P473, DOI 10.1016/0002-9610(87)90796-3; Bhandari PS, 2008, INDIAN J NEUROTRAUM, V5, P21, DOI 10.1016/S0973-0508(08)80024-X; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carvalho GA, 1997, J NEUROSURG, V86, P69, DOI 10.3171/jns.1997.86.1.0069; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Constantini S, 2001, J NEUROSURG, V94, P918, DOI 10.3171/jns.2001.94.6.0918; Dorsi MJ, 2012, SCHMIDEK SWEETS OPER, P2319; Ebegbulem JC, 2012, INT J BUSINESS SOCIA, V3, P11; Emejulu JKC, 2008, NIGER J CLIN PRACT, V11, P291; Emejulu JK, 2009, J CLIN MED RES, V1, P13; Fernandez E, 1996, SURG NEUROL, V46, P47, DOI 10.1016/0090-3019(96)00044-4; Filler A, 2009, NEUROSURGERY, V65, pA29, DOI 10.1227/01.NEU.0000351279.78110.00; Hadley MN, 2002, NEUROSURGERY, V50, pS85; HAMILTON MG, 1992, J NEUROSURG, V77, P700, DOI 10.3171/jns.1992.77.5.0700; Harper CM, 2005, HAND CLIN, V21, P39, DOI 10.1016/j.hcl.2004.09.003; Hawai'i Neurotrauma Registry, WHAT IS HAW NEUR REG; Henry S, 2018, ADV TRAUM LIF SUPP S; Huguenard AL, 2016, J NEUROSURG-PEDIATR, V17, P476, DOI 10.3171/2015.7.PEDS14723; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Lu WY, 1997, NEUROSURGERY, V41, P416, DOI 10.1097/00006123-199708000-00017; MAROON JC, 1979, NEUROSURGERY, V4, P223, DOI 10.1227/00006123-197903000-00005; MARSHALL LF, 1977, ANN NEUROL, V1, P201, DOI 10.1002/ana.410010220; Mehmood Amber, 2018, BMC Res Notes, V11, P299, DOI 10.1186/s13104-018-3419-1; Muhammad RM, 2018, AANS NEUROSURG, V27, P3; National Postgraduate Medical College of Nigeria, ACCR STAT DEC 2018; Newton TH, 1971, RADIOLOGY SKULL BRAI; NIHR Global Health Research Group on Neurotrauma, GEO TBI GLOB NEUR RE; ODEKU E L, 1965, West Afr Med J, V14, P85; Oremakinde AA, 2019, INTERDISCIP NEUROSUR, V15, P89, DOI 10.1016/j.inat.2018.10.005; Prasad MV, 2014, ROMANIAN NEUROSURGER, V21, P435; Quinsey C, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18281; REEDER RF, 1989, J NEUROSURG, V70, P201, DOI 10.3171/jns.1989.70.2.0201; Robert EG, 2009, NEUROSURGERY, V65, pA97, DOI 10.1227/01.NEU.0000347473.67188.75; State of Hawaii Department of Health EMS & Injury Prevention System Branch, HAW NEUR REG PROJ; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stern W, 1982, NEUROLOGICAL SURG, P51; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; Thompson TP, 1999, CONT NEUROSURG, V21, P1; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; West Africa College of Surgeons, ACCR STAT CHART FAC; WFNS, WFNS FELL GUID; WIJDICKS EFM, 1985, ANN NEUROL, V18, P211, DOI 10.1002/ana.410180208	47	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2020	138						E705	E711		10.1016/j.wneu.2020.03.036			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LY7RI	WOS:000540724700004	32179184				2022-02-06	
J	Franco, JG; Ocampo, MV; Velasquez-Tirado, JD; Zaraza, DR; Giraldo, AM; Serna, PA; Lopez, C; Zuluaga, A; Sepulveda, E; Kean, J; Trzepacz, PT				Franco, Jose G.; Ocampo, Maria V.; Velasquez-Tirado, Juan D.; Zaraza, Daniel R.; Giraldo, Alejandra M.; Serna, Paola A.; Lopez, Carolina; Zuluaga, Adolfo; Sepulveda, Esteban; Kean, Jacob; Trzepacz, Paula T.			Validation of the Delirium Diagnostic Tool-Provisional (DDT-Pro) With Medical Inpatients and Comparison With the Confusion Assessment Method Algorithm	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							RATING-SCALE REVISED-98; INFORMANT QUESTIONNAIRE; COGNITIVE DECLINE; CARE; POPULATION; ADAPTATION; CRITERIA; IQCODE	Objective: Delirium remains underdetected as a result of its broad constellation of symptoms and the inadequate neuropsychiatric expertise of most medical-surgical clinicians. Brief, accurate tools are needed to enhance detection. Methods: The authors extended validation of the Delirium Diagnostic Tool-Provisional (DDT-Pro), originally validated in a study of inpatients with traumatic brain injury for diagnosis of delirium by nonexpert clinicians, for 200 general medical inpatients in Colombia. The three structured, quantitatively rated items in DDT-Pro represent the three core delirium domains. Results: High interrater reliability between physician and nurse (0.873) administrators, internal consistency (>0.81), and content validity were found. Compared with independent reference standard diagnosis with DSM-5 or the Delirium Rating Scale-Revised-98, the area under the receiver operating characteristic (ROC) curve (global diagnostic accuracy) range was 93.8%-96.3%. ROC analysis revealed the same cutoff score (<= 6) as that for the original study, with somewhat lower sensitivities of 88.0%-90.0% and specificities of 85.3%-81.2% (independent expert physician or nurse ratings). Even when rated by a trained expert physician, the original version of the Confusion Assessment Method algorithm (CAM-A) performed moderately, with lower sensitivities (61.8%-70.0%) than the DDT-Pro (88.0%- 100%) and somewhat higher specificities (84.8%-95.3% versus 67.4%286.7%), with values depending on dementia status, reference standard, and rater type. Accuracies for the DDT-Pro and CAM-A were comparable (DDT-Pro: 83.0%-87.5% versus CAM-A: 87.5%-88.5%), although lower in the dementia subgroup, especially for CAM-A. However, these tools were significantly discordant, especially in negative cases, which suggests that they do not detect diagnosis of patients in the same way. Conclusions: The DDT-Pro had high validity and reliability in provisional delirium diagnosis by physicians and nonexpert clinicians, although further validation is warranted before widespread use can be recommended.	[Franco, Jose G.; Ocampo, Maria V.; Velasquez-Tirado, Juan D.; Giraldo, Alejandra M.; Serna, Paola A.; Lopez, Carolina; Zuluaga, Adolfo] Univ Pontificia Bolivariana, Grp Invest Psiquiatria Enlace GIPE, Fac Med, Medellin, Colombia; [Zaraza, Daniel R.] Univ Pontificia Bolivariana, Grp Invest Cuidado, Fac Enfermeria, Medellin, Colombia; [Sepulveda, Esteban] Univ Rovira & Virgili, Hosp Psiquiatr Univ Inst Pere Mata, IISPV, Ctr Invest Biomed Red Salud Mental CIBERSAM, Tarragona, Spain; [Kean, Jacob] Univ Utah, Dept Populat Hlth Sci, VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Kean, Jacob] Univ Utah, Dept Commun Sci & Disorders, VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Kean, Jacob] Univ Utah, Hlth Syst Innovat & Res, Salt Lake City, UT USA; [Trzepacz, Paula T.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Franco, JG (corresponding author), Univ Pontificia Bolivariana, Grp Invest Psiquiatria Enlace GIPE, Fac Med, Medellin, Colombia.	josefranco11@hotmail.com	Trzepacz, Paula/AAQ-3330-2021; Franco, Jose G./N-2850-2014	Franco, Jose G./0000-0001-9255-8084; Zaraza-Morales, Daniel/0000-0002-4197-3787; VELASQUEZ TIRADO, JUAN DAVID/0000-0002-4638-2927	Centro de Investigacion para El Desarrollo y la Innovacion from the Universidad Pontificia Bolivariana, Medellin, Colombia	Supported by the Centro de Investigacion para El Desarrollo y la Innovacion from the Universidad Pontificia Bolivariana, Medellin, Colombia.	Adamis D, 2015, INT PSYCHOGERIATR, V27, P883, DOI 10.1017/S1041610214002853; Ahmed S, 2014, AGE AGEING, V43, P326, DOI 10.1093/ageing/afu022; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; BERKMAN LF, 1992, ANN INTERN MED, V117, P1003, DOI 10.7326/0003-4819-117-12-1003; Choi SH, 2012, AM J PSYCHIAT, V169, P498, DOI 10.1176/appi.ajp.2012.11060976; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; de Jonghe JFM, 2005, INT J GERIATR PSYCH, V20, P1158, DOI 10.1002/gps.1410; FARRELL KR, 1995, ARCH INTERN MED, V155, P2459, DOI 10.1001/archinte.155.22.2459; Ferro JM, 2002, CURR OPIN NEUROL, V15, P51, DOI 10.1097/00019052-200202000-00009; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; Gaudreau JD, 2005, J PAIN SYMPTOM MANAG, V29, P368, DOI 10.1016/j.jpainsymman.2004.07.009; GONZALEZ JMM, 1992, ARCH NEUROBIOL, V55, P262; Gonzalez M, 2004, PSYCHOSOMATICS, V45, P426, DOI 10.1176/appi.psy.45.5.426; Hall RJ, 2012, BEST PRACT RES-CLIN, V26, P367, DOI 10.1016/j.bpa.2012.07.002; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; Hayden SR, 1999, ANN EMERG MED, V33, P575, DOI 10.1016/S0196-0644(99)70346-X; Hendry K, 2016, AGE AGEING, V45, P832, DOI 10.1093/ageing/afw130; Hustey FM, 2003, ANN EMERG MED, V41, P678, DOI 10.1067/mem.2003.152; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Inouye SK, 2003, CONFUSION ASSESSMENT; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kean J, 2010, BRAIN INJURY, V24, P1222, DOI 10.3109/02699052.2010.498008; Leonard M, 2011, J NEUROPSYCH CLIN N, V23, P180, DOI 10.1176/appi.neuropsych.23.2.180; Meagher D, 2012, BRIT J PSYCHIAT, V200, P37, DOI 10.1192/bjp.bp.111.095273; Meagher DJ, 2007, BRIT J PSYCHIAT, V190, P135, DOI 10.1192/bjp.bp.106.023911; Mukaka MM, 2012, MALAWI MED J, V24, P69; Ritter SRF, 2018, PSYCHOGERIATRICS, V18, P268, DOI 10.1111/psyg.12324; Rolfson D B, 1999, Int Psychogeriatr, V11, P431, DOI 10.1017/S1041610299006043; Ryan DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001772; Sands MB, 2010, PALLIATIVE MED, V24, P561, DOI 10.1177/0269216310371556; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425; Sepulveda E., 2016, ALZHEIMERS DEMENT, V7, P1; Sepulveda E, 2015, PSYCHOSOMATICS, V56, P530, DOI 10.1016/j.psym.2015.03.005; Thurber S, 2015, J NEUROPSYCH CLIN N, V27, pE122, DOI 10.1176/appi.neuropsych.13110345; Trzepacz P, 2011, AM PSYCHIAT PUBLISHI; Trzepacz PT, 2018, J NEUROPSYCH CLIN N, V30, P294, DOI 10.1176/appi.neuropsych.18020024; Trzepacz PT, 2016, J PSYCHOSOM RES, V84, P60, DOI 10.1016/j.jpsychores.2016.03.011; Trzepacz PT, 2012, J PSYCHOSOM RES, V73, P10, DOI 10.1016/j.jpsychores.2012.04.010; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Trzepacz PT, 1999, DEMENT GERIATR COGN, V10, P330, DOI 10.1159/000017164; Van Gemert LA, 2007, BMC NURS, V6, DOI 10.1186/1472-6955-6-3; Velasquez Gaviria LM, 2016, MED UPB, V35, P100; Wei LA, 2008, J AM GERIATR SOC, V56, P823, DOI 10.1111/j.1532-5415.2008.01674.x; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x	44	3	3	0	1	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2020	32	3					213	226		10.1176/appi.neuropsych.18110255			14	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	MV7XN	WOS:000556565800079	31662094	Bronze			2022-02-06	
J	Jenkins, PO; Roussakis, AA; De Simoni, S; Bourke, N; Fleminger, J; Cole, J; Piccini, P; Sharp, D				Jenkins, Peter Owen; Roussakis, Andreas-Antonios; De Simoni, Sara; Bourke, Niall; Fleminger, Jessica; Cole, James; Piccini, Paola; Sharp, David			Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							SLEEP BEHAVIOR DISORDER; ALPHA-SYNUCLEIN; HEAD-INJURY; TRANSPORTER; SYSTEM; IMPACT; SPECT; EXPRESSION; MANAGEMENT; DIAGNOSIS	Objective Traumatic brain injury (TBI) and rapid eye movement sleep behavioural disorder (RBD) are risk factors for Parkinson's disease (PD). Dopaminergic abnormalities are often seen after TBI, but patients usually lack parkinsonian features. We test whether TBI, PD and RBD have distinct striatal dopamine abnormalities using dopamine transporter (DaT) imaging. Methods I-123-ioflupane single-photon emission CT scans were used in a cross-sectional study to measure DaT levels in moderate/severe TBI, healthy controls, patients with early PD and RBD. Caudate and putamen DaT, putamen to caudate ratios and left-right symmetry of DaT were compared. Results 108 participants (43 TBI, 26 PD, 8 RBD, 31 controls) were assessed. Patients with early PD scored significantly higher on the Unified Parkinson's Disease Rating Scale motor subscale than other groups. Patients with TBI and PD had reduced DaT levels in the caudate (12.2% and 18.7%, respectively) and putamen (9.0% and 42.6%, respectively) compared with controls. Patients with RBD had reduced DaT levels in the putamen (12.8%) but not in the caudate compared with controls. Patients with PD and TBI showed distinct patterns of DaT reduction, with patients with PD showing a lower putamen to caudate ratio. DaT asymmetry was greater in the PD group than other groups. Conclusions The results show that patients with early PD and TBI have distinct patterns of striatal dopamine abnormalities. Patients with early PD and moderate/severe TBI showed similar reductions in caudate DaT binding, but patients with PD showed a greater reduction in putamen DaT and a lower putamen to caudate ratio. The results suggest that parkinsonian motor signs are absent in these patients with TBI because of relatively intact putaminal dopamine levels.	[Jenkins, Peter Owen; De Simoni, Sara; Bourke, Niall; Fleminger, Jessica; Cole, James; Sharp, David] Imperial Coll, Div Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London, England; [Roussakis, Andreas-Antonios; Piccini, Paola] Imperial Coll London, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, London, England; [Sharp, David] Imperial Coll, UK Dementia Res Inst, Care Res & Technol Ctr, London, England		Sharp, D (corresponding author), Imperial Coll, London SW7 2AZ, England.	david.sharp@imperial.ac.uk	Roussakis, Andreas-Antonios/ABC-7362-2021; Cole, James H/I-5197-2019	Roussakis, Andreas-Antonios/0000-0001-5748-6978; Cole, James H/0000-0003-1908-5588; Sharp, David/0000-0003-4995-2240; Jenkins, Peter/0000-0003-2060-6766; Piccini, Paola/0000-0003-4162-6141; Fleminger, Jessica/0000-0002-5744-5137	National Institute of Health Research Professorship [NIHR-R P-011-048]; NIHR CRF; Biomedical Research Centre at Imperial College Healthcare NHS Trust; Guarantors of Brain Clinical Fellowship; Michael J Fox Foundation for Parkinson's Research; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	This paper presents independent research funded by a National Institute of Health Research Professorship (NIHR-R P-011-048) awarded to DS and supported by the NIHR CRF and Biomedical Research Centre at Imperial College Healthcare NHS Trust. DS was funded by a National Institute of Health Research Professorship (NIHR-R P-011-048). POJ is funded by Guarantors of Brain Clinical Fellowship. PP received funding from the Michael J Fox Foundation for Parkinson's Research.	Bauckneht M, 2018, SLEEP MED REV, V41, P266, DOI 10.1016/j.smrv.2018.04.001; Boeve BF, 2013, LANCET NEUROL, V12, P469, DOI 10.1016/S1474-4422(13)70054-1; Catafau AM, 2004, MOVEMENT DISORD, V19, P1175, DOI 10.1002/mds.20112; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Ekman U, 2012, LANCET NEUROL, V11, P679, DOI 10.1016/S1474-4422(12)70138-2; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Gordon I, 1996, EUR J PHARMACOL, V298, P27, DOI 10.1016/0014-2999(95)00770-9; Guttman M, 1997, NEUROLOGY, V48, P1578, DOI 10.1212/WNL.48.6.1578; Iranzo A, 2011, LANCET NEUROL, V10, P797, DOI 10.1016/S1474-4422(11)70152-1; Jenkins PO, 2019, BRAIN, V142, P2367, DOI 10.1093/brain/awz149; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Kupsch AR, 2012, J NEUROL NEUROSUR PS, V83, P620, DOI 10.1136/jnnp-2011-301695; LAPIERRE O, 1992, NEUROLOGY, V42, P1371, DOI 10.1212/WNL.42.7.1371; Ma Y, 2002, SYNAPSE, V45, P125, DOI 10.1002/syn.10090; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zijlmans J, 2007, MOVEMENT DISORD, V22, P1278, DOI 10.1002/mds.21479	30	3	3	5	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2020	91	6					631	637		10.1136/jnnp-2019-321759			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	LW3RG	WOS:000539061900012	32381639	Green Submitted			2022-02-06	
J	Jiang, WQ; Jin, P; Wei, WF; Jiang, W				Jiang, Wenqing; Jin, Peng; Wei, Wenfeng; Jiang, Wei			Apoptosis in cerebrospinal fluid as outcome predictors in severe traumatic brain injury An observational study	MEDICINE			English	Article						apoptosis; cerebrospinal fluid; traumatic brain injury	FAS LIGAND; CYTOCHROME-C; CASPASE-3; INFANTS; DEATH; SERUM	Traumatic brain injury (TBI), due to its high mortality and morbidity, is an important research topic. Apoptosis plays a pathogenic role in a series of neurological disorders, from neurodegenerative diseases to acute neurological lesions. In this study, we analyzed the association between apoptosis and the Glasgow Outcome Scale (GOS), to examine the potential of apoptosis as a biomarker for a TBI outcome. Patients with severe TBI were recruited at the Department of Neurosurgery, Wujin Hospital Affiliated with Jiangsu University, between January 2018 and December 2019. As a control group, healthy subjects were recruited. The concentrations of caspase-3, cytochrome c, sFas, and caspase-9 in the cerebrospinal fluid (CSF) were analyzed by enzyme-linked immunosorbent assay (ELISA). The association between the GOS and the clinical variables age, sex, initial Glasgow Coma Scale (GCS) score, intracranial pressure (ICP), cerebral perfusion pressure (CPP), initial computed tomography (CT) findings, and apoptotic factors was determined using logistic regression. The area under the receiver operator characteristic (ROC) curve (AUC), and thus the sensitivity and specificity of each risk factor, were obtained. The levels of caspase-3, cytochrome c, sFas, and caspase-9 in the TBI group were significantly higher than those in the control group (P < .05). The logistic regression results showed that ICP and caspase-3 were significant predictors of outcome at 6 months post-TBI (P < .05). The AUC was 0.925 and 0.888 for ICP and caspase-3, respectively. However, the AUC for their combined prediction was 0.978, with a specificity and sensitivity of 96.0% and 95.2%, respectively, showing that the combined prediction was more reliable than that of the 2 separate factors. We demonstrated that caspase-3, cytochrome C, sFas, and caspase-9 were significantly increased in the CSF of patients following severe TBI. Furthermore, we found that ICP and caspase-3 were more reliable for outcome prediction in combination, rather than separately.	[Jiang, Wenqing; Jin, Peng; Wei, Wenfeng; Jiang, Wei] Jiangsu Univ, Dept Neurosurg, Wujin Hosp, Changzhou 213017, Jiangsu, Peoples R China; [Jiang, Wenqing; Jin, Peng; Wei, Wenfeng; Jiang, Wei] Xuzhou Med Univ, Dept Neurosurg, Wujin Clin Coll, Changzhou, Jiangsu, Peoples R China		Jiang, W (corresponding author), Jiangsu Univ, Dept Neurosurg, Wujin Hosp, Changzhou 213017, Jiangsu, Peoples R China.	jw7433150@163.com			Changzhou Key RD Program [CJ20180006]; Wujin Science and Technology Support Program [WS201815]; Clinical Science and Technology Foundation of Jiangsu University [JLY20180085]	This work was supported by the Changzhou Key R&D Program (CJ20180006), Wujin Science and Technology Support Program (WS201815), Clinical Science and Technology Foundation of Jiangsu University (JLY20180085).	Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Chen XH, 2017, PARASITOL RES, V116, P3027, DOI 10.1007/s00436-017-5613-9; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Darwish RS, 2010, NEUROCRIT CARE, V12, P337, DOI 10.1007/s12028-009-9328-3; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Ding YW, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00904; Eroglua O, 2017, INJURY, V48, P2675, DOI 10.1016/j.injury.2017.09.032; Ertel W, 1997, J NEUROIMMUNOL, V80, P93, DOI 10.1016/S0165-5728(97)00139-2; Felderhoff-Mueser U, 2003, PEDIATR RES, V54, P659, DOI 10.1203/01.PDR.0000084114.83724.65; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Kacira T, 2007, NEUROSURGERY, V60, P674, DOI 10.1227/01.NEU.0000255394.77538.BB; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Paul R, 2004, J NEUROIMMUNOL, V152, P78, DOI 10.1016/j.jneuroim.2004.04.004; Qiu JH, 2002, J NEUROSCI, V22, P3504; Rebolledo RA, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0890-0; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Sun YH, 2015, EXP THER MED, V10, P133, DOI 10.3892/etm.2015.2462; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wallisch JS, 2017, NEUROCRIT CARE, V27, P44, DOI 10.1007/s12028-017-0378-7; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Zhang PJ, 2017, CNS NEUROL DISORD-DR, V16, P724, DOI 10.2174/1871527316666170124164306; Zhu MX, 2015, STEM CELLS DEV, V24, P160, DOI 10.1089/scd.2014.0076	24	3	3	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JUN	2020	99	26							e20922	10.1097/MD.0000000000020922			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MM1AE	WOS:000549890000078	32590803	gold, Green Published			2022-02-06	
J	Kebapci, A; Topcu, S				Kebapci, Ayda; Topcu, Serpil			Interrater reliability in pupillary assessment among intensive care nurses	INTENSIVE AND CRITICAL CARE NURSING			English	Article						Critical care; Neurosurgery; Neurology; Nurses; Pupil	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; CRITICALLY-ILL PATIENTS; PUPILLOMETRY; AGREEMENT; MORTALITY; IMPACT; SCORE; SIZE; NEED	Background: Pupillary abnormalities are a common and reliable finding of brain herniation, ischaemia, and acute brain injury in critically ill patients. Reliable pupil assessment is a vital evaluation in diagnostic and therapeutic procedures for neurocritical patients. Aim: To evaluate inter-rater reliability of pupillary assessment among intensive care. Methods: In this prospective, blind observational study, intensive care nurses and two researchers evaluated the pupil size, reactivity and symmetry of 200 patients with neurosurgery or neurological diseases. A total of 200 pupillary measurement sets were completed independently and blindly. Results: Three observers -two researchers and the nurse- found fair-to-good and excellent agreements in initial pupil size evaluations of right and left pupils, respectively (ICC = 0.70, 95%; ICC = 0.75, 95%). In patients with pupil size >= 4 mm, the observers found fair-to-good agreements in both right and left pupil initial size measurements (ICC = 0.52; ICC = 0.65). Agreement in pupil symmetry was moderated (K = 0.58), and reactivity was near perfect (K = 0.89) between the three observers. Conclusion: Although the two researchers found near perfect agreement in pupil size, symmetry and reactivity assessment, two researchers and the nurse found moderate agreement in pupil symmetry and fair-to-good agreement in pre- and post-light stimulation pupil size. (C) 2020 Elsevier Ltd. All rights reserved.	[Kebapci, Ayda; Topcu, Serpil] Koc Univ, Sch Nursing, Davutpasa St 4, Istanbul 34010, Turkey		Kebapci, A (corresponding author), Koc Univ, Sch Nursing, Davutpasa St 4, Istanbul 34010, Turkey.	akebapci@ku.edu.tr; serpilakkustopcu@gmail.com					Aoun SG, 2019, WORLD NEUROSURG, V121, pE475, DOI 10.1016/j.wneu.2018.09.140; Birks M, 2013, COLLEGIAN, V20, P27, DOI 10.1016/j.colegn.2012.02.004; Cevik B., 2018, J HACETTEPE U FAC NU, V5; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Clark A, 2006, EMERG MED J, V23, P440, DOI 10.1136/emj.2005.030247; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Du R, 2005, NEUROSURGERY, V57, P198, DOI 10.1227/01.NEU.0000163425.79170.CB; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Emelifeonwu JA, 2018, BRAIN INJURY, V32, P675, DOI 10.1080/02699052.2018.1429021; Friedman N.J., 2009, MASSACHUSETTS EYE EA; Giddens J., 2006, J NURS EDUC, V45; Giddens J.F., 2007, J NURS EDUC, V46; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Hults Kathryn N, 2006, J Neurosci Nurs, V38, P447; Jeffery RCH, 2019, AUST J GEN PRACT, V48, P39, DOI 10.31128/AJGP-07-18-4641; Kerr RG, 2016, AM J CRIT CARE, V25, P213, DOI 10.4037/ajcc2016554; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kramer CL, 2014, NEUROCRIT CARE, V21, P309, DOI 10.1007/s12028-014-9988-5; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larson MD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1349-7; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Ong C, 2019, NEUROCRIT CARE, V30, P316, DOI 10.1007/s12028-018-0607-8; Papangelou A, 2018, MIL MED, V183, pE113, DOI 10.1093/milmed/usx018; Phillips SS, 2019, NEUROCRIT CARE, V31, P142, DOI 10.1007/s12028-018-0645-2; Portran P, 2017, J THORAC DIS, V9, P2528, DOI 10.21037/jtd.2017.07.58; Rouche O, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-5; Salandy S., 2019, CLIN ANAT; Sharshar T, 2014, INTENS CARE MED, V40, P484, DOI 10.1007/s00134-014-3214-y; Shoyombo I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25477-7; Smith J., 2019, AUSTR CRIT CARE; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; VANDENBERGE JH, 1979, J NEUROL NEUROSUR PS, V42, P1163, DOI 10.1136/jnnp.42.12.1163; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; von Gaudecker JR, 2018, J NEUROSCI NURS, V50, P367, DOI 10.1097/JNN.0000000000000413; Wilson S F, 1988, J Neurosci Nurs, V20, P189; Yalcin S, 2010, INDIAN J ANAESTH, V54, P365, DOI 10.4103/0019-5049.68398; Zafar SF, 2014, J CRIT CARE, V29, P599, DOI 10.1016/j.jcrc.2014.01.012	42	3	3	2	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0964-3397	1532-4036		INTENS CRIT CARE NUR	Intensive Crit. Care Nurs.	JUN	2020	58								102801	10.1016/j.iccn.2020.102801			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	LK5GE	WOS:000530893300004	32035804				2022-02-06	
J	Kim, JH; Goodrich, JA; Situ, R; Rapuano, A; Hetherington, H; Du, F; Parks, S; Taylor, W; Westmoreland, T; Ling, G; Bandak, FA; de Lanerolle, NC				Kim, Jung H.; Goodrich, James A.; Situ, Robert; Rapuano, Amedeo; Hetherington, Hoby; Du, Fu; Parks, Steve; Taylor, Wesley; Westmoreland, Ted; Ling, Geoffrey; Bandak, Faris A.; de Lanerolle, Nihal C.			Periventricular White Matter Alterations From Explosive Blast in a Large Animal Model: Mild Traumatic Brain Injury or "Subconcussive" Injury?	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Animal model; Axonal injury; Concussion; Explosive blast; Mild traumatic brain injury; Neuropathology; Periventricular region	AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; HEAD; NEUROPATHOLOGY; ASSOCIATION; EXPOSURE; DIFFUSE; MARKER; IRAQ; HYPERINTENSITIES	The neuropathology of mild traumatic brain injury in humans resulting from exposure to explosive blast is poorly understood as this condition is rarely fatal. A large animal model may better reflect the injury patterns in humans. We investigated the effect of explosive blasts on the constrained head minimizing the effects of whole head motion. Anesthetized Yucatan minipigs, with body and head restrained, were placed in a 3-walled test structure and exposed to 1, 2, or 3 explosive blast shock waves of the same intensity. Axonal injury was studied 3 weeks to 8 months postblast using beta-amyloid precursor protein immunohistochemistry. Injury was confined to the periventricular white matter as early as 3-5 weeks after exposure to a single blast. The pattern was also present at 8 months postblast. Animals exposed to 2 and 3 blasts had more axonal injury than those exposed to a single blast. Although such increases in axonal injury may relate to the longer postblast survival time, it may also be due to the increased number of blast exposures. It is possible that the injury observed is due to a condition akin to mild traumatic brain injury or subconcussive injury in humans, and that periventricular injury may have neuropsychiatric implications.	[Kim, Jung H.] Yale Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Goodrich, James A.] Yale Sch Med, Dept Comparat Med, New Haven, CT 06520 USA; [Situ, Robert; Rapuano, Amedeo; de Lanerolle, Nihal C.] Yale Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA; [Hetherington, Hoby] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Du, Fu] FD NeuroTechnol Inc, Ellicott City, MD USA; [Parks, Steve] ORA Inc, Fredericksburg, VA USA; [Taylor, Wesley; Westmoreland, Ted] Adv Med Training, Mckinney, TX USA; [Ling, Geoffrey] Uniformed Serv Univ Hlth Sci, Dept Neurol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Bandak, Faris A.] Integrated Serv Grp Inc, Potomac, MD USA		de Lanerolle, NC (corresponding author), Yale Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA.	nihal.delanerolle@yale.edu			Defense Advanced Research Project Agency (DARPA) Preventing Violent Explosive Neurologic Trauma "PREVENT" Research ProgramUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66001-10-C-2123]	The work was supported by a contract from the Defense Advanced Research Project Agency (DARPA) Preventing Violent Explosive Neurologic Trauma "PREVENT" Research Program Contract N66001-10-C-2123.	Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; CRAMER F, 1949, ARCH NEURO PSYCHIATR, V61, P1; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Groot JC, 2000, ANN NEUROL, V47, P145; de Lanerolle NC, 2015, SEMIN NEUROL, V35, P12, DOI 10.1055/s-0035-1544240; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Fix AS, 2000, TOXICOL PATHOL, V28, P122, DOI 10.1177/019262330002800115; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Gradus JL, 2015, J TRAUMA STRESS, V28, P361, DOI 10.1002/jts.22021; Grangeon MC, 2010, CNS SPECTRUMS, V15, P375, DOI 10.1017/S1092852900029242; Hetherington H, 2015, Handb Clin Neurol, V127, P309, DOI 10.1016/B978-0-444-52892-6.00020-9; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; HIRSCH AE, 1972, J NEUROSURG, V37, P95, DOI 10.3171/jns.1972.37.1.0095; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Ling G, 2007, J TRAUMA, V62, pS102, DOI 10.1097/TA.0b013e318065b442; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lotan E, 2018, AM J NEURORADIOL, V39, P1222, DOI 10.3174/ajnr.A5688; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnuson J., 2018, TRAUMATIC BRAIN INJU, P39; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mott FW, 1917, J ROY ARMY MED CORPS, V29, P662; MURTHY JMK, 1979, J NEUROSURG, V50, P260, DOI 10.3171/jns.1979.50.2.0260; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Pompili M, 2008, PROG NEURO-PSYCHOPH, V32, P1501, DOI 10.1016/j.pnpbp.2008.05.009; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Richard YF, 2015, AM J EPIDEMIOL, V182, P177, DOI 10.1093/aje/kwv014; Robertson CS, 2013, J NEUROTRAUM, V30, P609, DOI 10.1089/neu.2013.9940; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Slupe AM, 2018, J CEREBR BLOOD F MET, V38, P2192, DOI 10.1177/0271678X18789273; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Taber Katherine H, 2013, J Neuropsychiatry Clin Neurosci, V25, P1, DOI 10.1176/appi.neuropsych.12120401; Traystman RJ, 2004, J NEUROSURG ANESTH, V16, P308, DOI 10.1097/00008506-200410000-00012; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071	56	3	3	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUN	2020	79	6					605	617		10.1093/jnen/nlaa026			13	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pathology	LV9VS	WOS:000538796100004	32386412	Bronze			2022-02-06	
J	Kimball, R; Shachar, E; Eyerly-Webb, S; Patel, DM; Spader, H				Kimball, Rebekah; Shachar, Elad; Eyerly-Webb, Stephanie; Patel, Daxa M.; Spader, Heather			Using the neutrophil-to-lymphocyte ratio to predict outcomes in pediatric patients with traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Neutrophil-to-lymphocyte ratio; Outcomes; Pediatrics; Traumatic brain injury; Prognosis; Neurosurgery	NEUTROPHIL/LYMPHOCYTE RATIO; PROGNOSTIC-SIGNIFICANCE; HEAD TRAUMA; CHILDREN; MORTALITY; PLATELET; SCALE	Objective: The brain's inflammatory reaction to traumatic brain injury (TBI) generally peaks between 24 and 48 h after injury. This inflammatory cascade can be neuroprotective or may mediate secondary brain injury beyond the initial TBI. Therefore, circulating inflammatory markers may be useful for predicting outcomes in pediatric TBI. The goal of this study was to determine whether elevations in peripheral blood neutrophil-tolymphocyte ratios (NLRs) are associated with adverse outcomes in pediatric TBI patients. Patients and Methods: 188 pediatric patients (0-18 years) presenting to our institution with TBI from 2007 to 2017 were retrospectively reviewed. Absolute neutrophil and lymphocyte counts from a complete blood count (CBC) were used to calculate NLRs on admission ( < 12 h) and approximately 24, 48, and 72 h after injury. Data points included Glasgow Coma Scale (GCS) on admission, presence of post-traumatic amnesia (PTA), loss of consciousness (LOC), and Glasgow Outcome Scale Extended Pediatric Version (GOS-E Peds) with a median outcome span of 86 days. Results: A one-way ANOVA demonstrated statistically significant differences in NLR at 24 h (p = 0.004) and 48 h (p = 0.003) among patients stratified by GOS-E Peds. No significant differences in NLR were observed at any time point based on GCS or PTA. Patients who experienced LOC had a significantly higher NLR on admission (p = 0.013) and at 24h (p < 0.001) than those who did not. Conclusion: In this study, relatively higher NLRs at 24 and 48 h post-TBI were associated with worse outcomes in pediatric patients. This suggests that NLR may be a useful and cost-effective outcome predictor in pediatric TBI as well as a possible future target for therapeutic intervention, warranting larger prospective trials.	[Kimball, Rebekah] Florida Atlantic Univ, Coll Med, 777 Glades Rd, Boca Raton, FL 33431 USA; [Shachar, Elad] Florida Atlantic Univ, Charles E Schmidt Coll Sci, Dept Biol, 777 Glades Rd, Boca Raton, FL 33431 USA; [Eyerly-Webb, Stephanie] Mem Healthcare Syst, Off Human Res, 4411 Sheridan St, Hollywood, FL 33021 USA; [Patel, Daxa M.; Spader, Heather] Joe DiMaggio Childrens Hosp, Div Pediat Neurosurg, 1150 N 35thAve,Suite 520, Hollywood, FL 33021 USA		Spader, H (corresponding author), Joe DiMaggio Childrens Hosp, Div Pediat Neurosurg, 1150 N 35thAve,Suite 520, Hollywood, FL 33021 USA.	hspader@mhs.net					Acar E, 2016, EUR J TRAUMA EMERG S, V42, P611, DOI 10.1007/s00068-015-0579-8; Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Cassidy LD, 2003, J PEDIATR SURG, V38, P482, DOI 10.1053/jpsu.2003.50084; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Corbett JM, 2020, J NEUROSURG, V132, P545, DOI 10.3171/2018.10.JNS182293; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Davis K.C., 2016, TIME FOLLOW COMMANDS, pE39; Dong CH, 2018, CLIN BIOCHEM, V52, P131, DOI 10.1016/j.clinbiochem.2017.11.008; Ferrara P, 2016, PEDIATR NEUROSURG, V51, P249, DOI 10.1159/000445904; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Guo R, 2019, WORLD NEUROSURG, V127, pE1051, DOI 10.1016/j.wneu.2019.04.040; Hori YS, 2016, PEDIATR NEUROSURG, V51, P57, DOI 10.1159/000441390; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Lattanzi S, 2016, STROKE, V47, P1654, DOI 10.1161/STROKEAHA.116.013627; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Lumba-Brown A., 2018, JAMA PEDIAT, V172; McCluney SJ, 2018, J SURG ONCOL, V117, P1058, DOI 10.1002/jso.24996; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Pagowska-Klimek I, 2007, J TRAUMA, V63, P179, DOI 10.1097/TA.0b013e3180340dc9; Petrone AB, 2017, NEUROREHABILITATION, V40, P501, DOI 10.3233/NRE-171437; Rahimi S, 2014, ACTA NEUROCHIR, V156, P187, DOI 10.1007/s00701-013-1929-0; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Siwicka-Gieroba D, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091453; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Wilson JRF, 2018, ACTA NEUROCHIR, V160, P793, DOI 10.1007/s00701-017-3388-5; Yazici M, 2010, TURKISH J PEDIATR, V52, P400; Yodying H, 2016, ANN SURG ONCOL, V23, P646, DOI 10.1245/s10434-015-4869-5; Zhang Y, 2015, CLIN TRANSL ONCOL, V17, P810, DOI 10.1007/s12094-015-1310-2; Zhao JL, 2019, WORLD NEUROSURG, V124, pE411, DOI 10.1016/j.wneu.2018.12.107; Zheng J, 2017, CELL PHYSIOL BIOCHEM, V44, P967, DOI 10.1159/000485396	35	3	3	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUN	2020	193								105772	10.1016/j.clineuro.2020.105772			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LP5QC	WOS:000534371300017	32155528				2022-02-06	
J	Kornblith, LZ; Bainton, CMV; Fields, AT; Matthay, ZA; Magid, NT; Nunez-Garcia, B; Prakash, A; Kurien, PA; Callcut, RA; Cohen, MJ; Bainton, RJ				Kornblith, Lucy Zumwinkle; Bainton, Cedric M. V.; Fields, Alexander T.; Matthay, Zachary A.; Magid, Nina T.; Nunez-Garcia, Brenda; Prakash, Arun; Kurien, Philip A.; Callcut, Rachael A.; Cohen, Mitchell J.; Bainton, Roland J.			A journey upstream: Fluctuating platelet-specific genes in cell-free plasma as proof-of-concept for using ribonucleic acid sequencing to improve understanding of postinjury platelet biology	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	78th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 18-21, 2019	Dallas, TX	Amer Assoc Surg Trauma		Platelet activation; next generation sequencing; ribonucleic acid sequencing; cell-free plasma; prespliced RNA complexes; dynamically regulated RNA splicing	TRAUMATIC BRAIN-INJURY; FACTOR-XIII; HEMORRHAGIC-SHOCK; A-SUBUNITS; IN-VIVO; COAGULOPATHY; DYSFUNCTION; RESUSCITATION; COAGULATION; ACTIVATION	BACKGROUND The mechanisms of aberrant circulating platelet behavior following injury remain unclear. Platelets retain megakaryocyte immature ribonucleic acid (RNA) splicing and protein synthesis machinery to alter their functions based on physiologic signals. We sought to identify fluctuating platelet-specific RNA transcripts in cell-free plasma (CFP) from traumatic brain injury (TBI) patients as proof-of-concept for using RNA sequencing to improve our understanding of postinjury platelet behavior. We hypothesized that we could identifydifferential expression of activated platelet-specific spliced RNA transcriptsfrom CFP of patients with isolated severe fatal TBI (fTBI) compared with minimally injured trauma controls (t-controls), filtered by healthy control (h-control) data sets. METHODS High-read depth RNA sequencing was applied to CFP from 10 patients with fTBI (Abbreviated Injury Scale [AIS] for head >= 3, AIS for all other categories <3, and expired) and five t-controls (Injury Severity Score <= 1, and survived). A publicly available CFP RNA sequencing data set from 23 h-controls was used to determine the relative steady state of splice-form RNA transcripts discoverable in CFP. Activated platelet-specific spliced RNA transcripts were derived from studies of ex vivo platelet activation and identified by splice junction presence greater than 1.5-fold or less than 0.67-fold ex vivo nonactivated platelet-specific RNA transcripts. RESULTS Forty-two differentially spliced activated platelet-specific RNA transcripts in 34 genes were altered in CFP from fTBI patients (both upregulated and downregulated). CONCLUSION We have discovered differentially expressed activated platelet-specific spliced RNA transcripts present in CFP from isolated severe fTBI patients that are upregulated or downregulated compared with minimally injured trauma controls. This proof-of-concept suggests that a pool of immature platelet RNAs undergo splicing events after injury for presumed modulation of platelet protein products involved in platelet function. This validates our exploration of injury-induced platelet RNA transcript modulation as anupstream"liquid biopsy" to identify novel postinjury platelet biology and treatment targets for aberrant platelet behavior.	[Kornblith, Lucy Zumwinkle; Fields, Alexander T.; Matthay, Zachary A.; Nunez-Garcia, Brenda; Callcut, Rachael A.] Zuckerberg San Francisco Gen Hosp, Dept Surg, Ward 3A,Bldg 1,Ste 210,1001 Potrero Ave, San Francisco, CA 94110 USA; [Bainton, Cedric M. V.; Magid, Nina T.; Prakash, Arun; Kurien, Philip A.; Bainton, Roland J.] Zuckerberg San Francisco Gen Hosp, Dept Anesthesiol & Perioperat Care, Ward 3C-38,1001 Potrero Ave, San Francisco, CA 94110 USA; [Bainton, Cedric M. V.; Magid, Nina T.; Prakash, Arun; Kurien, Philip A.; Bainton, Roland J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cohen, Mitchell J.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Cohen, Mitchell J.] Univ Colorado, Denver, CO 80202 USA		Kornblith, LZ (corresponding author), Zuckerberg San Francisco Gen Hosp, Dept Surg, Ward 3A,Bldg 1,Ste 210,1001 Potrero Ave, San Francisco, CA 94110 USA.; Bainton, RJ (corresponding author), Zuckerberg San Francisco Gen Hosp, Dept Anesthesiol & Perioperat Care, Ward 3C-38,1001 Potrero Ave, San Francisco, CA 94110 USA.	lucy.kornblith@ucsf.edu; roland.bainton@ucsf.edu	Callcut, Rachael/ABE-1484-2021		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08GM110497, 1K23GM130892-01, UM1HL120877, K01ES026834, 5TL1TR001871-04]; Eastern Association for the Surgery of Trauma Research Scholarship; University of California San Francisco Irene Perstein Award; DoDUnited States Department of Defense [W911QY-15-C-0044]; University of California San Francisco Program for Breakthrough Biomedical Research Award; National Center for Advancing Translational Sciences of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [5TL1TR001871-04]	L.Z.K. is supported by NIH 1K23GM130892-01, Eastern Association for the Surgery of Trauma Research Scholarship, and University of California San Francisco Irene Perstein Award. R.A.C. is supported by NIH K01ES026834 and DoD W911QY-15-C-0044. M.J.C. is supported by DoD W911QY-15-C-0044 and NIH UM1HL120877. C.M.V.B. is supported by a University of California San Francisco Program for Breakthrough Biomedical Research Award. A.P. is supported by NIH K08GM110497. Z.A.M. is supported by The National Center for Advancing Translational Sciences of the NIH award 5TL1TR001871-04.	Amisten S, 2008, THROMB RES, V122, P47, DOI 10.1016/j.thromres.2007.08.014; Bray PF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-1; Brogren H, 2004, BLOOD, V104, P3943, DOI 10.1182/blood-2004-04-1439; Callcut RA, 2019, J TRAUMA ACUTE CARE, V86, P864, DOI 10.1097/TA.0000000000002205; Cannon JW, 2018, NEW ENGL J MED, V378, P1852, DOI 10.1056/NEJMc1802361; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Ding N, 2014, CIRC-CARDIOVASC GENE, V7, P615, DOI 10.1161/CIRCGENETICS.113.000398; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; DUNN EL, 1981, ARCH SURG-CHICAGO, V116, P1082; Englert JA, 2019, RESP RES, V20, DOI 10.1186/s12931-019-0981-6; Fehr M, 2008, CLIN HEMORHEOL MICRO, V39, P351, DOI 10.3233/CH-2008-1102; Gidlof O, 2013, BLOOD, V121, P3908, DOI 10.1182/blood-2012-10-461798; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Katona E, 2014, BLOOD, V123, P1757, DOI 10.1182/blood-2013-10-533596; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Kornblith LZ, 2018, J TRAUMA ACUTE CARE, V85, P873, DOI 10.1097/TA.0000000000002025; Kornblith LZ, 2014, J TRAUMA ACUTE CARE, V76, P255, DOI 10.1097/TA.0000000000000108; Kral JB, 2016, TRANSFUS MED HEMOTH, V43, P78, DOI 10.1159/000444807; Kutcher ME, 2014, ANN SURG, V260, P1103, DOI 10.1097/SLA.0000000000000366; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Li RZ, 2016, J TRAUMA ACUTE CARE, V80, P440, DOI 10.1097/TA.0000000000000915; Liu L, 2017, ALCOHOL CLIN EXP RES, V41, P291, DOI 10.1111/acer.13295; McGhan LJ, 2012, INJURY, V43, P129, DOI 10.1016/j.injury.2011.05.032; Nachman RL, 2008, NEW ENGL J MED, V359, P1261, DOI 10.1056/NEJMra0800887; Nassa G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18985-5; POON MC, 1989, J CLIN INVEST, V84, P787, DOI 10.1172/JCI114237; RADEK JT, 1993, BIOCHEMISTRY-US, V32, P3527, DOI 10.1021/bi00065a002; Ribizzi G, 2015, NEUROL SCI, V36, P1933, DOI 10.1007/s10072-015-2284-0; Rondina MT, 2015, J THROMB HAEMOST, V13, pS26, DOI 10.1111/jth.12965; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; Sirajuddin S, 2016, J TRAUMA ACUTE CARE, V81, P328, DOI 10.1097/TA.0000000000001057; Sol N, 2017, CANCER METAST REV, V36, P263, DOI 10.1007/s10555-017-9674-0; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Tran JQD, 2020, PLATELETS, V31, P365, DOI 10.1080/09537104.2019.1636019; Verni CC, 2019, J TRAUMA ACUTE CARE, V86, P250, DOI 10.1097/TA.0000000000002140; Vieira-de-Abreu A, 2012, SEMIN IMMUNOPATHOL, V34, P5, DOI 10.1007/s00281-011-0286-4; Vulliamy P, 2019, P NATL ACAD SCI USA, V116, P17444, DOI 10.1073/pnas.1904978116; WARSHAW AL, 1967, J BIOL CHEM, V242, P2094; Weyrich AS, 2004, SEMIN THROMB HEMOST, V30, P491, DOI 10.1055/s-2004-833484; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	43	3	3	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2020	88	6					742	750		10.1097/TA.0000000000002681			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	NE5VY	WOS:000562670100020	32195992	Green Accepted			2022-02-06	
J	LaFrance, WC; Ho, WLN; Bhatla, A; Baird, G; Altalib, HH; Godleski, L				LaFrance, W. Curt, Jr.; Ho, Wing Lam Natalie; Bhatla, Alana; Baird, Grayson; Altalib, Hamada Hamid; Godleski, Linda			Examination of Potential Differences in Reporting of Sensitive Psychosocial Measures via Diagnostic Evaluation Using Computer Video Telehealth	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							PSYCHOGENIC NONEPILEPTIC SEIZURES; FACE-TO-FACE; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; PRIMARY-CARE; MILITARY PERSONNEL; HEALTH; TELEPSYCHIATRY; VETERANS; DEPRESSION	Objective: The authors compared baseline characteristics and reporting of psychosocial measures among veterans with seizures who were evaluated in-clinic or remotely via computer video telehealth (CVT). It was hypothesized that the CVT group would report less trauma history, drug use, and comorbid symptoms compared with veterans seen in-clinic. Methods: A cross-sectional design was used to compare 72 veterans diagnosed with psychogenic nonepileptic seizures (PNES) or concurrent mixed epilepsy and PNES who were consecutively evaluated by a single clinician at the Providence Veterans Affairs Medical Center (PVAMC) Neuropsychiatric Clinic. In-clinic evaluations of veterans were performed at the PVAMC Neuropsychiatric Clinic (N=16), and remote evaluations of veterans referred to the VA National TeleMental Health Center were performed via CVT (N=56). All 72 patients were given comprehensive neuropsychiatric evaluations by direct interview, medical examination, and medical record review. Veterans' reporting of trauma and abuse history, drug use, and psychiatric comorbidities was assessed, along with neurologic and psychiatric variables. Results: No significant differences were found between veterans evaluated in-clinic or remotely with regard to baseline characteristics and reporting of potentially sensitive information, including trauma and abuse history, substance use, and comorbid symptoms. Conclusions: Veterans with PNES evaluated via telehealth did not appear to withhold sensitive or personal information compared with those evaluated in-clinic, suggesting that CVT may be a comparable alternative for conducting evaluations. Baseline evaluations are used to determine treatment suitability, and telehealth allows clinicians to gain access to important information that may improve or inform care.	[LaFrance, W. Curt, Jr.; Ho, Wing Lam Natalie; Bhatla, Alana] Brown Univ, Providence Vet Affairs Med Ctr PVAMC, Dept Psychiat, Providence, RI 02912 USA; [LaFrance, W. Curt, Jr.; Ho, Wing Lam Natalie; Bhatla, Alana] Brown Univ, Dept Neurol, Providence, RI 02912 USA; [LaFrance, W. Curt, Jr.; Ho, Wing Lam Natalie; Bhatla, Alana] Brown Univ, Dept Psychiat, Providence, RI 02912 USA; [LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Div Neuropsychiat, Providence, RI 02903 USA; [Baird, Grayson] Rhode Isl Hosp, Div Biostat, Providence, RI USA; [Altalib, Hamada Hamid] Yale Univ, Dept Neurol, New Haven, CT USA; [Altalib, Hamada Hamid] West Haven Vet Affairs Med Ctr, Dept Neurol, West Haven, CT USA; [Godleski, Linda] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Godleski, Linda] West Haven Vet Affairs Med Ctr, Dept Psychiat, West Haven, CT USA		LaFrance, WC (corresponding author), Brown Univ, Providence Vet Affairs Med Ctr PVAMC, Dept Psychiat, Providence, RI 02912 USA.; LaFrance, WC (corresponding author), Brown Univ, Dept Neurol, Providence, RI 02912 USA.; LaFrance, WC (corresponding author), Brown Univ, Dept Psychiat, Providence, RI 02912 USA.; LaFrance, WC (corresponding author), Rhode Isl Hosp, Div Neuropsychiat, Providence, RI 02903 USA.	william_lafrance_jr@brown.edu	LaFrance, W Curt/AAN-6707-2021	LaFrance, W Curt/0000-0002-4901-3852	Providence VA Center for Neurorestoration and Neurotechnology; Siravo Foundation; PVAMC	Supported by the Providence VA Center for Neurorestoration and Neurotechnology and a Siravo Foundation grant (to Dr. LaFrance).; This study is the result of work supported with resources and use of facilities at PVAMC.	Baird GL, 2017, EPILEPSY BEHAV, V73, P142, DOI 10.1016/j.yebeh.2017.04.040; Bashshur RL, 2009, TELEMED J E-HEALTH, V15, P600, DOI 10.1089/tmj.2009.9960; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bouchard S, 2004, TELEMED J E-HEALTH, V10, P13, DOI 10.1089/153056204773644535; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bugge C, 2006, SOC SCI MED, V63, P2065, DOI 10.1016/j.socscimed.2006.05.010; Chakrabarti S, 2015, WORLD J PSYCHIATR, V5, P286, DOI 10.5498/wjp.v5.i3.286; Day SX, 2002, J COUNS PSYCHOL, V49, P499, DOI 10.1037/0022-0167.49.4.499; Deen TL, 2012, PSYCHIAT SERV, V63, P1131, DOI 10.1176/appi.ps.201100458; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; Engel CC, 2016, JAMA INTERN MED, V176, P948, DOI 10.1001/jamainternmed.2016.2402; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franklin CL, 2017, J TRAUMA DISSOCIATIO, V18, P116, DOI 10.1080/15299732.2016.1205704; Friedman JH, 2010, ARCH NEUROL-CHICAGO, V67, P753, DOI 10.1001/archneurol.2010.91; Frueh BC, 2007, J TELEMED TELECARE, V13, P142, DOI 10.1258/135763307780677604; Hilty Donald M, 2007, Psychiatry (Edgmont), V4, P58; Hubley S, 2016, WORLD J PSYCHIATR, V6, P269, DOI 10.5498/wjp.v6.i2.269; Kirkwood KT, 2000, J TELEMED TELECARE, V6, P147, DOI 10.1258/1357633001935239; LaFrance WC, 2010, NEUROLOGY, V75, P1285, DOI 10.1212/WNL.0b013e3181f612bb; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; LaFrance WC, 2011, EPILEPSIA, V52, P292, DOI 10.1111/j.1528-1167.2010.02765.x; LaFrance WC, 2009, NEUROLOGY, V73, P366, DOI 10.1212/WNL.0b013e3181b04c83; Luxton DD, 2016, J CONSULT CLIN PSYCH, V84, P923, DOI 10.1037/ccp0000135; Maieritsch KP, 2016, J TELEMED TELECARE, V22, P238, DOI 10.1177/1357633X15596109; Oto M, 2005, J NEUROL NEUROSUR PS, V76, P1682, DOI 10.1136/jnnp.2005.064063; Reilly RO, 2007, PSYCHIAT SERV, V58, P836; Reuber M, 2002, NEUROLOGY, V58, P493, DOI 10.1212/WNL.58.3.493; Ruskin PE, 1998, PSYCHIATR SERV, V49, P1086, DOI 10.1176/ps.49.8.1086; Salinsky M, 2018, EPILEPSIA, V59, P1945, DOI 10.1111/epi.14542; Salinsky M, 2016, EPILEPSY BEHAV, V60, P107, DOI 10.1016/j.yebeh.2016.04.007; Salinsky M, 2015, J HEAD TRAUMA REHAB, V30, pE65, DOI 10.1097/HTR.0000000000000057; Salinsky M, 2012, EPILEPSY BEHAV, V25, P345, DOI 10.1016/j.yebeh.2012.07.013; Salinsky M, 2011, NEUROLOGY, V77, P945, DOI 10.1212/WNL.0b013e31822cfc46; Sankar P, 2005, ARCH INTERN MED, V165, P2378, DOI 10.1001/archinte.165.20.2378; Shore JH, 2007, GEN HOSP PSYCHIAT, V29, P199, DOI 10.1016/j.genhosppsych.2007.01.013; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Tolchin B, 2016, EPILEPSY BEHAV, V64, P26, DOI 10.1016/j.yebeh.2016.09.016; Turner TH, 2012, TELEMED E-HEALTH, V18, P662, DOI 10.1089/tmj.2011.0272; VA Epilepsy Centers of Excellence, 2016, Fed Pract, V33, P26; Vickrey BG, 1993, QUALITY LIFE EPILEPS, P1; WALLSTON BS, 1976, J CONSULT CLIN PSYCH, V44, P580, DOI 10.1037/0022-006X.44.4.580; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	47	3	3	2	6	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2020	32	3					294	301		10.1176/appi.neuropsych.19080177			8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	MV7XN	WOS:000556565800089	32054400				2022-02-06	
J	Lee, H; Lee, S; Black, I; Salado, L; Estrada, J; Isla, K				Lee, Hyunhwa; Lee, Sungchul; Black, Ipuna; Salado, Laura; Estrada, Jonica; Isla, Katrina			Long-Term Impact of Mild Traumatic Brain Injuries on Multiple Functional Outcomes and Epigenetics: A Pilot Study with College Students	APPLIED SCIENCES-BASEL			English	Article						mild traumatic brain injury; mTBI; concussion; cognitive; sensorimotor; visual; postural balance; methylation; 5-mC%; blood	HEAD-INJURY; CONCUSSION; BIOMARKERS; MANAGEMENT; EXPERIENCES; COGNITION; MILITARY; ISSUES; ADULTS	Featured Application N/A. People who suffer a mild traumatic brain injury (mTBI) have heterogeneous symptoms and disease trajectories, which make it difficult to precisely assess long-term complications. This pilot study assessed and compared deficits in cognitive, psychosocial, visual functions, and balance performance between college students with and without histories of mTBI. Global DNA methylation ratio (5-mC%) in blood was also compared as a peripheral epigenetic marker. Twenty-five volunteers participated, including 14 healthy controls (64.3% females; mean age of 22.0) and 11 mTBI cases (27.3% females; mean age of 28.7 years) who self-reported mTBI history (63.6% multiple; 2.5 +/- 1.29 injuries) with 7.1 years on average elapsed following the last injury. Every participant was assessed for cognitive (executive function, memory, and processing speed), psychological (depression, anxiety, and sleep disturbances), and visual function (by King-Devick and binocular accommodative tests); force-plate postural balance performance; and blood 5-mC% levels. Students with mTBI showed poorer episodic memory, severe anxiety, and higher blood 5-mC% ratio, compared to controls (allp's < 0.05), which were still significant after adjusting for age. No differences were detected in sleep problems (after adjusting for age), visual function, and postural balance. These findings identified changes in multiple functions and peripheral epigenetics long after mTBI.	[Lee, Hyunhwa; Isla, Katrina] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA; [Lee, Sungchul] Grand Valley State Univ, Sch Comp & Informat Syst, Allendale, MI 49401 USA; [Black, Ipuna] Nevada State Coll, Sch Nursing, Henderson, NV 89002 USA; [Salado, Laura] Faiss Middle Sch, Safe Sch Profess, Las Vegas, NV 89148 USA; [Estrada, Jonica] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA		Lee, H (corresponding author), Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA.	hyunhwa.lee@unlv.edu; leesung@gvsu.edu; ipuna.black@nsc.edu; Saladlc@nv.ccsd.net; jonicaestrada@gmail.com; katrinakeiko@gmail.com		Lee, Hyunhwa/0000-0002-5625-3141	School of Nursing of the University of Nevada, Las Vegas (UNLV)	This research was funded by the School of Nursing of the University of Nevada, Las Vegas (UNLV).	[Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Barter JD, 2018, NEUROSCIENTIST, V24, P516, DOI 10.1177/1073858418780971; Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Bellizzi D, 2012, AGE, V34, P169, DOI 10.1007/s11357-011-9216-6; Bennett E.R., 2016, TRANSLATIONAL RES TR; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bryson CN, 2017, DEATH STUD, V41, P399, DOI 10.1080/07481187.2017.1320340; Carulli LA, 2018, J REHABIL, V84, P29; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Childers C, 2016, J POSTSECOND EDUC DI, V29, P389; Chouliaras L, 2018, EPIGENOMICS-UK, V10, P585, DOI 10.2217/epi-2017-0132; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gill J, 2014, PSYCHIAT RES, V216, P116, DOI 10.1016/j.psychres.2014.01.046; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Jung M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0118-4; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee H., 2018, P 2018 AS AM PAC ISL; Lee Hyunhwa, 2018, Asian Pac Isl Nurs J, V3, P177, DOI 10.31372/20180304.1027; Lee H, 2017, BIOL RES NURS, V19, P229, DOI 10.1177/1099800416689822; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; PROMIS Network, PROMIS DYN TOOLS MEA; Sanchez-Mut JV, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.214; SANTOS M. E. T, 2017, THESIS; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Thastum MM, 2018, NEUROREHABILITATION, V43, P155, DOI 10.3233/NRE-172391; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Thompson C., 2016, P INT BRAIN INJ ASS; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; U.S. Food and Drug Administration, PROD CLASS BRAIN INJ; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Villela D, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2584940; VOELKER R, 2019, JAMA-J AM MED ASSOC, V321, P638, DOI DOI 10.1001/jama.2019.0509; Vosa L, 2019, BRAIN INJURY, V33, P1165, DOI 10.1080/02699052.2019.1637024; Wammes JD, 2017, BRAIN COGNITION, V111, P112, DOI 10.1016/j.bandc.2016.11.004; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wen KX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167201; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	74	3	3	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	JUN	2020	10	12							4131	10.3390/app10124131			13	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Chemistry; Engineering; Materials Science; Physics	ML5QP	WOS:000549520800001		gold			2022-02-06	
J	Narayan, SW; Castelino, R; Hammond, N; Patanwala, AE				Narayan, Sujita W.; Castelino, Ronald; Hammond, Naomi; Patanwala, Asad E.			Effect of mannitol plus hypertonic saline combination versus hypertonic saline monotherapy on acute kidney injury after traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						(MeSH): Hypertonic saline; Mannitol; Traumatic brain injury; Acute kidney injury	RENAL BLOOD-FLOW; INTRACRANIAL-PRESSURE; RISK-FACTOR; GUIDELINES; HEMORRHAGE; CHLORIDE	Purpose: To compare the effect of mannitol plus hypertonic saline combination (MHS) versus hypertonic saline monotherapy (HS) on renal function in patients with traumatic brain injury (TBI). Materials and methods: This was a secondary analysis of data from the Resuscitation Outcomes Consortium Hypertonic Saline Trial Shock Study and Traumatic Brain Injury Study. The study cohort included a propensity matched subset of patientswith TBIwho receivedMHS or HS. The primary outcome measurewas themaximum serum creatinine value during critical illness. Results: The cohort consisted of 163 patients in the MHS group and 163 patients in the HS group (n = 326). The maximum serum creatinine value during hospitalization was 82 +/- 47 mu mol/L (0.86 +/- 0.26 mg/dL) in the MHS group and 76 +/- 23 mu mol/L (0.92 +/- 0.53 mg/dL) in the HS group (difference -6 mu mol/L, 95% CI -14 to 2 mu mol/L, p =.151). The lowest eGFR during hospitalization was 108 +/- 25 mL/ min in the MHS group and 112 +/- 24 mL/min in the HS group (difference -4 mL/min, 95% CI -1 to 9 mLmin, p =.150). Conclusions: The addition ofmannitol toHS did not increase the risk of renal dysfunction compared to HS alone in patients with TBI. (c) 2020 Elsevier Inc. All rights reserved.	[Narayan, Sujita W.; Patanwala, Asad E.] Univ Sydney, Sch Pharm, Fac Med & Hlth, Sydney, NSW, Australia; [Castelino, Ronald] Univ Sydney, Sch Nursing, Fac Med & Hlth, Sydney, NSW, Australia; [Castelino, Ronald] Blacktown Hosp, Dept Pharm, Blacktown, NSW, Australia; [Hammond, Naomi] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Patanwala, Asad E.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Hammond, Naomi] Royal North Shore Hosp, Malcolm Fisher Dept Intens Care, St Leonards, NSW, Australia		Patanwala, AE (corresponding author), Univ Sydney, Sch Pharm, A15,Sci Rd, Camperdown, NSW 2006, Australia.	sujita.narayan@sydney.edu.au; ronald.castelino@sydney.edu.au; nhammond@georgeinstitute.org.au; asad.patanwala@sydney.edu.au					Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; B. Braun Medical Inc, 2019, MANN INJ PACK INS BE; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Boone Myles Dustin, 2015, Surg Neurol Int, V6, P177, DOI 10.4103/2152-7806.170248; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Bratton S, 2007, J NEUROTRAUM, V24, P14; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chowdhury AH, 2012, ANN SURG, V256, P18, DOI 10.1097/SLA.0b013e318256be72; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Eriksson M, 2015, J TRAUMA ACUTE CARE, V79, P407, DOI 10.1097/TA.0000000000000727; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; GERBER JG, 1979, AM J PHYSIOL, V237, pF441, DOI 10.1152/ajprenal.1979.237.6.F441; Gu JJ, 2019, NEUROSURG REV, V42, P499, DOI 10.1007/s10143-018-0991-8; Hays AN, 2011, NEUROCRIT CARE, V14, P222, DOI 10.1007/s12028-010-9477-4; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kim MY, 2014, J NEUROSURG, V120, P1340, DOI 10.3171/2013.12.JNS13888; Kumar AB, 2015, NEUROCRIT CARE, V22, P184, DOI 10.1007/s12028-014-0067-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin SY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002032; Mangat HS, 2020, NEUROSURGERY, V86, P221, DOI 10.1093/neuros/nyz046; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Oddo M, 2018, INTENS CARE MED, V44, P449, DOI 10.1007/s00134-018-5086-z; Rein JL, 2019, AM J PHYSIOL-RENAL, V316, pF587, DOI 10.1152/ajprenal.00130.2018; Schwimmbeck F, 2021, J NEUROSURG ANESTH, V33, P10, DOI 10.1097/ANA.0000000000000644; Suetrong B, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1499-7; U.S. National Institutes of Health National Heart L Blood Institute, BIOL SPEC DAT REP IN; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Witherspoon B, 2017, NURS CLIN N AM, V52, P249, DOI 10.1016/j.cnur.2017.01.002; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; Zeng JS, 2013, J NEUROSURG, V119, P1228, DOI 10.3171/2013.7.JNS122131	34	3	3	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	JUN	2020	57						220	224		10.1016/j.jcrc.2020.03.006			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS6NT	WOS:000536499000032	32220771				2022-02-06	
J	Rossini, Z; Franzini, A; Zaed, I; Zingaretti, N; Nicolosi, F; Zanotti, B				Rossini, Zefferino; Franzini, Andrea; Zaed, Ismail; Zingaretti, Nicola; Nicolosi, Federico; Zanotti, Bruno			Custom -Made Porous Hydroxyapatite Cranioplasty in Patients with Tumor Versus Traumatic Brain Injury: A Single -Center Case Series	WORLD NEUROSURGERY			English	Article							DECOMPRESSIVE CRANIECTOMY; SKULL BASE; IMPLANTS; TITANIUM; RECONSTRUCTION; MULTICENTER; COMPLEX; CEMENT		[Rossini, Zefferino; Franzini, Andrea; Zaed, Ismail; Nicolosi, Federico] Humanitas Clin & Res Ctr IRCCS, Dept Neurosurg, Rozzano, MI, Italy; [Zingaretti, Nicola] Azienda Osped Univ S Maria della Misericordia, Dept Plast Reconstruct Surg, Udine, Italy; [Zanotti, Bruno] Osped Carlo Poma, Dept Neurosurg, Mantua, Italy		Rossini, Z (corresponding author), Humanitas Clin & Res Ctr IRCCS, Dept Neurosurg, Rozzano, MI, Italy.	zefferino.rossini@humanitas.it	Rossini, Zefferino/AAW-5420-2021	Franzini, Andrea/0000-0002-2031-4547; zaed, ismail/0000-0003-3506-4111			Abe T, 2009, ACTA NEUROCHIR, V151, P1337, DOI 10.1007/s00701-009-0392-4; Arana E, 1999, INVEST RADIOL, V34, P636, DOI 10.1097/00004424-199910000-00005; Aydin S, 2011, J NEUROSCI RURAL PRA, V2, P162, DOI 10.4103/0976-3147.83584; Bjornson A, 2019, ACTA NEUROCHIR, V161, P467, DOI 10.1007/s00701-019-03820-9; Bruneau M, 2015, OPER NEUROSURG, V11, P484, DOI 10.1227/NEU.0000000000000971; Chaskis E, 2019, WORLD NEUROSURG, V124, P298, DOI 10.1016/j.wneu.2019.01.035; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Chistolini P, 1999, J MATER SCI-MATER M, V10, P739, DOI 10.1023/A:1008939524807; Corallo F, 2017, INT J NEUROSCI, V127, P688, DOI 10.1080/00207454.2016.1235045; Della Puppa A, 2010, ACTA NEUROCHIR, V152, P155, DOI 10.1007/s00701-009-0374-6; Foster KA, 2016, WORLD NEUROSURG, V95, P414, DOI 10.1016/j.wneu.2016.02.071; Frassanito P, 2013, J NEUROSURG-PEDIATR, V12, P633, DOI 10.3171/2013.9.PEDS13356; Fricia M, 2019, WORLD NEUROSURG, V121, P160, DOI 10.1016/j.wneu.2018.09.199; Hadley C, 2014, J NEUROSURG-PEDIATR, V13, P380, DOI 10.3171/2013.12.PEDS13359; Hatamleh MM, 2013, J CRANIOFAC SURG, V24, P2018, DOI 10.1097/SCS.0b013e3182a41bcc; Honeybul S, 2017, J CLIN NEUROSCI, V43, P11, DOI 10.1016/j.jocn.2017.04.032; Iaccarino C, 2018, J NEUROSURG SCI, V62, P765, DOI 10.23736/S0390-5616.16.03721-8; Kakkar A, 2016, J NEUROL SURG PART B, V77, P319, DOI 10.1055/s-0035-1570347; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kwan K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00876; Lethaus B, 2012, J NEUROTRAUM, V29, P1077, DOI 10.1089/neu.2011.1794; Lindner D, 2017, J NEUROSURG, V126, P175, DOI 10.3171/2015.10.JNS151245; Matsuura H, 2002, J NEUROSURG, V97, P1472, DOI 10.3171/jns.2002.97.6.1472; Mitsuya K, 2011, J NEURO-ONCOL, V104, P239, DOI 10.1007/s11060-010-0465-5; Morselli C, 2019, J NEUROSURG SCI, V63, P723, DOI 10.23736/S0390-5616.19.04779-9; Ono I, 1999, PLAST RECONSTR SURG, V104, P339, DOI 10.1097/00006534-199908000-00003; Pompili A, 1998, J NEUROSURG, V89, P236, DOI 10.3171/jns.1998.89.2.0236; Raza SM, 2020, NEUROSURGERY, V86, pE23, DOI 10.1093/neuros/nyz360; Rossini Z, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00458; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; Spetzger U, 2010, MINIM INVASIV THER, V19, P110, DOI 10.3109/13645701003644087; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Stefini R, 2015, J APPL BIOMATER FUNC, V13, pE136, DOI 10.5301/jabfm.5000211; Stefini Roberto, 2013, Surg Neurol Int, V4, P12, DOI 10.4103/2152-7806.106290; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wiggins A, 2013, NEUROSURGERY, V72, P248, DOI 10.1227/NEU.0b013e31827b98f3; Wind JJ, 2013, WORLD NEUROSURG, V79, DOI 10.1016/j.wneu.2011.02.013; Wong RK, 2011, J CRANIOFAC SURG, V22, P247, DOI 10.1097/SCS.0b013e3181f7b7db; Zanotti B, 2010, CRANIAL DEMOLITION R; Zanotti B, 2016, J CRANIOFAC SURG, V27, P2061, DOI 10.1097/SCS.0000000000003025; Zanotti B, 2015, ACTA NEUROCHIR, V157, P517, DOI 10.1007/s00701-014-2319-y	41	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2020	138						E922	E929		10.1016/j.wNEu.2020.03.144			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LY7RI	WOS:000540724700029	32272268				2022-02-06	
J	Smith, KA; Hiyoshi, A; Burkill, S; Bahmanyar, S; Ockinger, J; Alfredsson, L; Olsson, T; Montgomery, S				Smith, Kelsi A.; Hiyoshi, Ayako; Burkill, Sarah; Bahmanyar, Shahram; Ockinger, Johan; Alfredsson, Lars; Olsson, Tomas; Montgomery, Scott			Hospital diagnosed pneumonia before age 20 years and multiple sclerosis risk	BMJ NEUROLOGY OPEN			English	Article						multiple sclerosis; neuroepidemiology; respiratory medicine; renal medicine; infectious diseases	LYMPHOID-TISSUE BALT; STREPTOCOCCUS-PNEUMONIAE; T-CELLS; LUNG; INFECTIONS; CHILDHOOD; ADOLESCENCE; CONCUSSION; ADMISSION; CHILDREN	Introduction Respiratory inflammation has been proposed as a risk factor for MS. This study aims to determine if hospital-diagnosed pneumonia in adolescence (before age 20 years) is associated with subsequent multiple sclerosis (MS). Methods This case-control study included incident MS cases after age 20 years identified using the Swedish national registers. Cases were matched with 10 general population controls by age, sex and region. Pneumonia diagnoses were identified between 0-5, 6-10, 11-15 and 16-20 years of age. Conditional logistic regression models adjusted for infectious mononucleosis (IM) and education calculated ORs with 95% CIs. Urinary tract infections (UTIs), a common complication of MS, before age 20 years were included as a control diagnosis for reverse causation. Results There were 6109 cases and 49 479 controls included. Pneumonia diagnosed between age 11-15 years was associated with subsequent MS (adj OR 2.00, 95% CI 1.22 to 3.27). Although not statistically significant, sensitivity analyses showed similar magnitude associations of pneumonia between age 11-15 years and MS. No statistically significant associations with MS for pneumonia at other age groups were observed. Adjustment for IM had no notable effect on associations, but was statistically significantly associated with MS. UTIs were not associated with MS. Conclusion Pneumonia at 11-15 years of age was associated with MS, suggesting a possible role for inflammation of the respiratory system in the aetiology of MS during a period of susceptibility in adolescence. Further research on respiratory infections prior to MS onset should be conducted to replicate this finding and determine explanatory causal mechanisms.	[Smith, Kelsi A.; Ockinger, Johan; Montgomery, Scott] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Smith, Kelsi A.; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Hiyoshi, Ayako; Montgomery, Scott] Orebro Univ, Clin Epidemiol & Biostat, Campus USO, Orebro, Sweden; [Hiyoshi, Ayako] Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden; [Burkill, Sarah; Bahmanyar, Shahram] Karolinska Inst, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Burkill, Sarah] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Bahmanyar, Shahram] Karolinska Inst, Ctr Psychiat Res, Stockholm, Sweden; [Ockinger, Johan] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Alfredsson, Lars] Ctr Occupat & Environm Med, Stockholm, Sweden; [Olsson, Tomas] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden		Smith, KA (corresponding author), Karolinska Inst, Dept Med Solna, Stockholm, Sweden.; Smith, KA (corresponding author), Karolinska Inst, Inst Environm Med, Stockholm, Sweden.	kelsi.smith@ki.se	Smith, Kelsi A/AAT-1959-2020	Smith, Kelsi A/0000-0002-9811-908X; Olsson, Tomas/0000-0002-2938-1877; Hiyoshi, Ayako/0000-0002-2088-0530	F. Hoffmann-La RocheHoffmann-La Roche [ZZK2PERAPP]; Novartis Pharma [ZZK2PERAPP]; Nyckelfonden [266331]	This study was funded by F. Hoffmann--La Roche (ZZK2PERAPP), Novartis Pharma (ZZK2PERAPP), Nyckelfonden (266331).	Bagos PG, 2006, MULT SCLER J, V12, P397, DOI 10.1191/1352458506ms1291oa; Bahmanyar S, 2009, NEUROLOGY, V72, P1170, DOI 10.1212/01.wnl.0000345366.10455.62; Bergh C, 2017, EUR J PREV CARDIOL, V24, P1958, DOI 10.1177/2047487317724009; Bhuiyan MU, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020646; Bjornevik K, 2016, MULT SCLER J, V22, P104, DOI 10.1177/1352458515579444; Blakemore SJ, 2010, HUM BRAIN MAPP, V31, P926, DOI 10.1002/hbm.21052; Buljevac D, 2002, BRAIN, V125, P952, DOI 10.1093/brain/awf098; Chan JYC, 2015, PEDIATRICS, V135, P607, DOI 10.1542/peds.2014-3060; Cohen S, 2010, ANN NY ACAD SCI, V1186, P37, DOI 10.1111/j.1749-6632.2009.05334.x; Endriz J, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000308; Galli E, 2019, NAT MED, V25, P1290, DOI 10.1038/s41591-019-0521-4; Giovannoni G, 2016, MULT SCLER RELAT DIS, V7, P12, DOI 10.1016/j.msard.2016.02.010; HAMBLIN TJ, 1983, BRIT MED J, V287, P85, DOI 10.1136/bmj.287.6385.85; Hedstroem AK, 2016, MULT SCLER J, V22, P1021, DOI 10.1177/1352458515609794; Hedstrom AK, 2018, NEUROLOGY, V91, pE455, DOI 10.1212/WNL.0000000000005906; Hedstrom AK, 2014, INT J EPIDEMIOL, V43, P1791, DOI 10.1093/ije/dyu195; Heier I, 2011, THORAX, V66, P151, DOI 10.1136/thx.2010.149591; Hiller AS, 1998, SCAND J IMMUNOL, V47, P159; Hillert J, 2015, ACTA NEUROL SCAND, V132, P11, DOI 10.1111/ane.12425; Khundrakpam BS, 2016, NEUROIMAGE, V134, P192, DOI 10.1016/j.neuroimage.2016.03.062; Li WC, 2018, P NATL ACAD SCI USA, V115, pE7149, DOI 10.1073/pnas.1802261115; Lin CW, 2015, J NEUROTRAUM, V32, P655, DOI 10.1089/neu.2014.3723; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Marques JM, 2012, IMMUNOBIOLOGY, V217, P420, DOI 10.1016/j.imbio.2011.10.012; Mills KL, 2016, NEUROIMAGE, V141, P273, DOI 10.1016/j.neuroimage.2016.07.044; Montgomery S, 2013, EUR J NEUROL, V20, P1153, DOI 10.1111/ene.12130; Montgomery S, 2017, ANN NEUROL, V82, P652, DOI 10.1002/ana.25062; Montgomery S, 2017, ANN NEUROL, V82, P554, DOI 10.1002/ana.25036; Murley C, 2019, EUR J EPIDEMIOL, V34, P1161, DOI 10.1007/s10654-019-00558-7; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Public Health Agency of Sweden, VACC STAT PRIM HLTH; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Rosseau S, 2007, IMMUNOLOGY, V120, P380, DOI 10.1111/j.1365-2567.2006.02514.x; Shan M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranlsmed.3000154; Sundin PO, 2018, CLIN EPIDEMIOL, V10, P971, DOI 10.2147/CLEP.S169039; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Tsai PK, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/829706; Tschernig T, 2000, PATHOBIOLOGY, V68, P1, DOI 10.1159/000028109; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Wang Y, 2017, MUCOSAL IMMUNOL, V10, P250, DOI 10.1038/mi.2016.41; Whitaker KJ, 2016, P NATL ACAD SCI USA, V113, P9105, DOI 10.1073/pnas.1601745113; Wijnands JMA, 2018, MULT SCLER J, P1; Wijnands JMA, 2017, MULT SCLER J, V23, P1506, DOI 10.1177/1352458516681198	43	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2632-6140		BMJ NEUROL OPEN	BMJ Neurol Open	JUN	2020	2	1							e000044	10.1136/bmjno-2020-000044			10	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	SV3DA	WOS:000663701900003	33681783	gold, Green Published			2022-02-06	
J	Sutar, S; Ganpule, S				Sutar, Sunil; Ganpule, S.			Investigation of wave propagation through head layers with focus on understanding blast wave transmission	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Blast TBI; Wave propagation; Transmission mechanism; Head model; Helmet	POSSIBLE DAMAGE MECHANISM; BRAIN-INJURY; RAT; CAVITATION; MODEL; RESPONSES; EXPOSURE; LEADS	Blast-induced traumatic brain injury (bTBI) is a critical health concern. This issue is being addressed in terms of identifying a cause-effect relationship between the mechanical insult in the form of a blast and resulting injury to the brain. Understanding wave propagation through the head is an important aspect in this regard. The objective of this work was to study the blast wave propagation through the layered architecture of the head with an emphasis on understanding the wave transmission mechanism. Toward this end, one-dimensional (1D) finite element head model is built for a simplified surrogate, human, and rat. Motivated from experimental investigations, four different head layer configurations have been considered. These configurations are: (A) Skull-Brain, (B) Skin-Skull-Brain, (C) Skin-Skull-Dura-Arachnoid-CSF-Pia-Brain, (D) Skin-Skull-Dura-Arachnoid-AT-Pia-Brain. The validated head model is subjected to flattop and Friedlander loading implied in the blast, and the resulting response is evaluated in terms of brain pressures. Our results suggest that wave propagation through head parenchyma plays an important role in blast wave transmission. The thickness, material properties of head layers, and rise time of an input pulse govern the temporal evolution of pressure in the brain. The key findings of this work are: (a) Skin and meninges amplify the applied input pressure, whereas air sinus has an attenuation effect. (b) Model is able to describe experimentally recorded peak pressures and rise times in the brain, including variations within the aforementioned experimental head models of TBI. This reinforces that the wave transmission is an important loading pathway to the brain. (c) Equivalent layer theory for modeling meningeal layers as a single layer has been proposed, and it gives reasonable agreement with each meningeal layer modeled explicitly. This modeling approach has a great utility in 3D head models. The potential applications of 1D head model in evaluation of new helmet materials, brain sensor calibration, and brain pressure estimation for a given explosive strength have also been demonstrated. Overall, these results provide important insights into the understanding of mechanics of blast wave transmission in the head.	[Sutar, Sunil; Ganpule, S.] Indian Inst Technol Roorkee, Dept Mech & Ind Engn, Roorkee 247667, Uttar Pradesh, India		Ganpule, S (corresponding author), Indian Inst Technol Roorkee, Dept Mech & Ind Engn, Roorkee 247667, Uttar Pradesh, India.	shaileshfme@iitr.ac.in			Department of Science and technologyDepartment of Science & Technology (India) [ECR-2017-000417] Funding Source: Medline		Akula PK, 2013, J MED DEVICES, V7, DOI 10.1115/1.4024492; Bir C, 2011, W81XWH0910498 US ARM; BLANTON PL, 1969, AM J ANAT, V124, P135, DOI 10.1002/aja.1001240202; Bolander R, 2011, THESIS; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ganpule S, 2013, THESIS; Ganpule S., 2016, INT J EXP COMPUT BIO, V4, P13; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Garimella HT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190881; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Haniff S, 2017, SHOCK WAVES, V27, P929, DOI 10.1007/s00193-017-0765-1; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Kalra A, 2017, SHOCK WAVES, V27, P947, DOI 10.1007/s00193-017-0760-6; Kingery CN, 1984, 02555 BALL RES LAB; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Laury A, 2019, FRONTAL SINUS SURG, P411; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Lin YH, 2011, CMC-COMPUT MATER CON, V24, P15; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Meyers MA., 1994, DYNAMIC BEHAV MAT, V2nd ed.; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Nyein MK, 2013, THESIS; O'Higgins P, 2006, INT C SER, V1296, P55, DOI DOI 10.1016/J.ICS.2006.03.036; Ramesh K., 2008, HDB EXPT SOLID MECH, P929, DOI [10.1007/978-0-387-30877-7_33, DOI 10.1007/978-0-387-30877-7_33]; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Saboori P, 2011, THESIS; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Scott GG, 2016, BIOMECH MODEL MECHAN, V15, P1101, DOI 10.1007/s10237-015-0747-0; Sedberry K, 2018, FINAL REPORT US ARMY; Selvan V, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024132; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; SINGLETARY EM, 1990, AM J EMERG MED, V8, P329, DOI 10.1016/0735-6757(90)90088-H; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Slutzky MW, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026004; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Treuting P. M., 2017, COMP ANATOMY HISTOLO, V2; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518; Zhu Feng, 2010, Stapp Car Crash J, V54, P211; Zhuang SM, 2003, J MECH PHYS SOLIDS, V51, P245, DOI 10.1016/S0022-5096(02)00100-X	53	3	3	0	13	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	JUN	2020	19	3					875	892		10.1007/s10237-019-01256-9			18	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	LK5AX	WOS:000530879100008	31745681				2022-02-06	
J	Tsai, YC; Wu, SC; Hsieh, TM; Liu, HT; Huang, CY; Chou, SE; Su, WT; Hsu, SY; Hsieh, CH				Tsai, Yu-Chin; Wu, Shao-Chun; Hsieh, Ting-Min; Liu, Hang-Tsung; Huang, Chun-Ying; Chou, Sheng-En; Su, Wei-Ti; Hsu, Shiun-Yuan; Hsieh, Ching-Hua			Association of Stress-Induced Hyperglycemia and Diabetic Hyperglycemia with Mortality in Patients with Traumatic Brain Injury: Analysis of a Propensity Score-Matched Population	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						stress-induced hyperglycemia; diabetic hyperglycemia; traumatic brain injury; mortality	SURGICAL-SITE INFECTION; ADMISSION HYPERGLYCEMIA; GLUCOSE	Background:Hyperglycemia at the time of hospital admission is associated with higher morbidity and mortality rates in patients with traumatic brain injury (TBI). Using data from the Chang Gung Research Database (CGRD), this study aimed to compare mortality outcomes between patients with stress-induced hyperglycemia (SIH), diabetic hyperglycemia (DH), and nondiabetic normoglycemia (NDN). The study occurred at Keelung, Linkou, Chiayi, and Kaohsiung Chang Gung Memorial Hospitals (CGMHs).Methods:A total of 1166, 6318, 3622, and 5599 health records from Keelung, Linkou, Chiayi, and Kaohsiung CGMHs, respectively, were retrieved from the CGRD for hospitalized patients with TBI between January 2001 and December 2015. After propensity score matching for sex, age, and Glasgow Coma Scale (GCS) score, the matched cohorts were compared to evaluate differences in the primary outcome between patients with SIH, DH, and NDN. In-hospital mortality was the primary outcome.Results:The analysis of matched patient populations revealed that at the Kaohsiung CGMH, patients with SIH had 1.63-fold (95% CI: 1.09-2.44;p= 0.017) and 1.91-fold (95% CI: 1.12-3.23;p= 0.017) higher odds of mortality than patients with NDN and DH, respectively. Similar patterns were found at the Linkou CGMH; patients with SIH had higher odds of mortality than patients with NDN and DH. In contrast, at the Keelung CGMH, patients with SIH had significantly higher odds of mortality than those with NDN (OR: 3.25; 95% CI: 1.06-9.97;p= 0.039). At the Chiayi CGMH, there were no significant differences in mortality rates among all groups.Conclusions:This study's results suggest that SIH and DH differ in their effect on the outcomes of patients with TBI. The results were similar between medical centers but not nonmedical centers; in the medical centers, patients with SIH had significantly higher odds of mortality than patients with either NDN or DH.	[Tsai, Yu-Chin] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Coll Med, Kaohsiung 83301, Taiwan; [Wu, Shao-Chun] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Coll Med, Kaohsiung 83301, Taiwan; [Hsieh, Ting-Min; Liu, Hang-Tsung; Huang, Chun-Ying; Chou, Sheng-En; Su, Wei-Ti; Hsu, Shiun-Yuan] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Trauma Surg, Coll Med, Kaohsiung 83301, Taiwan; [Hsieh, Ching-Hua] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Coll Med, Kaohsiung 83301, Taiwan		Hsieh, CH (corresponding author), Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Coll Med, Kaohsiung 83301, Taiwan.	vagility@gmail.com; shaochunwu@gmail.com; hs168hs168@gmail.com; htl1688@yahoo.com.tw; junyinhaung@yahoo.com.tw; athenechou@gmail.com; s101132@adm.cgmh.org.tw; ah.lucy@hotmail.com; m93chinghua@gmail.com		WU, Shaochun/0000-0002-0984-6921; Hsieh, Ching-Hua/0000-0002-0945-2746	Chang Gung Memorial HospitalChang Gung Memorial Hospital [CDRPG8H0013]	This research was supported by a grant from the Chang Gung Memorial Hospital (CDRPG8H0013).	Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS62, DOI [10.2337/dc09-S062, 10.2337/dc11-S011, 10.2337/dc12-S064]; Bonizzoli M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-69; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Christiansen CF, 2013, CRIT CARE, V17, DOI 10.1186/cc12886; Hsieh CH, 2018, BIOMED J, V41, P321, DOI 10.1016/j.bj.2018.08.007; Hsieh CH, 2017, BIOMED J, V40, P113, DOI 10.1016/j.bj.2016.10.005; Hsieh CH, 2017, BIOMED J, V40, P121, DOI 10.1016/j.bj.2016.10.006; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC11, DOI 10.7860/JCDR/2016/17208.7686; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Leto R, 2015, EUR J EMERG MED, V22, P99, DOI 10.1097/MEJ.0000000000000119; Mraovic Boris, 2011, J Diabetes Sci Technol, V5, P412; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Prisco L, 2012, J NEUROSURG SCI, V56, P131; Rau CS, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010028; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111340; Richards JE, 2013, J ORTHOP TRAUMA, V27, P16, DOI 10.1097/BOT.0b013e31825d60e5; Richards JE, 2012, J BONE JOINT SURG AM, V94A, P1181, DOI 10.2106/JBJS.K.00193; Rostami Elham, 2011, J Diabetes Sci Technol, V5, P596; Shao SC, 2019, PHARMACOEPIDEM DR S, V28, P593, DOI 10.1002/pds.4713; Smit JWA, 2006, SEMIN CARDIOTHORAC V, V10, P215, DOI 10.1177/1089253206291153; Tsai MS, 2017, BIOMED J, V40, P263, DOI 10.1016/j.bj.2017.08.002; Tsai MS, 2016, PEERJ, V4, DOI 10.7717/peerj.2794	24	3	3	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JUN	2020	17	12							4266	10.3390/ijerph17124266			11	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	ML6FW	WOS:000549560500001	32549265	Green Published, gold			2022-02-06	
J	Bratt, M; Moen, KG; Nordgard, S; Helvik, AS; Skandsen, T				Bratt, Mette; Moen, Kent G.; Nordgard, Stale; Helvik, Anne-S.; Skandsen, Toril			Treatment of posttraumatic olfactory dysfunction with corticosteroids and olfactory training	ACTA OTO-LARYNGOLOGICA			English	Article						Anosmia; glucocorticosteroids; hyposmia; olfaction disorders; olfactory training	ODOR DISCRIMINATION; IDENTIFICATION; THRESHOLD; TESTS; MILD	Background:Few have investigated long-term effect of treatment of posttraumatic olfactory dysfunction (OD). Aims/objectives:To explore if sequential treatment with corticosteroids and olfactory training (OT) improved smell in patients with OD after moderate and severe traumatic brain injury (TBI). Material and methods:Twenty-two patients with persistent OD, mean 62 months after trauma, completed an open uncontrolled intervention study of treatment for 10 d with oral corticosteroids and thereafter for 3 months with OT twice daily. Olfaction was assessed by Sniffin' Sticks. They were tested at four-time points, with the last assessment 12 months after baseline measurements. Results:Mean age at trauma was 45 (SD 14) years. Mean threshold, discrimination and identification (TDI) score at baseline was 14.4 (SD 7.3) and increased to mean 20.8 (SD 7.4) after 1 year (minimum -3.0; maximum 19.5,pvalue <.001). Analysed separately, each TDI component increased significantly after 1 year. Half of the patients (11/22) experienced a clinically significant improvement of >= 6.0 TDI points. Improvement was not associated with any sociodemographic or trauma-related characteristics or with olfactory function at baseline. Conclusions and significance:Treatment with corticosteroids and OT was promising in persistent OD after TBI and should be further studied.	[Bratt, Mette; Nordgard, Stale; Helvik, Anne-S.] Univ Trondheim Hosp, St Olavs Hosp, Dept Otorhinolaryngol, Trondheim, Norway; [Bratt, Mette; Moen, Kent G.; Nordgard, Stale; Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci MH, Dept Neuromed & Movement Sci, Trondheim, Norway; [Moen, Kent G.] Nord Trondelag Hosp Trust, Levanger Hosp, Dept Radiol, Levanger, Norway; [Helvik, Anne-S.] NTNU, Fac MH, Gen Practice Res Unit, Dept Publ Hlth & Nursing, Trondheim, Norway; [Skandsen, Toril] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway		Skandsen, T (corresponding author), NTNU, Dept Neuromed & Movement Sci, Fac Med & Hlth Sci, N-7491 Trondheim, Norway.	toril.skandsen@ntnu.no					Bratt M, 2018, BRAIN INJURY, V32, P1021, DOI 10.1080/02699052.2018.1469043; Gudziol V, 2006, LARYNGOSCOPE, V116, P1858, DOI 10.1097/01.mlg.0000234915.51189.cb; Howell Jessica, 2018, World J Otorhinolaryngol Head Neck Surg, V4, P39, DOI 10.1016/j.wjorl.2018.02.001; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; Ikeda K, 1995, TOHOKU J EXP MED, V177, P343, DOI 10.1620/tjem.177.343; Jiang RS, 2019, INT FORUM ALLERGY RH, V9, P1244, DOI 10.1002/alr.22409; Jiang RS, 2017, AM J RHINOL ALLERGY, V31, P317, DOI 10.2500/ajra.2017.31.4466; Jiang RS, 2010, EUR ARCH OTO-RHINO-L, V267, P1563, DOI 10.1007/s00405-010-1240-0; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Kobayashi M, 2009, CHEM SENSES, V34, P573, DOI 10.1093/chemse/bjp038; Kollndorfer K, 2015, NEUROIMAGE-CLIN, V9, P401, DOI 10.1016/j.nicl.2015.09.004; Konstantinidis I, 2013, LARYNGOSCOPE, V123, pE85, DOI 10.1002/lary.24390; Langdon C, 2018, J NEUROTRAUM, V35, P2641, DOI 10.1089/neu.2017.5230; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Negoias S, 2017, BRAIN IMAGING BEHAV, V11, P998, DOI 10.1007/s11682-016-9567-9; Patel ZM, 2017, CURR OPIN OTOLARYNGO, V25, P43, DOI 10.1097/MOO.0000000000000328; Pellegrino R, 2019, LARYNGOSCOPE, V129, P1737, DOI 10.1002/lary.27832; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Whitcroft KL, 2019, JAMA OTOLARYNGOL, V145, P846, DOI 10.1001/jamaoto.2019.1728	20	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	SEP 1	2020	140	9					761	767		10.1080/00016489.2020.1767301		MAY 2020	7	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	NH9DJ	WOS:000545714100001	32491937	hybrid			2022-02-06	
J	Yuan, XY; Luo, QQ; Shen, LH; Chen, J; Gan, DQ; Sun, YC; Ding, LZ; Wang, GH				Yuan, Xiaoyu; Luo, Qianqian; Shen, Lihua; Chen, Jin; Gan, Deqiang; Sun, Yechao; Ding, Lingzhi; Wang, Guohua			Hypoxic preconditioning enhances the differentiation of bone marrow stromal cells into mature oligodendrocytes via the mTOR/HIF-1 alpha/VEGF pathway in traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						bone marrow stromal cells; hypoxic preconditioning; oligodendrogenesis; remyelination; traumatic brain injury	MESENCHYMAL STEM-CELLS; MAMMALIAN TARGET; RAPAMYCIN; PROMOTES; NEUROPROTECTION; TRANSPLANTATION; INHIBITION; RECOVERY; STROKE; DEATH	Objective Traumatic brain injury (TBI) results not only in gray matter damage, but also in severe white matter injury (WMI). Previous findings support hypoxic preconditioning (HP) could augment the efficacy of bone marrow stromal cell (BMSC) transplantation in a TBI mouse model. However, whether HP-treated BMSCs (H-BMSCs) could overcome remyelination failure after WMI is unclear, and the molecular mechanisms remain to be explored. Here, we focused on the therapeutic benefits of H-BMSC transplantation for treating WMI, as well as its underlying mechanisms. Methods In vitro, BMSCs were incubated at passage 4 in the hypoxic preconditioning (1.0% oxygen) for 8 hr. In vivo, a TBI mouse model was established, and DMEM cell culture medium (control), normal cultured BMSCs (N-BMSCs), or H-BMSCs were transplanted to mice 24 hr afterward. Neurobehavioral function, histopathological changes, and oligodendrogenesis were assessed for up to 35 days post-TBI. Results Compared with the control group, improvement of cognitive functions and smaller lesion volumes was observed in the two BMSC-transplanted groups, especially the H-BMSC group. H-BMSC transplantation resulted in a greater number of neural/glial antigen 2 (NG2)-positive and adenomatous polyposis coli (APC)-positive cells than N-BMSC transplantation in both the corpus callosum and the striatum. In addition, we observed that the expression levels of hypoxia-inducible factor-1a (HIF-1 alpha), phosphorylated mechanistic target of rapamycin (p-mTOR), and vascular endothelial growth factor (VEGF) were all increased in H-BMSC-transplanted mice. Furthermore, the mTOR pathway inhibitor rapamycin attenuated the impact of HP both in vivo and in vitro. Conclusion The results provided mechanistic evidences suggesting that HP-treated BMSCs promoted remyelination partly by modulating the pro-survival mTOR/HIF-1 alpha/VEGF signaling pathway.	[Yuan, Xiaoyu; Luo, Qianqian; Gan, Deqiang; Sun, Yechao; Ding, Lingzhi; Wang, Guohua] Nantong Univ, Dept Neurophysiol & Neuropharmacol, Inst Special Environm Med & Coinnovat, Ctr Neuroregenerat, 9 Seyuan Rd, Nantong 226019, Jiangsu, Peoples R China; [Yuan, Xiaoyu] Nantong Univ, Dept Emergency, Affiliated Hosp, Nantong, Peoples R China; [Shen, Lihua; Chen, Jin] Nantong Univ, Dept Neurol, Affiliated Hosp, 20 XiSi Rd, Nantong 226001, Peoples R China		Wang, GH (corresponding author), Nantong Univ, Dept Neurophysiol & Neuropharmacol, Inst Special Environm Med & Coinnovat, Ctr Neuroregenerat, 9 Seyuan Rd, Nantong 226019, Jiangsu, Peoples R China.; Shen, LH (corresponding author), Nantong Univ, Dept Neurol, Affiliated Hosp, 20 XiSi Rd, Nantong 226001, Peoples R China.	lihuashen139@yeah.net; wgh036@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471257, 81873924]; Nantong Science and Technology Project [MS12018030, MS12018048]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20161283]	National Natural Science Foundation of China, Grant/Award Number: 81471257 and 81873924; Nantong Science and Technology Project, Grant/Award Number: MS12018030 and MS12018048; Natural Science Foundation of Jiangsu Province, Grant/Award Number: BK20161283	Buzoianu-Anguiano V, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/389520; Carbonara M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00885; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chen J, 2017, CELL MOL NEUROBIOL, V37, P1115, DOI 10.1007/s10571-016-0445-1; Cui QL, 2007, J NEUROCHEM, V100, P1480, DOI 10.1111/j.1471-4159.2006.04329.x; Deng WM, 2004, EXP HEMATOL, V32, P861, DOI 10.1016/j.exphem.2004.06.009; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Feng YZ, 2015, INT J DEV NEUROSCI, V44, P6, DOI 10.1016/j.ijdevneu.2015.04.010; Goncalves MB, 2018, NEUROBIOL DIS, V111, P70, DOI 10.1016/j.nbd.2017.12.016; Guo X, 2010, ONCOGENE, V29, P3908, DOI 10.1038/onc.2010.143; Hu JN, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1210-4; Huang W, 2013, NEUROL RES, V35, P320, DOI 10.1179/1743132812Y.0000000151; Javazon EH, 2001, STEM CELLS, V19, P219, DOI 10.1634/stemcells.19-3-219; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Li HZ, 2016, ANN NY ACAD SCI, V1370, P109, DOI 10.1111/nyas.13102; Luo QQ, 2018, J CELL PHYSIOL, V233, P30, DOI 10.1002/jcp.25931; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Neirinckx V, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0202-2; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Shein NA, 2011, MOL MED, V17, P448, DOI 10.2119/molmed.2011.00038; Shen Q, 2016, CELL PHYSIOL BIOCHEM, V38, P748, DOI 10.1159/000443031; Sun JM, 2015, EXP NEUROL, V272, P78, DOI 10.1016/j.expneurol.2015.03.011; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang FW, 2015, EUR J PHARMACOL, V748, P157, DOI 10.1016/j.ejphar.2014.09.033; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang XW, 2016, EXP BIOL MED, V241, P177, DOI 10.1177/1535370215600548; Zhang HL, 2018, BRAIN RES, V1680, P143, DOI 10.1016/j.brainres.2017.12.017; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	31	3	5	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JUL	2020	10	7							e01675	10.1002/brb3.1675		MAY 2020	12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	MT3MI	WOS:000536336100001	32475084	Green Published, gold			2022-02-06	
J	Liktor-Busa, E; Blawn, KT; Kellohen, KL; Wiese, BM; Verkhovsky, V; Wahl, J; Vivek, A; Palomino, SM; Davis, TP; Vanderah, TW; Largent-Milnes, TM				Liktor-Busa, Erika; Blawn, Kiera T.; Kellohen, Kathryn L.; Wiese, Beth M.; Verkhovsky, Vani; Wahl, Jared; Vivek, Anjali; Palomino, Seph M.; Davis, Thomas P.; Vanderah, Todd W.; Largent-Milnes, Tally M.			Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake	PLOS ONE			English	Article							CORTICAL SPREADING DEPRESSION; SPINAL NA+/H+ EXCHANGER; INTRACELLULAR PH; ISOFORM 1; INFLAMMATORY PAIN; NEURONAL DEATH; IN-VITRO; MIGRAINE; ALLODYNIA; HEADACHE	Disruption of blood-brain barrier integrity and dramatic failure of brain ion homeostasis including fluctuations of pH occurs during cortical spreading depression (CSD) events associated with several neurological disorders, including migraine with aura, traumatic brain injury and stroke. NHE1 is the primary regulator of pH in the central nervous system. The goal of the current study was to investigate the role of sodium-hydrogen exchanger type 1 (NHE1) in blood brain barrier (BBB) integrity during CSD events and the contributions of this antiporter on xenobiotic uptake. Using immortalized cell lines, pharmacologic inhibition and genetic knockdown of NHE1 mitigated the paracellular uptake of radiolabeled sucrose implicating functional NHE1 in BBB maintenance. In contrast, loss of functional NHE1 in endothelial cells facilitated uptake of the anti-migraine therapeutic, sumatriptan. In female rats, cortical KCI but not aCSF selectively reduced total expression of NHE1 in cortex and PAG but increased expression in trigeminal ganglia; no changes were seen in trigeminal nucleus caudalis. Thus, in vitro observations may have a significance in vivo to increase brain sumatriptan levels. Pharmacological inhibition of NHE1 prior to cortical manipulations enhanced the efficacy of sumatriptan at early time-points but induced facial sensitivity alone. Overall, our results suggest that dysregulation of NHE1 contributes to breaches in BBB integrity, drug penetrance, and the behavioral sensitivity to the antimigraine agent, sumatriptan.	[Liktor-Busa, Erika; Blawn, Kiera T.; Kellohen, Kathryn L.; Wiese, Beth M.; Verkhovsky, Vani; Wahl, Jared; Vivek, Anjali; Palomino, Seph M.; Davis, Thomas P.; Vanderah, Todd W.; Largent-Milnes, Tally M.] Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA		Largent-Milnes, TM (corresponding author), Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA.	tlargent@email.arizona.edu		palomino, seph/0000-0001-8730-3271	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099292]; Arizona Biomedical Research Commission [ABRC45952]; Department of Pharmacology at the University of Arizona	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (R01NS099292, TML) of the National Institutes of Health, Arizona Biomedical Research Commission (ABRC45952, TML), and with monies from the Department of Pharmacology at the University of Arizona. Authors are solely responsible for the content which does not necessarily represent the official views of the National Institutes of Health, the State of Arizona, or the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Patricia Jansma in the Imaging Core Marley at the University of Arizona for her assistance in collecting live cell images and the Delamere and Porreca labs for use of their LiCor developer.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Andrew RD, 2017, J CEREBR BLOOD F MET, V37, P1735, DOI 10.1177/0271678X16657344; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Ayata C, 2010, HEADACHE, V50, P725, DOI 10.1111/j.1526-4610.2010.01647.x; Begum G, 2018, GLIA, V66, P126, DOI 10.1002/glia.23232; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Beydoun R, 2017, J BIOL CHEM, V292, P4293, DOI 10.1074/jbc.M116.769240; Bkaily G, 2004, CAN J PHYSIOL PHARM, V82, P805, DOI 10.1139/Y04-119; Blicher JU, 2016, CEPHALALGIA, V36, P279, DOI 10.1177/0333102415586064; Brennan KC, 2007, J NEUROPHYSIOL, V97, P4143, DOI 10.1152/jn.00028.2007; Bressler J, 2013, METHODS MOL BIOL, V1066, P67, DOI 10.1007/978-1-62703-604-7_6; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Burstein R, 2004, ANN NEUROL, V55, P19, DOI 10.1002/ana.10786; Burton WN, 2002, J OCCUP ENVIRON MED, V44, P523, DOI 10.1097/00043764-200206000-00013; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Castaneda-Corral G, 2012, BRAIN RES, V1475, P19, DOI 10.1016/j.brainres.2012.08.001; Castaneda-Corral G, 2011, NEUROSCI LETT, V501, P4, DOI 10.1016/j.neulet.2011.06.048; Charles Andrew, 2010, Handb Clin Neurol, V97, P99, DOI 10.1016/S0072-9752(10)97007-3; Charles AC, 2013, NAT REV NEUROL, V9, P637, DOI 10.1038/nrneurol.2013.192; Costa C, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-62; Cottier Karissa E, 2018, eNeuro, V5, DOI 10.1523/ENEURO.0116-18.2018; Crimi E, 2012, J CRIT CARE, V27, P108, DOI 10.1016/j.jcrc.2011.06.001; CSIBA L, 1985, BRAIN RES, V336, P167, DOI 10.1016/0006-8993(85)90430-5; del Rio MS, 2004, LANCET NEUROL, V3, P645, DOI 10.1016/S1474-4422(04)00904-4; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1, DOI [10.1038/jcbfm.2009.252, 10.1038/jcbfm.2010.191]; Dreier JP, 2005, NEUROLOGY, V64, P2145, DOI 10.1212/01.WNL.0000176298.63840.99; Ebner TJ, 2003, NEUROSCIENTIST, V9, P37, DOI 10.1177/1073858402239589; Edelmayer RM, 2012, METHODS MOL BIOL, V851, P109, DOI 10.1007/978-1-61779-561-9_7; Edelmayer RM, 2009, ANN NEUROL, V65, P184, DOI 10.1002/ana.21537; Edvinsson L, 2008, CEPHALALGIA, V28, P1245, DOI 10.1111/j.1468-2982.2008.01675.x; Elbrecht D.H., 2016, J RARE DIS RES TREAT, V1, P46, DOI [10.29245/2572-9411/2016/3.1026, DOI 10.29245/2572-9411/2016/3.1026]; Fioravanti B, 2011, CEPHALALGIA, V31, P1090, DOI 10.1177/0333102411410609; Fried NT, 2018, CEPHALALGIA, V38, P674, DOI 10.1177/0333102417703764; GAULT LM, 1994, BRAIN RES, V641, P176, DOI 10.1016/0006-8993(94)91835-X; Gentile S, 2009, CEPHALALGIA, V29, P687, DOI 10.1111/j.1468-2982.2008.01803.x; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Jakubowski M, 2005, NEUROLOGY, V65, P1419, DOI 10.1212/01.wnl.0000183358.53939.38; Lam TI, 2013, P NATL ACAD SCI USA, V110, pE4362, DOI 10.1073/pnas.1313029110; Lam TI, 2009, AM J PHYSIOL-CELL PH, V297, pC278, DOI 10.1152/ajpcell.00093.2009; Lochhead JJ, 2017, AAPS J, V19, P910, DOI 10.1208/s12248-017-0076-6; Lourenco CF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07119-6; Luo J, 2005, J NEUROSCI, V25, P11256, DOI 10.1523/JNEUROSCI.3271-05.2005; Mainero C, 2011, ANN NEUROL, V70, P838, DOI 10.1002/ana.22537; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Mason BN, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00233; McCaffrey G, 2007, J NEUROCHEM, V103, P2540, DOI 10.1111/j.1471-4159.2007.04943.x; Menyhart A, 2017, AM J PHYSIOL-HEART C, V313, pH328, DOI 10.1152/ajpheart.00222.2017; MOSKOWITZ MA, 1984, ANN NEUROL, V16, P157, DOI 10.1002/ana.410160202; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; NAGY Z, 1985, ACTA NEUROPATHOL, V68, P160, DOI 10.1007/BF00688639; Obrenovitch TP, 2002, J CEREBR BLOOD F MET, V22, P680, DOI 10.1097/00004647-200206000-00006; OLDENDORF W, 1979, STROKE, V10, P577, DOI 10.1161/01.STR.10.5.577; Olesen J, 2018, LANCET NEUROL, V17, P396, DOI 10.1016/S1474-4422(18)30085-1; Park SL, 2010, BRAIN RES, V1366, P189, DOI 10.1016/j.brainres.2010.09.077; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; RAPOPORT SI, 1964, J PHYSIOL-LONDON, V170, P238, DOI 10.1113/jphysiol.1964.sp007327; RASMUSSEN BK, 1992, CEPHALALGIA, V12, P221, DOI 10.1046/j.1468-2982.1992.1204221.x; Reinhold AK, 2017, PFLUG ARCH EUR J PHY, V469, P123, DOI 10.1007/s00424-016-1920-8; Rocha-Gonzalez HI, 2009, NEUROSCIENCE, V160, P156, DOI 10.1016/j.neuroscience.2009.02.033; Ruffin VA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00043; Schwedt TJ, 2014, PAIN MED, V15, P154, DOI 10.1111/pme.12267; Shi YJ, 2011, J NEUROCHEM, V119, P124, DOI 10.1111/j.1471-4159.2011.07403.x; Sinning A, 2013, FEBS LETT, V587, P1923, DOI 10.1016/j.febslet.2013.04.045; Somjen GG, 2005, J NEUROPHYSIOL, V94, P2, DOI 10.1152/classicessays.00031.2005; Song HC, 2019, CELL TRANSPLANT, V28, P985, DOI 10.1177/0963689719834873; Song SS, 2018, GLIA, V66, P2279, DOI 10.1002/glia.23456; Steen KH, 1999, EUR J NEUROSCI, V11, P2783, DOI 10.1046/j.1460-9568.1999.00695.x; Sun XL, 2011, NEUROIMAGE, V57, P873, DOI 10.1016/j.neuroimage.2011.05.040; Tfelt-Hansen PC, 2010, CEPHALALGIA, V30, P780, DOI 10.1111/j.1468-2982.2009.02015.x; Tietjen GE, 2009, HEADACHE, V49, P1333, DOI 10.1111/j.1526-4610.2009.01521.x; Tome ME, 2018, J CEREBR BLOOD F MET, V38, P2209, DOI 10.1177/0271678X18803623; Torres-Lopez JE, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/217864; Vgontzas A, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0735-z; Viana M, 2013, CEPHALALGIA, V33, P891, DOI 10.1177/0333102413480756; Willis CL, 2008, CURR PHARM DESIGN, V14, P1625, DOI 10.2174/138161208784705414; Witt KA, 2001, PEPTIDES, V22, P2329, DOI 10.1016/S0196-9781(01)00537-X; Wong Andrew D, 2013, Front Neuroeng, V6, P7, DOI 10.3389/fneng.2013.00007; Xiong ZQ, 2000, J NEUROPHYSIOL, V83, P3519, DOI 10.1152/jn.2000.83.6.3519; Yamazaki T, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00078; Yao H, 1999, J CLIN INVEST, V104, P637, DOI 10.1172/JCI6785; Yuen NY, 2019, J CEREBR BLOOD F MET, V39, P1678, DOI 10.1177/0271678X18770844; Zhang XC, 2010, J NEUROSCI, V30, P8807, DOI 10.1523/JNEUROSCI.0511-10.2010; Zhao HS, 2016, PROG NEUROBIOL, V138, P19, DOI 10.1016/j.pneurobio.2016.02.002; Zhao HN, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0158-3	88	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							0227463	10.1371/journal.pone.0227463			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	WOS:000537552800007	32469979	Green Published, Green Submitted, gold			2022-02-06	
J	Haagsma, JA; Spronk, I; de Jongh, MAC; Bonsel, GJ; Polinder, S				Haagsma, Juanita A.; Spronk, Inge; de Jongh, Mariska A. C.; Bonsel, Gouke J.; Polinder, Suzanne			Conventional and retrospective change in health-related quality of life of trauma patients: an explorative observational follow-up study	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article						Health-related quality of life; Mental recall; Wounds and injuries; Brain injuries traumatic	RESPONSE SHIFT; REPORTED OUTCOMES; OLDER-ADULTS; RECALL; EUROQOL; INJURY; CARE	Background Within trauma care measurement of changes in health-related quality of life (HRQL) is used in understanding patterns of recovery over time. However, conventionally-measured change in HRQL may not always reflect the change in HRQL as perceived by the patient. Recall bias and response shift may contribute to disagreement between conventional and retrospective change in HRQL. This study aimed to measure conventional and retrospective change of HRQL and assess to which extent recall bias and response shift contribute to disagreement between these two in a heterogeneous sample of adult trauma patients. Methods A sample of trauma patients (>= 18 years) who attended the Emergency Department and were admitted to an Intensive Care unit or ward of one of ten Dutch hospitals received postal questionnaires 1 week (T1) and 3 months (T2) post-injury. At T1 and T2 participants completed the EQ-5D-3 L and EQ-VAS for their current health status. At T2 participants also filled out a recall and then-test regarding their health status at T1. The responses were used to assess conventional and retrospective change, recall bias and response shift. Wilcoxon signed rank tests were used to examine conventional and retrospective change on a group level. The intraclass correlation coefficient (ICC) was used to examine individual agreement between conventional and retrospective change. Uni- and multivariate linear regression analysis were used to investigate the association between background factors and recall bias and response shift. Results The EQ-5D-3 L, recall and then-test were completed by 550 patients. Mean EQ-5D-3 L summary score improved from 0.48 at T1 to 0.74 at T2. Mean EQ-VAS score improved from 56 at T1 to 73 at T2. Retrospective change was significantly higher than conventional change (EQ-5D-3 L: Z = -5.2, p < 0.05; EQ-VAS Z = -2.1, p < 0.05). Pairwise comparisons showed that agreement between conventional and retrospective change was fair (EQ-5D-3 L: ICC = 0.49; EQ-VAS: ICC = 0.48). For EQ-5-3 L response shift was significantly higher than recall bias (Z = - 4.5, p < 0.05). Patients with traumatic brain injury (TBI), severe injury and/or posttraumatic stress symptoms were more susceptible to recall bias and response shift. Conclusions We conclude that, compared to recall bias, response shift contributed more to the disagreement between conventional and retrospective change in EQ-5D-3 L summary score and EQ-VAS. Predictable subgroups of trauma patients were more susceptible to recall bias and response shift.	[Haagsma, Juanita A.; Spronk, Inge; Bonsel, Gouke J.; Polinder, Suzanne] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Spronk, Inge] Maasstad Hosp, Assoc Dutch Burn Ctr, Rotterdam, Netherlands; [de Jongh, Mariska A. C.] ETZ Hosp, Dept Trauma TopCare, Tilburg, Netherlands		Haagsma, JA (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.haagsma@erasmusmc.nl	Spronk, Inge/AAZ-5905-2020	Spronk, Inge/0000-0001-9571-576X	EuroQoL group [2016160]	This study was funded by the EuroQoL group (Grant number EQ Project 2016160).	Agborsangaya CB, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-74; Ahmed S, 2004, J CLIN EPIDEMIOL, V57, P561, DOI 10.1016/j.jclinepi.2003.11.003; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brahmer JR, 2017, LANCET ONCOL, V18, P1600, DOI 10.1016/S1470-2045(17)30690-3; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Centraal Bureau voor de Statistiek, 2003, PERM OND LEEFS; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; de Jongh MAC, 2017, INJURY PREV, V23, P59, DOI 10.1136/injuryprev-2016-042032; Dhanda R, 2019, PATIENT PREFER ADHER, V13, P1037, DOI 10.2147/PPA.S202173; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Fanning J, 2018, J BEHAV MED, V41, P299, DOI 10.1007/s10865-017-9903-6; Gabbe BJ, 2016, ANN SURG, V263, P623, DOI 10.1097/SLA.0000000000001564; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Haagsma J, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1139-4; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Howell J, 2008, J ARTHROPLASTY, V23, P843, DOI 10.1016/j.arth.2007.07.020; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Janssen MF, 2018, PHARMACOECONOMICS, V36, P675, DOI 10.1007/s40273-018-0623-8; Khalil JG, 2019, SPINE J, V19, P1620, DOI 10.1016/j.spinee.2019.05.598; Kwong E, 2018, QUAL LIFE RES, V27, P1845, DOI 10.1007/s11136-018-1823-6; Liimatta H, 2019, SCAND J PRIM HEALTH, V37, P90, DOI 10.1080/02813432.2019.1569372; Litwin MS, 1999, J CLIN ONCOL, V17, P2882, DOI 10.1200/JCO.1999.17.9.2882; McPhail S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-65; Mosby, 2012, MOSBYS MED DICT; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Schmier Jordana K, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P159, DOI 10.1586/14737167.4.2.159; Schuitevoerder S, 2013, J ANXIETY DISORD, V27, P550, DOI 10.1016/j.janxdis.2013.01.001; Schwartz CE, 2004, PSYCHOL HEALTH, V19, P51, DOI 10.1080/0887044031000118456; Schwartz CE, 1999, SOC SCI MED, V48, P1531, DOI 10.1016/S0277-9536(99)00047-7; Silverberg ND, 2016, J HEAD TRAUMA REHAB, V31, P388, DOI 10.1097/HTR.0000000000000198; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Stull DE, 2009, CURR MED RES OPIN, V25, P929, DOI 10.1185/03007990902774765 ; Sullivan M, 2003, SOC SCI MED, V56, P1595, DOI 10.1016/S0277-9536(02)00159-4; Topp J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032859; Wohlfarth TD, 2003, PSYCHOL ASSESSMENT, V15, P101, DOI 10.1037/1040-3590.15.1.101	41	3	3	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1477-7525		HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	MAY 27	2020	18	1							157	10.1186/s12955-020-01404-1			13	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	LU8RR	WOS:000538016600002	32460896	Green Published, gold			2022-02-06	
